PMID,OWN,STAT,DCOM,LR,IS,VI,DP,TI,PG,LID,AB,FAU,AU,AUID,AD,LA,PT,DEP,PL,TA,JT,JID,RN,SB,MH,PMC,EDAT,MHDA,CRDT,PHST,AID,PST,SO,IP,CI,OTO,OT,COIS,CIN,GR,RF,CON,TT,MID,OID,OAB,OABL,GN,PMCR,EIN,CN,FIR,IR,PS,FPS,SI
27525287,NLM,MEDLINE,20170306,20220310,2314-7156 (Electronic) 2314-8861 (Print) 2314-7156 (Linking),2016,2016,"Dengue Fever: Causes, Complications, and Vaccine Strategies.",6803098,10.1155/2016/6803098 [doi] 6803098,"Dengue is a highly endemic infectious disease of the tropical countries and is rapidly becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is transmitted within humans through female Aedes mosquitoes. Dengue disease varies from mild fever to severe conditions of dengue hemorrhagic fever and shock syndrome. Globalization, increased air travel, and unplanned urbanization have led to increase in the rate of infection and helped dengue to expand its geographic and demographic distribution. Dengue vaccine development has been a challenging task due to the existence of four antigenically distinct dengue virus serotypes, each capable of eliciting cross-reactive and disease-enhancing antibody response against the remaining three serotypes. Recently, Sanofi Pasteur's chimeric live-attenuated dengue vaccine candidate has been approved in Mexico, Brazil, and Philippines for usage in adults between 9 and 45 years of age. The impact of its limited application to the public health system needs to be evaluated. Simultaneously, the restricted application of this vaccine candidate warrants continued efforts in developing a dengue vaccine candidate which is additionally efficacious for infants and naive individuals. In this context, alternative strategies of developing a designed vaccine candidate which does not allow production of enhancing antibodies should be explored, as it may expand the umbrella of efficacy to include infants and naive individuals.","['Khetarpal, Niyati', 'Khanna, Ira']","['Khetarpal N', 'Khanna I']",['ORCID: 0000-0003-1848-0631'],"['International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India; Department of Biochemistry, University of Delhi, Institute of Home Economics, Hauz Khas, New Delhi 110016, India.', 'International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India.']",['eng'],"['Journal Article', 'Review']",20160720,Egypt,J Immunol Res,Journal of immunology research,101627166,['0 (Dengue Vaccines)'],IM,"['Animals', 'Clinical Trials as Topic', 'Dengue/*diagnosis/epidemiology/etiology/*prevention & control', 'Dengue Vaccines/classification/genetics/immunology', 'Dengue Virus/*physiology', 'Disease Management', 'Humans', 'Outcome Assessment, Health Care']",PMC4971387,2016/08/16 06:00,2017/03/07 06:00,['2016/08/16 06:00'],"['2016/03/14 00:00 [received]', '2016/05/18 00:00 [revised]', '2016/06/01 00:00 [accepted]', '2016/08/16 06:00 [entrez]', '2016/08/16 06:00 [pubmed]', '2017/03/07 06:00 [medline]']",['10.1155/2016/6803098 [doi]'],ppublish,J Immunol Res. 2016;2016:6803098. doi: 10.1155/2016/6803098. Epub 2016 Jul 20.,,,,,,,,,,,,,,,,,,,,,,,
9665979,NLM,MEDLINE,19981005,20231105,0893-8512 (Print) 1098-6618 (Electronic) 0893-8512 (Linking),11,1998 Jul,Dengue and dengue hemorrhagic fever.,480-96,,"Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic fever in new geographic regions. In 1998 this mosquito-borne disease is the most important tropical infectious disease after malaria, with an estimated 100 million cases of dengue fever, 500,000 cases of dengue hemorrhagic fever, and 25,000 deaths annually. The reasons for this resurgence and emergence of dengue hemorrhagic fever in the waning years of the 20th century are complex and not fully understood, but demographic, societal, and public health infrastructure changes in the past 30 years have contributed greatly. This paper reviews the changing epidemiology of dengue and dengue hemorrhagic fever by geographic region, the natural history and transmission cycles, clinical diagnosis of both dengue fever and dengue hemorrhagic fever, serologic and virologic laboratory diagnoses, pathogenesis, surveillance, prevention, and control. A major challenge for public health officials in all tropical areas of the world is to develop and implement sustainable prevention and control programs that will reverse the trend of emergent dengue hemorrhagic fever.","['Gubler, D J']",['Gubler DJ'],,"['Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80522, USA. djg2@cdc.gov']",['eng'],"['Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,['0 (Viral Vaccines)'],IM,"['Dengue/diagnosis/epidemiology/immunology/prevention & control/*virology', 'Dengue Virus/immunology/isolation & purification/physiology', 'Humans', 'Incidence', 'Latin America/epidemiology', 'Severe Dengue/diagnosis/epidemiology/immunology/prevention & control/*virology', 'Travel', 'United States/epidemiology', 'Viral Vaccines/therapeutic use']",PMC88892,1998/07/17 00:00,1998/07/17 00:01,['1998/07/17 00:00'],"['1998/07/17 00:00 [pubmed]', '1998/07/17 00:01 [medline]', '1998/07/17 00:00 [entrez]']","['0020 [pii]', '10.1128/CMR.11.3.480 [doi]']",ppublish,Clin Microbiol Rev. 1998 Jul;11(3):480-96. doi: 10.1128/CMR.11.3.480.,3,,,,,,,,,,,,,,,,,,,,,,
35078789,NLM,MEDLINE,20220325,20220325,1473-4893 (Electronic) 1470-2118 (Print) 1470-2118 (Linking),22,2022 Jan,"Dengue infection: Global importance, immunopathology and management.",9-13,10.7861/clinmed.2021-0791 [doi],"Dengue is an arboviral infection that is hyperendemic in tropical and subtropical climates. Clinical manifestations of dengue can range from asymptomatic infection to severe infection with multi-organ failure. Dengue haemorrhagic fever (DHF) is a subcategory in dengue infection with a hallmark of plasma leak (ie critical phase). The plasma leak in DHF is selective (pleuroperitoneal spaces), transient and dynamic, and needs careful monitoring and meticulous fluid resuscitation. In addition, dengue fever may present with extended and unusual manifestations affecting any organ, including the heart, liver, kidney and brain. Studies on vaccine development and vector control are ongoing to prevent this infection of global importance. In this article, the clinicopathological features and management aspects of dengue are discussed.","['Kularatne, Senanayake Abeysinghe', 'Dalugama, Chamara']","['Kularatne SA', 'Dalugama C']",,"['University of Peradeniya, Peradeniya, Sri Lanka tbn1917@gmail.com.', 'University of Peradeniya, Peradeniya, Sri Lanka.']",['eng'],['Journal Article'],,England,Clin Med (Lond),"Clinical medicine (London, England)",101092853,,IM,"['*Dengue/diagnosis/therapy', 'Fluid Therapy', 'Humans', '*Severe Dengue']",PMC8813012,2022/01/27 06:00,2022/03/26 06:00,['2022/01/26 05:28'],"['2022/01/26 05:28 [entrez]', '2022/01/27 06:00 [pubmed]', '2022/03/26 06:00 [medline]']","['22/1/9 [pii]', 'clinmedicine [pii]', '10.7861/clinmed.2021-0791 [doi]']",ppublish,Clin Med (Lond). 2022 Jan;22(1):9-13. doi: 10.7861/clinmed.2021-0791.,1,['(c) Royal College of Physicians 2022. All rights reserved.'],['NOTNLM'],"['Aedes', 'Dengue haemorrhagic fever', 'NS1', 'critical phase', 'flavivirus', 'plasma leak']",,,,,,,,,,,,,,,,,,,
35543085,NLM,MEDLINE,20220602,20220915,1098-4275 (Electronic) 0031-4005 (Linking),149,2022 Jun 1,Dengue: A Growing Problem With New Interventions.,,e2021055522 [pii] 10.1542/peds.2021-055522 [doi],"Dengue is the disease caused by 1 of 4 distinct, but closely related dengue viruses (DENV-1-4) that are transmitted by Aedes spp. mosquito vectors. It is the most common arboviral disease worldwide, with the greatest burden in tropical and sub-tropical regions. In the absence of effective prevention and control measures, dengue is projected to increase in both disease burden and geographic range. Given its increasing importance as an etiology of fever in the returning traveler or the possibility of local transmission in regions in the United States with competent vectors, as well as the risk for large outbreaks in endemic US territories and associated states, clinicians should understand its clinical presentation and be familiar with appropriate testing, triage, and management of patients with dengue. Control and prevention efforts reached a milestone in June 2021 when the Advisory Committee on Immunization Practices (ACIP) recommended Dengvaxia for routine use in children aged 9 to 16 years living in endemic areas with laboratory confirmation of previous dengue virus infection. Dengvaxia is the first vaccine against dengue to be recommended for use in the United States and one of the first to require laboratory testing of potential recipients to be eligible for vaccination. In this review, we outline dengue pathogenesis, epidemiology, and key clinical features for front-line clinicians evaluating patients presenting with dengue. We also provide a summary of Dengvaxia efficacy, safety, and considerations for use as well as an overview of other potential new tools to control and prevent the growing threat of dengue .","['Wong, Joshua M', 'Adams, Laura E', 'Durbin, Anna P', 'Munoz-Jordan, Jorge L', 'Poehling, Katherine A', 'Sanchez-Gonzalez, Liliana M', 'Volkman, Hannah R', 'Paz-Bailey, Gabriela']","['Wong JM', 'Adams LE', 'Durbin AP', 'Munoz-Jordan JL', 'Poehling KA', 'Sanchez-Gonzalez LM', 'Volkman HR', 'Paz-Bailey G']",,"['Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Wake Forest School of Medicine, Winston-Salem, North Carolina.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatrics,Pediatrics,0376422,,IM,"['*Aedes', 'Animals', '*Arbovirus Infections', 'Child', '*Dengue/diagnosis/epidemiology/prevention & control', 'Disease Outbreaks', 'Humans', 'Mosquito Vectors', 'United States/epidemiology']",,2022/05/12 06:00,2022/06/03 06:00,['2022/05/11 04:16'],"['2022/03/11 00:00 [accepted]', '2022/05/12 06:00 [pubmed]', '2022/06/03 06:00 [medline]', '2022/05/11 04:16 [entrez]']","['187012 [pii]', '10.1542/peds.2021-055522 [doi]']",ppublish,Pediatrics. 2022 Jun 1;149(6):e2021055522. doi: 10.1542/peds.2021-055522.,6,['Copyright (c) 2022 by the American Academy of Pediatrics.'],,,,,,,,,,,,,,,,,,,,,
35727463,NLM,MEDLINE,20220714,20220908,1534-6293 (Electronic) 1528-4042 (Print) 1528-4042 (Linking),22,2022 Aug,Neurological Complications of Dengue Fever.,515-529,10.1007/s11910-022-01213-7 [doi],"PURPOSE OF REVIEW: To discuss the neurological complications of dengue virus (DENV) infection and their pathogenesis. RECENT FINDINGS: Include recognition of the four different serotypes of DENV and their epidemiology as well as recognition of the expanded dengue syndrome encompassing multisystem involvement in the severe form of the disease including involvement of the central nervous system (CNS). DENV is a neurotropic virus with the ability to infect the supporting cells of the CNS. Neural injury during the acute stage of the infection results from direct neuro-invasion and/or the phenomenon of antibody-dependent enhancement, resulting in plasma leakage and coagulopathy. Immune mechanisms have been implicated in the development of the delayed neurological sequelae through molecular mimicry. A myriad of neurological syndromes has been described as a result of the involvement of the CNS, the peripheral nervous system (PNS), or both. Neurological manifestations in DENV infection are increasingly being recognized, some of which are potentially fatal if not treated promptly. DENV encephalopathy and encephalitis should be considered in the differential diagnosis of other acute febrile encephalopathies, autoimmune encephalitides, and in cases of encephalopathy/encephalitis related to SARS-CoV2 infection, especially in dengue-endemic areas. Acute disseminated encephalomyelitis (ADEM) may be occasionally encountered. Clinicians should be knowledgeable of the expanded dengue syndrome characterized by the concurrent compromise of cardiac, neurological, gastrointestinal, renal, and hematopopoietic systems. Isolated cranial nerve palsies occur rather uncommonly and are often steroid responsive. These neuropathies may result from the direct involvement of cranial nerve nuclei or nerve involvement or may be immune-mediated. Even if the diagnosis of dengue is confirmed, it is absolutely imperative to exclude other well-known causes of isolated cranial nerve palsies. Ischemic and hemorrhagic strokes may occur following dengue fever. The pathogenesis may be beyond the commonly observed thrombocytopenia and include cerebral vasculitis. Involvement of ocular blood vessels may cause maculopathy or retinal hemorrhages. Posterior reversible encephalopathy syndrome (PRES) is uncommon and possibly related to dysregulated cytokine release phenomena. Lastly, any patient developing acute neuromuscular weakness during the course or within a fortnight of remission from dengue fever must be screened for acute inflammatory demyelinating polyneuropathy (AIDP), hypokalemic paralysis, or acute myositis. Rarely, a Miller-Fisher-like syndrome with negative anti-GQ1b antibody may develop.","['Trivedi, Sweety', 'Chakravarty, Ambar']","['Trivedi S', 'Chakravarty A']",,"['Department of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, India.', 'Department of Neurology, Vivekananda Institute of Medical Science, Kolkata, India. saschakra@yahoo.com.']",['eng'],"['Journal Article', 'Review']",20220621,United States,Curr Neurol Neurosci Rep,Current neurology and neuroscience reports,100931790,"['0 (RNA, Viral)']",IM,"['*Brain Diseases', '*COVID-19', '*Dengue/complications/diagnosis/pathology', '*Encephalitis', 'Humans', '*Posterior Leukoencephalopathy Syndrome/complications', 'RNA, Viral', 'SARS-CoV-2']",PMC9210046,2022/06/22 06:00,2022/07/15 06:00,['2022/06/21 11:21'],"['2022/05/01 00:00 [accepted]', '2022/06/22 06:00 [pubmed]', '2022/07/15 06:00 [medline]', '2022/06/21 11:21 [entrez]']","['10.1007/s11910-022-01213-7 [pii]', '1213 [pii]', '10.1007/s11910-022-01213-7 [doi]']",ppublish,Curr Neurol Neurosci Rep. 2022 Aug;22(8):515-529. doi: 10.1007/s11910-022-01213-7. Epub 2022 Jun 21.,8,"['(c) 2022. The Author(s), under exclusive licence to Springer Science+Business', 'Media, LLC, part of Springer Nature.']",['NOTNLM'],"['Dengue hemorrhagic fever', 'Dengue shock syndrome', 'Dengue virus', 'Neurological complications of dengue']","['Sweety Trivedi and Ambar Chakravarty each declare no potential conflicts of', 'interest.']",,,,,,,,,,,,,,,,,,
25225163,NLM,MEDLINE,20150723,20151014,1532-2742 (Electronic) 0163-4453 (Linking),69 Suppl 1,2014 Nov,Dengue in children.,S77-86,S0163-4453(14)00232-1 [pii] 10.1016/j.jinf.2014.07.020 [doi],"Dengue is a mosquito-borne viral disease of expanding geographical range and increasing incidence. The vast majority of dengue cases are children less than 15 years of age. Dengue causes a spectrum of illness from mild fever to severe disease with plasma leakage and shock. Infants and children with secondary heterologous dengue infections are most at risk for severe dengue disease. Laboratory diagnosis of dengue can be established within five days of disease onset by direct detection of viral components in serum. After day five, serologic diagnosis provides indirect evidence of dengue. Currently, no effective antiviral agents are available to treat dengue infection. Therefore, treatment remains supportive, with emphasis on close hematological monitoring, recognition of warning signs of severe disease and fluid-replacement therapy and/or blood transfusions when required. Development of a dengue vaccine is considered a high public health priority. A safe and efficacious dengue vaccine would also be important for travelers. This review highlights the current understanding of dengue in children, including its clinical manifestations, pathogenesis, diagnostic tests, management and prevention.","['Verhagen, Lilly M', 'de Groot, Ronald']","['Verhagen LM', 'de Groot R']",,"['Department of Pediatrics, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Electronic address: lillyverhagen@hotmail.com.', 'Department of Pediatrics, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Electronic address: Ronald.deGroot@radboudumc.nl.']",['eng'],"['Journal Article', 'Review']",20140913,England,J Infect,The Journal of infection,7908424,,IM,"['Age Factors', 'Child', 'Dengue/*diagnosis/*epidemiology/immunology/prevention & control/transmission/virology', 'Dengue Virus/*physiology', 'Disease Management', 'Global Health', 'Humans', 'Travel']",,2014/09/17 06:00,2015/07/24 06:00,['2014/09/17 06:00'],"['2014/07/18 00:00 [accepted]', '2014/09/17 06:00 [entrez]', '2014/09/17 06:00 [pubmed]', '2015/07/24 06:00 [medline]']","['S0163-4453(14)00232-1 [pii]', '10.1016/j.jinf.2014.07.020 [doi]']",ppublish,J Infect. 2014 Nov;69 Suppl 1:S77-86. doi: 10.1016/j.jinf.2014.07.020. Epub 2014 Sep 13.,,"['Copyright (c) 2014 The British Infection Association. Published by Elsevier Ltd.', 'All rights reserved.']",['NOTNLM'],"['Aedes aegypti', 'Flavivirus', 'Hemorrhagic fever', 'Mosquito-transmitted disease']",,['J Infect. 2015 Sep;71(3):397-9. PMID: 25912612'],,,,,,,,,,,,,,,,,
21781999,NLM,MEDLINE,20120111,20220408,1873-2518 (Electronic) 0264-410X (Linking),29,2011 Sep 23,The pathogenesis of dengue.,7221-8,10.1016/j.vaccine.2011.07.022 [doi],"Dengue is an important cause of childhood and adult morbidity in Asian and Latin American countries and its geographic footprint is growing. The clinical manifestations of dengue are the expression of a constellation of host and viral factors, some acquired, others intrinsic to the individual. The virulence of the virus plus the flavivirus infection history, age, gender and genotype of the host all appear to help shape the severity of infection. Similarly, the characteristics of the innate and acquired host immune response subsequent to infection are also likely determinants of outcome. This review summarises recent developments in the understanding of dengue pathogenesis and their relevance to dengue vaccine development.","['Whitehorn, Jamie', 'Simmons, Cameron P']","['Whitehorn J', 'Simmons CP']",,"['Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.']",['eng'],"['Journal Article', 'Review']",20110721,Netherlands,Vaccine,Vaccine,8406899,,IM,"['Asia/epidemiology', 'Dengue/*epidemiology/immunology/*pathology/virology', 'Dengue Virus/immunology/*pathogenicity', 'Host-Pathogen Interactions', 'Humans', 'Latin America/epidemiology', 'Virulence']",,2011/07/26 06:00,2012/01/12 06:00,['2011/07/26 06:00'],"['2011/05/09 00:00 [received]', '2011/06/21 00:00 [revised]', '2011/07/06 00:00 [accepted]', '2011/07/26 06:00 [entrez]', '2011/07/26 06:00 [pubmed]', '2012/01/12 06:00 [medline]']","['S0264-410X(11)01043-7 [pii]', '10.1016/j.vaccine.2011.07.022 [doi]']",ppublish,Vaccine. 2011 Sep 23;29(42):7221-8. doi: 10.1016/j.vaccine.2011.07.022. Epub 2011 Jul 21.,42,['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
29690895,NLM,MEDLINE,20180925,20181114,1756-3305 (Electronic) 1756-3305 (Linking),11,2018 Apr 24,"History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review.",264,10.1186/s13071-018-2830-8 [doi] 264,"Dengue virus (DENV), an arbovirus transmitted by mosquitoes, has become a major threat to American human life, reaching approximately 23 million cases from 1980 to 2017. Brazil is among the countries most affected by this terrible viral disease, with 13.6 million cases. DENV has four different serotypes, DENV1-4, which show a broad clinical spectrum. Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector control strategies, early disease diagnostics and the development of vaccines and antiviral drugs are priorities. In this study, we present the probable origins of dengue in America and the trajectories of its spread. Overall, dengue diagnostics are costly, making the monitoring of dengue epidemiology more difficult and affecting physicians' therapeutic decisions regarding dengue patients, especially in developing countries. This review also highlights some recent and important findings regarding dengue in Brazil and the Americas. We also summarize the existing DENV polymerase chain reaction (PCR) diagnostic tests to provide an improved reference since these tests are useful and accurate at discriminating DENV from other flaviviruses that co-circulate in the Americas. Additionally, these DENV PCR assays ensure virus serotyping, enabling epidemiologic monitoring.","['Salles, Tiago Souza', 'da Encarnacao Sa-Guimaraes, Thayane', 'de Alvarenga, Evelyn Seam Lima', 'Guimaraes-Ribeiro, Victor', 'de Meneses, Marcelo Damiao Ferreira', 'de Castro-Salles, Patricia Faria', 'Dos Santos, Carlucio Rocha', 'do Amaral Melo, Ana Claudia', 'Soares, Marcia Regina', 'Ferreira, Davis Fernandes', 'Moreira, Monica Ferreira']","['Salles TS', 'da Encarnacao Sa-Guimaraes T', 'de Alvarenga ESL', 'Guimaraes-Ribeiro V', 'de Meneses MDF', 'de Castro-Salles PF', 'Dos Santos CR', 'do Amaral Melo AC', 'Soares MR', 'Ferreira DF', 'Moreira MF']",,"['Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Departamento de Virologia, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-590, Brazil.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Departamento de Virologia, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-590, Brazil.', 'Amil, Americas Medical City, Hospital Vitoria, Pediatria, Rio de Janeiro, RJ, 22775-001, Brazil.', 'Universidade Federal do Rio de Janeiro, Instituto de Bioquimica Medica, Rio de Janeiro, RJ, 21941-902, Brazil.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, Rio de Janeiro, 21941-902, RJ, Brazil.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil.', 'Departamento de Virologia, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-590, Brazil.', 'Department of Molecular and Structural Biochemistry, North Carolina State University, 120 W Broughton Dr, Raleigh, NC, USA.', 'Departamento de Bioquimica, Instituto de Quimica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ,, 21941-909, Brazil. monica@iq.ufrj.br.', 'Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, Rio de Janeiro, 21941-902, RJ, Brazil. monica@iq.ufrj.br.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20180424,England,Parasit Vectors,Parasites & vectors,101462774,,IM,"['Americas/epidemiology', 'Dengue/*diagnosis/*epidemiology/history/pathology', 'Dengue Virus/*isolation & purification', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Humans']",PMC5937836,2018/04/25 06:00,2018/09/27 06:00,['2018/04/26 06:00'],"['2017/11/30 00:00 [received]', '2018/04/03 00:00 [accepted]', '2018/04/26 06:00 [entrez]', '2018/04/25 06:00 [pubmed]', '2018/09/27 06:00 [medline]']","['10.1186/s13071-018-2830-8 [pii]', '2830 [pii]', '10.1186/s13071-018-2830-8 [doi]']",epublish,Parasit Vectors. 2018 Apr 24;11(1):264. doi: 10.1186/s13071-018-2830-8.,1,,['NOTNLM'],"['Dengue epidemiology', 'Dengue history', 'Dengue virus', 'Diagnostics of dengue', 'Serotyping']","['ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. COMPETING INTERESTS:', ""The authors declare that they have no competing interests. PUBLISHER'S NOTE:"", 'Springer Nature remains neutral with regard to jurisdictional claims in published', 'maps and institutional affiliations.']",,,,,,,,,,,,,,,,,,
35381822,NLM,MEDLINE,20220407,20220407,0972-9062 (Print) 0972-9062 (Linking),58,2021 Oct-Dec,Predictors of severe dengue amongst children as per the revised WHO classification.,329-334,10.4103/0972-9062.318312 [doi],"BACKGROUND & OBJECTIVES: World Health Organization (WHO) revised its guidelines for classification and management of dengue in 2009. This revised system was found out to have good sensitivity and negative predictive value but poor specificity as well as positive predictive value. METHODS: This retrospective study was carried out in a tertiary care hospital of Delhi, India to assess factors predicting the occurrence of severe dengue in children as per the revised classification. A total of 647 suspected dengue cases were admitted in the hospital in the year 2015. Detailed clinical and epidemiological data of 170 patients who were confirmed as dengue either by NS1 antigen test or by serology (Ig M positive) were recorded and statistically analyzed. RESULTS: The number of laboratory-confirmed cases was 170 and included thirty (17.65%) dengue fever (DF), 106 (62.35%) dengue with warning signs (DWS) and 34 (20.0%) severe dengue (SD) patients. Regression analysis revealed that presence of vomiting, altered sensorium, shock, peri-orbital edema, hepatomegaly, splenomegaly, severe anemia, thrombocytopenia, elevated urea and creatinine, decreased total protein and globulin were significantly associated with occurrence of severe disease. INTERPRETATION & CONCLUSION: The addition of clinical features (peri-orbital edema and splenomegaly); and laboratory findings (elevated urea and creatinine, decreased serum protein and globulin) might help improve the sensitivity and specificity of the revised WHO dengue classification in predicting severe dengue.","['Arora, Shilpa Khanna', 'Nandan, Devki', 'Sharma, Anu', 'Benerjee, Pronita', 'Singh, Dhirendra Pratap']","['Arora SK', 'Nandan D', 'Sharma A', 'Benerjee P', 'Singh DP']",,"['Department of Pediatrics, ABVIMS and Dr. RML Hospital, Delhi, India.', 'Department of Pediatrics, ABVIMS and Dr. RML Hospital, Delhi, India.', 'Department of Pediatrics, ABVIMS and Dr. RML Hospital, Delhi, India.', 'Department of Pediatrics, ABVIMS and Dr. RML Hospital, Delhi, India.', 'Department of Pediatrics, ABVIMS and Dr. RML Hospital, Delhi, India.']",['eng'],['Journal Article'],,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['Child', '*Dengue/complications/diagnosis/epidemiology', 'Humans', 'Retrospective Studies', 'Sensitivity and Specificity', '*Severe Dengue/complications/diagnosis/epidemiology', 'World Health Organization']",,2022/04/07 06:00,2022/04/08 06:00,['2022/04/06 03:31'],"['2022/04/06 03:31 [entrez]', '2022/04/07 06:00 [pubmed]', '2022/04/08 06:00 [medline]']","['JVectorBorneDis_2021_58_4_329_318312 [pii]', '10.4103/0972-9062.318312 [doi]']",ppublish,J Vector Borne Dis. 2021 Oct-Dec;58(4):329-334. doi: 10.4103/0972-9062.318312.,4,,['NOTNLM'],"['Children', 'Dengue', 'Predictors', 'Severe', 'WHO 2009']",['None'],,,,,,,,,,,,,,,,,,
24468533,NLM,MEDLINE,20141021,20220410,1878-4380 (Electronic) 0966-842X (Print) 0966-842X (Linking),22,2014 Mar,Global spread of dengue virus types: mapping the 70 year history.,138-46,S0966-842X(13)00273-4 [pii] 10.1016/j.tim.2013.12.011 [doi],"Since the first isolation of dengue virus (DENV) in 1943, four types have been identified. Global phenomena such as urbanization and international travel are key factors in facilitating the spread of dengue. Documenting the type-specific record of DENV spread has important implications for understanding patterns in dengue hyperendemicity and disease severity as well as vaccine design and deployment strategies. Existing studies have examined the spread of DENV types at regional or local scales, or described phylogeographic relationships within a single type. Here we summarize the global distribution of confirmed instances of each DENV type from 1943 to 2013 in a series of global maps. These show the worldwide expansion of the types, the expansion of disease hyperendemicity, and the establishment of an increasingly important infectious disease of global public health significance.","['Messina, Jane P', 'Brady, Oliver J', 'Scott, Thomas W', 'Zou, Chenting', 'Pigott, David M', 'Duda, Kirsten A', 'Bhatt, Samir', 'Katzelnick, Leah', 'Howes, Rosalind E', 'Battle, Katherine E', 'Simmons, Cameron P', 'Hay, Simon I']","['Messina JP', 'Brady OJ', 'Scott TW', 'Zou C', 'Pigott DM', 'Duda KA', 'Bhatt S', 'Katzelnick L', 'Howes RE', 'Battle KE', 'Simmons CP', 'Hay SI']",,"['Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK. Electronic address: jane.messina@zoo.ox.ac.uk.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Department of Entomology, University of California Davis, Davis, California 95616, USA; Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Department of Zoology, University of Cambridge, Cambridge, CB2 3EJ, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK.', 'Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Centre for Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK; Nossal Institute of Global Health, University of Melbourne, Parkville, Victoria, Australia.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK; Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",20140124,England,Trends Microbiol,Trends in microbiology,9310916,,IM,"['Dengue/*epidemiology/history/*transmission/virology', 'Dengue Virus/*classification/isolation & purification', 'History, 20th Century', 'History, 21st Century', '*Phylogeography', '*Topography, Medical']",PMC3946041,2014/01/29 06:00,2014/10/22 06:00,['2014/01/29 06:00'],"['2013/11/08 00:00 [received]', '2013/12/20 00:00 [revised]', '2013/12/23 00:00 [accepted]', '2014/01/29 06:00 [entrez]', '2014/01/29 06:00 [pubmed]', '2014/10/22 06:00 [medline]']","['S0966-842X(13)00273-4 [pii]', '10.1016/j.tim.2013.12.011 [doi]']",ppublish,Trends Microbiol. 2014 Mar;22(3):138-46. doi: 10.1016/j.tim.2013.12.011. Epub 2014 Jan 24.,3,['Copyright (c) 2014 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['dengue', 'serotypes']",,,['095066/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
20616106,NLM,MEDLINE,20110120,20220318,1471-8391 (Electronic) 0007-1420 (Linking),95,2010,Dengue.,161-73,10.1093/bmb/ldq019 [doi],"INTRODUCTION: Dengue is a vector-borne viral infection that endangers an estimated 2.5 billion people. Disease caused by dengue ranges from a relatively minor febrile illness to a life-threatening condition characterized by extensive capillary leak. A greater understanding of dengue has the potential to improve both the clinical management of individual cases and the control of the disease. SOURCES OF DATA: We searched the available literature using PubMed, Embase and Web of Science for relevant articles and abstracts. AREAS OF AGREEMENT: Addressing our gaps in the understanding of disease pathogenesis and improving our knowledge of dengue virus biology are necessary in order to develop tools to effectively control, diagnose and treat the disease. AREAS OF CONTROVERSY: The pathogenesis of dengue is multifactorial and depends on both host and virus factors. A more integrated understanding of disease pathogenesis is necessary. AREAS TIMELY FOR DEVELOPING RESEARCH: There are many questions related to disease pathogenesis, development of diagnostics, drug and vaccine development and individual case management that need addressing if the disease is to be successfully tackled.","['Whitehorn, James', 'Farrar, Jeremy']","['Whitehorn J', 'Farrar J']",,"['London School of Hygiene and Tropical Medicine, London, UK.']",['eng'],"['Journal Article', 'Review']",20100708,England,Br Med Bull,British medical bulletin,0376542,['0 (Dengue Vaccines)'],IM,"['Dengue/pathology/*prevention & control/transmission', 'Dengue Vaccines/*therapeutic use', '*Drug Design', 'Humans']",,2010/07/10 06:00,2011/01/21 06:00,['2010/07/10 06:00'],"['2010/07/10 06:00 [entrez]', '2010/07/10 06:00 [pubmed]', '2011/01/21 06:00 [medline]']","['ldq019 [pii]', '10.1093/bmb/ldq019 [doi]']",ppublish,Br Med Bull. 2010;95:161-73. doi: 10.1093/bmb/ldq019. Epub 2010 Jul 8.,,,,,,,,,,,,,,,,,,,,,,,
28730853,NLM,MEDLINE,20180420,20180501,1744-8336 (Electronic) 1478-7210 (Linking),15,2017 Aug,Dengue in the elderly: a review.,729-735,10.1080/14787210.2017.1358610 [doi],"Changing dengue epidemiological trends have resulted in a shift in the disease burden to the adult population. Older adults suffer from poorer outcomes as compared to their younger counterparts, making clinical management of this sub-population particularly challenging. Areas covered: We present a review of the current literature on the changing epidemiology of dengue in the elderly, the atypical features of the clinical disease in this population with emphasis on severe disease presentations and challenges in the current management strategies. Expert commentary: Dengue in the elderly is an increasingly important yet greatly understudied area. There is an urgent need to refine the current diagnostic criteria to improve diagnosis, classification of disease severity and identify individuals in this population who are likely to progress to severe disease. Management strategies in this population would have to be adjusted to account for the increased number of co-morbidities. The role of the available dengue vaccines in this group is uncertain, and more studies into their safety and efficacy are critically needed.","['Lin, Ray Junhao', 'Lee, Tau Hong', 'Leo, Yee Sin']","['Lin RJ', 'Lee TH', 'Leo YS']",['ORCID: 0000-0001-7954-2926'],"['a Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology , Tan Tock Seng Hospital , Singapore.', 'a Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology , Tan Tock Seng Hospital , Singapore.', 'a Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology , Tan Tock Seng Hospital , Singapore.', 'b Saw Swee Hock School of Public Health , National University of Singapore , Singapore.', 'c Lee Kong Chian School of Medicine , Nanyang Technological University , Singapore.']",['eng'],"['Journal Article', 'Review']",20170728,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,['0 (Dengue Vaccines)'],IM,"['Aged', 'Comorbidity', 'Dengue/diagnosis/*epidemiology/prevention & control', 'Dengue Vaccines/*therapeutic use', 'Dengue Virus/*immunology', 'Humans']",,2017/07/22 06:00,2018/04/21 06:00,['2017/07/22 06:00'],"['2017/07/22 06:00 [pubmed]', '2018/04/21 06:00 [medline]', '2017/07/22 06:00 [entrez]']",['10.1080/14787210.2017.1358610 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2017 Aug;15(8):729-735. doi: 10.1080/14787210.2017.1358610. Epub 2017 Jul 28.,8,,['NOTNLM'],"['Dengue', 'clinical presentation', 'diagnosis', 'elderly', 'management']",,,,,,,,,,,,,,,,,,,
12686878,NLM,MEDLINE,20030507,20220419,0951-7375 (Print) 0951-7375 (Linking),15,2002 Oct,Dengue.,471-6,,"PURPOSE OF REVIEW: Because efforts to control dengue are flagging, this review focuses on the mechanisms underlying severe disease and on treatment options, good and bad. RECENT FINDINGS: The year 2001 witnessed unprecedented global dengue epidemic activity in the American hemisphere, the Pacific islands and continental Asia. Early diagnosis of dengue is important but what is the value and appropriate use of the tourniquet test? A negative test does not rule out dengue infection, a positive test should be followed by close surveillance for early signs of dengue hemorrhagic fever. Low platelet counts do not predict clinically significant bleeding in dengue. It follows that platelet or blood transfusions should not be administered based upon platelet count alone. Dengue hemorrhagic fever or dengue shock syndrome cases frequently have compensated consumptive coagulopathy that seldom requires treatment. Bleeding is most likely caused by activated platelets resulting from damaged capillary endothelium. Dengue hemorrhagic fever and dengue shock syndrome can be safely treated with just normal saline. Colloids should be immediately given to children presenting with a pulse pressure at or below 10 mmHg. Human leukocyte antigen alleles correlate with both protection and susceptibility to dengue hemorrhagic fever and dengue shock syndrome; studies in Haiti suggest that blacks have a gene providing nearly complete protection against severe dengue illness. SUMMARY: The role that antibodies play in protecting and enhancing dengue infections has been largely ignored. Such studies require definitive knowledge of what cells are infected in human dengue and an understanding of all the early antibody-accessible steps of infection of these target cells.","['Halstead, Scott B']",['Halstead SB'],,"['Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20852, USA. halsteads@erols.com']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Infect Dis,Current opinion in infectious diseases,8809878,,IM,"['Dengue/diagnosis/drug therapy/epidemiology/*prevention & control', 'Dengue Virus/immunology/pathogenicity/physiology', 'Humans', 'Severe Dengue/diagnosis/drug therapy/epidemiology']",,2003/04/11 05:00,2003/05/08 05:00,['2003/04/11 05:00'],"['2003/04/11 05:00 [pubmed]', '2003/05/08 05:00 [medline]', '2003/04/11 05:00 [entrez]']",['10.1097/00001432-200210000-00003 [doi]'],ppublish,Curr Opin Infect Dis. 2002 Oct;15(5):471-6. doi: 10.1097/00001432-200210000-00003.,5,,,,,,,40,,,,,,,,,,,,,,,
27091092,NLM,MEDLINE,20170612,20220408,1474-4457 (Electronic) 1473-3099 (Linking),16,2016 Aug,The global economic burden of dengue: a systematic analysis.,935-41,S1473-3099(16)00146-8 [pii] 10.1016/S1473-3099(16)00146-8 [doi],"BACKGROUND: Dengue is a serious global burden. Unreported and unrecognised apparent dengue virus infections make it difficult to estimate the true extent of dengue and current estimates of the incidence and costs of dengue have substantial uncertainty. Objective, systematic, comparable measures of dengue burden are needed to track health progress, assess the application and financing of emerging preventive and control strategies, and inform health policy. We estimated the global economic burden of dengue by country and super-region (groups of epidemiologically similar countries). METHODS: We used the latest dengue incidence estimates from the Institute for Health Metrics and Evaluation's Global Burden of Disease Study 2013 and several other data sources to assess the economic burden of symptomatic dengue cases in the 141 countries and territories with active dengue transmission. From the scientific literature and regressions, we estimated cases and costs by setting, including the non-medical setting, for all countries and territories. FINDINGS: Our global estimates suggest that in 2013 there were a total of 58.40 million symptomatic dengue virus infections (95% uncertainty interval [95% UI] 24 million-122 million), including 13 586 fatal cases (95% UI 4200-34 700), and that the total annual global cost of dengue illness was US$8.9 billion (95% UI 3.7 billion-19.7 billion). The global distribution of dengue cases is 18% admitted to hospital, 48% ambulatory, and 34% non-medical. INTERPRETATION: The global cost of dengue is substantial and, if control strategies could reduce dengue appreciably, billions of dollars could be saved globally. In estimating dengue costs by country and setting, this study contributes to the needs of policy makers, donors, developers, and researchers for economic assessments of dengue interventions, particularly with the licensure of the first dengue vaccine and promising developments in other technologies. FUNDING: Sanofi Pasteur.","['Shepard, Donald S', 'Undurraga, Eduardo A', 'Halasa, Yara A', 'Stanaway, Jeffrey D']","['Shepard DS', 'Undurraga EA', 'Halasa YA', 'Stanaway JD']",,"['Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. Electronic address: shepard@brandeis.edu.', 'Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.', 'Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.', 'Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.']",['eng'],['Journal Article'],20160416,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Communicable Disease Control/*economics/methods', 'Cost of Illness', 'Costs and Cost Analysis/methods/*statistics & numerical data', 'Dengue/*economics/*epidemiology/mortality/prevention & control/transmission', '*Global Burden of Disease', 'Global Health', 'Health Policy', 'Humans', 'Incidence']",,2016/04/20 06:00,2019/03/21 06:00,['2016/04/20 06:00'],"['2015/09/16 00:00 [received]', '2016/03/02 00:00 [revised]', '2016/03/02 00:00 [accepted]', '2016/04/20 06:00 [entrez]', '2016/04/20 06:00 [pubmed]', '2019/03/21 06:00 [medline]']","['S1473-3099(16)00146-8 [pii]', '10.1016/S1473-3099(16)00146-8 [doi]']",ppublish,Lancet Infect Dis. 2016 Aug;16(8):935-41. doi: 10.1016/S1473-3099(16)00146-8. Epub 2016 Apr 16.,8,['Copyright (c) 2016 Elsevier Ltd. All rights reserved.'],,,,['Lancet Infect Dis. 2016 Aug;16(8):873-4. PMID: 27091091'],,,,,,,,,,,,,,,,,
38017595,NLM,MEDLINE,20231130,20231130,1477-8920 (Print) 1477-8920 (Linking),21,2023 Nov,Dengue hemorrhagic fever: a growing global menace.,1632-1650,10.2166/wh.2023.114 [doi],"Dengue virus is an arthropod-borne virus, transmitted by Aedes aegypti among humans. In this review, we discussed the epidemiology of dengue hemorrhagic fever (DHF) as well as the disease's natural history, cycles of transmission, clinical diagnosis, aetiology, prevention, therapy, and management. A systematic literature search was done by databases such as PubMed and Google Scholar using search terms, 'dengue fever', 'symptoms and causes of dengue fever', 'dengue virus transmission', and 'strategies to control dengue'. We reviewed relevant literature to identify hazards related to DHF and the most recent recommendations for its management and prevention. Clinical signs and symptoms of dengue infection range from mild dengue fever (DF) to potentially lethal conditions like DHF or dengue shock syndrome (DSS). Acute-onset high fever, muscle and joint pain, myalgia, a rash on the skin, hemorrhagic episodes, and circulatory shock are among the most common symptoms. An early diagnosis is vital to lower mortality. As dengue virus infections are self-limiting, but in tropical and subtropical areas, dengue infection has become a public health concern. Hence, developing and executing long-term control policies that can reduce the global burden of DHF is a major issue for public health specialists everywhere.","['Parveen, Shakeela', 'Riaz, Zainab', 'Saeed, Saba', 'Ishaque, Urwah', 'Sultana, Mehwish', 'Faiz, Zunaira', 'Shafqat, Zainab', 'Shabbir, Saman', 'Ashraf, Sana', 'Marium, Amna']","['Parveen S', 'Riaz Z', 'Saeed S', 'Ishaque U', 'Sultana M', 'Faiz Z', 'Shafqat Z', 'Shabbir S', 'Ashraf S', 'Marium A']",['ORCID: 0000-0003-2486-6215'],"['Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan E-mail: drshakeela@gscwu.edu.pk.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.', 'Department of Zoology, The Government Sadiq College Women University, Bahawalpur 63100, Pakistan.']",['eng'],"['Journal Article', 'Review']",,England,J Water Health,Journal of water and health,101185420,,IM,"['Humans', '*Severe Dengue/epidemiology/diagnosis', '*Dengue/epidemiology/diagnosis', '*Dengue Virus/physiology', 'Disease Outbreaks', 'Public Health']",,2023/11/29 06:42,2023/11/30 06:44,['2023/11/29 00:17'],"['2023/11/30 06:44 [medline]', '2023/11/29 06:42 [pubmed]', '2023/11/29 00:17 [entrez]']",['10.2166/wh.2023.114 [doi]'],ppublish,J Water Health. 2023 Nov;21(11):1632-1650. doi: 10.2166/wh.2023.114.,11,,,,,,,,,,,,,,,,,,,,,,
30609456,NLM,MEDLINE,20190405,20190405,0047-1860 (Print) 0047-1860 (Linking),64,2016 Sep,[Dengue Fever].,1033-1043,,"Dengue fever is a painful, debilitating, arthropod-borne disease. In recent years, dengue endemic regions have markedly expanded in the tropics, South-east Asia, and the Americas. Epidemics have also been re- ported in subtropical regions of East Asia and Europe. Factors including an increase in the frequency of international travel and period of stay, increase in population density, and global warming, are hypothesized to be associated with the rapid spread of dengue. Approximately 4 billion people are estimated to be infected with the virus each year'). However, there are no effective therapeutics nor clinically approved vaccine for dengue in the region. In 2014, a local dengue outbreak involving 162 cases occurred in Japan2). With the increasing annual numbers of imported dengue cases, there is a need to strengthen and improve the capacity for disease control and prevention. [Review].","['Moi, Meng Ling', 'Takasaki, Tomohiko']","['Moi ML', 'Takasaki T']",,,['jpn'],"['Journal Article', 'Review']",,Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,,IM,"['Animals', '*Dengue/diagnosis/epidemiology/immunology/transmission', 'Disease Outbreaks', 'Humans', 'Risk Factors', 'Travel', 'Vaccination']",,2016/09/01 00:00,2016/09/01 00:01,['2019/01/05 06:00'],"['2019/01/05 06:00 [entrez]', '2016/09/01 00:00 [pubmed]', '2016/09/01 00:01 [medline]']",,ppublish,Rinsho Byori. 2016 Sep;64(9):1033-1043.,9,,,,,,,,,,,,,,,,,,,,,,
23041731,NLM,MEDLINE,20130509,20220331,0971-5916 (Print) 0975-9174 (Electronic) 0971-5916 (Linking),136,2012 Sep,Dengue in India.,373-90,,"Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of infected Aedes mosquitoes. It causes a wide spectrum of illness from mild asymptomatic illness to severe fatal dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Approximately 2.5 billion people live in dengue-risk regions with about 100 million new cases each year worldwide. The cumulative dengue diseases burden has attained an unprecedented proportion in recent times with sharp increase in the size of human population at risk. Dengue disease presents highly complex pathophysiological, economic and ecologic problems. In India, the first epidemic of clinical dengue-like illness was recorded in Madras (now Chennai) in 1780 and the first virologically proved epidemic of dengue fever (DF) occurred in Calcutta (now Kolkata) and Eastern Coast of India in 1963-1964. During the last 50 years a large number of physicians have treated and described dengue disease in India, but the scientific studies addressing various problems of dengue disease have been carried out at limited number of centres. Achievements of Indian scientists are considerable; however, a lot remain to be achieved for creating an impact. This paper briefly reviews the extent of work done by various groups of scientists in this country.","['Gupta, Nivedita', 'Srivastava, Sakshi', 'Jain, Amita', 'Chaturvedi, Umesh C']","['Gupta N', 'Srivastava S', 'Jain A', 'Chaturvedi UC']",,"['Indian Council of Medical Research, New Delhi, India.']",['eng'],"['Journal Article', 'Review']",,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Dengue/complications/*epidemiology/immunology/therapy', 'Dengue Virus/isolation & purification/pathogenicity', 'Humans', 'India/epidemiology']",PMC3510884,2012/10/09 06:00,2013/05/10 06:00,['2012/10/09 06:00'],"['2012/10/09 06:00 [entrez]', '2012/10/09 06:00 [pubmed]', '2013/05/10 06:00 [medline]']","['IndianJMedRes_2012_136_3_373_101976 [pii]', 'IJMR-136-373 [pii]']",ppublish,Indian J Med Res. 2012 Sep;136(3):373-90.,3,,,,,,,,,,,,,,,,,,,,,,
34960705,NLM,MEDLINE,20220214,20220214,1999-4915 (Electronic) 1999-4915 (Linking),13,2021 Dec 4,Towards Integrated Management of Dengue in Mumbai.,,10.3390/v13122436 [doi] 2436,"With increasing urbanisation, the dengue disease burden is on the rise in India, especially in large cities such as Mumbai. Current dengue surveillance in Mumbai includes municipal corporation carrying out specific activities to reduce mosquito breeding sites and the use of insecticides to suppress the adult mosquito populations. Clinical cases remain either underreported or misreported due to the restriction to government clinics, missing the large private health care sector. There is a need for an integrated approach to manage dengue outbreaks in Mumbai. There are various novel strategies available for use that can be utilised to improve disease detection, mosquito surveillance, and control of mosquito-borne diseases. These novel technologies are discussed in this manuscript. Given the complex ecosystem of mosquito-borne diseases in Mumbai, integrating data obtained from these technologies would support the ongoing mosquito control measures in Mumbai.","['Paradkar, Prasad N', 'Sahasrabudhe, Pallavi R', 'Ghag Sawant, Mrunal', 'Mukherjee, Sandeepan', 'Blasdell, Kim R']","['Paradkar PN', 'Sahasrabudhe PR', 'Ghag Sawant M', 'Mukherjee S', 'Blasdell KR']","['ORCID: 0000-0002-6553-2214', 'ORCID: 0000-0003-4794-137X']","['CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, 5 Portarlington Road, Geelong 3220, Australia.', 'Global Health Solutions, A.W. Vartak Marg, Vile Parle, Mumbai 400057, India.', 'Department of Zoonosis, Haffkine Institute for Training Research and Testing, Parel, Mumbai 400012, India.', 'Department of Virology, Haffkine Institute for Training Research and Testing, Parel, Mumbai 400012, India.', 'CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, 5 Portarlington Road, Geelong 3220, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20211204,Switzerland,Viruses,Viruses,101509722,,IM,"['Animals', 'Cities', 'Community Participation', 'Dengue/diagnosis/*epidemiology/*prevention & control/transmission', 'Disease Notification', '*Disease Outbreaks/prevention & control', 'Epidemiological Monitoring', 'Humans', 'India/epidemiology', 'Mosquito Control', 'Mosquito Vectors', 'Urban Health']",PMC8703503,2021/12/29 06:00,2022/02/15 06:00,['2021/12/28 01:07'],"['2021/11/15 00:00 [received]', '2021/11/30 00:00 [revised]', '2021/12/01 00:00 [accepted]', '2021/12/28 01:07 [entrez]', '2021/12/29 06:00 [pubmed]', '2022/02/15 06:00 [medline]']","['v13122436 [pii]', 'viruses-13-02436 [pii]', '10.3390/v13122436 [doi]']",epublish,Viruses. 2021 Dec 4;13(12):2436. doi: 10.3390/v13122436.,12,,['NOTNLM'],"['India', 'Mumbai', 'Wolbachia', 'dengue', 'disease surveillance', 'mosquito', 'novel strategies']",['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
11880737,NLM,MEDLINE,20020319,20190922,1040-8703 (Print) 1040-8703 (Linking),14,2002 Feb,Dengue virus infections.,67-71,,"Dengue is the most important arthropod-borne viral disease of public health significance. Its geographic distribution includes more than 100 countries worldwide, where more than 2.5 billion people are at risk for dengue infections. Most people will have asymptomatic infections, but the disease manifestations range from an influenza-like disease known as dengue fever to a severe, sometimes fatal disease characterized by hemorrhage and shock, known as dengue hemorrhagic fever/dengue shock syndrome. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are caused by the dengue viruses (dengue-1, dengue-2, dengue-3, and dengue-4) transmitted from viremic to susceptible humans mainly by the bites of Aedes aegypti. There is no specific management of dengue infections, no vaccine is commercially available, and vector control is the only alternative for stopping the spread of the disease. Knowledge of several aspects of dengue infections, especially of diagnosis and vaccine development, is continuously evolving, but several issues are still unresolved.","['da Fonseca, Benedito Antonio Lopes', 'Fonseca, Silvia Nunes Szente']","['da Fonseca BA', 'Fonseca SN']",,"['Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. baldfons@fmrp.usp.br']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Pediatr,Current opinion in pediatrics,9000850,,IM,"['Child', '*Dengue/diagnosis/physiopathology/therapy/transmission', 'Dengue Virus', 'Humans']",,2002/03/07 10:00,2002/03/20 10:01,['2002/03/07 10:00'],"['2002/03/07 10:00 [pubmed]', '2002/03/20 10:01 [medline]', '2002/03/07 10:00 [entrez]']",['10.1097/00008480-200202000-00012 [doi]'],ppublish,Curr Opin Pediatr. 2002 Feb;14(1):67-71. doi: 10.1097/00008480-200202000-00012.,1,,,,,,,45,,,,,,,,,,,,,,,
32792686,NLM,MEDLINE,20210729,20210729,2091-0320 (Electronic) 2072-6805 (Linking),11,2019 Jul,Dengue-associated Eye Disease.,115-121,10.3126/nepjoph.v11i2.27814 [doi],,"['Latif, Neethu', 'Mageshan, Kowsigan', 'Biswas, Jyotirmay', 'Majumder, Parthopratim Dutta']","['Latif N', 'Mageshan K', 'Biswas J', 'Majumder PD']",,"['Department of Uvea, Sankara Nethralaya, Chennai.']",['eng'],['Editorial'],,Nepal,Nepal J Ophthalmol,Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH,101505288,,IM,"['*Dengue/complications/diagnosis/epidemiology', '*Eye Diseases', 'Humans']",,2020/08/15 06:00,2021/07/30 06:00,['2020/08/15 06:00'],"['2020/08/15 06:00 [entrez]', '2020/08/15 06:00 [pubmed]', '2021/07/30 06:00 [medline]']",['10.3126/nepjoph.v11i2.27814 [doi]'],ppublish,Nepal J Ophthalmol. 2019 Jul;11(22):115-121. doi: 10.3126/nepjoph.v11i2.27814.,22,,,,,,,,,,,,,,,,,,,,,,
16858980,NLM,MEDLINE,20060928,20060724,0125-2208 (Print) 0125-2208 (Linking),88 Suppl 3,2005 Nov,Dengue vaccine.,S363-77,,"Dengue is an expanding health problem. About two-fifths of the world population are at risk for acquiring dengue with 50-100 million cases of acute febrile illness yearly including about 500,000 cases of DHF/DSS. No antiviral drugs active against the flavivirus exist. Attempts to control mosquito vector has been largely unsuccessful. Vaccination remains the most hopeful preventive measure. Dengue vaccine has been in development for more than 30 years, yet none has been licensed. The fact that enhancing antibody from previous infection and high level of T cell activation during secondary infection contribute to immunopathology of DHF, the vaccine must be able to induce protective response to four dengue serotypes simultaneously. Inactivated vaccine is safe but needs a repeated booster thus, development is delayed. Tetravalent live attenuated vaccine and chimeric vaccine using yellow fever or dengue viruses as a backbone are being carried out in human trials. DNA vaccine and subunit vaccine are being carried out in animal trials.","['Simasathien, Sriluck', 'Watanaveeradej, Veerachai']","['Simasathien S', 'Watanaveeradej V']",,"['Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand.']",['eng'],"['Journal Article', 'Review']",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,['0 (Viral Vaccines)'],IM,"['Dengue/epidemiology/*prevention & control/transmission', 'Dengue Virus/*immunology', 'Humans', '*Viral Vaccines']",,2006/07/25 09:00,2006/09/29 09:00,['2006/07/25 09:00'],"['2006/07/25 09:00 [pubmed]', '2006/09/29 09:00 [medline]', '2006/07/25 09:00 [entrez]']",,ppublish,J Med Assoc Thai. 2005 Nov;88 Suppl 3:S363-77.,,,,,,,,66,,,,,,,,,,,,,,,
30783665,NLM,MEDLINE,20201111,20201111,1537-6613 (Electronic) 0022-1899 (Linking),221,2020 Mar 2,"NS1, Dengue's Dagger.",857-860,10.1093/infdis/jiz083 [doi],,"['Halstead, Scott B', 'Russell, Philip K', 'Brandt, Walter E']","['Halstead SB', 'Russell PK', 'Brandt WE']",,"['Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland.', 'Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.', 'Walter Reed Army Institute of Research, Silver Spring, Maryland.']",['eng'],"['Comment', 'Editorial']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,"['0 (Dengue Vaccines)', '0 (Vaccines, Attenuated)']",IM,"['Antibody Formation', '*Dengue/epidemiology', '*Dengue Vaccines', 'Humans', 'Vaccines, Attenuated']",,2019/02/21 06:00,2020/11/12 06:00,['2019/02/21 06:00'],"['2019/02/13 00:00 [received]', '2019/02/15 00:00 [accepted]', '2019/02/21 06:00 [pubmed]', '2020/11/12 06:00 [medline]', '2019/02/21 06:00 [entrez]']","['5345047 [pii]', '10.1093/infdis/jiz083 [doi]']",ppublish,J Infect Dis. 2020 Mar 2;221(6):857-860. doi: 10.1093/infdis/jiz083.,6,,,,,,,,['J Infect Dis. 2020 Mar 2;221(6):867-877. PMID: 30783676'],,,,,,,,,,,,,,
2224837,NLM,MEDLINE,19901227,20210526,0893-8512 (Print) 1098-6618 (Electronic) 0893-8512 (Linking),3,1990 Oct,The dengue viruses.,376-96,,"Dengue, a major public health problem throughout subtropical and tropical regions, is an acute infectious disease characterized by biphasic fever, headache, pain in various parts of the body, prostration, rash, lymphadenopathy, and leukopenia. In more severe or complicated dengue, patients present with a severe febrile illness characterized by abnormalities of hemostasis and increased vascular permeability, which in some instances results in a hypovolemic shock. Four distinct serotypes of the dengue virus (dengue-1, dengue-2, dengue-3, and dengue-4) exist, with numerous virus strains found worldwide. Molecular cloning methods have led to a greater understanding of the structure of the RNA genome and definition of virus-specific structural and nonstructural proteins. Progress towards producing safe, effective dengue virus vaccines, a goal for over 45 years, has been made.","['Henchal, E A', 'Putnak, J R']","['Henchal EA', 'Putnak JR']",,"['Department of Virus Diseases, Walter Reed Army Institute of Research, Washington 20307-5100.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,"['0 (RNA, Viral)']",IM,"['Dengue/diagnosis/*microbiology/pathology/prevention & control', 'Dengue Virus/*classification/genetics/physiology/ultrastructure', 'Humans', 'RNA, Viral/biosynthesis', 'Virus Replication']",PMC358169,1990/10/01 00:00,1990/10/01 00:01,['1990/10/01 00:00'],"['1990/10/01 00:00 [pubmed]', '1990/10/01 00:01 [medline]', '1990/10/01 00:00 [entrez]']",['10.1128/CMR.3.4.376 [doi]'],ppublish,Clin Microbiol Rev. 1990 Oct;3(4):376-96. doi: 10.1128/CMR.3.4.376.,4,,,,,,,,,,,,,,,,,,,,,,
37547170,NLM,MEDLINE,20230808,20231106,2211-8179 (Electronic) 2211-8160 (Print) 2211-8160 (Linking),18,2023,Dengue Myocarditis: A Case Report and Major Review.,41,10.5334/gh.1254 [doi] 41,"Dengue is a viral disease transmitted by the bite of a female arthropod, prevalent primarily in tropical and subtropical regions. Its manifestations include asymptomatic infections, dengue fever, and a severe form called hemorrhagic dengue or dengue shock syndrome. Atypical manifestations can also occur, called expanded dengue syndrome. We describe the case of a 43-year-old man with an unusual presentation of dengue, demonstrating a workup suggestive of myocardial and pericardial damage. Symptoms and markers indicative of cardiac compromise improved after five days on anti-inflammatory treatment. Dengue myocarditis is considered an uncommon complication of dengue, although its reported incidence is likely an underestimation. In general, most cases of dengue myocarditis are self-limited, with only a minority at risk of progressing to heart failure. In order to improve recognition and prevent progression, healthcare providers should maintain a high degree of suspicion regarding potential cardiac complications in patients with dengue.","['Cristodulo, Roberto', 'Luoma-Overstreet, Gracia', 'Leite, Fernando', 'Vaca, Manuel', 'Navia, Michelle', 'Duran, Gustavo', 'Molina, Fernando', 'Zonneveld, Bozorg', 'Perrone, Sergio Victor', 'Barbagelata, Alejandro', 'Kaplinsky, Edgardo']","['Cristodulo R', 'Luoma-Overstreet G', 'Leite F', 'Vaca M', 'Navia M', 'Duran G', 'Molina F', 'Zonneveld B', 'Perrone SV', 'Barbagelata A', 'Kaplinsky E']","['ORCID: 0000-0002-1080-6273', 'ORCID: 0000-0002-7310-5968', 'ORCID: 0009-0007-4159-3331', 'ORCID: 0009-0003-9707-5833', 'ORCID: 0009-0000-4344-0186', 'ORCID: 0009-0004-8253-124X', 'ORCID: 0009-0001-0050-2102', 'ORCID: 0009-0002-3232-8417', 'ORCID: 0000-0002-3325-7633', 'ORCID: 0000-0001-6803-2605', 'ORCID: 0000-0002-6399-6736']","['Clinica de las Americas, Santa Cruz, Bolivia.', 'Virginia Commonwealth University School of Medicine, Richmond, VA, US.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Clinica de las Americas, Santa Cruz, Bolivia.', 'Catholic University of Argentina, Buenos Aires, Argentina.', 'Catholic University of Argentina, Buenos Aires, Argentina.', 'Duke University School of Medicine, Durham, NC, US.', 'Hospital Municipal de Badalona, Barcelona University, Barcelona, Spain.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",20230804,England,Glob Heart,Global heart,101584391,,IM,"['Male', 'Humans', 'Female', 'Adult', '*Myocarditis/diagnosis/etiology', '*Dengue/complications/diagnosis', '*Severe Dengue/complications/diagnosis', '*Heart Diseases', '*Heart Failure']",PMC10402786,2023/08/07 06:41,2023/08/08 06:42,['2023/08/07 04:48'],"['2023/04/06 00:00 [received]', '2023/07/07 00:00 [accepted]', '2023/08/08 06:42 [medline]', '2023/08/07 06:41 [pubmed]', '2023/08/07 04:48 [entrez]']",['10.5334/gh.1254 [doi]'],epublish,Glob Heart. 2023 Aug 4;18(1):41. doi: 10.5334/gh.1254. eCollection 2023.,1,['Copyright: (c) 2023 The Author(s).'],['NOTNLM'],"['Acute myocarditis', 'dengue', 'expanded dengue syndrome']",['The authors have no competing interests to declare.'],,,,,,,,,,,,,,,,,,
19150272,NLM,MEDLINE,20090227,20090119,1097-6787 (Electronic) 0190-9622 (Linking),60,2009 Feb,Dengue fever.,306-7,10.1016/j.jaad.2008.06.027 [doi],"Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Warren R. Heymann, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.","['Heymann, Warren R']",['Heymann WR'],,,['eng'],"['Journal Article', 'Review']",,United States,J Am Acad Dermatol,Journal of the American Academy of Dermatology,7907132,,IM,"['*Dengue/diagnosis/epidemiology/transmission', '*Dermatology', 'Humans', 'Risk Factors']",,2009/01/20 09:00,2009/02/28 09:00,['2009/01/20 09:00'],"['2008/06/15 00:00 [received]', '2008/06/15 00:00 [revised]', '2008/06/26 00:00 [accepted]', '2009/01/20 09:00 [entrez]', '2009/01/20 09:00 [pubmed]', '2009/02/28 09:00 [medline]']","['S0190-9622(08)00793-7 [pii]', '10.1016/j.jaad.2008.06.027 [doi]']",ppublish,J Am Acad Dermatol. 2009 Feb;60(2):306-7. doi: 10.1016/j.jaad.2008.06.027.,2,,,,,,,8,,,,,,,,,,,,,,,
37306140,NLM,MEDLINE,20230822,20230822,1365-4632 (Electronic) 0011-9059 (Linking),62,2023 Sep,Dengue: updates for dermatologists on the world's fastest-growing vector-borne disease.,1110-1120,10.1111/ijd.16739 [doi],"Dengue is the world's fastest-growing vector borne disease and has significant epidemic potential in suitable climates. Recent disease models incorporating climate change scenarios predict geographic expansion across the globe, including parts of the United States and Europe. It will be increasingly important in the next decade for dermatologists to become familiar with dengue, as it commonly manifests with rashes, which can be used to aid diagnosis. In this review, we discuss dengue for general dermatologists, specifically focusing on its cutaneous manifestations, epidemiology, diagnosis, treatment, and prevention. As dengue continues to spread in both endemic and new locations, dermatologists may have a larger role in the timely diagnosis and management of this disease.","['Braun, Mitchell', 'Andersen, Louise K', 'Norton, Scott A', 'Coates, Sarah J']","['Braun M', 'Andersen LK', 'Norton SA', 'Coates SJ']",['ORCID: 0000-0002-9872-5602'],"['Department of Dermatology, The University of California San Francisco, San Francisco, CA, USA.', 'Department of Dermatology, Aleris-Hamlet Private Hospital, Esbjerg, Denmark.', 'Departments of Dermatology and Preventive Medicine & Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.', 'Department of Dermatology, The University of California San Francisco, San Francisco, CA, USA.']",['eng'],"['Journal Article', 'Review']",20230612,England,Int J Dermatol,International journal of dermatology,0243704,,IM,"['Humans', '*Dengue/diagnosis/epidemiology/therapy', 'Dermatologists', 'Europe', 'Climate Change', '*Exanthema']",,2023/06/12 13:07,2023/08/22 06:42,['2023/06/12 06:23'],"['2023/04/30 00:00 [revised]', '2022/09/14 00:00 [received]', '2023/05/23 00:00 [accepted]', '2023/08/22 06:42 [medline]', '2023/06/12 13:07 [pubmed]', '2023/06/12 06:23 [entrez]']",['10.1111/ijd.16739 [doi]'],ppublish,Int J Dermatol. 2023 Sep;62(9):1110-1120. doi: 10.1111/ijd.16739. Epub 2023 Jun 12.,9,['(c) 2023 the International Society of Dermatology.'],,,,,,,,,,,,,,,,,,,,,
2647259,NLM,MEDLINE,19890511,20190912,0738-081X (Print) 0738-081X (Linking),7,1989 Jan-Mar,Dengue fever.,117-22,,,"['Waterman, S H', 'Gubler, D J']","['Waterman SH', 'Gubler DJ']",,"['Department of Acute Communicable Disease Control, Los Angeles County Department of Health Services, California.']",['eng'],"['Journal Article', 'Review']",,United States,Clin Dermatol,Clinics in dermatology,8406412,,IM,"['*Dengue/diagnosis/prevention & control/therapy', 'Humans', '*Skin Diseases, Infectious/diagnosis/etiology/prevention & control/therapy', 'Syndrome']",,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']","['0738-081X(89)90034-5 [pii]', '10.1016/0738-081x(89)90034-5 [doi]']",ppublish,Clin Dermatol. 1989 Jan-Mar;7(1):117-22. doi: 10.1016/0738-081x(89)90034-5.,1,,,,,,,22,,,,,,,,,,,,,,,
35213764,NLM,MEDLINE,20220913,20221005,1099-1654 (Electronic) 1052-9276 (Print) 1052-9276 (Linking),32,2022 Sep,Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence.,e2339,10.1002/rmv.2339 [doi] e2339,"In dengue-endemic regions, the co-infection with SARS-CoV-2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID-19 co-infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID-19 and dengue co-infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise-decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.","['El-Qushayri, Amr Ehab', 'Kamel, Ahmed Mostafa Ahmed', 'Reda, Abdullah', 'Ghozy, Sherief']","['El-Qushayri AE', 'Kamel AMA', 'Reda A', 'Ghozy S']","['ORCID: 0000-0002-3254-6097', 'ORCID: 0000-0003-3494-9188', 'ORCID: 0000-0002-2180-0029', 'ORCID: 0000-0001-5629-3023']","['Faculty of Medicine, Minia University, Minia, Egypt.', 'Faculty of Pharmacy, Minia University, Minia, Egypt.', 'Faculty of Medicine, Al-Azhar University, Cairo, Egypt.', 'Neuroradiology Department, Mayo Clinic, Rochester, Minnesota, USA.', 'Nuffield Department of Primary Care Health Sciences and Department for Continuing Education (EBHC Program), Oxford University, Oxford, UK.']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",20220225,England,Rev Med Virol,Reviews in medical virology,9112448,,IM,"['*COVID-19', '*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Female', 'Humans', 'Pregnancy', '*Premature Birth', 'SARS-CoV-2']",PMC9111070,2022/02/26 06:00,2022/09/14 06:00,['2022/02/25 17:17'],"['2022/02/01 00:00 [revised]', '2021/10/21 00:00 [received]', '2022/02/16 00:00 [accepted]', '2022/02/26 06:00 [pubmed]', '2022/09/14 06:00 [medline]', '2022/02/25 17:17 [entrez]']","['RMV2339 [pii]', '10.1002/rmv.2339 [doi]']",ppublish,Rev Med Virol. 2022 Sep;32(5):e2339. doi: 10.1002/rmv.2339. Epub 2022 Feb 25.,5,['(c) 2022 John Wiley & Sons Ltd.'],['NOTNLM'],"['COVID-19', 'SARS-CoV-2', 'co-infection', 'dengue', 'systematic review']",['None.'],,,,,,,,,,,,,,,,,,
35215827,NLM,MEDLINE,20220316,20230124,1999-4915 (Electronic) 1999-4915 (Linking),14,2022 Jan 25,"Uncovering the Burden of Dengue in Africa: Considerations on Magnitude, Misdiagnosis, and Ancestry.",,10.3390/v14020233 [doi] 233,"Dengue is a re-emerging neglected disease of major public health importance. This review highlights important considerations for dengue disease in Africa, including epidemiology and underestimation of disease burden in African countries, issues with malaria misdiagnosis and co-infections, and potential evidence of genetic protection from severe dengue disease in populations of African descent. The findings indicate that dengue virus prevalence in African countries and populations may be more widespread than reported data suggests, and that the Aedes mosquito vectors appear to be increasing in dissemination and number. Changes in climate, population, and plastic pollution are expected to worsen the dengue situation in Africa. Dengue misdiagnosis is also a problem in Africa, especially due to the typical non-specific clinical presentation of dengue leading to misdiagnosis as malaria. Finally, research suggests that a protective genetic component against severe dengue exists in African descent populations, but further studies should be conducted to strengthen this association in various populations, taking into consideration socioeconomic factors that may contribute to these findings. The main takeaway is that Africa should not be overlooked when it comes to dengue, and more attention and resources should be devoted to this disease in Africa.","['Gainor, Emily Mary', 'Harris, Eva', 'LaBeaud, A Desiree']","['Gainor EM', 'Harris E', 'LaBeaud AD']",['ORCID: 0000-0002-3148-682X'],"['Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA 94720-3370, USA.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA 94720-3370, USA.', 'Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",20220125,Switzerland,Viruses,Viruses,101509722,,IM,"['Africa/epidemiology', 'Black People', 'Coinfection', 'Dengue/*diagnosis/*epidemiology/genetics', 'Diagnostic Errors', 'Disease Outbreaks', 'Endemic Diseases', 'Humans', 'Malaria/diagnosis', 'Risk Factors', 'Severe Dengue/epidemiology/genetics/prevention & control']",PMC8877195,2022/02/27 06:00,2022/03/17 06:00,['2022/02/26 01:06'],"['2021/11/29 00:00 [received]', '2022/01/15 00:00 [revised]', '2022/01/18 00:00 [accepted]', '2022/02/26 01:06 [entrez]', '2022/02/27 06:00 [pubmed]', '2022/03/17 06:00 [medline]']","['v14020233 [pii]', 'viruses-14-00233 [pii]', '10.3390/v14020233 [doi]']",epublish,Viruses. 2022 Jan 25;14(2):233. doi: 10.3390/v14020233.,2,,['NOTNLM'],"['Aedes', 'Africa', 'ancestry', 'climate change', 'coinfection', 'dengue', 'epidemiology', 'misdiagnosis', 'mosquitoes', 'outbreaks']","['The authors declare no conflict of interest. The funders had no role in the', 'design of the study; in the collection, analyses, or interpretation of data; in', 'the writing of the manuscript, or in the decision to publish the results.']",,"['R01 AI102918/AI/NIAID NIH HHS/United States', 'P01 AI106695/AI/NIAID NIH HHS/United States', 'U01 AI151788/AI/NIAID NIH HHS/United States']",,,,,,,,,,,,,,,,
16135837,NLM,MEDLINE,20050906,20220311,1533-4406 (Electronic) 0028-4793 (Linking),353,2005 Sep 1,Dengue in travelers.,924-32,,,"['Wilder-Smith, Annelies', 'Schwartz, Eli']","['Wilder-Smith A', 'Schwartz E']",,"[""Travellers' Health and Vaccination Centre, Tan Tock Seng Hospital, Singapore. epvws@pacific.net.sg""]",['eng'],"['Journal Article', 'Review']",,United States,N Engl J Med,The New England journal of medicine,0255562,,IM,"['Aedes', 'Animals', 'Dengue/*diagnosis/epidemiology/prevention & control/therapy', 'Dengue Virus/pathogenicity', 'Diagnosis, Differential', 'Humans', 'Incidence', 'Insect Vectors', 'Risk', 'Severe Dengue/diagnosis', '*Travel']",,2005/09/02 09:00,2005/09/07 09:00,['2005/09/02 09:00'],"['2005/09/02 09:00 [pubmed]', '2005/09/07 09:00 [medline]', '2005/09/02 09:00 [entrez]']","['353/9/924 [pii]', '10.1056/NEJMra041927 [doi]']",ppublish,N Engl J Med. 2005 Sep 1;353(9):924-32. doi: 10.1056/NEJMra041927.,9,,,,,"['N Engl J Med. 2005 Dec 8;353(23):2511-3; author reply 2511-3. PMID: 16339102', 'N Engl J Med. 2005 Dec 8;353(23):2511-3; author reply 2511-3. PMID: 16353300', 'N Engl J Med. 2005 Dec 8;353(23):2511-3; author reply 2511-3. PMID: 16353301']",,73,,,,,,,,,,,,,,,
29465794,NLM,MEDLINE,20181024,20181024,1099-1654 (Electronic) 1052-9276 (Linking),28,2018 Mar,Liver involvement in dengue viral infections.,,10.1002/rmv.1971 [doi],"Dengue fever is the commonest viral haemorrhagic fever worldwide and is a leading cause of morbidity and mortality in the tropics. Dengue viral infections are frequently associated with varying degrees of liver injury. Liver injury is more severe in dengue haemorrhagic fever or severe dengue. We review the current knowledge on liver involvement following dengue viral infections and explore the links between clinical manifestations, pathogenesis, and their impact on management.","['Dissanayake, Harsha A', 'Seneviratne, Suranjith L']","['Dissanayake HA', 'Seneviratne SL']","['ORCID: 0000-0003-3903-9917', 'ORCID: 0000-0002-6548-5673']","['University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Institute of Immunity and Transplantation, Royal Free Hospital and University College London, London, UK.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.']",['eng'],"['Journal Article', 'Review']",20180221,England,Rev Med Virol,Reviews in medical virology,9112448,,IM,"['Animals', 'Dengue/*complications/diagnosis/epidemiology/*virology', 'Dengue Virus/classification/*physiology', 'Disease Management', 'Humans', 'Liver Diseases/diagnosis/epidemiology/*etiology/therapy', 'Liver Function Tests']",,2018/02/22 06:00,2018/10/26 06:00,['2018/02/22 06:00'],"['2017/10/10 00:00 [received]', '2018/01/03 00:00 [revised]', '2018/01/08 00:00 [accepted]', '2018/02/22 06:00 [pubmed]', '2018/10/26 06:00 [medline]', '2018/02/22 06:00 [entrez]']",['10.1002/rmv.1971 [doi]'],ppublish,Rev Med Virol. 2018 Mar;28(2). doi: 10.1002/rmv.1971. Epub 2018 Feb 21.,2,"['Copyright (c) 2018 John Wiley & Sons, Ltd.']",['NOTNLM'],"['animal', 'dengue', 'human', 'liver', 'pathogenesis']",,,,,,,,,,,,,,,,,,,
22034713,NLM,MEDLINE,20111123,20211020,1470-2118 (Print) 1473-4893 (Electronic) 1470-2118 (Linking),11,2011 Oct,Dengue.,483-7,,,"['Whitehorn, Jamie', 'Farrar, Jeremy']","['Whitehorn J', 'Farrar J']",,"['Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.']",['eng'],['Journal Article'],,England,Clin Med (Lond),"Clinical medicine (London, England)",101092853,,IM,"['Dengue/*diagnosis/epidemiology/physiopathology/*therapy', 'Exanthema/etiology', 'Fluid Therapy', 'Humans', 'Resuscitation', 'Severe Dengue/*diagnosis/therapy']",PMC4954247,2011/11/01 06:00,2011/12/13 00:00,['2011/11/01 06:00'],"['2011/11/01 06:00 [entrez]', '2011/11/01 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['clinmedicine [pii]', '10.7861/clinmedicine.11-5-483 [doi]']",ppublish,Clin Med (Lond). 2011 Oct;11(5):483-7. doi: 10.7861/clinmedicine.11-5-483.,5,,,,,,,,,,,,,,,,,,,,,,
25399556,NLM,MEDLINE,20150806,20141209,1744-8336 (Electronic) 1478-7210 (Linking),13,2015 Jan,Dengue fever in Europe: could there be an epidemic in the future?,29-40,10.1586/14787210.2015.982094 [doi],"Dengue virus (DENV) is the arbovirus with the widest impact on human health. Although its dispersal is partially conditioned by environmental constraints that limit the distribution of its main vector (Aedes aegypti), DENV has been spreading geographically in recent times, but mostly afflicting tropical and subtropical regions. With no prophylactic vaccine or specific therapeutics available, vector control remains the best alternative to restrain its circulation. Moreover, the establishment of thriving vector populations in peri urban environments brings humans and viruses together, opening the possibility for the occurrence of unexpected outbreaks. Europe is no exception: such was the case of Madeira in 2012. In addition to its impact on the health of the local population, health services, and economy, this outbreak revealed how difficult it may be to control the circulation of pathogenic arboviruses, especially taking into consideration that Europe is already partially colonized by another DENV vector, Aedes albopictus.","['Parreira, Ricardo', 'Sousa, Carla A']","['Parreira R', 'Sousa CA']",,"['Grupo de Virologia, Unidade de Ensino e Investigacao de Microbiologia Medica/UPMM, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa Rua da Junqueira 100, 1349-008 Lisboa, Portugal.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20141115,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,,IM,"['Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Dengue Virus/*pathogenicity', 'Disease Vectors', 'Europe/epidemiology', 'Humans']",,2014/11/18 06:00,2015/08/08 06:00,['2014/11/18 06:00'],"['2014/11/18 06:00 [entrez]', '2014/11/18 06:00 [pubmed]', '2015/08/08 06:00 [medline]']",['10.1586/14787210.2015.982094 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2015 Jan;13(1):29-40. doi: 10.1586/14787210.2015.982094. Epub 2014 Nov 15.,1,,['NOTNLM'],"['Aedes', 'Europe', 'dengue fever', 'dengue virus', 'flavivirus', 'mosquitoes']",,,,,,,,,,,,,,,,,,,
27093563,NLM,MEDLINE,20170222,20170720,1533-404X (Electronic) 0195-7910 (Linking),37,2016 Jun,Lethal Dengue Virus Infection: A Forensic Overview.,74-8,10.1097/PAF.0000000000000236 [doi],"Dengue virus is a single-stranded RNA virus that is a member of the family Flaviviridae, genus Flavivirus. It is usually transmitted by the female Aedes aegypti mosquito. Dengue fever is a febrile illness caused by 1 of 4 serotypes of the virus, which may progress to dengue hemorrhagic fever or dengue shock syndrome. The mortality rate of untreated dengue shock syndrome is more than 20%. The reported incidence has increased 30-fold for the past 50 years with an estimated 50 to 100 million dengue infections globally each year, which includes 22,000 deaths. Because of this rapid increase in numbers, more cases will be seen in forensic mortuaries, with diagnostic problems arising from nonspecific or unusual manifestations. In this review, the clinicopathological features of dengue viral infection are evaluated. Adequate blood and tissue sampling at the time of autopsy is mandatory for successful microbiological identification and characterization.","['Byard, Roger W']",['Byard RW'],,"['From the Discipline of Anatomy and Pathology, University of Adelaide, Adelaide, South Australia, Australia.']",['eng'],"['Journal Article', 'Review']",,United States,Am J Forensic Med Pathol,The American journal of forensic medicine and pathology,8108948,,IM,"['Animals', 'Death, Sudden/etiology', 'Dengue/*diagnosis/*epidemiology/transmission', '*Dengue Virus', '*Forensic Medicine', 'Humans', 'Incidence', 'Mosquito Vectors', 'Travel']",,2016/04/20 06:00,2017/02/23 06:00,['2016/04/20 06:00'],"['2016/04/20 06:00 [entrez]', '2016/04/20 06:00 [pubmed]', '2017/02/23 06:00 [medline]']",['10.1097/PAF.0000000000000236 [doi]'],ppublish,Am J Forensic Med Pathol. 2016 Jun;37(2):74-8. doi: 10.1097/PAF.0000000000000236.,2,,,,,['Am J Forensic Med Pathol. 2016 Sep;37(3):221. PMID: 27356013'],,,,,,,,,,,,,,,,,
34269994,NLM,MEDLINE,20211028,20220218,2196-5412 (Electronic) 2196-5412 (Linking),8,2021 Sep,A Review of Dengue's Historical and Future Health Risk from a Changing Climate.,245-265,10.1007/s40572-021-00322-8 [doi],"PURPOSE OF REVIEW: The purpose of this review is to summarize research articles that provide risk estimates for the historical and future impact that climate change has had upon dengue published from 2007 through 2019. RECENT FINDINGS: Findings from 30 studies on historical health estimates, with the majority of the studies conducted in Asia, emphasized the importance of temperature, precipitation, and relative humidity, as well as lag effects, when trying to understand how climate change can impact the risk of contracting dengue. Furthermore, 35 studies presented findings on future health risk based upon climate projection scenarios, with a third of them showcasing global level estimates and findings across the articles emphasizing the need to understand risk at a localized level as the impacts from climate change will be experienced inequitably across different geographies in the future. Dengue is one of the most rapidly spreading viral diseases in the world, with ~390 million people infected worldwide annually. Several factors have contributed towards its proliferation, including climate change. Multiple studies have previously been conducted examining the relationship between dengue and climate change, both from a historical and a future risk perspective. We searched the U.S. National Institute of Environmental Health (NIEHS) Climate Change and Health Portal for literature (spanning January 2007 to September 2019) providing historical and future health risk estimates of contracting dengue infection in relation to climate variables worldwide. With an overview of the evidence of the historical and future health risk posed by dengue from climate change across different regions of the world, this review article enables the research and policy community to understand where the knowledge gaps are and what areas need to be addressed in order to implement localized adaptation measures to mitigate the health risks posed by future dengue infection.","['Soneja, Sutyajeet', 'Tsarouchi, Gina', 'Lumbroso, Darren', 'Tung, Dao Khanh']","['Soneja S', 'Tsarouchi G', 'Lumbroso D', 'Tung DK']",,"['United Nations Development Programme, Vietnam Office, Washington, DC, USA.', 'HR Wallingford, Howbery Park, Wallingford, Oxfordshire, OX10 8BA, UK. G.Tsarouchi@hrwallingford.com.', 'HR Wallingford, Howbery Park, Wallingford, Oxfordshire, OX10 8BA, UK.', 'United Nations Development Programme, Vietnam Office, 304 Kim Ma, Hanoi, Vietnam.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20210716,Switzerland,Curr Environ Health Rep,Current environmental health reports,101629387,,IM,"['Asia', 'Climate Change', '*Dengue/epidemiology', 'Forecasting', 'Humans', 'Temperature']",PMC8416809,2021/07/17 06:00,2021/10/29 06:00,['2021/07/16 12:34'],"['2021/06/07 00:00 [accepted]', '2021/07/17 06:00 [pubmed]', '2021/10/29 06:00 [medline]', '2021/07/16 12:34 [entrez]']","['10.1007/s40572-021-00322-8 [pii]', '322 [pii]', '10.1007/s40572-021-00322-8 [doi]']",ppublish,Curr Environ Health Rep. 2021 Sep;8(3):245-265. doi: 10.1007/s40572-021-00322-8. Epub 2021 Jul 16.,3,['(c) 2021. The Author(s).'],['NOTNLM'],"['Climate change', 'Dengue', 'Global health', 'Vector borne disease']",['The authors declare no competing interests.'],,,,,,,,,,,,,,,,,,
30394209,NLM,MEDLINE,20181224,20181224,1873-4294 (Electronic) 1568-0266 (Linking),18,2018,"Dengue Fever: A Worldwide Threat An Overview of the Infection Process, Environmental Factors for a Global Outbreak, Diagnostic Platforms and Vaccine Developments.",1531-1549,10.2174/1568026618666181105130000 [doi],"Current review article focuses on dengue, which is one of the most fatal infectious illnesses and is considered to be a worldwide threat. The paper covers essential topics including an overview on neglected tropical diseases with specific emphasis on Dengue fever, mosquito's cycle of life and mechanism of infection, adaptive response, and different stages in dengue immunopathogenesis. The current work is also dedicated to the thorough study of dengue outbreak across the globe with a narrowed study to tropical and subtropical regions. Moreover, this review article demonstrates the correlation between climate factors and dengue incidence. Furthermore, we present an overview of the detection strategies of dengue including the latest developments in commercial and non-commercial platforms. Several attempts in developing an effective vaccine to protect individuals from dengue infection and the stage of clinical trials are gathered in the present work as well. Future directions including bio-control are also discussed in this review article. In an overall view, effective management of Dengue is a multidisciplinary task that requires international involvement from different backgrounds and expertise to address this global concern. This review article briefly portrays some of these connecting areas across the disciplines while many other perspectives remain uncovered.","['Hosseini, Samira', 'Oliva-Ramirez, Jacqueline', 'Vazquez-Villegas, Patricia', 'Rodriguez-Garcia, Aida', 'Munoz-Soto, Rodrigo B', 'Aghamohammadi, Nasrin', 'Martinez-Chapa, Sergio O']","['Hosseini S', 'Oliva-Ramirez J', 'Vazquez-Villegas P', 'Rodriguez-Garcia A', 'Munoz-Soto RB', 'Aghamohammadi N', 'Martinez-Chapa SO']",,"['Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Ave. Eugenio Garza Sada 2501, Monterrey, N.L, Mexico.', 'Tecnologico de Monterrey, Writing Lab, TecLabs, Vicerrectoria de Investigacion y Transferencia de Tecnologia, Monterrey 64849, NL, Mexico.', 'Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Ave. Lago de Guadalupe Km 3.5, Cd Lopez Mateos, Atizapan, Estado de Mexico, N.L, Mexico.', 'Tecnologico de Monterrey, Writing Lab, TecLabs, Vicerrectoria de Investigacion y Transferencia de Tecnologia, Monterrey 64849, NL, Mexico.', 'Universidad Autonoma de Nuevo Leon, Facultad de Ciencias Biologicas, Instituto de Biotecnologia. Ave. Pedro de Alba S/N, Ciudad Universitaria, CP. 66455, San Nicolas de los Garza, Nuevo Leon, Mexico.', 'Tecnologico de Monterrey, Campus Ciudad de Mexico, Escuela de Ingenieria y Ciencias, Calle del Puente 222, Mexico City, Mexico.', 'Centre for Occupational and Environmental Health, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.', 'Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Ave. Eugenio Garza Sada 2501, Monterrey, N.L, Mexico.']",['eng'],"['Journal Article', 'Review']",,United Arab Emirates,Curr Top Med Chem,Current topics in medicinal chemistry,101119673,['0 (Dengue Vaccines)'],IM,"['Animals', '*Dengue/diagnosis/drug therapy/epidemiology', 'Dengue Vaccines/*pharmacology', 'Dengue Virus/*drug effects', 'Humans']",,2018/11/06 06:00,2018/12/26 06:00,['2018/11/06 06:00'],"['2018/01/28 00:00 [received]', '2018/10/02 00:00 [revised]', '2018/10/07 00:00 [accepted]', '2018/11/06 06:00 [pubmed]', '2018/12/26 06:00 [medline]', '2018/11/06 06:00 [entrez]']","['CTMC-EPUB-94279 [pii]', '10.2174/1568026618666181105130000 [doi]']",ppublish,Curr Top Med Chem. 2018;18(18):1531-1549. doi: 10.2174/1568026618666181105130000.,18,"['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.org.']",['NOTNLM'],"['Bio-control of Dengue', 'Dengue fever', 'Dengue immunopathogenesis', 'Dengue outbreak', 'Detection platforms for Dengue', 'Effect of climate factors on Dengue.']",,,,,,,,,,,,,,,,,,,
25423800,NLM,MEDLINE,20150108,20181202,0125-1562 (Print) 0125-1562 (Linking),45 Suppl 1,2014,Dengue: global health threat.,107-12,,,"['Thisyakorn, Usa']",['Thisyakorn U'],,,['eng'],"['Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,['0 (Dengue Vaccines)'],IM,"['Asia/epidemiology', 'Coinfection', 'Dengue/*diagnosis/*epidemiology/prevention & control', 'Dengue Vaccines', '*Global Health', 'Humans', 'Incidence', 'World Health Organization']",,2014/11/27 06:00,2015/01/09 06:00,['2014/11/27 06:00'],"['2014/11/27 06:00 [entrez]', '2014/11/27 06:00 [pubmed]', '2015/01/09 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2014;45 Suppl 1:107-12.,,,,,,,,,,,,,,,,,,,,,,,
26855170,NLM,MEDLINE,20161213,20161230,1744-8395 (Electronic) 1476-0584 (Linking),15,2016,International Dengue Vaccine Communication and Advocacy: Challenges and Way Forward.,539-45,10.1586/14760584.2016.1152187 [doi],"Dengue vaccine introduction will likely occur soon. However, little has been published on international dengue vaccine communication and advocacy. More effort at the international level is required to review, unify and strategically disseminate dengue vaccine knowledge to endemic countries' decision makers and potential donors. Waiting to plan for the introduction of new vaccines until licensure may delay access in developing countries. Concerted efforts to communicate and advocate for vaccines prior to licensure are likely challenged by unknowns of the use of dengue vaccines and the disease, including uncertainties of vaccine impact, vaccine access and dengue's complex pathogenesis and epidemiology. Nevertheless, the international community has the opportunity to apply previous best practices for vaccine communication and advocacy. The following key strategies will strengthen international dengue vaccine communication and advocacy: consolidating existing coalitions under one strategic umbrella, urgently convening stakeholders to formulate the roadmap for integrated dengue prevention and control, and improving the dissemination of dengue scientific knowledge.","['Carvalho, Ana', 'Van Roy, Rebecca', 'Andrus, Jon']","['Carvalho A', 'Van Roy R', 'Andrus J']",,"['a Sabin Vaccine Institute , Washington , DC , USA.', 'a Sabin Vaccine Institute , Washington , DC , USA.', 'a Sabin Vaccine Institute , Washington , DC , USA.']",['eng'],"['Journal Article', 'Review']",,England,Expert Rev Vaccines,Expert review of vaccines,101155475,['0 (Dengue Vaccines)'],IM,"['Dengue/epidemiology/*prevention & control', 'Dengue Vaccines/*administration & dosage/*immunology', 'Disease Transmission, Infectious/*prevention & control', 'Global Health', '*Health Communication', 'Humans']",,2016/02/09 06:00,2016/12/15 06:00,['2016/02/09 06:00'],"['2016/02/09 06:00 [entrez]', '2016/02/09 06:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.1586/14760584.2016.1152187 [doi]'],ppublish,Expert Rev Vaccines. 2016;15(4):539-45. doi: 10.1586/14760584.2016.1152187.,4,,['NOTNLM'],"['Dengue', 'advocacy', 'communication', 'decision making', 'dengue vaccine', 'dengue-endemic countries', 'framing', 'international communication and advocacy', 'social marketing', 'strategic communication', 'vaccine introduction', 'vaccines']",,,,,,,,,,,,,,,,,,,
37335522,NLM,MEDLINE,20230719,20230908,0975-0711 (Electronic) 0254-8860 (Linking),42,2023 Jun,"Dengue hepatitis: Incidence, spectrum and outcome.",355-360,10.1007/s12664-023-01405-0 [doi],"BACKGROUND AND AIMS: While dengue infection is common in India, there is scarce information on dengue hepatitis. The aim of this study was to analyze the incidence, spectrum and outcome of dengue hepatitis. METHODS: We retrospectively analyzed consecutive patients, who had hepatitis among those with dengue infection admitted to two tertiary care hospitals in western India from January 2016 to March 2021. Diagnosis of dengue infection was made by serology. Dengue hepatitis was diagnosed and the severity of dengue was categorized by standard criteria. RESULTS: Of 1664 patients admitted with dengue fever during the study period, 199 patients had hepatitis (i.e. incidence of dengue hepatitis was 11.9%). Of the 199 dengue hepatitis patients (age: 29 [13 - 80] years, median [range], 67% males), 100 patients (50%) had severe dengue, 73 (36%) had severe dengue hepatitis, 32 (16%) had dengue shock syndrome and eight (4%) had acute liver failure. Forty-five patients (23%) had acute lung injury and 32 (16%) had acute kidney injury. The dengue hepatitis patients were treated with standard medical care, including vital organ support, as needed-166 (83%) patients survived, while 33 patients (17%) died (cause of death: multi-organ failure: 24 patients, septic shock: nine patients). The presence of shock independently predicted mortality (odds ratio 6.4, 95% confidence interval: 1.2 - 34). Among patients with dengue hepatitis, mortality rate was higher in those with severe dengue (23%), dengue shock syndrome (47%), severe dengue hepatitis (24%) and acute liver failure (38%). CONCLUSION: In this large series of hospitalized patients with dengue infection, the incidence of dengue hepatitis was 11.9%. Among 199 dengue hepatitis, 17% died; multi-organ failure was the commonest cause for death and death rate was higher in patients with more severe disease. The presence of shock at presentation independently predicted mortality.","['Prajapati, Ritesh', 'Mehta, Rajiv', 'Kabrawala, Mayank', 'Nandwani, Subhash', 'Patel, Nisharg', 'Sethia, Mohit', 'Magnani, Kamlesh', 'Tandel, Raj', 'Kumar, Ashish']","['Prajapati R', 'Mehta R', 'Kabrawala M', 'Nandwani S', 'Patel N', 'Sethia M', 'Magnani K', 'Tandel R', 'Kumar A']",['ORCID: 0000-0002-8458-276X'],"['Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India. riteshprajapati87@gmail.com.', 'Department of Gastroenterology, Smt. R. B. Shah Mahavir Super Speciality Hospital, Surat, 395 001, India. riteshprajapati87@gmail.com.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Smt. R. B. Shah Mahavir Super Speciality Hospital, Surat, 395 001, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Smt. R. B. Shah Mahavir Super Speciality Hospital, Surat, 395 001, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Smt. R. B. Shah Mahavir Super Speciality Hospital, Surat, 395 001, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Surat Institute of Digestive Sciences, Majura Gate, Ring Road, Surat, 395 002, India.', 'Department of Gastroenterology, Sir Ganga Ram Hospital, New Delhi, 110 060, India.']",['eng'],['Journal Article'],20230619,India,Indian J Gastroenterol,Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,8409436,,IM,"['Male', 'Humans', 'Adult', 'Female', '*Severe Dengue/diagnosis/therapy', 'Incidence', 'Retrospective Studies', '*Hepatitis/complications', 'Multiple Organ Failure', '*Liver Failure, Acute/etiology', '*Dengue/complications/epidemiology/diagnosis']",,2023/06/19 13:09,2023/07/19 06:42,['2023/06/19 11:11'],"['2021/11/15 00:00 [received]', '2023/05/22 00:00 [accepted]', '2023/07/19 06:42 [medline]', '2023/06/19 13:09 [pubmed]', '2023/06/19 11:11 [entrez]']","['10.1007/s12664-023-01405-0 [pii]', '10.1007/s12664-023-01405-0 [doi]']",ppublish,Indian J Gastroenterol. 2023 Jun;42(3):355-360. doi: 10.1007/s12664-023-01405-0. Epub 2023 Jun 19.,3,['(c) 2023. Indian Society of Gastroenterology.'],['NOTNLM'],"['Acute liver failure', 'Dengue', 'Dengue hemorrhagic fever', 'Dengue hepatitis', 'Ferritin', 'Hemophagocytosis', 'Lactate dehydrogenase', 'Mortality', 'Prognostic markers', 'Severe dengue']",,['Indian J Gastroenterol. 2023 Jun;42(3):308-310. PMID: 37300795'],,,,,,,,,,,,,,,,,
27427141,NLM,MEDLINE,20170302,20170302,0030-9982 (Print) 0030-9982 (Linking),66,2016 Jul,Dengue viral infections in Pakistan and other Asian countries: a comprehensive review.,884-8,,"Infections due to Dengue virus are widespread throughout the world. Disease starts with mild flu like sickness to a severe intricate condition which results in the death of the patient. Dengue illness has high morbidity and mortality in Pakistan as well as in other Asian countries. The Review article is a discourse analysis that explores the facts about the history, emergence and impact of dengue in Pakistan and other Asian countries. Data was collected from internet sources, mainly using Science Direct and PubMed. The final literature was reviewed and summarised. About 150 articles were identified and 47 articles were shortlisted for final review. Aedesaegypti was found to be a major vector for the transmission and spread of dengue illness. Treatment comprises supportive therapy as no specific treatment was available. During the last couple of years, the incidence of dengue fever was extraordinary in metropolitan cities of Pakistan.","['Zubair, Muhammad', 'Ashraf, Muhammad', 'Ahsan, Aitezaz', 'Nazir, Noor-Ul-Ain', 'Hanif, Hina', 'Khan, Haider Ali']","['Zubair M', 'Ashraf M', 'Ahsan A', 'Nazir NU', 'Hanif H', 'Khan HA']",,"['Institute of Microbiology, University of Agriculture Faisalabad (UAF), Faisalabad, Pakistan.', 'Institute of Microbiology, University of Agriculture Faisalabad (UAF), Faisalabad, Pakistan.', 'Institute of Microbiology, University of Agriculture Faisalabad (UAF), Faisalabad, Pakistan.', 'Institute of Microbiology, University of Agriculture Faisalabad (UAF), Faisalabad, Pakistan.', 'Institute of Microbiology, University of Agriculture Faisalabad (UAF), Faisalabad, Pakistan.', 'Livestock and Dairy Development Punjab, Pakistan.']",['eng'],"['Journal Article', 'Review']",,Pakistan,J Pak Med Assoc,JPMA. The Journal of the Pakistan Medical Association,7501162,,IM,"['*Communicable Disease Control/methods/organization & administration', '*Dengue/diagnosis/epidemiology/therapy/virology', '*Dengue Virus/drug effects/physiology', 'Global Health', 'Humans', 'Incidence']",,2016/07/19 06:00,2017/03/03 06:00,['2016/07/19 06:00'],"['2016/07/19 06:00 [entrez]', '2016/07/19 06:00 [pubmed]', '2017/03/03 06:00 [medline]']",['7832 [pii]'],ppublish,J Pak Med Assoc. 2016 Jul;66(7):884-8.,7,,['NOTNLM'],"['Dengue, Clinical features, Pathogenesis, Diagnosis, Treatment.']",,,,,,,,,,,,,,,,,,,
25730702,NLM,MEDLINE,20150601,20220409,1740-1534 (Electronic) 1740-1526 (Linking),13,2015 Apr,The many projected futures of dengue.,230-9,10.1038/nrmicro3430 [doi],"Dengue is a vector-borne disease that causes a substantial public health burden within its expanding range. Several modelling studies have attempted to predict the future global distribution of dengue. However, the resulting projections are difficult to compare and are sometimes contradictory because the models differ in their approach, in the quality of the disease data that they use and in the choice of variables that drive disease distribution. In this Review, we compare the main approaches that have been used to model the future global distribution of dengue and propose a set of minimum criteria for future projections that, by analogy, are applicable to other vector-borne diseases.","['Messina, Jane P', 'Brady, Oliver J', 'Pigott, David M', 'Golding, Nick', 'Kraemer, Moritz U G', 'Scott, Thomas W', 'Wint, G R William', 'Smith, David L', 'Hay, Simon I']","['Messina JP', 'Brady OJ', 'Pigott DM', 'Golding N', 'Kraemer MU', 'Scott TW', 'Wint GR', 'Smith DL', 'Hay SI']",,"['Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', 'Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', '1] Department of Entomology and Nematology, University of California Davis, Davis, California 95616, USA. [2] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.', 'Environmental Research Group Oxford, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', '1] Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK. [2] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.', '1] Spatial Ecology and Epidemiology Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK. [2] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",20150302,England,Nat Rev Microbiol,Nature reviews. Microbiology,101190261,,IM,"['Animals', 'Dengue/*epidemiology/transmission/virology', 'Forecasting', 'Humans', '*Models, Biological', 'Models, Statistical']",,2015/03/03 06:00,2015/06/02 06:00,['2015/03/03 06:00'],"['2015/03/03 06:00 [entrez]', '2015/03/03 06:00 [pubmed]', '2015/06/02 06:00 [medline]']","['nrmicro3430 [pii]', '10.1038/nrmicro3430 [doi]']",ppublish,Nat Rev Microbiol. 2015 Apr;13(4):230-9. doi: 10.1038/nrmicro3430. Epub 2015 Mar 2.,4,,,,,,"['095066/Wellcome Trust/United Kingdom', 'P01AI098670/AI/NIAID NIH HHS/United States', 'R01-AI069341/AI/NIAID NIH HHS/United States', 'R01-AI091980/AI/NIAID NIH HHS/United States', 'R01-GM08322/GM/NIGMS NIH HHS/United States', 'Biotechnology and Biological Sciences Research Council/United Kingdom']",,,,,,,,,,,,,,,,
29221616,NLM,MEDLINE,20180702,20220316,1557-8615 (Electronic) 0883-9441 (Linking),43,2018 Feb,Dengue fever: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine.,346-351,S0883-9441(17)31712-4 [pii] 10.1016/j.jcrc.2017.11.003 [doi],"Dengue is an arbovirus affecting humans and spread by mosquitoes. Severe dengue follows a secondary infection with a different virus serotype. The problem is truly global as it is endemic in over 100 countries. Severe dengue can be a life-threatening because of increased vascular permeability, resulting in leakage of fluid from the intravascular compartment to the extravascular space. When major bleeding does occur, it is almost invariably combined with profound shock since this, in combination with thrombocytopenia, hypoxia, and acidosis, can lead to multiple organ failure and disseminated intravascular coagulation. Dengue hemorrhagic fever and dengue shock syndrome are among the leading causes of morbidity and mortality in patients suffering from Dengue. Commercial rapid tests and ELISA kits are freely available, ensuring early diagnosis. The basis of management of severe dengue is effective fluid replacement. Future directions in management will involve vector control and development of effective vaccination.","['Amin, Pravin', 'Acicbe, Ozlem', 'Hidalgo, Jorge', 'Jimenez, Juan Ignacio Silesky', 'Baker, Tim', 'Richards, Guy A']","['Amin P', 'Acicbe O', 'Hidalgo J', 'Jimenez JIS', 'Baker T', 'Richards GA']",,"['Department of Critical Care Medicine, Bombay Hospital Institute of Medical Sciences, Mumbai, India. Electronic address: pamin@vsnl.com.', 'Van Teaching and Research Hospital Intensive Care Unit, Van, Turkey.', 'Division of Critical Care, Karl Heusner Memorial Hospital/Belize Healthcare Partners Belize Central America, Belize.', 'Critical Care Unit, Hospital San Juan de Dios and Hospital CIMA, San Jose, Costa Rica.', 'Department of Anaesthesia & Intensive Care, Queen Elizabeth Central Hospital, Blantyre, Malawi; Global Health - Health Systems & Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.', 'Global Health - Health Systems & Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; Department of Critical Care Medicine, Bombay Hospital Institute of Medical Sciences, Mumbai, India.']",['eng'],"['Journal Article', 'Review']",20171105,United States,J Crit Care,Journal of critical care,8610642,['0 (Dengue Vaccines)'],IM,"['*Advisory Committees', 'Community Health Services', '*Critical Care', '*Dengue/diagnosis/prevention & control/therapy', 'Dengue Vaccines', 'Developing Countries', 'Diagnostic Tests, Routine', 'Early Diagnosis', 'Health Resources', 'Humans', 'Practice Guidelines as Topic', 'Risk Factors', '*Societies, Medical', '*Tropical Medicine']",,2017/12/10 06:00,2018/07/03 06:00,['2017/12/10 06:00'],"['2017/10/31 00:00 [received]', '2017/11/01 00:00 [accepted]', '2017/12/10 06:00 [pubmed]', '2018/07/03 06:00 [medline]', '2017/12/10 06:00 [entrez]']","['S0883-9441(17)31712-4 [pii]', '10.1016/j.jcrc.2017.11.003 [doi]']",ppublish,J Crit Care. 2018 Feb;43:346-351. doi: 10.1016/j.jcrc.2017.11.003. Epub 2017 Nov 5.,,['Copyright (c) 2017 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Capillary permeability', 'DHF', 'DIC', 'DSS', 'Dengue', 'Shock', 'Thrombocytopenia']",,,,,,,,,,,,,,,,,,,
25426178,NLM,MEDLINE,20150722,20181113,1911-2092 (Electronic),8,2014,Dengue fever: a Wikipedia clinical review.,e105-15,,"Dengue fever, also known as breakbone fever, is a mosquito-borne infectious tropical disease caused by the dengue virus. Symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles. In a small proportion of cases, the disease develops into life-threatening dengue hemorrhagic fever, which results in bleeding, thrombocytopenia, and leakage of blood plasma, or into dengue shock syndrome, in which dangerously low blood pressure occurs. Treatment of acute dengue fever is supportive, with either oral or intravenous rehydration for mild or moderate disease and use of intravenous fluids and blood transfusion for more severe cases. Along with attempts to eliminate the mosquito vector, work is ongoing to develop a vaccine and medications targeted directly at the virus.","['Heilman, James M', 'De Wolff, Jacob', 'Beards, Graham M', 'Basden, Brian J']","['Heilman JM', 'De Wolff J', 'Beards GM', 'Basden BJ']",,"['James M. Heilman, MD, CCFP(EM), is the Emergency Department Head at the East Kootenay Regional Hospital, Cranbrook, British Columbia, and is also a Clinical Instructor in the Department of Emergency Medicine, The University of British Columbia, Vancouver, British Columbia.', 'Jacob De Wolff, MRCP(UK), is a Consultant in Acute Medicine and High Dependency Medicine at Northwick Park Hospital, Harrow, Middlesex, UK.', 'Graham M. Beards, DSc, FIBMS, is a Clinical and Biomedical Scientist in blood science at Walsall Manor Hospital, Walsall, UK.', 'Brian J. Basden, BSc, is a Researcher with Battelle Memorial Institute, Atlanta, Georgia.']",['eng'],"['Journal Article', 'Review']",20141002,Canada,Open Med,"Open medicine : a peer-reviewed, independent, open-access journal",101319172,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/*physiopathology/prevention & control/therapy', 'Dengue Vaccines', 'Fluid Therapy', 'Humans', 'Insect Vectors', 'Mosquito Control']",PMC4242787,2014/11/27 06:00,2015/07/23 06:00,['2014/11/27 06:00'],"['2014/11/27 06:00 [entrez]', '2014/11/27 06:00 [pubmed]', '2015/07/23 06:00 [medline]']",['OpenMed-8-e105-e115 [pii]'],epublish,Open Med. 2014 Oct 2;8(4):e105-15. eCollection 2014.,4,,,,"['James Heilman and Brian Basden are board members of the Wiki Project Med', 'Foundation. Jacob De Wolff is a board member of Wiki Project Med Foundation and', 'the founder of WikiProject Medicine. Graham Beards is a Featured Article', 'Coordinator for the English Wikipedia. No financial competing interests declared.']",,,,,,,,,,,,,,,,,,
4745119,NLM,MEDLINE,19731215,20170214,0049-4755 (Print) 0049-4755 (Linking),3,1973 Oct,Dengue.,147-9,,,"['Smith, C E']",['Smith CE'],,,['eng'],['Journal Article'],,England,Trop Doct,Tropical doctor,1301706,,IM,"['Aedes', 'Africa', 'Arbovirus Infections', 'Asia', 'Australia', 'Central America', '*Dengue/diagnosis/epidemiology/microbiology/physiopathology/prevention & control/therapy', 'Dengue Virus', 'Disease Outbreaks', 'Hemorrhagic Fevers, Viral/epidemiology', 'Humans', 'Insect Vectors', 'Prognosis']",,1973/10/01 00:00,1973/10/01 00:01,['1973/10/01 00:00'],"['1973/10/01 00:00 [pubmed]', '1973/10/01 00:01 [medline]', '1973/10/01 00:00 [entrez]']",['10.1177/004947557300300402 [doi]'],ppublish,Trop Doct. 1973 Oct;3(4):147-9. doi: 10.1177/004947557300300402.,4,,,,,,,,,,,,,,,,,,,,,,
15035267,NLM,MEDLINE,20040326,20131121,1661-8157 (Print) 1661-8157 (Linking),93,2004 Jan 7,[Dengue fever].,3-8,,,"['Kolyvanos Naumann, U', 'Kaser, L', 'Vetter, W']","['Kolyvanos Naumann U', 'Kaser L', 'Vetter W']",,,['ger'],"['Case Reports', 'Journal Article', 'Review']",,Switzerland,Praxis (Bern 1994),Praxis,101468093,"['0 (Analgesics, Non-Narcotic)', '362O9ITL9D (Acetaminophen)']",IM,"['Acetaminophen/therapeutic use', 'Adult', 'Analgesics, Non-Narcotic/therapeutic use', '*Dengue/complications/diagnosis/drug therapy/epidemiology', 'Diagnosis, Differential', 'Humans', 'Male', 'Prognosis', 'Risk Factors', 'Severe Dengue/diagnosis', 'Time Factors']",,2004/03/24 05:00,2004/03/27 05:00,['2004/03/24 05:00'],"['2004/03/24 05:00 [pubmed]', '2004/03/27 05:00 [medline]', '2004/03/24 05:00 [entrez]']",['10.1024/0369-8394.93.1.3 [doi]'],ppublish,Praxis (Bern 1994). 2004 Jan 7;93(1-2):3-8. doi: 10.1024/0369-8394.93.1.3.,1-2,,,,,,,3,,Dengue-Fieber.,,,,,,,,,,,,,
24008741,NLM,MEDLINE,20140324,20130906,1532-0987 (Electronic) 0891-3668 (Linking),32,2013 Sep,Dengue fever in children: where are we now?,1020-2,10.1097/INF.0b013e31829fd0e9 [doi],,"['Elling, Roland', 'Henneke, Philipp', 'Hatz, Christoph', 'Hufnagel, Markus']","['Elling R', 'Henneke P', 'Hatz C', 'Hufnagel M']",,"['From the *Center of Pediatrics and Adolescent Medicine; daggerCentre of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany; and double daggerSwiss Tropical and Public Health Institute, Basel, Switzerland.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,,IM,"['Child', 'Child, Preschool', 'Communicable Disease Control/methods', 'Dengue/diagnosis/*epidemiology/*pathology/therapy', 'Humans', 'Infant']",,2013/09/07 06:00,2014/03/25 06:00,['2013/09/07 06:00'],"['2013/09/07 06:00 [entrez]', '2013/09/07 06:00 [pubmed]', '2014/03/25 06:00 [medline]']","['00006454-201309000-00029 [pii]', '10.1097/INF.0b013e31829fd0e9 [doi]']",ppublish,Pediatr Infect Dis J. 2013 Sep;32(9):1020-2. doi: 10.1097/INF.0b013e31829fd0e9.,9,,,,,,,,,,,,,,,,,,,,,,
23904319,NLM,MEDLINE,20140313,20190319,1942-7522 (Electronic) 0145-5613 (Linking),92,2013 Jul,Dengue fever: a primer for the otolaryngologist.,E5-9,,"It has been estimated that more than 50 million cases of dengue occur worldwide each year, mostly in the tropics. In light of recent cases appearing in central and southern Florida, dengue has reemerged as a public health issue in the United States with respect to infection control and prevention. We review the course of dengue infection and its clinical presentation from the perspective of the practicing otolaryngologist, and we outline tactics for prevention and management.","['Arnaoutakis, Demetri', 'Padhya, Tapan A']","['Arnaoutakis D', 'Padhya TA']",,"['Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-9035, USA. takis.demetri@gmail.com']",['eng'],"['Journal Article', 'Review']",,United States,Ear Nose Throat J,"Ear, nose, & throat journal",7701817,,IM,"['Dengue/*diagnosis/therapy', 'Disease Progression', 'Flavivirus/pathogenicity', 'Humans']",,2013/08/02 06:00,2014/03/14 06:00,['2013/08/02 06:00'],"['2013/08/02 06:00 [entrez]', '2013/08/02 06:00 [pubmed]', '2014/03/14 06:00 [medline]']",['10.1177/014556131309200713 [doi]'],ppublish,Ear Nose Throat J. 2013 Jul;92(7):E5-9. doi: 10.1177/014556131309200713.,7,,,,,,,,,,,,,,,,,,,,,,
25630344,NLM,MEDLINE,20151104,20181113,2047-7732 (Electronic) 2047-7724 (Print) 2047-7724 (Linking),109,2015 Feb,WHO dengue case classification 2009 and its usefulness in practice: an expert consensus in the Americas.,19-25,10.1179/2047773215Y.0000000003 [doi],"INTRODUCTION: In 2009, the new World Health Organization (WHO) dengue case classification - dengue/severe dengue (D/SD) - was introduced, replacing the 1997 WHO dengue case classification: dengue fever/dengue haemorrhagic fever/dengue shock syndrome (DF/DHF/DSS). METHODS: A 2-day expert consensus meeting in La Habana/Cuba aimed to (1) share the experiences from Pan American Health Organization (PAHO) member states when applying D/SD, (2) present national and local data using D/SD, and (3) agree with the presented evidence on a list of recommendations for or against the use of D/SD for PAHO, and also globally. RESULTS: Eight key questions were discussed, concluding: (1) D/SD is useful describing disease progression because it considers the dynamic nature of the disease, (2) D/SD helps defining dengue cases correctly for clinical studies, because it defines more precisely disease severity and allows evaluating dynamically the progression of cases, (3) D/SD describes correctly all clinical forms of severe dengue. Further standards need to be developed regionally, especially related to severe organ involvement, (4) D/SD allows for pathophysiological research identifying - in a sequential manner - the clinical manifestations of dengue related to pathophysiological events, (5) the warning signs help identifying early cases at risk of shock (children and adults), pathophysiology of the warning signs deserves further studies, (6) D/SD helps treating individual dengue cases and also the reorganization of health-care services for outbreak management, (7) D/SD helps diagnosing dengue, in presumptive diagnosis and follow-up of the disease, because of its high sensitivity and high negative predictive value (NPV), and (8) there is currently no update of the International Disease Classification10 (ICD10) to include the new classification of dengue (D/SD); therefore, there are not enough experiences of epidemiological reporting. Once D/SD has been implemented in epidemiological surveillance, D/SD allows to (1) identify severity of dengue cases in real time, for any decision-making on actions, (2) measure and compare morbidity and mortality in countries, and also globally, and (3) trigger contingency plans early, not only based on the number of reported cases but also on the reported severity of cases. CONCLUSION: The expert panel recommends to (1) update ICD10, (2) include D/SD in country epidemiological reports, and (3) implement studies improving sensitivity/specificity of the dengue case definition.","['Horstick, Olaf', 'Martinez, Eric', 'Guzman, Maria Guadalupe', 'Martin, Jose Luis San', 'Ranzinger, Silvia Runge']","['Horstick O', 'Martinez E', 'Guzman MG', 'Martin JL', 'Ranzinger SR']",,,['eng'],"['Consensus Development Conference', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20150128,England,Pathog Glob Health,Pathogens and global health,101583421,,IM,"['Americas/epidemiology', 'Dengue/*diagnosis/epidemiology/*pathology', 'Disease Progression', 'Epidemiologic Methods', 'Female', 'Humans', 'Male', 'World Health Organization']",PMC4445290,2015/01/30 06:00,2015/11/05 06:00,['2015/01/30 06:00'],"['2015/01/30 06:00 [entrez]', '2015/01/30 06:00 [pubmed]', '2015/11/05 06:00 [medline]']","['PGH-109-19 [pii]', '10.1179/2047773215Y.0000000003 [doi]']",ppublish,Pathog Glob Health. 2015 Feb;109(1):19-25. doi: 10.1179/2047773215Y.0000000003. Epub 2015 Jan 28.,1,,['NOTNLM'],"['Dengue case classification,', 'Expert consensus', 'WHO 1997 dengue case classification,', 'WHO 2009 dengue case classification,']",,,,,,,,,,,,,,,,,,,
25650206,NLM,MEDLINE,20160825,20200225,1473-4893 (Electronic) 1470-2118 (Print) 1470-2118 (Linking),15,2015 Feb,Dengue: an update for clinicians working in non-endemic areas.,82-5,10.7861/clinmedicine.15-1-82 [doi],"Dengue is one of the most rapidly emerging viral infections globally, with 2.5 billion people now thought to live in dengue-endemic areas. In addition, reports of travel-related and autochthonous infections are increasing in non-endemic areas. Most patients with dengue experience a self-limiting febrile illness, but a proportion develop potentially life threatening complications around the time of fever clearance, including plasma leakage occasionally leading to shock, bleeding, and organ impairment. As dengue can present with non-specific symptoms of fever, headache and myalgias, the potential for misdiagnosis and inappropriate management by medical staff inexperienced with the disease is a concern. This short review will outline the latest World Health Organisation disease classification, potential complications, clinical assessment and management for clinicians working in non-endemic areas.","['Yacoub, Sophie', 'Wills, Bridget']","['Yacoub S', 'Wills B']",,"['Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, and specialist registrar in infectious diseases, Imperial College, Department of Medicine, London, UK syacoub@imperial.ac.uk.', 'Wellcome Trust Major Overseas Programme, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, and professor of tropical medicine, Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, Oxford, UK.']",['eng'],"['Journal Article', 'Review']",,England,Clin Med (Lond),"Clinical medicine (London, England)",101092853,,IM,"['*Dengue/complications/pathology/physiopathology/therapy', 'Exanthema/pathology/virology', 'Humans', 'Skin/pathology']",PMC4954533,2015/02/05 06:00,2016/08/26 06:00,['2015/02/05 06:00'],"['2015/02/05 06:00 [entrez]', '2015/02/05 06:00 [pubmed]', '2016/08/26 06:00 [medline]']","['15/1/82 [pii]', 'clinmedicine [pii]', '10.7861/clinmedicine.15-1-82 [doi]']",ppublish,Clin Med (Lond). 2015 Feb;15(1):82-5. doi: 10.7861/clinmedicine.15-1-82.,1,['(c) 2015 Royal College of Physicians.'],['NOTNLM'],"['Dengue', 'clinical', 'management', 'travel', 'update']",,,['089276/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
36705100,NLM,MEDLINE,20230130,20230202,1815-672X (Electronic) 0028-2715 (Print) 0028-2715 (Linking),60,2022 Dec 1,Experiencing Dengue as a Medical Student.,1073-1075,10.31729/jnma.7915 [doi],Dengue is a disease which spreads by the bite of an infected Aedes mosquito. Reading about a disease in a textbook and experiencing it as a patient is a completely different thing. This article highlights the feeling of a medical student as a patient. It provides the reader with an idea of how Basic Science knowledge can be used for rational decision-making. Self- prescription of medication without consulting a doctor can be more harmful in many circumstances. We also need to be aware of the warning signs of Dengue virus infection. KEYWORDS: clopidogrel; dengue; medical student.,"['Shrestha, Shubham']",['Shrestha S'],,"['Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal.']",['eng'],['Journal Article'],20221201,Nepal,JNMA J Nepal Med Assoc,JNMA; journal of the Nepal Medical Association,0045233,,IM,"['Animals', 'Humans', '*Dengue/diagnosis/therapy', '*Dengue Virus', '*Students, Medical', '*Aedes']",PMC9795126,2023/01/28 06:00,2023/01/31 06:00,['2023/01/27 06:23'],"['2022/10/28 00:00 [received]', '2023/01/27 06:23 [entrez]', '2023/01/28 06:00 [pubmed]', '2023/01/31 06:00 [medline]']",['10.31729/jnma.7915 [doi]'],epublish,JNMA J Nepal Med Assoc. 2022 Dec 1;60(256):1073-1075. doi: 10.31729/jnma.7915.,256,,,,['None.'],,,,,,,,,,,,,,,,,,
28185869,NLM,MEDLINE,20170613,20220310,1474-4457 (Electronic) 1473-3099 (Linking),17,2017 Mar,Disease and economic burdens of dengue.,e70-e78,S1473-3099(16)30545-X [pii] 10.1016/S1473-3099(16)30545-X [doi],"The burden of dengue is large and growing. More than half of the global population lives in areas with risk of dengue transmission. Uncertainty in burden estimates, however, challenges policy makers' ability to set priorities, allocate resources, and plan for interventions. In this report, the first in a Series on dengue, we explore the estimations of disease and economic burdens of dengue, and the major estimation challenges, limitations, and sources of uncertainty. We also reflect on opportunities to remedy these deficiencies. Point estimates of apparent dengue infections vary widely, although the confidence intervals of these estimates overlap. Cost estimates include different items, are mostly based on a single year of data, use different monetary references, are calculated from different perspectives, and are difficult to compare. Comprehensive estimates that decompose the cost by different stakeholders (as proposed in our framework), that consider the cost of epidemic years, and that account for productivity and tourism losses, are scarce. On the basis of these estimates, we propose the most comprehensive framework for estimating the economic burden of dengue in any region, differentiated by four very different domains of cost items and by three potential stakeholders who bear the costs. This framework can inform future estimations of the economic burden of dengue and generate demand for additional routine administrative data collection, or for systematic incorporation of additional questions in nationally representative surveys in dengue-endemic countries. Furthermore, scholars could use the framework to guide scenario simulations that consider ranges of possible values for cost items for which data are not yet available. Results would be valuable to policy makers and would also raise awareness among communities, potentially improving dengue control efforts.","['Castro, Marcia C', 'Wilson, Mary E', 'Bloom, David E']","['Castro MC', 'Wilson ME', 'Bloom DE']",,"['Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA. Electronic address: mcastro@hsph.harvard.edu.', 'Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA; School of Medicine, University of California, San Francisco, CA, USA.', 'Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA.']",['eng'],"['Journal Article', 'Review']",20170207,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['*Cost of Illness', 'Dengue/*economics/*epidemiology/prevention & control/therapy', 'Health Policy/economics', 'Humans', 'Public Health/economics']",,2017/02/12 06:00,2017/06/14 06:00,['2017/02/11 06:00'],"['2016/03/02 00:00 [received]', '2016/11/28 00:00 [revised]', '2016/11/29 00:00 [accepted]', '2017/02/12 06:00 [pubmed]', '2017/06/14 06:00 [medline]', '2017/02/11 06:00 [entrez]']","['S1473-3099(16)30545-X [pii]', '10.1016/S1473-3099(16)30545-X [doi]']",ppublish,Lancet Infect Dis. 2017 Mar;17(3):e70-e78. doi: 10.1016/S1473-3099(16)30545-X. Epub 2017 Feb 7.,3,['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
19690,NLM,MEDLINE,19771031,20210522,0025-729X (Print) 0025-729X (Linking),2,1977 Jul 16,Dengue fever.,75-6,,,"['Black, R H']",['Black RH'],,,['eng'],['Editorial'],,Australia,Med J Aust,The Medical journal of Australia,0400714,,IM,"['Animals', 'Asia, Southeastern', 'Australia', 'Child', 'Child, Preschool', 'Culicidae', '*Dengue/diagnosis/epidemiology/transmission', 'Haplorhini', 'Humans', 'Infant', 'Pacific Islands']",,1977/07/16 00:00,1977/07/16 00:01,['1977/07/16 00:00'],"['1977/07/16 00:00 [pubmed]', '1977/07/16 00:01 [medline]', '1977/07/16 00:00 [entrez]']",['10.5694/j.1326-5377.1977.tb99052.x [doi]'],ppublish,Med J Aust. 1977 Jul 16;2(3):75-6. doi: 10.5694/j.1326-5377.1977.tb99052.x.,3,,,,,,,,,,,,,,,,,,,,,,
26506726,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,DENGUE: GLOBAL THREAT.,3-10,,"Dengue is a mosquito-borne viral disease, which is currently an expanding global problem. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infection to undifferentiated fever, dengue fever (DF), and dengue hemorrhagic fever (DHF). DHF is characterized by fever, bleeding diathesis, and a tendency to develop a potentially fatal shock syndrome. Dengue infection with organ impairment mainly involves the central nervous system and the liver. Consistent hematological findings include vasculopathy, coagulopathy, and thrombocytopenia. Laboratory diagnosis includes virus isolation, serology, and detection of dengue ribonucleic acid. Successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. A severity-based revised dengue classification for medical interventions has been developed and validated in many countries. There is no specific dengue treatment, and prevention is currently limited to vector control measures. The world's first, large-scale dengue vaccine efficacy study demonstrated its efficacy and a reduction of dengue disease severity with a good safety profile in a study of more than 30,000 volunteers from Asia and Latin America.","['Thisyakorn, Usa', 'Thisyakorn, Chule']","['Thisyakorn U', 'Thisyakorn C']",,,['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['*Dengue/diagnosis/epidemiology/therapy/virology', 'Dengue Virus/*physiology', 'Humans', 'Severe Dengue/diagnosis/epidemiology/therapy/virology']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:3-10.,,,,,,,,,,,,,,,,,,,,,,,
21514129,NLM,MEDLINE,20110831,20110606,1879-0372 (Electronic) 0952-7915 (Linking),23,2011 Jun,Dengue vaccines: progress and challenges.,391-8,10.1016/j.coi.2011.03.005 [doi],"With several dengue vaccine candidates progressing through clinical trials, several options for controlling this disease appear feasible. This would represent a major achievement and reflect decades of research and development activities. The challenges associated with the limited understanding of protective responses and those factors which determine disease severity remain, but with prospective studies ongoing in various dengue endemic areas and the initiation of dengue vaccine efficacy trials, immune responses are being evaluated in the context of protection and severe disease and these studies are highly likely to provide additional insights.","['Coller, Beth-Ann G', 'Clements, David E']","['Coller BA', 'Clements DE']",,"['Vaccines Research, WP17-2131, Merck and Company, 770 Sumneytown Pike, P.O. Box 4, West Point, PA 19486, United States. beth-ann.coller@merck.com']",['eng'],"['Journal Article', 'Review']",20110421,England,Curr Opin Immunol,Current opinion in immunology,8900118,['0 (Dengue Vaccines)'],IM,"['Animals', 'Clinical Trials as Topic', '*Dengue/epidemiology/immunology/pathology/prevention & control', 'Dengue Vaccines/*immunology/therapeutic use', 'Humans']",,2011/04/26 06:00,2011/09/01 06:00,['2011/04/26 06:00'],"['2011/01/18 00:00 [received]', '2011/03/21 00:00 [revised]', '2011/03/23 00:00 [accepted]', '2011/04/26 06:00 [entrez]', '2011/04/26 06:00 [pubmed]', '2011/09/01 06:00 [medline]']","['S0952-7915(11)00030-6 [pii]', '10.1016/j.coi.2011.03.005 [doi]']",ppublish,Curr Opin Immunol. 2011 Jun;23(3):391-8. doi: 10.1016/j.coi.2011.03.005. Epub 2011 Apr 21.,3,['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
26093055,NLM,MEDLINE,20160623,20220309,1549-9642 (Electronic) 1549-9634 (Linking),11,2015 Oct,Diagnosing dengue virus infection: rapid tests and the role of micro/nanotechnologies.,1745-61,S1549-9634(15)00124-0 [pii] 10.1016/j.nano.2015.05.009 [doi],"Due to the progressive spread of the dengue virus and a rising incidence of dengue disease, its rapid diagnosis is important for developing countries and of increasing relevance for countries in temperate climates. Recent advances in bioelectronics, micro- and nanofabrication technologies have led to new miniaturized point-of-care devices and analytical platforms suited for rapid detection of infections. Starting from the available tests for dengue diagnosis, this review examines emerging rapid, micro/nanotechnologies-based tools, including label-free biosensor methods, microarray and microfluidic platforms, which hold significant potential, but still need further development and evaluation. The epidemiological and clinical setting as key determinants for selecting the best analytical strategy in patients presenting with fever is then discussed. This review is aimed at the clinicians and microbiologists to deepen understanding and enhance application of dengue diagnostics, and also serves as knowledge base for researchers and test developers to overcome the challenges posed by this disease. FROM THE CLINICAL EDITOR: Dengue disease remains a significant problem in many developing countries. Unfortunately rapid diagnosis with easy and low cost tests for this disease is currently still not realized. In this comprehensive review, the authors highlighted recent advances in nanotechnology which would enable development in this field, which would result in beneficial outcomes to the population.","['Zhang, Bei', 'Salieb-Beugelaar, Georgette B', 'Nigo, Maurice Mutro', 'Weidmann, Manfred', 'Hunziker, Patrick']","['Zhang B', 'Salieb-Beugelaar GB', 'Nigo MM', 'Weidmann M', 'Hunziker P']",,"['Nanomedicine Research Laboratory, Medical Intensive Care Clinic, University Hospital Basel, Basel, Switzerland. Electronic address: bei.zhang@usb.ch.', 'Nanomedicine Research Laboratory, Medical Intensive Care Clinic, University Hospital Basel, Basel, Switzerland; CLINAM-European Foundation for Clinical Nanomedicine, Basel, Switzerland. Electronic address: beugelaar@swissnano.org.', 'Nanomedicine Research Laboratory, Medical Intensive Care Clinic, University Hospital Basel, Basel, Switzerland; Institut Superieur des Techniques Medicales-NYANKUNDE, Bunia, Congo. Electronic address: mmnigo@swissnano.org.', 'Institute of Aquaculture, University of Stirling, Stirling, UK. Electronic address: m.w.weidmann@stir.ac.uk.', 'Nanomedicine Research Laboratory, Medical Intensive Care Clinic, University Hospital Basel, Basel, Switzerland; CLINAM-European Foundation for Clinical Nanomedicine, Basel, Switzerland. Electronic address: patrick.hunziker@usb.ch.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20150617,United States,Nanomedicine,"Nanomedicine : nanotechnology, biology, and medicine",101233142,,IM,"['*Biosensing Techniques', 'Dengue/*diagnosis/pathology/virology', 'Dengue Virus/isolation & purification/pathogenicity', 'Humans', 'Microfluidics', '*Nanotechnology']",,2015/06/21 06:00,2016/06/24 06:00,['2015/06/21 06:00'],"['2015/02/24 00:00 [received]', '2015/05/15 00:00 [revised]', '2015/05/25 00:00 [accepted]', '2015/06/21 06:00 [entrez]', '2015/06/21 06:00 [pubmed]', '2016/06/24 06:00 [medline]']","['S1549-9634(15)00124-0 [pii]', '10.1016/j.nano.2015.05.009 [doi]']",ppublish,Nanomedicine. 2015 Oct;11(7):1745-61. doi: 10.1016/j.nano.2015.05.009. Epub 2015 Jun 17.,7,['Copyright (c) 2015 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Dengue virus', 'Label-free biosensor', 'Microfluidic platform', 'Point-of-care', 'Rapid diagnosis']",,"['Nanomedicine. 2016 Jan;12(1):249. PMID: 26360415', 'Nanomedicine. 2016 Jan;12(1):251-2. PMID: 26360416']",,,,,,,,,,,,,,,,,
22506663,NLM,MEDLINE,20121009,20120619,1651-1980 (Electronic) 0036-5548 (Linking),44,2012 Jul,Dengue fever-like illnesses: how different are they from each other?,522-30,10.3109/00365548.2012.669044 [doi],"In tropical countries and possibly elsewhere, dengue fever can be confused with other common tropical infections like enteric fever, leptospirosis, typhus fever, malaria, etc. Many of these illnesses can present in significant numbers after rains, and because of similar early presentations, can cause confusion in decision-making. With global warming, these diseases can assume significant proportions even in non-endemic areas. Identifying these illnesses in a non-immune returning traveller is equally challenging. Recognition of these diseases is important to diagnose them and treat them early, in order to avoid potentially fatal complications. This review is an attempt to highlight important clinical and laboratory differences among dengue fever-like illnesses.","['Gulati, Sameer', 'Maheshwari, Anu']","['Gulati S', 'Maheshwari A']",,"['Department of Internal Medicine, St Stephens Hospital, Tis Hazari, Delhi, India. drsameergulati@gmail.com']",['eng'],"['Journal Article', 'Review']",20120416,England,Scand J Infect Dis,Scandinavian journal of infectious diseases,0215333,,IM,"['Dengue/*diagnosis/epidemiology/*pathology', 'Diagnosis, Differential', 'Global Warming', 'Humans', 'Travel', 'Tropical Climate', 'Weather']",,2012/04/18 06:00,2012/10/10 06:00,['2012/04/18 06:00'],"['2012/04/18 06:00 [entrez]', '2012/04/18 06:00 [pubmed]', '2012/10/10 06:00 [medline]']",['10.3109/00365548.2012.669044 [doi]'],ppublish,Scand J Infect Dis. 2012 Jul;44(7):522-30. doi: 10.3109/00365548.2012.669044. Epub 2012 Apr 16.,7,,,,,,,,,,,,,,,,,,,,,,
26494479,NLM,MEDLINE,20160920,20230920,1995-820X (Electronic) 1674-0769 (Print) 1995-820X (Linking),30,2015 Oct,Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.,326-43,10.1007/s12250-015-3624-1 [doi],"Every year, millions of individuals throughout the world are seriously affected by dengue virus. The unavailability of a vaccine and of anti-viral drugs has made this mosquito-borne disease a serious health concern. Not only does dengue cause fatalities but it also has a profoundly negative economic impact. In recent decades, extensive research has been performed on epidemiology, vector biology, life cycle, pathogenesis, vaccine development and prevention. Although dengue research is still not at a stage to suggest definite hopes of a cure, encouraging significant advances have provided remarkable progress in the fight against infection. Recent developments indicate that both anti-viral drug and vaccine research should be pursued, in parallel with vector control programs.","['Islam, Rashedul', 'Salahuddin, Mohammed', 'Ayubi, Md Salahuddin', 'Hossain, Tahmina', 'Majumder, Apurba', 'Taylor-Robinson, Andrew W', 'Mahmud-Al-Rafat, Abdullah']","['Islam R', 'Salahuddin M', 'Ayubi MS', 'Hossain T', 'Majumder A', 'Taylor-Robinson AW', 'Mahmud-Al-Rafat A']",,"['Bio-Resources Technology and Industrial Biotechnology Laboratory, Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, 1342, Bangladesh.', 'Bio-Resources Technology and Industrial Biotechnology Laboratory, Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, 1342, Bangladesh.', 'Bio-Resources Technology and Industrial Biotechnology Laboratory, Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, 1342, Bangladesh.', 'Bio-Resources Technology and Industrial Biotechnology Laboratory, Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Dhaka, 1342, Bangladesh.', 'Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9100, Bangladesh.', 'School of Medical & Applied Sciences, Central Queensland University, Rockhampton, 4701, Australia.', 'Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna, 9100, Bangladesh. mahmud0907@gmail.com.', 'Research and Development (R&D) Department, Incepta Vaccine Limited, Zirabo, Savar, Dhaka, 1341, Bangladesh. mahmud0907@gmail.com.']",['eng'],"['Journal Article', 'Review']",20151020,Netherlands,Virol Sin,Virologica Sinica,101514185,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/*epidemiology/*etiology/prevention & control', 'Dengue Vaccines/administration & dosage', 'Dengue Virus/pathogenicity', 'Disease Models, Animal', 'Humans', 'Life Cycle Stages', 'Mice']",PMC8200867,2015/10/24 06:00,2016/09/22 06:00,['2015/10/24 06:00'],"['2015/07/10 00:00 [received]', '2015/10/07 00:00 [accepted]', '2015/10/24 06:00 [entrez]', '2015/10/24 06:00 [pubmed]', '2016/09/22 06:00 [medline]']","['10.1007/s12250-015-3624-1 [pii]', '3624 [pii]', '10.1007/s12250-015-3624-1 [doi]']",ppublish,Virol Sin. 2015 Oct;30(5):326-43. doi: 10.1007/s12250-015-3624-1. Epub 2015 Oct 20.,5,,['NOTNLM'],"['animal model', 'anti-viral', 'dengue', 'dengue vaccine', 'epidemiology', 'pathogenesis', 'vector control']",,,,,,,,,,,,,,,,,,,
31326532,NLM,MEDLINE,20200218,20200218,1873-0442 (Electronic) 1477-8939 (Linking),31,2019 Sep-Oct,Dengue in Honduras and the Americas: The epidemics are back!,101456,S1477-8939(19)30137-1 [pii] 10.1016/j.tmaid.2019.07.012 [doi],,"['Zambrano, Lysien I', 'Rodriguez, Edith', 'Espinoza-Salvado, Ivan Alfonso', 'Rodriguez-Morales, Alfonso J']","['Zambrano LI', 'Rodriguez E', 'Espinoza-Salvado IA', 'Rodriguez-Morales AJ']",,"['Department of Morphological Sciences, School of Medical Sciences, Universidad Nacional Autonoma de Honduras, Tegucigalpa, Honduras; Cardiovascular Division, Department of Physiology, Escola Paulista de Medicina (UNIFESP-EPM), Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Colombian Collaborative Network of Zika (RECOLZIKA), Pereira, Risaralda, Colombia.', 'Unidad de Vigilancia de la Salud, Secretaria de Salud, Tegucigalpa, Honduras.', 'Unidad de Investigacion Cientifica, Facultad de Ciencias Medicas, Universidad Nacional Autonoma de Honduras, Tegucigalpa, Honduras.', 'Colombian Collaborative Network of Zika (RECOLZIKA), Pereira, Risaralda, Colombia; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama. Electronic address: arodriguezm@utp.edu.co.']",['eng'],['Editorial'],20190718,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,,IM,"['Dengue/*epidemiology/mortality/prevention & control', 'Honduras/epidemiology', 'Humans', 'Latin America/epidemiology', 'Risk Factors', 'Transients and Migrants', 'Travel']",,2019/07/22 06:00,2020/02/19 06:00,['2019/07/22 06:00'],"['2019/07/16 00:00 [received]', '2019/07/17 00:00 [accepted]', '2019/07/22 06:00 [pubmed]', '2020/02/19 06:00 [medline]', '2019/07/22 06:00 [entrez]']","['S1477-8939(19)30137-1 [pii]', '10.1016/j.tmaid.2019.07.012 [doi]']",ppublish,Travel Med Infect Dis. 2019 Sep-Oct;31:101456. doi: 10.1016/j.tmaid.2019.07.012. Epub 2019 Jul 18.,,,['NOTNLM'],"['Arbovirus', 'Chikungunya', 'Dengue', 'Epidemic', 'Honduras', 'Latin America', 'Severe dengue', 'Travelers', 'Zika']",,,,,,,,,,,,,,,,,,,
26061055,NLM,MEDLINE,20150824,20181113,0738-0658 (Print) 2373-6011 (Electronic) 0738-0658 (Linking),34,2015 Jun,Recent Advances in Dengue: Relevance to Puerto Rico.,65-70,,"Dengue represents an increasingly important public health challenge in Puerto Rico, with recent epidemics in 2007, 2010, and 2012-2013. Although recent advances in dengue vaccine development offer hope for primary prevention, the role of health professionals in the diagnosis and management of dengue patients is paramount. Case definitions for dengue, dengue with warning signs, and severe dengue provide a framework to guide clinical decision-making. Furthermore, the differentiation between dengue and other acute febrile illnesses, such as leptospirosis and chikungunya, is necessary for the appropriate diagnosis and management of cases. An understanding of dengue epidemiology and surveillance in Puerto Rico provides context for clinicians in epidemic and non-epidemic periods. This review aims to improve health professionals' ability to diagnose dengue, and as highlight the relevance of recent advances in dengue prevention and management in Puerto Rico.","['Noyd, David H', 'Sharp, Tyler M']","['Noyd DH', 'Sharp TM']",,"['Oregon Health and Science University, Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, PR.', 'Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, PR.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,Puerto Rico,P R Health Sci J,Puerto Rico health sciences journal,8303541,,IM,"['*Dengue/diagnosis/epidemiology/prevention & control', 'Epidemiological Monitoring', 'Humans', 'Puerto Rico/epidemiology']",PMC4587385,2015/06/11 06:00,2015/08/25 06:00,['2015/06/11 06:00'],"['2015/06/11 06:00 [entrez]', '2015/06/11 06:00 [pubmed]', '2015/08/25 06:00 [medline]']",,ppublish,P R Health Sci J. 2015 Jun;34(2):65-70.,2,,['NOTNLM'],"['Dengue', 'Epidemiology', 'Public Health']",['The authors have no conflicts of interest to disclose.'],,"['CC999999/Intramural CDC HHS/United States', 'TL1 TR000129/TR/NCATS NIH HHS/United States', 'TL1TR000129/TR/NCATS NIH HHS/United States']",,,,['NIHMS723031'],['NLM: HHSPA723031'],,,,,,,,,,,
10913412,NLM,MEDLINE,20001103,20220311,1058-4838 (Print) 1058-4838 (Linking),31,2000 Jul,Dengue fever in international travelers.,144-7,,"Dengue virus infection is becoming increasingly recognized as one of the world's major emerging infectious diseases. Although only a few systematic studies have been conducted to assess the incidence and clinical course of dengue fever in travelers, it is now possible to estimate risk factors for travelers to areas of endemicity. Dengue virus and its vector, Aedes mosquitoes, benefit from human habitation and travel-related aspects of human behavior. Thus, travelers serve an important double role as potential victims of the disease and as vehicles for further spread of dengue.","['Jelinek, T']",['Jelinek T'],,"['Department of Infectious Diseases and Tropical Medicine, University of Munich, 80802 Munich, Germany. jelinek@lrz.uni-muenchen.de']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20000726,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,,IM,"['Animals', 'Dengue/*epidemiology/physiopathology/prevention & control', 'Humans', 'Risk Factors', '*Travel']",,2000/07/29 11:00,2001/02/28 10:01,['2000/07/29 11:00'],"['2000/02/07 00:00 [received]', '2000/04/18 00:00 [revised]', '2000/07/29 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/07/29 11:00 [entrez]']","['CID000146 [pii]', '10.1086/313889 [doi]']",ppublish,Clin Infect Dis. 2000 Jul;31(1):144-7. doi: 10.1086/313889. Epub 2000 Jul 26.,1,,,,,,,36,,,,,,,,,,,,,,,
22585121,NLM,MEDLINE,20120619,20211021,1750-8460 (Print) 1750-8460 (Linking),73,2012 Apr,Dengue fever: a practical guide.,C60-4,,,"['Roberts, Catherine H', 'Mongkolsapaya, Juthathip', 'Screaton, Gavin']","['Roberts CH', 'Mongkolsapaya J', 'Screaton G']",,"['Hospital for Tropical Diseases, London WC1E 6JB. catherine.roberts@uclh.nhs.uk']",['eng'],"['Journal Article', 'Review']",,England,Br J Hosp Med (Lond),"British journal of hospital medicine (London, England : 2005)",101257109,,IM,"['Dengue/*diagnosis/pathology/therapy', 'Diagnosis, Differential', 'Fluid Therapy', 'Humans', 'Mosquito Control/methods', 'Severe Dengue/diagnosis/pathology/therapy', 'Travel']",,2012/05/16 06:00,2012/06/20 06:00,['2012/05/16 06:00'],"['2012/05/16 06:00 [entrez]', '2012/05/16 06:00 [pubmed]', '2012/06/20 06:00 [medline]']",['10.12968/hmed.2012.73.sup4.c60 [doi]'],ppublish,Br J Hosp Med (Lond). 2012 Apr;73(4):C60-4. doi: 10.12968/hmed.2012.73.sup4.c60.,4,,,,,,['095541/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
20103874,NLM,MEDLINE,20100514,20131121,1881-7823 (Electronic) 1881-7815 (Linking),1,2007 Oct,Dengue infection: a growing global health threat.,90-6,,"Dengue infection, one of the most devastating mosquito-borne viral diseases in humans, is now a significant problem in several tropical countries. The disease, caused by the four dengue virus serotypes, ranges from asymptomatic infection to undifferentiated fever, dengue fever (DF), and severe dengue hemorrhagic fever (DHF) with or without shock. DHF is characterized by fever, bleeding diathesis and a tendency to develop a potentially fatal shock syndrome. Consistent hematological findings include vasculopathy, coagulopathy, and thrombocytopenia. There are increasing reports of dengue infection with unusual manifestations that mainly involve cerebral and hepatic symptoms. Laboratory diagnosis includes virus isolation, serology, and detection of dengue ribonucleic acid. Successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. Prevention depends primarily on control of the mosquito vector. Further study of the pathogenesis of DHF is required for the development of a safe and effective dengue vaccine.","['Hemungkorn, Marisa', 'Thisyakorn, Usa', 'Thisyakorn, Chule']","['Hemungkorn M', 'Thisyakorn U', 'Thisyakorn C']",,"['Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.']",['eng'],"['Journal Article', 'Review']",,Japan,Biosci Trends,Bioscience trends,101502754,,IM,"['Dengue/*diagnosis/*epidemiology/pathology/physiopathology', 'Humans', 'Severe Dengue/diagnosis/epidemiology/pathology/physiopathology']",,2007/10/01 00:00,2010/05/15 06:00,['2010/01/28 06:00'],"['2010/01/28 06:00 [entrez]', '2007/10/01 00:00 [pubmed]', '2010/05/15 06:00 [medline]']",,ppublish,Biosci Trends. 2007 Oct;1(2):90-6.,2,,,,,,,65,,,,,,,,,,,,,,,
37401233,NLM,MEDLINE,20230705,20230705,1681-7168 (Electronic) 1022-386X (Linking),33,2023 Jul,Sequential Dengue Infection: Prevention Priorities.,831,10.29271/jcpsp.2023.07.831 [doi],Null.,"['Aslam, Javaria', 'Hassam, Khawaja', 'Naeem, Muhammad Abdullah']","['Aslam J', 'Hassam K', 'Naeem MA']",,"['Department of Medicine, Quaid-e-Azam Medical College, Bahawalpur, Pakistan.', 'Liver Centre Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA.', 'Department of Surgery, Sadiq Abbasi Hospital, Bahawalpur, Pakistan.']",['eng'],['Journal Article'],,Pakistan,J Coll Physicians Surg Pak,Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,9606447,,IM,"['Humans', '*Dengue/epidemiology/prevention & control']",,2023/07/04 06:42,2023/07/05 06:42,['2023/07/04 03:02'],"['2023/02/14 00:00 [received]', '2023/04/08 00:00 [accepted]', '2023/07/05 06:42 [medline]', '2023/07/04 06:42 [pubmed]', '2023/07/04 03:02 [entrez]']","['040579197 [pii]', '10.29271/jcpsp.2023.07.831 [doi]']",ppublish,J Coll Physicians Surg Pak. 2023 Jul;33(7):831. doi: 10.29271/jcpsp.2023.07.831.,7,,,,,,,,,,,,,,,,,,,,,,
36579820,NLM,MEDLINE,20230406,20230406,1758-1133 (Electronic) 0049-4755 (Linking),53,2023 Apr,Respiratory sequelae of dengue fever.,237-240,10.1177/00494755221127355 [doi],"Dengue viral illness is endemic in many tropical countries with temperate climates. The haematological and cardiovascular sequelae of dengue are well known; however, respiratory manifestations are still an area of active medical research. We conducted a literature search on PubMed, Medline CINAHIL, EMBASE and found 64 articles on respiratory sequelae of dengue. All relevant original articles and case reports were included and the relevant information regarding the respiratory manifestations of dengue was retrieved from the relevant eligible articles. Respiratory manifestations of dengue range from mild pleural effusion to acute respiratory distress syndrome. The former was the most common complication, seen in 5.1% of patients, followed by acute respiratory distress syndrome (ARDS) in 1.7%, pneumonia in 0.5%, respiratory distress in 0.3%, pulmonary hemorrhage in 0.1%, and haemothorax in 0.01%. Involvement of the respiratory system indicates severe disease and is difficult to manage. Therefore its early detection is important.","['Mehmood, Asad', 'Afzal, Muhammad Waqas', 'Ahmad, Muhammad', 'Mufti, Mahreen', 'Malik, Jahanzeb', 'Zaidi, Syed Muhammad Jawad']","['Mehmood A', 'Afzal MW', 'Ahmad M', 'Mufti M', 'Malik J', 'Zaidi SMJ']","['ORCID: 0000-0001-5093-0714', 'ORCID: 0000-0001-9015-3008', 'ORCID: 0000-0002-9343-4187', 'ORCID: 0000-0002-3513-6974']","['Department of Cardiology, 418648Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.', 'Sheikh Zayed Medical College, Rahim Yar Khan Pakistan.', 'Department of Medicine, Bahawal Victoria Hospital, Bahawalpur, Pakistan.', 'Department of Medicine, 66909Allama Iqbal Medical College, Lahore, Pakistan.', 'Department of Cardiac Electrophysiology, Armed Forces Institute of Cardiology, National Institute of Heart Diseases, Rawalpindi, Pakistan.', 'Department of Medicine, 123683Rawalpindi Medical University and Allied Hospitals, Rawalpindi, Pakistan.']",['eng'],['Journal Article'],20221229,England,Trop Doct,Tropical doctor,1301706,,IM,"['Humans', '*Dengue/complications/diagnosis/epidemiology', '*Severe Dengue/complications/diagnosis/epidemiology', '*Respiratory Distress Syndrome/diagnosis/etiology', '*Pleural Effusion', 'Early Diagnosis']",,2022/12/30 06:00,2023/04/06 10:16,['2022/12/29 07:53'],"['2023/04/06 10:16 [medline]', '2022/12/30 06:00 [pubmed]', '2022/12/29 07:53 [entrez]']",['10.1177/00494755221127355 [doi]'],ppublish,Trop Doct. 2023 Apr;53(2):237-240. doi: 10.1177/00494755221127355. Epub 2022 Dec 29.,2,,['NOTNLM'],"['Dengue', 'respiratory manifestations']",,,,,,,,,,,,,,,,,,,
23455936,NLM,MEDLINE,20130828,20211021,1432-1955 (Electronic) 0932-0113 (Linking),112,2013 Apr,Fight against dengue in India: progresses and challenges.,1367-78,10.1007/s00436-013-3342-2 [doi],"At the end of the last century, India has faced resurgence of many infectious diseases, of which dengue is one of the most important in terms of morbidity and mortality. The National Vector Borne Disease Control Program data show that dengue is established in India and is becoming endemic to many areas (dengue cases have increased steadily from  approximately 450 to  approximately 50,000 from 2000 to 2012). Despite extensive efforts being made in developing the effective dengue control measures, the number of dengue cases, their severity, and geographical boundaries are expanding alarmingly and posing dengue as one of the deadly disease. Recently, the increasing burden of dengue in the country has attracted the scientific as well as Indian Government's administrative attention; however, a lot remain to be achieved for managing the disease under threshold level. Like other vector-borne diseases, better management of the dengue needs balanced approach involving various aspects like disease prevention, cure/treatment, and the vector control, simultaneously. We have briefly discussed here the situation of dengue in India and have tried to highlight the worrying facets of dengue control and its implementation in Indian perspective. The review on various aspects of dengue control has revealed an urgent need for permanent surveillance programs, coupled with improvised disease diagnostics, effective anti-dengue treatment measures, and controlling the disease transmission by following an effective implementation of vector control programs.","['Gupta, Bhavna', 'Reddy, B P Niranjan']","['Gupta B', 'Reddy BP']",,"['Agriculture Department, Gole Pully, Talab Tillo, Jammu, 180002, India. bhavnaguptaster@gmail.com']",['eng'],"['Journal Article', 'Review']",20130228,Germany,Parasitol Res,Parasitology research,8703571,,IM,"['Communicable Disease Control/*methods', 'Dengue/*epidemiology/*prevention & control/transmission', 'Disease Transmission, Infectious/*prevention & control', 'Humans', 'Incidence', 'India/epidemiology']",,2013/03/05 06:00,2013/08/29 06:00,['2013/03/05 06:00'],"['2012/11/06 00:00 [received]', '2013/02/05 00:00 [accepted]', '2013/03/05 06:00 [entrez]', '2013/03/05 06:00 [pubmed]', '2013/08/29 06:00 [medline]']",['10.1007/s00436-013-3342-2 [doi]'],ppublish,Parasitol Res. 2013 Apr;112(4):1367-78. doi: 10.1007/s00436-013-3342-2. Epub 2013 Feb 28.,4,,,,,,,,,,,,,,,,,,,,,,
28757293,NLM,MEDLINE,20181109,20220321,1876-035X (Electronic) 1876-0341 (Linking),11,2018 Mar-Apr,Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.,215-223,S1876-0341(17)30195-8 [pii] 10.1016/j.jiph.2017.07.021 [doi],"BACKGROUND: Determining the disease and economic burden of dengue is critical for the allocation of public health resources. Several studies have used disability-adjusted life-years (DALYs) to estimate the disease burden of dengue in different regions. However, there are no published studies discussing the estimates of dengue-related economic and disease burden specifically in Taiwan. OBJECTIVES: We assessed the economic cost and disease burden of dengue infections in Taiwan for the period 1998-2014, and compared these during epidemic and non-epidemic years. METHODS: We estimated the annual DALYs per million population using the disability weights for dengue fever (DF), dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS), and death cases. Economic costs were estimated and divided into direct (medical costs) and indirect costs (lost work days and caregiver fees). RESULTS: For the period 1998-2014, a mean of 115.3 (range: 6.3-934.3) DALYs per million population annually were lost to dengue. In epidemic years, direct costs associated with dengue resulted mostly from hospitalization (86.09%), emergency (7.77%), outpatient (6.10%), and drug costs (0.03%). For indirect costs, lost productivity due to death (70.76%) was the dominant contributor. Overall, the costs were 12.3 times higher in epidemic years than in non-epidemic years (Wilcoxon rank sum test, p<0.05). CONCLUSIONS: This study is the first to evaluate the economic costs and disease burden of dengue infections for this period in Taiwan, and reveals significant differences in economic impact between epidemic and non-epidemic years.","['Luh, Dih-Ling', 'Liu, Cheng-Chieh', 'Luo, Yun-Ru', 'Chen, Szu-Chieh']","['Luh DL', 'Liu CC', 'Luo YR', 'Chen SC']",,"['Department of Public Health, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, ROC.', 'Department of Public Health, Chung Shan Medical University, Taichung 40201, Taiwan, ROC.', 'Department of Public Health, Chung Shan Medical University, Taichung 40201, Taiwan, ROC.', 'Department of Public Health, Chung Shan Medical University, Taichung 40201, Taiwan, ROC; Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, ROC. Electronic address: scchen@csmu.edu.tw.']",['eng'],"['Journal Article', 'Review']",20170727,England,J Infect Public Health,Journal of infection and public health,101487384,,IM,"['Asia, Southeastern/epidemiology', '*Cost of Illness', 'Dengue/complications/*economics/*epidemiology/mortality', 'Disabled Persons', '*Epidemics', 'Female', 'Humans', 'Male', 'Quality-Adjusted Life Years', 'Severe Dengue/economics/epidemiology', 'Taiwan/epidemiology']",,2017/08/02 06:00,2018/11/10 06:00,['2017/08/01 06:00'],"['2017/01/09 00:00 [received]', '2017/05/29 00:00 [revised]', '2017/07/09 00:00 [accepted]', '2017/08/02 06:00 [pubmed]', '2018/11/10 06:00 [medline]', '2017/08/01 06:00 [entrez]']","['S1876-0341(17)30195-8 [pii]', '10.1016/j.jiph.2017.07.021 [doi]']",ppublish,J Infect Public Health. 2018 Mar-Apr;11(2):215-223. doi: 10.1016/j.jiph.2017.07.021. Epub 2017 Jul 27.,2,['Copyright (c) 2017. Published by Elsevier Ltd.'],['NOTNLM'],"['Dengue', 'Disability-adjusted life years (DALYs)', 'Disease burden', 'Economic cost of disease', 'Epidemic']",,,,,,,,,,,,,,,,,,,
12089096,NLM,MEDLINE,20020718,20220408,1756-1833 (Electronic) 0959-8138 (Print) 0959-8138 (Linking),324,2002 Jun 29,Dengue: an escalating problem.,1563-6,,,"['Gibbons, Robert V', 'Vaughn, David W']","['Gibbons RV', 'Vaughn DW']",,"['Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910-7500, USA. robert.gibbons@na.amedd.army.mil']",['eng'],"['Journal Article', 'Review']",,England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['Animals', 'Culicidae', 'Dengue/diagnosis/*epidemiology/therapy', 'Diagnosis, Differential', 'Disease Vectors', 'Humans', 'Severe Dengue/diagnosis', 'Travel']",PMC1123504,2002/06/29 10:00,2002/07/19 10:01,['2002/06/29 10:00'],"['2002/06/29 10:00 [pubmed]', '2002/07/19 10:01 [medline]', '2002/06/29 10:00 [entrez]']",['10.1136/bmj.324.7353.1563 [doi]'],ppublish,BMJ. 2002 Jun 29;324(7353):1563-6. doi: 10.1136/bmj.324.7353.1563.,7353,,,,,,,,,,,,,,,,,,,,,,
8810940,NLM,MEDLINE,19961122,20041117,0022-2615 (Print) 0022-2615 (Linking),45,1996 Sep,Dengue in Australia.,159-61,,,"['Mackenzie, J S', 'la Brooy, J T', 'Hueston, L', 'Cunningham, A L']","['Mackenzie JS', 'la Brooy JT', 'Hueston L', 'Cunningham AL']",,,['eng'],"['Editorial', 'Historical Article']",,England,J Med Microbiol,Journal of medical microbiology,0224131,,IM,"['Australia', 'Dengue/diagnosis/epidemiology/*history', 'History, 19th Century', 'History, 20th Century', 'Humans']",,1996/09/01 00:00,1996/09/01 00:01,['1996/09/01 00:00'],"['1996/09/01 00:00 [pubmed]', '1996/09/01 00:01 [medline]', '1996/09/01 00:00 [entrez]']",['10.1099/00222615-45-3-159 [doi]'],ppublish,J Med Microbiol. 1996 Sep;45(3):159-61. doi: 10.1099/00222615-45-3-159.,3,,,,,,,,,,,,,,,,,,,,,,
11064583,NLM,MEDLINE,20001228,20190906,0037-8682 (Print) 0037-8682 (Linking),33,2000 Sep-Oct,[Dengue: a new approach].,465-76,,"Previous definition of classic dengue, with or without bleeding, and of dengue hemorrhagic fever (DHF) that may evolve without bleeding and with or without dengue shock syndrome (DSS) are reviewed here. The classical approach to the diagnosis and treatment of dengue, although useful in the past, nowadays breeds confusion and adds a burden to the physician's task of decision-making regarding the treatment of patients with severe forms of the disease. The classification of dengue proposed in this paper, and summarized in a diagram, incorporates new concepts about sepsis, systemic inflammatory response syndrome (SIRS), and acute respiratory distress syndrome (ARDS). This new approach, in our view, is a useful guide to initial evaluation and treatment of the disease. It also approximates the dengue syndrome to other protocols and medical procedures routinely used in intensive care units, making it easier to be followed by the health personnel working in areas subject to epidemic bursts.","['Serufo, J C', 'Nobre, V', 'Rayes, A', 'Marcial, T M', 'Lambertucci, J R']","['Serufo JC', 'Nobre V', 'Rayes A', 'Marcial TM', 'Lambertucci JR']",,"['Departamento de Clinica Medica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil. serufo@brhs.com.br']",['por'],"['English Abstract', 'Journal Article', 'Review']",,Brazil,Rev Soc Bras Med Trop,Revista da Sociedade Brasileira de Medicina Tropical,7507456,,IM,"['*Dengue/complications/diagnosis/etiology/physiopathology/therapy', 'Humans']",,2000/11/07 11:00,2001/02/28 10:01,['2000/11/07 11:00'],"['2000/11/07 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/11/07 11:00 [entrez]']",['10.1590/s0037-86822000000500008 [doi]'],ppublish,Rev Soc Bras Med Trop. 2000 Sep-Oct;33(5):465-76. doi: 10.1590/s0037-86822000000500008.,5,,,,,,,37,,Dengue: uma nova abordagem.,,,,,,,,,,,,,
9707855,NLM,MEDLINE,19980915,20051116,0019-6061 (Print) 0019-6061 (Linking),35,1998 Feb,Dengue viral infection.,129-37,,,"['Sarin, Y K', 'Singh, S', 'Singh, T']","['Sarin YK', 'Singh S', 'Singh T']",,"['Christian Medical College, Ludhiana.']",['eng'],"['Journal Article', 'Review']",,India,Indian Pediatr,Indian pediatrics,2985062R,['0 (Antiviral Agents)'],IM,"['Antiviral Agents/therapeutic use', 'Dengue/*diagnosis/drug therapy/epidemiology/virology', 'Dengue Virus/*isolation & purification', 'Diagnosis, Differential', 'Female', 'Humans', 'Incidence', 'India/epidemiology', 'Male', 'Prognosis', 'Survival Rate']",,1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']",,ppublish,Indian Pediatr. 1998 Feb;35(2):129-37.,2,,['PIP'],"['Asia', 'Biology', 'Body Temperature', '*Dengue', 'Developing Countries', 'Diseases', '*Epidemiology', '*Examinations And Diagnoses', '*Fever', 'Health', 'India', 'Physiology', 'Public Health', '*Signs And Symptoms', 'Southern Asia', '*Treatment', 'Viral Diseases']",,,,34,,,,"['PIP: 140661', 'POP: 00286577']","['Dengue viral infection produces a spectrum of disease. For example, mild dengue', 'disease is characterized by biphasic fever, myalgia, arthralgia, leukopenia, and', 'lymphadenopathy, while dengue hemorrhagic fever is an often fatal disease', 'characterized by hemorrhages and shock syndrome. The disease, especially in its', 'severe form, is seen more often among children than among adults. With focus upon', ""India, dengue's etiology, epidemiology, pathology, pathogenesis of dengue"", 'hemorrhagic fever, clinical manifestations of both the mild and severe forms of', 'dengue viral infection, diagnosis, differential diagnosis, treatment, prevention,', 'and prognosis are discussed.']",['eng'],['PIP: TJ: INDIAN PEDIATRICS.'],,,,,,,,
1565556,NLM,MEDLINE,19920521,20190818,0891-3668 (Print) 0891-3668 (Linking),11,1992 Apr,Dengue and dengue hemorrhagic fever.,311-7,,"Hundreds of thousands of dengue cases are reported worldwide each year. Given the difficulty in obtaining full reporting, the actual number of human infections is probably much higher than the number reported. Dengue is usually a nonspecific febrile illness that resolves with supportive therapy but the clinical spectrum ranges from asymptomatic infection through severe hemorrhage and sudden fatal shock. The pathophysiology of the severe forms of dengue may be related to sequential infection with different serotypes, variations in virus virulence, interaction of the virus with environmental and host factors or a combination of these factors. Control of dengue at the present time is dependent on control of the principal vector mosquito, A. aegypti. Efforts to achieve such control are now focusing on community education and action towards eliminating this mosquito's breeding sites near human dwellings. Vaccine development continues, but at present the only way to avoid dengue in an area where it is endemic or epidemic is to use repellents and mosquito barriers. The movement of people to and from tropical areas makes dengue an important differential diagnosis in any patient with an acute illness and history of recent travel to tropical areas. Because of continued infestation of the southeastern United States with A. aegypti, indigenous transmission in the continental United States remains a public health concern.","['Hayes, E B', 'Gubler, D J']","['Hayes EB', 'Gubler DJ']",,"['Dengue Branch, Centers for Disease Control, Fort Collins, CO 80522.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,,IM,"['*Dengue/diagnosis/epidemiology/etiology/therapy', 'Humans', 'United States/epidemiology']",,1992/04/01 00:00,1992/04/01 00:01,['1992/04/01 00:00'],"['1992/04/01 00:00 [pubmed]', '1992/04/01 00:01 [medline]', '1992/04/01 00:00 [entrez]']",['10.1097/00006454-199204000-00010 [doi]'],ppublish,Pediatr Infect Dis J. 1992 Apr;11(4):311-7. doi: 10.1097/00006454-199204000-00010.,4,,,,,,,83,,,,,,,,,,,,,,,
20954580,NLM,MEDLINE,20101210,20101019,0891-0162 (Print) 0891-0162 (Linking),58,2010 Oct,Dengue disease.,448,10.3928/08910162-20100928-03 [doi],Dengue is currently the world's most rapidly spreading mosquito-borne illness.,"['Girimont, Trina M']",['Girimont TM'],,"['Occupational Health Services, Shands Healthcare, Gainesville, FL 32610-0337, USA. girimt@shands.ufl.edu']",['eng'],['Journal Article'],,United States,AAOHN J,AAOHN journal : official journal of the American Association of Occupational Health Nurses,8608669,,,"['*Dengue/diagnosis/epidemiology/prevention & control', 'Diagnosis, Differential', 'Florida/epidemiology', 'Humans', 'Primary Prevention', 'Travel']",,2010/10/20 06:00,2010/12/14 06:00,['2010/10/20 06:00'],"['2010/10/20 06:00 [entrez]', '2010/10/20 06:00 [pubmed]', '2010/12/14 06:00 [medline]']",['10.3928/08910162-20100928-03 [doi]'],ppublish,AAOHN J. 2010 Oct;58(10):448. doi: 10.3928/08910162-20100928-03.,10,"['Copyright 2010, SLACK Incorporated.']",,,,,,,,,,,,,,,,,,,,,
24434336,NLM,MEDLINE,20141029,20151119,1872-7492 (Electronic) 0168-1702 (Linking),181,2014 Mar 6,The dengue virus non-structural 1 protein: risks and benefits.,53-60,S0168-1702(14)00003-3 [pii] 10.1016/j.virusres.2014.01.001 [doi],"The dengue virus (DENV) non-structural 1 (NS1) protein plays a critical role in viral RNA replication and has a central position in DENV pathogenesis. DENV NS1 is a glycoprotein expressed in infected mammalian cells as soluble monomers that dimerize in the lumen of the endoplasmic reticulum; NS1 is subsequently transported to the cell surface, where it remains membrane associated or is secreted into the extracellular milieu as a hexameric complex. During the last three decades, the DENV NS1 protein has also been intensively investigated as a potential target for vaccines and antiviral drugs. In addition, NS1 is the major diagnostic marker for dengue infection. This review highlights some important issues regarding the role of NS1 in DENV pathogenesis and its biotechnological applications, both as a target for the development of safe and effective vaccines and antiviral drugs and as a tool for the generation of accurate diagnostic methods.","['Amorim, Jaime Henrique', 'Alves, Rubens Prince dos Santos', 'Boscardin, Silvia Beatriz', 'Ferreira, Luis Carlos de Souza']","['Amorim JH', 'Alves RP', 'Boscardin SB', 'Ferreira LC']",,"['Vaccine Development Laboratory, Department of Microbiology, University of Sao Paulo, Brazil. Electronic address: jhamorim@usp.br.', 'Vaccine Development Laboratory, Department of Microbiology, University of Sao Paulo, Brazil.', 'Laboratory of Antigen Targeting to Dendritic Cells, Department of Parasitology, University of Sao Paulo, Brazil.', 'Vaccine Development Laboratory, Department of Microbiology, University of Sao Paulo, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20140113,Netherlands,Virus Res,Virus research,8410979,"['0 (Antiviral Agents)', '0 (Dengue Vaccines)', '0 (Viral Nonstructural Proteins)']",IM,"['Animals', 'Antiviral Agents/pharmacology/therapeutic use', 'Dengue/diagnosis/drug therapy/epidemiology/prevention & control/virology', 'Dengue Vaccines/immunology', 'Dengue Virus/*physiology', 'Humans', 'Life Cycle Stages', 'Public Health', 'Viral Nonstructural Proteins/antagonists & inhibitors/*physiology']",,2014/01/18 06:00,2014/10/30 06:00,['2014/01/18 06:00'],"['2013/11/26 00:00 [received]', '2013/12/26 00:00 [revised]', '2014/01/03 00:00 [accepted]', '2014/01/18 06:00 [entrez]', '2014/01/18 06:00 [pubmed]', '2014/10/30 06:00 [medline]']","['S0168-1702(14)00003-3 [pii]', '10.1016/j.virusres.2014.01.001 [doi]']",ppublish,Virus Res. 2014 Mar 6;181:53-60. doi: 10.1016/j.virusres.2014.01.001. Epub 2014 Jan 13.,,['Copyright (c) 2014 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Antiviral', 'Dengue virus', 'Diagnosis', 'NS1 protein', 'Pathogenesis', 'Vaccine']",,,,,,,,,,,,,,,,,,,
25790245,NLM,MEDLINE,20160126,20220408,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),9,2015 Mar,Epidemiological trends of dengue disease in Colombia (2000-2011): a systematic review.,e0003499,10.1371/journal.pntd.0003499 [doi] e0003499,"A systematic literature review was conducted to describe the epidemiology of dengue disease in Colombia. Searches of published literature in epidemiological studies of dengue disease encompassing the terms ""dengue"", ""epidemiology,"" and ""Colombia"" were conducted. Studies in English or Spanish published between 1 January 2000 and 23 February 2012 were included. The searches identified 225 relevant citations, 30 of which fulfilled the inclusion criteria defined in the review protocol. The epidemiology of dengue disease in Colombia was characterized by a stable ""baseline"" annual number of dengue fever cases, with major outbreaks in 2001-2003 and 2010. The geographical spread of dengue disease cases showed a steady increase, with most of the country affected by the 2010 outbreak. The majority of dengue disease recorded during the review period was among those <15 years of age. Gaps identified in epidemiological knowledge regarding dengue disease in Colombia may provide several avenues for future research, namely studies of asymptomatic dengue virus infection, primary versus secondary infections, and under-reporting of the disease. Improved understanding of the factors that determine disease expression and enable improvement in disease control and management is also important.","['Villar, Luis Angel', 'Rojas, Diana Patricia', 'Besada-Lombana, Sandra', 'Sarti, Elsa']","['Villar LA', 'Rojas DP', 'Besada-Lombana S', 'Sarti E']",,"['Clinical Epidemiology Unit, School of Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia.', 'Clinical Epidemiology Unit, School of Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia.', 'Dengue Medical Direction, Sanofi Pasteur LATAM, Bogota, Colombia.', 'Epidemiology Direction, Sanofi Pasteur LATAM, Mexico City, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",20150319,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Coinfection/epidemiology', 'Colombia/epidemiology', 'Dengue/*epidemiology/prevention & control/therapy', 'Disease Outbreaks', 'Female', 'Geography', 'Humans']",PMC4366106,2015/03/20 06:00,2016/01/27 06:00,['2015/03/20 06:00'],"['2014/02/12 00:00 [received]', '2014/12/27 00:00 [accepted]', '2015/03/20 06:00 [entrez]', '2015/03/20 06:00 [pubmed]', '2016/01/27 06:00 [medline]']","['PNTD-D-14-00248 [pii]', '10.1371/journal.pntd.0003499 [doi]']",epublish,PLoS Negl Trop Dis. 2015 Mar 19;9(3):e0003499. doi: 10.1371/journal.pntd.0003499. eCollection 2015 Mar.,3,,,,"['LAV and DPR declare that they received payments from Sanofi Pasteur in respect of', 'their work on this review. SBL and ES are employed by Sanofi Pasteur. This does', 'not alter our adherence to all PLOS policies on sharing data and materials. All', 'authors confirm that they had full access to all data and had final', 'responsibility for the decision to submit for publication.']","['Epidemiology of Dengue Disease in the Philippines (2000-2011): A Systematic', 'Literature Review.', 'Epidemiological Trends of Dengue Disease in Mexico (2000-2011): A Systematic', 'Literature Search and Analysis.', 'Epidemiology of Dengue Disease in Malaysia (2000-2012): A Systematic Literature', 'Review.', 'Recent Epidemiological Trends of Dengue in the French Territories of the Americas', '(2000-2012): A Systematic Literature Review.', 'Epidemiological Trends of Dengue Disease in Thailand (2000-2011): A Systematic', 'Literature Review.']",,,,,,,,,,,,,,,,,
10738676,NLM,MEDLINE,20000531,20191103,0891-5520 (Print) 0891-5520 (Linking),14,2000 Mar,Dengue and dengue hemorrhagic fever in Latin America and the Caribbean.,"121-40, ix",,"Four serotypes of dengue viruses produce dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. They are the most important arbovirus infections of humans, in terms of both morbidity and mortality, constituting one of the most rapidly expanding and re-emerging infectious disease problems in Latin America. In less than 20 years, the region has transformed itself from hypoendemic to hyperendemic, while serotype circulation in most countries has gone from none or single to multiple. Changes in endemicity have coincided with the emergence and increasing incidence of the severer forms of dengue infection. This article reviews the clinical presentations of these diseases. Health care providers who see patients in or returning from areas of Latin America, the Caribbean, and other tropical areas must consider dengue in the differential diagnosis of patients presenting with compatible symptoms, and must be knowledgeable in the current management of this important disease.","['Isturiz, R E', 'Gubler, D J', 'Brea del Castillo, J']","['Isturiz RE', 'Gubler DJ', 'Brea del Castillo J']",,"['Departamento de Medicina, Centro Medico de Caracas, Venezuela. ul3@bichat.inserm.fr']",['eng'],"['Journal Article', 'Review']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,['0 (Viral Vaccines)'],IM,"['Aedes/virology', 'Animals', 'Caribbean Region/epidemiology', '*Dengue/diagnosis/epidemiology/therapy/virology', 'Dengue Virus/immunology/*physiology', 'Humans', 'Insect Vectors', 'Latin America/epidemiology', 'Mosquito Control', '*Severe Dengue/diagnosis/epidemiology/therapy/virology', 'Viral Vaccines']",,2000/03/30 09:00,2000/06/03 09:00,['2000/03/30 09:00'],"['2000/03/30 09:00 [pubmed]', '2000/06/03 09:00 [medline]', '2000/03/30 09:00 [entrez]']","['S0891-5520(05)70221-X [pii]', '10.1016/s0891-5520(05)70221-x [doi]']",ppublish,"Infect Dis Clin North Am. 2000 Mar;14(1):121-40, ix. doi: 10.1016/s0891-5520(05)70221-x.",1,,,,,,,65,,,,,,,,,,,,,,,
37305420,NLM,MEDLINE,20230613,20230615,2235-2988 (Electronic) 2235-2988 (Linking),13,2023,"Editorial: Trends in dengue evolution, immune pathogenesis, and pathology.",1210316,10.3389/fcimb.2023.1210316 [doi] 1210316,,"['Gowri Sankar, S', 'Alwin Prem Anand, A', 'Chattopadhyay, Balaji']","['Gowri Sankar S', 'Alwin Prem Anand A', 'Chattopadhyay B']",,"['Department of Molecular Biology, Indian Council of Medical Research (ICMR)-Vector Control Research Center - Field Station, Madurai, India.', 'Institute of Clinical Anatomy and Cell Analysis, University of Tubingen, Tubingen, Germany.', 'Trivedi School of Biosciences, Ashoka University, Sonepat, India.']",['eng'],['Editorial'],20230525,Switzerland,Front Cell Infect Microbiol,Frontiers in cellular and infection microbiology,101585359,,IM,"['Humans', '*Dengue/epidemiology/immunology/pathology']",PMC10248524,2023/06/12 06:42,2023/06/13 06:42,['2023/06/12 04:23'],"['2023/04/22 00:00 [received]', '2023/05/03 00:00 [accepted]', '2023/06/13 06:42 [medline]', '2023/06/12 06:42 [pubmed]', '2023/06/12 04:23 [entrez]']",['10.3389/fcimb.2023.1210316 [doi]'],epublish,Front Cell Infect Microbiol. 2023 May 25;13:1210316. doi: 10.3389/fcimb.2023.1210316. eCollection 2023.,,,['NOTNLM'],"['B cell immune response', 'T cell immune response', 'adaptive immunity', 'dengue phylogeny', 'innate immunity']","['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",,,,"['Editorial on the Research Topic Trends in dengue evolution, immune pathogenesis,', 'and pathology']",,,,,,,,,,,,,,
19925879,NLM,MEDLINE,20100427,20161020,1769-714X (Electronic) 1286-4579 (Linking),12,2010 Feb,Severe dengue: questioning the paradigm.,113-8,10.1016/j.micinf.2009.11.006 [doi],"Severe dengue has been recognised for more than 200 years, but attempts to define, categorize and explain the condition have hotly contested for more than four decades. Resolution of this controversy may provide new insights for the management of patients.","['Murgue, Bernadette']",['Murgue B'],,"['Institut National de la Sante et de la Recherche Medicale (INSERM), Institut de Maladies Infectieuses, 101 rue de Tolbiac, 75013 Paris, France. bernadette.murgue@inserm.fr']",['eng'],"['Journal Article', 'Review']",20091117,France,Microbes Infect,Microbes and infection,100883508,,IM,"['Dengue/classification/epidemiology/virology', 'Dengue Virus/pathogenicity', 'Humans', 'Severe Dengue/*classification/epidemiology/virology', 'World Health Organization']",,2009/11/21 06:00,2010/04/28 06:00,['2009/11/21 06:00'],"['2009/03/06 00:00 [received]', '2009/10/09 00:00 [revised]', '2009/11/10 00:00 [accepted]', '2009/11/21 06:00 [entrez]', '2009/11/21 06:00 [pubmed]', '2010/04/28 06:00 [medline]']","['S1286-4579(09)00264-0 [pii]', '10.1016/j.micinf.2009.11.006 [doi]']",ppublish,Microbes Infect. 2010 Feb;12(2):113-8. doi: 10.1016/j.micinf.2009.11.006. Epub 2009 Nov 17.,2,['Copyright 2009 Elsevier Masson SAS. All rights reserved.'],,,,,,55,,,,,,,,,,,,,,,
15710058,NLM,MEDLINE,20050303,20190513,1195-1982 (Print) 1195-1982 (Linking),11,2004 May-Jun,Dengue in travelers: a review.,161-70,,,"['Wichmann, Ole', 'Jelinek, Tomas']","['Wichmann O', 'Jelinek T']",,"['Institute of Tropical Medicine, Humboldt University, Berlin, Germany.']",['eng'],"['Journal Article', 'Review']",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Dengue/*epidemiology/etiology/*prevention & control', 'Global Health', 'Humans', 'Risk Factors', '*Travel']",,2005/02/16 09:00,2005/03/04 09:00,['2005/02/16 09:00'],"['2005/02/16 09:00 [pubmed]', '2005/03/04 09:00 [medline]', '2005/02/16 09:00 [entrez]']",['10.2310/7060.2004.18503 [doi]'],ppublish,J Travel Med. 2004 May-Jun;11(3):161-70. doi: 10.2310/7060.2004.18503.,3,,,,,,,105,,,,,,,,,,,,,,,
18367922,NLM,MEDLINE,20080522,20131121,1538-7488 (Electronic) 0002-936X (Linking),108,2008 Apr,Dengue Fever.,26-8,10.1097/01.NAJ.0000315255.61576.48 [doi],,"['Leung-Chen, Pancy Y']",['Leung-Chen PY'],,"['Accreditation, Regulation, and Licensure Division at Kaiser Permanente-Northern California Region in Oakland, USA. pancyl@gmail.com']",['eng'],['Journal Article'],,United States,Am J Nurs,The American journal of nursing,0372646,,IM,"['Aedes', 'Animals', '*Dengue/diagnosis/epidemiology/therapy/transmission', 'Humans', 'Insect Vectors', 'Prevalence', 'Severe Dengue/diagnosis/therapy/transmission', 'Travel', 'United States/epidemiology']",,2008/03/28 09:00,2008/05/23 09:00,['2008/03/28 09:00'],"['2008/03/28 09:00 [pubmed]', '2008/05/23 09:00 [medline]', '2008/03/28 09:00 [entrez]']","['00000446-200804000-00014 [pii]', '10.1097/01.NAJ.0000315255.61576.48 [doi]']",ppublish,Am J Nurs. 2008 Apr;108(4):26-8. doi: 10.1097/01.NAJ.0000315255.61576.48.,4,,,,,,,,,,,,,,,,,,,,,,
12727523,NLM,MEDLINE,20030805,20191107,1386-6532 (Print) 1386-6532 (Linking),27,2003 May,Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges.,1-13,,"The incidence of dengue and dengue hemorrhagic fever (DF/DHF) has increased significantly over the last decades. Yearly, an estimated 50-100 million cases of DF and about 250000-500000 cases of DHF occur worldwide. The epidemiological situation in Latin America now resembles that in Southeast Asia. Here, the main clinical, epidemiological and virological observations in the American region are presented and compared with those previously reported from Southeast Asia. During 2002, more than 30 Latin American countries reported over 1000000 DF cases. DHF occurred in 20 countries with more than 17000 DHF cases, including 225 fatalities. The co-circulation of multiple serotypes has been reported from many countries. In the Americas, DHF is observed both in children and adults; secondary infection by a different dengue virus serotype has been confirmed as an important risk factor for this severe form of the disease. However, some new risk factors such as the interval of dengue virus infections and the ethnicity and underlying chronic conditions of the patient have also been identified. The sequence of dengue virus infections and association with certain genotypes are further factors of importance. We also discuss the control and prevention strategies. In conclusion, without urgent action for the prevention and control of dengue/DHF and its vector, the current situation will worsen and, more dramatical, there is a risk of the urbanization of yellow fever.","['Guzman, Maria G', 'Kouri, Gustavo']","['Guzman MG', 'Kouri G']",,"['Virology Department, PAHO/WHO Collaborating Center for Viral Diseases, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodia, Km 6 P.O. Box Marianao 13, Havana, Cuba. lupe@ipk.sld.cu']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,,IM,"['Americas/epidemiology', 'Animals', 'Dengue/*epidemiology/history/physiopathology/virology', 'Dengue Virus/classification/growth & development/isolation & purification', 'History, 20th Century', 'Humans', 'Severe Dengue/*epidemiology/history/physiopathology/virology']",,2003/05/03 05:00,2003/08/06 05:00,['2003/05/03 05:00'],"['2003/05/03 05:00 [pubmed]', '2003/08/06 05:00 [medline]', '2003/05/03 05:00 [entrez]']","['S1386653203000106 [pii]', '10.1016/s1386-6532(03)00010-6 [doi]']",ppublish,J Clin Virol. 2003 May;27(1):1-13. doi: 10.1016/s1386-6532(03)00010-6.,1,,,,,,,80,,,,,,,,,,,,,,,
22668448,NLM,MEDLINE,20121016,20220408,2046-9055 (Electronic) 2046-9047 (Print) 2046-9047 (Linking),32 Suppl 1,2012 May,The revised WHO dengue case classification: does the system need to be modified?,33-8,10.1179/2046904712Z.00000000052 [doi],"There has been considerable debate regarding the value of both the 1997 and 2009 World Health Organization (WHO) dengue case classification criteria for its diagnosis and management. Differentiation between classic dengue fever (DF) and dengue haemorrhagic fever (DHF) or severe dengue is a key aspect of dengue case classification. The geographic expansion of dengue and its increased incidence in older age groups have contributed to the limited applicability of the 1997 case definitions. Clinical experience of dengue suggests that the illness presents as a spectrum of disease instead of distinct phases. However, despite the rigid grouping of dengue into DF, DHF and dengue shock syndrome (DSS), overlap between the different manifestations has often been observed, which has affected clinical management and triage of patients. The findings of the DENCO study evaluating the 1997 case definitions formed the basis of the revised 2009 WHO case definitions, which classified the illness into dengue with and without warning signs and severe dengue. Although the revised scheme is more sensitive to the diagnosis of severe dengue, and beneficial to triage and case management, there remain issues with its applicability. It is considered by many to be too broad, requiring more specific definition of warning signs. Quantitative research into the predictive value of these warning signs on patient outcomes and the cost-effectiveness of the new classification system is required to ascertain whether the new classification system requires further modification, or whether elements of both classification systems can be combined.","['Hadinegoro, Sri Rezeki S']",['Hadinegoro SR'],,"['Department of Child Health, Faculty of Medicine, University of Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia. srh3546@centrin.net.id']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Paediatr Int Child Health,Paediatrics and international child health,101582666,,IM,"['Dengue/*classification/diagnosis/*pathology/therapy', 'Humans', '*Severity of Illness Index', 'World Health Organization']",PMC3381438,2012/06/08 06:00,2012/10/17 06:00,['2012/06/07 06:00'],"['2012/06/07 06:00 [entrez]', '2012/06/08 06:00 [pubmed]', '2012/10/17 06:00 [medline]']","['50 [pii]', '10.1179/2046904712Z.00000000052 [doi]']",ppublish,Paediatr Int Child Health. 2012 May;32 Suppl 1(s1):33-8. doi: 10.1179/2046904712Z.00000000052.,s1,,,,,,,,,,,,,,,,,,,,,,
23936833,NLM,MEDLINE,20140317,20220310,2314-6141 (Electronic) 2314-6133 (Print),2013,2013,Understanding the dengue viruses and progress towards their control.,690835,10.1155/2013/690835 [doi] 690835,"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this ""scourge"" of the tropical and subtropical world.","['Rodriguez-Roche, Rosmari', 'Gould, Ernest A']","['Rodriguez-Roche R', 'Gould EA']",,"['Pedro Kouri Tropical Medicine Institute, WHO/PAHO Collaborating Centre for the Study of Dengue and Its Vector, Havana, Cuba. rosmari@ipk.sld.cu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130709,United States,Biomed Res Int,BioMed research international,101600173,"['0 (NS2A protein, Dengue virus type 2)', '0 (Viral Nonstructural Proteins)']",IM,"['Dengue/*genetics/*pathology/prevention & control/virology', 'Dengue Virus/*genetics/pathogenicity', 'Epidemics', 'Humans', 'Tropical Medicine', 'Viral Nonstructural Proteins/genetics']",PMC3722981,2013/08/13 06:00,2014/03/19 06:00,['2013/08/13 06:00'],"['2013/03/13 00:00 [received]', '2013/05/08 00:00 [accepted]', '2013/08/13 06:00 [entrez]', '2013/08/13 06:00 [pubmed]', '2014/03/19 06:00 [medline]']",['10.1155/2013/690835 [doi]'],ppublish,Biomed Res Int. 2013;2013:690835. doi: 10.1155/2013/690835. Epub 2013 Jul 9.,,,,,,,,,,,,,,,,,,,,,,,
22534135,NLM,MEDLINE,20121204,20161209,2213-0276 (Electronic) 0755-4982 (Linking),41,2012 Oct,[Neurological manifestations of dengue].,e547-52,S0755-4982(12)00202-3 [pii] 10.1016/j.lpm.2012.03.010 [doi],"BACKGROUND: An epidemic of type 4 dengue was raging in the Pacific from 2008 to 2010. During this period, several patients were hospitalized at the Hospital Centre of Tahiti for neurological disorders occurring during a dengue fever. These events are not the typical picture, which is represented by a flu-like syndrome and sometimes, in severe cases, a haemorrhagic syndrome or shock. METHOD: We have established a review of the literature reporting the cases of dengue fever associated with neurological disorders with the terms ""dengue"" and ""neurology"". Despite the retrospective nature and incomplete data, we attempted to establish the epidemiological characteristics of these events, to give an order of frequency of these symptoms and the pathophysiological mechanisms involved. RESULTS: Among patients with neurological disorders occurring during a dengue fever, disorders of central nervous system are the most common. Among disorders of central nervous system, encephalopathy is by far the most encountered. CONCLUSION: None of observed neurologic disorders presenting with specific manifestation, discussion of dengue as etiology in endemic areas or in return from endemic area is well-founded.","['Oehler, Erwan', 'Le Henaff, Olivier', 'Ghawche, Frederic']","['Oehler E', 'Le Henaff O', 'Ghawche F']",,"['Centre hospitalier de Polynesie francaise, Papeete, 98713 Tahiti, Polynesie francaise, France. erwan.oehler@cht.pf']",['fre'],"['English Abstract', 'Journal Article', 'Review']",20120424,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Age of Onset', 'Dengue/*complications/diagnosis/epidemiology', 'Humans', 'Nervous System Diseases/*diagnosis/epidemiology/*etiology', 'Phenotype', 'Polynesia/epidemiology', 'Prevalence']",,2012/04/27 06:00,2012/12/10 06:00,['2012/04/27 06:00'],"['2011/12/14 00:00 [received]', '2012/02/16 00:00 [revised]', '2012/03/06 00:00 [accepted]', '2012/04/27 06:00 [entrez]', '2012/04/27 06:00 [pubmed]', '2012/12/10 06:00 [medline]']","['S0755-4982(12)00202-3 [pii]', '10.1016/j.lpm.2012.03.010 [doi]']",ppublish,Presse Med. 2012 Oct;41(10):e547-52. doi: 10.1016/j.lpm.2012.03.010. Epub 2012 Apr 24.,10,['Copyright (c) 2012 Elsevier Masson SAS. All rights reserved.'],,,,,,,,Manifestations neurologiques de la dengue.,,,,,,,,,,,,,
25453329,NLM,MEDLINE,20151207,20150302,1873-5967 (Electronic) 1386-6532 (Linking),64,2015 Mar,"Advances in the understanding, management, and prevention of dengue.",153-9,S1386-6532(14)00370-9 [pii] 10.1016/j.jcv.2014.08.031 [doi],"Dengue causes more human morbidity globally than any other vector-borne viral disease. Recent research has led to improved epidemiological methods that predict disease burden and factors involved in transmission, a better understanding of immune responses in infection, and enhanced animal models. In addition, a number of control measures, including preventative vaccines, are in clinical trials. However, significant gaps remain, including the need for better surveillance in large parts of the world, methods to predict which individuals will develop severe disease, and immunologic correlates of protection against dengue illness. During the next decade, dengue will likely expand its geographic reach and become an increasing burden on health resources in affected areas. Licensed vaccines and antiviral agents are needed in order to effectively control dengue and limit disease.","['Hermann, Laura L', 'Gupta, Swati B', 'Manoff, Susan B', 'Kalayanarooj, Siripen', 'Gibbons, Robert V', 'Coller, Beth-Ann G']","['Hermann LL', 'Gupta SB', 'Manoff SB', 'Kalayanarooj S', 'Gibbons RV', 'Coller BA']",,"['Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.', 'Merck and Company, 351 North Sumneytown Pike, North Wales, PA 19454, United States.', 'Merck and Company, 351 North Sumneytown Pike, North Wales, PA 19454, United States.', 'Queen Sirikit National Institute of Child Health, Bangkok, Thailand.', 'Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.', 'Merck and Company, 351 North Sumneytown Pike, North Wales, PA 19454, United States. Electronic address: beth-ann.coller@merck.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20141020,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,"['0 (Antiviral Agents)', '0 (Dengue Vaccines)']",IM,"['Animals', 'Antiviral Agents/therapeutic use', 'Dengue/*epidemiology/immunology/*prevention & control/virology', 'Dengue Vaccines/immunology', '*Disease Management', 'Humans']",,2014/12/03 06:00,2015/12/15 06:00,['2014/12/03 06:00'],"['2014/03/28 00:00 [received]', '2014/08/25 00:00 [accepted]', '2014/12/03 06:00 [entrez]', '2014/12/03 06:00 [pubmed]', '2015/12/15 06:00 [medline]']","['S1386-6532(14)00370-9 [pii]', '10.1016/j.jcv.2014.08.031 [doi]']",ppublish,J Clin Virol. 2015 Mar;64:153-9. doi: 10.1016/j.jcv.2014.08.031. Epub 2014 Oct 20.,,['Copyright (c) 2014 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Dengue', 'Diagnosis', 'Epidemiology', 'Treatment', 'Vaccine']",,,['Canadian Institutes of Health Research/Canada'],,,,,,,,,,,,,,,,
9155462,NLM,MEDLINE,19970529,20051116,0266-8130 (Print) 0266-8130 (Linking),12,1997 Apr,Dengue fever.,507-8,,"Dengue fever, and its more serious haemorrhagic form, is increasingly being found among UK travellers to tropical and sub-tropical countries. This Update examines transmission, the main symptoms and nursing care of affected people.","['Payling, K J']",['Payling KJ'],,"['KP Foods Business Unit, Rotherham.']",['eng'],"['Journal Article', 'Review']",,England,Prof Nurse,"Professional nurse (London, England)",8612884,,,"['*Dengue/diagnosis/epidemiology/therapy', 'Humans', 'Incidence', 'Mosquito Control', 'Primary Prevention', 'Travel']",,1997/04/01 00:00,1997/04/01 00:01,['1997/04/01 00:00'],"['1997/04/01 00:00 [pubmed]', '1997/04/01 00:01 [medline]', '1997/04/01 00:00 [entrez]']",,ppublish,Prof Nurse. 1997 Apr;12(7):507-8.,7,,,,,,,6,,,,,,,,,,,,,,,
25233937,NLM,MEDLINE,20150603,20141010,1878-3503 (Electronic) 0035-9203 (Linking),108,2014 Nov,Diagnosis of dengue in Sri Lanka: improvements to the existing state of the art in the island.,685-91,10.1093/trstmh/tru131 [doi],"Dengue fever (DF) is a mosquito borne virus infection which is endemic to the tropical regions of the world. In Sri Lanka, the first sero-positive case was reported in the 1960s; since then the island has experienced several outbreaks of DF/dengue haemorrhagic fever (DHF). The disease is more prevalent in some parts of the country where rapid urbanisation has taken place. Diagnosis of DF/DHF is mainly done using the clinical features only due to the unavailability of laboratory diagnosis in many parts of the country and this might lead to over or under diagnosis of the disease. A rational diagnostic approach which combines the history and clinical profiles together with specific virological laboratory data would help in the correct identification of the disease. Furthermore, a feasible algorithm for the laboratory diagnosis of dengue will help to confirm the cases with a high level of clinical suspicion. This would then facilitate the notification of correctly identified cases to the public health authorities to assess the dengue burden. The scope of this review is to improve the existing laboratory diagnosis of DF/DHF by proposing a feasible algorithm to implement in Sri Lanka that would enable better detection of cases.","['Senaratne, Thamarasi N', 'Noordeen, Faseeha']","['Senaratne TN', 'Noordeen F']",,"['Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka.', 'Department of Microbiology, Faculty of Medicine, University of Peradeniya, Sri Lanka faseehan@pdn.ac.lk faseeha.noordeen12@gmail.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20140918,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['*Algorithms', '*Clinical Laboratory Techniques', 'Dengue/*diagnosis/epidemiology/*virology', 'Diagnosis, Differential', 'Endemic Diseases', 'Humans', 'Severe Dengue/diagnosis/epidemiology/virology', 'Sri Lanka/epidemiology']",,2014/09/23 06:00,2015/06/04 06:00,['2014/09/20 06:00'],"['2014/09/20 06:00 [entrez]', '2014/09/23 06:00 [pubmed]', '2015/06/04 06:00 [medline]']","['tru131 [pii]', '10.1093/trstmh/tru131 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2014 Nov;108(11):685-91. doi: 10.1093/trstmh/tru131. Epub 2014 Sep 18.,11,"['(c) The Author 2014. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene. All rights reserved. For permissions,', 'please e-mail: journals.permissions@oup.com.']",['NOTNLM'],"['Dengue fever', 'Dengue haemorrhagic fever', 'Laboratory diagnosis', 'Sri Lanka']",,,,,,,,,,,,,,,,,,,
3277268,NLM,MEDLINE,19880302,20190618,0036-8075 (Print) 0036-8075 (Linking),239,1988 Jan 29,Pathogenesis of dengue: challenges to molecular biology.,476-81,,"Dengue viruses occur as four antigenically related but distinct serotypes transmitted to humans by Aedes aegypti mosquitoes. These viruses generally cause a benign syndrome, dengue fever, in the American and African tropics, and a severe syndrome, dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), in Southeast Asian children. This severe syndrome, which recently has also been identified in children infected with the virus in Puerto Rico, is characterized by increased vascular permeability and abnormal hemostasis. It occurs in infants less than 1 year of age born to dengue-immune mothers and in children 1 year and older who are immune to one serotype of dengue virus and are experiencing infection with a second serotype. Dengue viruses replicate in cells of mononuclear phagocyte lineage, and subneutralizing concentrations of dengue antibody enhance dengue virus infection in these cells. This antibody-dependent enhancement of infection regulates dengue disease in human beings, although disease severity may also be controlled genetically, possibly by permitting and restricting the growth of virus in monocytes. Monoclonal antibodies show heterogeneous distribution of antigenic epitopes on dengue viruses. These epitopes serve to regulate disease: when antibodies to shared antigens partially neutralize heterotypic virus, infection and disease are dampened; enhancing antibodies alone result in heightened disease response. Further knowledge of the structure of dengue genomes should permit rapid advances in understanding the pathogenetic mechanisms of dengue.","['Halstead, S B']",['Halstead SB'],,"['Division of Health Sciences, Rockefeller Foundation, New York, NY 10036.']",['eng'],"['Journal Article', 'Review']",,United States,Science,"Science (New York, N.Y.)",0404511,"['0 (Antibodies, Viral)', '0 (Antigens, Viral)']",IM,"['Adolescent', 'Antibodies, Viral/physiology', 'Antigens, Viral/immunology', 'Asia, Southeastern', 'Child', 'Child, Preschool', 'Cuba', 'Dengue/epidemiology/ethnology/*etiology/immunology/microbiology/prevention & control', '*Dengue Virus/classification/genetics/immunology/physiology', 'Female', 'Humans', 'Infant', 'Male', 'Puerto Rico', 'Serotyping']",,1988/01/29 00:00,1988/01/29 00:01,['1988/01/29 00:00'],"['1988/01/29 00:00 [pubmed]', '1988/01/29 00:01 [medline]', '1988/01/29 00:00 [entrez]']",['10.1126/science.3277268 [doi]'],ppublish,Science. 1988 Jan 29;239(4839):476-81. doi: 10.1126/science.3277268.,4839,,,,,,,67,,,,,,,,,,,,,,,
26458808,NLM,MEDLINE,20161005,20161230,1873-2518 (Electronic) 0264-410X (Linking),33,2015 Dec 10,Recent advances in dengue pathogenesis and clinical management.,7061-8,S0264-410X(15)01393-6 [pii] 10.1016/j.vaccine.2015.09.103 [doi],"This review describes and commentates on recent advances in the understanding of dengue pathogenesis and immunity, plus clinical research on vaccines and therapeutics. We expand specifically on the role of the dermis in dengue virus infection, the contribution of cellular and humoral immune responses to pathogenesis and immunity, NS1 and mechanisms of virus immune evasion. Additionally we review a series of therapeutic intervention trials for dengue, as well as recent clinical research aimed at improving clinical diagnosis, risk prediction and disease classification.","['Simmons, Cameron P', 'McPherson, Kirsty', 'Van Vinh Chau, Nguyen', 'Hoai Tam, D T', 'Young, Paul', 'Mackenzie, Jason', 'Wills, Bridget']","['Simmons CP', 'McPherson K', 'Van Vinh Chau N', 'Hoai Tam DT', 'Young P', 'Mackenzie J', 'Wills B']",,"['Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 764 Vo Van Kiet street, District 5, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia. Electronic address: csimmons@oucru.org.', 'Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.', 'Hospital for Tropical Diseases, 764 Vo Van Kiet, District 5, Ho Chi Minh City, Viet Nam.', 'University of Medicine and Pharmacy, 217 Hong Bang, District 5, Ho Chi Minh City, Viet Nam.', 'School of Chemistry and Molecular Biosciences, University of Queensland, Australia.', 'Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.', 'Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 764 Vo Van Kiet street, District 5, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.']",['eng'],"['Journal Article', 'Review']",20151014,Netherlands,Vaccine,Vaccine,8406899,,IM,"['Adaptive Immunity', 'Dengue/diagnosis/epidemiology/*pathology/*therapy', 'Diagnostic Tests, Routine', 'Host-Pathogen Interactions', 'Humans', 'Immune Evasion', 'Immunity, Cellular', 'Immunity, Humoral', 'Immunity, Innate', 'Immunotherapy/methods/trends']",,2015/10/16 06:00,2016/10/07 06:00,['2015/10/14 06:00'],"['2015/05/14 00:00 [received]', '2015/09/01 00:00 [revised]', '2015/09/03 00:00 [accepted]', '2015/10/14 06:00 [entrez]', '2015/10/16 06:00 [pubmed]', '2016/10/07 06:00 [medline]']","['S0264-410X(15)01393-6 [pii]', '10.1016/j.vaccine.2015.09.103 [doi]']",ppublish,Vaccine. 2015 Dec 10;33(50):7061-8. doi: 10.1016/j.vaccine.2015.09.103. Epub 2015 Oct 14.,50,['Copyright (c) 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Clinical research', 'Dengue', 'Immunology', 'Pathogenesis', 'Vaccine', 'Virology']",,,,,,,,,,,,,,,,,,,
23331749,NLM,MEDLINE,20130401,20150826,0443-5117 (Print) 0443-5117 (Linking),50,2012 Nov-Dec,[The dengue fever in Mexico. Knowledge for improving the quality in health].,631-9,,"Dengue is a systemic infectious disease of viral etiology, transmitted by Aedes mosquitoes. It causes between 50 and 100 million cases annually over 100 countries. In most of the cases it presents as influenza-like illness or undifferentiated fever and more than 500,000 patients develop dengue hemorrhagic fever. In America, dengue fever is considered the most important resurgent disease and its hemorrhagic form is becoming more relevant, especially given the steady increase in the number of deaths. The first outbreaks of dengue in America were described in 1635. Since the apparition of dengue hemorrhagic fever, in 1962, it has been considered a public health problem because half of the population lives in endemic areas. The purpose of this paper is to carry a briefly review of the epidemiology, clinical features, pathophysiology, prevention and treatment of dengue fever, as well as create recommendations in order to improve the quality of care and decrease mortality in these patients.","['Fajardo-Dolci, German', 'Meljem-Moctezuma, Jose', 'Vicente-Gonzalez, Esther', 'Venegas-Paez, Francisco Vicente', 'Mazon-Gonzalez, Betania', 'Aguirre-Gas, Hector Gerardo']","['Fajardo-Dolci G', 'Meljem-Moctezuma J', 'Vicente-Gonzalez E', 'Venegas-Paez FV', 'Mazon-Gonzalez B', 'Aguirre-Gas HG']",,"['Comision Nacional de Arbitraje Medico, Distrito Federal, Mexico.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",,Mexico,Rev Med Inst Mex Seguro Soc,Revista medica del Instituto Mexicano del Seguro Social,101243727,,IM,"['*Dengue/diagnosis/epidemiology/therapy', 'Humans', 'Mexico', 'Practice Guidelines as Topic', 'Quality Improvement']",,2013/01/22 06:00,2013/04/02 06:00,['2013/01/22 06:00'],"['2013/01/22 06:00 [entrez]', '2013/01/22 06:00 [pubmed]', '2013/04/02 06:00 [medline]']",,ppublish,Rev Med Inst Mex Seguro Soc. 2012 Nov-Dec;50(6):631-9.,6,,,,,,,,,El dengue en Mexico. Conocer para mejorar la calidad de la atencion.,,,,,,,,,,,,,
28716891,NLM,MEDLINE,20190813,20190813,1943-0264 (Electronic) 1943-0264 (Linking),10,2018 Jun 1,"Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.",,10.1101/cshperspect.a029371 [doi] a029371,"Dengue virus (DENV) is the most common arthropod-borne viral disease of humans. Although effective vaccines exist against other flaviviral diseases like yellow fever and Japanese encephalitis, dengue vaccine development is complicated by the presence of four virus serotypes and the possibility of partial immunity enhancing dengue disease severity. Several live attenuated dengue vaccines are being tested in human clinical trials. Initial results are mixed, with variable efficacy depending on DENV serotype and previous DENV exposure. Here, we highlight recent discoveries about the human antibody response to DENV and propose guidelines for advancing development of safe and effective dengue vaccines.","['de Silva, Aravinda M', 'Harris, Eva']","['de Silva AM', 'Harris E']",,"['Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California 94720-3370.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",20180601,United States,Cold Spring Harb Perspect Biol,Cold Spring Harbor perspectives in biology,101513680,['0 (Dengue Vaccines)'],,"['Dengue/immunology/pathology/*prevention & control/virology', 'Dengue Vaccines/*immunology', 'Dengue Virus/classification/genetics', 'Humans', 'Serogroup']",PMC5983190,2017/07/19 06:00,2019/08/14 06:00,['2017/07/19 06:00'],"['2017/07/19 06:00 [pubmed]', '2019/08/14 06:00 [medline]', '2017/07/19 06:00 [entrez]']","['cshperspect.a029371 [pii]', 'a029371 [pii]', '10.1101/cshperspect.a029371 [doi]']",epublish,Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):a029371. doi: 10.1101/cshperspect.a029371.,6,['Copyright (c) 2018 Cold Spring Harbor Laboratory Press; all rights reserved.'],,,,,"['P01 AI106695/AI/NIAID NIH HHS/United States', 'R01 AI107731/AI/NIAID NIH HHS/United States', 'R01 AI125198/AI/NIAID NIH HHS/United States']",,,,['NIHMS974625'],,,,,,,,,,,,
24710495,NLM,MEDLINE,20141030,20230208,1759-5010 (Electronic) 1759-5002 (Linking),11,2014 Jun,Cardiovascular manifestations of the emerging dengue pandemic.,335-45,10.1038/nrcardio.2014.40 [doi],"Dengue is one of the most important emerging viral diseases globally. The majority of symptomatic infections result in a relatively benign disease course. However, a small proportion of patients develop severe clinical manifestations, including bleeding, organ impairment, and endothelial dysfunction with increased capillary permeability causing hypovolaemic shock that can lead to cardiovascular collapse. Evidence is increasing that dengue can also cause myocardial impairment, arrhythmias and, occasionally, fulminant myocarditis. No antiviral agents or vaccines are licensed for dengue, and treatment remains supportive with judicious fluid replacement for patients with severe disease. Defining the role of cardiac dysfunction in the haemodynamic compromise of severe dengue has potentially important management implications. In this Review, we will outline the current understanding of the cardiovascular manifestations of dengue, including myocardial and vascular involvement, and conclude with a discussion of the available therapeutic options and potential future research directions.","['Yacoub, Sophie', 'Wertheim, Heiman', 'Simmons, Cameron P', 'Screaton, Gavin', 'Wills, Bridget']","['Yacoub S', 'Wertheim H', 'Simmons CP', 'Screaton G', 'Wills B']",,"['Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, National Hospital for Tropical Diseases, 78 Giai Phong Street, Hanoi, Vietnam.', 'Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, National Hospital for Tropical Diseases, 78 Giai Phong Street, Hanoi, Vietnam.', 'Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Hospital for Tropical Diseases, 764 Vo Van Kiet Street, Ward 1, District 5, Ho Chi Minh City, Vietnam.', 'Department of Medicine, Imperial College, Du Cane Road, London W12 0NN, UK.', 'Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Hospital for Tropical Diseases, 764 Vo Van Kiet Street, Ward 1, District 5, Ho Chi Minh City, Vietnam.']",['eng'],"['Journal Article', 'Review']",20140408,England,Nat Rev Cardiol,Nature reviews. Cardiology,101500075,,IM,"['Cardiovascular Diseases/diagnosis/*epidemiology/virology', 'Communicable Diseases, Emerging/*epidemiology', 'Dengue/diagnosis/*epidemiology/virology', 'Humans', '*Pandemics']",,2014/04/09 06:00,2014/10/31 06:00,['2014/04/09 06:00'],"['2014/04/09 06:00 [entrez]', '2014/04/09 06:00 [pubmed]', '2014/10/31 06:00 [medline]']","['nrcardio.2014.40 [pii]', '10.1038/nrcardio.2014.40 [doi]']",ppublish,Nat Rev Cardiol. 2014 Jun;11(6):335-45. doi: 10.1038/nrcardio.2014.40. Epub 2014 Apr 8.,6,,,,,,"['095541/WT_/Wellcome Trust/United Kingdom', 'G0400720/MRC_/Medical Research Council/United Kingdom', 'G0600000/MRC_/Medical Research Council/United Kingdom', 'G0801508/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,,,,,,,
26545718,NLM,MEDLINE,20160421,20160114,0022-2585 (Print) 0022-2585 (Linking),53,2016 Jan,How Important is Vertical Transmission of Dengue Viruses by Mosquitoes (Diptera: Culicidae)?,1-19,10.1093/jme/tjv168 [doi],"Vertical transmission of dengue viruses by mosquitoes was discovered at the end of the late 1970s and has been suggested to be a means by which these viruses persist. However, it is unclear how widespread it is in nature, and its importance in the epidemiology of this disease is still debated. Here, we review the literature on vertical transmission and discuss its role in dengue's epidemiology and control. We conclude that given the number of studies that failed to find evidence of vertical transmission, as well as mathematical models and its mechanistic basis, it is unlikely that vertical transmission is important for the epidemiological persistence of dengue viruses. A combination of asymptomatic infection in humans and movement of people are likely to be more important determinants of dengue's persistence. We argue, however, that there may be some need for further research into the prevalence of dengue viruses in desiccated, as well as diapausing, eggs and the role of horizontal transmission through larval cannibalism.","['Grunnill, Martin', 'Boots, Michael']","['Grunnill M', 'Boots M']",,"['Centre for Ecology and Conservation Biosciences, College of Life and Environmental Sciences, University of Exeter, Penryn Campus, Treliever Road, Penryn, Cornwall TR10 9FE, United Kingdom (mdg206@exeter.ac.uk), mg206@exeter.ac.uk.', 'Department of Integrative Biology, University of California, Berkeley, California, United States of America (mboots@berkeley.edu).']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20151105,England,J Med Entomol,Journal of medical entomology,0375400,,IM,"['Aedes/*virology', 'Animals', 'Dengue/*transmission', 'Diapause, Insect', 'Humans', '*Infectious Disease Transmission, Vertical', 'Insect Vectors/*virology', 'Ovum/virology']",,2015/11/08 06:00,2016/04/22 06:00,['2015/11/08 06:00'],"['2015/06/03 00:00 [received]', '2015/10/08 00:00 [accepted]', '2015/11/08 06:00 [entrez]', '2015/11/08 06:00 [pubmed]', '2016/04/22 06:00 [medline]']","['tjv168 [pii]', '10.1093/jme/tjv168 [doi]']",ppublish,J Med Entomol. 2016 Jan;53(1):1-19. doi: 10.1093/jme/tjv168. Epub 2015 Nov 5.,1,['(c) Crown copyright 2015.'],['NOTNLM'],"['Aedes aegypti', 'Aedes albopictus', 'arbovirus', 'dengue', 'persistence']",,,,,,,,,,,,,,,,,,,
390473,NLM,MEDLINE,19800215,20051117,0030-9311 (Print) 0030-9311 (Linking),19,1979 Jul-Aug,Dengue haemorrhagic fever.,202-18,,,['Sumarmo'],['Sumarmo'],,,['eng'],"['Journal Article', 'Review']",,Indonesia,Paediatr Indones,Paediatrica Indonesiana,0376416,['9007-36-7 (Complement System Proteins)'],IM,"['Complement System Proteins/immunology', '*Dengue/complications/etiology/immunology/physiopathology/therapy', 'Humans']",,1979/07/01 00:00,1979/07/01 00:01,['1979/07/01 00:00'],"['1979/07/01 00:00 [pubmed]', '1979/07/01 00:01 [medline]', '1979/07/01 00:00 [entrez]']",,ppublish,Paediatr Indones. 1979 Jul-Aug;19(7-8):202-18.,7-8,,,,,,,59,,,,,,,,,,,,,,,
32502429,NLM,MEDLINE,20200907,20220216,1474-4457 (Electronic) 1473-3099 (Linking),20,2020 Aug,Dengue virus on the rise in Nepal.,889-890,S1473-3099(20)30445-X [pii] 10.1016/S1473-3099(20)30445-X [doi],,"['Dumre, Shyam Prakash', 'Acharya, Dhiraj', 'Lal, Bibek Kumar', 'Brady, Oliver J']","['Dumre SP', 'Acharya D', 'Lal BK', 'Brady OJ']",,"['Department of Immunogenetics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.', 'Department of Microbiology, University of Chicago, Chicago, IL, USA.', 'Epidemiology and Disease Control Division, Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal.', 'Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Electronic address: oliver.brady@lshtm.ac.uk.']",['eng'],['Journal Article'],20200602,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Dengue/*epidemiology/prevention & control/*virology', '*Dengue Virus', '*Disease Outbreaks', 'Humans', 'Nepal/epidemiology']",,2020/06/06 06:00,2020/09/08 06:00,['2020/06/06 06:00'],"['2020/02/24 00:00 [received]', '2020/04/30 00:00 [accepted]', '2020/06/06 06:00 [pubmed]', '2020/09/08 06:00 [medline]', '2020/06/06 06:00 [entrez]']","['S1473-3099(20)30445-X [pii]', '10.1016/S1473-3099(20)30445-X [doi]']",ppublish,Lancet Infect Dis. 2020 Aug;20(8):889-890. doi: 10.1016/S1473-3099(20)30445-X. Epub 2020 Jun 2.,8,,,,,,['206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
30113689,NLM,MEDLINE,20190715,20190715,1708-8305 (Electronic) 1195-1982 (Print) 1195-1982 (Linking),25,2018 Aug 1,"Dengue infection in international travellers visiting Bali, Indonesia.",,10.1093/jtm/tay061 [doi] tay061,"BACKGROUND: Dengue, an acute febrile illness caused by infection with dengue virus (DENV), is endemic in Bali, Indonesia. As one of the world's most popular tourist destinations, Bali is regularly visited by domestic and international travellers, who are prone to infection by endemic pathogens, including DENV. Currently, limited data are available on the characteristics of dengue in travellers visiting Bali. Information on the epidemiology and virological aspects of dengue in these tourists is important to gain a better understanding of the dengue disease in international travellers. METHODS: We performed a prospective cross-sectional dengue study involving foreign travellers visiting Bali, Indonesia in the period of 2015-17. Patients presenting at Kasih Ibu Hospital with fever and clinical symptoms of dengue were asked to participate in the study. Clinical and laboratory assessments were performed and sera were collected for molecular analysis, which included DENV serotyping, genome sequencing and phylogenetic analysis. RESULTS: Among the 201 patients recruited, dengue was confirmed in 133 (66.2%) of them, based on detection of NS1 antigen and/or viral RNA. Of these, 115 (86.5%) manifested dengue fever (DF) and 18 (13.5%) dengue haemorrhagic fever (DHF). The temporal predominance of infecting DENV serotype was DENV-2 (48.7%), followed by DENV-3 (36.1%), DENV-1 (9.2%) and DENV-4 (3.4%). Phylogenetic analysis of DENV based on envelope gene sequences revealed that the source of DENVs was local endemic viruses. CONCLUSION: Our study confirms that dengue is one of the causes of fever in travellers visiting Bali. Although it is a cause of significant morbidity, the majority of patients only experienced mild DF, with only a small proportion developing DHF. We revealed that DENVs isolated were autochthonous. Accurate diagnosis, preventive measures and continuous disease surveillance will be useful for better management of dengue infection in travellers.","['Masyeni, Sri', 'Yohan, Benediktus', 'Somia, I Ketut Agus', 'Myint, Khin S A', 'Sasmono, R Tedjo']","['Masyeni S', 'Yohan B', 'Somia IKA', 'Myint KSA', 'Sasmono RT']",,"['Department of Internal Medicine, Faculty of Medicine and Health Sciences, Warmadewa University, Denpasar, Bali, Indonesia.', 'Eijkman Institute for Molecular Biology, Jakarta, Indonesia.', 'Department of Internal Medicine, Faculty of Medicine and Health Sciences, Udayana University, Denpasar, Bali, Indonesia.', 'Eijkman Institute for Molecular Biology, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Jakarta, Indonesia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Dengue/*diagnosis/therapy/virology', 'Dengue Virus/isolation & purification', 'Female', 'Humans', 'Indonesia', 'Male', 'Risk Factors', '*Travel', '*Travel-Related Illness']",PMC6118167,2018/08/17 06:00,2019/07/16 06:00,['2018/08/17 06:00'],"['2018/04/15 00:00 [received]', '2018/08/10 00:00 [accepted]', '2018/08/17 06:00 [pubmed]', '2019/07/16 06:00 [medline]', '2018/08/17 06:00 [entrez]']","['5065180 [pii]', 'tay061 [pii]', '10.1093/jtm/tay061 [doi]']",ppublish,J Travel Med. 2018 Aug 1;25(1):tay061. doi: 10.1093/jtm/tay061.,1,,,,,,['U18 CK000443/CK/NCEZID CDC HHS/United States'],,,,,,,,,,,,,,,,
36256125,NLM,MEDLINE,20221020,20221120,1465-3664 (Electronic) 0142-6338 (Linking),68,2022 Oct 6,Research necessities about myocarditis in dengue patients.,,fmac081 [pii] 10.1093/tropej/fmac081 [doi],,"['Ramirez-Palomino, J Sebastian']",['Ramirez-Palomino JS'],['ORCID: 0000-0002-6143-4879'],"['Faculty of Health Science, Central Unit of Valley of Cauca, Tulua 763022, Colombia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Trop Pediatr,Journal of tropical pediatrics,8010948,,IM,"['Humans', '*Myocarditis/diagnosis/etiology', '*Severe Dengue', '*Dengue/complications/diagnosis']",,2022/10/19 06:00,2022/10/21 06:00,['2022/10/18 11:45'],"['2022/10/18 11:45 [entrez]', '2022/10/19 06:00 [pubmed]', '2022/10/21 06:00 [medline]']","['6762944 [pii]', '10.1093/tropej/fmac081 [doi]']",ppublish,J Trop Pediatr. 2022 Oct 6;68(6):fmac081. doi: 10.1093/tropej/fmac081.,6,,,,,,,,,,,,,,,,,,,,,,
23567637,NLM,MEDLINE,20131105,20130527,1525-2191 (Electronic) 0002-9440 (Linking),182,2013 Jun,Inflammatory and innate immune responses in dengue infection: protection versus disease induction.,1950-61,S0002-9440(13)00206-X [pii] 10.1016/j.ajpath.2013.02.027 [doi],"Dengue disease is a mosquito-borne viral disease of expanding geographical range and incidence. Infection by one of the four serotypes of dengue virus induces a spectrum of disease manifestations, ranging from asymptomatic to life-threatening Dengue hemorrhagic fever/dengue shock syndrome. Many efforts have been made to elucidate several aspects of dengue virus-induced disease, but the pathogenesis of disease is complex and remains unclear. Understanding the mechanisms involved in the early stages of infection is crucial to determine and develop safe therapeutics to prevent the severe outcomes of disease without interfering with control of infection. In this review, we discuss the dual role of the innate and inflammatory pathways activated during dengue disease in mediating both protection and exacerbation of disease. We show that some mediators involved in each of these responses differ substantially, suggesting that interfering in disease-associated immune pathways may represent a potential therapeutic opportunity for the treatment of severe dengue.","['Costa, Vivian Vasconcelos', 'Fagundes, Caio Tavares', 'Souza, Danielle G', 'Teixeira, Mauro Martins']","['Costa VV', 'Fagundes CT', 'Souza DG', 'Teixeira MM']",,"['Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130406,United States,Am J Pathol,The American journal of pathology,0370502,['0 (Cytokines)'],IM,"['Animals', 'Cytokines/immunology', 'Dengue/complications/*immunology/physiopathology/prevention & control', 'Disease Models, Animal', 'Humans', 'Immunity, Innate', 'Inflammation/*virology', 'Mice']",,2013/04/10 06:00,2013/11/06 06:00,['2013/04/10 06:00'],"['2012/07/02 00:00 [received]', '2013/02/01 00:00 [revised]', '2013/02/05 00:00 [accepted]', '2013/04/10 06:00 [entrez]', '2013/04/10 06:00 [pubmed]', '2013/11/06 06:00 [medline]']","['S0002-9440(13)00206-X [pii]', '10.1016/j.ajpath.2013.02.027 [doi]']",ppublish,Am J Pathol. 2013 Jun;182(6):1950-61. doi: 10.1016/j.ajpath.2013.02.027. Epub 2013 Apr 6.,6,"['Copyright (c) 2013 American Society for Investigative Pathology. Published by', 'Elsevier Inc. All rights reserved.']",,,,,,,,,,,,,,,,,,,,,
19561427,NLM,MEDLINE,20100226,20131121,1532-0987 (Electronic) 0891-3668 (Linking),28,2009 Jul,Dengue fever and dengue hemorrhagic fever.,635-6,10.1097/INF.0b013e3181afcd5b [doi],,"['Morens, David M']",['Morens DM'],,"['Office of the Director, CAPT, US Public Health Service, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,['0 (Dengue Vaccines)'],IM,"['Dengue/*complications/diagnosis/epidemiology/*pathology', 'Dengue Vaccines/immunology', 'Humans', 'Severe Dengue/diagnosis/epidemiology/*pathology/prevention & control']",,2009/06/30 09:00,2010/02/27 06:00,['2009/06/30 09:00'],"['2009/06/30 09:00 [entrez]', '2009/06/30 09:00 [pubmed]', '2010/02/27 06:00 [medline]']","['00006454-200907000-00015 [pii]', '10.1097/INF.0b013e3181afcd5b [doi]']",ppublish,Pediatr Infect Dis J. 2009 Jul;28(7):635-6. doi: 10.1097/INF.0b013e3181afcd5b.,7,,,,,,,12,,,,,,,,,,,,,,,
34197697,NLM,MEDLINE,20220721,20220721,1865-1682 (Electronic) 1865-1674 (Linking),69,2022 Jul,Assessment of the global circulation and endemicity of dengue.,2148-2155,10.1111/tbed.14211 [doi],"Dengue is a significant public health issue, affecting hundreds of millions of people worldwide. As it is spreading from tropical and subtropical zones, some regions previously recognised as non-endemic are at risk of becoming endemic. However, the global circulation of dengue is not fully understood and quantitative measurements of endemicity levels are lacking, posing an obstacle in the precise control of dengue spread. In this study, a sequence-based pipeline was designed based on random sampling to study the transmission of dengue. The limited intercontinental transmission was identified, while regional circulation of dengue was quantified in terms of importation, local circulation and exportation. Additionally, hypo- and hyper-endemic regions were identified using a new metric, with the former characterised by low local circulation and increased importation, whereas the latter by high local circulation and reduced importation. In this study, the global circulation pattern of dengue was examined and a sequence-based endemicity measurement was proposed, which will be helpful for future surveillance and targeted control of dengue.","['Long, Haoyu', 'Zhang, Chi', 'Chen, Cai', 'Tang, Jing', 'Zhang, Bing', 'Wang, Yinghan', 'Pang, Jiali', 'Su, Wenzhe', 'Li, Kuibiao', 'Di, Biao', 'Chen, Yao-Qing', 'Shu, Yuelong', 'Du, Xiangjun']","['Long H', 'Zhang C', 'Chen C', 'Tang J', 'Zhang B', 'Wang Y', 'Pang J', 'Su W', 'Li K', 'Di B', 'Chen YQ', 'Shu Y', 'Du X']",['ORCID: 0000-0001-8184-8430'],"['School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Life Sciences, Sun Yat-Sen University, Guangzhou, China.', 'Guangzhou Center for Disease Control and Prevention, Guangzhou, China.', 'Guangzhou Center for Disease Control and Prevention, Guangzhou, China.', 'Guangzhou Center for Disease Control and Prevention, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-Sen University, Guangzhou, China.', 'School of Public Health (Shenzhen), Sun Yat-Sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-Sen University, Guangzhou, China.']",['eng'],['Journal Article'],20210710,Germany,Transbound Emerg Dis,Transboundary and emerging diseases,101319538,,IM,"['Animals', '*Dengue/epidemiology/prevention & control/veterinary', '*Dengue Virus', 'Humans', 'Public Health']",,2021/07/02 06:00,2022/07/22 06:00,['2021/07/01 17:32'],"['2021/02/15 00:00 [received]', '2021/06/27 00:00 [accepted]', '2021/07/02 06:00 [pubmed]', '2022/07/22 06:00 [medline]', '2021/07/01 17:32 [entrez]']",['10.1111/tbed.14211 [doi]'],ppublish,Transbound Emerg Dis. 2022 Jul;69(4):2148-2155. doi: 10.1111/tbed.14211. Epub 2021 Jul 10.,4,['(c) 2021 Wiley-VCH GmbH.'],['NOTNLM'],"['dengue', 'endemicity', 'envelope gene', 'local circulation', 'phylogenetic', 'transmission']",,,"['2019B020228001/Guangdong Frontier and Key Tech Innovation Program/', '2019B111103001/Guangdong Frontier and Key Tech Innovation Program/', '2021A1515011592/Natural Science Foundation of Guangdong Province/', 'KQTD20180411143323605/Shenzhen Science and Technology Program/']",,,,,,,,,,,,,,,,
35580949,NLM,MEDLINE,20220520,20220716,1757-790X (Electronic) 1757-790X (Linking),15,2022 May 17,Acute haemorrhagic encephalomyelitis following dengue infection.,,10.1136/bcr-2022-250516 [doi] e250516,,"['Vasireddy, Anila Rao', 'Mehta, Ami Mehul', 'Seshadri, Shubha', 'Madhyastha, Sharath P']","['Vasireddy AR', 'Mehta AM', 'Seshadri S', 'Madhyastha SP']","['ORCID: 0000-0002-7348-4013', 'ORCID: 0000-0002-9319-2181', 'ORCID: 0000-0003-2821-3473']","['Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.', 'Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.', 'Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.', 'Internal Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India dr.sharathymc@gmail.com.']",['eng'],"['Case Reports', 'Journal Article']",20220517,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['*Dengue/complications/diagnosis', 'Humans', '*Leukoencephalitis, Acute Hemorrhagic', '*Severe Dengue/complications/diagnosis']",PMC9114955,2022/05/18 06:00,2022/05/21 06:00,['2022/05/17 21:13'],"['2024/05/16 00:00 [pmc-release]', '2022/05/17 21:13 [entrez]', '2022/05/18 06:00 [pubmed]', '2022/05/21 06:00 [medline]']","['15/5/e250516 [pii]', 'bcr-2022-250516 [pii]', '10.1136/bcr-2022-250516 [doi]']",epublish,BMJ Case Rep. 2022 May 17;15(5):e250516. doi: 10.1136/bcr-2022-250516.,5,,['NOTNLM'],"['Infection (neurology)', 'Tropical medicine (infectious disease)']",['Competing interests: None declared.'],,,,,,,,,,,['2024/05/16'],,,,,,,
25412506,NLM,MEDLINE,20160218,20231110,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),8,2014 Nov,Approaches to refining estimates of global burden and economics of dengue.,e3306,10.1371/journal.pntd.0003306 [doi] e3306,"Dengue presents a formidable and growing global economic and disease burden, with around half the world's population estimated to be at risk of infection. There is wide variation and substantial uncertainty in current estimates of dengue disease burden and, consequently, on economic burden estimates. Dengue disease varies across time, geography and persons affected. Variations in the transmission of four different viruses and interactions among vector density and host's immune status, age, pre-existing medical conditions, all contribute to the disease's complexity. This systematic review aims to identify and examine estimates of dengue disease burden and costs, discuss major sources of uncertainty, and suggest next steps to improve estimates. Economic analysis of dengue is mainly concerned with costs of illness, particularly in estimating total episodes of symptomatic dengue. However, national dengue disease reporting systems show a great diversity in design and implementation, hindering accurate global estimates of dengue episodes and country comparisons. A combination of immediate, short-, and long-term strategies could substantially improve estimates of disease and, consequently, of economic burden of dengue. Suggestions for immediate implementation include refining analysis of currently available data to adjust reported episodes and expanding data collection in empirical studies, such as documenting the number of ambulatory visits before and after hospitalization and including breakdowns by age. Short-term recommendations include merging multiple data sources, such as cohort and surveillance data to evaluate the accuracy of reporting rates (by health sector, treatment, severity, etc.), and using covariates to extrapolate dengue incidence to locations with no or limited reporting. Long-term efforts aim at strengthening capacity to document dengue transmission using serological methods to systematically analyze and relate to epidemiologic data. As promising tools for diagnosis, vaccination, vector control, and treatment are being developed, these recommended steps should improve objective, systematic measures of dengue burden to strengthen health policy decisions.","['Shepard, Donald S', 'Undurraga, Eduardo A', 'Betancourt-Cravioto, Miguel', 'Guzman, Maria G', 'Halstead, Scott B', 'Harris, Eva', 'Mudin, Rose Nani', 'Murray, Kristy O', 'Tapia-Conyer, Roberto', 'Gubler, Duane J']","['Shepard DS', 'Undurraga EA', 'Betancourt-Cravioto M', 'Guzman MG', 'Halstead SB', 'Harris E', 'Mudin RN', 'Murray KO', 'Tapia-Conyer R', 'Gubler DJ']",,"['Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, United States of America.', 'Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, United States of America.', 'Carlos Slim Health Institute, Mexico City, Mexico.', 'Pedro Kouri Tropical Medicine Institute, Havana, Cuba.', 'Dengue Vaccine Initiative, Rockville, Maryland, United States of America.', 'University of California, Berkeley, California, United States of America.', 'Ministry of Health, Putrajaya, Malaysia.', ""Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States of America."", 'Carlos Slim Health Institute, Mexico City, Mexico.', 'Duke-NUS Graduate Medical School, Singapore.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",20141120,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Cost of Illness', 'Costs and Cost Analysis/methods', 'Dengue/*economics/*epidemiology/prevention & control/therapy', 'Global Health', 'Health Care Costs', 'Humans']",PMC4238988,2014/11/21 06:00,2016/02/19 06:00,['2014/11/21 06:00'],"['2014/01/31 00:00 [received]', '2014/10/01 00:00 [accepted]', '2014/11/21 06:00 [entrez]', '2014/11/21 06:00 [pubmed]', '2016/02/19 06:00 [medline]']","['PNTD-D-14-00173 [pii]', '10.1371/journal.pntd.0003306 [doi]']",epublish,PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3306. doi: 10.1371/journal.pntd.0003306. eCollection 2014 Nov.,11,,,,"['This study was supported in part by a research agreement between Sanofi Pasteur', 'and Brandeis University. This does not alter our adherence to all PLOS NTDs', 'policies on sharing data and materials.']",,,,,,,,,,,,,,,,,,
11347480,NLM,MEDLINE,20010531,20180612,0248-8663 (Print) 0248-8663 (Linking),21 Suppl 4,2000 Dec,[Dengue fever].,443s-445s,,,"['Strobel, M', 'Cabie, A']","['Strobel M', 'Cabie A']",,"['Service des maladies infectieuses, CHU Pointe a Pitre, Guadeloupe.']",['fre'],['Journal Article'],,France,Rev Med Interne,La Revue de medecine interne,8101383,,IM,"['Animals', 'Dengue/epidemiology/*pathology/therapy', 'Diagnosis, Differential', 'Disease Transmission, Infectious', 'Fever/etiology', 'Humans', 'Incidence', 'Insect Vectors', 'Prognosis', 'Public Health', 'Thrombocytopenia/etiology', 'Travel']",,2001/05/12 10:00,2001/06/02 10:01,['2001/05/12 10:00'],"['2001/05/12 10:00 [pubmed]', '2001/06/02 10:01 [medline]', '2001/05/12 10:00 [entrez]']",['S0248-8663(00)90006-7 [pii]'],ppublish,Rev Med Interne. 2000 Dec;21 Suppl 4:443s-445s.,,,,,,,,,,Fievre dengue.,,,,,,,,,,,,,
16640849,NLM,MEDLINE,20060512,20190608,1020-4989 (Print) 1020-4989 (Linking),19,2006 Mar,[Dengue and dengue hemorrhagic fever: research priorities].,204-15,,"Dengue is one of the most important infectious diseases in tropical and subtropical countries. At present, the only strategy available to reduce the incidence of dengue is vector control. The World Health Organization and the Pan American Health Organization have called on all nations to take the needed steps to help diminish the burden of this disease and its medical and socioeconomic impact. It is hoped that it will be possible to reverse the increase in dengue and help control its spread through a coordinated, effective international response, along with epidemiological, clinical, and virological research that brings together the most advanced methods and techniques. This piece summarizes the most up-to-date information on dengue, analyzes current epidemiologic trends in the Region of the Americas, discusses the main global and Western Hemisphere initiatives to control the disease, and presents the main areas of research that should be developed in the immediate future.","['Guzman, Maria G', 'Garcia, Gissel', 'Kouri, Gustavo']","['Guzman MG', 'Garcia G', 'Kouri G']",,"['Instituto de Medicina Tropical Pedro Kouri, Ciudad de La Habana, Cuba. lupe@ipk.sld.cu']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article', 'Review']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,['0 (Viral Vaccines)'],IM,"['Adult', 'Aedes', 'Animals', 'Biomedical Research', 'Child', 'Cohort Studies', '*Dengue/diagnosis/epidemiology/immunology/prevention & control/transmission/virology', 'Dengue Virus/genetics/immunology/pathogenicity', 'Humans', 'Insect Vectors', 'Latin America', 'Pan American Health Organization', 'Population Surveillance', 'Prognosis', 'Risk Factors', '*Severe Dengue/diagnosis/epidemiology/immunology/prevention & control/transmission/virology', 'Viral Vaccines/administration & dosage', 'Virulence', 'World Health Organization']",,2006/04/28 09:00,2006/05/13 09:00,['2006/04/28 09:00'],"['2006/04/28 09:00 [pubmed]', '2006/05/13 09:00 [medline]', '2006/04/28 09:00 [entrez]']","['S1020-49892006000300015 [pii]', '10.1590/s1020-49892006000300015 [doi]']",ppublish,Rev Panam Salud Publica. 2006 Mar;19(3):204-15. doi: 10.1590/s1020-49892006000300015.,3,,,,,,,87,,El dengue y el dengue hemorragico: prioridades de investigacion.,,,,,,,,,,,,,
34607402,NLM,MEDLINE,20211214,20231105,2092-7193 (Electronic) 2092-7193 (Linking),43,2021,Dengue and COVID-19 infections in the ASEAN region: a concurrent outbreak of viral diseases.,e2021070,10.4178/epih.e2021070 [doi] e2021070,"Member countries of the Association of Southeast Asian Nations (ASEAN) have faced dengue outbreaks for decades, and the region has one of the highest rates of dengue globally. Outbreaks continue to occur concurrently with the coronavirus disease 2019 (COVID-19) pandemic in the 10 ASEAN countries. Both infectious diseases pose a tremendous burden in these countries related to both infection control and the economy. Increases in the number of dengue cases occurred in part due to disruptions in the pathogen-host-vector relationship caused by changes in human behaviour in response to the COVID-19 pandemic. The spread of dengue was further aggravated by the implementation of lockdowns and social distancing policies. These measures limited the coverage of dengue preventive programs and delayed the medical management of both diseases due to co-infection and misdiagnosis. It is of the utmost importance for the population to remain aware of both diseases, and dengue vector control strategies must be devised to properly address outbreaks using digitalization and remote surveillance. Similarly, critical triage algorithms and further research are also needed to combat co-infection and misdiagnosis. Controlling the spread of COVID-19 though vaccination should also be undertaken to reduce the impact of the pandemic.","['Wiyono, Lowilius', 'Rocha, Ian Christoper N', 'Cedeno, Trisha Denise D', 'Miranda, Adriana Viola', 'Lucero-Prisno Iii, Don Eliseo']","['Wiyono L', 'Rocha ICN', 'Cedeno TDD', 'Miranda AV', 'Lucero-Prisno Iii DE']",,"['Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.', 'School of Medicine, Centro Escolar University, Manila, Philippines.', 'School of Medicine, Centro Escolar University, Manila, Philippines.', 'Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.', 'Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.', 'Faculty of Management and Development Studies, University of the Philippines Open University, Los Banos, Philippines.']",['eng'],['Journal Article'],20210916,Korea (South),Epidemiol Health,Epidemiology and health,101519472,,IM,"['*COVID-19', 'Communicable Disease Control', '*Dengue/diagnosis/epidemiology/prevention & control', 'Disease Outbreaks', 'Humans', 'Pandemics', 'SARS-CoV-2']",PMC8769803,2021/10/05 06:00,2021/12/15 06:00,['2021/10/04 20:51'],"['2021/07/09 00:00 [received]', '2021/09/16 00:00 [accepted]', '2021/10/05 06:00 [pubmed]', '2021/12/15 06:00 [medline]', '2021/10/04 20:51 [entrez]']","['epih.e2021070 [pii]', 'epih-43-e2021070 [pii]', '10.4178/epih.e2021070 [doi]']",ppublish,Epidemiol Health. 2021;43:e2021070. doi: 10.4178/epih.e2021070. Epub 2021 Sep 16.,,,['NOTNLM'],"['Asia', 'COVID-19', 'Dengue', 'Infection control']",['The authors have no conflicts of interest to declare for this study.'],,,,,,,,,,,,,,,,,,
9386651,NLM,MEDLINE,19980106,20220311,0022-3476 (Print) 0022-3476 (Linking),131,1997 Oct,"Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention.",516-24,,,"['Kautner, I', 'Robinson, M J', 'Kuhnle, U']","['Kautner I', 'Robinson MJ', 'Kuhnle U']",,"['Department of Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],"['Journal Article', 'Review']",,United States,J Pediatr,The Journal of pediatrics,0375410,"['0 (Adrenal Cortex Hormones)', '0 (Fibrinolytic Agents)', '9005-49-6 (Heparin)']",IM,"['Adolescent', 'Adrenal Cortex Hormones/therapeutic use', 'Child', 'Child, Preschool', '*Dengue/diagnosis/epidemiology/therapy/virology', 'Fibrinolytic Agents/therapeutic use', 'Global Health', 'Heparin/therapeutic use', 'Humans', 'Skin/*pathology']",,1997/12/05 00:00,1997/12/05 00:01,['1997/12/05 00:00'],"['1997/12/05 00:00 [pubmed]', '1997/12/05 00:01 [medline]', '1997/12/05 00:00 [entrez]']","['S0022-3476(97)70054-4 [pii]', '10.1016/s0022-3476(97)70054-4 [doi]']",ppublish,J Pediatr. 1997 Oct;131(4):516-24. doi: 10.1016/s0022-3476(97)70054-4.,4,,,,,,,143,,,,,,,,,,,,,,,
15115089,NLM,MEDLINE,20040519,20131121,0125-1562 (Print) 0125-1562 (Linking),34,2003 Dec,Perinatal dengue infection: a case report and review of literature.,793-6,,"A case of vertical transmission of dengue infection in the perinatal period is reported. The mother, a term pregnancy, had acute dengue the day before admission. The infant was born at term and developed fever on the fifth day of life which lasted for 5 days. No bleeding or plasma leakage was detected during the course of fever in infant or mother. A liver function test showed elevated SGOT and SGPT in the infant. The infant developed a convalescent rash on day 5 of the fever. The diagnosis of secondary dengue hemorrhagic fever in the mother was confirmed by serology and primary dengue infection in the infant was confirmed by serology and serotyped as dengue type 2 by PCR. The clinical course and management of mothers and infants with perinatal dengue infection are reviewed.","['Janjindamai, Waricha', 'Pruekprasert, Pornpimol']","['Janjindamai W', 'Pruekprasert P']",,"['Department of Pediatrics, Prince of Songkla University, Hat Yai, Songkhla, Thailand.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Acute Disease', 'Adult', 'Dengue/*congenital/therapy/*transmission', 'Female', 'Humans', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical', 'Pregnancy', '*Pregnancy Complications, Infectious', 'Severe Dengue/therapy', 'Thailand']",,2004/04/30 05:00,2004/05/20 05:00,['2004/04/30 05:00'],"['2004/04/30 05:00 [pubmed]', '2004/05/20 05:00 [medline]', '2004/04/30 05:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):793-6.,4,,,,,,,13,,,,,,,,,,,,,,,
7747082,NLM,MEDLINE,19950613,20190516,0034-8910 (Print) 0034-8910 (Linking),28,1994 Jun,[Dengue in a urban locality of southeastern Brazil: epidemiological aspects].,218-27,,"A dengue fever epidemic which occurred in Ribeirao Preto County, S. Paulo State, Brazil, during the period November, 1990 to March, 1991 has been analysed elsewhere. The general aspects of dengue epidemiology and control have been reviewed in this article. Emphasis is given to the analysis of some factors involved in the risk of dengue haemorrhagic fever and ecological aspects of the vector, as well as to the appropriateness of strategies for dengue eradication or control. Epidemiological characteristics of dengue, mainly those related to its occurrence in different geographical areas and periods of time are described. The Ribeirao Preto epidemic has thus, been set within the context of the spread of the disease at global level, in the Americas, and particularly in Brazil and S. Paulo State.","['Pontes, R J', 'Ruffino-Netto, A']","['Pontes RJ', 'Ruffino-Netto A']",,"['Departamento de Saude Comunitaria, Universidade Federal do Ceara, Fortaleza, CE, Brasil.']",['por'],"['English Abstract', 'Journal Article', 'Review']",,Brazil,Rev Saude Publica,Revista de saude publica,0135043,,IM,"['Brazil/epidemiology', 'Dengue/*epidemiology/etiology/prevention & control/transmission', 'Humans', 'Urban Population']",,1994/06/01 00:00,1994/06/01 00:01,['1994/06/01 00:00'],"['1994/06/01 00:00 [pubmed]', '1994/06/01 00:01 [medline]', '1994/06/01 00:00 [entrez]']",['10.1590/s0034-89101994000300010 [doi]'],ppublish,Rev Saude Publica. 1994 Jun;28(3):218-27. doi: 10.1590/s0034-89101994000300010.,3,,,,,,,53,,Dengue em localidade urbana da regiao sudeste do Brasil: aspectos epidemiologicos.,,,,,,,,,,,,,
12722233,NLM,MEDLINE,20030625,20131121,0047-1852 (Print) 0047-1852 (Linking),61 Suppl 2,2003 Feb,[Dengue/dengue hemorrhagic fever].,302-5,,,"['Morita, Kouichi']",['Morita K'],,"['Department of Virology, Institute of Tropical Medicine, Nagasaki University.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,,IM,"['Animals', 'Culicidae', '*Dengue/diagnosis/therapy/transmission/virology', 'Dengue Virus', 'Diagnosis, Differential', 'Humans', 'Insect Vectors', 'Prognosis', 'Severe Dengue/diagnosis/therapy/transmission/virology']",,2003/05/02 05:00,2003/06/26 05:00,['2003/05/02 05:00'],"['2003/05/02 05:00 [pubmed]', '2003/06/26 05:00 [medline]', '2003/05/02 05:00 [entrez]']",,ppublish,Nihon Rinsho. 2003 Feb;61 Suppl 2:302-5.,,,,,,,,5,,,,,,,,,,,,,,,
26232221,NLM,MEDLINE,20151028,20231111,1097-4172 (Electronic) 0092-8674 (Print) 0092-8674 (Linking),162,2015 Jul 30,Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control.,488-92,S0092-8674(15)00842-9 [pii] 10.1016/j.cell.2015.07.005 [doi],"Dengue virus (DENV) is a mosquito-transmitted RNA virus that infects an estimated 390 million humans each year. Here, we review recent advances in our understanding of the biology of DENV and describe knowledge gaps that have impacted the development of effective vaccines and therapeutics.","['Diamond, Michael S', 'Pierson, Theodore C']","['Diamond MS', 'Pierson TC']",,"['Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: diamond@wusm.wustl.edu.', 'Viral Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: piersontc@mail.nih.gov.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Research Support, N.I.H., Intramural', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Cell,Cell,0413066,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/immunology/prevention & control/therapy/*virology', 'Dengue Vaccines/immunology', 'Dengue Virus/immunology/*physiology', 'Humans', 'Immune Evasion']",PMC4522276,2015/08/02 06:00,2015/10/29 06:00,['2015/08/02 06:00'],"['2015/05/16 00:00 [received]', '2015/08/02 06:00 [entrez]', '2015/08/02 06:00 [pubmed]', '2015/10/29 06:00 [medline]']","['S0092-8674(15)00842-9 [pii]', '10.1016/j.cell.2015.07.005 [doi]']",ppublish,Cell. 2015 Jul 30;162(3):488-92. doi: 10.1016/j.cell.2015.07.005.,3,['Copyright (c) 2015 Elsevier Inc. All rights reserved.'],,,,,"['R01 AI073755/AI/NIAID NIH HHS/United States', 'R01 AI098723/AI/NIAID NIH HHS/United States', 'Intramural NIH HHS/United States']",,,,['NIHMS708449'],,,,,,,,,,,,
27583589,NLM,MEDLINE,20180427,20181202,1531-7072 (Electronic) 1070-5295 (Linking),22,2016 Oct,Critical care for dengue in adult patients: an overview of current knowledge and future challenges.,485-90,10.1097/MCC.0000000000000339 [doi],"PURPOSE OF REVIEW: This review aims to update and summarize the current knowledge about clinical features, management, and risk factors of adult dengue patients requiring intensive care with consequently higher risk of mortality. RECENT FINDINGS: Increasingly, there are more adult dengue patients who require intensive care. This may be due to a shift in epidemiology of dengue infection from mainly a pediatric disease toward adult disease. In addition, multiorgan dysfunction was observed to be a key risk factor for ICU admission and mortality. This may be due to older adults having preexisting comorbidities that potentially predispose to have multiple severe organ impairment. Interventions remain largely supportive but also require more evidence-based trials and treatment protocols. SUMMARY: These findings highlight the common clinical manifestations of adult dengue patients and the challenges of clinical management in ICU. Risk factors for prediction of adult dengue patients who require ICU are available, but they lack validation and consistent study design for meta-analysis in future. Early recognition of these risk factors, with close monitoring and prompt clinical management, remains critical to reduce mortality.","['Pang, Junxiong', 'Leo, Yee-Sin', 'Lye, David C']","['Pang J', 'Leo YS', 'Lye DC']",,"['aInstitute of Infectious Diseases and Epidemiology, Tan Tock Seng HospitalbSaw Swee Hock School of Public HealthcYong Loo Lin School of Medicine, National University of SingaporedLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Crit Care,Current opinion in critical care,9504454,,IM,"['Adult', '*Critical Care', 'Dengue/diagnosis/mortality/*therapy', 'Humans', '*Intensive Care Units', 'Risk Factors']",,2016/09/02 06:00,2018/04/28 06:00,['2016/09/02 06:00'],"['2016/09/02 06:00 [entrez]', '2016/09/02 06:00 [pubmed]', '2018/04/28 06:00 [medline]']","['00075198-201610000-00012 [pii]', '10.1097/MCC.0000000000000339 [doi]']",ppublish,Curr Opin Crit Care. 2016 Oct;22(5):485-90. doi: 10.1097/MCC.0000000000000339.,5,,,,,,,,,,,,,,,,,,,,,,
37876082,NLM,MEDLINE,20231026,20231026,0030-9982 (Print) 0030-9982 (Linking),73,2023 Oct,Dengue Fever Presenting As Acute Febrile Illness In Neonates: A Case Series From Pakistant.,2103-2107,10.47391/JPMA.8260 [doi],"Dengue fever is a mosquito-borne disease caused by flavivirus. It primarily infects people living in tropical and subtropical areas and can be transmitted vertically or horizontally to new-borns. We discuss the clinical spectrum, treatment, and outcomes of five neonates who presented with dengue fever at Aga Khan Hospital for Women in Karimabad, Karachi, Pakistan, during the 2021 post- monsoon season (October to December). Dengue infection was confirmed via positive NS1 antigen test. All new-borns had fever, flushing, and thrombocytopenia. Capillary leak syndrome and haemorrhagic complications occurred in one case. Two babies required oxygen support, with one mortality. Due to the severity of the disease in this population, we suggest that dengue fever should be evaluated as a differential diagnosis in neonates with sepsis and thrombocytopenia, especially in high-risk or endemic areas. Critical management strategies for neonatal dengue fever are the same as those for other paediatric patients and include judicious use of intravenous fluids and inotropes.","['Salim, Maliha', 'Kumar, Vinod', 'Zaheer, Hafsa', 'Shamim, Nazia', 'Hashmis, Hina Mumtaz']","['Salim M', 'Kumar V', 'Zaheer H', 'Shamim N', 'Hashmis HM']",,"['Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.', 'Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.', 'Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.', 'Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.', 'Department of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.']",['eng'],['Journal Article'],,Pakistan,J Pak Med Assoc,JPMA. The Journal of the Pakistan Medical Association,7501162,,IM,"['Animals', 'Infant, Newborn', 'Humans', 'Child', 'Female', '*Dengue/complications/diagnosis/therapy', 'Fever/etiology', 'Pakistan/epidemiology', 'Hospitals', '*Thrombocytopenia/diagnosis/etiology']",,2023/10/25 06:42,2023/10/26 06:42,['2023/10/25 00:23'],"['2023/10/26 06:42 [medline]', '2023/10/25 06:42 [pubmed]', '2023/10/25 00:23 [entrez]']","['8260/2680 [pii]', '10.47391/JPMA.8260 [doi]']",ppublish,J Pak Med Assoc. 2023 Oct;73(10):2103-2107. doi: 10.47391/JPMA.8260.,10,,['NOTNLM'],"['Neonate, dengue fever, thrombocytopenia, dengue haemorrhagic fever, dengue shock', 'syndrome.']",,,,,,,,,,,,,,,,,,,
32673584,NLM,MEDLINE,20200817,20200817,1474-547X (Electronic) 0140-6736 (Linking),394,2019 Dec 7,Picturing health: dengue in Vietnam.,2059-2066,S0140-6736(19)32940-X [pii] 10.1016/S0140-6736(19)32940-X [doi],,"['Gan, Pearl', 'Yacoub, Sophie']","['Gan P', 'Yacoub S']",,"['Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. Electronic address: http://www.pearlgan.com.', 'Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20191205,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Dengue/*epidemiology/prevention & control/therapy', 'Humans', '*Photography', 'Vietnam/epidemiology']",,2020/07/17 06:00,2020/08/18 06:00,['2020/07/17 06:00'],"['2020/07/17 06:00 [entrez]', '2020/07/17 06:00 [pubmed]', '2020/08/18 06:00 [medline]']","['S0140-6736(19)32940-X [pii]', '10.1016/S0140-6736(19)32940-X [doi]']",ppublish,Lancet. 2019 Dec 7;394(10214):2059-2066. doi: 10.1016/S0140-6736(19)32940-X. Epub 2019 Dec 5.,10214,,,,,,['106680/Z/14/A/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
15074231,NLM,MEDLINE,20040621,20051116,0871-2379 (Print) 0871-2379 (Linking),52,2004 Jan-Feb,"[Dengue, emerging disease].",31-7,,,"['Klement, Elise', 'Bricaire, Francois', 'Caumes, Eric']","['Klement E', 'Bricaire F', 'Caumes E']",,"['Servico de Doencas Infecciosas Tropicais, Grupo Hospitalar Pitie-Salpetriere, Paris.']",['por'],"['Journal Article', 'Review']",,Portugal,Servir,"Servir (Lisbon, Portugal)",8601748,,,"['*Communicable Diseases, Emerging/classification/diagnosis/epidemiology/etiology/therapy', '*Dengue/classification/diagnosis/epidemiology/etiology/therapy', 'Humans']",,2004/04/13 05:00,2004/06/24 05:00,['2004/04/13 05:00'],"['2004/04/13 05:00 [pubmed]', '2004/06/24 05:00 [medline]', '2004/04/13 05:00 [entrez]']",,ppublish,Servir. 2004 Jan-Feb;52(1):31-7.,1,,,,,,,19,,"A dengue, doenca emergente.",,,,,,,,,,,,,
11014134,NLM,MEDLINE,20001011,20141120,0041-5782 (Print) 0041-5782 (Linking),162,2000 Sep 18,[Dengue fever and dengue hemorrhagic fever].,5062-6,,"Dengue virus is transmitted by mosquitoes and causes dengue fever/dengue haemorrhagic fever throughout the tropical areas of the world. There is an increasing incidence of dengue infections. Because of increasing travel activity, infection among Danes travelling abroad as well as imported cases are expected to be seen more frequently. In this review we describe the clinical manifestations, diagnosis, pathogenesis, treatment and prevention of the disease.","['Fonsmark, L', 'Poulsen, A', 'Heegaard, E D']","['Fonsmark L', 'Poulsen A', 'Heegaard ED']",,,['dan'],"['English Abstract', 'Journal Article', 'Review']",,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Animals', '*Dengue/diagnosis/epidemiology/therapy/transmission', 'Denmark/epidemiology', 'Disease Vectors', 'Endemic Diseases/prevention & control/statistics & numerical data', 'Global Health', 'Humans', 'Incidence', '*Severe Dengue/diagnosis/epidemiology/therapy/transmission', 'Travel', 'Tropical Medicine']",,2000/10/03 11:00,2000/10/14 11:01,['2000/10/03 11:00'],"['2000/10/03 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/10/03 11:00 [entrez]']",,ppublish,Ugeskr Laeger. 2000 Sep 18;162(38):5062-6.,38,,,,,,,40,,Denguefeber og dengue haemorragisk feber.,,,,,,,,,,,,,
19923152,NLM,MEDLINE,20091130,20181023,1756-1833 (Electronic) 0959-8138 (Linking),339,2009 Nov 18,Diagnosis and management of dengue.,b4338,bmj.b4338 [pii] 10.1136/bmj.b4338 [doi],,"['Teixeira, Maria Gloria', 'Barreto, Mauricio L']","['Teixeira MG', 'Barreto ML']",,"['Instituto de Saude Coletiva, Federal University of Bahia, Rua Basilio da Gama s/n, Canela, 40110-040 Salvador, Bahia, Brazil. magloria@ufba.br']",['eng'],"['Journal Article', 'Review']",20091118,England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['Dengue/*diagnosis/epidemiology/*therapy', 'Diagnosis, Differential', 'Disease Outbreaks/prevention & control', 'Disease Susceptibility', 'Epidemiologic Methods', 'Global Health', 'Humans', 'Nervous System Diseases/virology', 'Practice Guidelines as Topic', 'Severe Dengue/diagnosis/epidemiology/therapy']",,2009/11/20 06:00,2009/12/16 06:00,['2009/11/20 06:00'],"['2009/11/20 06:00 [entrez]', '2009/11/20 06:00 [pubmed]', '2009/12/16 06:00 [medline]']","['bmj.b4338 [pii]', '10.1136/bmj.b4338 [doi]']",epublish,BMJ. 2009 Nov 18;339:b4338. doi: 10.1136/bmj.b4338.,,,,,,['BMJ. 2009;339:b5332. PMID: 20007231'],,35,,,,,,,,,['BMJ. 2009. doi: 10.1136/bmj.b5522'],,,,,,
31931886,NLM,MEDLINE,20200514,20200514,1756-3305 (Electronic) 1756-3305 (Linking),13,2020 Jan 13,Does Bangkok have a central role in the dengue dynamics of Thailand?,22,10.1186/s13071-020-3892-y [doi] 22,"BACKGROUND: Bangkok plays a central role in the commerce of Thailand. This study aimed to characterize the district-level spatial-temporal patterns of dengue in Thailand and explore if a dengue peak in Bangkok led the peaks of dengue in other Thai provinces. METHODS: Monthly dengue data at district level in Thailand from January 2004 to December 2017 were obtained and used to assess the spatial and seasonal patterns of dengue in Thailand. As our seasonal decomposition and cross-correlation analyses showed that dengue in Bangkok peaked in November, which was a few months after the dengue peak in most other provinces, we used a time-series generalized linear model to explore if there was another province in which the dengue case number was most predictive of dengue case numbers in other Thai provinces. RESULTS: The highest district-level annual dengue incidence rates (per 10,000) in the three time periods (i.e. 2004-2008, 2009-2013 and 2014-2017) were 58.08 (Samphanthawong), 85.93 (Mueang Krabi), and 66.60 (Mae Sariang), respectively. Dengue incidence rates in the western part of Northern Thailand, southern part of Central Thailand, southern part of Eastern Thailand, and Southern Thailand were higher than in other regions. Dengue in most districts of Thailand peaked in June, July or August, but dengue peaks in all districts of Bangkok occurred in November. The number of dengue cases in Nakhon Ratchasima was most predictive of the number of dengue cases in other provinces in Thailand by a one-month lag. CONCLUSIONS: Our results suggest that the dengue peak in Bangkok did not lead the peaks of dengue in other Thai provinces. Future research exploring how changes in socio-ecological factors (e.g. road network and climate factors) in Nakhon Ratchasima have affected the transmission of dengue in Thailand might shed some new light on the prevention and control of dengue.","['Xu, Zhiwei', 'Bambrick, Hilary', 'Pongsumpun, Puntani', 'Ming Tang, I', 'Yakob, Laith', 'Devine, Gregor', 'Frentiu, Francesca D', 'Williams, Gail', 'Hu, Wenbiao']","['Xu Z', 'Bambrick H', 'Pongsumpun P', 'Ming Tang I', 'Yakob L', 'Devine G', 'Frentiu FD', 'Williams G', 'Hu W']",,"['School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Australia.', 'Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, 4059, Australia.', 'School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, 4006, Australia.', 'School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Australia.', 'Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, 4059, Australia.', ""Department of Mathematics, Faculty of Science, King Mongkut's Institute of Technology Ladkrabang, Bangkok, 10520, Thailand."", ""Computational & Applied Science for Smart Innovation Cluster (CLASSIC), Faculty of Science, King Mongkut's University of Technology Thonburi, Bangkok, 10140, Thailand."", 'Department of Disease Control, London School of Hygiene and Tropical Medicine, London, WC1H 9SH, UK.', 'Mosquito Control Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, 4006, Australia.', 'Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, 4059, Australia.', 'School of Biomedical Sciences, Queensland University of Technology, Brisbane, 4059, Australia.', 'School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, 4006, Australia.', 'School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Australia. w2.hu@qut.edu.au.', 'Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, 4059, Australia. w2.hu@qut.edu.au.']",['eng'],['Journal Article'],20200113,England,Parasit Vectors,Parasites & vectors,101462774,,IM,"['Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Humans', 'Incidence', 'Seasons', 'Sociological Factors', 'Temperature', 'Thailand/epidemiology']",PMC6958813,2020/01/15 06:00,2020/05/15 06:00,['2020/01/15 06:00'],"['2019/06/12 00:00 [received]', '2020/01/07 00:00 [accepted]', '2020/01/15 06:00 [entrez]', '2020/01/15 06:00 [pubmed]', '2020/05/15 06:00 [medline]']","['10.1186/s13071-020-3892-y [pii]', '3892 [pii]', '10.1186/s13071-020-3892-y [doi]']",epublish,Parasit Vectors. 2020 Jan 13;13(1):22. doi: 10.1186/s13071-020-3892-y.,1,,['NOTNLM'],"['Bangkok', 'Dengue', 'Nakhon Ratchasima', 'Thailand']",['The authors declare that they have no completing interests.'],,"['APP 1138622/National Health and Medical Research Council, Australia/']",,,,,,,,,,,,,,,,
37935865,NLM,MEDLINE,20231127,20231208,1476-4687 (Electronic) 0028-0836 (Linking),623,2023 Nov,Dengue is spreading. Can new vaccines and antivirals halt its rise?,470,10.1038/d41586-023-03453-0 [doi],,"['Lenharo, Mariana']",['Lenharo M'],,,['eng'],['News'],,England,Nature,Nature,0410462,"['0 (Antiviral Agents)', '0 (Dengue Vaccines)']",IM,"['Humans', '*Antiviral Agents', '*Dengue/epidemiology/prevention & control/transmission/virology', '*Dengue Vaccines', 'Dengue Virus']",,2023/11/08 00:41,2023/11/27 12:43,['2023/11/07 23:41'],"['2023/11/27 12:43 [medline]', '2023/11/08 00:41 [pubmed]', '2023/11/07 23:41 [entrez]']","['10.1038/d41586-023-03453-0 [pii]', '10.1038/d41586-023-03453-0 [doi]']",ppublish,Nature. 2023 Nov;623(7987):470. doi: 10.1038/d41586-023-03453-0.,7987,,['NOTNLM'],"['Epidemiology', 'Infection', 'Public health', 'Virology']",,,,,,,,,,,,,,,,,,,
33048921,NLM,MEDLINE,20201211,20201214,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),14,2020 Oct,Dengue epidemic in a non-endemic zone of Bangladesh: Clinical and laboratory profiles of patients.,e0008567,10.1371/journal.pntd.0008567 [doi] e0008567,"BACKGROUNDS: Approximately, half of the population in the world including tropical and sub-tropical climates region is at risk of dengue. Being an endemic country, Bangladesh has experienced the largest dengue epidemic in 2019. The present study aimed at evaluating the clinical and laboratory profile of dengue patients in northern Bangladesh during the epidemic. METHODS: This cross-sectional study included 319 serologically confirmed dengue patients admitted in Shaheed Ziaur Rahman Medical College Hospital in Bogra district. It is one of the main tertiary care hospitals in northern Bangladesh. Data were collected from July to September 2019. Patients' clinical and laboratory data were extracted from clinical records. Patients were classified into two classes according to the WHO 2009 dengue classification such as (i) non-severe dengue and (ii) severe dengue. Chi-square test and independent t-test were used in this study. RESULTS: Of the 319 patients, 94.1% had non-severe dengue and the remaining 5.9% had severe dengue (severe plasma leakage 68.4%, severe organ involvement 68.4%, and severe clinical bleeding 10.5%). Most of the patients were suffering from primary dengue infection. The most common clinical presentation was fever followed by headache and myalgia. Vomiting and abdominal pain were the most prevalent warning signs. The common hematological findings on admission were leukopenia (63.3%), thrombocytopenia (30.4%) and increased hematocrit (26.6%). Raised serum ALT or AST was observed in 14.1% cases whereas raised serum creatinine was observed in 6.6% cases. Signs of plasma leakage (pleural effusion, respiratory distress, and ascites, rise of hematocrit >20% during hospital stay) and hepatic or renal involvement (serum ALT >42UI/L or serum creatinine >1.2 mg/dL) on admission were mostly associated with severe dengue. CONCLUSION: The study provides clinical evidence on presentation as well as hematological and biochemical profile of dengue patients in northern Bangladesh that should be implicated in effective patient management.","['Rafi, Abdur', 'Mousumi, Ashrafun Nahar', 'Ahmed, Reejvi', 'Chowdhury, Rezwanul Haque', 'Wadood, Abdul', 'Hossain, Golam']","['Rafi A', 'Mousumi AN', 'Ahmed R', 'Chowdhury RH', 'Wadood A', 'Hossain G']","['ORCID: 0000-0002-5415-6399', 'ORCID: 0000-0002-5506-6803', 'ORCID: 0000-0002-3822-5489']","['Rajshahi Medical College, Rajshahi, Rajshahi, Bangladesh.', 'Shaheed Ziaur Rahman Medical College, Bogra, Bogra, Bangladesh.', 'Sir Salimullah Medical College, Dhaka, Dhaka, Bangladesh.', 'Rangpur Medical College, Rangpur, Rangpur, Bangladesh.', 'Medical Centre, University of Rajshahi, Rajshahi, Bangladesh.', 'Health Research Group, Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh.']",['eng'],['Journal Article'],20201013,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adult', 'Bangladesh/epidemiology', 'Cross-Sectional Studies', 'Dengue/*classification/*diagnosis/epidemiology/pathology', 'Dengue Virus/isolation & purification', 'Epidemics', 'Female', 'Hospitals, Teaching', 'Humans', 'Male', 'Middle Aged', 'Prospective Studies', 'Severe Dengue/*diagnosis/pathology', 'Severity of Illness Index']",PMC7553334,2020/10/14 06:00,2020/12/15 06:00,['2020/10/13 17:11'],"['2020/04/11 00:00 [received]', '2020/07/06 00:00 [accepted]', '2020/10/13 17:11 [entrez]', '2020/10/14 06:00 [pubmed]', '2020/12/15 06:00 [medline]']","['PNTD-D-20-00595 [pii]', '10.1371/journal.pntd.0008567 [doi]']",epublish,PLoS Negl Trop Dis. 2020 Oct 13;14(10):e0008567. doi: 10.1371/journal.pntd.0008567. eCollection 2020 Oct.,10,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
35751352,NLM,MEDLINE,20220628,20220629,0030-9982 (Print) 0030-9982 (Linking),72,2022 Jun,Dengue presented with pancytopenia - call for physicians to think in different perspective.,1247,10.47391/JPMA.4941 [doi],,"['Ali, Farhan', 'Ali, Kashif', 'Mansoor, Sobia']","['Ali F', 'Ali K', 'Mansoor S']",,"['Department of Internal Medicine, Dr Ruth K.M Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan.', 'Department of Internal Medicine, Dr Ruth K.M Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan.', 'Department of Internal Medicine, Dr. Ruth K.M Pfau Civil Hospital, Dow University of Health Sciences, Karachi, Pakistan.']",['eng'],['Letter'],,Pakistan,J Pak Med Assoc,JPMA. The Journal of the Pakistan Medical Association,7501162,,IM,"['*Dengue/complications/diagnosis/therapy', 'Humans', '*Pancytopenia/diagnosis/etiology', '*Physicians']",,2022/06/26 06:00,2022/06/29 06:00,['2022/06/25 01:13'],"['2022/06/25 01:13 [entrez]', '2022/06/26 06:00 [pubmed]', '2022/06/29 06:00 [medline]']","['11351 [pii]', '10.47391/JPMA.4941 [doi]']",ppublish,J Pak Med Assoc. 2022 Jun;72(6):1247. doi: 10.47391/JPMA.4941.,6,,,,,,,,,,,,,,,,,,,,,,
7886614,NLM,MEDLINE,19950413,20051116,0125-1562 (Print) 0125-1562 (Linking),24 Suppl 1,1993,Abnormal hemostasis in dengue hemorrhagic fever.,80-5,,"Abstract. Abnormal hemostasis in dengue hemorrhagic fever includes:- 1. Vasculopathy which occurs during the early febrile to pre-shock and shock phase. The evidences support are: 1.1 Increased anaphylatoxin, released by complement activation causing leakage of intravascular fluid in to serous space. 1.2 Positive tourniquet test, some of which occur preceeding thrombocytopenia in the acute phase of DHF. 1.3 Excessive increased in PGI2 which is the most potent vasodilator and platelet aggregation inhibitor. 2. Platelets: 2.1 Thrombocytopenia due to 2.1.1 The bone marrow hypocellularity with increased in all forms of megakaryocytes but the vacuolated and disintegrated ones. 2.1.2 Destruction by the liver and spleen. 2.1.3 Immune-mediated injury as demonstration of dengue antibody complexes on the platelet surface. 2.1.4 The in vitro spontaneous aggregation to vascular endothelial cell pre-infected by dengue virus inducing platelet aggregation, causing lysis and platelet destruction. 2.2 Dysfunction shown by 2.2.1 Increased release of betathromboglobulin (BTG), PF4 and PGI2. 2.2.2 In vitro hypoaggregation stimulated by ADP and defect in ADP-releasing ability. 3. Coagulopathy including: 3.1 Prothrombin complex deficiency due to liver damage. 3.2 Consumptive coagulopathy due to the activation by mononuclear phagocytes, PF3 released from platelet aggregation. DIC is seen in prolonged shock cases of DSS.","['Hathirat, P', 'Isarangkura, P', 'Srichaikul, T', 'Suvatte, V', 'Mitrakul, C']","['Hathirat P', 'Isarangkura P', 'Srichaikul T', 'Suvatte V', 'Mitrakul C']",,"['Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.']",['eng'],"['Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*blood/immunology/pathology/virology', 'Hemostasis/*physiology', 'Humans']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:80-5.,,,,,,,,51,,,,,,,,,,,,,,,
7912702,NLM,MEDLINE,19940804,20051116,0891-5520 (Print) 0891-5520 (Linking),8,1994 Mar,Dengue in the Western Hemisphere.,107-28,,"Dengue is an important insect-borne viral disease, transmitted in the Western hemisphere by the A. aegypti mosquito. It is endemic in the Caribbean with sporadic outbreaks in different regions. Cases in the United States are mostly imported cases but can be seen in the Gulf states as well as the Southeast. Dengue is most frequently a self-limiting illness characterized by sudden onset of fever, chills, headache, retroocular pain, general malaise, myalgias, arthralgias, and a skin rash. In a small group of patients, the same viruses may cause dengue hemorrhagic fever and dengue shock syndrome. In the Western hemisphere, dengue with hemorrhagic manifestations and dengue with shock syndrome have been documented frequently in adults. There are four serotypes of dengue viruses and all have been documented to be present in the Western hemisphere. The clinical illness is similar for any of the four serotypes; after infection there is lifelong homotypic immunity and heterotypic immunity for several months. The diagnosis of dengue is based on clinical findings and can be confirmed by serologic tests or virus isolation. There is no specific treatment for dengue; hydration is important as well as aggressive fluid management if hypotension develops. It is important to avoid aspirin and salicylates. The best treatment is prevention through mosquito control and public education to eradicate the breeding grounds for the mosquito.","['Ramirez-Ronda, C H', 'Garcia, C D']","['Ramirez-Ronda CH', 'Garcia CD']",,"['Department of Medicine, University of Puerto Rico School of Medicine, San Juan.']",['eng'],"['Journal Article', 'Review']",,United States,Infect Dis Clin North Am,Infectious disease clinics of North America,8804508,,IM,"['Animals', 'Culicidae/microbiology', 'Dengue/*etiology/prevention & control/therapy', 'Humans', 'Insect Vectors']",,1994/03/01 00:00,1994/03/01 00:01,['1994/03/01 00:00'],"['1994/03/01 00:00 [pubmed]', '1994/03/01 00:01 [medline]', '1994/03/01 00:00 [entrez]']",,ppublish,Infect Dis Clin North Am. 1994 Mar;8(1):107-28.,1,,,,,,,83,,,,,,,,,,,,,,,
34030658,NLM,MEDLINE,20210602,20210602,1471-2334 (Electronic) 1471-2334 (Linking),21,2021 May 24,Development of a bedside score to predict dengue severity.,470,10.1186/s12879-021-06146-z [doi] 470,"BACKGROUND: In 2017, New Caledonia experienced an outbreak of severe dengue causing high hospital burden (4379 cases, 416 hospital admissions, 15 deaths). We decided to build a local operational model predictive of dengue severity, which was needed to ease the healthcare circuit. METHODS: We retrospectively analyzed clinical and biological parameters associated with severe dengue in the cohort of patients hospitalized at the Territorial Hospital between January and July 2017 with confirmed dengue, in order to elaborate a comprehensive patient's score. Patients were compared in univariate and multivariate analyses. Predictive models for severity were built using a descending step-wise method. RESULTS: Out of 383 included patients, 130 (34%) developed severe dengue and 13 (3.4%) died. Major risk factors identified in univariate analysis were: age, comorbidities, presence of at least one alert sign, platelets count < 30 x 10(9)/L, prothrombin time < 60%, AST and/or ALT > 10 N, and previous dengue infection. Severity was not influenced by the infecting dengue serotype nor by previous Zika infection. Two models to predict dengue severity were built according to sex. Best models for females and males had respectively a median Area Under the Curve = 0.80 and 0.88, a sensitivity = 84.5 and 84.5%, a specificity = 78.6 and 95.5%, a positive predictive value = 63.3 and 92.9%, a negative predictive value = 92.8 and 91.3%. Models were secondarily validated on 130 patients hospitalized for dengue in 2018. CONCLUSION: We built robust and efficient models to calculate a bedside score able to predict dengue severity in our setting. We propose the spreadsheet for dengue severity score calculations to health practitioners facing dengue outbreaks of enhanced severity in order to improve patients' medical management and hospitalization flow.","['Marois, Ingrid', 'Forfait, Carole', 'Inizan, Catherine', 'Klement-Frutos, Elise', 'Valiame, Anabelle', 'Aubert, Daina', 'Gourinat, Ann-Claire', 'Laumond, Sylvie', 'Barsac, Emilie', 'Grangeon, Jean-Paul', 'Cazorla, Cecile', 'Merlet, Audrey', 'Tarantola, Arnaud', 'Dupont-Rouzeyrol, Myrielle', 'Descloux, Elodie']","['Marois I', 'Forfait C', 'Inizan C', 'Klement-Frutos E', 'Valiame A', 'Aubert D', 'Gourinat AC', 'Laumond S', 'Barsac E', 'Grangeon JP', 'Cazorla C', 'Merlet A', 'Tarantola A', 'Dupont-Rouzeyrol M', 'Descloux E']",['ORCID: 0000-0001-6302-3785'],"['Internal Medicine and Infectious Diseases Department, Territorial Hospital Center (CHT), Dumbea, New Caledonia.', 'Health Authorities (DASS), Noumea, New Caledonia.', 'Institut Pasteur in New Caledonia, URE Dengue and Arboviruses, Institut Pasteur International Network, Noumea, New Caledonia.', 'Internal Medicine and Infectious Diseases Department, Territorial Hospital Center (CHT), Dumbea, New Caledonia. elisemma@hotmail.com.', 'Hopitaux Universitaires Pitie Salpetriere-Charles Foix, Paris, France. elisemma@hotmail.com.', 'Health Authorities (DASS), Noumea, New Caledonia.', 'Health Authorities (DASS), Noumea, New Caledonia.', 'Microbiology Laboratory, Territorial Hospital Center (CHT), Dumbea, New Caledonia.', 'Health Authorities (DASS), Noumea, New Caledonia.', 'Microbiology Laboratory, Territorial Hospital Center (CHT), Dumbea, New Caledonia.', 'Health Authorities (DASS), Noumea, New Caledonia.', 'Internal Medicine and Infectious Diseases Department, Territorial Hospital Center (CHT), Dumbea, New Caledonia.', 'Internal Medicine and Infectious Diseases Department, Territorial Hospital Center (CHT), Dumbea, New Caledonia.', 'Institut Pasteur in New Caledonia, URE Epidemiology, Institut Pasteur International Network, Noumea, New Caledonia.', 'Institut Pasteur in New Caledonia, URE Dengue and Arboviruses, Institut Pasteur International Network, Noumea, New Caledonia.', 'Internal Medicine and Infectious Diseases Department, Territorial Hospital Center (CHT), Dumbea, New Caledonia.']",['eng'],['Journal Article'],20210524,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Dengue/*classification/diagnosis/epidemiology/pathology', 'Female', 'Hospitalization', 'Humans', 'Male', 'Models, Theoretical', 'New Caledonia/epidemiology', 'Predictive Value of Tests', 'Prognosis', 'Retrospective Studies', 'Risk Factors', 'Triage']",PMC8142072,2021/05/26 06:00,2021/06/03 06:00,['2021/05/25 05:48'],"['2019/11/22 00:00 [received]', '2021/05/06 00:00 [accepted]', '2021/05/25 05:48 [entrez]', '2021/05/26 06:00 [pubmed]', '2021/06/03 06:00 [medline]']","['10.1186/s12879-021-06146-z [pii]', '6146 [pii]', '10.1186/s12879-021-06146-z [doi]']",epublish,BMC Infect Dis. 2021 May 24;21(1):470. doi: 10.1186/s12879-021-06146-z.,1,,['NOTNLM'],"['Arboviruses', 'Dengue', 'Hospital triage', 'Operational tool', 'Pacific', 'Severity score']",['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
31934823,NLM,MEDLINE,20210128,20210128,1557-7759 (Electronic) 1530-3667 (Linking),20,2020 May,Primary Dengue Infection in Patients Requiring Hospitalization During an Outbreak in a Low Incidence Mexican Region.,380-386,10.1089/vbz.2019.2497 [doi],"Background: Dengue manifestations can range from subclinical to fatal. The study of factors that influence dengue's clinical severity can provide information to potentially limit or predict severe cases. Secondary infection (SI) with a different dengue serotype has been recognized as an important determinant of severity. However, severe dengue (SD) manifestations, including shock, can happen during primary infection (PI) too and the mechanisms involved are less understood. To characterize the severe manifestations associated to PI, we distinguished between primary and secondary dengue cases in hospitalized patients from a region of low and recent dengue incidence in central Mexico. This region can serve as a model for dengue's behavior as it spreads to new areas worldwide. Methods: Dengue-specific immunoglobulin M (IgM) and IgG concentrations were measured in the serum of 78 hospitalized patients with dengue hemorrhagic fever, and their ratios were used to discriminate between PI and SI, as recommended by World Health Organization. Clinical and laboratory manifestations were compared between PI and SI. Results and Conclusions: PI was detected in 23% of hospitalized dengue cases, a proportion similar to that reported in high-incidence regions in Mexico. PI was more frequent in 16- to 40-year-olds, and was absent in patients older than 60 years. Only dengue with warning signs and SD were present in the studied population of hospitalized patients, and case frequency decreased with clinical severity both in PI and SI groups. No significant differences in demographics, laboratory tests, or symptoms were found between PI and SI, which illustrates that cases requiring hospitalization during outbreaks can be severe, even if they are PI. This information can help plan for sanitary contingencies in places where dengue is recently emergent and numerous PI cases are expected. The mechanisms involved in PI clinical severity need to be studied further.","['Cardenas-Perea, Maria Elena', 'Flores-Mendoza, Lilian Karem', 'Perez-Contreras, Irma', 'Diaz-Orea, Maria Alicia', 'Gomez-Conde, Eduardo', 'Cortes-Hernandez, Paulina', 'Reyes-Leyva, Julio', 'Santos-Lopez, Gerardo', 'Sosa-Jurado, Francisca']","['Cardenas-Perea ME', 'Flores-Mendoza LK', 'Perez-Contreras I', 'Diaz-Orea MA', 'Gomez-Conde E', 'Cortes-Hernandez P', 'Reyes-Leyva J', 'Santos-Lopez G', 'Sosa-Jurado F']",,"['Departamento de Microbiologia y Parasitologia, Facultad de Medicina de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.', 'Division de Ciencias e Ingenieria, Departamento de Ciencias Quimico Biologicas y Agropecuarias, Universidad de Sonora, Navojoa, Mexico.', 'Departamento de Salud Publica, Facultad de Medicina de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.', 'Departamento de Inmunologia, Facultad de Medicina de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.', 'Departamento de Inmunologia, Facultad de Medicina de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.', 'Laboratorio de Biologia Celular, Centro de Investigacion Biomedica de Oriente del Instituto Mexicano del Seguro Social en Metepec, Puebla, Mexico.', 'Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente del Instituto Mexicano del Seguro Social en Metepec, Puebla, Mexico.', 'Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente del Instituto Mexicano del Seguro Social en Metepec, Puebla, Mexico.', 'Laboratorio de Biologia Molecular y Virologia, Centro de Investigacion Biomedica de Oriente del Instituto Mexicano del Seguro Social en Metepec, Puebla, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20200114,United States,Vector Borne Zoonotic Dis,"Vector borne and zoonotic diseases (Larchmont, N.Y.)",100965525,,IM,"['Adolescent', 'Adult', 'Child', 'Dengue/*epidemiology/*pathology', 'Disease Outbreaks', 'Female', 'Hospitalization', 'Humans', 'Incidence', 'Male', 'Mexico/epidemiology', 'Middle Aged', 'Retrospective Studies', 'Young Adult']",,2020/01/15 06:00,2021/01/29 06:00,['2020/01/15 06:00'],"['2020/01/15 06:00 [pubmed]', '2021/01/29 06:00 [medline]', '2020/01/15 06:00 [entrez]']",['10.1089/vbz.2019.2497 [doi]'],ppublish,Vector Borne Zoonotic Dis. 2020 May;20(5):380-386. doi: 10.1089/vbz.2019.2497. Epub 2020 Jan 14.,5,,['NOTNLM'],"['dengue IgG and IgM', 'dengue outbreak', 'dengue primary infection']",,,,,,,,,,,,,,,,,,,
35735286,NLM,MEDLINE,20220624,20220624,0717-6341 (Electronic) 0716-1018 (Linking),39,2022 Feb,[Encephalitis as neurological complication due dengue].,91-94,S0716-10182022000100091 [pii] 10.4067/S0716-10182022000100091 [doi],"We present the case of a 32-year-old male, previously healthy, with a 5-day history of fever, frontal-occipital headache, retro-ocular pain, rash, petechiae, myalgia, arthralgia, and abdominal pain. Blood tests with leukopenia, severe thrombocytopenia, transaminitis, long clotting times. Severe dengue with associated coagulopathy was diagnosed, indicating transfer to ICU. Presents torpid evolution, altered state of consciousness, psychomotor agitation, and aggressiveness. Structural, ischemic-hemorrhagic alterations, bacterial and fungal infections were ruled out. Finally diagnosing dengue encephalitis, confirmed by DENV PCR in CSF. Support measures are provided with favorable evolution. Encephalitis is the most serious neurological complication after dengue virus infection.","['Lora-Andosilla, Mario', 'Almanza-Hurtado, Amilkar', 'Rodriguez-Yanez, Tomas', 'Martinez-Avila, Maria Cristina', 'Duenas-Castell, Carmelo']","['Lora-Andosilla M', 'Almanza-Hurtado A', 'Rodriguez-Yanez T', 'Martinez-Avila MC', 'Duenas-Castell C']",,"['Medicina Critica y Cuidados Intensivos, Universidad de Cartagena, Cartagena, Colombia.', 'Medicina Critica y Cuidados Intensivos, Universidad de Cartagena, Cartagena, Colombia.', 'Medicina Critica y Cuidados Intensivos, Universidad de Cartagena, Cartagena, Colombia.', 'Epidemiologia Clinica, Nuevo Hospital Bocagrande, Cartagena, Colombia.', 'UCI Gestion Salud, Medicina Critica y Cuidados Intensivos, Universidad de Cartagena, Cartagena, Colombia.']",['spa'],"['Case Reports', 'Journal Article']",,Chile,Rev Chilena Infectol,Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,9305754,,IM,"['Adult', '*Dengue/complications/diagnosis', '*Encephalitis/complications', 'Fever', 'Humans', 'Male', '*Purpura', '*Severe Dengue/complications/diagnosis', '*Thrombocytopenia']",,2022/06/24 06:00,2022/06/25 06:00,['2022/06/23 08:02'],"['2021/05/11 00:00 [received]', '2022/02/02 00:00 [accepted]', '2022/06/23 08:02 [entrez]', '2022/06/24 06:00 [pubmed]', '2022/06/25 06:00 [medline]']","['S0716-10182022000100091 [pii]', '10.4067/S0716-10182022000100091 [doi]']",ppublish,Rev Chilena Infectol. 2022 Feb;39(1):91-94. doi: 10.4067/S0716-10182022000100091.,1,,,,,,,,,Encefalitis como complicacion neurologica por dengue.,,,,,,,,,,,,,
32244954,NLM,MEDLINE,20200921,20200921,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),17,2020 Mar 20,Dengue Surveillance System in Brazil: A Qualitative Study in the Federal District.,,10.3390/ijerph17062062 [doi] 2062,"Dengue's increasing trends raise concerns over global health and pose a challenge to the Brazilian health system, highlighting the necessity of a strong surveillance system to reduce morbidity, mortality, and the economic burden of this disease. Although the Brazilian surveillance system reports more dengue cases than any other country, recent studies suggest that non-reported cases are the majority. The aim of the study is to explore the strengths and weaknesses of the Brazilian surveillance system, particularly looking at the functioning of data collection and reporting. This was done through qualitative semi-structured interviews with 17 experts in dengue surveillance, supported by quantitative data from the official notification system. To select the interviewees, purposive and theoretical sampling were used. Data were analyzed through thematic analysis. The research highlighted that a lack of human and technological resources in healthcare units and surveillance departments slows down the notification process and data analysis. Due to a lack of integration in the private sector, the surveillance system fails to detect the socioeconomic profile of the patients. Investments in public healthcare, human and technological resources for surveillance and better integration in the private healthcare system, and vector surveillance may improve dengue surveillance.","['Angelo, Marco', 'Ramalho, Walter Massa', 'Gurgel, Helen', 'Belle, Nayara', 'Pilot, Eva']","['Angelo M', 'Ramalho WM', 'Gurgel H', 'Belle N', 'Pilot E']","['ORCID: 0000-0002-4250-6742', 'ORCID: 0000-0003-4207-9055', 'ORCID: 0000-0003-3112-4447']","['Department of Health, Ethics & Society, Maastricht University, 6200 MD Maastricht, The Netherlands.', 'Nucleo de Medicina Tropical, Universidade de Brasilia, 70297-400 Brasilia, Brazil.', 'Nucleo de Medicina Tropical, Universidade de Brasilia, 70297-400 Brasilia, Brazil.', 'Laboratorio de Geografia, Ambiente e Saude da Universidade de Brasilia, 70904-970 Brasilia, Brazil.', 'Department of Health, Ethics & Society, Maastricht University, 6200 MD Maastricht, The Netherlands.', 'Laboratorio de Geografia, Ambiente e Saude da Universidade de Brasilia, 70904-970 Brasilia, Brazil.', 'Department of Health, Ethics & Society, Maastricht University, 6200 MD Maastricht, The Netherlands.', 'Centre of Studies in Geography and Spatial Planning (CEGOT), University of Coimbra, 3004-530 Coimbra, Portugal.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20200320,Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,,IM,"['Animals', 'Brazil', '*Dengue/diagnosis/epidemiology', 'Disease Vectors', 'Humans', '*Population Surveillance', 'Qualitative Research']",PMC7142734,2020/04/05 06:00,2020/09/22 06:00,['2020/04/05 06:00'],"['2020/02/01 00:00 [received]', '2020/03/11 00:00 [revised]', '2020/03/13 00:00 [accepted]', '2020/04/05 06:00 [entrez]', '2020/04/05 06:00 [pubmed]', '2020/09/22 06:00 [medline]']","['ijerph17062062 [pii]', 'ijerph-17-02062 [pii]', '10.3390/ijerph17062062 [doi]']",epublish,Int J Environ Res Public Health. 2020 Mar 20;17(6):2062. doi: 10.3390/ijerph17062062.,6,,['NOTNLM'],"['dengue', 'health geography', 'health information', 'infectious diseases', 'public health', 'qualitative research', 'surveillance', 'tropical diseases', 'underreporting', 'urban health']",['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
22943544,NLM,MEDLINE,20130123,20211021,2047-7732 (Electronic) 2047-7724 (Print) 2047-7724 (Linking),106,2012 May,"Reviewing the development, evidence base, and application of the revised dengue case classification.",94-101,10.1179/2047773212Y.0000000017 [doi],"With the example of dengue, an evidence-based approach to prospectively develop a case classification is described, gathering evidence for identifying strength and weaknesses of the existing model, collecting new data describing the disease as it occurs globally, further developing a new model that can be applied in practice and field testing the newly developed model in comparison to the previous model. For each step in this process, the highest available level of evidence has been applied. This process has been initiated by the World Health Organization's (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) and WHO's Department for Control of Neglected Tropical Diseases (NTD), developing the following for dengue. Since the early 1970s, dengue has been classified into dengue fever, dengue haemorrhagic fever grades I and II and dengue shock syndrome grades III and IV (DF/DHF/DSS). However, in recent years, a growing number of dengue clinicians have questioned the shortcomings of this scheme. The issues have revolved around the complexity of confirming DHF in clinical practice, misclassifying severe cases as DF, and the emphasis on haemorrhage rather than plasma leakage as the underlying problem in most severe dengue cases. Step 1: A systematic literature review highlighted the shortcomings of the DF/DHF/DSS scheme: (1) difficulties in applying the criteria for DHF/DSS; (2) the tourniquet test has a low sensitivity for distinguishing between DHF and DF; and (3) most DHF criteria had a large variability in frequency of occurrence. Step 2: An analysis of regional and national dengue guidelines and their application in the clinical practice showed a need to re-evaluate and standardize guidelines as the actual ones showed a large variation of definitions, an inconsistent application by medical staff, and a lack of diagnostic facilities necessary for the DHF diagnosis in frontline services. Step 3: A prospective cohort study in seven countries, confirmed the difficulties in applying the DF/DHF/DSS criteria even in tertiary care hospitals, that DF/DHF/DSS do not represent levels of disease severity and that a clear distinction between severe dengue (defined by plasma leakage and/or severe haemorrhage, and/or organ failure) and (non-severe) dengue can be made using highly sensitive and specific criteria. In contrast, the sub-grouping of (non-severe) dengue into two further severity levels was only possible with criteria that gave approximately 70% sensitivity and specificity. Step 4: Three regional expert consensus groups in the Americas and Asia concluded that 'dengue is one disease entity with different clinical presentations and often with unpredictable clinical evolution and outcome' and that, revising the results of Step 3, DF/DHF/DSS is not related to disease severity. Step 5: In a global expert consensus meeting at WHO in Geneva/Switzerland the evidence collected in Steps 1-4 was reviewed and a revised scheme was developed and accepted, distinguishing: dengue with or without warning signs and severe dengue; the further field testing and acquisition of further prospective evidence of the revised scheme was recommended. Step 6: In 18 countries, the usefulness and applicability of the revised classification compared to the DF/DHF/DSS scheme were tested showing clear results in favour of the revised classification. Step 7: Studies are under way on the predictive value of warning signs for severe dengue and on criteria for the clinical diagnosis of dengue which will complete the evidence foundation of the revised classification. The analysis has shown that the revised dengue case classification is better able to standardize clinical management, raise awareness about unnecessary interventions, match patient categories with specific treatment instructions, and make the key messages of patient management understandable for all health care staff dealing with dengue patients. Furthermore, the evidence-based approach to develop prospectively the dengue case classification could be a model approach for other disease classifications.","['Horstick, O', 'Farrar, J', 'Lum, L', 'Martinez, E', 'San Martin, J L', 'Ehrenberg, J', 'Velayudhan, R', 'Kroeger, A']","['Horstick O', 'Farrar J', 'Lum L', 'Martinez E', 'San Martin JL', 'Ehrenberg J', 'Velayudhan R', 'Kroeger A']",,"['Special Programme for Research and Training in Tropical Diseases (TDR_WHO), Geneva, Switzerland.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",,England,Pathog Glob Health,Pathogens and global health,101583421,,IM,"['Biomedical Research/trends', 'Clinical Medicine/trends', 'Dengue/*classification/*diagnosis/pathology', 'Humans', 'Tropical Medicine/*trends']",PMC3408880,2012/09/05 06:00,2013/01/24 06:00,['2012/09/05 06:00'],"['2012/09/05 06:00 [entrez]', '2012/09/05 06:00 [pubmed]', '2013/01/24 06:00 [medline]']","['42 [pii]', '10.1179/2047773212Y.0000000017 [doi]']",ppublish,Pathog Glob Health. 2012 May;106(2):94-101. doi: 10.1179/2047773212Y.0000000017.,2,,,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
21737578,NLM,MEDLINE,20111103,20130926,1535-3699 (Electronic) 1535-3699 (Linking),236,2011 Aug,The role of climate variability and change in the transmission dynamics and geographic distribution of dengue.,944-54,10.1258/ebm.2011.010402 [doi],"The mounting evidence for anthropogenic changes in global climate raises many pressing questions about the potential effects on biological systems, and in particular the transmission of infectious diseases. Vector-borne diseases, such as dengue, may be particularly sensitive to both periodic fluctuations and sustained changes in global and local climates, because vector biology and viral replication are temperature- and moisture-dependent. This paper reviews the current state of knowledge on the associations between climate variability, climate change and dengue transmission, and the tools being used to quantify these associations. The underlying causes of dengue's recent global expansion are multifactorial and poorly understood, but climatic factors should be considered within the context of the sociodemographic, economic and immunological determinants that have contributed to dengue's spread. These factors may mediate the direct effects of climate on dengue and many may operate at a very local level. Translating theoretical models of dengue transmission based on historical data into predictive models that can inform public health interventions is a critical next step and efforts should be focused on developing and refining models at smaller spatial scales to characterize the relationships between both climatic and non-climatic factors and dengue risk.","['Thai, Khoa T D', 'Anders, Katherine L']","['Thai KT', 'Anders KL']",,"['Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Vietnam. khoat@oucru.org']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20110707,England,Exp Biol Med (Maywood),"Experimental biology and medicine (Maywood, N.J.)",100973463,,IM,"['*Climate Change', 'Dengue/*epidemiology/*transmission', 'Humans', 'Humidity', 'Public Health', 'Temperature']",,2011/07/09 06:00,2011/11/04 06:00,['2011/07/09 06:00'],"['2011/07/09 06:00 [entrez]', '2011/07/09 06:00 [pubmed]', '2011/11/04 06:00 [medline]']","['ebm.2011.010402 [pii]', '10.1258/ebm.2011.010402 [doi]']",ppublish,Exp Biol Med (Maywood). 2011 Aug;236(8):944-54. doi: 10.1258/ebm.2011.010402. Epub 2011 Jul 7.,8,,,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
16903887,NLM,MEDLINE,20060828,20181201,1360-2276 (Print) 1360-2276 (Linking),11,2006 Aug,Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever.,1238-55,,"BACKGROUND: The current World Health Organisation (WHO) classification of dengue includes two distinct entities: dengue fever (DF) and dengue haemorrhagic fever (DHF)/dengue shock syndrome; it is largely based on pediatric cases in Southeast Asia. Dengue has extended to different tropical areas and older age groups. Variations from the original description of dengue manifestations are being reported. OBJECTIVES: To analyse the experience of clinicians in using the dengue case classification and identify challenges in applying the criteria in routine clinical practice. METHOD: Systematic literature review of post-1975 English-language publications on dengue classification. RESULTS: Thirty-seven papers were reviewed. Several studies had strictly applied all four WHO criteria in DHF cases; however, most clinicians reported difficulties in meeting all four criteria and used a modified classification. The positive tourniquet test representing the minimum requirement of a haemorrhagic manifestation did not distinguish between DHF and DF. In cases of DHF thrombocytopenia was observed in 8.6-96%, plasma leakage in 6-95% and haemorrhagic manifestations in 22-93%. The low sensitivity of classifying DHF could be due to failure to repeat the tests or physical examinations at the appropriate time, early intravenous fluid therapy, and lack of adequate resources in an epidemic situation and perhaps a considerable overlap of clinical manifestations in the different dengue entities. CONCLUSION: A prospective multi-centre study across dengue endemic regions, age groups and the health care system is required which describes the clinical presentation of dengue including simple laboratory parameters in order to review and if necessary modify the current dengue classification.","['Bandyopadhyay, Shibani', 'Lum, Lucy C S', 'Kroeger, Axel']","['Bandyopadhyay S', 'Lum LC', 'Kroeger A']",,"['Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Capillary Permeability/physiology', 'Dengue/*classification/complications/diagnosis', 'Hemorrhage/etiology', 'Humans', 'Sensitivity and Specificity', 'Severe Dengue/classification/complications/diagnosis', 'Thrombocytopenia/complications', 'Tourniquets', 'World Health Organization']",,2006/08/15 09:00,2006/08/29 09:00,['2006/08/15 09:00'],"['2006/08/15 09:00 [pubmed]', '2006/08/29 09:00 [medline]', '2006/08/15 09:00 [entrez]']","['TMI1678 [pii]', '10.1111/j.1365-3156.2006.01678.x [doi]']",ppublish,Trop Med Int Health. 2006 Aug;11(8):1238-55. doi: 10.1111/j.1365-3156.2006.01678.x.,8,,,,,,,84,,,,,,,,,,,,,,,
36573590,NLM,MEDLINE,20221228,20230131,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),29,2023 Jan,"Burden of Postinfectious Symptoms after Acute Dengue, Vietnam.",160-163,10.3201/eid2901.220838 [doi],"We assessed predominantly pediatric patients in Vietnam with dengue and other febrile illness 3 months after acute illness. Among dengue patients, 47% reported >1 postacute symptom. Most resolved by 3 months, but alopecia and vision problems often persisted. Our findings provide additional evidence on postacute dengue burden and confirm children are affected.","['Tam, Dong Thi Hoai', 'Clapham, Hannah', 'Giger, Elisabeth', 'Kieu, Nguyen Tan Thanh', 'Nam, Nguyen Tran', 'Hong, Dinh Thi Tri', 'Nuoi, Banh Thi', 'Cam, Nguyen Thi Hong', 'Quyen, Nguyen Than Ha', 'Turner, Hugo C', 'Jaenisch, Thomas', 'Simmons, Cameron P', 'Lam, Phung Khanh', 'Wills, Bridget']","['Tam DTH', 'Clapham H', 'Giger E', 'Kieu NTT', 'Nam NT', 'Hong DTT', 'Nuoi BT', 'Cam NTH', 'Quyen NTH', 'Turner HC', 'Jaenisch T', 'Simmons CP', 'Lam PK', 'Wills B']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Humans', 'Child', '*Dengue/complications/diagnosis/epidemiology', 'Vietnam/epidemiology']",PMC9796196,2022/12/28 06:00,2022/12/29 06:00,['2022/12/27 07:02'],"['2022/12/27 07:02 [entrez]', '2022/12/28 06:00 [pubmed]', '2022/12/29 06:00 [medline]']","['22-0838 [pii]', '10.3201/eid2901.220838 [doi]']",ppublish,Emerg Infect Dis. 2023 Jan;29(1):160-163. doi: 10.3201/eid2901.220838.,1,,['NOTNLM'],"['Vietnam', 'burden', 'dengue', 'vector-borne infections', 'viruses']",,,"['106680/B/14/Z/WT_/Wellcome Trust/United Kingdom', 'MR/R015600/1/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,,,,,,,
17562529,NLM,MEDLINE,20071023,20221207,1052-9276 (Print) 1052-9276 (Linking),17,2007 Sep-Oct,Research on dengue and dengue-like illness in East Asia and the Western Pacific during the First Half of the 20th century.,327-41,,"Dengue has become an enormous medical problem worldwide since the end of the World War II (WWII). Despite a voluminous amount of research conducted worldwide for many years to elucidate the mechanism of the development of the two severe forms of dengue (dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS)), to develop effective vaccines and to design reliable disease control and prevention strategies, the goals of achieving these objectives are not in sight yet. For such a medical research that requires a multi-directional approach to resolve a variety of research questions, sometimes it is necessary to step back and re-examine historically how the current status of the expanding global problems and sudden emergence of severe forms of dengue have evolved in the first place. To examine the history of dengue epidemiology, it is first necessary to put in perspective all relevant documents, including a large number of nearly forgotten, old Japanese publications regarding dengue outbreaks and allied background information in East Asia and the Western Pacific that were documented before the emergence of the haemorrhagic disease outbreaks in the 1950s there. The compiled data in this review, thus, fill in for the first time many blanks in the early epidemiologic history of dengue in this part of the world. Besides the data for epidemiologists, virologic data, clinical studies of haemorrhagic manifestation, significance in military medicine and entomologic investigations covered in this review should be useful for the current researchers investigating any of those subjects.","['Kuno, Goro']",['Kuno G'],,"['Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center of Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA. gok1@cdc.gov']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,England,Rev Med Virol,Reviews in medical virology,9112448,,IM,"['Asia, Southeastern', 'Dengue/*epidemiology/history', 'Asia, Eastern/epidemiology', 'History, 20th Century', 'Humans']",,2007/06/15 09:00,2007/10/24 09:00,['2007/06/15 09:00'],"['2007/06/15 09:00 [pubmed]', '2007/10/24 09:00 [medline]', '2007/06/15 09:00 [entrez]']",['10.1002/rmv.545 [doi]'],ppublish,Rev Med Virol. 2007 Sep-Oct;17(5):327-41. doi: 10.1002/rmv.545.,5,,,,,,,135,,,,,,,,,,,,,,,
37865115,NLM,MEDLINE,20231127,20231127,1474-4457 (Electronic) 1473-3099 (Linking),23,2023 Dec,"Dengue fever: working towards global control considering biological, social, and planetary determinants.",e506,S1473-3099(23)00632-1 [pii] 10.1016/S1473-3099(23)00632-1 [doi],,"['Bellissimo-Rodrigues, Fernando', 'Dal Fabbro, Amaury Lelis']","['Bellissimo-Rodrigues F', 'Dal Fabbro AL']",,"['Social Medicine Department, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14048-900, Brazil. Electronic address: fbellissimo@usp.br.', 'Social Medicine Department, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14048-900, Brazil.']",['eng'],['Letter'],20231018,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Humans', '*Dengue/epidemiology/prevention & control', 'Disease Outbreaks']",,2023/10/22 00:41,2023/11/27 12:42,['2023/10/21 18:54'],"['2023/10/03 00:00 [received]', '2023/10/04 00:00 [accepted]', '2023/11/27 12:42 [medline]', '2023/10/22 00:41 [pubmed]', '2023/10/21 18:54 [entrez]']","['S1473-3099(23)00632-1 [pii]', '10.1016/S1473-3099(23)00632-1 [doi]']",ppublish,Lancet Infect Dis. 2023 Dec;23(12):e506. doi: 10.1016/S1473-3099(23)00632-1. Epub 2023 Oct 18.,12,,,,['We declare no competing interests.'],,,,,,,,,,,,,,,,,,
27810313,NLM,MEDLINE,20171215,20181202,1873-2518 (Electronic) 0264-410X (Linking),34,2016 Dec 7,The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.,6133-6147,S0264-410X(16)30972-0 [pii] 10.1016/j.vaccine.2016.10.037 [doi],"BACKGROUND: Dengue fever is one of the most rapidly advancing viral vector-borne diseases worldwide and vaccine candidates are in the final stages of clinical trials, representing a decisive opportunity to control the disease. To decide whether and where to support the introduction of new vaccines it is crucial to assess costs imposed by the disease and cost-effectiveness of vaccine programmes. OBJECTIVE: To identify economic evidence about dengue fever immunization, by systematic review, to assist future policy decisions and investment. METHODS: The electronic search stage was conducted on PubMed/Medline, Embase, Web of Science, Global Health, NHS Economic Evaluation Database (NHS EED) and Latin American and Caribbean Health Sciences Literature (LILACS) databases. Searches were restricted to papers published between January 1970 and February 2016. Selected papers were quality assessed using three recognized checklists. RESULTS: Eleven relevant studies were identified and there is economic evidence of a satisfactory quality level, derived through modelling approaches, to conclude that dengue fever vaccines will be economically advantageous when compared to vector preventive strategies, despite uncertainties surrounding vaccine efficacy and costs per vaccine dose. Quality assessment based on checklists showed similar findings and although overall quality was considered satisfactory, there were relevant methodological issues not considered among studies reviewed. CONCLUSION: Several uncertainties still remain about effectiveness of dengue fever vaccines; however, the reviewed economic evidence suggests that, when available, the vaccine can be economically advantageous at moderate prices. Future research needs to confirm findings from the economic models by using actual costs and effectiveness data.","['Endo, Iara C', 'Ziegelmann, Patricia K', 'Patel, Anita']","['Endo IC', 'Ziegelmann PK', 'Patel A']",,"['Ministry of Planning, Development and Management, Brasilia, Brazil; Ministry of Health, Brasilia, Brazil. Electronic address: iara.endo@gmail.com.', 'Statistics Department, Mathematics Institute and Epidemiology Postgraduate Programme, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.', 'Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",20161031,Netherlands,Vaccine,Vaccine,8406899,['0 (Dengue Vaccines)'],IM,"['*Cost-Benefit Analysis', 'Dengue/*economics/epidemiology/*prevention & control', 'Dengue Vaccines/*administration & dosage/*economics', 'Global Health', 'Humans']",,2016/11/05 06:00,2017/12/16 06:00,['2016/11/05 06:00'],"['2015/12/20 00:00 [received]', '2016/10/16 00:00 [revised]', '2016/10/17 00:00 [accepted]', '2016/11/05 06:00 [pubmed]', '2017/12/16 06:00 [medline]', '2016/11/05 06:00 [entrez]']","['S0264-410X(16)30972-0 [pii]', '10.1016/j.vaccine.2016.10.037 [doi]']",ppublish,Vaccine. 2016 Dec 7;34(50):6133-6147. doi: 10.1016/j.vaccine.2016.10.037. Epub 2016 Oct 31.,50,['Copyright A(c) 2016 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Cost-effectiveness', 'Dengue', 'Economic', 'Quality assessment', 'Vaccine']",,,,,,,,,,,,,,,,,,,
18193662,NLM,MEDLINE,20080219,20161109,0065-2598 (Print) 0065-2598 (Linking),609,2008,Management of severe dengue in children.,131-44,10.1007/978-0-387-73960-1_10 [doi],"Dengue is a major global disease which, in its severe form, affects up to 500,000 people worldwide each year, most of whom are children. The development of a safe and effective vaccine is a clear priority, together with public health measures to prevent the spread of infection. However, while major epidemics continue to occur, clinicians must also focus on optimising management. Although no specific treatment is available at present, with good supportive care, mortality for children with DHF can be reduced to well below 1%. In patients without signs of shock, fluid replacement can be attempted orally, but in children with DSS parenteral treatment is essential. Very careful titration of fluid therapy is necessary combined with frequent reassessment for signs of worsening shock or the development of fluid overload. In most DSS cases isotonic crystalloid solutions are as effective as colloid solutions, but the question whether early intervention with colloid solutions improves outcome in more advanced shock requires further investigation. The outcome of studies to address this question, together with further research to examine the pathophysiological mechanisms underlying the plasma leakage, will hopefully result in better management of children with severe dengue but may also provide useful insights into other diseases that affect endothelial function.","['Moxon, Christopher', 'Wills, Bridget']","['Moxon C', 'Wills B']",,"['Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.']",['eng'],"['Journal Article', 'Review']",,United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,,IM,"['Child', 'Dengue/physiopathology/*therapy/virology', 'Dengue Virus/*physiology', 'Humans', 'Severe Dengue/physiopathology/*therapy']",,2008/01/16 09:00,2008/02/20 09:00,['2008/01/16 09:00'],"['2008/01/16 09:00 [pubmed]', '2008/02/20 09:00 [medline]', '2008/01/16 09:00 [entrez]']",['10.1007/978-0-387-73960-1_10 [doi]'],ppublish,Adv Exp Med Biol. 2008;609:131-44. doi: 10.1007/978-0-387-73960-1_10.,,,,,,,,44,,,,,,,,,,,,,,,
20520794,NLM,MEDLINE,20100806,20230522,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),4,2010 May 25,Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission.,e646,10.1371/journal.pntd.0000646 [doi] e646,"The dramatic global expansion of Aedes albopictus in the last three decades has increased public health concern because it is a potential vector of numerous arthropod-borne viruses (arboviruses), including the most prevalent arboviral pathogen of humans, dengue virus (DENV). Ae. aegypti is considered the primary DENV vector and has repeatedly been incriminated as a driving force in dengue's worldwide emergence. What remains unresolved is the extent to which Ae. albopictus contributes to DENV transmission and whether an improved understanding of its vector status would enhance dengue surveillance and prevention. To assess the relative public health importance of Ae. albopictus for dengue, we carried out two complementary analyses. We reviewed its role in past dengue epidemics and compared its DENV vector competence with that of Ae. aegypti. Observations from ""natural experiments"" indicate that, despite seemingly favorable conditions, places where Ae. albopictus predominates over Ae. aegypti have never experienced a typical explosive dengue epidemic with severe cases of the disease. Results from a meta-analysis of experimental laboratory studies reveal that although Ae. albopictus is overall more susceptible to DENV midgut infection, rates of virus dissemination from the midgut to other tissues are significantly lower in Ae. albopictus than in Ae. aegypti. For both indices of vector competence, a few generations of mosquito colonization appear to result in a relative increase of Ae. albopictus susceptibility, which may have been a confounding factor in the literature. Our results lead to the conclusion that Ae. albopictus plays a relatively minor role compared to Ae. aegypti in DENV transmission, at least in part due to differences in host preferences and reduced vector competence. Recent examples of rapid arboviral adaptation to alternative mosquito vectors, however, call for cautious extrapolation of our conclusion. Vector status is a dynamic process that in the future could change in epidemiologically important ways.","['Lambrechts, Louis', 'Scott, Thomas W', 'Gubler, Duane J']","['Lambrechts L', 'Scott TW', 'Gubler DJ']",,"['Department of Virology, Institut Pasteur, Paris, France. louis.lambrechts@pasteur.fr']",['eng'],"['Journal Article', 'Meta-Analysis', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",20100525,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Aedes/*growth & development', 'Animals', 'Dengue/*epidemiology/*transmission', 'Dengue Virus/*isolation & purification', 'Disease Outbreaks', '*Disease Vectors', 'Humans']",PMC2876112,2010/06/04 06:00,2010/08/07 06:00,['2010/06/04 06:00'],"['2010/06/04 06:00 [entrez]', '2010/06/04 06:00 [pubmed]', '2010/08/07 06:00 [medline]']","['09-PNTD-RV-0623R2 [pii]', '10.1371/journal.pntd.0000646 [doi]']",epublish,PLoS Negl Trop Dis. 2010 May 25;4(5):e646. doi: 10.1371/journal.pntd.0000646.,5,,,,['The authors have declared that no competing interests exist.'],,['R01 GM083224-01A1/GM/NIGMS NIH HHS/United States'],,,,,,,,,,,,,,,,
32125417,NLM,MEDLINE,20210624,20210624,1878-3503 (Electronic) 0035-9203 (Linking),114,2020 May 7,Persistence of symptoms in dengue patients: a clinical cohort study.,355-364,10.1093/trstmh/traa007 [doi],"BACKGROUND: Dengue is commonly considered an acute illness and follows three phases: febrile, critical in some cases and recovery. However, a number of studies have described a continuation of dengue symptoms for weeks or months, extending the recovery phase. Here we evaluate this persistence of dengue symptoms during convalescence. METHODS: Our clinical cohort study included patients who sought medical services 48 to 144 h from the onset of fever at seven hospitals or ambulatory centers in Morelos, Mexico. Seventy-nine laboratory-confirmed dengue patients were followed up regularly using clinic and/or home visits and telephone calls for as long as symptoms persisted or up to 6 mo. RESULTS: In total, 55.7% of patients had dengue-related symptoms 1 mo after the onset of fever; pain and dermatological manifestations were the most common persistent symptoms. Prognostic factors for symptom persistence were: >/=4 d of fever (RR 1.72; 95% CI 1.35 to 2.19), platelet count </=100 000/mm3 (RR 1.20; 95% CI 1.20 to 2.20), petechiae/bruises (RR 1.97; 95% CI 1.56 to 2.48) and abdominal pain/hepatomegaly (RR 1.79; 95% CI 1.41 to 2.28). CONCLUSIONS: Persistence of dengue symptoms were common in laboratory-confirmed dengue patients. Manifestations related to tissue damage were associated with persistence after 30 d; host characteristics, such as age and health status before infection, were associated with prolonged persistence (>60 d). The burden of dengue may be higher than previously estimated.","['Tiga-Loza, Diana Carolina', 'Martinez-Vega, Ruth A', 'Undurraga, Eduardo A', 'Tschampl, Cynthia A', 'Shepard, Donald S', 'Ramos-Castaneda, Jose']","['Tiga-Loza DC', 'Martinez-Vega RA', 'Undurraga EA', 'Tschampl CA', 'Shepard DS', 'Ramos-Castaneda J']",,"['Programa de enfermeria, Universidad Manuela Beltran, Bucaramanga, Santander, Colombia.', 'Centro de investigaciones sobre enfermedades infecciosas, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico.', 'Escuela de Microbiologia, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.', 'Escuela de Gobierno, Pontificia Universidad Catolica de Chile, Santiago, Chile.', 'Millennium Nucleus for the Study of the Life Course and Vulnerability (MLIV), Chile.', 'Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, USA.', 'Schneider Institutes for Health Policy, Heller School, Brandeis University, Waltham, Massachusetts, USA.', 'Centro de investigaciones sobre enfermedades infecciosas, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico.', 'Universidad Anahuac, Centro de Investigacion en Ciencias de la Salud. Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Cohort Studies', '*Dengue/complications/diagnosis/epidemiology', 'Fever/epidemiology/etiology', 'Humans', 'Mexico/epidemiology', 'Platelet Count']",,2020/03/04 06:00,2021/06/25 06:00,['2020/03/04 06:00'],"['2019/06/23 00:00 [received]', '2020/01/14 00:00 [revised]', '2020/01/16 00:00 [accepted]', '2020/03/04 06:00 [pubmed]', '2021/06/25 06:00 [medline]', '2020/03/04 06:00 [entrez]']","['5775493 [pii]', '10.1093/trstmh/traa007 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2020 May 7;114(5):355-364. doi: 10.1093/trstmh/traa007.,5,"['(c) The Author(s) 2020. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene. All rights reserved. For permissions,', 'please e-mail: journals.permissions@oup.com.']",['NOTNLM'],"['cohort study', 'convalescence', 'dengue', 'persistent symptoms', 'signs and symptoms']",,,,,,,,,,,,,,,,,,,
18367628,NLM,MEDLINE,20080618,20220318,1535-3702 (Print) 1535-3699 (Linking),233,2008 Apr,Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.,401-8,10.3181/0707-MR-198 [doi],"Dengue fever, caused by infection with dengue virus, is not a new disease, but recently because of its serious emerging health threats, coupled with possible dire consequences including death, it has aroused considerable medical and public health concerns worldwide. Today, dengue is considered one of the most important arthropod-borne viral diseases in humans in terms of morbidity and mortality. Globally, it is estimated that approximate 50 to 100 million new dengue virus infections occur annually. Among these, there are 200,000 to 500,000 cases of potential life-threatening dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS), characterized by thrombocytopenia and increased vascular permeability. The death rate associated with the more severe form DHF/DSS is approximately 5%, predominantly in children under the age of 15. Although intensive efforts have been made to study the early clinical pathophysiology of dengue infection with the objective to identify the potential cause of DHF, results or data that have accumulated from different regions of the world involving studies of different ethnicity groups are inconsistent at present in terms of identifying a unified hypothesis for the pathogenesis of DHF/DSS. Thus, the potential mechanisms involved in the pathogenesis of DHF and DSS remain elusive. The purpose of this review is to identify alternate factors, such as innate immune parameters, hyper-thermal factors, conditioning of neutralizing antibody, concept of vector transmission, and physical status of virus in viremic patients that may play a role in the induction of DHF and DSS, which might have directly or indirectly contributed to the discrepancies that are noted in the literature reported to date. It is the hope that identification of an alternative explanation for the pathogenesis of DHF/DSS will pave the way for the institution of new strategies for the prevention of this complicated disease.","['Noisakran, Sansanee', 'Perng, Guey Chuen']","['Noisakran S', 'Perng GC']",,"['Medical Biotechnology Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, 12120, Thailand.']",['eng'],"['Journal Article', 'Review']",,England,Exp Biol Med (Maywood),"Experimental biology and medicine (Maywood, N.J.)",100973463,['0 (Immunoglobulin M)'],IM,"['Animals', 'Blood Platelets/metabolism', 'Dengue/epidemiology/etiology/immunology/*physiopathology', 'Dengue Virus/*pathogenicity', 'Humans', 'Immunity, Innate/physiology', 'Immunoglobulin M/immunology', 'Insect Vectors', 'Severe Dengue/epidemiology/etiology/immunology/*physiopathology']",,2008/03/28 09:00,2008/06/19 09:00,['2008/03/28 09:00'],"['2008/03/28 09:00 [pubmed]', '2008/06/19 09:00 [medline]', '2008/03/28 09:00 [entrez]']","['233/4/401 [pii]', '10.3181/0707-MR-198 [doi]']",ppublish,Exp Biol Med (Maywood). 2008 Apr;233(4):401-8. doi: 10.3181/0707-MR-198.,4,,,,,,,105,,,,,,,,,,,,,,,
19800558,NLM,MEDLINE,20100118,20141120,1873-5967 (Electronic) 1386-6532 (Linking),46 Suppl 2,2009 Oct,Dengue is a major global health problem. Foreword.,S1-2,10.1016/S1386-6532(09)70285-9 [doi],"Dengue is a major global health concern. Its increasing incidence and continued geographical spread make the development of an effective vaccine an international health priority. Dengue is currently present in more than one hundred countries, while up to 3 billion people are estimated to be at risk of infection. In addition, dengue is associated with a substantial economic burden that is particularly severe at the individual family level. Establishing the full human cost and economic impact of dengue remains urgent. The approaches being investigated for vaccine development include the use of live, vectored and killed, and recombinant preparations. Vaccine candidates must provide broad and robust immunity to all four dengue serotypes simultaneously as secondary dengue infections may lead to enhanced disease severity. The design, implementation, and surveillance measures associated with dengue vaccine trials need to be particularly rigorous due to the complexity of the disease and its epidemiology. Therefore, eligible trial sites must satisfy several criteria including documented hyper-endemicity and a known epidemiological history of the circulating serotypes. Epidemiological data from Ratchaburi province in Thailand strongly support this location's suitability for a proof-of-concept efficacy trial of the sanofi pasteur tetravalent dengue vaccine. Accurate disease surveillance and carefully monitored clinical trials will provide essential evidence concerning the efficacy of candidate dengue vaccines, which will hopefully herald a new era in dengue disease prevention.","['Singhasivanon, Pratap', 'Jacobson, Julie']","['Singhasivanon P', 'Jacobson J']",,"['Regional Centre for Tropical Medicine, Mahidol University, Thailand. tmpsh@mucc.mahidol.ac.th']",['eng'],"['Introductory Journal Article', ""Research Support, Non-U.S. Gov't""]",,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,['0 (Dengue Vaccines)'],IM,"['Dengue/*epidemiology/*prevention & control', '*Dengue Vaccines', '*Global Health', 'Humans']",,2009/10/06 06:00,2010/01/19 06:00,['2009/10/06 06:00'],"['2009/10/06 06:00 [entrez]', '2009/10/06 06:00 [pubmed]', '2010/01/19 06:00 [medline]']","['S1386-6532(09)70285-9 [pii]', '10.1016/S1386-6532(09)70285-9 [doi]']",ppublish,J Clin Virol. 2009 Oct;46 Suppl 2:S1-2. doi: 10.1016/S1386-6532(09)70285-9.,,,,,,,,,,,,,,,,,,,,,,,
3313491,NLM,MEDLINE,19871204,20051116,0738-0658 (Print) 0738-0658 (Linking),6,1987 Aug,Dengue in Puerto Rico: clinical manifestations and management from 1960's to 1987.,113-8,,"Dengue is a viral disease transmitted by the Aedes aegypti mosquito. It is endemic in Puerto Rico and the Caribbean with periodic epidemics occurring at varying intervals. There are three dengue serotypes present in Puerto Rico, at the present time. The clinical manifestations of dengue in Puerto Rico are presented from a historical perspective. Dengue in Puerto Rico has evolved from a clinically mild illness in the 1960's to a devastating disease with hemorrhagic manifestations in the 1980's and dengue shock syndrome in 1987. The approach to clinical diagnosis and management is presented with emphasis on early recognition, performance of tourniquet test, serial hematocrits and aggressive intravenous fluid replacement with crystalloids of colloids in DSS. The best way to treat dengue is eliminating the vector, therefore, prevention.","['Ramirez-Ronda, C H']",['Ramirez-Ronda CH'],,"['Infectious Diseases, University of Puerto Rico School of Medicine, San Juan.']",['eng'],"['Journal Article', 'Review']",,Puerto Rico,P R Health Sci J,Puerto Rico health sciences journal,8303541,,IM,"['Dengue/diagnosis/*epidemiology/therapy', 'Humans', 'Mosquito Control', 'Puerto Rico', 'Shock, Hemorrhagic/diagnosis/*epidemiology/etiology/therapy']",,1987/08/01 00:00,1987/08/01 00:01,['1987/08/01 00:00'],"['1987/08/01 00:00 [pubmed]', '1987/08/01 00:01 [medline]', '1987/08/01 00:00 [entrez]']",,ppublish,P R Health Sci J. 1987 Aug;6(2):113-8.,2,,,,,,,23,,,,,,,,,,,,,,,
34472817,NLM,MEDLINE,20210906,20210906,0004-5772 (Print) 0004-5772 (Linking),69,2021 Aug,Dengue and COVID-19 Coinfection- A Double Trouble.,11-12,,"COVID 19 since its onset in Wuhan in 2019 has overburdened our existing health resources and infrastructure. Dengue virus has been endemic in Asian countries since decades. Both being viruses with similar clinical profile and overlapping laboratory parameters has posed a great challenge for Asian countries to combat a co epidemic, creating a double burden. We, as clinicians must be more vigilant in diagnosing the patients so that dengue is not missed in this covid pandemic era and does not progress to life threatening dengue shock syndrome. More importantly, we should emphasize on preventive measures for prevention of dengue so that we can reduce the burden on health care system.","['Kaur, Amandeep', 'Samagh, Navneh', 'Nimish', 'Kaur, Navdeep']","['Kaur A', 'Samagh N', 'Nimish', 'Kaur N']",,"['Assistant Professor, Department of General Medicine, Department of Radiodiagnosis, AIIMS, Bathinda, Punjab.', 'Assistant Professor,Department of Radiodiagnosis, AIIMS, Bathinda, Punjab.', 'Senior Resident, Department of Anaesthesiology, AIIMS, Bathinda, Punjab.', 'Assistant Professor, Department of Radiodiagnosis, AIIMS, Bathinda, Punjab.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['*COVID-19', '*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Humans', 'Pandemics', 'SARS-CoV-2']",,2021/09/03 06:00,2021/09/07 06:00,['2021/09/02 11:54'],"['2021/09/02 11:54 [entrez]', '2021/09/03 06:00 [pubmed]', '2021/09/07 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2021 Aug;69(8):11-12.,8,['(c) Journal of the Association of Physicians of India 2011.'],,,,,,,,,,,,,,,,,,,,,
20529038,NLM,MEDLINE,20110303,20100610,1445-5994 (Electronic) 1444-0903 (Linking),40,2010 Apr,Dengue fever: is it endemic in Australia?,247-9,10.1111/j.1445-5994.2010.02196.x [doi],,"['McBride, W J H']",['McBride WJ'],,,['eng'],"['Editorial', 'Historical Article']",,Australia,Intern Med J,Internal medicine journal,101092952,,IM,"['Australia/epidemiology', 'Dengue/*epidemiology/*history/mortality', 'Endemic Diseases/*history', 'Epidemics/*history', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Humans']",,2010/06/10 06:00,2011/03/04 06:00,['2010/06/10 06:00'],"['2010/06/10 06:00 [entrez]', '2010/06/10 06:00 [pubmed]', '2011/03/04 06:00 [medline]']","['IMJ2196 [pii]', '10.1111/j.1445-5994.2010.02196.x [doi]']",ppublish,Intern Med J. 2010 Apr;40(4):247-9. doi: 10.1111/j.1445-5994.2010.02196.x.,4,,,,,,,,,,,,,,,,,,,,,,
15685151,NLM,MEDLINE,20050406,20141120,1045-1870 (Print) 1045-1870 (Linking),16,2005 Jan,"Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention.",60-5,,,"['Ligon, B Lee']",['Ligon BL'],,"['Baylor College of Medicine, Department of Pediatrics, Houston, Texas 77030, USA. bligon@bcm.tmc.edu']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,Semin Pediatr Infect Dis,Seminars in pediatric infectious diseases,9008093,['0 (Viral Vaccines)'],IM,"['Animals', '*Dengue/epidemiology/history/prevention & control/therapy', 'Disease Outbreaks/history', 'Global Health', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Mosquito Control', '*Severe Dengue/epidemiology/history/prevention & control/therapy', 'Viral Vaccines']",,2005/02/03 09:00,2005/04/07 09:00,['2005/02/03 09:00'],"['2005/02/03 09:00 [pubmed]', '2005/04/07 09:00 [medline]', '2005/02/03 09:00 [entrez]']","['S1045187004000937 [pii]', '10.1053/j.spid.2004.09.013 [doi]']",ppublish,Semin Pediatr Infect Dis. 2005 Jan;16(1):60-5. doi: 10.1053/j.spid.2004.09.013.,1,,,,,,,26,,,,,,,,,,,,,,,
3566657,NLM,MEDLINE,19870505,20041117,0300-8495 (Print) 0300-8495 (Linking),16,1987 Feb,Dengue.,135-6,,,"['Aaskov, J']",['Aaskov J'],,,['eng'],['Journal Article'],,Australia,Aust Fam Physician,Australian family physician,0326701,,IM,"['Dengue/*diagnosis/therapy', 'Humans']",,1987/02/01 00:00,1987/02/01 00:01,['1987/02/01 00:00'],"['1987/02/01 00:00 [pubmed]', '1987/02/01 00:01 [medline]', '1987/02/01 00:00 [entrez]']",,ppublish,Aust Fam Physician. 1987 Feb;16(2):135-6.,2,,,,,,,,,,,,,,,,,,,,,,
24872393,NLM,MEDLINE,20140711,20211021,1537-6613 (Electronic) 0022-1899 (Print) 0022-1899 (Linking),209 Suppl 2,2014 Jun 15,Dengue human infection model: introduction.,S37-9,10.1093/infdis/jiu061 [doi],,"['Cassetti, M Cristina', 'Thomas, Stephen J']","['Cassetti MC', 'Thomas SJ']",,"['Virology Branch, National Institute of Allergy and Infectious Diseases, Bethesda.', 'Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland.']",['eng'],['Introductory Journal Article'],,United States,J Infect Dis,The Journal of infectious diseases,0413675,['0 (Dengue Vaccines)'],IM,"['Aedes/virology', 'Animals', 'Dengue/drug therapy/immunology/*pathology/prevention & control', 'Dengue Vaccines/therapeutic use', 'Dengue Virus', 'Humans', '*Models, Biological']",PMC4048991,2014/05/30 06:00,2014/07/12 06:00,['2014/05/30 06:00'],"['2014/05/30 06:00 [entrez]', '2014/05/30 06:00 [pubmed]', '2014/07/12 06:00 [medline]']","['jiu061 [pii]', '10.1093/infdis/jiu061 [doi]']",ppublish,J Infect Dis. 2014 Jun 15;209 Suppl 2(Suppl 2):S37-9. doi: 10.1093/infdis/jiu061.,Suppl 2,,,,,,,,,,,,,,,,,,,,,,
21675493,NLM,MEDLINE,20110630,20131121,1540-9740 (Print) 1540-9740 (Linking),9,2011 May-Jun,Dengue fever.,150-1,,,"['Franco-Arcia, Francisco', 'Goihman-Yahr, Mauricio']","['Franco-Arcia F', 'Goihman-Yahr M']",,"['Department of Dermatology, Military Hospital, ""Carlos Arvelo,"" Caracas, Venezuela.']",['eng'],['Journal Article'],,United States,Skinmed,Skinmed,101168327,,IM,"['Animals', 'Dengue/diagnosis/prevention & control/*therapy', 'Disease Outbreaks', 'Humans', 'Insect Vectors', 'Severe Dengue/diagnosis/prevention & control/*therapy']",,2011/06/17 06:00,2011/07/01 06:00,['2011/06/17 06:00'],"['2011/06/17 06:00 [entrez]', '2011/06/17 06:00 [pubmed]', '2011/07/01 06:00 [medline]']",,ppublish,Skinmed. 2011 May-Jun;9(3):150-1.,3,,,,,,,,,,,,,,,,,,,,,,
24957540,NLM,MEDLINE,20141112,20220330,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),91,2014 Sep,Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review.,621-634,10.4269/ajtmh.13-0676 [doi],"The 1997 and 2009 WHO dengue case classifications were compared in a systematic review with 12 eligible studies (4 prospective). Ten expert opinion articles were used for discussion. For the 2009 WHO classification studies show: when determining severe dengue sensitivity ranges between 59-98% (88%/98%: prospective studies), specificity between 41-99% (99%: prospective study) - comparing the 1997 WHO classification: sensitivity 24.8-89.9% (24.8%/74%: prospective studies), specificity: 25%/100% (100%: prospective study). The application of the 2009 WHO classification is easy, however for (non-severe) dengue there may be a risk of monitoring increased case numbers. Warning signs validation studies are needed. For epidemiological/pathogenesis research use of the 2009 WHO classification, opinion papers show that ease of application, increased sensitivity (severe dengue) and international comparability are advantageous; 3 severe dengue criteria (severe plasma leakage, severe bleeding, severe organ manifestation) are useful research endpoints. The 2009 WHO classification has clear advantages for clinical use, use in epidemiology is promising and research use may at least not be a disadvantage.","['Horstick, Olaf', 'Jaenisch, Thomas', 'Martinez, Eric', 'Kroeger, Axel', 'See, Lucy Lum Chai', 'Farrar, Jeremy', 'Ranzinger, Silvia Runge']","['Horstick O', 'Jaenisch T', 'Martinez E', 'Kroeger A', 'See LLC', 'Farrar J', 'Ranzinger SR']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",20140623,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Capillary Permeability', 'Dengue/*classification/diagnosis/virology', 'Hemorrhage', 'Humans', 'Practice Guidelines as Topic', 'Sensitivity and Specificity', 'Severe Dengue/classification/diagnosis/virology', 'Severity of Illness Index', 'Thrombocytopenia', 'World Health Organization']",PMC4155569,2014/06/25 06:00,2014/11/13 06:00,['2014/06/25 06:00'],"['2014/06/25 06:00 [entrez]', '2014/06/25 06:00 [pubmed]', '2014/11/13 06:00 [medline]']",['10.4269/ajtmh.13-0676 [doi]'],ppublish,Am J Trop Med Hyg. 2014 Sep;91(3):621-634. doi: 10.4269/ajtmh.13-0676. Epub 2014 Jun 23.,3,['(c) The American Society of Tropical Medicine and Hygiene.'],,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
27154247,NLM,MEDLINE,20161213,20220311,1743-422X (Electronic) 1743-422X (Linking),13,2016 May 6,Dengue research: a bibliometric analysis of worldwide and Arab publications during 1872-2015.,78,10.1186/s12985-016-0534-2 [doi] 78,"BACKGROUND: Dengue is an important emerging and re-emerging arboviral infection globally as a rapidly growing and widespread public health problem, with transmission occurring in more than 128 countries in Asia, Americas, southeast Africa, western Pacific, and eastern Mediterranean regions. Therefore, the aim of this study was to characterize and quantify the scientific output of dengue research in Arab countries relative to that worldwide by using a bibliometric analysis. METHODS: The standardized search approach based on the use of the the keyword ""dengue"" in the title, abstract, and keyword field was used to get research output related to dengue at a global level. All data related to dengue were collected from the past to December 31, 2015. RESULTS: A total of 19,581 dengue-related documents identified in the Scopus database. The results show that the study of dengue exhibits an overall upward trend from 1872 to 2015 with peak publications in 2014. The leading countries in dengue research were the USA (4,709; 24.05 %), India (1,942; 9.92 %), Brazil (1,530; 7.81 %), Thailand (1,260; 6.43 %), the UK (1,129; 5.77 %), and France (1,087; 5.55 %). Only 226 (1.16 % of the overall global research effort in the dengue field) articles were published from the Arab region. The total number of citations for all publications was 352,710, with an average of 18.0 citations per publication. Furthermore, the h-index for all extracted data related to dengue research was 186. Kingdom of Saudi Arabia (KSA) was the most productive country in Arab region with 102 documents representing 45.1 %. Furthermore, the h-index for all extracted data related to dengue research was 27. The USA was Arab's most main cooperative partner (46, 20.4 %), followed by India (36, 15.9 %). CONCLUSIONS: The amount of literature related to dengue research has considerably increased over the last decade. This bibliometric analysis has demonstrated the leading role that the USA, India, Brazil, Thailand, the UK, and France play in dengue research. The Arab world produced fewer publications related to dengue with lower quality than other world countries.","[""Zyoud, Sa'ed H""]",['Zyoud SH'],,"['Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com.', 'Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com.']",['eng'],"['Comparative Study', 'Journal Article']",20160506,England,Virol J,Virology journal,101231645,,IM,"['*Bibliometrics', '*Biomedical Research', 'Dengue/*epidemiology/*prevention & control/virology', 'Global Health', 'Humans', 'Middle East']",PMC4859974,2016/05/08 06:00,2016/12/15 06:00,['2016/05/08 06:00'],"['2016/03/16 00:00 [received]', '2016/05/03 00:00 [accepted]', '2016/05/08 06:00 [entrez]', '2016/05/08 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['10.1186/s12985-016-0534-2 [pii]', '534 [pii]', '10.1186/s12985-016-0534-2 [doi]']",epublish,Virol J. 2016 May 6;13:78. doi: 10.1186/s12985-016-0534-2.,,,['NOTNLM'],"['Arab world', 'Bibliometric', 'Citations', 'Dengue', 'Scopus']",,,,,,,,,,,,,,,,,,,
9145603,NLM,MEDLINE,19970612,20141120,0377-4929 (Print) 0377-4929 (Linking),40,1997 Jan,Dengue: the killer.,1-2,,,"['Talib, V H', 'Verma, S K', 'Dhupia, J S']","['Talib VH', 'Verma SK', 'Dhupia JS']",,,['eng'],['Editorial'],,India,Indian J Pathol Microbiol,Indian journal of pathology & microbiology,7605904,,IM,"['Dengue/*diagnosis/epidemiology/prevention & control/transmission', 'Dengue Virus/genetics/growth & development/immunology', 'Global Health', 'Humans', 'Immunoassay', 'Mosquito Control', 'Polymerase Chain Reaction']",,1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Indian J Pathol Microbiol. 1997 Jan;40(1):1-2.,1,,,,,,,,,,,,,,,,,,,,,,
7025743,NLM,MEDLINE,19811124,20200825,0304-4602 (Print) 0304-4602 (Linking),10,1981 Jan,Dengue haemorrhagic fever in Singapore.,91-8,,"The history of dengue haemorrhagic fever as distinct from dengue fever in South-East Asia is traced. The epidemiology of the disease in the various countries is contrasted with that in Singapore since DHF first appeared on the scene in South-East Asia. From this survey, it is concluded that the dengue haemorrhagic fever is a new disease presentation, and its fate in SE Asia depends on the immunological state of the community, attempts at vector control, and probably antigenic variation in the various types of dengue virus. The pathogenetic mechanisms are discussed in detail. Diagnosis is presented with a detailed discussion of diagnosis of the pre-shock stage. Finally, the management of dengue haemorrhagic fever is discussed.","['Wong, H B']",['Wong HB'],,,['eng'],"['Journal Article', 'Review']",,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,,IM,"['Dengue/diagnosis/epidemiology/*history/therapy', 'Dengue Virus/pathogenicity', 'Humans', 'Shock/*therapy', 'Shock, Septic/microbiology', 'Singapore']",,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Ann Acad Med Singap. 1981 Jan;10(1):91-8.,1,,,,,,,25,,,,,,,,,,,,,,,
32675555,NLM,MEDLINE,20210902,20210902,1536-3678 (Electronic) 1077-4114 (Linking),43,2021 Aug 1,Neonatal Dengue With HLH: Perks of Early Diagnosis and Management.,e770-e773,10.1097/MPH.0000000000001881 [doi],"BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, aggressive syndrome. It can be primary, which involves genetic mutation with an early presentation, or secondary to infections, malignancies, etc., due to absence of immune downregulation. It is a very rare condition in newborns. Dengue is a potential virus causing HLH, but, in newborns, there are only few case reports and limited clinical literature. OBSERVATION: Herein, in this report, we highlight a case of neonatal HLH, triggered by perinatal dengue. The neonate manifested clinically within the first week of life, the earliest reported timeline so far in the literature. CONCLUSION: HLH should be excluded in neonates especially when multisystem involvement cannot be explained by sepsis alone.","['Krishnappa, Archana', 'Munusamy, Jeyaraj', 'Ray, Somosri', 'Rameshbabu, Monisha', 'Bhatia, Prateek', 'Roy, Pritam S', 'Sundaram, Venkataseshan', 'Kumar, Praveen']","['Krishnappa A', 'Munusamy J', 'Ray S', 'Rameshbabu M', 'Bhatia P', 'Roy PS', 'Sundaram V', 'Kumar P']",,"['Departments of Pediatric Medicine.', 'Departments of Pediatric Medicine.', 'Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Neonatology.', 'Pediatric Hematology Oncology, Postgraduate Institute of Medical Education and Research.', 'Pediatric Hematology Oncology, Postgraduate Institute of Medical Education and Research.', 'Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Postgraduate Institute of Medical Education and Research, Chandigarh, India.']",['eng'],"['Case Reports', 'Journal Article']",,United States,J Pediatr Hematol Oncol,Journal of pediatric hematology/oncology,9505928,,IM,"['Dengue/*complications/diagnosis/therapy', 'Dengue Virus/isolation & purification', 'Disease Management', 'Early Diagnosis', 'Humans', 'Infant, Newborn', 'Lymphohistiocytosis, Hemophagocytic/diagnosis/*etiology/therapy', 'Male']",,2020/07/18 06:00,2021/09/03 06:00,['2020/07/18 06:00'],"['2020/04/25 00:00 [received]', '2020/05/29 00:00 [accepted]', '2020/07/18 06:00 [pubmed]', '2021/09/03 06:00 [medline]', '2020/07/18 06:00 [entrez]']","['00043426-202108000-00015 [pii]', '10.1097/MPH.0000000000001881 [doi]']",ppublish,J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e770-e773. doi: 10.1097/MPH.0000000000001881.,6,"['Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.']",,,['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
19914501,NLM,MEDLINE,20091201,20150616,1474-547X (Electronic) 0140-6736 (Linking),374,2009 Nov 14,Dengue in Cuba: research strategy to support dengue control.,1660-1,10.1016/S0140-6736(09)61975-9 [doi],,"['Guzman, Maria G', 'Kouri, Gustavo']","['Guzman MG', 'Kouri G']",,"['PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Institute of Tropical Medicine Pedro Kouri, Havana, Cuba. lupe@ipk.sld.cu']",['eng'],"['Journal Article', 'Review']",,England,Lancet,"Lancet (London, England)",2985213R,['0 (Dengue Vaccines)'],IM,"['Cuba/epidemiology', 'Dengue/diagnosis/epidemiology/*prevention & control', 'Dengue Vaccines', '*Global Health', 'Health Services Needs and Demand', 'Humans', 'Mosquito Control', 'Research/*trends']",,2009/11/17 06:00,2009/12/16 06:00,['2009/11/17 06:00'],"['2009/11/17 06:00 [entrez]', '2009/11/17 06:00 [pubmed]', '2009/12/16 06:00 [medline]']","['S0140-6736(09)61975-9 [pii]', '10.1016/S0140-6736(09)61975-9 [doi]']",ppublish,Lancet. 2009 Nov 14;374(9702):1660-1. doi: 10.1016/S0140-6736(09)61975-9.,9702,,,,,,,15,,,,,,,,,,,,,,,
16792957,NLM,MEDLINE,20060914,20190917,1695-4033 (Print) 1695-4033 (Linking),64,2006 Jun,[Persistence of dengue in the tropics].,515-6,,,"['Saez-Llorens, X']",['Saez-Llorens X'],,,['spa'],"['Comment', 'Editorial']",,Spain,An Pediatr (Barc),"Anales de pediatria (Barcelona, Spain : 2003)",101162596,,IM,"['Child', 'Dengue/*epidemiology/prevention & control', 'Humans', 'Tropical Medicine']",,2006/06/24 09:00,2006/09/15 09:00,['2006/06/24 09:00'],"['2006/06/24 09:00 [pubmed]', '2006/09/15 09:00 [medline]', '2006/06/24 09:00 [entrez]']","['13089914 [pii]', '10.1157/13089914 [doi]']",ppublish,An Pediatr (Barc). 2006 Jun;64(6):515-6. doi: 10.1157/13089914.,6,,,,,,,,['An Pediatr (Barc). 2006 Jun;64(6):517-22. PMID: 16792958'],Persistente presencia de dengue en el tropico.,,,,,,,,,,,,,
26506737,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.,118-22,,"Dengue has spread to new geographic areas affecting both children and adults, and it has become a global threat. Dengue with central nervous system involvement includes febrile seizures, encephalopathy, encephalitis, aseptic meningitis, intracranial hemorrhages, intracranial thrombosis, subdural effusions, mononeuropathies, polyneuropathies, Guillain-Barre syndrome, and transverse myelitis. These manifestations may be associated with co-infections, co-morbidities, or complications of prolonged shock. It is important to consider dengue as a cause for the above neurological presentations, particularly in endemic territories for dengue disease.","['Thisyakorn, Usa', 'Thisyakorn, Chule']","['Thisyakorn U', 'Thisyakorn C']",,,['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Central Nervous System Diseases/epidemiology/*physiopathology/virology', 'Child', 'Child, Preschool', 'Dengue/*complications/epidemiology/*physiopathology/virology', 'Dengue Virus', 'Female', 'Humans', 'Infant', 'Male', 'Thailand']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:118-22.,,,,,,,,,,,,,,,,,,,,,,,
19262377,NLM,MEDLINE,20090514,20120131,1473-6527 (Electronic) 0951-7375 (Linking),22,2009 Jun,Pathogenesis and prevention of dengue virus infection: state-of-the-art.,302-8,10.1097/QCO.0b013e328329ae32 [doi],"PURPOSE OF REVIEW: The spread of dengue (DEN) worldwide combined with an increased severity of the DEN-associated clinical outcomes has made this mosquito-borne virus of great global public health importance. This article reviews the latest findings in the field of DEN pathogenesis, vector control and vaccine development. RECENT FINDINGS: Atypical clinical manifestations as well as a shift in the age of DEN-infected patients have forced a revisit of the current definitions and classifications of the DEN-associated diseases. The antibody-mediated internalization of DEN virus triggers intracellular pathways that further enhance viral replication and output. A correlation between the human leukocyte antigen system and disease severity was found. The development of tetravalent DEN vaccine candidates is reaching its final stages, though the antibody levels required to protect against the four DEN serotypes are still unknown. SUMMARY: Efforts have been devoted to identify the host target cells that are permissive or resistant to DEN virus replication and to decipher the downstream events that would result in either disease enhancement or protection. Strong emphasis has recently been made on genetic polymorphisms that confer DEN protection versus susceptibility to severe DEN. The increasing knowledge gained from basic science should help to better design effective DEN vaccines.","['Tan, Grace K', 'Alonso, Sylvie']","['Tan GK', 'Alonso S']",,"['Department of Microbiology, Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.']",['eng'],"['Journal Article', 'Review']",,United States,Curr Opin Infect Dis,Current opinion in infectious diseases,8809878,['0 (Dengue Vaccines)'],IM,"['Dengue/epidemiology/*pathology/*prevention & control', 'Dengue Vaccines/*immunology', 'Humans', 'Mosquito Control/*methods']",,2009/03/06 09:00,2009/05/15 09:00,['2009/03/06 09:00'],"['2009/03/06 09:00 [entrez]', '2009/03/06 09:00 [pubmed]', '2009/05/15 09:00 [medline]']",['10.1097/QCO.0b013e328329ae32 [doi]'],ppublish,Curr Opin Infect Dis. 2009 Jun;22(3):302-8. doi: 10.1097/QCO.0b013e328329ae32.,3,,,,,,,75,,,,,,,,,,,,,,,
36691681,NLM,MEDLINE,20230406,20230406,1758-1133 (Electronic) 0049-4755 (Linking),53,2023 Apr,Varied presentations of congenital dengue infection in neonates.,279-281,10.1177/00494755231152646 [doi],Dengue fever is a common viral infection in the tropics and is prevalent in Southeast Asia. Dengue infection is associated with increased morbidity and mortality in the perinatal period. Transplacental transfer of dengue infection is rare. Here we report of four such cases.,"['Bhatter, Shivani', 'Jain, Jenisha']","['Bhatter S', 'Jain J']",['ORCID: 0000-0003-0119-2414'],"['DNB Resident, Department of Neonatology and Pediatrics, 75205Choithram Hospital and Research Centre, Indore, India.', 'Consultant Neonatologist, Department of Neonatology and Pediatrics, Choithram Hospital and Research Centre, Indore, India.']",['eng'],"['Case Reports', 'Journal Article']",20230123,England,Trop Doct,Tropical doctor,1301706,,IM,"['Female', 'Humans', 'Infant, Newborn', 'Pregnancy', '*Dengue/complications/diagnosis']",,2023/01/25 06:00,2023/04/06 10:16,['2023/01/24 01:53'],"['2023/04/06 10:16 [medline]', '2023/01/25 06:00 [pubmed]', '2023/01/24 01:53 [entrez]']",['10.1177/00494755231152646 [doi]'],ppublish,Trop Doct. 2023 Apr;53(2):279-281. doi: 10.1177/00494755231152646. Epub 2023 Jan 23.,2,,['NOTNLM'],"['Asia', 'Dengue fever', 'neonatal disease']",,,,,,,,,,,,,,,,,,,
32901596,NLM,MEDLINE,20210106,20210110,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),103,2020 Nov,"Cost of Dengue Illness in Indonesia across Hospital, Ambulatory, and not Medically Attended Settings.",2029-2039,10.4269/ajtmh.19-0855 [doi],"Informed decisions concerning emerging technologies against dengue require knowledge about the disease's economic cost and each stakeholder's potential benefits from better control. To generate such data for Indonesia, we reviewed recent literature, analyzed expenditure and utilization data from two hospitals and two primary care facilities in Yogyakarta city, and interviewed 67 dengue patients from hospital, ambulatory, and not medically attended settings. We derived the cost of a dengue episode by outcome, setting, and the breakdown by payer. We then calculated aggregate Yogyakarta and national costs and 95% uncertainty intervals (95% UIs). Dengue costs per nonfatal case in hospital, ambulatory, not medically attended, and overall average settings were US$316.24 (95% UI: $242.30-$390.18), US$22.45 (95% UI: $14.12-$30.77), US$7.48 (95% UI: $2.36-$12.60), and US$50.41 (95% UI: $35.75-$65.07), respectively. Costs of nonfatal episodes were borne by the patient's household (37%), social contributors (relatives and friends, 20%), national health insurance (25%), and other sources (government, charity, and private insurance, 18%). After including fatal cases, the average cost per episode became $90.41 (95% UI: $72.79-$112.35). Indonesia had an estimated 7.535 (95% UI: 1.319-16.513) million dengue episodes in 2017, giving national aggregate costs of $681.26 (95% UI: $232.28-$2,371.56) million. Unlike most previous research that examined only the formal medical sector, this study included the estimated 63% of national dengue episodes that were not medically attended. Also, this study used actual costs, rather than charges, which generally understate dengue's economic burden in public facilities. Overall, this study found that Indonesia's aggregate cost of dengue was 73% higher than previously estimated, strengthening the need for effective control.","['Wilastonegoro, Nandyan N', 'Kharisma, Dinar D', 'Laksono, Ida S', 'Halasa-Rappel, Yara A', 'Brady, Oliver J', 'Shepard, Donald S']","['Wilastonegoro NN', 'Kharisma DD', 'Laksono IS', 'Halasa-Rappel YA', 'Brady OJ', 'Shepard DS']",,"['Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.', 'Heller School for Social Management and Policy, Brandeis University, Waltham, Massachusetts.', 'Pediatrics Department, Faculty of Medicine, Public Health and Nursing, Dr. Sardjito General Hospital, Gadjah Mada University, Yogyakarta, Indonesia.', 'Heller School for Social Management and Policy, Brandeis University, Waltham, Massachusetts.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Heller School for Social Management and Policy, Brandeis University, Waltham, Massachusetts.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Ambulatory Care/*economics', 'Dengue/*economics/*epidemiology/therapy', 'Economics, Hospital', 'Female', '*Health Care Costs', '*Hospitals', 'Humans', 'Indonesia/epidemiology', 'Male']",PMC7646801,2020/09/10 06:00,2021/01/07 06:00,['2020/09/09 08:46'],"['2020/09/10 06:00 [pubmed]', '2021/01/07 06:00 [medline]', '2020/09/09 08:46 [entrez]']","['tpmd190855 [pii]', '10.4269/ajtmh.19-0855 [doi]']",ppublish,Am J Trop Med Hyg. 2020 Nov;103(5):2029-2039. doi: 10.4269/ajtmh.19-0855.,5,,,,"['Disclosure: The funders had no role in study design, data collection and', 'analysis, decision to publish, or preparation of the manuscript. D. S. S. has', 'received funding from Sanofi Pasteur and Takeda Vaccines for research on dengue,', 'but it is not related to Indonesia or to this study.']",,['206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
33089802,NLM,MEDLINE,20210218,20220716,0974-7559 (Electronic) 0019-6061 (Print) 0019-6061 (Linking),57,2020 Oct 15,Refining Clinical Triage and Management of Dengue Infection in Children: A Timely Approach.,895-896,,,"['Shet, Anita', 'Mehta, Kayur']","['Shet A', 'Mehta K']",,"['International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, USA. ashet1@jhu.edu.', 'International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, USA.']",['eng'],"['Comment', 'Editorial']",,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Child', '*Dengue/diagnosis/therapy', 'Disease Progression', 'Humans', '*Severe Dengue', 'Triage', 'World Health Organization']",PMC7605470,2020/10/23 06:00,2021/02/20 06:00,['2020/10/22 08:48'],"['2020/10/22 08:48 [entrez]', '2020/10/23 06:00 [pubmed]', '2021/02/20 06:00 [medline]']","['1987 [pii]', '10.1007/s13312-020-1987-3 [doi]']",ppublish,Indian Pediatr. 2020 Oct 15;57(10):895-896. doi: 10.1007/s13312-020-1987-3.,10,,,,,,,,['Indian Pediatr. 2020 Oct 15;57(10):899-903. PMID: 33089804'],,,,,,,,,,,,,,
8948275,NLM,MEDLINE,19970114,20190627,0002-9343 (Print) 0002-9343 (Linking),101,1996 Nov,Dengue fever among travelers.,516-20,,"PURPOSE: The present paper describes the epidemiology and clinical manifestations of dengue fever in a nonendemic population of travelers. PATIENTS AND METHODS: Clinical manifestations, epidemiologic information, and laboratory findings are described for a series of 18 Israeli travelers who tested serologically positive for dengue. RESULTS: All the patients in the series contracted the disease in Southeast Asia, mostly in Thailand; 30% had to be evacuated due to severe morbidity. The clinical symptoms in travelers somewhat differ from the classical description among endogenous populations. High fever, chills, extreme fatigue, and severe headaches were prevalent. Other symptoms considered to be typical of dengue fever, such as myalgia, arthralgia, rash, biphasic fever, were uncommon. Laboratory findings were marked leukopenia, usually accompanied by lymphopenia, thrombocytopenia, liver function impairment, and hyponatremia. Some hemorrhagic phenomena were manifest despite it being the first exposure, without mortality. CONCLUSIONS: Dengue fever among the nonimmune has a somewhat different manifestation from that reported for the Southeast Asian population. Although it is a significant cause for morbidity and hospitalization, it is underestimated as a factor affecting traveler's health. More efforts should be expended in developing an effective vaccine.","['Schwartz, E', 'Mendelson, E', 'Sidi, Y']","['Schwartz E', 'Mendelson E', 'Sidi Y']",,"['Center of Geographical Medicine, Chaim Sheba Medical Center, Tel Hashomer, Israel.']",['eng'],['Journal Article'],,United States,Am J Med,The American journal of medicine,0267200,,IM,"['Adult', 'Dengue/blood/*diagnosis/*etiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Male', 'Middle Aged', '*Travel']",,1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']","['S0002934396002781 [pii]', '10.1016/s0002-9343(96)00278-1 [doi]']",ppublish,Am J Med. 1996 Nov;101(5):516-20. doi: 10.1016/s0002-9343(96)00278-1.,5,,,,,,,,,,,,,,,,,,,,,,
29197500,NLM,MEDLINE,20180618,20181202,1873-6254 (Electronic) 0001-706X (Linking),178,2018 Feb,Dengue endemic and its impact on the gross national product of BRAZILIAN'S economy.,318-326,S0001-706X(17)30768-4 [pii] 10.1016/j.actatropica.2017.11.016 [doi],"In history disease has caused social and economic damage. Dengue is an illness typically found in the tropics that has affected more and more people. In Brazil, according to the Brazilian Institute of Geography and Statistics (IBGE), in 2013 at least 12.9% of the population (25.8 million) reported already having had dengue in their life. So, how wide are the economic impacts that dengue's contagion has on the gross national product? Using Leontief's method, it became possible to estimate the direct and indirect impact on the workforce and output by one country. Workforce absenteeism reduced the national productiveness and welfare state where we found maximum inoperability of 0.027% and a minimum of 0.002%. This paper develops a methodology for estimation of the impact dengue has incurred in each sector of an economy; designing a ranking with sectors that have been more affected and forecasting the propagation of the endemic throughout a region. This research measures the impact of dengue on economy, the result was that the total loss of the Brazilian economy in 2013 was around BRL 1,023,174,876.83; the importance of 0.02% of the Gross Domestic Product.","['Montibeler, Everlam Elias', 'Oliveira, Daniel Ribeiro de']","['Montibeler EE', 'Oliveira DR']",,"['Federal Rural University of Rio de Janeiro, Brazil. Electronic address: everlamelias@gmail.com.', 'Federal Rural University of Rio de Janeiro, Brazil; Federal Fluminense University, Brazil.']",['eng'],['Journal Article'],20171202,Netherlands,Acta Trop,Acta tropica,0370374,,IM,"['Brazil/epidemiology', 'Dengue/*economics/*epidemiology', 'Endemic Diseases', '*Gross Domestic Product', 'Humans']",,2017/12/05 06:00,2018/06/19 06:00,['2017/12/04 06:00'],"['2017/06/30 00:00 [received]', '2017/11/20 00:00 [revised]', '2017/11/26 00:00 [accepted]', '2017/12/05 06:00 [pubmed]', '2018/06/19 06:00 [medline]', '2017/12/04 06:00 [entrez]']","['S0001-706X(17)30768-4 [pii]', '10.1016/j.actatropica.2017.11.016 [doi]']",ppublish,Acta Trop. 2018 Feb;178:318-326. doi: 10.1016/j.actatropica.2017.11.016. Epub 2017 Dec 2.,,['Copyright (c) 2017 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Brazil', 'Dengue', 'Economic loss', 'Input-output table', 'Leontief', 'Workforce']",,,,,,,,,,,,,,,,,,,
35057590,NLM,MEDLINE,20220124,20220124,0004-5772 (Print) 0004-5772 (Linking),69,2022 Dec,Clinical and Laboratory Profile of Dengue in Kashmir Valley.,11-12,,"BACKGROUND: As majority of cases of dengue are associated with thrombocytopenia, it is indispensable to study clinical presentation, biochemical parameters and outcome of dengue fever in a population known with low platelet count. METHODOLOGY: A prospective observational study was conducted from September 2016 to August 2017that included forty NS-1 antigen (IgM) Dengue positive patients. Clinical features, laboratory parameters and outcome of dengue patients were noted. RESULTS: All the patients had travel history outside the valley into the neighbouring state. Most patients (70%) had duration of stay between 21-30 days in dengue prevalent areas before catching the illness. Duration of symptoms was between 4-9 days in majority of patients (92.5%). Most patients (85%) presented in months of September to November. The three most common symptoms were fever (100%), chills (92.5%) and headache (80%). The most common laboratory features were thrombocytopenia (97.5%), leukopenia (87.5%), transaminitis (87.5%) and raised LDH (32.5%). One patient developed Dengue Hemorrhagic Fever (DHF). All patients recovered completely. CONCLUSION: DF in Kashmir is seen exclusively in travellers to other states especially in the monsoon season.DF in Kashmiri patients has a favourable outcome despite low baseline platelet count. DHF is uncommon in Kashmiri population.","['Naik, Muzafar', 'Bhat, Tariq', 'Wani, Abdul Ahad', 'Amin, Abid', 'Jalaalie, Ummer']","['Naik M', 'Bhat T', 'Wani AA', 'Amin A', 'Jalaalie U']",,"['Associate Professor, SKIMS MCH, Srinagar, Jammu and Kashmir.', 'Associate Professor, SKIMS MCH, Srinagar, Jammu and Kashmir.', 'Assistant Professor, SKIMS MCH, Srinagar, Jammu and Kashmir; Corresponding Author.', 'Senior Resident, SKIMS MCH, Srinagar, Jammu and Kashmir.', 'Senior Resident, SKIMS MCH, Srinagar, Jammu and Kashmir.']",['eng'],"['Journal Article', 'Observational Study']",,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['*Dengue/complications/diagnosis/epidemiology', 'Fever', 'Humans', 'Laboratories', '*Leukopenia', '*Thrombocytopenia/epidemiology/etiology']",,2022/01/22 06:00,2022/01/27 06:00,['2022/01/21 04:43'],"['2022/01/21 04:43 [entrez]', '2022/01/22 06:00 [pubmed]', '2022/01/27 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2022 Dec;69(12):11-12.,12,['(c) Journal of the Association of Physicians of India 2011.'],,,,,,,,,,,,,,,,,,,,,
37792822,NLM,MEDLINE,20231121,20231121,1708-8305 (Electronic) 1195-1982 (Linking),30,2023 Nov 18,Epidemiology and burden of dengue fever in the United States: a systematic review.,,taad127 [pii] 10.1093/jtm/taad127 [doi],"BACKGROUND: Dengue is currently a global concern. The range of dengue vectors is expanding with climate change, yet United States of America (USA) studies on dengue epidemiology and burden are limited. This systematic review sought to characterize the epidemiology and disease burden of dengue within the USA. METHODS: Studies evaluating travel-related and endemic dengue in US states and territories were identified and qualitatively summarized. Commentaries and studies on ex-US cases were excluded. MEDLINE, Embase, Cochrane Library, Latin American and Caribbean Center of Health Sciences Information, Centre for Reviews and Dissemination and Clinicaltrials.gov were searched through January 2022. RESULTS: 116 studies were included. In US states, dengue incidence was generally low, with spikes occurring in recent years in 2013-16 (0.17-0.31 cases/100,000) and peaking in 2019 (0.35 cases/100,000). Most cases (94%, n = 7895, 2010-21) were travel related. Dengue was more common in Puerto Rico (cumulative average: 200 cases/100,000, 1980-2015); in 2010-21, 99.9% of cases were locally acquired. There were <50 severe cases in US states (2010-17); fatal cases were even rarer. Severe cases in Puerto Rico peaked in 1998 (n = 173) and 2021 (n = 76). Besides lower income, risk factors in US states included having birds in residence, suggesting unspecified environmental characteristics favourable to dengue vectors. Commonly reported symptoms included fever, headache and rash; median disease duration was 3.5-11 days. Hospitalization rates increased following 2009 World Health Organization disease classification changes (pre-2009: 0-54%; post-2009: 14-75%); median length of stay was 2.7-8 days (Puerto Rico) and 2-3 days (US states). Hospitalization costs/case (2010 USD) were$14 350 (US states),$1764-$5497 (Puerto Rico) and$4207 (US Virgin Islands). In Puerto Rico, average days missed were 0.2-5.3 (work) and 2.5 (school). CONCLUSIONS: Though dengue risk is ongoing, treatments are limited, and dengue's economic burden is high. There is an urgent need for additional preventive and therapeutic interventions.","['Chen, Lin H', 'Marti, Carlos', 'Diaz Perez, Clemente', 'Jackson, Bianca M', 'Simon, Alyssa M', 'Lu, Mei']","['Chen LH', 'Marti C', 'Diaz Perez C', 'Jackson BM', 'Simon AM', 'Lu M']",,"['Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, 330 Mount Auburn Street Suite 413 Cambridge, MA 02138, USA.', 'Associate Professor of Medicine, Harvard Medical School, 25 Shattuck Street Boston, MA 02115, USA.', 'Department of Pediatrics, San Juan City Hospital, Paseo Dr. Jose Celso Barbosa San Juan, PR 00921, Puerto Rico.', 'Department of Pediatrics, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, PR 00936, Puerto Rico.', 'Evidence & Access, OPEN Health, 25 Recreation Park Drive, Suite 200 Hingham, MA 02043, USA.', 'Evidence & Access, OPEN Health, 25 Recreation Park Drive, Suite 200 Hingham, MA 02043, USA.', 'Takeda Pharmaceuticals U.S.A., Inc., 95 Hayden Avenue Lexington, MA 0242195, USA.']",['eng'],"['Journal Article', 'Systematic Review']",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['United States/epidemiology', 'Humans', '*Travel', 'Travel-Related Illness', 'Caribbean Region', 'Climate Change', '*Dengue/epidemiology']",,2023/10/04 18:42,2023/11/21 06:43,['2023/10/04 13:45'],"['2023/06/23 00:00 [received]', '2023/09/25 00:00 [revised]', '2023/09/27 00:00 [accepted]', '2023/11/21 06:43 [medline]', '2023/10/04 18:42 [pubmed]', '2023/10/04 13:45 [entrez]']","['7288959 [pii]', '10.1093/jtm/taad127 [doi]']",ppublish,J Travel Med. 2023 Nov 18;30(7):taad127. doi: 10.1093/jtm/taad127.,7,"['(c) International Society of Travel Medicine 2023. Published by Oxford University', 'Press. All rights reserved. For Permissions, please e-mail:', 'journals.permissions@oup.com.']",['NOTNLM'],"['Dengue', 'burden of disease', 'risk factors', 'systematic review']",,,"['Takeda Pharmaceuticals U.S.A., Inc/']",,,,,,,,,,,,,,,,
18593719,NLM,MEDLINE,20080812,20120215,1530-6860 (Electronic) 0892-6638 (Linking),22,2008 Jul,Dengue fever in Rio: Macumba versus Voltaire.,2109-12,10.1096/fj.08-0701ufm [doi],,"['Weissmann, Gerald']",['Weissmann G'],,,['eng'],['Editorial'],,United States,FASEB J,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,8804484,['0 (Dengue Vaccines)'],IM,"['Animals', 'Arthropods/virology', 'Brazil/epidemiology', 'Dengue/*epidemiology/immunology/mortality/transmission', 'Dengue Vaccines/therapeutic use', 'Dengue Virus/pathogenicity', 'Disease Outbreaks', 'Humans']",,2008/07/03 09:00,2008/08/13 09:00,['2008/07/03 09:00'],"['2008/07/03 09:00 [pubmed]', '2008/08/13 09:00 [medline]', '2008/07/03 09:00 [entrez]']","['22/7/2109 [pii]', '10.1096/fj.08-0701ufm [doi]']",ppublish,FASEB J. 2008 Jul;22(7):2109-12. doi: 10.1096/fj.08-0701ufm.,7,,,,,,,,,,,,,,,,,,,,,,
25688021,NLM,MEDLINE,20151112,20190130,1471-2970 (Electronic) 0962-8436 (Print) 0962-8436 (Linking),370,2015 Apr 5,Dengue: recent past and future threats.,,10.1098/rstb.2013.0562 [doi] 20130562,"This article explores four key questions about statistical models developed to describe the recent past and future of vector-borne diseases, with special emphasis on dengue: (1) How many variables should be used to make predictions about the future of vector-borne diseases? (2) Is the spatial resolution of a climate dataset an important determinant of model accuracy? (3) Does inclusion of the future distributions of vectors affect predictions of the futures of the diseases they transmit? (4) Which are the key predictor variables involved in determining the distributions of vector-borne diseases in the present and future? Examples are given of dengue models using one, five or 10 meteorological variables and at spatial resolutions of from one-sixth to two degrees. Model accuracy is improved with a greater number of descriptor variables, but is surprisingly unaffected by the spatial resolution of the data. Dengue models with a reduced set of climate variables derived from the HadCM3 global circulation model predictions for the 1980s are improved when risk maps for dengue's two main vectors (Aedes aegypti and Aedes albopictus) are also included as predictor variables; disease and vector models are projected into the future using the global circulation model predictions for the 2020s, 2040s and 2080s. The Garthwaite-Koch corr-max transformation is presented as a novel way of showing the relative contribution of each of the input predictor variables to the map predictions.","['Rogers, David J']",['Rogers DJ'],,"['Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK david.rogers@zoo.ox.ac.uk.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Philos Trans R Soc Lond B Biol Sci,"Philosophical transactions of the Royal Society of London. Series B, Biological sciences",7503623,,IM,"['Aedes/*physiology/virology', '*Animal Distribution', 'Animals', '*Climate Change', 'Dengue/*epidemiology/transmission', 'Humans', '*Models, Biological']",PMC4342966,2015/02/18 06:00,2015/11/13 06:00,['2015/02/18 06:00'],"['2015/02/18 06:00 [entrez]', '2015/02/18 06:00 [pubmed]', '2015/11/13 06:00 [medline]']","['rstb.2013.0562 [pii]', 'rstb20130562 [pii]', '10.1098/rstb.2013.0562 [doi]']",ppublish,Philos Trans R Soc Lond B Biol Sci. 2015 Apr 5;370(1665):20130562. doi: 10.1098/rstb.2013.0562.,1665,,['NOTNLM'],"['Aedes aegypti', 'Aedes albopictus', 'corr-max rotation', 'dengue', 'global circulation models', 'risk maps']",,,,,,,,,,,,,,,,,,,
8470020,NLM,MEDLINE,19930513,20141120,0036-3634 (Print) 0036-3634 (Linking),35,1993 Jan-Feb,[Hemorrhagic fever and the dengue shock syndrome].,39-55,,"Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) are the severe and/or fatal clinical manifestations of dengue fever. Epidemics of DHF/DSS occur mainly in the southeast Asian countries where children are seriously affected and high case-fatality ratio is annually reported. Recently significant epidemics of DHF/DSS have been reported in Cuba, Venezuela and Brazil, which means that reinforcements of the epidemiological surveillance in the countries of the American region that show high virus transmission, are urgently needed. The main purpose of the present article is to review relevant information regarding the clinical manifestations, pathology, diagnostic procedures, treatment of cases, pathophysiologic mechanisms and some data related with specific DHF/DSS epidemics.","['Ramos, C', 'Garcia, H', 'Villaseca, J M']","['Ramos C', 'Garcia H', 'Villaseca JM']",,"['Departamento de Inmunologia, Centro de Investigaciones sobre Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/physiopathology/therapy', 'Disease Outbreaks', 'Female', 'Global Health', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Shock, Septic/*etiology/therapy', 'Syndrome']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1993 Jan-Feb;35(1):39-55.,1,,,,,,,146,,Fiebre hemorragica y sindrome de choque por dengue.,,,,,,,,,,,,,
35643097,NLM,MEDLINE,20220603,20221221,1474-4457 (Electronic) 1473-3099 (Print) 1473-3099 (Linking),22,2022 Jun,Additional considerations for assessing COVID-19 impact on dengue transmission.,762-763,S1473-3099(22)00293-6 [pii] 10.1016/S1473-3099(22)00293-6 [doi],,"['Yek, Christina', 'Pacheco, Andrea R', 'Lon, Chanthap', 'Leang, Rithea', 'Manning, Jessica E']","['Yek C', 'Pacheco AR', 'Lon C', 'Leang R', 'Manning JE']",,"['Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 12101, USA.', 'International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Phnom Penh, Cambodia.', 'Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 12101, USA; International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Phnom Penh, Cambodia.', 'National Dengue Control Program, Ministry of Health, Phnom Penh, Cambodia.', 'Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 12101, USA; International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Phnom Penh, Cambodia. Electronic address: jessica.manning@nih.gov.']",['eng'],"['Comment', 'Letter']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['*Aedes', 'Animals', '*COVID-19', '*Dengue/diagnosis/epidemiology/prevention & control', 'Humans']",PMC9132541,2022/06/02 06:00,2022/06/07 06:00,['2022/06/01 09:19'],"['2022/03/22 00:00 [received]', '2022/04/21 00:00 [accepted]', '2022/06/01 09:19 [entrez]', '2022/06/02 06:00 [pubmed]', '2022/06/07 06:00 [medline]']","['S1473-3099(22)00293-6 [pii]', '10.1016/S1473-3099(22)00293-6 [doi]']",ppublish,Lancet Infect Dis. 2022 Jun;22(6):762-763. doi: 10.1016/S1473-3099(22)00293-6.,6,,,,['We declare no competing interests.'],['Lancet Infect Dis. 2022 Jun;22(6):763. PMID: 35643098'],,,['Lancet Infect Dis. 2022 May;22(5):657-667. PMID: 35247320'],,,,,,,,,,,,,,
19366911,NLM,MEDLINE,20090814,20211020,1098-6618 (Electronic) 0893-8512 (Print) 0893-8512 (Linking),22,2009 Apr,Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation.,"186-201, Table of Contents",10.1128/CMR.00052-08 [doi],"Outbreaks of the severe dengue syndrome, dengue hemorrhagic fever (DHF), emerged beginning in the 1950s, marking a dramatic change in the dengue syndrome. While intense investigations in multiple directions have been conducted for many years to elucidate the intrinsic mechanisms conducive to the development of DHF, no consensus has yet emerged. Meanwhile, relatively little attention has been paid to the occurrence of severe dengue and death prior to the 1950s. This comprehensive review was designed to evaluate outbreak records in the early dengue history to better understand the epidemiologic background and other factors that existed before the emergence of DHF outbreaks. By applying a set of stringent criteria to remove unreliable data as much as possible and by interpreting the results conservatively, a short list of etiologically more reliable outbreaks with high mortality was obtained. The results show that severe dengue syndrome, clinically very much compatible with DHF, occurred far more frequently in multiple locations than it had been assumed before; that the magnitudes of mortality in several outbreaks were not negligible; and that the epidemiologic background features shared among these outbreaks in the early period were, with the exceptions of more limited demographic changes, generally similar to the post-1950 conditions.","['Kuno, Goro']",['Kuno G'],,"['Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA. gok1@cdc.gov']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,Clin Microbiol Rev,Clinical microbiology reviews,8807282,,IM,"['*Dengue/epidemiology/history/mortality/virology', 'Dengue Virus', '*Disease Outbreaks/history', 'History, 19th Century', 'History, 20th Century', 'Humans', '*Severe Dengue/epidemiology/history/mortality/virology']",PMC2668235,2009/04/16 09:00,2009/08/15 09:00,['2009/04/16 09:00'],"['2009/04/16 09:00 [entrez]', '2009/04/16 09:00 [pubmed]', '2009/08/15 09:00 [medline]']","['22/2/186 [pii]', '0052-08 [pii]', '10.1128/CMR.00052-08 [doi]']",ppublish,"Clin Microbiol Rev. 2009 Apr;22(2):186-201, Table of Contents. doi: 10.1128/CMR.00052-08.",2,,,,,,,,,,,,,,,,,,,,,,
27663790,NLM,MEDLINE,20180326,20220129,1878-0067 (Electronic) 1755-4365 (Print) 1878-0067 (Linking),16,2016 Sep,Dengue serotype immune-interactions and their consequences for vaccine impact predictions.,40-8,S1755-4365(16)30022-6 [pii] 10.1016/j.epidem.2016.05.003 [doi],"Dengue is one of the most important and wide-spread viral infections affecting human populations. The last few decades have seen a dramatic increase in the global burden of dengue, with the virus now being endemic or near-endemic in over 100 countries world-wide. A recombinant tetravalent vaccine candidate (CYD-TDV) has recently completed Phase III clinical efficacy trials in South East Asia and Latin America and has been licensed for use in several countries. The trial results showed moderate-to-high efficacies in protection against clinical symptoms and hospitalisation but with so far unknown effects on transmission and infections per se. Model-based predictions about the vaccine's short- or long-term impact on the burden of dengue are therefore subject to a considerable degree of uncertainty. Furthermore, different immune interactions between dengue's serotypes have frequently been evoked by modelling studies to underlie dengue's oscillatory dynamics in disease incidence and serotype prevalence. Here we show how model assumptions regarding immune interactions in the form of antibody-dependent enhancement, temporary cross-immunity and the number of infections required to develop full immunity can significantly affect the predicted outcome of a dengue vaccination campaign. Our results thus re-emphasise the important gap in our current knowledge concerning the effects of previous exposure on subsequent dengue infections and further suggest that intervention impact studies should be critically evaluated by their underlying assumptions about serotype immune-interactions.","['Lourenco, Jose', 'Recker, Mario']","['Lourenco J', 'Recker M']",,"['Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.', 'Centre for Mathematics and the Environment, University of Exeter, Penryn Campus, Penryn TR10 9EZ, UK. Electronic address: m.recker@exeter.ac.uk.']",['eng'],['Journal Article'],20160602,Netherlands,Epidemics,Epidemics,101484711,"['0 (Dengue Vaccines)', '0 (Vaccines, Attenuated)']",IM,"['Dengue/immunology/*prevention & control', 'Dengue Vaccines/*immunology', 'Humans', 'Immunization Programs', 'Latin America', '*Serogroup', 'Vaccines, Attenuated/*immunology']",PMC5030310,2016/09/25 06:00,2018/03/27 06:00,['2016/09/25 06:00'],"['2015/09/30 00:00 [received]', '2016/05/31 00:00 [revised]', '2016/05/31 00:00 [accepted]', '2016/09/25 06:00 [entrez]', '2016/09/25 06:00 [pubmed]', '2018/03/27 06:00 [medline]']","['S1755-4365(16)30022-6 [pii]', '10.1016/j.epidem.2016.05.003 [doi]']",ppublish,Epidemics. 2016 Sep;16:40-8. doi: 10.1016/j.epidem.2016.05.003. Epub 2016 Jun 2.,,['Copyright (c) 2016 The Authors. Published by Elsevier B.V. All rights reserved.'],,,,,['268904/ERC_/European Research Council/International'],,,,,,,,,,,,,,,,
37660714,NLM,MEDLINE,20231023,20231025,2214-109X (Electronic) 2214-109X (Linking),11,2023 Nov,Treatments for dengue: a Global Dengue Alliance to address unmet needs.,e1680-e1681,S2214-109X(23)00362-5 [pii] 10.1016/S2214-109X(23)00362-5 [doi],,,,,"['Drugs for Neglected Diseases initiative, Geneva 1202, Switzerland.']",['eng'],['Journal Article'],20230831,England,Lancet Glob Health,The Lancet. Global health,101613665,,IM,"['Humans', '*Dengue/epidemiology/prevention & control']",,2023/09/04 00:41,2023/10/23 12:43,['2023/09/03 18:54'],"['2023/06/20 00:00 [received]', '2023/07/19 00:00 [accepted]', '2023/10/23 12:43 [medline]', '2023/09/04 00:41 [pubmed]', '2023/09/03 18:54 [entrez]']","['S2214-109X(23)00362-5 [pii]', '10.1016/S2214-109X(23)00362-5 [doi]']",ppublish,Lancet Glob Health. 2023 Nov;11(11):e1680-e1681. doi: 10.1016/S2214-109X(23)00362-5. Epub 2023 Aug 31.,11,,,,['We declare no competing interests.'],,,,,,,,,,,,,"['Dengue Alliance. Electronic address: gnmalavige@dndi.org', 'Dengue Alliance']","['Anasir, Mohd Ishtiaq', 'Angkasekwinai, Nasikarn', 'Auewarakul, Prasert', 'Avirutnan, Panisadee', 'Bilbe, Graeme', 'Charvillon, Fabienne Burgat', 'Costa, Vivian Vasconcelos', 'Croda, Julio', 'Daher, Andre', 'Das, Supratik', 'Ellan, E Kavithambigai', 'Gani, Yasmin', 'Garg, Pramod', 'Uppal, Geetanjali', 'Guruge, Dinuka', 'Kalyanasundram, Jeevanathan', 'Kratz, Jadel Muller', 'Krieger, Marco A', 'Lapphra, Keswadee', 'Lim, Steven Chee Loon', 'Lodha, Rakesh', 'Mahajan, Dinesh', 'Malavige, Gathsaurie Neelika', 'Mairiang, Dumrong', 'Marques, Ernesto Torres D Azevedo', 'Md Jelas, Nur Hana', 'Medigeshi, Guruprasad R', 'Mohd Abd Razak, Mohd Ridzuan', 'Mohd Zain, Rozainanee', 'Mowbray, Charles', 'Nischal, Neeraj', 'Nogueira, Mauricio L', 'Noisakran, Sansanee', 'Punyadee, Nuntaya', 'Pedrique, Belen', 'Piedagnel, Jean-Michel', 'Punnawit Phongpitchanont, Surat', 'Ramanaidu, Tilakbabu', 'Ribeiro, Isabela', 'Rose, Winsley', 'Rupali, Priscilla', 'Samal, Sweety', 'Singh, Kavita', 'Siqueira, Andre M', 'Sjo, Peter', 'Sosa-Estani, Sergio', 'Souza, Thiago Moreno L', 'Suppiah, Jeyanthi', 'Syed Mohamed, Ami Fazlin', 'Mohd Tahir, Nur Zaidah', 'Tan, Terence Yew Chin', 'Teixeira, Mauro M', 'Thayan, Ravindran', 'Wadhwa, Nitya', 'Wijewickrama, Ananda', 'Mohamed Yusoff, Fazlina', 'Zainol, Murizal']","['Anasir MI', 'Angkasekwinai N', 'Auewarakul P', 'Avirutnan P', 'Bilbe G', 'Charvillon FB', 'Costa VV', 'Croda J', 'Daher A', 'Das S', 'Ellan EK', 'Gani Y', 'Garg P', 'Uppal G', 'Guruge D', 'Kalyanasundram J', 'Kratz JM', 'Krieger MA', 'Lapphra K', 'Lim SCL', 'Lodha R', 'Mahajan D', 'Malavige GN', 'Mairiang D', 'Marques ETDA', 'Md Jelas NH', 'Medigeshi GR', 'Mohd Abd Razak MR', 'Mohd Zain R', 'Mowbray C', 'Nischal N', 'Nogueira ML', 'Noisakran S', 'Punyadee N', 'Pedrique B', 'Piedagnel JM', 'Punnawit Phongpitchanont S', 'Ramanaidu T', 'Ribeiro I', 'Rose W', 'Rupali P', 'Samal S', 'Singh K', 'Siqueira AM', 'Sjo P', 'Sosa-Estani S', 'Souza TML', 'Suppiah J', 'Syed Mohamed AF', 'Mohd Tahir NZ', 'Tan TYC', 'Teixeira MM', 'Thayan R', 'Wadhwa N', 'Wijewickrama A', 'Mohamed Yusoff F', 'Zainol M']",,,
35443278,NLM,MEDLINE,20230104,20230215,1878-3503 (Electronic) 0035-9203 (Print) 0035-9203 (Linking),117,2023 Jan 3,"Clinical and laboratory characteristics of dengue and COVID-19 coinfected patients in Dhaka, Bangladesh.",50-54,10.1093/trstmh/trac031 [doi] trac031,"BACKGROUND: Dengue-COVID-19 coinfection is one of the greatest emerging challenges in dengue-endemic areas during the continuing pandemic. With coinciding clinical and laboratory pictures, early diagnosis becomes burdensome, with management discrepancy. METHODS: A descriptive study was performed on dengue-COVID-19 coinfected patients during July-August 2021 for an overview of disease progression, severity and outcome. A total of 11 patients who were positive for dengue NS1 and/or antidengue IgM were included in this study. RESULTS: In total, 45.5% patients developed severe COVID-19 disease, 45.5% patients developed group B dengue fever and 9% patients developed group C dengue fever. Concurrent severity of both diseases was seen to be rare, except for in one patient. CONCLUSION: Early diagnosis and compatible management still stand as basic principles to prevent fatality and morbidity.","['Hannan, Tabiha Binte', 'Hossain, Zazeba', 'Hasan, Md Nazmul', 'Khan, Abed Hussain', 'Alam, Md Rafiqul', 'Rahman, Md Mujibur', 'Arafat, Shohael Mahmud', 'Chowdhury, Fazle Rabbi']","['Hannan TB', 'Hossain Z', 'Hasan MN', 'Khan AH', 'Alam MR', 'Rahman MM', 'Arafat SM', 'Chowdhury FR']",['ORCID: 0000-0001-9579-0030'],"['Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, 1217, Bangladesh.', 'Department of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, 10400, Thailand.']",['eng'],['Journal Article'],,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Humans', '*COVID-19/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Bangladesh/epidemiology', '*Coinfection', 'Pandemics']",PMC9047248,2022/04/21 06:00,2023/01/05 06:00,['2022/04/20 20:04'],"['2022/03/23 00:00 [accepted]', '2022/01/01 00:00 [received]', '2022/03/03 00:00 [revised]', '2022/04/21 06:00 [pubmed]', '2023/01/05 06:00 [medline]', '2022/04/20 20:04 [entrez]']","['6571533 [pii]', 'trac031 [pii]', '10.1093/trstmh/trac031 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2023 Jan 3;117(1):50-54. doi: 10.1093/trstmh/trac031.,1,"['(c) The Author(s) 2022. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene.']",['NOTNLM'],"['BSMMU', 'COVID-19', 'dengue', 'dengue-COVID-19 coinfection', 'pandemic']",,,,,,,,,,,,,,,,,,,
8840030,NLM,MEDLINE,19961115,20050919,0037-9085 (Print) 0037-9085 (Linking),89,1996,Dengue hemorrhagic fever.,91-3; discussion 93-4,,"Dengue has been known for more than 200 years. The first dengue viruses were isolated about 50 years ago. Prior to the 1950's, dengue was considered a mild febrile disease, though rare hemorrhagic and fatal cases were known to occur. After that date, the first epidemics of dengue hemorrhagic fever (DHF) appeared in Southeast Asia, and DHF became the most important cause of childhood morbidity and mortality in the region. The emergence of DHF epidemics was first explained by mutations affecting dengue viruses, making them more virulent, but this hypothesis was not retained. Then, the ""secondary infection"" or ""immune enhancement"" theory was proposed to explain the increased virulence of dengue viruses when children had a secondary infection. This second hypothesis is still actually favoured. However, observations in Southeast Asia, some Pacific islands, and Americas do not agree with the ""secondary infection"" hypothesis, which consequently has been modified several times. Recent advances in molecular biology have led to the recognition that some viral strains are more virulent than others. Another hypothesis is the selection of more virulent dengue strains by the new vector Ae. aegypti, replacing the local vector Ae. albopictus, when urbanization and modern transportation increased in Southeast Asia after the last war. Comparisons between epidemics are very difficult, because of the distinction between DHF cases according to WHO criteria and dengue fever (DF) cases with hemorrhages. This distinction has no pathogenic or prognostic grounds, and makes the task of clinicians more difficult. The actual situation in countries facing dengue epidemics makes clear that this disease will continue to be a public health problem for some time to come.","['Rosen, L']",['Rosen L'],,['Institut Pasteur de Guyane.'],['eng'],"['Historical Article', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Asia, Southeastern/epidemiology', '*Dengue/epidemiology/history/virology', 'History, 20th Century', 'Humans']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):91-3; discussion 93-4.,2,,,,,,,,,,,,,,,,,,,,,,
33428750,NLM,MEDLINE,20220509,20220607,1930-613X (Electronic) 0026-4075 (Linking),187,2022 May 3,Independent Evaluation of Two Prototype Immunochromatographic Tests for Dengue Fever Developed by InBios.,e655-e660,10.1093/milmed/usaa553 [doi],"INTRODUCTION: Dengue fever, caused by any of the four dengue viruses (DENV1-4), is endemic in more than 100 countries around the world. Each year, up to 400 million people get infected with dengue virus. It is one of the most important arthropod-borne viral diseases. Dengue's global presence poses a medical threat to deploying military personnel and their dependents. An accurate diagnosis followed by attentive supportive care can improve outcomes in patients with severe dengue disease. Dengue diagnostic tests based on PCR and ELISA platforms have been developed and cleared by the U.S. FDA. However, these diagnostic assays are laborious and usually require highly trained personnel and specialized equipment, which presents a significant challenge when conducting operations in austere and resource-constrained areas. InBios International, Inc. (Seattle, WA) has developed two rapid and instrument-free immunochromatographic test prototype devices (multiplex and traditional formats) for dengue diagnosis. MATERIALS AND METHODS: To determine the performance of the InBios immunochromatographic tests, 183 clinical samples were tested on both prototype devices. Both assays were performed without any instruments and the results were read in 20 minutes. RESULTS: The traditional format had better overall performance (sensitivity: 97.4%; specificity: 90%) than the multiplex format (sensitivity: 86.9%; specificity: 63.3%). The traditional format was superior in serotype-specific detection with 100% overall sensitivity for DENV1, DENV3, and DENV4 and 93.3% sensitivity for DENV2 compared to the multiplex format (91.7%, 78.3%, 83.3%, and 96.3% for DENV1, 2, 3, and 4, respectively). The traditional format was easier to read than the multiplex format. The multiplex format was simpler and faster to set up than the traditional format. CONCLUSIONS: The InBios traditional format had a better overall performance and readability profile than the multiplex format, while the multiplex format was easier to set up. Both formats were highly sensitive and specific, were easy to perform, and did not require sophisticated equipment. They are ideal for use in resource-limited settings where dengue is endemic. Based on our overall assessment, the traditional format should be considered for further development and used in the upcoming multicenter clinical trial toward FDA clearance.","['Chen, Hua-Wei', 'Maldonado, Tania D', 'Lee, Cheng-Rei', 'Williams, Maya', 'Defang, Gabriel N', 'Ellison, Damon W', 'Van De Wyngaerde, Marshall', 'Rooney, Calli M', 'Wu, Shuenn-Jue L']","['Chen HW', 'Maldonado TD', 'Lee CR', 'Williams M', 'Defang GN', 'Ellison DW', 'Van De Wyngaerde M', 'Rooney CM', 'Wu SL']",,"['Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.', 'Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.', 'Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.', 'Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.', 'Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.', 'Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.', 'Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.', 'U.S. Army Medical Materiel Development Activity, Fort Detrick, MD 21702, USA.', 'Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD 20910, USA.']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, U.S. Gov't, Non-P.H.S.""]",,England,Mil Med,Military medicine,2984771R,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral', '*Dengue/diagnosis', 'Enzyme-Linked Immunosorbent Assay/methods', 'Humans', 'Nucleic Acid Amplification Techniques', 'Sensitivity and Specificity']",,2021/01/12 06:00,2022/05/10 06:00,['2021/01/11 17:11'],"['2020/08/11 00:00 [received]', '2020/12/02 00:00 [revised]', '2020/12/08 00:00 [accepted]', '2021/01/12 06:00 [pubmed]', '2022/05/10 06:00 [medline]', '2021/01/11 17:11 [entrez]']","['6080202 [pii]', '10.1093/milmed/usaa553 [doi]']",ppublish,Mil Med. 2022 May 3;187(5-6):e655-e660. doi: 10.1093/milmed/usaa553.,5-6,"['(c) The Association of Military Surgeons of the United States 2021. All rights', 'reserved. For permissions, please e-mail: journals.permissions@oup.com.']",,,,,,,,,,,,,,,,,,,,,
36939507,NLM,MEDLINE,20230322,20230718,2784-8450 (Electronic) 2784-8671 (Linking),158,2023 Feb,Acute telogen effluvium due to Dengue fever mimicking androgenetic alopecia.,66-67,10.23736/S2784-8671.22.07369-8 [doi],,"['Starace, Michela', 'Piraccini, Bianca M', 'Evangelista, Valeria', 'Bruni, Francesca', 'Alessandrini, Aurora']","['Starace M', 'Piraccini BM', 'Evangelista V', 'Bruni F', 'Alessandrini A']",,"['Unit of Dermatology, IRCCS University Hospital of Bologna, Bologna, Italy.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.', 'Unit of Dermatology, IRCCS University Hospital of Bologna, Bologna, Italy.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.', 'Unit of Dermatology, IRCCS University Hospital of Bologna, Bologna, Italy - valeria.evangelista91@gmail.com.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.', 'Unit of Dermatology, IRCCS University Hospital of Bologna, Bologna, Italy.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.', 'Unit of Dermatology, IRCCS University Hospital of Bologna, Bologna, Italy.', 'Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.']",['eng'],['Journal Article'],,Italy,Ital J Dermatol Venerol,Italian journal of dermatology and venereology,101778002,['Diffuse alopecia'],IM,"['Humans', '*Alopecia Areata', 'Acute Disease', '*Dengue/complications/diagnosis']",,2023/03/21 06:00,2023/03/23 06:00,['2023/03/20 10:39'],"['2023/03/20 10:39 [entrez]', '2023/03/21 06:00 [pubmed]', '2023/03/23 06:00 [medline]']","['S2784-8671.22.07369-8 [pii]', '10.23736/S2784-8671.22.07369-8 [doi]']",ppublish,Ital J Dermatol Venerol. 2023 Feb;158(1):66-67. doi: 10.23736/S2784-8671.22.07369-8.,1,,,,,,,,,,,,,,,,,,,,,,
21013943,NLM,MEDLINE,20101028,20181201,0096-9443 (Print) 0096-9443 (Linking),5,1946 Mar,Dengue-like fever on Okinawa.,306-11,,,"['JOHNSON, J A Jr', 'MARTIN, W B', 'BRESLOW, L']","['JOHNSON JA Jr', 'MARTIN WB', 'BRESLOW L']",,,['eng'],['Journal Article'],,United States,Bull U S Army Med Dep,Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department,0032166,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', '*Fever', 'Humans']",,1946/03/01 00:00,1946/03/01 00:01,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/03/01 00:00 [pubmed]', '1946/03/01 00:01 [medline]']",,ppublish,Bull U S Army Med Dep. 1946 Mar;5:306-11.,,,['NLM'],"['*DENGUE/epidemiology and statistics', '*FEVERS/dengue-like']",,,,,,,,['CLML: 4610:521u1'],,,,,,,,,,,
18258144,NLM,MEDLINE,20080326,20211020,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),14,2008 Feb,Dengue and relative bradycardia.,350-1,10.3201/eid1402.070401 [doi],,"['Senanayake, Sanjaya Naresh']",['Senanayake SN'],,,['eng'],"['Comment', 'Letter']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Bradycardia/*etiology', 'Dengue/*complications/*diagnosis/physiopathology', 'Humans']",PMC2600215,2008/02/09 09:00,2008/03/28 09:00,['2008/02/09 09:00'],"['2008/02/09 09:00 [pubmed]', '2008/03/28 09:00 [medline]', '2008/02/09 09:00 [entrez]']","['07-0401 [pii]', '10.3201/eid1402.070401 [doi]']",ppublish,Emerg Infect Dis. 2008 Feb;14(2):350-1. doi: 10.3201/eid1402.070401.,2,,,,,,,,['Emerg Infect Dis. 2007 Apr;13(4):650-1. PMID: 17561566'],,,,,,,,,,,,,,
26506732,NLM,MEDLINE,20151201,20181202,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,REPORTING PROGRESS ON THE USE OF THE WHO 2009 DENGUE CASE CLASSIFICATION: A REVIEW.,49-54,,"This review reports on the progress in the use of the WHO 2009 dengue case classification--dengue and severe dengue--following up on a previous review (Horstick et al, 2012). The previous review detailed Steps 1 - 5 in developing the 2009 WHO case classification. As a further step, a systematic review of published studies comparing the two classifications has been published with 12 studies and a further 10 expert opinion papers that recommend the use of the 2009 WHO dengue case classification for clinical management, epidemiology, and clinical research. Furthermore, a formal expert consensus was reached in La Habana, Cuba in 2013 with dengue experts from the Americas, sharing experiences that applied the 2009 WHO dengue case classification. The expert panel recommended to 1) update ICD10, 2) include the 2009 WHO case classification in country epidemiological reports globally, and 3) implement studies improving sensitivity/specificity of the dengue case definition.","['Horstick, Olaf', 'Ranzinger, Silvia Runge']","['Horstick O', 'Ranzinger SR']",,,['eng'],"['Journal Article', 'Review', 'Systematic Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/classification/*epidemiology/virology', 'Humans', 'Sensitivity and Specificity', 'Severe Dengue/classification/epidemiology/virology', '*Terminology as Topic', 'World Health Organization']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:49-54.,,,,,,,,,,,,,,,,,,,,,,,
32431221,NLM,MEDLINE,20210812,20210812,1744-1706 (Electronic) 1744-1692 (Linking),15,2020 Nov,Understanding India's urban dengue surveillance: A qualitative policy analysis of Hyderabad district.,1702-1717,10.1080/17441692.2020.1767674 [doi],"Dengue's re-emerging epidemiology poses a major global health threat. India contributes significantly to the global communicable disease burden has been declared highly dengue-endemic, exposing public health authorities to severe challenges. Our study aims to provide a deeper understanding of India's urban dengue surveillance policies as well as to explore the organisation, functioning and integration of existing disease control pillars. We conducted a qualitative regional case study, consisting of semi-structured expert interviews and observational data, covering the urban region of Hyderabad in South India. Our findings indicate that Hyderabad's dengue surveillance system predominantly relies on public reporting units, neglecting India's large private health sector. The surveillance system requires further strengthening and additional efforts to efficiently integrate existing governmental initiatives at all geographical levels and administrative boundaries. We concluded with recommendations for improved consistency, accuracy, efficiency and reduction of system fragmentation to enhance the integration of dengue surveillance and improved health information in urban India. Finally, our study underlines India's overall need to increase investment in public health and health infrastructures. That requires coordinated and multi-level action targeting the development of a competent, effective and motivated public health cadre, as well as truly integrated surveillance and epidemic response infrastructure, for dengue and beyond.","['Pilot, Eva', 'Murthy, G V S', 'Nittas, Vasileios']","['Pilot E', 'Murthy GVS', 'Nittas V']",,"['Department of Health, Ethics and Society, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.', 'Maastricht Centre for Global Health, Maastricht University, Maastricht, Netherlands.', 'Centre of Studies in Geography and Spatial Planning (CEGOT), University of Coimbra, Coimbra, Portugal.', 'Public Health Foundation India, Indian Institute of Public Health Hyderabad, Hyderabad, India.', 'International Centre for Eye Health, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.', 'Department of Health, Ethics and Society, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.']",['eng'],['Journal Article'],20200520,England,Glob Public Health,Global public health,101256323,,IM,"['*Dengue/epidemiology', 'Humans', 'India/epidemiology', 'Policy Making', '*Public Health Surveillance', 'Qualitative Research', '*Urban Health']",,2020/05/21 06:00,2021/08/13 06:00,['2020/05/21 06:00'],"['2020/05/21 06:00 [pubmed]', '2021/08/13 06:00 [medline]', '2020/05/21 06:00 [entrez]']",['10.1080/17441692.2020.1767674 [doi]'],ppublish,Glob Public Health. 2020 Nov;15(11):1702-1717. doi: 10.1080/17441692.2020.1767674. Epub 2020 May 20.,11,,['NOTNLM'],"['India', 'International Health Regulations', 'dengue', 'health information', 'policy integration', 'surveillance', 'urban health']",,,,,,,,,,,,,,,,,,,
1543101,NLM,MEDLINE,19920407,20051116,0002-838X (Print) 0002-838X (Linking),45,1992 Mar,Dengue fever: a resurgent risk for the international traveler.,1161-8,,"The incidence of dengue fever, an acute febrile illness transmitted by the Aedes aegypti mosquito, is on the rise. High fever, severe headache, skin rash and a variety of constitutional symptoms are hallmarks of classic dengue fever. Dengue hemorrhagic fever, a severe manifestation associated with secondary infection, most often occurs in children. Treatment of classic dengue fever is supportive, whereas urgent rehydration therapy is often required in more severe forms. Community-based and personal strategies for avoiding the mosquito vector represent the best methods of prevention, although vaccine development programs are under way.","['Lange, W R', 'Beall, B', 'Denny, S C']","['Lange WR', 'Beall B', 'Denny SC']",,"['Johns Hopkins University School of Medicine, Baltimore, Maryland.']",['eng'],"['Journal Article', 'Review']",,United States,Am Fam Physician,American family physician,1272646,,IM,"['Aedes', 'Animals', '*Dengue/diagnosis/epidemiology/therapy', 'Dengue Virus/classification', 'Humans', 'Risk Factors', '*Travel', 'United States']",,1992/03/01 00:00,1992/03/01 00:01,['1992/03/01 00:00'],"['1992/03/01 00:00 [pubmed]', '1992/03/01 00:01 [medline]', '1992/03/01 00:00 [entrez]']",,ppublish,Am Fam Physician. 1992 Mar;45(3):1161-8.,3,,,,,,,31,,,,,,,,,,,,,,,
11845665,NLM,MEDLINE,20020326,20061115,0738-0658 (Print) 0738-0658 (Linking),20,2001 Dec,Dengue in children: critical points in management.,343-6,,Dengue fever (DF) is endemic and occasionally epidemic in many tropical and subtropical areas inhabited by the mosquito vector Aedes aegypti. Infection with Dengue may present with varied clinical manifestations. Significant morbidity and mortality can result if early recognition and monitoring of its severe forms (DHF and DSS) is not done and if appropriate medical intervention is delayed. This article reviews several critical points in the basic evaluation and management of dengue in the pediatric age group and present our current approach in the form of a therapeutic algorithm.,"['Santiago, A', 'Fernandez-Sein, A']","['Santiago A', 'Fernandez-Sein A']",,"['Department of Pediatrics, Medical Sciences Campus, University of Puerto Rico School of Medicine, PO Box 365067 San Juan, Puerto Rico 00936-5067.']",['eng'],"['Comparative Study', 'Journal Article', 'Review']",,Puerto Rico,P R Health Sci J,Puerto Rico health sciences journal,8303541,,IM,"['Age Factors', 'Algorithms', 'Child', 'Critical Care', '*Dengue/diagnosis/therapy', 'Humans', 'Time Factors']",,2002/02/16 10:00,2002/03/27 10:01,['2002/02/16 10:00'],"['2002/02/16 10:00 [pubmed]', '2002/03/27 10:01 [medline]', '2002/02/16 10:00 [entrez]']",,ppublish,P R Health Sci J. 2001 Dec;20(4):343-6.,4,,,,,,,8,,,,,,,,,,,,,,,
28403440,NLM,MEDLINE,20170420,20190210,1537-6613 (Electronic) 0022-1899 (Print) 0022-1899 (Linking),215,2017 Mar 1,Case Management of Dengue: Lessons Learned.,S79-S88,10.1093/infdis/jiw609 [doi],"The global burden of dengue and its geographic distribution have increased over the past several decades. The introduction of dengue in new areas has often been accompanied by high case-fatality rates. Drawing on the experience in managing dengue cases at the Queen Sirikit National Institute of Child Health in Bangkok, Thailand, this article provides the authors' perspectives on key clinical lessons to improve dengue-related outcomes. Parallels between this clinical experience and outcomes reported in randomized controlled trials, results of efforts to disseminate practice recommendations, and suggestions for areas for further research are also discussed.","['Kalayanarooj, Siripen', 'Rothman, Alan L', 'Srikiatkhachorn, Anon']","['Kalayanarooj S', 'Rothman AL', 'Srikiatkhachorn A']",,"['Dengue Unit, Queen Sirikit National Institute of Child Health, Bangkok, Thailand; and.', 'Department of Cell and Molecular Biology and Institute for Immunology and Informatics, University of Rhode Island, Providence.', 'Dengue Unit, Queen Sirikit National Institute of Child Health, Bangkok, Thailand ; and.', 'Department of Cell and Molecular Biology and Institute for Immunology and Informatics, University of Rhode Island, Providence.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,['0 (Biomarkers)'],IM,"['Biomarkers/blood', 'Case Management', 'Child', 'Dengue/blood/diagnosis/mortality/*therapy', 'Early Diagnosis', 'Fluid Therapy', 'Humans', 'Thailand/epidemiology']",PMC5853291,2017/04/14 06:00,2017/04/21 06:00,['2017/04/14 06:00'],"['2017/04/14 06:00 [entrez]', '2017/04/14 06:00 [pubmed]', '2017/04/21 06:00 [medline]']","['3574517 [pii]', 'jiw609 [pii]', '10.1093/infdis/jiw609 [doi]']",ppublish,J Infect Dis. 2017 Mar 1;215(suppl_2):S79-S88. doi: 10.1093/infdis/jiw609.,suppl_2,"['(c) The Author 2017. Published by Oxford University Press for the Infectious', 'Diseases Society of America. All rights reserved. For permissions, e-mail:', 'journals.permissions@oup.com.']",['NOTNLM'],"['case management', 'case-fatality rate.', 'clinical care', 'dengue', 'hemorrhage', 'plasma leakage']",,,['P01 AI034533/AI/NIAID NIH HHS/United States'],,,,,,,,,,,,,,,,
26506725,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,PREFACE. Adult Dengue.,iii,,,"['Tantawichien, Terapong', 'Pengsaa, Krisana', 'Thisyakorn, Usa']","['Tantawichien T', 'Pengsaa K', 'Thisyakorn U']",,,['eng'],['Introductory Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adult', '*Dengue/diagnosis/epidemiology/therapy/virology', 'Dengue Virus/*physiology', 'Humans', 'Risk Factors']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:iii.,,,,,,,,,,,,,,,,,,,,,,,
30624838,NLM,MEDLINE,20191025,20191119,1365-3156 (Electronic) 1360-2276 (Print) 1360-2276 (Linking),24,2019 Apr,The decline of dengue in the Americas in 2017: discussion of multiple hypotheses.,442-453,10.1111/tmi.13200 [doi],"OBJECTIVE: Since the 1980s, dengue incidence has increased 30-fold. However, in 2017, there was a noticeable reduction in reported dengue incidence cases within the Americas, including severe and fatal cases. Understanding the mechanism underlying dengue's incidence and decline in the Americas is vital for public health planning. We aimed to provide plausible explanations for the decline in 2017. METHODS: An expert panel of representatives from scientific and academic institutions, Ministry of Health officials from Latin America and PAHO/WHO staff met in October 2017 to propose hypotheses. The meeting employed six moderated plenary discussions in which participants reviewed epidemiological evidence, suggested explanatory hypotheses, offered their expert opinions on each and developed a consensus. RESULTS: The expert group established that in 2017, there was a generalised decreased incidence, severity and number of deaths due to dengue in the Americas, accompanied by a reduction in reported cases of both Zika and chikungunya virus infections, with no change in distribution among age groups affected. This decline was determined to be unlikely due to changes in epidemiological surveillance systems, as similar designs of surveillance systems exist across the region. Although sudden surveillance disruption is possible at a country or regional level, it is unlikely to occur in all countries simultaneously. Retrospective modelling with epidemiological, immunological and entomological information is needed. Host or immunological factors may have influenced the decline in dengue cases at the population level through immunity; however, herd protection requires additional evidence. Uncertainty remains regarding the effect on the outcome of sequential infections of different dengue virus (DENV) types and Zika virus (ZIKV), and vice versa. Future studies were recommended that examine the epidemiological effect of prior DENV infection on Zika incidence and severity, the epidemiological effect of prior Zika virus infection on dengue incidence and severity, immune correlates based on new-generation ELISA assays, and impact of prior DENV/other arbovirus infection on ZIKV immune response in relation to number of infections and the duration of antibodies in relation to interval of protection. Follow-up studies should also investigate whether increased vector control intensification activities contributed to the decline in transmission of one or more of these arboviruses. Additionally, proposed studies should focus on the potential role of vector competence when simultaneously exposed to various arboviruses, and on entomological surveillance and its impact on circulating vector species, with a goal of applying specific measures that mitigate seasonal occurrence or outbreaks. CONCLUSIONS: Multifactorial events may have accounted for the decline in dengue seen in 2017. Differing elements might explain the reduction in dengue including elements of immunity, increased vector control, and even vector and\or viruses changes or adaptations. Most of the results of this expert consensus group meeting are hypothetical and based on limited evidence. Further studies are needed.","['Perez, Freddy', 'Llau, Anthony', 'Gutierrez, Gamaliel', 'Bezerra, Haroldo', 'Coelho, Giovanini', 'Ault, Steven', 'Barbiratto, Sulamita Brandao', 'de Resende, Marcelo Carballo', 'Cerezo, Lizbeth', 'Kleber, Giovanni Luz', 'Pacheco, Oscar', 'Perez, Octavio Lenin', 'Picos, Victor', 'Rojas, Diana P', 'Siqueira, Joao Bosco', 'Suarez, Marco Fidel', 'Harris, Eva', 'Castellanos, Luis Gerardo', 'Espinal, Carlos', 'Martin, Jose Luis San']","['Perez F', 'Llau A', 'Gutierrez G', 'Bezerra H', 'Coelho G', 'Ault S', 'Barbiratto SB', 'de Resende MC', 'Cerezo L', 'Kleber GL', 'Pacheco O', 'Perez OL', 'Picos V', 'Rojas DP', 'Siqueira JB', 'Suarez MF', 'Harris E', 'Castellanos LG', 'Espinal C', 'Martin JLS']",,"['Communicable Diseases and Environmental Determinants of Health Department, PAHO, Washington, DC, USA.', 'Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA.', 'Neglected, Tropical and Vector-borne Diseases, PAHO, Washington, DC, USA.', 'Neglected, Tropical and Vector-borne Diseases, PAHO, Washington, DC, USA.', 'Neglected, Tropical and Vector-borne Diseases, PAHO, Washington, DC, USA.', 'Department of Epidemiology and Biostatistics, University of Maryland, College Park, MD, USA.', 'National Dengue Control Program, Ministry of Health, Brasilia, Brazil.', 'Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.', 'National Epidemiology Department, Ministry of Health of Panama, Panama City, Panama.', 'Departamento de Infectologia, Universidade Federal do Rio Grande do Norte Hospital, Natal, Brazil.', 'Public Health Prevention and Surveillance, Ministry of Health, Bogota, Colombia.', 'Dengue Program, Ministry of Health, Managua, Nicaragua.', 'Research Laboratory of Dengue and other Viral Diseases, Ministry of Health, Maracay, Venezuela.', 'Department of Biostatistics, University of Florida, Gainesville, FL, USA.', 'Federal University of Goias, Goiania, Brazil.', 'Universidad Mayor de San Andres, La Paz, Bolivia.', 'Center for Global Public Health, University of California, Berkeley, CA, USA.', 'Neglected, Tropical and Vector-borne Diseases, PAHO, Washington, DC, USA.', 'Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA.', 'Neglected, Tropical and Vector-borne Diseases, PAHO, Washington, DC, USA.']",['eng'],['Journal Article'],20190128,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,"['0 (Antibodies, Viral)']",IM,"['Animals', 'Antibodies, Viral/blood', 'Central America/epidemiology', 'Chikungunya Fever/epidemiology/virology', 'Chikungunya virus', 'Consensus', 'Dengue/*epidemiology/immunology/virology', '*Dengue Virus/immunology', 'Disease Outbreaks', 'Disease Vectors', 'Enzyme-Linked Immunosorbent Assay', 'Humans', 'Incidence', 'North America/epidemiology', 'South America/epidemiology', 'United States/epidemiology', 'Zika Virus', 'Zika Virus Infection/epidemiology/virology']",PMC6850595,2019/01/10 06:00,2019/10/28 06:00,['2019/01/10 06:00'],"['2019/01/10 06:00 [pubmed]', '2019/10/28 06:00 [medline]', '2019/01/10 06:00 [entrez]']","['TMI13200 [pii]', '10.1111/tmi.13200 [doi]']",ppublish,Trop Med Int Health. 2019 Apr;24(4):442-453. doi: 10.1111/tmi.13200. Epub 2019 Jan 28.,4,"['(c) 2019 The Authors. Tropical Medicine & International Health Published by John', 'Wiley & Sons Ltd.']",['NOTNLM'],"['Americas', 'Ameriques', 'Dengue', 'decline', 'dengue', 'declin', 'hypotheses', 'hypotheses']",,,,,,,,,,,,,,,,,,,
35691652,NLM,MEDLINE,20220614,20220630,1877-5853 (Electronic) 1877-5845 (Linking),41,2022 Jun,"A joint spatial marked point process model for dengue and severe dengue in Medellin, Colombia.",100495,S1877-5845(22)00019-3 [pii] 10.1016/j.sste.2022.100495 [doi],"The spatial distribution of surveillance-reported dengue cases and severity are usually analyzed separately, assuming independence between the spatial distribution of non-severe and severe cases. Given the availability of data for the individual geo-location of surveillance-notified dengue cases, we conducted a spatial analysis to model non-severe and severe dengue simultaneously, using a hierarchical Bayesian model. We fit a joint model to the spatial pattern formed by dengue cases as well as to the severity status of the cases. Results showed that age and socioeconomic status were associated with dengue presence, and there was evidence of clustering for overall cases but not for severity. Our findings inform decision making to address the preparedness or implementation of dengue control strategies at the local level.","['Carabali, Mabel', 'Schmidt, Alexandra M', 'Restrepo, Berta N', 'Kaufman, Jay S']","['Carabali M', 'Schmidt AM', 'Restrepo BN', 'Kaufman JS']",,"['Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec H3A 1A2, Canada; Departement de Medecine Sociale et Preventive, Ecole de Sante Publique, Universite de Montreal. Montreal, Quebce, Canada. Electronic address: mabel.carabali@mail.mcgill.ca.', 'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec H3A 1A2, Canada.', 'Instituto Colombiano de Medicina Tropical (ICMT), Universidad CES, Sabaneta, Colombia.', 'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec H3A 1A2, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20220303,Netherlands,Spat Spatiotemporal Epidemiol,Spatial and spatio-temporal epidemiology,101516571,,IM,"['Bayes Theorem', 'Colombia/epidemiology', '*Dengue/epidemiology/prevention & control', 'Humans', '*Severe Dengue']",,2022/06/13 06:00,2022/06/15 06:00,['2022/06/12 21:04'],"['2020/06/19 00:00 [received]', '2022/01/19 00:00 [revised]', '2022/02/28 00:00 [accepted]', '2022/06/12 21:04 [entrez]', '2022/06/13 06:00 [pubmed]', '2022/06/15 06:00 [medline]']","['S1877-5845(22)00019-3 [pii]', '10.1016/j.sste.2022.100495 [doi]']",ppublish,Spat Spatiotemporal Epidemiol. 2022 Jun;41:100495. doi: 10.1016/j.sste.2022.100495. Epub 2022 Mar 3.,,['Copyright (c) 2022. Published by Elsevier Ltd.'],['NOTNLM'],"['Colombia', 'Dengue', 'Point processes models', 'Socioeconomic status', 'Spatial analysis', 'Surveillance']",,,['CIHR/Canada'],,,,,,,,,,,,,,,,
30260952,NLM,MEDLINE,20190114,20230928,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),12,2018 Sep,Economic analysis of dengue prevention and case management in the Maldives.,e0006796,10.1371/journal.pntd.0006796 [doi] e0006796,"As tourism is the mainstay of the Maldives' economy, this country recognizes the importance of controlling mosquito-borne diseases in an environmentally responsible manner. This study sought to estimate the economic costs of dengue in this Small Island Developing State of 417,492 residents. The authors reviewed relevant available documents on dengue epidemiology and conducted site visits and interviews with public health offices, health centers, referral hospitals, health insurers, and drug distribution organizations. An average of 1,543 symptomatic dengue cases was reported annually from 2011 through 2016. Intensive waste and water management on a resort island cost $1.60 per occupied room night. Local vector control programs on inhabited islands cost $35.93 for waste collection and $7.89 for household visits by community health workers per person per year. Ambulatory care for a dengue episode cost $49.87 at a health center, while inpatient episodes averaged $127.74 at a health center, $1,164.78 at a regional hospital, and $1,655.50 at a tertiary referral hospital. Overall, the cost of dengue illness in the Maldives in 2015 was $2,495,747 (0.06% of gross national income, GNI, or $6.10 per resident) plus $1,338,141 (0.03% of GNI or $3.27 per resident) for dengue surveillance. With tourism generating annual income of $898 and tax revenues of $119 per resident, results of an international analysis suggest that the risk of dengue lowers the country's gross annual income by $110 per resident (95% confidence interval $50 to $160) and its annual tax receipts by $14 per resident (95% confidence interval $7 to $22). Many innovative vector control efforts are affordable and could decrease future costs of dengue illness in the Maldives.","['Bangert, Mathieu', 'Latheef, Aishath Thimna', 'Dev Pant, Shushil', 'Nishan Ahmed, Ibrahim', 'Saleem, Sana', 'Nazla Rafeeq, Fathimath', 'Abdulla, Moomina', 'Shamah, Fathimath', 'Jamsheed Mohamed, Ahmed', 'Fitzpatrick, Christopher', 'Velayudhan, Raman', 'Shepard, Donald S']","['Bangert M', 'Latheef AT', 'Dev Pant S', 'Nishan Ahmed I', 'Saleem S', 'Nazla Rafeeq F', 'Abdulla M', 'Shamah F', 'Jamsheed Mohamed A', 'Fitzpatrick C', 'Velayudhan R', 'Shepard DS']","['ORCID: 0000-0003-1320-8145', 'ORCID: 0000-0003-2187-0593']","['Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.', 'World Health Organization Country Office, Male, Republic of Maldives.', 'World Health Organization Country Office, Male, Republic of Maldives.', 'Health Protection Agency, Ministry of Health, Male, Republic of Maldives.', 'Health Protection Agency, Ministry of Health, Male, Republic of Maldives.', 'Health Protection Agency, Ministry of Health, Male, Republic of Maldives.', 'Policy Planning and International Health, Ministry of Health, Male, Republic of Maldives.', 'Policy Planning and International Health, Ministry of Health, Male, Republic of Maldives.', 'Department of Control of Neglected Tropical Diseases, World Health Organization Regional Office for South East Asia, New Delhi, India.', 'Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.', 'Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.', 'Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, United States of America.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20180927,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Communicable Disease Control/*economics', 'Dengue/*diagnosis/*drug therapy/epidemiology/prevention & control', '*Disease Management', 'Disease Transmission, Infectious/*prevention & control', '*Health Care Costs', 'Humans', 'Indian Ocean Islands/epidemiology']",PMC6177194,2018/09/28 06:00,2019/01/15 06:00,['2018/09/28 06:00'],"['2018/05/27 00:00 [received]', '2018/08/27 00:00 [accepted]', '2018/10/09 00:00 [revised]', '2018/09/28 06:00 [pubmed]', '2019/01/15 06:00 [medline]', '2018/09/28 06:00 [entrez]']","['PNTD-D-18-00848 [pii]', '10.1371/journal.pntd.0006796 [doi]']",epublish,PLoS Negl Trop Dis. 2018 Sep 27;12(9):e0006796. doi: 10.1371/journal.pntd.0006796. eCollection 2018 Sep.,9,,,,['The authors have declared that no competing interests exist.'],,['001/WHO_/World Health Organization/International'],,,,,,,,,,,,,,,,
34717802,NLM,MEDLINE,20211224,20211224,1474-4457 (Electronic) 1473-3099 (Linking),21,2021 Nov,Transaminases and serum albumin as early predictors of severe dengue.,1488-1489,S1473-3099(21)00583-1 [pii] 10.1016/S1473-3099(21)00583-1 [doi],,"['Lazarus, Gilbert', 'Nelwan, Erni J', 'Hamers, Raph L']","['Lazarus G', 'Nelwan EJ', 'Hamers RL']",,"['Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia. Electronic address: gilbert.lazarus@ui.ac.id.', 'Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia.', 'Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia; Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.']",['eng'],"['Comment', 'Letter', ""Research Support, Non-U.S. Gov't""]",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,"['0 (Serum Albumin)', 'EC 2.6.1.- (Transaminases)']",IM,"['*Dengue/diagnosis/epidemiology', 'Humans', 'Liver Function Tests', 'Serum Albumin', '*Severe Dengue', 'Transaminases']",,2021/11/01 06:00,2021/12/25 06:00,['2021/10/31 20:41'],"['2021/07/18 00:00 [received]', '2021/08/24 00:00 [accepted]', '2021/11/01 06:00 [pubmed]', '2021/12/25 06:00 [medline]', '2021/10/31 20:41 [entrez]']","['S1473-3099(21)00583-1 [pii]', '10.1016/S1473-3099(21)00583-1 [doi]']",ppublish,Lancet Infect Dis. 2021 Nov;21(11):1488-1489. doi: 10.1016/S1473-3099(21)00583-1.,11,,,,['We declare no competing interests. RLH is funded by Wellcome Trust.'],,['WT_/Wellcome Trust/United Kingdom'],,"['Lancet Infect Dis. 2021 Jul;21(7):1014-1026. PMID: 33640077', 'Lancet Infect Dis. 2021 Nov;21(11):1489-1490. PMID: 34717803']",,,,,,,,,,,,,,
19836681,NLM,MEDLINE,20100108,20131121,1769-664X (Electronic) 0929-693X (Linking),16 Suppl 2,2009 Oct,[Dengue fever: clinical features].,S80-4,10.1016/S0929-693X(09)75306-0 [doi],"The vector for dengue fever and chikungunya, Aedes albopictus, was recently identified in Southeastern France, although the usual vector for dengue fever is Aedes aegypti, raising the possibility of cases occurring among the local population via viraemic individuals returning from endemic areas. Dengue fever is usually transmitted by Aedes aegypti. It is due to an arbovirus-flavivirus of which four different serotypes are known: Den 1 to 4. Each serotype is responsible for specific prolonged immunity but no cross-reactivity exists between serotypes. Clinically, the onset is abrupt with frontal headache, retro-orbital pain, myalgia, joint pain, prostration and, in many cases, a macular rash usually sparing the face and extremities. Haemorrhagic signs may occur, such as petechiae, purpura, epistaxis or bleeding gingivae. Two severe forms of dengue fever, particularly among children below 3 years of age, include dengue haemorrhagic fever (DHF) and DHF with shock (dengue shock syndrome). If a case is suspected in metropolitan France, the diagnosis should be systematically confirmed by positive specific IgM, RT-PCR or viral isolation. Treatment of dengue fever, whether in its uncomplicated form or with hemorrhagic manifestations or shock, remains symptomatic. There is no specific anti-viral treatment. A case should be notified to allow French health authorities to take the appropriate measures for vector control.","['Dellamonica, P']",['Dellamonica P'],,"['Universite de Nice-Sophia-Antipolis, Service Infectiologie, Hopital Archet 1, CHU de Nice, BP 3079, 06202 NICE cedex 3, France. dellamonica.p@chu-nice.fr']",['fre'],"['English Abstract', 'Journal Article']",,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,['0 (Antiviral Agents)'],IM,"['Adult', 'Aedes/virology', 'Animals', 'Antiviral Agents/therapeutic use', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/epidemiology/immunology/transmission', 'Disease Notification', 'France/epidemiology', 'Humans', 'Severe Dengue/diagnosis/epidemiology/immunology/transmission']",,2009/10/20 06:00,2010/01/09 06:00,['2009/10/20 06:00'],"['2009/10/20 06:00 [entrez]', '2009/10/20 06:00 [pubmed]', '2010/01/09 06:00 [medline]']","['S0929-693X(09)75306-0 [pii]', '10.1016/S0929-693X(09)75306-0 [doi]']",ppublish,Arch Pediatr. 2009 Oct;16 Suppl 2:S80-4. doi: 10.1016/S0929-693X(09)75306-0.,,,,,,,,,,La dengue: aspects cliniques.,,,,,,,,,,,,,
28796302,NLM,MEDLINE,20181105,20181105,1526-4610 (Electronic) 0017-8748 (Linking),57,2017 Oct,Post-Dengue New Daily Persistent Headache.,1449-1450,10.1111/head.13160 [doi],,"['Bordini, Carlos Alberto', 'Valenca, Marcelo M']","['Bordini CA', 'Valenca MM']",,"['UNIFACEF Medical School, Franca, Sao Paulo, Brazil.', 'Neurology and Neurosurgery Unit, Medical School, Federal University of Pernambuco, Recife, Pernambuco, Brazil.']",['eng'],"['Case Reports', 'Letter']",20170810,United States,Headache,Headache,2985091R,,IM,"['Adult', 'Dengue/*complications/drug therapy/therapy', 'Female', 'Headache Disorders/diagnosis/*etiology/therapy', 'Humans', 'Male', 'Young Adult']",,2017/08/11 06:00,2018/11/06 06:00,['2017/08/11 06:00'],"['2017/05/26 00:00 [received]', '2017/07/01 00:00 [revised]', '2017/07/02 00:00 [accepted]', '2017/08/11 06:00 [pubmed]', '2018/11/06 06:00 [medline]', '2017/08/11 06:00 [entrez]']",['10.1111/head.13160 [doi]'],ppublish,Headache. 2017 Oct;57(9):1449-1450. doi: 10.1111/head.13160. Epub 2017 Aug 10.,9,,['NOTNLM'],"['NDPH', 'dengue', 'etiology', 'new daily persistent headache']",,['Headache. 2017 Nov;57(10):1621. PMID: 29124756'],,,,,,,,,,,,,,,,,
9145625,NLM,MEDLINE,19970612,20141120,0377-4929 (Print) 0377-4929 (Linking),40,1997 Jan,Dengue haemorrhagic fever: an overview.,103-17,,,"['Ranga, S', 'Prakash, I', 'Choudhry, Y', 'Thergaonkar, A', 'Khurana, S K', 'Talib, V H']","['Ranga S', 'Prakash I', 'Choudhry Y', 'Thergaonkar A', 'Khurana SK', 'Talib VH']",,"['Department of Laboratory Medicine, Safdarjang Hospital, New Delhi.']",['eng'],"['Journal Article', 'Review']",,India,Indian J Pathol Microbiol,Indian journal of pathology & microbiology,7605904,,IM,"['Communicable Disease Control', 'Dengue/*diagnosis/epidemiology/pathology/therapy', 'Dengue Virus/genetics/immunology/pathogenicity', 'Diagnosis, Differential', 'Global Health', 'Humans', 'Immunity, Active', 'Serologic Tests']",,1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Indian J Pathol Microbiol. 1997 Jan;40(1):103-17.,1,,,,,,,23,,,,,,,,,,,,,,,
26047325,NLM,MEDLINE,20160209,20190202,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),9,2015 Jun,Cohorting Dengue Patients Improves the Quality of Care and Clinical Outcome.,e0003836,10.1371/journal.pntd.0003836 [doi] e0003836,"INTRODUCTION: The increasing incidence of dengue among adults in Malaysia and other countries has important implications for health services. Before 2004, in order to cope with the surge in adult dengue admissions, each of the six medical wards in a university hospital took turns daily to admit and manage patients with dengue. Despite regular in-house training, the implementation of the WHO 1997 dengue case management guidelines by the multiple medical teams was piecemeal and resulted in high variability of care. A restructuring of adult dengue inpatient service in 2004 resulted in all patients being admitted to one ward under the care of the infectious disease unit. Hospital and Intensive Care Unit admission criteria, discharge criteria and clinical laboratory testing were maintained unchanged throughout the study period. OBJECTIVES: To evaluate the impact of cohorting adult dengue patients on the quality of care and the clinical outcome in a university hospital in Malaysia. METHODS: A pre (2003) and post-intervention (2005-6) retrospective study was undertaken. INTERVENTION: Cohorting all dengue patients under the care of the Infectious Disease team in a designated ward in 2004. RESULTS: The number of patients enrolled was 352 in 2003, 785 in 2005 and 1158 in 2006. The evaluation and detection of haemorrhage remained high (>90%) and unchanged throughout the study period. The evaluation of plasma leakage increased from 35.4% pre-intervention to 78.8% post-intervention (p = <0.001) while its detection increased from 11.4% to 41.6% (p = <0.001). Examination for peripheral perfusion was undertaken in only 13.1% of patients pre-intervention, with a significant increase post-intervention, 18.6% and 34.2% respectively, p = <0.001. Pre-intervention, more patients had hypotension (21.5%) than detected peripheral hypoperfusion (11.4%), indicating that clinicians recognised shock only when patients developed hypotension. In contrast, post-intervention, clinicians recognised peripheral hypoperfusion as an early sign of shock. The highest haematocrit was significantly higher post-intervention but the lowest total white cell counts and platelet counts remained unchanged. A significant and progressive reduction in the use of platelet transfusions occurred, from 21.7% pre-intervention to 14.6% in 2005 and 5.2% in 2006 post-intervention, p<0.001. Likewise, the use of plasma transfusion decreased significantly from 6.1% pre-intervention to 4.0% and 1.6% in the post-intervention years of 2005 and 2006 respectively, p<0.001. The duration of intravenous fluid therapy decreased from 3 days pre-intervention to 2.5 days (p<0.001) post-intervention; the length of hospital stay reduced from 4 days pre- to 3 days (p<0.001) post-intervention and the rate of intensive care admission from 5.8% pre to 2.6% and 2.5% post-intervention, p = 0.005. CONCLUSION: Cohorting adult dengue patients under a dedicated and trained team of doctors and nurses led to a substantial improvement in quality of care and clinical outcome.","['Lum, Lucy C S', 'Syed Omar, Sharifah Faridah', 'Sri La Sri Ponnampalavanar, Sasheela', 'Tan, Lian H', 'Sekaran, Shamala Devi', 'Kamarulzaman, Adeeba']","['Lum LC', 'Syed Omar SF', 'Sri La Sri Ponnampalavanar S', 'Tan LH', 'Sekaran SD', 'Kamarulzaman A']",,"['Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Department of Medicine, Sunway Medical Centre, Petaling Jaya, Selangor, Malaysia.', 'Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20150605,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adult', 'Cohort Studies', 'Dengue/*classification/diagnosis/*therapy', 'Female', 'Hospitalization', 'Humans', 'Male', 'Patient Care/*methods', 'Quality of Health Care', 'Retrospective Studies', 'Treatment Outcome']",PMC4457480,2015/06/06 06:00,2016/02/10 06:00,['2015/06/06 06:00'],"['2014/12/25 00:00 [received]', '2015/05/18 00:00 [accepted]', '2015/06/06 06:00 [entrez]', '2015/06/06 06:00 [pubmed]', '2016/02/10 06:00 [medline]']","['PNTD-D-14-02226 [pii]', '10.1371/journal.pntd.0003836 [doi]']",epublish,PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003836. doi: 10.1371/journal.pntd.0003836. eCollection 2015 Jun.,6,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
30286086,NLM,MEDLINE,20190109,20190109,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),12,2018 Oct,Dengue illness index-A tool to characterize the subjective dengue illness experience.,e0006593,10.1371/journal.pntd.0006593 [doi] e0006593,"Dengue virus infections are a major cause of febrile illness that significantly affects individual and societal productivity and drives up health care costs principally in the developing world. Two dengue vaccine candidates are in advanced clinical efficacy trials in Latin America and Asia, and another has been licensed in more than fifteen countries but its uptake has been limited. Despite these advances, standardized metrics for comparability of protective efficacy between dengue vaccines remain poorly defined. The Dengue Illness Index (DII) is a tool that we developed thru refinement of previous similar iterations in an attempt to improve and standardize the measurement of vaccine and drug efficacy in reducing moderate dengue illness. The tool is designed to capture an individual's overall disease experience based on how the totality of their symptoms impacts their general wellness and daily functionality. We applied the DII to a diary card, the Dengue Illness Card (DIC), which was examined and further developed by a working group. The card was then refined with feedback garnered from a Delphi methodology-based query that addressed the adequacy and applicability of the tool in clinical dengue research. There was overall agreement that the tool would generate useful data and provide an alternative perspective to the assessment of drug or vaccine candidates, which in the case of vaccines, are assessed by their reduction in any virologically confirmed dengue of any severity with a focus on the more severe. The DIC needs to be evaluated in the field in the context of vaccine or drug trials, prospective cohort studies, or during experimental human infection studies. Here, we present the final DIC resulting from the Delphi process and offer its further development or use to the dengue research community.","['Thomas, Stephen J', 'Agulto, Liane', 'Hendrickx, Kim', 'Erpicum, Martin', 'Tomashek, Kay M', 'Cassetti, M Cristina', 'Laughlin, Catherine', 'Precioso, Alexander', 'Schmidt, Alexander C', 'Narvaez, Federico', 'Siqueira, Joao Bosco', 'Tissera, Hasitha', 'Edelman, Robert']","['Thomas SJ', 'Agulto L', 'Hendrickx K', 'Erpicum M', 'Tomashek KM', 'Cassetti MC', 'Laughlin C', 'Precioso A', 'Schmidt AC', 'Narvaez F', 'Siqueira JB', 'Tissera H', 'Edelman R']",['ORCID: 0000-0001-8657-9292'],"['Division of Infectious Diseases, State University of New York, Upstate Medical University, Syracuse, NY, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.', 'FWO Postdoctoral Fellow of the Life Sciences & Society Lab, Center for Sociological Research, KU Leuven, Flanders, Belgium.', 'SPIRAL Research Center, Departement de Science Politique, Universite de Liege, Liege, Belgium.', 'SPIRAL Research Center, Departement de Science Politique, Universite de Liege, Liege, Belgium.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.', 'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.', 'Division of Clinical Trials and Pharmacovigilance, Butantan Institute, Sao Paulo, Brazil.', 'Pediatrics Department of the Medical School of University of Sao Paulo, Sao Paulo, Brazil.', 'GSK Vaccines, Rockville, MD, United States of America.', 'Infectious Diseases Unit, National Pediatric Reference Hospital, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua.', 'Federal University of Goias, Brasilia, Brazil.', 'National Dengue Control Unit, Ministry of Health, Colombo, Sri Lanka.', 'Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States of America.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20181004,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Clinical Trials as Topic/methods', 'Dengue/*diagnosis/drug therapy/*pathology/prevention & control', 'Drug Evaluation, Preclinical/methods', 'Humans', 'Prospective Studies', '*Severity of Illness Index', 'Treatment Outcome']",PMC6171819,2018/10/05 06:00,2019/01/10 06:00,['2018/10/05 06:00'],"['2017/10/06 00:00 [received]', '2018/06/08 00:00 [accepted]', '2018/10/05 06:00 [entrez]', '2018/10/05 06:00 [pubmed]', '2019/01/10 06:00 [medline]']","['PNTD-D-17-01608 [pii]', '10.1371/journal.pntd.0006593 [doi]']",epublish,PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006593. doi: 10.1371/journal.pntd.0006593. eCollection 2018 Oct.,10,,,,"[""I have read the journal's policy and the authors of this manuscript have the"", 'following competing interests: at the time of the submission, AS was an employee', 'of GlaxoSmithKline Vaccines and holds shares related to this employment status.']","['Development of Standard Clinical Endpoints for Use in Dengue Interventional', 'Trials.']",,,,,,,,,,,,,,,,,
18406840,NLM,MEDLINE,20080424,20150616,1474-547X (Electronic) 0140-6736 (Linking),371,2008 Apr 12,International action needed on dengue.,1216,10.1016/S0140-6736(08)60531-0 [doi],,,,,,['eng'],['Editorial'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Brazil/epidemiology', 'Dengue/*epidemiology/mortality/therapy', '*Disease Outbreaks', 'Global Health', 'Humans', 'Urbanization/trends']",,2008/04/15 09:00,2008/04/25 09:00,['2008/04/15 09:00'],"['2008/04/15 09:00 [pubmed]', '2008/04/25 09:00 [medline]', '2008/04/15 09:00 [entrez]']","['S0140-6736(08)60531-0 [pii]', '10.1016/S0140-6736(08)60531-0 [doi]']",ppublish,Lancet. 2008 Apr 12;371(9620):1216. doi: 10.1016/S0140-6736(08)60531-0.,9620,,,,,['Lancet. 2008 Jul 19;372(9634):205. PMID: 18640455'],,,,,,,,,,,,,,,,,
35098790,NLM,MEDLINE,20220622,20220701,1758-1133 (Electronic) 0049-4755 (Linking),52,2022 Apr,A multifactorial strategy for dengue prevention and control: A public health situation analysis.,367-371,10.1177/00494755221076910 [doi],,"['Kua, Kok Pim']",['Kua KP'],['ORCID: 0000-0001-7910-4301'],"['Puchong Health Clinic, Petaling District Health Office, Ministry of Health Malaysia, Puchong, Petaling, Selangor, Malaysia.']",['eng'],['Journal Article'],20220131,England,Trop Doct,Tropical doctor,1301706,,IM,"['*Dengue/epidemiology/prevention & control', 'Humans', '*Public Health']",,2022/02/01 06:00,2022/06/23 06:00,['2022/01/31 08:42'],"['2022/02/01 06:00 [pubmed]', '2022/06/23 06:00 [medline]', '2022/01/31 08:42 [entrez]']",['10.1177/00494755221076910 [doi]'],ppublish,Trop Doct. 2022 Apr;52(2):367-371. doi: 10.1177/00494755221076910. Epub 2022 Jan 31.,2,,['NOTNLM'],"['dengue fever', 'disease control', 'disease prevention', 'environment', 'public health']",,,,,,,,,,,,,,,,,,,
26291469,NLM,MEDLINE,20160516,20190108,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),21,2015 Sep,Randomness of Dengue Outbreaks on the Equator.,1651-3,10.3201/eid2109.141030 [doi],A simple mathematical model without seasonality indicated that the apparently chaotic dengue epidemics in Singapore have characteristics similar to epidemics resulting from chance. Randomness as a sufficient condition for patterns of dengue epidemics in equatorial regions calls into question existing explanations for dengue outbreaks there.,"['Chen, Yirong', 'Cook, Alex R', 'Lim, Alisa X L']","['Chen Y', 'Cook AR', 'Lim AX']",,,['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Communicable Disease Control', 'Dengue/*epidemiology/etiology/prevention & control', 'Disease Outbreaks/*prevention & control', 'Humans', 'Incidence', 'Models, Theoretical', 'Singapore/epidemiology']",PMC4550167,2015/08/21 06:00,2016/05/18 06:00,['2015/08/21 06:00'],"['2015/08/21 06:00 [entrez]', '2015/08/21 06:00 [pubmed]', '2016/05/18 06:00 [medline]']","['14-1030 [pii]', '10.3201/eid2109.141030 [doi]']",ppublish,Emerg Infect Dis. 2015 Sep;21(9):1651-3. doi: 10.3201/eid2109.141030.,9,,['NOTNLM'],"['Singapore', 'aseasonality', 'dengue epidemics', 'equator', 'randomness', 'vectorborne infections', 'viral infections']",,,,,,,,,,,,,,,,,,,
15881451,NLM,MEDLINE,20050620,20051116,0029-6503 (Print) 0029-6503 (Linking),95,2004 Dec,"Dengue fever: diagnosis, prevention & control.",281-4,,,"['Placheril, Jincy George']",['Placheril JG'],,"['Lourdes School of Nursing, Holy Cross Hospital, Kottiyam.']",['eng'],"['Journal Article', 'Review']",,India,Nurs J India,The Nursing journal of India,0376403,,,"['Adult', 'Dengue/*diagnosis/nursing/*prevention & control/transmission', 'Female', 'Humans', 'India', 'Mosquito Control', 'Nursing Diagnosis']",,2005/05/11 09:00,2005/06/21 09:00,['2005/05/11 09:00'],"['2005/05/11 09:00 [pubmed]', '2005/06/21 09:00 [medline]', '2005/05/11 09:00 [entrez]']",,ppublish,Nurs J India. 2004 Dec;95(12):281-4.,12,,,,,,,7,,,,,,,,,,,,,,,
6272572,NLM,MEDLINE,19820128,20190511,0002-9262 (Print) 0002-9262 (Linking),114,1981 Nov,The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease.,632-48,,,"['Halstead, S B']",['Halstead SB'],,,['eng'],"['Journal Article', 'Review']",,United States,Am J Epidemiol,American journal of epidemiology,7910653,,IM,"['Age Factors', 'Animals', 'Asia', 'Dengue/epidemiology/*etiology/immunology', 'Flavivirus/classification', 'Humans', 'Sex Factors', 'Time Factors']",,1981/11/01 00:00,1981/11/01 00:01,['1981/11/01 00:00'],"['1981/11/01 00:00 [pubmed]', '1981/11/01 00:01 [medline]', '1981/11/01 00:00 [entrez]']",['10.1093/oxfordjournals.aje.a113235 [doi]'],ppublish,Am J Epidemiol. 1981 Nov;114(5):632-48. doi: 10.1093/oxfordjournals.aje.a113235.,5,,,,,,,62,,,,,,,,,,,,,,,
17612462,NLM,MEDLINE,20070907,20190608,1020-4989 (Print) 1020-4989 (Linking),21,2007 Apr,[Dengue and hemorrhagic dengue in the Americas].,187-91,,,"['Periago, Mirta Roses', 'Guzman, Maria G']","['Periago MR', 'Guzman MG']",,,['spa'],['Editorial'],,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Americas/epidemiology', '*Dengue/epidemiology/prevention & control', 'Humans', 'Severe Dengue/epidemiology/prevention & control']",,2007/07/07 09:00,2007/09/08 09:00,['2007/07/07 09:00'],"['2007/07/07 09:00 [pubmed]', '2007/09/08 09:00 [medline]', '2007/07/07 09:00 [entrez]']","['S1020-49892007000300001 [pii]', '10.1590/s1020-49892007000300001 [doi]']",ppublish,Rev Panam Salud Publica. 2007 Apr;21(4):187-91. doi: 10.1590/s1020-49892007000300001.,4,,,,,,,,,Dengue y dengue hemorragico en las Americas.,,,,,,,,,,,,,
3313490,NLM,MEDLINE,19871204,20051116,0738-0658 (Print) 0738-0658 (Linking),6,1987 Aug,Dengue and dengue hemorrhagic fever in the Americas.,107-11,,"There has been a constant increase in the incidence of dengue in the Americas over the past 15 years. This has been caused by increased frequency of epidemic activity in most countries, as a result of increased numbers of virus serotypes circulating in the region. The change in disease ecology has resulted in the emergence of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in the region, first with a major epidemic in Cuba, followed by increased occurrence of sporadic cases of DHF/DSS in many countries. The sequence of events in the Americas in the 1980's has been nearly identical to the pattern observed in Southeast Asia in the 1950's. Prospects for prevention of epidemic DHF/DSS in the American region, therefore, are not good. In the absence of Aedes aegypti eradication, the only hope for effective prevention and control is to develop more effective active surveillance for DHF/DSS and combine that with both emergency and community-based vector control programs.","['Gubler, D J']",['Gubler DJ'],,"['San Juan Laboratories, Centers for Disease Control, PR 00936.']",['eng'],"['Journal Article', 'Review']",,Puerto Rico,P R Health Sci J,Puerto Rico health sciences journal,8303541,,IM,"['Dengue/*epidemiology/mortality/prevention & control', 'Humans', 'Mosquito Control', 'United States']",,1987/08/01 00:00,1987/08/01 00:01,['1987/08/01 00:00'],"['1987/08/01 00:00 [pubmed]', '1987/08/01 00:01 [medline]', '1987/08/01 00:00 [entrez]']",,ppublish,P R Health Sci J. 1987 Aug;6(2):107-11.,2,,,,,,,18,,,,,,,,,,,,,,,
34302960,NLM,MEDLINE,20210928,20210928,1878-3511 (Electronic) 1201-9712 (Linking),110,2021 Sep,Evaluation of immature platelet fraction as a marker of dengue fever progression.,187-194,S1201-9712(21)00604-4 [pii] 10.1016/j.ijid.2021.07.048 [doi],"OBJECTIVES: Progression of dengue is often associated with thrombocytopenia resulting from viral-induced bone marrow suppression and immune-mediated peripheral platelet consumption. Immature platelet fraction (IPF), which can be measured using a haematology analyser, is a precursor indicating platelet formation in the bone marrow. This study evaluated the trend of IPF as an early recovery indicator of platelets in dengue patients with thrombocytopenia, and its relationship with severe dengue in conjunction with reticulocyte count. METHODS: Hospitalized patients with dengue were enrolled and followed-up daily until discharge. Blood investigations included daily full blood counts and IPF measured using a haematology analyser. RESULTS: In total, 287 patients with confirmed dengue were enrolled in this study, 25 of whom had severe dengue. All patients had a decreasing trend in platelet count in the first week of illness, concomitant with an increasing trend in the percentage of immature platelets to total platelets (IPF%) for more than 3 days prior to platelet recovery. IPF% was significantly increased in patients with severe dengue compared with patients with non-severe dengue on days 3-5 after the onset of fever. Reticulocyte count increased significantly in patients with severe dengue on day 5. CONCLUSIONS: IPF can be utilized as an early recovery indicator of platelets in patients with dengue and thrombocytopenia.","['Looi, Kah Wai', 'Matsui, Yukari', 'Kono, Mari', 'Samudi, Chandramathi', 'Kojima, Nozomi', 'Ong, Jin Xu', 'Tan, Chin Aun', 'Ang, Chong Siang', 'Tan, Peter Hao Yuan', 'Shamnugam, Hemalatha', 'Sekaran, Shamala Devi', 'Syed Omar, Sharifah Faridah', 'Lum, Lucy Chai See']","['Looi KW', 'Matsui Y', 'Kono M', 'Samudi C', 'Kojima N', 'Ong JX', 'Tan CA', 'Ang CS', 'Tan PHY', 'Shamnugam H', 'Sekaran SD', 'Syed Omar SF', 'Lum LCS']",,"['Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Scientific Affairs, Sysmex Corporation, Kobe, Japan.', 'Scientific Affairs, Sysmex Corporation, Kobe, Japan.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Scientific Affairs, Sysmex Corporation, Kobe, Japan.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine & Health Sciences, UCSI University, Kuala Lumpur, Malaysia. Electronic address: shamala@ucsiuniversity.edu.my.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: lumcs@ummc.edu.my.']",['eng'],['Journal Article'],20210722,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,['0 (Biomarkers)'],IM,"['Biomarkers', 'Blood Platelets', '*Dengue/complications/diagnosis', 'Humans', 'Platelet Count', '*Severe Dengue', '*Thrombocytopenia']",,2021/07/25 06:00,2021/09/29 06:00,['2021/07/24 20:13'],"['2021/05/20 00:00 [received]', '2021/07/05 00:00 [revised]', '2021/07/16 00:00 [accepted]', '2021/07/25 06:00 [pubmed]', '2021/09/29 06:00 [medline]', '2021/07/24 20:13 [entrez]']","['S1201-9712(21)00604-4 [pii]', '10.1016/j.ijid.2021.07.048 [doi]']",ppublish,Int J Infect Dis. 2021 Sep;110:187-194. doi: 10.1016/j.ijid.2021.07.048. Epub 2021 Jul 22.,,['Copyright (c) 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue fever', 'Disease progression', 'Immature platelet fraction', 'Platelet', 'Platelet recovery']","['Conflict of interest statement YM, MK and NK are employees of Sysmex Corporation.']",,,,,,,,,,,,,,,,,,
9522985,NLM,MEDLINE,19980507,20200825,0304-4602 (Print) 0304-4602 (Linking),26,1997 Nov,Dengue virus infection--the Malaysian experience.,815-9,,"Since dengue was first documented in Malaysia in 1902 and made notifiable in 1973, the disease pattern has changed from major outbreaks every four years to one of increasing trend yearly. The largest outbreak was seen in 1996 with 14,255 dengue cases reported and 32 deaths. The case fatality rate varied from a high of 10.43% in 1985 when dengue type 3 was the predominant type to a low of 1.29% when dengue type 1 predominated. Severe disease patterns have been observed with dengue 2 and 3 serotypes in the country. The clinical spectrum has also been changing and multisystem involvement with more severe manifestations are being seen. Liver involvement has been documented since 1987. Fulminant hepatitis with encephalopathy can resemble Reye's syndrome. Dengue type 3 has been isolated from liver biopsy specimens. Neurological manifestations can very from irritability, convulsions, coma to peripheral neuritis. The isolation of dengue viruses from cerebrospinal fluids recently strongly suggests that dengue viruses can be neurovirulent. Adult respiratory distress syndrome was seen in three children admitted with shock. Deaths were more frequent in children in the early period but since 1982, over 50% of deaths have occurred in patients over the age of 15 years.","['George, R', 'Lam, S K']","['George R', 'Lam SK']",,"['Department of Paediatrics, University Hospital, Malaysia.']",['eng'],['Journal Article'],,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,,IM,"['Adult', 'Child', '*Dengue/complications/diagnosis/epidemiology', 'Disease Outbreaks', 'Humans', 'Malaysia/epidemiology']",,1998/04/02 00:00,1998/04/02 00:01,['1998/04/02 00:00'],"['1998/04/02 00:00 [pubmed]', '1998/04/02 00:01 [medline]', '1998/04/02 00:00 [entrez]']",,ppublish,Ann Acad Med Singap. 1997 Nov;26(6):815-9.,6,,,,,,,,,,,,,,,,,,,,,,
15645983,NLM,MEDLINE,20050210,20051116,0004-5772 (Print) 0004-5772 (Linking),52,2004 Jul,Dengue: current trends and challenges--an Indian perspective.,561-3,,,"['Ahluwalia, G', 'Sharma, S K']","['Ahluwalia G', 'Sharma SK']",,"['Department of Medicine, Dayanand Medical College and Hospital, Ludhiana-141001.']",['eng'],"['Journal Article', 'Review']",,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Dengue/diagnosis/*therapy/transmission', '*Dengue Virus', 'Humans', 'India']",,2005/01/14 09:00,2005/02/11 09:00,['2005/01/14 09:00'],"['2005/01/14 09:00 [pubmed]', '2005/02/11 09:00 [medline]', '2005/01/14 09:00 [entrez]']",,ppublish,J Assoc Physicians India. 2004 Jul;52:561-3.,,,,,,,,27,,,,,,,,,,,,,,,
37918039,NLM,MEDLINE,20231127,20231205,1532-2653 (Electronic) 0967-5868 (Linking),118,2023 Dec,Ptosis in a patient with dengue fever: Applying the Occam's razor.,115-116,S0967-5868(23)00322-3 [pii] 10.1016/j.jocn.2023.10.017 [doi],,"['Devi Konsam, Biona', 'Das, Liza', 'Singh, Apinderpreet', 'Salunke, Pravin', 'Dutta, Pinaki']","['Devi Konsam B', 'Das L', 'Singh A', 'Salunke P', 'Dutta P']",,"['Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.', 'Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.', 'Department of Neurosurgery, PGIMER, Chandigarh, India.', 'Department of Neurosurgery, PGIMER, Chandigarh, India.', 'Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Electronic address: pinaki_dutta@hotmail.com.']",['eng'],['Journal Article'],20231031,Scotland,J Clin Neurosci,Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,9433352,,IM,"['Humans', '*Blepharoptosis/etiology', 'Patients', '*Dengue/complications/diagnosis']",,2023/11/03 00:42,2023/11/27 12:43,['2023/11/02 19:00'],"['2023/09/23 00:00 [received]', '2023/10/23 00:00 [revised]', '2023/10/24 00:00 [accepted]', '2023/11/27 12:43 [medline]', '2023/11/03 00:42 [pubmed]', '2023/11/02 19:00 [entrez]']","['S0967-5868(23)00322-3 [pii]', '10.1016/j.jocn.2023.10.017 [doi]']",ppublish,J Clin Neurosci. 2023 Dec;118:115-116. doi: 10.1016/j.jocn.2023.10.017. Epub 2023 Oct 31.,,,,,"['Declaration of Competing Interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",,,,,,,,,,,,,,,,,,
34340682,NLM,MEDLINE,20210924,20210924,1471-2334 (Electronic) 1471-2334 (Linking),21,2021 Aug 2,Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.,729,10.1186/s12879-021-06409-9 [doi] 729,"BACKGROUND: Dengue is the most common arboviral disease in the tropical and sub-tropical regions of the world. Like other regions, dengue-endemic areas have faced the additional public health and socio-economic impact of the ongoing coronavirus disease 2019 (COVID-19) pandemic. COVID-19 and dengue co-infections have been reported, with complicated patient management and care requirements. This review aimed to collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection, a potentially important new dimension to be considered in public health management of the COVID-19 pandemic. METHODS: A systematic literature review was conducted using PubMed, Web of Science and Scopus databases from 1st January to 21st November 2020. The key search terms used were ""dengue"" and ""coronavirus"". Descriptive analysis with graphical illustrations were used to present the clinical and laboratory parameters of the co-infection. RESULTS: Thirteen published papers and four news articles were included in the review. Most studies were case reports with a detailed description of the clinical and laboratory characteristics of the co-infection. All cases were in adults with the exception of a six-year old child. The common symptoms of co-infection were fever, dyspnea, headache, and cough. Common laboratory results included thrombocytopenia, lymphocytopenia, elevated transaminases, and leukopenia. Serious outcomes of co-infection included septic shock, acute respiratory disease syndrome and multi-organ failure, leading to death in some patients. CONCLUSIONS: COVID-19 and dengue co-infection was associated with severe disease and fatal outcomes. The correct diagnosis and treatment of co-infection poses a substantial challenge due to the overlapping clinical and laboratory parameters. Therefore, confirmative diagnostic tests are necessary for accurate and timely diagnosis and patient management.","['Tsheten, Tsheten', 'Clements, Archie C A', 'Gray, Darren J', 'Adhikary, Ripon K', 'Wangdi, Kinley']","['Tsheten T', 'Clements ACA', 'Gray DJ', 'Adhikary RK', 'Wangdi K']",,"['Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia. tsheten.tsheten@anu.edu.au.', 'Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan. tsheten.tsheten@anu.edu.au.', 'Telethon Kids Institute, Nedlands, Australia.', 'Curtin University, Perth, Australia.', 'Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.', 'Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.', 'Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.']",['eng'],"['Journal Article', 'Systematic Review']",20210802,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adult', '*COVID-19', 'Child', '*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Humans', 'Pandemics', 'SARS-CoV-2']",PMC8327042,2021/08/04 06:00,2021/09/25 06:00,['2021/08/03 05:34'],"['2021/04/25 00:00 [received]', '2021/07/21 00:00 [accepted]', '2021/08/03 05:34 [entrez]', '2021/08/04 06:00 [pubmed]', '2021/09/25 06:00 [medline]']","['10.1186/s12879-021-06409-9 [pii]', '6409 [pii]', '10.1186/s12879-021-06409-9 [doi]']",epublish,BMC Infect Dis. 2021 Aug 2;21(1):729. doi: 10.1186/s12879-021-06409-9.,1,['(c) 2021. The Author(s).'],['NOTNLM'],"['COVID-19', 'Clinical features', 'Co-infection', 'Dengue', 'Outcomes', 'Symptoms']",['The authors declare that they have no competing interest.'],,,,,,,,,,,,,,,,,,
25546995,NLM,MEDLINE,20150206,20141230,1426-9686 (Print) 1426-9686 (Linking),37,2014 Nov,[Modern immunological and clinical determinants of virus dengue infection].,305-10,,"The growing problem of widespread viral infections is a challenge for modern medicine. Emerging reports of dengue virus infections in Europe create a new epidemic problem. The virus responsible for causing the symptoms of the disease is transmitted by mosquitoes. Over 50% of the world's population lives in areas where the risk of dengue feveris high. In total, according to WHO, infected with dengue is 2.4 million people and outbreaks of endemic diseases are present in 100 countries that threaten the 2.5 billion population. There are four serotypes of dengue virus, which belong to the family Flaviviridae and the type of Flavirus. Serotypes are known as DENV-1, DENV-2, DENV-3 and DENV-4. Contact each of the serotypes of the virus causes long-lasting resistance to the other, and each of them is responsible for the induction of disease epidemics, including severe cases. In the first stage of the disease should seek to replace lost fluids and electrolytes. Because of the elevated body temperature is recommended to administer paracetamol formulations and the use of cold compresses. Contraindicated is the use of aspirin and non-steroidal anti-inflammatory drugs. In severe forms of dengue patients absolutely should be hospitalized and treatment in the intensive care centers. In the treatment of shock, it is recommended that the administration of isotonic crystalloid fluids at 5-10 ml/kg/hr. under the control of hematocrit and fill peripheral microcirculation. The administration of blood products for the large current is required to control bleeding. Dengue vaccine containing DEN-DEN chimeras is still at the stage of preclinical studies.","['Plusa, Tadeusz']",['Plusa T'],,,['pol'],"['English Abstract', 'Journal Article', 'Review']",,Poland,Pol Merkur Lekarski,Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,9705469,,IM,"['Animals', 'Dengue/*diagnosis/epidemiology/*immunology/therapy/transmission', 'Disease Outbreaks/statistics & numerical data', 'Disease Vectors', 'Europe/epidemiology', 'Fluid Therapy', 'Humans', 'Serotyping']",,2014/12/31 06:00,2015/02/07 06:00,['2014/12/31 06:00'],"['2014/12/31 06:00 [entrez]', '2014/12/31 06:00 [pubmed]', '2015/02/07 06:00 [medline]']",,ppublish,Pol Merkur Lekarski. 2014 Nov;37(221):305-10.,221,,,,,,,,,Wspolczesne immunologiczne i kliniczne uwarunkowania zakazenia wirusem dengi.,,,,,,,,,,,,,
9441466,NLM,MEDLINE,19980121,20141120,0029-2001 (Print) 0029-2001 (Linking),117,1997 Nov 30,[Dengue fever. Another infectious disease out of control?].,4225-7,,"In the 1950s dengue fever left its home in South-East Asia. The result, as we see it 40 years later, is terrifying. From being an almost unknown infection, dengue fever is today's most common arboviral disease with up to 100 million cases annually. In addition, the clinical picture has changed from a benign influenza-like disorder (classic dengue fever) to a serious disease with bleeding and hypovolemic shock (dengue hemorrhagic fever). In this article the authors give an overview of the present epidemiology, prognosis and possible preventive measures against dengue fever.","['Jensenius, M', 'Gundersen, S G']","['Jensenius M', 'Gundersen SG']",,"['Medisinsk avdeling, Lovisenberg Diakonale Sykehus, Oslo.']",['nor'],"['English Abstract', 'Journal Article', 'Review']",,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,,IM,"['Dengue/*epidemiology/prevention & control/transmission', '*Disease Outbreaks', '*Global Health', 'Humans', 'Severe Dengue/epidemiology/prevention & control/transmission']",,1998/01/24 00:00,1998/01/24 00:01,['1998/01/24 00:00'],"['1998/01/24 00:00 [pubmed]', '1998/01/24 00:01 [medline]', '1998/01/24 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1997 Nov 30;117(29):4225-7.,29,,,,,,,30,,Denguefeber. Enda en smittsom sykdom ute av kontroll?,,,,,,,,,,,,,
36828393,NLM,MEDLINE,20230403,20230403,1469-0756 (Electronic) 0032-5473 (Linking),99,2023 Mar 31,Central nervous system manifestations of dengue infection: data from a tertiary care Centre in South India.,50-55,10.1093/postmj/qgad004 [doi],"BACKGROUND: Dengue fever is the second most common mosquito-borne disease affecting human beings and neurological manifestations (NMs) of this arboviral infection are increasingly being reported. METHODS: In this retrospective study, conducted in a tertiary care centre in south India, we sought to describe the spectrum of NMs of dengue fever. The records of all patients admitted in the Department of Internal Medicine over 8 years, with a diagnosis of dengue-based on clinical symptoms and the detection of dengue IgM antibodies or detection of NS1 antigen or nucleic acid by reverse transcriptase-polymerase chain reaction (RT-PCR); with Glasgow coma score (GCS) </=14, neck stiffness, focal neurological signs, seizures, or visual disturbances-were explored. RESULTS: Of 1121 patients admitted with dengue fever, 341 (30%) had severe dengue and 23 (2%) had NMs. Encephalopathy was seen in 9 patients (39%), encephalitis in 6 (27%), cerebellitis in 4 (17%), acute disseminated encephalomyelitis (ADEM) in 2 (9%), ischaemic stroke in 1 (4%) patient, and neuro-ophthalmological manifestations in 1 (4%) patient. The median duration of hospital stay was 7 days. Nine (39% of) patients required intensive care unit (ICU) admission and 5 (22%) had fatal outcomes. There was no association between thrombocytopenia, metabolic acidosis, transaminitis, hyponatremia, the type of dengue infection, and the various NMs described. CONCLUSIONS: The NMs of dengue infection are varied, and a high index of suspicion is needed to identify them in patients who present with lethargy or altered sensorium on the background of an acute febrile illness suggestive of dengue.","['George, John Titus', 'Lenin, Audrin', 'Koshy, Maria', 'Vignesh, C V', 'Sathyendra, Sowmya']","['George JT', 'Lenin A', 'Koshy M', 'Vignesh CV', 'Sathyendra S']",,"['Department of Medicine, Christian Medical College, Vellore, Tamilnadu, 632004, India.', 'Department of Medicine, Christian Medical College, Vellore, Tamilnadu, 632004, India.', 'Department of Medicine, Christian Medical College, Vellore, Tamilnadu, 632004, India.', 'Department of Medicine, Christian Medical College, Vellore, Tamilnadu, 632004, India.', 'Department of Medicine, Christian Medical College, Vellore, Tamilnadu, 632004, India.']",['eng'],['Journal Article'],,England,Postgrad Med J,Postgraduate medical journal,0234135,,IM,"['Humans', '*Dengue/complications/diagnosis/epidemiology', 'Tertiary Care Centers', 'Retrospective Studies', '*Brain Ischemia', '*Stroke', 'Central Nervous System', 'India/epidemiology']",,2023/02/25 06:00,2023/04/03 06:41,['2023/02/24 19:43'],"['2022/09/21 00:00 [received]', '2022/11/07 00:00 [revised]', '2023/01/10 00:00 [accepted]', '2023/04/03 06:41 [medline]', '2023/02/25 06:00 [pubmed]', '2023/02/24 19:43 [entrez]']","['7056720 [pii]', '10.1093/postmj/qgad004 [doi]']",ppublish,Postgrad Med J. 2023 Mar 31;99(1168):50-55. doi: 10.1093/postmj/qgad004.,1168,"['(c) The Author(s) 2023. Published by Oxford University Press on behalf of', 'Postgraduate Medical Journal. All rights reserved. For permissions, please', 'e-mail: journals.permissions@oup.com.']",['NOTNLM'],"['acute disseminated encephalomyelitis', 'cerebellitis', 'dengue', 'encephalitis', 'neurologic manifestations']",,,,,,,,,,,,,,,,,,,
9752834,NLM,MEDLINE,19981001,20220419,0140-6736 (Print) 0140-6736 (Linking),352,1998 Sep 19,Dengue and dengue haemorrhagic fever.,971-7,,"The incidence and geographical distribution of dengue have greatly increased in recent years. Dengue is an acute mosquito-transmitted viral disease characterised by fever, headache, muscle and joint pains, rash, nausea, and vomiting. Some infections result in dengue haemorrhagic fever (DHF), a syndrome that in its most severe form can threaten the patient's life, primarily through increased vascular permeability and shock. The case fatality rate in patients with dengue shock syndrome can be as high as 44%. For decades, two distinct hypotheses to explain the mechanism of DHF have been debated-secondary infection or viral virulence. However, a combination of both now seems to be the plausible explanation. The geographical expansion of DHF presents the need for well-documented clinical, epidemiological, and virological descriptions of the syndrome in the Americas. Biological and social research are essential to develop effective mosquito control, medications to reduce capillary leakage, and a safe tetravalent vaccine.","['Rigau-Perez, J G', 'Clark, G G', 'Gubler, D J', 'Reiter, P', 'Sanders, E J', 'Vorndam, A V']","['Rigau-Perez JG', 'Clark GG', 'Gubler DJ', 'Reiter P', 'Sanders EJ', 'Vorndam AV']",,"['Dengue Branch, Division of Vector-borne Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico 00921-3200, USA. Jor1@cdc.gov']",['eng'],"['Comment', 'Journal Article']",,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['*Dengue/diagnosis/epidemiology/prevention & control/therapy', 'Global Health', 'Humans', 'Prevalence', 'Risk Factors', '*Severe Dengue/diagnosis/epidemiology/prevention & control/therapy']",,1998/09/30 00:00,1998/09/30 00:01,['1998/09/30 00:00'],"['1998/09/30 00:00 [pubmed]', '1998/09/30 00:01 [medline]', '1998/09/30 00:00 [entrez]']","['S0140673697124837 [pii]', '10.1016/s0140-6736(97)12483-7 [doi]']",ppublish,Lancet. 1998 Sep 19;352(9132):971-7. doi: 10.1016/s0140-6736(97)12483-7.,9132,,,,,['Lancet. 1998 Nov 21;352(9141):1712. PMID: 9853477'],,,['Lancet. 1999 Mar 27;353(9158):1100-1. PMID: 10199378'],,,,,,,,,,,,,,
29504327,NLM,MEDLINE,20180724,20181202,1819-2718 (Electronic) 1025-9589 (Linking),30,2018 Jan-Mar,"Dengue Knowledge In Indoor Dengue Patients From Low Socioeconomic Class; Aetiology, Symptoms, Mode Of Transmission And Prevention.",40-44,,"BACKGROUND: Dengue fever has emerged as an emerging public health issue during last decade bearing significant morbidity and economic burden particularly in third world countries. Current study aims to assess various domains of knowledge of indoor dengue patients.. METHODS: This descriptive crosssectional study was conducted at Medicine dept. Rawal Institute of Health Sciences Islamabad and BBH Rawalpindi over 6 months. One hundred & twenty-five adult indoor confirmed cases of dengue from lower socioeconomic class were included after ethical approval. The 25-item dengue knowledge questionnaire including aetiology, symptoms, modes of transmission and prevention of dengue was filled. RESULTS: Among 125 cases (77% males and 23% females), mean age was 30+/-13 years. Mean knowledge score was 11+/-5 points; with excellent knowledge in 6%, good knowledge (22%), moderate knowledge (23%), fair knowledge (34%) and poor knowledge (17%). Mosquito being a vector of dengue was identified by 78%, with peak time in afternoon (48%). Symptoms identified include fever (95%), headache (55%), muscle pain (44%), rash (33%), retro-orbital pain (32%), joint pains (28%) and abdominal pain (18%). Flies and ticks aren't the vectors of dengue according to 61% and 74% respectively, special mosquito is vector (54%), i.e., Aedes aegypti (18%) that breeds in standing water (53%). Preventive measures identified were netting (56%), insecticide sprays (54%), covering water containers (38%), removing standing water (36%), mosquito repellents (17%), cutting down bushes (22%) and pouring chemicals in standing water (18%). CONCLUSIONS: Our patients from lower socioeconomic class, though aware of vector and mode of transmission, have insufficient knowledge of prevention and vector control measures. There is need to strengthen dengue awareness through community-based programs, social media, schools and health care centres for high risk people well before the expected epidemic season about mode of transmission, vector control, screening and early approach to health care facility.","['Shams, Nadia', 'Amjad, Sadia', 'Yousaf, Nadeem', 'Ahmed, Waqar', 'Seetlani, Naresh Kumar', 'Farhat, Shazia']","['Shams N', 'Amjad S', 'Yousaf N', 'Ahmed W', 'Seetlani NK', 'Farhat S']",,"['Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan.', 'Benazir Bhutto Shaheed Hospital, Rawalpindi, Pakistan.', 'Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan.', 'Department of Medicine, Rawal Institute of Health Sciences, Islamabad, Pakistan.', 'Civil Hospital Karachi,Pakistan.', 'Airport Health Department, Karachi, Pakistan.']",['eng'],['Journal Article'],,Pakistan,J Ayub Med Coll Abbottabad,"Journal of Ayub Medical College, Abbottabad : JAMC",8910750,,IM,"['Adolescent', 'Adult', '*Aedes', 'Animals', 'Cross-Sectional Studies', 'Dengue/*complications/etiology/*prevention & control/transmission', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', '*Insect Vectors', 'Male', 'Mosquito Control', 'Socioeconomic Factors', 'Surveys and Questionnaires', 'Young Adult']",,2018/03/06 06:00,2018/07/25 06:00,['2018/03/06 06:00'],"['2018/03/06 06:00 [entrez]', '2018/03/06 06:00 [pubmed]', '2018/07/25 06:00 [medline]']",['1278/1853 [pii]'],ppublish,J Ayub Med Coll Abbottabad. 2018 Jan-Mar;30(1):40-44.,1,,['NOTNLM'],"['Dengue fever', 'Dengue knowledge', 'Dengue prevention']",,,,,,,,,,,,,,,,,,,
35968472,NLM,MEDLINE,20220816,20220816,2296-2565 (Electronic) 2296-2565 (Linking),10,2022,"A cross-sectional study to assess the epidemiological situation and associated risk factors of dengue fever; knowledge, attitudes, and practices about dengue prevention in Khyber Pakhtunkhwa Province, Pakistan.",923277,10.3389/fpubh.2022.923277 [doi] 923277,"BACKGROUND: Dengue fever has been responsible for around 12 countrywide large outbreaks in Pakistan, resulting in 286,262 morbidities and 1,108 deaths. Khyber Pakhtunkhwa (KP) is the most recently impacted province. This study aimed to investigate the molecular, epidemiological, and potential elements that contribute to increasing dengue transmission patterns, and knowledge, attitude, and practice (KAP) toward dengue in KP province. METHOD: This cross-sectional community-based study was conducted (June-December, 2021) in two phases. Phase I involved the epidemiological (n = 5,242) and molecular analysis of DENV in 500 randomly collected blood samples of the 2021 dengue outbreak in KP. Phase II focused on assessing dengue-KAP levels in healthy communities (n = 14,745, aged >18 years), adopting a cross-sectional clustered multistage sampling in eight districts (dengue-hotspot vs. non-hotspot) of KP. Chi-square tests and logistic regression analysis were applied. RESULTS: Peshawar district had the highest dengue cases (60.0%) associated with the predominant co-circulation of DENV-2 (45.8%) and DENV-3 (50.4%) serotypes. A rise in cases was reported in October (41.8%) followed by September (27.9%) and August (14.4%; p < 0.001). Males (63.7%, p < 0.001) and individuals aged 16-30 years (37.0%, p < 0.001) were highly affected. General workers (18.0%), families with a monthly income of 10,000-20,000 Pak rupees (50.5%), unmarried (71.0%), uneducated (31%), families with higher human density (>10 individuals per household), and those (29.0%) who faced power outages for more than 7/24 h were the most affected. Moreover, co-morbidities like renal failure and bronchial asthma were associated with disease severity. A community survey on KAP revealed that an average of 74, 60, and 43% of the participants demonstrated good knowledge, attitudes, and dengue preventive practices, respectively. CONCLUSION: Multiple poor socioeconomic elements are influencing dengue fever transmission in the province. Higher KAP levels may explain the low frequency of dengue in non-hotspot districts. Our study emphasizes the need for effective and long-term public health education, strengthened vector surveillance, and expanded laboratory capacity for better diagnosis and management of dengue cases to better predict the burden and seasonality of disease in the country.","['Khan, Jehangir', 'Adil, Muhammad', 'Wang, Gang', 'Tsheten, Tsheten', 'Zhang, Dongjing', 'Pan, Wenjie', 'Khan, Munir Ahmad', 'Rehman, Inayat Ur', 'Zheng, Xiaoying', 'Wu, Zhongdao', 'Wu, Yu']","['Khan J', 'Adil M', 'Wang G', 'Tsheten T', 'Zhang D', 'Pan W', 'Khan MA', 'Rehman IU', 'Zheng X', 'Wu Z', 'Wu Y']",,"['Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.', 'Department of Zoology, Abdul Wali Khan University Mardan, Mardan, Pakistan.', 'Pakistan Bureau of Statistics, Islamabad, Pakistan.', 'Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.', 'Department of Global Health, Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, ACT, Australia.', 'Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan.', 'Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.', 'Guangzhou SYSU Nuclear and Insect Biotechnology Co., Ltd., Guangzhou, China.', 'Medical Unit, Khyber Teaching Hospital Peshawar, Peshawar, Pakistan.', 'Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.', 'Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.', 'Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.', 'Department of Global Health, Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, ACT, Australia.', 'Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.', 'Key Laboratory of Tropical Disease Control of the Ministry of Education, Sun Yat-sen University-Michigan State University Joint Center of Vector Control for Tropical Disease, Zhongshan School of Medicine, Guangzhou, China.', 'Chinese Atomic Energy Agency Center of Excellence on Nuclear Technology Applications for Insect Control, Sun Yat-sen University, Guangzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20220729,Switzerland,Front Public Health,Frontiers in public health,101616579,,IM,"['Cross-Sectional Studies', '*Dengue/diagnosis/epidemiology/prevention & control', 'Health Knowledge, Attitudes, Practice', 'Humans', 'Male', 'Pakistan/epidemiology', 'Risk Factors']",PMC9372552,2022/08/16 06:00,2022/08/17 06:00,['2022/08/15 04:14'],"['2022/04/19 00:00 [received]', '2022/07/04 00:00 [accepted]', '2022/08/15 04:14 [entrez]', '2022/08/16 06:00 [pubmed]', '2022/08/17 06:00 [medline]']",['10.3389/fpubh.2022.923277 [doi]'],epublish,Front Public Health. 2022 Jul 29;10:923277. doi: 10.3389/fpubh.2022.923277. eCollection 2022.,,"['Copyright (c) 2022 Khan, Adil, Wang, Tsheten, Zhang, Pan, Khan, Rehman, Zheng, Wu', 'and Wu.']",['NOTNLM'],"['DENV', 'KAP', 'SES', 'epidemiology', 'serology']","['Author WP was employed by Guangzhou SYSU Nuclear and Insect biotechnology Co.,', 'Ltd. The remaining authors declare that the research was conducted in the absence', 'of any commercial or financial relationships that could be construed as a', 'potential conflict of interest.']",,,,,,,,,,,,,,,,,,
25764623,NLM,MEDLINE,20150519,20181202,0125-2208 (Print) 0125-2208 (Linking),98 Suppl 1,2015 Jan,Dengue: a global threat.,S118-22,,"Dengue, a mosquito-borne viral disease, is currently an expanding global problem. The disease is caused by four closely related dengue serotypes; it ranges from asymptomatic infection to undifferentiated fever, dengue fever (DF) and dengue hemorrhagic fever (DHF). DHF is characterized by fever, bleeding diathesis and a tendency to develop apotentially fatal shock syndrome. Dengue infection with organ impairment mainly involves the central nervous system and liver. Consistent hematological findings include vasculopathy, coagulopathy and thrombocytopenia. Laboratory diagnoses include virus isolation, serology, and detection ofdengue ribonucleic acid. Successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. A severity-based revised dengue classification for medical interventions has been developed and validated in many countries. So far however, there has not been any specific dengue treatment; prevention is currently limited to vector control measures. The world's first, large-scale dengue vaccine, efficacy study demonstrated its efficacy and a reduction of dengue's severity in a study of more than 10,000 volunteers in Asia. Initial safety data are consistent with a good safety profile.","['Thisyakorn, Usa', 'Thisyakorn, Chule']","['Thisyakorn U', 'Thisyakorn C']",,,['eng'],['Journal Article'],,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,['0 (Dengue Vaccines)'],IM,"['Dengue/diagnosis/*epidemiology/therapy', 'Dengue Vaccines/administration & dosage', 'Global Health', 'Humans', 'Severe Dengue/diagnosis/epidemiology/therapy']",,2015/03/15 06:00,2015/05/20 06:00,['2015/03/14 06:00'],"['2015/03/14 06:00 [entrez]', '2015/03/15 06:00 [pubmed]', '2015/05/20 06:00 [medline]']",,ppublish,J Med Assoc Thai. 2015 Jan;98 Suppl 1:S118-22.,,,,,,,,,,,,,,,,,,,,,,,
15200868,NLM,MEDLINE,20040713,20181113,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),10,2004 Apr,"Dengue 3 epidemic, Havana, 2001.",719-22,,"In June 2001, dengue transmission was detected in Havana, Cuba; 12,889 cases were reported. Dengue 3, the etiologic agent of the epidemic, caused the dengue hemorrhagic fever only in adults, with 78 cases and 3 deaths. After intensive vector control efforts, no new cases have been detected.","['Pelaez, Otto', 'Guzman, Maria G', 'Kouri, Gustavo', 'Perez, Raul', 'San Martin, Jose L', 'Vazquez, Susana', 'Rosario, Delfina', 'Mora, Regla', 'Quintana, Ibrahim', 'Bisset, Juan', 'Cancio, Reynel', 'Masa, Ana M', 'Castro, Osvaldo', 'Gonzalez, Daniel', 'Avila, Luis C', 'Rodriguez, Rosmari', 'Alvarez, Mayling', 'Pelegrino, Jose L', 'Bernardo, Lidice', 'Prado, Irina']","['Pelaez O', 'Guzman MG', 'Kouri G', 'Perez R', 'San Martin JL', 'Vazquez S', 'Rosario D', 'Mora R', 'Quintana I', 'Bisset J', 'Cancio R', 'Masa AM', 'Castro O', 'Gonzalez D', 'Avila LC', 'Rodriguez R', 'Alvarez M', 'Pelegrino JL', 'Bernardo L', 'Prado I']",,"['Centro Provincial de Higiene y Epidemiologia de Ciudad Habana, Habana, Cuba.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adolescent', 'Adult', 'Cuba/epidemiology', 'Dengue/*epidemiology/prevention & control/transmission', 'Female', 'Humans', 'Male', 'Middle Aged', 'Time Factors']",PMC3323093,2004/06/18 05:00,2004/07/14 05:00,['2004/06/18 05:00'],"['2004/06/18 05:00 [pubmed]', '2004/07/14 05:00 [medline]', '2004/06/18 05:00 [entrez]']","['03-0271 [pii]', '10.3201/eid1004.030271 [doi]']",ppublish,Emerg Infect Dis. 2004 Apr;10(4):719-22. doi: 10.3201/eid1004.030271.,4,,,,,,,,,,,,,,,,,,,,,,
22751631,NLM,MEDLINE,20120927,20120703,1939-2869 (Electronic) 0891-1150 (Linking),79,2012 Jul,Dengue: A reemerging concern for travelers.,474-82,10.3949/ccjm.79a.11048 [doi],"Dengue, a neglected tropical disease that is reemerging around the world, became a nationally notifiable disease in the United States in 2009. Travel to tropical and subtropical areas in the developing world poses the greatest risk of infection for US residents, and an increase in travel to these areas makes this infection more likely to be seen by primary care physicians in their practices.","['Hynes, Noreen A']",['Hynes NA'],,"['Johns Hopkins University School of Medicine, Geographic Medicine Center, Division of Infectious Diseases, Johns Hopkins Travel and Tropical Medicine Service, Baltimore, MD, USA. nhynes@jhmi.edu']",['eng'],['Journal Article'],,United States,Cleve Clin J Med,Cleveland Clinic journal of medicine,8703441,,IM,"['Dengue/*diagnosis/epidemiology/transmission', 'Diagnosis, Differential', 'Disease Notification', 'Epidemics', 'Fever/etiology', 'Humans', '*Travel', 'United States/epidemiology']",,2012/07/04 06:00,2012/09/28 06:00,['2012/07/04 06:00'],"['2012/07/04 06:00 [entrez]', '2012/07/04 06:00 [pubmed]', '2012/09/28 06:00 [medline]']","['79/7/474 [pii]', '10.3949/ccjm.79a.11048 [doi]']",ppublish,Cleve Clin J Med. 2012 Jul;79(7):474-82. doi: 10.3949/ccjm.79a.11048.,7,,,,,,,,,,,,,,,,,,,,,,
18181502,NLM,MEDLINE,20080221,20090713,1015-7867 (Print) 1015-7867 (Linking),12,2005 Sep,Dengue in the Pacific--an update of the current situation.,111-9,,"Dengue continues to be a threat to Pacific Island countries and territories (PICTs). The last DEN-1 epidemic reached 16 PICTs and in some of them it affected as much as 20 per cent of the population, aside from the massive impact on their fragile economies. Dengue is mostly introduced into PICTs from global travel, and many experts believe that it has a 3-4 year cyclical pattern of occurrence. All four virus serotypes (DEN-1, 2, 3 and 4) have caused epidemics, but those caused by DEN-1 and 2 have been somewhat larger. In light of this, dengue rightly remains a priority for the Pacific Public Health Surveillance Network (PPHSN). The paper updates the situation regarding dengue outbreaks in PICTs over the last four decades, describes the pattern of presentations in the recent past, and provides an update on the potential risk to PICTs for the near future. It follows on from an earlier dengue update written in 1998. The utility of PPHSN services is also demonstrated in the paper: PacNet for alerts and communication about dengue outbreaks (raising awareness and preparedness levels in the region) and LabNet for investigations relating to dengue. Creative interventions towards dengue control and prevention are being tried in PICTs and early assessment and evaluations of their effectiveness in the field are being examined.","['Singh, Narendra', 'Kiedrzynski, Tom', 'Lepers, Christelle', 'Benyon, Elise Kamisan']","['Singh N', 'Kiedrzynski T', 'Lepers C', 'Benyon EK']",,"['Secretariat of the Pacific Community, Noumea, New Caledonia. narendras@spc.int']",['eng'],['Journal Article'],,New Zealand,Pac Health Dialog,Pacific health dialog,9434923,,IM,"['Animals', 'Dengue/diagnosis/*epidemiology/etiology/prevention & control', 'Dengue Virus/classification/pathogenicity', 'Humans', 'Insect Vectors', 'Pacific Islands/epidemiology']",,2008/01/10 09:00,2008/02/22 09:00,['2008/01/10 09:00'],"['2008/01/10 09:00 [pubmed]', '2008/02/22 09:00 [medline]', '2008/01/10 09:00 [entrez]']",,ppublish,Pac Health Dialog. 2005 Sep;12(2):111-9.,2,,,,,,,,,,,,,,,,,,,,,,
25412699,NLM,MEDLINE,20150720,20181113,1752-1947 (Electronic) 1752-1947 (Linking),8,2014 Nov 21,Dengue fever in a liver-transplanted patient: a case report.,378,10.1186/1752-1947-8-378 [doi],"INTRODUCTION: Dengue fever is one of the commonest mosquito-borne diseases in the tropics, and Sri Lanka is no exception. Despite its commonness, dengue fever has rarely been described among patients who have undergone transplantation. We report the case of a patient with dengue fever after liver transplantation, which, to the best of our knowledge, is the first such reported case outside Brazil. CASE PRESENTATION: Our patient was a 46-year-old Sri Lakan man who presented to our institution two years after undergoing an ABO-compatible cadaveric liver transplant. At presentation, he had typical symptoms of dengue fever. He was taking prednisolone 5mg daily and tacrolimus 3mg twice daily as immunosuppression. Initial investigations showed thrombocytopenia and neutropenia that reached a nadir by day 7 of his illness. He had elevated liver enzymes as well. The diagnosis was confirmed on the basis of NS1 antigen detection by enzyme-linked immunosorbent assay. His blood cultures and polymerase chain reaction tests for cytomegalovirus were negative. He made an uneventful recovery and was discharged by day 9 of his illness. However, normalization of liver function took nearly two weeks. In three previously reported Brazilian cases of dengue after liver transplantation, the patients presented with dengue shock syndrome, in contrast to the relatively milder presentation of our patient. Because of the lack of case reports in the literature, it is difficult to ascertain the risk factors for severe dengue infection in transplants, but dengue fever reported in renal transplants sheds some light on them. High-dose steroids increase the risk of thrombocytopenia, whereas tacrolimus has been reported to prolong the duration of symptoms. Otherwise, dengue fever is a relatively mild illness in patients who have undergone renal transplantation, and renal allograft survival has been reported to be 86% following dengue fever. CONCLUSION: Dengue is a rarely reported infection in patients who have undergone transplantation. A high degree of suspicion is required for diagnosis. Dengue NS1 antigen detection is a useful addition to the already existing methods of diagnosis. Steroids and tacrolimus have effects on the morbidity of the disease. Graft outcomes following the infection has been excellent in all reported cases.","['Weerakkody, Ranga Migara', 'Palangasinghe, Dhammika Randula', 'Dalpatadu, Kaluthanthri Patabandi Chamila', 'Rankothkumbura, Jeewan Pradeep', 'Cassim, Mohammed Rezni Nizam', 'Karunanayake, Panduka']","['Weerakkody RM', 'Palangasinghe DR', 'Dalpatadu KP', 'Rankothkumbura JP', 'Cassim MR', 'Karunanayake P']",,"['University Medical Unit, National Hospital of Sri Lanka, Regent Street, Colombo 9 CO00900, Sri Lanka. rangamw2003@yahoo.com.']",['eng'],"['Case Reports', 'Journal Article']",20141121,England,J Med Case Rep,Journal of medical case reports,101293382,,IM,"['Dengue/diagnosis/epidemiology/*etiology', 'Humans', 'Immunocompromised Host', 'Liver Transplantation/*adverse effects', 'Male', 'Middle Aged', 'Sri Lanka/epidemiology']",PMC4244141,2014/11/22 06:00,2015/07/21 06:00,['2014/11/22 06:00'],"['2014/06/28 00:00 [received]', '2014/09/23 00:00 [accepted]', '2014/11/22 06:00 [entrez]', '2014/11/22 06:00 [pubmed]', '2015/07/21 06:00 [medline]']","['1752-1947-8-378 [pii]', '10.1186/1752-1947-8-378 [doi]']",epublish,J Med Case Rep. 2014 Nov 21;8:378. doi: 10.1186/1752-1947-8-378.,,,,,,,,,,,,,,,,,,,,,,,
33632964,NLM,MEDLINE,20210818,20210818,0974-7559 (Electronic) 0019-6061 (Print) 0019-6061 (Linking),58,2021 Feb 15,Prehospital Management of Children with Dengue Fever Admitted in a Tertiary-Care Center.,192,,,"['Sankar, Janani', 'Saravanan, Nithya']","['Sankar J', 'Saravanan N']",,"['Kanchi Kamakoti Childs Trust Hospital, Chennai, India. janani.sankar@yahoo.com.', 'Kanchi Kamakoti Childs Trust Hospital, Chennai, India.']",['eng'],['Letter'],,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Child', '*Dengue/diagnosis/therapy', '*Emergency Medical Services', 'Hospitalization', 'Humans', '*Severe Dengue', 'Tertiary Care Centers']",PMC7926065,2021/02/27 06:00,2021/08/19 06:00,['2021/02/26 05:54'],"['2021/02/26 05:54 [entrez]', '2021/02/27 06:00 [pubmed]', '2021/08/19 06:00 [medline]']","['2147 [pii]', '10.1007/s13312-021-2147-0 [doi]']",ppublish,Indian Pediatr. 2021 Feb 15;58(2):192. doi: 10.1007/s13312-021-2147-0.,2,,,,,,,,,,,,,,,,,,,,,,
31943116,NLM,MEDLINE,20210527,20210527,1878-3503 (Electronic) 0035-9203 (Linking),114,2020 Jan 6,Dynamic dengue haemorrhagic fever calculators as clinical decision support tools in adult dengue.,7-15,10.1093/trstmh/trz099 [doi],"BACKGROUND: The objective of this study was to develop multiple prediction tools that calculate the risk of developing dengue haemorrhagic fever. METHODS: Training data consisted of 1771 individuals from 2006-2008 admitted with dengue fever whereby 304 developed dengue haemorrhagic fever during hospitalisation. Least absolute shrinkage and selection operator regression was used to construct three types of calculators, static admission calculators and dynamic calculators that predict the risk of developing dengue haemorrhagic fever for a subsequent day (DAily Risk Tomorrow [DART]) or for any future point after a specific day since fever onset (DAily Risk Ever [DARE]). RESULTS: From 119 admission covariates, 35 were in at least one of the calculators, which reported area under the curve (AUC) values of at least 0.72. Addition of person-time data for DART improved AUC to 0.76. DARE calculators displayed a large increase in AUC to 0.79 past day 7 with the inclusion of a strong predictor, maximum temperature on day 6 since onset, indicative of a saddleback fever. CONCLUSIONS: All calculators performed well when validated with 2005 data. Addition of daily variables further improved the accuracy. These calculators can be used in tandem to assess the risk of dengue haemorrhagic fever upon admission and updated daily to obtain more precise risk estimates.","['Tan, Ken Wei', 'Tan, Ben', 'Thein, Tun L', 'Leo, Yee-Sin', 'Lye, David C', 'Dickens, Borame L', 'Wong, Joshua Guo Xian', 'Cook, Alex R']","['Tan KW', 'Tan B', 'Thein TL', 'Leo YS', 'Lye DC', 'Dickens BL', 'Wong JGX', 'Cook AR']",,"['Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore 117549.', 'Ministry of Education, 1 North Buona Vista Drive, Singapore 138675.', 'National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442.', 'Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore 117549.', 'National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442.', 'Tan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433.', 'Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore 117597.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, 59 Nanyang Drive, Singapore 636921.', 'National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442.', 'Tan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433.', 'Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore 117597.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, 59 Nanyang Drive, Singapore 636921.', 'Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore 117549.', 'Tan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433.', 'Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore 117549.']",['eng'],['Journal Article'],,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Adult', '*Decision Support Systems, Clinical', '*Dengue/diagnosis/epidemiology', 'Fever/etiology', 'Hospitalization', 'Humans', '*Severe Dengue/diagnosis/epidemiology']",,2020/01/17 06:00,2021/05/28 06:00,['2020/01/17 06:00'],"['2019/04/02 00:00 [received]', '2019/07/21 00:00 [revised]', '2019/08/15 00:00 [accepted]', '2020/01/17 06:00 [entrez]', '2020/01/17 06:00 [pubmed]', '2021/05/28 06:00 [medline]']","['5626017 [pii]', '10.1093/trstmh/trz099 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2020 Jan 6;114(1):7-15. doi: 10.1093/trstmh/trz099.,1,"['(c) The Author(s) 2019. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene.']",['NOTNLM'],"['Clinical Decision Support Tools', 'Dengue', 'Machine Learning']",,,,,,,,,,,,,,,,,,,
492017,NLM,MEDLINE,19791218,20210522,0025-729X (Print) 0025-729X (Linking),1,1979 Jun 30,Dengue fever.,622,,,"['Hennessy, W B']",['Hennessy WB'],,,['eng'],['Letter'],,Australia,Med J Aust,The Medical journal of Australia,0400714,,IM,"['Adult', 'Australia', 'Dengue/diagnosis/*epidemiology', 'Humans']",,1979/06/30 00:00,1979/06/30 00:01,['1979/06/30 00:00'],"['1979/06/30 00:00 [pubmed]', '1979/06/30 00:01 [medline]', '1979/06/30 00:00 [entrez]']",['10.5694/j.1326-5377.1979.tb119412.x [doi]'],ppublish,Med J Aust. 1979 Jun 30;1(13):622. doi: 10.5694/j.1326-5377.1979.tb119412.x.,13,,,,,,,,,,,,,,,,,,,,,,
11014142,NLM,MEDLINE,20001011,20131121,0041-5782 (Print) 0041-5782 (Linking),162,2000 Sep 18,[Dengue fever].,5089-91,,"Dengue virus infections have increased globally. This results in an increased incidence of patients with dengue fever in Denmark. In order to draw attention to this diagnosis among febrile persons returning from a stay in tropical and subtropical areas, we present two cases of dengue virus infection and describe the symptoms and diagnostic possibilities. Dengue Haemorrhagic Fever (DHF) is supposed to occur only in persons who have previously had dengue virus infection and who acquire a second infection with dengue virus.","['Sorensen, I J', 'Pedersen, S S']","['Sorensen IJ', 'Pedersen SS']",,"['Odense Universitetshospital, medicinsk afdeling C, infektionsmedicinsk afsnit.']",['dan'],"['Case Reports', 'English Abstract', 'Journal Article']",,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,"['0 (Antibodies, Viral)', '0 (Immunoglobulin M)']",IM,"['Adult', 'Antibodies, Viral/analysis', '*Dengue/diagnosis/therapy/transmission', 'Diagnosis, Differential', 'Female', 'Humans', 'Immunoglobulin M/analysis', 'Male', '*Severe Dengue/diagnosis/therapy/transmission', 'Travel', 'Tropical Medicine']",,2000/10/03 11:00,2000/10/14 11:01,['2000/10/03 11:00'],"['2000/10/03 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/10/03 11:00 [entrez]']",,ppublish,Ugeskr Laeger. 2000 Sep 18;162(38):5089-91.,38,,,,,,,,,Denguefeber.,,,,,,,,,,,,,
34338929,NLM,MEDLINE,20220223,20220223,1590-3478 (Electronic) 1590-1874 (Linking),43,2022 Mar,Correlation of serotype-specific strain in patients with dengue virus infection with neurological manifestations and its outcome.,1939-1946,10.1007/s10072-021-05477-8 [doi],"INTRODUCTION: Neurological manifestation of dengue virus infection is a rare entity. Serotypes commonly associated with neurological manifestation are DENV-2 and DENV-3. We plan to detect the serotypes related to the neurological presentation in dengue infection and its correlation with different neurological complications and outcome. METHODS: In this case-control study, consecutive dengue cases with different neurological manifestations were enrolled along with age and sex-matched controls (dengue patients without neurological complication). Serotyping using RT-PCR of samples of cases and controls were done. Level of correlation was analyzed with various parameters and outcomes. RESULTS: In cases out of 33 samples, 6 sample serotypes were detected, which were composed of DENV-1 (n = 2) and DENV-2 (n = 4). In controls, DENV-1 (n = 5), DENV-2 (n = 6), and DENV-3 (n = 3) were detected. When statistically correlated, no significant association was found in cases and controls with dengue virus serotype. The frequency of serotype 2 was higher in hypokalemic paralysis cases than non-hypokalemic paralysis cases and the difference was significant (p < 0.05). The outcome was good (mRS < 3) in all the cases where serotypes were detected, but on statistical correlation, it was not found significant (p > 0.05). CONCLUSION: DENV-1 and DENV-2 are associated with neurological manifestation of dengue infection, which is different from the existing literature, where DENV-2 and DENV-3 are reported. The detection of DENV serotype will help in predicting and best management of neurological complication. The serotype 2 of dengue virus is more commonly associated with dengue-associated hypokalemic paralysis than other neurological complication (p < 0.05). There is no significant association of serotypes with outcome or mortality.","['Pandey, Atul', 'Verma, Rajesh', 'Jain, Amita', 'Prakash, Shantanu', 'Garg, Ravindra Kumar', 'Malhotra, Hardeep Singh', 'Sharma, Praveen Kumar', 'Kumar, Neeraj', 'Uniyal, Ravi', 'Pandey, Sweta', 'Rizvi, Imran']","['Pandey A', 'Verma R', 'Jain A', 'Prakash S', 'Garg RK', 'Malhotra HS', 'Sharma PK', 'Kumar N', 'Uniyal R', 'Pandey S', 'Rizvi I']",['ORCID: 0000-0001-7016-2361'],"[""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003. drrajeshverma32@yahoo.com."", ""Department of Microbiology, King George's Medical University, Lucknow, India."", ""Department of Microbiology, King George's Medical University, Lucknow, India."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003."", ""Department of Neurology, King George's Medical University, Lucknow, India, PIN-226003.""]",['eng'],['Journal Article'],20210802,Italy,Neurol Sci,Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,100959175,,IM,"['Case-Control Studies', '*Dengue/complications/diagnosis/epidemiology', '*Dengue Virus', 'Humans', 'Serogroup', 'Serotyping']",,2021/08/03 06:00,2022/02/24 06:00,['2021/08/02 12:31'],"['2021/03/22 00:00 [received]', '2021/07/08 00:00 [accepted]', '2021/08/03 06:00 [pubmed]', '2022/02/24 06:00 [medline]', '2021/08/02 12:31 [entrez]']","['10.1007/s10072-021-05477-8 [pii]', '10.1007/s10072-021-05477-8 [doi]']",ppublish,Neurol Sci. 2022 Mar;43(3):1939-1946. doi: 10.1007/s10072-021-05477-8. Epub 2021 Aug 2.,3,['(c) 2021. Fondazione Societa Italiana di Neurologia.'],['NOTNLM'],"['Arbovirus', 'Dengue', 'Hypokalemic paralysis', 'Infection', 'Neurological manifestations', 'Serotype']",,,,,,,,,,,,,,,,,,,
29907741,NLM,MEDLINE,20181226,20181226,2041-1723 (Electronic) 2041-1723 (Linking),9,2018 Jun 15,Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context.,2355,10.1038/s41467-018-04595-w [doi] 2355,"An extensive body of theory addresses the topic of pathogen virulence evolution, yet few studies have empirically demonstrated the presence of fitness trade-offs that would select for intermediate virulence. Here we show the presence of transmission-clearance trade-offs in dengue virus using viremia measurements. By fitting a within-host model to these data, we further find that the interaction between dengue and the host immune response can account for the observed trade-offs. Finally, we consider dengue virulence evolution when selection acts on the virus's production rate. By combining within-host model simulations with empirical findings on how host viral load affects human-to-mosquito transmission success, we show that the virus's transmission potential is maximized at production rates associated with intermediate virulence and that the optimal production rate critically depends on dengue's epidemiological context. These results indicate that long-term changes in dengue's global distribution impact the invasion and spread of virulent dengue virus genotypes.","['Ben-Shachar, Rotem', 'Koelle, Katia']","['Ben-Shachar R', 'Koelle K']",,"['Program in Computational Biology and Bioinformatics, Duke University, Durham, NC, 27708, USA. rbenshachar@gmail.com.', 'Department of Biology, Duke University, Durham, NC, 27708, USA. rbenshachar@gmail.com.', 'Department of Integrative Biology, University of California, Berkeley, CA, 94720, USA. rbenshachar@gmail.com.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, 94720, USA. rbenshachar@gmail.com.', 'Department of Biology, Duke University, Durham, NC, 27708, USA. katia.koelle@emory.edu.', 'Department of Biology, Emory University, Atlanta, GA, 30322, USA. katia.koelle@emory.edu.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",20180615,England,Nat Commun,Nature communications,101528555,,IM,"['Adolescent', 'Adult', 'Animals', '*Biological Evolution', 'Culicidae', 'Dengue/*epidemiology/transmission/*virology', 'Dengue Virus/*genetics', 'Female', 'Genetic Fitness', 'Genetic Variation', 'Genotype', 'Host-Pathogen Interactions/*genetics', 'Humans', 'Immune System', 'Male', 'Vietnam/epidemiology', 'Viral Load', 'Virulence/*genetics', 'Young Adult']",PMC6003961,2018/06/17 06:00,2018/12/27 06:00,['2018/06/17 06:00'],"['2017/11/12 00:00 [received]', '2018/05/09 00:00 [accepted]', '2018/06/17 06:00 [entrez]', '2018/06/17 06:00 [pubmed]', '2018/12/27 06:00 [medline]']","['10.1038/s41467-018-04595-w [pii]', '4595 [pii]', '10.1038/s41467-018-04595-w [doi]']",epublish,Nat Commun. 2018 Jun 15;9(1):2355. doi: 10.1038/s41467-018-04595-w.,1,,,,['The authors declare no competing interests.'],,['U54 GM111274/GM/NIGMS NIH HHS/United States'],,,,,,,,,,,,,,,,
37424133,NLM,MEDLINE,20230711,20230913,0974-7559 (Electronic) 0019-6061 (Linking),60,2023 Jul 15,Dengue Severity Score for Predicting Severe Dengue in Children: Need to Validate in Different Settings.,601,,,"['Sookaromdee, Pathum', 'Wiwanitkit, Viroj']","['Sookaromdee P', 'Wiwanitkit V']",,"['Private Academic Consultant, Bangkok, Thailand. pathumsook@gmail.com.', 'Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria. pathumsook@gmail.com.']",['eng'],"['Comment', 'Letter']",,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Humans', 'Child', '*Severe Dengue/diagnosis/epidemiology', '*Dengue/diagnosis/epidemiology', 'Risk Factors', 'Severity of Illness Index']",,2023/07/10 06:42,2023/07/11 06:42,['2023/07/10 01:59'],"['2023/07/11 06:42 [medline]', '2023/07/10 06:42 [pubmed]', '2023/07/10 01:59 [entrez]']",,ppublish,Indian Pediatr. 2023 Jul 15;60(7):601.,7,,,,,,,,['Indian Pediatr. 2023 May 15;60(5):359-363. PMID: 36757000'],,,,,,,,,,,,,,
31082793,NLM,MEDLINE,20190805,20190805,2212-1102 (Electronic) 2212-1099 (Linking),18,2019 May,Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review.,132-144,S2212-1099(19)30055-X [pii] 10.1016/j.vhri.2019.02.004 [doi],"OBJECTIVES: To review the literature on the cost-effectiveness of dengue vaccination in Southeast Asian countries and possibly to provide recommendations on promoting dengue vaccination in this region. METHODS: A systematic search was conducted to identify relevant articles in 3 major databases (ProQuest, American Society of Tropical Medicine and Hygiene, and PubMed). Complete economic evaluation studies, including willingness-to-pay (WTP) studies, that were conducted in any Southeast Asian country were included in this study. Systematic review, non-full-text, and non-English studies were specifically excluded. RESULTS: Nine selected studies highlighted the economic evaluation of dengue vaccination in Southeast Asian countries by considering many parameters (eg, vaccine cost, vaccine efficacy, cost-effectiveness threshold, economic assessment, public acceptance, and WTP). All studies confirmed that dengue vaccine can be used as a prevention strategy to reduce the incidence rate of dengue cases by providing a variance of high cost-effectiveness values. In addition, communities provided a good assessment, acceptance, and WTP value for the vaccine. CONCLUSIONS: The use of dengue vaccine could reduce the burden of disease and economic burden due to dengue infection in Southeast Asian countries. The efficacy of dengue vaccine was estimated to be 50-95% for those <9 years, 9 years, and >9 years. In particular, several studies reported that dengue vaccine could be categorized as a cost-effective intervention in Southeast Asian countries within certain conditions.","['Supadmi, Woro', 'Suwantika, Auliya A', 'Perwitasari, Dyah A', 'Abdulah, Rizky']","['Supadmi W', 'Suwantika AA', 'Perwitasari DA', 'Abdulah R']",,"['Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Sumedang, Indonesia.', 'Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Sumedang, Indonesia. Electronic address: auliya@unpad.ac.id.', 'Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.', 'Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Sumedang, Indonesia.']",['eng'],"['Journal Article', 'Systematic Review']",20190510,United States,Value Health Reg Issues,Value in health regional issues,101592642,['0 (Dengue Vaccines)'],,"['Asia, Southeastern', 'Cost-Benefit Analysis', 'Dengue/economics/epidemiology/*prevention & control', 'Dengue Vaccines/*economics', 'Humans']",,2019/05/15 06:00,2019/08/06 06:00,['2019/05/15 06:00'],"['2018/04/18 00:00 [received]', '2019/02/05 00:00 [revised]', '2019/02/19 00:00 [accepted]', '2019/05/15 06:00 [pubmed]', '2019/08/06 06:00 [medline]', '2019/05/15 06:00 [entrez]']","['S2212-1099(19)30055-X [pii]', '10.1016/j.vhri.2019.02.004 [doi]']",ppublish,Value Health Reg Issues. 2019 May;18:132-144. doi: 10.1016/j.vhri.2019.02.004. Epub 2019 May 10.,,"['Copyright (c) 2019 ISPOR--The professional society for health economics and', 'outcomes research. Published by Elsevier Inc. All rights reserved.']",['NOTNLM'],"['SEAR', 'cost-effective', 'dengue', 'immunization', 'vaccine']",,,,,,,,,,,,,,,,,,,
17115561,NLM,MEDLINE,20061214,20091111,0040-4470 (Print) 0040-4470 (Linking),102,2006 Aug,Dengue and South Texas: information for clinicians.,56-8,,,"['Ramos, Mary', 'Abell, Allison', 'Smith, Brian']","['Ramos M', 'Abell A', 'Smith B']",,"['Dengue Branch, Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, USA. mramos@cdc.gov']",['eng'],"['Journal Article', 'Review']",,United States,Tex Med,Texas medicine,0051012,,IM,"['*Dengue/diagnosis/epidemiology/therapy', 'Diagnosis, Differential', 'Disease Outbreaks/prevention & control', 'Humans', 'Mosquito Control', 'Texas/epidemiology', 'Virus Diseases/diagnosis']",,2006/11/23 09:00,2006/12/15 09:00,['2006/11/23 09:00'],"['2006/11/23 09:00 [pubmed]', '2006/12/15 09:00 [medline]', '2006/11/23 09:00 [entrez]']",,ppublish,Tex Med. 2006 Aug;102(8):56-8.,8,,,,,,,25,,,,,,,,,,,,,,,
31800583,NLM,MEDLINE,20200331,20200331,1932-6203 (Electronic) 1932-6203 (Linking),14,2019,A global model for predicting the arrival of imported dengue infections.,e0225193,10.1371/journal.pone.0225193 [doi] e0225193,"With approximately half of the world's population at risk of contracting dengue, this mosquito-borne disease is of global concern. International travellers significantly contribute to dengue's rapid and large-scale spread by importing the disease from endemic into non-endemic countries. To prevent future outbreaks and dengue from establishing in non-endemic countries, knowledge about the arrival time and location of infected travellers is crucial. We propose a network model that predicts the monthly number of dengue-infected air passengers arriving at any given airport. We consider international air travel volumes to construct weighted networks, representing passenger flows between airports. We further calculate the probability of passengers, who travel through the international air transport network, being infected with dengue. The probability of being infected depends on the destination, duration and timing of travel. Our findings shed light onto dengue importation routes and reveal country-specific reporting rates that have been until now largely unknown. This paper provides important new knowledge about the spreading dynamics of dengue that is highly beneficial for public health authorities to strategically allocate the often limited resources to more efficiently prevent the spread of dengue.","['Liebig, Jessica', 'Jansen, Cassie', 'Paini, Dean', 'Gardner, Lauren', 'Jurdak, Raja']","['Liebig J', 'Jansen C', 'Paini D', 'Gardner L', 'Jurdak R']",['ORCID: 0000-0002-9706-9420'],"['Data61, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.', 'Communicable Diseases Branch, Department of Health, Brisbane, Queensland, Australia.', 'Health & Biosecurity, Commonwealth Scientific and Industrial Research Organisation, Canberra, Australian Capital Territory, Australia.', 'Data61, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.', 'Department of Civil Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America.', 'School of Civil and Environmental Engineering, University of New South Wales, Sydney, New South Wales, Australia.', 'Data61, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.', 'School of Electrical Engineering and Computer Science, Queensland University of Technology, Brisbane, Queensland, Australia.', 'School of Computer Science and Engineering, University of New South Wales, Sydney, New South Wales, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20191204,United States,PLoS One,PloS one,101285081,,IM,"['Airports/*statistics & numerical data', 'Aviation/statistics & numerical data', 'Dengue/*epidemiology/transmission', 'Disease Transmission, Infectious/*statistics & numerical data', 'Human Migration/*statistics & numerical data', 'Humans', 'Models, Statistical', 'Pandemics/*statistics & numerical data']",PMC6892502,2019/12/05 06:00,2020/04/01 06:00,['2019/12/05 06:00'],"['2019/05/14 00:00 [received]', '2019/10/30 00:00 [accepted]', '2019/12/05 06:00 [entrez]', '2019/12/05 06:00 [pubmed]', '2020/04/01 06:00 [medline]']","['PONE-D-19-13777 [pii]', '10.1371/journal.pone.0225193 [doi]']",epublish,PLoS One. 2019 Dec 4;14(12):e0225193. doi: 10.1371/journal.pone.0225193. eCollection 2019.,12,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
26122446,NLM,MEDLINE,20151014,20220408,1474-4457 (Electronic) 1473-3099 (Linking),15,2015 Jul,Dengue transmission during the 2014 FIFA World Cup in Brazil.,765-6,S1473-3099(15)00073-0 [pii] 10.1016/S1473-3099(15)00073-0 [doi],,"['Aguiar, Maira', 'Coelho, Giovanini Evelim', 'Rocha, Filipe', 'Mateus, Luis', 'Pessanha, Jose Eduardo Marques', 'Stollenwerk, Nico']","['Aguiar M', 'Coelho GE', 'Rocha F', 'Mateus L', 'Pessanha JE', 'Stollenwerk N']",,"['Centro de Matematica e Aplicacoes Fundamentais da Universidade de Lisboa, Avenida Prof. Gama Pinto 2, 1649-003 Lisbon, Portugal; Fundacao Ezequiel Dias, Servico de Virologia e Riquetisioses, Belo Horizonte, Brazil. Electronic address: mafsantos@fc.ul.pt.', 'Coordenacao Geral do Programa Nacional de Controle da Dengue, Ministerio da Saude, Brasilia, Brazil.', 'Centro de Matematica e Aplicacoes Fundamentais da Universidade de Lisboa, Avenida Prof. Gama Pinto 2, 1649-003 Lisbon, Portugal.', 'Centro de Matematica e Aplicacoes Fundamentais da Universidade de Lisboa, Avenida Prof. Gama Pinto 2, 1649-003 Lisbon, Portugal.', 'Secretaria Municipal de Saude de Belo Horizonte, Brazil; Observatorio de Saude Urbana de Belo Horizonte, Minas Gerais Federal University, Brazil.', 'Centro de Matematica e Aplicacoes Fundamentais da Universidade de Lisboa, Avenida Prof. Gama Pinto 2, 1649-003 Lisbon, Portugal.']",['eng'],['Letter'],,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Anniversaries and Special Events', 'Brazil/epidemiology', 'Dengue/*epidemiology/prevention & control/*transmission', 'Humans', 'Seasons', '*Soccer', '*Travel']",,2015/07/01 06:00,2015/10/16 06:00,['2015/07/01 06:00'],"['2015/02/23 00:00 [received]', '2015/04/26 00:00 [revised]', '2015/05/20 00:00 [accepted]', '2015/07/01 06:00 [entrez]', '2015/07/01 06:00 [pubmed]', '2015/10/16 06:00 [medline]']","['S1473-3099(15)00073-0 [pii]', '10.1016/S1473-3099(15)00073-0 [doi]']",ppublish,Lancet Infect Dis. 2015 Jul;15(7):765-6. doi: 10.1016/S1473-3099(15)00073-0.,7,,,,,,,,,,,,,,,,,,,,,,
30641201,NLM,MEDLINE,20191028,20191028,1878-3511 (Electronic) 1201-9712 (Linking),84S,2019 Jul,Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis.,S68-S73,S1201-9712(19)30021-9 [pii] 10.1016/j.ijid.2019.01.010 [doi],"OBJECTIVES: This paper concerns a systematic analysis of dengue illness and costs in India from 2013 to 2016. A previous study for 2006-2012 found that that projected annual number of dengue cases (5.78 million) was 282 times the officially reported number (20,474), highlighting enormous uncertainty. METHODS: This study updated primary data for India from 2012 to 2014 and synthesized the latest epidemiological and economic literature through 2018 using the country and global estimates. RESULTS: The first empirically-based publication of dengue costs by country (in 2016) estimated India experienced 18,618,706 symptomatic dengue cases and 1602 deaths, and cost $1.51 billion in 2013. With a combination of increased incidence, more refined methods, and better data this 2018 study raised the latest estimates to 53,210,706 cases, 22,527 deaths, and $5.71 billion economic costs for 2016, representing increases over the previous publication of 186%, 1306%, and 278%, respectively. When consistent methods and data were used to compare 2013 to 2016, the corresponding changes were only +29%, -9%, and +12%, respectively over these 3 years. CONCLUSIONS: India's burden of dengue is substantially greater than previously estimated. Although uncertainty intervals remain wide, these latest estimates reinforce the health and economic benefits that India would realize if dengue were substantially controlled.","['Hariharan, Dhwani', 'Das, Manoja Kumar', 'Shepard, Donald S', 'Arora, Narendra Kumar']","['Hariharan D', 'Das MK', 'Shepard DS', 'Arora NK']",,"['Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. Electronic address: dhwanihariharan@brandeis.edu.', 'The INCLEN Trust International, New Delhi, India. Electronic address: manoj@inclentrust.org.', 'Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. Electronic address: shepard@brandeis.edu.', 'The INCLEN Trust International, New Delhi, India. Electronic address: nkarora@inclentrust.org.']",['eng'],"['Journal Article', 'Systematic Review']",20190111,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,,IM,"['*Cost of Illness', 'Dengue/*economics/epidemiology/mortality', 'Humans', 'India/epidemiology']",,2019/01/15 06:00,2019/10/29 06:00,['2019/01/15 06:00'],"['2018/11/23 00:00 [received]', '2019/01/03 00:00 [revised]', '2019/01/04 00:00 [accepted]', '2019/01/15 06:00 [pubmed]', '2019/10/29 06:00 [medline]', '2019/01/15 06:00 [entrez]']","['S1201-9712(19)30021-9 [pii]', '10.1016/j.ijid.2019.01.010 [doi]']",ppublish,Int J Infect Dis. 2019 Jul;84S:S68-S73. doi: 10.1016/j.ijid.2019.01.010. Epub 2019 Jan 11.,,['Copyright (c) 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue', 'Direct cost', 'Economic burden', 'India', 'Indirect cost']",,,,,,,,,,,,,,,,,,,
25253221,NLM,MEDLINE,20150407,20140925,0972-9062 (Print) 0972-9062 (Linking),51,2014 Sep,Severe hypothermia in dengue.,245-6,,,"['Chandy, Anila']",['Chandy A'],,"['Department of Internal Medicine, Miot Hospital, Manapakkam, Chennai, India.']",['eng'],"['Case Reports', 'Journal Article']",,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['Dengue/complications/*diagnosis/*pathology', 'Humans', 'Hypothermia/*etiology/*pathology', 'Male', 'Middle Aged']",,2014/09/26 06:00,2015/04/08 06:00,['2014/09/26 06:00'],"['2014/09/26 06:00 [entrez]', '2014/09/26 06:00 [pubmed]', '2015/04/08 06:00 [medline]']",['JVectorBorneDis_2014_51_3_245_141770 [pii]'],ppublish,J Vector Borne Dis. 2014 Sep;51(3):245-6.,3,,,,,,,,,,,,,,,,,,,,,,
28727821,NLM,MEDLINE,20170821,20220408,1553-7358 (Electronic) 1553-734X (Print) 1553-734X (Linking),13,2017 Jul,Advances in using Internet searches to track dengue.,e1005607,10.1371/journal.pcbi.1005607 [doi] e1005607,"Dengue is a mosquito-borne disease that threatens over half of the world's population. Despite being endemic to more than 100 countries, government-led efforts and tools for timely identification and tracking of new infections are still lacking in many affected areas. Multiple methodologies that leverage the use of Internet-based data sources have been proposed as a way to complement dengue surveillance efforts. Among these, dengue-related Google search trends have been shown to correlate with dengue activity. We extend a methodological framework, initially proposed and validated for flu surveillance, to produce near real-time estimates of dengue cases in five countries/states: Mexico, Brazil, Thailand, Singapore and Taiwan. Our result shows that our modeling framework can be used to improve the tracking of dengue activity in multiple locations around the world.","['Yang, Shihao', 'Kou, Samuel C', 'Lu, Fred', 'Brownstein, John S', 'Brooke, Nicholas', 'Santillana, Mauricio']","['Yang S', 'Kou SC', 'Lu F', 'Brownstein JS', 'Brooke N', 'Santillana M']","['ORCID: 0000-0003-1026-5734', 'ORCID: 0000-0002-4206-418X']","['Department of Statistics, Harvard University, Cambridge, MA, USA.', 'Department of Statistics, Harvard University, Cambridge, MA, USA.', ""Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA."", ""Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA."", 'Harvard Medical School, Boston, MA, USA.', 'The Synergist, Brussels, Belgium.', ""Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA."", 'Harvard Medical School, Boston, MA, USA.']",['eng'],"['Historical Article', 'Journal Article']",20170720,United States,PLoS Comput Biol,PLoS computational biology,101238922,,IM,"['Asia, Southeastern', 'Brazil', 'Computational Biology', 'Databases, Factual', '*Dengue/epidemiology/history/transmission', 'History, 20th Century', 'History, 21st Century', 'Humans', '*Internet', 'Mexico', 'Population Surveillance', '*Search Engine']",PMC5519005,2017/07/21 06:00,2017/08/22 06:00,['2017/07/21 06:00'],"['2016/12/19 00:00 [received]', '2017/06/02 00:00 [accepted]', '2017/07/21 06:00 [entrez]', '2017/07/21 06:00 [pubmed]', '2017/08/22 06:00 [medline]']","['PCOMPBIOL-D-16-02052 [pii]', '10.1371/journal.pcbi.1005607 [doi]']",epublish,PLoS Comput Biol. 2017 Jul 20;13(7):e1005607. doi: 10.1371/journal.pcbi.1005607. eCollection 2017 Jul.,7,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
37494777,NLM,MEDLINE,20230811,20230811,1876-035X (Electronic) 1876-0341 (Linking),16,2023 Sep,Reinvestigation of the risk of stroke after dengue virus infection: A population-based cohort study.,1427-1434,S1876-0341(23)00236-8 [pii] 10.1016/j.jiph.2023.07.003 [doi],"BACKGROUND: Dengue virus (DENV) infection is the most prevalent mosquito-borne viral disease. Stroke is a severe manifestation of dengue. However, few large-scale studies have investigated post-dengue risk of stroke. METHODS: This population-based cohort study included 57,934 newly diagnosed, laboratory-confirmed dengue patients in Taiwan from 2002 to 2015; patients were matched to nondengue individuals by age, sex, and area of residence at a ratio of 1:4 (n = 231,736). We used subdistribution hazard regression to evaluate short-term (</= 30 days), medium-term (31-365 days), and long-term (1-3 years) risk of stroke after DENV infection. The robustness of the results to unmeasured confounding was assessed with E-values. RESULTS: DENV infection was associated with a significantly increased risk of overall stroke (aSHR 4.51; 95% CI: 3.23-6.32; P < 0.0001; E-value = 8.49), hemorrhagic stroke (aSHR 4.13; 95% CI: 2.20-7.76; P < 0.0001; E-value =7.73), and ischemic stroke (aSHR 3.80; 95% CI: 2.37-6.11; P < 0.0001; E-value = 7.06) within 30 days. Stratified analysis by age showed that the aSHRs for overall stroke, hemorrhagic stroke, and ischemic stroke were larger among dengue patients aged >/= 65 during the first 30 days. The 30-day risks of overall stroke, hemorrhagic stroke, and ischemic stroke among elderly dengue patients were 6.71, 1.29, and 3.49 per 1000, respectively. No increased risk was observed after 30 days. CONCLUSION: DENV infection was associated with a significant short-term increased risk of stroke. Clinical practitioners should remain alert to patients with stroke-associated symptoms during epidemic seasons, especially elderly patients.","['Chien, Yu-Wen', 'Wang, Yu-Ping', 'Chi, Chia-Yu', 'Shih, Hsin-I']","['Chien YW', 'Wang YP', 'Chi CY', 'Shih HI']",,"['Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.', 'Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.', 'National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Miaoli County, Taiwan. Electronic address: pedchi@nhri.org.tw.', 'Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: n506594@mail.hosp.ncku.edu.tw.']",['eng'],['Journal Article'],20230707,England,J Infect Public Health,Journal of infection and public health,101487384,,IM,"['Aged', 'Animals', 'Humans', '*Dengue/complications/epidemiology/diagnosis', '*Dengue Virus', 'Cohort Studies', '*Hemorrhagic Stroke', '*Stroke/epidemiology', '*Ischemic Stroke']",,2023/07/27 01:09,2023/08/11 06:43,['2023/07/26 18:01'],"['2023/01/12 00:00 [received]', '2023/06/13 00:00 [revised]', '2023/07/05 00:00 [accepted]', '2023/08/11 06:43 [medline]', '2023/07/27 01:09 [pubmed]', '2023/07/26 18:01 [entrez]']","['S1876-0341(23)00236-8 [pii]', '10.1016/j.jiph.2023.07.003 [doi]']",ppublish,J Infect Public Health. 2023 Sep;16(9):1427-1434. doi: 10.1016/j.jiph.2023.07.003. Epub 2023 Jul 7.,9,['Copyright (c) 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue', 'Dengue virus', 'Expanded dengue syndrome', 'Hemorrhagic stroke', 'Ischemic stroke', 'Stroke']",['Declaration of Competing Interest The authors have not interest to declare.'],,,,,,,,,,,,,,,,,,
27217229,NLM,MEDLINE,20180417,20181202,1096-0325 (Electronic) 0040-5809 (Linking),111,2016 Oct,The effect of Wolbachia on dengue outbreaks when dengue is repeatedly introduced.,9-15,S0040-5809(16)30019-3 [pii] 10.1016/j.tpb.2016.05.003 [doi],"Use of the Wolbachia bacterium is a proposed new strategy to reduce dengue transmission, which results in around 390 million individuals infected annually. In places with strong variations in climatic conditions such as temperature and rainfall, dengue epidemics generally occur only at a certain time of the year. Where dengue is not endemic, the time of year in which imported cases enter the population plays a crucial role in determining the likelihood of outbreak occurrence. We use a mathematical model to study the effects of Wolbachia on dengue transmission dynamics and dengue seasonality. We focus in regions where dengue is not endemic but can spread due to the presence of a dengue vector and the arrival of people with dengue on a regular basis. Our results show that the time-window in which outbreaks can occur is reduced in the presence of Wolbachia-carrying Aedes aegypti mosquitoes by up to six weeks each year. We find that Wolbachia reduces overall case numbers by up to 80%. The strongest effect is obtained when the amplitude of the seasonal forcing is low (0.02-0.30). The benefits of Wolbachia also depend on the transmission rate, with the bacteria most effective at moderate transmission rates ranging between 0.08-0.12. Such rates are consistent with fitted estimates for Cairns, Australia.","['Ndii, Meksianis Z', 'Allingham, David', 'Hickson, R I', 'Glass, Kathryn']","['Ndii MZ', 'Allingham D', 'Hickson RI', 'Glass K']",,"['School of Mathematical and Physical Sciences, The University of Newcastle, Australia; Department of Mathematics, Nusa Cendana University, Kupang-NTT, Indonesia. Electronic address: meksianis.ndii@uon.edu.au.', 'School of Mathematical and Physical Sciences, The University of Newcastle, Australia. Electronic address: David.Allingham@newcastle.edu.au.', 'School of Mathematical and Physical Sciences, The University of Newcastle, Australia; IBM Research - Australia, Melbourne, Australia. Electronic address: R.Hickson@UNSWalumni.com.', 'National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia. Electronic address: kathryn.glass@anu.edu.au.']",['eng'],['Journal Article'],20160520,United States,Theor Popul Biol,Theoretical population biology,0256422,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Disease Outbreaks/*prevention & control', 'Humans', '*Models, Theoretical', '*Pest Control, Biological', 'Wolbachia/*physiology']",,2016/05/25 06:00,2018/04/18 06:00,['2016/05/25 06:00'],"['2015/08/19 00:00 [received]', '2016/05/09 00:00 [revised]', '2016/05/11 00:00 [accepted]', '2016/05/25 06:00 [entrez]', '2016/05/25 06:00 [pubmed]', '2018/04/18 06:00 [medline]']","['S0040-5809(16)30019-3 [pii]', '10.1016/j.tpb.2016.05.003 [doi]']",ppublish,Theor Popul Biol. 2016 Oct;111:9-15. doi: 10.1016/j.tpb.2016.05.003. Epub 2016 May 20.,,['Copyright (c) 2016 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Dengue', 'Importation', 'Seasonality', 'Wolbachia']",,,,,,,,,,,,,,,,,,,
25889043,NLM,MEDLINE,20160108,20181113,1756-0500 (Electronic) 1756-0500 (Linking),8,2015 Mar 12,Dengue fever in a patient with severe haemophilia: a case report.,78,10.1186/s13104-015-1043-x [doi] 78,"BACKGROUND: Dengue fever is the most rapidly spreading mosquito-borne viral disease in the world. Haemophilia A is the commonest inherited bleeding disorder. There is little data on the incidence and outcome of dengue in patients with haemophila. We report a case of a patient with severe haemophila A, presenting with dengue fever, managed at a tertiary care hospital in Sri Lanka. CASE PRESENTATION: A 16-year-old Sinhalese male with severe haemophilia A (factor level < 1percent) was admitted to a teaching hospital in Sri Lanka on day 1 of an acute febrile illness, associated with arthralgia, myalgia, vomiting and headache. On admission, he had a tachycardia of 120 beats per minute, and blood pressure of 110/70 millimetres of mercury, with no bleeding manifestations. Baseline investigations revealed leukocyte and platelet counts of 4400 and 241,000 per cubic millimtre, respectively, and a haematocrit of 34.5 percent. Dengue was confirmed later by sero-conversion of the dengue IgM antibody test. Fluid balance, pulse rate and blood pressure were monitored hourly. The haematocrit and platelet counts were checked thrice daily, while he was clinically assessed for bleeding. On day 3 he developed bleeding from a tooth extraction site, with vomiting of dark red blood. His platelet level at that point was 124,000 per cubic millimetre with a haematocrit of 32 percent. Intravenous factor VIII was given to achieve a 100 percent factor correction over twenty-four hours. His platelet count dropped progressively from admission to a nadir of 50,000 per cubic millimetre on day 6. He did not develop clinical evidence of fluid leakage. On day 7 he was discharged after complete recovery. CONCLUSIONS: People with haemophilia may exhibit bleeding from the early febrile stage and at higher platelet levels than most other patients with dengue. Further discussion and research is necessary to decide on the optimal management of these patients, with regard to monitoring and timely treatment with blood products and/or factor correction, in order to prevent dengue-related morbidity and mortality whilst avoiding overtreatment. In endemic areas it is advisable that such patients seek early medical help in the event of an acute fever.","['Wijayaratne, Dilushi', 'Ranasinghe, Priyanga', 'Mohotti, Shanaka P', 'Dilrukshi, Shani Apsara', 'Katulanda, Prasad']","['Wijayaratne D', 'Ranasinghe P', 'Mohotti SP', 'Dilrukshi SA', 'Katulanda P']",,"['University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. dilushi_w@yahoo.com.', 'University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. priyanga.ranasinghe@gmail.com.', 'Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. priyanga.ranasinghe@gmail.com.', 'University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. shanaka.mohotti@gmail.com.', 'University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. dilrukmatharage@gmail.com.', 'University Medical Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. prasad.katulanda@yahoo.com.', 'Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. prasad.katulanda@yahoo.com.']",['eng'],"['Case Reports', 'Journal Article']",20150312,England,BMC Res Notes,BMC research notes,101462768,,IM,"['Adolescent', 'Dengue/complications/*diagnosis/therapy', 'Hemophilia A/*complications', 'Humans', 'Male']",PMC4365964,2015/04/19 06:00,2016/01/09 06:00,['2015/04/19 06:00'],"['2014/10/01 00:00 [received]', '2015/03/03 00:00 [accepted]', '2015/04/19 06:00 [entrez]', '2015/04/19 06:00 [pubmed]', '2016/01/09 06:00 [medline]']","['10.1186/s13104-015-1043-x [pii]', '1043 [pii]', '10.1186/s13104-015-1043-x [doi]']",epublish,BMC Res Notes. 2015 Mar 12;8:78. doi: 10.1186/s13104-015-1043-x.,,,,,,,,,,,,,,,,,,,,,,,
244434,NLM,MEDLINE,19780321,20041117,0014-9772 (Print) 0014-9772 (Linking),42,1977 Sep,[Dengue fever].,9-13,,,"['Ladnyi, I D']",['Ladnyi ID'],,,['rus'],['Journal Article'],,Russia (Federation),Feldsher Akush,Fel'dsher i akusherka,16930040R,,,"['Acute Disease', 'Dengue/*diagnosis/therapy/transmission', 'Humans', 'Shock, Septic/diagnosis']",,1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Feldsher Akush. 1977 Sep;42(9):9-13.,9,,,,,,,,,Likhoradka denge.,,,,,,,,,,,,,
22305127,NLM,MEDLINE,20120523,20211021,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),18,2012 Feb,Dengue surveillance among French military in Africa.,342-3,10.3201/eid1802.111333 [doi],,"['de Laval, Franck', 'Plumet, Sebastien', 'Simon, Fabrice', 'Deparis, Xavier', 'Leparc-Goffart, Isabelle']","['de Laval F', 'Plumet S', 'Simon F', 'Deparis X', 'Leparc-Goffart I']",,,['eng'],['Letter'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Africa/epidemiology', 'Dengue/diagnosis/*epidemiology/virology', 'Dengue Virus', 'France/ethnology', 'Military Facilities', '*Military Personnel', '*Population Surveillance']",PMC3311153,2012/02/07 06:00,2012/05/24 06:00,['2012/02/07 06:00'],"['2012/02/07 06:00 [entrez]', '2012/02/07 06:00 [pubmed]', '2012/05/24 06:00 [medline]']","['11-1333 [pii]', '10.3201/eid1802.111333 [doi]']",ppublish,Emerg Infect Dis. 2012 Feb;18(2):342-3. doi: 10.3201/eid1802.111333.,2,,,,,,,,"['AmarasingheA , KuritskyJN , LetsonGW , MargolisHS . Dengue virus infection in', 'Africa. Emerg Infect Dis. 2011;17:1349-54. PMID: 21801609']",,,,,,,,,,,,,,
1303471,NLM,MEDLINE,19930624,20051116,0037-5683 (Print) 0037-5683 (Linking),34,1992,Epidemiology of dengue and dengue haemorrhagic fever in Malaysia. III. A comparative study of clinical features seen in virologically confirmed cases for periods between 1963-1987--a review.,67-82,,"Dengue fever, Dengue hemorrhagic fever and Dengue shock syndrome within the dengue complex is a sinister disease of great public health importance and continues to ravage children, young adults and the aged in Malaysia. The history of the disease is traced for over the years and the changing pattern of clinical presentation are noted. Various hospital based studies have been compared and the pathognomonic features of the disease in Malaysia are highlighted.","['Shekhar, K C', 'Senan, P']","['Shekhar KC', 'Senan P']",,"['Department of Parasitology, Faculty of Medicine University of Malaya, Kuala Lumpur.']",['eng'],"['Journal Article', 'Review']",,Singapore,J Singapore Paediatr Soc,The Journal of the Singapore Paediatric Society,7507223,,IM,"['Adult', 'Child', 'Child, Preschool', 'Dengue/complications/*epidemiology/physiopathology', 'Female', 'Humans', 'Infant', 'Malaysia/epidemiology', 'Male']",,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,J Singapore Paediatr Soc. 1992;34(1-2):67-82.,1-2,,,,,,,37,,,,,,,,,,,,,,,
21569427,NLM,MEDLINE,20111201,20211020,1471-2334 (Electronic) 1471-2334 (Linking),11,2011 May 12,Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study.,123,10.1186/1471-2334-11-123 [doi],"BACKGROUND: Dengue re-emerges in Singapore despite decades of effective vector control; the infection predominantly afflicts adults. Severe dengue not fulfilling dengue hemorrhagic fever (DHF) criteria according to World Health Organization (WHO) 1997 guideline was increasingly reported. A new WHO 2009 guideline emphasized warning signs and a wider range of severe dengue manifestations. We aim to evaluate the utility of these two guidelines in confirmed adult dengue fatalities. METHODS: We conducted a multi-center retrospective chart review of all confirmed adult dengue deaths in Singapore from 1 January 2004 to 31 December 2008. RESULTS: Of 28 adult dengue deaths, median age was 59 years. Male gender comprised 67.9% and co-morbidities existed in 75%. From illness onset, patients presented for admission at a median of 4 days and death occurred at a median of 12 days. Intensive care admission was required in 71.4%. Probable dengue was diagnosed in 32.1% by WHO 1997 criteria and 78.6% by WHO 2009. The earliest warning sign was persistent vomiting at a median of 1.5 days. Hematocrit change >/=20% concurrent with platelet count <20 x 10;9/L was associated with the shortest interval to death at a median of 3 days. Only 35.7% of death cases fulfilled DHF criteria by WHO 1997 versus severe dengue in 100.0% by WHO 2009 criteria. Deaths were due to shock and organ failure. Acute renal impairment occurred in 71.4%, impaired consciousness 57.1% and severe hepatitis 53.6%. CONCLUSIONS: In our adult fatal dengue cohort, WHO 2009 criteria had higher sensitivity in diagnosing probable dengue and severe dengue compared with WHO 1997. As warning signs, persistent vomiting occurred early and hematocrit change >/=20% concurrent with platelet count <20 x 10;9/L preceded death most closely.","['Leo, Yee-Sin', 'Thein, Tun L', 'Fisher, Dale A', 'Low, Jenny G', 'Oh, Helen M', 'Narayanan, Rajmohan L', 'Gan, Victor C', 'Lee, Vernon J', 'Lye, David C']","['Leo YS', 'Thein TL', 'Fisher DA', 'Low JG', 'Oh HM', 'Narayanan RL', 'Gan VC', 'Lee VJ', 'Lye DC']",,"['Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore. yee_sin_leo@ttsh.com.sg']",['eng'],"['Journal Article', 'Multicenter Study']",20110512,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adult', 'Cohort Studies', 'Dengue/diagnosis/*epidemiology/*mortality', 'Female', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Singapore/epidemiology', 'World Health Organization']",PMC3112097,2011/05/17 06:00,2011/12/13 00:00,['2011/05/17 06:00'],"['2011/01/19 00:00 [received]', '2011/05/12 00:00 [accepted]', '2011/05/17 06:00 [entrez]', '2011/05/17 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['1471-2334-11-123 [pii]', '10.1186/1471-2334-11-123 [doi]']",epublish,BMC Infect Dis. 2011 May 12;11:123. doi: 10.1186/1471-2334-11-123.,,,,,,,,,,,,,,,,,,,,,,,
35227623,NLM,MEDLINE,20220823,20220831,1953-8022 (Electronic) 1246-7820 (Linking),29,2022 Aug,Platelet transfusion therapy in the management of dengue patients: Role of fundus examination.,275-276,S1246-7820(22)00029-5 [pii] 10.1016/j.tracli.2022.02.002 [doi],,"['Jain, Manish', 'Bansal, Naveen', 'Raturi, Manish', 'Bansal, Yashik']","['Jain M', 'Bansal N', 'Raturi M', 'Bansal Y']",,"['Department of Ophthalmology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.', 'Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India. Electronic address: drnaveenbansal87@gmail.com.', 'Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India.', 'Department of Microbiology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.']",['eng'],['Letter'],20220212,France,Transfus Clin Biol,Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,9423846,,IM,"['*Dengue/diagnosis/therapy', 'Humans', 'Platelet Transfusion', '*Thrombocytopenia/therapy']",,2022/03/02 06:00,2022/08/24 06:00,['2022/03/01 05:46'],"['2022/02/07 00:00 [received]', '2022/02/10 00:00 [accepted]', '2022/03/02 06:00 [pubmed]', '2022/08/24 06:00 [medline]', '2022/03/01 05:46 [entrez]']","['S1246-7820(22)00029-5 [pii]', '10.1016/j.tracli.2022.02.002 [doi]']",ppublish,Transfus Clin Biol. 2022 Aug;29(3):275-276. doi: 10.1016/j.tracli.2022.02.002. Epub 2022 Feb 12.,3,,,,,,,,,,,,,,,,,,,,,,
28355620,NLM,MEDLINE,20170901,20180308,1708-8305 (Electronic) 1195-1982 (Linking),24,2017 May 1,Imported dengue fever in East London: a 6-year retrospective observational study.,,10.1093/jtm/tax015 [doi],"BACKGROUND: Dengue fever (DF) is a frequently imported arthropod-borne infection in the United Kingdom but its broad range of clinical presentations makes it potentially unrecognized by clinicians. METHODS: We conducted a 6-year retrospective case note review of laboratory confirmed DF patients in East London in the period from 1 January 2010 through 31 December 2015. Epidemiological, clinical and laboratory features of imported DF were described. Risk factors associated with viraemic DF presentations were assessed. RESULTS: Forty-four patients (4 from primary care clinics and 40 from three acute hospitals) were confirmed to have DF through RNA and/or IgM detection. In total, 86.4% (38/44) had primary infection compared to 13.6% (6/44) with secondary infection. Viraemic DF presentations accounted for 59.1% (26/44) of cases. The median age was 34 years (IQR 25-43). Most patients were males (68.2%, 30/44) and of non-white ethnicity (81.8%, 36/44). South Asia was the most frequent travel destination (52.3%, 23/44) followed by Southeast Asia (20.5%, 9/44). July-September was the peak season of presentation (43.2%, 19/44). The median interval between arrival in the UK and laboratory testing was 7 days (IQR 4-13). Arriving from abroad </= 7 days before molecular testing (age-adjusted odds ratios [OR] 16.98, 95% CI 2.43-118.75, P  =   0.004) and travel to South or Southeast Asia regions (age-adjusted OR 4.41, 95% CI 1.07-18.21, P  =   0.040) were associated with detectable viraemia at presentation. Only one DF patient met the WHO severity criteria. HIV serostatus was determined in 61.4% (27/44) of cases. CONCLUSION: Clinicians need to improve DF recognition as well as rates of HIV testing in tropical travellers. Region of travel and time since arrival from DF endemic settings may help clinicians optimize requests for molecular testing. Further research on the clinical and public health aspects of imported DF is needed.","['Riddell, Anna', 'Babiker, Zahir Osman Eltahir']","['Riddell A', 'Babiker ZO']",,"['Department of Infection, Royal London Hospital, Barts Health NHS Trust, Newark Street, London, UK.', 'Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.']",['eng'],"['Journal Article', 'Observational Study']",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Communicable Disease Control', 'Dengue/blood/*epidemiology/etiology/prevention & control', 'Female', 'Humans', 'London/epidemiology', 'Male', 'Retrospective Studies', '*Travel']",,2017/03/30 06:00,2017/09/02 06:00,['2017/03/30 06:00'],"['2017/02/14 00:00 [received]', '2017/02/17 00:00 [accepted]', '2017/03/30 06:00 [entrez]', '2017/03/30 06:00 [pubmed]', '2017/09/02 06:00 [medline]']","['3062597 [pii]', '10.1093/jtm/tax015 [doi]']",ppublish,J Travel Med. 2017 May 1;24(3). doi: 10.1093/jtm/tax015.,3,"['(c) International Society of Travel Medicine, 2017. Published by Oxford University', 'Press. All rights reserved. For Permissions, please e-mail:', 'journals.permissions@oup.com']",['NOTNLM'],"['Dengue fever', 'United Kingdom', 'clinical features', 'travellers', 'viraemia']",,,,,,,,,,,,,,,,,,,
37256450,NLM,MEDLINE,20230816,20230912,0973-7693 (Electronic) 0019-5456 (Linking),90,2023 Sep,Dengue Shock Syndrome with Acute Liver Failure- A Stormy Presentation of Congenital Dengue.,949,10.1007/s12098-023-04657-y [doi],,"['Subashri, P', 'G, Bhoojata', 'Rao, P V Rama']","['Subashri P', 'G B', 'Rao PVR']",,"['Department of Pediatrics & Neonatology, Andhra Hospitals, Vijayawada, Andhra Pradesh, 520010, India.', 'Department of Pediatrics & Neonatology, Andhra Hospitals, Vijayawada, Andhra Pradesh, 520010, India. bhooja808@gmail.com.', 'Department of Pediatrics & Neonatology, Andhra Hospitals, Vijayawada, Andhra Pradesh, 520010, India.']",['eng'],['Letter'],20230531,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Humans', '*Severe Dengue/complications/diagnosis', '*Liver Failure, Acute/diagnosis/etiology', '*Dengue/complications/diagnosis']",,2023/05/31 13:11,2023/08/16 06:43,['2023/05/31 11:10'],"['2023/01/17 00:00 [received]', '2023/05/02 00:00 [accepted]', '2023/08/16 06:43 [medline]', '2023/05/31 13:11 [pubmed]', '2023/05/31 11:10 [entrez]']","['10.1007/s12098-023-04657-y [pii]', '10.1007/s12098-023-04657-y [doi]']",ppublish,Indian J Pediatr. 2023 Sep;90(9):949. doi: 10.1007/s12098-023-04657-y. Epub 2023 May 31.,9,,,,,,,,,,,,,,,,,,,,,,
8924780,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[The situation of dengue in the world].,87-90,,"The situation of dengue in the world can be summarized as follows: 2,5 billions persons at risk, 60 millions cases per year, and 30 000 deaths per year. The four dengue serotypes, DEN-1, DEN-2, DEN-3 and DEN-4 are nearly human-specific. Clinical symptoms of dengue vary from unapparent infection, mild febrile manifestations to hemorrhagic forms with or without shock syndrome. Dengue viruses are transmitted by Aedes mosquitoes, the most important vectors being Aedes aegypti and Aedes albopictus. The epidemiology of the disease can be divided into endemo-epidemic situations occurring in South-East Asia, and epidemic situations found in Pacific islands, Africa and Tropical America. Maintenance of dengue is supported by an increasing demography, uncontrolled urbanization and climatic conditions favorable to the vectors. Spread of dengue is primarily caused by modern transportation means, especially the aircraft. The geographical distribution of dengue is pantropical, except for Madagascar and some african regions. Because no vaccine and no specific treatment actually exist against dengue viruses, mosquito control is the only way to reduce the incidence of dengue around the world. However, the evolution of the dengue situation is not satisfactory.","['Rodhain, F']",['Rodhain F'],,"[""Unite d'Ecologie des systemes vectoriels, Insitut Pasteur, Paris.""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Dengue/diagnosis/*epidemiology/mortality/transmission/virology', 'Dengue Virus/classification', 'Humans']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):87-90.,2,,,,,,,0,,La situation de la dengue dans le monde.,,,,,,,,,,,,,
2635391,NLM,MEDLINE,19900614,20041117,0037-5675 (Print) 0037-5675 (Linking),30,1989 Dec,Dengue virus infection.,523-4,,,"['Doraisingham, S']",['Doraisingham S'],,,['eng'],['Journal Article'],,India,Singapore Med J,Singapore medical journal,0404516,,IM,"['Dengue/*diagnosis/epidemiology/prevention & control', 'Dengue Virus/classification/immunology', 'Humans', 'Serotyping', 'Singapore']",,1989/12/01 00:00,1989/12/01 00:01,['1989/12/01 00:00'],"['1989/12/01 00:00 [pubmed]', '1989/12/01 00:01 [medline]', '1989/12/01 00:00 [entrez]']",,ppublish,Singapore Med J. 1989 Dec;30(6):523-4.,6,,,,,,,,,,,,,,,,,,,,,,
27821892,NLM,MEDLINE,20170223,20221207,1657-9534 (Electronic) 0120-8322 (Print) 0120-8322 (Linking),47,2016 Sep 30,"AfroColombian ethnicity, a paradoxical protective factor against Dengue.",133-141,,"INTRODUCTION: Dengue is a priority public health problem. During epidemics in Cuba and Haiti, ethnic African descendant population had lower risk of dengue, and the ethnic factor was proposed as a protective one. OBJECTIVE: To determine the relation between the Dengue's cumulative incidence and the Afro-Colombian proportion in communities of Cali, during the epidemic of 2013. METHODS: This study was conducted in Cali, Colombia. The design was ecological, using information from the National Census 2005 projected to 2013, from the National Administrative Department of Statistics (DANE), and the National Epidemiological Surveillance System. It was obtained the Pearson s correlation coefficient between cumulative incidence and the proportion of Afro-Colombian population by communities. Additionally, the cumulative incidences of dengue were evaluated in two zones with different proportion of Afro-Colombian population. The association was also evaluated for aggregation bias, confounding by social variables, and interaction by area of residence. RESULTS: Dengue s cumulative incidence was significantly lower for Afro-Colombians regardless of the proportion of Afro-Colombian population in the area of residence. The relative risk of dengue between non-Afro-Colombians and Afro-Colombians was 9.4 (95% CI=8.4-10.6) in zones with high proportion of Afro-Colombian population, while the relative risk of dengue was 4.0 (95% CI :3.6 - 4.4) in the zone with lower proportion of Afro-Colombian population. There was no evidence of aggregation bias or confounding in the association by social variables. CONCLUSIONS: The Afro-Colombian population had a significantly lower risk of getting dengue and its complications, compared with the non-Afro-Colombian population. The non-Afro-Colombian populations living in areas with a high proportion of Afro-Colombians increase their risk of dengue more than double, suggesting an asymptomatic viremic environment. INTRODUCCION: el dengue es un problema prioritario en salud publica. Durante epidemias en Cuba y Haiti, la poblacion etnica afro-descendiente tuvo menor riesgo de dengue. Por ello, se propuso el factor etnico como protector. OBJETIVO: Determinar la relacion entre la incidencia acumulada de dengue y la proporcion de poblacion Afrocolombiana de Cali, durante la epidemia de 2013. METODOS: Este estudio se realizo en Cali, Colombia. El diseno fue ecologico, con informacion del Censo Nacional 2005 y su proyeccion a 2013 del DANE y del Sistema de entre las incidencias acumuladas de dengue y la proporcion de afrocolombianos, segun comunidades. Adicionalmente, fueron evaluadas las incidencias acumuladas de dos zonas con diferente proporcion de habitantes afrocolombianos. Tambien se evaluo la presencia del sesgo de agregacion, de confusion por variables sociales y de interaccion segun la zona de residencia. RESULTADOS: Para afrocolombianos, la incidencia acumulada de dengue fue significativamente menor, independientemente de la proporcion de poblacion afrocolombiana en la zona de residencia. El riesgo relativo de dengue entre no-afrocolombianos y afrocolombianos fue 9.4 (IC 95%= 8.4-10.6) en la zona con mas alta proporcion de poblacion afrocolombiana, mientras que el riesgo relativo fue 4.0 (IC 95%= 3.6-4.4) en la zona de mas baja proporcion de poblacion afrocolombiana. No se evidencio sesgo de agregacion ni confusion de la asociacion por variables sociales. CONCLUSIONES: La poblacion afrocolombiana presento un riesgo significativamente menor de enfermar por dengue y sus complicaciones en comparacion con no-afrocolombianos. La poblacion no-afrocolombiana que reside en zonas con alta proporcion de poblacion afrocolombiana aumenta el riesgo de dengue a mas del doble, lo cual sugiere un entorno viremico asintomatico.","['Rojas Palacios, Jorge Humberto', 'Alzate, Alberto', 'Martinez Romero, Hector Jairo', 'Concha-Eastman, Alberto Ignacio']","['Rojas Palacios JH', 'Alzate A', 'Martinez Romero HJ', 'Concha-Eastman AI']",,"['Grupo de Epidemiologia y Salud Publica, Secretaria de Salud Publica Municipal de Cali, Alcaldia Municipal de Santiago de Cali, Cali Colombia; Grupo de Investigacion en modelos y metodos matematicos para el control y vigilancia del dengue, Cali, Colombia.', 'Grupo de Investigacion en Epidemiologia y Servicios (GRIEPIS). Postgrado en Epidemiologia, Universidad Libre, Cali, Colombia.', 'Grupo de Investigacion en modelos y metodos matematicos para el control y vigilancia del dengue, Cali, Colombia; Departamento de Matematicas, Universidad del Valle. Cali, Colombia.', 'Alcaldia Municipal de Santiago de Cali, Cali, Colombia.']",['eng'],['Journal Article'],20160930,Colombia,Colomb Med (Cali),"Colombia medica (Cali, Colombia)",9212578,,IM,"['Adolescent', 'Adult', 'Black People/*statistics & numerical data', 'Child', 'Cities/epidemiology/ethnology', 'Colombia/epidemiology/ethnology', 'Dengue/epidemiology/*ethnology', 'Humans', 'Incidence', 'Middle Aged', 'Protective Factors', 'Risk']",PMC5091271,2016/11/09 06:00,2017/02/24 06:00,['2016/11/09 06:00'],"['2016/11/09 06:00 [entrez]', '2016/11/09 06:00 [pubmed]', '2017/02/24 06:00 [medline]']",,epublish,Colomb Med (Cali). 2016 Sep 30;47(3):133-141.,3,,['NOTNLM'],"['*African continental ancestry group', '*AfroColombian', '*Ethnicity', '*dengue', '*ecological', '*epidemiological surveillance', '*ethnic groups', '*protective factors', '*risk factors']",['The authors declare no conflict of interest'],,,,,,,,,,,,,,,,,,
31495336,NLM,MEDLINE,20200106,20200309,1741-7015 (Electronic) 1741-7015 (Linking),17,2019 Sep 9,Estimating the burden of dengue and the impact of release of wMel Wolbachia-infected mosquitoes in Indonesia: a modelling study.,172,10.1186/s12916-019-1396-4 [doi] 172,"BACKGROUND: Wolbachia-infected mosquitoes reduce dengue virus transmission, and city-wide releases in Yogyakarta city, Indonesia, are showing promising entomological results. Accurate estimates of the burden of dengue, its spatial distribution and the potential impact of Wolbachia are critical in guiding funder and government decisions on its future wider use. METHODS: Here, we combine multiple modelling methods for burden estimation to predict national case burden disaggregated by severity and map the distribution of burden across the country using three separate data sources. An ensemble of transmission models then predicts the estimated reduction in dengue transmission following a nationwide roll-out of wMel Wolbachia. RESULTS: We estimate that 7.8 million (95% uncertainty interval [UI] 1.8-17.7 million) symptomatic dengue cases occurred in Indonesia in 2015 and were associated with 332,865 (UI 94,175-754,203) lost disability-adjusted life years (DALYs). The majority of dengue's burden was due to non-severe cases that did not seek treatment or were challenging to diagnose in outpatient settings leading to substantial underreporting. Estimated burden was highly concentrated in a small number of large cities with 90% of dengue cases occurring in 15.3% of land area. Implementing a nationwide Wolbachia population replacement programme was estimated to avert 86.2% (UI 36.2-99.9%) of cases over a long-term average. CONCLUSIONS: These results suggest interventions targeted to the highest burden cities can have a disproportionate impact on dengue burden. Area-wide interventions, such as Wolbachia, that are deployed based on the area covered could protect people more efficiently than individual-based interventions, such as vaccines, in such dense environments.","[""O'Reilly, Kathleen M"", 'Hendrickx, Emilie', 'Kharisma, Dinar D', 'Wilastonegoro, Nandyan N', 'Carrington, Lauren B', 'Elyazar, Iqbal R F', 'Kucharski, Adam J', 'Lowe, Rachel', 'Flasche, Stefan', 'Pigott, David M', 'Reiner, Robert C Jr', 'Edmunds, W John', 'Hay, Simon I', 'Yakob, Laith', 'Shepard, Donald S', 'Brady, Oliver J']","[""O'Reilly KM"", 'Hendrickx E', 'Kharisma DD', 'Wilastonegoro NN', 'Carrington LB', 'Elyazar IRF', 'Kucharski AJ', 'Lowe R', 'Flasche S', 'Pigott DM', 'Reiner RC Jr', 'Edmunds WJ', 'Hay SI', 'Yakob L', 'Shepard DS', 'Brady OJ']",,"['Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.', 'Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.', 'Oxford University Clinical Research Unit, Wellcome Trust Asia-Africa Programme, Ho Chi Minh City, Vietnam.', 'Nuffield Department of Medicine, University of Oxford, Oxford, UK.', 'Eijkman Oxford Clinical Research Unit, Eijkman Institute for Molecular Biology, Jakarta, Indonesia.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.', 'Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.', 'Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK. oliver.brady@lshtm.ac.uk.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK. oliver.brady@lshtm.ac.uk.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20190909,England,BMC Med,BMC medicine,101190723,,IM,"['Aedes/*microbiology', 'Animals', 'Cost of Illness', 'Dengue/epidemiology/*prevention & control/transmission', 'Dengue Virus', 'Humans', 'Indonesia/epidemiology', '*Models, Theoretical', 'Pest Control, Biological/*methods', '*Wolbachia']",PMC6732838,2019/09/10 06:00,2020/01/07 06:00,['2019/09/10 06:00'],"['2019/03/18 00:00 [received]', '2019/07/24 00:00 [accepted]', '2019/09/10 06:00 [entrez]', '2019/09/10 06:00 [pubmed]', '2020/01/07 06:00 [medline]']","['10.1186/s12916-019-1396-4 [pii]', '1396 [pii]', '10.1186/s12916-019-1396-4 [doi]']",epublish,BMC Med. 2019 Sep 9;17(1):172. doi: 10.1186/s12916-019-1396-4.,1,,['NOTNLM'],"['Burden', 'Dengue', 'Elimination', 'Indonesia', 'Maps', 'Model', 'Wolbachia']",['The authors declare that they have no competing interests.'],,"['206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom', '206250/Z/17/Z/WT_/Wellcome Trust/United Kingdom', '208812/Z/17/Z/WT_/Wellcome Trust/United Kingdom']",,,,,,,,,,,,,,,,
36316901,NLM,MEDLINE,20221102,20230103,1536-5964 (Electronic) 0025-7974 (Print) 0025-7974 (Linking),101,2022 Oct 28,Clinical features and management of children with dengue-associated obstructive shock syndrome: A case report.,e31322,10.1097/MD.0000000000031322 [doi] e31322,"RATIONALE: Dengue obstructive shock syndrome is a fatal complication commonly observed in the late critical phase of dengue infection and is associated with a high mortality rate. The main pathogenesis involves a dramatic increase in chest pressure, owing to severe plasma leakage and mechanical respiratory support, hampering the heart's ability to pump effectively and impeding adequate blood venous return to the heart chambers. To date, there is a paucity of clinical data about Dengue obstructive shock syndrome reported. PATIENT CONCERNS: The 2 reported patients presented with prolonged and decompensated dengue shock with critical multi-organ failures and mechanical ventilation. The patients' hemodynamics were profoundly affected by high pressure in the thoracic and abdominal cavities resulting from Dengue-induced severe plasma leakage and mechanical ventilation. DIAGNOSES: Clinical presentations, laboratory data, mini-fluid challenge test, and point-of-care (POCUS) were used to make diagnoses and guide management. INTERVENTIONS: Clinical monitoring, judicious fluid (colloids and blood products) administration guided by repeated POCUS to properly assess the adequacy of the intravascular volume, homeostasis adjustments by plasma exchange, and continuous renal replacement therapies. OUTCOMES: The patients had favorable outcomes. LESSONS: Our study highlights the clinical manifestations and management of children with dengue obstructive shock syndrome and underscores the importance of monitoring hemodynamics by consecutive POCUS at the bedside in order to make a timely diagnosis and assess intravascular fluid volume inadequacy accurately as well as closely monitor the fluid management responses.","['Nguyen, Thanh Tat', 'Le, Nhung Thi-Hong', 'Nguyen, Ngoc Minh', 'Do, Viet Chau', 'Trinh, Tung Huu', 'Vo, Luan Thanh']","['Nguyen TT', 'Le NT', 'Nguyen NM', 'Do VC', 'Trinh TH', 'Vo LT']",['ORCID: 0000-0003-3188-5967'],"[""Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh City, Vietnam."", 'Woolcock Institute of Medical Research, Ho Chi Minh City, Vietnam.', 'Pediatric Department, Binh Duong General Hospital, Binh Duong, Vietnam.', ""Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh City, Vietnam."", ""Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh City, Vietnam."", ""Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh City, Vietnam."", ""Department of Infectious Diseases, Children's Hospital No.2, Ho Chi Minh City, Vietnam.""]",['eng'],"['Case Reports', 'Journal Article']",,United States,Medicine (Baltimore),Medicine,2985248R,,IM,"['Child', 'Humans', '*Respiration, Artificial', 'Hemodynamics', 'Monitoring, Physiologic', 'Plasma', '*Dengue/complications/diagnosis/therapy']",PMC9622697,2022/11/02 06:00,2022/11/03 06:00,['2022/11/01 01:04'],"['2022/11/01 01:04 [entrez]', '2022/11/02 06:00 [pubmed]', '2022/11/03 06:00 [medline]']","['00005792-202210280-00078 [pii]', '10.1097/MD.0000000000031322 [doi]']",ppublish,Medicine (Baltimore). 2022 Oct 28;101(43):e31322. doi: 10.1097/MD.0000000000031322.,43,"['Copyright (c) 2022 the Author(s). Published by Wolters Kluwer Health, Inc.']",,,['The authors have no conflicts of interest to disclose.'],,,,,,,,,,,,,,,,,,
8052809,NLM,MEDLINE,19940908,20190825,0036-5548 (Print) 0036-5548 (Linking),25,1993,Dengue fever among Swedish tourists.,699-704,,"Serologically confirmed cases of dengue fever among Swedish tourists were studied retrospectively. Dengue fever was found to be the most commonly diagnosed imported arbovirus disease in Sweden during the period December 1989-November 1990. 24 cases were diagnosed. The geographical epidemiology showed that 17/23 who answered a questionnaire were infected in Thailand, most often during spring and early summer. 17 patients were admitted to hospital. All patients had high fever. Other common symptoms were myalgia, headache, fatigue/prostration and erythema. All patients but 1 with a long-standing ataxia recovered without sequelae. Low white blood cell and platelet counts were registered in all sampled patients. Depressed sodium levels and elevated liver enzymes were seen regularly. Dengue virus type 1 was isolated from 2 patients who suffered from dengue haemorrhagic fever grade II in the course of their primary dengue virus infection.","['Wittesjo, B', 'Eitrem, R', 'Niklasson, B']","['Wittesjo B', 'Eitrem R', 'Niklasson B']",,"['Department of the Infectious Diseases, Central Hospital, Karlskrona, Sweden.']",['eng'],"['Case Reports', 'Journal Article']",,England,Scand J Infect Dis,Scandinavian journal of infectious diseases,0215333,,IM,"['Adult', 'Asia, Southeastern', 'Dengue/classification/diagnosis/*epidemiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Surveys and Questionnaires', 'Sweden/epidemiology', '*Travel', 'Vaccination']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.3109/00365549309008566 [doi]'],ppublish,Scand J Infect Dis. 1993;25(6):699-704. doi: 10.3109/00365549309008566.,6,,,,,,,,,,,,,,,,,,,,,,
21011278,NLM,MEDLINE,20101028,20190612,0140-6736 (Print) 0140-6736 (Linking),1,1946 Jan 19,Dengue group of fevers in India.,92,,,"['KARAMCHANDANI, P V']",['KARAMCHANDANI PV'],,,['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,,OM,"['Dengue/*epidemiology/*statistics & numerical data', '*Fever', 'Humans', 'India']",,1946/01/19 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/01/19 00:00 [pubmed]', '2010/12/14 06:00 [medline]']","['S0140-6736(46)91229-9 [pii]', '10.1016/s0140-6736(46)91229-9 [doi]']",ppublish,Lancet. 1946 Jan 19;1(6386):92. doi: 10.1016/s0140-6736(46)91229-9.,6386,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,,,['CLML: 4610:405r'],,,,,,,,,,,
28159953,NLM,MEDLINE,20170601,20190918,0974-7559 (Electronic) 0019-6061 (Linking),54,2017 Apr 15,Clinical Profile of Dengue Infection in Immune-compromised Children.,330-331,S097475591600046 [pii],"Review of records of children admitted with dengue infection was carried out to compare clinical and laboratory parameters, course of illness, and outcome between immune-compromised and immune-competent patients. Statistically significant differences were found in days to platelet recovery (P=0.03), hepatic dysfunction (P= 0.04), and higher requirement of fluid (P= 0.01) in immune-compromised group.","['Singh, Amitabh', 'Seth, Rachna', 'Singla, Mohit', 'Kabra, S K', 'Lodha, Rakesh']","['Singh A', 'Seth R', 'Singla M', 'Kabra SK', 'Lodha R']",,"['Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. rakesh_lodha@hotmail.com.']",['eng'],['Journal Article'],20170202,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Child', 'Child, Preschool', '*Dengue/diagnosis/epidemiology/physiopathology', 'Humans', '*Immunocompromised Host', 'Infant', 'Infant, Newborn', 'Retrospective Studies']",,2017/02/06 06:00,2017/06/02 06:00,['2017/02/05 06:00'],"['2017/02/06 06:00 [pubmed]', '2017/06/02 06:00 [medline]', '2017/02/05 06:00 [entrez]']","['S097475591600046 [pii]', '10.1007/s13312-017-1099-x [doi]']",ppublish,Indian Pediatr. 2017 Apr 15;54(4):330-331. doi: 10.1007/s13312-017-1099-x. Epub 2017 Feb 2.,4,,,,,,,,,,,,,,,,,,,,,,
36921001,NLM,MEDLINE,20230329,20230329,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),17,2023 Mar,"Demographic characteristics, clinical symptoms, biochemical markers and probability of occurrence of severe dengue: A multicenter hospital-based study in Bangladesh.",e0011161,10.1371/journal.pntd.0011161 [doi] e0011161,"Establishing reliable early warning models for severe dengue cases is a high priority to facilitate triage in dengue-endemic areas and optimal use of limited resources. However, few studies have identified the complex interactive relationship between potential risk factors and severe dengue. This research aimed to assess the potential risk factors and detect their high-order combinative effects on severe dengue. A structured questionnaire was used to collect detailed dengue outbreak data from eight representative hospitals in Dhaka, Bangladesh, in 2019. Logistic regression and machine learning models were used to examine the complex effects of demographic characteristics, clinical symptoms, and biochemical markers on severe dengue. A total of 1,090 dengue cases (158 severe and 932 non-severe) were included in this study. Dyspnoea (Odds Ratio [OR] = 2.87, 95% Confidence Interval [CI]: 1.72 to 4.77), plasma leakage (OR = 3.61, 95% CI: 2.12 to 6.15), and hemorrhage (OR = 2.33, 95% CI: 1.46 to 3.73) were positively and significantly associated with the occurrence of severe dengue. Classification and regression tree models showed that the probability of occurrence of severe dengue cases ranged from 7% (age >12.5 years without plasma leakage) to 92.9% (age </=12.5 years with dyspnoea and plasma leakage). The random forest model indicated that age was the most important factor in predicting severe dengue, followed by education, plasma leakage, platelet, and dyspnoea. The research provides new evidence to identify key risk factors contributing to severe dengue cases, which could be beneficial to clinical doctors to identify and predict the severity of dengue early.","['Yang, Jingli', 'Mosabbir, Abdullah Al', 'Raheem, Enayetur', 'Hu, Wenbiao', 'Hossain, Mohammad Sorowar']","['Yang J', 'Mosabbir AA', 'Raheem E', 'Hu W', 'Hossain MS']","['ORCID: 0000-0001-6422-9240', 'ORCID: 0000-0001-7143-2909']","['Ecosystem Change and Population Health Research Group, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia.', 'College of Earth and Environmental Sciences, Lanzhou University, Lanzhou, China.', 'Department of Emerging and Neglected Diseases, Biomedical Research Foundation, Dhaka, Bangladesh.', 'Department of Emerging and Neglected Diseases, Biomedical Research Foundation, Dhaka, Bangladesh.', 'Ecosystem Change and Population Health Research Group, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Australia.', 'Department of Emerging and Neglected Diseases, Biomedical Research Foundation, Dhaka, Bangladesh.', 'School of Environment and Life Sciences, Independent University, Dhaka, Bangladesh.']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, Non-U.S. Gov't""]",20230315,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,['0 (Biomarkers)'],IM,"['Humans', 'Child', '*Severe Dengue/diagnosis/epidemiology/complications', 'Bangladesh/epidemiology', 'Logistic Models', 'Hospitals', 'Biomarkers', 'Demography', '*Dengue/diagnosis/epidemiology/etiology']",PMC10042364,2023/03/16 06:00,2023/03/29 06:05,['2023/03/15 13:53'],"['2022/08/19 00:00 [received]', '2023/02/10 00:00 [accepted]', '2023/03/27 00:00 [revised]', '2023/03/29 06:05 [medline]', '2023/03/16 06:00 [pubmed]', '2023/03/15 13:53 [entrez]']","['PNTD-D-22-01070 [pii]', '10.1371/journal.pntd.0011161 [doi]']",epublish,PLoS Negl Trop Dis. 2023 Mar 15;17(3):e0011161. doi: 10.1371/journal.pntd.0011161. eCollection 2023 Mar.,3,"['Copyright: (c) 2023 Yang et al. This is an open access article distributed under', 'the terms of the Creative Commons Attribution License, which permits unrestricted', 'use, distribution, and reproduction in any medium, provided the original author', 'and source are credited.']",,,['The authors report there are no competing interests to declare.'],,,,,,,,,,,,,,,,,,
30121308,NLM,MEDLINE,20190107,20190107,1878-3511 (Electronic) 1201-9712 (Linking),75,2018 Oct,"Spatial analysis of dengue fever and exploration of its environmental and socio-economic risk factors using ordinary least squares: A case study in five districts of Guangzhou City, China, 2014.",39-48,S1201-9712(18)34484-9 [pii] 10.1016/j.ijid.2018.07.023 [doi],"OBJECTIVE: Spatial patterns and environmental and socio-economic risk factors of dengue fever have been studied widely on a coarse scale; however, there are few such quantitative studies on a fine scale. There is a need to investigate these factors on a fine scale for dengue fever. METHODS: In this study, a dataset of dengue fever cases and environmental and socio-economic factors was constructed at 1-km spatial resolution, in particular 'land types' (LT), obtained from the first high resolution remote sensing satellite launched from China (GF-1 satellite), and 'land surface temperature', obtained from moderate resolution imaging spectroradiometer (MODIS) images. Spatial analysis methods, including point density, average nearest neighbor, spatial autocorrelation, and hot spot analysis, were used to analyze spatial patterns of dengue fever. Spearman rank correlation and ordinary least squares (OLS) were used to explore associated environmental and socio-economic risk factors of dengue fever in five districts of Guangzhou City, China in 2014. RESULTS: A total of 30553 dengue fever cases were reported in the districts of Baiyun, Haizhu, Yuexiu, Liwan, and Tianhe of Guangzhou, China in 2014. Dengue fever cases showed strong seasonal variation. The cases from August to October accounted for 96.3% of the total cases in 2014. The top three districts for dengue fever morbidity were Baiyun (1.32%), Liwan (0.62%), and Haizhu (0.60%). Strong spatial clusters of dengue fever cases were observed. Areas of high density for dengue fever were located at the district junctions. The dengue fever outbreak was significantly correlated with LT, normalized difference water index (NDWI), land surface temperature of daytime (LSTD), land surface temperature of nighttime (LSTN), population density (PD), and gross domestic product (GDP) (correlation coefficients of 0.483, 0.456, 0.612, 0.699, 0.705, and 0.205, respectively). The OLS equation was built with dengue fever cases as the dependent variable and LT, LSTN, and PD as explanatory variables. The residuals were not spatially autocorrelated. The adjusted R-squared was 0.320. CONCLUSIONS: The findings of spatio-temporal patterns and risk factors of dengue fever can provide scientific information for public health practitioners to formulate targeted, strategic plans and implement effective public health prevention and control measures.","['Yue, Yujuan', 'Sun, Jimin', 'Liu, Xiaobo', 'Ren, Dongsheng', 'Liu, Qiyong', 'Xiao, Xiangming', 'Lu, Liang']","['Yue Y', 'Sun J', 'Liu X', 'Ren D', 'Liu Q', 'Xiao X', 'Lu L']",,"[""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China."", 'Department of Microbiology and Plant Biology, University of Oklahoma, OK, USA.', ""State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People's Republic of China. Electronic address: luliang@icdc.cn.""]",['eng'],['Journal Article'],20180816,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,,IM,"['China/epidemiology', 'Dengue/*epidemiology/etiology/prevention & control', 'Humans', 'Least-Squares Analysis', 'Risk Factors', 'Socioeconomic Factors', 'Temperature']",,2018/08/20 06:00,2019/01/08 06:00,['2018/08/20 06:00'],"['2018/05/22 00:00 [received]', '2018/07/24 00:00 [revised]', '2018/07/27 00:00 [accepted]', '2018/08/20 06:00 [pubmed]', '2019/01/08 06:00 [medline]', '2018/08/20 06:00 [entrez]']","['S1201-9712(18)34484-9 [pii]', '10.1016/j.ijid.2018.07.023 [doi]']",ppublish,Int J Infect Dis. 2018 Oct;75:39-48. doi: 10.1016/j.ijid.2018.07.023. Epub 2018 Aug 16.,,['Copyright (c) 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue fever', 'Environmental and socio-economic factors', 'Guangzhou', 'OLS', 'Spatial pattern analysis', 'Spatial statistics analysis', 'Spearman rank correlation']",,,,,,,,,,,,,,,,,,,
8924782,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[Dengue in French Guiana. History and present status].,98-100; discussion 101,,"The evolution of dengue in French Guiana has the same trend as in most tropical American countries, with emergence of dengue hemorrhagic fever (DHF) and endemicity of the disease. During the 1940's, several dengue-like outbreaks were reported from French Guiana. Then, the only dengue vector, Aedes aegypti, was eradicated between 1950 and 1963, when it started to reinfest the country. By the end of the 1960's, new dengue epidemics with serological confirmation were described. After 1970, the first dengue strains were isolated, firstly dengue-2 strains, then dengue-1 and dengue-4 strains. Between 1970 and 1990, several dengue outbreaks struck French Guiana with 2 to 6 years intervals. In July 1991, started the first DHF outbreak in French Guiana which spread in all the most important towns until October 1992. About 3,000 cases were reported, that is almost 3% of the population, from which about 1/3 had serological confirmation; more than 300 people were hospitalized and some 80 with hemorrhages. Finally 6 deaths were reported, 5 of which had hemorrhages but could not be included into DHF cases according to WHO criteria. The dengue-2 strain responsible for this outbreak is close to the Jamaican topotype known to be particularly virulent. Since the beginning of 1993 and actually, dengue is still circulating in French Guiana, but at low level and dengue-1 and dengue-4 strains are occasionally isolated.","['Reynes, J M']",['Reynes JM'],,"[""Laboratoire d'entomologie medicale, Institut Pasteur de Guyane, Cayenne, Guyane francaise.""]",['fre'],"['English Abstract', 'Historical Article', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Dengue/*epidemiology/*history/virology', 'Dengue Virus/classification/isolation & purification', 'French Guiana/epidemiology', 'History, 20th Century', 'Humans']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):98-100; discussion 101.,2,,,,,,,,,La dengue en Guyane Francaise. Historique et actualites.,,,,,,,,,,,,,
17213511,NLM,MEDLINE,20070320,20130418,0971-5916 (Print) 0971-5916 (Linking),124,2006 Nov,The curse of dengue.,467-70,,,"['Chaturvedi, U C']",['Chaturvedi UC'],,,['eng'],['Editorial'],,India,Indian J Med Res,The Indian journal of medical research,0374701,['0 (Dengue Vaccines)'],IM,"['Dengue/diagnosis/*epidemiology/prevention & control', 'Dengue Vaccines/immunology', 'Humans']",,2007/01/11 09:00,2007/03/21 09:00,['2007/01/11 09:00'],"['2007/01/11 09:00 [pubmed]', '2007/03/21 09:00 [medline]', '2007/01/11 09:00 [entrez]']",,ppublish,Indian J Med Res. 2006 Nov;124(5):467-70.,5,,,,,,,,,,,,,,,,,,,,,,
23973561,NLM,MEDLINE,20140711,20141120,1873-6254 (Electronic) 0001-706X (Linking),129,2014 Jan,Using global maps to predict the risk of dengue in Europe.,1-14,S0001-706X(13)00213-1 [pii] 10.1016/j.actatropica.2013.08.008 [doi],"This article attempts to quantify the risk to Europe of dengue, following the arrival and spread there of one of dengue's vector species Aedes (Stegomyia) albopictus. A global risk map for dengue is presented, based on a global database of the occurrence of this disease, derived from electronic literature searches. Remotely sensed satellite data (from NASA's MODIS series), interpolated meteorological data, predicted distribution maps of dengue's two main vector species, Aedes aegypti and Aedes albopictus, a digital elevation surface and human population density data were all used as potential predictor variables in a non-linear discriminant analysis modelling framework. One hundred bootstrap models were produced by randomly sub-sampling three different training sets for dengue fever, severe dengue (i.e. dengue haemorrhagic fever, DHF) and all-dengue, and output predictions were averaged to produce a single global risk map for each type of dengue. This paper concentrates on the all-dengue models. Key predictor variables were various thermal data layers, including both day- and night-time Land Surface Temperature, human population density, and a variety of rainfall variables. The relative importance of each may be shown visually using rainbow files and quantitatively using a ranking system. Vegetation Index variables (a common proxy for humidity or saturation deficit) were rarely chosen in the models. The kappa index of agreement indicated an excellent (dengue haemorrhagic fever, Cohen's kappa=0.79 +/- 0.028, AUC=0.96 +/- 0.007) or good fit of the top ten models in each series to the data (Cohen's kappa=0.73 +/- 0.018, AUC=0.94 +/- 0.007 for dengue fever and 0.74 +/- 0.017, AUC=0.95 +/- 0.005 for all dengue). The global risk map predicts widespread dengue risk in SE Asia and India, in Central America and parts of coastal South America, but in relatively few regions of Africa. In many cases these are less extensive predictions than those of other published dengue risk maps and arise because of the key importance of high human population density for the all-dengue risk maps produced here. Three published dengue risk maps are compared using the Fleiss kappa index, and are shown to have only fair agreement globally (Fleiss kappa=0.377). Regionally the maps show greater (but still only moderate) agreement in SE Asia (Fleiss kappa=0.566), fair agreement in the Americas (Fleiss kappa=0.325) and only slight agreement in Africa (Fleiss kappa=0.095). The global dengue risk maps show that very few areas of rural Europe are presently suitable for dengue, but several major cities appear to be at some degree of risk, probably due to a combination of thermal conditions and high human population density, the top two variables in many models. Mahalanobis distance images were produced of Europe and the southern United States showing the distance in environmental rather than geographical space of each site from any site where dengue currently occurs. Parts of Europe are quite similar in Mahalanobis distance terms to parts of the southern United States, where dengue occurred in the recent past and which remain environmentally suitable for it. High standards of living rather than a changed environmental suitability keep dengue out of the USA. The threat of dengue to Europe at present is considered to be low but sufficiently uncertain to warrant monitoring in those areas of greatest predicted environmental suitability, especially in northern Italy and parts of Austria, Slovenia and Croatia, Bosnia and Herzegovina, Serbia and Montenegro, Albania, Greece, south-eastern France, Germany and Switzerland, and in smaller regions elsewhere.","['Rogers, David J', 'Suk, Jonathan E', 'Semenza, Jan C']","['Rogers DJ', 'Suk JE', 'Semenza JC']",,"['University of Oxford, Department of Zoology, South Parks Road, Oxford OX1 3PS, United Kingdom. Electronic address: david.rogers@zoo.ox.ac.uk.']",['eng'],['Journal Article'],20130821,Netherlands,Acta Trop,Acta tropica,0370374,,IM,"['Aedes/*growth & development', 'Animals', 'Computer Simulation', 'Dengue/*epidemiology/*transmission', 'Europe/epidemiology', 'Global Health', 'Humans', 'Insect Vectors/*growth & development', 'Population Density', 'Risk Assessment', 'Temperature']",,2013/08/27 06:00,2014/07/12 06:00,['2013/08/27 06:00'],"['2013/02/21 00:00 [received]', '2013/07/02 00:00 [revised]', '2013/08/12 00:00 [accepted]', '2013/08/27 06:00 [entrez]', '2013/08/27 06:00 [pubmed]', '2014/07/12 06:00 [medline]']","['S0001-706X(13)00213-1 [pii]', '10.1016/j.actatropica.2013.08.008 [doi]']",ppublish,Acta Trop. 2014 Jan;129:1-14. doi: 10.1016/j.actatropica.2013.08.008. Epub 2013 Aug 21.,,['Copyright (c) 2013 The Authors. Published by Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Dengue', 'Discriminant analysis', 'Fleiss kappa', 'Mahalanobis distance', 'Risk maps', 'Satellite data']",,,,,,,,,,,,,,,,,,,
8924770,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[Prediction and prevention of dengue epidemics].,123-6; discussion 127,,"Prediction and prevention of dengue epidemics are based on informations gathered about the mosquito vector species, the dengue types transmitted, the vertebrate hosts and their environment. Although Aedes aegypti is the most important vector, other Aedes may also propagate the dengue viruses. The populations of vector mosquitoes are evaluated through several indices: Breteau and/or positive house index, number of indoor resting Aedes females, etc.... The four dengue types can replicate in vertebrate hosts beside humans and in other mosquito species than Ae. aegypti. The incidence of dengue on a population is largely variable according to the immunity status, the vector competence and the virus strains. Concomitant infections by two types of dengue virus or by an another pathogen (Alphavirus) have been observed. The environmental factors influencing the dengue ecosystem are mostly climatic (temperature, rainfall, wind) but also anthropic (transportation means, public buildings). Prevention of dengue epidemics must be based on public health education in schools, community participation, epidemiological surveillance linked with good vector control teams. Nevertheless intensive research on dengue and the actions undertaken for the last forty years, dengue remains the first cause of viral morbidity worldwide.","['Fauran, P']",['Fauran P'],,"['Le Chantilly, Nice.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Aedes', 'Animals', 'Climate', 'Dengue/*epidemiology/*prevention & control/transmission/virology', 'Dengue Virus', 'Humans', 'Insect Vectors']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):123-6; discussion 127.,2,,,,,,,8,,Prevision et prevention des epidemies de dengue.,,,,,,,,,,,,,
33987662,NLM,MEDLINE,20210809,20210809,1708-8305 (Electronic) 1195-1982 (Linking),28,2021 Jul 7,Atypical imported severe primary dengue presenting with neutrophilic leukocytosis and cardiac tamponade in a young female traveler.,,taab074 [pii] 10.1093/jtm/taab074 [doi],,"['Vellere, Iacopo', 'Di Lauria, Nicoletta', 'Mantella, Antonia', 'Cavallo, Annalisa', 'Bresci, Silvia', 'Bartoloni, Alessandro', 'Zammarchi, Lorenzo']","['Vellere I', 'Di Lauria N', 'Mantella A', 'Cavallo A', 'Bresci S', 'Bartoloni A', 'Zammarchi L']",,"['Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.', 'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.', 'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.', 'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.', 'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.', 'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.', 'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.', 'Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.', 'Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.']",['eng'],['Journal Article'],,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['*Cardiac Tamponade/diagnosis/etiology', '*Dengue/complications/diagnosis', 'Female', 'Humans', 'Leukocytosis', '*Severe Dengue', 'Travel']",,2021/05/15 06:00,2021/08/10 06:00,['2021/05/14 07:07'],"['2021/04/12 00:00 [received]', '2021/05/04 00:00 [revised]', '2021/05/05 00:00 [accepted]', '2021/05/15 06:00 [pubmed]', '2021/08/10 06:00 [medline]', '2021/05/14 07:07 [entrez]']","['6274744 [pii]', '10.1093/jtm/taab074 [doi]']",ppublish,J Travel Med. 2021 Jul 7;28(5):taab074. doi: 10.1093/jtm/taab074.,5,,['NOTNLM'],"['primary infection', 'severe dengue', 'traveler']",,,"['Department of Experimental and Clinical Medicine, University of Florence/']",,,,,,,,,,,,,,,,
33602052,NLM,MEDLINE,20211125,20211125,1758-1133 (Electronic) 0049-4755 (Linking),51,2021 Oct,Isolated abducens nerve palsy - A rare clinical presentation in dengue haemorrhagic fever.,611-612,10.1177/0049475520983643 [doi],"Dengue fever is the most prevalent flavivirus infection in tropical and subtropical areas of the world. It is transmitted by the haematophagous mosquito Aedes aegypti, and it manifests clinically as classical dengue fever, dengue haemorrhagic fever and dengue shock syndrome. Rarely, dengue can be associated with neurophthalmic manifestations. We present the case of a 21-year-old woman, suffering from dengue with an isolated abducens nerve palsy.","['Thakur, Sanjay Kd', 'Dubey, Surabhi', 'Gupta, Somedeb']","['Thakur SK', 'Dubey S', 'Gupta S']",['ORCID: 0000-0003-1864-8131'],"['Professor, Department of Ophthalmology, Midnapore Medical College & Hospital, Kolkata, India.', 'Postgraduate Trainee, Department of Ophthalmology, Midnapore Medical College & Hospital, Kolkata, India.', 'Assistant Professor, Department of Ophthalmology, Midnapore Medical College & Hospital, Kolkata, India.']",['eng'],"['Case Reports', 'Journal Article']",20210218,England,Trop Doct,Tropical doctor,1301706,,IM,"['*Abducens Nerve Diseases/diagnosis/etiology', 'Adult', '*Aedes', 'Animals', '*Dengue/complications/diagnosis', 'Female', 'Humans', '*Severe Dengue/complications/diagnosis', 'Young Adult']",,2021/02/20 06:00,2021/11/26 06:00,['2021/02/19 05:40'],"['2021/02/20 06:00 [pubmed]', '2021/11/26 06:00 [medline]', '2021/02/19 05:40 [entrez]']",['10.1177/0049475520983643 [doi]'],ppublish,Trop Doct. 2021 Oct;51(4):611-612. doi: 10.1177/0049475520983643. Epub 2021 Feb 18.,4,,['NOTNLM'],"['Abducens nerve palsy', 'Aedes aegypti', 'Dengue fever']",,,,,,,,,,,,,,,,,,,
6464114,NLM,MEDLINE,19840918,20211203,0035-9203 (Print) 0035-9203 (Linking),78,1984,Dengue haemorrhagic fever in Cuba. II. Clinical investigations.,239-41,,"Clinical and serological studies were carried out on 114 patients admitted to hospital in Havana, Cuba with Dengue Haemorrhagic Fever and Dengue Shock Syndrome (DHF/DSS). Serological confirmation of dengue was obtained in 90% of cases, with 5% of cases primary and 95% secondary. Fever, haemorrhagic manifestations, vomiting and headache were the most frequent signs and symptoms. Among haemorrhagic manifestations, petechiae and vaginal bleeding were reported in a larger number of patients. 21 patients presented shock and, of these, 20 were secondary infections. The disease appeared more frequently in white persons and in women. The aetiopathogenicity of the syndromes is discussed. 95% of the cases could be explained on the basis of the secondary infection hypothesis.","['Guzman, M G', 'Kouri, G P', 'Bravo, J', 'Soler, M', 'Vazquez, S', 'Santos, M', 'Villaescusa, R', 'Basanta, P', 'Indan, G', 'Ballester, J M']","['Guzman MG', 'Kouri GP', 'Bravo J', 'Soler M', 'Vazquez S', 'Santos M', 'Villaescusa R', 'Basanta P', 'Indan G', 'Ballester JM']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', 'Child, Preschool', 'Dengue/complications/*diagnosis/epidemiology', 'Female', 'Hemorrhage/etiology', 'Humans', 'Infant', 'Male', 'Racial Groups', 'Sex Factors']",,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",['10.1016/0035-9203(84)90286-4 [doi]'],ppublish,Trans R Soc Trop Med Hyg. 1984;78(2):239-41. doi: 10.1016/0035-9203(84)90286-4.,2,,,,,,,,,,,,,,,,,,,,,,
21005335,NLM,MEDLINE,20101028,20190606,0002-9637 (Print) 0002-9637 (Linking),25,1945,Dengue-like fever on the Isthmus of Panama.,397-401,,,"['FAIRCHILD, L M']",['FAIRCHILD LM'],,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,OM,"['Dengue/*epidemiology/*statistics & numerical data', '*Fever', 'Humans', 'Panama']",,1945/01/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1945/01/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",['10.4269/ajtmh.1945.s1-25.397 [doi]'],ppublish,Am J Trop Med Hyg. 1945;25:397-401. doi: 10.4269/ajtmh.1945.s1-25.397.,,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,,,['CLML: 4610:99j'],,,,,,,,,,,
15115091,NLM,MEDLINE,20040519,20081121,0125-1562 (Print) 0125-1562 (Linking),34,2003 Dec,Vertical transmission of dengue: first case report from Bangladesh.,800-3,,"We report a case of vertical transmission of dengue infection in a new born from Bangladesh. The mother was primigravida with an uneventful antenatal period except the fever she developed at 37 weeks of gestation. She underwent cesarean section for decreased fetal movement. The fever lasted for 7 days and was associated with intense bodyache, and a positive tourniquet test. She did not experience any hemorrhages including from the surgical wound. Her platelet count fell at its lowest to 100,000/mm3. She had bilateral mild pleural effusions and positive anti-dengue antibodies (both IgG and IgM). She received symptomatic treatment. The baby was deeply meconium stained and was resuscitated by a pediatrician. His postnatal period went well until day-3 of life when he developed fever and respiratory distress. There were no signs of meconiun aspiration syndrome (MAS) and the septic work up was negative. The platelets count fell to its lowest of 40,000/mm3 on day-3 and day-5 of his illness. Anti-dengue antibodies (both IgG and IgM) were positive with a nearly four-fold rise of IgM antibodies in the convalescent sera. The boy was treated with platelet transfusions and was discharged on day-6 after becoming ill. This report emphasizes that in a dengue epidemic or when dengue is endemic (which Bangladesh has experienced recently), a pregnant woman with fever, myalgia and/or bleeding manifestations should raise a high suspicion that the baby may develop the disease, and both the mother and baby should be closely followed-up. Viral isolation could not be done due to the unavailability of the test.","['Fatimil, Luthful Ehsan', 'Mollah, Abid Hossain', 'Ahmed, Shakil', 'Rahman, Mukibur']","['Fatimil LE', 'Mollah AH', 'Ahmed S', 'Rahman M']",,"['Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Dhaka [corrected]']",['eng'],"['Case Reports', 'Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adult', 'Bangladesh', 'Dengue/*congenital/diagnosis/*transmission', 'Female', 'Humans', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical', 'Male', 'Pregnancy', '*Pregnancy Complications, Infectious/diagnosis']",,2004/04/30 05:00,2004/05/20 05:00,['2004/04/30 05:00'],"['2004/04/30 05:00 [pubmed]', '2004/05/20 05:00 [medline]', '2004/04/30 05:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):800-3.,4,,,,,,,18,,,,,,,,,['Southeast Asian J Trop Med Public Health. 2004 Jun;35(2):494'],,,,,,
20559202,NLM,MEDLINE,20100621,20100618,1545-861X (Electronic) 0149-2195 (Linking),59,2010 Jun 18,"Travel-associated Dengue surveillance - United States, 2006-2008.",715-9,,"Dengue is caused by four antigenically related viruses (DENV-1, DENV-2, DENV-3, and DENV-4). Dengue fever is endemic in most tropical and subtropical areas of the world, and in 2007 nearly 1 million cases were reported in the Americas alone. Dengue infections commonly occur among U.S. residents returning from travel to endemic areas and are more prevalent than malaria among returning travelers from the Caribbean, South America, South Central Asia, and Southeast Asia. This report summarizes information about dengue cases reported to CDC through two CDC-maintained passive surveillance systems: 1) the ArboNET surveillance system, a national CDC arboviral surveillance system maintained by CDC's Arboviral Diseases Branch and initially developed in response to the introduction of West Nile virus in the United States, and 2) a system maintained for decades by the CDC Dengue Branch (CDCDB), which collects information on all suspected dengue cases whose specimens are sent to the branch. During 2006-2008, a total of 1,125 unique reports were made to either ArboNET or CDCDB. Of these, the highest proportion of laboratory-confirmed and probable cases with known travel histories were in persons who reported travel to the Dominican Republic (121; 20%), Mexico (55; 9%), and India (43; 7%). Health-care providers should consider dengue in the differential diagnosis of patients with a history of travel to endemic areas within 14 days of fever onset.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adult', 'Dengue/complications/*diagnosis/*epidemiology', 'Dominican Republic', 'Female', 'Humans', 'India', 'Male', 'Mexico', 'Middle Aged', '*Population Surveillance', '*Travel', 'United States/epidemiology', 'Young Adult']",,2010/06/19 06:00,2010/06/22 06:00,['2010/06/19 06:00'],"['2010/06/19 06:00 [entrez]', '2010/06/19 06:00 [pubmed]', '2010/06/22 06:00 [medline]']",['mm5923a3 [pii]'],ppublish,MMWR Morb Mortal Wkly Rep. 2010 Jun 18;59(23):715-9.,23,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
31701852,NLM,MEDLINE,20200421,20210110,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),102,2020 Jan,"Dengue Incidence and Sociodemographic Conditions in Pucallpa, Peruvian Amazon: What Role for Modification of the Dengue-Temperature Relationship?",180-190,10.4269/ajtmh.19-0033 [doi],"Dengue is a climate-sensitive disease with an increasing global burden. Although the relationship between meteorological conditions and dengue incidence is well established, less is known about the modifying nature of sociodemographic variables on that relationship. We assess the strength and direction of sociodemographic effect modification of the temperature-dengue relationship in the second largest city of the Peruvian Amazon to identify populations that may have heightened vulnerability to dengue under varying climate conditions. We used weekly dengue counts and averaged meteorological variables to evaluate the association between disease incidence, meteorological exposures, and sociodemographic effect modifiers (gender, age, and district) in negative binomial regression models. District was included to consider geographical effect modification. We found that being a young child or elderly, being female, and living in the district of Manantay increased dengue's incidence rate ratio (IRR) as a result of 1 degrees C increase in weekly mean temperature (IRR = 2.99, 95% CI: 1.99-4.50 for women less than 5 years old and IRR = 2.86, 95% CI: = 1.93-4.22 for women older than 65 years, both estimates valid for the rainy season). The effect of temperature on dengue depended on season, with stronger effects during rainy seasons. Sociodemographic variables can provide options for intervention to mitigate health impacts with a changing climate. Our results indicate that patterns of baseline risk between regions and sociodemographic conditions can differ substantially from trends in climate sensitivity. These results challenge the assumption that the distribution of climate change impacts will be patterned similarly to existing social gradients in health.","['Charette, Margot', 'Berrang-Ford, Lea', 'Coomes, Oliver', 'Llanos-Cuentas, Elmer Alejandro', 'Carcamo, Cesar', 'Kulkarni, Manisha', 'Harper, Sherilee L']","['Charette M', 'Berrang-Ford L', 'Coomes O', 'Llanos-Cuentas EA', 'Carcamo C', 'Kulkarni M', 'Harper SL']",,"['Department of Geography, McGill University, Montreal, Canada.', 'Priestley International Centre for Climate, University of Leeds, Leeds, United Kingdom.', 'Department of Geography, McGill University, Montreal, Canada.', 'School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.', 'School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.', 'School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.', 'School of Public Health, University of Alberta, Edmonton, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Climate Change', 'Dengue/*epidemiology/*etiology', 'Female', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Peru/epidemiology', 'Seasons', 'Socioeconomic Factors', 'Temperature', 'Time Factors', 'Young Adult']",PMC6947766,2019/11/09 06:00,2020/04/22 06:00,['2019/11/09 06:00'],"['2019/11/09 06:00 [pubmed]', '2020/04/22 06:00 [medline]', '2019/11/09 06:00 [entrez]']","['tpmd190033 [pii]', '10.4269/ajtmh.19-0033 [doi]']",ppublish,Am J Trop Med Hyg. 2020 Jan;102(1):180-190. doi: 10.4269/ajtmh.19-0033.,1,,,,,,['CAPMC/CIHR/Canada'],,,,,,,,,,,,,,,,
26506744,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,DENGUE INFECTION IN ELDERLY PATIENTS.,165-8,,"From 2005 to 2013, there were 15 dengue patients aged over 60 years old who were admitted to Photharam Hospital, Ratchaburi, Thailand. Ten were females and five were males. Nine had dengue fever (DF), and 6 had dengue hemorrhagic fever (DHF). A trending shift in age group towards adults has been seen during the past decades. No deaths were seen in these elderly patients with dengue disease, indicating early recognition and effective management of these dengue patients. The trend towards higher age in dengue patients is a problem of concern, which needs further elaboration.","['Tiawilai, Thawat', 'Tiawilai, Anongrat', 'Nunthanid, Somboon']","['Tiawilai T', 'Tiawilai A', 'Nunthanid S']",,,['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Aged', 'Aged, 80 and over', 'Dengue/epidemiology/*therapy/virology', '*Disease Management', 'Female', 'Hospitals', 'Humans', 'Male', 'Severe Dengue/epidemiology/therapy/virology', 'Thailand/epidemiology']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:165-8.,,,,,,,,,,,,,,,,,,,,,,,
36796966,NLM,MEDLINE,20230222,20230228,2214-109X (Electronic) 2214-109X (Linking),11,2023 Mar,Differentiating dengue from other febrile illnesses: a dilemma faced by clinicians in dengue endemic countries.,e306-e307,S2214-109X(22)00547-2 [pii] 10.1016/S2214-109X(22)00547-2 [doi],,"['Malavige, Gathsaurie Neelika', 'Wijewickrama, Ananda', 'Ogg, Graham S']","['Malavige GN', 'Wijewickrama A', 'Ogg GS']",,"['Allergy, Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda 10250, Sri Lanka; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. Electronic address: gathsaurie.malavige@ndm.ox.ac.uk.', 'National Institute of Infectious Diseases, Angoda, Sri Lanka.', 'Allergy, Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda 10250, Sri Lanka; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.']",['eng'],"['Comment', 'Journal Article']",,England,Lancet Glob Health,The Lancet. Global health,101613665,,IM,"['Humans', '*Dengue/diagnosis/epidemiology', '*Dengue Virus']",,2023/02/17 06:00,2023/02/22 06:00,['2023/02/16 20:59'],"['2022/12/09 00:00 [received]', '2022/12/16 00:00 [accepted]', '2023/02/16 20:59 [entrez]', '2023/02/17 06:00 [pubmed]', '2023/02/22 06:00 [medline]']","['S2214-109X(22)00547-2 [pii]', '10.1016/S2214-109X(22)00547-2 [doi]']",ppublish,Lancet Glob Health. 2023 Mar;11(3):e306-e307. doi: 10.1016/S2214-109X(22)00547-2.,3,,,,['We declare no competing interests.'],,,,['Lancet Glob Health. 2023 Mar;11(3):e361-e372. PMID: 36796983'],,,,,,,,,,,,,,
24286460,NLM,MEDLINE,20140310,20220408,1365-3156 (Electronic) 1360-2276 (Linking),19,2014 Feb,Expansion of the dengue transmission area in Brazil: the role of climate and cities.,159-68,10.1111/tmi.12227 [doi],"OBJECTIVES: To examine the spatial and temporal patterns of the recent expansion of dengue transmission area in Brazil (2001-2012) with the aim to identify pathways and constraints to dengue diffusion. METHODS: Synthetic indicators were calculated to characterise timing (year of first dengue outbreak), permanence (number of years with dengue outbreaks) and intensity (outbreak occurrence). The indicators were used to map dengue diffusion and compare cities within different climatic zones, with varying population densities. RESULTS: Currently, a large portion of the country comprises a dengue transmission area, but cities situated in the mesothermal zone, in the south, and remote areas, in the north, are relatively exempt. Diffusion waves are spread from metropolitan areas towards medium and small cities generating outbreaks in their influence region. However, long-term permanence of transmission depends on the existence of a favourable climate, abundant population and connectivity. CONCLUSIONS: Large and warm cities sustain and spread dengue viruses, for which specific dengue control measures must be developed. The concentration of outbreaks along climate transition fringes indicates a boundary between two transmission regimes and raises awareness to the effects of ongoing climatic and socio-economic changes.","['Barcellos, Christovam', 'Lowe, Rachel']","['Barcellos C', 'Lowe R']",,"['Instituto de Comunicacao e Informacao Cientifica e Tecnologica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20131129,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Brazil/epidemiology', '*Cities', '*Climate', 'Dengue/*epidemiology/transmission/virology', '*Dengue Virus', '*Disease Outbreaks', 'Humans']",,2013/11/30 06:00,2014/03/13 06:00,['2013/11/30 06:00'],"['2013/11/30 06:00 [entrez]', '2013/11/30 06:00 [pubmed]', '2014/03/13 06:00 [medline]']",['10.1111/tmi.12227 [doi]'],ppublish,Trop Med Int Health. 2014 Feb;19(2):159-68. doi: 10.1111/tmi.12227. Epub 2013 Nov 29.,2,['(c) 2013 John Wiley & Sons Ltd.'],['NOTNLM'],"['climate change', 'dengue epidemics', 'disease diffusion', 'urban health']",,,,,,,,,,,,,,,,,,,
34154705,NLM,MEDLINE,20211027,20220129,2050-084X (Electronic) 2050-084X (Linking),10,2021 Jun 22,Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes.,,10.7554/eLife.67460 [doi] e67460,"BACKGROUND: Early identification of severe dengue patients is important regarding patient management and resource allocation. We investigated the association of 10 biomarkers (VCAM-1, SDC-1, Ang-2, IL-8, IP-10, IL-1RA, sCD163, sTREM-1, ferritin, CRP) with the development of severe/moderate dengue (S/MD). METHODS: We performed a nested case-control study from a multi-country study. A total of 281 S/MD and 556 uncomplicated dengue cases were included. RESULTS: On days 1-3 from symptom onset, higher levels of any biomarker increased the risk of developing S/MD. When assessing together, SDC-1 and IL-1RA were stable, while IP-10 changed the association from positive to negative; others showed weaker associations. The best combinations associated with S/MD comprised IL-1RA, Ang-2, IL-8, ferritin, IP-10, and SDC-1 for children, and SDC-1, IL-8, ferritin, sTREM-1, IL-1RA, IP-10, and sCD163 for adults. CONCLUSIONS: Our findings assist the development of biomarker panels for clinical use and could improve triage and risk prediction in dengue patients. FUNDING: This study was supported by the EU's Seventh Framework Programme (FP7-281803 IDAMS), the WHO, and the Bill and Melinda Gates Foundation.","['Vuong, Nguyen Lam', 'Lam, Phung Khanh', 'Ming, Damien Keng Yen', 'Duyen, Huynh Thi Le', 'Nguyen, Nguyet Minh', 'Tam, Dong Thi Hoai', 'Duong Thi Hue, Kien', 'Chau, Nguyen Vv', 'Chanpheaktra, Ngoun', 'Lum, Lucy Chai See', 'Pleites, Ernesto', 'Simmons, Cameron P', 'Rosenberger, Kerstin D', 'Jaenisch, Thomas', 'Bell, David', 'Acestor, Nathalie', 'Halleux, Christine', 'Olliaro, Piero L', 'Wills, Bridget A', 'Geskus, Ronald B', 'Yacoub, Sophie']","['Vuong NL', 'Lam PK', 'Ming DKY', 'Duyen HTL', 'Nguyen NM', 'Tam DTH', 'Duong Thi Hue K', 'Chau NV', 'Chanpheaktra N', 'Lum LCS', 'Pleites E', 'Simmons CP', 'Rosenberger KD', 'Jaenisch T', 'Bell D', 'Acestor N', 'Halleux C', 'Olliaro PL', 'Wills BA', 'Geskus RB', 'Yacoub S']","['ORCID: 0000-0003-2684-3041', 'ORCID: 0000-0001-7968-473X', 'ORCID: 0000-0003-3125-6378', 'ORCID: 0000-0002-5960-7849', 'ORCID: 0000-0002-7452-4208', 'ORCID: 0000-0002-9039-7392', 'ORCID: 0000-0002-7010-6340', 'ORCID: 0000-0001-9086-8804', 'ORCID: 0000-0002-2740-3155']","['Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.', 'Department of Infectious Disease, Imperial College London, London, United Kingdom.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Hospital for Tropical Diseases, Ho Chi Minh city, Viet Nam.', 'Angkor Hospital for Children, Siem Reap, Cambodia.', 'University of Malaya Medical Centre, Kuala Lumpur, Malaysia.', 'Hospital Nacional de Ninos Benjamin Bloom, San Salvador, El Salvador.', 'Centre for Tropical Medicine and Global health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.', 'Institute for Vector-Borne Disease, Monash University, Clayton, Australia.', 'Section Clinical Tropical Medicine, Department for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.', 'Section Clinical Tropical Medicine, Department for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.', 'Heidelberg Institute of Global Health (HIGH), Heidelberg University Hospital, Heidelberg, Germany.', 'Independent consultant, Issaquah, United States.', 'Consultant, Intellectual Ventures, Global Good Fund, Bellevue, United States.', 'UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland.', 'Centre for Tropical Medicine and Global health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Centre for Tropical Medicine and Global health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Centre for Tropical Medicine and Global health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.', 'Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Viet Nam.', 'Centre for Tropical Medicine and Global health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, Non-U.S. Gov't""]",20210622,England,Elife,eLife,101579614,"['0 (Biomarkers)', '0 (Cytokines)']",IM,"['Adolescent', 'Adult', 'Biomarkers/blood', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Cytokines/blood/metabolism', 'Dengue/*blood/*metabolism/pathology', 'Female', 'Humans', 'Inflammation/*metabolism', 'Male', 'Young Adult']",PMC8331184,2021/06/23 06:00,2021/10/28 06:00,['2021/06/22 05:42'],"['2021/02/11 00:00 [received]', '2021/06/11 00:00 [accepted]', '2021/06/23 06:00 [pubmed]', '2021/10/28 06:00 [medline]', '2021/06/22 05:42 [entrez]']","['67460 [pii]', '10.7554/eLife.67460 [doi]']",epublish,Elife. 2021 Jun 22;10:e67460. doi: 10.7554/eLife.67460.,,"['(c) 2021, Vuong et al.']",['NOTNLM'],"['biomarkers', 'dengue', 'infectious disease', 'medicine', 'microbiology', 'prognostic', 'virus']","['NV, PL, HD, NN, DT, KD, NC, NC, EP, CS, KR, DB, NA, CH, PO No competing interests', 'declared, DM reports receiving personal fees from the Wellcome Trust (grant', 'number 215010/Z/18/Z), during the conduct of the study. LL reports receiving', 'personal fees from ROCHE Advisory Board on Severe Dengue. TJ reports receiving', 'personal fees as members of the ROCHE Advisory Board on Severe Dengue, outside', 'the submitted work. BW reports personal fees as a member of the Data Monitoring', 'and Adjudication Committees for the Takeda dengue vaccine trials and as a member', 'of the ROCHE Advisory Board on Severe Dengue, outside the submitted work. RG', 'reports receiving personal fees from the Wellcome Trust (grant number', '106680/Z/14/Z), during the conduct of the study. SY reports receiving personal', 'fees as a member of the ROCHE Advisory Board on Severe Dengue, for work on', 'Janssen Pharmaceuticals Advisory Board for Dengue Antiviral Development, and from', 'the Wellcome Trust (grant number 106680/Z/14/Z).']",,"['WT_/Wellcome Trust/United Kingdom', '001/WHO_/World Health Organization/International', '106680/Z/14/Z/WT_/Wellcome Trust/United Kingdom', '215010/Z/18/Z/WT_/Wellcome Trust/United Kingdom']",,,,,,,,,,,,,,,,
25912612,NLM,MEDLINE,20151014,20181202,1532-2742 (Electronic) 0163-4453 (Linking),71,2015 Sep,Epidemiologic characteristics of dengue in China (2010-2014).,397-9,S0163-4453(15)00111-5 [pii] 10.1016/j.jinf.2015.04.018 [doi],,"['Wang, Ligui', 'Yang, Guang', 'Jia, Leili', 'Zhu, Jiangong', 'Xie, Jing', 'Li, Peng', 'Qiu, Shaofu', 'Hao, Rongzhang', 'Wu, Zhihao', 'Pu, Wei', 'Sun, Yansong', 'Li, Zhenjun', 'Song, Hongbin']","['Wang L', 'Yang G', 'Jia L', 'Zhu J', 'Xie J', 'Li P', 'Qiu S', 'Hao R', 'Wu Z', 'Pu W', 'Sun Y', 'Li Z', 'Song H']",,"['Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Clinical Diagnostic Center, 302 Hospital of PLA, 100 Xi-Si-Huan-Zhong-Lu Street, Fengtai District, Beijing 100039, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', ""The Center for Health Information of People's Liberation Army, Beijing, China."", 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China. Electronic address: lizhenjun@icdc.cn.', 'Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, China. Electronic address: hongbinsong@263.net.']",['eng'],"['Comment', 'Letter', ""Research Support, Non-U.S. Gov't""]",20150423,England,J Infect,The Journal of infection,7908424,,IM,"['Dengue/*diagnosis/*epidemiology', 'Dengue Virus/*physiology', 'Humans']",,2015/04/29 06:00,2015/10/16 06:00,['2015/04/28 06:00'],"['2015/03/11 00:00 [received]', '2015/04/17 00:00 [revised]', '2015/04/18 00:00 [accepted]', '2015/04/28 06:00 [entrez]', '2015/04/29 06:00 [pubmed]', '2015/10/16 06:00 [medline]']","['S0163-4453(15)00111-5 [pii]', '10.1016/j.jinf.2015.04.018 [doi]']",ppublish,J Infect. 2015 Sep;71(3):397-9. doi: 10.1016/j.jinf.2015.04.018. Epub 2015 Apr 23.,3,,,,,,,,['J Infect. 2014 Nov;69 Suppl 1:S77-86. PMID: 25225163'],,,,,,,,,,,,,,
8599146,NLM,MEDLINE,19960424,20061115,0036-3634 (Print) 0036-3634 (Linking),37 Suppl,1995,[Dengue and hemorrhagic dengue: the clinical aspects].,S29-44,,"Dengue is a viral disease with clinical features that vary in intensity according to certain host and viral strain characteristics. Dengue hemorrhagic fever is practically a new clinical entity for the majority of physicians in the Americas and therefore the need to disseminate the most important clinical and epidemiological features that allow for the opportune diagnosis and therapy. The clinical spectrum of the disease includes asymptomatic to severe hemorrhagic forms and each stage has its own signs and symptoms. This clinical description explores the physiological mechanisms involved in the pathogenesis of dengue hemorrhagic fever. This paper gives special emphasis to the alarm signs that foretell the presentation of the shock syndrome requiring emergency treatment and advances a classification scheme for epidemics. This scheme identifies the type of treatment and which patients need observation, laboratory tests and hospital care.","['Martinez-Torres, E']",['Martinez-Torres E'],,"['Hospital Pediatrico William Soler, Habana, Cuba.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Dengue/classification/*diagnosis/physiopathology/therapy', 'Diagnosis, Differential', 'Humans']",,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1995;37 Suppl:S29-44.,,,,,,,,107,,Dengue y dengue hemorragico: aspectos clinicos.,,,,,,,,,,,,,
3048296,NLM,MEDLINE,19881103,20141120,0004-4849 (Print) 0004-4849 (Linking),80,1988 Jun,Neurological disorders associated to dengue infection.,208-11,,,"['Jimenez, D R', 'Santana, J L', 'Ramirez-Ronda, C H']","['Jimenez DR', 'Santana JL', 'Ramirez-Ronda CH']",,,['eng'],"['Journal Article', 'Review']",,Puerto Rico,Bol Asoc Med P R,Boletin de la Asociacion Medica de Puerto Rico,7505267,,IM,"['Adolescent', 'Adult', 'Dengue/*complications/epidemiology/pathology', 'Encephalitis/etiology', 'Global Health', 'Humans', 'Middle Aged', 'Nervous System Diseases/*etiology/pathology']",,1988/06/01 00:00,1988/06/01 00:01,['1988/06/01 00:00'],"['1988/06/01 00:00 [pubmed]', '1988/06/01 00:01 [medline]', '1988/06/01 00:00 [entrez]']",,ppublish,Bol Asoc Med P R. 1988 Jun;80(6):208-11.,6,,,,,,,7,,,,,,,,,,,,,,,
1983046,NLM,MEDLINE,19910729,20181130,0125-1562 (Print) 0125-1562 (Linking),21,1990 Dec,Dengue and dengue hemorrhagic fever.,520-1,,,"['Lam, S K']",['Lam SK'],,,['eng'],"['Congress', 'Editorial']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*epidemiology/immunology/prevention & control', '*Global Health', 'Humans', 'Thailand/epidemiology']",,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):520-1.,4,,,,,,,,,,,,,,,,,,,,,,
31815826,NLM,MEDLINE,20201030,20210201,1532-0987 (Electronic) 0891-3668 (Linking),39,2020 Feb,"Clinical Profile, Liver Dysfunction and Outcome of Dengue Infection in Children: A Prospective Observational Study.",97-101,10.1097/INF.0000000000002519 [doi],"BACKGROUND: Liver involvement in dengue illness is common and can lead to acute liver failure (ALF). No single method can effectively identify patients at risk for disease progression and bad outcome. We aimed to determine the relationship between liver dysfunction, kinetics of liver function tests (LFTs) and severity of hepatitis on the outcome in pediatric dengue illness. METHODS: We conducted a prospective observational study of hospitalized children (1-12 years) with dengue infection (July 2014-July 2015). Serial monitoring of LFTs was done in confirmed dengue cases. Patients were classified into non-severe (NSD) and severe dengue (SD). Severity of hepatitis was graded: mild, moderate and severe hepatitis. Events were noted during hospitalization. RESULTS: One hundred two children (66, boys), median age 72 (48-96) months, were analyzed (NSD, n = 41; SD, n = 61). Elevated transaminases (92%) was the most common abnormality; aspartate transaminase (AST) and alanine transaminase (ALT) in 87% and 82%, respectively. Maximum abnormalities in LFTs peaked at day 5 (AST, ALT) and day 7 (Alkaline Phosphatase [ALP], gamma-glutamyl transferase) of illness. Elevated transaminases was found to be higher in SD than NSD (100% vs. 80%, P = 0.006). Severe hepatitis developed organ dysfunction such as altered sensorium (P < 0.001), ALF (P < 0.001), acute kidney injury (P < 0.001) and shock (P < 0.001), more commonly than those with mild to moderate hepatitis. Fourteen patients died, two-thirds of whom had severe hepatitis (P < 0.001). Using binary logistic regression, presence of severe hepatitis and shock at presentation was an independent predictor for ALF (odds ratio: 77; 95% confidence interval : 13-457, P < 0.001) and mortality (odds ratio: 55; 95% confidence interval: 4.6-66, P < 0.001), respectively. CONCLUSIONS: Many children with dengue have liver involvement. Severe hepatitis in dengue is associated with significant organ dysfunction and poor outcome.","['Prasad, Durga', 'Bhriguvanshi, Arpita']","['Prasad D', 'Bhriguvanshi A']",,"[""Department of Pediatrics King George's Medical University Lucknow 226003, Uttar Pradesh, India.""]",['eng'],"['Journal Article', 'Observational Study']",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,['0 (Biomarkers)'],IM,"['Biomarkers', 'Child', 'Child, Preschool', 'Dengue/*complications/diagnosis/epidemiology/*virology', 'Female', 'Humans', 'Infant', 'Liver Diseases/*diagnosis/epidemiology/*etiology', 'Liver Function Tests', 'Male', 'Patient Outcome Assessment', 'Prospective Studies', 'Severity of Illness Index', 'Symptom Assessment']",,2019/12/10 06:00,2020/10/31 06:00,['2019/12/10 06:00'],"['2019/12/10 06:00 [pubmed]', '2020/10/31 06:00 [medline]', '2019/12/10 06:00 [entrez]']","['00006454-202002000-00002 [pii]', '10.1097/INF.0000000000002519 [doi]']",ppublish,Pediatr Infect Dis J. 2020 Feb;39(2):97-101. doi: 10.1097/INF.0000000000002519.,2,,,,,,,,,,,,,,,,,,,,,,
30408524,NLM,MEDLINE,20190507,20190507,1873-0442 (Electronic) 1477-8939 (Linking),28,2019 Mar-Apr,The Grand Magal of Touba in the time of a dengue outbreak in Senegal.,107-108,S1477-8939(18)30393-4 [pii] 10.1016/j.tmaid.2018.11.002 [doi],,"['Sokhna, Cheikh', ""Goumballa, N'Diaw"", 'Gautret, Philippe']","['Sokhna C', 'Goumballa N', 'Gautret P']",,"['Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Mediterranee Infection, Marseille, France.', 'VITROME, Campus International IRD-UCAD, Dakar, Senegal.', 'Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Mediterranee Infection, Marseille, France. Electronic address: philippe.gautret@ap-hm.fr.']",['eng'],['Letter'],20181105,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,,IM,"['Crowding', 'Dengue/epidemiology/*prevention & control/transmission', 'Dengue Virus', 'Disease Outbreaks/*prevention & control', 'Humans', 'Senegal/epidemiology', '*Travel']",,2018/11/09 06:00,2019/05/08 06:00,['2018/11/09 06:00'],"['2018/11/02 00:00 [received]', '2018/11/04 00:00 [accepted]', '2018/11/09 06:00 [pubmed]', '2019/05/08 06:00 [medline]', '2018/11/09 06:00 [entrez]']","['S1477-8939(18)30393-4 [pii]', '10.1016/j.tmaid.2018.11.002 [doi]']",ppublish,Travel Med Infect Dis. 2019 Mar-Apr;28:107-108. doi: 10.1016/j.tmaid.2018.11.002. Epub 2018 Nov 5.,,,,,,,,,,,,,,,,,,,,,,,
11952282,NLM,MEDLINE,20020418,20080214,0149-2195 (Print) 0149-2195 (Linking),51,2002 Apr 5,"Imported dengue--United States, 1999 and 2000.",281-3,,"Dengue is a mosquito-transmitted acute viral illness caused by any of the four dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Dengue is endemic in most tropical and subtropical areas of the world and has occurred among U.S. residents returning from travel to such areas. CDC maintains a laboratory-based passive surveillance system for imported dengue among U.S. residents (laboratory-diagnosed dengue in a U.S. resident living in an area without known authochthonous dengue transmission, with travel history outside the United States in the 14 days before symptom onset). The system relies on reports by clinicians to state health departments, which forward patient specimens to CDC for diagnostic testing. This report summarizes information about imported dengue cases among U.S. residents during 1999-2000. The findings indicate that dengue continues to cause disease in U.S. travelers abroad. Travelers to tropical areas should protect themselves from mosquito bites, and health-care providers should consider dengue in the differential diagnosis of illness for patients who have returned recently from such areas.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/transmission', 'Female', 'Humans', 'Male', 'Middle Aged', '*Travel', 'United States/epidemiology']",,2002/04/16 10:00,2002/04/19 10:01,['2002/04/16 10:00'],"['2002/04/16 10:00 [pubmed]', '2002/04/19 10:01 [medline]', '2002/04/16 10:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 2002 Apr 5;51(13):281-3.,13,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
23926138,NLM,MEDLINE,20131106,20211021,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),89,2013 Aug,Dogma in classifying dengue disease.,198-201,10.4269/ajtmh.13-0157 [doi],,"['Farrar, Jeremy J', 'Hien, Tran T', 'Horstick, Olaf', 'Hung, Nguyen T', 'Jaenisch, Thomas', 'Junghanns, Thomas', 'Kroeger, Axel', 'Laksono, Ida S', 'Lum, Lucy', 'Martinez, Eric', 'Simmons, Cameron P', 'Tami, Adriana', 'Tomashek, Kay M', 'Wills, Bridget A']","['Farrar JJ', 'Hien TT', 'Horstick O', 'Hung NT', 'Jaenisch T', 'Junghanns T', 'Kroeger A', 'Laksono IS', 'Lum L', 'Martinez E', 'Simmons CP', 'Tami A', 'Tomashek KM', 'Wills BA']",,,['eng'],"['Comment', 'Journal Article']",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Dengue/*classification/*diagnosis', 'Humans', '*World Health Organization']",PMC3741235,2013/08/09 06:00,2013/11/07 06:00,['2013/08/09 06:00'],"['2013/08/09 06:00 [entrez]', '2013/08/09 06:00 [pubmed]', '2013/11/07 06:00 [medline]']",['10.4269/ajtmh.13-0157 [doi]'],ppublish,Am J Trop Med Hyg. 2013 Aug;89(2):198-201. doi: 10.4269/ajtmh.13-0157.,2,,,,,,['089276/Wellcome Trust/United Kingdom'],,['Am J Trop Med Hyg. 2013 Feb;88(2):212-5. PMID: 23390220'],,,,,,,,,,,,,,
29945778,NLM,MEDLINE,20190219,20190320,1878-0067 (Electronic) 1878-0067 (Linking),25,2018 Dec,Estimating the effective reproduction number of dengue considering temperature-dependent generation intervals.,101-111,S1755-4365(17)30090-7 [pii] 10.1016/j.epidem.2018.05.011 [doi],"The effective reproduction number, R(t), is a measure of transmission that can be calculated from standard incidence data to timely detect the beginning of epidemics. It has being increasingly used for surveillance of directly transmitted diseases. However, current methods for R(t) estimation do not apply for vector borne diseases, whose transmission cycle depends on temperature. Here we propose a method that provides dengue's R(t) estimates in the presence of temperature-mediated seasonality and apply this method to simulated and real data from two cities in Brazil where dengue is endemic. The method shows good precision in the simulated data. When applied to the real data, it shows differences in the transmission profile of the two cities and identifies periods of higher transmission.","['Codeco, Claudia T', 'Villela, Daniel A M', 'Coelho, Flavio C']","['Codeco CT', 'Villela DAM', 'Coelho FC']",,"['Scientific Computing Program/Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address: claudia.codeco@fiocruz.br.', 'Scientific Computing Program/Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.', 'School of Applied Mathematics/Getulio Vargas Foundation, Rio de Janeiro, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20180531,Netherlands,Epidemics,Epidemics,101484711,,IM,"['Aedes', 'Animals', '*Basic Reproduction Number', 'Brazil/epidemiology', 'Dengue/*epidemiology/*transmission', 'Epidemics', 'Humans', 'Seasons', '*Temperature']",,2018/06/28 06:00,2019/03/21 06:00,['2018/06/28 06:00'],"['2017/06/19 00:00 [received]', '2018/05/14 00:00 [revised]', '2018/05/29 00:00 [accepted]', '2018/06/28 06:00 [pubmed]', '2019/03/21 06:00 [medline]', '2018/06/28 06:00 [entrez]']","['S1755-4365(17)30090-7 [pii]', '10.1016/j.epidem.2018.05.011 [doi]']",ppublish,Epidemics. 2018 Dec;25:101-111. doi: 10.1016/j.epidem.2018.05.011. Epub 2018 May 31.,,['Copyright (c) 2018 The Authors. Published by Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Dengue', 'Generation interval', 'Reproductive number']",,,,,,,,,,,,,,,,,,,
23113325,NLM,MEDLINE,20121106,20161201,0049-8114 (Print) 0049-8114 (Linking),87,2012 Oct 26,"Outbreak news. Dengue fever in Madeira,Portugal.",413,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission', '*Disease Outbreaks', 'Disease Vectors', 'Humans', 'Portugal/epidemiology']",,2012/11/02 06:00,2012/11/07 06:00,['2012/11/02 06:00'],"['2012/11/02 06:00 [entrez]', '2012/11/02 06:00 [pubmed]', '2012/11/07 06:00 [medline]']",,ppublish,Wkly Epidemiol Rec. 2012 Oct 26;87(43):413.,43,,,,,,,,,,,,,,,,,,,,,,
8924778,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[New epidemiological aspects of dengue].,163-4; discussion 165,,"Since the 1940s, the dengue epidemics occur more and more often in the Pacific islands with an increased severity. For example, in New Caledonia, outbreaks of dengue-like diseases have been reported since the end of the last century but the first epidemic due to an identified virus occurred in 1942-1943 and was caused by the DEN-1 type. The next, due to the DEN-2 type, was reported thirty years later, in 1972-1973. After that, three outbreaks burst between 1975 and 1990, caused successively by dengue types 1, 4 and 3 but from 1985, human strains of different types were isolated at the same time. The vector control measures, mainly aerial ULV spraying had a variable efficacy. The most important vector was Aedes aegypti but dengue virus strains were also isolated from other mosquito species (Aedes vigilax, Culex annulirostris, C. bitaeniorhynchus, Coquillettidia xanthogaster); their role in the interhuman transmission of dengue was not demonstrated. In New Caledonia, the development of international travels, an extension of suburbs and an increased insecticide resistance of Ae. aegypti are the obvious causes of the problem but an unknown transmission cycle, involving different hosts and vectors may also be suspected.","['Fauran, P']",['Fauran P'],,"['Le Chantilly, Nice.']",['fre'],"['English Abstract', 'Historical Article', 'Journal Article', 'Review']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Animals', 'Dengue/*epidemiology/history/transmission/virology', 'Dengue Virus/classification/isolation & purification', 'History, 20th Century', 'Humans', 'Insect Vectors', 'Mosquito Control', 'Pacific Islands/epidemiology']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):163-4; discussion 165.,2,,,,,,,4,,Nouveaux aspects epidemiologiques de la dengue.,,,,,,,,,,,,,
25159130,NLM,MEDLINE,20150914,20221207,1708-8305 (Electronic) 1195-1982 (Linking),22,2015 Jan-Feb,Dengue-associated hemophagocytic syndrome in a Japanese traveler: a case report.,64-6,10.1111/jtm.12158 [doi],"Hemophagocytic syndrome (HPS) can develop as a complication of dengue in rare cases, but its relationship with dengue is not well known. We report a case of dengue-associated HPS with liver involvement and coagulopathy. The patient, a Japanese female traveler who had recently returned from Thailand, had severe complications of dengue infection, but she recovered fully with symptomatic treatment.","['Kobayashi, Ken-ichiro', 'Hikone, Mayu', 'Sakamoto, Naoya', 'Iwabuchi, Sentaro', 'Kashiura, Masahiro', 'Takasaki, Tomohiko', 'Fujita, Hiroshi', 'Ohnishi, Kenji']","['Kobayashi K', 'Hikone M', 'Sakamoto N', 'Iwabuchi S', 'Kashiura M', 'Takasaki T', 'Fujita H', 'Ohnishi K']",,"['Department of Infectious Diseases, Tokyo, Japan.']",['eng'],"['Case Reports', 'Journal Article']",20140827,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Asian People', 'Dengue/*complications/*diagnosis/drug therapy', 'Diagnosis, Differential', 'Female', 'Humans', 'Lymphohistiocytosis, Hemophagocytic/complications/*diagnosis', 'Thailand', '*Travel']",,2014/08/28 06:00,2015/09/15 06:00,['2014/08/28 06:00'],"['2013/07/30 00:00 [received]', '2014/05/07 00:00 [revised]', '2014/05/12 00:00 [accepted]', '2014/08/28 06:00 [entrez]', '2014/08/28 06:00 [pubmed]', '2015/09/15 06:00 [medline]']",['10.1111/jtm.12158 [doi]'],ppublish,J Travel Med. 2015 Jan-Feb;22(1):64-6. doi: 10.1111/jtm.12158. Epub 2014 Aug 27.,1,['(c) 2014 International Society of Travel Medicine.'],,,,,,,,,,,,,,,,,,,,,
24161462,NLM,MEDLINE,20140928,20211021,1095-8541 (Electronic) 0022-5193 (Print) 0022-5193 (Linking),342,2014 Feb 7,Country- and age-specific optimal allocation of dengue vaccines.,15-22,S0022-5193(13)00498-0 [pii] 10.1016/j.jtbi.2013.10.006 [doi],"Several dengue vaccines are under development, and some are expected to become available imminently. Concomitant with the anticipated release of these vaccines, vaccine allocation strategies for dengue-endemic countries in Southeast Asia and Latin America are currently under development. We developed a model of dengue transmission that incorporates the age-specific distributions of dengue burden corresponding to those in Thailand and Brazil, respectively, to determine vaccine allocations that minimize the incidence of dengue hemorrhagic fever, taking into account limited availability of vaccine doses in the initial phase of production. We showed that optimal vaccine allocation strategies vary significantly with the demographic burden of dengue hemorrhagic fever. Consequently, the strategy that is optimal for one country may be sub-optimal for another country. More specifically, we showed that, during the first years following introduction of a dengue vaccine, it is optimal to target children for dengue mass vaccination in Thailand, whereas young adults should be targeted in Brazil.","['Ndeffo Mbah, Martial L', 'Durham, David P', 'Medlock, Jan', 'Galvani, Alison P']","['Ndeffo Mbah ML', 'Durham DP', 'Medlock J', 'Galvani AP']",,"['School of Public Health, Yale University Suite 200, 135 College Street, New Haven, CT 06510, USA. Electronic address: martial.ndeffo-mbah@yale.edu.', 'School of Public Health, Yale University Suite 200, 135 College Street, New Haven, CT 06510, USA.', 'Department of Biomedical Sciences, Oregon State University, Corvallis, OR, USA.', 'School of Public Health, Yale University Suite 200, 135 College Street, New Haven, CT 06510, USA.']",['eng'],['Journal Article'],20131023,England,J Theor Biol,Journal of theoretical biology,0376342,['0 (Dengue Vaccines)'],IM,"['Adult', 'Aging/*physiology', 'Asia, Southeastern/epidemiology', 'Dengue/*epidemiology/immunology/*prevention & control/transmission', 'Dengue Vaccines/*immunology', 'Geography', 'Humans', 'Latin America/epidemiology', 'Mass Vaccination']",PMC3947060,2013/10/29 06:00,2014/10/01 06:00,['2013/10/29 06:00'],"['2012/11/22 00:00 [received]', '2013/10/09 00:00 [revised]', '2013/10/16 00:00 [accepted]', '2013/10/29 06:00 [entrez]', '2013/10/29 06:00 [pubmed]', '2014/10/01 06:00 [medline]']","['S0022-5193(13)00498-0 [pii]', '10.1016/j.jtbi.2013.10.006 [doi]']",ppublish,J Theor Biol. 2014 Feb 7;342:15-22. doi: 10.1016/j.jtbi.2013.10.006. Epub 2013 Oct 23.,,['(c) 2013 Published by Elsevier Ltd.'],['NOTNLM'],"['Dengue hemorrhagic fever', 'Dengue vaccine', 'Mathematical modeling', 'Optimization']",,,['U01 GM087719/GM/NIGMS NIH HHS/United States'],,,,['NIHMS534691'],,,,,,,,,,,,
10419380,NLM,MEDLINE,19990719,20190516,0074-0276 (Print) 0074-0276 (Linking),94,1999 May-Jun,"Dengue in the State of Rio de Janeiro, Brazil, 1986-1998.",297-304,,"This paper presents epidemiological, laboratory, and clinical data on 12 years of dengue virus activity in the State of Rio de Janeiro from the time the disease was first confirmed virologically in April 1986 through April 1998. DEN-1 and DEN-2 viruses are the serotypes circulating in the state and were responsible for the epidemics reported during the last 12 years. The results published here show both the impact of dengue virus infections on the population and laboratory advances that have improved dengue diagnosis.","['Nogueira, R M', 'Miagostovich, M P', 'Schatzmayr, H G', 'dos Santos, F B', 'de Araujo, E S', 'de Filippis, A M', 'de Souza, R V', 'Zagne, S M', 'Nicolai, C', 'Baran, M', 'Teixeira Filho, G']","['Nogueira RM', 'Miagostovich MP', 'Schatzmayr HG', 'dos Santos FB', 'de Araujo ES', 'de Filippis AM', 'de Souza RV', 'Zagne SM', 'Nicolai C', 'Baran M', 'Teixeira Filho G']",,"['Laboratorio de Flavivirus, Departamento de Virologia, Instituto Oswaldo Cruz, Rio de Janeiro, RJ, Brasil. rita@gene.dbbm.fiocruz.br']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Brazil,Mem Inst Oswaldo Cruz,Memorias do Instituto Oswaldo Cruz,7502619,,IM,"['Brazil/epidemiology', 'Dengue/diagnosis/*epidemiology/virology', 'Dengue Virus/*isolation & purification', '*Disease Outbreaks', 'Humans']",,1999/07/27 00:00,1999/07/27 00:01,['1999/07/27 00:00'],"['1999/07/27 00:00 [pubmed]', '1999/07/27 00:01 [medline]', '1999/07/27 00:00 [entrez]']","['S0074-02761999000300004 [pii]', '10.1590/s0074-02761999000300004 [doi]']",ppublish,Mem Inst Oswaldo Cruz. 1999 May-Jun;94(3):297-304. doi: 10.1590/s0074-02761999000300004.,3,,,,,,,,,,,,,,,,,,,,,,
8924768,NLM,MEDLINE,19961115,20081121,0037-9085 (Print) 0037-9085 (Linking),89,1996,"[Aedes aegypti in French Guiana. Some aspects of history, general ecology and vertical transmission of the dengue virus].",115-9,,"Aedes aegypti is suspected to be present in the country since the late 18th century, and was responsible of urban yellow fever epidemics in the last century. This mosquito was identified for the first time in French Guiana in 1902. More recently, in 1940, an eradication campaign started and Aedes aegypti was eradicated between 1950 and 1963, date of the reinfestation. During the past 30 years, some dengue outbreaks occurred every 2 to 6 years, and the first dengue haemorrhagic fever epidemic spread over the country in 1992. Actually, Ae. aegypti is distributed almost all inhabited areas of French Guiana: in the towns, villages, smaller human settlements, and was also found in a wild area. The most frequent Ae. aegypti breeding-sources are the outside discarded small containers, other less frequent breeding-sites are the outside flower pots and the outside big containers. The type of breeding-source significantly influences the duration of larval and pupal development. In French Guiana, Ae. aegypti is the only vector of dengue. The vertical transmission of dengue viruses under field conditions was demonstrated. Dengue is thus endemic in the country and has almost the same distribution as Ae. aegypti, with most probably the same possibilities of extension. Ae. aegypti can be considered not only as vector and an amplificator of dengue in French Guiana, but also as a reservoir, even if occasional.","['Fouque, F', 'Carinci, R']","['Fouque F', 'Carinci R']",,"[""Laboratoire d'eptomologie medicale, Institut Pasteur de Guyane francaise, Cayenne, Guyane francaise.""]",['fre'],"['English Abstract', 'Historical Article', 'Journal Article', 'Review']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Aedes/*growth & development', 'Animals', 'Dengue/epidemiology/*history/*transmission/virology', 'Ecology', 'French Guiana/epidemiology', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', '*Infectious Disease Transmission, Vertical']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):115-9.,2,,,,,,,7,,"Aedes Aegypti en Guyane Franaise. Quelques aspects de i'histoire, de l'ecologie generale et de la transmission verticale des virus de la dengue.",,,,,,,,,,,,,
23390220,NLM,MEDLINE,20130401,20211021,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),88,2013 Feb,Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition.,212-215,10.4269/ajtmh.12-0197 [doi],,"['Halstead, Scott B']",['Halstead SB'],,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Dengue/*classification/*diagnosis/pathology', 'Dengue Virus/pathogenicity', 'Guidelines as Topic', 'Hemorrhage/pathology', 'Humans', 'Interviews as Topic', '*World Health Organization']",PMC3583306,2013/02/08 06:00,2013/04/02 06:00,['2013/02/08 06:00'],"['2013/02/08 06:00 [entrez]', '2013/02/08 06:00 [pubmed]', '2013/04/02 06:00 [medline]']",['10.4269/ajtmh.12-0197 [doi]'],ppublish,Am J Trop Med Hyg. 2013 Feb;88(2):212-215. doi: 10.4269/ajtmh.12-0197.,2,,,,,['Am J Trop Med Hyg. 2013 Aug;89(2):198-201. PMID: 23926138'],,,,,,,,,,,,,,,,,
19111871,NLM,MEDLINE,20100319,20090814,1878-3503 (Electronic) 0035-9203 (Linking),103,2009 Sep,Early clinical features of dengue infection in Puerto Rico.,878-84,10.1016/j.trstmh.2008.11.009 [doi],"Early diagnosis of dengue is challenging because the initial symptoms are often non-specific, viraemia may be below detectable levels and serological tests confirm dengue late in the course of illness. Identifying dengue early in the clinical course could be useful in reducing dengue virus transmission in a community. This study analyzed data from 145 laboratory-positive and 293 laboratory-negative dengue cases in Puerto Rico to define the early clinical features of dengue infection in children and adults and to identify the clinical features that predict a laboratory-positive dengue infection. Among children, rash and age were independently associated with laboratory-positive dengue infection. Rash in the absence of cough had a positive predictive value of 100% and a negative predictive value of 82.4% as a paediatric dengue screen. Among adults, eye pain, diarrhoea and absence of upper respiratory symptoms were independently associated with laboratory-positive dengue infection. No useful early predictors of dengue infection among adults were found. Using clinical features may promote earlier identification of a subset of paediatric dengue patients in Puerto Rico. Laboratory confirmation is still necessary for the accurate diagnosis of dengue infection.","['Ramos, Mary M', 'Tomashek, Kay M', 'Arguello, D Fermin', 'Luxemburger, Christine', 'Quinones, Luz', 'Lang, Jean', 'Munoz-Jordan, Jorge L']","['Ramos MM', 'Tomashek KM', 'Arguello DF', 'Luxemburger C', 'Quinones L', 'Lang J', 'Munoz-Jordan JL']",,"['Dengue Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, San Juan, PR 00920-3860, USA. mramos@salud.unm.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20081227,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/epidemiology/prevention & control', 'Early Diagnosis', 'Humans', 'Puerto Rico/epidemiology']",,2008/12/30 09:00,2010/03/20 06:00,['2008/12/30 09:00'],"['2008/07/31 00:00 [received]', '2008/11/12 00:00 [revised]', '2008/11/13 00:00 [accepted]', '2008/12/30 09:00 [entrez]', '2008/12/30 09:00 [pubmed]', '2010/03/20 06:00 [medline]']","['S0035-9203(08)00499-9 [pii]', '10.1016/j.trstmh.2008.11.009 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2009 Sep;103(9):878-84. doi: 10.1016/j.trstmh.2008.11.009. Epub 2008 Dec 27.,9,,,,,,,,,,,,,,,,,,,,,,
31584762,NLM,MEDLINE,20200317,20210110,2590-7379 (Electronic) 0120-4157 (Print) 0120-4157 (Linking),39,2019 Sep 1,"Knowledge, attitudes, and practices about dengue among pupils from rural schools in an endemic area in Colombia.",478-490,10.7705/biomedica.4255 [doi],"INTRODUCTION: Dengue is a public health problem in tropical and subtropical regions of the world. Studies on dengue in rural areas are scarce since the disease is considered mainly urban. OBJECTIVE: To determine the knowledge (K), attitudes (A) and practices (P) of dengue in an endemic area in Colombia. MATERIALS AND METHODS: We conducted a cross-sectional study with 515 pupils (7-16 years old) in 34 rural schools in Anapoima and La Mesa municipalities during 2011. Each KAP category was evaluated independently by a scoring system and then categorized into high, medium or low. RESULTS: Pupils recognized knowledge variables such as the symptoms (fever, bone pain), transmission route (mosquito bites), and mosquito breeding sites (uncovered water tanks, solid waste). Average scores on attitude were high in both municipalities indicating a well-developed perception of disease severity. Seeking treatment in medical centers and self-medication for fever management and the use of mosquito net and space-spraying of insecticides were the most frequently identified practices. DISCUSSION: This is the first KAP dengue study performed in a rural area in Colombia and as such it contributes to the understanding of dengue perceptions by the inhabitants of these areas. It showed a medium level of knowledge about dengue and a lower level of preventive practices in pupils from rural schools. It also showed that pupils considered space-spraying as crucial for vector control. The presence of the vector in rural areas of the country underlines the need to improve surveillance and education to more effectively control the vector and promote prevention methods including community participation.","['Sarmiento-Senior, Diana', 'Matiz, Maria Ines', 'Jaramillo-Gomez, Juan Felipe', 'Olano, Victor Alberto', 'Vargas, Sandra Lucia', 'Alexander, Neal', 'Lenhart, Audrey', 'Stenstrom, Thor Axel', 'Overgaard, Hans Jorgen']","['Sarmiento-Senior D', 'Matiz MI', 'Jaramillo-Gomez JF', 'Olano VA', 'Vargas SL', 'Alexander N', 'Lenhart A', 'Stenstrom TA', 'Overgaard HJ']",,"['Instituto de Salud y Ambiente, Universidad El Bosque, Bogota, D.C., Colombia. sarmientodiana@unbosque.edu.co.']","['eng', 'spa']",['Journal Article'],20190901,Colombia,Biomedica,Biomedica : revista del Instituto Nacional de Salud,8205605,['0 (Insecticides)'],IM,"['Adolescent', 'Breeding', 'Child', 'Colombia', 'Cross-Sectional Studies', '*Dengue/complications/diagnosis/therapy/transmission', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Insect Bites and Stings/virology', 'Insecticides', 'Male', 'Mosquito Nets', '*Rural Population', 'Schools', 'Symptom Assessment']",PMC7357362,2019/10/05 06:00,2020/03/18 06:00,['2019/10/05 06:00'],"['2017/12/18 00:00 [received]', '2019/10/05 06:00 [entrez]', '2019/10/05 06:00 [pubmed]', '2020/03/18 06:00 [medline]']",['10.7705/biomedica.4255 [doi]'],epublish,Biomedica. 2019 Sep 1;39(3):478-490. doi: 10.7705/biomedica.4255.,3,,['NOTNLM'],"['Dengue/prevention & control', 'health knowledge attitudes practice', 'rural health', 'ethnology', 'Colombia']","['Conflicts of interest: The authors have declared that no competing interests', 'exist']",,['MR/R010161/1/MRC_/Medical Research Council/United Kingdom'],,,"Conocimientos, actitudes y practicas sobre dengue en estudiantes de escuelas rurales de un area endemica en Colombia.",,,,,,,,,,,,,
2261667,NLM,MEDLINE,19910207,20041117,0009-0875 (Print) 0009-0875 (Linking),35,1990 Sep,Dengue haemorrhagic fever.,83-7,,,"['Vitarana, T']",['Vitarana T'],,"['Medical Research Institute, Colombo.']",['eng'],['Journal Article'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['Asia, Southeastern/epidemiology', 'Child', 'Child, Preschool', '*Dengue/epidemiology/etiology/mortality', 'Humans', 'Sri Lanka/epidemiology']",,1990/09/01 00:00,1990/09/01 00:01,['1990/09/01 00:00'],"['1990/09/01 00:00 [pubmed]', '1990/09/01 00:01 [medline]', '1990/09/01 00:00 [entrez]']",,ppublish,Ceylon Med J. 1990 Sep;35(3):83-7.,3,,,,,,,,,,,,,,,,,,,,,,
22953405,NLM,MEDLINE,20120924,20161125,0029-6570 (Print) 0029-6570 (Linking),26,2012 Aug 22-28,Raising awareness of dengue fever.,53-6; quiz 58,,"Dengue fever is a disease of increasing relevance to international travellers. Transmitted by the bite of infected mosquitoes, it is recognised as the most common arthropod-borne infection worldwide. With no vaccine available to prevent infection, accurate pre-travel advice and post-travel follow up is necessary. Healthcare professionals who provide advice to overseas travellers need to have a comprehensive understanding of the disease.","['Pye, Jacqueline']",['Pye J'],,"['Complete Healthcare International Pte, Singapore. jacquipye@yahoo.co.uk']",['eng'],['Journal Article'],,England,Nurs Stand,Nursing standard (Royal College of Nursing (Great Britain) : 1987),9012906,,,"['*Awareness', '*Dengue/diagnosis/therapy', 'Education, Nursing, Continuing', 'Humans', 'Seasons', 'United Kingdom']",,2012/09/08 06:00,2012/09/25 06:00,['2012/09/08 06:00'],"['2012/09/08 06:00 [entrez]', '2012/09/08 06:00 [pubmed]', '2012/09/25 06:00 [medline]']",['10.7748/ns2012.08.26.51.53.c9244 [doi]'],ppublish,Nurs Stand. 2012 Aug 22-28;26(51):53-6; quiz 58. doi: 10.7748/ns2012.08.26.51.53.c9244.,51,,,,,,,,,,,,,,,,,,,,,,
20808806,NLM,MEDLINE,20101104,20211028,1932-6203 (Electronic) 1932-6203 (Linking),5,2010 Aug 23,The effects of tertiary and quaternary infections on the epidemiology of dengue.,e12347,10.1371/journal.pone.0012347 [doi] e12347,"The epidemiology of dengue is characterised by irregular epidemic outbreaks and desynchronised dynamics of its four co-circulating virus serotypes. Whilst infection by one serotype appears to convey life-long protection to homologous infection, it is believed to be a risk factor for severe disease manifestations upon secondary, heterologous infection due to the phenomenon of Antibody-Dependent Enhancement (ADE). Subsequent clinical infections are rarely reported and, since the majority of dengue infections are generally asymptomatic, it is not clear if and to what degree tertiary or quaternary infections contribute to dengue epidemiology. Here we investigate the effect of third and subsequent infections on the transmission dynamics of dengue and show that although the qualitative patterns are largely equivalent, the system more readily exhibits the desynchronised serotype oscillations and multi-annual epidemic outbreaks upon their inclusion. More importantly, permitting third and fourth infections significantly increases the force of infection without resorting to high basic reproductive numbers. Realistic age-prevalent patterns and seroconversion rates are therefore easier reconciled with a low value of dengue's transmission potential if allowing for more than two infections; this should have important consequences for dengue control and intervention measures.","['Wikramaratna, Paul S', 'Simmons, Cameron P', 'Gupta, Sunetra', 'Recker, Mario']","['Wikramaratna PS', 'Simmons CP', 'Gupta S', 'Recker M']",,"['Department of Zoology, University of Oxford, Oxford, United Kingdom.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100823,United States,PLoS One,PloS one,101285081,,IM,"['Age Distribution', 'Dengue Virus/*classification/*physiology', 'Humans', 'Incidence', 'Models, Biological', 'Severe Dengue/*epidemiology/transmission/*virology', 'Time Factors']",PMC2925950,2010/09/03 06:00,2010/11/05 06:00,['2010/09/03 06:00'],"['2010/05/26 00:00 [received]', '2010/07/30 00:00 [accepted]', '2010/09/03 06:00 [entrez]', '2010/09/03 06:00 [pubmed]', '2010/11/05 06:00 [medline]']","['10-PONE-RA-19289R1 [pii]', '10.1371/journal.pone.0012347 [doi]']",epublish,PLoS One. 2010 Aug 23;5(8):e12347. doi: 10.1371/journal.pone.0012347.,8,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,"['084368/WT_/Wellcome Trust/United Kingdom', 'BB_/Biotechnology and Biological Sciences Research Council/United Kingdom']",,,,,,,,,,,,,,,,
28138048,NLM,MEDLINE,20170731,20181113,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),96,2017 Mar,"Clinician Survey to Determine Knowledge of Dengue and Clinical Management Practices, Texas, 2014.",708-714,10.4269/ajtmh.16-0367 [doi],"Dengue, a mosquito-borne viral disease, is increasingly being identified as a cause of outbreaks in the United States. During July-December 2013, a total of three south Texas counties reported 53 laboratory-confirmed dengue cases; 26 were locally acquired, constituting the largest outbreak in Texas since 2005. Because dengue outbreaks are expected to continue in south Texas and early case identification and timely treatment can reduce mortality, we sought to determine clinicians' knowledge of dengue and its clinical management. A survey was sent to 2,375 south Texas clinicians; 217 (9%) completed the survey. Approximately half of participants demonstrated knowledge needed to identify dengue cases, including symptoms (56%), early indicators of shock (54%), or timing of thrombocytopenia (48%). Fewer than 20% correctly identified all prevention messages, severe dengue warning signs, or circumstances in which a dengue patient should return for care. Knowledge of clinical management was limited; few participants correctly identified scenarios when plasma leakage occurred (10%) or a crystalloid solution was indicated (7%); however, 45% correctly identified when a blood transfusion was indicated. Because of the ongoing threat of dengue, we recommend clinicians in south Texas receive dengue clinical management training.","['Adam, Jessica K', 'Abeyta, Roman', 'Smith, Brian', 'Gaul, Linda', 'Thomas, Dana L', 'Han, George', 'Sharp, Tyler M', 'Waterman, Stephen H', 'Tomashek, Kay M']","['Adam JK', 'Abeyta R', 'Smith B', 'Gaul L', 'Thomas DL', 'Han G', 'Sharp TM', 'Waterman SH', 'Tomashek KM']",,"['Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Texas Department of State Health Services, Harlingen, Texas.', 'Texas Department of State Health Services, Harlingen, Texas.', 'Texas Department of State Health Services, Austin, Texas.', 'Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.']",['eng'],['Journal Article'],20170406,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Dengue/diagnosis/*epidemiology/*therapy', 'Dengue Virus/isolation & purification', '*Disease Outbreaks', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Physicians', 'Professional Competence/*statistics & numerical data', 'Severe Dengue/diagnosis/epidemiology/therapy', 'Surveys and Questionnaires', 'Texas/epidemiology']",PMC5361550,2017/02/01 06:00,2017/08/02 06:00,['2017/02/01 06:00'],"['2017/02/01 06:00 [pubmed]', '2017/08/02 06:00 [medline]', '2017/02/01 06:00 [entrez]']","['ajtmh.16-0367 [pii]', '10.4269/ajtmh.16-0367 [doi]']",ppublish,Am J Trop Med Hyg. 2017 Mar;96(3):708-714. doi: 10.4269/ajtmh.16-0367. Epub 2017 Apr 6.,3,,,,,,,,,,,,,,,,,,,,,,
34193263,NLM,MEDLINE,20210702,20210704,1756-0500 (Electronic) 1756-0500 (Linking),14,2021 Jun 30,Predictive value of hepatic transaminases during febrile phase as a predictor of a severe form of Dengue: analysis of adult Dengue patients from a tertiary care setting of Sri Lanka.,251,10.1186/s13104-021-05670-0 [doi] 251,"OBJECTIVES: Dengue viral infection is an ongoing epidemic in Sri Lanka, causing significant mortality and morbidity. A descriptive-analytical study was carried out using serologically confirmed Dengue patients during a 6 month period. The relationship between the elevation of hepatic enzymes and severity of Dengue was assessed after stratifying recorded maximum AST/ALT (SGOT/SGPT) values 2-15 times elevated and by the phases of the illness. Sensitivity, specificity, predictive values, and ROC curves were assessed using maximum values for AST and ALT. RESULTS: Out of 255 patients, 107(42%) were females. The majority (52.9%) were in the 20-39 year age group. Only 19.6% had DHF. No statistically significant difference was noticed in the values of maximum transaminases during the febrile phase among DF and DHF patients. Higher sensitivity and low specificity with the 1-5 times elevation range was noticed, and a higher cut-off level of more than 5 times elevation showed low sensitivity and higher specificity. The combination of both transaminases cut-offs with age and sex also does not show clinically significant predictability of severe disease. The AST and ALT elevations are not showing discriminatory predictive value on dengue severity. As different serotypes cause different epidemics, it is important to carry out large-scale specific studies considering the serotypes.","['Priyangika, Dickowita Kankanamge Dilani', 'Premawansa, Gayani', 'Adikari, Madura', 'Thillainathan, Sharmila', 'Premawansa, Sunil', 'Jayamanne, Bernard Deepal Wanniarachchi', 'Premaratna, Ranjan']","['Priyangika DKD', 'Premawansa G', 'Adikari M', 'Thillainathan S', 'Premawansa S', 'Jayamanne BDW', 'Premaratna R']",['ORCID: 0000-0002-8040-1546'],"['University Medical Unit, Teaching Hospital, Ragama, Sri Lanka.', 'Colombo North Teaching Hospital, Ragama, Sri Lanka.', 'Colombo North Teaching Hospital, Ragama, Sri Lanka.', 'Colombo North Teaching Hospital, Ragama, Sri Lanka.', 'Zoology and Environmental Science, Faculty of Science, University of Colombo, Colombo, Sri Lanka.', 'Department of Public Health, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka. bdw.jayamanne@kln.ac.lk.', 'Department of Medicine, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.']",['eng'],['Journal Article'],20210630,England,BMC Res Notes,BMC research notes,101462768,,IM,"['Adult', '*Dengue/diagnosis/epidemiology', 'Female', 'Humans', 'Liver Function Tests', '*Severe Dengue/diagnosis/epidemiology', 'Sri Lanka/epidemiology', 'Tertiary Healthcare']",PMC8243863,2021/07/02 06:00,2021/07/03 06:00,['2021/07/01 05:51'],"['2021/01/02 00:00 [received]', '2021/06/23 00:00 [accepted]', '2021/07/01 05:51 [entrez]', '2021/07/02 06:00 [pubmed]', '2021/07/03 06:00 [medline]']","['10.1186/s13104-021-05670-0 [pii]', '5670 [pii]', '10.1186/s13104-021-05670-0 [doi]']",epublish,BMC Res Notes. 2021 Jun 30;14(1):251. doi: 10.1186/s13104-021-05670-0.,1,,['NOTNLM'],"['And liver enzymes', 'Dengue', 'Dengue severity prediction', 'Transaminases in Dengue']",['No financial and non-financial competing interests to declare.'],,,,,,,,,,,,,,,,,,
32618241,NLM,MEDLINE,20201116,20220317,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),103,2020 Sep,"Clinical and Laboratory Profile of Fatal Dengue Cases at a Tertiary Care Private Hospital in Mumbai, India.",1223-1227,tpmd190425 [pii] 10.4269/ajtmh.19-0425 [doi],"Dengue-related mortality has significantly reduced with early and appropriate fluid resuscitation. However, we continue to see dengue-related fatalities in patients despite early intervention and advanced critical care support. This was a retrospective study conducted at a tertiary care private hospital in Mumbai, India. All patients dying of dengue in the calendar year 2017 were studied. Details related to age, gender, condition at presentation, laboratory parameters, treatment administered, and time to death were abstracted from case records. A total of 575 patients with a diagnosis of dengue were admitted to the hospital in 2017, of which 15 died (mortality rate 2.6%). Four patients died in the emergency medical unit; 11 patients who died after admission to the inpatient unit had multi-organ dysfunction at the time of presentation, with shock, severe liver dysfunction, and severe metabolic acidosis. Only 4/11 patients had hemoconcentration, and 10/11 patients had high white cell counts. In five patients where serum ferritin was performed, it was more than 40,000 ng/mL. Death occurred at a median time of 2 days after hospitalization despite good supportive care. Although there is scope for improvement of supportive care in these patients, it appears that other interventions are urgently needed to improve outcomes in severe dengue. This calls for more research into the immunopathology of dengue, evaluation of anti-inflammatory drugs, intravenous immunoglobulins, antivirals, and improved vaccines.","['Singhal, Tanu', 'Kothari, Vatsal']","['Singhal T', 'Kothari V']",,"['1Department of Paediatrics, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India.', '2Department of Critical Care, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India.']",['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Critical Care', 'Dengue/*diagnosis/immunology/therapy/virology', 'Female', 'Fluid Therapy', 'Hospitalization', 'Hospitals, Private', 'Humans', 'India', 'Male', 'Middle Aged', 'Retrospective Studies', 'Severe Dengue/*diagnosis/immunology/therapy/virology', 'Tertiary Healthcare', 'Young Adult']",PMC7470572,2020/07/04 06:00,2020/11/18 06:00,['2020/07/04 06:00'],"['2020/07/04 06:00 [pubmed]', '2020/11/18 06:00 [medline]', '2020/07/04 06:00 [entrez]']","['tpmd190425 [pii]', '10.4269/ajtmh.19-0425 [doi]']",ppublish,Am J Trop Med Hyg. 2020 Sep;103(3):1223-1227. doi: 10.4269/ajtmh.19-0425.,3,,,,,,,,,,,,,,,,,,,,,,
12531616,NLM,MEDLINE,20030128,20220321,0140-6736 (Print) 0140-6736 (Linking),361,2003 Jan 11,Dengue fever and dengue haemorrhagic fever.,181-2,,,"['John, T Jacob']",['John TJ'],,,['eng'],"['Comment', 'Letter']",,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Dengue/diagnosis/*physiopathology', 'Diagnosis, Differential', 'Humans', 'Severe Dengue/diagnosis/*physiopathology']",,2003/01/18 04:00,2003/01/29 04:00,['2003/01/18 04:00'],"['2003/01/18 04:00 [pubmed]', '2003/01/29 04:00 [medline]', '2003/01/18 04:00 [entrez]']","['S0140-6736(03)12220-9 [pii]', '10.1016/S0140-6736(03)12220-9 [doi]']",ppublish,Lancet. 2003 Jan 11;361(9352):181-2. doi: 10.1016/S0140-6736(03)12220-9.,9352,,,,,,,,['Lancet. 2002 Oct 5;360(9339):1070. PMID: 12383989'],,,,,,,,,,,,,,
22413033,NLM,MEDLINE,20120709,20211021,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),6,2012,Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis.,e1562,10.1371/journal.pntd.0001562 [doi] e1562,"BACKGROUND: Tens of millions of dengue cases and approximately 500,000 life-threatening complications occur annually. New tools are needed to distinguish dengue from other febrile illnesses. In addition, the natural history of pediatric dengue early in illness in a community-based setting has not been well-defined. METHODS: Data from the multi-year, ongoing Pediatric Dengue Cohort Study of approximately 3,800 children aged 2-14 years in Managua, Nicaragua, were used to examine the frequency of clinical signs and symptoms by day of illness and to generate models for the association of signs and symptoms during the early phase of illness and over the entire course of illness with testing dengue-positive. Odds ratios (ORs) and 95% confidence intervals were calculated using generalized estimating equations (GEE) for repeated measures, adjusting for age and gender. RESULTS: One-fourth of children who tested dengue-positive did not meet the WHO case definition for suspected dengue. The frequency of signs and symptoms varied by day of illness, dengue status, and disease severity. Multivariable GEE models showed increased odds of testing dengue-positive associated with fever, headache, retro-orbital pain, myalgia, arthralgia, rash, petechiae, positive tourniquet test, vomiting, leukopenia, platelets </=150,000 cells/mL, poor capillary refill, cold extremities and hypotension. Estimated ORs tended to be higher for signs and symptoms over the course of illness compared to the early phase of illness. CONCLUSIONS: Day-by-day analysis of clinical signs and symptoms together with longitudinal statistical analysis showed significant associations with testing dengue-positive and important differences during the early phase of illness compared to the entire course of illness. These findings stress the importance of considering day of illness when developing prediction algorithms for real-time clinical management.","['Biswas, Hope H', 'Ortega, Oscar', 'Gordon, Aubree', 'Standish, Katherine', 'Balmaseda, Angel', 'Kuan, Guillermina', 'Harris, Eva']","['Biswas HH', 'Ortega O', 'Gordon A', 'Standish K', 'Balmaseda A', 'Kuan G', 'Harris E']",,"['Division of Epidemiology, School of Public Health, University of California, Berkeley, California, United States of America.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20120306,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adolescent', 'Animals', 'Child', 'Child, Preschool', 'Cohort Studies', 'Dengue/diagnosis/*pathology/*physiopathology', 'Dengue Virus/*pathogenicity', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Nicaragua', 'Time Factors']",PMC3295819,2012/03/14 06:00,2012/07/10 06:00,['2012/03/14 06:00'],"['2011/10/20 00:00 [received]', '2012/01/25 00:00 [accepted]', '2012/03/14 06:00 [entrez]', '2012/03/14 06:00 [pubmed]', '2012/07/10 06:00 [medline]']","['PNTD-D-11-01034 [pii]', '10.1371/journal.pntd.0001562 [doi]']",ppublish,PLoS Negl Trop Dis. 2012;6(3):e1562. doi: 10.1371/journal.pntd.0001562. Epub 2012 Mar 6.,3,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
17386105,NLM,MEDLINE,20070426,20181113,1471-2334 (Electronic) 1471-2334 (Linking),7,2007 Mar 26,Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system.,22,,"BACKGROUND: Dengue disease severity is usually classified using criteria set up by the World Health Organization (WHO). We aimed to assess the diagnostic accuracy of the WHO classification system and modifications to this system, and evaluated their potential practical usefulness. METHODS: Patients, admitted consecutively to the hospital with severe dengue, were classified using the WHO classification system and modifications to this system. Treating physicians were asked to classify patients immediately after discharge. We calculated the sensitivity of the various classification systems for the detection of shock and the agreement between the various classification systems and the treating physician's classification. RESULTS: Of 152 patients with confirmed dengue, sixty-six (43%) had evidence of circulatory failure. The WHO classification system had a sensitivity of 86% (95%CI 76-94) for the detection of patients with shock. All modifications to the WHO classification system had a higher sensitivity than the WHO classification system (sensitivity ranging from 88% to 99%). The WHO classification system was in only modest agreement with the intuitive classification by treating physicians whereas several modified classification systems were in good agreement. CONCLUSION: The use of the WHO classification system to classify dengue disease severity is to be questioned, because it is not accurate in correctly classifying dengue disease severity and it lacks sufficient agreement with clinical practice.","['Setiati, Tatty E', 'Mairuhu, Albert T A', 'Koraka, Penelopie', 'Supriatna, Mohamed', 'Mac Gillavry, Melvin R', 'Brandjes, Dees P M', 'Osterhaus, Albert D M E', 'van der Meer, Jos W M', 'van Gorp, Eric C M', 'Soemantri, Augustinus']","['Setiati TE', 'Mairuhu AT', 'Koraka P', 'Supriatna M', 'Mac Gillavry MR', 'Brandjes DP', 'Osterhaus AD', 'van der Meer JW', 'van Gorp EC', 'Soemantri A']",,"['Department of Child Health, Dr. Kariadi Hospital, Semarang, Indonesia. tatty@smg.melsa.net.id <tatty@smg.melsa.net.id>']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20070326,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*classification/complications/diagnosis', 'Dengue Virus', 'Humans', 'Indonesia', 'Severity of Illness Index', 'Shock/etiology', 'World Health Organization']",PMC1847434,2007/03/28 09:00,2007/04/27 09:00,['2007/03/28 09:00'],"['2006/07/19 00:00 [received]', '2007/03/26 00:00 [accepted]', '2007/03/28 09:00 [pubmed]', '2007/04/27 09:00 [medline]', '2007/03/28 09:00 [entrez]']","['1471-2334-7-22 [pii]', '10.1186/1471-2334-7-22 [doi]']",epublish,BMC Infect Dis. 2007 Mar 26;7:22. doi: 10.1186/1471-2334-7-22.,,,,,,,,,,,,,,,,,,,,,,,
25211865,NLM,MEDLINE,20141030,20211021,0026-6620 (Print) 0026-6620 (Linking),111,2014 Jul-Aug,Prospects for a dengue vaccine: progress and pitfalls.,337-42,,"Dengue virus is now the world's most common arboviral infection and has spread to the continental United States. The Aedes mosquito which transmits dengue is prevalent throughout Missouri, so clinicians should be familiar with dengue. While there are no licensed vaccines, five are in human trials including two tested at the Saint Louis University Center for Vaccine Development. Our deepening understanding of the correlates of protective immunity to dengue improves near-term prospects for a vaccine.","['George, Sarah L']",['George SL'],,,['eng'],['Journal Article'],,United States,Mo Med,Missouri medicine,0400744,['0 (Dengue Vaccines)'],IM,"['Academic Medical Centers', 'Dengue/diagnosis/*prevention & control/transmission', '*Dengue Vaccines', 'Drug Discovery/*organization & administration', 'Humans', 'Missouri', 'Research/*organization & administration']",PMC6179479,2014/09/13 06:00,2014/10/31 06:00,['2014/09/13 06:00'],"['2014/09/13 06:00 [entrez]', '2014/09/13 06:00 [pubmed]', '2014/10/31 06:00 [medline]']",['ms111_p0337 [pii]'],ppublish,Mo Med. 2014 Jul-Aug;111(4):337-42.,4,,,,,,,,,,,,,,,,,,,,,,
23780868,NLM,MEDLINE,20131217,20181202,1758-1133 (Electronic) 0049-4755 (Linking),43,2013 Jul,Current emerging situation of dengue in India.,116-9,10.1177/0049475513491944 [doi],"Outbreaks of dengue fever (DF) have been reported from various countries. Although DF has been endemic in India from the nineteenth century, dengue haemorrhagic fever (DHF) was first reported in 1987. The first major widespread epidemic of DHF and dengue shock syndrome (DSS) was reported in 1996 with four serotypes reported to be in co-circulation. In 2012 an outbreak occurred in India during which a total of 47,029 DF cases and 242 deaths were reported - three times higher than the previous year. Twelve states reported a large number of cases, including Tamil Nadu which recorded 12,264 from various districts. We discuss methods of prevention and control.","['Mariappan, Thiruppathi']",['Mariappan T'],,"['Centre for Research in Medical Entomology (CRME), Indian Council of Medical Research (ICMR), Tamil Nadu 625002, India. crmeicmr@icmr.org.in']",['eng'],['Journal Article'],20130618,England,Trop Doct,Tropical doctor,1301706,,IM,"['Dengue/*epidemiology/prevention & control/transmission', 'Disease Outbreaks/*statistics & numerical data', 'Humans', 'India/epidemiology']",,2013/06/20 06:00,2013/12/18 06:00,['2013/06/20 06:00'],"['2013/06/20 06:00 [entrez]', '2013/06/20 06:00 [pubmed]', '2013/12/18 06:00 [medline]']","['0049475513491944 [pii]', '10.1177/0049475513491944 [doi]']",ppublish,Trop Doct. 2013 Jul;43(3):116-9. doi: 10.1177/0049475513491944. Epub 2013 Jun 18.,3,,['NOTNLM'],"['Dengue fever', 'disease control', 'epidemiology']",,['Trop Doct. 2014 Oct;44(4):246-7. PMID: 25096277'],,,,,,,,,,,,,,,,,
25019967,NLM,MEDLINE,20160101,20220321,1932-6203 (Electronic) 1932-6203 (Linking),9,2014,"Predicting local dengue transmission in Guangzhou, China, through the influence of imported cases, mosquito density and climate variability.",e102755,10.1371/journal.pone.0102755 [doi] e102755,"INTRODUCTION: Each year there are approximately 390 million dengue infections worldwide. Weather variables have a significant impact on the transmission of Dengue Fever (DF), a mosquito borne viral disease. DF in mainland China is characterized as an imported disease. Hence it is necessary to explore the roles of imported cases, mosquito density and climate variability in dengue transmission in China. The study was to identify the relationship between dengue occurrence and possible risk factors and to develop a predicting model for dengue's control and prevention purpose. METHODOLOGY AND PRINCIPAL FINDINGS: Three traditional suburbs and one district with an international airport in Guangzhou city were selected as the study areas. Autocorrelation and cross-correlation analysis were used to perform univariate analysis to identify possible risk factors, with relevant lagged effects, associated with local dengue cases. Principal component analysis (PCA) was applied to extract principal components and PCA score was used to represent the original variables to reduce multi-collinearity. Combining the univariate analysis and prior knowledge, time-series Poisson regression analysis was conducted to quantify the relationship between weather variables, Breteau Index, imported DF cases and the local dengue transmission in Guangzhou, China. The goodness-of-fit of the constructed model was determined by pseudo-R2, Akaike information criterion (AIC) and residual test. There were a total of 707 notified local DF cases from March 2006 to December 2012, with a seasonal distribution from August to November. There were a total of 65 notified imported DF cases from 20 countries, with forty-six cases (70.8%) imported from Southeast Asia. The model showed that local DF cases were positively associated with mosquito density, imported cases, temperature, precipitation, vapour pressure and minimum relative humidity, whilst being negatively associated with air pressure, with different time lags. CONCLUSIONS: Imported DF cases and mosquito density play a critical role in local DF transmission, together with weather variables. The establishment of an early warning system, using existing surveillance datasets will help to control and prevent dengue in Guangzhou, China.","['Sang, Shaowei', 'Yin, Wenwu', 'Bi, Peng', 'Zhang, Honglong', 'Wang, Chenggang', 'Liu, Xiaobo', 'Chen, Bin', 'Yang, Weizhong', 'Liu, Qiyong']","['Sang S', 'Yin W', 'Bi P', 'Zhang H', 'Wang C', 'Liu X', 'Chen B', 'Yang W', 'Liu Q']",,"['State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, China; Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China; WHO Collaborating Centre for Vector Surveillance and Management, Changping, Beijing, China; Shandong University Climate Change and Health Center, Jinan, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.', 'Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.', 'School of Population Health, University of Adelaide, Adelaide, South Australia, Australia.', 'Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, China; Department of Preventive Medicine, College of Basic Medical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China; Shandong University Climate Change and Health Center, Jinan, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, China; Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China; WHO Collaborating Centre for Vector Surveillance and Management, Changping, Beijing, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, China; Xiamen Entry-Exit Inspection and Quarantine Bureau, Xiamen, China.', 'Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.', 'State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, China; Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China; WHO Collaborating Centre for Vector Surveillance and Management, Changping, Beijing, China; Centre for Environment and Population Health, Nathan Campus, Griffith University, Nathan, Queensland, Australia; Shandong University Climate Change and Health Center, Jinan, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20140714,United States,PLoS One,PloS one,101285081,,IM,"['Animals', 'China/epidemiology', '*Climate', 'Culicidae/*physiology', 'Dengue/epidemiology/*transmission', 'Disease Outbreaks/prevention & control', 'Forecasting', 'Geography', 'Humans', 'Humidity', 'Population Density', 'Principal Component Analysis', 'Risk Factors', 'Temperature']",PMC4097061,2014/07/16 06:00,2016/01/02 06:00,['2014/07/15 06:00'],"['2014/01/26 00:00 [received]', '2014/06/23 00:00 [accepted]', '2014/07/15 06:00 [entrez]', '2014/07/16 06:00 [pubmed]', '2016/01/02 06:00 [medline]']","['PONE-D-14-03943 [pii]', '10.1371/journal.pone.0102755 [doi]']",epublish,PLoS One. 2014 Jul 14;9(7):e102755. doi: 10.1371/journal.pone.0102755. eCollection 2014.,7,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
15906499,NLM,MEDLINE,20050617,20191109,0124-0064 (Print) 0124-0064 (Linking),7,2005 Jan-Apr,"Dengue and dengue and vector behaviour in Caqueza, Colombia, 2004.",1-15,,"OBJECTIVE: Describing the behaviour of dengue and its vector in Caqueza, Colombia (1746 masl) by serological, entomological and virological monitoring between March and June 2004. METHODS: Two types of study were carried out. One was a cross-sectional study for serologically monitoring the population and taking entomological indicators; participants were selected from the general population by random conglomerate sampling. The second study consisted of monitoring febrile cases suspected of dengue during a four-week period. Vector behaviour (bite-rate and hours of activity) was also included by using the landing-on-humans technique; a rubbish-collecting day was run during the same period for evaluating this intervention's short-term effectiveness. RESULTS: Total prevalence of infection by dengue (IgG positive) was 23.3% in 252 people examined in the surveyed population. Household infestation index was 32.9%; deposit index was 8.4%; and Breteau index was 43.9. Following the rubbish-collection day, the infestation index became reduced by 56% (14.5% post-intervention), deposit index by 43% (4.8% post-intervention) and Breteau index by 59% (17.9% post-intervention). Two of the febrile patients (n=83) were IgM positive. CONCLUSIONS: The study showed that dengue's urban vector can reach dangerous levels of infestation above 1700 masl; however, a deeper study of its bionomy is needed at these heights above sea-level during different times of the year for improving knowledge regarding climatic and environmental factors affecting their efficiency as vector in these conditions.","['Rodriguez, Hernan', 'de la Hoz, Fernando']","['Rodriguez H', 'de la Hoz F']",,['Secretaria de Salud de Cundinamarca. mamanu123@hotmail.com'],['eng'],"['Comparative Study', 'Journal Article']",,Colombia,Rev Salud Publica (Bogota),"Revista de salud publica (Bogota, Colombia)",100936348,,IM,"['Adolescent', 'Adult', '*Aedes/physiology', 'Aged', 'Aged, 80 and over', 'Animals', 'Child', 'Child, Preschool', 'Colombia/epidemiology', 'Cross-Sectional Studies', 'Dengue/diagnosis/*epidemiology', 'Female', 'Humans', '*Insect Vectors/physiology', 'Male', 'Middle Aged', 'Prevalence', 'Seasons', 'Sentinel Surveillance', 'Seroepidemiologic Studies']",,2005/05/24 09:00,2005/06/18 09:00,['2005/05/24 09:00'],"['2005/05/24 09:00 [pubmed]', '2005/06/18 09:00 [medline]', '2005/05/24 09:00 [entrez]']","['S0124-00642005000100001 [pii]', '10.1590/s0124-00642005000100001 [doi]']",ppublish,Rev Salud Publica (Bogota). 2005 Jan-Apr;7(1):1-15. doi: 10.1590/s0124-00642005000100001.,1,,,,,,,,,,,,,,,,,,,,,,
23559167,NLM,MEDLINE,20140310,20190911,1984-0446 (Electronic) 0034-7167 (Linking),65,2012 Nov-Dec,[Dengue Almanac: readings and narratives of Community Health Agents].,909-15,S0034-71672012000600004 [pii],"This article discusses the results of a reading-and-appropriation study, as an approach methodology to narrative universe of Health Community Agents (ACS), using the Dengue Almanac (AD), an information-communication device. Workshops with groups of ACS from Rio de Janeiro city were developed using the Almanac, aiming it's de-construction and relational reading, to improve the comprehension about knowledge's construction and appropriation on dengue and health, and evaluate the AD as an info-communicational device. The results were categorized within three axes: informational abundance during dengue's epidemics and silence between them, meaning non-information; the victim's blaming in health information's processes; ACS labor's contradictions and ambiguities as mediators. The Almanac proved to be a useful tool to discussion and appropriation of health information, due to the relational and non-linear reading characteristics of it's contents, and the interactive and nonauthoritative format of it's formulations on dengue and health.","['David, Helena Maria Scherlowski Leal', 'Marteleto, Regina Maria']","['David HM', 'Marteleto RM']",,"['Departamento de Enfermagem de Saude Publica, Faculdade de Enfermagem, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. helena.david@uol.com.br']",['por'],"['English Abstract', 'Journal Article']",,Brazil,Rev Bras Enferm,Revista brasileira de enfermagem,7910105,,,"['*Community Health Workers', '*Dengue/epidemiology', 'Humans', '*Information Dissemination']",,2013/04/06 06:00,2014/03/13 06:00,['2013/04/06 06:00'],"['2013/01/16 00:00 [received]', '2013/01/31 00:00 [accepted]', '2013/04/06 06:00 [entrez]', '2013/04/06 06:00 [pubmed]', '2014/03/13 06:00 [medline]']","['S0034-71672012000600004 [pii]', '10.1590/s0034-71672012000600004 [doi]']",ppublish,Rev Bras Enferm. 2012 Nov-Dec;65(6):909-15. doi: 10.1590/s0034-71672012000600004.,6,,,,,,,,,Almanaque da Dengue: leituras e narrativas de Agentes Comunitarios de Saude.,,,,,,,,,,,,,
20194064,NLM,MEDLINE,20110328,20211020,1552-9924 (Electronic) 0091-6765 (Print) 0091-6765 (Linking),118,2010 Mar,Americas' dengue escalation is real--and shifting.,A 117,10.1289/ehp.118-a117 [doi],,"['Weinhold, Bob']",['Weinhold B'],,,['eng'],['News'],,United States,Environ Health Perspect,Environmental health perspectives,0330411,,IM,"['Americas/epidemiology', 'Dengue/*epidemiology/etiology/transmission/virology', 'Dengue Virus/classification/physiology', 'Disease Outbreaks/statistics & numerical data', 'Global Warming', 'Humans']",PMC2854786,2010/03/03 06:00,2011/03/29 06:00,['2010/03/03 06:00'],"['2010/03/03 06:00 [entrez]', '2010/03/03 06:00 [pubmed]', '2011/03/29 06:00 [medline]']","['ehp-118-a117 [pii]', '10.1289/ehp.118-a117 [doi]']",ppublish,Environ Health Perspect. 2010 Mar;118(3):A 117. doi: 10.1289/ehp.118-a117.,3,,,,,,,,,,,,,,,,,,,,,,
34379641,NLM,MEDLINE,20211116,20230222,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),15,2021 Aug,Case-area targeted interventions (CATI) for reactive dengue control: Modelling effectiveness of vector control and prophylactic drugs in Singapore.,e0009562,10.1371/journal.pntd.0009562 [doi] e0009562,"BACKGROUND: Targeting interventions to areas that have recently experienced cases of disease is one strategy to contain outbreaks of infectious disease. Such case-area targeted interventions (CATI) have become an increasingly popular approach for dengue control but there is little evidence to suggest how precisely targeted or how recent cases need to be, to mount an effective response. The growing interest in the development of prophylactic and therapeutic drugs for dengue has also given new relevance for CATI strategies to interrupt transmission or deliver early treatment. METHODS/PRINCIPAL FINDINGS: Here we develop a patch-based mathematical model of spatial dengue spread and fit it to spatiotemporal datasets from Singapore. Simulations from this model suggest CATI strategies could be effective, particularly if used in lower density areas. To maximise effectiveness, increasing the size of the radius around an index case should be prioritised even if it results in delays in the intervention being applied. This is partially because large intervention radii ensure individuals receive multiple and regular rounds of drug dosing or vector control, and thus boost overall coverage. Given equivalent efficacy, CATIs using prophylactic drugs are predicted to be more effective than adult mosquito-killing vector control methods and may even offer the possibility of interrupting individual chains of transmission if rapidly deployed. CATI strategies quickly lose their effectiveness if baseline transmission increases or case detection rates fall. CONCLUSIONS/SIGNIFICANCE: These results suggest CATI strategies can play an important role in dengue control but are likely to be most relevant for low transmission areas where high coverage of other non-reactive interventions already exists. Controlled field trials are needed to assess the field efficacy and practical constraints of large operational CATI strategies.","['Brady, Oliver J', 'Kucharski, Adam J', 'Funk, Sebastian', 'Jafari, Yalda', 'Loock, Marnix Van', 'Herrera-Taracena, Guillermo', 'Menten, Joris', 'Edmunds, W John', 'Sim, Shuzhen', 'Ng, Lee-Ching', 'Hue, Stephane', 'Hibberd, Martin L']","['Brady OJ', 'Kucharski AJ', 'Funk S', 'Jafari Y', 'Loock MV', 'Herrera-Taracena G', 'Menten J', 'Edmunds WJ', 'Sim S', 'Ng LC', 'Hue S', 'Hibberd ML']","['ORCID: 0000-0002-3235-2129', 'ORCID: 0000-0001-8814-9421', 'ORCID: 0000-0002-2842-3406', 'ORCID: 0000-0003-4151-4588', 'ORCID: 0000-0001-6033-0915', 'ORCID: 0000-0002-6925-6683', 'ORCID: 0000-0002-9179-2917', 'ORCID: 0000-0002-8580-6905']","['Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Janssen Global Public Health, Janssen Pharmaceutica NV, Beerse, Belgium.', 'Janssen Global Public Health, Janssen Research & Development, LLC, Horsham, Pennsylvania, United States of America.', 'Quantitative Sciences, Janssen Pharmaceutica NV, Beerse, Belgium.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Environmental Health Institute, National Environment Agency, Singapore, Singapore.', 'Environmental Health Institute, National Environment Agency, Singapore, Singapore.', 'Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.', 'Department of Infection Biology, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20210811,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Animals', '*Case Management', 'Computer Simulation', 'Dengue/*epidemiology/prevention & control/*therapy/transmission', 'Disease Outbreaks/prevention & control', 'Humans', '*Models, Theoretical', 'Mosquito Control/methods', 'Regression Analysis', 'Singapore']",PMC8357181,2021/08/12 06:00,2021/11/17 06:00,['2021/08/11 17:19'],"['2020/12/16 00:00 [received]', '2021/06/14 00:00 [accepted]', '2021/08/11 17:19 [entrez]', '2021/08/12 06:00 [pubmed]', '2021/11/17 06:00 [medline]']","['PNTD-D-20-02174 [pii]', '10.1371/journal.pntd.0009562 [doi]']",epublish,PLoS Negl Trop Dis. 2021 Aug 11;15(8):e0009562. doi: 10.1371/journal.pntd.0009562. eCollection 2021 Aug.,8,,,,"[""I have read the journal's policy and the authors of this manuscript have the"", 'following competing interests: MVL, GHT and JM are employees of Johnson &', 'Johnson. LS and LN are employees of the Singapore national Environment Agency']",,"['206250/Z/17/Z/WT_/Wellcome Trust/United Kingdom', '206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom', 'MR/V031112/1/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,,,,,,,
23711716,NLM,MEDLINE,20140318,20180219,2352-4146 (Electronic) 1995-7645 (Linking),6,2013 Jun,"Outbreak of dengue infection in rural Davangere, Karnataka.",502-3,S1995-7645(13)60084-X [pii] 10.1016/S1995-7645(13)60084-X [doi],,"['Kalappanvar, N K', 'VinodKumar, C S', 'Basavarajappa, K G', 'Chandrasekhar, G', 'Sanjay, D']","['Kalappanvar NK', 'VinodKumar CS', 'Basavarajappa KG', 'Chandrasekhar G', 'Sanjay D']",,"['Department of Paediatrics, S. S. Institute of Medical Sciences and Research Centre, NH-4, By pass, Davangere-577005, Karnataka, India.']",['eng'],['Journal Article'],,India,Asian Pac J Trop Med,Asian Pacific journal of tropical medicine,101533720,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/mortality', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Male']",,2013/05/29 06:00,2014/03/19 06:00,['2013/05/29 06:00'],"['2013/05/29 06:00 [entrez]', '2013/05/29 06:00 [pubmed]', '2014/03/19 06:00 [medline]']","['S1995-7645(13)60084-X [pii]', '10.1016/S1995-7645(13)60084-X [doi]']",ppublish,Asian Pac J Trop Med. 2013 Jun;6(6):502-3. doi: 10.1016/S1995-7645(13)60084-X.,6,,,,,,,,,,,,,,,,,,,,,,
28970005,NLM,MEDLINE,20210201,20220902,1808-8686 (Electronic) 1808-8694 (Print) 1808-8686 (Linking),86 Suppl 1,2020 Dec,Different cochleovestibular manifestations and outcomes in patients diagnosed with dengue.,55-60,S1808-8694(17)30138-6 [pii] 10.1016/j.bjorl.2017.07.008 [doi],,"['Rahme, Isabella Marques Pereira', 'Pereira, Geraldo Majela', 'Sanchez, Tanit Ganz']","['Rahme IMP', 'Pereira GM', 'Sanchez TG']",,"['Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. Electronic address: isa_marquess@hotmail.com.', 'Otorrino Clinica, Itauna, MG, Brazil.', 'Universidade de Sao Paulo (USP), Faculdade de Medicina, Departamento de Otorrinolaringologia, Sao Paulo, SP, Brazil; Instituto Ganz Sanchez, Sao Paulo, SP, Brazil.']",['eng'],['Case Reports'],20170919,Brazil,Braz J Otorhinolaryngol,Brazilian journal of otorhinolaryngology,101207337,,IM,"['*Dengue/complications/diagnosis', 'Humans']",PMC9422408,2017/10/04 06:00,2021/02/02 06:00,['2017/10/04 06:00'],"['2017/05/10 00:00 [received]', '2017/07/10 00:00 [revised]', '2017/07/17 00:00 [accepted]', '2017/10/04 06:00 [pubmed]', '2021/02/02 06:00 [medline]', '2017/10/04 06:00 [entrez]']","['S1808-8694(17)30138-6 [pii]', '10.1016/j.bjorl.2017.07.008 [doi]']",ppublish,Braz J Otorhinolaryngol. 2020 Dec;86 Suppl 1(Suppl 1):55-60. doi: 10.1016/j.bjorl.2017.07.008. Epub 2017 Sep 19.,Suppl 1,,,,,,,,,,,,,,,,,,,,,,
6464113,NLM,MEDLINE,19840918,20211203,0035-9203 (Print) 0035-9203 (Linking),78,1984,Dengue haemorrhagic fever in Cuba. I. Serological confirmation of clinical diagnosis.,235-8,,"Serological studies by the haemagglutinin inhibition test to confirm a clinical diagnosis of dengue were done on 406 patients during the dengue 2 epidemic in Cuba in 1981. 49% of the cases were serologically positive; of these 64% was classified as primary and 36% as secondary. The frequency of symptoms is described: the most frequent were fever, headache, malaise and vomiting. Haemorrhagic manifestations predominated significantly in the secondary cases. The white race and female sex were found to predominate in the positive cases.","['Guzman, M G', 'Kouri, G P', 'Bravo, J', 'Calunga, M', 'Soler, M', 'Vazquez, S', 'Venereo, C']","['Guzman MG', 'Kouri GP', 'Bravo J', 'Calunga M', 'Soler M', 'Vazquez S', 'Venereo C']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cuba', 'Dengue/complications/*diagnosis/epidemiology/immunology', 'Female', 'Hemagglutination Inhibition Tests', 'Humans', 'Male', 'Middle Aged', 'Racial Groups', 'Sex Factors']",,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",['10.1016/0035-9203(84)90285-2 [doi]'],ppublish,Trans R Soc Trop Med Hyg. 1984;78(2):235-8. doi: 10.1016/0035-9203(84)90285-2.,2,,,,,,,,,,,,,,,,,,,,,,
18982798,NLM,MEDLINE,20081204,20191111,0009-0875 (Print) 0009-0875 (Linking),53,2008 Sep,Dengue fever--predictors of disease severity and their influence on management.,75-8,,,"['Sellahewa, Kolitha H']",['Sellahewa KH'],,"['National Hospital of Sri Lanka, Colombo. kolithah@gmail.com']",['eng'],['Journal Article'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['Blood Pressure', '*Dengue/diagnosis/epidemiology/prevention & control/therapy', 'Fluid Therapy', 'Forecasting', 'Hematocrit', 'Humans', 'Platelet Transfusion', 'Severity of Illness Index']",,2008/11/06 09:00,2008/12/17 09:00,['2008/11/06 09:00'],"['2008/11/06 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/11/06 09:00 [entrez]']",['10.4038/cmj.v53i3.245 [doi]'],ppublish,Ceylon Med J. 2008 Sep;53(3):75-8. doi: 10.4038/cmj.v53i3.245.,3,,,,,,,,,,,,,,,,,,,,,,
2611461,NLM,MEDLINE,19900307,20041117,0085-4638 (Print) 0085-4638 (Linking),23,1989,Surveillance for dengue and dengue hemorrhagic fever.,397-404,,"Dengue and dengue hemorrhagic fever are emerging as major public health problems in most tropical countries. Effective prevention and control programs will depend on improved surveillance designed to provide early warning of dengue epidemics. This article outlines a reasonable approach to dengue surveillance of this kind. Virologic surveillance should be considered the most important element in any such early warning system. Dengue virus transmission should be monitored to determine which serotypes are present, their distribution, and the type of illnesses associated with each. Other key components of an active surveillance system should include monitoring of fever activity and clinical surveillance for cases of severe and fatal disease associated with viral syndromes. Collectively, these three surveillance components can provide an early warning capability permitting emergency mosquito control measures to be implemented and major epidemics to be averted.","['Gubler, D J']",['Gubler DJ'],,,['eng'],['Journal Article'],,United States,Bull Pan Am Health Organ,Bulletin of the Pan American Health Organization,7505403,,IM,"['Dengue/*diagnosis/epidemiology/prevention & control', 'Humans', 'Puerto Rico']",,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Bull Pan Am Health Organ. 1989;23(4):397-404.,4,,,,,,,,,,,,,,,,,,,,,,
33089804,NLM,MEDLINE,20210818,20210818,0974-7559 (Electronic) 0019-6061 (Linking),57,2020 Oct 15,WHO 2009 Warning Signs as Predictors of Time Taken for Progression to Severe Dengue in Children.,899-903,,"OBJECTIVES: To identify WHO 2009 warning signs that can predict time taken for progression to severe dengue in a pediatric population. DESIGN: Prospective analytical study over 1 year and 2 months. SETTING: Tertiary care center. PARTICIPANTS: 350 children aged 1 mo-12 y with serologically confirmed dengue without co-morbidities/co-infections; conse-cutive sampling. PROCEDURE: At admission, clinical and laboratory details were noted. Disease progression, time of onset of each warning sign, hematocrit, and platelet counts were recorded daily till discharge/ death. If progressing to severe dengue, its time of onset was noted. Time to event analysis with Log Rank test, Kaplan Meier plots and Cox Proportional Hazards Model was done. OUTCOME MEASURES: Primary outcome was time interval from onset of first warning sign to onset of severe dengue (defined as per WHO 2009 guidelines). Predictors were WHO 2009 warning signs: abdominal pain, lethargy, persistent vomiting, mucosal bleed, clinical fluid accumulation, hepatomegaly >2 cm, hematocrit >/=0.40 and platelet count <100x109/L. RESULTS: Among 350 children followed up completely till discharge/death, 90 developed severe dengue (event) while 260 did not (censored). Median age of study population was 7.75 y. Clinical fluid accumulation [(P=0.002, Hazard Ratio (HR) 2.19, 95% CI 1.33-3.60)] and hematocrit >/=0.40 [(P=0.009, HR (95%CI) 1.715, (1.13-2.60)] were significant in univariate analysis. Final multivariate model includes clinical fluid accumulation [(P=0.02, HR (95%CI) 1.89, (1.116-3.202)], hematocrit >/=0.40 (P=0.07), mucosal bleed (P=0.56) and persistent vomiting (P=0.32). CONCLUSION: WHO warning signs that predict time taken for progression to severe dengue in children include clinical fluid accumulation, hematocrit >/=0.40, persistent vomiting and mucosal bleed. Study results have implications in policy making and practice guidelines to triage children attending a health care facility with or without warning signs.","['Sreenivasan, Priya', 'Geetha, S', 'Kumar, A Santhosh']","['Sreenivasan P', 'Geetha S', 'Kumar AS']",,"['Department of Pediatrics, and Clinical Epidemiology Resource and Training Centre (CERTC), Government Medical College, Thiruvananthapuram, Kerala. Correspondence to: Dr Priya Sreenivasan, Associate Professor of Pediatrics, Government Medical College, Thiruvananthapuram, Kerala, India. priyavineed16@gmail.com.', 'Department of Pediatrics, and Clinical Epidemiology Resource and Training Centre (CERTC), Government Medical College, Thiruvananthapuram, Kerala.', 'Department of Pediatrics, Government Medical College, Thiruvananthapuram, Kerala.']",['eng'],['Journal Article'],,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Abdominal Pain', 'Child', '*Dengue/diagnosis/epidemiology', 'Humans', 'Prospective Studies', '*Severe Dengue/diagnosis/epidemiology', 'World Health Organization']",,2020/10/23 06:00,2021/08/19 06:00,['2020/10/22 08:48'],"['2020/10/22 08:48 [entrez]', '2020/10/23 06:00 [pubmed]', '2021/08/19 06:00 [medline]']",,ppublish,Indian Pediatr. 2020 Oct 15;57(10):899-903.,10,,,,,['Indian Pediatr. 2020 Oct 15;57(10):895-896. PMID: 33089802'],,,,,,,,,,,,,,,,,
29709965,NLM,MEDLINE,20181002,20181004,1884-2836 (Electronic) 1344-6304 (Linking),71,2018 May 24,A Multicenter Study of Clinical Presentations and Predictive Factors for Severe Manifestation of Dengue in Adults.,239-243,10.7883/yoken.JJID.2017.457 [doi],"Severe dengue is more prevalent in adults than in children. Our objectives were to determine the clinical presentations of dengue in adults and to identify predictive factors for severe dengue. A retrospective cohort study was performed in adults with dengue, as confirmed by a positive NS1 antigen test result. Patients were classified as with non-severe or severe dengue. A total of 357 patients were enrolled; 45.4% were men, with a median (interquartile range [IQR]) age of 27.9 (21.8-43.5) years. Of all patients, 28.3% had warning signs and 10.6% had severe dengue. Patients with severe dengue were significantly older (35.1 [26.2-50.6] vs. 26.7 [21.7-43.3] years, P = 0.010), immunocompromised (7.9% vs. 0.9%, P = 0.018), and had cough (29% vs. 16%, P = 0.046), hepatomegaly (10.5% vs. 3.1%, P = 0.050), impaired consciousness (5.3% vs. 0%, P = 0.011) or higher (IQR) alanine aminotransferase (ALT) level (151 [57-295] vs. 66 [37-114] U/L, P = 0.008). By multivariate analysis, having cough (odds ratio [OR], 8.07; 95% confidence interval [CI], 2.51-30.16, P = 0.001) and ALT>120 U/L (OR, 3.51; 95% CI, 1.11-11.14, P = 0.033) were predictors of severe dengue. Early recognition of risk variables may be important for healthcare providers to appropriately manage dengue patients.","['Temprasertrudee, Saranya', 'Thanachartwet, Vipa', 'Desakorn, Varunee', 'Keatkla, Jiraporn', 'Chantratita, Wasun', 'Kiertiburanakul, Sasisopin']","['Temprasertrudee S', 'Thanachartwet V', 'Desakorn V', 'Keatkla J', 'Chantratita W', 'Kiertiburanakul S']",,"['Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University.', 'Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University.', 'Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University.', 'Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University.']",['eng'],"['Journal Article', 'Multicenter Study']",20180427,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,,IM,"['Adult', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Female', 'Humans', 'Male', 'Retrospective Studies', 'Thailand/epidemiology', 'Young Adult']",,2018/05/02 06:00,2018/10/03 06:00,['2018/05/01 06:00'],"['2018/05/02 06:00 [pubmed]', '2018/10/03 06:00 [medline]', '2018/05/01 06:00 [entrez]']",['10.7883/yoken.JJID.2017.457 [doi]'],ppublish,Jpn J Infect Dis. 2018 May 24;71(3):239-243. doi: 10.7883/yoken.JJID.2017.457. Epub 2018 Apr 27.,3,,['NOTNLM'],"['adult', 'dengue', 'dengue hemorrhagic fever', 'dengue shock syndrome']",,,,,,,,,,,,,,,,,,,
25531934,NLM,MEDLINE,20150902,20181113,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),21,2015 Jan,"Autochthonous dengue fever imported to England from Japan, 2014.",182-4,10.3201/eid2101.141581 [doi],,"['Kojima, Gotaro']",['Kojima G'],,,['eng'],"['Case Reports', 'Letter']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adult', 'Dengue/*diagnosis/epidemiology/transmission', 'Disease Outbreaks', 'England/ethnology', 'Humans', 'Japan/epidemiology', 'Male']",PMC4285239,2014/12/23 06:00,2015/09/04 06:00,['2014/12/23 06:00'],"['2014/12/23 06:00 [entrez]', '2014/12/23 06:00 [pubmed]', '2015/09/04 06:00 [medline]']","['14-1581 [pii]', '10.3201/eid2101.141581 [doi]']",ppublish,Emerg Infect Dis. 2015 Jan;21(1):182-4. doi: 10.3201/eid2101.141581.,1,,,,,,,,,,,,,,,,,,,,,,
10588771,NLM,MEDLINE,20000104,20190921,1360-2276 (Print) 1360-2276 (Linking),4,1999 Nov,Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases.,765-73,,"We conducted a retrospective study of 403 laboratory-confirmed dengue cases hospitalized in Tahiti between August 1989 and March 1997. According to standard WHO criteria, 337 of these cases were dengue fever (DF) and 64 were dengue haemorrhagic fever (DHF). Of the 10 fatal cases, 6 were DF and 4 were DHF. As an alternative, we used a correspondence analysis procedure to define dengue severity based on basic clinical and biological criteria for which we assigned a severity score, and then selected the 50 most severe cases from this analysis. Of the latter, 17 patients had been classified as DF and 33 as DHF by the WHO criteria. From this analysis, haemorrhages and decreased platelets counts associated with hepatic disorders are the main criteria associated with the severe dengue cases. Thus in our study population, the WHO classification does not account for the overall severity of dengue; hepatic failure should be considered as a specific severe form of dengue since plasma leakage, which is the pathophysiological hallmark of DHF, is only one of the pathogenic mechanisms leading to severity.","['Murgue, B', 'Deparis, X', 'Chungue, E', 'Cassar, O', 'Roche, C']","['Murgue B', 'Deparis X', 'Chungue E', 'Cassar O', 'Roche C']",,"['Unite de Virologie, Institut Territorial de Recherches de Medicales Louis Malarde, Papeete, Tahiti, French Polynesia.']",['eng'],['Journal Article'],,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Adolescent', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Dengue/classification/*diagnosis/*epidemiology/mortality', 'Female', 'Hematocrit', 'Humans', 'Infant', 'Male', 'Polynesia/epidemiology', 'Retrospective Studies', 'Serologic Tests', 'Severe Dengue/classification/*diagnosis/*epidemiology/mortality', '*Severity of Illness Index']",,1999/12/10 00:00,1999/12/10 00:01,['1999/12/10 00:00'],"['1999/12/10 00:00 [pubmed]', '1999/12/10 00:01 [medline]', '1999/12/10 00:00 [entrez]']","['tmi478 [pii]', '10.1046/j.1365-3156.1999.00478.x [doi]']",ppublish,Trop Med Int Health. 1999 Nov;4(11):765-73. doi: 10.1046/j.1365-3156.1999.00478.x.,11,,,,,,,,,,,,,,,,,,,,,,
34605479,NLM,MEDLINE,20211005,20220531,2408-8757 (Electronic) 1022-4742 (Linking),30,2021 Oct,"Sociodemographic and Clinico-laboratory Profile of Expanded Dengue Syndrome: Experience from a Tertiary Hospital of Dhaka, Bangladesh.",1073-1078,,"Dengue is endemic in more than a hundred countries throughout the tropics. The classic presentation of dengue fever has expanded its horizon by involving different organ systems, and these system-specific presentations pose a diagnostic dilemma. The objective of this prospective observational study was to evaluate the sociodemographic, and clinical profile of expanded dengue syndrome (EDS) patients admitted to a tertiary hospital in Dhaka, Bangladesh. Data were collected from all admitted patients from April 2019 to September 2019 and diagnosed with dengue. The patients with dengue having EDS were followed up till discharge. Of 4200 dengue cases admitted during this period, 108 patients (2.57%) were diagnosed with EDS. Among the EDS cases, 94% were from Dhaka city, and 6% were outside Dhaka city; 66% of the patients were male. Gastrointestinal (GI) manifestations were the most common (87%) type of EDS, and among the GI presentations, acute acalculous cholecystitis (38.3%), acute pancreatitis (30.85%), acute hepatitis (21.27%) were the most frequent. Among the EDS cases, 5.55% had a central nervous system (CNS), 4.6% cardiovascular (CVS), and 1.88% had renal complications; 0.93% presented with myositis. The majority (90.74%) of the patients recovered with conservative management, 10 (9.26%) died. This study shows that expanded dengue syndrome (EDS) is not uncommon in Bangladesh's dengue viral infection. A high degree of clinical suspicion is the key to early diagnosis and treatment.","['Salma, U', 'Sarker, M A', 'Zafrin, N', 'Rahman, M M', 'Kamrul-Hasan, A B']","['Salma U', 'Sarker MA', 'Zafrin N', 'Rahman MM', 'Kamrul-Hasan AB']",,"['Dr Umma Salma, Associate Professor, Department of Medicine, Dhaka National Medical College & Hospital, Dhaka, Bangladesh; E-mail: dr.salma19@gmail.com.']",['eng'],"['Journal Article', 'Observational Study']",,Bangladesh,Mymensingh Med J,Mymensingh medical journal : MMJ,9601799,,IM,"['Acute Disease', 'Bangladesh/epidemiology', '*Dengue/diagnosis/epidemiology/therapy', 'Humans', 'Laboratories', 'Male', '*Pancreatitis', 'Prospective Studies', 'Tertiary Care Centers']",,2021/10/05 06:00,2021/10/06 06:00,['2021/10/04 08:47'],"['2021/10/04 08:47 [entrez]', '2021/10/05 06:00 [pubmed]', '2021/10/06 06:00 [medline]']",,ppublish,Mymensingh Med J. 2021 Oct;30(4):1073-1078.,4,,,,,,,,,,,,,,,,,,,,,,
37899487,NLM,MEDLINE,20231031,20231101,1471-2458 (Electronic) 1471-2458 (Linking),23,2023 Oct 30,Assessment of the readiness and response toward the dengue fever outbreak (2019) in Sudan: a qualitative exploration.,2122,10.1186/s12889-023-17020-9 [doi] 2122,"BACKGROUND: Dengue fever (DF) is a mosquito-borne viral disease transmitted by Aedes mosquito species and has been considered a major public health problem in Kassala State for tens of years. This study aimed to assess the level of readiness and response toward the 2019 dengue fever outbreak in Kassala at the state and community levels. METHODS: This exploratory cross-sectional study was conducted in Kassala State, Sudan, from January to March 2020. The researcher conducted interviews with the key respondents at the state level to assess the level of readiness and response and to reflect the capacity of institutions-public health authorities, health systems, and emergency response bodies. RESULTS: The surveillance system reported 3961 DF cases in Kassala State, representing 93.5% of the total cases in Sudan between August 2019 and January 2020. This outbreak was identified by passive surveillance, 51 samples were tested during the outbreak period, and private clinics and labs were not included in the surveillance system. According to the WHO checklist of outbreak readiness and response, Kassala's surveillance system and public health laboratory received the lowest scores. CONCLUSIONS: The study concludes that outbreak readiness and response could be considered below standards, mainly in the surveillance system and laboratory diagnostic facilities, due to the absence of intersectoral collaboration with a regulatory framework in terms of financial and operational participation.","['Bagahizel, Abdulla M', 'Elkhatim, Hamadnalla Sir']","['Bagahizel AM', 'Elkhatim HS']",,"['College of Medicine, Hadhramout University, Mukalla, Yemen. abdullabagahizel@gmail.com.', 'University of Medical Sciences and Technology, Khartoum, Sudan. abdullabagahizel@gmail.com.', 'University of Medical Sciences and Technology, Khartoum, Sudan.']",['eng'],['Journal Article'],20231030,England,BMC Public Health,BMC public health,100968562,,IM,"['Animals', 'Humans', '*Dengue/epidemiology/prevention & control/diagnosis', '*Dengue Virus', 'Sudan/epidemiology', 'Cross-Sectional Studies', 'Disease Outbreaks/prevention & control']",PMC10614372,2023/10/30 06:47,2023/10/31 06:42,['2023/10/30 00:20'],"['2023/03/12 00:00 [received]', '2023/10/19 00:00 [accepted]', '2023/10/31 06:42 [medline]', '2023/10/30 06:47 [pubmed]', '2023/10/30 00:20 [entrez]']","['10.1186/s12889-023-17020-9 [pii]', '17020 [pii]', '10.1186/s12889-023-17020-9 [doi]']",epublish,BMC Public Health. 2023 Oct 30;23(1):2122. doi: 10.1186/s12889-023-17020-9.,1,['(c) 2023. The Author(s).'],['NOTNLM'],"['Dengue fever', 'Outbreak', 'Readiness assessment', 'Response assessment', 'Sudan']",['The authors declare no competing interests.'],,,,,,,,,,,,,,,,,,
11014132,NLM,MEDLINE,20001011,20060328,0041-5782 (Print) 0041-5782 (Linking),162,2000 Sep 18,[Dengue fever in Denmark].,5054,,,"['Nielsen, H I']",['Nielsen HI'],,,['dan'],['Editorial'],,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Dengue/diagnosis/*epidemiology/transmission', 'Denmark/epidemiology', 'Humans', 'Travel', 'Tropical Medicine']",,2000/10/03 11:00,2000/10/14 11:01,['2000/10/03 11:00'],"['2000/10/03 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/10/03 11:00 [entrez]']",,ppublish,Ugeskr Laeger. 2000 Sep 18;162(38):5054.,38,,,,,,,,,Denguefeber i Danmark.,,,,,,,,,,,,,
31414637,NLM,MEDLINE,20190918,20190918,0374-9096 (Print) 0374-9096 (Linking),53,2019 Jul,[Travel Related Fever and Rash: Two Cases of Dengue Fever].,348-353,10.5578/mb.68050 [doi],"The frequency of travel-related infections in the world has increased due to the easily and widespread use of travel facilities in the 21st century. Vector-borne diseases are an important part of infectious diseases. Dengue fever is one of the travel-related infections that has been reported increasingly in recent years through the development of diagnostic methods. The aim of this report was to present two Dengue fever cases originating from travel. There was a story of mosquito bite during a trip to Sri Lanka travel in our first case. The patient was 30 years old and maculopapular rash appeared on the fifth day of contact. Three days after the onset of the rash, she has admitted to our clinic, complaining with fever and chills. Increased leukopenia and muscle enzymes were detected in the laboratory analysis. Real-time reverse transcriptase polimerase chain reaction (RT-PCR) was positive in the serum sample. The patient was followed up with supportive care and discharged by improvement. The second case, a 24-year-old male, had a story of mosquito bite during his trip to Malaysia. After the patient complained of fever, chills, fever, nausea, vomiting and muscle pain, the Dengue virus (DENV) NS1 antigen test performed in this country was found to be positive. In the second case, there was no maculopapular rash and laboratory analysis showed an increase in leukopenia, thrombocytopenia and muscle enzymes. RT-PCR positivity was detected in the serum sample. The patient was followed up with supportive treatment and discharged with cure. DENV infections are caused by DENV which is common in the tropical areas of the world. There are four DENV-1, DENV-2, DENV-3 and DENV-4 serotypes. DENV infections can present different clinical manifestations such as asymptomatic disease, viral syndrome, Dengue haemorrhagic fever, and Dengue shock syndrome. Dengue fever is often accompanied by arthritis, maculopapular rash and high fever. Our cases were defined as Dengue fever according to this definition. In the diagnosis of the disease, it is necessary first to be suspicious of the disease and the travel history must be questioned. In the definitive diagnosis, virus isolation, antigen, nucleic acid detection and serological tests are used. The virus can be isolated from blood, serum, urine and tissues. In the first five days after beginning of the symptoms associated with DENV infections, serum RT-PCR and Dengue NS1 antigen test may be positive.","['Karabay, Oguz', 'Guclu, Ertugrul', 'Simsek, Adem', 'Okan, Huseyin Dogus', 'Ogutlu, Aziz', 'Cosgun, Yasemin', 'Menemenlioglu, Dilek']","['Karabay O', 'Guclu E', 'Simsek A', 'Okan HD', 'Ogutlu A', 'Cosgun Y', 'Menemenlioglu D']",,"['Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.', 'Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.', 'Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.', 'Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.', 'Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.', 'Public Health General Directorate of Turkey, Department of Microbiology Reference and Biological Products Laboratories, National Arboviruses and Viral Zoonoses Laboratory, Ankara, Turkey.', 'Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.']",['tur'],"['Case Reports', 'Journal Article']",,Turkey,Mikrobiyol Bul,Mikrobiyoloji bulteni,7503830,,IM,"['Adult', '*Dengue/complications/diagnosis/pathology/virology', '*Dengue Virus/classification', 'Exanthema/etiology', 'Female', 'Humans', 'Malaysia', 'Male', 'Sri Lanka', '*Travel-Related Illness', 'Treatment Outcome', 'Young Adult']",,2019/08/16 06:00,2019/09/19 06:00,['2019/08/16 06:00'],"['2019/08/16 06:00 [entrez]', '2019/08/16 06:00 [pubmed]', '2019/09/19 06:00 [medline]']",['10.5578/mb.68050 [doi]'],ppublish,Mikrobiyol Bul. 2019 Jul;53(3):348-353. doi: 10.5578/mb.68050.,3,,,,,,,,,Seyahat Iliskili Ates ve Dokuntu: Iki Dengue Atesi Olgusu.,,,,,,,,,,,,,
16880752,NLM,MEDLINE,20060829,20060801,0127-5720 (Print) 0127-5720 (Linking),22,2005 Jun,"Dengue vector surveillance in urban residential and settlement areas in Selangor, Malaysia.",39-43,,"Ovitrap surveillance was conducted in two urban residential areas (Taman Samudera Timur and Taman Samudera Selatan) and in a settlement area (Kampung Banjar), which is located 16 km from Kuala Lumpur city center, Malaysia. In Taman Samudera, dengue cases were reported monthly in 2003/2004. Thus, a study was initiated to determine the distribution and abundance of dengue vectors, Aedes aegypti and Ae. albopictus. The ovitrap surveillance indicated that Ae. aegypti and Ae. albopictus were present both indoors and outdoors. The residential sites had 73 - 79% of the ovitraps with just Ae. aegypti population and Kg. Banjar had 56% of the ovitraps with just Ae. aegypti. In the indoor and outdoor of the residential areas, together with the settlement area, the Ae. aegypti density was significantly more than Ae. albopictus (p < 0.05) by 3 - 50 folds. There was no significant difference in the larval numbers of Ae. aegypti between indoors and outdoors (p > 0.05), thus implicating that adult gravid female Ae. aegypti are present both indoors and outdoors and they do oviposit indoors and outdoors. Ae. aegypti can be incriminated as the principal dengue vector in the urban residential site, Taman Samudera and in the settlement area, Kg. Banjar.","['Chen, Chee Dhang', 'Benjamin, Seleena', 'Saranum, Mohd Masri', 'Chiang, Yee Fook', 'Lee, Han Lim', 'Nazni, Wasi Ahmad', 'Sofian-Azirun, Mohd']","['Chen CD', 'Benjamin S', 'Saranum MM', 'Chiang YF', 'Lee HL', 'Nazni WA', 'Sofian-Azirun M']",,"['Medical Entomology Unit, Institute for Medical Research, Jalan Pahang, 50588 Kuala Lumpur, Malaysia.']",['eng'],['Journal Article'],,Malaysia,Trop Biomed,Tropical biomedicine,8507086,,IM,"['*Aedes', 'Animals', 'Dengue/*epidemiology/etiology/prevention & control/*transmission', 'Housing', 'Humans', '*Insect Vectors', 'Malaysia/epidemiology', 'Mosquito Control', 'Population Density', 'Seasons', 'Urban Health']",,2006/08/02 09:00,2006/08/30 09:00,['2006/08/02 09:00'],"['2006/08/02 09:00 [pubmed]', '2006/08/30 09:00 [medline]', '2006/08/02 09:00 [entrez]']",,ppublish,Trop Biomed. 2005 Jun;22(1):39-43.,1,,,,,,,,,,,,,,,,,,,,,,
16130612,NLM,MEDLINE,20051101,20220408,0970-258X (Print) 0970-258X (Linking),18,2005 May-Jun,Profile of liver involvement in dengue virus infection.,127-30,,"BACKGROUND: Data are scarce on liver involvement in adult patients with dengue virus infection. METHODS: During a recent outbreak of dengue fever in Uttar Pradesh, India, we looked for evidence of liver dysfunction among patients with dengue fever. RESULTS: A total of 45 patients with dengue fever (age 7-65 [median 33] years; 29 men; 39 adults) were studied, including 23 with uncomplicated dengue fever, 15 with dengue haemorrhagic fever and 7 with dengue shock syndrome. The median platelet count was 34 x 10(9)/L (9-99 x 10(9)). Seven patients (15%) had jaundice, 11 (24%) hepatomegaly and 9 clinically detectable ascites; none had splenomegaly. Twelve patients (30%) had hyperbilirubinaemia. Serum alanine and aspartate aminotransferase activities were elevated in 43 patients (96%) each; 5-fold elevated levels were more frequent in severe disease. Hypoalbuminaemia was found in 31/41 patients (76%). Seven patients died, including 2 with acute liver failure. CONCLUSION: Our data show that liver injury is common in adult patients with dengue infection. Further studies are needed to determine the mechanism of liver injury in this disease.","['Itha, Srivenu', 'Kashyap, Rajesh', 'Krishnani, Narendra', 'Saraswat, Vivek A', 'Choudhuri, Gourdas', 'Aggarwal, Rakesh']","['Itha S', 'Kashyap R', 'Krishnani N', 'Saraswat VA', 'Choudhuri G', 'Aggarwal R']",,"['Sanjay Gandhi Postgraduate Institute of Medical Sciences, Rae Bareli Road, Lucknow 226014, Uttar Pradesh, India.']",['eng'],['Journal Article'],,India,Natl Med J India,The National medical journal of India,8809315,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Dengue/*complications/epidemiology/physiopathology', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Liver Diseases/*etiology', 'Liver Function Tests', 'Male', 'Middle Aged']",,2005/09/01 09:00,2005/11/03 09:00,['2005/09/01 09:00'],"['2005/09/01 09:00 [pubmed]', '2005/11/03 09:00 [medline]', '2005/09/01 09:00 [entrez]']",,ppublish,Natl Med J India. 2005 May-Jun;18(3):127-30.,3,,,,,,,,,,,,,,,,,,,,,,
20924690,NLM,MEDLINE,20110316,20211020,1613-7671 (Electronic) 0043-5325 (Linking),122 Suppl 3,2010 Oct,[Psychiatric manifestation of a dengue-encephalopathy].,87-90,10.1007/s00508-010-1460-8 [doi],"Psychiatric manifestation of dengue virus infections is seldom reported. Here a case is presented of a 21-year-old man who developed mainly neuropsychiatric symptoms which he caught one week after a feverish infection during his stay in India: troubles with concentration and memory, confusion, as well as depressive delusions and agoraphobia. Liquor diagnosis as well as CCT and MRI was mainly inconspicuous. The FDG-PET showed a diffuse lack of activity. IgM and IgG antibodies of dengue virus were positive. We interpreted these psychiatric symptoms as a result of a dengue virus infection.","['Rittmannsberger, Hans', 'Foff, Christian', 'Doppler, Stefan', 'Pichler, Robert']","['Rittmannsberger H', 'Foff C', 'Doppler S', 'Pichler R']",,"['Psychiatrie 1, OO Landes-Nervenklinik Wagner-Jauregg, Eine Gesundheitseinrichtung der gespag, Linz, Osterreich. Hans.rittmannsberger@gespag.at']",['ger'],"['English Abstract', 'Journal Article']",,Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,,IM,"['Delusions/*diagnosis/*etiology/psychology', 'Dengue/*complications/*diagnosis/psychology', 'Humans', 'Male', 'Mental Disorders/*diagnosis/*etiology/psychology', 'Young Adult']",,2010/10/07 06:00,2011/03/17 06:00,['2010/10/07 06:00'],"['2010/10/07 06:00 [entrez]', '2010/10/07 06:00 [pubmed]', '2011/03/17 06:00 [medline]']",['10.1007/s00508-010-1460-8 [doi]'],ppublish,Wien Klin Wochenschr. 2010 Oct;122 Suppl 3:87-90. doi: 10.1007/s00508-010-1460-8.,,,,,,,,,,Psychiatrische Manifestation einer Dengue-Encephalopathie.,,,,,,,,,,,,,
37002764,NLM,MEDLINE,20230404,20230404,2408-8757 (Electronic) 1022-4742 (Linking),32,2023 Apr,Clinical Profile of Pediatric Cases of Dengue during the 2019 Epidemic in Bangladesh: A Multicenter Cross-Sectional Study.,502-509,,"Bangladesh experienced the largest dengue epidemic during 2019, with more than 100,000 confirmed cases and 164 deaths. Almost one-third of these cases were children. The present study aimed to investigate the clinical and hematological manifestations of pediatric dengue cases during the epidemic. This was a multicenter cross-sectional study conducted in Dhaka Medical College Hospital, Dhaka, Dr. Sirajul Islam Medical College Hospital and Tangail Sadar Hospital, Tangail, Bangladesh between the period of June 2019 and September 2019. The study included 208 pediatric patients (age <18 years) with confirmed dengue fever. Patient's demographics, clinical and laboratory features of dengue were collected through patients' interview, clinical examination and laboratory investigations. Descriptive statistics were used to represent the patients' socio-demographic information, clinical presentations and hematological parameters. The majority of the patients were aged between 6 and 17 years with male predominance. The most commonly presented clinical manifestations were fever (100.0%), headache (59.0%), myalgia (42.0%), rash (36.0%), retro-orbital pain (28.0%) and diarrhea (24.0%). Warning signs abdominal pain (40.0%) and persistent vomiting (29.0%), bleeding manifestations such as melena (17.0%), gum bleeding (7.0%) and epistaxis (6.0%) and evidence of plasma leakage such as oliguria (3.4%), ascites (2.4%), pleural effusion (1.4%), and shock (1.0%) were also present in the patients. Raised HCT levels, leucopenia and thrombocytopenia were present in almost 23.0%, 43.0% and 28.0% of children, respectively. Warning signs and plasma leakage were present in a substantial number of patients indicating potential risk of severe dengue. Prompt diagnosis and management based on best clinical judgment might prevent severe dengue at an early stage.","['Yesmin, S', 'Ahammad, A M', 'Sarmin, S', 'Rafi, M A', 'Islam, S', 'Hasan, M J']","['Yesmin S', 'Ahammad AM', 'Sarmin S', 'Rafi MA', 'Islam S', 'Hasan MJ']",,"['Dr Sabrina Yesmin, Associate Professor, BIRDEM General Hospital, Dhaka, Bangladesh; E-mail: dr.sabrina37@gmail.com.']",['eng'],"['Journal Article', 'Multicenter Study']",,Bangladesh,Mymensingh Med J,Mymensingh medical journal : MMJ,9601799,,IM,"['Humans', 'Child', 'Male', 'Adolescent', 'Female', '*Severe Dengue/diagnosis/epidemiology/therapy', '*Dengue/diagnosis/epidemiology/therapy', 'Cross-Sectional Studies', 'Bangladesh/epidemiology', 'Headache', '*Thrombocytopenia']",,2023/04/02 06:00,2023/04/04 06:42,['2023/04/01 04:33'],"['2023/04/04 06:42 [medline]', '2023/04/01 04:33 [entrez]', '2023/04/02 06:00 [pubmed]']",,ppublish,Mymensingh Med J. 2023 Apr;32(2):502-509.,2,,,,,,,,,,,,,,,,,,,,,,
21854808,NLM,MEDLINE,20120208,20211020,1872-9096 (Electronic) 0166-3542 (Print) 0166-3542 (Linking),92,2011 Nov,Competitive inhibitor of cellular alpha-glucosidases protects mice from lethal dengue virus infection.,369-71,10.1016/j.antiviral.2011.08.003 [doi],"Dengue virus infection causes diseases in people, ranging from the acute febrile illness dengue fever, to life-threatening dengue hemorrhagic fever/dengue shock syndrome. We previously reported that a host cellular alpha-glucosidases I and II inhibitor, imino sugar CM-10-18, potently inhibited dengue virus replication in cultured cells, and significantly reduced viremia in dengue virus infected AG129 mice. In this report we show that CM-10-18 also significantly protects mice from death and/or disease progress in two mouse models of lethal dengue virus infection. Our results thus provide a strong support for the development of CM-10-18 or its derivatives as antiviral agents to treat servere dengue virus infections.","['Chang, Jinhong', 'Schul, Wouter', 'Yip, Andy', 'Xu, Xiaodong', 'Guo, Ju-Tao', 'Block, Timothy M']","['Chang J', 'Schul W', 'Yip A', 'Xu X', 'Guo JT', 'Block TM']",,"['Drexel Institute for Biotechnology and Virology Research, Department of Microbiology and Immunology, Drexel University College of Medicine, Doylestown, PA 18902, United States. jinhong.chang@drexelmed.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20110811,Netherlands,Antiviral Res,Antiviral research,8109699,"['0 (Antiviral Agents)', '0 (Enzyme Inhibitors)', '0 (Glycoside Hydrolase Inhibitors)']",IM,"['Animals', 'Antiviral Agents/*administration & dosage', 'Dengue/*drug therapy/mortality/pathology/*prevention & control', 'Enzyme Inhibitors/*administration & dosage', '*Glycoside Hydrolase Inhibitors', 'Mice', 'Survival Analysis', 'Treatment Outcome']",PMC3209657,2011/08/23 06:00,2012/02/09 06:00,['2011/08/23 06:00'],"['2011/04/25 00:00 [received]', '2011/07/07 00:00 [revised]', '2011/08/03 00:00 [accepted]', '2011/08/23 06:00 [entrez]', '2011/08/23 06:00 [pubmed]', '2012/02/09 06:00 [medline]']","['S0166-3542(11)00392-5 [pii]', '10.1016/j.antiviral.2011.08.003 [doi]']",ppublish,Antiviral Res. 2011 Nov;92(2):369-71. doi: 10.1016/j.antiviral.2011.08.003. Epub 2011 Aug 11.,2,['Copyright (c) 2011 Elsevier B.V. All rights reserved.'],,,,,"['AI061441/AI/NIAID NIH HHS/United States', 'U01 AI061441-01/AI/NIAID NIH HHS/United States', 'AI084267-0109/AI/NIAID NIH HHS/United States', 'U01 AI061441/AI/NIAID NIH HHS/United States', 'R43 AI084267-01/AI/NIAID NIH HHS/United States']",,,,['NIHMS317938'],,,,,,,,,,,,
25605570,NLM,MEDLINE,20150819,20171116,1537-2995 (Electronic) 0041-1132 (Linking),55,2015 May,Real-time symptomatic case of transfusion-transmitted dengue.,961-4,10.1111/trf.12944 [doi],"BACKGROUND: Dengue virus transmission by blood transfusion is a rarely reported event. CASE REPORT: During a dengue outbreak in Sao Paulo city, a regular plateletpheresis donor informed the blood bank of being diagnosed a few days after donation. The recipient was hospitalized and displayed symptoms and laboratory evidence of dengue after transfusion. RESULTS: The donor was immunoglobulin (Ig)G, IgM, and polymerase chain reaction nonreactive on the index sample, seroconverting 20 days later. The platelet units were transfused into two patients. One of them developed fever 3 days after transfusion, with high viral load. His pretransfusion sample was negative for IgG, IgM, and dengue RNA, while the second recipient did not show any symptoms nor laboratory evidence of dengue infection. CONCLUSIONS: This case brings additional evidence that dengue is indeed transmissible by blood transfusion and clinical manifestations, although rare, do occur.","['Levi, Jose Eduardo', 'Nishiya, Anna', 'Felix, Alvina Clara', 'Salles, Nanci Alves', 'Sampaio, Luciana Ribeiro', 'Hangai, Fatima', 'Sabino, Ester Cerdeira', 'Mendrone, Alfredo Jr']","['Levi JE', 'Nishiya A', 'Felix AC', 'Salles NA', 'Sampaio LR', 'Hangai F', 'Sabino EC', 'Mendrone A Jr']",,"['Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Virology Lab, Instituto de Medicina Tropical da Universidade de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Virology Lab, Instituto de Medicina Tropical da Universidade de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.', 'Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil.', 'Fundacao Pro-Sangue, Hemocentro de Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil.']",['eng'],"['Case Reports', 'Journal Article']",20150121,United States,Transfusion,Transfusion,0417360,,IM,"['Dengue/*etiology/*transmission', 'Humans', 'Male', 'Middle Aged', '*Transfusion Reaction']",,2015/01/22 06:00,2015/08/20 06:00,['2015/01/22 06:00'],"['2014/07/21 00:00 [received]', '2014/09/11 00:00 [revised]', '2014/09/20 00:00 [accepted]', '2015/01/22 06:00 [entrez]', '2015/01/22 06:00 [pubmed]', '2015/08/20 06:00 [medline]']",['10.1111/trf.12944 [doi]'],ppublish,Transfusion. 2015 May;55(5):961-4. doi: 10.1111/trf.12944. Epub 2015 Jan 21.,5,['(c) 2015 AABB.'],,,,,,,,,,,,,,,,,,,,,
36379813,NLM,MEDLINE,20221227,20230104,1579-2129 (Electronic) 0300-2896 (Linking),59,2023 Jan,Effectiveness of Physiotherapy Intervention in Case of Extended Dengue Syndrome: An Undocumented Case Study.,46-47,S0300-2896(22)00594-4 [pii] 10.1016/j.arbres.2022.10.006 [doi],,"['Rai, Jaishree', 'Kumar, Amit']","['Rai J', 'Kumar A']",,"['Apex College of Physiotherapy, BLW, Hydel Road, Varanasi, India.', 'Department of Alllied Medical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, Punjab 144411, India. Electronic address: amit.28649@lpu.co.in.']","['eng', 'spa']",['Case Reports'],20221101,Spain,Arch Bronconeumol,Archivos de bronconeumologia,0354720,,IM,"['Humans', '*Physical Therapy Modalities', '*Dengue/complications/therapy']",,2022/11/16 06:00,2022/12/28 06:00,['2022/11/15 22:04'],"['2022/09/01 00:00 [received]', '2022/10/19 00:00 [revised]', '2022/10/20 00:00 [accepted]', '2022/11/16 06:00 [pubmed]', '2022/12/28 06:00 [medline]', '2022/11/15 22:04 [entrez]']","['S0300-2896(22)00594-4 [pii]', '10.1016/j.arbres.2022.10.006 [doi]']",ppublish,Arch Bronconeumol. 2023 Jan;59(1):46-47. doi: 10.1016/j.arbres.2022.10.006. Epub 2022 Nov 1.,1,,,,,,,,,,,,,,,,,,,,,,
2652338,NLM,MEDLINE,19890607,20061115,0036-3634 (Print) 0036-3634 (Linking),31,1989 Jan-Feb,[Biology of infection caused by the dengue virus].,54-72,,"In this review the most important aspects of the biology of the disease caused by the dengue virus are described: the characteristics of the disease, the epidemiology, the vector, the virus (proteins and genome), the diagnostic techniques and the vaccines.","['Ramos, C']",['Ramos C'],,,['spa'],"['English Abstract', 'Journal Article', 'Review']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['*Dengue/complications/epidemiology/etiology/prevention & control/transmission', '*Dengue Virus/classification/genetics/growth & development/isolation & purification/ultrastructure', 'Humans', 'Vaccination']",,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1989 Jan-Feb;31(1):54-72.,1,,,,,,,99,,Biologia de la infeccion causada por el virus del dengue.,,,,,,,,,,,,,
35435434,NLM,MEDLINE,20220420,20220515,0009-0875 (Print) 0009-0875 (Linking),66,2021 Sep 30,Real-time laboratory surveillance of Dengue antigen(NS1) - Best proposed early warning and response system for Dengue in Sri Lanka? - Results from a pilot study.,121-128,10.4038/cmj.v66i3.9490 [doi],"INTRODUCTION: During the recent past, dengue fever and associated complications have been the most important concern for health policy makers of Sri Lanka. The current notification system has considerable inevitable delays in preventive measures. OBJECTIVES: Implementing a laboratory-based real-time antigen (NS1) surveillance system for notification coupled with a rapid preventive response within the Colombo district as a pilot project and compares the notifications with existing national surveillance systems. METHODS: An online notification platform was established with a centralized database. Seven main laboratories of the private sector linked with the notification system, where they can create new notifications at the central database, whenever the NS1 test detected as positive. Relevant Medical Officers of Health should update action implemented to complete the response process. A dashboard was designed to visualize each notification and its status with a predefined colour code. RESULTS: Patients from 14 Medical Officer of Health (MOH) areas out of 15 were captured. The immediate preventive response was recorded from the field preventive staff for 90% of the reporting. All most all attended patients have given health advice on awareness, prevention, and source reduction through premise inspection by trained field staff with 24hrs of notification. CONCLUSIONS: Salient features of the novel system are notification of antigen-positive patients, the rapidity of notification (real-time) and response, user-friendliness, access to multiple stakeholders simultaneously without data duplication, early involvement of the field staff, the ability to trace the cases using checklists and a color-coding system from a dashboard.","['Ranwala, Lasantha', 'Wedisinghe, Yudhisteera', 'Perera, Sathira', 'Jayamanne, Deepal']","['Ranwala L', 'Wedisinghe Y', 'Perera S', 'Jayamanne D']",,"['Regional Directorate of Health Services, Colombo, Sri Lanka, bdw.jayamanne@kln.ac.lk.', 'Provincial Directorate of Health Services, Colombo, Sri Lanka.', 'Ministry of Health, Sri Lanka.', 'Department of Public Health, Faculty of Medicine-University of Kelaniya, Sri Lanka.']",['eng'],['Journal Article'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['*Dengue/diagnosis/epidemiology/prevention & control', 'Humans', '*Laboratories', 'Pilot Projects', 'Sri Lanka/epidemiology']",,2022/04/19 06:00,2022/04/21 06:00,['2022/04/18 09:50'],"['2022/04/18 09:50 [entrez]', '2022/04/19 06:00 [pubmed]', '2022/04/21 06:00 [medline]']",['10.4038/cmj.v66i3.9490 [doi]'],ppublish,Ceylon Med J. 2021 Sep 30;66(3):121-128. doi: 10.4038/cmj.v66i3.9490.,3,,['NOTNLM'],"['Early warning and response system , NS1 surveillance, real-time surveillance,', 'real-time biosurveillance, Dengue , Dengue notifications']",,,,,,,,,,,,,,,,,,,
20639831,NLM,MEDLINE,20110223,20220317,1022-4742 (Print) 1022-4742 (Linking),19,2010 Jul,Testing blood glucose may be useful in the management of dengue.,382-5,,"Recently dengue viral fever is observed each year in Bangladesh. Overall skills for diagnosis and management have improved owing to national awareness for the disease. We have observed and investigated the frequency of glucose intolerance in the early phase of dengue fever. A two-sampled challenge test by 75 gm oral glucose (OGTT) was done in 133 patients [age (mean+/-SD):33+/-13 years, sex (male/female): 97/36] suffering from dengue fever during their illness. Diagnosis of dengue was based on serologic test for anti-dengue antibodies after the first week. Other investigations were done as part of the management. Among 133 studied dengue patients, 100 were found to have glucose intolerance by OGTT (75.2%). In regards to intensity of intolerance, 21.1%(28/133) had diabetes while 54.1%(72/133) had impaired glucose tolerance (IGT). Among the patients who agreed for a second OGTT (n=40) during discharge, 11(28%) had normal OGTT at both events, 22(55%) revert to normal on second OGTT while 7(17.5%) persisted abnormal glucose intolerance. On regression analysis, glucose intolerance was independently related to increased age (p=0.001) and higher titre of IgG antibody (p=0.006). The study demonstrated that glucose intolerance is frequently associated with dengue fever in its early course. These findings may help for the early diagnosis of dengue fever; and warrants for avoidance of dextrose infusions as fluid replacement in dengue fever. Moreover, patients suffering from dengue fever should be cautioned for development of diabetes in future.","['Hasanat, M A', 'Ananna, M A', 'Ahmed, M U', 'Alam, M N']","['Hasanat MA', 'Ananna MA', 'Ahmed MU', 'Alam MN']",,"['Dr MA Hasanat, Department of Endocrine Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbagh, Dhaka, Bangladesh. hasanatdr@yahoo.com']",['eng'],['Journal Article'],,Bangladesh,Mymensingh Med J,Mymensingh medical journal : MMJ,9601799,"['0 (Blood Glucose)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adult', 'Blood Glucose/*analysis', 'Contraindications', 'Dengue/*complications/diagnosis/therapy', 'Early Diagnosis', 'Female', 'Fluid Therapy/methods', 'Glucose', 'Glucose Intolerance/diagnosis/*etiology', 'Humans', 'Male']",,2010/07/20 06:00,2011/02/24 06:00,['2010/07/20 06:00'],"['2010/07/20 06:00 [entrez]', '2010/07/20 06:00 [pubmed]', '2011/02/24 06:00 [medline]']",,ppublish,Mymensingh Med J. 2010 Jul;19(3):382-5.,3,,,,,,,,,,,,,,,,,,,,,,
27650706,NLM,MEDLINE,20170911,20180926,1095-8541 (Electronic) 0022-5193 (Linking),410,2016 Dec 7,Modelling weekly vector control against Dengue in the Guangdong Province of China.,65-76,S0022-5193(16)30300-9 [pii] 10.1016/j.jtbi.2016.09.012 [doi],"We develop a mathematical model to closely mimic the integrated program of impulsive vector control (every Friday afternoon since the initiation of the program) and continuous patient treatment and isolation implemented in the Guangdong Province of China during its 2014 dengue outbreak. We fitted the data of accumulated infections and used the parameterized model to carry out a retrospective analysis to estimate the basic reproduction number 1.7425 (95% CI 1.4443-2.0408), the control reproduction number 0.1709, and the mosquito-killing ratios 0.1978, 0.2987, 0.6158 and 0.5571 on October 3, 10, 17 and 24, respectively. This suggests that integrated intervention is highly effective in controlling the dengue outbreak. We also simulated outbreak outcomes under different variations of the implemented interventions. We showed that skipping one Friday for vector control would not result in raising the control reproduction number to the threshold value 1 but would lead to significant increase in the accumulated infections at the end of the outbreak. The findings indicate that quick and persistent impulsive implementation of vector control result in an effective reduction in the control reproduction number and hence lead to significant decline of new infections.","['Tang, Biao', 'Xiao, Yanni', 'Tang, Sanyi', 'Wu, Jianhong']","['Tang B', 'Xiao Y', 'Tang S', 'Wu J']",,"[""School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, PR China; Centre for Disease Modelling, York Institute for Health Research, York University, Toronto, ON, Canada M3J 1P3."", ""School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, PR China. Electronic address: yxiao@mail.xjtu.edu.cn."", ""College of Mathematics and Information Science, Shaanxi Normal University, Xi'an 710062, PR China."", 'Centre for Disease Modelling, York Institute for Health Research, York University, Toronto, ON, Canada M3J 1P3.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20160917,England,J Theor Biol,Journal of theoretical biology,0376342,,IM,"['China/epidemiology', 'Dengue/epidemiology/*prevention & control/*transmission', 'Humans', '*Models, Biological', '*Mosquito Vectors', '*Pest Control', 'Time Factors']",,2016/10/23 06:00,2017/09/12 06:00,['2016/09/22 06:00'],"['2016/05/06 00:00 [received]', '2016/09/13 00:00 [revised]', '2016/09/15 00:00 [accepted]', '2016/10/23 06:00 [pubmed]', '2017/09/12 06:00 [medline]', '2016/09/22 06:00 [entrez]']","['S0022-5193(16)30300-9 [pii]', '10.1016/j.jtbi.2016.09.012 [doi]']",ppublish,J Theor Biol. 2016 Dec 7;410:65-76. doi: 10.1016/j.jtbi.2016.09.012. Epub 2016 Sep 17.,,['Copyright (c) 2016 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Control reproduction number', 'Dengue', 'Impulsive control strategy', 'Parameter estimation', 'Sensitive analysis']",,,,,,,,,,,,,,,,,,,
29233775,NLM,MEDLINE,20190722,20190722,1095-8541 (Electronic) 0022-5193 (Linking),439,2018 Feb 14,"An exploration of the role of asymptomatic infections in the epidemiology of dengue viruses through susceptible, asymptomatic, infected and recovered (SAIR) models.",195-204,S0022-5193(17)30548-9 [pii] 10.1016/j.jtbi.2017.12.009 [doi],"It is estimated that 20-97% of all dengue infections could be asymptomatic. I used SIR models to investigate the epidemiological role of such infections, by adding an asymptomatic class (SAIR models). Upon infection in one of the models, a human becomes either symptomatic or asymptomatic. In the other, a human becomes asymptomatic and may progress to being symptomatic. The robustness of results from these models is examined by incorporating the mosquito-vector into one of the models, followed by simulating epidemic dynamics stochastically. Results from the first two models were very similar, with epidemics typically lasting less than one year. When mosquitoes were explicitly modelled in a high-transmission setting, if the level or duration of infectivity from asymptomatic infections was high relative to symptomatic infections, dengue would become endemic. Under stochastic simulation this effect of asymptomatic infections leading to dengue persisting was no longer guaranteed. Longer durations in asymptomatic infections had a higher chance of causing dengue's persistence in stochastic simulation, indicating that this may be more of a key determinant for dengue's persistence to 10 years than the infectivity of such infections. Otherwise, the level and duration of infectivity from asymptomatic infections had similar effects on R(0) and other epidemiological measures. With all models, outbreaks often led to a larger proportion of the population being immune than suggested by monitoring symptomatic dengue infections. This population would be at risk of developing severe dengue in a subsequent outbreak with a different dengue serotype, and would have to be determined via expansion factors.","['Grunnill, Martin']",['Grunnill M'],,"['Center for Ecology and Conservation, University of Exeter, Penryn Campus, Penryn, Cornwall TR10 9FE, United Kingdom; USGS National Wildlife Health Center, 6006 Schroeder Road, Madison, WI 53711-6223, United States of America. Electronic address: grunnill@wisc.edu.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20171209,England,J Theor Biol,Journal of theoretical biology,0376342,,IM,"['Animals', 'Asymptomatic Infections/*epidemiology', 'Computer Simulation', 'Culicidae', 'Dengue/epidemiology/*transmission', 'Disease Outbreaks/statistics & numerical data', 'Disease Susceptibility/epidemiology', 'Epidemics/*statistics & numerical data', 'Humans', '*Models, Biological', 'Stochastic Processes']",,2017/12/14 06:00,2019/07/23 06:00,['2017/12/14 06:00'],"['2017/03/26 00:00 [received]', '2017/11/21 00:00 [revised]', '2017/12/08 00:00 [accepted]', '2017/12/14 06:00 [pubmed]', '2019/07/23 06:00 [medline]', '2017/12/14 06:00 [entrez]']","['S0022-5193(17)30548-9 [pii]', '10.1016/j.jtbi.2017.12.009 [doi]']",ppublish,J Theor Biol. 2018 Feb 14;439:195-204. doi: 10.1016/j.jtbi.2017.12.009. Epub 2017 Dec 9.,,['Copyright (c) 2017. Published by Elsevier Ltd.'],['NOTNLM'],"['Asymptomatic infection', 'Dengue', 'Epidemiology', 'Flavivirus', 'Severe dengue']",,,,,,,,,,,,,,,,,,,
9289616,NLM,MEDLINE,19970911,20141120,0025-682X (Print) 0025-682X (Linking),57,1997,[Current status of dengue virus infections. Epidemiologic and pathogenetic aspects].,71-6,,"The epidemiology of dengue fever is changing dramatically. The worldwide incidence is rising and clinical symptoms are worsening. Reports describing forms associated with hemorrhage or shock syndrome involving both children and adults are increasingly frequent in regions beyond Southeast Asia where the first cases were observed. Many mechanisms could be implicated in these changes including modifications of the virus, host, vector, or socioeconomic factors. Since no current model allows laboratory analysis of these mechanisms, observation of epidemics is still a major source of data. The findings of well conducted epidemiological studies allow not only assessment of morbidity and mortality in endemic areas and early detection of epidemic outbreaks but also evaluation of socioeconomic impact and effectiveness of control measures. Surveillance techniques must be chosen in function of prevailing local conditions. To ensure reliable results studies should be carried out in collaboration with an international network and a simple and accurate method of disease identification should be used.","['Tolou, H', 'Baudon, D', 'Laroche, R']","['Tolou H', 'Baudon D', 'Laroche R']",,"['Unite de Virologie Tropicale, Institut de Medecine Tropicale du Service de Sante des Armees, Marseille-Armees, France.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['Adult', 'Animals', 'Asia, Southeastern/epidemiology', 'Child', 'Dengue/diagnosis/*epidemiology/etiology/mortality/prevention & control', 'Dengue Virus/physiology', 'Disease Models, Animal', 'Disease Outbreaks', 'Disease Vectors', 'Epidemiologic Methods', 'Evaluation Studies as Topic', 'Global Health', 'Hemorrhage/physiopathology', 'Humans', 'Incidence', 'International Cooperation', 'Population Surveillance', 'Reproducibility of Results', 'Shock/physiopathology', 'Socioeconomic Factors']",,1997/01/01 00:00,1997/01/01 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1997/01/01 00:01 [medline]', '1997/01/01 00:00 [entrez]']",,ppublish,Med Trop (Mars). 1997;57(1):71-6.,1,,,,,,,33,,Actualites des infections a virus dengue. Aspects epidemiologiques et pathogeniques.,,,,,,,,,,,,,
25111156,NLM,MEDLINE,20150505,20221009,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),143,2015 Apr,The introduction of dengue vaccine may temporarily cause large spikes in prevalence.,1276-86,10.1017/S0950268814001939 [doi],"A dengue vaccine is expected to be available within a few years. Once vaccine is available, policy-makers will need to develop suitable policies to allocate the vaccine. Mathematical models of dengue transmission predict complex temporal patterns in prevalence, driven by seasonal oscillations in mosquito abundance. In particular, vaccine introduction may induce a transient period immediately after vaccine introduction where prevalence can spike higher than in the pre-vaccination period. These spikes in prevalence could lead to doubts about the vaccination programme among the public and even among decision-makers, possibly impeding the vaccination programme. Using simple dengue transmission models, we found that large transient spikes in prevalence are robust phenomena that occur when vaccine coverage and vaccine efficacy are not either both very high or both very low. Despite the presence of transient spikes in prevalence, the models predict that vaccination does always reduce the total number of infections in the 15 years after vaccine introduction. We conclude that policy-makers should prepare for spikes in prevalence after vaccine introduction to mitigate the burden of these spikes and to accurately measure the effectiveness of the vaccine programme.","['Pandey, A', 'Medlock, J']","['Pandey A', 'Medlock J']",,"['Department of Mathematical Sciences,Clemson University,Clemson, SC,USA.', 'Department of Biomedical Sciences,Oregon State University,Corvallis, OR,USA.']",['eng'],['Journal Article'],20140811,England,Epidemiol Infect,Epidemiology and infection,8703737,['0 (Dengue Vaccines)'],IM,"['Dengue/*epidemiology/prevention & control/transmission', 'Dengue Vaccines/*therapeutic use', 'Dengue Virus', 'Humans', 'Immunization Programs/methods', 'Models, Statistical', 'Prevalence']",PMC9507178,2014/08/12 06:00,2015/05/06 06:00,['2014/08/12 06:00'],"['2014/08/12 06:00 [entrez]', '2014/08/12 06:00 [pubmed]', '2015/05/06 06:00 [medline]']","['S0950268814001939 [pii]', '00193 [pii]', '10.1017/S0950268814001939 [doi]']",ppublish,Epidemiol Infect. 2015 Apr;143(6):1276-86. doi: 10.1017/S0950268814001939. Epub 2014 Aug 11.,6,,['NOTNLM'],['vaccination effectiveness'],['None.'],,,,,,,,,,,,,,,,,,
22257469,NLM,MEDLINE,20120515,20211021,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),18,2012 Jan,"Daily newspaper view of dengue fever epidemic, Athens, Greece, 1927-1931.",78-82,10.3201/eid1801.110191 [doi],"During the late summers of 1927 and 1928, a biphasic dengue epidemic affected the Athens, Greece, metropolitan area; >90% of the population became sick, and >1,000 persons (1,553 in the entire country) died. This epidemic was the most recent and most serious dengue fever epidemic in Europe. Review of all articles published by one of the most influential Greek daily newspapers (I Kathimerini) during the epidemic and the years that followed it did not shed light on the controversy about whether the high number of deaths resulted from dengue hemorrhagic fever after sequential infections with dengue virus types 1 and 2 or to a particularly virulent type 1 virus. Nevertheless, study of the old reports is crucial considering the relatively recent introduction of Aedes albopictus mosquitoes and the frequent warnings of a possible reemergence of dengue fever in Europe.","['Louis, Christos']",['Louis C'],,"['Foundation for Research and Technology-Hellas, Heraklion, Greece. louis@imbb.forth.gr']",['eng'],"['Historical Article', 'Journal Article']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Aedes', 'Animals', 'Communicable Diseases, Emerging/history', 'Dengue/epidemiology/*history/mortality/virology', 'Epidemics/*history', 'Greece/epidemiology', 'History, 20th Century', 'Humans', 'Insect Vectors', 'Newspapers as Topic/*history']",PMC3310089,2012/01/20 06:00,2012/05/16 06:00,['2012/01/20 06:00'],"['2012/01/20 06:00 [entrez]', '2012/01/20 06:00 [pubmed]', '2012/05/16 06:00 [medline]']","['11-0191 [pii]', '10.3201/eid1801.110191 [doi]']",ppublish,Emerg Infect Dis. 2012 Jan;18(1):78-82. doi: 10.3201/eid1801.110191.,1,,,,,,,,,,,,,,,,,,,,,,
20890686,NLM,MEDLINE,20110217,20211020,0973-7693 (Electronic) 0019-5456 (Linking),77,2010 Oct,Clinico-epidemiological profile of children hospitalized with dengue.,1103-7,10.1007/s12098-010-0202-2 [doi],"OBJECTIVE: To study the clinico-epidemiological profile of children hospitalized with dengue illness. METHODS: Prospective study of children hospitalized with the diagnosis of dengue illness during from September through November 2006 at a tertiary care centre in Jaipur. RESULTS: A total of 948 children including 671 (70.8%) boys and 277 (29.2%) girls were diagnosed to have dengue illness during the outbreak. Two third of children were from urban areas while 6-12 years was the most commonly affected age group (45.8%). 58.3% cases had dengue fever (DF) while 41.7% had DHF (dengue hemorrhagic fever). Dengue fever with bleed (DFB) accounted for 32% of cases. Common constitutional symptoms were vomiting (35.2%), pain abdomen (22.1%) and myalgia (10.1%). Bleeding manifestations were observed in 44.5% of cases.. Positive tourniquet test was the most common manifestation which was seen in 300 cases (31.6%) while in 9.2% cases bleeding was the only manifestation. Epistaxis (25%) was the most common spontaneous bleeding manifestation. Thrombocytopenia was documented in 84% of total cases and bleeding occurred more often in patients with severe thrombocytopenia. Ten children expired with a case fatality rate of 1.1%. CONCLUSIONS: Children between 6 and 12 yrs were most affected by dengue with larger number of cases from urban areas. DFB cases accounted for almost one third cases of dengue. Epistaxis was the most common spontaneous bleeding manifestation. Bleeding occurs more often in patients with severe thrombocytopenia.","['Kulkarni, Manjunath J', 'Sarathi, Vijaya', 'Bhalla, Vikas', 'Shivpuri, Deepak', 'Acharya, Usha']","['Kulkarni MJ', 'Sarathi V', 'Bhalla V', 'Shivpuri D', 'Acharya U']",,"['Department of Pediatrics, Sir Padampat Mother and Child Health Institute, SMS Medical College, Jaipur, Rajasthan, India.']",['eng'],['Journal Article'],20101002,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Child', 'Dengue/complications/*diagnosis/epidemiology', 'Epistaxis/etiology', 'Female', 'Hospitalization', 'Humans', 'Male', 'Prospective Studies']",,2010/10/05 06:00,2011/02/18 06:00,['2010/10/05 06:00'],"['2009/11/26 00:00 [received]', '2010/06/16 00:00 [accepted]', '2010/10/05 06:00 [entrez]', '2010/10/05 06:00 [pubmed]', '2011/02/18 06:00 [medline]']",['10.1007/s12098-010-0202-2 [doi]'],ppublish,Indian J Pediatr. 2010 Oct;77(10):1103-7. doi: 10.1007/s12098-010-0202-2. Epub 2010 Oct 2.,10,,,,,,,,,,,,,,,,,,,,,,
25141561,NLM,MEDLINE,20140911,20140821,0019-5138 (Print) 0019-5138 (Linking),45,2013 Mar-Jun,Postnatally acquired dengue in a neonate--a case report.,101-3,,"Dengue was earlier a disease of children. But with increasing incidence in adults, dengue is increasingly encountered in infants and sometimes in neonates. The usual mode of transmission in neonates is vertical. We report a neonate with horizontal transmission of dengue. Dengue should be considered in the differential diagnosis of neonatal septicemia especially during dengue season even in the absence of maternal symptoms, to ensure proper case management.","['Kanwaljeet, Kaur Chopra', 'Varun, Singh', 'Anita, Arora']","['Kanwaljeet KC', 'Varun S', 'Anita A']",,,['eng'],"['Case Reports', 'Journal Article']",,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['Dengue/*diagnosis/etiology/therapy', 'Diagnosis, Differential', 'Humans', 'Infant, Newborn', 'Male']",,2013/03/01 00:00,2014/09/12 06:00,['2014/08/22 06:00'],"['2014/08/22 06:00 [entrez]', '2013/03/01 00:00 [pubmed]', '2014/09/12 06:00 [medline]']",,ppublish,J Commun Dis. 2013 Mar-Jun;45(1-2):101-3.,1-2,,,,,,,,,,,,,,,,,,,,,,
34812173,NLM,MEDLINE,20211124,20211124,1812-2078 (Electronic) 1812-2027 (Linking),19,2021 Jan.-Mar,The Double Burden of COVID-19 and Dengue in Nepal: The challenges ahead.,140-142,,"Coronavirus disease 2019 (COVID-19) pandemic has caused significant impact on the health care system. As a consequence, diagnosis and treatment of vector borne diseases including dengue has been equally affected. Nepal is no exception to this, where COVID-19 cases is exponentially increased and all resources are concentrated on its prevention, control and management. Dengue, one of the major vector-borne diseases in Nepal, is apparently overlooked despite approaching the peak season of the disease. The aim of this paper is to describe the double burden of COVID-19 and dengue in Nepal, particularly highlighting the co-circulation and possible coinfections. This has posed higher risk of increased severity, more severe cases and deaths in Nepal. Moreover, potential misdiagnosis of these viral diseases may lead to delayed or, inappropriate treatment and poor allocation of resources.","['Pandey, K', 'Dumre, S P', 'Dhimal, M', 'Pun, S B', 'Shah, Y', 'Fernandez, S', 'Morita, K', 'Pandey, B D']","['Pandey K', 'Dumre SP', 'Dhimal M', 'Pun SB', 'Shah Y', 'Fernandez S', 'Morita K', 'Pandey BD']",,"['Central Department of Zoology, Tribhuvan University, Kirtipur, Nepal.', 'Central Department of Microbiology, Tribhuvan University, Kirtipur, Nepal.', 'Nepal Health Research Council, Kathmandu, Nepal.', 'Sukraraj Tropical and Infectious Diseases Hospital, Kathmandu, Nepal.', 'Everest International Clinic and Research Center, Kathmandu, Nepal.', 'Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.', 'Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.', 'Ministry of Health and Population, Government of Nepal, Kathmandu, Nepal.']",['eng'],['Journal Article'],,Nepal,Kathmandu Univ Med J (KUMJ),Kathmandu University medical journal (KUMJ),101215359,,IM,"['*COVID-19', '*Dengue/diagnosis/epidemiology/therapy', 'Humans', 'Nepal/epidemiology', 'Pandemics', 'SARS-CoV-2']",,2021/11/24 06:00,2021/11/25 06:00,['2021/11/23 09:23'],"['2021/11/23 09:23 [entrez]', '2021/11/24 06:00 [pubmed]', '2021/11/25 06:00 [medline]']",,ppublish,Kathmandu Univ Med J (KUMJ). 2021 Jan.-Mar;19(73):140-142.,73,,,,,,,,,,,,,,,,,,,,,,
26506745,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,PRACTICAL GUIDELINE FOR MANAGEMENT OF DENGUE IN ADULTS: 2014.,169-85,,,,,,,['eng'],"['Journal Article', 'Practice Guideline']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adult', 'Aged', 'Dengue/*diagnosis/*therapy', '*Disease Management', 'Humans', 'Middle Aged', 'Severe Dengue/diagnosis/therapy', 'Young Adult']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:169-85.,,,,,,,,,,,,,,,,,,['Royal College Physician of Thailand'],,,,,
9111782,NLM,MEDLINE,19970508,20090730,0970-258X (Print) 0970-258X (Linking),9,1996 Nov-Dec,Dengue haemorrhagic fever and shock syndrome.,256-8,,,"['Pande, J N', 'Kabra, S K']","['Pande JN', 'Kabra SK']",,,['eng'],['Editorial'],,India,Natl Med J India,The National medical journal of India,8809315,,IM,"['Dengue/diagnosis/etiology/*therapy', 'Humans']",,1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']",,ppublish,Natl Med J India. 1996 Nov-Dec;9(6):256-8.,6,,,,,,,,,,,,,,,,,,,,,,
25022297,NLM,MEDLINE,20160513,20191210,1972-2680 (Electronic) 1972-2680 (Linking),8,2014 Jul 14,An evaluation of the World Health Organization's 1997 and 2009 dengue classifications in hospitalized dengue patients in Malaysia.,869-75,10.3855/jidc.4283 [doi],"INTRODUCTION: The latest revised version of the World Health Organization's dengue classification was released in 2009. A handful of studies have taken initiatives to evaluate the old and revised guidelines to determine early signs and symptoms of severe dengue. This retrospective study aimed to compare the classification of dengue using both the 1997 and 2009 guidelines in a selected cohort of dengue patients from Peninsular Malaysia between 2008 and 2012. METHODOLOGY: Adult dengue patients were recruited from tertiary hospitals in two different states, Selangor and Kelantan, in Peninsular Malaysia. Their clinical manifestations were assessed. RESULTS: A total of 281 confirmed dengue patients were enrolled; the mean duration of illness at admission was five days. Of these, 88.6%, 10.7%, and 0.7% were classified according to the 1997 guidelines as having dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS), respectively. When the WHO 2009 guidelines were applied, 17.1%, 78.3%, and 4.6% were classified as dengue without warning signs, dengue with warning signs, and severe dengue, respectively. CONCLUSIONS: Our data suggests that the revised WHO 2009 guidelines stratify a much larger proportion of patients into a category that requires a higher level of medical and nursing care.","['Zakaria, Zuraihan', 'Zainordin, Nur A', 'Sim, Benedict L H', 'Zaid, Masliza', 'Haridan, Umi S', 'Aziz, Abu T A', 'Shueb, Rafidah H', 'Mustafa, Mahiran', 'Yusoff, Nik K N', 'Malik, Alam S', 'Lee, Christopher K C', 'Abubakar, Sazaly', 'Hoh, Boon Peng']","['Zakaria Z', 'Zainordin NA', 'Sim BL', 'Zaid M', 'Haridan US', 'Aziz AT', 'Shueb RH', 'Mustafa M', 'Yusoff NK', 'Malik AS', 'Lee CK', 'Abubakar S', 'Hoh BP']",,"['Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia. zuraihanzakaria@gmail.com.']",['eng'],"['Evaluation Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20140714,Italy,J Infect Dev Ctries,Journal of infection in developing countries,101305410,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Dengue/*classification/*diagnosis/*etiology', 'Female', 'Guidelines as Topic', 'Hospitalization', 'Humans', 'Malaysia', 'Male', 'Middle Aged', 'Retrospective Studies', 'Severe Dengue/classification/diagnosis/etiology', 'World Health Organization', 'Young Adult']",,2014/07/16 06:00,2016/05/14 06:00,['2014/07/16 06:00'],"['2013/10/06 00:00 [received]', '2014/02/05 00:00 [accepted]', '2014/01/22 00:00 [revised]', '2014/07/16 06:00 [entrez]', '2014/07/16 06:00 [pubmed]', '2016/05/14 06:00 [medline]']",['10.3855/jidc.4283 [doi]'],epublish,J Infect Dev Ctries. 2014 Jul 14;8(7):869-75. doi: 10.3855/jidc.4283.,7,,,,,,,,,,,,,,,,,,,,,,
25423801,NLM,MEDLINE,20150108,20181202,0125-1562 (Print) 0125-1562 (Linking),45 Suppl 1,2014,Dengue infection in Lao PDR.,113-9,,,"['Soukaloun, Douangdao']",['Soukaloun D'],,,['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*epidemiology/physiopathology/therapy', 'Disease Progression', 'Humans', 'Laos/epidemiology']",,2014/11/27 06:00,2015/01/09 06:00,['2014/11/27 06:00'],"['2014/11/27 06:00 [entrez]', '2014/11/27 06:00 [pubmed]', '2015/01/09 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2014;45 Suppl 1:113-9.,,,,,,,,,,,,,,,,,,,,,,,
25186647,NLM,MEDLINE,20150610,20211021,1756-0500 (Electronic) 1756-0500 (Linking),7,2014 Sep 3,The re-emergence of dengue virus in non-endemic countries: a case series.,596,10.1186/1756-0500-7-596 [doi] 596,"BACKGROUND: Dengue has been designated a major international public health problem by the World Health Organization. It is endemic in most tropical and sub-tropical countries, which are also popular tourist destinations. Travelers are at significant risk of acquiring the disease and also contribute to its spread to non-endemic countries where the vector is present. Children represent a particular susceptible category, since they have a higher risk than adults of developing severe dengue. CASE PRESENTATION: We describe 3 cases of imported dengue fever in Italy in three children (two born in the Philippines and one of Bangladeshi ethnicity) who acquired dengue fever during a recent travel to Southeast Asia, initially not-recognized because of the low index of suspicion of physicians not working in dengue endemic areas. Clinical presentations, differential diagnosis and management of these children are presented and discussed. CONCLUSIONS: Due to global urbanization and increased air travel, it is nowadays important that physicians who practice outside of traditionally dengue endemic areas are adept at the recognition of potentially fatal reemerging infectious diseases such as dengue.","['Buonsenso, Danilo', 'Barone, Giovanni', 'Onesimo, Roberta', 'Calzedda, Roberta', 'Chiaretti, Antonio', 'Valentini, Piero']","['Buonsenso D', 'Barone G', 'Onesimo R', 'Calzedda R', 'Chiaretti A', 'Valentini P']",,"['Pediatric Infectious Diseases Unit, Department of Pediatrics, Catholic University A, Gemelli Hospital, L,go A, Gemelli 8, 00168 Rome, Italy. danilobuonsenso@gmail.com.']",['eng'],"['Case Reports', 'Journal Article']",20140903,England,BMC Res Notes,BMC research notes,101462768,,IM,"['Age Factors', 'Bangladesh/ethnology', 'Child', '*Communicable Diseases, Emerging', 'Dengue/diagnosis/epidemiology/therapy/*transmission/virology', 'Dengue Virus/*pathogenicity', 'Female', 'Humans', 'Infant', 'Italy/epidemiology', 'Male', 'Philippines/ethnology', 'Predictive Value of Tests', 'Risk Factors', 'Travel', 'Treatment Outcome']",PMC4174650,2014/09/05 06:00,2015/06/11 06:00,['2014/09/05 06:00'],"['2013/10/16 00:00 [received]', '2014/08/22 00:00 [accepted]', '2014/09/05 06:00 [entrez]', '2014/09/05 06:00 [pubmed]', '2015/06/11 06:00 [medline]']","['1756-0500-7-596 [pii]', '3169 [pii]', '10.1186/1756-0500-7-596 [doi]']",epublish,BMC Res Notes. 2014 Sep 3;7:596. doi: 10.1186/1756-0500-7-596.,,,,,,,,,,,,,,,,,,,,,,,
17928264,NLM,MEDLINE,20071211,20151119,1386-6532 (Print) 1386-6532 (Linking),40,2007 Nov,Clinicians' diagnostic practice of dengue infections.,202-6,,"BACKGROUND: Difficulties in the classification of dengue infection have been documented. Such difficulties could be due to the low awareness of the World Health Organization diagnostic guidelines among clinicians. OBJECTIVE: To study the diagnostic practices of clinicians in classifying patients as dengue fever (DF) or dengue haemorrhagic fever (DHF)/dengue shock syndrome (DSS) at the time of discharge during an outbreak. METHODS: A prospective descriptive study of clinical features and disease classification in adult and pediatric dengue patients in the University of Malaya Medical Centre. RESULTS: Five hundred and twenty adult and 191 pediatric patients were enrolled. Thrombocytopenia and evidence of plasma leakage were present in 8% of adult and 19% of pediatric patients. Of these, 93% and 49%, respectively, were given the discharge diagnoses of DF instead of DHF/DSS. Hemoconcentration, serous effusion and thrombocytopenia were not recognized in clinicians' discharge diagnosis of DHF/DSS for adult patients. The receiver operating characteristic (ROC) curve suggested a lack of consistency in the use of WHO guidelines in establishing DHF/DSS in adult patients, while implying otherwise for pediatric patients. CONCLUSION: DHF/DSS is an under-recognized condition by clinicians managing these patients. This can affect the case fatality rate of DHF/DSS and the economic burden of the disease. The lack of awareness in disease manifestations especially plasma leakage, can lead to delayed recognition of DHF/DSS.","['Ng, Chris Fook Sheng', 'Lum, Lucy Chai See', 'Ismail, Noor Azina', 'Tan, Lian Huat', 'Tan, Christina Phoay Lay']","['Ng CF', 'Lum LC', 'Ismail NA', 'Tan LH', 'Tan CP']",,"['Department of Applied Statistics, Faculty of Economics and Administration, University of Malaya, Malaysia. chrisng@um.edu.my']",['eng'],['Journal Article'],,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,,IM,"['Academic Medical Centers', 'Adolescent', 'Adult', 'Area Under Curve', 'Child', 'Child, Preschool', 'Dengue/classification/*diagnosis/*epidemiology/physiopathology', '*Disease Outbreaks', 'Humans', 'Malaysia/epidemiology', ""*Practice Patterns, Physicians'"", 'ROC Curve', 'Severe Dengue/classification/*diagnosis/*epidemiology/physiopathology', 'World Health Organization']",,2007/10/12 09:00,2007/12/12 09:00,['2007/10/12 09:00'],"['2007/03/08 00:00 [received]', '2007/08/18 00:00 [revised]', '2007/08/20 00:00 [accepted]', '2007/10/12 09:00 [pubmed]', '2007/12/12 09:00 [medline]', '2007/10/12 09:00 [entrez]']","['S1386-6532(07)00303-4 [pii]', '10.1016/j.jcv.2007.08.017 [doi]']",ppublish,J Clin Virol. 2007 Nov;40(3):202-6. doi: 10.1016/j.jcv.2007.08.017.,3,,,,,,,,,,,,,,,,,,,,,,
27196051,NLM,MEDLINE,20170707,20190213,1932-6203 (Electronic) 1932-6203 (Linking),11,2016,Dynamic Measurement of Hemodynamic Parameters and Cardiac Preload in Adults with Dengue: A Prospective Observational Study.,e0156135,10.1371/journal.pone.0156135 [doi] e0156135,"Few previous studies have monitored hemodynamic parameters to determine the physiological process of dengue or examined inferior vena cava (IVC) parameters to assess cardiac preload during the clinical phase of dengue. From January 2013 to July 2015, we prospectively studied 162 hospitalized adults with confirmed dengue viral infection using non-invasive cardiac output monitoring and bedside ultrasonography to determine changes in hemodynamic and IVC parameters and identify the types of circulatory shock that occur in patients with dengue. Of 162 patients with dengue, 17 (10.5%) experienced dengue shock and 145 (89.5%) did not. In patients with shock, the mean arterial pressure was significantly lower on day 6 after fever onset (P = 0.045) and the pulse pressure was significantly lower between days 4 and 7 (P<0.05). The stroke volume index and cardiac index were significantly decreased between days 4 and 15 and between days 5 and 8 after fever onset (P<0.05), respectively. A significant proportion of patients with dengue shock had an IVC diameter <1.5 cm and IVC collapsibility index >50% between days 4 and 5 (P<0.05). Hypovolemic shock was observed in 9 (52.9%) patients and cardiogenic shock in 8 (47.1%), with a median (interquartile range) time to shock onset of 6.0 (5.0-6.5) days after fever onset, which was the median day of defervescence. Intravascular hypovolemia occurred before defervescence, whereas myocardial dysfunction occurred on the day of defervescence until 2 weeks after fever onset. Hypovolemic shock and cardiogenic shock each occurred in approximately half of the patients with dengue shock. Therefore, dynamic measures to estimate changes in hemodynamic parameters and preload should be monitored to ensure adequate fluid therapy among patients with dengue, particularly patients with dengue shock.","['Thanachartwet, Vipa', 'Wattanathum, Anan', 'Sahassananda, Duangjai', 'Wacharasint, Petch', 'Chamnanchanunt, Supat', 'Khine Kyaw, Ei', 'Jittmittraphap, Akanitt', 'Naksomphun, Mali', 'Surabotsophon, Manoon', 'Desakorn, Varunee']","['Thanachartwet V', 'Wattanathum A', 'Sahassananda D', 'Wacharasint P', 'Chamnanchanunt S', 'Khine Kyaw E', 'Jittmittraphap A', 'Naksomphun M', 'Surabotsophon M', 'Desakorn V']",,"['Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Pulmonary and Critical Care Division, Department of Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand.', 'Information Technology Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Critical Care Division, Department of Anesthesiology, Phramongkutklao Hospital, Bangkok 10400, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.', 'Pulmonary and Critical Care Division, Department of Medicine, Ramkhamhaeng Hospital, Bangkok 10240, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.']",['eng'],"['Journal Article', 'Observational Study', ""Research Support, Non-U.S. Gov't""]",20160519,United States,PLoS One,PloS one,101285081,,IM,"['Adult', 'Dengue/complications/*diagnosis/diagnostic imaging', 'Female', 'Heart Function Tests', '*Hemodynamics', 'Humans', 'Male', 'Shock/*diagnosis/etiology', 'Ultrasonography']",PMC4873173,2016/05/20 06:00,2017/07/08 06:00,['2016/05/20 06:00'],"['2015/12/15 00:00 [received]', '2016/05/10 00:00 [accepted]', '2016/05/20 06:00 [entrez]', '2016/05/20 06:00 [pubmed]', '2017/07/08 06:00 [medline]']","['PONE-D-15-54436 [pii]', '10.1371/journal.pone.0156135 [doi]']",epublish,PLoS One. 2016 May 19;11(5):e0156135. doi: 10.1371/journal.pone.0156135. eCollection 2016.,5,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
4941592,NLM,MEDLINE,19720202,20041117,0028-4793 (Print) 0028-4793 (Linking),285,1971 Dec 23,"Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems.",1460-9,,,"['Ehrenkranz, N J', 'Ventura, A K', 'Cuadrado, R R', 'Pond, W L', 'Porter, J E']","['Ehrenkranz NJ', 'Ventura AK', 'Cuadrado RR', 'Pond WL', 'Porter JE']",,,['eng'],"['Historical Article', 'Journal Article']",,United States,N Engl J Med,The New England journal of medicine,0255562,['0 (Antibodies)'],IM,"['Aedes', 'Antibodies/analysis', 'Cuba', '*Dengue/epidemiology/etiology/*history/immunology/prevention & control', 'Dengue Virus/isolation & purification', 'Disease Outbreaks', 'Hemagglutination Inhibition Tests', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Insect Vectors', 'Mosquito Control', 'Neutralization Tests', 'Panama', 'United States', 'Venezuela', 'West Indies']",,1971/12/23 00:00,1971/12/23 00:01,['1971/12/23 00:00'],"['1971/12/23 00:00 [pubmed]', '1971/12/23 00:01 [medline]', '1971/12/23 00:00 [entrez]']",['10.1056/NEJM197112232852606 [doi]'],ppublish,N Engl J Med. 1971 Dec 23;285(26):1460-9. doi: 10.1056/NEJM197112232852606.,26,,,,,,,,,,,,,,,,,,,,,,
24115243,NLM,MEDLINE,20140721,20131128,1527-6473 (Electronic) 1527-6465 (Linking),19,2013 Dec,Transmission of dengue virus from a donor to a recipient after living donor liver transplantation.,1413-4,10.1002/lt.23755 [doi],,"['Saigal, Sanjiv', 'Choudhary, Narendra S', 'Saraf, Neeraj', 'Kataria, Sushila', 'Mohanka, Ravi', 'Soin, Arvinder S']","['Saigal S', 'Choudhary NS', 'Saraf N', 'Kataria S', 'Mohanka R', 'Soin AS']",,"['Institute of Liver Transplantation and Regenerative Medicine and Medanta-The Medicity, Gurgaon, Haryana, India.']",['eng'],['Letter'],20131021,United States,Liver Transpl,Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,100909185,,IM,"['Adult', 'Dengue/diagnosis/therapy/*transmission/virology', 'Dengue Virus/*pathogenicity', 'Humans', 'Liver Transplantation/*adverse effects', '*Living Donors', 'Risk Factors', 'Time Factors']",,2013/10/12 06:00,2014/07/22 06:00,['2013/10/12 06:00'],"['2013/08/24 00:00 [received]', '2013/09/08 00:00 [accepted]', '2013/10/12 06:00 [entrez]', '2013/10/12 06:00 [pubmed]', '2014/07/22 06:00 [medline]']",['10.1002/lt.23755 [doi]'],ppublish,Liver Transpl. 2013 Dec;19(12):1413-4. doi: 10.1002/lt.23755. Epub 2013 Oct 21.,12,,,,,,,,,,,,,,,,,,,,,,
22890033,NLM,MEDLINE,20121221,20220408,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),87,2012 Oct,Total economic cost and burden of dengue in Nicaragua: 1996-2010.,616-22,10.4269/ajtmh.2012.12-0146 [doi],"The burden of dengue in Nicaragua has been steadily rising during the last three decades; however, there have been few efforts to quantify the burden (measured in disability-adjusted life years [DALYs]) and cost to society. Using primary data from the Nicaraguan Ministry of Health (MINSA), the total cost and burden of dengue were calculated from 1996 to 2010. Total costs included both direct costs from medical expenditures and prevention activities and indirect costs from lost productivity. The annual disease burden ranged from 99 to 805 DALYs per million, with a majority associated with classic dengue fever. The total cost was estimated to be US$13.5 million/year (range: US$5.1-27.6 million). This analysis can help improve allocation of dengue control resources in Nicaragua and the region. As one of the most comprehensive analyses of its type to date in Nicaragua and Latin America, this study can serve as a model to determine the burden and cost of dengue.","['Wettstein, Zachary S', 'Fleming, Michael', 'Chang, Aileen Y', 'Copenhaver, David J', 'Wateska, Angela R', 'Bartsch, Sarah M', 'Lee, Bruce Y', 'Kulkarni, Rajan P']","['Wettstein ZS', 'Fleming M', 'Chang AY', 'Copenhaver DJ', 'Wateska AR', 'Bartsch SM', 'Lee BY', 'Kulkarni RP']",,"['Dengue Relief Foundation, Managua, Nicaragua. zwettstein@gmail.com']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20120813,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['*Cost of Illness', 'Dengue/*economics/epidemiology/prevention & control', 'Disability Evaluation', '*Health Care Costs', 'Humans', 'Nicaragua/epidemiology', 'Quality-Adjusted Life Years', 'Severe Dengue/*economics/epidemiology/prevention & control']",PMC3516309,2012/08/15 06:00,2012/12/22 06:00,['2012/08/15 06:00'],"['2012/08/15 06:00 [entrez]', '2012/08/15 06:00 [pubmed]', '2012/12/22 06:00 [medline]']","['ajtmh.2012.12-0146 [pii]', '10.4269/ajtmh.2012.12-0146 [doi]']",ppublish,Am J Trop Med Hyg. 2012 Oct;87(4):616-22. doi: 10.4269/ajtmh.2012.12-0146. Epub 2012 Aug 13.,4,,,,,,['1U54GM088491-01-09/GM/NIGMS NIH HHS/United States'],,,,,,,,,,,,,,,,
27626476,NLM,MEDLINE,20170628,20220629,1980-5322 (Electronic) 1807-5932 (Print) 1807-5932 (Linking),71,2016 Aug,"Age and regional differences in clinical presentation and risk of hospitalization for dengue in Brazil, 2000-2014.",455-63,10.6061/clinics/2016(08)08 [doi],"OBJECTIVES: Dengue cases range from asymptomatic to severe, eventually leading to hospitalization and death. Timely and appropriate management is critical to reduce morbidity. Since 1980, dengue has spread throughout Brazil, affecting an increasing number of individuals. This paper describes age and regional differences in dengue's clinical presentation and associated risk of hospitalization based on more than 5 million cases reported to the Brazilian Ministry of Health from 2000-2014. METHODS: We performed a retrospective analysis of  approximately 5,450,000 dengue cases, relating clinical manifestations and the risk of hospitalization to age, gender, previous infection by dengue, dengue virus serotype, years of formal education, delay to first attendance and the occurrence of dengue during outbreaks and in different Brazilian regions. RESULTS: Complicated forms of dengue occurred more frequently among those younger than 10 years (3.12% vs 1.92%) and those with dengue virus 2 infection (7.65% vs 2.42%), with a delay to first attendance >2 days (3.18% vs 0.82%) and with </=4 years of formal education (2.02% vs 1.46%). The risk of hospitalization was higher among those aged 6-10 years old (OR 4.57; 95% CI 1.43-29.96) and those who were infected by dengue virus 2 (OR 6.36; 95% CI 2.52-16.06), who lived in the Northeast region (OR 1.38; 95% CI 1.11-2.10) and who delayed first attendance by >5 days (composite OR 3.15; 95% CI 1.33-8.9). CONCLUSIONS: In Brazil, the occurrence of severe dengue and related hospitalization is associated with being younger than 10 years old, being infected by dengue virus 2 or 3, living in the Northeast region (the poorest and the second most populated) and delaying first attendance for more than 2 days.","['Burattini, Marcelo N', 'Lopez, Luis F', 'Coutinho, Francisco A B', 'Siqueira, Joao B Jr', 'Homsani, Sheila', 'Sarti, Elsa', 'Massad, Eduardo']","['Burattini MN', 'Lopez LF', 'Coutinho FA', 'Siqueira JB Jr', 'Homsani S', 'Sarti E', 'Massad E']",,"['Faculdade de Medicina da Universidade de Sao Paulo, Divisao de Informatica Medica, Sao Paulo/SP, Brazil.', 'Hospital Sao Paulo, Escola Paulista de Medicina, Sao Paulo/SP, Brazil.', 'Faculdade de Medicina da Universidade de Sao Paulo, Divisao de Informatica Medica, Sao Paulo/SP, Brazil.', 'CIARA, Florida International University, Miami, Florida, United States of America.', 'Faculdade de Medicina da Universidade de Sao Paulo, Divisao de Informatica Medica, Sao Paulo/SP, Brazil.', 'Universidade Federal de Goias, Instituto Tropical de Patologia e Saude Publica, Goiania/GO, Brazil.', 'Sanofi Pasteur, Sao Paulo/SP, Brazil.', 'Sanofi Pasteur Latinoamerica, Mexico City, Mexico.', 'Faculdade de Medicina da Universidade de Sao Paulo, Divisao de Informatica Medica, Sao Paulo/SP, Brazil.', 'London School of Hygiene and Tropical Medicine, London, UK.']",['eng'],['Journal Article'],,United States,Clinics (Sao Paulo),"Clinics (Sao Paulo, Brazil)",101244734,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Age Factors', 'Aged', 'Brazil/epidemiology', 'Child', 'Child, Preschool', 'Dengue/complications/*epidemiology', 'Dengue Virus', 'Epidemics', 'Female', 'Geographic Mapping', 'Hospitalization/*statistics & numerical data', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Retrospective Studies', 'Risk Assessment', 'Risk Factors', 'Severity of Illness Index', 'Sex Distribution', 'Socioeconomic Factors', 'Time Factors', 'Young Adult']",PMC4975787,2016/09/15 06:00,2017/06/29 06:00,['2016/09/15 06:00'],"['2015/11/06 00:00 [received]', '2016/04/29 00:00 [accepted]', '2016/09/15 06:00 [entrez]', '2016/09/15 06:00 [pubmed]', '2017/06/29 06:00 [medline]']","['S1807-5932(22)01070-5 [pii]', 'cln_71p455 [pii]', '10.6061/clinics/2016(08)08 [doi]']",ppublish,Clinics (Sao Paulo). 2016 Aug;71(8):455-63. doi: 10.6061/clinics/2016(08)08.,8,,,,['No potential conflict of interest was reported.'],,,,,,,,,,,,,,,,,,
8764455,NLM,MEDLINE,19960913,20041117,1157-5999 (Print) 1157-5999 (Linking),6,1996 May-Jun,[Dengue: a current arboviral disease on the American continent].,193,,,"['Gangneux, J P']",['Gangneux JP'],,,['fre'],['Journal Article'],,France,Sante,"Sante (Montrouge, France)",9212437,,IM,"['Americas/epidemiology', 'Dengue/diagnosis/*epidemiology/therapy', 'Disease Outbreaks', 'Humans']",,1996/05/01 00:00,1996/05/01 00:01,['1996/05/01 00:00'],"['1996/05/01 00:00 [pubmed]', '1996/05/01 00:01 [medline]', '1996/05/01 00:00 [entrez]']",,ppublish,Sante. 1996 May-Jun;6(3):193.,3,,,,,,,,,La dengue: arbovirose d'actualite sur le continent Americain.,,,,,,,,,,,,,
18582420,NLM,MEDLINE,20081126,20190823,0025-7753 (Print) 0025-7753 (Linking),131,2008 Jun 7,[Clinical and epidemiological features of imported dengue in Spain].,18-21,,"BACKGROUND AND OBJECTIVE: Dengue is the most common imported arbovirus infection in Europe. International travel and an increasing incidence of dengue fever in tropical areas have defined the disease as an emerging infection in returning travellers. We describe the clinical and microbiological features of imported dengue in 3 referral hospitals in Spain. PATIENTS AND METHOD: We included patients diagnosed with dengue infection during a 3-year period (2002--2005). We recorded clinical and epidemiological data and collected blood samples for serological and molecular studies of dengue infection. Data was analyzed with the statistical package Stata 9.2. RESULTS: We diagnosed 61 dengue cases, mostly European tourists who travelled to Latin America. Fever was found in 98.4% of patients and 80.3% presented with cutaneous eruption. Five patients had severe symptoms. Eighteen percent were considered to have secondary infections, although no patients met the WHO criteria for hemorrhagic dengue. In 26 cases, dengue was confirmed through viral genome detection and 35 cases through serology. Four patients were considered as <<probable>> dengue infection, and 57 as <<confirmed>>. CONCLUSIONS: Dengue is a common diagnosis for returning travellers, and it may present with severe manifestations. In our sample, there was an elevated percentage of secondary infections even though no previous history of dengue was reported by the patients. Hemorrhagic dengue and septic shock dengue are a risk for travellers returning from endemic areas.","['Munoz, Jose', 'Puente, Sabino', 'Lopez-Velez, Rogelio', 'Domingo, Cristina', 'Ruiz, Joaquim', 'Ramirez, German', 'Navarro, Miriam', 'de Orye, Fernando', 'Sanz, Sergi', 'Rivas, Pablo', 'Turrientes, M Carmen', 'Tenorio, Antonio', 'Gascon, Joaquim']","['Munoz J', 'Puente S', 'Lopez-Velez R', 'Domingo C', 'Ruiz J', 'Ramirez G', 'Navarro M', 'de Orye F', 'Sanz S', 'Rivas P', 'Turrientes MC', 'Tenorio A', 'Gascon J']",,"['Seccion de Medicina Tropical, Centro de Salud Internacional, IDIBAPS, Hospital Clinic, Barcelona, Espana. jose.munoz@manhica.net']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Spain,Med Clin (Barc),Medicina clinica,0376377,,IM,"['Adolescent', 'Adult', '*Dengue/diagnosis/epidemiology/microbiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prospective Studies', 'Spain/epidemiology', 'Travel']",,2008/06/28 09:00,2008/12/17 09:00,['2008/06/28 09:00'],"['2008/06/28 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/06/28 09:00 [entrez]']","['13123037 [pii]', '10.1157/13123037 [doi]']",ppublish,Med Clin (Barc). 2008 Jun 7;131(1):18-21. doi: 10.1157/13123037.,1,,,,,,,,,Estudio clinicoepidemiologico del dengue importado en Espana.,,,,,,,,,,,,,
23011449,NLM,MEDLINE,20130510,20190608,1678-9946 (Electronic) 0036-4665 (Linking),54 Suppl 18,2012 Oct,Few characteristics of dengue's fever epidemiology in Brazil.,S1-4,S0036-46652012000700002 [pii],,"['Teixeira, Maria Gloria']",['Teixeira MG'],,"['Public Health Institute, Federal University of Bahia, Bahia, Brazil. magloria@ufba.br']",['eng'],['Journal Article'],,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Brazil/epidemiology', 'Child', 'Child, Preschool', 'Dengue/*epidemiology', 'Hospitalization', 'Humans', 'Incidence', 'Infant', 'Middle Aged', 'Young Adult']",,2012/10/04 06:00,2013/05/11 06:00,['2012/09/27 06:00'],"['2012/09/27 06:00 [entrez]', '2012/10/04 06:00 [pubmed]', '2013/05/11 06:00 [medline]']","['S0036-46652012000700002 [pii]', '10.1590/s0036-46652012000700002 [doi]']",ppublish,Rev Inst Med Trop Sao Paulo. 2012 Oct;54 Suppl 18:S1-4. doi: 10.1590/s0036-46652012000700002.,,,,,,,,,,,,,,,,,,,,,,,
23011451,NLM,MEDLINE,20130510,20190608,1678-9946 (Electronic) 0036-4665 (Linking),54 Suppl 18,2012 Oct,Clinical experience in dengue: experience of specialized service.,S7-9,S0036-46652012000700004 [pii],,"['Souza, Luiz Jose de', 'Boulos, Marcos']","['Souza LJ', 'Boulos M']",,"['Faculty of Medicine, Campos, Campos Goytacazes, Rio de Janeiro, Brazil.']",['eng'],['Journal Article'],,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Adolescent', 'Brazil/epidemiology', 'Child', 'Child, Preschool', '*Community Health Centers', 'Dengue/complications/*diagnosis/epidemiology', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male']",,2012/10/04 06:00,2013/05/11 06:00,['2012/09/27 06:00'],"['2012/09/27 06:00 [entrez]', '2012/10/04 06:00 [pubmed]', '2013/05/11 06:00 [medline]']","['S0036-46652012000700004 [pii]', '10.1590/s0036-46652012000700004 [doi]']",ppublish,Rev Inst Med Trop Sao Paulo. 2012 Oct;54 Suppl 18:S7-9. doi: 10.1590/s0036-46652012000700004.,,,,,,,,,,,,,,,,,,,,,,,
26403283,NLM,MEDLINE,20160407,20181202,2095-5162 (Print) 2049-9957 (Electronic) 2049-9957 (Linking),4,2015 Sep 24,"A study of the correlation between dengue and weather in Kandy City, Sri Lanka (2003 -2012) and lessons learned.",42,10.1186/s40249-015-0075-8 [doi] 42,"BACKGROUND: Weather variables affect dengue transmission. This study aimed to identify a dengue weather correlation pattern in Kandy, Sri Lanka, compare the results with results of similar studies, and establish ways for better control and prevention of dengue. METHOD: We collected data on reported dengue cases in Kandy and mid-year population data from 2003 to 2012, and calculated weekly incidences. We obtained daily weather data from two weather stations and converted it into weekly data. We studied correlation patterns between dengue incidence and weather variables using the wavelet time series analysis, and then calculated cross-correlation coefficients to find magnitudes of correlations. RESULTS: We found a positive correlation between dengue incidence and rainfall in millimeters, the number of rainy and wet days, the minimum temperature, and the night and daytime, as well as average, humidity, mostly with a five- to seven-week lag. Additionally, we found correlations between dengue incidence and maximum and average temperatures, hours of sunshine, and wind, with longer lag periods. Dengue incidences showed a negative correlation with wind run. CONCLUSION: Our results showed that rainfall, temperature, humidity, hours of sunshine, and wind are correlated with local dengue incidence. We have suggested ways to improve dengue management routines and to control it in these times of global warming. We also noticed that the results of dengue weather correlation studies can vary depending on the data analysis.","['Ehelepola, N D B', 'Ariyaratne, Kusalika', 'Buddhadasa, W M N P', 'Ratnayake, Sunil', 'Wickramasinghe, Malani']","['Ehelepola ND', 'Ariyaratne K', 'Buddhadasa WM', 'Ratnayake S', 'Wickramasinghe M']",,"['The Teaching (General) Hospital - Kandy, Kandy, Sri Lanka. drehelepola@gmail.com.', 'Faculty of Engineering, University of Ruhuna, Hapugala, Sri Lanka. kusalika@yahoo.com.', 'The Teaching (General) Hospital - Kandy, Kandy, Sri Lanka. namalbuddhadasa@gmail.com.', 'The Teaching (General) Hospital - Kandy, Kandy, Sri Lanka. msskbandara@yahoo.com.', 'The Teaching (General) Hospital - Kandy, Kandy, Sri Lanka. malani0718201970@gmail.com.']",['eng'],"['Historical Article', 'Journal Article']",20150924,England,Infect Dis Poverty,Infectious diseases of poverty,101606645,,IM,"['Animals', '*Cities', 'Dengue/*epidemiology/history/prevention & control/transmission', 'History, 21st Century', 'Humans', 'Incidence', 'Rain', 'Seasons', 'Sri Lanka/epidemiology', '*Weather']",PMC4581090,2015/09/26 06:00,2016/04/08 06:00,['2015/09/26 06:00'],"['2015/05/13 00:00 [received]', '2015/09/09 00:00 [accepted]', '2015/09/26 06:00 [entrez]', '2015/09/26 06:00 [pubmed]', '2016/04/08 06:00 [medline]']","['10.1186/s40249-015-0075-8 [pii]', '75 [pii]', '10.1186/s40249-015-0075-8 [doi]']",epublish,Infect Dis Poverty. 2015 Sep 24;4:42. doi: 10.1186/s40249-015-0075-8.,,,,,,,,,,,,,,,,,,,,,,,
11068089,NLM,MEDLINE,20010201,20191104,0188-4409 (Print) 0188-4409 (Linking),31,2000 Jul-Aug,Dengue virus (serotype 3) circulation in endemic countries and its reappearance in America.,429-30,,,"['Figueroa, R', 'Ramos, C']","['Figueroa R', 'Ramos C']",,,['eng'],['Letter'],,United States,Arch Med Res,Archives of medical research,9312706,,IM,"['Americas/epidemiology', 'Dengue/*epidemiology/transmission/virology', 'Dengue Virus', 'Endemic Diseases', 'Global Health', 'Humans']",,2000/11/09 11:00,2001/02/28 10:01,['2000/11/09 11:00'],"['2000/11/09 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/11/09 11:00 [entrez]']","['S0188-4409(00)00082-5 [pii]', '10.1016/s0188-4409(00)00082-5 [doi]']",ppublish,Arch Med Res. 2000 Jul-Aug;31(4):429-30. doi: 10.1016/s0188-4409(00)00082-5.,4,,,,,,,,,,,,,,,,,,,,,,
19248708,NLM,MEDLINE,20090331,20220331,0300-5283 (Print) 0300-5283 (Linking),63,2008 Aug,Acute dengue in a neonate secondary to perinatal transmission.,265-6,,"We report a newborn baby girl with acute dengue due to vertical transmission. A 31 year old factory worker of 38+ week gestation, gravida 5 para 3+1, developed acute dengue fever two days prior to delivery. She delivered a normal term baby girl by spontaneous vaginal delivery and recovered uneventfully without peripartum haemorrhage despite the presence of thrombocytopenia. The baby girl developed low grade fever on day four of post-natal life and except for the transient thrombocytopenia, also recovered uneventfully following three days of mild illness. The clinical diagnosis of acute dengue virus infection was confirmed by laboratory tests.","['Chin, P S', 'Khoo, A P C', 'Asmah Hani, A W', 'Chem, Y K', 'Norizah, I', 'Chua, K B']","['Chin PS', 'Khoo AP', 'Asmah Hani AW', 'Chem YK', 'Norizah I', 'Chua KB']",,"['Hospital Taiping, Jalan Taming Sari, 34000 Taiping, Perak, Malaysia.']",['eng'],"['Case Reports', 'Journal Article']",,Malaysia,Med J Malaysia,The Medical journal of Malaysia,0361547,,IM,"['Dengue/*diagnosis/therapy/*transmission', 'Female', 'Humans', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical']",,2009/03/03 09:00,2009/04/01 09:00,['2009/03/03 09:00'],"['2009/03/03 09:00 [entrez]', '2009/03/03 09:00 [pubmed]', '2009/04/01 09:00 [medline]']",,ppublish,Med J Malaysia. 2008 Aug;63(3):265-6.,3,,,,,,,,,,,,,,,,,,,,,,
27625400,NLM,MEDLINE,20170314,20181113,1708-8305 (Electronic) 1195-1982 (Print) 1195-1982 (Linking),23,2016 Jun,Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians.,,taw062 [pii] 10.1093/jtm/taw062 [doi],"BACKGROUND: International travel can expose travellers to pathogens not commonly found in their countries of residence, like dengue virus. Travellers and the clinicians who advise and treat them have unique needs for understanding the geographic extent of risk for dengue. Specifically, they should assess the need for prevention measures before travel and ensure appropriate treatment of illness post-travel. Previous dengue-risk maps published in the Centers for Disease Control and Prevention's Yellow Book lacked specificity, as there was a binary (risk, no risk) classification. We developed a process to compile evidence, evaluate it and apply more informative risk classifications. METHODS: We collected more than 839 observations from official reports, ProMED reports and published scientific research for the period 2005-2014. We classified each location as frequent/continuous risk if there was evidence of more than 10 dengue cases in at least three of the previous 10 years. For locations that did not fit this criterion, we classified locations as sporadic/uncertain risk if the location had evidence of at least one locally acquired dengue case during the last 10 years. We used expert opinion in limited instances to augment available data in areas where data were sparse. RESULTS: Initial categorizations classified 134 areas as frequent/continuous and 140 areas as sporadic/uncertain. CDC subject matter experts reviewed all initial frequent/continuous and sporadic/uncertain categorizations and the previously uncategorized areas. From this review, most categorizations stayed the same; however, 11 categorizations changed from the initial determinations. CONCLUSIONS: These new risk classifications enable detailed consideration of dengue risk, with clearer meaning and a direct link to the evidence that supports the specific classification. Since many infectious diseases have dynamic risk, strong geographical heterogeneities and varying data quality and availability, using this approach for other diseases can improve the accuracy, clarity and transparency of risk communication.","['Jentes, Emily S', 'Lash, R Ryan', 'Johansson, Michael A', 'Sharp, Tyler M', 'Henry, Ronnie', 'Brady, Oliver J', 'Sotir, Mark J', 'Hay, Simon I', 'Margolis, Harold S', 'Brunette, Gary W']","['Jentes ES', 'Lash RR', 'Johansson MA', 'Sharp TM', 'Henry R', 'Brady OJ', 'Sotir MJ', 'Hay SI', 'Margolis HS', 'Brunette GW']",,"['Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, MS E-03, Atlanta, GA 30333, USA ejentes@cdc.gov.', 'Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, MS E-03, Atlanta, GA 30333, USA.', 'Division of Vector-Borne Diseases, CDC, San Juan, Puerto Rico 00920.', 'Division of Vector-Borne Diseases, CDC, San Juan, Puerto Rico 00920.', 'Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, MS E-03, Atlanta, GA 30333, USA.', 'Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford OX3 7BN, UK.', 'Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, MS E-03, Atlanta, GA 30333, USA.', 'Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford OX3 7BN, UK Institute for Health Metrics and Evaluation, University of Washington, Seattle, 2301 Fifth Ave., Suite 600 Seattle, WA 98121.', 'Division of Vector-Borne Diseases, CDC, San Juan, Puerto Rico 00920.', 'Division of Global Migration and Quarantine, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, MS E-03, Atlanta, GA 30333, USA.']",['eng'],['Journal Article'],20160913,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Asia, Southeastern/epidemiology', 'Dengue/*diagnosis/epidemiology/*prevention & control', 'Dengue Virus', 'Evidence-Based Practice/*organization & administration', 'Humans', '*Travel', 'Travel Medicine/methods', 'Tropical Climate']",PMC5345513,2016/09/15 06:00,2017/03/16 06:00,['2016/09/15 06:00'],"['2016/08/18 00:00 [accepted]', '2016/09/15 06:00 [entrez]', '2016/09/15 06:00 [pubmed]', '2017/03/16 06:00 [medline]']","['taw062 [pii]', '10.1093/jtm/taw062 [doi]']",epublish,J Travel Med. 2016 Sep 13;23(6):taw062. doi: 10.1093/jtm/taw062. Print 2016 Jun.,6,"['Published by Oxford University Press 2016. This work is written by US Government', 'employees and is in the public domain in the US.']",['NOTNLM'],"['Dengue', 'clinical guidance', 'epidemiology', 'risk maps']",,,['095066/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
21124880,NLM,MEDLINE,20110412,20211020,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),4,2010 Nov 23,Viral and epidemiological determinants of the invasion dynamics of novel dengue genotypes.,e894,10.1371/journal.pntd.0000894 [doi] e894,"BACKGROUND: Dengue has become a major concern for international public health. Frequent epidemic outbreaks are believed to be driven by a complex interplay of immunological interactions between its four co-circulating serotypes and large fluctuations in mosquito densities. Viral lineage replacement events, caused for example by different levels of cross-protection or differences in viral fitness, have also been linked to a temporary change in dengue epidemiology. A major replacement event was recently described for South-East Asia where the Asian-1 genotype of dengue serotype 2 replaced the resident Asian/American type. Although this was proposed to be due to increased viral fitness in terms of enhanced human-to-mosquito transmission, no major change in dengue epidemiology could be observed. METHODS/RESULTS: Here we investigate the invasion dynamics of a novel, advantageous dengue genotype within a model system and determine the factors influencing the success and rate of fixation as well as their epidemiological consequences. We find that while viral fitness overall correlates with invasion success and competitive exclusion of the resident genotype, the epidemiological landscape plays a more significant role for successful emergence. Novel genotypes can thus face high risks of stochastic extinction despite their fitness advantage if they get introduced during episodes of high dengue prevalence, especially with respect to that particular serotype. CONCLUSION: The rarity of markers for positive selection has often been explained by strong purifying selection whereby the constraints imposed by dengue's two-host cycle are expected to result in a high rate of deleterious mutations. Our results demonstrate that even highly beneficial mutants are under severe threat of extinction, which would suggest that apart from purifying selection, stochastic effects and genetic drift beyond seasonal bottlenecks are equally important in shaping dengue's viral ecology and evolution.","['Lourenco, Jose', 'Recker, Mario']","['Lourenco J', 'Recker M']",,"['Department of Zoology, University of Oxford, Oxford, United Kingdom.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20101123,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Americas/epidemiology', 'Asia, Southeastern/epidemiology', 'Dengue/*epidemiology/*virology', 'Dengue Virus/*genetics/isolation & purification/physiology', 'Epidemics', 'Genotype', 'Humans']",PMC2990689,2010/12/03 06:00,2011/04/13 06:00,['2010/12/03 06:00'],"['2010/06/17 00:00 [received]', '2010/10/25 00:00 [accepted]', '2010/12/03 06:00 [entrez]', '2010/12/03 06:00 [pubmed]', '2011/04/13 06:00 [medline]']","['10-PNTD-RA-1302R3 [pii]', '10.1371/journal.pntd.0000894 [doi]']",epublish,PLoS Negl Trop Dis. 2010 Nov 23;4(11):e894. doi: 10.1371/journal.pntd.0000894.,11,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
21073029,NLM,MEDLINE,20101223,20101115,0125-1562 (Print) 0125-1562 (Linking),41,2010 Sep,Application of revised dengue classification criteria as a severity marker of dengue viral infection in Indonesia.,1088-94,,"A prospective study of dengue infected patients at Dr.Soetomo Hospital pediatric ward was carried out from October 2008 to April 2009 to evaluate the revised dengue classification system proposed by the Dengue Control (DENCO), for early detection of severe dengue infected patients using the WHO classification system for comparison, with the addition of clinical interventions as a tool to grade for severity. One hundred forty-five patients were included in the study. Using the WHO classification system, 122 cases (84.1%) were classified as having non-severe dengue, of which 70 (48.3%) were classified as having dengue fever (DF), 39 (26.9%) as having dengue hemorrhagic fever (DHF) grade I, and 13 (9%) as having DHF grade II. Twenty-three (15.9%) were classified as having severe dengue, of which 16 (11%) were classified as having DHF grade III and 7 (4.8%) as having DHF grade IV. With clinical interventions included, 8 cases (6.6%) originally classified as having non-severe dengue infection were reclassified as having severe infection (sensitivity = 74%, specificity = 100%, likelihood ratio (-) = 0.26). Using the new dengue classification system, 117 cases (80.7%) were classified as having non-severe dengue infection, of which 79 (54.5%) were classified as having dengue without warning signs and 38 (26.2%) were classified as having dengue with warning signs, while 28 (19.3%) were classified as having severe dengue infection. Using clinical intervention, 4 cases (3.4%) which were originally classified as having non-severe dengue infection were reclassified as having severe dengue infection (sensitivity = 88%, specificity = 99%, likelihood ratio (+) = 98.88, likelihood ratio (-) = 0.13). Binary logistic regression showed the revised dengue classification system (p = 0.000, Wald:22.446) was better in detecting severe dengue infections than the WHO classification system (p = 0.175, Wald:6.339).","['Basuki, Parwati Setiono', 'Budiyanto', 'Puspitasari, Dwiyanti', 'Husada, Dominicus', 'Darmowandowo, Widodo', 'Ismoedijanto', 'Soegijanto, Soegeng', 'Yamanaka, Atsushi']","['Basuki PS', 'Budiyanto', 'Puspitasari D', 'Husada D', 'Darmowandowo W', 'Ismoedijanto', 'Soegijanto S', 'Yamanaka A']",,"['Department of Child Health, Faculty of Medicine, University of Airlangga Dr. Soetomo Hospital, Surabaya, Indonesia. parwati@pediatrik.com']",['eng'],"['Comparative Study', 'Journal Article']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*classification/diagnosis/epidemiology', 'Humans', 'Indonesia/epidemiology', 'Logistic Models', 'Prospective Studies', '*Severity of Illness Index', 'Statistics, Nonparametric', 'World Health Organization']",,2010/11/16 06:00,2010/12/25 06:00,['2010/11/16 06:00'],"['2010/11/16 06:00 [entrez]', '2010/11/16 06:00 [pubmed]', '2010/12/25 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2010 Sep;41(5):1088-94.,5,,,,,,,,,,,,,,,,,,,,,,
33187032,NLM,MEDLINE,20201117,20220418,0004-5772 (Print) 0004-5772 (Linking),68,2020 Nov,Demographic and Clinical Profile of Dengue Fever in a Tertiary Care Hospital of South India.,24-27,,"BACKGROUND: Dengue fever is the most common viral communicable disease caused by the bite of Aedes aegypti mosquito. Worldwide about 3.9 billion people are at the risk of this infection. MATERIALS AND METHODS: This prospective study was done in patients of dengue fever admitted in a service hospital in the coastal area of southern India from 01 Jan 2018 to 31 Dec 2018. RESULTS: 751 patients of confirmed dengue patients were admitted with 555 (73.9%) males and 196 (26.1%) females. The mean age was 30.6 (SD+/- 10.48) years, mean day of admission after the onset of illness was 3.4 days (SD+/-2.76). The most common presentation was fever (99.33%) followed by myalgia (77.62%), headache (67.24%), vomiting (35.41%), nausea (26.76%) and fatigue (9.05%). Bleeding diathesis was evident in 97patients (12.91%). 306 (40.75%) patients presented with warning signs. The mean duration of hospitalization was 5.73 (SD+/- 2.75) days. Four patients died due to severe dengue (mortality rate-0.53%). CONCLUSION: Intense monitoring, early detection, and management of complications can prevent mortality in dengue.","['Padmaprakash, K V', 'Jha, Vijoy Kumar', 'Bhushan, Shashi', 'Deepkamal', 'Sowmya, Karantha C']","['Padmaprakash KV', 'Jha VK', 'Bhushan S', 'Deepkamal', 'Sowmya KC']",,"['HOD Medicine, INHS Kalyani, Vizag, Andhra Pradesh.', 'Physician and Nephrologist, Command Hospital Air Force, Bangalore, Karnataka.', 'Physician, INHS Kalyani, Vizag, Andhra Pradesh.', 'Physician, INHS Kalyani, Vizag, Andhra Pradesh.', 'Medical Officer, INHS Kalyani, Vizag, Andhra Pradesh.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Animals', 'Child', 'Demography', '*Dengue/complications/diagnosis/epidemiology', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Prospective Studies', 'Tertiary Care Centers']",,2020/11/14 06:00,2020/11/18 06:00,['2020/11/13 21:55'],"['2020/11/13 21:55 [entrez]', '2020/11/14 06:00 [pubmed]', '2020/11/18 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2020 Nov;68(11):24-27.,11,['(c) Journal of the Association of Physicians of India 2011.'],,,,,,,,,,,,,,,,,,,,,
19369266,NLM,MEDLINE,20090728,20211028,0962-8452 (Print) 1471-2954 (Electronic) 0962-8452 (Linking),276,2009 Jul 22,Immunological serotype interactions and their effect on the epidemiological pattern of dengue.,2541-8,10.1098/rspb.2009.0331 [doi],"Long-term epidemiological data reveal multi-annual fluctuations in the incidence of dengue fever and dengue haemorrhagic fever, as well as complex cyclical behaviour in the dynamics of the four serotypes of the dengue virus. It has previously been proposed that these patterns are due to the phenomenon of the so-called antibody-dependent enhancement (ADE) among dengue serotypes, whereby viral replication is increased during secondary infection with a heterologous serotype; however, recent studies have implied that this positive reinforcement cannot account for the temporal patterns of dengue and that some form of cross-immunity or external forcing is necessary. Here, we show that ADE alone can produce the observed periodicities and desynchronized oscillations of individual serotypes if its effects are decomposed into its two possible manifestations: enhancement of susceptibility to secondary infections and increased transmissibility from individuals suffering from secondary infections. This decomposition not only lowers the level of enhancement necessary for realistic disease patterns but also reduces the risk of stochastic extinction. Furthermore, our analyses reveal a time-lagged correlation between serotype dynamics and disease incidence rates, which could have important implications for understanding the irregular pattern of dengue epidemics.","['Recker, Mario', 'Blyuss, Konstantin B', 'Simmons, Cameron P', 'Hien, Tran Tinh', 'Wills, Bridget', 'Farrar, Jeremy', 'Gupta, Sunetra']","['Recker M', 'Blyuss KB', 'Simmons CP', 'Hien TT', 'Wills B', 'Farrar J', 'Gupta S']",,"['Department of Zoology, University of Oxford, Oxford OX1 3PS, UK. mario.recker@zoo.ox.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20090415,England,Proc Biol Sci,Proceedings. Biological sciences,101245157,,IM,"['Dengue/*classification/*epidemiology/immunology', 'Humans', 'Models, Theoretical', '*Serotyping', 'Time Factors', 'Vietnam/epidemiology']",PMC2684681,2009/04/17 09:00,2009/07/29 09:00,['2009/04/17 09:00'],"['2009/04/17 09:00 [entrez]', '2009/04/17 09:00 [pubmed]', '2009/07/29 09:00 [medline]']","['rspb.2009.0331 [pii]', 'rspb20090331 [pii]', '10.1098/rspb.2009.0331 [doi]']",ppublish,Proc Biol Sci. 2009 Jul 22;276(1667):2541-8. doi: 10.1098/rspb.2009.0331. Epub 2009 Apr 15.,1667,,,,,,"['WT_/Wellcome Trust/United Kingdom', '084368/WT_/Wellcome Trust/United Kingdom']",,,,,,,,,,,,,,,,
32417869,NLM,MEDLINE,20210513,20210513,1815-672X (Electronic) 0028-2715 (Print) 0028-2715 (Linking),58,2020 Apr 30,"Triage, Surge Capacity, and Epidemic Emergency Unit: An experience from the 2019 dengue outbreak at a Tertiary Care Centre.",272-275,10.31729/jnma.4771 [doi],"In September 2019, a dengue outbreak was observed in many non-endemic areas of Nepal. The emergency department of Patan Academy of Health Sciences also received febrile patients exceeding usual daily numbers. This surge of the patient was managed by epidemic triage and activation of surge capacity. A part of the surge plan was to activate an epidemic emergency unit. An observation ward adjacent to the emergency was used for the epidemic emergency unit. The febrile patients who were triaged yellow and green were treated in this unit. The patients who were triaged as Red were treated in the emergency department.","['Shrestha, Ashis', 'Bajracharya, Sumana', 'House, Darlene Rose']","['Shrestha A', 'Bajracharya S', 'House DR']",,"['Department of General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lagankhel, Nepal.', 'Department of General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lagankhel, Nepal.', 'Department of Paediatric Emergency, Indiana University.']",['eng'],['Journal Article'],20200430,Nepal,JNMA J Nepal Med Assoc,JNMA; journal of the Nepal Medical Association,0045233,,IM,"['*Dengue/diagnosis/epidemiology/therapy', '*Emergency Service, Hospital', '*Epidemics', 'Humans', 'Nepal/epidemiology', '*Surge Capacity', '*Tertiary Care Centers', '*Triage']",PMC7580463,2020/05/18 06:00,2021/05/14 06:00,['2020/05/18 06:00'],"['2020/05/18 06:00 [entrez]', '2020/05/18 06:00 [pubmed]', '2021/05/14 06:00 [medline]']",['10.31729/jnma.4771 [doi]'],epublish,JNMA J Nepal Med Assoc. 2020 Apr 30;58(224):272-275. doi: 10.31729/jnma.4771.,224,,['NOTNLM'],['dengue; epidemics; surge capacity; triage.'],['None.'],,,,,,,,,,,,,,,,,,
10223224,NLM,MEDLINE,19990519,20190921,1360-2276 (Print) 1360-2276 (Linking),4,1999 Mar,Clinical and biological manifestations of dengue.,239-40,,,"['Van den Ende, J', 'Lynen, L']","['Van den Ende J', 'Lynen L']",,,['eng'],"['Comment', 'Letter']",,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Dengue/complications/*diagnosis', 'Humans', 'Predictive Value of Tests']",,1999/05/01 00:00,1999/05/01 00:01,['1999/05/01 00:00'],"['1999/05/01 00:00 [pubmed]', '1999/05/01 00:01 [medline]', '1999/05/01 00:00 [entrez]']",['10.1046/j.1365-3156.1999.03842.x [doi]'],ppublish,Trop Med Int Health. 1999 Mar;4(3):239-40. doi: 10.1046/j.1365-3156.1999.03842.x.,3,,,,,,,,['Trop Med Int Health. 1998 Nov;3(11):859-65. PMID: 9855396'],,,,,,,,,,,,,,
24820925,NLM,MEDLINE,20140825,20160307,1784-3286 (Print) 1784-3286 (Linking),69,2014 Jun,Hemophagocytic lymphohistiocytosis and dengue infection: rare case report.,210-3,10.1179/2295333714Y.0000000019 [doi],"We describe a 21-year-old female patient returning from a journey to Cambodia, who developed dengue fever complicated with hemophagocytic lymphohistiocytosis. Hectic fever, rash, leukopenia, thrombocytopenia, hepatocellular dysfunction, a markedly elevated ferritin level, and a bone marrow demonstrating abundant hemophagocytosis were present. The patient recovered within 14 days. To our knowledge, this is only the second reported case of dengue virus-associated hemophagocytosis in Europe. As dengue is a rising pathogen in tropical import diseases, clinicians must be aware of its rare but serious complications.","['De Koninck, A-S', 'Dierick, J', 'Steyaert, S', 'Taelman, P']","['De Koninck AS', 'Dierick J', 'Steyaert S', 'Taelman P']",,,['eng'],"['Case Reports', 'Journal Article']",20140320,England,Acta Clin Belg,Acta clinica Belgica,0370306,,IM,"['Belgium', 'Cambodia', 'Dengue/*complications/diagnosis/therapy', 'Female', 'Humans', 'Lymphohistiocytosis, Hemophagocytic/*complications/diagnosis/therapy', 'Travel', 'Young Adult']",,2014/05/14 06:00,2014/08/26 06:00,['2014/05/14 06:00'],"['2014/05/14 06:00 [entrez]', '2014/05/14 06:00 [pubmed]', '2014/08/26 06:00 [medline]']",['10.1179/2295333714Y.0000000019 [doi]'],ppublish,Acta Clin Belg. 2014 Jun;69(3):210-3. doi: 10.1179/2295333714Y.0000000019. Epub 2014 Mar 20.,3,,['NOTNLM'],"['Hemophagocytic lymphohistiocytosis,', 'Hemophagocytic syndrome', 'Infection-associated hemophagocytic syndrome,', 'Pancytopenia,', 'Primary dengue infection,']",,['Acta Clin Belg. 2015 Feb;70(1):72. PMID: 25649532'],,,,,,,,,,,,,,,,,
27286230,NLM,MEDLINE,20170710,20191210,1932-6203 (Electronic) 1932-6203 (Linking),11,2016,Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection.,e0155993,10.1371/journal.pone.0155993 [doi] e0155993,"BACKGROUND: Dengue results in a significant public health burden in endemic regions. The World Health Organization (WHO) recommended the use of warning signs (WS) to stratify patients at risk of severe dengue disease in 2009. However, WS is limited in stratifying adult dengue patients at early infection (Day 1-3 post fever), who require close monitoring in hospitals to prevent severe dengue. The aim of this study is to identify and validate prognostic models, built with differentially expressed biomarkers, that enable the early identification of those with early dengue infection that require close clinical monitoring. METHODS: RNA microarray and protein assays were performed to identify differentially expressed biomarkers of severity among 92 adult dengue patients recruited at early infection from years 2005-2008. This comprised 47 cases who developed WS after first presentation and required hospitalization (WS+Hosp), as well as 45 controls who did not develop WS after first presentation and did not require hospitalization (Non-WS+Non-Hosp). Independent validation was conducted with 80 adult dengue patients recruited from years 2009-2012. Prognostic models were developed based on forward stepwise and backward elimination estimation, using multiple logistic regressions. Prognostic power was estimated by the area under the receiver operating characteristic curve (AUC). RESULTS: The WS+Hosp group had significantly higher viral load (P<0.001), lower platelet (P<0.001) and lymphocytes counts (P = 0.004) at early infection compared to the Non-WS+Non-Hosp group. From the RNA microarray and protein assays, the top single RNA and protein prognostic models at early infection were CCL8 RNA (AUC:0.73) and IP-10 protein (AUC:0.74), respectively. The model with CCL8, VPS13C RNA, uPAR protein, and with CCL8, VPS13C RNA and platelets were the best biomarker models for stratifying adult dengue patients at early infection, with sensitivity and specificity up to 83% and 84%, respectively. These results were tested in the independent validation group, showing sensitivity and specificity up to 96% and 54.6%, respectively. CONCLUSIONS: At early infection, adult dengue patients who later presented WS and require hospitalization have significantly different pathophysiology compared with patients who consistently presented no WS and / or require no hospitalization. The molecular prognostic models developed and validated here based on these pathophysiology differences, could offer earlier and complementary indicators to the clinical WHO 2009 WS guide, in order to triage adult dengue patients at early infection.","['Pang, Junxiong', 'Lindblom, Anna', 'Tolfvenstam, Thomas', 'Thein, Tun-Linn', 'Naim, Ahmad Nazri Mohamed', 'Ling, Ling', 'Chow, Angelia', 'Chen, Mark I-Cheng', 'Ooi, Eng Eong', 'Leo, Yee Sin', 'Hibberd, Martin L']","['Pang J', 'Lindblom A', 'Tolfvenstam T', 'Thein TL', 'Naim AN', 'Ling L', 'Chow A', 'Chen MI', 'Ooi EE', 'Leo YS', 'Hibberd ML']",,"['Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.', 'Communicable Diseases Center, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore.', 'Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Department of Medicine Solna, Unit of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.', 'Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Department of Medicine Solna, Unit of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.', 'Unit for Highly Pathogenic Viruses, Public Health Agency of Sweden, Stockholm, Sweden.', 'Communicable Diseases Center, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore.', 'Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.', 'Communicable Diseases Center, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore.', 'Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore, Singapore.', 'DSO National Laboratories, Singapore, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.', 'Communicable Diseases Center, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore.', 'Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.', 'Infectious Disease, Genome Institute of Singapore, Singapore, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.', 'London School of Hygiene & Tropical Medicine, London, United Kingdom.']",['eng'],"['Journal Article', 'Validation Study']",20160610,United States,PLoS One,PloS one,101285081,['0 (Biomarkers)'],IM,"['Adult', 'Aged', 'Biomarkers/*analysis/metabolism', 'Case-Control Studies', 'Dengue/classification/*diagnosis/genetics/therapy', 'Early Diagnosis', 'Female', 'Gene Expression Profiling', 'Hospitalization', 'Humans', 'Male', 'Microarray Analysis', 'Middle Aged', 'Prognosis', 'Sensitivity and Specificity', 'Triage/*methods', 'Young Adult']",PMC4902184,2016/06/11 06:00,2017/07/14 06:00,['2016/06/11 06:00'],"['2015/06/09 00:00 [received]', '2016/05/06 00:00 [accepted]', '2016/06/11 06:00 [entrez]', '2016/06/11 06:00 [pubmed]', '2017/07/14 06:00 [medline]']","['PONE-D-15-19461 [pii]', '10.1371/journal.pone.0155993 [doi]']",epublish,PLoS One. 2016 Jun 10;11(6):e0155993. doi: 10.1371/journal.pone.0155993. eCollection 2016.,6,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
8563691,NLM,MEDLINE,19960307,20041117,1188-4169 (Print) 1188-4169 (Linking),21,1995 Oct 30,Dengue fever in Canada.,185-7,,,"['McCarthy, M A', 'Carpenter, D', 'Goyette, M', 'Nguyen, D T']","['McCarthy MA', 'Carpenter D', 'Goyette M', 'Nguyen DT']",,"['Centre Hospitalier Saint-Joseph, Trois-Rivieres, DT Nguyen, MD, FRCP(C), Internal Medicine, Hopital Maisonneuve-Rosemont, Montreal, Quebec.']","['eng', 'fre']","['Case Reports', 'Journal Article']",,Canada,Can Commun Dis Rep,Canada communicable disease report = Releve des maladies transmissibles au Canada,9303729,,IM,"['Aged', 'Canada/epidemiology', 'Dengue/diagnosis/*epidemiology/transmission', 'Humans', 'Incidence', 'Male', 'Military Personnel', 'Risk Factors', 'Travel']",,1995/10/30 00:00,1995/10/30 00:01,['1995/10/30 00:00'],"['1995/10/30 00:00 [pubmed]', '1995/10/30 00:01 [medline]', '1995/10/30 00:00 [entrez]']",,ppublish,Can Commun Dis Rep. 1995 Oct 30;21(20):185-7.,20,,,,,,,,,,,,,,,,,,,,,,
30311755,NLM,MEDLINE,20181211,20181211,0023-2149 (Print) 0023-2149 (Linking),95,2017,[DENGUE FEVER IN RUSSIA: PROBLEMS OF DIAGNOSTICS].,154-7,,The authors report clinical and laboratory data concerning a case of hemorrhagic dengue fever introduced to Ul'yanovsk by a tourist who had spent holiday in Vietnam. The clinical picture of the disease is described along with results of clinical and laboratory analyses. The approaches to the evaluation of the patient's health status during the period of primary examination and medical care as well as the problems that arose after the final diagnosis was established are discussed.,"['Nafeev, A A', ""Il'mukhina, L V""]","['Nafeev AA', ""Il'mukhina LV""]",,,['rus'],"['Case Reports', 'Journal Article']",,Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,,IM,"['Adult', 'Clinical Laboratory Techniques/methods', '*Dengue/diagnosis/etiology/physiopathology/therapy', 'Diagnosis, Differential', 'Female', 'Humans', 'Patient Care Management/methods', 'Russia', 'Symptom Assessment/methods', 'Travel-Related Illness', 'Treatment Outcome', 'Vietnam']",,2017/01/01 00:00,2018/12/12 06:00,['2018/10/13 06:00'],"['2018/10/13 06:00 [entrez]', '2017/01/01 00:00 [pubmed]', '2018/12/12 06:00 [medline]']",,ppublish,Klin Med (Mosk). 2017;95(2):154-7.,2,,,,,,,,,,,,,,,,,,,,,,
20962733,NLM,MEDLINE,20110406,20101021,0127-5720 (Print) 0127-5720 (Linking),27,2010 Aug,"Studies on community knowledge and behavior following a dengue epidemic in Chennai city, Tamil Nadu, India.",330-6,,"In 2001, a major dengue outbreak was recorded in Chennai city, with 737 cases (90%) out of a total of 861 cases recorded from Tamil Nadu state. A KAP survey was carried out to assess the community knowledge, attitude and practice on dengue fever (DF), following the major dengue outbreak in 2001. A pre- tested, structured questionnaire was used for data collection. The multistage cluster sampling method was employed and 640 households (HHs) were surveyed. Among the total HHs surveyed, 34.5% of HHs were aware of dengue and only 3.3% of HHs knew that virus is the causative agent for DF. Majority of the HHs (86.5%) practiced water storage and only 3% of them stored water more than 5 days. No control measures were followed to avoid mosquito breeding in the water holding containers by majority of HHs (65%). Sixty percent of HHs did not know the biting behaviour of dengue vector mosquitoes. The survey results indicate that the community knowledge was very poor on dengue, its transmission, vector breeding sources, biting behavior and preventive measures. The lack of basic knowledge of the community on dengue epidemiology and vector bionomics would be also a major cause of increasing trend of dengue in this highly populated urban environment. There is an inevitable need to organize health education programmes about dengue disease to increase community knowledge and also to sensitize the community to participate in integrated vector control programme to resolve the dengue problem.","['Ashok Kumar, V', 'Rajendran, R', 'Manavalan, R', 'Tewari, S C', 'Arunachalam, N', 'Ayanar, K', 'Krishnamoorthi, R', 'Tyagi, B K']","['Ashok Kumar V', 'Rajendran R', 'Manavalan R', 'Tewari SC', 'Arunachalam N', 'Ayanar K', 'Krishnamoorthi R', 'Tyagi BK']",,"['Centre for Research in Medical Entomology (ICMR), 4, Sarojini Street, China Chokikulam, Madurai-625 002, India.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Malaysia,Trop Biomed,Tropical biomedicine,8507086,,IM,"['Data Collection', 'Dengue/*epidemiology/prevention & control/transmission', '*Epidemics', '*Health Behavior', 'Health Knowledge, Attitudes, Practice', 'Humans', 'India/epidemiology']",,2010/10/22 06:00,2011/04/07 06:00,['2010/10/22 06:00'],"['2010/10/22 06:00 [entrez]', '2010/10/22 06:00 [pubmed]', '2011/04/07 06:00 [medline]']",,ppublish,Trop Biomed. 2010 Aug;27(2):330-6.,2,,,,,,,,,,,,,,,,,,,,,,
16131779,NLM,MEDLINE,20060613,20230315,0973-7693 (Electronic) 0019-5456 (Linking),72,2005 Aug,Clinical profile and outcome of Dengue fever cases.,705-6,,"Dengue fever is on rise globally. In India, Dengue epidemics are expanding geographically, even into the rural areas. Dengue can present with varied manifestations. The mortality rate has been brought down with high index of suspicion, strict monitoring and proper fluid resuscitation. Herewith, we are presenting clinical features and outcome of Dengue cases seen in and around Hubli (North Karnataka).","['Ratageri, Vinod H', 'Shepur, T A', 'Wari, P K', 'Chavan, S C', 'Mujahid, I B', 'Yergolkar, P N']","['Ratageri VH', 'Shepur TA', 'Wari PK', 'Chavan SC', 'Mujahid IB', 'Yergolkar PN']",,"['Department of Pediatrics, Karnataka Institute of Medical Sciences, Hubli, India. ratageri@rediffmail.com']",['eng'],['Journal Article'],,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Child', 'Dengue/complications/diagnosis/*epidemiology/therapy', 'Encephalitis/*etiology', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Prognosis', 'Retrospective Studies']",,2005/09/01 09:00,2006/06/14 09:00,['2005/09/01 09:00'],"['2005/09/01 09:00 [pubmed]', '2006/06/14 09:00 [medline]', '2005/09/01 09:00 [entrez]']",['10.1007/BF02724083 [doi]'],ppublish,Indian J Pediatr. 2005 Aug;72(8):705-6. doi: 10.1007/BF02724083.,8,,,,,,,,,,,,,,,,,,,,,,
9527381,NLM,MEDLINE,19980402,20041117,0213-005X (Print) 0213-005X (Linking),15,1997 Nov,"[Dengue, an imported disease underdiagnosed in our environment].",498-9,,,"['Llibre, J M', 'Madurell, J', 'Falgueras, M T', 'Vidal, J']","['Llibre JM', 'Madurell J', 'Falgueras MT', 'Vidal J']",,,['spa'],"['Case Reports', 'Letter']",,Spain,Enferm Infecc Microbiol Clin,Enfermedades infecciosas y microbiologia clinica,9104081,,IM,"['Adult', 'Asia', 'Dengue/complications/*diagnosis/epidemiology/transmission', 'Female', 'Humans', 'Metrorrhagia/etiology', 'Spain/epidemiology/ethnology', 'Travel']",,1998/04/04 00:00,1998/04/04 00:01,['1998/04/04 00:00'],"['1998/04/04 00:00 [pubmed]', '1998/04/04 00:01 [medline]', '1998/04/04 00:00 [entrez]']",,ppublish,Enferm Infecc Microbiol Clin. 1997 Nov;15(9):498-9.,9,,,,,,,,,"Dengue, una enfermedad importada infradiagnosticada en nuestro medio.",,,,,,,,,,,,,
23916457,NLM,MEDLINE,20140127,20220902,1678-4391 (Electronic) 1413-8670 (Print) 1413-8670 (Linking),17,2013 Sep-Oct,Categorization of dengue fever according to phase of illness--a suggestion for clinical studies using single diagnostic sample.,622-3,S1413-8670(13)00153-0 [pii] 10.1016/j.bjid.2013.05.003 [doi],,"['Bhaskar, Emmanuel', 'Praveena, Raveendran', 'Sowmya, Gopalan', 'Moorthy, Swathy']","['Bhaskar E', 'Praveena R', 'Sowmya G', 'Moorthy S']",,"['Department of Medicine, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, India. Electronic address: drmeb1974@yahoo.co.in.']",['eng'],['Letter'],20130731,Brazil,Braz J Infect Dis,The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,9812937,,IM,"['Dengue/classification/*diagnosis', 'Humans', 'Severity of Illness Index']",PMC9425121,2013/08/07 06:00,2014/01/28 06:00,['2013/08/07 06:00'],"['2013/04/01 00:00 [received]', '2013/05/02 00:00 [accepted]', '2013/08/07 06:00 [entrez]', '2013/08/07 06:00 [pubmed]', '2014/01/28 06:00 [medline]']","['S1413-8670(13)00153-0 [pii]', '10.1016/j.bjid.2013.05.003 [doi]']",ppublish,Braz J Infect Dis. 2013 Sep-Oct;17(5):622-3. doi: 10.1016/j.bjid.2013.05.003. Epub 2013 Jul 31.,5,,,,,,,,,,,,,,,,,,,,,,
27654728,NLM,MEDLINE,20180820,20181202,0030-9982 (Print) 0030-9982 (Linking),66,2016 Sep,Association of metabolic factors with dengue viral infection on admission triage which predict its clinical course during Lahore dengue epidemic.,1102-1106,,"OBJECTIVE: The study was done to identify metabolic factors which were associated with an increased risk of dengue haemorrhagic fever in clinically diagnosed patients of dengue viral infection. METHODS: 563 patients with dengue viral infection that presented to 3 tertiary care hospitals of Lahore were included in this study, out of which approximately half of the patients were diagnosed as dengue haemorrhagic fever. RESULTS: A total of 563 patients with 263(46.7%) dengue fever and 300(53.3%) dengue haemorrhagic fever patients were studied. The mean age of patients was 48.48 +/- 20.07 years. In patients younger than 60 (n=355), 171 patients had DF and 184 had DHF, while 116 patients above 60 years had DHF and 92 had DF (n=208). The presence of metabolic risk factors such as diabetes (OR = 2.146), hypertension (OR =1.65), diabetes and hypertension (OR =3.56), abnormal liver function tests (OR = 2.27), abnormal renal function tests (OR = 2.282) all increased the risk of DHF relative to DF. CONCLUSIONS: The study showed that metabolic factors especially diabetes with and without hypertension are important risk factors for the development of DHF.","['Baig Mirza, Amena Moazzam', 'Fida, Madiha', 'Murtaza, Ghulam', 'Niazi, Rizwan', 'Hanif, Asif', 'Irfan, Khadija', 'Masud, Faisal']","['Baig Mirza AM', 'Fida M', 'Murtaza G', 'Niazi R', 'Hanif A', 'Irfan K', 'Masud F']",,"['Department of Endocrinology and Metabolism, Services Hospital, Lahore.', 'House Officer, Lahore.', 'Medical Officer, Lahore.', 'Medical Officer, Lahore.', 'Department of Biostatistics, Ghulab Devi Hospital, Lahore.', 'Department of Endocrinology and Metabolism, Services Hospital, Lahore.', 'Department of Endocrinology and Metabolism, Services Hospital, Lahore.']",['eng'],['Journal Article'],,Pakistan,J Pak Med Assoc,JPMA. The Journal of the Pakistan Medical Association,7501162,,IM,"['Adult', 'Aged', 'Dengue/*diagnosis/epidemiology/metabolism', 'Dengue Virus', '*Diabetes Complications', 'Epidemics', 'Humans', 'Hypertension/*complications', 'Middle Aged', 'Risk Factors', 'Severe Dengue', '*Triage']",,2016/09/23 06:00,2018/08/21 06:00,['2016/09/23 06:00'],"['2016/09/23 06:00 [entrez]', '2016/09/23 06:00 [pubmed]', '2018/08/21 06:00 [medline]']",['7896 [pii]'],ppublish,J Pak Med Assoc. 2016 Sep;66(9):1102-1106.,9,,['NOTNLM'],"['DHF: Dengue hemorrhagic Fever, DF: Dengue Fever, LFT: Liver Function tests, RFT:', 'Renal Function Test.']",,,,,,,,,,,,,,,,,,,
9454563,NLM,MEDLINE,19980317,20181113,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),4,1998 Jan-Mar,Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.,89-92,,"After 15 years of absence, dengue reemerged in the municipality of Santiago de Cuba because of increasing migration to the area by people from disease-endemic regions, a high level of vector infestation, and the breakdown of eradication measures. The 1997 epidemic was detected early through an active surveillance system. Of 2,946 laboratory-confirmed cases, 205 were dengue hemorrhagic fever, and 12 were fatal. No deaths were reported in persons under 16 years of age. Now the epidemic is fully controlled.","['Kouri, G', 'Guzman, M G', 'Valdes, L', 'Carbonel, I', 'del Rosario, D', 'Vazquez, S', 'Laferte, J', 'Delgado, J', 'Cabrera, M V']","['Kouri G', 'Guzman MG', 'Valdes L', 'Carbonel I', 'del Rosario D', 'Vazquez S', 'Laferte J', 'Delgado J', 'Cabrera MV']",,"['Instituto de Medicina Tropical ""Pedro Kouri"", Marianao, Havana, Cuba.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Aedes', 'Animals', 'Cuba/epidemiology', 'Dengue/diagnosis/*epidemiology/prevention & control/therapy', 'Disease Management', '*Disease Outbreaks', 'Humans', 'Insect Control', 'Insect Vectors', 'Population Surveillance']",PMC2627664,1998/03/21 00:00,1998/03/21 00:01,['1998/03/21 00:00'],"['1998/03/21 00:00 [pubmed]', '1998/03/21 00:01 [medline]', '1998/03/21 00:00 [entrez]']",['10.3201/eid0401.980111 [doi]'],ppublish,Emerg Infect Dis. 1998 Jan-Mar;4(1):89-92. doi: 10.3201/eid0401.980111.,1,,,,,,,,,,,,,,,,,,,,,,
26102118,NLM,MEDLINE,20170601,20170601,1726-4642 (Electronic) 1726-4634 (Linking),32,2015 Jan-Mar,[Dengue in Peru: a quarter century after its reemergence].,146-56,S1726-46342015000100021 [pii],"A health problem each time more frequent and dispersed in tropical and subtropical areas of the world, including Peru where it entered in 1990, is dengue. It is produced by the dengue virus with four serotypes and transmitted by Aedes aegypti, a vector that coexists with humans and whose presence is favored by deficient sanitary, social and economic conditions. Manifestations of severe forms of the disease such as shock and bleeding, are related to the frequent co-circulation of the four serotypes and the emergence of new genotypes such as American/Asian serotype 2. The new classification of the disease by WHO as dengue with or without warning signs and severe dengue, is contributing to more timely diagnosis and treatment, enabling reductions in mortality. Of note is the need to highlight the surveillance of acute febrile illness and Aedes indices that contribute to a timely diagnosis and guide vector control measures through sanitary education and environmental management with community and intersectoral participation, in a creative manner according to ecological niches. An alternative for complementary prevention would be vaccination using tetravalent vaccines whose safety and efficacy must be guaranteed before its use in the population under the framework of comprehensive strategies.","['Cabezas, Cesar', 'Fiestas, Victor', 'Garcia-Mendoza, Maria', 'Palomino, Miriam', 'Mamani, Enrique', 'Donaires, Fernando']","['Cabezas C', 'Fiestas V', 'Garcia-Mendoza M', 'Palomino M', 'Mamani E', 'Donaires F']",,"['Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru', 'Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru', 'Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru', 'Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru', 'Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru', 'Centro Nacional de Salud Publica, Instituto Nacional de Salud, Lima, Peru']",['spa'],['Journal Article'],,Peru,Rev Peru Med Exp Salud Publica,Revista peruana de medicina experimental y salud publica,101227566,,IM,"['Aedes', 'Animals', 'Communicable Diseases, Emerging/*epidemiology', 'Dengue/classification/diagnosis/*epidemiology/transmission', 'Dengue Virus', 'Humans', 'Mosquito Vectors', 'Peru/epidemiology', 'Time Factors']",,2015/06/24 06:00,2017/06/02 06:00,['2015/06/24 06:00'],"['2015/02/24 00:00 [received]', '2015/03/18 00:00 [accepted]', '2015/06/24 06:00 [entrez]', '2015/06/24 06:00 [pubmed]', '2017/06/02 06:00 [medline]']",['S1726-46342015000100021 [pii]'],ppublish,Rev Peru Med Exp Salud Publica. 2015 Jan-Mar;32(1):146-56.,1,,,,,,,,,Dengue en el Peru: a un cuarto de siglo de su reemergencia.,,,,,,,,,,,,,
23936394,NLM,MEDLINE,20140401,20220321,1932-6203 (Electronic) 1932-6203 (Linking),8,2013,"Nation-wide, web-based, geographic information system for the integrated surveillance and control of dengue fever in Mexico.",e70231,10.1371/journal.pone.0070231 [doi] e70231,"Dengue fever incidence and its geographical distribution are increasing throughout the world. Quality and timely information is essential for its prevention and control. A web based, geographically enabled, dengue integral surveillance system (Dengue-GIS) was developed for the nation-wide collection, integration, analysis and reporting of geo-referenced epidemiologic, entomologic, and control interventions data. Consensus in the design and practical operation of the system was a key factor for its acceptance. Working with information systems already implemented as a starting point facilitated its acceptance by officials and operative personnel. Dengue-GIS provides the geographical detail needed to plan, asses and evaluate the impact of control activities. The system is beginning to be adopted as a knowledge base by vector control programs. It is used to generate evidence on impact and cost-effectiveness of control activities, promoting the use of information for decision making at all levels of the vector control program. Dengue-GIS has also been used as a hypothesis generator for the academic community. This GIS-based model system for dengue surveillance and the experience gathered during its development and implementation could be useful in other dengue endemic countries and extended to other infectious or chronic diseases.","['Hernandez-Avila, Juan Eugenio', 'Rodriguez, Mario-Henry', 'Santos-Luna, Rene', 'Sanchez-Castaneda, Veronica', 'Roman-Perez, Susana', 'Rios-Salgado, Victor Hugo', 'Salas-Sarmiento, Jesus Alberto']","['Hernandez-Avila JE', 'Rodriguez MH', 'Santos-Luna R', 'Sanchez-Castaneda V', 'Roman-Perez S', 'Rios-Salgado VH', 'Salas-Sarmiento JA']",,"['National Institute of Public Health of Mexico, Cuernavaca, Morelos, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130806,United States,PLoS One,PloS one,101285081,,IM,"['Animals', 'Dengue/*epidemiology/*prevention & control/transmission', '*Epidemiological Monitoring', '*Geographic Information Systems', 'Humans', 'Insect Vectors/physiology', '*Internet', 'Mexico/epidemiology']",PMC3735575,2013/08/13 06:00,2014/04/02 06:00,['2013/08/13 06:00'],"['2013/01/15 00:00 [received]', '2013/06/17 00:00 [accepted]', '2013/08/13 06:00 [entrez]', '2013/08/13 06:00 [pubmed]', '2014/04/02 06:00 [medline]']","['PONE-D-13-02807 [pii]', '10.1371/journal.pone.0070231 [doi]']",epublish,PLoS One. 2013 Aug 6;8(8):e70231. doi: 10.1371/journal.pone.0070231. Print 2013.,8,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
9803808,NLM,MEDLINE,19981209,20141120,0037-5675 (Print) 0037-5675 (Linking),39,1998 Jun,The challenge of dengue--desperately seeking solutions.,234-5,,,"['Chow, V T']",['Chow VT'],,,['eng'],['Editorial'],,India,Singapore Med J,Singapore medical journal,0404516,"['0 (Vaccines, Synthetic)']",IM,"['Dengue/diagnosis/*epidemiology/prevention & control', '*Disease Outbreaks', 'Drug Therapy/trends', '*Global Health', 'Humans', 'Population Surveillance', 'Vaccines, Synthetic']",,1998/11/06 00:00,1998/11/06 00:01,['1998/11/06 00:00'],"['1998/11/06 00:00 [pubmed]', '1998/11/06 00:01 [medline]', '1998/11/06 00:00 [entrez]']",,ppublish,Singapore Med J. 1998 Jun;39(6):234-5.,6,,,,,,,,,,,,,,,,,,,,,,
20075426,NLM,MEDLINE,20100405,20131121,1758-1133 (Electronic) 0049-4755 (Linking),40,2010 Jan,"A profile of dengue cases admitted to a tertiary care hospital in Karnataka, southern India.",45-6,10.1258/td.2009.080376 [doi],"During the past two decades, epidemics of dengue fever have been causing concern in several South-East Asian countries, including India. A study was conducted in a tertiary care hospital situated in Southern India to determine the trends and outcome of dengue cases. There was a steady rise in number of cases from 2002 to 2007, with the largest number of cases seen in 2007. Most cases were observed in the post-monsoon season in the month of September. Out of a total of 344 cases, 285 (82.8%) patients had dengue fever, 34 (9.8%) had dengue haemorrhagic fever and 25 (7.3%) had dengue shock syndrome. Deaths were reported in nine cases, with the majority of deaths occurring in 2003. The disease control programme should emphasise on vector surveillance, integrated vector control, emergency response, early clinical diagnosis and appropriate management of the cases.","['Kumar, Ashwini', 'Pandit, Vinay Ramakrishna', 'Shetty, Sirish', 'Pattanshetty, Sanjay', 'Krish, Sonia Nagesh', 'Roy, Sreoshi']","['Kumar A', 'Pandit VR', 'Shetty S', 'Pattanshetty S', 'Krish SN', 'Roy S']",,"['Kasturba Medical College, Manipal, Karnataka, India. drashwiniin@gmail.com']",['eng'],['Journal Article'],,England,Trop Doct,Tropical doctor,1301706,,IM,"['Adolescent', 'Adult', 'Child, Preschool', 'Dengue/complications/diagnosis/*epidemiology/mortality', 'Dengue Virus', 'Female', 'Hospitals, Teaching', 'Humans', 'India/epidemiology', 'Length of Stay', 'Male', 'Seasons', 'Severe Dengue/complications/diagnosis/epidemiology/mortality', 'Young Adult']",,2010/01/16 06:00,2010/04/07 06:00,['2010/01/16 06:00'],"['2010/01/16 06:00 [entrez]', '2010/01/16 06:00 [pubmed]', '2010/04/07 06:00 [medline]']","['40/1/45 [pii]', '10.1258/td.2009.080376 [doi]']",ppublish,Trop Doct. 2010 Jan;40(1):45-6. doi: 10.1258/td.2009.080376.,1,,,,,,,,,,,,,,,,,,,,,,
12001919,NLM,MEDLINE,20020604,20041117,0024-6921 (Print) 0024-6921 (Linking),151,1999 Jun,Dengue fever risk and prevention for short-term group travelers to tropical regions.,313-8,,"The purpose of this study is to describe dengue fever infections in a group traveling from northern Louisiana to Mexico. Of 50 travelers in the group, three adolescents aged 15-16 developed febrile symptoms a few days after returning. Clinical diagnosis suggested dengue fever. Serum samples were obtained from the three adolescents and from 19 of the adults (age 18 and older) who were in the group. The samples were analyzed by the Centers for Disease Control using dengue IgM capture enzyme linked immunosorbant assay. Results confirmed the three symptomatic adolescents and five asymptomatic adults had been infected with the Flaviviridae virus that causes dengue. We conclude that since there is no vaccine to prevent dengue infections, travelers to high-risk areas should take steps to prevent infection and that clinicians encountering patients with febrile illnesses after travel to such regions should consider a diagnosis of dengue fever.","['Norwood, C G', 'Larocco, A', 'Laravia, D A', 'Moore, R W', 'Pittman-Cooley, L']","['Norwood CG', 'Larocco A', 'Laravia DA', 'Moore RW', 'Pittman-Cooley L']",,"['Department of Family Medicine, Louisiana State University Medical Center-Shreveport, Alexandria, USA.']",['eng'],['Journal Article'],,United States,J La State Med Soc,The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,7505618,,IM,"['Adolescent', 'Adult', 'Dengue/diagnosis/*prevention & control/transmission', 'Female', 'Humans', 'Louisiana', 'Male', 'Mexico', 'Risk', 'Travel', 'Tropical Climate']",,2002/05/11 10:00,2002/06/05 10:01,['2002/05/11 10:00'],"['2002/05/11 10:00 [pubmed]', '2002/06/05 10:01 [medline]', '2002/05/11 10:00 [entrez]']",,ppublish,J La State Med Soc. 1999 Jun;151(6):313-8.,6,,,,,,,,,,,,,,,,,,,,,,
18250338,NLM,MEDLINE,20080331,20211020,1091-6490 (Electronic) 0027-8424 (Print) 0027-8424 (Linking),105,2008 Feb 12,Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever.,2238-43,10.1073/pnas.0709029105 [doi],"Dengue hemorrhagic fever (DHF) is a potentially fatal manifestation of an infection with the mosquito-borne dengue virus. Because of the social and economic costs of DHF, many countries in Asia and South America have initiated public health measures aimed at vector control. Despite these measures, DHF incidence rates do not appear to be declining. The effectiveness of vector control in reducing dengue transmissibility has thereby been questioned. Here, we revisit this conclusion using epidemiological data from Thailand. We first show, with age incidence data, that dengue transmission rates have fallen since 1981; surprisingly, however, these declines are not associated with decreases in DHF incidence. Instead, district-level analyses indicate a nonmonotonic relationship between the basic reproductive number R0 and DHF incidence. To understand this relationship, we formulated three mathematical models, which differ in their assumptions of transient between-serotype cross-protection. Unlike the first two models, the previously unconsidered third model with clinical cross-protection can reproduce this nonmonotonic relationship. Simulation of this model with nonstationary R0 reproduces several previously unexplained patterns of dengue dynamics, including a transition from a approximately 2-year cycle to a approximately 4-year cycle and a transient trough in DHF incidence in provinces with rapid R0 declines. These results imply that DHF incidence can be effectively controlled with a sufficiently large reduction in R0 but that moderate reductions may be counterproductive. More broadly, these results show that assuming parameter stationarity in systems with approximate stationarity in disease incidence is unjustified and may result in missed opportunities to understand the drivers of disease variability.","['Nagao, Yoshiro', 'Koelle, Katia']","['Nagao Y', 'Koelle K']",,"['Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita, Osaka 565-0871, Japan.']",['eng'],['Journal Article'],20080204,United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,,IM,"['Dengue/epidemiology/immunology/*transmission', 'Humans', 'Incidence', 'Species Specificity']",PMC2538904,2008/02/06 09:00,2008/04/01 09:00,['2008/02/06 09:00'],"['2008/02/06 09:00 [pubmed]', '2008/04/01 09:00 [medline]', '2008/02/06 09:00 [entrez]']","['0709029105 [pii]', '9252 [pii]', '10.1073/pnas.0709029105 [doi]']",ppublish,Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2238-43. doi: 10.1073/pnas.0709029105. Epub 2008 Feb 4.,6,,,,['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
19221023,NLM,MEDLINE,20090710,20090324,1464-360X (Electronic) 1101-1262 (Linking),19,2009 Apr,"First description of a dengue fever outbreak in the interior of French Guiana, February 2006.",183-8,10.1093/eurpub/ckn137 [doi],"BACKGROUND: A dengue fever outbreak occurred in the interior of French Guiana from November 2005 onwards. An investigation, with epidemiological, entomological and public health inputs, was initiated. Its objectives were to confirm the outbreak, to describe the emergence of dengue fever in the High Maroni area and to initiate a specific public health response. METHODS: The investigation was conducted in Maripasoula in February 2006, the biggest community in that part of the country. Definition criteria were used for suspected, probable and confirmed cases of dengue fever. An entomological evaluation for larvae and adult mosquitoes was carried out. Some personal and collective vector control measures were set up by the vector control team. RESULTS: This survey identified 127 suspected dengue fever cases, whereas the epidemiological surveillance system detected only six probable and confirmed cases from the same place and for the same period. The proportion of dengue fever was higher in those people who had not travelled (23.5%) than within the population that had travelled (15.3%) in the three previous months (P = 0.01). Larvae of Stegomyia aegypti were found throughout the town, and adults were captured in 90.9% of the houses. CONCLUSION: This is the first time that a dengue fever outbreak has been described beyond the coastal region of this French overseas Department.","['Meynard, Jean-Baptiste', 'Ardillon, Vanessa', 'Venturin, Cathy', 'Ravachol, Francoise', 'Basurko, Celia', 'Matheus, Severine', 'Gaborit, Pascal', 'Grenier, Claire', 'Dussart, Philippe', 'Quenel, Philippe']","['Meynard JB', 'Ardillon V', 'Venturin C', 'Ravachol F', 'Basurko C', 'Matheus S', 'Gaborit P', 'Grenier C', 'Dussart P', 'Quenel P']",,"['Institut Pasteur de la Guyane, Cayenne, France. jbmeynard@pasteur-cayenne.fr']",['eng'],['Journal Article'],20090212,England,Eur J Public Health,European journal of public health,9204966,,IM,"['Adult', 'Animals', 'Culicidae/virology', 'Dengue/diagnosis/*epidemiology/etiology/transmission', '*Disease Outbreaks', 'Female', 'French Guiana/epidemiology', 'Humans', 'Male', 'Population Surveillance/methods']",,2009/02/18 09:00,2009/07/11 09:00,['2009/02/18 09:00'],"['2009/02/18 09:00 [entrez]', '2009/02/18 09:00 [pubmed]', '2009/07/11 09:00 [medline]']","['ckn137 [pii]', '10.1093/eurpub/ckn137 [doi]']",ppublish,Eur J Public Health. 2009 Apr;19(2):183-8. doi: 10.1093/eurpub/ckn137. Epub 2009 Feb 12.,2,,,,,,,,,,,,,,,,,,,,,,
20683676,NLM,MEDLINE,20110718,20220801,1741-0444 (Electronic) 0140-0118 (Linking),48,2010 Nov,Non-invasive diagnosis of risk in dengue patients using bioelectrical impedance analysis and artificial neural network.,1141-8,10.1007/s11517-010-0669-z [doi],"This paper presents a new approach to diagnose and classify early risk in dengue patients using bioelectrical impedance analysis (BIA) and artificial neural network (ANN). A total of 223 healthy subjects and 207 hospitalized dengue patients were prospectively studied. The dengue risk severity criteria was determined and grouped based on three blood investigations, namely, platelet (PLT) count (less than or equal to 30,000 cells per mm(3)), hematocrit (HCT) (increase by more than or equal to 20%), and either aspartate aminotransferase (AST) level (raised by fivefold the normal upper limit) or alanine aminotransferase (ALT) level (raised by fivefold the normal upper limit). The dengue patients were classified according to their risk groups and the corresponding BIA parameters were subsequently obtained and quantified. Four parameters were used for training and testing the ANN which are day of fever, reactance, gender, and risk group's quantification. Day of fever was defined as the day of fever subsided, i.e., when the body temperature fell below 37.5 degrees C. The blood investigation and the BIA data were taken for 5 days. The ANN was trained via the steepest descent back propagation with momentum algorithm using the log-sigmoid transfer function while the sum-squared error was used as the network's performance indicator. The best ANN architecture of 3-6-1 (3 inputs, 6 neurons in the hidden layer, and 1 output), learning rate of 0.1, momentum constant of 0.2, and iteration rate of 20,000 was pruned using a weight-eliminating method. Eliminating a weight of 0.05 enhances the dengue's prediction risk classification accuracy of 95.88% for high risk and 96.83% for low risk groups. As a result, the system is able to classify and diagnose the risk in the dengue patients with an overall prediction accuracy of 96.27%.","['Ibrahim, F', 'Faisal, T', 'Salim, M I Mohamad', 'Taib, M N']","['Ibrahim F', 'Faisal T', 'Salim MI', 'Taib MN']",,"['Department of Biomedical Engineering, Faculty of Engineering, University of Malaya, 50603, Kuala Lumpur, Malaysia. fatimah@um.edu.my']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100804,United States,Med Biol Eng Comput,Medical & biological engineering & computing,7704869,,IM,"['Algorithms', 'Dengue/*diagnosis', 'Diagnosis, Computer-Assisted/*methods', 'Early Diagnosis', '*Electric Impedance', 'Female', 'Humans', 'Male', '*Neural Networks, Computer', 'Risk Assessment']",,2010/08/05 06:00,2011/07/19 06:00,['2010/08/05 06:00'],"['2009/05/28 00:00 [received]', '2010/07/09 00:00 [accepted]', '2010/08/05 06:00 [entrez]', '2010/08/05 06:00 [pubmed]', '2011/07/19 06:00 [medline]']",['10.1007/s11517-010-0669-z [doi]'],ppublish,Med Biol Eng Comput. 2010 Nov;48(11):1141-8. doi: 10.1007/s11517-010-0669-z. Epub 2010 Aug 4.,11,,,,,,,,,,,,,,,,,,,,,,
15978393,NLM,MEDLINE,20051107,20191109,0399-077X (Print) 0399-077X (Linking),35 Suppl 2,2005 Jun,[Severe dengue in Caribbean French departments as viewed by general practitioners (GPs)].,S67-8,,,"['Helene-Pelage, J', 'Zami-Rinaldo, F']","['Helene-Pelage J', 'Zami-Rinaldo F']",,"['Faculte des Antiles, Guadeloupe, France.']",['fre'],['Journal Article'],,France,Med Mal Infect,Medecine et maladies infectieuses,0311416,,IM,"['Caribbean Region', 'Dengue/diagnosis/*therapy', 'Diagnosis, Differential', 'Humans', '*Physicians, Family']",,2005/06/28 09:00,2005/11/08 09:00,['2005/06/28 09:00'],"['2005/06/28 09:00 [pubmed]', '2005/11/08 09:00 [medline]', '2005/06/28 09:00 [entrez]']","['S0399-077X(05)80884-4 [pii]', '10.1016/s0399-077x(05)80884-4 [doi]']",ppublish,Med Mal Infect. 2005 Jun;35 Suppl 2:S67-8. doi: 10.1016/s0399-077x(05)80884-4.,,,,,,,,,,Connaissances et attitudes pratiques des medecins generalistes guadeloupeens: a propros des dengues severes.,,,,,,,,,,,,,
25409275,NLM,MEDLINE,20170203,20220408,1557-7759 (Electronic) 1530-3667 (Linking),14,2014 Nov,An estimate of the global health care and lost productivity costs of dengue.,824-6,10.1089/vbz.2013.1528 [doi],"Contemporary cost estimates of dengue fever are difficult to attain in many countries in which the disease is endemic. By applying publicly available health care costs and wage data to recently available country-level estimates of dengue incidence, we estimate the total cost of dengue to be nearly 40 billion dollars in 2011.","['Selck, Frederic W', 'Adalja, Amesh A', 'Boddie, Crystal R']","['Selck FW', 'Adalja AA', 'Boddie CR']",,"['UPMC Center for Health Security , Baltimore, Maryland.']",['eng'],['Journal Article'],,United States,Vector Borne Zoonotic Dis,"Vector borne and zoonotic diseases (Larchmont, N.Y.)",100965525,,IM,"['Dengue/*economics/mortality/therapy', 'Efficiency', 'Geography', 'Global Health/*economics', 'Health Care Costs', 'Humans', 'Mortality, Premature']",,2014/11/20 06:00,2017/02/06 06:00,['2014/11/20 06:00'],"['2014/11/20 06:00 [entrez]', '2014/11/20 06:00 [pubmed]', '2017/02/06 06:00 [medline]']",['10.1089/vbz.2013.1528 [doi]'],ppublish,Vector Borne Zoonotic Dis. 2014 Nov;14(11):824-6. doi: 10.1089/vbz.2013.1528.,11,,['NOTNLM'],"['Dengue fever', 'Global cost estimate']",,,,,,,,,,,,,,,,,,,
24818352,NLM,MEDLINE,20140619,20140513,0004-5772 (Print) 0004-5772 (Linking),61,2013 Aug,Dengue panic syndrome: lesson to be learnt.,583,,,"['Chaturvedi, Mridul', 'Garg, Ajay', 'Oza, Pranav A', 'Pandey, Anjana']","['Chaturvedi M', 'Garg A', 'Oza PA', 'Pandey A']",,,['eng'],['Letter'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Dengue/*epidemiology/psychology/therapy', '*Epidemics', 'Humans', 'India/epidemiology', 'Platelet Count', 'Platelet Transfusion', 'Severe Dengue/psychology']",,2014/05/14 06:00,2014/06/20 06:00,['2014/05/14 06:00'],"['2014/05/14 06:00 [entrez]', '2014/05/14 06:00 [pubmed]', '2014/06/20 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2013 Aug;61(8):583.,8,,,,,,,,,,,,,,,,,,,,,,
24389569,NLM,MEDLINE,20150925,20210227,1936-7163 (Electronic) 0033-6572 (Linking),45,2014 Feb,Severe oral manifestation of dengue viral infection: a rare clinical description.,151-6,10.3290/j.qi.a30992 [doi],"Dengue infection is one of the most common mosquito-borne viral diseases of humans worldwide, representing a significant public health problem in over 100 tropical countries where its primary vector Aedes aegypti occurs. Although the disease is frequently limited to an abrupt febrile illness, it may also cause significant morbidity and if not adequately treated, mortality. Therefore, it requires a correct and early diagnosis. Oral manifestations of dengue infection are commonly reported as gingival bleeding, but detailed description of oral alterations in the context of dengue infection is lacking in the literature. Thus, in the current manuscript the authors aimed to report a case of dengue viral infection in an 18-year-old male patient who was primarily diagnosed due to extensive oral involvement characterized by the presence of gingival and lip reddish swelling, highlighting the importance of an adequate oral evaluation of patients with symptoms suggestive of dengue, especially in known endemic regions.","['Pontes, Flavia Sirotheau Correa', 'Frances, Larissa Tatiana Martins', 'Carvalho, Marianne de Vasconcelos', 'Fonseca, Felipe Paiva', 'Neto, Nicolau Conte', 'do Nascimento, Liliane Silva', 'Pontes, Helder Antonio Rebelo']","['Pontes FS', 'Frances LT', 'Carvalho Mde V', 'Fonseca FP', 'Neto NC', 'do Nascimento LS', 'Pontes HA']",,,['eng'],"['Case Reports', 'Journal Article']",,Germany,Quintessence Int,"Quintessence international (Berlin, Germany : 1985)",0342677,,,"['Adolescent', 'Dengue/*diagnosis/physiopathology/therapy', 'Fluid Therapy', 'Gingiva/*physiopathology', 'Humans', 'Lip/*physiopathology', 'Male', 'Platelet Transfusion']",,2014/01/07 06:00,2015/09/26 06:00,['2014/01/07 06:00'],"['2014/01/07 06:00 [entrez]', '2014/01/07 06:00 [pubmed]', '2015/09/26 06:00 [medline]']","['840709 [pii]', '10.3290/j.qi.a30992 [doi]']",ppublish,Quintessence Int. 2014 Feb;45(2):151-6. doi: 10.3290/j.qi.a30992.,2,,,,,,,,,,,,,,,,,,,,,,
28891000,NLM,MEDLINE,20180820,20191210,1741-0444 (Electronic) 0140-0118 (Linking),56,2018 Apr,Clinical application of modified bag-of-features coupled with hybrid neural-based classifier in dengue fever classification using gene expression data.,709-720,10.1007/s11517-017-1722-y [doi],"Dengue fever detection and classification have a vital role due to the recent outbreaks of different kinds of dengue fever. Recently, the advancement in the microarray technology can be employed for such classification process. Several studies have established that the gene selection phase takes a significant role in the classifier performance. Subsequently, the current study focused on detecting two different variations, namely, dengue fever (DF) and dengue hemorrhagic fever (DHF). A modified bag-of-features method has been proposed to select the most promising genes in the classification process. Afterward, a modified cuckoo search optimization algorithm has been engaged to support the artificial neural (ANN-MCS) to classify the unknown subjects into three different classes namely, DF, DHF, and another class containing convalescent and normal cases. The proposed method has been compared with other three well-known classifiers, namely, multilayer perceptron feed-forward network (MLP-FFN), artificial neural network (ANN) trained with cuckoo search (ANN-CS), and ANN trained with PSO (ANN-PSO). Experiments have been carried out with different number of clusters for the initial bag-of-features-based feature selection phase. After obtaining the reduced dataset, the hybrid ANN-MCS model has been employed for the classification process. The results have been compared in terms of the confusion matrix-based performance measuring metrics. The experimental results indicated a highly statistically significant improvement with the proposed classifier over the traditional ANN-CS model.","['Chatterjee, Sankhadeep', 'Dey, Nilanjan', 'Shi, Fuqian', 'Ashour, Amira S', 'Fong, Simon James', 'Sen, Soumya']","['Chatterjee S', 'Dey N', 'Shi F', 'Ashour AS', 'Fong SJ', 'Sen S']",,"['Department of Computer Science & Engineering, University of Calcutta, Kolkata, India. chatterjeesankhadeep.cu@gmail.com.', 'Department of Information Technology, Techno India College of Technology, Kolkata, India.', ""College of Information and Engineering, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China."", 'Department of Electronics and Electrical Communications Engineering, Faculty of Engineering, Tanta University, Tanta, Egypt.', ""Department of Computer and Information Science Data Analytics and Collaborative Computing Laboratory, University of Macau, Taipa, Zhuhai, Macau, People's Republic of China."", 'A.K. Choudhury School of Information Technology, University of Calcutta, Kolkata, India.']",['eng'],['Journal Article'],20170911,United States,Med Biol Eng Comput,Medical & biological engineering & computing,7704869,,IM,"['Algorithms', 'Computational Biology/*methods', '*Dengue/classification/diagnosis/genetics/metabolism', 'Diagnosis, Computer-Assisted', 'Gene Expression Profiling/*methods', 'Humans', 'Neural Networks, Computer']",,2017/09/12 06:00,2018/08/21 06:00,['2017/09/12 06:00'],"['2017/06/14 00:00 [received]', '2017/08/28 00:00 [accepted]', '2017/09/12 06:00 [pubmed]', '2018/08/21 06:00 [medline]', '2017/09/12 06:00 [entrez]']","['10.1007/s11517-017-1722-y [pii]', '10.1007/s11517-017-1722-y [doi]']",ppublish,Med Biol Eng Comput. 2018 Apr;56(4):709-720. doi: 10.1007/s11517-017-1722-y. Epub 2017 Sep 11.,4,,['NOTNLM'],"['Artificial neural networks', 'Bag-of-features', 'Dengue fever', 'Gene expression data', 'Incremental feature selection scheme', 'Modified cuckoo search']",,,,,,,,,,,,,,,,,,,
3433157,NLM,MEDLINE,19880324,20220316,0125-1562 (Print) 0125-1562 (Linking),18,1987 Sep,Dengue haemorrhagic fever in Indonesia.,269-74,,"Dengue haemorrhagic fever (DHF) was first recognized in Indonesia in the cities of Jakarta and Surabaya in 1968, 15 years after its recognition in the Philippines. During the 1968 outbreak, a total of 58 clinical cases with 24 deaths were reported. The number of reported cases since then has increased sharply, with the highest number of cases recorded in the years 1973 (10, 189 cases), 1983 (13,668 cases), and 1985 (13,588 cases). Outbreaks of the disease have spread to involve most of the major urban areas, as well as some of the rural areas. In 1985, the disease had spread to 26 of 27 Provinces and 160 of 300 regencies or municipalities. At present, the disease is endemic in many large cities and small towns. Interestingly, DHF has not been reported in some cities, even though dengue virus transmission rates in those cities are high. The epidemic pattern of DHF for the country as a whole has become irregular. Since 1982, the intensity and spread of DHF has created an increasing public health problem in Indonesia, particularly in Java where 60% of the total population of the country resides. Java contributed about 71% of all cases occurring in the country in 1982, 84% in 1983, and 91% in 1984. The peak monthly incidence of DHF was frequently reported during October through April, months which coincide with the rainy season. The morbidity rate for Indonesia, estimated from reported cases over five years (1981-1985), ranged between 3.39 to 8.65 per 100,000 population.",['Sumarmo'],['Sumarmo'],,"['Department of Child Health, Medical School, University of Indonesia, Jakarta.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Child', 'Child, Preschool', 'Dengue/*epidemiology/mortality/prevention & control', 'Humans', 'Indonesia', 'Serotyping']",,1987/09/01 00:00,1987/09/01 00:01,['1987/09/01 00:00'],"['1987/09/01 00:00 [pubmed]', '1987/09/01 00:01 [medline]', '1987/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):269-74.,3,,,,,,,,,,,,,,,,,,,,,,
15497028,NLM,MEDLINE,20050505,20191109,1076-0296 (Print) 1076-0296 (Linking),10,2004 Oct,Bleeding and other presentations in Thai patients with dengue infection.,397-8,,"Dengue infection is a major public health problem, affecting the general population in Southeast Asia. Hematologic aberrations in dengue infection include atypical lymphocytosis, coagulopathy, and predominant thrombocytopenia. Bleeding and other presentations in 30 Thai patients with dengue infection during an endemic season (2003) are presented. A review of the clinical presentation of these patients was performed. All had fever as a chief complaint. The three most common complaints were fever (100%), vomiting (90%), and cough (90%), respectively. Concerning bleeding, only eight cases (26.6%) had signs of bleeding. Those manifestations included petechiae (seven cases, 23.3%) and melena (one case, 3.3%). Skin bleeding (petechiae) due to thrombocytopenia is the most common bleeding manifestation in dengue infection. However, physicians should not overlook bleeding from other less common sites such as the gastrointestinal tract and genitourinary tract.","['Wiwanitkit, Viroj']",['Wiwanitkit V'],,"['Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.']",['eng'],['Journal Article'],,United States,Clin Appl Thromb Hemost,Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,9508125,,IM,"['Dengue/*complications/diagnosis/epidemiology', 'Endemic Diseases', 'Female', 'Hemorrhage/*etiology', 'Humans', 'Male', 'Purpura/etiology', 'Thailand/epidemiology']",,2004/10/22 09:00,2005/05/06 09:00,['2004/10/22 09:00'],"['2004/10/22 09:00 [pubmed]', '2005/05/06 09:00 [medline]', '2004/10/22 09:00 [entrez]']",['10.1177/107602960401000414 [doi]'],ppublish,Clin Appl Thromb Hemost. 2004 Oct;10(4):397-8. doi: 10.1177/107602960401000414.,4,,,,,,,,,,,,,,,,,,,,,,
1708958,NLM,MEDLINE,19910531,20191021,0272-4936 (Print) 0272-4936 (Linking),10,1990,An epidemic of dengue haemorrhagic fever and dengue shock syndrome in Delhi: a clinical study.,329-34,,"Twenty-four cases of dengue haemorrhagic fever/dengue shock syndrome were studied in Delhi in the months of September and October, 1988. The majority of these cases were boys aged 6-10 years. Classical symptoms of dengue (fever, headache, aesthesia, myalgia) occurred in all the patients. Digestive symptoms (nausea, vomiting, anorexia, abdominal pain and hepatomegaly) were also common. Haemorrhagic manifestations were present in 41.7% of the cases. Of these, 90% had gastrointestinal haemorrhages. Shock occurred in 17 cases (70.8%). Thrombocytopenia and prolongation of coagulation profile were found in 62.5% of cases. Three patients (12.5%) who presented with encephalopathy died. The other 21 patients recovered after an average period of 2-8 days.","['Srivastava, V K', 'Suri, S', 'Bhasin, A', 'Srivastava, L', 'Bharadwaj, M']","['Srivastava VK', 'Suri S', 'Bhasin A', 'Srivastava L', 'Bharadwaj M']",,"['Department of Pediatrics, Safdarjang Hospital, New Delhi, India.']",['eng'],['Journal Article'],,England,Ann Trop Paediatr,Annals of tropical paediatrics,8210625,,IM,"['Child', 'Child, Preschool', 'Dengue/complications/*diagnosis/*epidemiology/therapy', '*Disease Outbreaks', 'Female', 'Follow-Up Studies', 'Humans', 'India/epidemiology', 'Male', 'Serologic Tests', 'Severity of Illness Index', 'Shock/etiology/therapy']",,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",['10.1080/02724936.1990.11747453 [doi]'],ppublish,Ann Trop Paediatr. 1990;10(4):329-34. doi: 10.1080/02724936.1990.11747453.,4,,,,,,,,,,,,,,,,,,,,,,
22799448,NLM,MEDLINE,20130118,20211021,1471-2334 (Electronic) 1471-2334 (Linking),12,2012 Jul 16,Paralytic squint due to abducens nerve palsy: a rare consequence of dengue fever.,156,10.1186/1471-2334-12-156 [doi],"BACKGROUND: Dengue fever is an endemic illness in the tropics with early and post infectious complications affecting multiple systems. Though neurological sequelae including mononeuropathy, encephalopathy, transverse myelitis, polyradiculopathy, Guillain-Barre syndrome , optic neuropathy and oculomotor neuropathy have been reported in medical literature, the abducens nerve despite its notoriety in cranial neuropathies in a multitude of condition due to its long intracranial course had not been to date reported to manifest with lateral rectus paralysis following dengue. CASE PRESENTATION: A previously well 29 year old male with serologically confirmed dengue hemorrhagic fever developed symptomatic right lateral rectus palsy during the critical phase of the illness, which persisted into convalescence and post convalescence with proven deficit on Hess screen. Alternate etiologies were excluded by imaging, serology and electrophysiology. CONCLUSIONS: The authors detail the first reported case of abducens nerve palsy complicating dengue fever in a previously healthy male from Sri Lanka. In a tropical country with endemic dengue infections, dengue related abducens neuropathy may be considered as a differential diagnosis in cases of acquired lateral rectus palsy after dengue fever.","['Shivanthan, Mitrakrishnan C', 'Ratnayake, Eranda C', 'Wijesiriwardena, Bandula C', 'Somaratna, Kalum C', 'Gamagedara, Lakmal K G K']","['Shivanthan MC', 'Ratnayake EC', 'Wijesiriwardena BC', 'Somaratna KC', 'Gamagedara LK']",,"['Wards 45 & 46 A, National Hospital of Sri Lanka, Regent Street, Hospital Square, Colombo, Sri Lanka. mcs627@gmail.com']",['eng'],"['Case Reports', 'Journal Article']",20120716,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Abducens Nerve Diseases/*etiology/*pathology', 'Adult', 'Dengue/*complications/*diagnosis/pathology', 'Humans', 'Male', 'Sri Lanka', 'Strabismus/*etiology/*pathology']",PMC3437196,2012/07/18 06:00,2013/01/19 06:00,['2012/07/18 06:00'],"['2011/07/18 00:00 [received]', '2012/06/28 00:00 [accepted]', '2012/07/18 06:00 [entrez]', '2012/07/18 06:00 [pubmed]', '2013/01/19 06:00 [medline]']","['1471-2334-12-156 [pii]', '10.1186/1471-2334-12-156 [doi]']",epublish,BMC Infect Dis. 2012 Jul 16;12:156. doi: 10.1186/1471-2334-12-156.,,,,,,,,,,,,,,,,,,,,,,,
19721698,NLM,MEDLINE,20091103,20211028,1549-1676 (Electronic) 1549-1277 (Print) 1549-1277 (Linking),6,2009 Sep,Changing patterns of dengue epidemiology and implications for clinical management and vaccines.,e1000129,10.1371/journal.pmed.1000129 [doi] e1000129,"Cameron Simmons and Jeremy Farrar discuss the changing patterns of dengue epidemiology and the implications for clinical management and vaccines, drawing upon a recent study by Derek Cummings and colleagues in Thailand.","['Simmons, Cameron P', 'Farrar, Jeremy']","['Simmons CP', 'Farrar J']",,"['Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam. csimmons@oucru.org']",['eng'],"['Comment', 'Journal Article']",20090901,United States,PLoS Med,PLoS medicine,101231360,['0 (Dengue Vaccines)'],IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', '*Dengue/epidemiology/immunology/prevention & control/therapy', '*Dengue Vaccines/administration & dosage', 'Humans', 'Thailand/epidemiology']",PMC2727698,2009/09/02 06:00,2009/11/05 06:00,['2009/09/02 09:00'],"['2009/09/02 09:00 [entrez]', '2009/09/02 06:00 [pubmed]', '2009/11/05 06:00 [medline]']","['09-PLME-P-1938 [pii]', '10.1371/journal.pmed.1000129 [doi]']",ppublish,PLoS Med. 2009 Sep;6(9):e1000129. doi: 10.1371/journal.pmed.1000129. Epub 2009 Sep 1.,9,,,,['The authors have declared that no competing interests exist.'],,['084368/WT_/Wellcome Trust/United Kingdom'],,['PLoS Med. 2009 Sep;6(9):e1000139. PMID: 19721696'],,,,,,,,,,,,,,
7819798,NLM,MEDLINE,19950214,20061115,0037-9085 (Print) 0037-9085 (Linking),86,1993,[Dengue epidemic in New Caledonia (1989). Environmental factors and prevention].,442-9,,"An extensive dengue epidemic was reported in New Caledonia en 1989. Environmental factors (temperature and rainfalls) directly controlled the mosquitos population at the end of 1988. The introduction of a new dengue virus, transmitted by Aedes aegypti, was responsible for an epidemic that occurred in January-April 1989 and lasted until July 1989. The estimated number of cases was 25,000 and the attack rate was close to 120 per thousand inhabitants for a six month-period. The epidemic involved mainly the adult population in 84% of cases and 6-8% of patients was admitted in hospital with thrombopenia, leucopenia, minor haemorrhages in 2/3 of cases and 12 patients died with severe hemorrhagic disease or shock syndrome; initial serological results from suspected cases were positive against dengue by haemaglutination inhibition. Two dengue viruses were involved (dengue 1 and dengue 3) but dengue 3 was by far the most common. Ultra-low volume aerosols of diluted insecticide (decamethrine K'Othrine, Roussel) from road vehicles and aircraft was used from February to May to kill the adult mosquitoes (adulticiding). The efficacy dependent on the interaction of the insecticide and the flying mosquitoes is relative and debated but played probably a major role on the transmission, though the reduction of breeding sites was primarily uncovered. Since the epidemic, only sporadic cases were observed in 1991 and 1992.","['Laille, M', 'Huerre, M', 'Dubourdieu, H', 'Flye Sainte Marie, F']","['Laille M', 'Huerre M', 'Dubourdieu H', 'Flye Sainte Marie F']",,"['Institut Pasteur de Noumea, Nouvelle-Caledonie.']",['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Animals', 'Dengue/*epidemiology/*prevention & control/transmission', '*Environment', 'Hospitalization', 'Humans', 'Insect Vectors', 'Mosquito Control', 'New Caledonia/epidemiology']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1993;86(5 Pt 2):442-9.,5 Pt 2,,,,,,,,,Epidemie de dengue en Nouvelle-Caledonie (1989). Facteurs environnementaux et prevention.,,,,,,,,,,,,,
15694537,NLM,MEDLINE,20050329,20061115,0929-693X (Print) 0929-693X (Linking),12,2005 Feb,[An epidemic of dengue fever in a department of paediatrics: report on 58 cases in Lamentin (Martinique)].,144-50,,"Dengue fever is caused by a virus transmitted by an Aedes mosquito, and infects 80 million people in the world annually. 30 000 case fatality of Dengue hemorrhagic fever are estimated each year. The disease, endemo-epidemic in the inter-tropical area, is a public health problem. PATIENTS AND METHODS: An epidemic of dengue fever occurred in Martinique, French department of the Caribbean, in 2001-2002. This work was a clinical and epidemiologic study of dengue and dengue hemorrhagic fever in 58 children. RESULTS: Three children (5%) developed a hemorrhagic dengue, and 13 subjects (24%) presented at least with one hemorrhagic sign. Symptoms were polymorphous, certain forms were only myalgic; the main reason for consultation was the fever (89%). The principal characteristics were a leucopenia (56%) associated with a neutropenia (80%), a thrombocytopenia (54%), a hepatic cytolysis (66%) and sometimes a muscular cytolysis (9/15) and a increase in the ferritinemia (16/27). No death was noted. CONCLUSION: The treatment of the dengue is above all preventive, it consists in the antivector fight.","['Monnin, M', ""M'bou, F""]","['Monnin M', ""M'bou F""]",,"['Service de pediatrie, centre hospitalier de Lamentin, 97232 Lamentin, Martinique.']",['fre'],"['English Abstract', 'Journal Article']",,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/complications/*epidemiology/*pathology', '*Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Martinique', 'Pediatrics/statistics & numerical data', 'Prognosis']",,2005/02/08 09:00,2005/03/30 09:00,['2005/02/08 09:00'],"['2004/10/25 00:00 [received]', '2004/11/03 00:00 [accepted]', '2005/02/08 09:00 [pubmed]', '2005/03/30 09:00 [medline]', '2005/02/08 09:00 [entrez]']","['S0929-693X(04)00606-2 [pii]', '10.1016/j.arcped.2004.11.006 [doi]']",ppublish,Arch Pediatr. 2005 Feb;12(2):144-50. doi: 10.1016/j.arcped.2004.11.006.,2,,,,,,,,,Une epidemie de dengue dans un service de pediatrie. A propos de 58 cas au Lamentin (Martinique).,,,,,,,,,,,,,
23257182,NLM,MEDLINE,20131206,20130624,1532-656X (Electronic) 0891-5245 (Linking),27,2013 Jul-Aug,Dengue fever in a 16-year-old girl after travel in Asia.,308-11,S0891-5245(12)00221-0 [pii] 10.1016/j.pedhc.2012.10.002 [doi],,"['Reilly, Marianne W', 'Kuehne, Elizabeth A']","['Reilly MW', 'Kuehne EA']",,"['Holy Name Medical Center, 718 Teaneck Rd, Teaneck, N.J. 07666, USA. Mar-reilly@holyname.org']",['eng'],"['Case Reports', 'Journal Article']",20121217,United States,J Pediatr Health Care,Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,8709735,,,"['Adolescent', 'Asia', 'Dengue/*diagnosis/therapy', 'Female', 'Humans', '*Travel']",,2012/12/22 06:00,2013/12/16 06:00,['2012/12/22 06:00'],"['2012/04/12 00:00 [received]', '2012/09/26 00:00 [revised]', '2012/10/09 00:00 [accepted]', '2012/12/22 06:00 [entrez]', '2012/12/22 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['S0891-5245(12)00221-0 [pii]', '10.1016/j.pedhc.2012.10.002 [doi]']",ppublish,J Pediatr Health Care. 2013 Jul-Aug;27(4):308-11. doi: 10.1016/j.pedhc.2012.10.002. Epub 2012 Dec 17.,4,,,,,,,,,,,,,,,,,,,,,,
12118460,NLM,MEDLINE,20021220,20041117,0125-1562 (Print) 0125-1562 (Linking),33,2002 Mar,Dengue hemorrhagic fever in infants.,49-55,,"A report of 19 cases of serologically-proven dengue hemorrhagic fever (DHF) in infants aged 3-12 months who were admitted to the Department of Pediatrics, Chon Buri Regional Hospital, Thailand, during 1995 to 1998. Subjects were 8 males and 11 females, with the peak age of 8 months. Four cases (21%) had DHF and other common co-infections ie pneumonia (2 cases), Staphylococcus aureus sepsis (1 case) and Haemophilus influenzae meningitis (1 case). The clinical manifestations of the 15 DHF cases were high fever (100%), coryza (93.3%), hepatomegaly (80%), drowsiness (53.3 %), and vomiting (46.7%); rash was observed in only 27%; one-fifth developed febrile convulsions. Sites of bleeding were the skin (petechiae) 58%, gastrointestinal system (melena) 16%, and mucous membrane (epistaxis) 5%; thrombocytopenia and increased hematocrit (> or =20%) were noted in 95% and 84% respectively. The majority of the patients (18 cases, 95%) had primary infection; only one (5%) had secondary infection. The clinical severity of the DHF was Grade I, II, and III (dengue shock syndrome) in 21%, 47% and 32% of cases respectively. After appropriate and effective management, all the infants recovered fully.","['Hongsiriwon, Suchat']",['Hongsiriwon S'],,"['Department of Pediatrics, Chon Buri Regional Hospital, Ministry of Public Health, Thailand. suchat845@hotmail.com']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/complications/diagnosis/*epidemiology', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'Infant', 'Male', 'Thailand/epidemiology']",,2002/07/18 10:00,2002/12/21 04:00,['2002/07/18 10:00'],"['2002/07/18 10:00 [pubmed]', '2002/12/21 04:00 [medline]', '2002/07/18 10:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):49-55.,1,,,,,,,,,,,,,,,,,,,,,,
6844807,NLM,MEDLINE,19830623,20190829,0162-0886 (Print) 0162-0886 (Linking),5,1983 Mar-Apr,Delayed-type hypersensitivity: probable role in the pathogenesis of dengue hemorrhagic fever/dengue shock syndrome.,346-52,,"The hypothesis presented proposes the involvement of a systemic form of a delayed-type hypersensitivity reaction in the pathogenesis of dengue hemorrhagic fever/dengue shock syndrome. It envisages the activation of sensitized T lymphocytes during a secondary infection by viral antigen present on the surfaces of mononuclear phagocytic cells. These antigen-activated T cells then release a variety of biologically active chemical mediators (lymphokines), which then produce the symptoms of shock and hemorrhage seen in cases of dengue hemorrhagic fever/dengue shock syndrome.","['Pang, T']",['Pang T'],,,['eng'],['Journal Article'],,United States,Rev Infect Dis,Reviews of infectious diseases,7905878,,IM,"['Capillary Permeability', 'Dengue/blood/complications/immunology/*physiopathology', 'Humans', '*Hypersensitivity, Delayed', 'Immunity, Cellular', 'Shock/blood/etiology/*physiopathology']",,1983/03/01 00:00,1983/03/01 00:01,['1983/03/01 00:00'],"['1983/03/01 00:00 [pubmed]', '1983/03/01 00:01 [medline]', '1983/03/01 00:00 [entrez]']",['10.1093/clinids/5.2.346 [doi]'],ppublish,Rev Infect Dis. 1983 Mar-Apr;5(2):346-52. doi: 10.1093/clinids/5.2.346.,2,,,,,,,,,,,,,,,,,,,,,,
15534953,NLM,MEDLINE,20041110,20131121,0741-6245 (Print) 0741-6245 (Linking),22,2004 Aug,Dengue fever. World travelers beware.,7,,,,,,,['eng'],['Journal Article'],,United States,Mayo Clin Health Lett,Mayo Clinic health letter (English ed.),8507508,,,"['Aedes', 'Animals', '*Dengue/complications/prevention & control/transmission', 'Humans', 'Severe Dengue/complications/prevention & control/transmission', '*Travel']",,2004/11/13 09:00,2004/11/13 09:01,['2004/11/13 09:00'],"['2004/11/13 09:00 [pubmed]', '2004/11/13 09:01 [medline]', '2004/11/13 09:00 [entrez]']",,ppublish,Mayo Clin Health Lett. 2004 Aug;22(8):7.,8,,,,,,,,,,,,,,,,,,,,,,
6152850,NLM,MEDLINE,19880121,20041117,0126-8635 (Print) 0126-8635 (Linking),6,1983 Aug,Dengue haemorrhagic fever: recent advances.,27-30,,,"['Pang, T']",['Pang T'],,,['eng'],['Journal Article'],,Malaysia,Malays J Pathol,The Malaysian journal of pathology,8101177,['0 (Viral Vaccines)'],IM,"['Animals', 'Culicidae', '*Dengue/diagnosis/epidemiology/immunology/transmission', 'Dengue Virus/genetics', 'Humans', 'Insect Vectors', 'Viral Vaccines']",,1983/08/01 00:00,1983/08/01 00:01,['1983/08/01 00:00'],"['1983/08/01 00:00 [pubmed]', '1983/08/01 00:01 [medline]', '1983/08/01 00:00 [entrez]']",,ppublish,Malays J Pathol. 1983 Aug;6:27-30.,,,,,,,,,,,,,,,,,,,,,,,
7046045,NLM,MEDLINE,19820814,20170214,0036-9330 (Print) 0036-9330 (Linking),27,1982 Apr,Some medical aspects of the Darien scheme: was it dengue?,183-4,,,"['McSherry, J A']",['McSherry JA'],,,['eng'],"['Historical Article', 'Journal Article']",,Scotland,Scott Med J,Scottish medical journal,2983335R,,IM,"['Dengue/diagnosis/*history', 'History, 17th Century', 'Humans', 'Male', 'Panama']",,1982/04/01 00:00,1982/04/01 00:01,['1982/04/01 00:00'],"['1982/04/01 00:00 [pubmed]', '1982/04/01 00:01 [medline]', '1982/04/01 00:00 [entrez]']",['10.1177/003693308202700215 [doi]'],ppublish,Scott Med J. 1982 Apr;27(2):183-4. doi: 10.1177/003693308202700215.,2,,,,,,,,,,,,,,,,,,,,,,
10226460,NLM,MEDLINE,19990517,20171206,0026-4075 (Print) 0026-4075 (Linking),164,1999 Apr,"Dengue among United Nations mission in Haiti personnel, 1995: implications for preventive medicine.",300-2,,"The incidence of dengue infections has been increasing in the Caribbean, and cases have been identified among successive deployments of multinational peacekeepers to Haiti (1994-1997). In the absence of an effective vaccine or chemoprophylaxis to prevent dengue fever, vector-control operations and use of personal protection measures to prevent arthropod bites are the most effective means of limiting disease transmission. During our 5-month deployment as part of the United Nations Mission in Haiti, 79 cases of recent dengue fever were identified among 249 patients (32%) presenting with febrile illness to the 86th Combat Support Hospital. Further investigation revealed low unit readiness to perform standard vector-control activities and poor individual adherence to measures to prevent arthropod bites. Command enforcement of existing field preventive medicine doctrine is essential to prevent casualties caused by dengue, other arthropod-borne infections, and nuisance arthropod bites during military deployments.","['Gambel, J M', 'Drabick, J J', 'Swalko, M A', 'Henchal, E A', 'Rossi, C A', 'Martinez-Lopez, L']","['Gambel JM', 'Drabick JJ', 'Swalko MA', 'Henchal EA', 'Rossi CA', 'Martinez-Lopez L']",,"['Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.']",['eng'],['Journal Article'],,England,Mil Med,Military medicine,2984771R,,IM,"['Dengue/blood/*diagnosis/etiology/*prevention & control', 'Haiti', 'Humans', 'Military Medicine/*methods', 'Military Personnel/*statistics & numerical data', 'Needs Assessment', 'Primary Prevention/*methods', 'Risk Factors', 'Surveys and Questionnaires', 'United States']",,1999/05/05 00:00,1999/05/05 00:01,['1999/05/05 00:00'],"['1999/05/05 00:00 [pubmed]', '1999/05/05 00:01 [medline]', '1999/05/05 00:00 [entrez]']",,ppublish,Mil Med. 1999 Apr;164(4):300-2.,4,,,,,,,,,,,,,,,,,,,,,,
677371,NLM,MEDLINE,19780915,20190516,0002-9637 (Print) 0002-9637 (Linking),27,1978 May,"Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga.",581-9,,"An outbreak of dengue type 2 infection occurred in the Pacific island Kingdom of Tonga in 1974 and an outbreak of dengue type 1 occurred there in 1975. The 1974 outbreak was characterized by relatively mild clinical disease with few hemorrhagic manifestations, a low attack rate, and relatively low viremia levels. The 1975 outbreak was characterized by relatively severe disease with frequent hemorrhagic manifestations and a high attack rate. The differences between the outbreaks could not be attributed to differences in abudance of, or susceptibility to infection of, mosquito vectors or to the prior immune status or other characteristics of the human population. It appeared that a difference in viral virulence was the most likely explanation.","['Gubler, D J', 'Reed, D', 'Rosen, L', 'Hitchcock, J R Jr']","['Gubler DJ', 'Reed D', 'Rosen L', 'Hitchcock JR Jr']",,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/microbiology', 'Dengue Virus/isolation & purification', 'Female', 'Humans', 'Male', 'Middle Aged', 'Tonga']",,1978/05/01 00:00,2001/03/28 10:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.4269/ajtmh.1978.27.581 [doi]'],ppublish,Am J Trop Med Hyg. 1978 May;27(3):581-9. doi: 10.4269/ajtmh.1978.27.581.,3,,,,,,,,,,,,,,,,,,,,,,
16354812,NLM,MEDLINE,20060620,20191210,0002-9637 (Print) 0002-9637 (Linking),73,2005 Dec,Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua.,1059-62,,"The World Health Organization (WHO) scheme for classification of dengue severity was evaluated in a three-year study of 1,671 confirmed dengue cases in three Nicaraguan hospitals. The WHO classification of dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) was compared with the presence of hemorrhagic manifestations, signs of vascular permeability, marked thrombocytopenia, and shock in 114 infants, 1,211 children, and 346 adults. We found that strict application of the WHO criteria fails to detect a significant number of patients with severe manifestations of dengue, especially in adults.","['Balmaseda, Angel', 'Hammond, Samantha Nadia', 'Perez, Maria Angeles', 'Cuadra, Ricardo', 'Solano, Soraya', 'Rocha, Julio', 'Idiaquez, Wendy', 'Harris, Eva']","['Balmaseda A', 'Hammond SN', 'Perez MA', 'Cuadra R', 'Solano S', 'Rocha J', 'Idiaquez W', 'Harris E']",,"['Departamento de Virologia, Centro Nacional de Diagnostico y Referencia, Ministerio de Salud, Managua, Nicaragua.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/etiology/*pathology', 'Female', '*Guidelines as Topic', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Nicaragua/epidemiology', '*Outcome Assessment, Health Care', 'Severe Dengue/epidemiology/etiology/pathology', '*Severity of Illness Index', '*World Health Organization']",,2005/12/16 09:00,2006/06/21 09:00,['2005/12/16 09:00'],"['2005/12/16 09:00 [pubmed]', '2006/06/21 09:00 [medline]', '2005/12/16 09:00 [entrez]']",['73/6/1059 [pii]'],ppublish,Am J Trop Med Hyg. 2005 Dec;73(6):1059-62.,6,,,,,,['TW-0095/TW/FIC NIH HHS/United States'],,,,,,,,,,,,,,,,
30129543,NLM,MEDLINE,20180926,20180926,0974-7559 (Electronic) 0019-6061 (Linking),55,2018 Jul 15,The Growing Menace of Dengue - Is Detection and Diagnosis Enough?,598-600,,,"['Chhapola, Viswas', 'Mukherjee, Sharmila B']","['Chhapola V', 'Mukherjee SB']",,"['Department of Pediatrics, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India.', 'Department of Pediatrics, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India. theshormi@gmail.com.']",['eng'],"['Historical Article', 'Journal Article']",,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['China/epidemiology', 'Dengue/diagnosis/epidemiology/*history/prevention & control', 'History, 17th Century', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'History, Ancient', 'Humans', 'India/epidemiology', 'United States/epidemiology', 'West Indies/epidemiology']",,2018/08/22 06:00,2018/09/27 06:00,['2018/08/22 06:00'],"['2018/08/22 06:00 [entrez]', '2018/08/22 06:00 [pubmed]', '2018/09/27 06:00 [medline]']",,ppublish,Indian Pediatr. 2018 Jul 15;55(7):598-600.,7,,,,,,,,,,,,,,,,,,,,,,
21888156,NLM,MEDLINE,20110922,20220331,0019-5847 (Print) 0019-5847 (Linking),109,2011 Jan,National guidelines for diagnosis and management of dengue fever/dengue haemorrhagic fever and dengue shock syndrome.,30-5,,,"['Dutta, A K', 'Biswas, Ashutosh', 'Baruah, Kalpana', 'Dhariwal, A C']","['Dutta AK', 'Biswas A', 'Baruah K', 'Dhariwal AC']",,"['Directorate of Nalional Vector Borne Disease Control Programme, Ministry of Health and Family Welfare, Government of India, Delhi 110054.']",['eng'],['Journal Article'],,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,,IM,"['Dengue/classification/*diagnosis/*therapy', 'Humans', '*Practice Guidelines as Topic', 'Severe Dengue/diagnosis/therapy']",,2011/09/06 06:00,2011/09/23 06:00,['2011/09/06 06:00'],"['2011/09/06 06:00 [entrez]', '2011/09/06 06:00 [pubmed]', '2011/09/23 06:00 [medline]']",,ppublish,J Indian Med Assoc. 2011 Jan;109(1):30-5.,1,,,,,,,,,,,,,,,,,,,,,,
17018226,NLM,MEDLINE,20061221,20190608,1020-4989 (Print) 1020-4989 (Linking),20,2006 Jul,[Preventing deaths from dengue: a space and challenge for primary health care].,60-74,,"Dengue is an arthropod-borne viral disease whose frequency has increased steadily in the Americas over the past 25 years. The type of dengue that carries the highest mortality is the clinical variant known as dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Even though no vaccine or drug against the disease is available, successful management consists of preventing serious illness through patient follow-up and monitoring danger signals so as to be able to initiate aggressive intravenous rehydration and prevent shock or treat it early and successfully. These measures are also useful in preventing other complications, such as massive hemorrhage, disseminated intravascular coagulation, multiple organ failure, and respiratory failure due to non-cardiogenic pulmonary edema. Primary health care (PHC) settings and the community are ideal spaces for this type of preventive management based on health education and active case detection. It involves training all medical and nursing staff, students, and community health workers, as well as reorganizing health care in PHC units and hospitals and redistributing available resources during a dengue epidemic.","['Martinez Torres, Eric']",['Martinez Torres E'],,"['Subdierccion de Docencia de Postgrado. Instituto de Medicina Tropical Pedro Kouri, Centro Colaborador OPS/OMS para el Estudio del Dengue y su Vector, Ciudad de La Habana, Cuba. eric.martinez@infomed.sld.cu']",['spa'],"['English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Americas/epidemiology', 'Dengue/classification/diagnosis/epidemiology/*mortality/*prevention & control/therapy', 'Humans', '*Primary Health Care']",,2006/10/05 09:00,2006/12/22 09:00,['2006/10/05 09:00'],"['2006/10/05 09:00 [pubmed]', '2006/12/22 09:00 [medline]', '2006/10/05 09:00 [entrez]']","['S1020-49892006000700013 [pii]', '10.1590/s1020-49892006000700013 [doi]']",ppublish,Rev Panam Salud Publica. 2006 Jul;20(1):60-74. doi: 10.1590/s1020-49892006000700013.,1,,,,,,,,,La prevencion de la mortalidad por dengue: un espacio y un reto para la atencion primaria de salud.,,,,,,,,,,,,,
24772736,NLM,MEDLINE,20140520,20150818,0004-5772 (Print) 0004-5772 (Linking),61,2013 Oct,Acute acalculus cholecystitis in dengue fever.,750-2,,"Atypical manifestations of dengue fever (DF) and dengue haemorrhagic fever (DHF) involving different organs are being increasingly recognised, especially in the dengue endemic areas. We report an atypical presentation of DF in a 22 year old lady presenting with fever and acute pain in the right hypochondrium, diagnosed to be acute acalculus cholecystitis (AAC).","['Das, Tanima', 'Kundu, Arup K', 'Maity, Anupam', 'Manna, Satyaki']","['Das T', 'Kundu AK', 'Maity A', 'Manna S']",,,['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Cholecystitis/diagnosis/*etiology/therapy', 'Dengue/*complications/diagnosis/therapy', 'Diagnosis, Differential', 'Diagnostic Imaging', 'Female', 'Humans', 'Young Adult']",,2014/04/30 06:00,2014/05/21 06:00,['2014/04/30 06:00'],"['2014/04/30 06:00 [entrez]', '2014/04/30 06:00 [pubmed]', '2014/05/21 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2013 Oct;61(10):750-2.,10,,,,,"['J Assoc Physicians India. 2014 Nov;62(11):79. PMID: 26281496', 'J Assoc Physicians India. 2014 Nov;62(11):79. PMID: 26281497']",,,,,,,,,,,,,,,,,
9096490,NLM,MEDLINE,19970828,20041117,0029-6503 (Print) 0029-6503 (Linking),87,1996 Nov,Dengue fever. Role of nursing personnel.,252,,,"['Nandi, M']",['Nandi M'],,"['AIIMS, New Delhi.']",['eng'],['Journal Article'],,India,Nurs J India,The Nursing journal of India,0376403,,,"['Dengue/classification/*nursing/prevention & control', 'Fever/prevention & control', 'Humans']",,1996/11/01 00:00,1996/11/01 00:01,['1996/11/01 00:00'],"['1996/11/01 00:00 [pubmed]', '1996/11/01 00:01 [medline]', '1996/11/01 00:00 [entrez]']",,ppublish,Nurs J India. 1996 Nov;87(11):252.,11,,,,,,,,,,,,,,,,,,,,,,
6552175,NLM,MEDLINE,19830623,20131111,0045-0758 (Print) 0045-0758 (Linking),12,1983 Mar,The dengue fever threat.,44-5,,,"['Glazebrook, R']",['Glazebrook R'],,,['eng'],['Journal Article'],,Australia,Aust Nurses J,The Australian nurses' journal. Royal Australian Nursing Federation,0370074,,,"['Aedes/parasitology', 'Animals', 'Australia', 'Dengue/diagnosis/epidemiology/*transmission', 'Humans']",,1983/03/01 00:00,1983/03/01 00:01,['1983/03/01 00:00'],"['1983/03/01 00:00 [pubmed]', '1983/03/01 00:01 [medline]', '1983/03/01 00:00 [entrez]']",,ppublish,Aust Nurses J. 1983 Mar;12(8):44-5.,8,,,,,,,,,,,,,,,,,,,,,,
27739289,NLM,MEDLINE,20181011,20181011,0004-5772 (Print) 0004-5772 (Linking),64,2016 Jun,Clinical and Laboratory Profile of Dengue Fever.,102-103,,,"['Mishra, V N', 'Motiramani, Nikhil']","['Mishra VN', 'Motiramani N']",,"['Professor, Dept. of Medicine, Pt. J. N. M. Medical College, Raipur.', 'Senior Resident, Dept. of Medicine, Pt. J. N. M. Medical College, Raipur, Chhattisgarh.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Dengue/*diagnosis/physiopathology', 'Humans', 'Laboratories']",,2016/10/16 06:00,2018/10/12 06:00,['2016/10/15 06:00'],"['2016/10/15 06:00 [entrez]', '2016/10/16 06:00 [pubmed]', '2018/10/12 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2016 Jun;64(6):102-103.,6,,,,,,,,,,,,,,,,,,,,,,
21826915,NLM,MEDLINE,20110901,20110810,0035-2640 (Print) 0035-2640 (Linking),61,2011 Jun,[Dengue: an emerging infection in travelers].,755-9,,"Dengue is a common, mosquito borne, travel-related, viral infection in the tropical traveler caused by an arbovirus. This virus has 4 different serotypes and is responsible for approximately 50 to 100 million cases per year. Its incidence and geographic distribution are clearly increasing lately. Although occurring in tropical endemic areas, sporadic and autochthonous cases have been recently reported in temperate countries including France. The tropical influenza-like clinical presentation is not very specific except for rash. Diagnosis is facilitated by the existence of thrombocytopenia and the early detection of NS1 antigen using rapid test. Hemorragic forms with or without shock syndrome are rare in travelers and represent the severe manifestations especially in children. Their pathophysiology remains controversial. Management is essentially symptomatic. Aspirine should be avoided because of bleeding risk. Beyond individual (travel) or collective (endemic zone) vector control measures, the development of a quadrivalent vaccine seems about to succeed.","['Mechai, Frederic', 'Bouchaud, Olivier']","['Mechai F', 'Bouchaud O']",,"['Service des maladies infectieuses et tropicales, CHU Avicenne, AP-HP, universite Paris-13, 93009 Bobigny Cedex.']",['fre'],"['English Abstract', 'Journal Article']",,France,Rev Prat,La Revue du praticien,0404334,,IM,"['*Dengue/diagnosis/epidemiology/therapy/transmission/virology', 'Humans', '*Travel']",,2011/08/11 06:00,2011/09/02 06:00,['2011/08/11 06:00'],"['2011/08/11 06:00 [entrez]', '2011/08/11 06:00 [pubmed]', '2011/09/02 06:00 [medline]']",,ppublish,Rev Prat. 2011 Jun;61(6):755-9.,6,,,,,,,,,La dengue: une infection emergente chez le voyageur.,,,,,,,,,,,,,
9813910,NLM,MEDLINE,19981203,20041117,1188-4169 (Print) 1188-4169 (Linking),24,1998 Oct 15,"Imported dengue--United States, 1996.","164-5, 168",,,,,,,['eng'],['Journal Article'],,Canada,Can Commun Dis Rep,Canada communicable disease report = Releve des maladies transmissibles au Canada,9303729,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Dengue/diagnosis/*epidemiology/*etiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Population Surveillance', 'Risk Factors', '*Travel', 'United States/epidemiology']",,1998/11/14 00:00,1998/11/14 00:01,['1998/11/14 00:00'],"['1998/11/14 00:00 [pubmed]', '1998/11/14 00:01 [medline]', '1998/11/14 00:00 [entrez]']",,ppublish,"Can Commun Dis Rep. 1998 Oct 15;24(20):164-5, 168.",20,,,,,,,,,,,,,,,,,,,,,,
24204241,NLM,MEDLINE,20140616,20211021,1553-7358 (Electronic) 1553-734X (Print) 1553-734X (Linking),9,2013 Oct,"Natural, persistent oscillations in a spatial multi-strain disease system with application to dengue.",e1003308,10.1371/journal.pcbi.1003308 [doi] e1003308,"Many infectious diseases are not maintained in a state of equilibrium but exhibit significant fluctuations in prevalence over time. For pathogens that consist of multiple antigenic types or strains, such as influenza, malaria or dengue, these fluctuations often take on the form of regular or irregular epidemic outbreaks in addition to oscillatory prevalence levels of the constituent strains. To explain the observed temporal dynamics and structuring in pathogen populations, epidemiological multi-strain models have commonly evoked strong immune interactions between strains as the predominant driver. Here, with specific reference to dengue, we show how spatially explicit, multi-strain systems can exhibit all of the described epidemiological dynamics even in the absence of immune competition. Instead, amplification of natural stochastic differences in disease transmission, can give rise to persistent oscillations comprising semi-regular epidemic outbreaks and sequential dominance of dengue's four serotypes. Not only can this mechanism explain observed differences in serotype and disease distributions between neighbouring geographical areas, it also has important implications for inferring the nature and epidemiological consequences of immune mediated competition in multi-strain pathogen systems.","['Lourenco, Jose', 'Recker, Mario']","['Lourenco J', 'Recker M']",,"['Department of Zoology, University of Oxford, Oxford, United Kingdom.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20131024,United States,PLoS Comput Biol,PLoS computational biology,101238922,,IM,"['*Communicable Diseases', '*Dengue', '*Epidemics', 'Humans', '*Models, Biological']",PMC3812071,2013/11/10 06:00,2014/06/17 06:00,['2013/11/09 06:00'],"['2013/04/06 00:00 [received]', '2013/09/13 00:00 [accepted]', '2013/11/09 06:00 [entrez]', '2013/11/10 06:00 [pubmed]', '2014/06/17 06:00 [medline]']","['PCOMPBIOL-D-13-00579 [pii]', '10.1371/journal.pcbi.1003308 [doi]']",ppublish,PLoS Comput Biol. 2013 Oct;9(10):e1003308. doi: 10.1371/journal.pcbi.1003308. Epub 2013 Oct 24.,10,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
12466573,NLM,MEDLINE,20030115,20131121,0019-6061 (Print) 0019-6061 (Linking),39,2002 Nov,Dengue fever epidemic in Chennai--a study of clinical profile and outcome.,1027-33,,"Children with dengue fever presenting to the Institute of Social Pediatrics, Government Stanley Hospital, during the months of October to December 2001, were prospectively followed up for clinical profile and outcome. Commonest clinical features were fever, vomiting, bleeding, body pain and hepatomegaly. Elevated liver enzymes and low platelet counts were common laboratory findings in dengue. Hepatomegaly, positive tourniquet test, elevated haematocrit and thrombocytopenia were more common in DHF and DSS group. Retro-orbital pain was slightly more in DHF and DSS groups and there was a tendency for DSS to present at an earlier age. There was no correlation between platelet counts and bleeding in classical dengue cases.","['Narayanan, Manjith', 'Aravind, M A', 'Thilothammal, N', 'Prema, R', 'Sargunam, C S Rex', 'Ramamurty, Nalini']","['Narayanan M', 'Aravind MA', 'Thilothammal N', 'Prema R', 'Sargunam CS', 'Ramamurty N']",,"[""Institute of Social Pediatrics, Government stanley medical college and hospital, chennai, King's Institute of Preventive Medicine, Chennai, India. doctormn76@hotmail.com""]",['eng'],['Journal Article'],,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Female', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Prospective Studies', 'Severe Dengue/diagnosis/epidemiology/physiopathology']",,2002/12/06 04:00,2003/01/16 04:00,['2002/12/06 04:00'],"['2002/12/06 04:00 [pubmed]', '2003/01/16 04:00 [medline]', '2002/12/06 04:00 [entrez]']",,ppublish,Indian Pediatr. 2002 Nov;39(11):1027-33.,11,,,,,,,,,,,,,,,,,,,,,,
11725386,NLM,MEDLINE,20011220,20161026,0006-9248 (Print) 0006-9248 (Linking),102,2001,Dengue fever in the Czech Republic.,322-5,,"BACKGROUND: Dengue fever has become, in Western Europe, the second most frequently imported disease after viral hepatitis A. OBJECTIVES: Dengue fever was diagnosed at the Department of Infectious Disease, University Hospital in Brno, so the authors decided to make local physicians aware of the possibility of the disease being contracted by Czech travelers. METHODS: The first two cases of dengue fever, with the patients hospitalized at the Department of Infectious Disease, University Hospital in Brno, Czech Republic, are described. RESULTS: A young couple contracted this infection in a region usually visited by tourists in Thailand. The disease broke out 12 hours after their return home. The clinical and laboratory pictures of the disease and the kinetics of serological responses are described in detail. CONCLUSION: The chief diagnostic clue with this disease, beside a visit to a high-risk area, can be considered a sudden onset of fever accompanied by marked fatigue, myalgia, and arthralgia. Laboratory tests showed characteristic thrombocytopenia, leukopenia, and pathological values of AST and ALT. The clinical picture is characterized by symptoms of persisting fatigue and exhaustion, even after the fever has subsided.","['Chalupa, P', 'Kubek, J', 'Hejlova, A']","['Chalupa P', 'Kubek J', 'Hejlova A']",,"['Clinic of Infectious Diseases, University Hospital, Jihlavska 20, CZ-639 00 Brno, Czech Republic. pchalupa@fnbrno.cz']",['eng'],"['Case Reports', 'Journal Article']",,Slovakia,Bratisl Lek Listy,Bratislavske lekarske listy,0065324,,IM,"['Adult', 'Czech Republic/epidemiology', 'Dengue/*diagnosis/epidemiology/therapy', 'Female', 'Humans', 'Male', 'Thailand', 'Travel']",,2001/12/01 10:00,2002/01/05 10:01,['2001/12/01 10:00'],"['2001/12/01 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/12/01 10:00 [entrez]']",,ppublish,Bratisl Lek Listy. 2001;102(7):322-5.,7,,,,,,,,,,,,,,,,,,,,,,
11273345,NLM,MEDLINE,20010329,20131121,0004-5772 (Print) 0004-5772 (Linking),46,1998 Mar,Experience in adult population in dengue outbreak in Delhi.,273-6,,"A dengue outbreak has recently hit the Indian capital. We studied the clinical profile of adult patients. Five hundred and sixty patients of dengue infection were admitted in a specially created ward according to the criteria laid down by WHO. Haematemesis (28.28%), epistaxis (26.78%) and malena (14.28%) were some of the common presentations. Similarly lymphadenopathy, especially cervical (30.89%), palatal rashes (26.96%) and hepatomegaly (23.75%) were the most commonly encountered findings on physical examination. Most of the cases were of dengue fever with haemorrhage and only 2.5% cases were classified under dengue haemorrhagic fever or dengue shock syndrome. The average hospital stay was 3.4 days but only 9.8 hours in the eleven patients who died, suggesting their late arrival in preterminal situation giving little time for resuscitation. Thrombocytopenia was not a feature and only 12.85% patients had platelet count less than 70,000/cmm. Most of the patients who were admitted with thrombocytopenia, showed normalization in their platelet counts in next few days. Serological examination demonstrated evidence of recent dengue infection in 41.17% patients. Few patients required blood or platelet concentrate transfusion. Eleven patients died, three due to DIC, one of intracranial haemorrhage and seven due to massive gastric haemorrhage. Rest of the patients recovered completely. Thus we can conclude that recent outbreak in Delhi was of dengue fever with haemorrhage and mortality was very low in patients who came early to the hospital.","['Tripathi, B K', 'Gupta, B', 'Sinha, R S', 'Prasad, S', 'Sharma, D K']","['Tripathi BK', 'Gupta B', 'Sinha RS', 'Prasad S', 'Sharma DK']",,"['Dept of Medicine, Safdarjang Hospital, New Delhi.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Adolescent', 'Adult', 'Child', 'Dengue/diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Middle Aged', 'Severe Dengue/diagnosis/epidemiology']",,2001/03/29 10:00,2001/04/03 10:01,['2001/03/29 10:00'],"['2001/03/29 10:00 [pubmed]', '2001/04/03 10:01 [medline]', '2001/03/29 10:00 [entrez]']",,ppublish,J Assoc Physicians India. 1998 Mar;46(3):273-6.,3,,,,,['J Assoc Physicians India. 1999 Jun;47(6):653-4. PMID: 10999179'],,,,,,,,,,,,,,,,,
18232180,NLM,MEDLINE,20080228,20080131,0019-5847 (Print) 0019-5847 (Linking),105,2007 Jun,Dengue fever presenting as acute acalculus cholecystitis.,338-9,,Classically dengue fever presents as fever with myalgia. A patient of dengue fever presented with classical symptoms and signs of acute acalculous cholecystitis. Serology and ultrasound examination identified dengue as the aetiology. Patient was treated successfully by conservative measures.,"['Joshipura, Vismit P', 'Soni, Harshad N', 'Patel, Nitin R', 'Haribhakti, Sanjiv P']","['Joshipura VP', 'Soni HN', 'Patel NR', 'Haribhakti SP']",,"['Department of GI and Laparoscopic Surgery, Sterling Hospital, Ahmedabad.']",['eng'],"['Case Reports', 'Journal Article']",,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,,IM,"['Acalculous Cholecystitis/*diagnosis/pathology', 'Acute Disease', 'Adult', 'Dengue/*diagnosis/pathology/therapy', 'Female', 'Humans']",,2008/02/01 09:00,2008/02/29 09:00,['2008/02/01 09:00'],"['2008/02/01 09:00 [pubmed]', '2008/02/29 09:00 [medline]', '2008/02/01 09:00 [entrez]']",,ppublish,J Indian Med Assoc. 2007 Jun;105(6):338-9.,6,,,,,,,,,,,,,,,,,,,,,,
744911,NLM,MEDLINE,19790523,20041117,0125-2208 (Print) 0125-2208 (Linking),61 Suppl 3,1978 Dec,Dengue hemorrhagic fever: hematological abnormalities and pathogenesis.,53-8,,,"['Suvatte, V']",['Suvatte V'],,,['eng'],['Journal Article'],,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Child', 'Dengue/blood/complications/*etiology', 'Hematocrit', 'Humans', 'Lymphocyte Activation', 'Thrombocytopenia/etiology']",,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",,ppublish,J Med Assoc Thai. 1978 Dec;61 Suppl 3:53-8.,,,,,,,,,,,,,,,,,,,,,,,
17251078,NLM,MEDLINE,20070302,20140815,1473-3099 (Print) 1473-3099 (Linking),7,2007 Feb,Indian perspective on the need for new case definitions of severe dengue.,81-2,,,"['Thangaratham, P S', 'Tyagi, B K']","['Thangaratham PS', 'Tyagi BK']",,,['eng'],"['Comment', 'Letter']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Child', 'Child, Preschool', 'Dengue/*diagnosis/epidemiology/*physiopathology/therapy', 'Dengue Virus/*pathogenicity', 'Humans', 'India/epidemiology', 'Infant', '*Severity of Illness Index']",,2007/01/26 09:00,2007/03/03 09:00,['2007/01/26 09:00'],"['2007/01/26 09:00 [pubmed]', '2007/03/03 09:00 [medline]', '2007/01/26 09:00 [entrez]']","['S1473-3099(07)70005-1 [pii]', '10.1016/S1473-3099(07)70005-1 [doi]']",ppublish,Lancet Infect Dis. 2007 Feb;7(2):81-2. doi: 10.1016/S1473-3099(07)70005-1.,2,,,,,,,,['Lancet Infect Dis. 2006 May;6(5):297-302. PMID: 16631550'],,,,,,,,,,,,,,
18603866,NLM,MEDLINE,20080731,20161021,1812-2078 (Electronic) 1812-2027 (Linking),4,2006 Jan-Mar,Clinical and laboratory profile of dengue infection in children.,40-3,,"The present work is a prospective, observational, hospital based study on 100 sero positive cases of dengue infection, admitted to Dhaka Children Hospital, Dhaka, Bangladesh during the period 2000 -2001. The patients were in the age group 8 months to 14 years with a mean age of 8.3 years. The serological tests were performed by rapid strip test. Primary dengue infection (only Ig M positive) was observed in 15% cases while rest 85% were secondary dengue infection (either Ig G or both Ig M and Ig G positive). Classical dengue fever (DF) was noted in 11% patients and 89% children presented with dengue hemorrhagic fever / dengue shock syndrome (DHF / DSS). Common clinical presentations were fever, headache, retro- orbital pain, arthralgia / bone pain, vomiting, abdominal pain and bleeding manifestations. Other presentations were tachycardia, bradycardia, hypotension, hepatomegaly, splenomegaly, pleural effusion, ascites, thrombocytopenia and high hematocrit values. The incidences of tachycardia, hypotension, hepatomegaly, high hematocrit and thrombocytopenia were significantly higher in DHF / DSS cases. The tourniquet test was positive in significantly higher percentage of DF cases. The tourniquet test and thrombocytopenia did not correlate well with other bleeding manifestations suggesting alternate pathogenesis for bleeding. In an epidemic setting, if a child presents with fever, vomiting, musculoskeletal pain and bleeding along with hepatomegaly, low platelet count and high hematocrit, a strong possibility of DHF/ DSS should be kept.","['Shah, G S', 'Islam, S', 'Das, B K']","['Shah GS', 'Islam S', 'Das BK']",,"['Department of Paediatrics, B P Koirala Institute of Health Sciences, Dharan, Nepal. gaurisshah@yahoo.com']",['eng'],['Journal Article'],,Nepal,Kathmandu Univ Med J (KUMJ),Kathmandu University medical journal (KUMJ),101215359,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/complications/diagnosis/*epidemiology', 'Humans', 'Infant', 'Nepal/epidemiology', 'Prospective Studies']",,2008/07/08 09:00,2008/08/01 09:00,['2008/07/08 09:00'],"['2008/07/08 09:00 [pubmed]', '2008/08/01 09:00 [medline]', '2008/07/08 09:00 [entrez]']",,ppublish,Kathmandu Univ Med J (KUMJ). 2006 Jan-Mar;4(1):40-3.,1,,,,,,,,,,,,,,,,,,,,,,
18974496,NLM,MEDLINE,20090105,20191111,0255-0857 (Print) 0255-0857 (Linking),26,2008 Oct-Dec,A successful management of dengue fever in pregnancy: report of two cases.,377-80,,"In the most recent outbreak of dengue fever in India, we encountered at least seven cases of fever with thrombocytopenia in pregnancy but only two were seropositive for dengue. In one of the cases there was postpartum hemorrhage while in the other case there was perinatal transmission to the neonate requiring platelet transfusions. The diagnostic difficulties in pregnancy and the management are discussed.","['Singh, N', 'Sharma, K A', 'Dadhwal, V', 'Mittal, S', 'Selvi, A S']","['Singh N', 'Sharma KA', 'Dadhwal V', 'Mittal S', 'Selvi AS']",,"['Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Indian J Med Microbiol,Indian journal of medical microbiology,8700903,,IM,"['Adult', 'Dengue/complications/diagnosis/*therapy/transmission', 'Dengue Virus', 'Female', 'Humans', 'India', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical', 'Postpartum Hemorrhage', 'Pregnancy', 'Pregnancy Complications, Infectious/diagnosis/*therapy', 'Thrombocytopenia', 'Young Adult']",,2008/11/01 09:00,2009/01/06 09:00,['2008/11/01 09:00'],"['2008/11/01 09:00 [pubmed]', '2009/01/06 09:00 [medline]', '2008/11/01 09:00 [entrez]']",['10.4103/0255-0857.43577 [doi]'],ppublish,Indian J Med Microbiol. 2008 Oct-Dec;26(4):377-80. doi: 10.4103/0255-0857.43577.,4,,,,,,,,,,,,,,,,,,,,,,
10909208,NLM,MEDLINE,20000901,20041117,0256-1859 (Print) 0256-1859 (Linking),21,2000 Jun,Case definitions. Dengue fever.,14-5,,,,,,,['eng'],['Journal Article'],,United States,Epidemiol Bull,Epidemiological bulletin,8011598,,IM,"['Arthropod Vectors', 'Dengue/diagnosis/*epidemiology/transmission', 'Humans', 'Population Surveillance', 'Tropical Climate']",,2000/07/26 11:00,2000/09/09 11:01,['2000/07/26 11:00'],"['2000/07/26 11:00 [pubmed]', '2000/09/09 11:01 [medline]', '2000/07/26 11:00 [entrez]']",,ppublish,Epidemiol Bull. 2000 Jun;21(2):14-5.,2,,,,,,,,,,,,,,,,,,,,,,
20714259,NLM,MEDLINE,20101202,20100817,1538-8689 (Electronic) 0360-4039 (Linking),40,2010 Sep,Dengue returns to the United States.,67,10.1097/01.NURSE.0000387751.30111.d2 [doi],,,,,,['eng'],['Journal Article'],,United States,Nursing,Nursing,7600137,,,"['Adult', 'Animals', 'Culicidae', 'Dengue/diagnosis/*epidemiology/prevention & control/therapy', 'Female', 'Humans', 'Insect Vectors', 'United States/epidemiology']",,2010/08/18 06:00,2010/12/14 06:00,['2010/08/18 06:00'],"['2010/08/18 06:00 [entrez]', '2010/08/18 06:00 [pubmed]', '2010/12/14 06:00 [medline]']","['00152193-201009000-00021 [pii]', '10.1097/01.NURSE.0000387751.30111.d2 [doi]']",ppublish,Nursing. 2010 Sep;40(9):67. doi: 10.1097/01.NURSE.0000387751.30111.d2.,9,,,,,,,,,,,,,,,,,,,,,,
2206927,NLM,MEDLINE,19901107,20161201,0049-8114 (Print) 0049-8114 (Linking),65,1990 Aug 17,Dengue in the South Pacific.,255-6,,,,,,,['eng'],['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adult', 'Child', 'Dengue/*epidemiology/physiopathology/transmission', 'Dengue Virus/*classification', 'Humans', 'Infant, Newborn', 'Pacific Islands/epidemiology', 'Serotyping']",,1990/08/17 00:00,1990/08/17 00:01,['1990/08/17 00:00'],"['1990/08/17 00:00 [pubmed]', '1990/08/17 00:01 [medline]', '1990/08/17 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1990 Aug 17;65(33):255-6.,33,,,,,,,,,,,,,,,,,,,,,,
22693183,NLM,MEDLINE,20130429,20211021,1757-790X (Electronic) 1757-790X (Linking),2011,2011 Jun 29,Unusual manifestation of dengue fever.,,10.1136/bcr.02.2011.3839 [doi] bcr0220113839,"Dengue fever is an important public health problem in India and has various serious manifestations, which if not identified and treated at appropriate time can lead to dire consequences. Quadriparesis during the course of dengue infection is quite unusual and rarely reported. The authors hereby report a case of acute motor quadriparesis due to Guillain-Barre syndrome during the course of dengue infection, who showed gradual response to conservative treatment.","['Chaudhary, Shyam Chand', 'Mohanty, D', 'Sonkar, S K', 'Gupta, Durgesh Kumar', 'Gupta, Abhinav']","['Chaudhary SC', 'Mohanty D', 'Sonkar SK', 'Gupta DK', 'Gupta A']",,"['Department of Medicine, Chhatrapati Shahuji Maharaj Medical University, Lucknow, India. drshyamchandchaudhary@rediffmail.com']",['eng'],"['Case Reports', 'Journal Article']",20110629,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['Adult', 'Dengue/complications/*diagnosis', 'Humans', 'Male', 'Quadriplegia/etiology']",PMC3128332,2011/01/01 00:00,2013/04/30 06:00,['2012/06/14 06:00'],"['2012/06/14 06:00 [entrez]', '2011/01/01 00:00 [pubmed]', '2013/04/30 06:00 [medline]']","['bcr.02.2011.3839 [pii]', '10.1136/bcr.02.2011.3839 [doi]']",epublish,BMJ Case Rep. 2011 Jun 29;2011:bcr0220113839. doi: 10.1136/bcr.02.2011.3839.,,,,,['Competing interests None.'],,,,,,,,,,,,,,,,,,
19547796,NLM,MEDLINE,20090824,20190907,1678-4561 (Electronic) 1413-8123 (Linking),14,2009 May-Jun,[The historical evolution of dengue prevention and control programs in Brazil].,961-72,S1413-81232009000300032 [pii],"An epidemiological analysis of the forms and distribution of Dengue fever in Brazil and worldwide was carried out. The National Program of Dengue Control (NPDC) was evaluated based on the data available at 'Diagdengue' an official computerized information system allowing to follow-up the implantation and impact of the Program. A factorial analysis was performed by means of a set of indicators contributing to variability. The indicator scores were added and the cities demanding for prior attention of the NPCD were classified for the construction of an index, which is presented three-monthly for every state, with intervals distributed between 0 and 9. The implantation of the NCPD is irregular. Cities with bad implantation are predominating in the north and northeast of the country. In the second analysis, socio-economic variables of the selected cities were added. For the association tests these cities were classified into two groups: 'Bad' and 'Good/Very Good', based on the association of the index of building infestation informed in the FAD (Yellow Fever and Dengue) database and the constructed index. Associations were verified based on variance analysis, trend test and trend estimate. It was observed that cities with low rates of illiteracy, efficient garbage collection and high ratio of sanitary installations are correlated with a good classification of the city according to Diagdengue.","['Ferreira, Beatriz Jansen', 'Souza, Maria de Fatima Marinho', 'Soares Filho, Adauto Martins', 'Carvalho, Andre Anderson']","['Ferreira BJ', 'Souza Mde F', 'Soares Filho AM', 'Carvalho AA']",,"['Universidade Estadual de Campinas, Campinas, SP, Brazil. beatrizjansen@reitoria.unicamp.br']",['por'],"['English Abstract', 'Historical Article', 'Journal Article']",,Brazil,Cien Saude Colet,Ciencia & saude coletiva,9713483,,IM,"['Brazil', 'Dengue/epidemiology/history/*prevention & control', 'History, 20th Century', 'History, 21st Century', '*National Health Programs/history', 'Program Evaluation']",,2009/06/24 09:00,2009/08/25 09:00,['2009/06/24 09:00'],"['2006/08/14 00:00 [received]', '2007/10/30 00:00 [accepted]', '2009/06/24 09:00 [entrez]', '2009/06/24 09:00 [pubmed]', '2009/08/25 09:00 [medline]']","['S1413-81232009000300032 [pii]', '10.1590/s1413-81232009000300032 [doi]']",ppublish,Cien Saude Colet. 2009 May-Jun;14(3):961-72. doi: 10.1590/s1413-81232009000300032.,3,,,,,,,,,Evolucao historica dos programas de prevencao e controle da dengue no Brasil.,,,,,,,,,,,,,
3433160,NLM,MEDLINE,19880324,20041117,0125-1562 (Print) 0125-1562 (Linking),18,1987 Sep,Dengue haemorrhagic fever in Thailand.,291-4,,,"['Nimmannitya, S']",['Nimmannitya S'],,"[""Children's Hospital, Bangkok, Thailand.""]",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/mortality/prevention & control', 'Female', 'Humans', 'Infant', 'Male', 'Serotyping', 'Thailand']",,1987/09/01 00:00,1987/09/01 00:01,['1987/09/01 00:00'],"['1987/09/01 00:00 [pubmed]', '1987/09/01 00:01 [medline]', '1987/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):291-4.,3,,,,,,,,,,,,,,,,,,,,,,
7052954,NLM,MEDLINE,19830817,20041117,0037-5683 (Print) 0037-5683 (Linking),22,1980,Dengue haemorrhagic fever in Singapore.,15-23,,,"['Wong, H B']",['Wong HB'],,,['eng'],['Journal Article'],,Singapore,J Singapore Paediatr Soc,The Journal of the Singapore Paediatric Society,7507223,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/therapy', 'Disease Outbreaks/*epidemiology', 'Female', 'Humans', 'Male', 'Philippines', 'Shock/etiology/therapy', 'Singapore', 'Thailand']",,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,J Singapore Paediatr Soc. 1980;22(1-4):15-23.,1-4,,,,,,,,,,,,,,,,,,,,,,
2364597,NLM,MEDLINE,19900813,20041117,0722-5091 (Print) 0722-5091 (Linking),9,1990 May-Jun,Dengue: neuropathological findings in 5 fatal cases from Brazil.,157-62,,"Neuropathological examination of 5 patients with dengue who died of shock in Rio de Janeiro during an outbreak in summer 1987, showed nonspecific lesions (edema, vascular congestion, hemorrhagic foci and perivascular lymphocytic infiltrates). In one case with delayed marked neurological symptoms, several foci of perivenous demyelination were observed. Neurological manifestations are various and not uncommon in dengue, but their anatomical substratum is not known. An immunopathological mechanism has been postulated in some cases but has never been demonstrated morphologically. The perivenous leukoencephalitis observed in one of our cases could represent the morphological substratum of such an immunological mechanism.","['Chimelli, L', 'Hahn, M D', 'Netto, M B', 'Ramos, R G', 'Dias, M', 'Gray, F']","['Chimelli L', 'Hahn MD', 'Netto MB', 'Ramos RG', 'Dias M', 'Gray F']",,"['Departmento de Patologia (Neuropatologia), Universidade Federal Fluminense, Niteroi, RJ, Brasil.']",['eng'],['Journal Article'],,Germany,Clin Neuropathol,Clinical neuropathology,8214420,,IM,"['Adolescent', 'Adult', 'Brazil', 'Dengue/ethnology/mortality/*pathology', 'Female', 'Humans', 'Male', 'Middle Aged']",,1990/05/01 00:00,1990/05/01 00:01,['1990/05/01 00:00'],"['1990/05/01 00:00 [pubmed]', '1990/05/01 00:01 [medline]', '1990/05/01 00:00 [entrez]']",,ppublish,Clin Neuropathol. 1990 May-Jun;9(3):157-62.,3,,,,,,,,,,,,,,,,,,,,,,
18368205,NLM,MEDLINE,20080529,20211020,1564-0604 (Electronic) 0042-9686 (Print) 0042-9686 (Linking),86,2008 Mar,Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control.,187-96,,"OBJECTIVE: To reconstruct the historical changes in force of dengue infection in Singapore, and to better understand the relationship between control of Aedes mosquitoes and incidence of classic dengue fever. METHODS: Seroprevalence data were abstracted from surveys performed in Singapore from 1982 to 2002. These data were used to develop two mathematical models of age seroprevalence. In the first model, force of infection was allowed to vary independently each year, while in the second it was described by a polynomial function. Model-predicted temporal trends were analysed using linear regression. Time series techniques were employed to investigate periodicity in predicted forces of infection, dengue fever incidence and mosquito breeding. FINDINGS: Force of infection estimates showed a significant downward trend from 1966, when vector control was instigated. Force of infection estimates from both models reproduced significant increases in the percentage and average age of the population susceptible to dengue infections. Importantly, the year-on-year model independently predicted a five to six year periodicity that was also displayed by clinical incidence but absent from the Aedes household index. CONCLUSION: We propose that the rise in disease incidence was due in part to a vector-control-driven reduction in herd immunity in older age groups that are more susceptible to developing clinical dengue.","['Egger, Joseph R', 'Ooi, Eng Eong', 'Kelly, David W', 'Woolhouse, Mark E', 'Davies, Clive R', 'Coleman, Paul G']","['Egger JR', 'Ooi EE', 'Kelly DW', 'Woolhouse ME', 'Davies CR', 'Coleman PG']",,"['Disease Control and Vector Biology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England. Joe.Egger@lshtm.ac.uk']",['eng'],['Journal Article'],,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,,IM,"['Adolescent', 'Adult', 'Animals', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', 'Dengue/*epidemiology/parasitology/prevention & control/transmission', 'Humans', 'Infant', 'Middle Aged', 'Mosquito Control', '*Population Surveillance', 'Seroepidemiologic Studies', 'Singapore/epidemiology']",PMC2647409,2008/03/28 09:00,2008/05/30 09:00,['2008/03/28 09:00'],"['2007/01/09 00:00 [received]', '2007/04/02 00:00 [accepted]', '2008/03/28 09:00 [pubmed]', '2008/05/30 09:00 [medline]', '2008/03/28 09:00 [entrez]']","['S0042-96862008000300011 [pii]', '10.2471/blt.07.040170 [doi]']",ppublish,Bull World Health Organ. 2008 Mar;86(3):187-96. doi: 10.2471/blt.07.040170.,3,,,,,,,,,,,,,,,,,,,,,,
12649961,NLM,MEDLINE,20031030,20061115,0036-3634 (Print) 0036-3634 (Linking),45,2003 Jan-Feb,[Determinants of dengue transmission in Veracruz: an ecological approach to its control].,43-53,,"OBJECTIVE: To assess the ecological, social, and demographic factors associated with the transmission of dengue virus infection in Veracruz, Mexico, and to identify risk areas to target control measures. MATERIAL AND METHODS: This ecological study included data for 1,249 localities within the 11 Health Jurisdictions of the State of Veracruz, Mexico, for the 1995-1998 period. The following data were collected for each locality: total number of cases per year, population by sex, number of households, provision of public services, altitude, latitude, longitude, and deprivation index. RESULTS: Dengue transmission was registered in 17% of the localities in the State; 70% of the cases were concentrated in only 6% of the localities. Recurrent localities were urban centers with adequate availability of public services and low deprivation indices. Dengue transmission was detected in rural areas, but it was not common. The average number of cases differed according to the size of the locality and the number of years dengue was reported. A population threshold to maintain transmission was found. CONCLUSION: Recurrent localities concentrating 70% of dengue fever cases were identified, as well as the ecological and demographic factors associated with dengue transmission. The risk stratification approach to dengue transmission may improve control and prevention of this disease in high-risk areas.","['Escobar-Mesa, Javier', 'Gomez-Dantes, Hector']","['Escobar-Mesa J', 'Gomez-Dantes H']",,"['Division Tecnica de Informacion Estadistica en Salud, Direccion de Prestaciones Medicas, Instituto Mexicano del Seguro Social (IMSS), Mexico.']",['spa'],"['English Abstract', 'Journal Article']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Dengue/epidemiology/*prevention & control/*transmission', 'Ecology', 'Humans', 'Mexico']",,2003/03/26 04:00,2003/10/31 05:00,['2003/03/26 04:00'],"['2003/03/26 04:00 [pubmed]', '2003/10/31 05:00 [medline]', '2003/03/26 04:00 [entrez]']",,ppublish,Salud Publica Mex. 2003 Jan-Feb;45(1):43-53.,1,,,,,,,,,Determinantes de la transmision de dengue en Veracruz: un abordaje ecologico para su control.,,,,,,,,,,,,,
18998766,NLM,MEDLINE,20090115,20181113,1549-1676 (Electronic) 1549-1277 (Print) 1549-1277 (Linking),5,2008 Nov 4,A prospective study of spatial clusters gives valuable insights into dengue transmission.,e220,10.1371/journal.pmed.0050220 [doi] e220,Steven Riley discusses the public health implications of a new prospective spatial cluster study of dengue transmission in a rural population in Thailand.,"['Riley, Steven']",['Riley S'],,"[""Department of Community Medicine and School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China. steven.riley@hku.hk""]",['eng'],"['Comment', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,PLoS Med,PLoS medicine,101231360,,IM,"['Child', 'Child, Preschool', 'Cluster Analysis', 'Dengue/blood/*epidemiology/*transmission/virology', 'Dengue Virus', 'Female', 'Humans', 'Male', 'Prospective Studies', 'Thailand/epidemiology']",PMC2577697,2008/11/13 09:00,2009/01/16 09:00,['2008/11/13 09:00'],"['2008/11/13 09:00 [pubmed]', '2009/01/16 09:00 [medline]', '2008/11/13 09:00 [entrez]']","['08-PLME-P-2593 [pii]', '10.1371/journal.pmed.0050220 [doi]']",ppublish,PLoS Med. 2008 Nov 4;5(11):e220. doi: 10.1371/journal.pmed.0050220.,11,,,,['Competing Interests: The author has declared that no competing interests exist.'],,,,['PLoS Med. 2008 Nov 4;5(11):e205. PMID: 18986209'],,,,,,,,,,,,,,
17710833,NLM,MEDLINE,20070919,20131121,0029-6503 (Print) 0029-6503 (Linking),97,2006 Nov,Dengue fever and dengue haemorrhagic fever.,246-7,,,,,,,['eng'],['Journal Article'],,India,Nurs J India,The Nursing journal of India,0376403,,,"['Animals', 'Dengue/*diagnosis/*therapy/transmission', 'Humans', 'Mosquito Control', ""Nurse's Role"", 'Primary Prevention', 'Severe Dengue/*diagnosis/*therapy/transmission']",,2007/08/23 09:00,2007/09/20 09:00,['2007/08/23 09:00'],"['2007/08/23 09:00 [pubmed]', '2007/09/20 09:00 [medline]', '2007/08/23 09:00 [entrez]']",,ppublish,Nurs J India. 2006 Nov;97(11):246-7.,11,,,,,,,,,,,,,,,,,['WHO'],,,,,
19541160,NLM,MEDLINE,20091001,20090622,0929-693X (Print) 0929-693X (Linking),16,2009 Jun,[Protective measures against mosquitos in French West Indies during dengue's epidemics].,760-2,10.1016/S0929-693X(09)74142-9 [doi],,"['Hatchuel, Y', 'Cecile, W', 'Thomas, L', 'Cesaire, R']","['Hatchuel Y', 'Cecile W', 'Thomas L', 'Cesaire R']",,"[""Pediatrie, Maison de la Femme, de la Mere et de l'Enfant CHU, BP 632, 97261 Fort-de-France cedex. Yves.Hatchuel@chu-fortdefrance.fr""]",['fre'],['Journal Article'],,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Animals', 'Child', '*Culicidae', 'Dengue/*epidemiology/*prevention & control', '*Disease Outbreaks', 'French Guiana/epidemiology', 'Humans', 'Insect Bites and Stings/*prevention & control', 'Martinique/epidemiology', 'Mosquito Control/*methods']",,2009/06/23 09:00,2009/10/02 06:00,['2009/06/23 09:00'],"['2009/06/23 09:00 [entrez]', '2009/06/23 09:00 [pubmed]', '2009/10/02 06:00 [medline]']","['S0929-693X(09)74142-9 [pii]', '10.1016/S0929-693X(09)74142-9 [doi]']",ppublish,Arch Pediatr. 2009 Jun;16(6):760-2. doi: 10.1016/S0929-693X(09)74142-9.,6,,,,,,,,,Mesures de protection contre les moustiques aux Antilles francaises durant les epidemies de dengue.,,,,,,,,,,,,,
22298216,NLM,MEDLINE,20120315,20120202,0009-0875 (Print) 0009-0875 (Linking),56,2011 Dec,Shift in the transmission pattern of dengue serotypes and concurrent infection with more than one dengue virus serotype.,176-8,10.4038/cmj.v56i4.3903 [doi],,"['Dissanayake, V H W', 'Gunawardena, N D', 'Gunasekara, N C A', 'Siriwardhana, D R S', 'Senarath, N']","['Dissanayake VH', 'Gunawardena ND', 'Gunasekara NC', 'Siriwardhana DR', 'Senarath N']",,,['eng'],['Letter'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['Dengue/epidemiology/*transmission/*virology', 'Dengue Virus/*classification', 'Humans', 'Serotyping', 'Sri Lanka/epidemiology']",,2012/02/03 06:00,2012/03/16 06:00,['2012/02/03 06:00'],"['2012/02/03 06:00 [entrez]', '2012/02/03 06:00 [pubmed]', '2012/03/16 06:00 [medline]']",['10.4038/cmj.v56i4.3903 [doi]'],ppublish,Ceylon Med J. 2011 Dec;56(4):176-8. doi: 10.4038/cmj.v56i4.3903.,4,,,,,,,,,,,,,,,,,,,,,,
22930935,NLM,MEDLINE,20121016,20120830,0024-3477 (Print) 0024-3477 (Linking),134,2012 May-Jun,[Virology diagnosis of re-emergent infections: dengue virus].,164-7,,"Dengue is acute viral disease transmitted to humans by Aedes mosquitoes (Ae. aegypti, Ae. albopictus). Dengue virus belongs to the family Flaviviridae, genus Flavivirus. There are four dengue virus serotypes (1-4) which are maintained endemically. The disease is endemic in tropical and subtropical areas between latitudes 35 degrees N and 35 degrees S. Infections may be asymptomatic or may produce a wide spectrum of diseases: non-specific febrile illness, dengue fever, dengue haemorrhagic fever or dengue shock syndrome. For the first time in Croatia, Ae. albopictus was registered in Zagreb in October 2004. In autumn 2005, additional records of Ae. albopictus presence were made in many places along the Adriatic coast. During 2007, two cases of imported dengue fever were reported in Croatia, after which similar imported cases appeared continually. In August 2010, the first autochthonous case of dengue fever was recorded on the peninsula Peljesac. Though Croatia is not endemic for dengue, the existence of a corresponding vector and a latent threat by imported dengue cases demand state-of-the-art and timely diagnostics. The most commonly used methods in laboratory diagnosis of dengue infections involve detection of viral RNA, antigen detection and serologic methods (detection of antibodies).","['Vilibic-Cavlek, Tatjana', 'Ljubin-Sternak, Suncanica', 'Babic-Erceg, Andrea', 'Sviben, Mario', 'Mlinaric-Galinovic, Gordana']","['Vilibic-Cavlek T', 'Ljubin-Sternak S', 'Babic-Erceg A', 'Sviben M', 'Mlinaric-Galinovic G']",,"['Odjel za virologiju, Hrvatski zavod za javno zdravstvo, Medicinski fakultet Sveucilisa u Zagrebu. tatjana.vilibic-cavlek@hzjz.hr']",['hrv'],"['English Abstract', 'Journal Article']",,Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,,IM,"['Aedes', 'Animals', 'Croatia/epidemiology', 'Dengue/*diagnosis/epidemiology/transmission', 'Dengue Virus/isolation & purification', 'Humans', 'Insect Vectors', 'Reverse Transcriptase Polymerase Chain Reaction']",,2012/08/31 06:00,2012/10/17 06:00,['2012/08/31 06:00'],"['2012/08/31 06:00 [entrez]', '2012/08/31 06:00 [pubmed]', '2012/10/17 06:00 [medline]']",,ppublish,Lijec Vjesn. 2012 May-Jun;134(5-6):164-7.,5-6,,,,,,,,,Viroloska dijagnostika reemergentnih infekcija: virus dengue.,,,,,,,,,,,,,
7669530,NLM,MEDLINE,19951019,20161201,0049-8114 (Print) 0049-8114 (Linking),70,1995 Aug 18,Dengue and dengue haemorrhagic fever.,237-8,,,,,,,"['eng', 'fre']","['Case Reports', 'Journal Article']",,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adult', 'Dengue/blood/*epidemiology/prevention & control/virology', 'Humans', 'Population Surveillance', 'Saudi Arabia/epidemiology', 'Seroepidemiologic Studies']",,1995/08/18 00:00,1995/08/18 00:01,['1995/08/18 00:00'],"['1995/08/18 00:00 [pubmed]', '1995/08/18 00:01 [medline]', '1995/08/18 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1995 Aug 18;70(33):237-8.,33,,,,,,,,,,,,,,,,,,,,,,
3599927,NLM,MEDLINE,19870724,20041117,0037-5683 (Print) 0037-5683 (Linking),28,1986,Dengue haemorrhagic fever in Singapore--the future.,210-5,,,"['Wong, H B']",['Wong HB'],,,['eng'],['Journal Article'],,Singapore,J Singapore Paediatr Soc,The Journal of the Singapore Paediatric Society,7507223,,IM,"['Dengue/diagnosis/epidemiology/*prevention & control', 'Disease Outbreaks/*prevention & control', 'Humans', 'Singapore']",,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,J Singapore Paediatr Soc. 1986;28(3-4):210-5.,3-4,,,,,,,,,,,,,,,,,,,,,,
25327063,NLM,MEDLINE,20141103,20220330,0004-5772 (Print) 0004-5772 (Linking),62,2014 Mar,An observational study of dengue fever in a tertiary care hospital of eastern India.,224-7,,"BACKGROUND: Dengue fever (DF) has become a significant resurgent tropical disease in the past 20 years all over the globe. The recent outbreak in West Bengal has once again underlined our failure in vector control and prevention. Our study outlines the clinical spectrum as well as the geographical expansion of the disease beyond urban confines. MATERIAL AND METHODS: All patients with acute febrile illness positive for IgM antibody for Dengue virus were taken as cases. The patients were subjected to clinical examination and baseline investigations so as to fill in a structured proforma. RESULT: The total number of patients were 180 of whom 92 (51.1%) were male and 88 (48.9%) were female. The maximum number of patients belonged to the age group 20-29 years (26.9%). The patients mostly hailed from Kolkata followed by Nadia, 24- Parganas(S), Murshidabad and Midnapur. The most common presentation apart from fever and bodyache were gastrointestinal symptoms. 42% patients complained of abdominal pain, 24% had vomiting, 9.6% diarrhoea. Bleeding manifestations occurred in 23% of patients. CNS features were documented 10.4%. Case fatality came out to be 3.8%. Investigations revealed thrombocytopenia in 55% and leucopenia 32.7%, transaminitis in 72% Evidence of organomegaly (22.2%) and serositis (42%) were detected. Complications included intracranial haemorrhage, DIC, pancreatitis, myocarditis and even a solitary case of splenic rupture. CONCLUSION: The current outbreak was affecting both the genders equitably and mostly the younger age group from rural as well as urban areas. A febrile illness characterised by myalgia, mild bleeding and gastrointestinal symptoms, it was more or less promptly responsive to early conservative therapy like fluids, FFP and platelet transfusion where required.","['Chatterjee, Nandini', 'Mukhopadhyay, Mainak', 'Ghosh, Sinjon', 'Mondol, Manas', 'Das, Chiranjib', 'Patar, Kartik']","['Chatterjee N', 'Mukhopadhyay M', 'Ghosh S', 'Mondol M', 'Das C', 'Patar K']",,,['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Adolescent', 'Adult', 'Aged', 'Dengue/*diagnosis/*epidemiology/therapy', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Middle Aged', '*Tertiary Healthcare', 'Young Adult']",,2014/10/21 06:00,2014/11/05 06:00,['2014/10/21 06:00'],"['2014/10/21 06:00 [entrez]', '2014/10/21 06:00 [pubmed]', '2014/11/05 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2014 Mar;62(3):224-7.,3,,,,,,,,,,,,,,,,,,,,,,
25327070,NLM,MEDLINE,20141103,20141020,0004-5772 (Print) 0004-5772 (Linking),62,2014 Mar,Cardiac tamponade presenting as early manifestation in dengue fever.,257-9,,"Dengue fever (DF) is an outbreak prone viral disease transmitted by aedes mosquitoes. It is often associated with evidence of plasma leakage due to increased vascular permeability manifested by pleural effusion, ascites, hypoproteinaemia and pericardial effusion. Cases of small pericardial effusion have been reported in association with dengue fever, largely with dengue haemorrhagic fever (DHF) during epidemic outbreaks. Dengue may rarely present with cardiac tamponade as early manifestation and urgent pericardiocentesis is life saving. A 34 year old male presented with low grade fever, headache, myalgia and breathlessness. Echocardiography revealed large pericardial effusion with right ventricular diagnostic collapse requiring urgent drainage. Subsequently patient improved. Dengue serology (both IgM and IgG) was reported as markedly elevated supporting a diagnosis of classic dengue fever.","['Bendwal, Suresh', 'Malviya, Kavita', 'Jatav, O P', 'Malviya, Kapil']","['Bendwal S', 'Malviya K', 'Jatav OP', 'Malviya K']",,,['eng'],"['Case Reports', 'Journal Article']",,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Adult', 'Cardiac Tamponade/*diagnosis/*etiology/therapy', 'Dengue/*complications/*diagnosis/therapy', 'Humans', 'Male']",,2014/10/21 06:00,2014/11/05 06:00,['2014/10/21 06:00'],"['2014/10/21 06:00 [entrez]', '2014/10/21 06:00 [pubmed]', '2014/11/05 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2014 Mar;62(3):257-9.,3,,,,,,,,,,,,,,,,,,,,,,
1523654,NLM,MEDLINE,19921015,20080716,0029-2001 (Print) 0029-2001 (Linking),112,1992 Jun 30,[Dengue hemorrhagic fever. Experiences from Thailand].,2194-5,,"Increased incidence of dengue haemorrhagic fever has been observed in South East Asia. The etiology, clinical features and epidemiology of dengue virus infections are presented, with special emphasis on experience from Thailand. Reduction of sources, in terms of eliminating breeding sites for mosquitos, is the major approach in controlling dengue haemorrhagic fever, an approach which can succeed only through participation by the local community. The involvement of schools has proven to be successful in campaigns to reduce mosquito breeding sites in Thailand.","['Sorensen, E']",['Sorensen E'],,"['Section for Infectious Diseases, Children Hospital, Bangkok, Thailand.']",['nor'],"['English Abstract', 'Journal Article']",,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,,IM,"['Dengue/*epidemiology/prevention & control/transmission', 'Humans', 'Thailand/epidemiology']",,1992/06/30 00:00,1992/06/30 00:01,['1992/06/30 00:00'],"['1992/06/30 00:00 [pubmed]', '1992/06/30 00:01 [medline]', '1992/06/30 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1992 Jun 30;112(17):2194-5.,17,,,,,,,,,Dengue hemoragisk feber. Erfaringer fra Thailand.,,,,,,,,,,,,,
18572844,NLM,MEDLINE,20080918,20190911,0034-7167 (Print) 0034-7167 (Linking),61,2008 Mar-Apr,"[Clinical-epidemiologic profile of Dengue suspicious cases in a district in the south zone of Teresina, PI, Brazil].",227-32,,"The objective of the study was to establish a clinical-epidemiologic profile of Dengue suspicious cases in a district in the south zone of Teresina, PI, Brazil. This study is a descriptive-exploratory survey in which it was applied a questionnaire to 28 residents of the mentioned district. 88.9% had garbage collection 3 times per week; 57.1% of the deposits had construction material or car parts; 75% destine served waters to opencast; 60.7% had developed first-infection, 75% were submitted to serology, 33.3% cases were confirmed. More effectiveness of sanitary action by government and population involvement in the development of preventive programs is missed in the fight against Dengue.","['Ribeiro, Polyana da Costa', 'de Sousa, Debora Costa', 'de Araujo, Telma Maria Evangelista']","['Ribeiro Pda C', 'de Sousa DC', 'de Araujo TM']",,"['Universidade Federal do Piaui, Departamento de Enfermagem, Teresina, PI.']",['por'],"['English Abstract', 'Journal Article']",,Brazil,Rev Bras Enferm,Revista brasileira de enfermagem,7910105,,,"['Adult', 'Brazil', 'Dengue/*diagnosis/*epidemiology', 'Humans']",,2008/06/25 09:00,2008/09/19 09:00,['2008/06/25 09:00'],"['2008/06/25 09:00 [pubmed]', '2008/09/19 09:00 [medline]', '2008/06/25 09:00 [entrez]']",['10.1590/s0034-71672008000200013 [doi]'],ppublish,Rev Bras Enferm. 2008 Mar-Apr;61(2):227-32. doi: 10.1590/s0034-71672008000200013.,2,,,,,,,,,"Perfil clinico-epidemiologico dos casos suspeitos de Dengue em um bairro da zona sul de teresina, PI, Brasil.",,,,,,,,,,,,,
11014137,NLM,MEDLINE,20001011,20131121,0041-5782 (Print) 0041-5782 (Linking),162,2000 Sep 18,[Dengue fever among 44 Danish travellers investigated in the department of epidemics at the Rigshospitalet during 1988-1998].,5074-7,,"Dengue fever is a major cause of febrile illness in the tropics, and we describe 44 patients with dengue fever seen at Rigshospitalet, Copenhagen from 1988-98. A worldwide increase in transmission of dengue fever was reflected in the number of patients seen in 1997-1998. All patients had fever and headache, and were biochemically characterised by thrombocytopenia, leucopenia, increased levels of alanine aminotransferase and a rise in haematocrit. One patient had dengue haemorrhagic fever, and two patients exhibited unusual reactions to the infection, one in the form of extended febrile neutropenia complicated by an episode of of E. coli septicaemia, and one patient developed progressive paralysis of both legs, and remains partially paretic.","['David, K P', ""O'Hare, M R"", 'Skinhoj, P']","['David KP', ""O'Hare MR"", 'Skinhoj P']",,,['dan'],"['English Abstract', 'Journal Article']",,Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Adolescent', 'Adult', 'Aged', '*Dengue/diagnosis/epidemiology/transmission', 'Denmark/epidemiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', '*Severe Dengue/diagnosis/epidemiology/transmission', 'Travel', 'Tropical Medicine']",,2000/10/03 11:00,2000/10/14 11:01,['2000/10/03 11:00'],"['2000/10/03 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/10/03 11:00 [entrez]']",,ppublish,Ugeskr Laeger. 2000 Sep 18;162(38):5074-7.,38,,,,,,,,,Denguefeber hos 44 danske rejsende undersogt pa rigshospitalets epidemiafdeling 1988-1998.,,,,,,,,,,,,,
10030050,NLM,MEDLINE,19990512,20131121,0001-5504 (Print) 0001-5504 (Linking),49 Suppl 1,1998,"[Basic standards in handling patients with dengue fever, hemorrhagic dengue and dengue shock].",18-24,,"The Dengue epidemic in Venezuela has increase dramatically during the last years. There is a rise in the number of cases as well as in the severity of the disease. The fact that it circulates more than one serotype of the virus (1, 2 and 4), from the four described turn us into a hyperendemic region. The symptoms produce in the patient as a consequence of the infection with the Dengue virus, varies from a mild fever to the severe Dengue Shock. Here, the characteristics and classification of the different clinical manifestation are presented as well as the basic procedures in the management of the patient in every case.","['Finizola Celli, F']",['Finizola Celli F'],,"['Departamento de Pediatria Dr. Agustin Zubillaga, Hospital Central Antonio Maria Pineda, Edo, Lara.']",['spa'],"['English Abstract', 'Journal Article']",,Venezuela,Acta Cient Venez,Acta cientifica venezolana,0070154,,IM,"['Ambulatory Care/standards', 'Dengue/blood/diagnosis/*therapy', 'Diagnosis, Differential', 'Hemocytes', 'Humans', 'Severe Dengue/therapy', 'Severity of Illness Index']",,1999/02/25 00:00,1999/02/25 00:01,['1999/02/25 00:00'],"['1999/02/25 00:00 [pubmed]', '1999/02/25 00:01 [medline]', '1999/02/25 00:00 [entrez]']",,ppublish,Acta Cient Venez. 1998;49 Suppl 1:18-24.,,,,,,,,,,"Normas basicas en el manejo del paciente con fiebre dengue, dengue hemorragico y dengue shock.",,,,,,,,,,,,,
18541760,NLM,MEDLINE,20080806,20080610,1476-1645 (Electronic) 0002-9637 (Linking),78,2008 Jun,Quality of life of dengue patients.,862-7,,"Although the disease burden of dengue is increasing, the impact on the quality of life (QoL) has not been investigated. A study to determine the QoL of confirmed dengue patients using the EuroQol visual thermometer scale was carried out at the University Malaya Medical Center. Of the 207 participants, 40% were ambulatory and 60% were hospitalized. Of eight health domains, 6.2 and 5.0 domains were affected in the hospitalized and ambulatory cohorts, respectively (P < 0.001), with cognition and interpersonal activities affected most. All patients experienced a drastic decrease in their QoL from the onset of symptoms. The QoL deteriorated to the lowest point (40% of healthy status) between the third and seventh days of illness. The duration of impaired QoL (9 days for ambulatory or 13 days for hospitalized patients) was longer than the duration of fever (5 and 7 days, respectively). Symptomatic dengue has major effects on patients' health.","['Lum, Lucy C S', 'Suaya, Jose A', 'Tan, Lian H', 'Sah, Binod K', 'Shepard, Donald S']","['Lum LC', 'Suaya JA', 'Tan LH', 'Sah BK', 'Shepard DS']",,"['Department of Pediatrics, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia. lumcs@ummc.edu.my']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cohort Studies', 'Dengue/complications/epidemiology/*physiopathology/psychology', 'Depression/complications', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Malaysia/epidemiology', 'Male', 'Middle Aged', '*Quality of Life']",,2008/06/11 09:00,2008/08/07 09:00,['2008/06/11 09:00'],"['2008/06/11 09:00 [pubmed]', '2008/08/07 09:00 [medline]', '2008/06/11 09:00 [entrez]']",['78/6/862 [pii]'],ppublish,Am J Trop Med Hyg. 2008 Jun;78(6):862-7.,6,,,,,,,,,,,,,,,,,,,,,,
6506212,NLM,MEDLINE,19850122,20041117,0041-3232 (Print) 0041-3232 (Linking),36,1984 Sep,A case of hemorrhagic dengue without hypovolemia in an adult.,305-7,,"Dengue hemorrhagic fever, though prevalent in South East Asia was diagnosed for the first time in Hong Kong. The subject in this report made frequent visits to endemic areas including the Philippines. Hypovolemia was not evident at the time of presentation. The nature and the status of the disease in this area are discussed.","['Pan, H Y', 'Chow, J S']","['Pan HY', 'Chow JS']",,,['eng'],"['Case Reports', 'Journal Article']",,Netherlands,Trop Geogr Med,Tropical and geographical medicine,0376231,,IM,"['Aedes', 'Asia, Southeastern', 'Dengue/diagnosis/*epidemiology/transmission', 'Hong Kong', 'Humans', 'Insect Vectors', 'Male', 'Middle Aged', 'Philippines', 'Shock/etiology']",,1984/09/01 00:00,1984/09/01 00:01,['1984/09/01 00:00'],"['1984/09/01 00:00 [pubmed]', '1984/09/01 00:01 [medline]', '1984/09/01 00:00 [entrez]']",,ppublish,Trop Geogr Med. 1984 Sep;36(3):305-7.,3,,,,,,,,,,,,,,,,,,,,,,
3067278,NLM,MEDLINE,19890406,20091111,0375-0760 (Print) 0375-0760 (Linking),40,1988 May-Aug,[Dengue in Cuba: history of an epidemic].,29-49,,,"['Guzman, M G', 'Kouri, G', 'Bravo, J', 'Soler, M', 'Morier, L', 'Vazquez, S', 'Diaz, A', 'Fernandez, R', 'Ruiz, A', 'Ramos, A']","['Guzman MG', 'Kouri G', 'Bravo J', 'Soler M', 'Morier L', 'Vazquez S', 'Diaz A', 'Fernandez R', 'Ruiz A', 'Ramos A', 'et al.']",,,['spa'],"['English Abstract', 'Historical Article', 'Journal Article']",,Cuba,Rev Cubana Med Trop,Revista cubana de medicina tropical,0074364,,IM,"['Cuba', 'Dengue/diagnosis/*epidemiology/history', 'Dengue Virus/classification/isolation & purification', 'Disease Outbreaks/*history', 'Disease Susceptibility', 'History, 20th Century', 'Humans', 'Risk Factors']",,1988/05/01 00:00,1988/05/01 00:01,['1988/05/01 00:00'],"['1988/05/01 00:00 [pubmed]', '1988/05/01 00:01 [medline]', '1988/05/01 00:00 [entrez]']",,ppublish,Rev Cubana Med Trop. 1988 May-Aug;40(2):29-49.,2,,,,,,,,,Dengue en Cuba: historia de una epidemia.,,,,,,,,,,,,,
9055483,NLM,MEDLINE,19970401,20061115,0256-1859 (Print) 0256-1859 (Linking),17,1996 Dec,"Dengue and dengue hemorrhagic fever, 1996.",12-4,,,,,,,['eng'],"['Comparative Study', 'Journal Article']",,United States,Epidemiol Bull,Epidemiological bulletin,8011598,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Humans', 'Insect Vectors', 'Latin America/epidemiology', 'Pan American Health Organization', 'United States/epidemiology']",,1996/12/01 00:00,1996/12/01 00:01,['1996/12/01 00:00'],"['1996/12/01 00:00 [pubmed]', '1996/12/01 00:01 [medline]', '1996/12/01 00:00 [entrez]']",,ppublish,Epidemiol Bull. 1996 Dec;17(4):12-4.,4,,,,,,,,,,,,,,,,,,,,,,
3433159,NLM,MEDLINE,19880324,20041117,0125-1562 (Print) 0125-1562 (Linking),18,1987 Sep,Dengue fever/dengue haemorrhagic fever in Filipino children: clinical experience during the 1983-1984 epidemic.,284-90,,"A total of 377 Filipino children out of a total of 5,427 admissions from October 31, 1983 to March 31, 1984 were found to have dengue fever/dengue haemorrhagic fever The present clinical presentation of these infections was basically similar to that in previous epidemics but hepatomegaly and pleural effusion were less frequent and cardiac involvement, more frequent. The discrepancies between the clinical syndromes and HI antibody responses were evident; thus, the values used for the interpretation of the antibody titers must be reassessed.","['Songco, R S', 'Hayes, C G', 'Leus, C D', 'Manaloto, C O']","['Songco RS', 'Hayes CG', 'Leus CD', 'Manaloto CO']",,"['Hospital of the Infant Jesus, Manila, Philippines.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/therapy', '*Disease Outbreaks', 'Female', 'Hemagglutination Inhibition Tests', 'Humans', 'Infant', 'Male', 'Philippines']",,1987/09/01 00:00,1987/09/01 00:01,['1987/09/01 00:00'],"['1987/09/01 00:00 [pubmed]', '1987/09/01 00:01 [medline]', '1987/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):284-90.,3,,,,,,,,,,,,,,,,,,,,,,
16615627,NLM,MEDLINE,20060504,20060417,0025-682X (Print) 0025-682X (Linking),66,2006 Feb,[Dengue fever epidemic in Afghanistan: false alarm].,98-9,,,"['Meynard, J-B', 'Summers, R H', 'Faulde, M', 'Texier, G', 'Deparis, X', 'MacDonald, P', 'Snow, A', 'Tuka, A', 'Heyl, G', 'Duffy, K', 'Queyriaux, B', 'Decam, C', 'Green, A D']","['Meynard JB', 'Summers RH', 'Faulde M', 'Texier G', 'Deparis X', 'MacDonald P', 'Snow A', 'Tuka A', 'Heyl G', 'Duffy K', 'Queyriaux B', 'Decam C', 'Green AD']",,,['fre'],['Letter'],,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['Afghanistan/epidemiology', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Disease Vectors', 'Humans', 'Military Personnel']",,2006/04/18 09:00,2006/05/05 09:00,['2006/04/18 09:00'],"['2006/04/18 09:00 [pubmed]', '2006/05/05 09:00 [medline]', '2006/04/18 09:00 [entrez]']",,ppublish,Med Trop (Mars). 2006 Feb;66(1):98-9.,1,,,,,,,,,Epidemie de dengue en Afghanistan: une fausse alerte.,,,,,,,,,,,,,
3405527,NLM,MEDLINE,19880922,20041117,0028-8446 (Print) 0028-8446 (Linking),101,1988 Aug 10,An epidemic of type 3 dengue on Niue Island.,500-2,,"An epidemic of dengue fever type 3 occurred on the island of Niue late in 1985 and during the first quarter of 1986. Just over 18% of the population reported for medical attention, the disease predominantly affecting teenagers and young adults, with equal sex distribution. The epidemic was of the classical dengue syndrome and there were no deaths. There were some unusual features. The magnitude of antibody rise was unusually high in many of those with no preexisting antibody. Despite the large proportion of the population with preexisting dengue type 2 antibodies, no cases of dengue haemorrhagic fever/dengue shock syndrome were observed, confirming the observations made in many other epidemics that these serious complications do not always follow in sequential epidemics caused by two different types. A high level of awareness, combined public health measures and active community involvement helped to control the epidemic early.","['Tukuitonga, C F', 'Maguire, T']","['Tukuitonga CF', 'Maguire T']",,"['Fiji School of Medicine, Suva.']",['eng'],['Journal Article'],,New Zealand,N Z Med J,The New Zealand medical journal,0401067,"['0 (Antibodies, Viral)']",IM,"['Adolescent', 'Adult', 'Antibodies, Viral/analysis', 'Child', 'Dengue/classification/*epidemiology/immunology', '*Disease Outbreaks', 'Female', 'Fiji', 'Humans', 'Male', 'Middle Aged']",,1988/08/10 00:00,1988/08/10 00:01,['1988/08/10 00:00'],"['1988/08/10 00:00 [pubmed]', '1988/08/10 00:01 [medline]', '1988/08/10 00:00 [entrez]']",,ppublish,N Z Med J. 1988 Aug 10;101(851):500-2.,851,,,,,,,,,,,,,,,,,,,,,,
7008103,NLM,MEDLINE,19810413,20091111,0375-0760 (Print) 0375-0760 (Linking),32,1980 May-Aug,[Dengue. I. Historical antecedents; etiological agents; clinical picture].,123-30,,"A bibliographic review of the dengue virus involving the 1952-1978 period and including viral characteristics (serotypes, physical and biological properties, susceptibility within different biological systems, antigenic characteristics, chemical constitution and viral multiplication) and the clinical picture of the disease is made.","['Guzman Tirado, M G']",['Guzman Tirado MG'],,,['spa'],"['English Abstract', 'Historical Article', 'Journal Article']",,Cuba,Rev Cubana Med Trop,Revista cubana de medicina tropical,0074364,"['0 (Antigens, Viral)']",IM,"['Antigens, Viral/analysis', 'Dengue/etiology/*history/immunology/microbiology', 'Dengue Virus/isolation & purification', 'History, 18th Century', 'History, 19th Century', 'Humans', 'Indonesia', 'Virus Replication']",,1980/05/01 00:00,1980/05/01 00:01,['1980/05/01 00:00'],"['1980/05/01 00:00 [pubmed]', '1980/05/01 00:01 [medline]', '1980/05/01 00:00 [entrez]']",,ppublish,Rev Cubana Med Trop. 1980 May-Aug;32(2):123-30.,2,,,,,,,,,Dengue. I. Antecedentes historicos; agentes etiologicos; cuadro clinico.,,,,,,,,,,,,,
7278574,NLM,MEDLINE,19811124,20061115,0025-682X (Print) 0025-682X (Linking),41,1981 Jan-Feb,[Dengue outbreak by virus type 4 in French Polynesia. I. General epidemiology - clinical specific aspects (author's transl)].,93-6,,Authors describe an extensive outbreak of dengue 4 virus which is observed for the first time out of its Asian original focus. The whole archipelagos of French Polynesia have been contaminated in a space of four months. Usual form of the disease is typical with lightness of the symptoms. This outbreak has been implicated in the death of a child by shock; and two cases of reversible encephalitis have been certainly caused by this virus. The neurotropism is the main characteristic of dengue virus type 4.,"['Parc, F', 'Pichon, G', 'Tetaria, C', 'Louis, F', 'Laigret, J']","['Parc F', 'Pichon G', 'Tetaria C', 'Louis F', 'Laigret J']",,,['fre'],"['English Abstract', 'Journal Article']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['Adult', 'Aedes', 'Child', 'Dengue/diagnosis/*epidemiology/microbiology', 'Dengue Virus/isolation & purification', '*Disease Outbreaks', 'Female', 'Humans', 'Insect Vectors', 'Male', 'Polynesia']",,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Med Trop (Mars). 1981 Jan-Feb;41(1):93-6.,1,,,,,,,,,La dengue due au virus de type 4 en Polynesie Francaise. I.--Epidemiologie generale aspects cliniques particuliers.,,,,,,,,,,,,,
9376243,NLM,MEDLINE,19971107,20131121,0256-1859 (Print) 0256-1859 (Linking),18,1997 Jul,Re-emergence of dengue in the Americas.,1-6,,,,,,,['eng'],"['Historical Article', 'Journal Article']",,United States,Epidemiol Bull,Epidemiological bulletin,8011598,,IM,"['Adolescent', 'Adult', 'Americas/epidemiology', 'Child', 'Dengue/*epidemiology/history/prevention & control/virology', '*Disease Outbreaks/history/prevention & control', 'Female', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Male', 'Severe Dengue/*epidemiology/history/prevention & control/virology']",,1997/07/01 00:00,1997/11/05 00:01,['1997/07/01 00:00'],"['1997/07/01 00:00 [pubmed]', '1997/11/05 00:01 [medline]', '1997/07/01 00:00 [entrez]']",,ppublish,Epidemiol Bull. 1997 Jul;18(2):1-6.,2,,,,,,,,,,,,,,,,,,,,,,
1063000,NLM,MEDLINE,19760706,20041117,0145-6245 (Print) 0145-6245 (Linking),2,1976 Mar,[Controlling the dengue virus].,24-5,,,,,,,['spa'],['Journal Article'],,Puerto Rico,Bol Col Prof Enferm P R,Boletin - Colegio de Profesionales de la Enfermeria de Puerto Rico,7700173,,,"['Dengue/epidemiology/*prevention & control', 'Humans', 'Puerto Rico']",,1976/03/01 00:00,1976/03/01 00:01,['1976/03/01 00:00'],"['1976/03/01 00:00 [pubmed]', '1976/03/01 00:01 [medline]', '1976/03/01 00:00 [entrez]']",,ppublish,Bol Col Prof Enferm P R. 1976 Mar;2(5):24-5.,5,,,,,,,,,Sigue brote de dengue.,,,,,,,,,,,,,
653807,NLM,MEDLINE,19780715,20170214,0049-4755 (Print) 0049-4755 (Linking),8,1978 Apr,Clinical management of severe dengue.,54-61,,,"['Rohde, J E']",['Rohde JE'],,,['eng'],['Journal Article'],,England,Trop Doct,Tropical doctor,1301706,,IM,"['Adult', 'Child, Preschool', 'Dengue/diagnosis/etiology/*therapy', 'Humans', 'Infant']",,1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1177/004947557800800204 [doi]'],ppublish,Trop Doct. 1978 Apr;8(2):54-61. doi: 10.1177/004947557800800204.,2,,,,,,,,,,,,,,,,,,,,,,
3575766,NLM,MEDLINE,19870529,20061115,0033-2100 (Print) 0033-2100 (Linking),40,1986,[A case of dengue].,408-10,,,"['Dziubek, Z', 'Powalowska, J', 'Olszynska, M']","['Dziubek Z', 'Powalowska J', 'Olszynska M']",,,['pol'],"['Case Reports', 'English Abstract', 'Journal Article']",,Poland,Przegl Epidemiol,Przeglad epidemiologiczny,0413725,,IM,"['Adult', 'Dengue/diagnosis/*etiology', 'Female', 'Humans', 'India', 'Poland', 'Travel']",,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Przegl Epidemiol. 1986;40(4):408-10.,4,,,,,,,,,Przypadek goraczki denga.,,,,,,,,,,,,,
12606835,NLM,MEDLINE,20030418,20061115,1344-6304 (Print) 1344-6304 (Linking),55,2002 Dec,Detection of dengue virus-infected patients among passengers at the quarantine station of the New Tokyo International Airport.,215-6,,,"['Takahashi, Masaki', 'Miwa, Toshiki', 'Yamada, Ken-Ichiro', 'Sato, Yukiyoshi', 'Ikawa, Keikin', 'Matsumoto, Yasuharu', 'Sano, Tomoaki', 'Takasaki, Tomohiko', 'Nerome, Reiko', 'Ito, Mikako', 'Kurane, Ichiro']","['Takahashi M', 'Miwa T', 'Yamada K', 'Sato Y', 'Ikawa K', 'Matsumoto Y', 'Sano T', 'Takasaki T', 'Nerome R', 'Ito M', 'Kurane I']",,"['Narita Airport Quarantine Station, New Tokyo International Airport, Passenger Terminal 2, Japan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,,IM,"['Adult', 'Dengue/*diagnosis/*prevention & control/transmission', 'Dengue Virus/*isolation & purification', 'Female', 'Humans', 'Male', 'Middle Aged', '*Quarantine', 'Tokyo', '*Travel']",,2003/02/28 04:00,2003/04/19 05:00,['2003/02/28 04:00'],"['2003/02/28 04:00 [pubmed]', '2003/04/19 05:00 [medline]', '2003/02/28 04:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2002 Dec;55(6):215-6.,6,,,,,,,,,,,,,,,,,,,,,,
7990612,NLM,MEDLINE,19950112,20041117,0023-7205 (Print) 0023-7205 (Linking),91,1994 Oct 12,[Dengue fever in travellers to Asia. Development of a vaccine is important].,3691-2,,,"['Iwarson, S']",['Iwarson S'],,"['Infektionskliniken, Ostra sjukhuset, Goteborg.']",['swe'],['Journal Article'],,Sweden,Lakartidningen,Lakartidningen,0027707,['0 (Viral Vaccines)'],IM,"['Asia', 'Dengue/diagnosis/*prevention & control/transmission', 'Humans', 'Travel', 'Viral Vaccines/*supply & distribution']",,1994/10/12 00:00,1994/10/12 00:01,['1994/10/12 00:00'],"['1994/10/12 00:00 [pubmed]', '1994/10/12 00:01 [medline]', '1994/10/12 00:00 [entrez]']",,ppublish,Lakartidningen. 1994 Oct 12;91(41):3691-2.,41,,,,,,,,,Denguefeber hos asienresenarer. Utveckling av vaccin angelagen.,,,,,,,,,,,,,
20982566,NLM,MEDLINE,20101028,20201005,0370-632X (Print) 0370-632X (Linking),4,1945 Dec,[Epidemiology of dengue in Lebanon].,76-9,,,['HAYEK'],['HAYEK'],,,['fre'],['Journal Article'],,Lebanon,Rev Med Moyen Orient,Revue medicale du Moyen-Orient,20340240R,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', 'Humans']",,1945/12/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1945/12/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",,ppublish,Rev Med Moyen Orient. 1945 Dec;4:76-9.,,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,Epidemiologie de la dengue au Liban.,,['CLML: 4611:31m1'],,,,,,,,,,,
7990613,NLM,MEDLINE,19950112,20041117,0023-7205 (Print) 0023-7205 (Linking),91,1994 Oct 12,[Dengue fever. Important differential diagnosis from malaria and typhoid fever].,3692-4,,,"['Hokenberg, I', 'Vene, S']","['Hokenberg I', 'Vene S']",,"['Infektionskliniken, Akademiska sjukhuset, Uppsala.']",['swe'],"['Case Reports', 'Journal Article']",,Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Adult', 'Dengue/*diagnosis/immunology/microbiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Malaria/diagnosis', 'Male', 'Serologic Tests', 'Travel', 'Typhoid Fever/diagnosis']",,1994/10/12 00:00,1994/10/12 00:01,['1994/10/12 00:00'],"['1994/10/12 00:00 [pubmed]', '1994/10/12 00:01 [medline]', '1994/10/12 00:00 [entrez]']",,ppublish,Lakartidningen. 1994 Oct 12;91(41):3692-4.,41,,,,,,,,,Denguefeber. Viktig differentialdiagnos till malaria och tyfoidfeber.,,,,,,,,,,,,,
19028931,NLM,MEDLINE,20090729,20090522,0009-9228 (Print) 0009-9228 (Linking),48,2009 Jun,A traveler with rash and thrombocytopenia.,568-71,10.1177/0009922808325463 [doi],,"['Douvoyiannis, Miltiadis', 'Litman, Nathan', 'Goldman, David L']","['Douvoyiannis M', 'Litman N', 'Goldman DL']",,"[""Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York 10467, USA. mdouvoyi@montefiore.org""]",['eng'],"['Case Reports', 'Journal Article']",20081121,United States,Clin Pediatr (Phila),Clinical pediatrics,0372606,,IM,"['Adolescent', 'Dengue/complications/*diagnosis/therapy', 'Dominican Republic', 'Exanthema/etiology', 'Humans', 'Male', 'Thrombocytopenia/etiology', '*Travel']",,2008/11/26 09:00,2009/07/30 09:00,['2008/11/26 09:00'],"['2008/11/26 09:00 [pubmed]', '2009/07/30 09:00 [medline]', '2008/11/26 09:00 [entrez]']","['0009922808325463 [pii]', '10.1177/0009922808325463 [doi]']",ppublish,Clin Pediatr (Phila). 2009 Jun;48(5):568-71. doi: 10.1177/0009922808325463. Epub 2008 Nov 21.,5,,,,,,,,,,,,,,,,,,,,,,
18900917,NLM,MEDLINE,20081016,20201005,0035-1636 (Print) 0035-1636 (Linking),47,1947 Nov-Dec,[Dengue and pseudo-dengue in the Southern Mediterranean].,463-5,,,"['HARANT, H', 'GALAN, G']","['HARANT H', 'GALAN G']",,,['fre'],['Journal Article'],,France,Rev Pathol Comp,Revue de pathologie comparee,0166253,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', 'Humans']",,1947/11/01 00:00,2008/10/24 09:00,['1947/11/01 00:00'],"['1947/11/01 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1947/11/01 00:00 [entrez]']",,ppublish,Rev Pathol Comp. 1947 Nov-Dec;47(591-592):463-5.,591-592,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,Dengue et pseudo-dengue dans le Midi Mediterraneen.,,['CLML: 4814:451a1'],,,,,,,,,,,
10999179,NLM,MEDLINE,20001024,20041117,0004-5772 (Print) 0004-5772 (Linking),47,1999 Jun,The dengue fever epidemic in Delhi.,653-4,,,"['Goel, A']",['Goel A'],,,['eng'],"['Comment', 'Letter']",,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['Dengue/complications/*diagnosis/epidemiology', 'Disease Outbreaks', 'Disseminated Intravascular Coagulation/etiology/mortality', 'Humans', 'India/epidemiology', 'Male']",,2000/09/22 11:00,2001/02/28 10:01,['2000/09/22 11:00'],"['2000/09/22 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/22 11:00 [entrez]']",,ppublish,J Assoc Physicians India. 1999 Jun;47(6):653-4.,6,,,,,,,,['J Assoc Physicians India. 1998 Mar;46(3):273-6. PMID: 11273345'],,,,,,,,,,,,,,
8669976,NLM,MEDLINE,19960805,20150811,0772-4128 (Print) 0772-4128 (Linking),75,1995 Dec,"Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia.",291-5,,"To describe the clinical manifestations of dengue haemorrhagic fever (DHF) all children with a clinical diagnosis of DHF admitted to the paediatric ward of the Dr. Hassan Sadikin General Hospital (Bandung, Indonesia) between April 1st 1991 and September 30th 1993 were enrolled in a prospective study. Of the 306 children with a clinical diagnosis of DHF on admission in only 128 (41.8%) the diagnosis of DHF was confirmed by HI test. Of the confirmed cases, 24 (19%) developed shock and 1 (0.7%) died. Of the 174 cases with a negative HI test, 33 (19%) developed shock and 4 (2%) died. Four of the children died of shock before an hemagglutination inhibitor (HI) test was performed. The overall case mortality rate was 2.9%. The symptoms and signs of the 128 children with serologically confirmed DHF included fever or a history of fever (100%), petechiae (29.7%), epistaxis (39.1%), other forms of bleeding (5.5%), a positive Tourniquet test (78.1%), hepatomegaly (46.9%), epigastric pain (61.7%), vomiting (55.5%), thrombocytopenia < 100,000/mm3 (3.2% on admission and 15.3% during hospitalisation). Four (3%) children developed encephalopathy and 1 child an acute liver failure. In order to decrease the mortality associated with DHF early diagnosis and adequate case management are essential.","['Chairulfatah, A', 'Setiabudi, D', 'Ridad, A', 'Colebunders, R']","['Chairulfatah A', 'Setiabudi D', 'Ridad A', 'Colebunders R']",,"['Department of Child Health, University School of Medicine, Padjadjaran.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Belgium,Ann Soc Belg Med Trop,Annales de la Societe belge de medecine tropicale,7511864,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/immunology/mortality/therapy', 'False Negative Reactions', 'Hemagglutination Inhibition Tests', 'Humans', 'Indonesia', 'Infant', 'Prospective Studies']",,1995/12/01 00:00,1995/12/01 00:01,['1995/12/01 00:00'],"['1995/12/01 00:00 [pubmed]', '1995/12/01 00:01 [medline]', '1995/12/01 00:00 [entrez]']",,ppublish,Ann Soc Belg Med Trop. 1995 Dec;75(4):291-5.,4,,,,,,,,,,,,,,,,,,,,,,
2529867,NLM,MEDLINE,19891205,20080128,0030-0632 (Print) 0030-0632 (Linking),107,1989 Jul,[Active surveillance for dengue and dengue hemorrhagic fever].,22-30,,"Dengue and dengue hemorrhagic fever are emerging as major public health problems in most tropical countries. Effective prevention and control programs will depend on improved surveillance. A new approach to active surveillance is outlined with emphasis on the interepidemic period. The objective is to develop an early warning surveillance system than can predict epidemic dengue. Virologic surveillance is the most important in an early warning system. Dengue virus transmission should be monitored to provide information on which serotypes are present, their distribution, and the type of illness associated with each serotype. Other components of the active surveillance system include fever alert and clinical surveillance for severe and fatal disease associated with viral syndrome. Individually, each component is not very sensitive, but collectively, they provide an early warning capability that allows detection of newly introduced dengue virus serotypes well in advance of epidemic transmission. With such information, emergency mosquito control can be implemented and major epidemics averted.","['Gubler, D J']",['Gubler DJ'],,,['spa'],"['English Abstract', 'Journal Article']",,United States,Bol Oficina Sanit Panam,Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,0414762,,IM,"['Dengue/epidemiology/*prevention & control', 'Humans', 'Puerto Rico']",,1989/07/01 00:00,1989/07/01 00:01,['1989/07/01 00:00'],"['1989/07/01 00:00 [pubmed]', '1989/07/01 00:01 [medline]', '1989/07/01 00:00 [entrez]']",,ppublish,Bol Oficina Sanit Panam. 1989 Jul;107(1):22-30.,1,,,,,,,,,Vigilancia activa del dengue y de la fiebre hemorragica del dengue.,,,,,,,,,,,,,
15676241,NLM,MEDLINE,20100211,20191109,1769-6690 (Electronic) 0399-077X (Linking),34 Suppl 1,2004 Jun,[Pathogenesis of dengue: the emperor is still naked].,S31-3,,,"['Murgue, B', 'Cassar, O', 'Roche, C', 'Deparis, X']","['Murgue B', 'Cassar O', 'Roche C', 'Deparis X']",,"['Institut de recherche pour le developpement, Paris cedex 10, France.']",['fre'],['Journal Article'],,France,Med Mal Infect,Medecine et maladies infectieuses,0311416,,IM,"['Dengue/classification/diagnosis/epidemiology/*etiology', 'Humans']",,2005/01/29 09:00,2010/02/12 06:00,['2005/01/29 09:00'],"['2005/01/29 09:00 [pubmed]', '2010/02/12 06:00 [medline]', '2005/01/29 09:00 [entrez]']","['S0399077X04900108 [pii]', '10.1016/s0399-077x(04)90010-8 [doi]']",ppublish,Med Mal Infect. 2004 Jun;34 Suppl 1:S31-3. doi: 10.1016/s0399-077x(04)90010-8.,,,,,,,,,,Pathogenese de la dengue: l'empereur est toujours nu!,,,,,,,,,,,,,
9441467,NLM,MEDLINE,19980121,20131121,0029-2001 (Print) 0029-2001 (Linking),117,1997 Nov 30,[Dengue fever imported to Norway. Serologically confirmed cases 1991-96].,4230-3,,"With up to 100 million cases annually, dengue fever is today's most important arboviral disease. Dengue fever is endemic in many parts of South-East Asia, the Indian subcontinent, Oceania and the Americas. The disease mainly affects the local population, but occasionally also visitors from non-endemic areas. In this article we present epidemiological and clinical data on all 26 cases with serological confirmed dengue fever diagnosed in Norway in 1991-1996. 21 patients (81%) were infected in Asia. Typical exanthema, leucopenia, and thrombocytopenia were seen in 71%, 79% and 84% of the cases, respectively. A 37-year-old Indian-born woman developed dengue haemorrhagic fever grade 1 after a visit to New Delhi, while the remaining 25 patients had classical dengue fever. Postinfectious complications were common, and four weeks after the acute illness, hair loss, mental depression and asthenia were reported by 45%, 50% and 100% of the cases, respectively.","['Jensenius, M', 'Gundersen, S G', 'Vene, S', 'Bruu, A L']","['Jensenius M', 'Gundersen SG', 'Vene S', 'Bruu AL']",,"['Medisinsk avdeling, Lovisenberg Diakonale Sykehus, Oslo.']",['nor'],"['Case Reports', 'English Abstract', 'Journal Article']",,Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,,IM,"['Adult', '*Dengue/diagnosis/epidemiology/immunology', 'Disease Outbreaks', 'Female', 'Humans', 'Male', 'Middle Aged', 'Norway/epidemiology', 'Severe Dengue/diagnosis', 'Thailand/epidemiology', 'Travel', 'West Indies/epidemiology']",,1998/01/24 00:00,1998/01/24 00:01,['1998/01/24 00:00'],"['1998/01/24 00:00 [pubmed]', '1998/01/24 00:01 [medline]', '1998/01/24 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1997 Nov 30;117(29):4230-3.,29,,,,,,,,,Denguefeber importert til Norge. Serologisk verifiserte tilfeller 1991-96.,,,,,,,,,,,,,
9162587,NLM,MEDLINE,19970523,20190517,1020-4989 (Print) 1020-4989 (Linking),1,1997 Mar,"[Surveillance and active search of suspected cases of hemorrhagic dengue in Ribeirao Preto, Sao Paulo].",186-92,,"A clinical-epidemiological case study was carried out to evaluate a surveillance and active search system for suspect cases of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during a dengue epidemic in the Ribeirao Preto municipality, State of Sao Paulo, Brazil, between November 1990 and March 199. This was the first dengue epidemic ever recorded in this region. Although dengue is a growing public health problem in Brazil, and DHF/DSS has been reported to be evolving in the Americas, health officials have shown a passive attitude towards the disease, partly due to lack of experience. Reporting dengue occurrences, both of isolated cases and of epidemics, is essential to reduce mortality. The data analyzed were collected through the official epidemiological surveillance system during the 1990-1991 epidemic. Out of 2,521 confirmed cases of dengue, 34 cases of febrile acute illness with hemorrhagic manifestations were identified as possible cases of DHF/DSS, as well as two deaths associated to dengue. From these 36 cases, 12 cases were confirmed by laboratory exams as dengue with hemorrhagic manifestations. Examinations of clinical and laboratory data, and results of the autopsies suggested that the two deaths were cases of primary DHF/DSS. The difficulty of the health system in establishing the clinical suspicion of DHF/DSS was confirmed in the study. This resulted in delayed and inadequate clinical procedure. The present study also confirmed the need for a permanent active epidemiological surveillance system for the early identification of DHF/DSS suspect cases thus enabling quick and adequate control actions.","['Pontes, R J', 'Ruffino-Netto, A']","['Pontes RJ', 'Ruffino-Netto A']",,"['Universidade Federal do Ceara, Departamento de Saude Comunitaria, Centro de Ciencias de Saude, Fortaleza, Cear, Brasil.']",['por'],"['English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Brazil/epidemiology', 'Child', 'Child, Preschool', 'Dengue/classification/*epidemiology/prevention & control', '*Disease Outbreaks', 'Epidemiologic Methods', 'Female', 'Humans', 'Male', 'Middle Aged', 'Sex Factors']",,1997/03/01 00:00,1997/03/01 00:01,['1997/03/01 00:00'],"['1997/03/01 00:00 [pubmed]', '1997/03/01 00:01 [medline]', '1997/03/01 00:00 [entrez]']",['S1020-49891997000300004 [pii]'],ppublish,Rev Panam Salud Publica. 1997 Mar;1(3):186-92.,3,,,,,,,,,"Vigilancia e busca ativa de casos suspeitos de dengue hemorragico em Ribeirao Preto, Sao Paulo.",,,,,,,,,,,,,
18294440,NLM,MEDLINE,20080602,20150826,0443-5117 (Print) 0443-5117 (Linking),45,2007 Sep-Oct,[Clinical and epidemiological characteristic of dengue].,485-91,,"OBJECTIVE: To describe the clinical and epidemiological characteristics of dengue fever (DF) and dengue hemorrhagic fever (DHF). MATERIAL AND METHODS: A cross-sectional study was conducted in the Hospital General de Culiacan Dr. Bernardo J. Gastelum and the Hospital General de Zona 28 of IMSS from September to November 2003, with patients having dengue diagnosis, which was classified according to the WHO criteria. The statistical program Stata v6 was used for the analysis. RESULTS: 231 dengue cases (DF: 90.48 %; DHF 9.52 %) were included. Average age was 34.5 +/- 15 years. 61.7% of DF cases were women, while 77.3% of DHF cases were men. DHF cases went to the hospital in 4.7 +/- 2 days, while DF cases went in 3.4 +/- 2.2 days (p = 0.004). DHF cases had more often headache, retroocular pain, arthralgias, diarrhea and vomiting (p < 0.05). DF cases showed hemorrhagic manifestations (24.8%); plasma leakage (6.7%) and thrombocytopenia (34.4%); petequiae, gingival bleeding and epistaxis were associated to thrombocytopenia below 39 000/mm(3) (p < 0.05); neutropenia, prolonged partial thromboplastin time elevated transaminases were observed more often in DHF cases (p <0.05). CONCLUSIONS: the main variables associated with DHF were: male gender, fever, vomiting and gingival bleeding but not previous history of dengue; the major hemoconcentration, the major severity of thrombocytopenia.","['Murillo-Llanes, Joel', 'Soto-Valenzuela, Humberto', 'Flores-Flores, Paula', 'Peraza-Garay, Felipe']","['Murillo-Llanes J', 'Soto-Valenzuela H', 'Flores-Flores P', 'Peraza-Garay F']",,"['Departamento de Investigacion, Hospital General de Culiacan Dr. Bernardo J. Gastelum, Secretaria de Salud, Instituto Mexicano del Seguro Social (IMSS), Navolato, Sinaloa, Mexico. invhgc@yahoo.com']",['spa'],"['English Abstract', 'Journal Article']",,Mexico,Rev Med Inst Mex Seguro Soc,Revista medica del Instituto Mexicano del Seguro Social,101243727,,IM,"['Adolescent', 'Adult', 'Cross-Sectional Studies', 'Dengue/*diagnosis/*epidemiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Severe Dengue/diagnosis/epidemiology']",,2008/02/26 09:00,2008/06/03 09:00,['2008/02/26 09:00'],"['2008/02/26 09:00 [pubmed]', '2008/06/03 09:00 [medline]', '2008/02/26 09:00 [entrez]']",,ppublish,Rev Med Inst Mex Seguro Soc. 2007 Sep-Oct;45(5):485-91.,5,,,,,,,,,Caracterizacion clinica y epidemiologica del dengue.,,,,,,,,,,,,,
23437536,NLM,MEDLINE,20130401,20130226,0375-0760 (Print) 0375-0760 (Linking),63,2011 Jan-Apr,"[Clinical and pathological correlation in fatal dengue cases found in Maracaibo, Venezuela].",44-51,,"INTRODUCTION: Given the importance of dengue in America, it is indispensable to know the cause of death of the infected people and to evaluate the few necropsy studies available. OBJECTIVE: To describe and to analyze the relevant clinical and pathological findings in fatal dengue cases of dengue in a Venezuelan endemic area. METHODS: Eight fatal cases, according to clinical and epidemiological dengue criteria and/or confirmed by complete serological tests were studied after complete clinical necropsy. The tissues were processed by standard histopathological techniques. RESULTS: All these cases showed severe lung disease (diffuse alveolar damage, non cardiogenic pulmonary edema, thromboembolism, bronchopneumonia, pneumonitis, intralveolar hemorrhage). Six presented with pleural or abdominal effusion. Focal hepatic necrosis was found in two cases. The cause of death was related to respiratory failure in six (6) cases secondary to lung disease; two with hypovolemic shock, and one developed liver failure. CONCLUSION: the studied dengue cases showed fatal severe pulmonary compromise leading to death, unlike those reported in other studies of autopsies in The Americas. They also developed multiple organ failure, which in most cases led to death not directly associated to hypovolemic shock. These findings in autopsies will allow designing therapeutic strategies to avoid mortality.","['Arismendi-Morillo, Gabriel', 'Mauriello-Rivas, Carla', 'Maldonado-Reverol, Maria', 'Fernandez-Abreu, Mary', 'Larreal, Marcos', 'Torres-Nava, V Gustavo', 'Romero-Amaro, Zoila']","['Arismendi-Morillo G', 'Mauriello-Rivas C', 'Maldonado-Reverol M', 'Fernandez-Abreu M', 'Larreal M', 'Torres-Nava VG', 'Romero-Amaro Z']",,"['Instituto de Investigaciones Biologicas-Laboratorio de Microscopia Electronica, Facultad de Medicina-Universidad del Zulia, Servicio de Anatomia Patologica, Hospital General del Sur ""Dr. Pedro Iturbe"", Maracaibo, Venezuela. gabrielarismendi@gmail.com']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Cuba,Rev Cubana Med Trop,Revista cubana de medicina tropical,0074364,,IM,"['Aged', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/*mortality/pathology', 'Female', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Venezuela/epidemiology']",,2011/01/01 00:00,2013/04/02 06:00,['2013/02/27 06:00'],"['2013/02/27 06:00 [entrez]', '2011/01/01 00:00 [pubmed]', '2013/04/02 06:00 [medline]']",,ppublish,Rev Cubana Med Trop. 2011 Jan-Apr;63(1):44-51.,1,,,,,,,,,"Correlacion clinico-patologica en casos fatales de dengue en Maracaibo, Venezuela.",,,,,,,,,,,,,
1983048,NLM,MEDLINE,19910729,20181130,0125-1562 (Print) 0125-1562 (Linking),21,1990 Dec,International symposium on dengue and dengue hemorrhagic fever. Introduction.,634-5,,,"['Bhamarapravati, N']",['Bhamarapravati N'],,"['Mahidol University, Bangkok Noi Bangkok, Thailand.']",['eng'],['Congress'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/classification/*epidemiology/physiopathology', 'Humans']",,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):634-5.,4,,,,,,,,,,,,,,,,,,,,,,
16276688,NLM,MEDLINE,20051221,20191210,0120-4157 (Print) 0120-4157 (Linking),25,2005 Sep,[Evaluation of the World Health Organization clinical definition of dengue].,412-6,,"INTRODUCTION: The distinction between dengue and other acute febrile diseases is difficult when based solely on symptoms. OBJECTIVE: An attempt was made to evaluate usefulness of dengue diagnoses in an endemic area (Bucaramanga, Colombia), based on the definitions recommended by the World Health Organization. MATERIALS AND METHODS: In a cohort >12 years of age with indications of acute febrile illness, the sensitivity, the specificity and the predictive values were determined based on the WHO dengue definition. Two or more of the following symptoms were included: headache, retroorbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, or leucopenia. RESULTS: One hundred-one cases of dengue and 89 patients with acute febrile illness were enrolled in the study. The dengue cases were confirmed by serological or by virus presence. The WHO case definitions showed sensitivity, 99%; specificity, 1%; positive predictive value, 53%, and negative predictive value, 50%. CONCLUSION: This clinical definition demonstrated high sensitivity, but a low specificity. Therefore, the clinical definition was useful for screening, but it did not differentiate between dengue and other febrile diseases.","['Martinez, Ruth Arali', 'Diaz, Fredi Alexander', 'Villar, Luis Angel']","['Martinez RA', 'Diaz FA', 'Villar LA']",,"['Centro de Investigaciones Epidemiologicas, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia. rutharam@yahoo.com']",['spa'],"['Evaluation Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Colombia,Biomedica,Biomedica : revista del Instituto Nacional de Salud,8205605,,IM,"['Adolescent', 'Dengue/*classification/*diagnosis/physiopathology', 'Humans', 'Predictive Value of Tests', 'Sensitivity and Specificity', '*World Health Organization']",,2005/11/10 09:00,2005/12/22 09:00,['2005/11/10 09:00'],"['2005/11/10 09:00 [pubmed]', '2005/12/22 09:00 [medline]', '2005/11/10 09:00 [entrez]']",,ppublish,Biomedica. 2005 Sep;25(3):412-6.,3,,,,,,,,,Evaluacion de la definicion clinica de dengue sugerida por la Organizacion Mundial de la Salud.,,,,,,,,,,,,,
2098928,NLM,MEDLINE,19910729,20141120,0125-1562 (Print) 0125-1562 (Linking),21,1990 Dec,Global epidemiology of dengue hemorrhagic fever.,636-41,,,"['Halstead, S B']",['Halstead SB'],,"['Health Sciences Division, Rockefeller Foundation, New York, NY 10036.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*epidemiology/etiology/immunology', '*Global Health', 'Humans', 'Incidence', 'World Health Organization']",,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):636-41.,4,,,,,,,,,,,,,,,,,,,,,,
5506194,NLM,MEDLINE,19701120,20130418,0971-5916 (Print) 0971-5916 (Linking),58,1970 Feb,Isolation of dengue type I virus.,168-73,,,"['Hermon, Y E', 'Anandarajah, M', 'Pavri, K M']","['Hermon YE', 'Anandarajah M', 'Pavri KM']",,,['eng'],['Journal Article'],,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Child, Preschool', 'Dengue/blood/diagnosis/microbiology', 'Dengue Virus/*isolation & purification', 'Humans', 'Male']",,1970/02/01 00:00,1970/02/01 00:01,['1970/02/01 00:00'],"['1970/02/01 00:00 [pubmed]', '1970/02/01 00:01 [medline]', '1970/02/01 00:00 [entrez]']",,ppublish,Indian J Med Res. 1970 Feb;58(2):168-73.,2,,,,,,,,,,,,,,,,,,,,,,
19718899,NLM,MEDLINE,20090929,20090901,0001-4079 (Print) 0001-4079 (Linking),193,2009 Feb,[Lessons from the Greek dengue epidemic of 1927-1928].,485-93,,"Epidemics of dengue have occurred in Greece in 1881, 1889, 1895-1897 and 1910, but the outbreak which has affected this country in 1927-1928 has been of a peculiar severity and geographic extension. More than one million inhabitants were sick and about 1500 died. The outbreak extended to the whole Greek territory and evolved in two epidemics waves. The first one occurred during the second half of 1927, was not very extensive and relatively benign. The second wave, explosive, started on July 1928, reached its summit in August and then declined until November. During this second part of the outbreak severe clinical events were identified, such as hemorrhagic, neurological or renal disorders, along with infections during pregnancy. The mosquito Aedes aegypti was the alone vector of the disease and dengue type 1 virus was the main etiological agent both in 1927 and 1928. The eventual activity of the dengue type 2 virus and its possible role in the pathogenesis of severe clinical forms of dengue, during 1928, remains unclear. Relatively speaking, it is possible to parallel this ""historical"" outbreak with the recent epidemic episode which appeared in 2007 in the Ravenne's area in northern Italy. This outbreak was caused by the Chikungunya virus after its importation from southern India by an infected traveller. There were 249 autochthonous registered cases but no severity nor death was observed. The local vector was Aedes albopictus, an invasive mosquito of Asian origin which has progressively invaded a number of European countries including France. Thus, Europe is now at risk to the emergence of outbreaks caused by ""exotic"" viruses imported by travellers returning from other parts of the world.","['Chastel, Claude']",['Chastel C'],,['chastelc@aol.com'],['fre'],"['English Abstract', 'Historical Article', 'Journal Article']",,Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,IM,"['Animals', 'Dengue/*epidemiology', 'Disease Outbreaks/*history', 'Greece', 'History, 20th Century', 'Humans', 'Travel']",,2009/09/02 06:00,2009/09/30 06:00,['2009/09/02 09:00'],"['2009/09/02 09:00 [entrez]', '2009/09/02 06:00 [pubmed]', '2009/09/30 06:00 [medline]']",,ppublish,Bull Acad Natl Med. 2009 Feb;193(2):485-93.,2,,,,,,,,,"En 1927-1928, la dengue s'abattait sur la Grece: les enseignements d'une epidemie.",,,,,,,,,,,,,
6955640,NLM,MEDLINE,19821029,20041117,0028-7628 (Print) 0028-7628 (Linking),82,1982 Jun,Imported dengue fever in New York State.,1057-9,,,"['Srihongse, S', 'Deibel, R', 'Sather, G E', 'Woodall, J P']","['Srihongse S', 'Deibel R', 'Sather GE', 'Woodall JP']",,,['eng'],['Journal Article'],,United States,N Y State J Med,New York state journal of medicine,0401064,,IM,"['Dengue/diagnosis/*transmission', 'Humans', 'Jamaica', 'New York']",,1982/06/01 00:00,1982/06/01 00:01,['1982/06/01 00:00'],"['1982/06/01 00:00 [pubmed]', '1982/06/01 00:01 [medline]', '1982/06/01 00:00 [entrez]']",,ppublish,N Y State J Med. 1982 Jun;82(7):1057-9.,7,,,,,,,,,,,,,,,,,,,,,,
31389545,NLM,MEDLINE,20200122,20200122,1678-4561 (Electronic) 1413-8123 (Linking),24,2019 Aug 5,"The social face of Aedes control: women take the floor in a suburban district of Fortaleza, Brazil.",2983-2992,S1413-81232019000802983 [pii] 10.1590/1413-81232018248.21522017 [doi],"Aedes aegypti is currently a critical disease agent and is responsible for viruses such as Zika, Chikungunya and Dengue's four serotypes. This mosquito's relevance to the current social body has come to the fore and triggered urgent EcoHealth investigations since this approach aims to articulate different theoretical fields to understand the historical linkages between nature, society and health. Based on an ethnographic premise, this study considered the unequal and unfair conditions that make women's health vulnerable to dengue, analyzing their practices and perceptions about the potential breeding grounds in the public space. A semi-structured interview and participant observation, as well as a field diary, were used to compose the study. The research included the participation of ten women living in the outskirts of Fortaleza, Ceara, Brazil, from January to August 2014. The category ""Social inequality, context and practices in the public space"" emerged from the content analysis. The narratives revealed that unstable living conditions and evident social inequality might influence in a context permeated by waste, with great potential for dengue's mosquito proliferation.","['Oliveira, Krysne Kelly de Franca', 'Caprara, Andrea']","['Oliveira KKF', 'Caprara A']","['ORCID: 0000-0002-2154-5064', 'ORCID: 0000-0003-1972-8205']","['Universidade Estadual do Ceara. Av. Dr. Silas Munguba 1700, Itaperi. 60741-000 Fortaleza CE Brasil. krysnek13@hotmail.com.', 'Universidade Estadual do Ceara. Av. Dr. Silas Munguba 1700, Itaperi. 60741-000 Fortaleza CE Brasil. krysnek13@hotmail.com.']","['por', 'eng']",['Journal Article'],20190805,Brazil,Cien Saude Colet,Ciencia & saude coletiva,9713483,,IM,"['Adult', 'Aedes/virology', 'Aged', 'Animals', 'Brazil', 'Chikungunya Fever/*prevention & control/transmission', 'Dengue/*prevention & control/transmission', 'Female', 'Humans', 'Interviews as Topic', 'Middle Aged', 'Mosquito Control/*methods', 'Mosquito Vectors/virology', 'Socioeconomic Factors', 'Young Adult', 'Zika Virus Infection/*prevention & control/transmission']",,2019/08/08 06:00,2020/01/23 06:00,['2019/08/08 06:00'],"['2016/11/03 00:00 [received]', '2017/11/14 00:00 [accepted]', '2019/08/08 06:00 [entrez]', '2019/08/08 06:00 [pubmed]', '2020/01/23 06:00 [medline]']","['S1413-81232019000802983 [pii]', '10.1590/1413-81232018248.21522017 [doi]']",epublish,Cien Saude Colet. 2019 Aug 5;24(8):2983-2992. doi: 10.1590/1413-81232018248.21522017.,8,,,,,,,,,"Face social do controle do Aedes: em um bairro periferico de Fortaleza, Brasil, as mulheres tomam a palavra.",,,,,,,,,,,,,
4059898,NLM,MEDLINE,19851209,20061115,0036-7672 (Print) 0036-7672 (Linking),115,1985 Sep 14,[Dengue fever as an imported disease in Switzerland].,1273-7,,"A report is presented on 2 tourists returning from the Indian Ocean area in whom clinically overt dengue fever was diagnosed. The epidemiology, pathogenesis and clinical course of the disease are discussed.","['Vogtlin, J', 'Gyr, K']","['Vogtlin J', 'Gyr K']",,,['ger'],"['English Abstract', 'Journal Article']",,Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,,IM,"['Aedes', 'Animals', 'Dengue/classification/*diagnosis/transmission', 'Sri Lanka', 'Switzerland', 'Travel']",,1985/09/14 00:00,1985/09/14 00:01,['1985/09/14 00:00'],"['1985/09/14 00:00 [pubmed]', '1985/09/14 00:01 [medline]', '1985/09/14 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1985 Sep 14;115(37):1273-7.,37,,,,,,,,,Dengue-Fieber als Importkrankheit in der Schweiz.,,,,,,,,,,,,,
2635392,NLM,MEDLINE,19900614,20061115,0037-5675 (Print) 0037-5675 (Linking),30,1989 Dec,A practical community-based approach to the diagnosis of dengue virus infections.,525-7,,"A study is described in which private physicians participated in the surveillance and diagnosis for dengue disease within a community. Using simple, economical methods it was shown that a significant proportion of specimens submitted were positive for dengue infection. Of 610 fingerprick blood specimens collected on filter paper strips, 7% to 33% were positive by serology. Of these specimens, 423 (69%) were single specimens and 92 (22%) of the single specimens were positive by serology. Of 153 fingerprick blood specimens collected in heparinized, glass capillary tubes, 15% to 50% yielded a dengue virus isolate. When a positive result was based on serology and/or virus isolation, an overall positive rate of 39% was obtained for one of the participating clinics. Inclusion of thrombocytopenia and leukopenia in selection of cases significantly improved the positive rate. It is argued that this simple and practical community-based approach will result in more accurate surveillance of dengue transmission within an endemic area and thus aid in the development of long-term strategies for control of disease.","['Pang, T', 'Lam, S K', 'Kok, M L', 'Kok, K Y', 'Tho, Y C']","['Pang T', 'Lam SK', 'Kok ML', 'Kok KY', 'Tho YC']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,India,Singapore Med J,Singapore medical journal,0404516,,IM,"['Dengue/*diagnosis/epidemiology/prevention & control', 'Humans', 'Population Surveillance', 'Serologic Tests', 'Singapore', 'Specimen Handling']",,1989/12/01 00:00,1989/12/01 00:01,['1989/12/01 00:00'],"['1989/12/01 00:00 [pubmed]', '1989/12/01 00:01 [medline]', '1989/12/01 00:00 [entrez]']",,ppublish,Singapore Med J. 1989 Dec;30(6):525-7.,6,,,,,,,,,,,,,,,,,,,,,,
18219146,NLM,MEDLINE,20080313,20080125,1344-6304 (Print) 1344-6304 (Linking),61,2008 Jan,"An imported dengue fever case by dengue virus 3 (DENV-3) infection in Gunma, Japan.",90-2,,,"['Morita, Yukio', 'Kogure, Hayato', 'Sandoh, Mitsuru', 'Kawashima, Gihei', 'Sato, Yoshitake', 'Nanba, Sadao', 'Shoda, Yoshihiro', 'Suzuki, Tomoyuki', 'Shiono, Masataka', 'Shiobara, Masae', 'Kato, Masahiko', 'Kozawa, Kunihisa', 'Noda, Masahiro', 'Okabe, Nobuhiko', 'Kimura, Hirokazu']","['Morita Y', 'Kogure H', 'Sandoh M', 'Kawashima G', 'Sato Y', 'Nanba S', 'Shoda Y', 'Suzuki T', 'Shiono M', 'Shiobara M', 'Kato M', 'Kozawa K', 'Noda M', 'Okabe N', 'Kimura H']",,"['Gunma Prefectural Institute of Public Health and Environmental Sciences, Gunma, Japan. morita-yu@pref.gunma.jp']",['eng'],"['Case Reports', 'Journal Article']",,Japan,Jpn J Infect Dis,Japanese journal of infectious diseases,100893704,,IM,"['Adult', 'Dengue/diagnosis/therapy/*virology', 'Dengue Virus/classification/*isolation & purification', 'Female', 'Humans', 'Japan', 'Phylogeny']",,2008/01/26 09:00,2008/03/14 09:00,['2008/01/26 09:00'],"['2008/01/26 09:00 [pubmed]', '2008/03/14 09:00 [medline]', '2008/01/26 09:00 [entrez]']",,ppublish,Jpn J Infect Dis. 2008 Jan;61(1):90-2.,1,,,,,,,,,,,,,,,,,,,,,,
7819799,NLM,MEDLINE,19950214,20061115,0037-9085 (Print) 0037-9085 (Linking),86,1993,[Hemorrhagic dengue with shock in children in French Polynesia].,450-4,,"The dengue fever is an intertropical arbovirus, well known in French Polynesia where the first cases of dengue haemorrhagic fever appeared at the end of 1989. The authors report their experience in the paediatrics ward of the Centre Hospitalier Territorial (CHT) of Papeete, where, from 1990 to 1992, 310 cases of dengue fever have been registered with 79 cases of dengue shock syndrome (25.5%) and 12 deaths (4%). Then, following an epidemiologic summary and a description of how the clinical picture evolves in children, they insist on the fact that the pathophysiology of dengue fever is unknown, and there is no predictive factor; even if, in this study, the young age seems to be factor of severity. Therefore, an epidemiologic survey, and a very close monitoring of each case are necessary, in order to start an aggressive symptomatic treatment as soon as possible. The antivector's fight is still the only prevention against this arbovirosis.","['Mallet, E C', 'Gestas, P', 'Pilorget, H', 'Bataille, H']","['Mallet EC', 'Gestas P', 'Pilorget H', 'Bataille H']",,"['Service de pediatrie, CHG Saint-Pierre, Le Tampon.']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Child', 'Child, Preschool', 'Dengue/*complications/physiopathology/therapy', 'Female', 'Humans', 'Infant', 'Male', 'Polynesia', 'Shock/*etiology/therapy']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1993;86(5 Pt 2):450-4.,5 Pt 2,,,,,,,,,La dengue hemorragique avec choc chez l'enfant en Polynesie francaise.,,,,,,,,,,,,,
27839573,NLM,MEDLINE,20171113,20180317,1877-5853 (Electronic) 1877-5845 (Linking),19,2016 Nov,Accelerating the discovery of space-time patterns of infectious diseases using parallel computing.,10-20,S1877-5845(15)30040-X [pii] 10.1016/j.sste.2016.05.002 [doi],"Infectious diseases have complex transmission cycles, and effective public health responses require the ability to monitor outbreaks in a timely manner. Space-time statistics facilitate the discovery of disease dynamics including rate of spread and seasonal cyclic patterns, but are computationally demanding, especially for datasets of increasing size, diversity and availability. High-performance computing reduces the effort required to identify these patterns, however heterogeneity in the data must be accounted for. We develop an adaptive space-time domain decomposition approach for parallel computation of the space-time kernel density. We apply our methodology to individual reported dengue cases from 2010 to 2011 in the city of Cali, Colombia. The parallel implementation reaches significant speedup compared to sequential counterparts. Density values are visualized in an interactive 3D environment, which facilitates the identification and communication of uneven space-time distribution of disease events. Our framework has the potential to enhance the timely monitoring of infectious diseases.","['Hohl, Alexander', 'Delmelle, Eric', 'Tang, Wenwu', 'Casas, Irene']","['Hohl A', 'Delmelle E', 'Tang W', 'Casas I']",,"['Department of Geography and Earth Sciences and Center for Applied GIScience, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.', 'Department of Geography and Earth Sciences and Center for Applied GIScience, University of North Carolina at Charlotte, Charlotte, NC 28223, USA . Electronic address: eric.delmelle@uncc.edu.', 'Department of Geography and Earth Sciences and Center for Applied GIScience, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.', 'School of History and Social Sciences, Louisiana Tech University, Ruston, Louisiana, 71272, USA.']",['eng'],['Journal Article'],20160527,Netherlands,Spat Spatiotemporal Epidemiol,Spatial and spatio-temporal epidemiology,101516571,,IM,"['Colombia/epidemiology', 'Dengue/*epidemiology/prevention & control/transmission', '*Disease Outbreaks', 'Humans', 'Mathematical Computing', 'Spatio-Temporal Analysis']",,2016/11/15 06:00,2017/11/14 06:00,['2016/11/15 06:00'],"['2015/11/16 00:00 [received]', '2016/05/03 00:00 [revised]', '2016/05/17 00:00 [accepted]', '2016/11/15 06:00 [entrez]', '2016/11/15 06:00 [pubmed]', '2017/11/14 06:00 [medline]']","['S1877-5845(15)30040-X [pii]', '10.1016/j.sste.2016.05.002 [doi]']",ppublish,Spat Spatiotemporal Epidemiol. 2016 Nov;19:10-20. doi: 10.1016/j.sste.2016.05.002. Epub 2016 May 27.,,['Copyright (c) 2016 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Dengue fever', 'Parallel computing', 'Space-time analysis']",,,,,,,,,,,,,,,,,,,
7235443,NLM,MEDLINE,19810723,20061115,0003-410X (Print) 0003-410X (Linking),132,1981,"[Asiatic dengue in France: 9 cases, of which one of the thrombopenic type (author's transl)].",106-8,,"Asiatic dengue was detected in nine tourists. In eight patients it was of the classical benign type, the ninth case being associated with severe thrombopenia (4 000/mm3), but without signs of shock. A brief summary is given of the physiopathology of the hemorrhagic forms of the disease: acquired sensitivity from a primary attack and reinfection with a heterologous virus; selection of virulent strains by an atypical vector; genetic recombination producing a strongly pathogenic virus.","['Bastin, R', 'Rodhain, F', 'Frottier, J', 'Vilde, J L', 'Dournon, E', 'Bricaire, F', 'Charmot, G']","['Bastin R', 'Rodhain F', 'Frottier J', 'Vilde JL', 'Dournon E', 'Bricaire F', 'Charmot G']",,,['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Ann Med Interne (Paris),Annales de medecine interne,0171744,,IM,"['Adult', 'Asia', 'Dengue/*diagnosis/physiopathology/therapy', 'Diagnosis, Differential', 'Female', 'France', 'Humans', 'Male', 'Thrombocytopenia/*etiology', 'Travel']",,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1981;132(2):106-8.,2,,,,,,,,,Dengues d'origine asiatique observees en France. 9 cas dont 1 a forme thrombopenique.,,,,,,,,,,,,,
8924773,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[The prevention of dengue in Guadeloupe].,143-4,,"Dengue is the only disease transmitted by mosquitoes in the Guadeloupe islands of French Antilles. Two dengue outbreaks were reported in 1992 and 1994. Aedes aegypti is recognized the only vector of dengue in Guadeloupe, and the 200 l drums are the most important breeding-sites. Vector control in Guadeloupe includes community health education, larvicide and adulticide spraying, and the destruction of the breeding-sites. However, Ae. aegypti control has limitations such as the lack of participation from the local population, and the resistance of Ae. aegypti to the insecticides. Prevention of dengue in Guadeloupe will rely on a reinforcement of the community education, the development of new tools to control Ae. aegypti, mechanical tools and biological control, and the improvement of the epidemiological surveillance.","['Gustave, J']",['Gustave J'],,"['Service de Lutte antivectorielle, DDASS-Guadeloupe Zone industrielle de Jarry. Baie.Mahault']",['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Aedes', 'Animals', 'Dengue/epidemiology/*prevention & control/transmission', 'Guadeloupe/epidemiology', 'Humans', 'Insect Vectors', 'Mosquito Control']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):143-4.,2,,,,,,,,,La prevention de la dengue en Guadeloupe.,,,,,,,,,,,,,
18181500,NLM,MEDLINE,20080221,20090713,1015-7867 (Print) 1015-7867 (Linking),12,2005 Sep,An outbreak of dengue fever in Yap State.,99-102,,"Between May and December 2004,Yap State experienced an outbreak of Dengue Fever, type 1 with a final total of 658 recorded clinically compatible cases, including 42 hospitalisations and 12 cases of dengue haemorrhagic fever/shock syndrome. There were no fatalities. Lessons learned from this outbreak include: the importance maintaining a high index of suspicion and on-site diagnostic capability for dengue fever, the importance of prompt in-service training for health care workers, the danger posed to neighbors by local lapses in outbreak prone disease surveillance and the utility of the Pacific Public Health Surveillance Network in responding to such diseases, the importance of active disease surveillance in outer island populations, and the importance of instituting preventive measures against the nosocomial spread of dengue fever.","['Durand, Mark A', 'Bel, Martin', 'Ruwey, Ignathia', 'Marfel, Maria', 'Yug, Laurence', 'Ngaden, Victor']","['Durand MA', 'Bel M', 'Ruwey I', 'Marfel M', 'Yug L', 'Ngaden V']",,"['Department of Health Services, Yap State. durand@mail.fm']",['eng'],['Journal Article'],,New Zealand,Pac Health Dialog,Pacific health dialog,9434923,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/etiology/physiopathology', '*Disease Outbreaks', 'Female', 'Humans', 'Male', 'Micronesia/epidemiology', 'Middle Aged']",,2008/01/10 09:00,2008/02/22 09:00,['2008/01/10 09:00'],"['2008/01/10 09:00 [pubmed]', '2008/02/22 09:00 [medline]', '2008/01/10 09:00 [entrez]']",,ppublish,Pac Health Dialog. 2005 Sep;12(2):99-102.,2,,,,,,,,,,,,,,,,,,,,,,
8277784,NLM,MEDLINE,19940209,20071115,0126-8635 (Print) 0126-8635 (Linking),15,1993 Jun,"Outpatient management of dengue infection in the University Hospital, Kuala Lumpur.",21-3,,,"['Chin, C K']",['Chin CK'],,"['Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],['Journal Article'],,Malaysia,Malays J Pathol,The Malaysian journal of pathology,8101177,,IM,"['*Ambulatory Care', 'Dengue/complications/diagnosis/*therapy', 'Guidelines as Topic', 'Humans', ""Physician's Role"", 'Thailand']",,1993/06/01 00:00,1993/06/01 00:01,['1993/06/01 00:00'],"['1993/06/01 00:00 [pubmed]', '1993/06/01 00:01 [medline]', '1993/06/01 00:00 [entrez]']",,ppublish,Malays J Pathol. 1993 Jun;15(1):21-3.,1,,,,,,,,,,,,,,,,,,,,,,
6372125,NLM,MEDLINE,19840607,20041117,0036-3634 (Print) 0036-3634 (Linking),26,1984 Jan-Feb,[Ecology of dengue and Aedes aegypti. Preliminary study].,63-76,,,"['Carrada Bravo, T', 'Vazquez Vazquez, L', 'Lopez Garcia, I']","['Carrada Bravo T', 'Vazquez Vazquez L', 'Lopez Garcia I']",,,['spa'],"['Historical Article', 'Journal Article']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['*Aedes', 'Dengue/diagnosis/epidemiology/history/therapy/*transmission', 'Dengue Virus', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Insect Vectors']",,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1984 Jan-Feb;26(1):63-76.,1,,,,,,,,,Ecologia del dengue y el Aedes aegypti. Investigacion preliminar.,,,,,,,,,,,,,
8277785,NLM,MEDLINE,19940209,20041117,0126-8635 (Print) 0126-8635 (Linking),15,1993 Jun,Problems in diagnosis and classification of dengue virus infection.,25-7,,,"['George, R']",['George R'],,"['Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],['Journal Article'],,Malaysia,Malays J Pathol,The Malaysian journal of pathology,8101177,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', 'Child, Preschool', 'Dengue/*classification/*diagnosis/epidemiology', 'Disease Outbreaks', 'Humans', 'Infant', 'Middle Aged', 'World Health Organization']",,1993/06/01 00:00,1993/06/01 00:01,['1993/06/01 00:00'],"['1993/06/01 00:00 [pubmed]', '1993/06/01 00:01 [medline]', '1993/06/01 00:00 [entrez]']",,ppublish,Malays J Pathol. 1993 Jun;15(1):25-7.,1,,,,,,,,,,,,,,,,,,,,,,
5132230,NLM,MEDLINE,19720308,20130418,0971-5916 (Print) 0971-5916 (Linking),59,1971 Aug,"A note on sequential dengue infection, presumptive and proved, with report of an instance of a third proved attack in one individual.",1231-6,,,"['Myers, R M', 'Varkey, M J']","['Myers RM', 'Varkey MJ']",,,['eng'],['Journal Article'],,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Dengue/complications/diagnosis/*epidemiology', 'Dengue Virus', 'Hemorrhage/epidemiology', 'Humans', 'India']",,1971/08/01 00:00,1971/08/01 00:01,['1971/08/01 00:00'],"['1971/08/01 00:00 [pubmed]', '1971/08/01 00:01 [medline]', '1971/08/01 00:00 [entrez]']",,ppublish,Indian J Med Res. 1971 Aug;59(8):1231-6.,8,,,,,,,,,,,,,,,,,,,,,,
27522803,NLM,MEDLINE,20161213,20190724,0021-5384 (Print) 0021-5384 (Linking),103,2014 Nov 10,[Progress in Diagnostic Technology and Management of Infectious Diseases. Special Columns; Domestic dengue virus infection].,2653-6,,,"['Sakamoto, Naoya']",['Sakamoto N'],,,['jpn'],['Journal Article'],,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,,IM,"['Animals', 'Dengue/*diagnosis/prevention & control/therapy/transmission', '*Dengue Virus', 'Humans', 'Severity of Illness Index']",,2014/11/10 00:00,2016/12/15 06:00,['2016/08/16 06:00'],"['2016/08/16 06:00 [entrez]', '2014/11/10 00:00 [pubmed]', '2016/12/15 06:00 [medline]']",['10.2169/naika.103.2653 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2014 Nov 10;103(11):2653-6. doi: 10.2169/naika.103.2653.,11,,,,,,,,,,,,,,,,,,,,,,
7726789,NLM,MEDLINE,19950519,20041117,0095-6562 (Print) 0095-6562 (Linking),66,1995 Feb,You're the flight surgeon. Dengue fever.,185-6,,,"['Schmitz, R A']",['Schmitz RA'],,,['eng'],"['Case Reports', 'Journal Article']",,United States,Aviat Space Environ Med,"Aviation, space, and environmental medicine",7501714,,IM,"['Adult', 'Dengue/classification/*diagnosis/therapy', 'Diagnosis, Differential', 'Humans', 'Japan', 'Male', '*Military Personnel', 'United States']",,1995/02/01 00:00,1995/02/01 00:01,['1995/02/01 00:00'],"['1995/02/01 00:00 [pubmed]', '1995/02/01 00:01 [medline]', '1995/02/01 00:00 [entrez]']",,ppublish,Aviat Space Environ Med. 1995 Feb;66(2):185-6.,2,,,,,,,,,,,,,,,,,,,,,,
21028602,NLM,MEDLINE,20101028,20201005,,12,1946 Jan-Mar,[The pandemic endemicity of dengue in warm countries].,"11-8, English translation 19-24",,,"['HOFFMANN, W H']",['HOFFMANN WH'],,,['spa'],['Journal Article'],,Cuba,Rev Med Trop Parasitol Bacteriol Clin Lab,"Revista de medicina tropical y parasitologia, bacteriologia, clinica y laboratorio",20220020R,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', 'Humans']",,1946/01/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/01/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",,ppublish,"Rev Med Trop Parasitol Bacteriol Clin Lab. 1946 Jan-Mar;12:11-8, English translation 19-24.",,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,La endemicidad pandemica del dengue en los paises calidos.,,['CLML: 4610:1249j'],,,,,,,,,,,
20987462,NLM,MEDLINE,20101028,20201005,,2,1946 Apr 1,[The pandemic endemicity of dengue in warm countries].,84-91,,,"['HOFFMANN, W H']",['HOFFMANN WH'],,,['spa'],['Journal Article'],,Cuba,Kuba,Kuba; revista de medicina tropical y parasitologia,20230490R,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', 'Humans']",,1946/04/01 00:00,2010/12/14 06:00,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1946/04/01 00:00 [pubmed]', '2010/12/14 06:00 [medline]']",,ppublish,Kuba. 1946 Apr 1;2:84-91.,,,['NLM'],['*DENGUE/epidemiology and statistics'],,,,,,La endemicidad pandemica del dengue en los paises calidos.,,['CLML: 4611:247t'],,,,,,,,,,,
7819789,NLM,MEDLINE,19950214,20061115,0037-9085 (Print) 0037-9085 (Linking),86,1993,[Imported dengue in france (1989-1993). Conditions to be met for assuring an accurate etiological diagnosis].,402-5,,"Every year, many travellers are going in endemic zone of dengue for more or less long stay. Back home, they show sometimes a feverish and algic syndrome reminding the dengue, and the confirmation of the diagnosis is required at the laboratory. In most cases, the impossibility to proceed to the isolation of the virus, the relative lack of specificity and the cross-reactions, that the available serological techniques do not allow to avoid, make delicate even impossible the interpretation of the results. A five-year assessment has nevertheless been attempted: it allows to establish that probably about several tens of dengue cases are imported each year in France. The conditions allowing to confirm biologically the clinical diagnosis are recalled and strict interpretation criteria are proposed.","['Chippaux, A', 'Poveda, J D']","['Chippaux A', 'Poveda JD']",,"['Centre National et Collaborateur OMS de Reference et de Recherche sur les arbovirus, Institut Pasteur, Paris.']",['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Dengue/*diagnosis/epidemiology', 'France', 'Humans', 'Serologic Tests', 'Travel']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1993;86(5 Pt 2):402-5.,5 Pt 2,,,,,,,,,La dengue d'importation en France (1989-1993). Conditions a realiser pour assurer un diagnostic etiologique fiable.,,,,,,,,,,,,,
7336273,NLM,MEDLINE,19820512,20041117,0038-5077 (Print) 0038-5077 (Linking),,1981,[Clinical picture of imported dengue].,94-5,,,"['Lisukova, T E', ""Astaf'eva, N V""]","['Lisukova TE', ""Astaf'eva NV""]",,,['rus'],"['Case Reports', 'Journal Article']",,Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,,IM,"['Adult', 'Cuba', 'Dengue/*diagnosis/pathology/transmission', 'Female', 'Humans', 'India', 'Male', 'Middle Aged', 'USSR']",,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Sov Med. 1981;(12):94-5.,12,,,,,,,,,Klinicheskaia kartina zavoznoi denge.,,,,,,,,,,,,,
23250316,NLM,MEDLINE,20131206,20191112,2539-3596 (Electronic) 0124-0064 (Linking),14,2012 Jan-Feb,[Cultural dimensions concerning healthcare workers in Mexico and Colombia having dengue].,67-80,S0124-00642012000100006 [pii],"OBJECTIVE: Understanding cultural dimensions concerning Mexican and Colombian healthcare workers suffering from dengue to produce information and elements for healthcare and prevention. METHOD: This was a cognitive anthropological study. Purposive sampling was used to select 197 healthcare workers in Morelia, Mexico, and Santiago de Cali, Colombia; free associations lists and pile sorting were used. Terms associated with the concept of dengue and conceptual dimension groups were investigated. RESULTS: Participants cultural conceptions regarding dengue in Mexico emphasised prevention, whilst those in Colombia concentrated on biomedical language and symptoms. Overall, a holistic vision was shown which included a medical vision and related social aspects. CONCLUSIONS: Health professionals require more information about dengue and its prevention.","['Torres-Lopez, Teresa M', 'Soltero-Avelar, Ruben', 'Herrera-Perez, Juana I']","['Torres-Lopez TM', 'Soltero-Avelar R', 'Herrera-Perez JI']",,"['Departamento de Salud Publica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico. tere.torres.cucs@gmail.com']",['spa'],"['English Abstract', 'Journal Article']",,Colombia,Rev Salud Publica (Bogota),"Revista de salud publica (Bogota, Colombia)",100936348,,IM,"['Adult', 'Aged', 'Attitude of Health Personnel/*ethnology', 'Colombia', '*Cross-Cultural Comparison', 'Dengue/diagnosis/*ethnology/prevention & control/psychology', 'Female', 'Humans', 'Male', 'Mexico', 'Middle Aged', 'Qualitative Research', 'Social Values']",,2012/12/20 06:00,2013/12/16 06:00,['2012/12/20 06:00'],"['2011/04/19 00:00 [received]', '2012/02/22 00:00 [accepted]', '2012/12/20 06:00 [entrez]', '2012/12/20 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['S0124-00642012000100006 [pii]', '10.1590/s0124-00642012000100006 [doi]']",ppublish,Rev Salud Publica (Bogota). 2012 Jan-Feb;14(1):67-80. doi: 10.1590/s0124-00642012000100006.,1,,,,,,,,,Dimensiones culturales sobre el Dengue en profesionales de la salud de Mexico y Colombia.,,,,,,,,,,,,,
1749446,NLM,MEDLINE,19920123,20061115,0028-2162 (Print) 0028-2162 (Linking),135,1991 Dec 14,[Hemorrhagic fever caused by dengue in 2 tourists].,2394-7,,"Dengue haemorrhagic fever in two female tourists to Thailand (1990) and Indonesia (1989) respectively, is reported for the first time in the Netherlands. The main symptoms directly after return were high fever, haemorrhagic exanthema, thrombocytopenia and in one patient signs of haemoconcentration. Initially both patients were treated with antibiotics. They recovered after intravenous fluid therapy; one of them received a thrombocyte transfusion. Increasing travel to Asia and South America will result in more tourists returning with this potentially serious arboviral disease (dengue haemorrhagic shock).","['Ligtenberg, J J', 'Hospers, G A', 'Sprenger, H G', 'Weits, J']","['Ligtenberg JJ', 'Hospers GA', 'Sprenger HG', 'Weits J']",,"['Academisch Ziekenhuis, afd. Algemene Interne Geneeskunde, sectie Infectieziekten, Groningen.']",['dut'],"['Case Reports', 'English Abstract', 'Journal Article']",,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,,IM,"['Adult', 'Blood Component Transfusion', 'Dengue/*diagnosis/therapy/transmission', 'Female', 'Fluid Therapy', 'Humans', 'Indonesia', 'Netherlands/ethnology', 'Thailand', 'Travel']",,1991/12/14 00:00,1991/12/14 00:01,['1991/12/14 00:00'],"['1991/12/14 00:00 [pubmed]', '1991/12/14 00:01 [medline]', '1991/12/14 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1991 Dec 14;135(50):2394-7.,50,,,,,,,,,Hemorragische koorts door dengue bij twee toeristen.,,,,,,,,,,,,,
537809,NLM,MEDLINE,19800530,20091021,0030-6002 (Print) 0030-6002 (Linking),120,1979 Dec 9,"[Clinical aspects of dengue, based on experience in Cuba].",2985-7,,,"['Visi, Z', 'Timar, L']","['Visi Z', 'Timar L']",,,['hun'],['Journal Article'],,Hungary,Orv Hetil,Orvosi hetilap,0376412,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Child', 'Cuba', 'Dengue/*epidemiology/etiology/therapy', 'Disease Outbreaks', 'Humans']",,1979/12/09 00:00,1979/12/09 00:01,['1979/12/09 00:00'],"['1979/12/09 00:00 [pubmed]', '1979/12/09 00:01 [medline]', '1979/12/09 00:00 [entrez]']",,ppublish,Orv Hetil. 1979 Dec 9;120(49):2985-7.,49,,,,,,,,,A dengue klinikumarol kubai tapasztalatok alapjan.,,,,,,,,,,,,,
18468367,NLM,MEDLINE,20080604,20190923,1547-1896 (Print) 0893-7400 (Linking),21,2008 Apr,"Fever, nausea, and vomiting in a student from Thailand.","32, 34-5",,,"['Lloyd, Adam T', 'McKenna, Dennis P']","['Lloyd AT', 'McKenna DP']",,"['Department of Emergency Medicine, Albany Medical Center, New York, USA.']",['eng'],"['Case Reports', 'Journal Article']",,United States,JAAPA,JAAPA : official journal of the American Academy of Physician Assistants,9513102,,,"['Adult', 'Dengue/*diagnosis/physiopathology/transmission', 'Female', 'Humans', 'Nausea', 'Thailand', 'United States', 'Vomiting']",,2008/05/13 09:00,2008/06/05 09:00,['2008/05/13 09:00'],"['2008/05/13 09:00 [pubmed]', '2008/06/05 09:00 [medline]', '2008/05/13 09:00 [entrez]']",['10.1097/01720610-200804000-00013 [doi]'],ppublish,"JAAPA. 2008 Apr;21(4):32, 34-5. doi: 10.1097/01720610-200804000-00013.",4,,,,,,,,,,,,,,,,,,,,,,
5014139,NLM,MEDLINE,19720601,20070813,0025-8458 (Print) 0025-8458 (Linking),67,1972 Feb 4,[current spread of dengue hemorrhagic fever in South Asia].,152-6,,,"['Jusatz, H J']",['Jusatz HJ'],,,['ger'],['Journal Article'],,Germany,Med Klin,Medizinische Klinik,0376637,,IM,"['Aedes', 'Asia, Southeastern', 'Child', 'Child, Preschool', 'Dengue/complications/diagnosis/*epidemiology/immunology/mortality', 'Dengue Virus/classification', 'Diagnosis, Differential', 'Hemorrhage/complications', 'Hemorrhagic Fevers, Viral/epidemiology', 'Humans', 'Infant', 'Insect Vectors', 'Philippines', 'Seasons', 'Shock, Hemorrhagic/complications', 'Thailand']",,1972/02/04 00:00,2000/03/22 09:00,['1972/02/04 00:00'],"['1972/02/04 00:00 [pubmed]', '2000/03/22 09:00 [medline]', '1972/02/04 00:00 [entrez]']",,ppublish,Med Klin. 1972 Feb 4;67(5):152-6.,5,,,,,,,,,Gegenwartige Verbreitung des Dengue-hamorrhagischen-Fiebers in Sudasien.,,,,,,,,,,,,,
9053042,NLM,MEDLINE,19970313,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[First case of dengue hemorrhagic fever with shock syndrome in Martinique].,243-4,,"Since mid 95, many Caribbean islands and America's countries suffer from a new outbreak of an epidemic of dengue fever and dengue haemorrhagic fever. Until today, no case of dengue haemorrhagic fever was reported in Martinique (FWI) in spite of the high prevalence of dengue fever in the island. The first identified case asserts the severity of illness. In Martinique, these arbovirosis is often underestimated. Nowadays, the disease prevention must become one of the principal targets of the medical corporation and the Public Health Authorities. Consequently, epidemiologic survey and principally vector's control must be reinforced.","['Mansuy, J M', 'Delor, R', 'Mehdaoui, H', 'Elizabeth, L']","['Mansuy JM', 'Delor R', 'Mehdaoui H', 'Elizabeth L']",,"[""Laboratoire departemental d'hygiene de la Martinique, Fort-de-France.""]",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Adult', 'Dengue/*diagnosis/epidemiology/prevention & control', 'Fatal Outcome', 'Humans', 'Male', 'Martinique/epidemiology', 'Population Surveillance', 'Prevalence']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(4):243-4.,4,,,,,,,,,Premier cas de dengue hemorragique avec syndrome de choc observe en Martinique.,,,,,,,,,,,,,
7595991,NLM,MEDLINE,19950731,20161017,0098-7484 (Print) 0098-7484 (Linking),274,1995 Jul 12,"From the Centers for Disease Control and Prevention. Imported dengue--United States, 1993-1994.",113,,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/transmission', 'Female', 'Humans', 'Infant', 'Male', 'Middle Aged', '*Travel', 'United States/epidemiology']",,1995/07/12 00:00,1995/07/12 00:01,['1995/07/12 00:00'],"['1995/07/12 00:00 [pubmed]', '1995/07/12 00:01 [medline]', '1995/07/12 00:00 [entrez]']",,ppublish,JAMA. 1995 Jul 12;274(2):113.,2,,,,,,,,,,,,,,,,,,,,,,
15088549,NLM,MEDLINE,20040520,20061115,0035-3655 (Print) 0035-3655 (Linking),123,2003 Apr,[Fever after returning from a trip: report of 3 cases of dengue fever].,219-21,,We present two cases of dengue fever after a trip in Asia and the most relevant epidemiological and clinical aspects to be known in general practice.,"['Bassi, Cecile', 'Landry, Pierre', 'Malinverni, Raffaele']","['Bassi C', 'Landry P', 'Malinverni R']",,"['Hopital des Cadolles, 2000 Neuchatel.']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,IM,"['Adult', '*Dengue/diagnosis/epidemiology/therapy', 'Diagnosis, Differential', 'Female', 'Humans', 'Male', 'Sri Lanka', 'Thailand', 'Travel']",,2004/04/20 05:00,2004/05/21 05:00,['2004/04/20 05:00'],"['2004/04/20 05:00 [pubmed]', '2004/05/21 05:00 [medline]', '2004/04/20 05:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 2003 Apr;123(4):219-21.,4,,,,,,,,,Etat febrile au retour d'un voyage: a propos de deux cas de fievre dengue.,,,,,,,,,,,,,
6800616,NLM,MEDLINE,19820527,20061115,0376-2491 (Print) 0376-2491 (Linking),61,1981 Aug,[Clinical analysis of 583 cases of dengue fever (author's transl)].,470-4,,,"['Wei, X A']",['Wei XA'],,,['chi'],"['Case Reports', 'English Abstract', 'Journal Article']",,China,Zhonghua Yi Xue Za Zhi,Zhonghua yi xue za zhi,7511141,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Dengue/blood/classification/*therapy', 'Female', 'Humans', 'Male', 'Medicine, Chinese Traditional', 'Middle Aged']",,1981/08/01 00:00,1981/08/01 00:01,['1981/08/01 00:00'],"['1981/08/01 00:00 [pubmed]', '1981/08/01 00:01 [medline]', '1981/08/01 00:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi. 1981 Aug;61(8):470-4.,8,,,,,,,,,,,,,,,,,,,,,,
12688255,NLM,MEDLINE,20030423,20041117,1537-6591 (Electronic) 1058-4838 (Linking),36,2003 Apr 15,"Fever in a returned traveler: an ""off the cuff"" diagnosis.","1004-5, 1074-5",,,"['Ellerin, Todd', 'Hurtado, Rocio', 'Lockman, Shahin', 'Baden, Lindsey']","['Ellerin T', 'Hurtado R', 'Lockman S', 'Baden L']",,"[""Department of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA. tellerin@partners.org""]",['eng'],"['Case Reports', 'Journal Article']",,United States,Clin Infect Dis,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,9203213,,IM,"['Adult', 'Dengue/*diagnosis/immunology/physiopathology', 'Female', 'Fever/*etiology', 'Humans', 'Sri Lanka', 'Travel']",,2003/04/12 05:00,2003/04/24 05:00,['2003/04/12 05:00'],"['2003/04/12 05:00 [pubmed]', '2003/04/24 05:00 [medline]', '2003/04/12 05:00 [entrez]']",['10.1086/368193 [doi]'],ppublish,"Clin Infect Dis. 2003 Apr 15;36(8):1004-5, 1074-5. doi: 10.1086/368193.",8,,,,,,,,,,,,,,,,,,,,,,
3802313,NLM,MEDLINE,19870316,20130405,,79,1986,[Encephalitic syndrome caused by flavivirus diagnosed after return from a voyage to South India: probably dengue with neurological manifestations].,531-8,,"The authors report the case of a flavivirus encephalitis (probable Dengue) in a 70 year old female, occurring twenty days after a fewer of unknown origin, contracted in the South of India. Most of the cases of such encephalitis have been reported from children, but they may occur also in adults.","['Chabasse, D', 'De Bray, J M', 'Le Lay-Rogues, G', 'Nedelec, C', 'Chastel, C']","['Chabasse D', 'De Bray JM', 'Le Lay-Rogues G', 'Nedelec C', 'Chastel C']",,,['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot Filiales,Bulletin de la Societe de pathologie exotique et de ses filiales,7503399,,IM,"['Aged', 'Dengue/complications/*diagnosis/epidemiology', 'Dengue Virus', 'Encephalitis/*etiology', 'Female', 'France', 'Humans', 'India', 'Syndrome', 'Travel']",,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot Filiales. 1986;79(4):531-8.,4,,,,,,,,,Syndrome encephalitique attribuable un flavivirus observe au retour d'un voyage en Inde du sud: dengue probable a expression neurologique.,,,,,,,,,,,,,
9119346,NLM,MEDLINE,19970418,20041117,0015-8178 (Print) 0015-8178 (Linking),114,1996 Dec 20,[Currently some concern about dengue fever. Interview by Dr. rer. nat. Anita Schweiger].,20-1,,,"['Fruhwein, N']",['Fruhwein N'],,,['ger'],['Interview'],,Germany,Fortschr Med,Fortschritte der Medizin,2984763R,,IM,"['Dengue/diagnosis/prevention & control/*transmission', 'Developing Countries', 'Diagnosis, Differential', 'Humans', '*Travel']",,1996/12/20 00:00,1996/12/20 00:01,['1996/12/20 00:00'],"['1996/12/20 00:00 [pubmed]', '1996/12/20 00:01 [medline]', '1996/12/20 00:00 [entrez]']",,ppublish,Fortschr Med. 1996 Dec 20;114(35-36):20-1.,35-36,,,,,,,,,Etwas Sorge bereitet derzeit das Denguefieber.,,,,,,,,,,,,,
15846947,NLM,MEDLINE,20060221,20091111,0375-0760 (Print) 0375-0760 (Linking),54,2002 Sep-Dec,"[Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997].",220-7,,,"['Valdes, Luis G', 'Mizhrahi, Jesus Vila', 'Guzman, Maria G']","['Valdes LG', 'Mizhrahi JV', 'Guzman MG']",,"['Centro Provincial de Higiene y Epidemiologia de Santiago de Cuba, Instituto de Medicina Tropical Pedro Kouri, Ciudad de La Habana. ciipk@ipk.sld.cu']",['spa'],['Journal Article'],,Cuba,Rev Cubana Med Trop,Revista cubana de medicina tropical,0074364,,IM,"['Cuba/epidemiology', 'Dengue/*economics/*epidemiology/prevention & control', '*Health Care Costs', 'Humans']",,2005/04/26 09:00,2006/02/24 09:00,['2005/04/26 09:00'],"['2005/04/26 09:00 [pubmed]', '2006/02/24 09:00 [medline]', '2005/04/26 09:00 [entrez]']",,ppublish,Rev Cubana Med Trop. 2002 Sep-Dec;54(3):220-7.,3,,,,,,,,,"Impacto economico de la epidemia de dengue 2 en Santiago de Cuba, 1997.",,,,,,,,,,,,,
20464521,NLM,MEDLINE,20110504,20211020,1522-9602 (Electronic) 0092-8240 (Print) 0092-8240 (Linking),73,2011 Jan,Asymmetry in the presence of migration stabilizes multistrain disease outbreaks.,248-60,10.1007/s11538-010-9541-4 [doi],"We study the effect of migration between coupled populations, or patches, on the stability properties of multistrain disease dynamics. The epidemic model used in this work displays a Hopf bifurcation to oscillations in a single, well-mixed population. It is shown numerically that migration between two non-identical patches stabilizes the endemic steady state, delaying the onset of large amplitude outbreaks and reducing the total number of infections. This result is motivated by analyzing generic Hopf bifurcations with different frequencies and with diffusive coupling between them. Stabilization of the steady state is again seen, indicating that our observation in the full multistrain model is based on qualitative characteristics of the dynamics rather than on details of the disease model.","['Bianco, Simone', 'Shaw, Leah B']","['Bianco S', 'Shaw LB']",,"['Department of Applied Science, The College of William and Mary, P.O. Box 8795, Williamsburg, VA 23187-8795, USA. sbianco@wm.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20100513,United States,Bull Math Biol,Bulletin of mathematical biology,0401404,,IM,"['Dengue/epidemiology/immunology/prevention & control/transmission', 'Disease Outbreaks/*statistics & numerical data', 'Emigration and Immigration', 'Humans', 'Mathematical Concepts', 'Models, Biological', 'Models, Statistical', 'Population Dynamics']",PMC2995850,2010/05/14 06:00,2011/05/05 06:00,['2010/05/14 06:00'],"['2009/08/04 00:00 [received]', '2010/04/09 00:00 [accepted]', '2010/05/14 06:00 [entrez]', '2010/05/14 06:00 [pubmed]', '2011/05/05 06:00 [medline]']","['9541 [pii]', '10.1007/s11538-010-9541-4 [doi]']",ppublish,Bull Math Biol. 2011 Jan;73(1):248-60. doi: 10.1007/s11538-010-9541-4. Epub 2010 May 13.,1,,,,,,"['R01 GM090204/GM/NIGMS NIH HHS/United States', 'R01 GM090204-01/GM/NIGMS NIH HHS/United States', 'R01GM090204/GM/NIGMS NIH HHS/United States']",,,,['NIHMS225438'],,,,,,,,,,,,
8353470,NLM,MEDLINE,19930923,20061115,0037-9085 (Print) 0037-9085 (Linking),86,1993,[A case of polyradiculoneuritis associated with dengue in a patient native to French Guiana].,117-8; discussion 119,,"An acute polyradiculoneuritis in a woman native of French Guiana has been observed with serologic conversion against flaviviruses by inhibition of hemagglutination test. Dengue's diagnostic was been kept in spite of lack of causal virus isolation and non-typical clinical symptoms. Association dengue-polyradiculoneuritis appears quite uncommon and is worthy of note, in view of frequency of infection by Flaviviruses.","['Sainte-Foie, S', 'Niel, L', 'Moreau, J P', 'Ast-Ravallec', 'Chippaux, A']","['Sainte-Foie S', 'Niel L', 'Moreau JP', 'Ast-Ravallec', 'Chippaux A']",,"['Service de Neurologie, Centre hospitalier general, Cayenne, Guyane.']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Adult', 'Dengue/*diagnosis', 'Female', 'French Guiana', 'Humans', 'Polyradiculoneuropathy/diagnosis/*microbiology']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1993;86(2):117-8; discussion 119.,2,,,,,,,,,Un cas de polyradiculonevrite associe a une dengue chez une patiente originaire de la Guyane Francaise.,,,,,,,,,,,,,
16465802,NLM,MEDLINE,20060228,20060209,0025-682X (Print) 0025-682X (Linking),65,2005 Nov,"[International conference on tropical medicine ""Medicine and health in the Tropics"" September 11 to 15 2005. Dengue fever].",425-7,,,"['Geraut, L', 'Juzan, N', 'Tolou, H']","['Geraut L', 'Juzan N', 'Tolou H']",,,['fre'],['Journal Article'],,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['*Dengue/epidemiology/pathology/transmission', 'Dengue Virus/*pathogenicity', 'Humans', 'Incidence', 'Public Health', 'Risk Factors']",,2006/02/10 09:00,2006/03/01 09:00,['2006/02/10 09:00'],"['2006/02/10 09:00 [pubmed]', '2006/03/01 09:00 [medline]', '2006/02/10 09:00 [entrez]']",,ppublish,Med Trop (Mars). 2005 Nov;65(5):425-7.,5,,,,,,,,,"Congres international de medecine tropicale ""Medecine and health in the tropics"" 11 au 15 Septembre 2005. La dengue.",,,,,,,,,,,,,
17953257,NLM,MEDLINE,20071210,20071023,1438-3276 (Print) 1438-3276 (Linking),149,2007 Apr 19,[First success of research. Soon a drug against dengue fever?].,12,,,"['Herrling, Paul']",['Herrling P'],,,['ger'],['Interview'],,Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,,IM,"['Biomedical Research', 'Dengue/diagnosis/*drug therapy', 'Forecasting', 'Humans', '*Tropical Medicine']",,2007/10/24 09:00,2007/12/11 09:00,['2007/10/24 09:00'],"['2007/10/24 09:00 [pubmed]', '2007/12/11 09:00 [medline]', '2007/10/24 09:00 [entrez]']",,ppublish,MMW Fortschr Med. 2007 Apr 19;149(16):12.,16,,,,,,,,,Erste Forschungserfolge. Bald ein Medikament gegen das Denguefieber?,,,,,,,,,,,,,
14587181,NLM,MEDLINE,20040206,20041117,1438-3276 (Print) 1438-3276 (Linking),145,2003 Jul 10,[In travellers already more frequent than malaria. Dengue fever in advance].,15,,,"['Neumaier, Judith']",['Neumaier J'],,,['ger'],['Journal Article'],,Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,,IM,"['Blood Transfusion', 'Dengue/diagnosis/*epidemiology/mortality/prevention & control/therapy', 'Diagnosis, Differential', 'Germany/epidemiology', 'Humans', '*Travel']",,2003/11/01 05:00,2004/02/10 05:00,['2003/11/01 05:00'],"['2003/11/01 05:00 [pubmed]', '2004/02/10 05:00 [medline]', '2003/11/01 05:00 [entrez]']",,ppublish,MMW Fortschr Med. 2003 Jul 10;145(27-28):15.,27-28,,,,,,,,,Bei Reisenden schon haufiger als Malaria. Denguefieber auf dem Vormarsch.,,,,,,,,,,,,,
9663316,NLM,MEDLINE,19980924,20200825,0304-4602 (Print) 0304-4602 (Linking),27,1998 Mar,The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future.,227-34,,"Dengue/dengue haemorrhagic fever has been one of the most important resurgent tropical diseases in the past 17 years, with expanding geographic distribution of both the viruses and the mosquito vectors, increased frequency of epidemics, the development of hyperendemicity (co-circulation of multiple virus serotypes) and the emergence of dengue haemorrhagic fever in new areas. This paper briefly reviews the changing epidemiology of dengue, discusses some of the factors responsible for the recent resurgence, and reviews the current options for reversing the trend of emergent disease.","['Gubler, D J']",['Gubler DJ'],,"['Division of Vector-Borne Infectious Diseases, U S Department of Health and Human Services, Fort Collins, CO 80522, USA.']",['eng'],"['Journal Article', 'Review']",,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,,IM,"['Aedes/physiology', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission/virology', 'Dengue Virus/classification', 'Developing Countries/statistics & numerical data', 'Disease Outbreaks', 'Endemic Diseases', 'Global Health', 'Humans', 'Incidence', 'Insect Vectors', 'Serotyping', 'Severe Dengue/*epidemiology/prevention & control/transmission/virology']",,1998/07/15 00:00,1998/07/15 00:01,['1998/07/15 00:00'],"['1998/07/15 00:00 [pubmed]', '1998/07/15 00:01 [medline]', '1998/07/15 00:00 [entrez]']",,ppublish,Ann Acad Med Singap. 1998 Mar;27(2):227-34.,2,,,,,,,38,,,,,,,,,,,,,,,
22232468,NLM,MEDLINE,20120309,20211021,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),86,2012 Jan,Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort.,166-70,10.4269/ajtmh.2012.11-0491 [doi],"The classification of dengue virus-infected patients continues to be a challenge to researchers and clinicians in the field. The accuracy of the 1997 World Health Organization (WHO) dengue case definition has been debated for a decade, because the definition was very stringent, for instance, several researchers showed that apparently severe cases were misclassified as not severe. Therefore the WHO issued revised guidelines in 2009. Here, we retrospectively compared the performance of the WHO case definition of 2009 with the WHO case definition of 1997 in a detailed documented pediatric cohort from Indonesia. Intensive treatment intervention was used as an indicator of severity of disease. In line with our expectations, the 2009 WHO case classification proved to be significantly more specific, albeit less sensitive than the WHO case classification of 1997. We conclude that the revised classification is promising both from research and clinical perspectives, but validation of the classification criteria still needs to be addressed.","['van de Weg, Cornelia A M', 'van Gorp, Eric C M', 'Supriatna, Mohamad', 'Soemantri, Augustinus', 'Osterhaus, Albert D M E', 'Martina, Byron E E']","['van de Weg CA', 'van Gorp EC', 'Supriatna M', 'Soemantri A', 'Osterhaus AD', 'Martina BE']",,"['Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands. c.vandeweg@erasmusmc.nl']",['eng'],"['Evaluation Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Child', 'Child, Preschool', 'Cohort Studies', 'Dengue/*classification/diagnosis/physiopathology/virology', 'Dengue Virus', 'Female', 'Humans', 'Indonesia', 'Male', 'Practice Guidelines as Topic/*standards', 'Sensitivity and Specificity', 'Severity of Illness Index', '*World Health Organization']",PMC3247126,2012/01/11 06:00,2012/03/10 06:00,['2012/01/11 06:00'],"['2012/01/11 06:00 [entrez]', '2012/01/11 06:00 [pubmed]', '2012/03/10 06:00 [medline]']","['86/1/166 [pii]', '10.4269/ajtmh.2012.11-0491 [doi]']",ppublish,Am J Trop Med Hyg. 2012 Jan;86(1):166-70. doi: 10.4269/ajtmh.2012.11-0491.,1,,,,,,,,,,,,,,,,,,,,,,
23077811,NLM,MEDLINE,20121108,20121019,0125-1562 (Print) 0125-1562 (Linking),43,2012 Jul,Early predictors of clinically significant bleeding in adults with dengue infection.,890-9,,"Hemorrhage is an important complication in dengue infection, but early predictors of clinically significant bleeding are undefined. This study aimed to determine clinical factors on admission associated with Type I bleeding, defined as gastrointestinal bleed, hematuria and menorrhagia, among adult patients with dengue infection. We carried out a retrospective study among 277 patients aged >15 years with serologically-confirmed dengue infection admitted to the Hospital for Tropical Diseases, Bangkok, Thailand during 2006-2009. Female gender (p<0.001), vomiting (p=0.05), severe thrombocytopenia (platelet count < 25 x 10(9)/l; p=0.007), high absolute lymphocyte count (ALC >500; p=0.05) and high aspartate aminotransferase level (AST >200; p=0.02) were significantly associated with hemorrhage on univariate analysis. Multivariate analysis revealed variables associated with bleeding were female gender [odds ratio (OR) 14.5; 95% confidence interval (CI) 0.16-0.56, p<0.001], thrombocytopenia (OR 4.7; 95%CI 0.13-0.9, p=0.03) and ALC >500 (OR 5.7; 95%CI 1.17-4.99, p=0.02). These data identify patients at high risk for developing clinically significant bleeding with dengue infection.","['Chamnanchanunt, Supat', 'Kanagaraj, Deena', 'Thanachartwet, Vipa', 'Desakorn, Varunee', 'Rojnuckarin, Ponlapat']","['Chamnanchanunt S', 'Kanagaraj D', 'Thanachartwet V', 'Desakorn V', 'Rojnuckarin P']",,"['Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. supat.cha@mahidol.ac.th']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Adult', 'Comorbidity', 'Dengue/blood/*complications/epidemiology/*physiopathology', 'Female', 'Hemorrhage/epidemiology/*etiology', 'Humans', 'Male', 'Retrospective Studies', 'Socioeconomic Factors', 'Young Adult']",,2012/10/20 06:00,2012/11/09 06:00,['2012/10/20 06:00'],"['2012/10/20 06:00 [entrez]', '2012/10/20 06:00 [pubmed]', '2012/11/09 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2012 Jul;43(4):890-9.,4,,,,,,,,,,,,,,,,,,,,,,
2386710,NLM,MEDLINE,19900924,20161201,0049-8114 (Print) 0049-8114 (Linking),65,1990 Jan 19,Dengue haemorrhagic fever (DHF). Increase in number of cases in the Americas 1980-1987.,13-5,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adolescent', 'Child', 'Dengue/*epidemiology/mortality/physiopathology', '*Disease Outbreaks', 'Female', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'South America']",,1990/01/19 00:00,1990/01/19 00:01,['1990/01/19 00:00'],"['1990/01/19 00:00 [pubmed]', '1990/01/19 00:01 [medline]', '1990/01/19 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1990 Jan 19;65(3):13-5.,3,,,,,,,,,,,,,,,,,,,,,,
28187147,NLM,MEDLINE,20170809,20220311,1932-6203 (Electronic) 1932-6203 (Linking),12,2017,"Widespread fear of dengue transmission but poor practices of dengue prevention: A study in the slums of Delhi, India.",e0171543,10.1371/journal.pone.0171543 [doi] e0171543,"BACKGROUND: This study has been conducted to throw light on the knowledge and practices related to dengue fever among the poor population living in Delhi's slums. MATERIALS: A household survey was conducted in 2013 among 3,350 households. The households were stratified by a number of variables related to socio-economic status and health events such as hospitalisation. The data collection was completed through face-to-face interviews conducted with the help of 25 field investigators. RESULTS: About 8% of the households had at least one diagnosed dengue case. In comparison to the population surveyed, teenagers (15-19 years) and adults (30-34 years) were more affected whereas children under four years of age were underrepresented. Housewives are more affected by dengue (24%) compared to their share of the population surveyed (17%). Despite the fact that 77% of the respondents are worried about mosquitoes, only 43% of them monitor environment to avoid the presence of breeding sites. CONCLUSION: One cannot exclude the possibility that though young children under the age of four years are exposed to the virus, either their cases were asymptomatic or family members infected during this period had potentially more serious symptoms leading to hospitalisation. This result could thus be explained by budget-related health choices made by this population which do not favour small children. Educational programs should target housewives to improve their impact, as they are the ones mostly responsible for water storage and cleanliness of the house and its neighbourhood. Even with a dengue experience and potentially an acute perception of the risk and its factors, a proper management of environmental conditions is lacking. This along with the fact that word-of-mouth is the main source of information quoted should be a message for municipality health workers to give door-to-door information on how to prevent breeding sites and dengue infection.","['Daude, Eric', 'Mazumdar, Sumit', 'Solanki, Vandana']","['Daude E', 'Mazumdar S', 'Solanki V']",['ORCID: 0000-0001-8656-3346'],"['The National Center for Scientific Research, Center for Social Sciences and Humanities, Delhi, India.', 'Institute of Public Health, Kalyani, West Bengal, India.', 'The National Center for Scientific Research, Center for Social Sciences and Humanities, Delhi, India.']",['eng'],['Journal Article'],20170210,United States,PLoS One,PloS one,101285081,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cities', 'Dengue/*epidemiology/prevention & control/psychology/transmission', 'Fear', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'India', 'Infant', 'Male', 'Middle Aged', 'Mosquito Control/*statistics & numerical data', 'Poverty Areas', 'Primary Prevention/statistics & numerical data']",PMC5302449,2017/02/12 06:00,2017/08/10 06:00,['2017/02/11 06:00'],"['2016/05/18 00:00 [received]', '2017/01/23 00:00 [accepted]', '2017/02/11 06:00 [entrez]', '2017/02/12 06:00 [pubmed]', '2017/08/10 06:00 [medline]']","['PONE-D-16-19074 [pii]', '10.1371/journal.pone.0171543 [doi]']",epublish,PLoS One. 2017 Feb 10;12(2):e0171543. doi: 10.1371/journal.pone.0171543. eCollection 2017.,2,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
31782396,NLM,MEDLINE,20200615,20200615,1474-4457 (Electronic) 1473-3099 (Linking),19,2019 Dec,Unprecedented rise in dengue outbreaks in Bangladesh.,1287,S1473-3099(19)30616-4 [pii] 10.1016/S1473-3099(19)30616-4 [doi],,"['Hsan, Kamrul', 'Hossain, Md Mahfuz', 'Sarwar, Md Shanjid', 'Wilder-Smith, Annelies', 'Gozal, David']","['Hsan K', 'Hossain MM', 'Sarwar MS', 'Wilder-Smith A', 'Gozal D']",,"['Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh; Institute of Allergy and Clinical Immunology of Bangladesh, Savar, Dhaka, Bangladesh; Humanitarian Response Organisation, Dhaka, Bangladesh. Electronic address: kamrul.phi.ju@gmail.com.', 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.', 'Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.', 'Department for Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Heidelberg Institute of Global Health, Heidelberg, Germany.', 'Department of Child Health, and the Child Health Research Institute, University of Missouri School of Medicine, Columbia, MO, USA.']",['eng'],['Letter'],,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Bangladesh/epidemiology', 'Dengue/*epidemiology/transmission/virology', '*Dengue Virus', '*Disease Outbreaks', 'Humans', 'Public Health Surveillance']",,2019/11/30 06:00,2020/06/17 06:00,['2019/11/30 06:00'],"['2019/09/17 00:00 [received]', '2019/10/18 00:00 [accepted]', '2019/11/30 06:00 [entrez]', '2019/11/30 06:00 [pubmed]', '2020/06/17 06:00 [medline]']","['S1473-3099(19)30616-4 [pii]', '10.1016/S1473-3099(19)30616-4 [doi]']",ppublish,Lancet Infect Dis. 2019 Dec;19(12):1287. doi: 10.1016/S1473-3099(19)30616-4.,12,,,,,,,,,,,,,,,,,,,,,,
16869969,NLM,MEDLINE,20061017,20220318,1471-2334 (Electronic) 1471-2334 (Linking),6,2006 Jul 25,Dengue as a cause of acute undifferentiated fever in Vietnam.,123,,"BACKGROUND: Dengue is a common cause of fever in the tropics but its contribution to the total burden of febrile illnesses that is presented to primary health facilities in endemic regions such as Vietnam, is largely unknown. We aimed to report the frequency of dengue as a cause of fever in Binh Thuan Province, to describe the characteristics of dengue patients, and analyze the diagnostic accuracy of the health care workers and the determinants of the diagnostic process. METHODS: All patients presenting with acute undifferentiated fever at twelve community health posts and one clinic at the provincial malaria station, Binh Thuan Province, a dengue endemic province in southern Vietnam, were included. Record forms were used to fill in patient and diseases characteristics, pre-referral treatment, signs and symptoms, provisional diagnosis and prescribed treatment, referral and final outcome. Serum samples were collected at first presentation and after 3 weeks for serologic diagnosis. RESULTS: 2096 patients were included from April 2001 to March 2002. All 697 patients with paired serum samples were tested for dengue virus IgM and IgG. Acute dengue was found in 33.6% cases and past dengue virus infections were found in 57.1% cases. Acute primary infections were more common among children under 15 years old than among adults (7.7% vs. 3.5%, p value < 0.001). Younger age significantly predicted acute dengue (RR per increasing year of age (95 % CI): 0.986 (0.975-0.997, p value = 0.014). 48.9% of cases with clinical diagnosis of acute dengue were serologically confirmed and 32.5% of cases without clinical diagnosis of acute dengue were positive by serology after all (OR = 1.981, p value 0.025, 95% CI: 1.079-3.635). Tourniquet test was not a predictor for dengue diagnosis. CONCLUSION: Dengue is responsible for one third of the fevers presented to the public primary health services in Binh Thuan, southern Vietnam. It presents as a highly unspecific illness and is hardly recognized as a clinical entity by primary physicians.","['Phuong, Hoang Lan', 'de Vries, Peter J', 'Nga, Tran T T', 'Giao, Phan T', 'Hung, Le Q', 'Binh, Tran Q', 'Nam, Nguyen V', 'Nagelkerke, Nico', 'Kager, Piet A']","['Phuong HL', 'de Vries PJ', 'Nga TT', 'Giao PT', 'Hung le Q', 'Binh TQ', 'Nam NV', 'Nagelkerke N', 'Kager PA']",,"['Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, Amsterdam, The Netherlands. lanphuongh@hcm.vnn.vn']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20060725,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Dengue/*complications/diagnosis/epidemiology', 'Endemic Diseases', 'Female', 'Fever/*etiology', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Vietnam/epidemiology']",PMC1579223,2006/07/28 09:00,2006/10/18 09:00,['2006/07/28 09:00'],"['2006/04/11 00:00 [received]', '2006/07/25 00:00 [accepted]', '2006/07/28 09:00 [pubmed]', '2006/10/18 09:00 [medline]', '2006/07/28 09:00 [entrez]']","['1471-2334-6-123 [pii]', '10.1186/1471-2334-6-123 [doi]']",epublish,BMC Infect Dis. 2006 Jul 25;6:123. doi: 10.1186/1471-2334-6-123.,,,,,,,,,,,,,,,,,,,,,,,
21888168,NLM,MEDLINE,20110926,20110905,0019-5847 (Print) 0019-5847 (Linking),109,2011 Feb,"Epidemiology of dengue, its prevention and control in India.",82-6,,,"['Baruah, Kalpana', 'Dhariwal, A C']","['Baruah K', 'Dhariwal AC']",,"['Ministry of Health and Family Welfare, Government of India, Delhi 110054.']",['eng'],['Journal Article'],,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,,IM,"['Dengue/*epidemiology/immunology/*prevention & control/transmission', 'Dengue Virus/genetics/immunology', 'Humans', 'India/epidemiology', 'Prevalence']",,2011/09/06 06:00,2011/09/29 06:00,['2011/09/06 06:00'],"['2011/09/06 06:00 [entrez]', '2011/09/06 06:00 [pubmed]', '2011/09/29 06:00 [medline]']",,ppublish,J Indian Med Assoc. 2011 Feb;109(2):82-6.,2,,,,,,,,,,,,,,,,,,,,,,
33971383,NLM,MEDLINE,20210531,20210531,1872-7654 (Electronic) 0301-2115 (Linking),261,2021 Jun,Dengue in pregnancy: Review article.,205-210,S0301-2115(21)00206-2 [pii] 10.1016/j.ejogrb.2021.04.035 [doi],"Dengue is the most common viral mosquito- borne disease. It is a major public health problem, especially in tropical and sub-tropical areas worldwide. According to the World Health Organization (WHO), approximately 40% of the world's population (over 2.5 billion people) live in areas with high risk of contracting dengue infection. Adults of childbearing age and pregnant women are travelling more frequently to tropical areas. Therefore exposing themselves to specific arboviral infections such as dengue, which may impact ongoing and future pregnancies. Clinical manifestations of dengue are wide ranging from asymptomatic to needing intensive care in cases of hemorrhagic dengue fever. The effects of dengue during and on pregnancy are unclear, moreover there is a lack of a cohesive reference to inform women of reproductive age who live in or travel to endemic areas and are at risk of contracting dengue. Here we present review of literature specifically looking at etiology, pathogenesis, clinical manifestations, management of dengue in pregnancy as well as its effect on maternal health and fetal outcomes. There is clear evidence to suggest adverse maternal outcomes in women with symptomatic dengue in low resource countries. A high index of clinical suspicion and early referral to tertiary center will prevent maternal -fetal serious adverse events in endemic areas. This review will help Clinicians in advising as well as managing women who travel during pregnancy to endemic areas as well as clinicians based in endemic areas who are managing women with dengue in pregnancy.","['Mulik, Varsha', 'Dad, Nimra', 'Buhmaid, Sara']","['Mulik V', 'Dad N', 'Buhmaid S']",,"['Sidra Medicine, Education City, Al Luqta Street, Doha, Qatar. Electronic address: vmulik@sidra.org.', 'Sidra Medicine, Education City, Al Luqta Street, Doha, Qatar.', 'Sidra Medicine, Education City, Al Luqta Street, Doha, Qatar.']",['eng'],"['Journal Article', 'Review']",20210430,Ireland,Eur J Obstet Gynecol Reprod Biol,"European journal of obstetrics, gynecology, and reproductive biology",0375672,,IM,"['Adult', 'Animals', '*Dengue/diagnosis/epidemiology', 'Female', 'Humans', 'Pregnancy', '*Pregnancy Complications, Infectious/diagnosis/epidemiology', '*Severe Dengue', 'Travel']",,2021/05/11 06:00,2021/06/01 06:00,['2021/05/10 20:16'],"['2020/11/06 00:00 [received]', '2021/04/16 00:00 [revised]', '2021/04/23 00:00 [accepted]', '2021/05/11 06:00 [pubmed]', '2021/06/01 06:00 [medline]', '2021/05/10 20:16 [entrez]']","['S0301-2115(21)00206-2 [pii]', '10.1016/j.ejogrb.2021.04.035 [doi]']",ppublish,Eur J Obstet Gynecol Reprod Biol. 2021 Jun;261:205-210. doi: 10.1016/j.ejogrb.2021.04.035. Epub 2021 Apr 30.,,['Copyright (c) 2021 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Dengue', 'Perinatal outcome', 'Pregnancy']",['Declaration of Competing Interest The authors report no declarations of interest.'],,,,,,,,,,,,,,,,,,
2185596,NLM,MEDLINE,19900606,20080310,0043-3144 (Print) 0043-3144 (Linking),39,1990 Mar,Dengue fever in the Caribbean.,59-62,,,"['Hospedales, C J']",['Hospedales CJ'],,"['Epidemiology Division, Caribbean Epidemiology Centre, Port-of-Spain, Trinidad.']",['eng'],"['Journal Article', 'Review']",,Jamaica,West Indian Med J,The West Indian medical journal,0417410,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/prevention & control/transmission', 'Humans', 'Insect Vectors', 'Mosquito Control', 'West Indies/epidemiology']",,1990/03/01 00:00,1990/03/01 00:01,['1990/03/01 00:00'],"['1990/03/01 00:00 [pubmed]', '1990/03/01 00:01 [medline]', '1990/03/01 00:00 [entrez]']",,ppublish,West Indian Med J. 1990 Mar;39(1):59-62.,1,,,,,,,4,,,,,,,,,,,,,,,
5419208,NLM,MEDLINE,19700723,20181113,0044-0086 (Print) 1551-4056 (Electronic) 0044-0086 (Linking),42,1970 Apr,Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.,350-62,,,"['Halstead, S B']",['Halstead SB'],,,['eng'],['Journal Article'],,United States,Yale J Biol Med,The Yale journal of biology and medicine,0417414,,IM,"['Age Factors', 'Antibody Formation', 'Dengue/complications/*etiology/immunology/physiopathology', 'Dengue Virus/classification/*immunology', 'Female', 'Hemorrhagic Disorders/etiology', 'Humans', '*Hypersensitivity, Delayed', 'Male', 'Sex Factors', 'Shock/etiology', 'Time Factors', 'Virulence', 'Virus Replication']",PMC2591710,1970/04/01 00:00,1970/04/01 00:01,['1970/04/01 00:00'],"['1970/04/01 00:00 [pubmed]', '1970/04/01 00:01 [medline]', '1970/04/01 00:00 [entrez]']",,ppublish,Yale J Biol Med. 1970 Apr;42(5):350-62.,5,,,,,,,,,,,,,,,,,,,,,,
20807395,NLM,MEDLINE,20110110,20220408,1471-2458 (Electronic) 1471-2458 (Linking),10,2010 Aug 31,Cost and disease burden of dengue in Cambodia.,521,10.1186/1471-2458-10-521 [doi],"BACKGROUND: Dengue is endemic in Cambodia (pop. estimates 14.4 million), a country with poor health and economic indicators. Disease burden estimates help decision makers in setting priorities. Using recent estimates of dengue incidence in Cambodia, we estimated the cost of dengue and its burden using disability adjusted life years (DALYs). METHODS: Recent population-based cohort data were used to calculate direct and productive costs, and DALYs. Health seeking behaviors were taken into account in cost estimates. Specific age group incidence estimates were used in DALYs calculation. RESULTS: The mean cost per dengue case varied from US$36 - $75 over 2006-2008 respectively, resulting in an overall annual cost from US$3,327,284 in 2008 to US$14,429,513 during a large epidemic in 2007. Patients sustain the highest share of costs by paying an average of 78% of total costs and 63% of direct medical costs. DALY rates per 100,000 individuals ranged from 24.3 to 100.6 in 2007-2008 with 80% on average due to premature mortality. CONCLUSION: Our analysis confirmed the high societal and individual family burden of dengue. Total costs represented between 0.03 and 0.17% of Gross Domestic Product. Health seeking behavior has a major impact on costs. The more accurate estimate used in this study will better allow decision makers to account for dengue costs particularly among the poor when balancing the benefits of introducing a potentially effective dengue vaccine.","['Beaute, Julien', 'Vong, Sirenda']","['Beaute J', 'Vong S']",,"['Epidemiology and Public Health Unit, Institut Pasteur in Cambodia, Bd Monivong 5, BP 983 Phnom Penh, Cambodia. julbeaute@yahoo.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100831,England,BMC Public Health,BMC public health,100968562,,IM,"['Cambodia/epidemiology', '*Cost of Illness', 'Costs and Cost Analysis', 'Dengue/*economics/epidemiology/physiopathology', 'Health Policy', 'Humans', 'Quality-Adjusted Life Years']",PMC2941493,2010/09/03 06:00,2011/01/11 06:00,['2010/09/03 06:00'],"['2010/05/07 00:00 [received]', '2010/08/31 00:00 [accepted]', '2010/09/03 06:00 [entrez]', '2010/09/03 06:00 [pubmed]', '2011/01/11 06:00 [medline]']","['1471-2458-10-521 [pii]', '10.1186/1471-2458-10-521 [doi]']",epublish,BMC Public Health. 2010 Aug 31;10:521. doi: 10.1186/1471-2458-10-521.,,,,,,,,,,,,,,,,,,,,,,,
14652535,NLM,MEDLINE,20040428,20191108,0147-9563 (Print) 0147-9563 (Linking),32,2003 Nov-Dec,Dengue fever: diagnostic importance of a camelback fever pattern.,414-8,,"We present a case of imported dengue fever in a 52-year-old man acquired during a recent trip to Ecuador. Fever in a returning traveler from tropical areas often presents a diagnostic problem for clinicians. Our patient presented with severe arthralgias and myalgias and had a camelback/saddleback fever pattern accompanied by relative bradycardia, which was a clue to the diagnosis. He had conjunctival suffusion and the truncal rash, but adenopathy was not present. He also had a generalized headache and abdominal pain. Nonspecific laboratory abnormalities included leukopenia, lymphopenia, atypical lymphocytes, thrombocytopenia, and mildly increased serum transaminases. Clinicians should consider dengue fever in the differential diagnosis in travelers returning from dengue fever endemic areas of Southeast Asia, Latin America, and Africa. Although early findings are nonspecific, a truncal rash accompanied by leukopenia and thrombocytopenia, if followed by biphasic fever pattern (ie, camelback/saddleback fever curve with relative bradycardia), suggest dengue fever as the primary diagnostic consideration.","['Sideridis, Kostas', 'Canario, Daniel', 'Cunha, Burke A']","['Sideridis K', 'Canario D', 'Cunha BA']",,"['Infectious Disease Division, Winthrop-University Hospital Mineola, New York 11501, USA.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Heart Lung,Heart & lung : the journal of critical care,0330057,['N12000U13O (Doxycycline)'],IM,"['Bradycardia/physiopathology', 'Dengue/*diagnosis/drug therapy/physiopathology', 'Diagnosis, Differential', 'Doxycycline/therapeutic use', 'Ecuador', 'Humans', 'Male', 'Middle Aged', 'Travel']",,2003/12/04 05:00,2004/04/29 05:00,['2003/12/04 05:00'],"['2003/12/04 05:00 [pubmed]', '2004/04/29 05:00 [medline]', '2003/12/04 05:00 [entrez]']","['S0147956303001055 [pii]', '10.1016/s0147-9563(03)00105-5 [doi]']",ppublish,Heart Lung. 2003 Nov-Dec;32(6):414-8. doi: 10.1016/s0147-9563(03)00105-5.,6,,,,,,,,,,,,,,,,,,,,,,
7896394,NLM,MEDLINE,19950427,20041117,0019-6061 (Print) 0019-6061 (Linking),31,1994 Jun,Dengue hemorrhagic fever in Calcutta.,685-7,,,"['Banik, G B', 'Pal, T K', 'Mandal, A', 'Chakraborty, M S', 'Chakravarti, S K']","['Banik GB', 'Pal TK', 'Mandal A', 'Chakraborty MS', 'Chakravarti SK']",,"['Department of Pediatrics and Virology, Medical College and School of Tropical Medicine, Calcutta.']",['eng'],['Journal Article'],,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Child', 'Child, Preschool', 'Dengue/blood/diagnosis/*epidemiology', 'Humans', 'India/epidemiology', 'Infant', 'Survival Rate', 'Urban Population']",,1994/06/01 00:00,1994/06/01 00:01,['1994/06/01 00:00'],"['1994/06/01 00:00 [pubmed]', '1994/06/01 00:01 [medline]', '1994/06/01 00:00 [entrez]']",,ppublish,Indian Pediatr. 1994 Jun;31(6):685-7.,6,,,,,,,,,,,,,,,,,,,,,,
3238469,NLM,MEDLINE,19890511,20061115,0125-1562 (Print) 0125-1562 (Linking),19,1988 Dec,Unusual clinical manifestations of dengue virus infection.,585-90,,"Four recent cases of dengue fever with severe, unusual clinical manifestations are described. Two of these cases had features of fulminant hepatitis and encephalopathy; one of these cases was fatal. The two remaining cases showed hepatitis with renal impairment. The significance and importance of these unusual manifestations of dengue disease are discussed.","['George, R', 'Liam, C K', 'Chua, C T', 'Lam, S K', 'Pang, T', 'Geethan, R', 'Foo, L S']","['George R', 'Liam CK', 'Chua CT', 'Lam SK', 'Pang T', 'Geethan R', 'Foo LS']",,"['Paediatrics Unit, General Hospital, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Adult', 'Central Nervous System/physiopathology', 'Child', 'Dengue/*diagnosis/epidemiology/physiopathology', 'Female', 'Hepatitis/etiology', 'Humans', 'Infant', 'Kidney/physiopathology', 'Malaysia', 'Male']",,1988/12/01 00:00,1988/12/01 00:01,['1988/12/01 00:00'],"['1988/12/01 00:00 [pubmed]', '1988/12/01 00:01 [medline]', '1988/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1988 Dec;19(4):585-90.,4,,,,,,,,,,,,,,,,,,,,,,
22666931,NLM,MEDLINE,20120719,20151119,0019-5847 (Print) 0019-5847 (Linking),109,2011 Nov,Clinical profile of dengue during 2005 outbreak in Kolkata and predictive markers of dengue haemorrhagic fever.,790-3,,"Epidemics of dengue outbreak are frequent in south-east Asian countries. Dengue is a major cause of morbidity and mortality in this region. This prospective observational study was done at Dr BC Roy Memorial for Children during the outbreak in 2005 in Kolkata to know the clinical pattern of dengue cases and to find the possible markers of development of dengue hemorrhagic fever. Two hundred and eighty seropositive cases of dengue were included in the study. Among paediatric population, 5 to 10 years age group was most commonly affected. One-sixth of the cases were from villages indicating the extension of the epidemic in rural areas. Abrupt onset of high fever, non-purulent conjunctival injection, erythematous lips, flushed appearance, myalgia, arthralgia, headache and thrombocytopenia were the predominant features. Rhinitis and pharyngitis were rarely found. Prolonged fever more than 7 days, flushed appearance, pharyngeal congestion, shock evidence, serous effusion, bleeding manifestations, thrombocytopenia, elevated liver enzymes and elevated PCV were associated with development of dengue haemorrhagic fever and dengue shock syndrome.","['Ghosh, Sanat Kumar', 'De, Saumyen', 'Sarkar, Uttam', 'Ghosh, Mausumi', 'Chatterjee, Mrinal Kanti', 'Samanta, Sandip']","['Ghosh SK', 'De S', 'Sarkar U', 'Ghosh M', 'Chatterjee MK', 'Samanta S']",,"['Department of Paediatric Medicine, Dr BC Roy Memorial Hospital for Children, Kolkata 700054.']",['eng'],['Journal Article'],,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,['0 (Biomarkers)'],IM,"['Biomarkers/blood', 'Child', 'Child, Preschool', 'Dengue/blood/*complications/*epidemiology/physiopathology', '*Disease Outbreaks', 'Disease Progression', 'Female', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Prospective Studies', 'Severe Dengue/epidemiology']",,2012/06/07 06:00,2012/07/20 06:00,['2012/06/07 06:00'],"['2012/06/07 06:00 [entrez]', '2012/06/07 06:00 [pubmed]', '2012/07/20 06:00 [medline]']",,ppublish,J Indian Med Assoc. 2011 Nov;109(11):790-3.,11,,,,,,,,,,,,,,,,,,,,,,
12188420,NLM,MEDLINE,20020917,20051116,0125-2208 (Print) 0125-2208 (Linking),85 Suppl 1,2002 Jun,Dengue infection: a global concern.,S25-33,,"Dengue infection, one of the most important mosquito-borne viral diseases of humans, is now a significant problem in several tropical countries. The disease, caused by the four dengue virus serotypes, ranges from asymptomatic infection, undifferentiated fever, dengue fever (DF) to severe dengue hemorrhagic fever (DHF) with or without shock. DHF is characterized by fever, bleeding diathesis and a tendency to develop a potentially fatal shock syndrome. Hematological findings include vasculopathy, coagulopathy and thrombocytopenia as the most constant findings. During the last twenty-five years, there have been increasing reports of dengue infection with unusual manifestations, mainly with cerebral and hepatic symptoms. Laboratory diagnosis includes virus isolation, serology and detection of dengue ribonucleic acid. Successful treatment, which is mainly supportive, depends on early recognition of the disease and careful monitoring for shock. Prevention depends on control of the mosquito vector. More efforts must be made to understand the pathogenesis of DHF in order to develop a safe and effective dengue vaccine.","['Pancharoen, Chitsanu', 'Kulwichit, Wanla', 'Tantawichien, Terapong', 'Thisyakorn, Usa', 'Thisyakorn, Chule']","['Pancharoen C', 'Kulwichit W', 'Tantawichien T', 'Thisyakorn U', 'Thisyakorn C']",,"['Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.']",['eng'],"['Journal Article', 'Review']",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Combined Modality Therapy', 'Dengue/*diagnosis/*epidemiology/prevention & control/therapy', '*Endemic Diseases', 'Female', 'Humans', 'Incidence', 'Male', 'Primary Prevention/methods', 'Risk Factors', 'Severity of Illness Index', 'Survival Rate', 'Thailand/epidemiology', 'Tropical Climate', 'World Health Organization']",,2002/08/22 10:00,2002/09/18 10:01,['2002/08/22 10:00'],"['2002/08/22 10:00 [pubmed]', '2002/09/18 10:01 [medline]', '2002/08/22 10:00 [entrez]']",,ppublish,J Med Assoc Thai. 2002 Jun;85 Suppl 1:S25-33.,,,,,,,,60,,,,,,,,,,,,,,,
8504268,NLM,MEDLINE,19930702,20061115,0037-9085 (Print) 0037-9085 (Linking),86,1993,[Cutaneous signs of dengue. Apropos of 3 cases].,7-11,,"We report three cases of dengue with cutaneous signs that were observed in three women returning from Asia (and that were confirmed by serology). The exanthem has common characteristics: progressive appearance beginning on thewer limbs, macula-type elementary lesion associated with purpura, evolution in one single upward spread, confluent lesions with intervals of healthy skin, palmoplantar affection, disappearance of the eruption in an average of ten days, association with conjunctivitis in three cases, pharyngitis in two, epistaxis in two and haematuria in one. The lesions spread to the trunk in one patient only and another patient had pruritus. None of the patients showed signs of a state of shock. According to WHO and, despite the existence of haemorrhages and of a purpura, the three cases reported here cannot be considered as being dengue haemorrhagic fever due to the absence of hemoconcentration. The two types of cutaneous signs observed during the fever are described and their physiopathology is discussed.","['Caumes, E', 'Santi, C', 'Felix, H', 'Bricaire, F', 'Danis, M', 'Gentilini, M']","['Caumes E', 'Santi C', 'Felix H', 'Bricaire F', 'Danis M', 'Gentilini M']",,"['Departement de Maladies Infectieuses, Parasitologie-Mycologie et Sante Publique, Hopital de la Salpetriere, Paris.']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Adult', 'Asia', 'Dengue/complications/*diagnosis', 'Female', 'Humans', 'Skin Diseases/*microbiology']",,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1993;86(1):7-11.,1,,,,,,,,,Signes cutanes de la dengue. A propos de trois cas.,,,,,,,,,,,,,
37881896,NLM,MEDLINE,20231115,20231116,1941-2479 (Electronic) 1010-5395 (Linking),35,2023 Nov,Dengue: The Public Health Threat That Never Goes Away.,469-470,10.1177/10105395231210362 [doi],,"['Binns, Colin', 'Low, Wah Yun']","['Binns C', 'Low WY']",,"['School of Population Health, Curtin University, Perth, WA, Australia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.']",['eng'],['Editorial'],20231026,China,Asia Pac J Public Health,Asia-Pacific journal of public health,8708538,,IM,"['Humans', '*Public Health', '*Dengue/epidemiology/prevention & control']",,2023/10/26 06:42,2023/11/15 06:43,['2023/10/26 04:42'],"['2023/11/15 06:43 [medline]', '2023/10/26 06:42 [pubmed]', '2023/10/26 04:42 [entrez]']",['10.1177/10105395231210362 [doi]'],ppublish,Asia Pac J Public Health. 2023 Nov;35(8):469-470. doi: 10.1177/10105395231210362. Epub 2023 Oct 26.,8,,,,,,,,,,,,,,,,,,,,,,
36097713,NLM,MEDLINE,20220914,20221003,2411-2097 (Electronic) 0507-4088 (Linking),67,2022 Sep 12,[Characteristics of imported cases of Dengue fever and hemorrhagic Dengue fever in 2009-2019].,322-330,10.36233/0507-4088-126 [doi],"INTRODUCTION: In Russia, the approved morbidity statistics system is represented by the International Classification of Diseases of the 10th revision (ICD-10). This classification provides two forms of dengue fever (DF): dengue fever (A90) and hemorrhagic dengue (A91). Official statistics on the ratio of forms of DF is not published in open sources and this lack of information about the real ratio of the forms of DF makes it difficult to objectively assess the factors that determine the severity of this disease. THE AIM: compare the clinical and epidemiological features of dengue fever and hemorrhagic dengue fever in patients hospitalized in 2009-2019 to the City Infectious Clinical Hospital No. 1, Moscow. MATERIALS AND METHODS: A retrospective cohort study. We analyzed the patient database and reviewed 391 medical records of patients with diagnosed dengue fever. We compared gender, age characteristics, travel geography including information about previous visits of patients to endemic regions and dengue virus serotype. To determine the primary and re-infection rate, an analysis of IgG for the dengue virus was carried out on days 1-5 of the disease. To compare indicators, 95% confidence intervals for proportions, medians, and interquartile ranges were calculated. The significance of differences between independent samples for assessing qualitative characteristics was carried out using the criteria chi2, the odds ratio. To assess the quantitative characteristics, the Mann-Whitney test was used. Differences were considered statistically significant at p </= 0.05. RESULTS: The proportion of patients with dengue fever was 14.9% of all hospitalized with febrile illnesses that developed after international travel. Hemorrhagic dengue fever (DHF) was diagnosed in 15.7% of patients with dengue fever. DHF developed significantly more often in women, as well as in those who had history of repeated visits to endemic regions. However, DHF was also diagnosed in 10.9% of first-time travelers to tropical countries. We did not find significant differences in the rates of DHF development depending on age and dengue virus serotype. In a number of patients who had not previously traveled to endemic regions, IgG to the dengue virus were detected, which may indicate a previous infection with related flaviviruses. CONCLUSION: It has been established that in the regions most visited by Russians, there is a circulation of all serotypes of the dengue virus with an annual change in the predominant serotype.","['Sayfullin, M A', 'Zvereva, N N', 'Karan, L S', 'Grigoreva, Ya E', 'Akinshina, Yu A', 'Larichev, V F', 'Shamsheva, O V', 'Bazarova, M V', 'Smetanina, S V']","['Sayfullin MA', 'Zvereva NN', 'Karan LS', 'Grigoreva YE', 'Akinshina YA', 'Larichev VF', 'Shamsheva OV', 'Bazarova MV', 'Smetanina SV']",,"['Pirogov Russian National Research Medical University; Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Healthcare of the Russian Federation.', 'Pirogov Russian National Research Medical University.', 'Central Research Institute of Epidemiology>> of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.', 'Central Research Institute of Epidemiology>> of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.', 'Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Healthcare of the Russian Federation; CJSC ""EcoLab"".', 'Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Healthcare of the Russian Federation.', 'Pirogov Russian National Research Medical University.', 'City Infectious Clinical Hospital No. 1.', 'City Infectious Clinical Hospital No. 1.']",['rus'],['Journal Article'],20220912,Russia (Federation),Vopr Virusol,Voprosy virusologii,0417337,['0 (Immunoglobulin G)'],IM,"['*Dengue/diagnosis/epidemiology', 'Female', 'Humans', 'Immunoglobulin G', 'Odds Ratio', 'Retrospective Studies', '*Severe Dengue/diagnosis/epidemiology']",,2022/09/14 06:00,2022/09/15 06:00,['2022/09/13 03:03'],"['2022/09/12 00:00 [received]', '2022/09/12 00:00 [accepted]', '2022/09/13 03:03 [entrez]', '2022/09/14 06:00 [pubmed]', '2022/09/15 06:00 [medline]']",['10.36233/0507-4088-126 [doi]'],epublish,Vopr Virusol. 2022 Sep 12;67(4):322-330. doi: 10.36233/0507-4088-126.,4,,,,,,,,,,,,,,,,,,,,,,
9951995,NLM,MEDLINE,19990513,20190818,0891-3668 (Print) 0891-3668 (Linking),18,1999 Jan,Case definition for dengue hemorrhagic fever.,80,,,"['Rigau-Perez, J G']",['Rigau-Perez JG'],,,['eng'],"['Comment', 'Letter']",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,,IM,"['Dengue/complications/*diagnosis', 'Humans', 'Pleural Effusion/etiology', 'Thrombocytopenia/etiology']",,1999/02/10 00:00,1999/02/10 00:01,['1999/02/10 00:00'],"['1999/02/10 00:00 [pubmed]', '1999/02/10 00:01 [medline]', '1999/02/10 00:00 [entrez]']",['10.1097/00006454-199901000-00027 [doi]'],ppublish,Pediatr Infect Dis J. 1999 Jan;18(1):80. doi: 10.1097/00006454-199901000-00027.,1,,,,,,,,"['Pediatr Infect Dis J. 1998 Aug;17(8):761-2, 764-5. PMID: 9726360']",,,,,,,,,,,,,,
15944525,NLM,MEDLINE,20050610,20080214,1545-861X (Electronic) 0149-2195 (Linking),54,2005 Jun 10,"Travel-associated dengue infections--United States, 2001-2004.",556-8,,"Dengue is a mosquito-transmitted, acute viral disease caused by any of the four dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Dengue is endemic in most tropical and subtropical areas of the world and has occurred in U.S. residents returning from travel to such areas. CDC maintains a laboratory-based passive surveillance system for travel-associated dengue among U.S. residents. The system relies on voluntary reports submitted to state health departments by clinicians; patient specimens are then forwarded to CDC for diagnostic testing. This report summarizes information about travel-associated dengue cases among U.S. residents during 2001-2004. The risk for dengue infection among travelers can be reduced by use of repellents and by avoiding exposure to mosquitoes.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Dengue/*epidemiology/transmission', 'Humans', '*Travel', 'United States/epidemiology']",,2005/06/10 09:00,2005/06/11 09:00,['2005/06/10 09:00'],"['2005/06/10 09:00 [pubmed]', '2005/06/11 09:00 [medline]', '2005/06/10 09:00 [entrez]']",['mm5422a2 [pii]'],ppublish,MMWR Morb Mortal Wkly Rep. 2005 Jun 10;54(22):556-8.,22,,,,,,,,,,,,,,,,['MMWR Morb Mortal Wkly Rep.2005 Jun 17;54(23):584'],['Centers for Disease Control and Prevention (CDC)'],,,,,
33994537,NLM,MEDLINE,20210518,20210526,1941-5923 (Electronic) 1941-5923 (Linking),22,2021 May 17,A Rare Case of Dengue Encephalitis with Raised Procalcitonin.,e931519,10.12659/AJCR.931519 [doi],"BACKGROUND Dengue virus is a common arbovirus with uncertain neurotropism. Dengue encephalitis is a rare but fatal manifestation of severe dengue. Diagnosis requires high clinical suspicion. It should be routinely considered in patients with encephalopathy, especially in countries where dengue virus is endemic. Unlike other forms of severe dengue, the typical warning signs and biochemical derangements are not reliable markers for dengue encephalitis. Alternative biochemical markers of dengue encephalitis are needed. CASE REPORT We present a case of dengue encephalitis with distinctly raised procalcitonin (13.2 mug/L), in the absence of the typical warning signs and biochemical derangements of severe dengue. The patient was a 65-year-old man with fever and sudden loss of consciousness in the absence of other localizing signs/symptoms. Inflammatory markers were raised, with findings of leptomeningeal enhancement on brain computed tomography suggestive of meningoencephalitis. Septic workup was unremarkable (normal renal and liver functions, negative blood and urine cultures). The typical neurotropic microorganisms were not detected in the cerebrospinal fluid. On day 4 of admission, the patient reported abdominal pain and hematuria with a new onset of bicytopenia. Subsequent investigations for dengue infection were positive for serum dengue NS1 antigen and dengue RNA (type 2 strain) in cerebrospinal fluid, confirming the diagnosis of dengue encephalitis. The patient was managed supportively and experienced full clinical recovery. CONCLUSIONS Dengue encephalitis is a rare condition with nonspecific biochemical and imaging abnormalities. We demonstrated that a raised procalcitonin level can occur in the setting of dengue encephalitis. In endemic countries, this finding may prompt further investigations for dengue encephalitis in patients with meningoencephalitis.","['Xu, Flora', 'Nadarajan, Krithikaa', 'Toh, Ming Ren']","['Xu F', 'Nadarajan K', 'Toh MR']",,"['Yong Loo Ling School of Medicine, Singapore, Singapore.', 'Department of Internal Medicine, Singapore General Hospital, Singapore, Singapore.', 'Department of Internal Medicine, Singapore General Hospital, Singapore, Singapore.']",['eng'],"['Case Reports', 'Journal Article']",20210517,United States,Am J Case Rep,The American journal of case reports,101489566,['0 (Procalcitonin)'],IM,"['Aged', '*Dengue/complications/diagnosis', '*Encephalitis', 'Fever', 'Humans', 'Male', 'Procalcitonin']",PMC8141333,2021/05/18 06:00,2021/05/19 06:00,['2021/05/17 05:53'],"['2021/05/17 05:53 [entrez]', '2021/05/18 06:00 [pubmed]', '2021/05/19 06:00 [medline]']","['931519 [pii]', '10.12659/AJCR.931519 [doi]']",epublish,Am J Case Rep. 2021 May 17;22:e931519. doi: 10.12659/AJCR.931519.,,,,,['Conflict of interest: None declared Conflict of Interest None.'],,,,,,,,,,,,,,,,,,
28545598,NLM,MEDLINE,20170818,20181113,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),145,2017 Aug,Indonesian dengue burden estimates: review of evidence by an expert panel.,2324-2329,10.1017/S0950268817001030 [doi],"Routine, passive surveillance systems tend to underestimate the burden of communicable diseases such as dengue. When empirical methods are unavailable, complimentary opinion-based or extrapolative methods have been employed. Here, an expert Delphi panel estimated the proportion of dengue captured by the Indonesian surveillance system, and associated health system parameters. Following presentation of medical and epidemiological data and subsequent discussions, the panel made iterative estimates from which expansion factors (EF), the ratio of total:reported cases, were calculated. Panelists estimated that of all symptomatic Indonesian dengue episodes, 57.8% (95% confidence interval (CI) 46.6-59.8) enter healthcare facilities to seek treatment; 39.3% (95% CI 32.8-42.0) are diagnosed as dengue; and 20.3% (95% CI 16.1-24.3) are subsequently reported in the surveillance system. They estimated most hospitalizations occur in the public sector, while ~55% of ambulatory episodes are seen privately. These estimates gave an overall EF of 5.00; hospitalized EF of 1.66; and ambulatory EF of 34.01 which, when combined with passive surveillance data, equates to an annual average (2006-2015) of 612 005 dengue cases, and 183 297 hospitalizations. These estimates are lower than those published elsewhere, perhaps due to case definitions, local clinical perceptions and treatment-seeking behavior. These findings complement global burden estimates, support health economic analyses, and can be used to inform decision-making.","['Wahyono, T Y M', 'Nealon, J', 'Beucher, S', 'Prayitno, A', 'Moureau, A', 'Nawawi, S', 'Thabrany, H', 'Nadjib, M']","['Wahyono TYM', 'Nealon J', 'Beucher S', 'Prayitno A', 'Moureau A', 'Nawawi S', 'Thabrany H', 'Nadjib M']",['ORCID: 0000-0003-1538-4636'],"['Center for Health Economics and Policy Studies, Universitas Indonesia,Depok,Indonesia.', 'Sanofi Pasteur,Asia & JPAC Region,Singapore.', 'Sanofi Pasteur,Asia & JPAC Region,Singapore.', 'Department of Child Health,Faculty of Medicine,University of Indonesia,Cipto Mangunkusumo Hospital,Jakarta,Indonesia.', ""Sanofi Pasteur,Marcy L'Etoile,France."", 'Sanofi Pasteur,Jakarta,Indonesia.', 'Center for Health Economics and Policy Studies, Universitas Indonesia,Depok,Indonesia.', 'Center for Health Economics and Policy Studies, Universitas Indonesia,Depok,Indonesia.']",['eng'],['Journal Article'],20170526,England,Epidemiol Infect,Epidemiology and infection,8703737,,IM,"['Delphi Technique', 'Dengue/*epidemiology/prevention & control/virology', 'Hospitalization/*statistics & numerical data', 'Humans', 'Indonesia/epidemiology', '*Population Surveillance']",PMC5647663,2017/05/27 06:00,2017/08/19 06:00,['2017/05/27 06:00'],"['2017/05/27 06:00 [pubmed]', '2017/08/19 06:00 [medline]', '2017/05/27 06:00 [entrez]']","['S0950268817001030 [pii]', '00103 [pii]', '10.1017/S0950268817001030 [doi]']",ppublish,Epidemiol Infect. 2017 Aug;145(11):2324-2329. doi: 10.1017/S0950268817001030. Epub 2017 May 26.,11,,['NOTNLM'],"['Delphi', 'Epidemiology', 'Indonesia', 'dengue', 'under-reporting']","['J.N., S.B., S.N. and A.M. are/were employees of Sanofi Pasteur, a company which', 'produces a vaccine against dengue. A.P. has acted as an investigator for research', 'studies funded by Sanofi Pasteur. T.Y.M.W., H.T. and M.N. declared no conflicts.']",,,,,,,,,,,,,,,,,,
26159629,NLM,MEDLINE,20161213,20180630,1873-0442 (Electronic) 1477-8939 (Linking),14,2016 Jan-Feb,Dengue fever in Czech travellers: A 10-year retrospective study in a tertiary care centre.,32-38,S1477-8939(15)00106-4 [pii] 10.1016/j.tmaid.2015.06.005 [doi],"BACKGROUND: Dengue fever is a frequent cause of morbidity in travellers. The objective was to describe the epidemiological and clinical characteristics of dengue fever in Czech travellers. METHOD: This descriptive study includes patients with acute dengue fever diagnosed at Hospital Na Bulovce during 2004-2013. Data were collected and analysed retrospectively. RESULTS: A total of 132 patients (83 males and 49 females) of median age 33 years (IQR 29-40) were included. Diagnosis was established by NS1 antigen detection in 87/107 cases (81.3%) and/or RT-PCR in 50/72 (69.4%) and by serology in 25 cases (18.9%). Dengue was acquired in South-East Asia in 69 cases (52.3%), followed by South Asia (48 cases; 36.3%), Latin America (14; 10.6%) and Sub-Saharan Africa (1; 0.8%). The most frequent symptoms included fever, rash and headache. Initial leukocyte and lymphocyte counts were lower in patients who presented in the early phase (0-4 days), however, platelet count was lower and AST, ALT and LDH activity higher in patients with a longer symptoms duration (>/=5 days). The clinical course was mostly uncomplicated. CONCLUSIONS: Dengue fever is becoming a frequent cause of fever in Czech travellers. Clinicians should be familiar with the typical clinical findings and novel diagnostic methods.","['Trojanek, Milan', 'Maixner, Jan', 'Sojkova, Nadezda', 'Kyncl, Jan', 'Rohacova, Hana', 'Maresova, Vilma', 'Stejskal, Frantisek']","['Trojanek M', 'Maixner J', 'Sojkova N', 'Kyncl J', 'Rohacova H', 'Maresova V', 'Stejskal F']",,"['1st Department of Infectious Diseases, 2nd Medical Faculty, Charles University in Prague, Budinova 2, 180 81 Prague, Czech Republic; Department of Infectious, Parasitic and Tropical Diseases, Hospital Na Bulovce, Budinova 2, 180 81 Prague, Czech Republic. Electronic address: milan.trojanek@bulovka.cz.', 'Department of Virology, Institute of Public Health in Usti nad Labem, Budinova 2, 180 81 Prague, Czech Republic.', 'Department of Virology, Institute of Public Health in Usti nad Labem, Budinova 2, 180 81 Prague, Czech Republic.', 'Department of Epidemiology of Infectious Diseases, National Institute of Public Health, Srobarova 48, 100 42 Prague, Czech Republic; Department of Epidemiology, 3rd Medical Faculty, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic.', '1st Department of Infectious Diseases, 2nd Medical Faculty, Charles University in Prague, Budinova 2, 180 81 Prague, Czech Republic; Department of Infectious, Parasitic and Tropical Diseases, Hospital Na Bulovce, Budinova 2, 180 81 Prague, Czech Republic.', '1st Department of Infectious Diseases, 2nd Medical Faculty, Charles University in Prague, Budinova 2, 180 81 Prague, Czech Republic; Department of Infectious, Parasitic and Tropical Diseases, Hospital Na Bulovce, Budinova 2, 180 81 Prague, Czech Republic.', '1st Department of Infectious Diseases, 2nd Medical Faculty, Charles University in Prague, Budinova 2, 180 81 Prague, Czech Republic; Department of Infectious, Parasitic and Tropical Diseases, Hospital Na Bulovce, Budinova 2, 180 81 Prague, Czech Republic; Institute of Immunology and Microbiology, 1st Medical Faculty, Charles University in Prague, Studnickova 7, 128 00 Prague, Czech Republic; Department of Infectious Diseases, Regional Hospital Liberec, Husova 10, 460 63 Liberec, Czech Republic.']",['eng'],['Journal Article'],20150625,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,,IM,"['Acute Disease', 'Adult', 'Asia/epidemiology', 'Asia, Southeastern/epidemiology', 'Czech Republic/epidemiology', 'Dengue/diagnosis/*epidemiology/prevention & control/*virology', 'Female', 'Fever', 'Hospitalization', 'Humans', 'Male', 'Retrospective Studies', '*Tertiary Care Centers', 'Time Factors', '*Travel']",,2015/07/15 06:00,2016/12/15 06:00,['2015/07/11 06:00'],"['2015/04/26 00:00 [received]', '2015/06/10 00:00 [revised]', '2015/06/12 00:00 [accepted]', '2015/07/11 06:00 [entrez]', '2015/07/15 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['S1477-8939(15)00106-4 [pii]', '10.1016/j.tmaid.2015.06.005 [doi]']",ppublish,Travel Med Infect Dis. 2016 Jan-Feb;14(1):32-38. doi: 10.1016/j.tmaid.2015.06.005. Epub 2015 Jun 25.,1,['Copyright (c) 2015 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Arthropod-borne viruses', 'Dengue', 'Fever', 'Travel-acquired infections', 'Travellers']",,,,,,,,,,,,,,,,,,,
16828097,NLM,MEDLINE,20070109,20161229,0020-7292 (Print) 0020-7292 (Linking),94,2006 Aug,Dengue infection in pregnancy.,131-2,,,"['Malhotra, N', 'Chanana, C', 'Kumar, S']","['Malhotra N', 'Chanana C', 'Kumar S']",,"['Department of Gynecology and Obstetrics, All India Institute of Medical Sciences, Sukhdev Vihar, New Delhi, India.']",['eng'],['Journal Article'],20060707,United States,Int J Gynaecol Obstet,International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,0210174,['362O9ITL9D (Acetaminophen)'],IM,"['Acetaminophen/therapeutic use', 'Dengue/diagnosis/*epidemiology/therapy', 'Diagnosis, Differential', '*Disease Outbreaks', 'Female', 'Humans', 'Platelet Transfusion', 'Pregnancy', 'Pregnancy Complications, Infectious/diagnosis/*epidemiology/therapy']",,2006/07/11 09:00,2007/01/11 09:00,['2006/07/11 09:00'],"['2005/12/15 00:00 [received]', '2006/04/17 00:00 [revised]', '2006/05/03 00:00 [accepted]', '2006/07/11 09:00 [pubmed]', '2007/01/11 09:00 [medline]', '2006/07/11 09:00 [entrez]']","['S0020-7292(06)00207-4 [pii]', '10.1016/j.ijgo.2006.05.002 [doi]']",ppublish,Int J Gynaecol Obstet. 2006 Aug;94(2):131-2. doi: 10.1016/j.ijgo.2006.05.002. Epub 2006 Jul 7.,2,,,,,,,,,,,,,,,,,,,,,,
14655536,NLM,MEDLINE,20040301,20141120,0012-7183 (Print) 0012-7183 (Linking),119,2003,[Dengue fever--an increasing global problem and illness of Finns traveling to exotic countries].,2051-61,,,"['Siikamaki, Heli', 'Vapalahti, Olli', 'Nohynek, Hanna']","['Siikamaki H', 'Vapalahti O', 'Nohynek H']",,"['HYKS Infektioklinikka, Auroran sairaala PL 348, 00029 HUS. heli.siikamaki@hus.fi']",['fin'],"['Case Reports', 'Journal Article', 'Review']",,Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,,IM,"['Adult', 'Animals', 'Culicidae', 'Dengue/*epidemiology/prevention & control/transmission', 'Diagnosis, Differential', 'Disease Vectors', 'Finland/epidemiology', '*Global Health', 'Humans', 'Male', '*Travel']",,2003/12/06 05:00,2004/03/03 05:00,['2003/12/06 05:00'],"['2003/12/06 05:00 [pubmed]', '2004/03/03 05:00 [medline]', '2003/12/06 05:00 [entrez]']",,ppublish,Duodecim. 2003;119(21):2051-61.,21,,,,,,,18,,Denguekuume--kasvava maailmanlaajuinen ongelma ja suomalaisten kaukomatkailijoiden tauti.,,,,,,,,,,,,,
17550466,NLM,MEDLINE,20070709,20230707,1360-2276 (Print) 1365-3156 (Electronic) 1360-2276 (Linking),12,2007 Jun,Towards a global dengue research agenda.,695-9,,,"['Farrar, J', 'Focks, D', 'Gubler, D', 'Barrera, R', 'Guzman, M G', 'Simmons, C', 'Kalayanarooj, S', 'Lum, L', 'McCall, P J', 'Lloyd, L', 'Horstick, O', 'Dayal-Drager, R', 'Nathan, M B', 'Kroeger, A']","['Farrar J', 'Focks D', 'Gubler D', 'Barrera R', 'Guzman MG', 'Simmons C', 'Kalayanarooj S', 'Lum L', 'McCall PJ', 'Lloyd L', 'Horstick O', 'Dayal-Drager R', 'Nathan MB', 'Kroeger A']",,,['eng'],"['Editorial', ""Research Support, Non-U.S. Gov't""]",,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,['0 (Antiviral Agents)'],IM,"['Animals', 'Antiviral Agents/therapeutic use', 'Dengue/*epidemiology/prevention & control/transmission', 'Health Policy', 'Humans', 'Insect Vectors', 'International Cooperation', 'Research/trends']",PMC4333199,2007/06/07 09:00,2007/07/10 09:00,['2007/06/07 09:00'],"['2007/06/07 09:00 [pubmed]', '2007/07/10 09:00 [medline]', '2007/06/07 09:00 [entrez]']","['TMI1838 [pii]', '10.1111/j.1365-3156.2007.01838.x [doi]']",ppublish,Trop Med Int Health. 2007 Jun;12(6):695-9. doi: 10.1111/j.1365-3156.2007.01838.x.,6,,,,,,"['WT_/Wellcome Trust/United Kingdom', '074636/WT_/Wellcome Trust/United Kingdom']",,,,['EMS30370'],['NLM: EMS30370'],,,,,,['WHO/TDR Dengue Scientific Working Group'],,,,,
18069294,NLM,MEDLINE,20080214,20190724,0021-5384 (Print) 0021-5384 (Linking),96,2007 Nov 10,[Mosquito-vector infections: Dengue fever].,2429-34,,,"['Tadano, Masayuki']",['Tadano M'],,,['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,,IM,"['Animals', 'Communicable Diseases, Emerging', '*Culicidae', 'Dengue/diagnosis/epidemiology/*transmission/*virology', 'Dengue Virus/*pathogenicity', 'Diagnosis, Differential', 'Global Health', 'Greenhouse Effect', 'Humans', '*Insect Vectors', 'Molecular Diagnostic Techniques', 'Serologic Tests', 'Severity of Illness Index', 'Travel']",,2007/12/12 09:00,2008/02/15 09:00,['2007/12/12 09:00'],"['2007/12/12 09:00 [pubmed]', '2008/02/15 09:00 [medline]', '2007/12/12 09:00 [entrez]']",['10.2169/naika.96.2429 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 2007 Nov 10;96(11):2429-34. doi: 10.2169/naika.96.2429.,11,,,,,,,0,,,,,,,,,,,,,,,
21099655,NLM,MEDLINE,20110302,20101124,1532-0987 (Electronic) 0891-3668 (Linking),29,2010 Dec,Fever and bleeding in a newborn baby.,1153-8,10.1097/INF.0b013e3181e50e24 [doi],,"['Bugna, Jimena', 'Moreno, Julio', 'Sanchez, Sandra', 'Sanchez, Isabel', 'Polack, Fernando P']","['Bugna J', 'Moreno J', 'Sanchez S', 'Sanchez I', 'Polack FP']",,"['Fundacion INFANT, Gavilan 94, 1406 Buenos Aires, Argentina. jbugna@infant.org.ar']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,,IM,"['Argentina', 'Dengue/*congenital/*diagnosis/pathology', 'Fever of Unknown Origin/*complications', 'Hemorrhage/*complications', 'Humans', 'Infant, Newborn', 'Infectious Disease Transmission, Vertical', 'Male']",,2010/11/26 06:00,2011/03/03 06:00,['2010/11/25 06:00'],"['2010/11/25 06:00 [entrez]', '2010/11/26 06:00 [pubmed]', '2011/03/03 06:00 [medline]']","['00006454-201012000-00025 [pii]', '10.1097/INF.0b013e3181e50e24 [doi]']",ppublish,Pediatr Infect Dis J. 2010 Dec;29(12):1153-8. doi: 10.1097/INF.0b013e3181e50e24.,12,,,,,,,,,,,,,,,,,,,,,,
12946298,NLM,MEDLINE,20031209,20190513,1195-1982 (Print) 1195-1982 (Linking),10,2003 Jul-Aug,Dengue Fever in travelers returning from southeast Asia.,208-13,,"BACKGROUND: Dengue fever is an important illness facing travelers from nonendemic to endemic countries. METHODS: We reviewed 696 consecutive returned travelers managed at an Australian tertiary-care hospital for an illness acquired overseas. Patients with dengue fever were compared to those with a dengue-like illness, malaria, typhoid fever and rickettsial infections. RESULTS: In total, 19 cases of dengue fever and 20 cases of dengue-like illness were diagnosed, with 85% of cases acquired in Asia. The most common presenting features of dengue were fever (100%), myalgia (79%), rash (74%), headache (68%), nausea (37%), and diarrhea (37%). Compared to those with malaria, typhoid fever and rickettsial infections, patients with dengue were significantly more likely to have myalgia and a temperature <39 degrees C. Compared to all other illnesses in our returned travelers, dengue fever was 18 times more likely if fever and leukopenia were present, 71 times if fever and rash were present, and 230 times if fever, rash and leukopenia were present. All patients with dengue recovered completely. CONCLUSIONS: Dengue fever is an important health problem for travelers not only to Southeast Asia but to all endemic countries. The prevalence appears to be increasing in travelers, and health care professionals need to be familiar with its presentation in travelers. The clinical presenting features provide important guides to establishing the diagnosis.","['Sung, Valerie', ""O'Brien, Daniel P"", 'Matchett, Elizabeth', 'Brown, Graham V', 'Torresi, Joseph']","['Sung V', ""O'Brien DP"", 'Matchett E', 'Brown GV', 'Torresi J']",,"['Victorian Infectious Disease Service, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adolescent', 'Adult', 'Asia, Southeastern', 'Dengue/blood/*epidemiology/etiology/pathology', 'Female', 'Humans', 'Leukocyte Count', 'Male', 'Medical Records', 'Middle Aged', 'Retrospective Studies', '*Travel', 'Victoria/epidemiology']",,2003/08/30 05:00,2003/12/11 05:00,['2003/08/30 05:00'],"['2003/08/30 05:00 [pubmed]', '2003/12/11 05:00 [medline]', '2003/08/30 05:00 [entrez]']",['10.2310/7060.2003.40555 [doi]'],ppublish,J Travel Med. 2003 Jul-Aug;10(4):208-13. doi: 10.2310/7060.2003.40555.,4,,,,,,,,,,,,,,,,,,,,,,
19389025,NLM,MEDLINE,20090731,20171116,1537-2995 (Electronic) 0041-1132 (Linking),49,2009 Jul,"The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia.",1482-7,10.1111/j.1537-2995.2009.02159.x [doi],"BACKGROUND: Dengue virus (DENV) is a Flavivirus transmitted by the Aedes mosquito. The related arbovirus, West Nile virus, has been shown to be transfusion transmitted, which, added to the four recorded dengue transfusion-associated cases, indicates that DENV is also transfusion transmitted. The purpose of this study was to assess the risk of transfusion-transmitted DENV during a 2004 outbreak in the Australian city of Cairns. STUDY DESIGN AND METHODS: A mathematical model was constructed to estimate the risk of transfusion-transmitted dengue. The model's central premise is that the transmission risk is proportional to the frequency of dengue-viremic donations and correlates with the incidence of asymptomatic dengue viremia among the population at large. RESULTS: The modeling predicted that the total number of DENV infections (clinical plus subclinical) among the population at large during the entire outbreak ranged from 156 to 569 with the epidemic peak occurring between February 8 and March 6, 2004. The overall transmission risk during the entire outbreak was estimated as 1 in 19,759 (range, 1 in 3404 to 75,486) peaking at 1 in 5968 (range 1 in 1028 to 22,800). CONCLUSION: By use of the most conservative estimates for key variables, the risk of collecting a viremic donation could have been as high as 1 in 1028 during the peak of the 2004 outbreak. The model can be used to determine transfusion transmission risk levels during DENV outbreaks and inform decisions as to when fresh component restriction measures are required to minimize transfusion transmission risk.","['Seed, Clive R', 'Kiely, Philip', 'Hyland, Catherine A', 'Keller, Anthony J']","['Seed CR', 'Kiely P', 'Hyland CA', 'Keller AJ']",,"['Australian Red Cross Blood Service, University of Western Australia, 69 Walters Drive, Osborne Park, WA 6017, Australia. cseed@arcbs.redcross.org.au']",['eng'],['Journal Article'],20090331,United States,Transfusion,Transfusion,0417360,,IM,"['Australia/epidemiology', 'Dengue/*epidemiology/*transmission/virology', 'Humans', 'Models, Theoretical', 'Risk Assessment', '*Transfusion Reaction']",,2009/04/25 09:00,2009/08/01 09:00,['2009/04/25 09:00'],"['2009/04/25 09:00 [entrez]', '2009/04/25 09:00 [pubmed]', '2009/08/01 09:00 [medline]']","['TRF02159 [pii]', '10.1111/j.1537-2995.2009.02159.x [doi]']",ppublish,Transfusion. 2009 Jul;49(7):1482-7. doi: 10.1111/j.1537-2995.2009.02159.x. Epub 2009 Mar 31.,7,,,,,,,,,,,,,,,,,,,,,,
25230594,NLM,MEDLINE,20150402,20220409,1474-547X (Electronic) 0140-6736 (Linking),385,2015 Jan 31,Dengue.,453-65,S0140-6736(14)60572-9 [pii] 10.1016/S0140-6736(14)60572-9 [doi],"Dengue viruses have spread rapidly within countries and across regions in the past few decades, resulting in an increased frequency of epidemics and severe dengue disease, hyperendemicity of multiple dengue virus serotypes in many tropical countries, and autochthonous transmission in Europe and the USA. Today, dengue is regarded as the most prevalent and rapidly spreading mosquito-borne viral disease of human beings. Importantly, the past decade has also seen an upsurge in research on dengue virology, pathogenesis, and immunology and in development of antivirals, vaccines, and new vector-control strategies that can positively impact dengue control and prevention.","['Guzman, Maria G', 'Harris, Eva']","['Guzman MG', 'Harris E']",,"['Pedro Kouri Tropical Medicine Institute, Havana, Cuba. Electronic address: lupe@ipk.sld.cu.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA. Electronic address: eharris@berkeley.edu.']",['eng'],"['Journal Article', 'Review']",20140914,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['*Dengue/diagnosis/immunology/transmission', 'Dengue Virus/genetics/immunology/physiology', 'Humans']",,2014/09/19 06:00,2015/04/04 06:00,['2014/09/19 06:00'],"['2014/09/19 06:00 [entrez]', '2014/09/19 06:00 [pubmed]', '2015/04/04 06:00 [medline]']","['S0140-6736(14)60572-9 [pii]', '10.1016/S0140-6736(14)60572-9 [doi]']",ppublish,Lancet. 2015 Jan 31;385(9966):453-65. doi: 10.1016/S0140-6736(14)60572-9. Epub 2014 Sep 14.,9966,['Copyright (c) 2015 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
34342343,NLM,MEDLINE,20210820,20210820,2972-4066 (Electronic) 0304-4602 (Linking),50,2021 Jul,Permanent visual impairment in dengue fever following platelet transfusion: A series of 5 cases.,588-592,10.47102/annals-acadmedsg.202154 [doi],,"['Sanjay, Srinivasan', 'Agrawal, Sameeksha', 'Jain, Pooja', 'Mahendradas, Padmamalini', 'Kawali, Ankush', 'Shetty, Naren']","['Sanjay S', 'Agrawal S', 'Jain P', 'Mahendradas P', 'Kawali A', 'Shetty N']",,"['Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bengaluru, India.']",['eng'],['Journal Article'],,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,,IM,"['*Dengue/complications/therapy', 'Humans', '*Platelet Transfusion', 'Vision Disorders/etiology']",,2021/08/04 06:00,2021/08/21 06:00,['2021/08/03 08:52'],"['2021/08/03 08:52 [entrez]', '2021/08/04 06:00 [pubmed]', '2021/08/21 06:00 [medline]']",['10.47102/annals-acadmedsg.202154 [doi]'],ppublish,Ann Acad Med Singap. 2021 Jul;50(7):588-592. doi: 10.47102/annals-acadmedsg.202154.,7,,,,,,,,,,,,,,,,,,,,,,
15116315,NLM,MEDLINE,20040604,20121115,0022-1899 (Print) 0022-1899 (Linking),189,2004 May 1,Experimental investigations regarding the etiology of dengue fever. 1907.,1747-83; discussion 1744-6,,,"['Ashburn, P M', 'Craig, Charles F']","['Ashburn PM', 'Craig CF']",,,['eng'],"['Biography', 'Classical Article', 'Historical Article', 'Journal Article']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,,IM,"['Animals', 'Culex/virology', 'Dengue/*etiology/*history/transmission', 'History, 20th Century', 'Humans', 'Research/*history', 'Research Design']",,2004/04/30 05:00,2004/06/05 05:00,['2004/04/30 05:00'],"['2004/04/30 05:00 [pubmed]', '2004/06/05 05:00 [medline]', '2004/04/30 05:00 [entrez]']","['JID32484 [pii]', '10.1086/383418 [doi]']",ppublish,J Infect Dis. 2004 May 1;189(9):1747-83; discussion 1744-6. doi: 10.1086/383418.,9,,,,,,,,,,,,,,,,,['US Army Board for the Study of Tropical Diseases'],,,"['Ashburn PM', 'Craig CF']","['Ashburn, P M', 'Craig, Charles F']",
15521519,NLM,MEDLINE,20050429,20191026,0036-3634 (Print) 0036-3634 (Linking),46,2004 Sep-Oct,[Factors involved in the onset of a dengue epidemic].,373,,,"['Mota, Javier']",['Mota J'],,,['spa'],['Letter'],,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Dengue/*epidemiology/transmission', '*Disease Outbreaks', 'Humans', 'Mexico/epidemiology']",,2004/11/04 09:00,2005/04/30 09:00,['2004/11/04 09:00'],"['2004/11/04 09:00 [pubmed]', '2005/04/30 09:00 [medline]', '2004/11/04 09:00 [entrez]']",['10.1590/s0036-36342004000500001 [doi]'],ppublish,Salud Publica Mex. 2004 Sep-Oct;46(5):373. doi: 10.1590/s0036-36342004000500001.,5,,,,,,,,,Factores que intervienen en la genesis de una epidemia por dengue.,,,,,,,,,,,,,
29067972,NLM,MEDLINE,20180709,20220316,0971-5916 (Print) 0971-5916 (Linking),145,2017 Jun,Challenges & options in dengue prevention & control: A perspective from the 2015 outbreak.,718-721,10.4103/ijmr.IJMR_1325_16 [doi],,"['Jain, Siddharth', 'Sharma, Surendra K']","['Jain S', 'Sharma SK']",,"['Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.', 'Adjunct Professor, Department of Molecular Medicine, Jamia Hamdard Institute of Molecular Medicine, Hamdard University, New Delhi; Director Research and Adjunct Professor, Departments of General Medicine and Pulmonary Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India.']",['eng'],['Journal Article'],,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Animals', 'Dengue/epidemiology/*prevention & control/transmission/virology', 'Dengue Virus/*pathogenicity', '*Disease Outbreaks', 'Humans', 'India/epidemiology', 'Insect Vectors/pathogenicity/virology']",PMC5674540,2017/10/27 06:00,2018/07/10 06:00,['2017/10/26 06:00'],"['2017/10/26 06:00 [entrez]', '2017/10/27 06:00 [pubmed]', '2018/07/10 06:00 [medline]']","['IndianJMedRes_2017_145_6_718_216962 [pii]', 'IJMR-145-718 [pii]', '10.4103/ijmr.IJMR_1325_16 [doi]']",ppublish,Indian J Med Res. 2017 Jun;145(6):718-721. doi: 10.4103/ijmr.IJMR_1325_16.,6,,,,['Conflicts of Interest: None.'],,,,,,,,,,,,,,,,,,
20360406,NLM,MEDLINE,20100716,20161020,1526-3347 (Electronic) 0191-9601 (Linking),31,2010 Apr,Diagnosis and management of dengue fever in children.,e28-35,10.1542/pir.31-4-e28 [doi],,"['Kaushik, Ashlesha', 'Pineda, Carol', 'Kest, Helen']","['Kaushik A', 'Pineda C', 'Kest H']",,"[""Department of Pediatrics, St Joseph's Children's Hospital, Patterson, NJ, USA.""]",['eng'],"['Journal Article', 'Review']",,United States,Pediatr Rev,Pediatrics in review,8103046,"['0 (Analgesics, Non-Narcotic)', '362O9ITL9D (Acetaminophen)']",IM,"['Acetaminophen/therapeutic use', 'Adolescent', 'Analgesics, Non-Narcotic/therapeutic use', 'Animals', 'Child', 'Culicidae/growth & development', 'Dengue/complications/*diagnosis/*drug therapy/prevention & control', 'Female', 'Humans', 'Male', 'Severity of Illness Index', 'Travel']",,2010/04/03 06:00,2010/07/17 06:00,['2010/04/03 06:00'],"['2010/04/03 06:00 [entrez]', '2010/04/03 06:00 [pubmed]', '2010/07/17 06:00 [medline]']","['31/4/e28 [pii]', '10.1542/pir.31-4-e28 [doi]']",ppublish,Pediatr Rev. 2010 Apr;31(4):e28-35. doi: 10.1542/pir.31-4-e28.,4,,,,,,,32,,,,,,,,,,,,,,,
32776660,NLM,MEDLINE,20220103,20220103,1099-1654 (Electronic) 1052-9276 (Linking),31,2021 Jan,Association of dengue disease severity and blood group: A systematic review and meta-analysis.,1-9,10.1002/rmv.2147 [doi],"Dengue disease encompasses various clinical manifestations including dengue fever (DF) and dengue hemorrhagic fever (DHF). In this article, we aimed to systematically review and analyze the association between different blood groups and severity of dengue. We searched nine databases for eligible papers reporting prevalence, distribution, and frequency of blood group type among dengue patients. Network meta-analysis using R software was used to analyze the data. Of a total of 63 reports screened, we included 10 studies with total sample size 1977 patients (1382 DF and 595 DHF). Blood group O was found to have the worst outcome with the highest risk of developing DF (P-score = 0.01) followed by group B (P-score = 0.34), group A (P-score = 0.64), and group AB (P-score = 1), respectively. Blood group O also had the worst outcome with highest risk of developing DHF (P-score = 0.1) followed by group B (P-score = 0.29), group A (P-score = 0.61), and group AB (P-score = 1), respectively. There was a significant increase (P-value <.001) in the overall odds risk of dengue infection among patients with Rhesus-positive blood groups [OR = 540.03; (95% CI = 151.48-1925.18)]. However, there was no significant difference in the odds risk of DF when compared to DHF according to Rhesus status (P-value = .954). This study identified the O blood group as a potential risk factor in predicting clinical severity in dengue patients which may be helpful in evaluating patients for their likely need for critical care.","['Hashan, Mohammad Rashidul', 'Ghozy, Sherief', 'El-Qushayri, Amr Ehab', 'Pial, Rejwana Haque', 'Hossain, Md Anwar', 'Al Kibria, Gulam Muhammed']","['Hashan MR', 'Ghozy S', 'El-Qushayri AE', 'Pial RH', 'Hossain MA', 'Al Kibria GM']","['ORCID: 0000-0002-1627-4976', 'ORCID: 0000-0001-5629-3023', 'ORCID: 0000-0002-7012-7889', 'ORCID: 0000-0001-8215-9792', 'ORCID: 0000-0002-7037-6658']","['Bangladesh Civil Service, Ministry of Health and Family Welfare, Government of Bangladesh, Dhaka, Bangladesh.', 'Faculty of Medicine, Mansoura University, Mansoura, Egypt.', 'Faculty of Medicine, Minia University, Minia, Egypt.', 'Infectious Disease Division, International Center for Diarrheal Disease Research, Dhaka, Bangladesh.', 'Infectious Disease Division, International Center for Diarrheal Disease Research, Dhaka, Bangladesh.', 'Department of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.']",['eng'],"['Journal Article', 'Meta-Analysis', 'Review', 'Systematic Review']",20200810,England,Rev Med Virol,Reviews in medical virology,9112448,['0 (Blood Group Antigens)'],IM,"['*Blood Group Antigens', '*Dengue/diagnosis/epidemiology', 'Humans', 'Severity of Illness Index']",,2020/08/11 06:00,2022/01/04 06:00,['2020/08/11 06:00'],"['2020/04/14 00:00 [received]', '2020/06/27 00:00 [revised]', '2020/06/29 00:00 [accepted]', '2020/08/11 06:00 [pubmed]', '2022/01/04 06:00 [medline]', '2020/08/11 06:00 [entrez]']",['10.1002/rmv.2147 [doi]'],ppublish,Rev Med Virol. 2021 Jan;31(1):1-9. doi: 10.1002/rmv.2147. Epub 2020 Aug 10.,1,"['(c) 2020 John Wiley & Sons, Ltd.']",['NOTNLM'],"['blood group', 'dengue', 'severity']",,,,,,,,,,,,,,,,,,,
23437406,NLM,MEDLINE,20130729,20231104,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),7,2013,Economic and disease burden of dengue in Southeast Asia.,e2055,10.1371/journal.pntd.0002055 [doi] e2055,"BACKGROUND: Dengue poses a substantial economic and disease burden in Southeast Asia (SEA). Quantifying this burden is critical to set policy priorities and disease-control strategies. METHODS AND FINDINGS: We estimated the economic and disease burden of dengue in 12 countries in SEA: Bhutan, Brunei, Cambodia, East-Timor, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Viet Nam. We obtained reported cases from multiple sources--surveillance data, World Health Organization (WHO), and published studies--and adjusted for underreporting using expansion factors from previous literature. We obtained unit costs per episode through a systematic literature review, and completed missing data using linear regressions. We excluded costs such as prevention and vector control, and long-term sequelae of dengue. Over the decade of 2001-2010, we obtained an annual average of 2.9 million (m) dengue episodes and 5,906 deaths. The annual economic burden (with 95% certainty levels) was US$950m (US$610m-US$1,384m) or about US$1.65 (US$1.06-US$2.41) per capita. The annual number of disability-adjusted life years (DALYs), based on the original 1994 definition, was 214,000 (120,000-299,000), which is equivalent to 372 (210-520) DALYs per million inhabitants. CONCLUSION: Dengue poses a substantial economic and disease burden in SEA with a DALY burden per million inhabitants in the region. This burden is higher than that of 17 other conditions, including Japanese encephalitis, upper respiratory infections, and hepatitis B.","['Shepard, Donald S', 'Undurraga, Eduardo A', 'Halasa, Yara A']","['Shepard DS', 'Undurraga EA', 'Halasa YA']",,"['Schneider Institutes for Health Policy, Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA. shepard@brandeis.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",20130221,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Asia, Southeastern/epidemiology', '*Cost of Illness', 'Dengue/*economics/*epidemiology/mortality', 'Health Care Costs', 'Humans', 'Survival Analysis']",PMC3578748,2013/02/26 06:00,2013/07/31 06:00,['2013/02/26 06:00'],"['2012/08/03 00:00 [received]', '2012/12/26 00:00 [accepted]', '2013/02/26 06:00 [entrez]', '2013/02/26 06:00 [pubmed]', '2013/07/31 06:00 [medline]']","['PNTD-D-12-00973 [pii]', '10.1371/journal.pntd.0002055 [doi]']",ppublish,PLoS Negl Trop Dis. 2013;7(2):e2055. doi: 10.1371/journal.pntd.0002055. Epub 2013 Feb 21.,2,,,,['The authors have declared that no competing interests exist.'],"['Use of Expansion Factors to Estimate the Burden of Dengue in Southeast Asia: a', 'Systematic Analysis.']",,,,,,,,,,,,,,,,,
1633562,NLM,MEDLINE,19920826,20061115,0001-4079 (Print) 0001-4079 (Linking),176,1992 Feb,[Recent data on the epidemiology of dengue fever].,223-36; discussion 236-9,,"Because of its haemorrhagic forms often with shock syndrome, dengue fever is presently one of the most important pediatric health problems, particularly in South-east Asia. The natural reservoir of dengue is now constituted by urban human populations; travellers are the only dissemination factor of the viruses from one country to another, and all vectors are domestic species of the genus Aedes; in these mosquitoes, a vertical transmission can take place. The persistence mechanisms of dengue fever are closely related to demographic explosion, uncontrolled growth of towns and deterioration of urban environment which comes of it. The spreading mechanisms of outbreaks are related to dramatic increase of travels and the variable susceptibility of the natural Aedes populations to the viruses. All these factors appear to be directly connected with human activities; they were submitted to considerable changes since World War II and the epidemiology of the disease has been widely modified; the incidence of the disease is continuously growing year after year, building up a very worrying situation, more especially as we have no etiologic treatment nor vaccine against it.","['Rodhain, F']",['Rodhain F'],,"[""Unite d'Ecologie des Systemes Vectoriels, Institut Pasteur, Paris.""]",['fre'],"['English Abstract', 'Journal Article']",,Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,IM,"['Asia, Southeastern/epidemiology', 'Dengue/*epidemiology/prevention & control', 'Humans']",,1992/02/01 00:00,1992/02/01 00:01,['1992/02/01 00:00'],"['1992/02/01 00:00 [pubmed]', '1992/02/01 00:01 [medline]', '1992/02/01 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1992 Feb;176(2):223-36; discussion 236-9.,2,,,,,,,,,Quelques donnees recentes concernant l'epidemiologie de la dengue.,,,,,,,,,,,,,
16294811,NLM,MEDLINE,20060531,20071115,0972-9062 (Print) 0972-9062 (Linking),42,2005 Sep,Awareness about dengue syndrome and related preventive practices amongst residents of an urban resettlement colony of south Delhi.,122-7,,,"['Acharya, Anita', 'Goswami, K', 'Srinath, S', 'Goswami, A']","['Acharya A', 'Goswami K', 'Srinath S', 'Goswami A']",,"['Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India. dranitaacharya@yahoo.co.in']",['eng'],"['Comparative Study', 'Journal Article']",,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['Adolescent', 'Adult', 'Dengue/etiology/*prevention & control/transmission', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'India', 'Interviews as Topic', 'Male', 'Middle Aged', 'Social Class', 'Urban Population/*statistics & numerical data']",,2005/11/22 09:00,2006/06/01 09:00,['2005/11/22 09:00'],"['2005/11/22 09:00 [pubmed]', '2006/06/01 09:00 [medline]', '2005/11/22 09:00 [entrez]']",,ppublish,J Vector Borne Dis. 2005 Sep;42(3):122-7.,3,,,,,,,,,,,,,,,,,,,,,,
35364020,NLM,MEDLINE,20220603,20220621,1474-4457 (Electronic) 1473-3099 (Linking),22,2022 Jun,Dengue vaccines: where are we now and where we are going?,756-757,S1473-3099(21)00753-2 [pii] 10.1016/S1473-3099(21)00753-2 [doi],,"['Amorim, Jaime Henrique', 'Birbrair, Alexander']","['Amorim JH', 'Birbrair A']",,"['Laboratory of Infectious Agents and Vectors, Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, CEP 47810-047, BA, Brazil. Electronic address: jaime.amorim@ufob.edu.br.', 'Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.']",['eng'],"['Comment', 'Journal Article']",20220329,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,"['0 (Dengue Vaccines)', '0 (Vaccines, Attenuated)']",IM,"['*Dengue/epidemiology/prevention & control', '*Dengue Vaccines', '*Dengue Virus', 'Humans', 'Vaccines, Attenuated']",,2022/04/02 06:00,2022/06/07 06:00,['2022/04/01 20:10'],"['2021/11/23 00:00 [received]', '2021/11/23 00:00 [accepted]', '2022/04/02 06:00 [pubmed]', '2022/06/07 06:00 [medline]', '2022/04/01 20:10 [entrez]']","['S1473-3099(21)00753-2 [pii]', '10.1016/S1473-3099(21)00753-2 [doi]']",ppublish,Lancet Infect Dis. 2022 Jun;22(6):756-757. doi: 10.1016/S1473-3099(21)00753-2. Epub 2022 Mar 29.,6,,,,['We declare no competing interests.'],,,,['Lancet Infect Dis. 2022 Jun;22(6):901-911. PMID: 35364022'],,,,,,,,,,,,,,
29512853,NLM,MEDLINE,20181121,20211204,1399-3062 (Electronic) 1398-2273 (Linking),20,2018 Jun,Dengue fever in renal allograft recipients: Clinical course and outcome.,e12875,10.1111/tid.12875 [doi],"BACKGROUND: There are annual outbreaks of dengue infection in tropical and subtropical countries. This retrospective study aimed to assess the clinical manifestation of dengue and outcome in renal transplant recipients. METHODS: Renal transplant recipients diagnosed with dengue in the nephrology department during the outbreak from August 2015 to December 2015 were included in the study. RESULTS: Twenty patients developed dengue presenting during the outbreak. Mean age was 31.9 +/- 8.8 years and all were males. Two patients had severe dengue (dengue hemorrhagic fever, dengue shock syndrome). Clinical presentation included febrile illness (95%), myalgia (65%), headache (30%), retro-orbital pain (10%), and mucocutaneous bleeding manifestations (10%). Three (15%) had third space fluid accumulation and 2 (10%) had hypotension. Ninety percent patients had thrombocytopenia, with 4 requiring platelet transfusion. Leucopenia (WBC < 4000/mm(3) ) developed in 50% patients. About 60% had transient transaminitis. One patient with severed dengue expired and 1 recovered with IV immunoglobulin therapy. About 40% patients had rise in serum creatinine, with complete recovery in all patients. CONCLUSION: Clinical manifestations of dengue infection in renal transplant recipients were similar to that in general population. However, leucopenia necessitating temporary withdrawal of immunosuppression was common. Renal dysfunction was frequent but completely reversible.","['Subbiah, Arunkumar', 'Bagchi, Soumita', 'Bhowmik, Dipankar', 'Mahajan, Sandeep', 'Yadav, Raj K', 'Chhabra, Yogesh', 'Agarwal, Sanjay']","['Subbiah A', 'Bagchi S', 'Bhowmik D', 'Mahajan S', 'Yadav RK', 'Chhabra Y', 'Agarwal S']","['ORCID: 0000-0001-5925-9111', 'ORCID: 0000-0003-1562-9912']","['Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.', 'Department of Nephrology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.']",['eng'],['Journal Article'],20180330,Denmark,Transpl Infect Dis,Transplant infectious disease : an official journal of the Transplantation Society,100883688,,IM,"['Adult', 'Dengue/diagnosis/*epidemiology/etiology/virology', 'Disease Outbreaks', 'Humans', 'Immunosuppression Therapy', 'Kidney/pathology/virology', 'Kidney Transplantation/*adverse effects', 'Leukopenia', 'Male', 'Retrospective Studies', 'Severe Dengue/*epidemiology/etiology/virology', 'Transplant Recipients/*statistics & numerical data', 'Transplantation, Homologous/*adverse effects', 'Young Adult']",,2018/03/08 06:00,2018/11/22 06:00,['2018/03/08 06:00'],"['2017/09/19 00:00 [received]', '2017/12/04 00:00 [accepted]', '2018/03/08 06:00 [pubmed]', '2018/11/22 06:00 [medline]', '2018/03/08 06:00 [entrez]']",['10.1111/tid.12875 [doi]'],ppublish,Transpl Infect Dis. 2018 Jun;20(3):e12875. doi: 10.1111/tid.12875. Epub 2018 Mar 30.,3,['(c) 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],['NOTNLM'],"['dengue', 'outcome', 'renal transplantation']",,,,,,,,,,,,,,,,,,,
34850225,NLM,MEDLINE,20220302,20220302,1460-2393 (Electronic) 1460-2393 (Linking),115,2022 Feb 21,Hemolytic anemia in expanded dengue syndrome.,103-104,10.1093/qjmed/hcab298 [doi],,"['Arora, N', 'Gulati, P', 'Suri, V', 'Bhalla, A', 'Singh, H']","['Arora N', 'Gulati P', 'Suri V', 'Bhalla A', 'Singh H']","['ORCID: 0000-0002-4507-2468', 'ORCID: 0000-0001-6379-2744']","['Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.', 'Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.', 'Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.', 'Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.', 'Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.']",['eng'],['Journal Article'],,England,QJM,QJM : monthly journal of the Association of Physicians,9438285,,IM,"['*Anemia, Hemolytic/etiology', '*Dengue/complications/diagnosis', 'Humans', 'Syndrome']",,2021/12/02 06:00,2022/03/03 06:00,['2021/12/01 07:30'],"['2021/11/20 00:00 [received]', '2021/12/02 06:00 [pubmed]', '2022/03/03 06:00 [medline]', '2021/12/01 07:30 [entrez]']","['6443169 [pii]', '10.1093/qjmed/hcab298 [doi]']",ppublish,QJM. 2022 Feb 21;115(2):103-104. doi: 10.1093/qjmed/hcab298.,2,,,,,,,,,,,,,,,,,,,,,,
12133691,NLM,MEDLINE,20020806,20150616,0140-6736 (Print) 0140-6736 (Linking),360,2002 Jul 20,Encephalitis and dengue.,261,,,"['Garcia-Rivera, Enid J', 'Rigau-Perez, Jose G']","['Garcia-Rivera EJ', 'Rigau-Perez JG']",,,['eng'],"['Comment', 'Letter']",,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Child', 'Dengue/diagnosis/*physiopathology', 'Diagnosis, Differential', 'Encephalitis/*diagnosis', 'Humans']",,2002/07/23 10:00,2002/08/07 10:01,['2002/07/23 10:00'],"['2002/07/23 10:00 [pubmed]', '2002/08/07 10:01 [medline]', '2002/07/23 10:00 [entrez]']","['S0140-6736(02)09481-3 [pii]', '10.1016/S0140-6736(02)09481-3 [doi]']",ppublish,Lancet. 2002 Jul 20;360(9328):261. doi: 10.1016/S0140-6736(02)09481-3.,9328,,,,,,,,"['Lancet. 2000 Mar 25;355(9209):1053-9. PMID: 10744091', 'Lancet. 2002 Feb 9;359(9305):507-13. PMID: 11853816']",,,,,,,,,,,,,,
25474614,NLM,MEDLINE,20161006,20220318,2150-4113 (Electronic) 1079-0969 (Linking),16,2014 Jun 14,"Social justice, climate change, and dengue.",93-104,,"Climate change should be viewed fundamentally as an issue of global justice. Understanding the complex interplay of climatic and socioeconomic trends is imperative to protect human health and lessen the burden of diseases such as dengue fever. Dengue fever is rapidly expanding globally. Temperature, rainfall, and frequency of natural disasters, as well as non-climatic trends involving population growth and migration, urbanization, and international trade and travel, are expected to increase the prevalence of mosquito breeding sites, mosquito survival, the speed of mosquito reproduction, the speed of viral incubation, the distribution of dengue virus and its vectors, human migration patterns towards urban areas, and displacement after natural disasters. The burden of dengue disproportionately affects the poor due to increased environmental risk and decreased health care. Mobilization of social institutions is needed to improve the structural inequalities of poverty that predispose the poor to increased dengue fever infection and worse outcomes. This paper reviews the link between dengue and climatic factors as a starting point to developing a comprehensive understanding of how climate change affects dengue risk and how institutions can address the issues of social justice and dengue outbreaks that increasingly affect vulnerable urban populations.","['Chang, Aileen Y', 'Fuller, Douglas O', 'Carrasquillo, Olveen', 'Beier, John C']","['Chang AY', 'Fuller DO', 'Carrasquillo O', 'Beier JC']",,"['Clinical Instructor of Medicine at the in the Department of General Internal Medicine at the University of Miami.', 'Professor of Geography in the College of Arts and Sciences at the University of Miami.', 'Professor of Medicine and Public Health Sciences in the Department of General Internal Medicine at the University of Miami.', 'Professor of Epidemiology and Public Health Sciences at the University of Miami.']",['eng'],"['Journal Article', 'Review']",20140614,United States,Health Hum Rights,Health and human rights,9502498,,IM,"['*Climate Change', 'Dengue/*epidemiology/etiology', 'Disasters', 'Humans', '*Social Justice', 'Vulnerable Populations']",,2014/12/05 06:00,2016/10/08 06:00,['2014/12/05 06:00'],"['2014/12/05 06:00 [entrez]', '2014/12/05 06:00 [pubmed]', '2016/10/08 06:00 [medline]']",,epublish,Health Hum Rights. 2014 Jun 14;16(1):93-104.,1,"['Copyright (c) 2014 Chang, Fuller, Carrasquillo, Beier. This is an open access', 'article distributed under the terms of the Creative Commons Attribution', 'Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which', 'permits unrestricted non-commercial use, distribution, and reproduction in any', 'medium, provided the original author and source are credited.']",,,,,,,,,,,,,,,,,,,,,
20739796,NLM,MEDLINE,20101026,20100826,0028-3886 (Print) 0028-3886 (Linking),58,2010 Jul-Aug,Neurological complication of dengue infection.,581-4,10.4103/0028-3886.68654 [doi],"Dengue infection is endemic in more than 100 countries, mostly in the developing world. Recent observations indicate that the clinical profile of dengue is changing, and that neurological manifestations are being reported more frequently. The exact incidence of various neurological complications is uncertain. The pathogenesis of neurological manifestations is multiple and includes: neurotrophic effect of the dengue virus, related to the systemic effects of dengue infection, and immune mediated. In countries endemic to dengue, it will be prudent to investigate for dengue infection in patients with fever and acute neurological manifestations. There is need for understanding of the pathogenesis of various neurological manifestations.","['Murthy, J M K']",['Murthy JM'],,"['Department of Neurology, the Institute of Neurological Sciences, CARE Hospital, Hyderabad, India. jmkmurthy@satyam.net.in']",['eng'],"['Journal Article', 'Review']",,India,Neurol India,Neurology India,0042005,,IM,"['Dengue/*complications/epidemiology/virology', 'Dengue Virus/*physiology', 'Humans', 'India/epidemiology', 'Nervous System Diseases/classification/*etiology/*virology']",,2010/08/27 06:00,2010/10/27 06:00,['2010/08/27 06:00'],"['2010/08/27 06:00 [entrez]', '2010/08/27 06:00 [pubmed]', '2010/10/27 06:00 [medline]']","['ni_2010_58_4_581_68654 [pii]', '10.4103/0028-3886.68654 [doi]']",ppublish,Neurol India. 2010 Jul-Aug;58(4):581-4. doi: 10.4103/0028-3886.68654.,4,,,,,,,,,,,,,,,,,,,,,,
2812084,NLM,MEDLINE,19891201,20041117,0028-2162 (Print) 0028-2162 (Linking),133,1989 Oct 7,"[Dengue; fever, exanthema and arthralgia].",1977-8,,,"['Kager, P A']",['Kager PA'],,,['dut'],"['Case Reports', 'Journal Article']",,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,"['0 (Antibodies, Viral)']",IM,"['Adult', 'Antibodies, Viral/isolation & purification', 'Dengue/*diagnosis/immunology/transmission', 'Dengue Virus/immunology', 'Female', 'Humans', 'Male', 'Travel']",,1989/10/07 00:00,1989/10/07 00:01,['1989/10/07 00:00'],"['1989/10/07 00:00 [pubmed]', '1989/10/07 00:01 [medline]', '1989/10/07 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1989 Oct 7;133(40):1977-8.,40,,,,,,,,,"Dengue; koorts, exantheem en gewrichtspijn.",,,,,,,,,,,,,
30124409,NLM,MEDLINE,20190422,20190422,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),24,2018 Sep,"Estimating Frequency of Probable Autochthonous Cases of Dengue, Japan.",1705-1708,10.3201/eid2409.170408 [doi],"Imported dengue into naive areas is a recognized but unquantified threat. Differentiating imported and autochthonous cases remains problematic. A threshold approach applied to Japan identified several aberrant incidences of dengue. Despite these alerts, no epidemics occurred other than 1 in Yoyogi Park in Tokyo, which was probably an unusual event.","['Senda, Akiyoshi', 'Sakuntabhai, Anavaj', 'Inaida, Shinako', 'Teissier, Yoann', 'Matsuda, Fumihiko', 'Paul, Richard E']","['Senda A', 'Sakuntabhai A', 'Inaida S', 'Teissier Y', 'Matsuda F', 'Paul RE']",,,['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Dengue/*epidemiology/prevention & control/transmission', 'Dengue Virus/*isolation & purification', 'Disease Outbreaks/*prevention & control', 'Disease Transmission, Infectious', 'Humans', 'Incidence', 'Japan/epidemiology']",PMC6106439,2018/08/21 06:00,2019/04/23 06:00,['2018/08/21 06:00'],"['2018/08/21 06:00 [entrez]', '2018/08/21 06:00 [pubmed]', '2019/04/23 06:00 [medline]']","['17-0408 [pii]', '10.3201/eid2409.170408 [doi]']",ppublish,Emerg Infect Dis. 2018 Sep;24(9):1705-1708. doi: 10.3201/eid2409.170408.,9,,['NOTNLM'],"['Japan', 'autochthonous', 'dengue', 'epidemic', 'outbreak threshold', 'surveillance', 'vector-borne infections', 'viruses']",,,,,,,,,,,,,,,,,,,
4150910,NLM,MEDLINE,19740619,20220310,0002-9637 (Print) 0002-9637 (Linking),23,1974 May,Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island.,495-506,,,"['Barnes, W J', 'Rosen, L']","['Barnes WJ', 'Rosen L']",,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Child', 'Child, Preschool', 'Culicidae', 'Dengue/complications/*epidemiology/mortality/prevention & control', 'Disease Outbreaks', 'Hemagglutination Inhibition Tests', 'Hemorrhage/*etiology', 'Humans', 'Male', 'Middle Aged', 'Neutralization Tests', 'Pacific Islands', 'Shock/*etiology']",,1974/05/01 00:00,1974/05/01 00:01,['1974/05/01 00:00'],"['1974/05/01 00:00 [pubmed]', '1974/05/01 00:01 [medline]', '1974/05/01 00:00 [entrez]']",['10.4269/ajtmh.1974.23.495 [doi]'],ppublish,Am J Trop Med Hyg. 1974 May;23(3):495-506. doi: 10.4269/ajtmh.1974.23.495.,3,,,,,,,,,,,,,,,,,,,,,,
10901098,NLM,MEDLINE,20000815,20161201,0049-8114 (Print) 0049-8114 (Linking),75,2000 Jun 16,Dengue/dengue haemorrhagic fever.,193-6,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Communicable Disease Control', 'Dengue/*epidemiology/transmission/virology', 'Dengue Virus/isolation & purification', 'Humans', 'Insect Vectors/virology', 'Severe Dengue/*epidemiology/transmission/virology', 'World Health Organization']",,2000/07/20 11:00,2000/08/19 11:00,['2000/07/20 11:00'],"['2000/07/20 11:00 [pubmed]', '2000/08/19 11:00 [medline]', '2000/07/20 11:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 2000 Jun 16;75(24):193-6.,24,,,,,,,,,,,,,,,,,,,,,,
32641039,NLM,MEDLINE,20210203,20220213,1741-7015 (Electronic) 1741-7015 (Linking),18,2020 Jul 9,The cost-effectiveness of controlling dengue in Indonesia using wMel Wolbachia released at scale: a modelling study.,186,10.1186/s12916-020-01638-2 [doi] 186,"BACKGROUND: Release of virus-blocking Wolbachia-infected mosquitoes is an emerging disease control strategy that aims to control dengue and other arboviral infections. Early entomological data and modelling analyses have suggested promising outcomes, and wMel Wolbachia releases are now ongoing or planned in 12 countries. To help inform government, donor, or philanthropist decisions on scale-up beyond single city releases, we assessed this technology's cost-effectiveness under alternative programmatic options. METHODS: Using costing data from existing Wolbachia releases, previous dynamic model-based estimates of Wolbachia effectiveness, and a spatially explicit model of release and surveillance requirements, we predicted the costs and effectiveness of the ongoing programme in Yogyakarta City and three new hypothetical programmes in Yogyakarta Special Autonomous Region, Jakarta, and Bali. RESULTS: We predicted Wolbachia to be a highly cost-effective intervention when deployed in high-density urban areas with gross cost-effectiveness below $1500 per DALY averted. When offsets from the health system and societal perspective were included, such programmes even became cost saving over 10-year time horizons with favourable benefit-cost ratios of 1.35 to 3.40. Sequencing Wolbachia releases over 10 years could reduce programme costs by approximately 38% compared to simultaneous releases everywhere, but also delays the benefits. Even if unexpected challenges occurred during deployment, such as emergence of resistance in the medium-term or low effective coverage, Wolbachia would remain a cost-saving intervention. CONCLUSIONS: Wolbachia releases in high-density urban areas are expected to be highly cost-effective and could potentially be the first cost-saving intervention for dengue. Sites with strong public health infrastructure, fiscal capacity, and community support should be prioritised.","['Brady, Oliver J', 'Kharisma, Dinar D', 'Wilastonegoro, Nandyan N', ""O'Reilly, Kathleen M"", 'Hendrickx, Emilie', 'Bastos, Leonardo S', 'Yakob, Laith', 'Shepard, Donald S']","['Brady OJ', 'Kharisma DD', 'Wilastonegoro NN', ""O'Reilly KM"", 'Hendrickx E', 'Bastos LS', 'Yakob L', 'Shepard DS']",['ORCID: 0000-0002-3235-2129'],"['Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK. oliver.brady@lshtm.ac.uk.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK. oliver.brady@lshtm.ac.uk.', 'Heller School for Social Policy and Management, Brandeis University,, Waltham, MA, USA.', 'Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.', 'Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.', 'Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Department of Disease Control, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.', 'Heller School for Social Policy and Management, Brandeis University,, Waltham, MA, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20200709,England,BMC Med,BMC medicine,101190723,,IM,"['Animals', 'Cost-Benefit Analysis/*methods', 'Dengue/*economics/epidemiology/*therapy', 'Humans', 'Indonesia/epidemiology', 'Wolbachia/*pathogenicity']",PMC7346418,2020/07/10 06:00,2021/02/04 06:00,['2020/07/10 06:00'],"['2020/01/11 00:00 [received]', '2020/05/15 00:00 [accepted]', '2020/07/10 06:00 [entrez]', '2020/07/10 06:00 [pubmed]', '2021/02/04 06:00 [medline]']","['10.1186/s12916-020-01638-2 [pii]', '1638 [pii]', '10.1186/s12916-020-01638-2 [doi]']",epublish,BMC Med. 2020 Jul 9;18(1):186. doi: 10.1186/s12916-020-01638-2.,1,,['NOTNLM'],"['Cost-effectiveness analysis', 'Dengue', 'Indonesia', 'Maps', 'Model', 'Mosquito', 'Policy', 'Spatial', 'Wolbachia']",['The authors declare that they have no competing interests.'],,"['206471/Z/17/Z/WT_/Wellcome Trust/United Kingdom', 'OPP1187889/Bill and Melinda Gates Foundation/International', '206471/Z/17/Z/Wellcome Trust (GB)/International', 'OP1183567/Bill and Melinda Gates Foundation/International']",,,,,,,,,,,,,,,,
37189054,NLM,MEDLINE,20230517,20230517,1471-2334 (Electronic) 1471-2334 (Linking),23,2023 May 15,"Frequency of pleural effusion in dengue patients by severity, age and imaging modality: a systematic review and meta-analysis.",327,10.1186/s12879-023-08311-y [doi] 327,"BACKGROUND: Identification of pleural effusion (PE) in dengue infection is an objective measure of plasma leakage and may predict disease progression. However, no studies have systematically assessed the frequency of PE in patients with dengue, and whether this differs across age and imaging modality. METHODS: We searched Pubmed, Embase Web of Science and Lilacs (period 1900-2021) for studies reporting on PE in dengue patients (hospitalized and outpatient). We defined PE as fluid in the thoracic cavity detected by any imaging test. The study was registered in PROSPERO (CRD42021228862). Complicated dengue was defined as hemorrhagic fever, dengue shock syndrome or severe dengue. RESULTS: The search identified 2,157 studies of which 85 studies were eligible for inclusion. The studies (n = 31 children, n = 10 adults, n = 44 mixed age) involved 12,800 patients (30% complicated dengue). The overall frequency of PE was 33% [95%CI: 29 to 37%] and the rate of PE increased significantly with disease severity (P = 0.001) such that in complicated vs. uncomplicated dengue the frequencies were 48% and 17% (P < 0.001). When assessing all studies, PE occurred significantly more often in children compared to adults (43% vs. 13%, P = 0.002) and lung ultrasound more frequently detected PE than conventional chest X-ray (P = 0.023). CONCLUSIONS: We found that 1/3 of dengue patients presented with PE and the frequency increased with severity and younger age. Importantly, lung ultrasound demonstrated the highest rate of detection. Our findings suggest that PE is a relatively common finding in dengue and that bedside imaging tools, such as lung ultrasound, potentially may enhance detection.","['Kaagaard, Molly D', 'Matos, Luan Oliveira', 'Evangelista, Marliton V P', 'Wegener, Alma', 'Holm, Anna Engell', 'Vestergaard, Lasse S', 'Do Valle, Suiane C N', 'Silvestre, Odilson M', 'Lacerda, Marcus Vinicius Guimaraes', 'de Souza, Rodrigo Medeiros', 'Barreto Dos Santos, Flavia', 'Biering-Sorensen, Tor', 'Brainin, Philip']","['Kaagaard MD', 'Matos LO', 'Evangelista MVP', 'Wegener A', 'Holm AE', 'Vestergaard LS', 'Do Valle SCN', 'Silvestre OM', 'Lacerda MVG', 'de Souza RM', 'Barreto Dos Santos F', 'Biering-Sorensen T', 'Brainin P']",,"['Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil. mollykaagaard@gmail.com.', 'Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark. mollykaagaard@gmail.com.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.', 'Department of Bacteria, Parasites and Fungi, National Malaria Reference Laboratory, Statens Serum Institut, Copenhagen, Denmark.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Health and Sport Science Center, Federal University of Acre, Rio Branco, Acre, Brazil.', 'Foundation of Tropical Medicine Dr Heitor Vieira Dourado, Fiocruz, Manaus, Brazil.', 'University of Texas Medical Branch, Galveston, USA.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Laboratory of Host-Virus Interactions, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil.', 'Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.', 'Faculty of Biomedical Sciences, Copenhagen University, Copenhagen, Denmark.', 'Multidisciplinary Center, Federal University of Acre, Campus Floresta, Cruzeiro do Sul, Acre, Brazil.', 'Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.', 'Sound Bioventures, Hellerup, Denmark.']",['eng'],"['Journal Article', 'Meta-Analysis', 'Systematic Review']",20230515,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adult', 'Child', 'Humans', '*Severe Dengue/complications/diagnostic imaging/epidemiology', 'Exudates and Transudates', '*Pleural Effusion/diagnostic imaging/epidemiology/complications', 'Plasma', 'Ultrasonography', '*Dengue/complications/diagnostic imaging/epidemiology']",PMC10184094,2023/05/16 01:09,2023/05/17 06:42,['2023/05/15 23:34'],"['2023/02/17 00:00 [received]', '2023/05/06 00:00 [accepted]', '2023/05/17 06:42 [medline]', '2023/05/16 01:09 [pubmed]', '2023/05/15 23:34 [entrez]']","['10.1186/s12879-023-08311-y [pii]', '8311 [pii]', '10.1186/s12879-023-08311-y [doi]']",epublish,BMC Infect Dis. 2023 May 15;23(1):327. doi: 10.1186/s12879-023-08311-y.,1,['(c) 2023. The Author(s).'],['NOTNLM'],"['Dengue fever', 'Plasma leakage', 'Pleural effusion', 'Ultrasound']",['The authors declare no competing interests.'],,"['NNF20OC0062782/Novo Nordisk Fonden/', '20-R139-A9644-22165/Hjerteforeningen/', '20-1257/William Demant Fonden/', '20-01-1076/Knud Hojgaards Fond/', '18-05-2487/Knud Hojgaards Fond/', '18-05-2487/Knud Hojgaards Fond/', '20-JU-0145/Reinholdt W. Jorck og Hustrus Fond/', '18-JU-0485/Reinholdt W. Jorck og Hustrus Fond/', '18-JU-0485/Reinholdt W. Jorck og Hustrus Fond/', '0129-0003B/Danmarks Frie Forskningsfond/', '0129-0003B/Danmarks Frie Forskningsfond/', '120620-kms/Dansk Medicinsk Selskab, Kobenhavn/', '120620-kms/Dansk Medicinsk Selskab, Kobenhavn/', '18-L-0026/A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene', 'Formaal/', '18-L-0026/A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene', 'Formaal/', 'NLA-080919/Eva og Henrik Fraenkels Mindefond/', 'NLA-080919/Eva og Henrik Fraenkels Mindefond/', 'TA250419/Torben og Alice Frimodts Fond/', 'TA250419/Torben og Alice Frimodts Fond/', '12038-1-hh/Brorsons Fond/', '12038-1-hh/Brorsons Fond/', 'R373-2021-1201/Lundbeckfonden/', 'R373-2021-1201/Lundbeckfonden/']",,,,,,,,,,,,,,,,
31356608,NLM,MEDLINE,20191223,20200309,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),13,2019 Jul,The evolutionary dynamics of DENV 4 genotype I over a 60-year period.,e0007592,10.1371/journal.pntd.0007592 [doi] e0007592,"Dengue virus serotype 4 (DENV 4) has had a relatively low prevalence worldwide for decades; however, likely due to data paucity, no study has investigated the epidemiology and evolutionary dynamics of DENV 4 genotype I (DENV 4-I). This study aims to understand the diversity, epidemiology and dynamics of DENV 4-I. We collected 404 full length DENV4-1 envelope (E) gene sequences from 14 countries using two sources: Yunnan Province in China (15 strains during 2013-2016) and GenBank (489 strains up to 2018-01-11). Conducting phylogenetic and phylogeographical analyses, we estimated the virus spread, population dynamics, and selection pressures using different statistical analysis methods (substitution saturation, likelihood mapping, Bayesian coalescent inference, and maximum likelihood estimation). Our results show that during the last 60 years (1956-2016), DENV 4-I was present in mainland and maritime Southeast Asia, the Indian subcontinent, the southern provinces of China, parts of Brazil and Australia. The recent spread of DENV 4-I likely originated in the Philippines and later spread to Thailand. From Thailand, it spread to adjacent countries and eventually the Indian subcontinent. Apparently diverging around years 1957, 1963, 1976 and 1990, the different Clades (Clade I-V) were defined. The mean overall evolution rate of DENV 4-I was 9.74 (95% HPD: 8.68-10.82) x 10-4 nucleotide substitutions/site/year. The most recent common ancestor for DENV 4-I traces back to 1956. While the demographic history of DENV 4-I fluctuated, peaks appeared around 1982 and 2006. While purifying selection dominated the majority of E-gene evolution of DENV 4-I, positive selection characterized Clade III (Vietnam). DENV 4-I evolved in situ in Southeast Asia and the Indian subcontinent. Thailand and Indian acted as the main and secondary virus distribution hubs globally and regionally. Our phylogenetic analysis highlights the need for strengthened regional cooperation on surveillance and sharing of sample sequences to improve global dengue control and cross-border transmission prevention efforts.","['Sang, Shaowei', 'Liu-Helmersson, Jing', 'Quam, Mikkel B M', 'Zhou, Hongning', 'Guo, Xiaofang', 'Wu, Haixia', 'Liu, Qiyong']","['Sang S', 'Liu-Helmersson J', 'Quam MBM', 'Zhou H', 'Guo X', 'Wu H', 'Liu Q']",['ORCID: 0000-0001-6298-4621'],"[""Clinical Epidemiology Unit, Qilu Hospital of Shandong University, Jinan, Shandong, People's Republic of China."", ""Department of Epidemiology and Health Statistics, School of Public Health, Shandong University, Jinan, Shandong, People's Republic of China."", 'Department of Epidemiology and Global Health, Umea University, Umea, Sweden.', 'Department of Epidemiology and Global Health, Umea University, Umea, Sweden.', ""Yunnan Provincial Center of Arborvirus Research, Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Yunnan Institute of Parasitic Diseases, Pu'er, Yunnan, People's Republic of China."", ""Yunnan Provincial Center of Arborvirus Research, Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Yunnan Institute of Parasitic Diseases, Pu'er, Yunnan, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, People's Republic of China."", ""State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing, People's Republic of China.""]",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20190729,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['China', 'Dengue/epidemiology/*history/transmission/*virology', 'Dengue Virus/*genetics', '*Evolution, Molecular', 'Genetic Variation', 'Genome, Viral', 'Genotype', 'Global Health', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Phylogeography']",PMC6663010,2019/07/30 06:00,2019/12/24 06:00,['2019/07/30 06:00'],"['2018/11/14 00:00 [received]', '2019/07/01 00:00 [accepted]', '2019/07/30 06:00 [entrez]', '2019/07/30 06:00 [pubmed]', '2019/12/24 06:00 [medline]']","['PNTD-D-18-01752 [pii]', '10.1371/journal.pntd.0007592 [doi]']",epublish,PLoS Negl Trop Dis. 2019 Jul 29;13(7):e0007592. doi: 10.1371/journal.pntd.0007592. eCollection 2019 Jul.,7,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
8115814,NLM,MEDLINE,19940329,20190606,0036-4665 (Print) 0036-4665 (Linking),35,1993 Sep-Oct,"Epidemic dengue 4 in the Yucatan, Mexico, 1984.",449-55,,"An outbreak of dengue 4 occurred in the Yucatan, Mexico in 1984. During the course of the outbreak, 538 of 5486 reported cases of dengue-like illness were studied; 200 were confirmed as dengue serologically and/or virologically. Dengue 4 virus was isolated from 34 patients and dengue 1 from one. Severe haemorrhagic symptoms were observed in 9 laboratory confirmed patients, including four deaths. Thus, the outbreak in Yucatan is the second dengue epidemic in the Americas after the Cuban epidemic in 1981 in which a number of patients suffered from haemorrhagic complications. It was notable that 5 of 9 hospitalized, severe cases were young adults and that only one met the WHO criteria of DHF, in contrast to primary pediatric nature of DHF in Southeast Asia. In this paper we describe clinical, serologic, and virologic studies conducted during the outbreak.","['Lorono Pino, M A', 'Farfan Ale, J A', 'Rosado Paredes, E P', 'Kuno, G', 'Gubler, D J']","['Lorono Pino MA', 'Farfan Ale JA', 'Rosado Paredes EP', 'Kuno G', 'Gubler DJ']",,"['Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autonoma de Yucatan, Mexico.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Child', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Dengue Virus/*isolation & purification', '*Disease Outbreaks', 'Female', 'Humans', 'Male', 'Mexico/epidemiology', 'Middle Aged', 'Sex Distribution']",,1993/09/01 00:00,1993/09/01 00:01,['1993/09/01 00:00'],"['1993/09/01 00:00 [pubmed]', '1993/09/01 00:01 [medline]', '1993/09/01 00:00 [entrez]']",['10.1590/s0036-46651993000500011 [doi]'],ppublish,Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):449-55. doi: 10.1590/s0036-46651993000500011.,5,,,,,,,,,,,,,,,,,,,,,,
440463,NLM,MEDLINE,19790725,20061115,0028-2162 (Print) 0028-2162 (Linking),123,1979 May 12,"[Dengue, an imported disease in the Netherlands].",784-8,,,"['Haverman, J F', 'van der Heide, R M', 'van Tongeren, H A']","['Haverman JF', 'van der Heide RM', 'van Tongeren HA']",,,['dut'],"['Case Reports', 'English Abstract', 'Journal Article']",,Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,"['0 (Antibodies, Viral)']",IM,"['Adult', 'Antibodies, Viral/analysis', 'Dengue/diagnosis/*epidemiology/immunology', 'Dengue Virus/immunology', 'Female', 'Humans', 'Indonesia', 'Male', 'Netherlands', 'Netherlands Antilles', '*Travel']",,1979/05/12 00:00,1979/05/12 00:01,['1979/05/12 00:00'],"['1979/05/12 00:00 [pubmed]', '1979/05/12 00:01 [medline]', '1979/05/12 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1979 May 12;123(19):784-8.,19,,,,,,,,,"Dengue, importziekte in Nederland.",,,,,,,,,,,,,
17266861,NLM,MEDLINE,20070629,20190917,1695-4033 (Print) 1695-4033 (Linking),66,2007 Jan,[Children against dengue].,89,,,"['Nunez-Samudio, V']",['Nunez-Samudio V'],,,['spa'],"['Comment', 'Letter']",,Spain,An Pediatr (Barc),"Anales de pediatria (Barcelona, Spain : 2003)",101162596,,IM,"['Adolescent', 'Child', 'Dengue/*epidemiology/*prevention & control', '*Health Education', 'Humans']",,2007/02/03 09:00,2007/06/30 09:00,['2007/02/03 09:00'],"['2007/02/03 09:00 [pubmed]', '2007/06/30 09:00 [medline]', '2007/02/03 09:00 [entrez]']","['13097369 [pii]', '10.1016/s1695-4033(07)70302-8 [doi]']",ppublish,An Pediatr (Barc). 2007 Jan;66(1):89. doi: 10.1016/s1695-4033(07)70302-8.,1,,,,,,,,['An Pediatr (Barc). 2006 Jun;64(6):517-22. PMID: 16792958'],Ninos contra el dengue.,,,,,,,,,,,,,
34315755,NLM,MEDLINE,20210820,20230728,1757-790X (Electronic) 1757-790X (Linking),14,2021 Jul 27,Dengue encephalitis and 'double doughnut' sign.,,10.1136/bcr-2021-244870 [doi] e244870,,"['Arora, Navneet', 'Kumar, Devender', 'Kiran, Ravindran', 'Pannu, Ashok Kumar']","['Arora N', 'Kumar D', 'Kiran R', 'Pannu AK']","['ORCID: 0000-0002-4507-2468', 'ORCID: 0000-0002-4476-3478']","['Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India gawaribacchi@gmail.com.']",['eng'],"['Case Reports', 'Journal Article']",20210727,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['Adolescent', '*Dengue/complications/diagnosis', '*Encephalitis', 'Female', 'Humans']",PMC8317103,2021/07/29 06:00,2021/08/21 06:00,['2021/07/28 05:45'],"['2021/07/28 05:45 [entrez]', '2021/07/29 06:00 [pubmed]', '2021/08/21 06:00 [medline]']","['14/7/e244870 [pii]', 'bcr-2021-244870 [pii]', '10.1136/bcr-2021-244870 [doi]']",epublish,BMJ Case Rep. 2021 Jul 27;14(7):e244870. doi: 10.1136/bcr-2021-244870.,7,,['NOTNLM'],"['infection (neurology)', 'infectious diseases', 'intensive care', 'radiology', 'tropical medicine (infectious disease)']",['Competing interests: None declared.'],,,,,,,,,,,,,,,,,,
727327,NLM,MEDLINE,19790226,20190516,0002-9637 (Print) 0002-9637 (Linking),27,1978 Nov,Dengue fever with hemorrhagic manifestations: a report of three cases from Puerto Rico.,1216-24,,"During the 1975 dengue epidemic in Puerto Rico, we studied three patients who had serologically confirmed dengue with hemorrhagic manifestations. None of the patients went into shock and none died. Only one of the patients had disease that resembled dengue hemorrhagic fever (DHF) as observed in Southeast Asia. This patient was a 14-year-old boy who had epistaxis, a positive tourniquet test, moderate thrombocytopenia, and significant hemoconcentration. The other two patients had hemorrhagic disease which was of clinical importance, but was not typical of DHF. These cases of dengue with hemorrhagic manifestations are the only ones known to have been documented in Puerto Rico.","['Lopez-Correa, R H', 'Cline, B L', 'Ramirez-Ronda, C', 'Bermudez, R', 'Sather, G E', 'Kuno, G']","['Lopez-Correa RH', 'Cline BL', 'Ramirez-Ronda C', 'Bermudez R', 'Sather GE', 'Kuno G']",,,['eng'],"['Case Reports', 'Journal Article']",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Adult', 'Dengue/*diagnosis/epidemiology', 'Humans', 'Male', 'Middle Aged', 'Puerto Rico', 'Serologic Tests']",,1978/11/01 00:00,1978/11/01 00:01,['1978/11/01 00:00'],"['1978/11/01 00:00 [pubmed]', '1978/11/01 00:01 [medline]', '1978/11/01 00:00 [entrez]']",['10.4269/ajtmh.1978.27.1216 [doi]'],ppublish,Am J Trop Med Hyg. 1978 Nov;27(6):1216-24. doi: 10.4269/ajtmh.1978.27.1216.,6,,,,,,,,,,,,,,,,,,,,,,
19062602,NLM,MEDLINE,20090305,20220321,1020-4989 (Print) 1020-4989 (Linking),24,2008 Aug,[Cost-benefit analysis of vector control in areas of potential dengue transmission].,113-9,,"OBJECTIVES: To evaluate the cost-benefit of an intervention utilizing fumigation against adult mosquitoes along with actions to control immature Aedes aegypti to prevent transmission in a high-risk area. METHODS: A cost-benefit analysis was performed from the social perspective. A program to control both adult mosquitoes and immature forms was compared to a nonintervention hypothesis, from January to April 2007, in the city of Clorinda, Argentina. Direct costs, as well as indirect and intangible benefits, were taken into account and standardized in international dollars (I$) using purchasing power parity. An incidence rate of 50 cases of dengue per 1000 inhabitants was used in the non-intervention hypothesis. RESULTS: From January to April 2007 there were 176 cases of dengue in Clorinda, but only five were autochthonous. The net present value was I$ 196,879 with the control strategy, whereas the non-intervention was calculated to be I$ -106,724, indicating a savings of I$ 303,602 (I$ 6.46 per inhabitant) for the intervention. The sensitivity analysis showed that, with more than 1363 cases of dengue (total incidence rate of 29 per 1000 inhabitants) and one case of dengue hemorrhagic fever, there is a cost-benefit to intervention. CONCLUSIONS: The results suggest that vector control, including fumigation of adult mosquitoes, should be considered in high-risk areas as a cost-effective option for nonendemic countries.","['Orellano, Pablo Wenceslao', 'Pedroni, Elena']","['Orellano PW', 'Pedroni E']",,"['Ministerio de Salud de la Nacion, Argentina, Direccion de Epidemiologia. porellano@msal.gov.ar']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['*Aedes', 'Animals', 'Argentina', 'Cost-Benefit Analysis', 'Dengue/*economics/*prevention & control/transmission', '*Disease Vectors', 'Humans', 'Mosquito Control/*economics']",,2008/12/10 09:00,2009/03/06 09:00,['2008/12/10 09:00'],"['2008/12/10 09:00 [pubmed]', '2009/03/06 09:00 [medline]', '2008/12/10 09:00 [entrez]']","['S1020-49892008000800005 [pii]', '10.1590/s1020-49892008000800005 [doi]']",ppublish,Rev Panam Salud Publica. 2008 Aug;24(2):113-9. doi: 10.1590/s1020-49892008000800005.,2,,,,,,,,,Analisis costo-beneficio del control de vectores en la transmision potencial de dengue.,,,,,,,,,,,,,
11944704,NLM,MEDLINE,20020429,20220331,0125-1562 (Print) 0125-1562 (Linking),32,2001 Sep,Perinatal dengue infection.,488-93,,"We report a case of vertical transmission of dengue infection in an infant. The mother's was a term pregnancy with a history of chronic hypertension. She presented with high fever of 3 days duration 5 days prior to delivery. Her initial complete blood count showed platelet count of 64,000/mm3. Dengue hemorrhagic fever was diagnosed 2 days later and symptomatic treatment was given. During labor her platelets dropped to 11,000/mm3 and platelet concentrate was given. Cesarean section was performed due to prolonged second stage of labor. Her infant was normal at birth except for petechiae on the left thigh. The child's platelet count was 34,000/mm3 and low grade fever was detected on the first day. Clinical sepsis was suspected and antibiotic treatment was started and continued for 4 days until all the cultures came back as negative. Both mother and her baby made an uneventful recovery and were discharged 6 days after delivery with normal platelet counts. Maternal blood was positive for IgM antibody to dengue virus. Both cord blood and the baby's blood were positive for dengue virus serotype 2 by PCR.","['Kerdpanich, A', 'Watanaveeradej, V', 'Samakoses, R', 'Chumnanvanakij, S', 'Chulyamitporn, T', 'Sumeksri, P', 'Vuthiwong, C', 'Kounruang, C', 'Nisalak, A', 'Endy, T']","['Kerdpanich A', 'Watanaveeradej V', 'Samakoses R', 'Chumnanvanakij S', 'Chulyamitporn T', 'Sumeksri P', 'Vuthiwong C', 'Kounruang C', 'Nisalak A', 'Endy T']",,"['Pediatric Department, Phramongkutklao Hospital, Bangkok, Thailand.']",['eng'],"['Case Reports', 'Journal Article']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adult', 'Dengue/complications/physiopathology/*transmission', 'Female', 'Humans', 'Infant, Newborn', 'Infant, Newborn, Diseases/*physiopathology', 'Infectious Disease Transmission, Vertical', 'Pregnancy', 'Pregnancy Complications, Infectious/*physiopathology', 'Thailand']",,2002/04/12 10:00,2002/05/01 10:01,['2002/04/12 10:00'],"['2002/04/12 10:00 [pubmed]', '2002/05/01 10:01 [medline]', '2002/04/12 10:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):488-93.,3,,,,,,,,,,,,,,,,,,,,,,
21903297,NLM,MEDLINE,20120215,20111219,1097-6760 (Electronic) 0196-0644 (Linking),59,2012 Jan,"Clinical presentation of dengue among patients admitted to the adult emergency department of a tertiary care hospital in Martinique: implications for triage, management, and reporting.",42-50,10.1016/j.annemergmed.2011.08.010 [doi],"STUDY OBJECTIVE: During dengue epidemics, emergency physicians face large numbers of patients with acute febrile illness. Triage algorithms and appropriate reporting systems are useful to manage patients and prioritize resources. We identify possible adaptations to these systems to improve the management of patients during epidemics. METHODS: In a prospective observational study in the adult emergency department (ED) of a tertiary care hospital, we enrolled all patients with febrile illness and a confirmed diagnosis of dengue (ribonucleic acid identification). We then retrospectively classified cases according to the initial clinical presentation at the ED. RESULTS: We enrolled 715 patients (332 male patients), aged 14 to 91 years (median 35 years). Severe illness was documented in 332 cases (46.4%) and was mostly caused by serotype 2, or a secondary infection of any serotype. Severe forms included dengue hemorrhagic fever or dengue shock syndrome (104/332; 31.3%), severe bleeding (9/332; 2.7%), and acute organ failure (56/332; 16.9%). The other patients with severe illness (171/332; 51.5%) presented with symptoms of presyncope, intense weakness, prolonged gastrointestinal symptoms, and hypotension. This presentation was common during epidemics and appeared to be associated with dehydration and electrolyte loss that improved markedly within 24 hours with saline solution infusion. This group did not have evidence of plasma leakage, although similar features were observed in patients with dengue hemorrhagic fever/dengue shock syndrome. CONCLUSION: Dengue has a wide range of clinical presentations in the ED. Many patients who appear seriously ill on presentation will respond to intravenous fluids.","['Thomas, Laurent', 'Moravie, Victor', 'Besnier, Francois', 'Valentino, Ruddy', 'Kaidomar, Stephane', 'Coquet, Laurent Villain', 'Najioullah, Fatiha', 'Lengelle, Francois', 'Cesaire, Raymond', 'Cabie, Andre']","['Thomas L', 'Moravie V', 'Besnier F', 'Valentino R', 'Kaidomar S', 'Coquet LV', 'Najioullah F', 'Lengelle F', 'Cesaire R', 'Cabie A']",,"['Emergency and Intensive Care Department, University Hospital, Fort-de-France, Martinique. laurent.thomas@chu-fortdefrance.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20110908,United States,Ann Emerg Med,Annals of emergency medicine,8002646,,IM,"['Academic Medical Centers/statistics & numerical data', 'Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Dengue/*diagnosis/epidemiology/pathology/therapy', '*Emergency Service, Hospital/statistics & numerical data', 'Epidemics/statistics & numerical data', 'Female', 'Humans', 'Male', 'Martinique/epidemiology', 'Middle Aged', 'Prospective Studies', 'Triage', 'Young Adult']",,2011/09/10 06:00,2012/02/16 06:00,['2011/09/10 06:00'],"['2011/04/22 00:00 [received]', '2011/08/05 00:00 [revised]', '2011/08/11 00:00 [accepted]', '2011/09/10 06:00 [entrez]', '2011/09/10 06:00 [pubmed]', '2012/02/16 06:00 [medline]']","['S0196-0644(11)01451-X [pii]', '10.1016/j.annemergmed.2011.08.010 [doi]']",ppublish,Ann Emerg Med. 2012 Jan;59(1):42-50. doi: 10.1016/j.annemergmed.2011.08.010. Epub 2011 Sep 8.,1,"['Copyright (c) 2011 American College of Emergency Physicians. Published by Mosby,', 'Inc. All rights reserved.']",,,,,,,,,,,,,,,,['Working Group on Dengue'],"['Abel, Sylvie', 'Avenin, Guillaume', 'Brihier, Pierre', 'Brouste, Yannick', 'Deligny, Christophe', 'Dueyme, Jean-Marc', 'Elana, Gisele', 'Fonteau, Christiane', 'Hochedez, Patrick', 'Hurtrel, Guillaume', 'Jean-Marie, Janick', 'Leonard, Christian', 'Mainguy, Sophie', 'Martial, Jenny', 'Mehdaoui, Hossein', 'Merle, Harold', 'Mourlhou, Paul', 'Plumelle, Yves', 'Resieres, Dabor', 'Vignier, Nicolas']","['Abel S', 'Avenin G', 'Brihier P', 'Brouste Y', 'Deligny C', 'Dueyme JM', 'Elana G', 'Fonteau C', 'Hochedez P', 'Hurtrel G', 'Jean-Marie J', 'Leonard C', 'Mainguy S', 'Martial J', 'Mehdaoui H', 'Merle H', 'Mourlhou P', 'Plumelle Y', 'Resieres D', 'Vignier N']",,,
11095371,NLM,MEDLINE,20010103,20041117,0002-9270 (Print) 0002-9270 (Linking),95,2000 Nov,Acalculous cholecystitis as an atypical presentation of dengue fever.,3316-7,,,"['Sood, A', 'Midha, V', 'Sood, N', 'Kaushal, V']","['Sood A', 'Midha V', 'Sood N', 'Kaushal V']",,,['eng'],"['Case Reports', 'Letter']",,United States,Am J Gastroenterol,The American journal of gastroenterology,0421030,,IM,"['Acute Disease', 'Adult', 'Cholecystitis/*etiology', 'Dengue/*complications/diagnosis', 'Humans', 'Male']",,2000/11/30 11:00,2001/02/28 10:01,['2000/11/30 11:00'],"['2000/11/30 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/11/30 11:00 [entrez]']","['S0002-9270(00)02109-2 [pii]', '10.1111/j.1572-0241.2000.03316.x [doi]']",ppublish,Am J Gastroenterol. 2000 Nov;95(11):3316-7. doi: 10.1111/j.1572-0241.2000.03316.x.,11,,,,,,,,,,,,,,,,,,,,,,
37192216,NLM,MEDLINE,20230714,20230714,1538-3598 (Electronic) 0098-7484 (Linking),330,2023 Jul 3,Opportunities for Improved Dengue Control in the US Territories.,19-20,10.1001/jama.2023.8567 [doi],,"['Hernandez-Romieu, Alfonso C', 'Adams, Laura E', 'Paz-Bailey, Gabriela']","['Hernandez-Romieu AC', 'Adams LE', 'Paz-Bailey G']",,"['Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.']",['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Humans', '*Dengue/epidemiology/prevention & control', 'United States/epidemiology']",,2023/05/16 19:10,2023/07/05 06:42,['2023/05/16 13:35'],"['2023/07/05 06:42 [medline]', '2023/05/16 19:10 [pubmed]', '2023/05/16 13:35 [entrez]']","['2805282 [pii]', '10.1001/jama.2023.8567 [doi]']",ppublish,JAMA. 2023 Jul 3;330(1):19-20. doi: 10.1001/jama.2023.8567.,1,,,,,,,,,,,,"['This Viewpoint from the CDC discusses the prevalence of dengue infection in US', 'territories and opportunities to combat it, such as vaccines and novel vector', 'control methods.']",['eng'],,,,,,,,,
18461223,NLM,MEDLINE,20081201,20190823,0102-311X (Print) 0102-311X (Linking),24,2008 May,Challenges for dengue control in Brazil.,948-9,,,"['Medronho, Roberto de Andrade']",['Medronho Rde A'],,,"['eng', 'por']",['Editorial'],,Brazil,Cad Saude Publica,Cadernos de saude publica,8901573,,IM,"['Brazil/epidemiology', 'Dengue/epidemiology/*prevention & control', 'Humans', 'Policy Making']",,2008/05/08 09:00,2008/12/17 09:00,['2008/05/08 09:00'],"['2008/05/08 09:00 [pubmed]', '2008/12/17 09:00 [medline]', '2008/05/08 09:00 [entrez]']","['S0102-311X2008000500001 [pii]', '10.1590/s0102-311x2008000500001 [doi]']",ppublish,Cad Saude Publica. 2008 May;24(5):948-9. doi: 10.1590/s0102-311x2008000500001.,5,,,,,,,,,,,,,,,,,,,,,,
10460181,NLM,MEDLINE,19991104,20181113,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),5,1999 Jul-Aug,Dengue reemergence in Argentina.,575-8,,"Aedes aegypti, eradicated from Argentina in 1963, has now reinfested the country as far south as Buenos Aires. In 1997, four persons with travel histories to Brazil, Ecuador, or Venezuela had confirmed dengue, and surveillance for indigenous transmission allowed the detection of 19 dengue cases in Salta Province. These cases of dengue are the first in Argentina since 1916 and represent a new southern extension of dengue virus.","['Aviles, G', 'Rangeon, G', 'Vorndam, V', 'Briones, A', 'Baroni, P', 'Enria, D', 'Sabattini, M S']","['Aviles G', 'Rangeon G', 'Vorndam V', 'Briones A', 'Baroni P', 'Enria D', 'Sabattini MS']",,"['Instituto Nacional de Enfermedades Virales Humanas Dr. J.I. Maiztegui, Administracion Nacional de Laboratorios e Institutos de Salud Dr. C. Malbran, Pergamino, Argentina.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Aedes', 'Animals', 'Argentina/epidemiology', 'Dengue/blood/*epidemiology/physiopathology/virology', 'Dengue Virus/genetics/immunology', '*Disease Outbreaks']",PMC2627740,1999/08/25 00:00,1999/08/25 00:01,['1999/08/25 00:00'],"['1999/08/25 00:00 [pubmed]', '1999/08/25 00:01 [medline]', '1999/08/25 00:00 [entrez]']",['10.3201/eid0504.990424 [doi]'],ppublish,Emerg Infect Dis. 1999 Jul-Aug;5(4):575-8. doi: 10.3201/eid0504.990424.,4,,,,,,,,,,,,,,,,,,,,,,
7986693,NLM,MEDLINE,19950109,20161201,0049-8114 (Print) 0049-8114 (Linking),69,1994 Sep 9,Dengue and dengue haemorrhagic fever.,265-6,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/prevention & control/transmission', '*Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Laos/epidemiology', 'Male', 'Mosquito Control', '*Population Surveillance']",,1994/09/09 00:00,1994/09/09 00:01,['1994/09/09 00:00'],"['1994/09/09 00:00 [pubmed]', '1994/09/09 00:01 [medline]', '1994/09/09 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1994 Sep 9;69(36):265-6.,36,,,,,,,,,,,,,,,,,,,,,,
7917888,NLM,MEDLINE,19941117,20161201,0049-8114 (Print) 0049-8114 (Linking),69,1994 Aug 12,Dengue and dengue haemorrhagic fever.,237-9,,,,,,,"['eng', 'fre']","['Comparative Study', 'Journal Article']",,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/mortality/prevention & control', 'Female', 'Health Education', 'Humans', 'Malaysia/epidemiology', 'Male', 'Mosquito Control', 'Seasons']",,1994/08/12 00:00,1994/08/12 00:01,['1994/08/12 00:00'],"['1994/08/12 00:00 [pubmed]', '1994/08/12 00:01 [medline]', '1994/08/12 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1994 Aug 12;69(32):237-9.,32,,,,,,,,,,,,,,,,,,,,,,
20586568,NLM,MEDLINE,20101112,20100630,1744-8336 (Electronic) 1478-7210 (Linking),8,2010 Jul,Dengue fever: diagnosis and treatment.,841-5,10.1586/eri.10.53 [doi],"Dengue fever is a common tropical infection. This acute febrile illness can be a deadly infection in cases of severe manifestation, causing dengue hemorrhagic shock. In this brief article, I will summarize and discuss the diagnosis and treatment of this disease. For diagnosis of dengue, most tropical doctors make use of presumptive diagnosis; however, the definite diagnosis should be based on immunodiagnosis or viral study. Focusing on treatment, symptomatic and supportive treatment is the main therapeutic approach. The role of antiviral drugs in the treatment of dengue fever has been limited, but is currently widely studied.","['Wiwanitkit, Viroj']",['Wiwanitkit V'],,"['Wiwanitkit House, 38/167 Soi Yim Prayoon Sukhapiban, 1 Road Bangkhae, Bangkok 10160, Thailand. wviroj@yahoo.com']",['eng'],['Journal Article'],,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,"['0 (Antiviral Agents)', '0 (RNA, Viral)']",IM,"['Antiviral Agents/therapeutic use', 'Dengue/*diagnosis/drug therapy/*therapy', 'Dengue Virus/drug effects/*immunology/*isolation & purification', 'Diagnosis, Differential', 'Fluid Therapy', 'Humans', 'RNA, Viral/analysis']",,2010/07/01 06:00,2010/11/13 06:00,['2010/07/01 06:00'],"['2010/07/01 06:00 [entrez]', '2010/07/01 06:00 [pubmed]', '2010/11/13 06:00 [medline]']",['10.1586/eri.10.53 [doi]'],ppublish,Expert Rev Anti Infect Ther. 2010 Jul;8(7):841-5. doi: 10.1586/eri.10.53.,7,,,,,,,,,,,,,,,,,,,,,,
3774341,NLM,MEDLINE,19861128,20041117,0030-9311 (Print) 0030-9311 (Linking),26,1986 Jul-Aug,"Clinical observations on hospitalized patients with virologically confirmed dengue hemorrhagic fever in Jakarta, Indonesia 1975-1983.",137-51,,,"['Sumarmo', 'Wuryadi, S', 'Gubler, D J']","['Sumarmo', 'Wuryadi S', 'Gubler DJ']",,,['eng'],['Journal Article'],,Indonesia,Paediatr Indones,Paediatrica Indonesiana,0376416,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/microbiology/mortality/*physiopathology', 'Dengue Virus/isolation & purification', 'Female', 'Humans', 'Indonesia', 'Infant', 'Infant, Newborn', 'Male', 'Shock, Hemorrhagic/therapy']",,1986/07/01 00:00,1986/07/01 00:01,['1986/07/01 00:00'],"['1986/07/01 00:00 [pubmed]', '1986/07/01 00:01 [medline]', '1986/07/01 00:00 [entrez]']",,ppublish,Paediatr Indones. 1986 Jul-Aug;26(7-8):137-51.,7-8,,,,,,,,,,,,,,,,,,,,,,
22389984,NLM,MEDLINE,20120322,20120306,0041-4301 (Print) 0041-4301 (Linking),53,2011 Nov-Dec,Profile of dengue patients admitted to a tertiary care hospital in Mumbai.,626-31,,"Dengue is a mosquito-borne arboviral infection that has become a public health concern in India and particularly Mumbai, where endemicity is on the rise. Fifty-seven children having dengue infection admitted over 12 months (2008) in a child health unit of a teaching hospital in Mumbai and who were positive for IgM antibodies by ELISA test were retrospectively studied for clinical profile and outcome. Common clinical findings were fever (100%), hepatomegaly (66.6%), vomiting (40.3%), and significant bleeding manifestations (38.5%). Common laboratory findings were thrombocytopenia (platelet < 100,000/mm3 in 96.5% patients), increased liver enzymes (59.6%), hypoalbuminemia (50.8%), hyponatremia (40.3%), and deranged prothrombin time/partial thromboplastin time (PT/PTT) (33.3%). Third spacing in the form of ascites and pleural effusion was present in 15.7% and 31.5% of patients, respectively. There was no correlation between platelet count and bleeding manifestation. Patients with dengue shock syndrome required more supportive therapy with blood products and inotropes and had a longer recovery time. Mortality in the study was 3.5%. PT/PTT, serum sodium, albumin, and white blood cell (WBC) counts were predictors of severity of dengue. To summarize, fever, hemorrhagic manifestations, hepatomegaly, thrombocytopenia, and evidence of plasma leakage (hemoconcentration, pleural effusion, ascites or hypoproteinemia) should lead a clinician to suspect dengue infection.","['Joshi, Rajesh', 'Baid, Vikram']","['Joshi R', 'Baid V']",,"['Department of Pediatrics, B. J. Wadia Hospital for Children, Parel, Mumbai, India.']",['eng'],['Journal Article'],,Turkey,Turk J Pediatr,The Turkish journal of pediatrics,0417505,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/therapy', 'Female', 'Hospitalization', 'Humans', 'India', 'Infant', 'Male']",,2012/03/07 06:00,2012/03/23 06:00,['2012/03/07 06:00'],"['2012/03/07 06:00 [entrez]', '2012/03/07 06:00 [pubmed]', '2012/03/23 06:00 [medline]']",,ppublish,Turk J Pediatr. 2011 Nov-Dec;53(6):626-31.,6,,,,,,,,,,,,,,,,,,,,,,
1304624,NLM,MEDLINE,19930708,20061115,0126-8635 (Print) 0126-8635 (Linking),14,1992 Dec,Use of dengue blot in dengue diagnosis: the Malaysian experience.,117-20,,"Dengue fever/Dengue haemorrhagic fever (DF/DHF) has been a public health problem in Malaysia with an endemic level of about 7 per 100,000 population per year. In 1990, Malaysia experienced its most severe outbreak of DF/DHF with a record total of 5,590 cases referred to the Division of Virology, Institute for Medical Research (IMR). Of these, 1,880 were confirmed serologically to be DF/DHF. The conventional serological procedure, the Haemagglutination Inhibition (HI) test, for the diagnosis of DF/DHF is cumbersome and causes delay in diagnosis. Another problem associated with the HI test has been that it has often been difficult to obtain a second convalescent serum sample for an accurate diagnosis. This has raised an urgent need to establish a ""rapid"" test for diagnosis of DF/DHF. As such the authors recently carried out an evaluation of a newly available commercial rapid test, namely, the Dengue Blot Assay (Diagnostic Biotechnology Singapore Pte Ltd). The test is intended for use in laboratory confirmation of dengue virus infection. The evaluation was to determine if the test could be utilised as a routine laboratory test and to establish its sensitivity and specificity. Over 400 samples were tested against the Dengue Blot Assay. Results were checked against an in-house Dengue IgM ELISA and HI assay. Preliminary results indicate that the sensitivity and specificity of the Dengue Blot is satisfactory. Our results also indicate that the Dengue Blot has a useful role to play in a routine laboratory especially since it provides rapid results on single serum samples thereby reducing the workload in a busy diagnostic laboratory.","['Fang, R', 'Sinniah, M', 'Kuen, L S']","['Fang R', 'Sinniah M', 'Kuen LS']",,"['Division of Virology, Institute for Medical Research, Kuala Lumpur.']",['eng'],"['Comparative Study', 'Journal Article']",,Malaysia,Malays J Pathol,The Malaysian journal of pathology,8101177,"['0 (Reagent Kits, Diagnostic)']",IM,"['Dengue/blood/*diagnosis/microbiology', 'Dengue Virus/*isolation & purification', 'Enzyme-Linked Immunosorbent Assay', 'Hemagglutination Inhibition Tests', 'Humans', 'Malaysia', '*Reagent Kits, Diagnostic']",,1992/12/01 00:00,1992/12/01 00:01,['1992/12/01 00:00'],"['1992/12/01 00:00 [pubmed]', '1992/12/01 00:01 [medline]', '1992/12/01 00:00 [entrez]']",,ppublish,Malays J Pathol. 1992 Dec;14(2):117-20.,2,,,,,,,,,,,,,,,,,,,,,,
16449254,NLM,MEDLINE,20060512,20181113,1468-2044 (Electronic) 0003-9888 (Print) 0003-9888 (Linking),91,2006 May,Patterns of disease in Sri Lankan dengue patients.,396-400,,"BACKGROUND: Dengue is the most important mosquito borne viral infection in the world. Nearly 90% of infections occur in children. At present, prospective information on clinical and laboratory findings in South Asian children with dengue is generally lacking. AIM: To describe patterns of clinical disease in a cohort of children hospitalised with dengue during a major dengue epidemic in Sri Lanka. RESULTS: A total of 104 children were studied during a three month period. Eighteen had dengue fever (DF) and 86 had dengue haemorrhagic fever (DHF). Of those with DHF, 34, 23, 27, and 2 had DHF grade I, II, III, and IV respectively. Based on dengue serology testing, 13 of the DF patients had a primary infection and 5 had secondary dengue infections. In contrast, 68 of the children with DHF had secondary and 18 had primary dengue infections. Oral candidiasis was seen in 19 children. The odds ratio for children with secondary dengue infection to develop DHF was 9.8 (95% CI 3.1 to 31.2). CONCLUSION: Studies on patterns of paediatric dengue disease in different regions should help clinicians and health administrators make more informed and evidence based health planning decisions. It should also help towards mapping out dengue trends on a global scale. Oral candidiasis has not been previously documented in children suffering with acute dengue in Sri Lanka or elsewhere. Studying underlying reasons for this manifestation during future dengue epidemics may provide useful leads in understanding overall dengue pathogenesis.","['Malavige, G N', 'Ranatunga, P K', 'Velathanthiri, V G N S', 'Fernando, S', 'Karunatilaka, D H', 'Aaskov, J', 'Seneviratne, S L']","['Malavige GN', 'Ranatunga PK', 'Velathanthiri VG', 'Fernando S', 'Karunatilaka DH', 'Aaskov J', 'Seneviratne SL']",,"['Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardenapura, Sri Lanka.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20060131,England,Arch Dis Child,Archives of disease in childhood,0372434,,IM,"['Acute Disease', 'Child', 'Child, Preschool', 'Dengue/complications/*diagnosis/epidemiology', 'Disease Outbreaks', 'Female', 'Humans', 'Hypersensitivity/complications', 'Infant', 'Male', 'Malnutrition/complications', 'Prospective Studies', 'Risk Factors', 'Serologic Tests', 'Severe Dengue/complications/diagnosis/epidemiology', 'Sex Factors', 'Sri Lanka', 'Unconsciousness/microbiology']",PMC2082720,2006/02/02 09:00,2006/05/13 09:00,['2006/02/02 09:00'],"['2006/02/02 09:00 [pubmed]', '2006/05/13 09:00 [medline]', '2006/02/02 09:00 [entrez]']","['adc.2005.085191 [pii]', 'ac85191 [pii]', '10.1136/adc.2005.085191 [doi]']",ppublish,Arch Dis Child. 2006 May;91(5):396-400. doi: 10.1136/adc.2005.085191. Epub 2006 Jan 31.,5,,,,['Competing interests: none declared'],,,,,,,,,,,,,,,,,,
3324361,NLM,MEDLINE,19880324,20051116,0125-1562 (Print) 0125-1562 (Linking),18,1987 Sep,Dengue haemorrhagic fever in Malaysia: a review.,278-83,,"The historical background, epidemiology and changing pattern of clinical disease as seen in Malaysia is reviewed. The preliminary results of the longitudinal study of epidemiology of dengue in Malaysia is also presented. Studies led by Rudnick et al. over some 18 years have established that the disease is endemically transmitted by both Aedes aegypti and Aedes albopictus causing illnesses ranging from mild febrile episodes through classical dengue fever, dengue haemorrhagic fever and the dengue shock syndrome. The first epidemic occurred in 1962 in Penang, and the second major epidemic in 1974 in Selangor. From then on epidemics seem to occur every 4 years, i.e. 1978, and then in 1982. With increasing number of cases being seen from the end of 1985 and in 1986, and with the increasing numbers of positive virus isolates, another epidemic may occur this year. Though in the early years, mainly children were affected, recently more cases are being seen in 16-30 years age group. There is also a changing pattern in the clinical presentation of the cases. The clinician has to be aware of the various modes of presentation of this sinister disease. A high index of suspicion is needed for early diagnosis, as management is mainly symptomatic and there is no specific drug as yet to combat the shock and bleeding manifestations.","['George, R']",['George R'],,"['General Hospital, Kuala Lumpur, Malaysia.']",['eng'],"['Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology', 'Female', 'Humans', 'Infant', 'Malaysia', 'Male']",,1987/09/01 00:00,1987/09/01 00:01,['1987/09/01 00:00'],"['1987/09/01 00:00 [pubmed]', '1987/09/01 00:01 [medline]', '1987/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):278-83.,3,,,,,,,10,,,,,,,,,,,,,,,
3217826,NLM,MEDLINE,19890309,20041117,0125-1562 (Print) 0125-1562 (Linking),19,1988 Sep,"Dengue haemorrhagic fever in Thailand, 1987.",487-90,,"In 1987, situation of DHF in Thailand was the worst for the past 30 years. There were 152,840 cases and 785 deaths from the preliminary report. The incidence was highest ever reported. Outbreak begun early in January and reached its peak in July. All 73 provinces were affected except six provinces which had incidence of less than 60 per 100,000 population. The highest attack rates were in school children, especially 5-9 year olds. Virus isolation in a north-eastern province recovered Den-3 and Den-2 more common than other serotypes. Although a large outbreak in 1987 is unlikely to happen in 1988 but with the endemic areas all over the country there is a potential for small outbreaks to occur. The Ministry of Public Health needs new approaches and increased resources to control this disease.","['Ungchusak, K', 'Kunasol, P']","['Ungchusak K', 'Kunasol P']",,"['Division of Epidemiology, Ministry of Public Health, Bangkok, Thailand.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/mortality/prevention & control', 'Disease Outbreaks', 'Female', 'Health Education', 'Humans', 'Infant', 'Male', 'Mosquito Control', 'Thailand']",,1988/09/01 00:00,1988/09/01 00:01,['1988/09/01 00:00'],"['1988/09/01 00:00 [pubmed]', '1988/09/01 00:01 [medline]', '1988/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1988 Sep;19(3):487-90.,3,,,,,,,,,,,,,,,,,,,,,,
34449967,NLM,MEDLINE,20211227,20211227,1365-3156 (Electronic) 1360-2276 (Linking),26,2021 Oct,Dengue virus detection in Lao PDR and Colombia: Comparative evaluation of PCR tests.,1296-1302,10.1111/tmi.13670 [doi],"OBJECTIVES: Dengue virus (DENV) detection by polymerase chain reaction (PCR) facilitates diagnosis of dengue fever, which is the most frequent arboviral disease globally. Two studies were performed in countries with high dengue incidence, to assess the diagnostic performance of different PCR techniques. METHODS/RESULTS: Two hundred and seventy-nine acute phase blood samples from febrile patients were analyzed for DENV by the RealStar Dengue RT-PCR kit (Altona Diagnostics) as gold standard in comparison with the Tropical Fever Core multiplex PCR (Fast Track Diagnostics). In total, 102 samples collected in Savannakhet Province (Lao PDR, Southeast Asia) in 2013 and 35 samples from Valledupar (Colombia, South America) tested positive for DENV by RealStar RT-PCR. In comparison, the Tropical Fever Core multiplex PCR detected 65.0% (65/102) and 68.6% (24/35) of these samples as positive for DENV in Savannakhet and Valledupar, respectively. Diagnostic sensitivity of the multiplex PCR strongly correlated with viral load. A subset of DENV PCR-confirmed samples was additionally tested by BNITM in house Dengue Type RT-PCR in comparison with two commercial test kits (RealStar Dengue Type RT-PCR [Altona Diagnostics], Dengue differentiation PCR [Fast Track Diagnostics]). The leading dengue serotype in Savannakhet was DENV-3 (58% [29/50]), while DENV-1 (53.8% [14/26]) was the predominant serotype found in samples collected in Valledupar by BNITM-type PCR. However, three DENV serotypes were circulating in Valledupar and in Savannakhet. In 2015, additional studies found predominantly DENV-4 (71% [12/17]) in Savannakhet. CONCLUSIONS: Both studies emphasized that routine diagnostics in both regions will benefit from an expanded use of highly sensitive pan-dengue PCRs.","['Kann, Simone', 'Blessmann, Joerg', 'Winkelmann, Yvonne', 'Hansen, Jessica', 'Maya Amaya, Leonardo J', 'Rivera Salcedo, Gadith E', 'Halas, Hussein El', 'Schmidt-Chanasit, Jonas', 'Keoviengkhone, Latdamone', 'Sopraseuth, Vatsana', 'Deschermeier, Christina', 'Mika, Angela']","['Kann S', 'Blessmann J', 'Winkelmann Y', 'Hansen J', 'Maya Amaya LJ', 'Rivera Salcedo GE', 'Halas HE', 'Schmidt-Chanasit J', 'Keoviengkhone L', 'Sopraseuth V', 'Deschermeier C', 'Mika A']",,"['Medical Mission Institute, Wurzburg, Germany.', 'Department for Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', 'Diagnostics Development Laboratory, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', 'Diagnostics Development Laboratory, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', 'Hospital Eduardo Arredondo Daza, Valledupar, Colombia.', 'Hospital Eduardo Arredondo Daza, Valledupar, Colombia.', 'Altona Diagnostics GmbH, Hamburg, Germany.', 'Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', 'Savannakhet Provincial Hospital, Savannakhet, Lao PDR.', 'Savannakhet Provincial Hospital, Savannakhet, Lao PDR.', 'Diagnostics Development Laboratory, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', 'Diagnostics Development Laboratory, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.']",['eng'],"['Comparative Study', 'Evaluation Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20210914,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Colombia/epidemiology', 'Dengue/*diagnosis/*epidemiology/virology', 'Dengue Virus/*isolation & purification', 'Humans', 'Polymerase Chain Reaction/*methods', 'Sensitivity and Specificity']",,2021/08/28 06:00,2021/12/28 06:00,['2021/08/27 17:45'],"['2021/08/28 06:00 [pubmed]', '2021/12/28 06:00 [medline]', '2021/08/27 17:45 [entrez]']",['10.1111/tmi.13670 [doi]'],ppublish,Trop Med Int Health. 2021 Oct;26(10):1296-1302. doi: 10.1111/tmi.13670. Epub 2021 Sep 14.,10,"['(c) 2021 The Authors Tropical Medicine & International Health Published by John', 'Wiley & Sons Ltd.']",['NOTNLM'],"['Colombia', 'Lao PDR', 'PCR diagnostics', 'dengue infections', 'dengue serotypes']",,,,,,,,,,,,,,,,,,,
21517627,NLM,MEDLINE,20110818,20110426,1550-2376 (Electronic) 1539-3755 (Linking),83,2011 Mar,Explaining the high number of infected people by dengue in Rio de Janeiro in 2008 using a susceptible-infective-recovered model.,037101,,"An epidemiological model for dengue propagation using cellular automata is constructed. Dependence on temperature and rainfall index are taken into account. Numerical results fit pretty well with the registered cases of dengue for the city of Rio de Janeiro for the period from 2006 to 2008. In particular, our approach explains very well an abnormally high number of cases registered in 2008. A phase transition from endemic to epidemic regimes is discussed.","['Botari, Tiago', 'Alves, S G', 'Leonel, Edson D']","['Botari T', 'Alves SG', 'Leonel ED']",,"['Departamento de Fisica, UNESP-Universidade Estadual Paulista, Av. 24A, 1515, 13506-900, Rio Claro, SP, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20110318,United States,Phys Rev E Stat Nonlin Soft Matter Phys,"Physical review. E, Statistical, nonlinear, and soft matter physics",101136452,,IM,"['Brazil/epidemiology', 'Dengue/*epidemiology/physiopathology/*transmission', 'Disease Susceptibility', 'Endemic Diseases', 'Humans', '*Models, Theoretical', 'Rain', 'Recovery of Function', 'Temperature']",,2011/04/27 06:00,2011/08/19 06:00,['2011/04/27 06:00'],"['2010/10/13 00:00 [received]', '2011/01/25 00:00 [revised]', '2011/04/27 06:00 [entrez]', '2011/04/27 06:00 [pubmed]', '2011/08/19 06:00 [medline]']",['10.1103/PhysRevE.83.037101 [doi]'],ppublish,Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Mar;83(3 Pt 2):037101. doi: 10.1103/PhysRevE.83.037101. Epub 2011 Mar 18.,3 Pt 2,,,,,,,,,,,,,,,,,,,,,,
7731451,NLM,MEDLINE,19950526,20080214,0149-2195 (Print) 0149-2195 (Linking),44,1995 May 12,"Imported dengue--United States, 1993-1994.",353-6,,"Dengue is a mosquito-transmitted acute disease caused by any of four virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4) and characterized by the sudden onset of fever, headache, myalgia, rash, nausea, and vomiting. The disease is endemic in most tropical areas of the world and has occurred in U.S. residents returning from travel to such areas. This report summarizes information about cases of imported dengue among U.S. residents during 1993 and 1994.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/transmission', 'Female', 'Humans', 'Infant', 'Male', 'Middle Aged', '*Travel', 'United States/epidemiology']",,1995/05/12 00:00,1995/05/12 00:01,['1995/05/12 00:00'],"['1995/05/12 00:00 [pubmed]', '1995/05/12 00:01 [medline]', '1995/05/12 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1995 May 12;44(18):353-6.,18,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
29606534,NLM,MEDLINE,20181106,20181202,1876-035X (Electronic) 1876-0341 (Linking),11,2018 Sep-Oct,"Timely diagnosis, use of information technology and mosquito control prevents dengue outbreaks: Experience from central India.",739-741,S1876-0341(18)30036-4 [pii] 10.1016/j.jiph.2018.03.002 [doi],BACKGROUND: Dengue is most important arboviral disease spreading to newer areas. Timely diagnosis and mosquito control are only ways to prevent outbreaks; however there are very few studies demonstrating this hypothesis. METHODS: During this study laboratory diagnosis for Dengue was provided to patient and the programme manager on the same day of receipt of the sample. The mobile number of the patient/kin of patient was used to contact patient and reach their address to conduct vector control within 24h of case detection. RESULTS: Eighty three present cases were diagnosed within 24h and 82% houses were surveyed within 24h of reporting of the positive cases. The prompt diagnosis proactive vector control model helped keeping dengue outbreaks at bay. CONCLUSION: Timely diagnosis and prompt vector control activities can prevent dengue outbreaks. It is suggested to enhance diagnostic capabilities at local level and use new technologies such as mobile phones and internet to strengthen health systems to curb DEN.,"['Barde, Pradip V', 'Mishra, Neeta', 'Singh, Neeru']","['Barde PV', 'Mishra N', 'Singh N']",,"['ICMR-National Institute for Research in Tribal Health, Nagpur Road, Garha, Jabalpur 482003, India. Electronic address: pradip_barde@hotmail.com.', 'Indira Market Compound, Jabalpur 482001, India.', 'ICMR-National Institute for Research in Tribal Health, Nagpur Road, Garha, Jabalpur 482003, India.']",['eng'],['Journal Article'],20180330,England,J Infect Public Health,Journal of infection and public health,101487384,,IM,"['Cell Phone/statistics & numerical data', 'Dengue/*diagnosis/epidemiology/*prevention & control', 'Disease Transmission, Infectious/*prevention & control', 'Humans', 'India/epidemiology', 'Information Technology/*statistics & numerical data', 'Mosquito Control/*methods']",,2018/04/03 06:00,2018/11/07 06:00,['2018/04/03 06:00'],"['2017/07/12 00:00 [received]', '2018/03/13 00:00 [accepted]', '2018/04/03 06:00 [pubmed]', '2018/11/07 06:00 [medline]', '2018/04/03 06:00 [entrez]']","['S1876-0341(18)30036-4 [pii]', '10.1016/j.jiph.2018.03.002 [doi]']",ppublish,J Infect Public Health. 2018 Sep-Oct;11(5):739-741. doi: 10.1016/j.jiph.2018.03.002. Epub 2018 Mar 30.,5,['Copyright (c) 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue', 'Diagnosis', 'Mosquito control', 'Outbreak prevention']",,,,,,,,,,,,,,,,,,,
27773682,NLM,MEDLINE,20170904,20180719,1879-3134 (Electronic) 0025-5564 (Linking),287,2017 May,Transmission dynamics of two dengue serotypes with vaccination scenarios.,54-71,S0025-5564(16)30240-1 [pii] 10.1016/j.mbs.2016.10.001 [doi],"In this work we present a mathematical model that incorporates two Dengue serotypes. The model has been constructed to study both the epidemiological trends of the disease and conditions that allow coexistence in competing strains under vaccination. We consider two viral strains and temporary cross-immunity with one vector mosquito population. Results suggest that vaccination scenarios will not only reduce disease incidence but will also modify the transmission dynamics. Indeed, vaccination and cross immunity period are seen to decrease the frequency and magnitude of outbreaks but in a differentiated manner with specific effects depending upon the interaction vaccine and strain type.","['Gonzalez Morales, N L', 'Nunez-Lopez, M', 'Ramos-Castaneda, J', 'Velasco-Hernandez, J X']","['Gonzalez Morales NL', 'Nunez-Lopez M', 'Ramos-Castaneda J', 'Velasco-Hernandez JX']",,"['Instituto de Matematicas, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla No. 3001, Juriquilla, 76230, Mexico.', 'Departamento de Matematicas Aplicadas y Sistemas, DMAS, Universidad Autonoma Metropolitana, Cuajimalpa, Av. Vasco de Quiroga 4871, Col. Santa Fe Cuajimalpa, Cuajimalpa de Morelos, 05300, Mexico, D.F., Mexico. Electronic address: maynunlop@gmail.com.', 'Centro de Investigaciones sobre Enfermedades Infecciosas, Instituto Nacional de Salud Publica, Cuernavaca, Mexico.', 'Instituto de Matematicas, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla No. 3001, Juriquilla, 76230, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20161020,United States,Math Biosci,Mathematical biosciences,0103146,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/immunology/prevention & control/*transmission', '*Dengue Vaccines', 'Dengue Virus/*immunology', 'Humans', '*Models, Theoretical', '*Mosquito Vectors', '*Serogroup']",,2016/10/27 06:00,2017/09/05 06:00,['2016/10/27 06:00'],"['2016/05/01 00:00 [received]', '2016/10/08 00:00 [revised]', '2016/10/11 00:00 [accepted]', '2016/10/27 06:00 [pubmed]', '2017/09/05 06:00 [medline]', '2016/10/27 06:00 [entrez]']","['S0025-5564(16)30240-1 [pii]', '10.1016/j.mbs.2016.10.001 [doi]']",ppublish,Math Biosci. 2017 May;287:54-71. doi: 10.1016/j.mbs.2016.10.001. Epub 2016 Oct 20.,,['Copyright (c) 2016 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Dengue', 'Serotypes', 'Vaccine effects']",,,,,,,,,,,,,,,,,,,
23251466,NLM,MEDLINE,20130611,20220321,1932-6203 (Electronic) 1932-6203 (Linking),7,2012,Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination.,e51244,10.1371/journal.pone.0051244 [doi] e51244,"BACKGROUND: With approximately 2.5 billion people at risk, dengue is a major international public health concern. Dengue vaccines currently in development should help reduce the burden associated with this disease but the most efficient way of using future dengue vaccines remains to be defined. Mathematical models of transmission can provide insight into the expected impact of different vaccination strategies at a population level and contribute to this definition. METHODS AND FINDINGS: We developed and analyzed an age-structured, host-vector and serotype-specific compartmental model, including seasonality. We first used this transmission model to identify the immunological interactions between serotypes that affect the risks and consequences of secondary infections (cross-protection, increased susceptibility, increased severity, and increased infectiousness) and reproduce the observed epidemiology of dengue. For populating this model, we used routine surveillance data from Southern Vietnam and the results of a prospective cohort study conducted in the same area. The model provided a good fit to the observed data for age, severity of cases, serotype distribution, and dynamics over time, using two scenarios of immunological interaction : short term cross-protection alone (6-17 months) or a combination of short term cross-protection with cross-enhancement (increased susceptibility, severity and infectiousness in the case of secondary infections). Finally, we explored the potential impact of vaccination for these two scenarios. Both highlighted that vaccination can substantially decrease dengue burden by reducing the magnitude and frequency of outbreaks. CONCLUSION: Our model suggests that seasonality and short term cross-protection are key factors for explaining dengue dynamics in Southern Vietnam. Vaccination was predicted to significantly reduce the disease burden, even in the situation where immunological cross-enhancement affects the risks and consequences of secondary infections.","['Coudeville, Laurent', 'Garnett, Geoff P']","['Coudeville L', 'Garnett GP']",,"['Dengue Company, Sanofi Pasteur, Lyon, France. laurent.coudeville@sanofipasteur.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20121210,United States,PLoS One,PloS one,101285081,['0 (Dengue Vaccines)'],IM,"['Calibration', 'Dengue/epidemiology/prevention & control/*transmission', 'Dengue Vaccines/*administration & dosage', 'Dengue Virus/*classification', 'Host-Pathogen Interactions', 'Humans', 'Vietnam/epidemiology']",PMC3519629,2012/12/20 06:00,2013/06/12 06:00,['2012/12/20 06:00'],"['2011/11/08 00:00 [received]', '2012/11/05 00:00 [accepted]', '2012/12/20 06:00 [entrez]', '2012/12/20 06:00 [pubmed]', '2013/06/12 06:00 [medline]']","['PONE-D-11-22515 [pii]', '10.1371/journal.pone.0051244 [doi]']",ppublish,PLoS One. 2012;7(12):e51244. doi: 10.1371/journal.pone.0051244. Epub 2012 Dec 10.,12,,,,"['Competing Interests: LC is an employee of Sanofi Pasteur, a company that is', ""developing a dengue vaccine. This does not alter the authors' adherence to all"", 'the PLOS ONE policies on sharing data and materials.']",,,,,,,,,,,,,,,,,,
1026894,NLM,MEDLINE,19770718,20041117,0030-9311 (Print) 0030-9311 (Linking),16,1976 Nov-Dec,"Dengue haemorrhagic fever in Manado, North Sulawesi.",496-508,,,"['Husada, T', 'Munir, M']","['Husada T', 'Munir M']",,,['eng'],['Journal Article'],,Indonesia,Paediatr Indones,Paediatrica Indonesiana,0376416,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology', 'Female', 'Humans', 'Indonesia', 'Infant', 'Male']",,1976/11/01 00:00,1976/11/01 00:01,['1976/11/01 00:00'],"['1976/11/01 00:00 [pubmed]', '1976/11/01 00:01 [medline]', '1976/11/01 00:00 [entrez]']",,ppublish,Paediatr Indones. 1976 Nov-Dec;16(11-12):496-508.,11-12,,,,,,,,,,,,,,,,,,,,,,
11225377,NLM,MEDLINE,20010322,20041117,0725-3141 (Print) 0725-3141 (Linking),24,2000 Dec,Public health implications of dengue in personnel returning from East Timor.,365-8,,"In north Queensland the vector of dengue fever (Aedes aegypti) is present; hence any viraemic individual importing dengue has the potential to transmit the disease locally. In early 2000 approximately 2,000 personnel returned from East Timor to Townsville, north Queensland. Seven importations of dengue occurred and individual cases were viraemic for up to 6 days in Townsville. No subsequent local transmission occurred. There were 3 cases each of dengue type 2 and dengue type 3. One case could not be serotyped. A response, including mosquito control measures, was initiated in another 18 cases in which dengue fever was clinically suspected but which subsequently proved not to be dengue. The planning and processes undertaken to prevent local transmission of dengue in Townsville during an intense period are described.","['Hills, S', 'Piispanen, J', 'Foley, P', 'Smith, G', 'Humphreys, J', 'Simpson, J', 'McDonald, G']","['Hills S', 'Piispanen J', 'Foley P', 'Smith G', 'Humphreys J', 'Simpson J', 'McDonald G']",,"['Tropical Public Health Unit, Queensland Health, Townsville, Queensland. susan_hills@health.qld.gov.au']",['eng'],['Journal Article'],,Australia,Commun Dis Intell,Communicable diseases intelligence,9108419,,IM,"['Dengue/*epidemiology/*prevention & control/transmission', '*Health Personnel', 'Health Planning', 'Humans', 'Indonesia', 'Mosquito Control', 'Occupational Diseases/*epidemiology/*prevention & control', 'Occupational Health', '*Public Health Practice', 'Queensland/epidemiology', '*Relief Work']",,2001/02/28 10:00,2001/03/27 10:01,['2001/02/28 10:00'],"['2001/02/28 10:00 [pubmed]', '2001/03/27 10:01 [medline]', '2001/02/28 10:00 [entrez]']",,ppublish,Commun Dis Intell. 2000 Dec;24(12):365-8.,12,,,,,,,,,,,,,,,,,,,,,,
10582094,NLM,MEDLINE,20000218,20220317,0065-3527 (Print) 0065-3527 (Linking),53,1999,Impact of dengue/dengue hemorrhagic fever on the developing world.,35-70,,,"['Gubler, D J', 'Meltzer, M']","['Gubler DJ', 'Meltzer M']",,"['Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Fort Collins, Colorado 80522, USA.']",['eng'],"['Historical Article', 'Journal Article', 'Review']",,United States,Adv Virus Res,Advances in virus research,0370441,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Animals', 'Asia, Southeastern/epidemiology', 'Caribbean Region/epidemiology', 'Child', 'Dengue/diagnosis/economics/*epidemiology/therapy', '*Developing Countries', 'Disease Outbreaks/history/*prevention & control', 'Global Health', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Prevalence', 'Severe Dengue/diagnosis/economics/epidemiology/virology', 'South America/epidemiology', 'Survival Rate']",,1999/12/03 09:00,2000/02/26 09:00,['1999/12/03 09:00'],"['1999/12/03 09:00 [pubmed]', '2000/02/26 09:00 [medline]', '1999/12/03 09:00 [entrez]']",['10.1016/s0065-3527(08)60342-5 [doi]'],ppublish,Adv Virus Res. 1999;53:35-70. doi: 10.1016/s0065-3527(08)60342-5.,,,,,,,,72,,,,,,,,,,,,,,,
25223497,NLM,MEDLINE,20150813,20220419,1879-3304 (Electronic) 0039-6257 (Linking),60,2015 Mar-Apr,Dengue eye disease.,106-14,S0039-6257(14)00167-2 [pii] 10.1016/j.survophthal.2014.07.003 [doi],"Dengue fever, a viral disease epidemic in some parts of the world, is of considerable international concern, with a growing incidence owing to developing urbanization, tourism, and trade. Ocular manifestations of dengue fever are uncommon, but of great significance. Proposed mechanisms include direct viral infection as well as immunologic phenomena. Common manifestations include subconjunctival, vitreous, and retinal hemorrhages; posterior uveitis; optic neuritis; and maculopathies such as foveolitis, hemorrhage, and edema. Main symptoms include blurring of vision, scotomata, metamorphopsia, and floaters. Diagnostic and monitoring investigations described included optical coherence tomography, fundus fluorescein and indocyanine green angiography, visual field analysis, and electrophysiologic tests. Management is based on clinical presentation and includes active surveillance as well as various anti-inflammatory and immunosuppressive therapies. There have been no prospective, randomized therapeutic trials, and it is unclear if the disease is self-limiting or if treatment is actually beneficial. Prognosis varies, ranging from full resolution to permanent vision loss despite intervention.","['Ng, Aaron W', 'Teoh, Stephen C']","['Ng AW', 'Teoh SC']",,"['Yong Loo Lin School of Medicine, National University of Singapore, Singapore.', 'Eagle Eye Centre, Singapore; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore. Electronic address: drstephenteoh@gmail.com.']",['eng'],"['Journal Article', 'Review']",20140812,United States,Surv Ophthalmol,Survey of ophthalmology,0404551,"['0 (Adrenal Cortex Hormones)', '0 (Immunoglobulins, Intravenous)']",IM,"['Adrenal Cortex Hormones/therapeutic use', '*Dengue/diagnosis/epidemiology/etiology/therapy', '*Eye Infections, Viral/diagnosis/epidemiology/etiology/therapy', 'Humans', 'Immunoglobulins, Intravenous/therapeutic use', 'Risk Factors', 'Vision Disorders/virology']",,2014/09/17 06:00,2015/08/14 06:00,['2014/09/17 06:00'],"['2014/05/14 00:00 [received]', '2014/07/27 00:00 [revised]', '2014/07/29 00:00 [accepted]', '2014/09/17 06:00 [entrez]', '2014/09/17 06:00 [pubmed]', '2015/08/14 06:00 [medline]']","['S0039-6257(14)00167-2 [pii]', '10.1016/j.survophthal.2014.07.003 [doi]']",ppublish,Surv Ophthalmol. 2015 Mar-Apr;60(2):106-14. doi: 10.1016/j.survophthal.2014.07.003. Epub 2014 Aug 12.,2,['Copyright (c) 2015 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['chorioretinitis', 'complications', 'dengue', 'foveolitis', 'hemorrhage', 'infection', 'macular edema', 'maculopathy', 'optic neuritis', 'uveitis', 'viral']",,,,,,,,,,,,,,,,,,,
30180448,NLM,MEDLINE,20181002,20190318,0578-1426 (Print) 0578-1426 (Linking),57,2018 Sep 1,[Guidelines for diagnosis and treatment of dengue in China].,642-648,10.3760/cma.j.issn.0578-1426.2018.09.005 [doi],"Dengue is the most prevalent and rapidly spreading mosquito-borne viral disease. As a dengue non-endemic country, China has experienced several dengue outbreaks in recent years. However, dengue patients in China displayed distinct clinical characteristics compared to patients in endemic countries. To standardize the diagnosis and treatment of dengue fever, the experts of the Society of Infectious Diseases, Society of Tropical Medicine and Parasitology of Chinese Medical Association, and the Society of Emergency Medicine, China Association of Chinese Medicine have reached this guideline based on guidelines for diagnosis, treatment, prevention and control of dengue (World Health Organization, 2009); guidelines for diagnosis and treatment of dengue (National Health and Family Planning Commission of the People's Republic of China, 2014, Edition 2), health industry standard of the People's Republic of China ""diagnosis for dengue fever (WS216-2018)"" and systemic reports on dengue. The guideline includes 8 aspects: introduction, terminology, epidemiology and prevention, etiology and pathogenesis, clinical features, diagnosis, treatment and problems to be solved.","['Zhang, F C', 'He, J F', 'Peng, J', 'Tang, X P', 'Qin, C F', 'Lu, H Z', 'Li, X W', 'Liu, Q Q', 'Zhao, H', 'Sheng, J F', 'Wang, G J']","['Zhang FC', 'He JF', 'Peng J', 'Tang XP', 'Qin CF', 'Lu HZ', 'Li XW', 'Liu QQ', 'Zhao H', 'Sheng JF', 'Wang GJ']",,"['Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing 100034, China.']",['chi'],['Journal Article'],,China,Zhonghua Nei Ke Za Zhi,Zhonghua nei ke za zhi,16210490R,,IM,"['China', 'Dengue/*diagnosis/*drug therapy', 'Disease Outbreaks/*prevention & control', 'Humans', '*Practice Guidelines as Topic', 'World Health Organization']",,2018/09/06 06:00,2018/10/03 06:00,['2018/09/06 06:00'],"['2018/09/06 06:00 [entrez]', '2018/09/06 06:00 [pubmed]', '2018/10/03 06:00 [medline]']",['10.3760/cma.j.issn.0578-1426.2018.09.005 [doi]'],ppublish,Zhonghua Nei Ke Za Zhi. 2018 Sep 1;57(9):642-648. doi: 10.3760/cma.j.issn.0578-1426.2018.09.005.,9,,['NOTNLM'],"['Dengue', 'Diagnosis', 'Treatment']",,,"['2017ZX10305501-003/Science and Technology Major Project of China/', '2013A020229001, 2013A020229002/Special Program of Science and Technology of', 'Guangdong Province/', '201508020263, 201803040006/The Major Program of Guangzhou Healthcare', 'Collaborative Innovation/', '2014Y2-00550/Pilot Project of Guangzhou Clinical Medicine Research And', 'Transformation Center/']",,,,,,,,,,,"['Society of Infectious Diseases, Chinese Medical Association', 'Society of Tropical Medicine and Parasitology, Chinese Medical Association', 'Society of Emergency Medicine, China Association of Chinese Medicine']",,,,,
22087348,NLM,MEDLINE,20120307,20220330,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),5,2011 Nov,Evaluation of the traditional and revised WHO classifications of Dengue disease severity.,e1397,10.1371/journal.pntd.0001397 [doi] e1397,"Dengue is a major public health problem worldwide and continues to increase in incidence. Dengue virus (DENV) infection leads to a range of outcomes, including subclinical infection, undifferentiated febrile illness, Dengue Fever (DF), life-threatening syndromes with fluid loss and hypotensive shock, or other severe manifestations such as bleeding and organ failure. The long-standing World Health Organization (WHO) dengue classification and management scheme was recently revised, replacing DF, Dengue Hemorrhagic Fever (DHF), and Dengue Shock Syndrome (DSS) with Dengue without Warning Signs, Dengue with Warning Signs (abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, increasing hematocrit with decreasing platelets) and Severe Dengue (SD; dengue with severe plasma leakage, severe bleeding, or organ failure). We evaluated the traditional and revised classification schemes against clinical intervention levels to determine how each captures disease severity using data from five years (2005-2010) of a hospital-based study of pediatric dengue in Managua, Nicaragua. Laboratory-confirmed dengue cases (n = 544) were categorized using both classification schemes and by level of care (I-III). Category I was out-patient care, Category II was in-patient care that did not meet criteria for Category III, which included ICU admission, ventilation, administration of inotropic drugs, or organ failure. Sensitivity and specificity to capture Category III care for DHF/DSS were 39.0% and 75.5%, respectively; sensitivity and specificity for SD were 92.1% and 78.5%, respectively. In this data set, DENV-2 was found to be significantly associated with DHF/DSS; however, this association was not observed with the revised classification. Among dengue-confirmed cases, the revised WHO classification for severe dengue appears to have higher sensitivity and specificity to identify cases in need of heightened care, although it is no longer as specific for a particular pathogenic entity as was the traditional schema.","['Narvaez, Federico', 'Gutierrez, Gamaliel', 'Perez, Maria Angeles', 'Elizondo, Douglas', 'Nunez, Andrea', 'Balmaseda, Angel', 'Harris, Eva']","['Narvaez F', 'Gutierrez G', 'Perez MA', 'Elizondo D', 'Nunez A', 'Balmaseda A', 'Harris E']",,"['Infectious Diseases Unit, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua.']",['eng'],"['Comparative Study', 'Evaluation Study', 'Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20111108,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/complications/*diagnosis/*pathology', 'Female', 'Humans', 'Infant', 'Male', 'Nicaragua', 'Sensitivity and Specificity', '*Severity of Illness Index', 'Shock/diagnosis/pathology', 'World Health Organization']",PMC3210746,2011/11/17 06:00,2012/03/08 06:00,['2011/11/17 06:00'],"['2011/05/20 00:00 [received]', '2011/09/29 00:00 [accepted]', '2011/11/17 06:00 [entrez]', '2011/11/17 06:00 [pubmed]', '2012/03/08 06:00 [medline]']","['PNTD-D-11-00464 [pii]', '10.1371/journal.pntd.0001397 [doi]']",ppublish,PLoS Negl Trop Dis. 2011 Nov;5(11):e1397. doi: 10.1371/journal.pntd.0001397. Epub 2011 Nov 8.,11,,,,['The authors have declared that no competing interests exist.'],,"['AI62100/AI/NIAID NIH HHS/United States', 'R42 AI062100/AI/NIAID NIH HHS/United States', 'R41 AI062100/AI/NIAID NIH HHS/United States', 'U54 AI065359/AI/NIAID NIH HHS/United States', 'AI65359/AI/NIAID NIH HHS/United States']",,,,,,,,,,,,,,,,
23011458,NLM,MEDLINE,20130510,20120926,1678-9946 (Electronic) 0036-4665 (Linking),54 Suppl 18,2012 Oct,Journal of Sao Paulo Institute of Tropical Medicine. Editorial.,V-VI,S0036-46652012000700001 [pii],,"['Boulos, Marcos']",['Boulos M'],,,['eng'],"['Editorial', 'Introductory Journal Article']",,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Dengue/epidemiology/*prevention & control', 'Humans', 'Tropical Medicine']",,2012/10/04 06:00,2013/05/11 06:00,['2012/09/27 06:00'],"['2012/09/27 06:00 [entrez]', '2012/10/04 06:00 [pubmed]', '2013/05/11 06:00 [medline]']",['S0036-46652012000700001 [pii]'],ppublish,Rev Inst Med Trop Sao Paulo. 2012 Oct;54 Suppl 18:V-VI.,,,,,,,,,,,,,,,,,,,,,,,
29419739,NLM,MEDLINE,20180918,20181113,1999-4915 (Electronic) 1999-4915 (Linking),10,2018 Feb 8,Transcytosis Involvement in Transport System and Endothelial Permeability of Vascular Leakage during Dengue Virus Infection.,,10.3390/v10020069 [doi] 69,"The major role of endothelial cells is to maintain homeostasis of vascular permeability and to preserve the integrity of vascular vessels to prevent fluid leakage. Properly functioning endothelial cells promote physiological balance and stability for blood circulation and fluid components. A monolayer of endothelial cells has the ability to regulate paracellular and transcellular pathways for transport proteins, solutes, and fluid. In addition to the paracellular pathway, the transcellular pathway is another route of endothelial permeability that mediates vascular permeability under physiologic conditions. The transcellular pathway was found to be associated with an assortment of disease pathogeneses. The clinical manifestation of severe dengue infection in humans is vascular leakage and hemorrhagic diatheses. This review explores and describes the transcellular pathway, which is an alternate route of vascular permeability during dengue infection that corresponds with the pathologic finding of intact tight junction. This pathway may be the route of albumin transport that causes endothelial dysfunction during dengue virus infection.","['Chanthick, Chanettee', 'Suttitheptumrong, Aroonroong', 'Rawarak, Nantapon', 'Pattanakitsakul, Sa-Nga']","['Chanthick C', 'Suttitheptumrong A', 'Rawarak N', 'Pattanakitsakul SN']",,"['Kasetsart University Veterinary Teaching Hospital, Faculty of Veterinay Medicine, Kasetsart University, Bangkok 10900, Thailand. lchanette@gmail.com.', 'Division of Molecular Medicine, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. lchanette@gmail.com.', 'Division of Molecular Medicine, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. suttitheptumrong@yahoo.com.', 'Division of Molecular Medicine, Office for Research and Development, 4th Floor SiMR Building, 2 Wanglang Road, Faculty of Medicine Siriraj Hospital, Bangkoknoi, Bangkok 10700, Thailand. suttitheptumrong@yahoo.com.', 'Division of Molecular Medicine, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. n_1103@hotmail.com.', 'Division of Molecular Medicine, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. sanga.pat@mahidol.ac.th.', 'Division of Molecular Medicine, Office for Research and Development, 4th Floor SiMR Building, 2 Wanglang Road, Faculty of Medicine Siriraj Hospital, Bangkoknoi, Bangkok 10700, Thailand. sanga.pat@mahidol.ac.th.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20180208,Switzerland,Viruses,Viruses,101509722,,IM,"['Biological Transport', '*Capillary Permeability', 'Dengue/diagnosis/immunology/*metabolism/*virology', 'Dengue Virus/*physiology', 'Endothelial Cells/metabolism/virology', 'Endothelium, Vascular/*metabolism', 'Humans', '*Transcytosis']",PMC5850376,2018/02/09 06:00,2018/09/19 06:00,['2018/02/09 06:00'],"['2017/12/14 00:00 [received]', '2018/01/19 00:00 [revised]', '2018/02/01 00:00 [accepted]', '2018/02/09 06:00 [entrez]', '2018/02/09 06:00 [pubmed]', '2018/09/19 06:00 [medline]']","['v10020069 [pii]', 'viruses-10-00069 [pii]', '10.3390/v10020069 [doi]']",epublish,Viruses. 2018 Feb 8;10(2):69. doi: 10.3390/v10020069.,2,,['NOTNLM'],"['Thailand', 'dengue virus infection', 'endothelial permeability', 'transcytosis', 'transport system', 'vascular leakage']","['All authors declare no personal or professional conflicts of interest, and no', 'financial support from the companies that produce and/or distribute the drugs,', 'devices, or materials described in this report.']",,,,,,,,,,,,,,,,,,
37203936,NLM,MEDLINE,20230522,20230602,1815-672X (Electronic) 0028-2715 (Print) 0028-2715 (Linking),61,2023 Mar 1,Dengue Fever in a Neonate: A Case Report.,287-289,10.31729/jnma.8099 [doi],"Dengue is one of the most common viral infections affecting the general population in endemic areas annually. However, it is barely reported in newborns owing to a widespread belief that they are protected from severe viral infections in the first six months of life by the presence of maternal antibodies. Here we present a case of a 23-day-old male infant born to primigravida with dengue fever with the post-natal transmission of infection. He presented with complaints of fever for three days. On general examination, red-coloured pinpoint macular rashes were observed bilaterally on lower limbs. No significant findings were present on systemic examination. On routine sepsis workup, thrombocytopenia was present. Acknowledging the endemicity and expanding dengue cases, NS1 antigen and antibody IgM and IgG of the baby were tested which came positive for antigen and IgM antibody. Even so, the mother was asymptomatic with NS1 antigen, IgG and IgM antibodies negative with a normal range of platelet count. KEYWORDS: case report; dengue fever; neonates, Nepal.","['Bhattarai, Chaitanya Darshan', 'Yadav, Birendra Kumar', 'Basnet, Rabin', 'Karki, Manish', 'Chauhan, Shanta']","['Bhattarai CD', 'Yadav BK', 'Basnet R', 'Karki M', 'Chauhan S']",,"['Department of Pediatrics, Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal.', 'Telemedicine Center COVID-19 Unified Central Hospital, Bir Hospital, Kanti Path, Kathmandu, Nepal.', 'Telemedicine Center COVID-19 Unified Central Hospital, Bir Hospital, Kanti Path, Kathmandu, Nepal.', 'Telemedicine Center COVID-19 Unified Central Hospital, Bir Hospital, Kanti Path, Kathmandu, Nepal.', 'Department of Emergency Medicine, Himal Hospital, Thirbum Marg, Kathmandu, Nepal.']",['eng'],"['Case Reports', 'Journal Article']",20230301,Nepal,JNMA J Nepal Med Assoc,JNMA; journal of the Nepal Medical Association,0045233,"['0 (Immunoglobulin M)', '0 (Immunoglobulin G)', '0 (Antibodies, Viral)']",IM,"['Infant', 'Female', 'Humans', 'Male', 'Infant, Newborn', '*Dengue/complications/diagnosis/epidemiology', 'Platelet Count', '*Thrombocytopenia', 'Immunoglobulin M', 'Immunoglobulin G', 'Antibodies, Viral']",PMC10231546,2023/05/19 13:05,2023/05/22 06:42,['2023/05/19 06:23'],"['2023/02/25 00:00 [received]', '2023/05/22 06:42 [medline]', '2023/05/19 13:05 [pubmed]', '2023/05/19 06:23 [entrez]']",['10.31729/jnma.8099 [doi]'],epublish,JNMA J Nepal Med Assoc. 2023 Mar 1;61(259):287-289. doi: 10.31729/jnma.8099.,259,,,,['None.'],,,,,,,,,,,,,,,,,,
26976885,NLM,MEDLINE,20170509,20231111,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),94,2016 May 4,Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico.,1085-1089,10.4269/ajtmh.15-0896 [doi],"Dengue is mostly considered an acute illness with three phases: febrile, critical with possible hemorrhagic manifestations, and recovery. But some patients present persistent symptoms, including fatigue and depression, as acknowledged by the World Health Organization. If persistent symptoms affect a non-negligible share of patients, the burden of dengue will be underestimated. On the basis of a systematic literature review and econometric modeling, we found a significant relationship between the share of patients reporting persisting symptoms and time. We updated estimates of the economic burden of dengue in Mexico, addressing uncertainty in productivity loss and incremental expenses using Monte Carlo simulations. Persistent symptoms represent annually about US$22.6 (95% certainty level [CL]: US$13-US$29) million in incremental costs and 28.2 (95% CL: 21.6-36.2) additional disability-adjusted life years per million population, or 13% and 43% increases over previous estimates, respectively. Although our estimates have uncertainty from limited data, they show a substantial, unmeasured burden. Similar patterns likely extend to other dengue-endemic countries.","['Tiga, D Carolina', 'Undurraga, Eduardo A', 'Ramos-Castaneda, Jose', 'Martinez-Vega, Ruth A', 'Tschampl, Cynthia A', 'Shepard, Donald S']","['Tiga DC', 'Undurraga EA', 'Ramos-Castaneda J', 'Martinez-Vega RA', 'Tschampl CA', 'Shepard DS']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20160314,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Computer Simulation', 'Dengue/*economics/*epidemiology/pathology', 'Health Care Costs', 'Humans', 'Mexico/epidemiology', 'Models, Economic', 'Monte Carlo Method']",PMC4856607,2016/03/16 06:00,2017/05/10 06:00,['2016/03/16 06:00'],"['2015/12/12 00:00 [received]', '2016/02/07 00:00 [accepted]', '2016/03/16 06:00 [entrez]', '2016/03/16 06:00 [pubmed]', '2017/05/10 06:00 [medline]']",['10.4269/ajtmh.15-0896 [doi]'],ppublish,Am J Trop Med Hyg. 2016 May 4;94(5):1085-1089. doi: 10.4269/ajtmh.15-0896. Epub 2016 Mar 14.,5,['(c) The American Society of Tropical Medicine and Hygiene.'],,,,,,,,,,,,,,,,,,,,,
25253746,NLM,MEDLINE,20150114,20141028,1526-632X (Electronic) 0028-3878 (Linking),83,2014 Oct 28,Dengue is coming!,1590-1,10.1212/WNL.0000000000000949 [doi],,"['Sharer, Leroy R', 'McCarthy, Micheline']","['Sharer LR', 'McCarthy M']",,"['From Rutgers New Jersey Medical School (L.R.S.), Newark; and the Miller School of Medicine (M.M.), University of Miami, FL. sharer@njms.rutgers.edu.', 'From Rutgers New Jersey Medical School (L.R.S.), Newark; and the Miller School of Medicine (M.M.), University of Miami, FL.']",['eng'],['Editorial'],20140924,United States,Neurology,Neurology,0401060,,IM,"['Central Nervous System Diseases/*etiology', 'Dengue/*complications/*epidemiology', 'Humans']",,2014/09/26 06:00,2015/01/15 06:00,['2014/09/26 06:00'],"['2014/09/26 06:00 [entrez]', '2014/09/26 06:00 [pubmed]', '2015/01/15 06:00 [medline]']","['WNL.0000000000000949 [pii]', '10.1212/WNL.0000000000000949 [doi]']",ppublish,Neurology. 2014 Oct 28;83(18):1590-1. doi: 10.1212/WNL.0000000000000949. Epub 2014 Sep 24.,18,,,,,,,,,,,,,,,,,,,,,,
12702223,NLM,MEDLINE,20030513,20220311,1080-6040 (Print) 1080-6059 (Electronic) 1080-6040 (Linking),9,2003 Apr,"Dengue fever in travelers to the tropics, 1998 and 1999.",438-42,,"Dengue fever (DF) has become common in western travelers to the tropics. To improve the basis for travel advice, risk factors and dengue manifestations were assessed in 107 Swedish patients for whom DF was diagnosed after return from travel in 1998 and 1999. Patient data were compared with data on a sample of all Swedish travelers to dengue-endemic countries in the same years. Only three of the patients had received pretravel advice concerning DF from their physicians. Hemorrhagic manifestations were common (21 of 74 patients) but caused no deaths. Risk factors for a DF diagnosis were travel to the Malay Peninsula (odds ratio [OR] 4.95; confidence interval [CI] 2.92 to 8.46), age 15-29 years (OR 3.03; CI 1.87 to 4.92), and travel duration >25 days (OR 8.75; CI 4.79 to 16.06). Pretravel advice should be given to all travelers to DF-endemic areas, but young persons traveling to southern and Southeast Asia for >3 weeks (who constituted 31% of the patients in our study) may be more likely to benefit by adhering to it.","['Lindback, Heidi', 'Lindback, Johan', 'Tegnell, Anders', 'Janzon, Ragnhild', 'Vene, Sirkka', 'Ekdahl, Karl']","['Lindback H', 'Lindback J', 'Tegnell A', 'Janzon R', 'Vene S', 'Ekdahl K']",,"['Uppsala University, Uppsala, Sweden.']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adolescent', 'Adult', 'Child', 'Confidence Intervals', 'Dengue/diagnosis/epidemiology/*etiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Risk Factors', 'Sweden/epidemiology', '*Travel', 'Tropical Climate']",PMC2957980,2003/04/19 05:00,2003/05/14 05:00,['2003/04/19 05:00'],"['2003/04/19 05:00 [pubmed]', '2003/05/14 05:00 [medline]', '2003/04/19 05:00 [entrez]']","['02-0267 [pii]', '10.3201/eid0904.020267 [doi]']",ppublish,Emerg Infect Dis. 2003 Apr;9(4):438-42. doi: 10.3201/eid0904.020267.,4,,,,,,,,,,,,,,,,,,,,,,
29488594,NLM,MEDLINE,20180507,20180507,0717-6341 (Electronic) 0716-1018 (Linking),34,2017 Oct,[Dengue in a newborn].,494-498,S0716-10182017000500494 [pii] 10.4067/S0716-10182017000500494 [doi],"Dengue is the disease transmitted by arthropods of major importance in public health; however its presence in the neonatal stage is poorly studied, with few cases described worldwide. We present the case report of a neonate who started illness at 12 days of age, characterized by fever and irritability. He was hospitalized for suspicion of neonatal sepsis; later he presented thrombocytopenia and due the antecedent of his mother with diagnosis of dengue after childbirth, dengue tests were obtained in the neonate, resulting positive, then support treatment and fluid treatment is performed, with subsequent recovery. Dengue in the neonatal stage should always be suspected in areas where the disease is endemic and management guides should be proposed.","['Arteaga-Livias, Kovy', 'Bonilla-Crispin, Angela', 'Panduro-Correa, Vicky', 'Martinez-Enriquez, Carlos', 'Damaso-Mata, Bernardo']","['Arteaga-Livias K', 'Bonilla-Crispin A', 'Panduro-Correa V', 'Martinez-Enriquez C', 'Damaso-Mata B']",,"['Facultad de Medicina, Universidad Nacional Hermilio Valdizan, Valdizan, Peru.', 'Facultad de Medicina, Universidad Nacional Hermilio Valdizan, Valdizan, Peru.', 'Facultad de Medicina, Universidad Nacional Hermilio, Valdizan, Peru.', 'Facultad de Medicina, Universidad Nacional Hermilio Valdizan, Valdizan, Peru.', 'Facultad de Medicina, Universidad Nacional Hermilio Valdizan, Valdizan, Peru.']",['spa'],"['Case Reports', 'Journal Article']",,Chile,Rev Chilena Infectol,Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,9305754,,IM,"['Adult', 'Dengue/*diagnosis/therapy', 'Disease Progression', 'Female', 'Humans', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical', 'Male', 'Pregnancy', 'Pregnancy Complications, Infectious']",,2018/03/01 06:00,2018/05/08 06:00,['2018/03/01 06:00'],"['2017/03/07 00:00 [received]', '2017/08/08 00:00 [accepted]', '2018/03/01 06:00 [entrez]', '2018/03/01 06:00 [pubmed]', '2018/05/08 06:00 [medline]']","['S0716-10182017000500494 [pii]', '10.4067/S0716-10182017000500494 [doi]']",ppublish,Rev Chilena Infectol. 2017 Oct;34(5):494-498. doi: 10.4067/S0716-10182017000500494.,5,,,,,,,,,Dengue en un neonato.,,,,,,,,,,,,,
23800514,NLM,MEDLINE,20140326,20220716,1469-4409 (Electronic) 0950-2688 (Print) 0950-2688 (Linking),142,2014 Mar,Modelling interventions during a dengue outbreak.,545-61,10.1017/S0950268813001301 [doi],"We present a stochastic dynamical model for the transmission of dengue that considers the co-evolution of the spatial dynamics of the vectors (Aedes aegypti) and hosts (human population), allowing the simulation of control strategies adapted to the actual evolution of an epidemic outbreak. We observed that imposing restrictions on the movement of infected humans is not a highly effective strategy. In contrast, isolating infected individuals with high levels of compliance by the human population is efficient even when implemented with delays during an ongoing outbreak. We also studied insecticide-spraying strategies assuming different (hypothetical) efficiencies. We observed that highly efficient fumigation strategies seem to be effective during an outbreak. Nevertheless, taking into account the controversial results on the use of spraying as a single control strategy, we suggest that carrying out combined strategies of fumigation and isolation during an epidemic outbreak should account for a suitable strategy for the attenuation of epidemic outbreaks.","['Barmak, D H', 'Dorso, C O', 'Otero, M', 'Solari, H G']","['Barmak DH', 'Dorso CO', 'Otero M', 'Solari HG']",,"['Departamento de Fisica, FCEN-UBA and IFIBA-CONICET, Pabellon I, Ciudad Universitaria, Buenos Aires, Argentina.', 'Departamento de Fisica, FCEN-UBA and IFIBA-CONICET, Pabellon I, Ciudad Universitaria, Buenos Aires, Argentina.', 'Departamento de Fisica, FCEN-UBA and IFIBA-CONICET, Pabellon I, Ciudad Universitaria, Buenos Aires, Argentina.', 'Departamento de Fisica, FCEN-UBA and IFIBA-CONICET, Pabellon I, Ciudad Universitaria, Buenos Aires, Argentina.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130626,England,Epidemiol Infect,Epidemiology and infection,8703737,['0 (Insecticides)'],IM,"['Aedes', 'Animals', 'Dengue/epidemiology/*prevention & control/transmission', 'Disease Outbreaks/*prevention & control', 'Humans', 'Insect Vectors', 'Insecticides', 'Models, Biological', '*Models, Theoretical', 'Patient Isolation']",PMC9151143,2013/06/27 06:00,2014/03/29 06:00,['2013/06/27 06:00'],"['2013/06/27 06:00 [entrez]', '2013/06/27 06:00 [pubmed]', '2014/03/29 06:00 [medline]']","['S0950268813001301 [pii]', '00130 [pii]', '10.1017/S0950268813001301 [doi]']",ppublish,Epidemiol Infect. 2014 Mar;142(3):545-61. doi: 10.1017/S0950268813001301. Epub 2013 Jun 26.,3,,,,,,,,,,,,,,,,,,,,,,
23381875,NLM,MEDLINE,20131022,20220801,1439-0973 (Electronic) 0300-8126 (Linking),41,2013 Aug,Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India.,775-82,10.1007/s15010-013-0405-3 [doi],"BACKGROUND: Revised case definitions of dengue into dengue with/without warning signs (DWS/D) and severe dengue (SD) was proposed by the World Health Organization (WHO)/Tropical Disease Research (TDR) in 2009. To date, there has been no Indian study that has applied this classification. AIMS AND OBJECTIVES: To assess the accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in India. MATERIALS AND METHODS: Over a period of 1 year children from the pediatric ward and Out Patient Department (OPD) of the King George Medical University Hospital, Lucknow were enrolled in the study according to predefined criteria and tested for dengue. Each dengue-positive patient was classified according to both the older system [dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS)] and the new system (D, DWS, and SD). The severity of dengue was compared to the level of treatment received. RESULTS: A total of 56 patients tested positive for dengue--51 from the pediatric ward and five from the OPD. According to the older WHO classification, 42 (75 %) patients were classified as DF and 13 (23.2 %) as DHF/DSS; one patient was unclassifiable. Five patients (8.9 %) received level 1 treatment, ten (17.8 %) received level 2 treatment, and 41 (73.2 %) received level 3 treatment. According to the new WHO/TDR classification, 46 (82.1 %) patients were classified as SD, nine (16 %) as DWS, and only one (1.7 %) as D. Many of the severe manifestations (encephalopathy, shock, mucosal bleed, platelet count <20,000, respiratory distress, liver enzymes >1,000 U/L) were seen in patients who were classified as DF according to old classification, whereas these patients were mostly classified as SD by the new classification. Sensitivity of the older and new classifications was 24.8 and 98 %, respectively. CONCLUSIONS: The revised WHO/TDR (2009) classification has very high sensitivity for identifying severe dengue and is easy to apply.","['Prasad, D', 'Kumar, Chandrakanta', 'Jain, A', 'Kumar, R']","['Prasad D', 'Kumar C', 'Jain A', 'Kumar R']",,"['Department of Pediatrics, King George Medical University, Lucknow, UP, 226003, India.']",['eng'],"['Evaluation Study', 'Journal Article']",20130205,Germany,Infection,Infection,0365307,,IM,"['Child', 'Child, Preschool', 'Clinical Medicine/*methods/*standards', 'Dengue/*classification/*diagnosis/pathology', 'Female', 'Hospitals, University', 'Humans', 'India', 'Male', 'Sensitivity and Specificity', '*Severity of Illness Index', 'Tertiary Healthcare']",,2013/02/06 06:00,2013/10/23 06:00,['2013/02/06 06:00'],"['2012/11/05 00:00 [received]', '2013/01/04 00:00 [accepted]', '2013/02/06 06:00 [entrez]', '2013/02/06 06:00 [pubmed]', '2013/10/23 06:00 [medline]']",['10.1007/s15010-013-0405-3 [doi]'],ppublish,Infection. 2013 Aug;41(4):775-82. doi: 10.1007/s15010-013-0405-3. Epub 2013 Feb 5.,4,,,,,['Infection. 2013 Oct;41(5):1047. PMID: 23475504'],,,,,,,,,,,,,,,,,
3775560,NLM,MEDLINE,19861125,20140912,0256-9574 (Print),Suppl,1986 Oct 11,The pathogenesis of dengue haemorrhagic fever. A critical appraisal of current hypotheses.,40-2,,,"['Rosen, L']",['Rosen L'],,,['eng'],['Journal Article'],,South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,"['0 (Antibodies, Viral)']",IM,"['Animals', 'Antibodies, Viral', 'Cercopithecidae', 'Dengue/*etiology/immunology/microbiology', 'Dengue Virus/immunology/pathogenicity', 'Humans', 'Virulence']",,1986/10/11 00:00,1986/10/11 00:01,['1986/10/11 00:00'],"['1986/10/11 00:00 [pubmed]', '1986/10/11 00:01 [medline]', '1986/10/11 00:00 [entrez]']",,ppublish,S Afr Med J. 1986 Oct 11;Suppl:40-2.,,,,,,,,,,,,,,,,,,,,,,,
3603210,NLM,MEDLINE,19870810,20061115,0036-3634 (Print) 0036-3634 (Linking),29,1987 Jan-Feb,[The epidemiology of dengue in America 1982-1984. 5].,15-25,,,"['Carrada Bravo, T']",['Carrada Bravo T'],,,['spa'],"['English Abstract', 'Journal Article']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Dengue/*epidemiology/microbiology/transmission', 'Dengue Virus/classification/isolation & purification', 'Disease Outbreaks/*epidemiology', 'Disease Reservoirs', 'Humans', 'Latin America', 'Mosquito Control', 'Travel', 'United States']",,1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1987 Jan-Feb;29(1):15-25.,1,,,,,,,,,La epidemiologia del dengue en America 1982-1984. Quinta parte.,,,,,,,,,,,,,
26827371,NLM,MEDLINE,20160201,20161201,0387-5911 (Print) 0387-5911 (Linking),Suppl 13,2015 Jul,[A case of dengue fever that was most likely infected at Yoyogi park in Japan].,29-33,,,"['Kutsuna, Satoshi', 'Yamamoto, K', 'Fujitani, Yoshihiro', 'Umato, Momoko', 'Hayakawa, Kayoko', 'Takeshita, Nozomi', 'Kato, Yasuyuki', 'Kanekawa, Shuzo', 'omagari, Takao', 'Sato, Tatsuya']","['Kutsuna S', 'Yamamoto K', 'Fujitani Y', 'Umato M', 'Hayakawa K', 'Takeshita N', 'Kato Y', 'Kanekawa S', 'omagari T', 'Sato T']",,"['Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.']",['jpn'],"['Case Reports', 'Journal Article']",,Japan,Kansenshogaku Zasshi,Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,0236671,,IM,"['Adolescent', 'Dengue/physiopathology/*transmission', 'Diagnostic Errors', 'Humans', 'Male']",,2016/02/02 06:00,2016/02/02 06:01,['2016/02/02 06:00'],"['2016/02/02 06:00 [entrez]', '2016/02/02 06:00 [pubmed]', '2016/02/02 06:01 [medline]']",,ppublish,Kansenshogaku Zasshi. 2015 Jul;Suppl 13:29-33.,,,,,,,,,,,,,,,,,,,,,,,
23132108,NLM,MEDLINE,20140106,20141120,1947-3613 (Electronic) 1937-0660 (Linking),5,2012 Fall,Travel-related health risks part 2: emerging mosquito-borne infectious illnesses.,E41-5,,,"['Levison, Matthew E']",['Levison ME'],,"['Drexel University School of Public Health, USA.']",['eng'],"['Journal Article', 'Review']",,United States,MD Advis,MD advisor : a journal for New Jersey medical community,101522608,,IM,"['Alphavirus Infections/*diagnosis/*prevention & control/therapy/transmission', 'Animals', 'Chikungunya Fever', 'Culicidae', 'Dengue/*diagnosis/*prevention & control/therapy/transmission', 'Humans', '*Insect Vectors', '*Travel']",,2012/11/08 06:00,2014/01/07 06:00,['2012/11/08 06:00'],"['2012/11/08 06:00 [entrez]', '2012/11/08 06:00 [pubmed]', '2014/01/07 06:00 [medline]']",,ppublish,MD Advis. 2012 Fall;5(4):E41-5.,4,,,,,,,,,,,,,,,,,,,,,,
34818871,NLM,MEDLINE,20220111,20220111,0972-9062 (Print) 0972-9062 (Linking),58,2021 Jan-Mar,Zika and dengue in donor plasma.,97,10.4103/0972-9062.330642 [doi],,"['Mungmunpuntipantip, Rujittika', 'Wiwanitkit, Viroj']","['Mungmunpuntipantip R', 'Wiwanitkit V']",,"['26 Medical Center, Bangkok, Thailand.', 'Joseph Ayobabalola, Ikeji-Arakeji, Nigeria.']",['eng'],['Letter'],,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['*Dengue/diagnosis/epidemiology', 'Humans', '*Zika Virus', '*Zika Virus Infection/diagnosis']",,2021/11/26 06:00,2022/01/12 06:00,['2021/11/25 02:04'],"['2021/11/25 02:04 [entrez]', '2021/11/26 06:00 [pubmed]', '2022/01/12 06:00 [medline]']","['JVectorBorneDis_2021_58_1_97_330642 [pii]', '10.4103/0972-9062.330642 [doi]']",ppublish,J Vector Borne Dis. 2021 Jan-Mar;58(1):97. doi: 10.4103/0972-9062.330642.,1,,,,['None'],,,,,,,,,,,,,,,,,,
4801857,NLM,MEDLINE,19740730,20130405,,66,1973 May-Jun,[Dengue epidemic in Tahiti in 1971. Evolution of hemorrhagic tendency and comparisons with previous epidemics].,381-5,,,"['Saugrain, J', 'Moreau, J P', 'Rosen, L']","['Saugrain J', 'Moreau JP', 'Rosen L']",,,['fre'],['Journal Article'],,France,Bull Soc Pathol Exot Filiales,Bulletin de la Societe de pathologie exotique et de ses filiales,7503399,,IM,"['Antibody Formation', 'Dengue/diagnosis/*epidemiology/microbiology', 'Dengue Virus/classification/isolation & purification', 'Disease Outbreaks', 'Hemorrhage/etiology', 'Humans', 'Polynesia', 'Serologic Tests', 'Statistics as Topic']",,1973/05/01 00:00,1973/05/01 00:01,['1973/05/01 00:00'],"['1973/05/01 00:00 [pubmed]', '1973/05/01 00:01 [medline]', '1973/05/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot Filiales. 1973 May-Jun;66(3):381-5.,3,,,,,,,,,L'epidemie de dengue de Tahiti en 1971. Evolution de la tendance hemorragique et comparaisons avec les epidemies precedentes.,,,,,,,,,,,,,
36036222,NLM,MEDLINE,20230118,20230829,2047-7732 (Electronic) 2047-7724 (Print) 2047-7724 (Linking),117,2023 Feb,Dengue fever on the rise in Southeast Asia.,1-2,10.1080/20477724.2022.2116550 [doi],,"['Alied, Marcel', 'Nguyen, Dang', 'Abdul Aziz, Jeza Muhamad', 'Vinh, Dang Phuc', 'Huy, Nguyen Tien']","['Alied M', 'Nguyen D', 'Abdul Aziz JM', 'Vinh DP', 'Huy NT']","['ORCID: 0000-0002-7725-4127', 'ORCID: 0000-0002-9622-8370', 'ORCID: 0000-0002-1522-1880', 'ORCID: 0000-0002-3722-8362', 'ORCID: 0000-0002-9543-9440']","['Faculty of Pharmacy, University of Aleppo, Aleppo, Syria.', 'Online Research Club (https://www.onlineresearchclub.org/), Nagasaki, Japan.', 'Online Research Club (https://www.onlineresearchclub.org/), Nagasaki, Japan.', 'Department of Biomedical Engineering, University of South Florida, Tampa, Florida, United states.', 'Department of Medical Laboratory Science, College of Health Sciences, University of Human Development, Sulaimani, Kurdistan, Iraq.', 'Baxshin Research center, Baxshin Hospital, Sulaimani, Kurdistan region, Iraq.', 'Online Research Club (https://www.onlineresearchclub.org/), Nagasaki, Japan.', 'Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.', 'Online Research Club (https://www.onlineresearchclub.org/), Nagasaki, Japan.', 'School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.']",['eng'],['Journal Article'],20220828,England,Pathog Glob Health,Pathogens and global health,101583421,,IM,"['Humans', 'Asia, Southeastern/epidemiology', '*Dengue/epidemiology/prevention & control']",PMC9848297,2022/08/30 06:00,2023/01/19 06:00,['2022/08/29 06:02'],"['2022/08/30 06:00 [pubmed]', '2023/01/19 06:00 [medline]', '2022/08/29 06:02 [entrez]']","['2116550 [pii]', '10.1080/20477724.2022.2116550 [doi]']",ppublish,Pathog Glob Health. 2023 Feb;117(1):1-2. doi: 10.1080/20477724.2022.2116550. Epub 2022 Aug 28.,1,,['NOTNLM'],"['Dengue', 'Southeast Asia', 'arboviral diseases', 'epidemiology', 'outbreak', 'vector-borne infections']",['No potential conflict of interest was reported by the author(s).'],,,,,,,,,,,,,,,,,,
26374064,NLM,MEDLINE,20151231,20181023,1756-1833 (Electronic) 0959-8138 (Linking),351,2015 Sep 15,Dengue fever.,h4661,10.1136/bmj.h4661 [doi],,"['Kularatne, Senanayake A M']",['Kularatne SA'],,"['Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka samkul@sltnet.lk.']",['eng'],"['Journal Article', 'Review']",20150915,England,BMJ,BMJ (Clinical research ed.),8900488,"['0 (Adrenal Cortex Hormones)', '0 (Colloids)', '0 (Dengue Vaccines)']",IM,"['Adrenal Cortex Hormones/therapeutic use', '*Aedes', 'Animals', 'Child', 'Colloids/therapeutic use', '*Dengue/diagnosis/epidemiology/physiopathology/therapy', 'Dengue Vaccines/therapeutic use', '*Dengue Virus', 'Female', '*Fluid Therapy', 'Humans', '*Insect Vectors', 'Pregnancy', 'Pregnancy Complications, Infectious/diagnosis/epidemiology/physiopathology/therapy']",,2015/09/17 06:00,2016/01/01 06:00,['2015/09/17 06:00'],"['2015/09/17 06:00 [entrez]', '2015/09/17 06:00 [pubmed]', '2016/01/01 06:00 [medline]']",['10.1136/bmj.h4661 [doi]'],epublish,BMJ. 2015 Sep 15;351:h4661. doi: 10.1136/bmj.h4661.,,,,,,,,,,,,,,,,,,,,,,,
6408372,NLM,MEDLINE,19830817,20080214,0149-2195 (Print) 0149-2195 (Linking),32,1983 Mar 25,"Imported dengue fever--United States, 1982.",145-6,,,,,,,['eng'],"['Case Reports', 'Journal Article']",,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adult', 'Dengue/*epidemiology/transmission', 'Humans', 'Male', 'Middle Aged', '*Travel', 'United States']",,1983/03/25 00:00,1983/03/25 00:01,['1983/03/25 00:00'],"['1983/03/25 00:00 [pubmed]', '1983/03/25 00:01 [medline]', '1983/03/25 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1983 Mar 25;32(11):145-6.,11,,,,,,,,,,,,,,,,,['Centers for Disease Control (CDC)'],,,,,
18597694,NLM,MEDLINE,20080718,20211020,1472-6947 (Electronic) 1472-6947 (Linking),8,2008 Jul 2,Value of syndromic surveillance within the Armed Forces for early warning during a dengue fever outbreak in French Guiana in 2006.,29,10.1186/1472-6947-8-29 [doi],"BACKGROUND: A dengue fever outbreak occured in French Guiana in 2006. The objectives were to study the value of a syndromic surveillance system set up within the armed forces, compared to the traditional clinical surveillance system during this outbreak, to highlight issues involved in comparing military and civilian surveillance systems and to discuss the interest of syndromic surveillance for public health response. METHODS: Military syndromic surveillance allows the surveillance of suspected dengue fever cases among the 3,000 armed forces personnel. Within the same population, clinical surveillance uses several definition criteria for dengue fever cases, depending on the epidemiological situation. Civilian laboratory surveillance allows the surveillance of biologically confirmed cases, within the 200,000 inhabitants. RESULTS: It was shown that syndromic surveillance detected the dengue fever outbreak several weeks before clinical surveillance, allowing quick and effective enhancement of vector control within the armed forces. Syndromic surveillance was also found to have detected the outbreak before civilian laboratory surveillance. CONCLUSION: Military syndromic surveillance allowed an early warning for this outbreak to be issued, enabling a quicker public health response by the armed forces. Civilian surveillance system has since introduced syndromic surveillance as part of its surveillance strategy. This should enable quicker public health responses in the future.","['Meynard, Jean-Baptiste', 'Chaudet, Herve', 'Texier, Gaetan', 'Ardillon, Vanessa', 'Ravachol, Francoise', 'Deparis, Xavier', 'Jefferson, Henry', 'Dussart, Philippe', 'Morvan, Jacques', 'Boutin, Jean-Paul']","['Meynard JB', 'Chaudet H', 'Texier G', 'Ardillon V', 'Ravachol F', 'Deparis X', 'Jefferson H', 'Dussart P', 'Morvan J', 'Boutin JP']",,"['Institut Pasteur de la Guyane, Cayenne 97306, French Guiana. jbmeynard@pasteur-cayenne.fr']",['eng'],['Journal Article'],20080702,England,BMC Med Inform Decis Mak,BMC medical informatics and decision making,101088682,,IM,"['Dengue/diagnosis/*epidemiology/prevention & control', '*Disease Outbreaks/prevention & control', 'Early Diagnosis', 'French Guiana/epidemiology', 'Humans', 'Military Medicine', '*Military Personnel', 'Population Surveillance/*methods']",PMC2459153,2008/07/04 09:00,2008/07/19 09:00,['2008/07/04 09:00'],"['2007/12/18 00:00 [received]', '2008/07/02 00:00 [accepted]', '2008/07/04 09:00 [pubmed]', '2008/07/19 09:00 [medline]', '2008/07/04 09:00 [entrez]']","['1472-6947-8-29 [pii]', '10.1186/1472-6947-8-29 [doi]']",epublish,BMC Med Inform Decis Mak. 2008 Jul 2;8:29. doi: 10.1186/1472-6947-8-29.,,,,,,,,,,,,,,,,,,,,,,,
34115753,NLM,MEDLINE,20211019,20211019,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),15,2021 Jun,"Temperature, traveling, slums, and housing drive dengue transmission in a non-endemic metropolis.",e0009465,10.1371/journal.pntd.0009465 [doi] e0009465,"Dengue is steadily increasing worldwide and expanding into higher latitudes. Current non-endemic areas are prone to become endemic soon. To improve understanding of dengue transmission in these settings, we assessed the spatiotemporal dynamics of the hitherto largest outbreak in the non-endemic metropolis of Buenos Aires, Argentina, based on detailed information on the 5,104 georeferenced cases registered during summer-autumn of 2016. The highly seasonal dengue transmission in Buenos Aires was modulated by temperature and triggered by imported cases coming from regions with ongoing outbreaks. However, local transmission was made possible and consolidated heterogeneously in the city due to housing and socioeconomic characteristics of the population, with 32.8% of autochthonous cases occurring in slums, which held only 6.4% of the city population. A hierarchical spatiotemporal model accounting for imperfect detection of cases showed that, outside slums, less-affluent neighborhoods of houses (vs. apartments) favored transmission. Global and local spatiotemporal point-pattern analyses demonstrated that most transmission occurred at or close to home. Additionally, based on these results, a point-pattern analysis was assessed for early identification of transmission foci during the outbreak while accounting for population spatial distribution. Altogether, our results reveal how social, physical, and biological processes shape dengue transmission in Buenos Aires and, likely, other non-endemic cities, and suggest multiple opportunities for control interventions.","['Gurevitz, Juan Manuel', 'Antman, Julian Gustavo', 'Laneri, Karina', 'Morales, Juan Manuel']","['Gurevitz JM', 'Antman JG', 'Laneri K', 'Morales JM']","['ORCID: 0000-0002-5611-8927', 'ORCID: 0000-0002-1686-2890', 'ORCID: 0000-0001-8536-4695']","['Grupo de Ecologia Cuantitativa, INIBIOMA-CONICET, Universidad Nacional del Comahue, S.C. de Bariloche, Rio Negro, Argentina.', 'Gerencia Operativa de Epidemiologia, Ministerio de Salud de la Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina.', 'Grupo de Fisica Estadistica e Interdisciplinaria, CONICET, Centro Atomico Bariloche-CNEA, S.C. de Bariloche, Rio Negro, Argentina.', 'Grupo de Ecologia Cuantitativa, INIBIOMA-CONICET, Universidad Nacional del Comahue, S.C. de Bariloche, Rio Negro, Argentina.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20210611,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Animals', 'Argentina/epidemiology', 'Cities/statistics & numerical data', 'Dengue/economics/*epidemiology/*transmission/virology', 'Disease Outbreaks', 'Housing', 'Humans', 'Poverty Areas', 'Seasons', 'Temperature', 'Travel']",PMC8221794,2021/06/12 06:00,2021/10/21 06:00,['2021/06/11 17:19'],"['2020/09/22 00:00 [received]', '2021/05/10 00:00 [accepted]', '2021/06/23 00:00 [revised]', '2021/06/12 06:00 [pubmed]', '2021/10/21 06:00 [medline]', '2021/06/11 17:19 [entrez]']","['PNTD-D-20-01700 [pii]', '10.1371/journal.pntd.0009465 [doi]']",epublish,PLoS Negl Trop Dis. 2021 Jun 11;15(6):e0009465. doi: 10.1371/journal.pntd.0009465. eCollection 2021 Jun.,6,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
19462558,NLM,MEDLINE,20090609,20090525,0120-4157 (Print) 0120-4157 (Linking),28,2008 Dec,[Clinical evolution of dengue in hospitalized patients].,531-43,,"INTRODUCTION: Dengue hemorrhagic fever has extended to every tropical and subtropical area of the world, resulting in a half million hospitalizations every year. This disease appears to affect increasing numbers of adolescents and young adults. OBJECTIVE: The clinical characteristics were described for adult and pediatric dengue inpatients to establish risk factors associated with bad prognosis. MATERIALS AND METHODS: A cohort of dengue inpatients of years 2006 and 2007 was evaluated retrospectively at ""Clinica Chicamocha"", a high level hospital in Bucaramanga, Colombia. RESULTS: Of 328 patients evaluated, 165 were female and 163 were male with a median age of 25 years. Dengue hemorrhagic fever was diagnosed in 116 patients, of which 113 were classified grade II. Of the 212 patients with dengue fever, 156 developed signs of plasma leakage, bleeding or thrombocytopenia. A positive serology was indicated in 82.4% of the patients. Inpatients with dengue hemorrhagic fever were younger (20.1 vs. 25.7 years, p<0.0054). Both lowest level of platelets and highest hematocrit were reached at the sixth day of illness. Children presented the typical symptoms of dengue less frequently, but demonstrated a greater proportion of ascites, pleural effusion and bleeding, and a higher risk of developing respiratory distress (RR=3.59, 95%CI 1.3-9.9, p<0.014) and hypotension (RR=10.77, 95%CI 5.56-20.86, p<0.001). CONCLUSIONS: Age was the most determinant factor of severity in dengue inpatients. In addition, a combination of particular symptoms and laboratory data at the day of admission may predict the development of complications.","['Gonzalez, Andres Leonardo', 'Martinez, Ruth Arali', 'Villar, Luis Angel']","['Gonzalez AL', 'Martinez RA', 'Villar LA']",,"['Grupo de Epidemiologia Clinica, Centro de Investigaciones Epidemiologicas, Universidad Industrial de Santander, Bucaramanga, Santander. andreslgonzalezr@gmail.com']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Colombia,Biomedica,Biomedica : revista del Instituto Nacional de Salud,8205605,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Colombia', 'Dengue/diagnosis/*pathology/*physiopathology', '*Disease Progression', 'Female', '*Hospitalization', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Prognosis', 'Retrospective Studies', 'Young Adult']",,2009/05/26 09:00,2009/06/10 09:00,['2009/05/26 09:00'],"['2009/05/26 09:00 [entrez]', '2009/05/26 09:00 [pubmed]', '2009/06/10 09:00 [medline]']",['S0120-41572008000400007 [pii]'],ppublish,Biomedica. 2008 Dec;28(4):531-43.,4,,,,,,,,,"Evolucion clinica de pacientes hospitalizados por dengue en una institucion de salud de Bucaramanga, Colombia.",,,,,,,,,,,,,
6763734,NLM,MEDLINE,19830715,20091111,0375-0760 (Print) 0375-0760 (Linking),34,1982 May-Aug,[Activities of the arbovirology laboratory during the hemorrhagic dengue epidemic in Cuba. 1981].,107-13,,,"['Kouri Flores, G', 'Guzman Tirado, M G', 'Bravo Gonzalez, J', 'Calunga Rios, M']","['Kouri Flores G', 'Guzman Tirado MG', 'Bravo Gonzalez J', 'Calunga Rios M']",,,['spa'],"['English Abstract', 'Journal Article']",,Cuba,Rev Cubana Med Trop,Revista cubana de medicina tropical,0074364,,IM,"['Cuba', 'Dengue/epidemiology/*microbiology', 'Dengue Virus/*isolation & purification', 'Humans']",,1982/05/01 00:00,1982/05/01 00:01,['1982/05/01 00:00'],"['1982/05/01 00:00 [pubmed]', '1982/05/01 00:01 [medline]', '1982/05/01 00:00 [entrez]']",,ppublish,Rev Cubana Med Trop. 1982 May-Aug;34(2):107-13.,2,,,,,,,,,Actividades del laboratorio de arbovirologia durante la epidemia de dengue hemorragico en Cuba. 1981.,,,,,,,,,,,,,
17507286,NLM,MEDLINE,20070724,20220330,1386-6532 (Print) 1386-6532 (Linking),39,2007 Jun,The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection.,76-81,,"BACKGROUND: Dengue haemorrhagic fever is an important public health problem and mainly occurs in children less than 15 years of age. Recently, the incidence of the disease have increased in adults but data on clinical and laboratory presentations of those affected are limited. OBJECTIVES: To assess and compare clinical manifestations and laboratory findings of dengue virus infected children and adults in Thailand. STUDY DESIGN: A 1-year study was conducted from September 2003 to August 2004 for dengue virus infected patients admitted to Phetchabun Provincial Hospital, Thailand. Physical signs, symptoms, and laboratory features were recorded. All dengue patients were confirmed using immunochromatographic test on convalescent sera. RESULTS: Based on serology-confirmed dengue virus infection, there was 286 dengue patients including 15 (5.3%) dengue fever and 271 (94.7%) dengue haemorrhagic fever (DHF). Among DHF cases, clinical classifications were DHF I, 40.9%; DHF II, 43%; and DHF III or dengue shock syndrome (DSS), 10.8%. Of all dengue patients, 231 cases (80.8%) were children aged less than 15 years and 55 cases (19.2%) were adults. The highest proportion of child cases was DHF I (42.9%), whereas that of adults was DHF II (51%). Some clinical manifestations were more common in adult patients, such as petechiae, melena, headache, retro-orbital pain, joint pain, myalgia, nausea and vomiting (p-value<0.05). Signs found commonly in children were epistaxis, oliguria, and liver enlargement (p-value<0.05). Haemoconcentration, thrombocytopenia, increased alanine aminotransferase, and longer prothrombin time were found to be significantly higher in adults than in children (p-value<0.05). CONCLUSIONS: Some clinical presentations of dengue disease and laboratory findings in adults are different from those in children. Therefore, adults as well as pediatric cases of DHF need appropriate and prompt case management to reduce the mortality rate of DHF.","['Kittigul, Leera', 'Pitakarnjanakul, Piyamard', 'Sujirarat, Dusit', 'Siripanichgon, Kanokrat']","['Kittigul L', 'Pitakarnjanakul P', 'Sujirarat D', 'Siripanichgon K']",,"['Department of Microbiology, Faculty of Public Health, Mahidol University, Bangkok, Thailand. phlkt@mahidol.ac.th']",['eng'],"['Comparative Study', 'Journal Article']",20070515,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cohort Studies', 'Dengue/*epidemiology/immunology/*physiopathology', 'Female', 'Humans', 'Incidence', 'Infant', 'Male', 'Middle Aged', 'Severe Dengue/*epidemiology/immunology/*physiopathology', 'Thailand/epidemiology']",,2007/05/18 09:00,2007/07/25 09:00,['2007/05/18 09:00'],"['2006/10/30 00:00 [received]', '2007/02/02 00:00 [revised]', '2007/04/04 00:00 [accepted]', '2007/05/18 09:00 [pubmed]', '2007/07/25 09:00 [medline]', '2007/05/18 09:00 [entrez]']","['S1386-6532(07)00135-7 [pii]', '10.1016/j.jcv.2007.04.006 [doi]']",ppublish,J Clin Virol. 2007 Jun;39(2):76-81. doi: 10.1016/j.jcv.2007.04.006. Epub 2007 May 15.,2,,,,,,,,,,,,,,,,,,,,,,
31835302,NLM,MEDLINE,20200924,20200924,1999-4915 (Electronic) 1999-4915 (Linking),11,2019 Dec 9,Insight into the Tropism of Dengue Virus in Humans.,,10.3390/v11121136 [doi] 1136,"In tropical and subtropical zones, arboviruses are among the major threats to human life, affecting a large number of populations with serious diseases. Worldwide, over three hundred million people are infected with dengue virus (DENV) every year as per the World Health Organization (WHO). DENV-mediated disease severity ranges from a mild fever to hemorrhagic fever and shock syndrome. Patients suffering from severe infection might experience multi-organ failure, cardiomyopathy and even encephalopathy, further complicating the disease pathogenesis. In life-threatening cases, DENV has been reported to affect almost all organs of the human body. In this review, we discuss the organ tropism of DENV in humans in depth as detected in various autopsy studies. Keeping in mind the fact that there is currently no DENV-specific antiviral, it is of utmost importance to achieve a vivid picture of the susceptible cells in humans which might help in designing antivirals against DENV, especially targeting those tissues in which infection might lead to life-threatening conditions.","['Begum, Feroza', 'Das, Sandeepan', 'Mukherjee, Debica', 'Mal, Sweety', 'Ray, Upasana']","['Begum F', 'Das S', 'Mukherjee D', 'Mal S', 'Ray U']",,"['CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700032, India.', 'Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.', 'CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700032, India.', 'Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.', 'CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700032, India.', 'Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.', 'CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700032, India.', 'CSIR-Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road, Jadavpur, Kolkata700032, India.', 'Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20191209,Switzerland,Viruses,Viruses,101509722,,IM,"['Animals', 'Dengue/immunology/metabolism/*virology', 'Dengue Virus/*physiology', '*Host-Pathogen Interactions', 'Humans', 'Organ Specificity', '*Viral Tropism']",PMC6950149,2019/12/15 06:00,2020/09/25 06:00,['2019/12/15 06:00'],"['2019/10/15 00:00 [received]', '2019/11/01 00:00 [revised]', '2019/11/04 00:00 [accepted]', '2019/12/15 06:00 [entrez]', '2019/12/15 06:00 [pubmed]', '2020/09/25 06:00 [medline]']","['v11121136 [pii]', 'viruses-11-01136 [pii]', '10.3390/v11121136 [doi]']",epublish,Viruses. 2019 Dec 9;11(12):1136. doi: 10.3390/v11121136.,12,,['NOTNLM'],"['DENV', 'receptors', 'tropism']",['We declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
32623587,NLM,MEDLINE,20210527,20210731,0973-7693 (Electronic) 0019-5456 (Linking),88,2021 Jun,Mild Encephalitis/Encephalopathy with Reversible Splenial Change in Dengue Fever: The Boomerang Sign.,619-620,10.1007/s12098-020-03420-x [doi],,"['Tripathi, Anchal Kumar', 'Verma, Prashant Kumar', 'Panda, Prateek Kumar', 'Sharawat, Indar Kumar']","['Tripathi AK', 'Verma PK', 'Panda PK', 'Sharawat IK']",['ORCID: 0000-0002-7003-7218'],"['Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.', 'Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.', 'Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, 249203, India.', 'Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, 249203, India. sherawatdrindar@gmail.com.']",['eng'],['Journal Article'],20200704,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['*Brain Diseases', '*Dengue/complications/diagnosis', '*Encephalitis', 'Humans', 'Magnetic Resonance Imaging']",,2020/07/06 06:00,2021/05/28 06:00,['2020/07/06 06:00'],"['2020/03/11 00:00 [received]', '2020/06/15 00:00 [accepted]', '2020/07/06 06:00 [pubmed]', '2021/05/28 06:00 [medline]', '2020/07/06 06:00 [entrez]']","['10.1007/s12098-020-03420-x [pii]', '10.1007/s12098-020-03420-x [doi]']",ppublish,Indian J Pediatr. 2021 Jun;88(6):619-620. doi: 10.1007/s12098-020-03420-x. Epub 2020 Jul 4.,6,,,,,,,,,,,,,,,,,,,,,,
36076697,NLM,MEDLINE,20220913,20221012,1998-4022 (Electronic) 0028-3886 (Linking),70,2022 Jul-Aug,Atypical Radiological Features in Dengue Encephalitis.,1700-1701,10.4103/0028-3886.355181 [doi],,"['Juneja, Abhishek', 'Anand, Kuljeet S', 'Agrawal, Arpit']","['Juneja A', 'Anand KS', 'Agrawal A']",,"['Department of Neurology, Dr RML Hospital, Delhi, India.', 'Department of Neurology, Dr RML Hospital, Delhi, India.', 'Department of Neurology, Dr RML Hospital, Delhi, India.']",['eng'],['Letter'],,India,Neurol India,Neurology India,0042005,,IM,"['*Dengue/complications/diagnostic imaging', '*Encephalitis', 'Humans', 'Radiography']",,2022/09/10 06:00,2022/09/14 06:00,['2022/09/09 01:03'],"['2022/09/09 01:03 [entrez]', '2022/09/10 06:00 [pubmed]', '2022/09/14 06:00 [medline]']","['ni_2022_70_4_1700_355181 [pii]', '10.4103/0028-3886.355181 [doi]']",ppublish,Neurol India. 2022 Jul-Aug;70(4):1700-1701. doi: 10.4103/0028-3886.355181.,4,,,,['None'],,,,,,,,,,,,,,,,,,
22043757,NLM,MEDLINE,20120131,20111102,0125-2208 (Print) 0125-2208 (Linking),94 Suppl 3,2011 Aug,Dengue classification: current WHO vs. the newly suggested classification for better clinical application?,S74-84,,"INTRODUCTION: There has been confusion regarding the clinical classification of dengue. The current WHO classification used since the 70s classifies dengue into dengue fever (DF), dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS). In 2009, a new classification of dengue proposed by WHO Tropical Disease Research (TDR) was published in the WHO TDR 2009 dengue guidelines. This new classification classifies dengue into dengue (D), dengue with warning signs (DW) and severe dengue (SD). OBJECTIVE: To compare the effectiveness in clinical management between the current WHO classification and the newly suggested classification (TDR) and to assess the 4 criteria of the DHF case definition of the current WHO classification for possible modification. MATERIAL AND METHOD: A prospective study of suspected dengue patients admitted to the Dengue Unit, Queen Sirikit National Institute of Child Health between June-August 2009 was done. All cases were managed according to the Thai National Dengue Guidelines 2008. The final diagnoses were based on the current WHO Classification together with dengue laboratory confirmation. TDR classification was applied later by the author, using the data from the present study case report forms of each patient. Statistical analysis comparing clinical and laboratory data between each group of patients was done by using SPSS version 14. RESULTS: Total 274 confirmed dengue patients and 24 non-dengue febrile illnesses (ND) were used for analysis. There were 180 DF (65.7%), 53 DHF grade I (19.3%), 19 DHF grade II (6.9%), 19 DHF grade II (6.9%) and 3 DHF grade IV (1.1%) as classified by the current WHO classification while the suggested TDR classified 85 (31%), 160 (58.4%) and 29 (1.1%) as D, DW and SD respectively. At least one of the warning signs were found in 50, 53.3, 83, 88.2, 100 and 100% of ND, DF, DHF grade I, DHF grade II, DHF grade III and DHF grade IV patients. Vomiting and abdominal pain were the 2 most common warning signs found in both ND and dengue patients. Intensive monitoring and careful medical and i.v. fluid management were needed for 94 DHF patients compared to 189 DW and SD patients by the new TDR classification. There were 8 DSS patients who had AST > 1,000U and one patient presented with encephalopathy. These 8 patients cannot be classified properly in the current WHO classification. One non-dengue patient who presented with gastrointestinal bleeding was classified as SD. Bleeding and/or positive tourniquet test was found in and 69.7% of DHF patients. Plasma leakage detected using hemoconcentration, chest x-ray (CXR) and ultrasonography. Hemoconcentration could detect plasma leakage in 44.7% and CXR added up evidence of plasma leakage to 86.3%. Ultrasonography was the most sensitive technique to add evidence of plasma leakage up to 100%. Platelet < or = 100,000 cells/mm3 was found in 93.5% of DHF patients. CONCLUSION: Current WHO classification is recommended for continuing use because the newly suggested TDR classification creates about 2 times the workload to health care personnel. In addition, the TDR classification needs dengue confirmatory tests. More than 90% of DHF defined by WHO case definition are dengue confirmed. However, current WHO classification needs to be modified for more simple and friendly use. The suggested modification is to address plasma leakage as the major criteria. Tourniquet test positive or bleeding symptoms can be considered as minor criteria. Unusual dengue is proposed to be added to the current WHO classification to cover those patients who do not fit with the current WHO classification.","['Kalayanarooj, Siripen']",['Kalayanarooj S'],,"['Dengue Unit, Queen Sirikit National Institute of Child Health, College of Medicine, Rangsit University, Bangkok, Thailand. siripenk@gmail.com']",['eng'],['Journal Article'],,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Abdominal Pain/etiology', 'Child', 'Child, Preschool', 'Dengue/*classification/*diagnosis/therapy/virology', 'Dengue Virus/*isolation & purification', 'Female', 'Fever/etiology', 'Fluid Therapy', 'Hospitals, Pediatric', 'Humans', 'Male', 'Patients/statistics & numerical data', 'Prospective Studies', 'Serologic Tests', 'Sex Distribution', 'Treatment Outcome', 'Vomiting/etiology', 'World Health Organization']",,2011/11/03 06:00,2012/02/01 06:00,['2011/11/03 06:00'],"['2011/11/03 06:00 [entrez]', '2011/11/03 06:00 [pubmed]', '2012/02/01 06:00 [medline]']",,ppublish,J Med Assoc Thai. 2011 Aug;94 Suppl 3:S74-84.,,,,,,,,,,,,,,,,,,,,,,,
9747766,NLM,MEDLINE,19980929,20190516,0950-2688 (Print) 0950-2688 (Linking),121,1998 Aug,"The 1993 dengue 2 epidemic in Charters Towers, North Queensland: clinical features and public health impact.",151-6,,"In 1993 an epidemic caused by dengue virus type 2 occurred in several North Queensland population centres. Charters Towers, estimated population 10,000, had 155 officially notified cases. An analysis of symptoms was undertaken using a random sample of 1000 residents to determine specificity of symptoms, the subclinical infection rate, and to establish the true extent of the epidemic. Retrospective diagnoses of dengue fever were based on the presence of both serum dengue 2 neutralizing antibody and presence of symptoms. An estimated 20% of the population had dengue fever. The rate of subclinical infections in this epidemic was 14.6%. There were no symptoms that were specific for dengue fever. Bleeding occurred more frequently in people who recalled a previous dengue infection during a dengue 1 epidemic 12 years earlier (55.6% vs. 16.8%, P = 0.003). Surveillance for future epidemics should be based on serological and virological confirmation of dengue virus infection amongst symptomatic patient.","['McBride, W J', 'Mullner, H', 'LaBrooy, J T', 'Wronski, I']","['McBride WJ', 'Mullner H', 'LaBrooy JT', 'Wronski I']",,"['School of Public Health and Tropical Medicine, James Cook University, Townsville, Queensland, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Epidemiol Infect,Epidemiology and infection,8703737,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Disease Outbreaks', 'Female', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Queensland/epidemiology', 'Serologic Tests']",PMC2809485,1998/09/25 00:00,1998/09/25 00:01,['1998/09/25 00:00'],"['1998/09/25 00:00 [pubmed]', '1998/09/25 00:01 [medline]', '1998/09/25 00:00 [entrez]']",['10.1017/s0950268898001058 [doi]'],ppublish,Epidemiol Infect. 1998 Aug;121(1):151-6. doi: 10.1017/s0950268898001058.,1,,,,,,,,,,,,,,,,,,,,,,
11930865,NLM,MEDLINE,20020430,20191025,1041-2972 (Print) 1041-2972 (Linking),13,2001 Jun,Infectious diseases of refugees and immigrants: dengue fever.,243-5,,"PURPOSE: To describe the assessment and management of chronic wounds and detail current recommendations for optimal wound care practices. DATA SOURCES: Selected scientific literature, clinical practice guidelines, and the authors' clinical experience. CONCLUSION: Multiple factors play a role in the problems associated with chronic wounds. Wound care is costly in regards to medical care, as well as costly in terms of the hardship placed on the patient, family and staff. Too often, wound care practices are based on rituals than research. IMPLICATIONS FOR PRACTICE: The assessment and management of chronic wounds needs to be individualized according to a thorough assessment of the wound, the patients' lifestyle, and the caregiver's knowledge and skill for managing th wound. It is also important to know what wound care products are available and the types of wounds appropriate for their use.","['Roberts, A', 'Kemp, C']","['Roberts A', 'Kemp C']",,"['Louise Herrington School of Nursing, Baylor University, USA. amy_roberts@baylor.edu']",['eng'],"['Journal Article', 'Review']",,United States,J Am Acad Nurse Pract,Journal of the American Academy of Nurse Practitioners,8916634,,,"['Bed Rest', '*Dengue/diagnosis/epidemiology/therapy', 'Dengue Virus/pathogenicity', 'Diagnosis, Differential', '*Emigration and Immigration', 'Fluid Therapy', 'Humans', 'Pain/drug therapy', 'Prognosis', '*Refugees']",,2002/04/05 10:00,2002/05/01 10:01,['2002/04/05 10:00'],"['2002/04/05 10:00 [pubmed]', '2002/05/01 10:01 [medline]', '2002/04/05 10:00 [entrez]']",['10.1111/j.1745-7599.2001.tb00028.x [doi]'],ppublish,J Am Acad Nurse Pract. 2001 Jun;13(6):243-5. doi: 10.1111/j.1745-7599.2001.tb00028.x.,6,,,,,,,13,,,,,,,,,,,,,,,
16391444,NLM,MEDLINE,20060711,20230315,0973-7693 (Electronic) 0019-5456 (Linking),72,2005 Nov,The 2001 dengue epidemic in Chennai.,919-23,,"Dengue is emerging as a serious public health problem in Tamil Nadu. The present surveillance system is unlikely to generate proper information on the epidemiology of the disease, which is essential for planning and development of relevant control/preventive measures against dengue. OBJECTIVE: Between November 2001 and January 2002, a descriptive study was undertaken on children with clinical dengue attending Kanchi Kamakoti Child Trust Hospital (KKCTH, a major private referral pediatric hospital in Tamil Nadu, India) to define the magnitude of dengue burden, the natural history of this disease in terms of clinical presentation, and outcome of the infections in hospitalized children (< 15) with clinical dengue. METHODS: The sera collected from patients analyzed for dengue specific IgM and IgG antibodies by IgM, IgG antibody capture enzyme linked immunosorbent assay (ELISA) using alternatively two commercial kits. World Health Organization clinical case definition was adopted to categorize the dengue confirmed children. RESULTS: Dengue was diagnosed in 74.5% (143) of the 192 hospitalized children with clinical dengue. A considerable proportion (20%) of the total dengue infections were constituted by infants less than 1 yr of age. DF [dengue fever], DHF [dengue hemorrhagic fever] and DSS [dengue shock syndrome] were diagnosed in 65%, 11.2% and 23.8% of 143 dengue confirmed patients respectively. Though severe dengue (DSS + DHF) was present in 35% of the patients, the mortality rate was low during the study period due to timely diagnosis and clinical management of the patients. CONCLUSION: In developing countries like India, building of laboratory capacity for diagnosis and combat-mode ready preparedness for the management of dengue cases in emergency situation may reduce dengue-related mortality. This can be achieved in a wider scale through an integrated approach through the community, professionals and the public health departments.","['Kabilan, L', 'Balasubramanian, S', 'Keshava, S M', 'Satyanarayana, K']","['Kabilan L', 'Balasubramanian S', 'Keshava SM', 'Satyanarayana K']",,"['Centre for Research in Medical Entomology, Indian Council of Medical Research, Chennai, India. d1crme@sify.com']",['eng'],['Journal Article'],,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Adolescent', 'Age Distribution', 'Child', 'Child, Preschool', 'Dengue/classification/complications/*epidemiology', 'Female', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Severe Dengue/epidemiology', 'Shock/epidemiology/etiology']",,2006/01/05 09:00,2006/07/13 09:00,['2006/01/05 09:00'],"['2006/01/05 09:00 [pubmed]', '2006/07/13 09:00 [medline]', '2006/01/05 09:00 [entrez]']",['10.1007/BF02731664 [doi]'],ppublish,Indian J Pediatr. 2005 Nov;72(11):919-23. doi: 10.1007/BF02731664.,11,,,,,,,,,,,,,,,,,,,,,,
22189046,NLM,MEDLINE,20120214,20150616,1474-547X (Electronic) 0140-6736 (Linking),379,2012 Feb 4,Call for a World Dengue Day.,411-2,10.1016/S0140-6736(11)61922-3 [doi],,"['Lam, Sai Kit', 'Burke, Donald', 'Gubler, Duane', 'Mendez-Galvan, Jorge', 'Thomas, Laurent']","['Lam SK', 'Burke D', 'Gubler D', 'Mendez-Galvan J', 'Thomas L']",,,['eng'],['Letter'],20111219,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Asia, Southeastern/epidemiology', 'Dengue/epidemiology/*prevention & control', 'Global Health', 'Humans']",,2011/12/23 06:00,2012/02/15 06:00,['2011/12/23 06:00'],"['2011/12/23 06:00 [entrez]', '2011/12/23 06:00 [pubmed]', '2012/02/15 06:00 [medline]']","['S0140-6736(11)61922-3 [pii]', '10.1016/S0140-6736(11)61922-3 [doi]']",ppublish,Lancet. 2012 Feb 4;379(9814):411-2. doi: 10.1016/S0140-6736(11)61922-3. Epub 2011 Dec 19.,9814,,,,,,,,,,,,,,,,,,,,,,
7844837,NLM,MEDLINE,19950307,20150901,0257-5655 (Print) 0257-5655 (Linking),10 Suppl,1994 Dec,"The epidemiology, prevention and control of dengue hemorrhagic fever in Indonesia.",S109-12,,,"['Soedarmo, S P']",['Soedarmo SP'],,"['Ministry of Health, Jakarta, Indonesia.']",['eng'],['Journal Article'],,China (Republic : 1949- ),Gaoxiong Yi Xue Ke Xue Za Zhi,Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,8603880,,IM,"['Dengue/epidemiology/*prevention & control', 'Humans', 'Indonesia/epidemiology']",,1994/12/01 00:00,1994/12/01 00:01,['1994/12/01 00:00'],"['1994/12/01 00:00 [pubmed]', '1994/12/01 00:01 [medline]', '1994/12/01 00:00 [entrez]']",,ppublish,Gaoxiong Yi Xue Ke Xue Za Zhi. 1994 Dec;10 Suppl:S109-12.,,,,,,,,,,,,,,,,,,,,,,,
34472798,NLM,MEDLINE,20210908,20210908,0004-5772 (Print) 0004-5772 (Linking),69,2021 Jun,Co-infection of SARS-CoV-2 with Malaria or Dengue in 91 Patients at a First Dedicated COVID-19 Hospital in India.,11-12,,,"['Mahajan, Niraj N', 'Kaushal, Nandita', 'Junare, Parmeshwar R', 'Bansal, Saurabh', 'Rathi, Pravin M', 'Srivastava, Vartika', 'Bahirat, Shubhada']","['Mahajan NN', 'Kaushal N', 'Junare PR', 'Bansal S', 'Rathi PM', 'Srivastava V', 'Bahirat S']",,"['Department of Obstetrics and Gynecology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Obstetrics and Gynecology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Gastroenterology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Gastroenterology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Gastroenterology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Obstetrics and Gynecology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.', 'Department of Obstetrics and Gynecology, BYL Nair Charitable Hospital and Topiwala National Medical College, Mumbai, Maharashtra.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['*COVID-19', '*Coinfection', '*Dengue/complications/diagnosis/epidemiology', 'Hospitals', 'Humans', '*Malaria/complications/epidemiology', 'SARS-CoV-2']",,2021/09/03 06:00,2021/09/09 06:00,['2021/09/02 10:36'],"['2021/09/02 10:36 [entrez]', '2021/09/03 06:00 [pubmed]', '2021/09/09 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2021 Jun;69(6):11-12.,6,,,,,,,,,,,,,,,,,,,,,,
16995286,NLM,MEDLINE,20060925,20161201,0049-8114 (Print) 0049-8114 (Linking),81,2006 Sep 22,"Dengue haemorrhagic fever: early recognition, diagnosis and hospital management--an audiovisual guide for health-care workers responding to outbreaks.",362-3,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['CD-ROM', 'Child', 'Dengue/*diagnosis/therapy', 'Disease Outbreaks', 'Humans']",,2006/09/26 09:00,2006/09/26 09:01,['2006/09/26 09:00'],"['2006/09/26 09:00 [pubmed]', '2006/09/26 09:01 [medline]', '2006/09/26 09:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 2006 Sep 22;81(38):362-3.,38,,,,,,,,,,,,,,,,,,,,,,
20403310,NLM,MEDLINE,20100729,20130501,1560-7917 (Electronic) 1025-496X (Linking),15,2010 Mar 11,Yellow fever and dengue: a threat to Europe?,19509,19509 [pii],"The introduction and rapidly expanding range of Aedes albopictus in Europe is an iconic example of the growing risk of the globalization of vectors and vector-borne diseases. The history of yellow fever and dengue in temperate regions confirms that transmission of both diseases could recur, particularly if Ae. aegypti, a more effective vector, were to be re-introduced. The article is a broad overview of the natural history and epidemiology of both diseases in the context of these risks.","['Reiter, P']",['Reiter P'],,"['Insects and Infectious Disease Unit, Institut Pasteur, Paris, France. paul.reiter@pasteur.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20100311,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,,IM,"['Dengue/*epidemiology/etiology/physiopathology/prevention & control/transmission', 'Europe/epidemiology', 'Humans', 'Yellow Fever/*epidemiology/etiology/physiopathology/prevention & control/transmission']",,2010/04/21 06:00,2010/07/30 06:00,['2010/04/21 06:00'],"['2010/04/21 06:00 [entrez]', '2010/04/21 06:00 [pubmed]', '2010/07/30 06:00 [medline]']",['19509 [pii]'],epublish,Euro Surveill. 2010 Mar 11;15(10):19509.,10,,,,,,,,,,,,,,,,,,,,,,
34669324,NLM,MEDLINE,20211028,20211028,1549-9669 (Electronic) 1549-9650 (Linking),18,2021 Nov,Recognition and management of pediatric travel-associated infectious diseases in the emergency department.,1-32,,"Global travel has made travel-associated infectious diseases (TAIDs) a more frequent consideration in the pediatric emergency department. Studies show that physicians may either omit a travel history or, even with a positive travel history, do not consider potentially serious illnesses, such as dengue and malaria. A thorough travel history including the purpose, location, activities, diet, and exposures can help the emergency clinician develop and narrow the differential diagnosis. This issue reviews the epidemiology, clinical presentation, diagnosis, and management of various TAIDs, with the goal of early recognition and disease-specific treatment.","['Walker, David M']",['Walker DM'],,"[""Chief, Pediatric Emergency Medicine, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center; Associate Professor of Pediatrics, Hackensack Meridian School of Medicine, Hackensack, NJ.""]",['eng'],['Journal Article'],20211102,United States,Pediatr Emerg Med Pract,Pediatric emergency medicine practice,101260506,,IM,"['Child', '*Dengue/diagnosis/epidemiology/therapy', 'Emergency Service, Hospital', 'Humans', '*Malaria/diagnosis/epidemiology/therapy', 'Travel', 'Travel-Related Illness']",,2021/10/21 06:00,2021/10/29 06:00,['2021/10/20 13:21'],"['2021/08/02 00:00 [received]', '2021/08/10 00:00 [accepted]', '2021/10/20 13:21 [entrez]', '2021/10/21 06:00 [pubmed]', '2021/10/29 06:00 [medline]']",,ppublish,Pediatr Emerg Med Pract. 2021 Nov;18(11):1-32. Epub 2021 Nov 2.,11,,,,,,,,,,,,,,,,,,,,,,
8924777,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[Control of Aedes aegypti in Martinique. Contribution of entomology studies].,161-2,,"The dengue prevention activities in Martinique are based on: Entomological surveillance (including the use of insecticide in all parts of the Island). Epidemiological (clinical, serological and virological) surveillance. Health Education (radio, TV, exhibitions, talks in primaries and secondaries schools, in associations,...). The main breeding sites of Aedes aegypti are maintained by human practices: flowers vases, containers, used tyres, waste... The role of those human practices in the standing of Aedes aegypti populations at high level in Martinique have lead us to emphasize entomological observations and Health education. The calculation of classical Breteau Index abstracts the nature and the productivity of the breeding sites (f.e.: no difference between a flower vase and a drum). In operational way, we have introduced a new approach for calculating the Breteau index value which includes the breeding sites nature and productivity. This approach permit us to adapt the Health education message in each geographical sector.","['Yebakima, A']",['Yebakima A'],,"['Entomologiste medical, Service demoustication, Fort-de-France, Martinique.']",['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,['0 (Insecticides)'],IM,"['*Aedes', 'Animals', 'Dengue/epidemiology/prevention & control/transmission', '*Entomology', 'Health Education', 'Humans', '*Insect Vectors', 'Insecticides', 'Martinique', '*Mosquito Control']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):161-2.,2,,,,,,,,,Lutte contre aedes aegypti en martinique. Apport des etudes entomologiques.,,,,,,,,,,,,,
19802574,NLM,MEDLINE,20100114,20161026,0070-217X (Print) 0070-217X (Linking),338,2010,Prospective cohort studies of dengue viral transmission and severity of disease.,1-13,10.1007/978-3-642-02215-9_1 [doi],"As the four serotypes of dengue virus (DENV) systematically spread throughout the tropical and subtropical regions globally, dengue is increasingly contributing to the overall morbidity and mortality sustained by populations and thereby challenging the health infrastructures of most endemic countries. DENV-human host-mosquito vector interactions are complex and cause in humans either asymptomatic or subclinical DENV infection, mild to severe dengue fever (DF), severe dengue hemorrhagic fever (DHF), or dengue shock syndrome (DSS). Over the past decade, we have seen an increase in research funding and public health efforts to offset the effects of this pandemic. Though multiple vaccine development efforts are underway, the need remains to further characterize the determinants of varying severities of clinical outcomes. Several long-term prospective studies on DENV transmission and dengue severity have sought to define the epidemiology and pathogenesis of this disease. Yet, more studies are required to quantify the disease burden on different populations, explore the impact of DENV serotype-specific transmission on host-responses and dengue severity and measure the economic impact of dengue on a population. In this section, we will review the critical past and recent findings of dengue prospective studies on our understanding of the disease and the potential role of future prospective cohort studies in advancing issues required for vaccine field evaluations.","['Endy, Timothy P', 'Yoon, In-Kyu', 'Mammen, Mammen P']","['Endy TP', 'Yoon IK', 'Mammen MP']",,"['Infectious Disease Division, Department of Medicine, State University of New York, Upstate Medical University, 725 Irving Avenue, Suite 304, Syracuse, NY 13210, USA. endyt@upstate.edu']",['eng'],"['Journal Article', 'Review']",,Germany,Curr Top Microbiol Immunol,Current topics in microbiology and immunology,0110513,['0 (Dengue Vaccines)'],IM,"['Animals', 'Cohort Studies', 'Cost-Benefit Analysis', 'Dengue/epidemiology/prevention & control/*transmission/*virology', 'Dengue Vaccines/economics', 'Dengue Virus/classification/*physiology', 'Global Health', 'Host-Pathogen Interactions', 'Humans', 'Incidence', 'Serotyping']",,2009/10/06 06:00,2010/01/15 06:00,['2009/10/06 06:00'],"['2009/10/06 06:00 [entrez]', '2009/10/06 06:00 [pubmed]', '2010/01/15 06:00 [medline]']",['10.1007/978-3-642-02215-9_1 [doi]'],ppublish,Curr Top Microbiol Immunol. 2010;338:1-13. doi: 10.1007/978-3-642-02215-9_1.,,,,,,,,14,,,,,,,,,,,,,,,
16631550,NLM,MEDLINE,20060516,20141120,1473-3099 (Print) 1473-3099 (Linking),6,2006 May,Severe dengue: the need for new case definitions.,297-302,,"Dengue fever imposes a societal burden that is difficult to measure because of the disease's non-specific symptoms and the lack of easily applied case definitions for its more severe manifestations. An efficacy trial of a tetravalent vaccine is expected in the near future, but only one of the severe dengue syndromes-the continuum of dengue haemorrhagic fever and dengue shock syndrome-is well defined. One of the results of the focus on dengue haemorrhagic fever is the false perception of low disease burden in the Americas, which is an obstacle to the mobilisation of political and economic resources to fight the disease. Three improvements are necessary to standardise the dengue haemorrhagic fever definition and to allow it to do well in different populations: (1) redefine the threshold for thrombocytopenia, (2) clarify the standard practice and value of the tourniquet test, and (3) incorporate a criterion to measure intravenous fluid replacement. In addition, for an accurate estimation of dengue burden, locally appropriate definitions of severe dengue must be devised and standardised so they will be considered valid in the global research community.","['Rigau-Perez, Jose G']",['Rigau-Perez JG'],,"['Dengue Branch, Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, San Juan, PR, USA. jgrigau@prdigital.com']",['eng'],"['Journal Article', 'Review']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,['0 (Viral Vaccines)'],IM,"['*Cost of Illness', 'Dengue/economics/*epidemiology/*prevention & control', 'Dengue Virus/*immunology', '*Global Health', 'Humans', 'Prevalence', 'Risk Factors', 'Severe Dengue/economics/epidemiology/prevention & control', '*Viral Vaccines/immunology']",,2006/04/25 09:00,2006/05/17 09:00,['2006/04/25 09:00'],"['2006/04/25 09:00 [pubmed]', '2006/05/17 09:00 [medline]', '2006/04/25 09:00 [entrez]']","['S1473-3099(06)70465-0 [pii]', '10.1016/S1473-3099(06)70465-0 [doi]']",ppublish,Lancet Infect Dis. 2006 May;6(5):297-302. doi: 10.1016/S1473-3099(06)70465-0.,5,,,,,['Lancet Infect Dis. 2007 Feb;7(2):81-2. PMID: 17251078'],,53,,,,,,,,,,,,,,,
36096518,NLM,MEDLINE,20220914,20220928,1756-1833 (Electronic) 0959-8138 (Linking),378,2022 Sep 12,"Asia's ""twindemic"": dengue fever cases rocket as covid-19 rages on.",o2090,10.1136/bmj.o2090 [doi],,"['Sarkar, Sonia']",['Sarkar S'],,"['New Delhi, India.']",['eng'],['Journal Article'],20220912,England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['Asia/epidemiology', '*COVID-19', '*Dengue/complications/diagnosis', 'Humans']",,2022/09/13 06:00,2022/09/15 06:00,['2022/09/12 20:43'],"['2022/09/12 20:43 [entrez]', '2022/09/13 06:00 [pubmed]', '2022/09/15 06:00 [medline]']",['10.1136/bmj.o2090 [doi]'],epublish,BMJ. 2022 Sep 12;378:o2090. doi: 10.1136/bmj.o2090.,,,,,"['Competing interests: I have read and understood BMJ policy on declaration of', 'interests and have no relevant interests to declare. Provenance and peer review:', 'Commissioned; not externally peer reviewed.']",,,,,,,,,,,,,,,,,,
20520589,NLM,MEDLINE,20100607,20141120,1545-861X (Electronic) 0149-2195 (Linking),59,2010 Jun 4,"Dengue fever among U.S. travelers returning from the Dominican Republic - Minnesota and Iowa, 2008.",654-6,,"In February 2008, a group of U.S. residents became ill with symptoms and clinical findings suggestive of dengue fever after returning from the Dominican Republic, where they had traveled to work as missionaries. Dengue is endemic in the Dominican Republic and most tropical and subtropical areas of the world, including the Caribbean, and represents a known health risk for U.S. residents traveling to or working in those areas. Subsequent investigation by the Minnesota Department of Health (MDH), the Iowa Department of Public Health (IDPH), and CDC determined that at least 14 (42%) of 33 missionaries traveling to the Dominican Republic met the case definition for dengue fever, and 12 had cases that were confirmed serologically. Of the 13 patients interviewed, all had weakness and fever, with 12 reporting chills and body or joint pain. Ten patients had noticed mosquitoes inside or outside their house in the Dominican Republic, but only three had used repellent. Before departing on their trip, none of the 13 ill travelers interviewed had been aware of dengue in the Dominican Republic, and only two had sought pre-travel medical advice. The Dominican Republic is a frequent destination for U.S. travelers providing missionary and humanitarian services and also for vacationers. These cases indicate a need to increase awareness of dengue prevention measures among U.S. travelers to areas where they might be at risk for dengue.",,,,,['eng'],"['Case Reports', 'Journal Article']",,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,"['0 (Immunoglobulin M)', '0 (Insect Repellents)']",IM,"['Adolescent', 'Adult', 'Aged', 'Child', '*Dengue/complications/diagnosis/etiology', 'Dominican Republic', 'Female', 'Humans', 'Immunoglobulin M/analysis', 'Insect Repellents', 'Iowa', 'Male', 'Middle Aged', 'Minnesota', 'Missionaries', 'Religious Missions', '*Travel']",,2010/06/04 06:00,2010/06/09 06:00,['2010/06/04 06:00'],"['2010/06/04 06:00 [entrez]', '2010/06/04 06:00 [pubmed]', '2010/06/09 06:00 [medline]']",['mm5921a2 [pii]'],ppublish,MMWR Morb Mortal Wkly Rep. 2010 Jun 4;59(21):654-6.,21,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
8731263,NLM,MEDLINE,19961205,20190606,0036-4665 (Print) 0036-4665 (Linking),37,1995 Nov-Dec,"Dengue type 2 outbreak in the south of the state of Bahia, Brazil: laboratorial and epidemiological studies.",507-10,,"During March 1994 cases of a exanthematic acute disease were reported in the municipalities of Itagemirim, Eunapolis and Belmonte, state of Bahia. Dengue fever was confirmed by serology (MAC-ELISA) and by dengue virus type 2 isolation, genotype Jamaica. Signs and symptoms of classic dengue fever were observed with a high percentual of rash (73.8%) and pruritus (50.5%). Major haemorrhagic manifestations were unfrequent and only bleeding gum was reported. Dengue virus activity spreaded rapidly to important tourism counties like Porto Seguro, Ilheus, Santa Cruz de Cabralia, Prado, Alcobaca and others, representing a risk for the spreading of dengue virus into the country and abroad.","['Nogueira, R M', 'Miagostovich, M P', 'Schatzmayr, H G', 'Moraes, G C', 'Cardoso, M A', 'Ferreira, J', 'Cerqueira, V', 'Pereira, M']","['Nogueira RM', 'Miagostovich MP', 'Schatzmayr HG', 'Moraes GC', 'Cardoso MA', 'Ferreira J', 'Cerqueira V', 'Pereira M']",,"['Department of Virology, Laboratory of Flavivirus, Rio de Janeiro, Brasil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Brazil/epidemiology', 'Dengue/diagnosis/*epidemiology/virology', 'Dengue Virus/isolation & purification/physiology', '*Disease Outbreaks', 'Enzyme-Linked Immunosorbent Assay/methods', 'Humans']",,1995/11/01 00:00,1995/11/01 00:01,['1995/11/01 00:00'],"['1995/11/01 00:00 [pubmed]', '1995/11/01 00:01 [medline]', '1995/11/01 00:00 [entrez]']",['10.1590/s0036-46651995000600006 [doi]'],ppublish,Rev Inst Med Trop Sao Paulo. 1995 Nov-Dec;37(6):507-10. doi: 10.1590/s0036-46651995000600006.,6,,,,,,,,,,,,,,,,,,,,,,
19951833,NLM,MEDLINE,20110106,20100823,1769-6690 (Electronic) 0399-077X (Linking),40,2010 Aug,"Prospective and descriptive study of adult dengue cases in an emergency department, in Martinique.",480-9,10.1016/j.medmal.2009.10.001 [doi],"OBJECTIVE: Knowing about the clinical aspects of dengue in endemic zones is essential to implementation of appropriate case management protocols and public health interventions. PATIENTS AND METHODS: The authors made a 4-year prospective, observational study of dengue-infected patients admitted to the emergency department of the Fort-de-France University Hospital. RESULTS: Two hundred and sixty-three male and 297 female patients were included. The median age was 37 years (range: 14-91). The diagnosis was based on a positive RT-PCR (463 patients) or on the presence of specific IgM (97 patients). Two hundred and seventy-seven patients (49.5%) presented with dengue fever without complications. According to WHO criteria, 95 patients (17%) developed plasma leakage, including 39 patients (7%) diagnosed with DHF, and 10 (1.8%) diagnosed with DSS. Among the other patients without plasma leakage, 84 (15%) had isolated thrombocytopenia, 14 (2.5%) had internal bleeding, and 90 (16%) had unusual manifestations. Seven patients died (1.3%): fulminant hepatitis (two), myocarditis (one), encephalitis (one), acute respiratory failure (one), gangrenous cholecystitis (one), and post-traumatic intracranial hemorrhage (one). The other patients recovered. Seven patients were pregnant (1.3%) from 6 to 27 weeks of amenorrhea and carried their pregnancy to term without complications. CONCLUSION: With this experience, we were able to develop appropriate case management protocols for patients during dengue epidemics.","['Thomas, L', 'Brouste, Y', 'Najioullah, F', 'Hochedez, P', 'Hatchuel, Y', 'Moravie, V', 'Kaidomar, S', 'King, J P', 'Besnier, F', 'Abel, S', 'Carmes, S', 'Schmitt, S', 'Brihier, P', 'Meunier, C', 'Cardoso, T', 'Rosine, J', 'Quenel, P', 'Cesaire, R', 'Cabie, A']","['Thomas L', 'Brouste Y', 'Najioullah F', 'Hochedez P', 'Hatchuel Y', 'Moravie V', 'Kaidomar S', 'King JP', 'Besnier F', 'Abel S', 'Carmes S', 'Schmitt S', 'Brihier P', 'Meunier C', 'Cardoso T', 'Rosine J', 'Quenel P', 'Cesaire R', 'Cabie A']",,"[""CIC-EC 802 Inserm, service des urgences, centre d'investigation clinique et d'epidemiologie clinique Antilles-Guyane, centre hospitalier universitaire, 97200 Fort-de-France, Martinique. laurent.thomas@chu-fortdefrance.fr""]",['eng'],['Journal Article'],20091129,France,Med Mal Infect,Medecine et maladies infectieuses,0311416,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', '*Dengue/complications/diagnosis/epidemiology', 'Emergency Service, Hospital', 'Female', 'Humans', 'Male', 'Martinique', 'Middle Aged', 'Prospective Studies', 'Young Adult']",,2009/12/03 06:00,2011/01/07 06:00,['2009/12/03 06:00'],"['2009/04/03 00:00 [received]', '2009/04/30 00:00 [revised]', '2009/10/27 00:00 [accepted]', '2009/12/03 06:00 [entrez]', '2009/12/03 06:00 [pubmed]', '2011/01/07 06:00 [medline]']","['S0399-077X(09)00316-3 [pii]', '10.1016/j.medmal.2009.10.001 [doi]']",ppublish,Med Mal Infect. 2010 Aug;40(8):480-9. doi: 10.1016/j.medmal.2009.10.001. Epub 2009 Nov 29.,8,['(c) 2009 Elsevier Masson SAS. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
31996463,NLM,MEDLINE,20200925,20220922,1946-6242 (Electronic) 1946-6234 (Linking),12,2020 Jan 29,Mapping global variation in dengue transmission intensity.,,eaax4144 [pii] 10.1126/scitranslmed.aax4144 [doi],"Intervention planning for dengue requires reliable estimates of dengue transmission intensity. However, current maps of dengue risk provide estimates of disease burden or the boundaries of endemicity rather than transmission intensity. We therefore developed a global high-resolution map of dengue transmission intensity by fitting environmentally driven geospatial models to geolocated force of infection estimates derived from cross-sectional serological surveys and routine case surveillance data. We assessed the impact of interventions on dengue transmission and disease using Wolbachia-infected mosquitoes and the Sanofi-Pasteur vaccine as specific examples. We predicted high transmission intensity in all continents straddling the tropics, with hot spots in South America (Colombia, Venezuela, and Brazil), Africa (western and central African countries), and Southeast Asia (Thailand, Indonesia, and the Philippines). We estimated that 105 [95% confidence interval (CI), 95 to 114] million dengue infections occur each year with 51 (95% CI, 32 to 66) million febrile disease cases. Our analysis suggests that transmission-blocking interventions such as Wolbachia, even at intermediate efficacy (50% transmission reduction), might reduce global annual disease incidence by up to 90%. The Sanofi-Pasteur vaccine, targeting only seropositive recipients, might reduce global annual disease incidence by 20 to 30%, with the greatest impact in high-transmission settings. The transmission intensity map presented here, and made available for download, may help further assessment of the impact of dengue control interventions and prioritization of global public health efforts.","['Cattarino, Lorenzo', 'Rodriguez-Barraquer, Isabel', 'Imai, Natsuko', 'Cummings, Derek A T', 'Ferguson, Neil M']","['Cattarino L', 'Rodriguez-Barraquer I', 'Imai N', 'Cummings DAT', 'Ferguson NM']","['ORCID: 0000-0003-3975-550X', 'ORCID: 0000-0001-6784-1021', 'ORCID: 0000-0002-4218-9716', 'ORCID: 0000-0002-9437-1907', 'ORCID: 0000-0002-1154-8093']","['MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London W2 1PG, UK. l.cattarino@imperial.ac.uk.', 'Department of Medicine, University of California San Francisco, San Francisco, CA 94110, USA.', 'MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London W2 1PG, UK.', 'Department of Biology and Emerging Pathogens Institute, University of Florida, P. O. Box 100009, Gainesville, FL 32610, USA.', 'MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, Norfolk Place, London W2 1PG, UK.']",['eng'],['Journal Article'],,United States,Sci Transl Med,Science translational medicine,101505086,['0 (Dengue Vaccines)'],IM,"['Basic Reproduction Number', 'Cost of Illness', 'Dengue/*epidemiology/immunology/*transmission/virology', 'Dengue Vaccines/immunology', 'Geography', 'Humans', '*Internationality', 'Risk Factors']",,2020/01/31 06:00,2020/09/26 06:00,['2020/01/31 06:00'],"['2019/03/21 00:00 [received]', '2019/09/12 00:00 [revised]', '2020/01/02 00:00 [accepted]', '2020/01/31 06:00 [entrez]', '2020/01/31 06:00 [pubmed]', '2020/09/26 06:00 [medline]']","['12/528/eaax4144 [pii]', '10.1126/scitranslmed.aax4144 [doi]']",ppublish,Sci Transl Med. 2020 Jan 29;12(528):eaax4144. doi: 10.1126/scitranslmed.aax4144.,528,"['Copyright (c) 2020 The Authors, some rights reserved; exclusive licensee American', 'Association for the Advancement of Science. No claim to original U.S. Government', 'Works.']",,,,,"['MR/R015600/1/MRC_/Medical Research Council/United Kingdom', 'U01 CK000510/CK/NCEZID CDC HHS/United States', 'U01 GM110721/GM/NIGMS NIH HHS/United States']",,,,,,,,,,,,,,,,
8950563,NLM,MEDLINE,19970325,20190830,0934-9723 (Print) 0934-9723 (Linking),15,1996 Oct,Dengue in Spanish travelers returning from the tropics.,823-6,,"Dengue is seldom recognized as an imported disease in Europe. A prospective clinical study was carried out in 37 travelers suspected to have dengue infection on their return from dengue-endemic areas. Anti-dengue antibodies were found in 24 of 37 patients (14 recent infections and 10 undetermined). The most common features among the recent infections were fever (100%), thrombocytopenia (61.5%), abnormal liver function tests (61.5%), and rash (53.8%). In one case, denguehemorrhagic fever grade III was confirmed and later followed by depression and suicide of the patient. The possibility of local transmission of dengue in Spain is discussed.","['Lopez-Velez, R', 'Perez-Casas, C', 'Vorndam, A V', 'Rigau, J']","['Lopez-Velez R', 'Perez-Casas C', 'Vorndam AV', 'Rigau J']",,"['Department of Clinical Microbiology and Infectious Diseases, Hospital Ramon y Cajal, Madrid, Spain.']",['eng'],['Journal Article'],,Germany,Eur J Clin Microbiol Infect Dis,European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,8804297,"['0 (Antibodies, Viral)']",IM,"['Adult', 'Aged', 'Antibodies, Viral/analysis', 'Dengue/diagnosis/*epidemiology/transmission', 'Disease Transmission, Infectious', 'Female', 'Humans', 'Male', 'Seroepidemiologic Studies', 'Spain/epidemiology', '*Travel', 'Tropical Climate']",,1996/10/01 00:00,1996/10/01 00:01,['1996/10/01 00:00'],"['1996/10/01 00:00 [pubmed]', '1996/10/01 00:01 [medline]', '1996/10/01 00:00 [entrez]']",['10.1007/BF01701528 [doi]'],ppublish,Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):823-6. doi: 10.1007/BF01701528.,10,,,,,,,,,,,,,,,,,,,,,,
29779571,NLM,MEDLINE,20200227,20200227,1578-8989 (Electronic) 0025-7753 (Linking),152,2019 Jan 4,Abdominal pain as a warning sign in dengue.,37-38,S0025-7753(18)30246-X [pii] 10.1016/j.medcli.2018.04.006 [doi],,"['Marco-Hernandez, Javier', 'Oliveira, Ines', 'Pinazo, Maria Jesus']","['Marco-Hernandez J', 'Oliveira I', 'Pinazo MJ']",,"['Servicio de Medicina Interna, Hospital Clinic de Barcelona, Barcelona, Espana. Electronic address: JMARCO@clinic.ub.es.', 'Servicio de Salud Internacional, Hospital Clinic de Barcelona, Barcelona, Espana.', 'Servicio de Salud Internacional, Hospital Clinic de Barcelona, Barcelona, Espana.']","['eng', 'spa']","['Case Reports', 'Letter']",20180518,Spain,Med Clin (Barc),Medicina clinica,0376377,,IM,"['Abdominal Pain/*etiology', 'Dengue/*complications/diagnosis', 'Humans', 'Male', 'Middle Aged']",,2018/05/22 06:00,2020/02/28 06:00,['2018/05/22 06:00'],"['2018/02/20 00:00 [received]', '2018/04/10 00:00 [revised]', '2018/04/12 00:00 [accepted]', '2018/05/22 06:00 [pubmed]', '2020/02/28 06:00 [medline]', '2018/05/22 06:00 [entrez]']","['S0025-7753(18)30246-X [pii]', '10.1016/j.medcli.2018.04.006 [doi]']",ppublish,Med Clin (Barc). 2019 Jan 4;152(1):37-38. doi: 10.1016/j.medcli.2018.04.006. Epub 2018 May 18.,1,,,,,,,,,Dolor abdominal como signo de alarma del dengue.,,,,,,,,,,,,,
27789173,NLM,MEDLINE,20170419,20170511,1769-664X (Electronic) 0929-693X (Linking),23,2016 Dec,[Autochthonous dengue].,1284-1290,S0929-693X(16)30424-9 [pii] 10.1016/j.arcped.2016.09.009 [doi],"Dengue is the arboviral disease that has massively spread in intertropical regions these past few years. The rise in imported cases of dengue and the rapid spread of the Aedes vector mosquitoes in continental France since 2004 explain the occurrence of indigenous dengue cases among the nonimmune population and points to an epidemic risk. Severe dengue cases are rare, but lethality is highest among children under 5 years of age. Like pediatricians in tropical regions, we must learn how dengue presents in metropolitan France and how it can be managed, and pay special attention to severe and potentially fatal forms. The epidemiological, pathophysiological, clinical, diagnostic, and therapeutic characteristics of dengue are presented herein.","['Sorge, F', 'Minodier, P', 'Velayudhan-Deschamps, N']","['Sorge F', 'Minodier P', 'Velayudhan-Deschamps N']",,"['Service de pediatrie, hopital Necker, 149, rue de Sevres, 75015 Paris, France; Service de pediatrie, hopital Robert-Debre, 48, boulevard Serurier, 75019 Paris, France. Electronic address: freedso@gmail.com.', 'Service de pediatrie, hopital Robert-Debre, 48, boulevard Serurier, 75019 Paris, France; Service de pediatrie, urgences enfants CHU Nord, chemin des Bourrely, 13015 Marseille, France.', 'Service de pediatrie, hopital Robert-Debre, 48, boulevard Serurier, 75019 Paris, France; Service de pediatrie, centre hospitalier, 1, rue Marne, 35400 Saint-Malo, France.']",['fre'],"['Journal Article', 'Review']",20161024,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,"['0 (Dengue Vaccines)', '0 (Insecticides)']",IM,"['Animals', 'Dengue/*diagnosis/epidemiology/*prevention & control', 'Dengue Vaccines', 'Diagnosis, Differential', 'Humans', 'Insecticide-Treated Bednets', 'Insecticides/administration & dosage', 'Mosquito Vectors', 'Population Surveillance', 'Watchful Waiting']",,2016/10/30 06:00,2017/04/20 06:00,['2016/10/30 06:00'],"['2016/02/01 00:00 [received]', '2016/09/15 00:00 [revised]', '2016/09/16 00:00 [accepted]', '2016/10/30 06:00 [pubmed]', '2017/04/20 06:00 [medline]', '2016/10/30 06:00 [entrez]']","['S0929-693X(16)30424-9 [pii]', '10.1016/j.arcped.2016.09.009 [doi]']",ppublish,Arch Pediatr. 2016 Dec;23(12):1284-1290. doi: 10.1016/j.arcped.2016.09.009. Epub 2016 Oct 24.,12,['Copyright A(c) 2016 Elsevier Masson SAS. All rights reserved.'],,,,,,,,La dengue autochtone.,,,,,,,,,,,,,
26112592,NLM,MEDLINE,20160328,20150626,1769-664X (Electronic) 0929-693X (Linking),22,2015 May,[Dengue in the child].,202-3,S0929-693X(15)30101-9 [pii] 10.1016/S0929-693X(15)30101-9 [doi],,"['Minodier, P', 'Laporte, R', 'Miramont, S', 'Noel, G']","['Minodier P', 'Laporte R', 'Miramont S', 'Noel G']",,"['Urgences enfants, CHU Nord, Chemin des Bourrelly, 13015 Marseille, France. Electronic address: philippe.minodier@ap-hm.fr.', 'Urgences enfants, CHU Nord, Chemin des Bourrelly, 13015 Marseille, France.', 'Urgences enfants, CHU Nord, Chemin des Bourrelly, 13015 Marseille, France.', 'Urgences enfants, CHU Nord, Chemin des Bourrelly, 13015 Marseille, France.']",['fre'],['Journal Article'],,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,"['0 (Antipyretics)', '0 (DNA, Viral)', '362O9ITL9D (Acetaminophen)']",IM,"['Acetaminophen/therapeutic use', 'Antipyretics/therapeutic use', 'Child', 'DNA, Viral/genetics', 'Dengue/*diagnosis/epidemiology/*therapy', 'Fluid Therapy', 'Humans', 'Leukopenia/etiology', 'Real-Time Polymerase Chain Reaction', 'Severity of Illness Index']",,2015/06/27 06:00,2016/03/29 06:00,['2015/06/27 06:00'],"['2015/06/27 06:00 [entrez]', '2015/06/27 06:00 [pubmed]', '2016/03/29 06:00 [medline]']","['S0929-693X(15)30101-9 [pii]', '10.1016/S0929-693X(15)30101-9 [doi]']",ppublish,Arch Pediatr. 2015 May;22(5 Suppl 1):202-3. doi: 10.1016/S0929-693X(15)30101-9.,5 Suppl 1,,,,,,,,,La dengue chez l'enfant.,,,,,,,,,,,,,
9287725,NLM,MEDLINE,19970918,20041117,0029-6503 (Print) 0029-6503 (Linking),88,1997 Feb,Dengue fever. Some basic facts.,26-7,,,['Innocentia Sister'],['Innocentia Sister'],,"['School of Nursing, Holy Family Hospital, New Delhi.']",['eng'],['Journal Article'],,India,Nurs J India,The Nursing journal of India,0376403,,,"['Aedes/virology', 'Animals', 'Dengue/diagnosis/*therapy/transmission', 'Humans', 'Insect Vectors/virology']",,1997/02/01 00:00,1997/02/01 00:01,['1997/02/01 00:00'],"['1997/02/01 00:00 [pubmed]', '1997/02/01 00:01 [medline]', '1997/02/01 00:00 [entrez]']",,ppublish,Nurs J India. 1997 Feb;88(2):26-7.,2,,,,,,,,,,,,,,,,,,,,,,
7496434,NLM,MEDLINE,19960117,20141120,1350-9357 (Print) 1350-9357 (Linking),5,1995 Oct 13,Dengue: current epidemics and risks to travellers.,201,,,,,,,['eng'],['Journal Article'],,England,Commun Dis Rep CDR Wkly,Communicable disease report. CDR weekly,9312012,,IM,"['Dengue/*epidemiology/transmission/virology', 'England/epidemiology', 'Global Health', 'Humans', 'Population Surveillance', '*Travel', 'Wales/epidemiology']",,1995/10/13 00:00,1995/10/13 00:01,['1995/10/13 00:00'],"['1995/10/13 00:00 [pubmed]', '1995/10/13 00:01 [medline]', '1995/10/13 00:00 [entrez]']",,ppublish,Commun Dis Rep CDR Wkly. 1995 Oct 13;5(41):201.,41,,,,,,,,,,,,,,,,,,,,,,
4198024,NLM,MEDLINE,19730913,20190511,0022-1899 (Print) 0022-1899 (Linking),128,1973 Jul,Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.,15-22,,,"['Halstead, S B', 'Shotwell, H', 'Casals, J']","['Halstead SB', 'Shotwell H', 'Casals J']",,,['eng'],['Journal Article'],,United States,J Infect Dis,The Journal of infectious diseases,0413675,"['0 (Antibodies, Viral)', '9007-36-7 (Complement System Proteins)']",IM,"['Animals', 'Antibodies, Viral/analysis', 'Arboviruses/immunology', 'Blood Cell Count', 'Child', 'Complement System Proteins/analysis', 'Dengue/blood/*etiology/immunology/microbiology/pathology/veterinary', 'Dengue Virus/analysis/*pathogenicity', '*Disease Models, Animal', 'Haplorhini', 'Hemagglutination Inhibition Tests', 'Hemorrhagic Fevers, Viral/microbiology', 'Humans', 'Hypoproteinemia/etiology', '*Macaca', 'Male', '*Monkey Diseases', 'Prothrombin Time', 'Shock, Septic/etiology', 'Thailand', 'Thrombocytopenia/etiology', 'Time Factors', 'Viral Plaque Assay']",,1973/07/01 00:00,1973/07/01 00:01,['1973/07/01 00:00'],"['1973/07/01 00:00 [pubmed]', '1973/07/01 00:01 [medline]', '1973/07/01 00:00 [entrez]']",['10.1093/infdis/128.1.15 [doi]'],ppublish,J Infect Dis. 1973 Jul;128(1):15-22. doi: 10.1093/infdis/128.1.15.,1,,,,,,,,,,,,,,,,,,,,,,
24602277,NLM,MEDLINE,20140429,20190608,1560-7917 (Electronic) 1025-496X (Linking),19,2014 Feb 27,The 2012 dengue outbreak in Madeira: exploring the origins.,20718,20718 [pii],"In 2012, Madeira reported its first major outbreak of dengue. To identify the origin of the imported dengue virus, we investigated the interconnectivity via air travel between dengue-endemic countries and Madeira, and compared available sequences against GenBank. There were 22,948 air travellers to Madeira in 2012, originating from twenty-nine dengue-endemic countries; 89.6% of these international travellers originated from Venezuela and Brazil. We developed an importation index that takes into account both travel volume and the extent of dengue incidence in the country of origin. Venezuela and Brazil had by far the highest importation indices compared with all other dengue-endemic countries. The importation index for Venezuela was twice as high as that for Brazil. When taking into account seasonality in the months preceding the onset of the Madeira outbreak, this index was even seven times higher for Venezuela than for Brazil during this time. Dengue sequencing shows that the virus responsible for the Madeira outbreak was most closely related to viruses circulating in Venezuela, Brazil and Columbia. Applying the importation index, Venezuela was identified as the most likely origin of importation of dengue virus via travellers to Madeira. We propose that the importation index is a new additional tool that can help to identify and anticipate the most probable country of origin for importation of dengue into currently non-endemic countries.","['Wilder-Smith, A', 'Quam, M', 'Sessions, O', 'Rocklov, J', 'Liu-Helmersson, J', 'Franco, L', 'Khan, K']","['Wilder-Smith A', 'Quam M', 'Sessions O', 'Rocklov J', 'Liu-Helmersson J', 'Franco L', 'Khan K']",,"['Department of Public Health and Clinical Medicine, Epidemiology and Global Health, Umea University, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20140227,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,"['0 (RNA, Viral)']",IM,"['Dengue/diagnosis/*epidemiology/transmission/virology', 'Dengue Virus/genetics/*isolation & purification', 'Disease Outbreaks/*statistics & numerical data', 'Genotype', 'Humans', 'Molecular Epidemiology', 'Portugal/epidemiology', 'RNA, Viral/*genetics', 'Sequence Analysis, DNA', '*Travel']",,2014/03/08 06:00,2014/04/30 06:00,['2014/03/08 06:00'],"['2014/03/08 06:00 [entrez]', '2014/03/08 06:00 [pubmed]', '2014/04/30 06:00 [medline]']","['20718 [pii]', '10.2807/1560-7917.es2014.19.8.20718 [doi]']",epublish,Euro Surveill. 2014 Feb 27;19(8):20718. doi: 10.2807/1560-7917.es2014.19.8.20718.,8,,,,,,,,,,,,,,,,['Euro Surveill. 2014;19(9):20725'],,,,,,
25271370,NLM,MEDLINE,20150629,20220414,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),20,2014 Oct,Dengue expansion in Africa-not recognized or not happening?,,10.3201/eid2010.140487 [doi] e140487,"An expert conference on Dengue in Africa was held in Accra, Ghana, in February 2013 to consider key questions regarding the possible expansion of dengue in Africa. Four key action points were highlighted to advance our understanding of the epidemiology of dengue in Africa. First, dengue diagnostic tools must be made more widely available in the healthcare setting in Africa. Second, representative data need to be collected across Africa to uncover the true burden of dengue. Third, established networks should collaborate to produce these types of data. Fourth, policy needs to be informed so the necessary steps can be taken to provide dengue vector control and health services.","['Jaenisch, Thomas', 'Junghanss, Thomas', 'Wills, Bridget', 'Brady, Oliver J', 'Eckerle, Isabella', 'Farlow, Andrew', 'Hay, Simon I', 'McCall, Philip J', 'Messina, Jane P', 'Ofula, Victor', 'Sall, Amadou A', 'Sakuntabhai, Anavaj', 'Velayudhan, Raman', 'Wint, G R William', 'Zeller, Herve', 'Margolis, Harold S', 'Sankoh, Osman']","['Jaenisch T', 'Junghanss T', 'Wills B', 'Brady OJ', 'Eckerle I', 'Farlow A', 'Hay SI', 'McCall PJ', 'Messina JP', 'Ofula V', 'Sall AA', 'Sakuntabhai A', 'Velayudhan R', 'Wint GR', 'Zeller H', 'Margolis HS', 'Sankoh O']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Aedes', 'Africa/epidemiology', 'Animals', 'Dengue/*diagnosis/*epidemiology/prevention & control', 'Dengue Virus', 'Disease Outbreaks', 'Endemic Diseases', 'Health Policy', 'Humans', 'Incidence', 'Mosquito Control']",PMC4193177,2014/10/02 06:00,2015/06/30 06:00,['2014/10/02 06:00'],"['2014/10/02 06:00 [entrez]', '2014/10/02 06:00 [pubmed]', '2015/06/30 06:00 [medline]']","['14-0487 [pii]', '10.3201/eid2010.140487 [doi]']",ppublish,Emerg Infect Dis. 2014 Oct;20(10):e140487. doi: 10.3201/eid2010.140487.,10,,,,,,['095066/Wellcome Trust/United Kingdom'],,,,,,,,,,,['Dengue in Africa Study Group'],"['Ouedraogo, Thierry A', 'Brady, Oliver J', 'Farlow, Andrew', 'Hay, Simon I', 'Messina, Janey P', 'Eckerle, Isabella', 'Gwamaka, Moses', 'Jaenisch, Thomas', 'Junghanss, Thomas', 'Margolis, Harold S', 'McCall, Philip J', 'Oduro, Abraham', 'Ofula, Victor', 'Sankoh, Osman', 'Sakunthabhai, Anavaj', 'Sall, Amadou A', 'Sorgho, Herrmann', 'Tiono, Alfred', 'Velayudhan, Raman', 'Wills, Bridget', 'Wint, G R William', 'Zeller, Herve']","['Ouedraogo TA', 'Brady OJ', 'Farlow A', 'Hay SI', 'Messina JP', 'Eckerle I', 'Gwamaka M', 'Jaenisch T', 'Junghanss T', 'Margolis HS', 'McCall PJ', 'Oduro A', 'Ofula V', 'Sankoh O', 'Sakunthabhai A', 'Sall AA', 'Sorgho H', 'Tiono A', 'Velayudhan R', 'Wills B', 'Wint GR', 'Zeller H']",,,
18689312,NLM,MEDLINE,20081016,20080811,0025-682X (Print) 0025-682X (Linking),68,2008 Jun,"[The ""red fever"" epidemic of 1873 on Reunion Island: was it dengue fever or a dengue-like syndrome?].",236-7,,,"['Aubry, P', 'Gauzere, B A']","['Aubry P', 'Gauzere BA']",,"[""Faculte de Medecine d'Antananarivo, Madagascar, 11 avenue Pierre Loti, 64500, Saint Jean de Luz, France. aubry.pierre@wanadoo.fr""]",['fre'],"['Historical Article', 'Journal Article']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['Dengue/epidemiology/*history', 'Disease Outbreaks/*history', 'History, 19th Century', 'Humans', 'Reunion/epidemiology']",,2008/08/12 09:00,2008/10/17 09:00,['2008/08/12 09:00'],"['2008/08/12 09:00 [pubmed]', '2008/10/17 09:00 [medline]', '2008/08/12 09:00 [entrez]']",,ppublish,Med Trop (Mars). 2008 Jun;68(3):236-7.,3,,,,,,,,,"L'epideme de ""fievre rouge"" a La Reunion en 1873: dengue ou syndrome dengue-like?",,,,,,,,,,,,,
26506730,NLM,MEDLINE,20151201,20151028,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,DENGUE VIRUS VIRULENCE AND DISEASES SEVERITY.,35-42,,"The dengue virus is the causative agent of a wide spectrum of clinical manifestations, ranging from mild acute febrile illness to classical dengue fever, dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS). DHF and DSS are the potentially fatal forms of dengue virus infection, which has become an intractable public health problem in many countries. The pathogeneses of DHF/ DSS are not clearly understood. One hypothesis concerning virus virulence and the immune enhancement hypothesis has been debated. Although dengue disease severity has been associated with evidence of genetic differences in dengue strains, virus virulence has been difficult to measure because of the lack of in vivo and in vitro models of the disease.","['Prommalikit, Olarn', 'Thisyakorn, Usa']","['Prommalikit O', 'Thisyakorn U']",,,['eng'],"['Journal Article', 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/genetics/immunology/*virology', 'Dengue Virus/*pathogenicity/*physiology', 'Humans', 'Severe Dengue/genetics/immunology/virology', 'Virulence']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:35-42.,,,,,,,,,,,,,,,,,,,,,,,
5419207,NLM,MEDLINE,19700723,20181113,0044-0086 (Print) 1551-4056 (Electronic) 0044-0086 (Linking),42,1970 Apr,Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of agspecific sequential infection rates using a mathematical model.,329-49,,,"['Fischer, D B', 'Halstead, S B']","['Fischer DB', 'Halstead SB']",,,['eng'],['Journal Article'],,United States,Yale J Biol Med,The Yale journal of biology and medicine,0417414,,IM,"['Adolescent', '*Age Factors', 'Child', 'Child, Preschool', 'Computers', 'Dengue/*epidemiology/etiology/immunology', 'Hemorrhagic Disorders/epidemiology', 'Hospitalization', 'Humans', 'Infant', 'Mathematics', 'Models, Theoretical', 'Thailand', 'Time Factors']",PMC2591712,1970/04/01 00:00,1970/04/01 00:01,['1970/04/01 00:00'],"['1970/04/01 00:00 [pubmed]', '1970/04/01 00:01 [medline]', '1970/04/01 00:00 [entrez]']",,ppublish,Yale J Biol Med. 1970 Apr;42(5):329-49.,5,,,,,,,,,,,,,,,,,,,,,,
31264953,NLM,MEDLINE,20200710,20200710,1557-8976 (Electronic) 0882-8245 (Linking),32,2019 Jul/Aug,Dengue Vaccines.,235,10.1089/vim.2019.29039.dlw [doi],,"['Woodland, David L']",['Woodland DL'],,"['Trudeau Institute, Saranac Lake, New York.']",['eng'],"['Editorial', 'Introductory Journal Article']",20190702,United States,Viral Immunol,Viral immunology,8801552,"['0 (Adjuvants, Immunologic)', '0 (Dengue Vaccines)']",IM,"['Adjuvants, Immunologic', 'Dengue/immunology/*prevention & control', '*Dengue Vaccines', 'Dengue Virus', 'Humans']",,2019/07/03 06:00,2020/07/11 06:00,['2019/07/03 06:00'],"['2019/07/03 06:00 [pubmed]', '2020/07/11 06:00 [medline]', '2019/07/03 06:00 [entrez]']",['10.1089/vim.2019.29039.dlw [doi]'],ppublish,Viral Immunol. 2019 Jul/Aug;32(6):235. doi: 10.1089/vim.2019.29039.dlw. Epub 2019 Jul 2.,6,,,,,,,,,,,,,,,,,,,,,,
37104529,NLM,MEDLINE,20230511,20230514,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),17,2023 Apr,Self-care practices and health-seeking behaviours in patients with dengue fever: A qualitative study from patients' and physicians' perspectives.,e0011302,10.1371/journal.pntd.0011302 [doi] e0011302,"INTRODUCTION: Outpatient management for dengue fever is the mainstay of treatment for most dengue cases. However, severe dengue can develop rapidly while patients are at home. Understanding the self-care practices and healthcare-seeking behaviours among dengue patients managed as outpatients will help improve the delivery of care to these patients. OBJECTIVE: This study aimed to explore the self-care practices, health-seeking behaviour and outpatient management of dengue fever from the perspectives of patients and primary care physicians. METHODOLOGY: This qualitative study used in-depth interviews and focus group discussions to obtain information from laboratory-confirmed dengue patients who received outpatient care and primary care physicians who cared for them. Patients and physicians shared their experiences and perceptions of self-care practices, decisions to seek urgent care, and outpatient management procedures and visit frequency. Data were coded and analysed using thematic analysis. RESULTS: 13 patients and 11 physicians participated. We discovered that the use of traditional remedies was common with patients perceiving no harm from it, whereas physicians did not see a benefit. Dengue patients' knowledge of warning signs was inadequate despite the information being provided by physicians during clinical follow-up visits. Regarding the decision to seek urgent medical care, physicians assumed patients would seek help immediately once they experienced warning signs. However, for the patients, other factors influenced their health-seeking behaviour, such as their personal perceptions of symptom severity and often more importantly, their social circumstances (e.g., availability of childcare). Patients also described regular outpatient follow-up for dengue as inconvenient. There was variation in the prescribed outpatient follow-up interval recommended by participating physicians who complained about the lack of clear guidelines. CONCLUSION: Perceptions around self-care practices, health-seeking behaviour and outpatient management of dengue often differed between physicians and patients, especially on comprehension of dengue warning signs. Addressing these gaps between patient and physician perceptions and recognition of patient drivers of health-seeking behaviour are needed to improve the safety and delivery of outpatient care for dengue patients.","['Ng, Wei Leik', 'Toh, Jia Yong', 'Ng, Chirk Jenn', 'Teo, Chin Hai', 'Lee, Yew Kong', 'Loo, Kim Kee', 'Abdul Hadi, Haireen', 'Noor Azhar, Abdul Muhaimin']","['Ng WL', 'Toh JY', 'Ng CJ', 'Teo CH', 'Lee YK', 'Loo KK', 'Abdul Hadi H', 'Noor Azhar AM']",['ORCID: 0000-0002-3074-9114'],"['Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Research, SingHealth Polyclinics, Singapore, Singapore.', 'Health Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'UM eHealth Unit, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'UM eHealth Unit, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Department of Emergency Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20230427,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Humans', 'Self Care', 'Qualitative Research', '*Physicians', 'Patient Acceptance of Health Care', '*Dengue/diagnosis/therapy']",PMC10168551,2023/04/27 18:41,2023/05/11 06:42,['2023/04/27 13:53'],"['2022/09/12 00:00 [received]', '2023/04/11 00:00 [accepted]', '2023/05/09 00:00 [revised]', '2023/05/11 06:42 [medline]', '2023/04/27 18:41 [pubmed]', '2023/04/27 13:53 [entrez]']","['PNTD-D-22-01181 [pii]', '10.1371/journal.pntd.0011302 [doi]']",epublish,PLoS Negl Trop Dis. 2023 Apr 27;17(4):e0011302. doi: 10.1371/journal.pntd.0011302. eCollection 2023 Apr.,4,"['Copyright: (c) 2023 Ng et al. This is an open access article distributed under the', 'terms of the Creative Commons Attribution License, which permits unrestricted', 'use, distribution, and reproduction in any medium, provided the original author', 'and source are credited.']",,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
34375166,NLM,MEDLINE,20220831,20221024,1744-1706 (Electronic) 1744-1692 (Linking),17,2022 Aug-Sep,Medical populism and the politics of dengue epidemics in the Global South.,1795-1808,10.1080/17441692.2021.1965181 [doi],"With millions of cases and thousands of deaths every year in Asia and Latin America, dengue fever continues to be of global public health significance. This article uses the concept of 'medical populism' to analyse the political construction of the 2019 dengue epidemics in Bangladesh, the Philippines, and Honduras. Through this framework, we examine the narratives of these outbreaks by reconstructing how political actors simplified the discourse, spectacularised the crises, offered multiple knowledge claims, and forged divisions between the people and 'dangerous others'. Taken together, our case studies, obtained through government, journalistic, and scholarly sources, illuminate the role of medical populists (who are almost always politicians) in defining and responding to public health emergencies, underscoring the performative dimension of disease outbreaks. By detracting attention from less spectacular but more substantive policies and programs, these 'performances' of health crises perpetuate health inequities, especially in fragile democracies like the aforementioned Global South countries. We conclude by reflecting on the implications of medical populism to public health, health communications, and the inevitable recurrence of epidemics.","['Lasco, Gideon', 'Gregory Yu, Vincen']","['Lasco G', 'Gregory Yu V']",['ORCID: 0000-0002-6402-682X'],"['Development Studies Program, Ateneo de Manila University, Quezon City, Philippines.', 'Department of Anthropology, University of the Philippines Diliman, Quezon City, Philippines.', 'Development Studies Program, Ateneo de Manila University, Quezon City, Philippines.']",['eng'],['Journal Article'],20210810,England,Glob Public Health,Global public health,101256323,,IM,"['*Dengue/epidemiology/prevention & control', 'Disease Outbreaks', '*Epidemics', 'Humans', 'Politics', 'Public Health']",,2021/08/11 06:00,2022/09/01 06:00,['2021/08/10 17:12'],"['2021/08/11 06:00 [pubmed]', '2022/09/01 06:00 [medline]', '2021/08/10 17:12 [entrez]']",['10.1080/17441692.2021.1965181 [doi]'],ppublish,Glob Public Health. 2022 Aug-Sep;17(9):1795-1808. doi: 10.1080/17441692.2021.1965181. Epub 2021 Aug 10.,9,,['NOTNLM'],"['Dengue', 'Global South', 'epidemics', 'health crisis', 'medical populism', 'politics of health']",,,,,,,,,,,,,,,,,,,
27548481,NLM,MEDLINE,20170720,20190202,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),10,2016 Aug,Community Involvement in Dengue Outbreak Control: An Integrated Rigorous Intervention Strategy.,e0004919,10.1371/journal.pntd.0004919 [doi] e0004919,"BACKGROUND: An explosive outbreak of dengue fever occurred in Guangdong Province, China in 2014. A community-based integrated intervention was applied to control this outbreak in the capital city Guangzhou, where dengue epidemic was mainly caused by imported cases. METHODOLOGY/PRINCIPAL FINDINGS: We used a time series generalized additive model based on meteorological factors to assess the effectiveness of this intervention. The results showed that there was significant reduction in mosquito density following the intervention, and there was a 70.47% (95% confidence interval: 66.07%, 74.88%) reduction in the reported dengue cases compared with the predicted cases after 12 days since the beginning of the intervention, we estimated that a total of 23,302 dengue cases were prevented. CONCLUSIONS: This study suggests that an integrated dengue intervention program has significant effects to control a dengue outbreak in areas where dengue epidemic was mainly caused by imported dengue cases.","['Lin, Hualiang', 'Liu, Tao', 'Song, Tie', 'Lin, Lifeng', 'Xiao, Jianpeng', 'Lin, Jinyan', 'He, Jianfeng', 'Zhong, Haojie', 'Hu, Wenbiao', 'Deng, Aiping', 'Peng, Zhiqiang', 'Ma, Wenjun', 'Zhang, Yonghui']","['Lin H', 'Liu T', 'Song T', 'Lin L', 'Xiao J', 'Lin J', 'He J', 'Zhong H', 'Hu W', 'Deng A', 'Peng Z', 'Ma W', 'Zhang Y']",,"['Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'School of Public Health and Social Work, Queensland University of Technology, Australia.', 'Institute of Health and Biomedical Innovation, Queensland University of Technology, Australia.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.', 'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20160822,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Animals', 'China', '*Community Participation', 'Culicidae/virology', 'Dengue/*epidemiology/*prevention & control/transmission/virology', 'Disease Outbreaks/*prevention & control/statistics & numerical data', 'Epidemics/prevention & control', 'Humans']",PMC4993447,2016/08/23 06:00,2017/07/21 06:00,['2016/08/23 06:00'],"['2016/02/16 00:00 [received]', '2016/07/22 00:00 [accepted]', '2016/08/23 06:00 [entrez]', '2016/08/23 06:00 [pubmed]', '2017/07/21 06:00 [medline]']","['PNTD-D-16-00270 [pii]', '10.1371/journal.pntd.0004919 [doi]']",epublish,PLoS Negl Trop Dis. 2016 Aug 22;10(8):e0004919. doi: 10.1371/journal.pntd.0004919. eCollection 2016 Aug.,8,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
16763344,NLM,MEDLINE,20060811,20191126,0254-8860 (Print) 0254-8860 (Linking),25,2006 Mar-Apr,Dengue fever presenting with acute colitis.,97-8,,Gastrointestinal manifestations of dengue fever are mainly in the form of bleeding or liver function abnormalities. Dengue fever presenting as acute colitis-like picture is not reported to date. We report a 50-year-old man with dengue fever presenting with lower gastrointestinal bleeding and colonoscopic features of acute inflammatory colitis.,"['Rama Krishna, A K', 'Patil, Shivanand', 'Srinivas Rao, Grs', 'Kumar, Ajit']","['Rama Krishna AK', 'Patil S', 'Srinivas Rao G', 'Kumar A']",,"[""Department Of Gastroenterology, Nizam's Institute of Medical Sciences, Panjagutta, Hyderabad, India. ramakappa69@yahoo.co.in""]",['eng'],"['Case Reports', 'Journal Article']",,India,Indian J Gastroenterol,Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,8409436,,IM,"['Acute Disease', 'Colitis/*etiology', 'Dengue/complications/*diagnosis', 'Humans', 'Male', 'Middle Aged']",,2006/06/10 09:00,2006/08/12 09:00,['2006/06/10 09:00'],"['2006/06/10 09:00 [pubmed]', '2006/08/12 09:00 [medline]', '2006/06/10 09:00 [entrez]']",,ppublish,Indian J Gastroenterol. 2006 Mar-Apr;25(2):97-8.,2,,,,,,,,,,,,,,,,,,,,,,
19270769,NLM,MEDLINE,20090331,20211020,0091-6765 (Print) 1552-9924 (Electronic) 0091-6765 (Linking),117,2009 Feb,Dengue transmission.,A56,10.1289/ehp.0800227 [doi],,"['Mariappan, Thiruppathi']",['Mariappan T'],,,['eng'],"['Comment', 'Letter']",,United States,Environ Health Perspect,Environmental health perspectives,0330411,,IM,"['Aedes/virology', 'Animals', 'Dengue/epidemiology/prevention & control/*transmission', 'Disease Vectors', 'Humans', 'Mosquito Control']",PMC2649238,2009/03/10 09:00,2009/04/01 09:00,['2009/03/10 09:00'],"['2009/03/10 09:00 [entrez]', '2009/03/10 09:00 [pubmed]', '2009/04/01 09:00 [medline]']","['ehp-117-a56a [pii]', '10.1289/ehp.0800227 [doi]']",ppublish,Environ Health Perspect. 2009 Feb;117(2):A56. doi: 10.1289/ehp.0800227.,2,,,,,,,,['Environ Health Perspect. 2008 Sep;116(9):A382-8. PMID: 18795135'],,,,,,,,,,,,,,
20171916,NLM,MEDLINE,20110218,20131121,1878-3511 (Electronic) 1201-9712 (Linking),14 Suppl 3,2010 Sep,"Multiple dengue serotypes and high frequency of dengue hemorrhagic fever at two tertiary care hospitals in Lahore during the 2008 dengue virus outbreak in Punjab, Pakistan.",e54-9,10.1016/j.ijid.2009.10.008 [doi],"OBJECTIVE: The objective of this study was to investigate the clinical characteristics of patients with dengue viral infection during the 2008 outbreak in Lahore in order to better understand the clinical pattern and severity of disease in Lahore. METHODS: We analyzed the clinical characteristics of 110 patients infected with dengue virus; data were collected on standardized data collection sheets at two tertiary care hospitals from September to December 2008. Dengue infection was confirmed serologically or by real-time polymerase chain reaction (RT-PCR). RESULTS: Out of the total of 110 dengue infected patients, 70 were male and 40 were female. The most common symptoms included fever (100%), myalgia (68.2%), headache (55.5%), nausea (39.1%), skin rash (53.6%), mucocutaneous hemorrhagic manifestations (58.2%), and ocular pain (20%). Classic dengue fever (DF) was seen in 41.8% of the patients, 56.4% had dengue hemorrhagic fever (DHF), and only 1.8% developed dengue shock syndrome (DSS). The mean duration of fever was 6 days. Thrombocytopenia, leukopenia, and abnormal aspartate aminotransferase (AST)/alanine aminotransferase (ALT) were more frequently encountered in DHF and DSS as compared to DF. Viral RNA detection was done by RT-PCR in 17 patients. Ten patients had DEN4, five had DEN2, and two had DEN3 serotypes. The majority of the patients recovered completely without complications. CONCLUSION: The high frequency of DHF during the 2008 outbreak and the presence of three different dengue serotypes, emphasize the need to prevent and control dengue infection. Health authorities should consider strengthening surveillance for dengue infection, given the potential for future outbreaks with increased severity. It is also suggested that primary care physicians should be educated regarding recognition of DHF and to identify patients at high risk of developing DHF and DSS.","['Humayoun, Malik Asif', 'Waseem, Tariq', 'Jawa, Ali A', 'Hashmi, Mubashar S', 'Akram, Javed']","['Humayoun MA', 'Waseem T', 'Jawa AA', 'Hashmi MS', 'Akram J']",,"['Department of Medicine, Allama Iqbal Medical College and Jinnah Hospital, Maulana Shabbir Ahmed Usmani Road, Lahore, Punjab, Pakistan. doctormalikasif@gmail.com']",['eng'],['Journal Article'],20100219,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,,IM,"['Adolescent', 'Adult', 'Aged', 'Dengue/diagnosis/*epidemiology/*virology', 'Dengue Virus/*classification/isolation & purification', '*Disease Outbreaks', 'Female', 'Hospitals, Teaching', 'Humans', 'Male', 'Middle Aged', 'Pakistan/epidemiology', 'Serotyping', 'Severe Dengue/diagnosis/*epidemiology/*virology', 'Young Adult']",,2010/02/23 06:00,2011/02/22 06:00,['2010/02/23 06:00'],"['2009/06/15 00:00 [received]', '2009/10/09 00:00 [revised]', '2009/10/15 00:00 [accepted]', '2010/02/23 06:00 [entrez]', '2010/02/23 06:00 [pubmed]', '2011/02/22 06:00 [medline]']","['S1201-9712(10)00018-4 [pii]', '10.1016/j.ijid.2009.10.008 [doi]']",ppublish,Int J Infect Dis. 2010 Sep;14 Suppl 3:e54-9. doi: 10.1016/j.ijid.2009.10.008. Epub 2010 Feb 19.,,"['Copyright (c) 2010 International Society for Infectious Diseases. Published by', 'Elsevier Ltd. All rights reserved.']",,,,,,,,,,,,,,,,,,,,,
18335069,NLM,MEDLINE,20100323,20211020,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),2,2008 Mar 12,Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness.,e196,10.1371/journal.pntd.0000196 [doi] e196,"BACKGROUND: Dengue is re-emerging throughout the tropical world, causing frequent recurrent epidemics. The initial clinical manifestation of dengue often is confused with other febrile states confounding both clinical management and disease surveillance. Evidence-based triage strategies that identify individuals likely to be in the early stages of dengue illness can direct patient stratification for clinical investigations, management, and virological surveillance. Here we report the identification of algorithms that differentiate dengue from other febrile illnesses in the primary care setting and predict severe disease in adults. METHODS AND FINDINGS: A total of 1,200 patients presenting in the first 72 hours of acute febrile illness were recruited and followed up for up to a 4-week period prospectively; 1,012 of these were recruited from Singapore and 188 from Vietnam. Of these, 364 were dengue RT-PCR positive; 173 had dengue fever, 171 had dengue hemorrhagic fever, and 20 had dengue shock syndrome as final diagnosis. Using a C4.5 decision tree classifier for analysis of all clinical, haematological, and virological data, we obtained a diagnostic algorithm that differentiates dengue from non-dengue febrile illness with an accuracy of 84.7%. The algorithm can be used differently in different disease prevalence to yield clinically useful positive and negative predictive values. Furthermore, an algorithm using platelet count, crossover threshold value of a real-time RT-PCR for dengue viral RNA, and presence of pre-existing anti-dengue IgG antibodies in sequential order identified cases with sensitivity and specificity of 78.2% and 80.2%, respectively, that eventually developed thrombocytopenia of 50,000 platelet/mm(3) or less, a level previously shown to be associated with haemorrhage and shock in adults with dengue fever. CONCLUSION: This study shows a proof-of-concept that decision algorithms using simple clinical and haematological parameters can predict diagnosis and prognosis of dengue disease, a finding that could prove useful in disease management and surveillance.","['Tanner, Lukas', 'Schreiber, Mark', 'Low, Jenny G H', 'Ong, Adrian', 'Tolfvenstam, Thomas', 'Lai, Yee Ling', 'Ng, Lee Ching', 'Leo, Yee Sin', 'Thi Puong, Le', 'Vasudevan, Subhash G', 'Simmons, Cameron P', 'Hibberd, Martin L', 'Ooi, Eng Eong']","['Tanner L', 'Schreiber M', 'Low JG', 'Ong A', 'Tolfvenstam T', 'Lai YL', 'Ng LC', 'Leo YS', 'Thi Puong L', 'Vasudevan SG', 'Simmons CP', 'Hibberd ML', 'Ooi EE']",,"['Novartis Institute for Tropical Diseases, Singapore.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20080312,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,"['0 (RNA, Viral)']",IM,"['Adolescent', 'Adult', '*Algorithms', '*Decision Trees', 'Dengue/*diagnosis/pathology/*virology', 'Dengue Virus/genetics', 'Humans', 'RNA, Viral/genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Severe Dengue/diagnosis/pathology/virology', 'Young Adult']",PMC2263124,2008/03/13 09:00,2010/03/24 06:00,['2008/03/13 09:00'],"['2007/06/05 00:00 [received]', '2008/01/18 00:00 [accepted]', '2008/03/13 09:00 [pubmed]', '2010/03/24 06:00 [medline]', '2008/03/13 09:00 [entrez]']","['07-PNTD-RA-0116R2 [pii]', '10.1371/journal.pntd.0000196 [doi]']",epublish,PLoS Negl Trop Dis. 2008 Mar 12;2(3):e196. doi: 10.1371/journal.pntd.0000196.,3,,,,['The authors have declared that no competing interests exist.'],,['074636/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
34011654,NLM,MEDLINE,20210521,20230520,1757-790X (Electronic) 1757-790X (Linking),14,2021 May 19,Dengue and hantavirus coinfection with good outcomes: a clinical case from Panama.,,10.1136/bcr-2020-235779 [doi] e235779,"Dengue and hantavirus are endemic in central Panama. We present a case report of a patient coinfected with dengue and hantavirus who presented overlapping clinical manifestations of both infections. The patient did not require intensive care-as it is commonplace during hantavirus pulmonary syndrome-and he had a good outcome. Patient's care was positively impacted due to correct diagnosis of coinfection. This case highlights that in endemic areas, coinfection with dengue virus and hantavirus should be suspected. To the best of our knowledge, this case is the first documented case of coinfection with dengue virus and hantavirus in Central America.","['Nunez-Samudio, Virginia', 'Meza, Martin', 'Landires, Ivan']","['Nunez-Samudio V', 'Meza M', 'Landires I']",['ORCID: 0000-0001-6323-1170'],"['Instituto de Ciencias Medicas, Las Tablas, Los Santos, Panama.', 'Seccion de Epidemiologia, Departamento de Salud Publica, Region de Salud de Herrera, Ministry of Health, Chitre, Herrera, Panama.', 'Seccion de Epidemiologia, Departamento de Salud Publica, Region de Salud de Herrera, Ministry of Health, Chitre, Herrera, Panama.', 'Instituto de Ciencias Medicas, Las Tablas, Los Santos, Panama ilandires@institutodecienciasmedicas.org.', 'Centro Regional Universitario de Azuero, CRUA, Universidad de Panama, Chitre, Herrera, Panama.', 'Hospital Joaquin Pablo Franco Sayas, Region de Salud de Los Santos, Ministry of Health, Las Tablas, Los Santos, Panama.']",['eng'],"['Case Reports', 'Journal Article']",20210519,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['*Coinfection', '*Dengue/complications/diagnosis', '*Orthohantavirus', '*Hantavirus Pulmonary Syndrome', 'Humans', 'Male', 'Panama']",PMC8137157,2021/05/21 06:00,2021/05/22 06:00,['2021/05/20 05:48'],"['2021/05/20 05:48 [entrez]', '2021/05/21 06:00 [pubmed]', '2021/05/22 06:00 [medline]']","['14/5/e235779 [pii]', 'bcr-2020-235779 [pii]', '10.1136/bcr-2020-235779 [doi]']",epublish,BMJ Case Rep. 2021 May 19;14(5):e235779. doi: 10.1136/bcr-2020-235779.,5,"['(c) BMJ Publishing Group Limited 2021. No commercial re-use. See rights and', 'permissions. Published by BMJ.']",['NOTNLM'],"['infectious diseases', 'public health', 'tropical medicine (infectious disease)']",['Competing interests: None declared.'],,,,,,,,,,,,,,,,,,
22292098,NLM,MEDLINE,20120516,20211021,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),6,2012 Jan,Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project.,e1482,10.1371/journal.pntd.0001482 [doi] e1482,"BACKGROUND: Dengue has emerged as the most important vector-borne viral disease in tropical areas. Evaluations of the burden and severity of dengue disease have been hindered by the frequent lack of laboratory confirmation and strong selection bias toward more severe cases. METHODOLOGY: A multinational, prospective clinical study was carried out in South-East Asia (SEA) and Latin America (LA), to ascertain the proportion of inapparent dengue infections in households of febrile dengue cases, and to compare clinical data and biological markers from subjects with various dengue disease patterns. Dengue infection was laboratory-confirmed during the acute phase, by virus isolation and detection of the genome. The four participating reference laboratories used standardized methods. PRINCIPAL FINDINGS: Among 215 febrile dengue subjects-114 in SEA and 101 in LA-28 (13.0%) were diagnosed with severe dengue (from SEA only) using the WHO definition. Household investigations were carried out for 177 febrile subjects. Among household members at the time of the first home visit, 39 acute dengue infections were detected of which 29 were inapparent. A further 62 dengue cases were classified at early convalescent phase. Therefore, 101 dengue infections were found among the 408 household members. Adding these together with the 177 Dengue Index Cases, the overall proportion of dengue infections among the study participants was estimated at 47.5% (278/585; 95% CI 43.5-51.6). Lymphocyte counts and detection of the NS1 antigen differed significantly between inapparent and symptomatic dengue subjects; among inapparent cases lymphocyte counts were normal and only 20% were positive for NS1 antigen. Primary dengue infection and a specific dengue virus serotype were not associated with symptomatic dengue infection. CONCLUSION: Household investigation demonstrated a high proportion of household members positive for dengue infection, including a number of inapparent cases, the frequency of which was higher in SEA than in LA.","['Dussart, Philippe', 'Baril, Laurence', 'Petit, Laure', 'Beniguel, Lydie', 'Quang, Luong Chan', 'Ly, Sowath', 'Azevedo, Raimunda do Socorro Silva', 'Meynard, Jean-Baptiste', 'Vong, Sirenda', 'Chartier, Loic', 'Diop, Aba', 'Sivuth, Ong', 'Duong, Veasna', 'Thang, Cao Minh', 'Jacobs, Michael', 'Sakuntabhai, Anavaj', 'Nunes, Marcio Roberto Teixeira', 'Huong, Vu Ti Que', 'Buchy, Philippe', 'Vasconcelos, Pedro Fernando da Costa']","['Dussart P', 'Baril L', 'Petit L', 'Beniguel L', 'Quang LC', 'Ly S', 'Azevedo Rdo S', 'Meynard JB', 'Vong S', 'Chartier L', 'Diop A', 'Sivuth O', 'Duong V', 'Thang CM', 'Jacobs M', 'Sakuntabhai A', 'Nunes MR', 'Huong VT', 'Buchy P', 'Vasconcelos PF']",,"['Institut Pasteur de la Guyane, Laboratoire de Virologie, Cayenne, French Guiana. pdussart@pasteur-cayenne.fr']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, Non-U.S. Gov't""]",20120124,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adolescent', 'Asia, Southeastern/epidemiology', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/*pathology/transmission/virology', 'Dengue Virus', 'Family Characteristics', '*Family Health', 'Humans', 'Incidence', 'Internationality', 'Latin America/epidemiology', 'Prevalence', 'Prospective Studies']",PMC3265457,2012/02/01 06:00,2012/05/17 06:00,['2012/02/01 06:00'],"['2011/01/05 00:00 [received]', '2011/11/30 00:00 [accepted]', '2012/02/01 06:00 [entrez]', '2012/02/01 06:00 [pubmed]', '2012/05/17 06:00 [medline]']","['PNTD-D-11-00013 [pii]', '10.1371/journal.pntd.0001482 [doi]']",ppublish,PLoS Negl Trop Dis. 2012 Jan;6(1):e1482. doi: 10.1371/journal.pntd.0001482. Epub 2012 Jan 24.,1,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
18697444,NLM,MEDLINE,20080904,20191210,0300-9041 (Print) 0300-9041 (Linking),75,2007 Nov,[Dengue fever during pregnancy. Cases report].,687-90,,"Dengue is known as an endemic disease of tropical and subtropical regions. It was considered a disease very frequent on kids, but recently an increase was reported on adult people. Some of these cases were related to pregnant women, for that reason, we decided to check eight cases, including just the mothers who presented dengue virus infection through ELISA IgM. IgG and ELISA IgM studies. Five products were determined between 3 and 9-born-babies. Eight cases of dengue were analyzed during pregnancy, three cases of fever dengue and five cases of hemorrhagic dengue; main complications detected were threat of abortion, and premature labour, postsurgical bleeding with desiccant haematoma of uterine artery, oligohydramnios, as well as pleural effusion, two of the neonates were classified as septic for presenting fever. In no case, IgG or IgM for fever dengue was detected in neonates.","['Rosado Leon, Rocio', 'Munoz Rodriguez, Mario R', 'Soler Huerta, Elizabeth', 'Parissi Crivelli, Aurora', 'Mendez Machado, Gustavo F']","['Rosado Leon R', 'Munoz Rodriguez MR', 'Soler Huerta E', 'Parissi Crivelli A', 'Mendez Machado GF']",,"['Delegacion Veracruz Norte, IMSS, Mexico. rocio.rosado@imss.gob.mx']",['spa'],['Journal Article'],,Mexico,Ginecol Obstet Mex,Ginecologia y obstetricia de Mexico,0376552,,IM,"['Adult', 'Catchment Area, Health', 'Dengue/*diagnosis/epidemiology/physiopathology', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'Mexico/epidemiology', 'Pregnancy', 'Pregnancy Complications/*epidemiology', 'Retrospective Studies']",,2008/08/14 09:00,2008/09/05 09:00,['2008/08/14 09:00'],"['2008/08/14 09:00 [pubmed]', '2008/09/05 09:00 [medline]', '2008/08/14 09:00 [entrez]']",,ppublish,Ginecol Obstet Mex. 2007 Nov;75(11):687-90.,11,,,,,,,,,Dengue durante el embarazo. Comunicacion de casos.,,,,,,,,,,,,,
29209680,NLM,MEDLINE,20180730,20181113,1658-3175 (Electronic) 0379-5284 (Print) 0379-5284 (Linking),38,2017 Dec,Dengue fever in Saudi Arabia.,1264,10.15537/smj.2017.12.21335 [doi],[No Abstract Available].,"['Joob, Beuy', 'Wiwanikit, Viroj']","['Joob B', 'Wiwanikit V']",,"['Medical Academic Center, Bangkok, Thailand. E-mail. beuyjoob@hotmail.com.']",['eng'],['Letter'],,Saudi Arabia,Saudi Med J,Saudi medical journal,7909441,,IM,"['Dengue/*epidemiology/physiopathology', 'Humans', 'Saudi Arabia/epidemiology']",PMC5787642,2017/12/07 06:00,2018/07/31 06:00,['2017/12/07 06:00'],"['2017/12/07 06:00 [entrez]', '2017/12/07 06:00 [pubmed]', '2018/07/31 06:00 [medline]']","['SaudiMedJ-38-1264 [pii]', '10.15537/smj.2017.12.21335 [doi]']",ppublish,Saudi Med J. 2017 Dec;38(12):1264. doi: 10.15537/smj.2017.12.21335.,12,,,,,,,,,,,,,,,,,,,,,,
28405982,NLM,MEDLINE,20181113,20181113,0004-5772 (Print) 0004-5772 (Linking),64,2016 Dec,India in Grip of Dengue - Yet Again.,13-14,,,"['Trivedi, Trupti H']",['Trivedi TH'],,"['Associate Professor, Department of Medicine, LTM Medical College and General Hospital, Mumbai, Maharashtra.']",['eng'],['Editorial'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,IM,"['*Dengue/epidemiology/prevention & control', 'Humans', 'India/epidemiology']",,2017/04/14 06:00,2018/11/14 06:00,['2017/04/14 06:00'],"['2017/04/14 06:00 [entrez]', '2017/04/14 06:00 [pubmed]', '2018/11/14 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2016 Dec;64(12):13-14.,12,,,,,,,,,,,,,,,,,,,,,,
32858540,NLM,MEDLINE,20211029,20230922,1533-4058 (Electronic) 1533-4058 (Linking),29,2021 Feb 1,One-step Multiplex Real-time RT-PCR for Molecular Detection and Typing of Dengue Virus Infection From Paraffin-embedded Tissues During the Brazilian 2019 Outbreak.,158-162,10.1097/PAI.0000000000000870 [doi],"Formalin-fixed paraffin-embedded (FFPE) tissues are an important source for investigation of dengue virus (DENV) infection, particularly when blood or fresh frozen (FF) samples are unavailable. Histopathologic features and immunohistochemistry may have poor sensitivity and serotype determination is not always possible. Viral RNA genome detection tests are faster and considered the most sensitive technique for this kind of analysis, however, the use of molecular methods applied to FFPE tissues is still limited. The authors applied a single-step multiplex reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for the investigation of DENV infection and typing to FFPE samples of 32 fatal cases received during the 2019 outbreak that occurred in Sao Paulo state, Brazil. The authors compared the results with those obtained using FF tissues. Of the 24 cases with both FF and FFPE samples, 22 (91.67%) of the FF and 19 (76.20%) of the FFPE specimens were positive. Two cases (8.33%) tested negative in both types of samples. All 8 cases with only FFPE samples available were positive. The accuracy (87.5%) of the RT-qPCR for DENV in FFPE samples were satisfactory. Although the cycle quantification (Cq) values were significantly higher in these materials (P<0.0001, Wilcoxon signed-rank test) when compared with FF tissues, Spearman's rank coefficient indicated a good correlation between the Cq values from both sample types (P=0.0063; rho=0.576). RT-qPCR applied to FFPE samples improved detection of DENV in fatal cases and represents a useful tool for diagnosis and epidemiologic studies.","['Mariotti Guerra, Juliana', 'Santos da Silva Ferreira, Camila', 'Rosa Fernandes Beraldo, Karolina', 'Midori Kimura, Lidia', 'Possatto Fernandes Takahashi, Juliana', 'Salas-Gomez, David', 'Sequetin Cunha, Mariana', 'Fletcher Buss, Lewis', 'Silva Nogueira, Juliana', 'Yurika Maeda, Adriana', 'Jose Tadeu de Araujo, Leonardo']","['Mariotti Guerra J', 'Santos da Silva Ferreira C', 'Rosa Fernandes Beraldo K', 'Midori Kimura L', 'Possatto Fernandes Takahashi J', 'Salas-Gomez D', 'Sequetin Cunha M', 'Fletcher Buss L', 'Silva Nogueira J', 'Yurika Maeda A', 'Jose Tadeu de Araujo L']",,"['Pathology Center.', 'Pathology Center.', 'Pathology Center.', 'Central Laboratory, Federal University of Sao Paulo.', 'Pathology Center.', 'Pathology Center.', 'Pathology Center.', 'Virology Center, Adolfo Lutz Institute.', 'Institute of Tropical Medicine, University of Sao Paulo Medical School USP, Sao Paulo, Brazil.', 'Virology Center, Adolfo Lutz Institute.', 'Virology Center, Adolfo Lutz Institute.', 'Pathology Center.']",['eng'],['Journal Article'],,United States,Appl Immunohistochem Mol Morphol,Applied immunohistochemistry & molecular morphology : AIMM,100888796,,IM,"['Brazil/epidemiology', 'Cross-Sectional Studies', '*Dengue/diagnosis/genetics/mortality/pathology', 'Dengue Virus/*genetics', '*Disease Outbreaks', 'Female', 'Humans', 'Male', '*Multiplex Polymerase Chain Reaction', '*Paraffin Embedding', '*Real-Time Polymerase Chain Reaction', '*Reverse Transcriptase Polymerase Chain Reaction']",,2020/08/29 06:00,2021/10/30 06:00,['2020/08/29 06:00'],"['2020/02/17 00:00 [received]', '2020/07/27 00:00 [accepted]', '2020/08/29 06:00 [pubmed]', '2021/10/30 06:00 [medline]', '2020/08/29 06:00 [entrez]']","['00129039-202102000-00012 [pii]', '10.1097/PAI.0000000000000870 [doi]']",ppublish,Appl Immunohistochem Mol Morphol. 2021 Feb 1;29(2):158-162. doi: 10.1097/PAI.0000000000000870.,2,"['Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.']",,,['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
20989408,NLM,MEDLINE,20101028,20201005,0037-9026 (Print) 0037-9026 (Linking),139,1945 Dec,"[Research on the etiology of a short-lived epidemic fever with meningeal reaction, recently observed in France].",1142-4,,,"['SCHIER, R', 'REQUET, A', 'GIRIER, L']","['SCHIER R', 'REQUET A', 'GIRIER L']",,,['fre'],['Journal Article'],,France,C R Seances Soc Biol Fil,Comptes rendus des seances de la Societe de biologie et de ses filiales,7505439,,OM,"['*Biometry', 'Dengue/*epidemiology/*statistics & numerical data', '*Fever', 'Humans', 'Meningitis/*etiology']",,1945/12/01 00:00,1945/12/01 00:01,['2010/10/29 06:00'],"['2010/10/29 06:00 [entrez]', '1945/12/01 00:00 [pubmed]', '1945/12/01 00:01 [medline]']",,ppublish,C R Seances Soc Biol Fil. 1945 Dec;139:1142-4.,,,['NLM'],"['*DENGUE/epidemiology and statistics', '*FEVER/obscure', '*MENINGITIS/etiology and pathogenesis']",,,,,,"Recherches sur l'etiologie d'une fievre epidemique de courte duree avec reaction meningee, observee recemment en France.",,['CLML: 4611:332p'],,,,,,,,,,,
2665014,NLM,MEDLINE,19890816,20190828,0162-0886 (Print) 0162-0886 (Linking),11 Suppl 4,1989 May-Jun,Hemostatic defects in dengue hemorrhagic fever.,S826-9,,"Dengue hemorrhagic fever is characterized by a sudden onset of fever that lasts for 2-7 days and then subsides, at which time hemorrhagic manifestations become evident. Sometimes there is an associated form of hypovolemic shock known as dengue shock syndrome. There are usually significant changes in the liver, the reticuloendothelial system, and the vascular system (e.g., necrosis of liver cells and focal hemorrhage, increase in turnover of lymphocytes, and diapedesis of erythrocytes through vessel walls). Because of the lack of pathologic findings in major organs and the rapid recovery (without sequelae) of survivors, physiologic dysfunction is thought to be secondary to the action of biologic mediators that are capable of producing severe illness with minimal structural injury.","['Bhamarapravati, N']",['Bhamarapravati N'],,"['Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.']",['eng'],"['Journal Article', 'Review']",,United States,Rev Infect Dis,Reviews of infectious diseases,7905878,,IM,"['Animals', 'Blood Coagulation Disorders/etiology', 'Dengue/*blood/complications/pathology', 'Hemorrhage/*etiology', '*Hemostasis', 'Humans', 'Shock/*etiology', 'Thrombocytopenia/etiology']",,1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']",['10.1093/clinids/11.supplement_4.s826 [doi]'],ppublish,Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S826-9. doi: 10.1093/clinids/11.supplement_4.s826.,,,,,,,,21,,,,,,,,,,,,,,,
34107185,NLM,MEDLINE,20210614,20210614,1533-4406 (Electronic) 0028-4793 (Linking),384,2021 Jun 10,Dengue - Perils and Prevention.,2252-2253,10.1056/NEJMe2107325 [doi],,"['Hamer, Davidson H']",['Hamer DH'],['ORCID: 0000-0002-4700-1495'],"['From the Department of Global Health, School of Public Health, and the Section of Infectious Diseases, Department of Medicine, School of Medicine National Emerging Infectious Diseases Laboratory, Boston University, Boston.']",['eng'],"['Comment', 'Editorial']",,United States,N Engl J Med,The New England journal of medicine,0255562,,IM,"['*Dengue/epidemiology/prevention & control', 'Florida', 'Health Knowledge, Attitudes, Practice', 'Humans']",,2021/06/10 06:00,2021/06/16 06:00,['2021/06/09 17:39'],"['2021/06/09 17:39 [entrez]', '2021/06/10 06:00 [pubmed]', '2021/06/16 06:00 [medline]']",['10.1056/NEJMe2107325 [doi]'],ppublish,N Engl J Med. 2021 Jun 10;384(23):2252-2253. doi: 10.1056/NEJMe2107325.,23,,,,,,,,['N Engl J Med. 2021 Jun 10;384(23):2257-2259. PMID: 34107186'],,,,,,,,,,,,,,
19392949,NLM,MEDLINE,20090722,20211020,1365-3148 (Electronic) 0958-7578 (Print) 0958-7578 (Linking),19,2009 Apr,Is dengue a threat to the blood supply?,66-77,10.1111/j.1365-3148.2009.00916.x [doi],"Dengue is the most common arthropod-borne infection worldwide, affecting at least 50 million people every year and endemic in more than 100 countries. The dengue virus is a single-stranded RNA virus with four major serotypes. Infection with one serotype confers homotypic immunity but not heterologous immunity, and secondary infection with another serotype may lead to more severe disease. The major route of transmission occurs through the Aedes aegypti mosquito vector, but dengue has also been transmitted through blood transfusion and organ transplantation. Infection results in a spectrum of clinical illness ranging from asymptomatic infection, undifferentiated fever, dengue fever, dengue haemorrhagic fever (DHF) to dengue shock syndrome (DSS). Dengue is spreading rapidly to new areas and with increasing frequency of major outbreaks. A trend has also been observed towards increasing age among infected patients. This will impact blood supply availability as more blood donors are deferred because of dengue infection or exposure to infection. The risk of transmission through transfusion of blood from asymptomatic viraemic donors will also increase. Although screening tests for dengue and effective pathogen reduction processes are now available for the blood supply, the value of implementing these costly measures needs to be carefully considered. Demand for platelets and fresh frozen plasma will rise with increasing number of DHF/DSS. Evidence-based guidelines for the clinical use of these blood components in the management of patients with DHF/DSS have not been well established, and inappropriate use will contribute to the challenges faced by blood services.","['Teo, D', 'Ng, L C', 'Lam, S']","['Teo D', 'Ng LC', 'Lam S']",,"['Blood Services Group, Health Sciences Authority, Singapore, Singapore. Diana_Teo@HSA.gov.sg']",['eng'],"['Journal Article', 'Review']",,England,Transfus Med,"Transfusion medicine (Oxford, England)",9301182,,IM,"['Blood Donors/*supply & distribution', 'Dengue/epidemiology/*transmission', 'Disease Outbreaks', 'Humans', 'Transfusion Reaction']",PMC2713854,2009/04/28 09:00,2009/07/23 09:00,['2009/04/28 09:00'],"['2009/04/28 09:00 [entrez]', '2009/04/28 09:00 [pubmed]', '2009/07/23 09:00 [medline]']","['TME916 [pii]', '10.1111/j.1365-3148.2009.00916.x [doi]']",ppublish,Transfus Med. 2009 Apr;19(2):66-77. doi: 10.1111/j.1365-3148.2009.00916.x.,2,,,,,,,,,,,,,,,,,,,,,,
18524685,NLM,MEDLINE,20081218,20081017,1532-0480 (Electronic) 1532-0464 (Linking),41,2008 Oct,Ontology-centric integration and navigation of the dengue literature.,806-15,10.1016/j.jbi.2008.04.004 [doi],"Uninhibited access to the unstructured information distributed across the web and in scientific literature databases continues to be beyond the reach of scientists and health professionals. To address this challenge we have developed a literature driven, ontology-centric navigation infrastructure consisting of a content acquisition engine, a domain-specific ontology (in OWL-DL) and an ontology instantiation pipeline delivering sentences derived by domain-specific text mining. A visual query tool for reasoning over A-box instances in the populated ontology is presented and used to build conceptual queries that can be issued to the knowledgebase. We have deployed this generic infrastructure to facilitate data integration and knowledge sharing in the domain of dengue, which is one of the most prevalent viral diseases that continue to infect millions of people in the tropical and subtropical regions annually. Using our unique methodology we illustrate simplified search and discovery on dengue information derived from distributed resources and aggregated according to dengue ontology. Furthermore we apply data mining to the instantiated ontology to elucidate trends in the mentions of dengue serotypes in scientific abstracts since 1974.","['Rajapakse, Menaka', 'Kanagasabai, Rajaraman', 'Ang, Wee Tiong', 'Veeramani, Anitha', 'Schreiber, Mark J', 'Baker, Christopher J O']","['Rajapakse M', 'Kanagasabai R', 'Ang WT', 'Veeramani A', 'Schreiber MJ', 'Baker CJ']",,"['Institute for Infocomm Research (I(2)R), Data Mining Department, 21, Heng Mui Keng Terrace, Singapore 119613, Singapore.']",['eng'],['Journal Article'],20080505,United States,J Biomed Inform,Journal of biomedical informatics,100970413,,IM,"['*Artificial Intelligence', '*Database Management Systems', '*Dengue/epidemiology/immunology/physiopathology', 'Humans', 'Information Storage and Retrieval/methods', 'Internet', 'Publications', 'Terminology as Topic', '*User-Computer Interface', 'Vocabulary, Controlled']",,2008/06/06 09:00,2008/12/19 09:00,['2008/06/06 09:00'],"['2007/10/09 00:00 [received]', '2008/03/30 00:00 [revised]', '2008/04/05 00:00 [accepted]', '2008/06/06 09:00 [pubmed]', '2008/12/19 09:00 [medline]', '2008/06/06 09:00 [entrez]']","['S1532-0464(08)00054-3 [pii]', '10.1016/j.jbi.2008.04.004 [doi]']",ppublish,J Biomed Inform. 2008 Oct;41(5):806-15. doi: 10.1016/j.jbi.2008.04.004. Epub 2008 May 5.,5,,,,,,,,,,,,,,,,,,,,,,
6976230,NLM,MEDLINE,19820313,20181113,0042-9686 (Print) 0042-9686 (Linking),59,1981,Viraemia in patients with naturally acquired dengue infection.,623-30,,"The magnitude and duration of dengue viraemia were studied in 153 patients with naturally acquired dengue infection in Jakarta, Indonesia. The duration of viraemia ranged from 2 to 12 days, but most patients had detectable circulating virus for 4-5 days. Accurate measurement of peak virus titres was not possible for many patients because of late admission to the hospital. Composite pictures of viraemia for each serotype, however, showed that many patients infected with dengue 1, 2, or 3 had circulating virus titres ranging from barely detectable to over 10(8) MID(50) per ml for 3-5 days. Virus titres in patients infected with dengue 4 were about 100-fold lower. Dengue haemagglutination-inhibition antibody titres of 80 or less had little effect on viraemia, but antibody titres of 160 or greater were associated with a decrease in virus isolation rate and in virus titre. The duration and magnitude of viraemia did not vary significantly with the severity of the disease and was only slightly higher in patients classified as primary dengue infections than in those classified as secondary infections. Measurement of viraemia in fatal dengue haemorrhagic fever (DHF) cases showed that these patients had significant quantities of circulating virus at the time of death.","['Gubler, D J', 'Suharyono, W', 'Tan, R', 'Abidin, M', 'Sie, A']","['Gubler DJ', 'Suharyono W', 'Tan R', 'Abidin M', 'Sie A']",,,['eng'],['Journal Article'],,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,,IM,"['Dengue/*diagnosis/epidemiology', 'Hemagglutination Inhibition Tests', 'Humans', 'Indonesia', 'Viremia/*diagnosis']",PMC2396101,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Bull World Health Organ. 1981;59(4):623-30.,4,,,,,,,,,,,,,,,,,,,,,,
31378686,NLM,MEDLINE,20200521,20200521,2352-4650 (Electronic) 2352-4642 (Linking),3,2019 Oct,Dengue infection and advances in dengue vaccines for children.,734-741,S2352-4642(19)30205-6 [pii] 10.1016/S2352-4642(19)30205-6 [doi],"Dengue viruses are endemic in most tropical and subtropical countries where they produce disease ranging from a mild fever to a severe, potentially fatal vascular permeability syndrome. We reviewed the status of development and testing in children of three vaccines designed to protect against the four dengue viruses. The first dengue virus vaccine, Dengvaxia, now licensed in 20 endemic countries, the EU and the USA, provides protection against severe dengue in seropositive individuals but increases the risk for naive recipients to develop severe dengue and to be hospitalised. We discuss mechanisms and implications of shortcomings of the licensed vaccine and describe the structure and attributes of two other dengue virus vaccines. Based upon human dengue challenge studies, one of these vaccines promises to deliver solid, long-lasting immunity after a single dose. Because dengue virus infections are ubiquitous in residents and visitors to tropical countries, in the absence of a protective vaccine paediatricians should recognise the early signs and clinical presentation of severe dengue, understand its pathophysiology and appropriate management.","['Halstead, Scott B', 'Dans, Leonila F']","['Halstead SB', 'Dans LF']",,"['Uniformed Services University of the Health Sciences, Bethesda, MD, USA. Electronic address: halsteads@erols.com.', 'Departments of Pediatrics and Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.']",['eng'],"['Journal Article', 'Review']",20190801,England,Lancet Child Adolesc Health,The Lancet. Child & adolescent health,101712925,['0 (Dengue Vaccines)'],IM,"['Child', 'Dengue/diagnosis/epidemiology/*prevention & control', 'Dengue Vaccines/*immunology', 'Dengue Virus/immunology', 'Global Health', 'Humans', 'Incidence']",,2019/08/06 06:00,2020/05/22 06:00,['2019/08/06 06:00'],"['2019/03/11 00:00 [received]', '2019/05/23 00:00 [revised]', '2019/06/10 00:00 [accepted]', '2019/08/06 06:00 [pubmed]', '2020/05/22 06:00 [medline]', '2019/08/06 06:00 [entrez]']","['S2352-4642(19)30205-6 [pii]', '10.1016/S2352-4642(19)30205-6 [doi]']",ppublish,Lancet Child Adolesc Health. 2019 Oct;3(10):734-741. doi: 10.1016/S2352-4642(19)30205-6. Epub 2019 Aug 1.,10,['Copyright (c) 2019 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
24595236,NLM,MEDLINE,20150105,20211021,1932-6203 (Electronic) 1932-6203 (Linking),9,2014,"Demographic and clinico-epidemiological features of dengue fever in Faisalabad, Pakistan.",e89868,10.1371/journal.pone.0089868 [doi] e89868,"This cross-sectional study was carried out to explore the epidemiological and clinical features of dengue fever in Faisalabad, Pakistan during 2011 and 2012. During the study period, anti-dengue IgM positive cases were reported in the post-monsoon period during the months of August-December. Certain hotspots for the dengue infection were identified in the city that coincide with the clusters of densely populated urban regions of the city. Out of total 299 IgM positive patients (male 218 and female 81); there were 239 dengue fever (DF) and 60 dengue hemorrhagic fever (DHF) patients. There was decrease in the median age of dengue patients from 31 years in 2011 to 21.5 years in 2012 (p<0.001). Abdominal pain was seen in 35% DHF patients followed by nausea in 28.3%, epistaxis in 25% and rash in 20% patients (p<0.05). Patients reported to be suffering from high-grade fever for an average of 8.83 days in DHF as compared to 5.82 days in DF before being hospitalized. Co-morbidities were found to be risk factor for the development of DHF in dengue patients. Clinical and laboratory features of dengue cases studied could be used for the early identification of patients at risk of severe dengue fever.","['Raza, Faiz Ahmed', 'Rehman, Shafiq ur', 'Khalid, Ruqyya', 'Ahmad, Jameel', 'Ashraf, Sajjad', 'Iqbal, Mazhar', 'Hasnain, Shahida']","['Raza FA', 'Rehman Su', 'Khalid R', 'Ahmad J', 'Ashraf S', 'Iqbal M', 'Hasnain S']",,"['Pakistan Medical Research Council, Research Centre, Punjab Medical College, Faisalabad, Pakistan; Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.', 'Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.', 'School of Biological Sciences, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.', 'Department of Pathology, Allied Hospital, Faisalabad, Pakistan.', 'Nano Bio Energy Engineering School of Integrative Engineering, Chung-Ang University, Seoul, Korea.', 'Pakistan Medical Research Council, Research Centre, Punjab Medical College, Faisalabad, Pakistan.', 'Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20140303,United States,PLoS One,PloS one,101285081,,IM,"['Adult', 'Case Management', 'Cluster Analysis', 'Cross-Sectional Studies', 'Demography', 'Dengue/*epidemiology/pathology/therapy', 'Female', 'Humans', 'Male', 'Pakistan/epidemiology', 'Treatment Outcome', 'Urban Population']",PMC3940608,2014/03/07 06:00,2015/01/06 06:00,['2014/03/06 06:00'],"['2013/09/20 00:00 [received]', '2014/01/24 00:00 [accepted]', '2014/03/06 06:00 [entrez]', '2014/03/07 06:00 [pubmed]', '2015/01/06 06:00 [medline]']","['PONE-D-13-38809 [pii]', '10.1371/journal.pone.0089868 [doi]']",epublish,PLoS One. 2014 Mar 3;9(3):e89868. doi: 10.1371/journal.pone.0089868. eCollection 2014.,3,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,"['PLoS One. 2014;9(10):e112196', 'PLoS One. 2014;9(11):e113174']",,,,,,
17359563,NLM,MEDLINE,20080229,20181113,0950-2688 (Print) 1469-4409 (Electronic) 0950-2688 (Linking),136,2008 Jan,"Environmental factors and incidence of dengue fever and dengue haemorrhagic fever in an urban area, Southern Thailand.",135-43,,"Using the enumeration district (ED) block level this study looked at the incidence of dengue fever and dengue haemorrhagic fever (DF/DHF) within the Songkhla municipality in Thailand. Each of the 146 blocks in this area were considered as study units and surveyed for their environmental characteristics. A total of 287 cases of DH/DHF occurring in the year 1998 were selected for this study and the location of their homes mapped. Clustering analysis showed point clustering of the homes (P<0.0001) which was probably due to high density habitation, without any actual prevalence of case clustering. There was no evidence of clustering of the ED blocks with an incidence of DF/DHF (P=0.32). DF/DHF incidence for each block was strongly associated with the percentages of shop-houses, brick-made houses and houses with poor garbage disposal (all P<0.01). DF/DHF control should be emphasized for the areas which have a predominance of these housing types.","['Thammapalo, S', 'Chongsuvivatwong, V', 'Geater, A', 'Dueravee, M']","['Thammapalo S', 'Chongsuvivatwong V', 'Geater A', 'Dueravee M']",,"['Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. sthammapalo@yahoo.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20070315,England,Epidemiol Infect,Epidemiology and infection,8703737,,IM,"['Demography', 'Dengue/*epidemiology/etiology/pathology', 'Housing', 'Humans', 'Incidence', 'Population Surveillance', 'Risk Factors', 'Severe Dengue/epidemiology/etiology/pathology', 'Severity of Illness Index', 'Thailand/epidemiology', 'Urban Population']",PMC2870760,2007/03/16 09:00,2008/03/01 09:00,['2007/03/16 09:00'],"['2007/03/16 09:00 [pubmed]', '2008/03/01 09:00 [medline]', '2007/03/16 09:00 [entrez]']","['S0950268807008126 [pii]', '00812 [pii]', '10.1017/S0950268807008126 [doi]']",ppublish,Epidemiol Infect. 2008 Jan;136(1):135-43. doi: 10.1017/S0950268807008126. Epub 2007 Mar 15.,1,,,,,,,,,,,,,,,,,,,,,,
15109477,NLM,MEDLINE,20040625,20190513,1195-1982 (Print) 1195-1982 (Linking),11,2004 Mar-Apr,Dengue fever and long thoracic nerve palsy in a traveler returning from Thailand.,112-4,,,"['Chappuis, Francois', 'Justafre, Jean-Claude', 'Duchunstang, Lobsang', 'Loutan, Louis', 'Taylor, Walter R J']","['Chappuis F', 'Justafre JC', 'Duchunstang L', 'Loutan L', 'Taylor WR']",,"['Travel and Migration Medicine Unit, Department of Community Medicine, Geneva University Hospital, Switzerland.']",['eng'],"['Case Reports', 'Journal Article']",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Dengue/complications/*diagnosis/pathology', 'Diagnosis, Differential', 'Humans', 'Male', 'Paralysis/complications/*diagnosis/pathology', 'Switzerland', 'Thailand', '*Thoracic Nerves', '*Travel']",,2004/04/28 05:00,2004/06/26 05:00,['2004/04/28 05:00'],"['2004/04/28 05:00 [pubmed]', '2004/06/26 05:00 [medline]', '2004/04/28 05:00 [entrez]']",['10.2310/7060.2004.16983 [doi]'],ppublish,J Travel Med. 2004 Mar-Apr;11(2):112-4. doi: 10.2310/7060.2004.16983.,2,,,,,,,,,,,,,,,,,,,,,,
7310249,NLM,MEDLINE,19820225,20131121,0125-2208 (Print) 0125-2208 (Linking),64,1981 Oct,Pulse therapy in severe form of dengue shock syndrome.,485-91,,,"['Futrakul, P', 'Vasanauthana, S', 'Poshyachinda, M', 'Mitrakul, C', 'Cherdboonchart, V', 'Kanthirat, V']","['Futrakul P', 'Vasanauthana S', 'Poshyachinda M', 'Mitrakul C', 'Cherdboonchart V', 'Kanthirat V']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,['X4W7ZR7023 (Methylprednisolone)'],IM,"['Adolescent', 'Blood Transfusion', 'Child', 'Child, Preschool', 'Dengue/*drug therapy/physiopathology/therapy', 'Female', 'Fluid Therapy', 'Hemodynamics/drug effects', 'Humans', 'Infant', 'Male', 'Methylprednisolone/pharmacology/*therapeutic use']",,1981/10/01 00:00,1981/10/01 00:01,['1981/10/01 00:00'],"['1981/10/01 00:00 [pubmed]', '1981/10/01 00:01 [medline]', '1981/10/01 00:00 [entrez]']",,ppublish,J Med Assoc Thai. 1981 Oct;64(10):485-91.,10,,,,,,,,,,,,,,,,,,,,,,
30550569,NLM,MEDLINE,20190204,20200309,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),12,2018 Dec,Economic impact of dengue in Mexico considering reported cases for 2012 to 2016.,e0006938,10.1371/journal.pntd.0006938 [doi] e0006938,"BACKGROUND: Given that dengue disease is growing and may progress to dengue hemorrhagic fever (DHF), data on economic cost and disease burden are important. However, data for Mexico are limited. METHODOLOGY/PRINCIPAL FINDINGS: Burden of dengue fever (DF) and DHF in Mexico was assessed using official databases for epidemiological information, disabilities weights from Shepard et al, the reported number of cases and deaths, and costs. Overall costs of dengue were summed from direct medical costs to the health system, cost of dengue to the patient (out-of-pocket expenses [medical and non-medical], indirect costs [loss of earnings, patient and/or caregiver]), and other government expenditures on prevention/surveillance. The first three components, calculated as costs per case by a micro-costing approach (PAATI; program, actions, activities, tasks, inputs), were scaled up to overall cost using epidemiology data from official databases. PAATI was used to calculate cost of vector control and prevention, education, and epidemiological surveillance, based on an expert consensus and normative construction of an ideal scenario. Disability-adjusted life years (DALYs) for Mexico in 2016 were calculated to be 2283.46 (1.87 per 100,000 inhabitants). Overall economic impact of dengue in Mexico for 2012 was US$144 million, of which US$44 million corresponded to direct medical costs and US$5 million to the costs from the patient's perspective. The estimated cost of prevention/surveillance was calculated with information provided by federal government to be US$95 million. The overall economic impact of DF and DHF showed an increase in 2013 to US$161 million and a decrease to US$133, US$131 and US$130 million in 2014, 2015 and 2016, respectively. CONCLUSIONS/SIGNIFICANCE: The medical and economic impact of dengue were in agreement with other international studies, and highlight the need to include governmental expenditure for prevention/surveillance in overall cost analyses given the high economic impact of these, increasing the necessity to evaluate its effectiveness.","['Zubieta-Zavala, Adriana', 'Lopez-Cervantes, Malaquias', 'Salinas-Escudero, Guillermo', 'Ramirez-Chavez, Adrian', 'Castaneda, Jose Ramos', 'Hernandez-Gaytan, Sendy Isarel', 'Lopez Yescas, Juan Guillermo', 'Duran-Arenas, Luis']","['Zubieta-Zavala A', 'Lopez-Cervantes M', 'Salinas-Escudero G', 'Ramirez-Chavez A', 'Castaneda JR', 'Hernandez-Gaytan SI', 'Lopez Yescas JG', 'Duran-Arenas L']",,"['Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.', 'Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.', ""Center for Economic Studies and Social Health, Children's Hospital of Mexico Federico Gomez, Ministry of Health, Mexico City, Mexico."", 'Private Practice, Mexico City, Mexico.', 'Departamento de Arbovirus, National Institute of Public Health, Cuernavaca, Mexico.', 'Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.', 'Medical Affairs, Sanofi Pasteur Latin America, Mexico City, Mexico.', 'Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20181214,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adolescent', 'Adult', 'Aged', 'Caregivers', 'Child', 'Child, Preschool', 'Dengue/*economics/epidemiology/prevention & control', 'Disabled Persons', 'Government Programs', 'Health Care Costs', 'Health Expenditures', 'Humans', 'Infant', 'Mexico/epidemiology', 'Middle Aged', 'Quality-Adjusted Life Years', 'Severe Dengue/*economics/epidemiology/prevention & control', 'Young Adult']",PMC6310288,2018/12/15 06:00,2019/02/05 06:00,['2018/12/15 06:00'],"['2017/09/01 00:00 [received]', '2018/10/22 00:00 [accepted]', '2018/12/28 00:00 [revised]', '2018/12/15 06:00 [pubmed]', '2019/02/05 06:00 [medline]', '2018/12/15 06:00 [entrez]']","['PNTD-D-17-01373 [pii]', '10.1371/journal.pntd.0006938 [doi]']",epublish,PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0006938. doi: 10.1371/journal.pntd.0006938. eCollection 2018 Dec.,12,,,,"[""I have read the journal's policy and the authors of this manuscript have the"", 'following competing interests: JRC is member of the Scientific Advisory Board on', 'Dengue Vaccine from Sanofi Pasteur and has received honoraria for their', 'participation. JRC has also received funding for scientific research from Sanofi', 'Pasteur. JGLY is an employee of Sanofi Pasteur. This does not alter our adherence', 'to all PLOS policies on sharing data and materials.']",,,,,,,,,,,,,,,,,,
18949127,NLM,MEDLINE,20090824,20200413,1678-4782 (Electronic) 0021-7557 (Linking),84,2008 Nov-Dec,Case report: vertical dengue infection.,556-9,10.2223/JPED.1826 [doi],"OBJECTIVES: To report a case of vertical dengue infection in a newborn from Rio de Janeiro, Brazil, and to review the literature concerning this problem. DESCRIPTION: We report a case of vertical dengue infection. Female neonate, birth weight 3,940 g, term, was admitted to a neonatal intensive care unit on the fifth day of life with fever and erythematous rash. Her mother had had dengue fever 3 days before delivery. Her platelet count was 38,000, dropping to 15,000. She did not have any hemorrhagic episodes, including cerebral hemorrhages. Anti-dengue antibodies (IgM) were positive in the mother and infant. Dengue type 2 was detected in the infant using polymerase chain reaction. COMMENTS: This report emphasizes that pediatricians should be aware of the possibility of vertical dengue infection so that early management can be instituted.","['Maroun, Samara L C', 'Marliere, Roberta C C', 'Barcellus, Rovena C', 'Barbosa, Claudia N', 'Ramos, Jose R M', 'Moreira, Maria E L']","['Maroun SL', 'Marliere RC', 'Barcellus RC', 'Barbosa CN', 'Ramos JR', 'Moreira ME']",,"['Instituto Fernandes Figueira, Fundacao Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil.']","['eng', 'por']","['Case Reports', 'Journal Article', 'Review']",20081023,Brazil,J Pediatr (Rio J),Jornal de pediatria,2985188R,,IM,"['Dengue/diagnosis/*transmission', 'Female', 'Humans', 'Infant, Newborn', '*Infectious Disease Transmission, Vertical', 'Pregnancy', '*Pregnancy Complications, Infectious/diagnosis']",,2008/10/25 09:00,2009/08/25 09:00,['2008/10/25 09:00'],"['2008/10/25 09:00 [pubmed]', '2009/08/25 09:00 [medline]', '2008/10/25 09:00 [entrez]']",['10.2223/JPED.1826 [doi]'],ppublish,J Pediatr (Rio J). 2008 Nov-Dec;84(6):556-9. doi: 10.2223/JPED.1826. Epub 2008 Oct 23.,6,,,,,,,15,,,,,,,,,,,,,,,
3433163,NLM,MEDLINE,19880324,20081121,0125-1562 (Print) 0125-1562 (Linking),18,1987 Sep,Pathogenesis of dengue haemorrhagic fever: towards a more balanced view.,321-5,,,"['Pang, T']",['Pang T'],,"['Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*etiology/immunology/microbiology', 'Dengue Virus/genetics/immunology', 'Genetic Variation', 'Humans', 'Research']",,1987/09/01 00:00,1987/09/01 00:01,['1987/09/01 00:00'],"['1987/09/01 00:00 [pubmed]', '1987/09/01 00:01 [medline]', '1987/09/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1987 Sep;18(3):321-5.,3,,,,,,,,,,,,,,,,,,,,,,
34616083,NLM,MEDLINE,20211108,20230207,1476-4687 (Electronic) 0028-0836 (Linking),598,2021 Oct,A step towards therapeutics for dengue.,420-421,10.1038/d41586-021-02638-9 [doi],,"['Biering, Scott B', 'Harris, Eva']","['Biering SB', 'Harris E']",,,['eng'],"['Comment', 'News']",,England,Nature,Nature,0410462,,IM,"['*Dengue/drug therapy/epidemiology', '*Dengue Virus/genetics', 'Humans']",,2021/10/08 06:00,2021/11/09 06:00,['2021/10/07 06:50'],"['2021/10/08 06:00 [pubmed]', '2021/11/09 06:00 [medline]', '2021/10/07 06:50 [entrez]']","['10.1038/d41586-021-02638-9 [pii]', '10.1038/d41586-021-02638-9 [doi]']",ppublish,Nature. 2021 Oct;598(7881):420-421. doi: 10.1038/d41586-021-02638-9.,7881,,['NOTNLM'],"['Drug discovery', 'Infection', 'Virology']",,,,,['Nature. 2021 Oct;598(7881):504-509. PMID: 34616043'],,,,,,,,,,,,,,
27159023,NLM,MEDLINE,20170329,20190202,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),10,2016 May,The Role of Serotype Interactions and Seasonality in Dengue Model Selection and Control: Insights from a Pattern Matching Approach.,e0004680,10.1371/journal.pntd.0004680 [doi] e0004680,"The epidemiology of dengue fever is characterized by highly seasonal, multi-annual fluctuations, and the irregular circulation of its four serotypes. It is believed that this behaviour arises from the interplay between environmental drivers and serotype interactions. The exact mechanism, however, is uncertain. Constraining mathematical models to patterns characteristic to dengue epidemiology offers a means for detecting such mechanisms. Here, we used a pattern-oriented modelling (POM) strategy to fit and assess a range of dengue models, driven by combinations of temporary cross protective-immunity, cross-enhancement, and seasonal forcing, on their ability to capture the main characteristics of dengue dynamics. We show that all proposed models reproduce the observed dengue patterns across some part of the parameter space. Which model best supports the dengue dynamics is determined by the level of seasonal forcing. Further, when tertiary and quaternary infections are allowed, the inclusion of temporary cross-immunity alone is strongly supported, but the addition of cross-enhancement markedly reduces the parameter range at which dengue dynamics are produced, irrespective of the strength of seasonal forcing. The implication of these structural uncertainties on predicted vulnerability to control is also discussed. With ever expanding spread of dengue, greater understanding of dengue dynamics and control efforts (e.g. a near-future vaccine introduction) has become critically important. This study highlights the capacity of multi-level pattern-matching modelling approaches to offer an analytic tool for deeper insights into dengue epidemiology and control.","['Ten Bosch, Quirine A', 'Singh, Brajendra K', 'Hassan, Muhammad R A', 'Chadee, Dave D', 'Michael, Edwin']","['Ten Bosch QA', 'Singh BK', 'Hassan MR', 'Chadee DD', 'Michael E']",['ORCID: 0000-0001-5847-8750'],"['Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.', 'Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.', 'Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia.', 'Department of Life Sciences, University of the West Indies, Saint Augustine, Trinidad and Tobago.', 'Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20160509,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Computer Simulation', 'Dengue/*epidemiology/immunology/*prevention & control', 'Dengue Virus/*classification', 'Humans', '*Models, Biological', '*Pattern Recognition, Automated', '*Seasons', 'Serogroup', 'Trinidad and Tobago/epidemiology']",PMC4861330,2016/05/10 06:00,2017/03/31 06:00,['2016/05/10 06:00'],"['2015/07/03 00:00 [received]', '2016/04/11 00:00 [accepted]', '2016/05/10 06:00 [entrez]', '2016/05/10 06:00 [pubmed]', '2017/03/31 06:00 [medline]']","['PNTD-D-15-01168 [pii]', '10.1371/journal.pntd.0004680 [doi]']",epublish,PLoS Negl Trop Dis. 2016 May 9;10(5):e0004680. doi: 10.1371/journal.pntd.0004680. eCollection 2016 May.,5,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
32429727,NLM,MEDLINE,20210621,20210621,2164-554X (Electronic) 2164-5515 (Print) 2164-5515 (Linking),16,2020 Nov 1,Dengue vaccines: the road to failure or to success?,2677-2679,10.1080/21645515.2020.1733367 [doi],"A licensed vaccine against dengue was shown to enhance disease under some circumstances, even though it protected most vaccinees. We discuss the implication of these results for the future of dengue vaccines.","['Plotkin, Stanley A']",['Plotkin SA'],,"['Department of Pediatrics, University of Pennsylvania, Vaxconsult , Doylestown, PA, USA.', 'Vaxconsult , Doylestown, PA, USA.']",['eng'],['Journal Article'],20200519,United States,Hum Vaccin Immunother,Human vaccines & immunotherapeutics,101572652,"['0 (Antibodies, Viral)', '0 (Dengue Vaccines)', '0 (Vaccines, Attenuated)']",IM,"['Antibodies, Viral', '*Dengue/epidemiology/prevention & control', '*Dengue Vaccines', '*Dengue Virus', 'Humans', 'Vaccines, Attenuated']",PMC7733934,2020/05/21 06:00,2021/06/22 06:00,['2020/05/21 06:00'],"['2020/05/21 06:00 [pubmed]', '2021/06/22 06:00 [medline]', '2020/05/21 06:00 [entrez]']","['1733367 [pii]', '10.1080/21645515.2020.1733367 [doi]']",ppublish,Hum Vaccin Immunother. 2020 Nov 1;16(11):2677-2679. doi: 10.1080/21645515.2020.1733367. Epub 2020 May 19.,11,,['NOTNLM'],"['Dengue', 'correlate of protection', 'enhancement']",,,,,,,,,,,,,,,,,,,
37782021,NLM,MEDLINE,20231102,20231102,1533-4406 (Electronic) 0028-4793 (Linking),389,2023 Oct 5,Convalescent Rash of Dengue.,e28,10.1056/NEJMicm2305074 [doi],,"['Ong, Erika P', 'Ho, Frances V']","['Ong EP', 'Ho FV']",['ORCID: 0000-0002-2785-0182'],"['University of the Philippines College of Medicine, Manila, Philippines epoerika10@gmail.com.', 'University of the Philippines College of Medicine, Manila, Philippines epoerika10@gmail.com.']",['eng'],"['Case Reports', 'Journal Article']",20230930,United States,N Engl J Med,The New England journal of medicine,0255562,"['0 (Antibodies, Viral)']",IM,"['Humans', 'Antibodies, Viral', '*Dengue/complications/diagnosis', '*Exanthema/etiology', 'Convalescence']",,2023/10/02 12:42,2023/11/02 12:46,['2023/10/02 07:53'],"['2023/11/02 12:46 [medline]', '2023/10/02 12:42 [pubmed]', '2023/10/02 07:53 [entrez]']",['10.1056/NEJMicm2305074 [doi]'],ppublish,N Engl J Med. 2023 Oct 5;389(14):e28. doi: 10.1056/NEJMicm2305074. Epub 2023 Sep 30.,14,,,,,,,,,,,,,,,,,,,,,,
28380060,NLM,MEDLINE,20170905,20190208,1932-6203 (Electronic) 1932-6203 (Linking),12,2017,"Cost-effectiveness of dengue vaccination in Yucatan, Mexico using a dynamic dengue transmission model.",e0175020,10.1371/journal.pone.0175020 [doi] e0175020,"BACKGROUND: The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health systems with consequent morbidities and mortalities. On December 9th, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In anticipation of a vaccine rollout, analysis of the cost-effectiveness of the dengue vaccination program that quantifies the dynamics of disease transmission is essential. METHODS: We developed a dynamic transmission model of dengue in Yucatan, Mexico and its proposed vaccination program to incorporate herd immunity into our analysis of cost-effectiveness analysis. Our model also incorporates important characteristics of dengue epidemiology, such as clinical cross-immunity and susceptibility enhancement upon secondary infection. Using our model, we evaluated the cost-effectiveness and economic impact of an imperfect dengue vaccine in Yucatan, Mexico. CONCLUSIONS: Our study indicates that a dengue vaccination program would prevent 90% of cases of symptomatic DF incidence as well as 90% of dengue hemorrhagic fever (DHF) incidence and dengue-related deaths annually. We conclude that a dengue vaccine program in Yucatan, Mexico would be very cost-effective as long as the vaccination cost per individual is less than $140 and $214 from health care and societal perspectives, respectively. Furthermore, at an exemplary vaccination cost of $250 USD per individual on average, dengue vaccination is likely to be cost-effective 43% and 88% of the time from health care and societal perspectives, respectively.","['Shim, Eunha']",['Shim E'],,"['Department of Mathematics, Soongsil University, Seoul, Republic of Korea.']",['eng'],['Journal Article'],20170405,United States,PLoS One,PloS one,101285081,['0 (Dengue Vaccines)'],IM,"['Adolescent', 'Adult', 'Child', 'Cost-Benefit Analysis', 'Dengue/economics/epidemiology/*prevention & control/transmission', 'Dengue Vaccines/economics/*therapeutic use', 'Drug Costs/statistics & numerical data', 'Health Care Costs/statistics & numerical data', 'Humans', 'Mexico/epidemiology', 'Middle Aged', 'Models, Statistical', 'Young Adult']",PMC5381893,2017/04/06 06:00,2017/09/07 06:00,['2017/04/06 06:00'],"['2016/02/17 00:00 [received]', '2017/03/20 00:00 [accepted]', '2017/04/06 06:00 [entrez]', '2017/04/06 06:00 [pubmed]', '2017/09/07 06:00 [medline]']","['PONE-D-16-06852 [pii]', '10.1371/journal.pone.0175020 [doi]']",epublish,PLoS One. 2017 Apr 5;12(4):e0175020. doi: 10.1371/journal.pone.0175020. eCollection 2017.,4,,,,['Competing Interests: The author has declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
22461739,NLM,MEDLINE,20120810,20220121,1551-4056 (Electronic) 0044-0086 (Print) 0044-0086 (Linking),85,2012 Mar,Role of microparticles in dengue virus infection and its impact on medical intervention strategies.,3-18,,"Dengue virus (DV) is one of the most important vector-borne diseases in the world. It causes a disease that manifests as a spectrum of clinical symptoms, including dengue hemorrhagic fever. DV is proficient at diverting the immune system to facilitate transmission through its vector host, Aedes spp. mosquito. Similar to other vector-borne parasites, dengue may also require a second structural form, a virus of alternative morphology (VAM), to complete its life cycle. DV can replicate to high copy numbers in patient plasma, but no classical viral particles can be detected by ultra-structural microscopy analysis. A VAM appearing as a microparticle has been recapitulated with in vitro cell lines Meg01 and K562, close relatives to the cells harboring dengue virus in vivo. VAMs are likely to contribute to the high viremia levels observed in dengue patients. This review discusses the possible existence of a VAM in the DV life cycle.","['Bargeron Clark, Kristina', 'Hsiao, Hui-Mien', 'Noisakran, Sansanee', 'Tsai, Jih-Jin', 'Perng, Guey Chuen']","['Bargeron Clark K', 'Hsiao HM', 'Noisakran S', 'Tsai JJ', 'Perng GC']",,"['Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20120329,United States,Yale J Biol Med,The Yale journal of biology and medicine,0417414,['0 (Dengue Vaccines)'],IM,"['Animals', 'Cell-Derived Microparticles/*metabolism', 'Dengue/immunology/*therapy/transmission/*virology', 'Dengue Vaccines/immunology', 'Dengue Virus/*physiology/ultrastructure', 'Disease Vectors', 'Drug Design', 'Humans']",PMC3313537,2012/03/31 06:00,2012/08/11 06:00,['2012/03/31 06:00'],"['2012/03/31 06:00 [entrez]', '2012/03/31 06:00 [pubmed]', '2012/08/11 06:00 [medline]']",['yjbm8513 [pii]'],ppublish,Yale J Biol Med. 2012 Mar;85(1):3-18. Epub 2012 Mar 29.,1,,['NOTNLM'],"['Aedes mosquitoes', 'Dengue virus', 'alternative virion', 'microparticles', 'vaccine', 'vector-borne transmission']",,,,,,,,,,,,,,,,,,,
17693155,NLM,MEDLINE,20070821,20150616,1474-547X (Electronic) 0140-6736 (Linking),370,2007 Aug 11,Looking for a volunteer to help fight dengue fever.,458,,,,,,,['eng'],['Editorial'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Asia, Southeastern/epidemiology', 'Dengue/epidemiology/mortality/*prevention & control', 'Disease Outbreaks/*prevention & control', 'Humans', '*Public Health', 'Seasons', 'Volunteers/*organization & administration']",,2007/08/19 09:00,2007/08/22 09:00,['2007/08/19 09:00'],"['2007/08/19 09:00 [pubmed]', '2007/08/22 09:00 [medline]', '2007/08/19 09:00 [entrez]']","['S0140-6736(07)61206-9 [pii]', '10.1016/S0140-6736(07)61206-9 [doi]']",ppublish,Lancet. 2007 Aug 11;370(9586):458. doi: 10.1016/S0140-6736(07)61206-9.,9586,,,,,,,,,,,,,,,,,,,,,,
27313125,NLM,MEDLINE,20170421,20220318,1873-0442 (Electronic) 1477-8939 (Linking),14,2016 Jul-Aug,Estimation of dengue infection for travelers in Thailand.,398-406,S1477-8939(16)30060-6 [pii] 10.1016/j.tmaid.2016.06.002 [doi],"BACKGROUND: Dengue infection among travelers has become one of the most public health concerns in present days. The importation of dengue virus can initiate an outbreak in non-endemic regions. Thailand is one of the countries topping the list of highest dengue infections in travelers. METHOD: This study estimates the risk of dengue infection among travelers during their visit in Thailand by using a mathematical model with seasonal variations. RESULTS: The risk of dengue infection in high dengue season is 2.50-4.07 times that on low dengue season depending on the locations. The average daily risk of dengue infections of Thailand per 100,000 travelers is 2.14 and 7.03 for low and high dengue season, respectively. The highest rate of infection is Rayong and the lowest rate is Sing Buri. Several popular tourist provinces are high dengue endemic areas. CONCLUSIONS: This study provides useful information on dengue infection among travelers. The main factors are the time of arrival in the year, the duration of stay of the travelers and the locations where the travelers spend most of their time.","['Polwiang, Sittisede']",['Polwiang S'],,"['Department of Mathematics, Faculty of Science, Silpakorn University, Thailand; The Center of Excellence in Mathematics, CHE, Bangkok 10400, Thailand. Electronic address: polwiang_s@su.ac.th.']",['eng'],['Journal Article'],20160614,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,,IM,"['Dengue/*epidemiology/prevention & control/*transmission/virology', 'Dengue Virus/isolation & purification', 'Disease Outbreaks', 'Endemic Diseases', 'Humans', 'Models, Statistical', 'Public Health/*statistics & numerical data', 'Risk Assessment', 'Seasons', 'Thailand/epidemiology', '*Travel']",,2016/06/18 06:00,2017/04/22 06:00,['2016/06/18 06:00'],"['2016/03/23 00:00 [received]', '2016/06/01 00:00 [revised]', '2016/06/06 00:00 [accepted]', '2016/06/18 06:00 [entrez]', '2016/06/18 06:00 [pubmed]', '2017/04/22 06:00 [medline]']","['S1477-8939(16)30060-6 [pii]', '10.1016/j.tmaid.2016.06.002 [doi]']",ppublish,Travel Med Infect Dis. 2016 Jul-Aug;14(4):398-406. doi: 10.1016/j.tmaid.2016.06.002. Epub 2016 Jun 14.,4,['Copyright (c) 2016 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Dengue', 'Mathematical model', 'Risk of infection', 'Travelers']",,,,,,,,,,,,,,,,,,,
26593704,NLM,MEDLINE,20170117,20170117,1879-3134 (Electronic) 0025-5564 (Linking),271,2016 Jan,Modeling the spread and control of dengue with limited public health resources.,136-45,S0025-5564(15)00236-9 [pii] 10.1016/j.mbs.2015.11.004 [doi],"A deterministic model for the transmission dynamics of dengue fever is formulated to study, with a nonlinear recovery rate, the impact of available resources of the health system on the spread and control of the disease. Model results indicate the existence of multiple endemic equilibria, as well as coexistence of an endemic equilibrium with a periodic solution. Additionally, our model exhibits the phenomenon of backward bifurcation. The results of this study could be helpful for public health authorities in their planning of a proper resource allocation for the control of dengue transmission.","['Abdelrazec, Ahmed', 'Belair, Jacques', 'Shan, Chunhua', 'Zhu, Huaiping']","['Abdelrazec A', 'Belair J', 'Shan C', 'Zhu H']",,"['Department of Mathematics and Statistics, Arizona State University, USA.', 'Departement de mathematiques et de statistique, Universite de Montreal, Canada.', 'Department of Mathematical and Statistical Sciences, University of Alberta, Canada.', 'LAMPS and Department of Mathematics and Statistics, York University, Canada. Electronic address: huaiping@mathstat.yorku.ca.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20151122,United States,Math Biosci,Mathematical biosciences,0103146,,IM,"['Dengue/prevention & control/*transmission', '*Health Resources', 'Humans', '*Models, Theoretical', '*Public Health']",,2015/11/26 06:00,2017/01/18 06:00,['2015/11/24 06:00'],"['2015/03/25 00:00 [received]', '2015/09/07 00:00 [revised]', '2015/11/16 00:00 [accepted]', '2015/11/24 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2017/01/18 06:00 [medline]']","['S0025-5564(15)00236-9 [pii]', '10.1016/j.mbs.2015.11.004 [doi]']",ppublish,Math Biosci. 2016 Jan;271:136-45. doi: 10.1016/j.mbs.2015.11.004. Epub 2015 Nov 22.,,['Copyright (c) 2015 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Backward bifurcation', 'Dengue fever', 'Dynamics', 'Hopf bifurcation', 'Hospital bed', 'Nonlinear recovery rate']",,,['Canadian Institutes of Health Research/Canada'],,,,,,,,,,,,,,,,
23840070,NLM,MEDLINE,20150130,20220310,1474-7766 (Electronic) 1474-7758 (Linking),14,2014 Jun,Spontaneously resolving cerebellar syndrome as a sequelae of dengue viral infection: a case series from Sri Lanka.,176-8,10.1136/practneurol-2013-000571 [doi],Sri Lanka is hyperendemic for dengue viral infection. Dengue has a wide spectrum of neurological manifestations including previously reported Sri Lankan cases with a 6th nerve palsy and a cerebellar syndrome from a co-infection with dengue and Epstein-Barr virus. This series describes a spontaneously resolving cerebellar syndrome following a dengue viral infection. Dengue is potentially an important cause of cerebellar syndromes in countries hyperendemic for the disease; patients need further studies to identify the responsible serotypes.,"['Weeratunga, Praveen N', 'Caldera, H P Manjula C', 'Gooneratne, I Kishara', 'Gamage, Ranjanie', 'Perera, W Sujith P', 'Ranasinghe, Gayan V', 'Niraj, Mahboob']","['Weeratunga PN', 'Caldera HP', 'Gooneratne IK', 'Gamage R', 'Perera WS', 'Ranasinghe GV', 'Niraj M']",,"['Institute of Neurology, National Hospital of Sri Lanka, , Colombo, Sri Lanka.']",['eng'],"['Case Reports', 'Journal Article']",20130709,England,Pract Neurol,Practical neurology,101130961,,IM,"['Adult', 'Cerebellar Diseases/pathology/physiopathology/*virology', 'Dengue/*complications/pathology/physiopathology', 'Female', 'Humans', 'Male', 'Sri Lanka']",,2013/07/11 06:00,2015/01/31 06:00,['2013/07/11 06:00'],"['2013/07/11 06:00 [entrez]', '2013/07/11 06:00 [pubmed]', '2015/01/31 06:00 [medline]']","['practneurol-2013-000571 [pii]', '10.1136/practneurol-2013-000571 [doi]']",ppublish,Pract Neurol. 2014 Jun;14(3):176-8. doi: 10.1136/practneurol-2013-000571. Epub 2013 Jul 9.,3,,,,,,,,,,,,,,,,,,,,,,
23886895,NLM,MEDLINE,20140331,20211021,1096-3618 (Electronic) 1044-5323 (Linking),25,2013 Apr,"Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil.",104-13,S1044-5323(13)00026-2 [pii] 10.1016/j.smim.2013.04.010 [doi],"The incidence of dengue has been on the rise since at least the 1960s, bringing greater urgency to the need for a vaccine to prevent the disease. Recent advances suggest that the scientific world is moving closer to an effective dengue vaccine. However, there are concerns that the price of a future vaccine could limit its uptake. High prices, in addition to other challenges, have already weighed negatively in government decisions to include other new vaccines in national immunization programs, e.g., the pneumococcal, rotavirus, and human papillomavirus vaccines. Recent research on the value of vaccination, however, suggests that vaccination confers benefits that are often neglected by traditional economic evaluations. In the case of dengue, commonly overlooked benefits are likely to include reduced spending on outbreak control, averted losses in tourism flows, and avoided productivity losses due to long-term dengue sequelae. Accounting for these and other broader benefits of dengue vaccination could reveal significantly greater economic value and strengthen the case for inclusion of dengue vaccination in national immunization programs. In this article we discuss a framework for the broader value of vaccination and review its application in the context of dengue vaccination for Brazil.","['Barnighausen, Till', 'Bloom, David E', 'Cafiero, Elizabeth T', ""O'Brien, Jennifer C""]","['Barnighausen T', 'Bloom DE', 'Cafiero ET', ""O'Brien JC""]",,"['Harvard School of Public Health, Department of Global Health and Population, Boston, MA 02115, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130722,England,Semin Immunol,Seminars in immunology,9009458,['0 (Dengue Vaccines)'],IM,"['Animals', 'Brazil', 'Cost-Benefit Analysis', 'Dengue/epidemiology/*prevention & control', '*Dengue Vaccines', 'Humans', 'Quality Improvement']",,2013/07/28 06:00,2014/04/01 06:00,['2013/07/27 06:00'],"['2013/03/04 00:00 [received]', '2013/04/28 00:00 [accepted]', '2013/07/27 06:00 [entrez]', '2013/07/28 06:00 [pubmed]', '2014/04/01 06:00 [medline]']","['S1044-5323(13)00026-2 [pii]', '10.1016/j.smim.2013.04.010 [doi]']",ppublish,Semin Immunol. 2013 Apr;25(2):104-13. doi: 10.1016/j.smim.2013.04.010. Epub 2013 Jul 22.,2,['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Dengue', 'Economic evaluation', 'Immunization', 'Vaccination', 'Vaccine']",,,['097410/WT_/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
5501443,NLM,MEDLINE,19710413,20130418,0971-5916 (Print) 0971-5916 (Linking),58,1970 Oct,Detection of sporadic cases of dengue hemorrhagic fever.,1301-6,,,"['Myers, R M', 'Varkey, M J']","['Myers RM', 'Varkey MJ']",,,['eng'],['Journal Article'],,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Adult', 'Dengue/*diagnosis/microbiology', 'Dengue Virus/isolation & purification', 'Disease Outbreaks', 'Female', 'Humans', 'Male']",,1970/10/01 00:00,1970/10/01 00:01,['1970/10/01 00:00'],"['1970/10/01 00:00 [pubmed]', '1970/10/01 00:01 [medline]', '1970/10/01 00:00 [entrez]']",,ppublish,Indian J Med Res. 1970 Oct;58(10):1301-6.,10,,,,,,,,,,,,,,,,,,,,,,
35503505,NLM,MEDLINE,20220822,20220826,2410-8650 (Electronic) 1607-551X (Linking),38,2022 Aug,Dengue prevention and control strategies for overseas immigration in Kaohsiung City.,810-811,10.1002/kjm2.12553 [doi],,"['Lin, Chun-Yu', 'Lo, Shih-Hao', 'Pan, Chao-Ying', 'Chang, Ko']","['Lin CY', 'Lo SH', 'Pan CY', 'Chang K']",['ORCID: 0000-0002-6447-8703'],"['Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.', 'College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.', 'Department of Internal Medicine, Kaohsiung Municipal Min-Sheng Hospital, Kaohsiung, Taiwan.', 'Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.', 'Bureau of Public Health, Kaohsiung City Government, Kaohsiung, Taiwan.', 'College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.', 'Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.']",['eng'],['Letter'],20220503,China (Republic : 1949- ),Kaohsiung J Med Sci,The Kaohsiung journal of medical sciences,100960562,,IM,"['*Dengue/epidemiology/prevention & control', 'Disease Outbreaks', '*Emigration and Immigration', 'Humans', 'Taiwan']",,2022/05/04 06:00,2022/08/23 06:00,['2022/05/03 12:49'],"['2022/04/01 00:00 [revised]', '2021/12/31 00:00 [received]', '2022/04/06 00:00 [accepted]', '2022/05/04 06:00 [pubmed]', '2022/08/23 06:00 [medline]', '2022/05/03 12:49 [entrez]']",['10.1002/kjm2.12553 [doi]'],ppublish,Kaohsiung J Med Sci. 2022 Aug;38(8):810-811. doi: 10.1002/kjm2.12553. Epub 2022 May 3.,8,,,,,,,,,,,,,,,,,,,,,,
31725549,NLM,MEDLINE,20201119,20210201,1532-0987 (Electronic) 0891-3668 (Linking),39,2020 Mar,Daily Dengue Severity Score to Assess Severe Manifestations.,184-187,10.1097/INF.0000000000002533 [doi],"BACKGROUND: The study aimed to develop dengue severity score to assess severe manifestations among hospitalized patients with dengue infection. METHOD: Children and adolescents with serologically confirmed dengue infection admitted at Ramathibodi Hospital from 2004 to 2018 and treated by an expert multidisciplinary team were recruited. Medical records were retrospectively reviewed and 14 items, related to clinical parameters and managements during hospitalization, were obtained daily as dengue severity score. RESULTS: A total of 191 patients with a mean age of 10.7 years from 2004 to 2013 were recruited. They were classified as dengue fever (35), dengue hemorrhagic fever (DHF) I (53), II (50), III (37) and IV (16). The analysis of 593 daily records revealed the range of daily severity score among patients with DHF grades III (10-20) and IV (31-47) were significantly higher than those of other groups (dengue fever, 5-13; DHF I, 2-10; DHF II, 6-11) with P-values of 0.0001. Using a validity test, a total daily score of >/=12 was an assessment tool for dengue shock syndrome with sensitivity, 86% and specificity, 84%. An additional 51 hospitalized patients with DHF grades II, III and IV with similar ages from 2014 to 2018 were recruited. The number of patients with severe manifestations, having daily score of >/=12, was significantly higher than those without severe manifestations starting from Day -3 to Day +1 of illness. CONCLUSIONS: Daily dengue severity score of >/=12 was an accurate assessment tool for severe manifestations.","['Tangnararatchakit, Kanchana', 'Chuansumrit, Ampaiwan', 'Watcharakuldilok, Piangor', 'Apiwattanakul, Nopporn', 'Lertbunrian, Rojjanee', 'Keatkla, Jiraporn', 'Yoksan, Sutee']","['Tangnararatchakit K', 'Chuansumrit A', 'Watcharakuldilok P', 'Apiwattanakul N', 'Lertbunrian R', 'Keatkla J', 'Yoksan S']",,"['From the Department of Pediatrics, Mahidol University, Bangkok, Thailand.', 'From the Department of Pediatrics, Mahidol University, Bangkok, Thailand.', 'Department of Pediatrics, Buriram Hospital, Buriram, Thailand.', 'From the Department of Pediatrics, Mahidol University, Bangkok, Thailand.', 'From the Department of Pediatrics, Mahidol University, Bangkok, Thailand.', 'Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.', 'Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.']",['eng'],['Journal Article'],,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/mortality/virology', '*Dengue Virus', 'Female', 'Hospitalization', 'Humans', 'Male', 'Prognosis', 'Severity of Illness Index', 'Symptom Assessment', 'Time Factors']",,2019/11/15 06:00,2020/11/20 06:00,['2019/11/15 06:00'],"['2019/11/15 06:00 [pubmed]', '2020/11/20 06:00 [medline]', '2019/11/15 06:00 [entrez]']","['00006454-202003000-00002 [pii]', '10.1097/INF.0000000000002533 [doi]']",ppublish,Pediatr Infect Dis J. 2020 Mar;39(3):184-187. doi: 10.1097/INF.0000000000002533.,3,,,,,['Pediatr Infect Dis J. 2020 Mar;39(3):e28. PMID: 32032314'],,,,,,,,,,,,,,,,,
1822723,NLM,MEDLINE,19920908,20061115,0535-5133 (Print) 0535-5133 (Linking),32,1991,[Dengue. A review].,201-17,,"Dengue fever is an acute and infectious disease produced by a togavirus. This clinical syndrome being benign or severe like the Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), has been associated with a very high mortality rate specifically in children with different ages and those under 1 year of age from mothers having antibodies to dengue virus. Other groups with potential risk factors are those patients with chronic diseases like asthma, sickle cell anaemia and diabetes mellitus. Dengue virus show a highly tropism for endothelial reticulum system as the bone marrow, spleen, liver and lymph nodes where viral antigens can be demonstrated by several immunological methods. The pathogenesis of the DHF/DSS can be considered to result from a delayed type hypersensitivity reaction where antigen-activated T lymphocytes release a variety of biologically active chemical mediators (lymphokines) with further effects on blood clotting system and vascular permeability producing the symptoms of shock and hemorrhage seen in these cases. The rapid control and hospitalization of the patients allow them to get a fast recovery without any sequelae.","['Teruel-Lopez, E']",['Teruel-Lopez E'],,"['Instituto de Investigaciones Clinicas, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",,Venezuela,Invest Clin,Investigacion clinica,0421531,"['0 (Antibodies, Viral)', '0 (Hemagglutinins, Viral)', '0 (RNA, Viral)']",IM,"['Adolescent', 'Adult', 'Aedes/microbiology', 'Animals', 'Antibodies, Viral/analysis', 'Child', 'Child, Preschool', '*Dengue/complications/diagnosis/epidemiology/prevention & control/therapy/transmission', 'Dengue Virus/classification/genetics/immunology/isolation & purification', 'Disease Outbreaks', 'Disease Susceptibility', 'Female', 'Hemagglutinins, Viral', 'Humans', 'Immunity, Cellular', 'Infant', 'Male', 'RNA, Viral/genetics', 'Shock/etiology']",,1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Invest Clin. 1991;32(4):201-17.,4,,,,,,,69,,Dengue. Revision.,,,,,,,,,,,,,
25409269,NLM,MEDLINE,20170203,20170203,1557-7759 (Electronic) 1530-3667 (Linking),14,2014 Nov,"Evaluating public housing residents for knowledge, attitudes, and practices following dengue prevention outreach in Key West, Florida.",788-93,10.1089/vbz.2014.1664 [doi],"BACKGROUND: In 2009-2010, 93 cases of dengue were identified in Key West, Florida. This was the first outbreak of autochthonous transmission of dengue in Florida since 1934. In response to this outbreak, a multifaceted public education outreach campaign was launched. The aim of this study is to compare dengue prevention knowledge, attitudes, perceptions, and prevention practices among residents of subsidized public housing to the general population in Key West and to assess whether there were barriers preventing effective outreach from reaching specific vulnerable populations. METHODS: A randomized population-based evaluation of knowledge, attitudes, and behaviors toward dengue prevention consisting of 521 separate household interviews was undertaken in July of 2011. A subset analysis was performed on interviews collected from 28 public housing units within four subsidized public housing complexes. Analysis was performed to determine whether knowledge, attitudes, and behaviors exhibited by public housing residents differed from the non-public housing study population. RESULTS: Public housing residents recalled fewer outreach materials (p=0.01) and were 3.4 times (95% confidence interval [CI] 1.4-8.3) more likely not to recall any outreach materials. Public housing residents were less likely to correctly identify how dengue transmission occurs (61% vs. 89%), where mosquitoes lay their eggs (54% vs. 85%), or to identify any signs or symptoms related to dengue (36% vs. 64%). Public housing residents were less likely to perform dengue prevention practices such as removing standing water or always using air conditioning. CONCLUSIONS: Examination of public housing residents identified an at-risk population that recalled less exposure to outreach materials and had less knowledge about dengue infection and prevention than the randomized study population. This provides public health systems the opportunity to target or modify future health messages and interventions to this group. Differences identified in the demographics of this population suggest that alternative methods or non-English materials may be required to reach desired outcomes.","['Matthias, James', 'Zielinski-Gutierrez, Emily C', 'Tisch, Daniel J', 'Stanek, Danielle', 'Blanton, Ronald E', 'Doyle, Michael S', 'Eadie, Robert B', 'Gazdick, Elizabeth J', 'Leal, Andrea L', 'Pattison, Kimberly J', 'Perez-Guerra, Carmen L', 'Tittel, Christopher J', 'Vyas, Jooi', 'Wagner, Todd', 'Blackmore, Carina G M']","['Matthias J', 'Zielinski-Gutierrez EC', 'Tisch DJ', 'Stanek D', 'Blanton RE', 'Doyle MS', 'Eadie RB', 'Gazdick EJ', 'Leal AL', 'Pattison KJ', 'Perez-Guerra CL', 'Tittel CJ', 'Vyas J', 'Wagner T', 'Blackmore CG']",,"['1 Florida Department of Health , Tallahassee, Florida.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",,United States,Vector Borne Zoonotic Dis,"Vector borne and zoonotic diseases (Larchmont, N.Y.)",100965525,,IM,"['Demography', 'Dengue/epidemiology/*prevention & control/transmission', '*Disease Outbreaks', 'Female', 'Florida/epidemiology', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Male', 'Middle Aged', 'Public Housing', 'Surveys and Questionnaires']",,2014/11/20 06:00,2017/02/06 06:00,['2014/11/20 06:00'],"['2014/11/20 06:00 [entrez]', '2014/11/20 06:00 [pubmed]', '2017/02/06 06:00 [medline]']",['10.1089/vbz.2014.1664 [doi]'],ppublish,Vector Borne Zoonotic Dis. 2014 Nov;14(11):788-93. doi: 10.1089/vbz.2014.1664.,11,,['NOTNLM'],"['Dengue', 'Health education', 'Key West', 'Outreach', 'Public housing']",,,['5U38HM000414/HM/NCHM CDC HHS/United States'],,,,,,,,,,,,,,,,
23324429,NLM,MEDLINE,20130305,20181202,1560-7917 (Electronic) 1025-496X (Linking),18,2013 Jan 10,"Letter to the editor: ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal.",,20351 [pii],,"['Ramchurn, S K', 'Goorah, S S']","['Ramchurn SK', 'Goorah SS']",,,['eng'],"['Comment', 'Letter']",20130110,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,,IM,"['Animals', 'Dengue/*diagnosis/*epidemiology', 'Dengue Virus/*isolation & purification', '*Disease Outbreaks', 'Female', 'Humans', 'Male']",,2013/01/18 06:00,2013/03/06 06:00,['2013/01/18 06:00'],"['2013/01/18 06:00 [entrez]', '2013/01/18 06:00 [pubmed]', '2013/03/06 06:00 [medline]']",['20351 [pii]'],epublish,Euro Surveill. 2013 Jan 10;18(2):20351.,2,,,,,,,,['Euro Surveill. 2012;17(49). pii: 20333. PMID: 23231893'],,,,,,,,,,,,,,
9786018,NLM,MEDLINE,19981207,20091111,0040-4470 (Print) 0040-4470 (Linking),94,1998 Oct,Dengue: a review.,53-9,,"Millions of dengue cases occur worldwide each year. Most recently, an outbreak occurred in Texas. Though usually a nonspecific febrile illness that resolves with supportive therapy, the clinical spectrum ranges from asymptomatic to severe hemorrhage and sudden fatal shock. The potential exists for the introduction of dengue virus into other parts of the United States, and for secondary transmission in areas with vector mosquitoes, because of increased travel to and from regions of the Americas where dengue is endemic. The discovery of Aedes (Ae) albopictus strains adapted to temperate conditions makes this threat much greater. With global warming, a more rapid distribution of the Aedes species may occur, moving northward, encompassing larger population centers and leading to increased vectorborne diseases. Control of dengue currently requires control of the principal vector mosquitoes. Vaccine development continues, but at present the only way to avoid dengue in an area where it is endemic or epidemic is to use repellents and mosquito barriers. Lifesaving intervention and management of a patient with dengue and its complications depend upon a complete history, to include travel and physical examination with a high level of suspicion. Physicians and other health care providers should learn to recognize this disease. Once a person is infected, the key to survival is early diagnosis and appropriate treatment for the severe, life-threatening complications of dengue hemorrhagic fever and dengue shock syndrome.","['Rodriguez-Tan, R S', 'Weir, M R']","['Rodriguez-Tan RS', 'Weir MR']",,"['Department of Pediatrics, Scott & White Clinic and Memorial Hospital, Temple, TX, USA.']",['eng'],"['Journal Article', 'Review']",,United States,Tex Med,Texas medicine,0051012,,IM,"['Aedes/virology', 'Animals', 'Dengue/diagnosis/prevention & control/*transmission', 'Disease Outbreaks/*prevention & control', 'Humans', 'Mosquito Control', 'Texas']",,1998/10/24 00:00,1998/10/24 00:01,['1998/10/24 00:00'],"['1998/10/24 00:00 [pubmed]', '1998/10/24 00:01 [medline]', '1998/10/24 00:00 [entrez]']",,ppublish,Tex Med. 1998 Oct;94(10):53-9.,10,,,,,,,61,,,,,,,,,,,,,,,
22069072,NLM,MEDLINE,20120309,20190608,1680-5348 (Electronic) 1020-4989 (Linking),30,2011 Sep,[Reducing hospitalization with the use of a dengue management algorithm in Colombia].,248-54,S1020-49892011000900009 [pii],"OBJECTIVE: Assess the impact of a dengue management algorithm on the hospitalization rate of patients with suspected disease in a primary care health facility in an endemic area of Colombia. METHODS: A quasi-experimental study was conducted at the local hospital in Piedecuesta, Santander, Colombia, based on comparison of two periods (18 weeks each), before and after use of the algorithm. This included recommendations for clinical diagnosis of dengue and the planning of follow-up visits and hemograms, as well as criteria for hospitalization and the discontinuation of follow-up. Hospitalization rates in the two periods were compared using the Poisson analysis. The population analyzed consisted of patients seen in the facility for acute febrile syndrome. For adjustment purposes, the number of dengue cases (IgM positive) identified in the municipality was included. RESULTS: Information was obtained on 964 patients in the first period and 1350 patients in the second. There were 44 and 13 hospitalizations during the respective periods. Use of the algorithm was associated with a significant reduction in the hospitalization rate (ratio: 0.21; 95% confidence interval; 0.11-0.39). This association did not change when adjusted for the number of dengue cases identified in the city. There were no significant differences in the rate of follow-up visits (P = 0.85) and hemograms (P = 0.24) in the two periods. There were no case fatalities. CONCLUSIONS: The results suggest that health care resources for dengue management can be optimized with the use of the algorithm.","['Diaz-Quijano, Fredi Alexander', 'Villar-Centeno, Luis Angel', 'Martinez-Vega, Ruth Arali']","['Diaz-Quijano FA', 'Villar-Centeno LA', 'Martinez-Vega RA']",,"['Centro de Investigaciones Epidemiologicas, Universidad Industrial de Santander, Bucaramanga, Colombia. frediazq@msn.com']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['*Algorithms', 'Child', 'Colombia', 'Dengue/*diagnosis/*therapy', 'Female', 'Hospitalization/*statistics & numerical data', 'Humans', 'Male']",,2011/11/10 06:00,2012/03/10 06:00,['2011/11/10 06:00'],"['2010/08/21 00:00 [received]', '2011/02/26 00:00 [accepted]', '2011/11/10 06:00 [entrez]', '2011/11/10 06:00 [pubmed]', '2012/03/10 06:00 [medline]']","['S1020-49892011000900009 [pii]', '10.1590/s1020-49892011000900009 [doi]']",ppublish,Rev Panam Salud Publica. 2011 Sep;30(3):248-54. doi: 10.1590/s1020-49892011000900009.,3,,,,,,,,,Reduccion de la hospitalizacion mediante un algoritmo de manejo del dengue en Colombia.,,,,,,,,,,,,,
18598878,NLM,MEDLINE,20081118,20080707,0399-077X (Print) 0399-077X (Linking),38 Suppl 2,2008 Jun,[Perceptions and preventive behavior against dengue fever in Martinique].,S78-81,10.1016/S0399-077X(08)72999-8 [doi],,"['Setbon, M', 'Raude, J']","['Setbon M', 'Raude J']",,,['fre'],['Journal Article'],,France,Med Mal Infect,Medecine et maladies infectieuses,0311416,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral/blood', 'Dengue/epidemiology/immunology/*prevention & control/transmission', 'Dengue Virus/immunology', 'Humans', 'Martinique/epidemiology', 'Perception', 'Preventive Medicine']",,2008/07/05 09:00,2008/11/19 09:00,['2008/07/05 09:00'],"['2008/07/05 09:00 [pubmed]', '2008/11/19 09:00 [medline]', '2008/07/05 09:00 [entrez]']","['S0399-077X(08)72999-8 [pii]', '10.1016/S0399-077X(08)72999-8 [doi]']",ppublish,Med Mal Infect. 2008 Jun;38 Suppl 2:S78-81. doi: 10.1016/S0399-077X(08)72999-8.,,,,,,,,,,Perceptions et comportements de prevention face a la dengue en Martinique.,,,,,,,,['Cire Antilles-Guyane'],,,,,
17278661,NLM,MEDLINE,20070222,20070206,0019-5138 (Print) 0019-5138 (Linking),37,2005 Dec,"An outbreak of dengue fever in Veerannapet village, Cherial Mandal, of Warangal district, Andhra Pradesh.",301-6,,"An epidemiological and entomological investigation was carried out in Veerannapet village, Cherial Mandal of Warangal district, Andhra Pradesh. The study showed that all age groups and both the sexes were affected with the disease. Fever and bodyache was the first presenting feature, which was self-limiting and lasted for 4-5 days. Of the 19 Serum Samples tested, 17 showed high titre to Dengue antigen with 10 showing diagnostic titre. Five samples were positive for IgM antibodies to dengue virus. Larval surveys indicates high Breteau index (30.40%), House index (23.20%) and Container index (9.17%). The clinico-epidemiological and entomological investigation indicates present episode of fever outbreak is due to dengue fever. Strengthening and intensification of surveillance along with educating the community is recommended for prevention of outbreak.","['Kamal, S', 'Jain, S K', 'Patnaik, S K', 'Lal, S']","['Kamal S', 'Jain SK', 'Patnaik SK', 'Lal S']",,"['National Institute of Communicable Diseases, Varanasi 221010, U.P.']",['eng'],['Journal Article'],,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['Adolescent', 'Adult', 'Animals', 'Child', 'Child, Preschool', 'Culicidae', 'Dengue/*epidemiology/mortality/physiopathology', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Middle Aged']",,2007/02/07 09:00,2007/02/23 09:00,['2007/02/07 09:00'],"['2007/02/07 09:00 [pubmed]', '2007/02/23 09:00 [medline]', '2007/02/07 09:00 [entrez]']",,ppublish,J Commun Dis. 2005 Dec;37(4):301-6.,4,,,,,,,,,,,,,,,,,,,,,,
12467151,NLM,MEDLINE,20021223,20161209,0755-4982 (Print) 0755-4982 (Linking),31,2002 Nov 9,[A psychiatric form of dengue after a visit to Djibouti].,1704,,,"['Rapp, Christophe', 'Debord, Thierry', 'Imbert, Patrick', 'Roue, Rene']","['Rapp C', 'Debord T', 'Imbert P', 'Roue R']",,,['fre'],"['Case Reports', 'Letter']",,France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Adult', 'Dengue/*complications/*diagnosis', 'Diagnosis, Differential', 'Djibouti', 'Humans', 'Male', 'Mental Disorders/*etiology', 'Prognosis', '*Travel']",,2002/12/07 04:00,2002/12/27 04:00,['2002/12/07 04:00'],"['2002/12/07 04:00 [pubmed]', '2002/12/27 04:00 [medline]', '2002/12/07 04:00 [entrez]']",,ppublish,Presse Med. 2002 Nov 9;31(36):1704.,36,,,,,,,,,Forme psychiatrique de la dengue au retour de Djibouti.,,,,,,,,,,,,,
19102972,NLM,MEDLINE,20090326,20081223,2542-5641 (Electronic) 0366-6999 (Linking),121,2008 Dec 5,Cases of dengue fever on rise in Vietnam.,2464,,,,,,,['eng'],['News'],,China,Chin Med J (Engl),Chinese medical journal,7513795,,IM,"['Dengue/*epidemiology/prevention & control', 'Humans', 'Vietnam/epidemiology']",,2008/12/24 09:00,2009/03/27 09:00,['2008/12/24 09:00'],"['2008/12/24 09:00 [entrez]', '2008/12/24 09:00 [pubmed]', '2009/03/27 09:00 [medline]']",,ppublish,Chin Med J (Engl). 2008 Dec 5;121(23):2464.,23,,,,,,,,,,,,,,,,,,,,,,
36272245,NLM,MEDLINE,20221214,20221228,1878-0067 (Electronic) 1878-0067 (Linking),41,2022 Dec,Considering waning immunity to better explain dengue dynamics.,100630,S1755-4365(22)00070-6 [pii] 10.1016/j.epidem.2022.100630 [doi],"Life-long serotype-specific immunity following dengue virus infection may not always occur, but the true extent of this effect is unknown. Analysis of more than 20 years of monotypic epidemics in the isolated French Polynesian islands revealed that whilst the risk of symptomatic dengue infection did conform to the classical paradigms of homotypic immunity and increased disease risk in heterotypic secondary infections, incorporation of waning immunity improved the ability of epidemiological models to capture the observed epidemic dynamics. Not only does this show how inclusion of waning immunity into classical models can reveal important facets of the immune response to natural dengue virus infection, it also has significant ramifications for vaccine development and implementation in dengue endemic areas.","['Lopez, Leonardo', 'Paul, Richard E', 'Cao-Lormeau, Van-Mai', 'Rodo, Xavier']","['Lopez L', 'Paul RE', 'Cao-Lormeau VM', 'Rodo X']",,"['CLIMA (Climate and Health) Program, ISGlobal, c/Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: leonardorafael.lopez@isglobal.org.', 'Institut Pasteur, Universite de Paris, CNRS UMR2000, Ecology and Emergence of Arthropod-borne Pathogens Unit, F-75015 Paris, France.', 'Laboratoire de recherche sur les maladies infectieuses a transmission vectorielle, Institut Louis Malarde, 98713 Papeete, Tahiti, French Polynesia.', 'CLIMA (Climate and Health) Program, ISGlobal, c/Dr. Aiguader 88, 08003 Barcelona, Spain; ICREA, Passeig de Lluis Companys 23, 08010 Barcelona, Spain. Electronic address: xavier.rodo@isglobal.org.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20221010,Netherlands,Epidemics,Epidemics,101484711,,IM,"['Humans', '*Dengue Virus', '*Dengue/epidemiology/prevention & control', 'Serogroup', '*Epidemics', '*Coinfection/epidemiology']",,2022/10/23 06:00,2022/12/15 06:00,['2022/10/22 18:22'],"['2021/11/17 00:00 [received]', '2022/07/25 00:00 [revised]', '2022/09/20 00:00 [accepted]', '2022/10/23 06:00 [pubmed]', '2022/12/15 06:00 [medline]', '2022/10/22 18:22 [entrez]']","['S1755-4365(22)00070-6 [pii]', '10.1016/j.epidem.2022.100630 [doi]']",ppublish,Epidemics. 2022 Dec;41:100630. doi: 10.1016/j.epidem.2022.100630. Epub 2022 Oct 10.,,['Copyright (c) 2022 The Author(s). Published by Elsevier B.V. All rights reserved.'],['NOTNLM'],"['DENV', 'Dengue', 'Epidemics', 'French', 'Immunity', 'Model', 'Monotypic', 'Polynesia', 'Vaccine']","['Declaration of Competing Interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",,,,,,,,,,,,,,,,,,
18581021,NLM,MEDLINE,20080825,20080626,2737-5935 (Electronic) 0037-5675 (Linking),49,2008 Jun,Do young adults with uncomplicated dengue fever need hospitalisation? A retrospective analysis of clinical and laboratory features.,476-9,,"INTRODUCTION: Approximately 80 percent of all notified cases of dengue infections in Singapore were hospitalised from 2000 to 2005. We aimed to determine if hospitalised dengue patients had significant morbidity and mortality, and if admissions were in accordance with previously-published admission criteria. METHODS: The medical records of the first 20 patients with laboratory-confirmed dengue from two consecutive months in three time periods were retrospectively reviewed. Demographical, clinical and laboratory data on admission, during hospitalisation and on discharge, were compared. RESULTS: There were 120 patients with a mean age of 35 years. Males comprised 77 percent and foreign workers 51 percent. Of the published admission criteria, 33 percent had vomiting, 22 percent diarrhoea, 13 percent abdominal pain, 18 percent bleeding and one patient had hypotension. 30 percent were above the minimum platelet threshold of 80,000/microL, but 50 percent had safe levels of platelets between 50,000 and 80,000/microL. Dengue haemorrhagic fever occurred in 4 percent with no death. After admission, platelet nadir was below 20,000/microL in only 9 percent and below 10,000/microL in only 2 percent of cases. Bleeding did not correlate with platelet count. Medical referral to the hospital was significantly associated with thrombocytopenia, while self-referral was significantly associated with vomiting. CONCLUSION: Severe adverse outcome among young adults with uncomplicated dengue fever is rare. Instead of hospitalisation, daily outpatient monitoring with symptomatic treatment and medical leave may be a safe and feasible alternative.","['Lye, D C', 'Chan, M', 'Lee, V J', 'Leo, Y S']","['Lye DC', 'Chan M', 'Lee VJ', 'Leo YS']",,"['Department of Infectious Diseases, Communicable Disease Centre, Tan Tock Seng Hospital, Singapore. david_lye@ttsh.com.sg']",['eng'],['Journal Article'],,India,Singapore Med J,Singapore medical journal,0404516,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Dengue/diagnosis/*therapy', 'Female', '*Hospitalization', 'Humans', 'Male', 'Middle Aged']",,2008/06/27 09:00,2008/08/30 09:00,['2008/06/27 09:00'],"['2008/06/27 09:00 [pubmed]', '2008/08/30 09:00 [medline]', '2008/06/27 09:00 [entrez]']",,ppublish,Singapore Med J. 2008 Jun;49(6):476-9.,6,,,,,,,,,,,,,,,,,,,,,,
8983243,NLM,MEDLINE,19970109,20080128,0030-0632 (Print) 0030-0632 (Linking),121,1996 Aug,"[Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas].",102-10,,"The principal aim of this work was to report the reintroduction of dengue virus serotype 3 in the Americas after an absence of 17 years. In addition, it describes the most common symptoms associated with classical dengue and hemorrhagic dengue and presents data on the distribution of the epidemic in the various comprehensive local health care systems of Nicaragua. The study group consisted of 39 patients hospitalized in Managua and Leon for dengue with hemorrhagic manifestations and hemorrhagic dengue. Of these patients, 34 were classified as probable or confirmed cases of dengue. The most frequent symptoms were fever, headache, vomiting, and muscle and joint pains. The tourniquet test was positive and thrombocytopenia was confirmed in 56% and 44% of the patients, respectively. Epistaxis (67%) was the most common hemorrhagic sign. Of the 356 serum samples received through the dengue surveillance systems in October 1994, IgM antibodies were detected in 43%. The virus was isolated from 5 of 24 samples tested (serotype 3 from 3 and serotype 1 from 2). The reintroduction of serotype 3 of dengue into the Region was demonstrated, along with its ability to produce epidemics of hemorrhagic dengue. The countries are warned that if they do not quickly take the measures described in the guidelines for the prevention and control of dengue and dengue hemorrhagic fever, new epidemics may occur in the Americas, given the large number of persons susceptible to this serotype and the high density of the mosquito vector in most of the countries of the Region.","['Guzman, M G', 'Vazquez, S', 'Martinez, E', 'Alvarez, M', 'Rodriguez, R', 'Kouri, G', 'de los Reyes, J', 'Acevedo, F']","['Guzman MG', 'Vazquez S', 'Martinez E', 'Alvarez M', 'Rodriguez R', 'Kouri G', 'de los Reyes J', 'Acevedo F']",,"['Instituto de Medicina Tropical Pedro Kouri, La Habana, Cuba.']",['spa'],"['English Abstract', 'Journal Article']",,United States,Bol Oficina Sanit Panam,Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,0414762,,IM,"['Adolescent', 'Adult', 'Americas', 'Dengue/blood/diagnosis/*epidemiology', 'Dengue Virus/classification', 'Female', 'Humans', 'Male', 'Middle Aged', 'Nicaragua/epidemiology', 'Serotyping']",,1996/08/01 00:00,1996/08/01 00:01,['1996/08/01 00:00'],"['1996/08/01 00:00 [pubmed]', '1996/08/01 00:01 [medline]', '1996/08/01 00:00 [entrez]']",,ppublish,Bol Oficina Sanit Panam. 1996 Aug;121(2):102-10.,2,,,,,,,,,"Dengue en Nicaragua, 1994: reintroduccion del serotipo 3 en las Americas.",,,,,,,,,,,,,
1568274,NLM,MEDLINE,19920528,20181113,0042-9686 (Print) 0042-9686 (Linking),70,1992,Dengue haemorrhagic fever in children in Delhi.,105-8,,"An epidemic of dengue haemorrhagic fever occurred in Delhi during 1988. A total of 21 paediatric patients with dengue haemorrhagic fever/dengue shock syndrome were evaluated from September to November 1988. All the patients had fever, restlessness, ecchymotic spots and ascites. Pleural effusion occurred in 19 patients (90%), and 18 (86%) exhibited each of the following: vomiting, thrombocytopenia, and haemoconcentration. Hepatomegaly was observed in 15 patients (71%) and splenomegaly in three (14%). Titres of haemagglutination inhibition (HI) antibodies against dengue virus type 2 were raised in all the 15 cases from whom sera were collected during the acute stage. Convalescent sera from five patients had increased titres of HI antibodies to dengue virus type 2. The remaining 10 cases exhibited raised IgM antibody levels against dengue virus type 2. The fatality rate for serologically proven cases was 13% (2 of 15 patients), while for all patients (including those diagnosed clinically (6) and serologically (15)) it was 33.3% (7 of 21). Patients who survived had no sequelae, except one who had transient hypertension that lasted for two weeks.","['Kabra, S K', 'Verma, I C', 'Arora, N K', 'Jain, Y', 'Kalra, V']","['Kabra SK', 'Verma IC', 'Arora NK', 'Jain Y', 'Kalra V']",,"['Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.']",['eng'],['Journal Article'],,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral/isolation & purification', 'Dengue/*epidemiology/immunology/mortality', '*Disease Outbreaks', 'Hemagglutination Inhibition Tests', 'India/epidemiology']",PMC2393341,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,Bull World Health Organ. 1992;70(1):105-8.,1,,['PIP'],"['Age Factors', '*Antibodies', 'Asia', 'Biology', '*Child', '*Child Mortality', 'Demographic Factors', 'Developing Countries', 'Diseases', 'Examinations And Diagnoses', 'Immunity', 'Immunologic Factors', '*Incidence', 'India', '*Laboratory Examinations And Diagnoses', 'Measurement', 'Mortality', 'Physiology', 'Population', 'Population Characteristics', 'Population Dynamics', 'Research Methodology', '*Signs And Symptoms', 'Southern Asia', '*Treatment', '*Viral Diseases', 'Youth']",,,,,,,,"['PIP: 072486', 'POP: 00210936']","['An epidemic of dengue hemorrhagic fever occurred in Delhi during 1988. A total of', '21 pediatric patients with that illness or dengue shock syndrome were evaluated', 'from September-November 1988. All patients had fever, restlessness, ecchymotic', 'spots, and ascites. Pleural effusion occurred in 19 patients (90%) and 18 (86%)', 'exhibited each of the following: vomiting, thrombocytopenia, and', 'hemoconcentration. Hepatomegaly was observed in 15 patients (71%) and', 'splenomegaly in 3 (14%). Titers of hemagglutination inhibition (HI) antibodies', 'against dengue virus type 2 were raised in all 15 cases from whom sera were', 'collected during the acute stage. Convalescent sera from 5 patients had increased', 'titers of HI antibodies to dengue virus type 2. The remaining 10 cases exhibited', 'raised IgM antibody levels against dengue virus type 2. The fatality rate for', 'serologically proven cases was 13% (2 of 15 patients) while for all patients', '(including those diagnosed clinically [n=6] and serologically [n=15]), it was', '33.3% (7 of 21). Patients who survived had no sequelae, except 1 who had', 'transient hypertension which continued for 2 weeks.']",['eng'],,,,,,,,,
22569693,NLM,MEDLINE,20120829,20190517,1680-5348 (Electronic) 1020-4989 (Linking),31,2012 Mar,[Cultural dimensions of dengue that help or hinder its prevention in Mexico].,197-203,S1020-49892012000300003 [pii],"OBJECTIVE: To describe the cultural dimensions that might help or hinder dengue prevention in two Mexican localities having different experiences related to this disease. METHODS: A cognitive-cultural anthropological study was conducted involving the participation of 160 adults selected through purposeful sampling. The techniques of free lists and pile-sorting were used for investigating terms associated with the concept ""dengue."" A consensus analysis was carried out by the factoring of principal components, hierarchical cluster analysis, and multidimensional scaling. RESULTS: Greater consensus was observed among participants from the population having more historical experience with dengue-Santiago Ixcuintla, Nayarit-as well as more structured cultural and complex dimensions than in Guadalajara. In the latter case, participants showed a more fragmented conception of dengue, with insufficient information on its symptoms, mechanisms of transmission, and vector reservoirs. Three cultural dimensions were identified as hindering dengue prevention: confusing and insufficient information, placing responsibility for prevention on other people or on public agencies, and excessive confidence in fumigation as a preventive measure. CONCLUSIONS: These obstacles will need to be taken into account in the design and implementation of future prevention campaigns, disseminating information that explains the risks of fumigation and the importance of citizens and authorities jointly participating in the search for a comprehensive and sustainable solution to the dengue problem.","['Torres Lopez, Teresa M', 'Guerrero Cordero, Joana Lizeth', 'Salazar Estrada, Jose Guadalupe']","['Torres Lopez TM', 'Guerrero Cordero JL', 'Salazar Estrada JG']",,"['Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Departamento de Salud Publica, Guadalajara, Jalisco, Mexico. tere.torres.cucs@gmail.com']",['spa'],"['English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Adult', 'Anthropology, Cultural', '*Cultural Characteristics', 'Dengue/complications/*prevention & control/transmission', 'Female', 'Fumigation/adverse effects', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Male', 'Mexico', 'Sex Factors']",,2012/05/10 06:00,2012/08/30 06:00,['2012/05/10 06:00'],"['2011/04/07 00:00 [received]', '2011/12/06 00:00 [accepted]', '2012/05/10 06:00 [entrez]', '2012/05/10 06:00 [pubmed]', '2012/08/30 06:00 [medline]']",['S1020-49892012000300003 [pii]'],ppublish,Rev Panam Salud Publica. 2012 Mar;31(3):197-203.,3,,,,,,,,,Dimensiones culturales del dengue que favorecen o dificultan su prevencion en Mexico.,,,,,,,,,,,,,
8924779,NLM,MEDLINE,19961115,20181130,0037-9085 (Print) 0037-9085 (Linking),89,1996,"[Present and future entomological aspects of dengue and dengue hemorrhagic fever in French Guiana and some neighboring countries. Cayenne, Guiana, 23-24 May 1995. Proceedings].",83-166,,,,,,,['fre'],"['Congress', 'Overall']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Animals', '*Dengue/epidemiology/transmission', 'French Guiana', '*Global Health', 'Humans', '*Insect Vectors']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):83-166.,2,,,,,,,,,"Aspects entomologiques presents et futurs de la dengue et dengue hemorragique en Guyane francaise et quelques pays voisins. Cayenne, Guyane,23-24 mai 1995.",,,,,,,,,,,,,
554772,NLM,MEDLINE,19810413,20130405,,72,1979 May-Jun,[Dengue at Reunion: isolation of a strain at the Pasteur Institute of Madagascar].,205-9,,"During the dengue outbreak which occurred in Reunion Island, one dengue type 2 strain was isolated at Institute Pasteur in Madagascar.","['Coulanges, P', 'Clercy, Y', 'Jousset, F X', 'Rodhain, F', 'Hannoun, C']","['Coulanges P', 'Clercy Y', 'Jousset FX', 'Rodhain F', 'Hannoun C']",,,['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot Filiales,Bulletin de la Societe de pathologie exotique et de ses filiales,7503399,,IM,"['Dengue/epidemiology/*microbiology', 'Dengue Virus/*isolation & purification', 'Disease Outbreaks', 'Madagascar']",,1979/05/01 00:00,1979/05/01 00:01,['1979/05/01 00:00'],"['1979/05/01 00:00 [pubmed]', '1979/05/01 00:01 [medline]', '1979/05/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot Filiales. 1979 May-Jun;72(3):205-9.,3,,,,,,,,,Dengue a le Reunion: isolement d'une souch a l'Institut Pasteur de Madagascar.,,,,,,,,,,,,,
7564804,NLM,MEDLINE,19951113,20190611,0140-6736 (Print) 0140-6736 (Linking),346,1995 Oct 21,Changing epidemiology of dengue in Singapore.,1098,,,"['Goh, K T']",['Goh KT'],,,['eng'],['Letter'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Adolescent', 'Adult', 'Aedes', 'Animals', 'Child', 'Dengue/*epidemiology/mortality/transmission', 'Humans', 'Incidence', 'Mosquito Control', 'Singapore/epidemiology']",,1995/10/21 00:00,1995/10/21 00:01,['1995/10/21 00:00'],"['1995/10/21 00:00 [pubmed]', '1995/10/21 00:01 [medline]', '1995/10/21 00:00 [entrez]']","['S0140-6736(95)91771-3 [pii]', '10.1016/s0140-6736(95)91771-3 [doi]']",ppublish,Lancet. 1995 Oct 21;346(8982):1098. doi: 10.1016/s0140-6736(95)91771-3.,8982,,,,,,,,,,,,,,,,,,,,,,
29200423,NLM,MEDLINE,20171229,20181113,1932-6203 (Electronic) 1932-6203 (Linking),12,2017,Analysing increasing trends of Guillain-Barre Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.,e0187830,10.1371/journal.pone.0187830 [doi] e0187830,"BACKGROUND: Guillain-Barre Syndrome (GBS) is a severe paralytic neuropathy associated with virus infections such as Zika virus and Chikungunya virus. There were also case reports of dengue fever preceding GBS. With the aim to understand the mechanisms of GBS and dengue outbreaks, this ecological study investigates the relationships between GBS, dengue, meteorological factors in Hong Kong and global climatic factors from January 2000 to June 2016. METHODS: The correlations between GBS, dengue, Multivariate El Nino Southern Oscillation Index (MEI) and local meteorological data were explored by Spearman's Rank correlations and cross-correlations. Three Poisson regression models were fitted to identify non-linear associations among GBS, dengue and MEI. Cross wavelet analyses were applied to infer potential non-stationary oscillating associations among GBS, dengue and MEI. FINDINGS AND CONCLUSION: We report a substantial increasing of local GBS and dengue cases (mainly imported) in recent year in Hong Kong. The seasonalities of GBS and dengue are different, in particular, GBS is low while dengue is high in the summer. We found weak but significant correlations between GBS and local meteorological factors. MEI could explain over 17% of dengue's variations based on Poisson regression analyses. We report a possible non-stationary oscillating association between dengue fever and GBS cases in Hong Kong. This study has led to an improved understanding about the timing and ecological relationships between MEI, GBS and dengue.","['Tang, Xiujuan', 'Zhao, Shi', 'Chiu, Alice P Y', 'Wang, Xin', 'Yang, Lin', 'He, Daihai']","['Tang X', 'Zhao S', 'Chiu APY', 'Wang X', 'Yang L', 'He D']",['ORCID: 0000-0003-3253-654X'],"['Shenzhen Center for Disease Control and Prevention, Shenzhen, China.', 'Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong SAR, China.', 'Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong SAR, China.', 'Shenzhen Center for Disease Control and Prevention, Shenzhen, China.', 'School of Nursing, Hong Kong Polytechnic University, Hong Kong SAR, China.', 'Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong SAR, China.']",['eng'],['Journal Article'],20171204,United States,PLoS One,PloS one,101285081,,IM,"['Chikungunya virus/isolation & purification', 'Cold Temperature/*adverse effects', 'Dengue/complications/*epidemiology', 'Dengue Virus/isolation & purification', '*Disease Outbreaks', '*El Nino-Southern Oscillation', 'Guillain-Barre Syndrome/*epidemiology/virology', 'Hong Kong/epidemiology', 'Humans', 'Seasons', 'Sunlight', 'Zika Virus/isolation & purification', 'Zika Virus Infection/epidemiology']",PMC5714337,2017/12/05 06:00,2017/12/30 06:00,['2017/12/05 06:00'],"['2017/06/14 00:00 [received]', '2017/10/26 00:00 [accepted]', '2017/12/05 06:00 [entrez]', '2017/12/05 06:00 [pubmed]', '2017/12/30 06:00 [medline]']","['PONE-D-17-22683 [pii]', '10.1371/journal.pone.0187830 [doi]']",epublish,PLoS One. 2017 Dec 4;12(12):e0187830. doi: 10.1371/journal.pone.0187830. eCollection 2017.,12,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
22709430,NLM,MEDLINE,20121022,20220410,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),18,2012 Jul,"Electronic event-based surveillance for monitoring dengue, Latin America.",1147-50,10.3201/eid1807.120055 [doi],"The current dengue epidemic in Latin America represents a major threat to health. However, surveillance of affected regions lacks timeliness and precision. We investigated real-time electronic sources for monitoring spread of dengue into new regions. This approach could provide timely estimates of changes in distribution of dengue, a critical component of prevention and control efforts.","['Hoen, Anne G', 'Keller, Mikaela', 'Verma, Aman D', 'Buckeridge, David L', 'Brownstein, John S']","['Hoen AG', 'Keller M', 'Verma AD', 'Buckeridge DL', 'Brownstein JS']",,"[""Children's Hospital Boston, Boston, Massachusetts, USA. anne.g.hoen@dartmouth.edu""]",['eng'],"['Evaluation Study', 'Journal Article', 'Research Support, N.I.H., Extramural']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Animals', 'Dengue/*epidemiology/prevention & control/*transmission', 'Disease Outbreaks/prevention & control', 'Humans', '*Internet', 'Latin America/epidemiology', 'Population Surveillance/*methods', 'Public Health Informatics/methods']",PMC3376807,2012/06/20 06:00,2012/10/23 06:00,['2012/06/20 06:00'],"['2012/06/20 06:00 [entrez]', '2012/06/20 06:00 [pubmed]', '2012/10/23 06:00 [medline]']","['12-0055 [pii]', '10.3201/eid1807.120055 [doi]']",ppublish,Emerg Infect Dis. 2012 Jul;18(7):1147-50. doi: 10.3201/eid1807.120055.,7,,,,,,"['G08 LM009776/LM/NLM NIH HHS/United States', 'R01 LM010812/LM/NLM NIH HHS/United States']",,,,,,,,,,,,,,,,
19116042,NLM,MEDLINE,20090318,20220126,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),15,2009 Jan,Threat of dengue to blood safety in dengue-endemic countries.,8-11,10.3201/eid1501.071097 [doi],"Dengue, the most common arbovirus infection globally, is transmitted by mosquito vectors. Healthcare-related transmission, including transmission by blood products, has been documented, although the frequency of these occurrences is unknown. Dengue is endemic to Singapore, a city-state in Asia. Using mathematical modeling, we estimated the risk for dengue-infected blood transfusions in Singapore in 2005 to be 1.625-6/10,000 blood transfusions, assuming a ratio of asymptomatic to symptomatic infections of 2:1 to 10:1. However, the level of viremia required to cause clinical dengue cases is person-dependent and unknown. Further studies are needed to establish the magnitude of the threat that dengue poses to blood safety in countries where it is endemic. It will then be possible after this information is obtained to assess whether screening is feasible and to identify approaches that are most cost-effective on the basis of characteristics of local populations and seasonality of dengue.","['Wilder-Smith, Annelies', 'Chen, Lin H', 'Massad, Eduardo', 'Wilson, Mary E']","['Wilder-Smith A', 'Chen LH', 'Massad E', 'Wilson ME']",,"['Department of Medicine, National University Singapore, Singapore. epvws@pacific.net.sg']",['eng'],['Journal Article'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adolescent', 'Adult', 'Blood/virology', 'Dengue/diagnosis/*epidemiology/*transmission/virology', 'Dengue Virus/*isolation & purification', '*Endemic Diseases', 'Humans', 'Mass Screening', '*Models, Biological', '*Risk Assessment', 'Singapore/epidemiology', '*Transfusion Reaction', 'Young Adult']",PMC2660677,2009/01/01 09:00,2009/03/19 09:00,['2009/01/01 09:00'],"['2009/01/01 09:00 [entrez]', '2009/01/01 09:00 [pubmed]', '2009/03/19 09:00 [medline]']","['07-1097 [pii]', '10.3201/eid1501.071097 [doi]']",ppublish,Emerg Infect Dis. 2009 Jan;15(1):8-11. doi: 10.3201/eid1501.071097.,1,,,,,,,,,,,,,,,,,,,,,,
28443981,NLM,MEDLINE,20170824,20181113,1678-8060 (Electronic) 0074-0276 (Print) 0074-0276 (Linking),112,2017 May,Mapping the dengue scientific landscape worldwide: a bibliometric and network analysis.,354-363,10.1590/0074-02760160423 [doi],"BACKGROUND: Despite the current global trend of reduction in the morbidity and mortality of neglected diseases, dengue's incidence has increased and occurrence areas have expanded. Dengue also persists as a scientific and technological challenge since there is no effective treatment, vaccine, vector control or public health intervention. Combining bibliometrics and social network analysis methods can support the mapping of dengue research and development (R&D) activities worldwide. OBJECTIVES: The aim of this paper is to map the scientific scenario related to dengue research worldwide. METHODS: We use scientific publication data from Web of Science Core Collection - articles indexed in Science Citation Index Expanded (SCI-EXPANDED) - and combine bibliometrics and social network analysis techniques to identify the most relevant journals, scientific references, research areas, countries and research organisations in the dengue scientific landscape. FINDINGS: Our results show a significant increase of dengue publications over time; tropical medicine and virology as the most frequent research areas and biochemistry and molecular biology as the most central area in the network; USA and Brazil as the most productive countries; and Mahidol University and Fundacao Oswaldo Cruz as the main research organisations and the Centres for Disease Control and Prevention as the most central organisation in the collaboration network. MAIN CONCLUSIONS: Our findings can be used to strengthen a global knowledge platform guiding policy, planning and funding decisions as well as to providing directions to researchers and institutions. So that, by offering to the scientific community, policy makers and public health practitioners a mapping of the dengue scientific landscape, this paper has aimed to contribute to upcoming debates, decision-making and planning on dengue R&D and public health strategies worldwide.","['Mota, Fabio Batista', 'Fonseca, Bruna de Paula Fonseca E', 'Galina, Andreia Cristina', 'Silva, Roseli Monteiro da']","['Mota FB', 'Fonseca BPFE', 'Galina AC', 'Silva RMD']",,"['Fundacao Oswaldo Cruz-Fiocruz, Vice-Presidencia de Pesquisa e Laboratorios de Referencia, Rio de Janeiro, RJ, Brasil.', 'Fundacao Oswaldo Cruz-Fiocruz, Centro de Desenvolvimento Tecnologico em Saude, Rio de Janeiro, RJ, Brasil.', 'Fundacao Oswaldo Cruz-Fiocruz, Vice-Presidencia de Pesquisa e Laboratorios de Referencia, Rio de Janeiro, RJ, Brasil.', 'Fundacao Oswaldo Cruz-Fiocruz, Centro de Desenvolvimento Tecnologico em Saude, Rio de Janeiro, RJ, Brasil.']",['eng'],['Journal Article'],20170327,Brazil,Mem Inst Oswaldo Cruz,Memorias do Instituto Oswaldo Cruz,7502619,,IM,"['*Bibliometrics', 'Biomedical Research/*statistics & numerical data', '*Dengue', '*Global Health', 'Humans']",PMC5398162,2017/04/27 06:00,2017/08/25 06:00,['2017/04/27 06:00'],"['2016/09/19 00:00 [received]', '2017/01/23 00:00 [accepted]', '2017/04/27 06:00 [entrez]', '2017/04/27 06:00 [pubmed]', '2017/08/25 06:00 [medline]']","['S0074-02762017005005103 [pii]', '0074-02760160423 [pii]', '10.1590/0074-02760160423 [doi]']",ppublish,Mem Inst Oswaldo Cruz. 2017 May;112(5):354-363. doi: 10.1590/0074-02760160423. Epub 2017 Mar 27.,5,,,,,,,,,,,,,,,,,,,,,,
7499775,NLM,MEDLINE,19960118,20041117,0019-5138 (Print) 0019-5138 (Linking),27,1995 Jun,Febrile episode among a floating population of C.R.P.F. Jawans stationed at Calcutta.,70-6,,"A virological investigation was carried out to establish the etiologic agent of a febrile outbreak amongst a floating population of C.R.P.F. Jawans, stationed at Calcutta during May-July, 1993. The illness was associated with fever, severe headache, bodyache and arthralgia which lasted for 2-4 days in most of the cases. Fifty cases were examined clinically and blood samples (both acute and convalescent) were subjected to virological study. One mouse-pathogenic agent could be isolated in suckling mice and identified as DEN-3. Sero-investigation of 50 single sera by HI & CF method revealed evidence of presumptive dengue infection in 33, while sero-conversion could be noted in 10 out of 25 available paired sera tested. Results of MAC ELISA revealed evidence of primary dengue infection in 6 out of 12 acute phase sera examined. Thus, the study shows that the episode is strongly suggestive of primary dengue infection.","['Bhattacharjee, N', 'De, P M', 'Chakravarti, S K', 'Chakraborty, M S', 'Neogi, D K', 'Mukherjee, K K']","['Bhattacharjee N', 'De PM', 'Chakravarti SK', 'Chakraborty MS', 'Neogi DK', 'Mukherjee KK']",,"['Department of Virology, School of Tropical Medicine, Calcutta, India.']",['eng'],['Journal Article'],,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['Adult', 'Animals', 'Complement Fixation Tests', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Dengue Virus/*isolation & purification', '*Disease Outbreaks', 'Humans', 'India/epidemiology', 'Male', 'Mice', 'Middle Aged', 'Police']",,1995/06/01 00:00,1995/06/01 00:01,['1995/06/01 00:00'],"['1995/06/01 00:00 [pubmed]', '1995/06/01 00:01 [medline]', '1995/06/01 00:00 [entrez]']",,ppublish,J Commun Dis. 1995 Jun;27(2):70-6.,2,,,,,,,,,,,,,,,,,,,,,,
30053833,NLM,MEDLINE,20190521,20190521,1471-2334 (Electronic) 1471-2334 (Linking),18,2018 Jul 27,30 years of dengue fatal cases in Brazil: a laboratorial-based investigation of 1047 cases.,346,10.1186/s12879-018-3255-x [doi] 346,"BACKGROUND: Dengue viruses (DENV) have emerged and reemerged in Brazil in the past 30 years causing explosive epidemics. The disease may range from clinically asymptomatic infections to severe and fatal outcomes. We aimed to describe the epidemiological, clinical and laboratorial aspects of the dengue fatal cases received by a Regional Reference Laboratory, Brazil in 30 years. METHODS: A total of 1047 suspected fatal dengue cases were received from 1986 to 2015 and analyzed in the Laboratory of Flavivirus, FIOCRUZ. Suspected cases were submitted to viral detection, serological and molecular methods for cases confirmation. Influence of gender, age, serotype and type of infection (primary/secondary) on death outcome, as well the interactions between serotype and age or infection and age and type of infection were also studied. RESULTS: A total of 359 cases (34.2%) were confirmed and DENV-1 (11.1%), DENV-2 (43.9%), DENV-3 (32.8%) and DENV-4 (13.7%) were detected. Overall, fatal cases occurred more often in primary infections (59.3%, p = 0.001). However, in 2008, fatal cases were mainly associated to secondary infections (p = 0.003). In 2008 and 2011, deaths were more frequent on children and those infected by DENV-2 presented a higher risk for fatal outcome. Moreover, children with secondary infections had a 4-fold higher risk for death. CONCLUSIONS: Dengue is a multifactorial disease and, factors such as viral strain/serotype, occurrence of secondary infections and co-morbidities may lead to a severe outcome. However, the high dengue incidence and transmission during epidemics, such as those observed in Brazil may overwhelm and collapse the public health services, potentially impacting on increased disease severity and mortality.","['Nunes, Priscila Conrado Guerra', 'de Filippis, Ana Maria Bispo', 'Lima, Monique Queiroz da Rocha', 'Faria, Nieli Rodrigues da Costa', 'de Bruycker-Nogueira, Fernanda', 'Santos, Jaqueline Bastos', 'Heringer, Manoela', 'Chouin-Carneiro, Thais', 'Couto-Lima, Dinair', 'de Santis Goncalves, Bianca', 'Sampaio, Simone Alves', 'de Araujo, Eliane Saraiva Machado', 'Sanchez-Arcila, Juan Camilo', 'Dos Santos, Flavia Barreto', 'Nogueira, Rita Maria Ribeiro']","['Nunes PCG', 'de Filippis AMB', 'Lima MQDR', 'Faria NRDC', 'de Bruycker-Nogueira F', 'Santos JB', 'Heringer M', 'Chouin-Carneiro T', 'Couto-Lima D', 'de Santis Goncalves B', 'Sampaio SA', 'de Araujo ESM', 'Sanchez-Arcila JC', 'Dos Santos FB', 'Nogueira RMR']",['ORCID: 0000-0002-1309-5366'],"['Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Hematozoa Transmittors Mosquitoes Laboratory, Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Hematozoa Transmittors Mosquitoes Laboratory, Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory (LIV), Oswaldo Cruz Institute, IOC, FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil. flaviab@ioc.fiocruz.br.', 'Flavivirus Laboratory (LABFLA), Oswaldo Cruz Institute- FIOCRUZ, Avenida Brasil, 4365. Manguinhos, Rio de Janeiro, Brazil.']",['eng'],['Journal Article'],20180727,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Brazil/epidemiology', '*Dengue/epidemiology/mortality/virology', 'Humans', 'Molecular Epidemiology']",PMC6062978,2018/07/29 06:00,2019/05/22 06:00,['2018/07/29 06:00'],"['2017/10/25 00:00 [received]', '2018/07/13 00:00 [accepted]', '2018/07/29 06:00 [entrez]', '2018/07/29 06:00 [pubmed]', '2019/05/22 06:00 [medline]']","['10.1186/s12879-018-3255-x [pii]', '3255 [pii]', '10.1186/s12879-018-3255-x [doi]']",epublish,BMC Infect Dis. 2018 Jul 27;18(1):346. doi: 10.1186/s12879-018-3255-x.,1,,['NOTNLM'],"['Brazil', 'Dengue', 'Epidemiology', 'Fatal cases', 'Laboratorial diagnosis']","['ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The dengue suspected fatal cases', 'analyzed in this study belong to a previously-gathered collection from a Project', 'in the Laboratory of Flavivirus, Oswaldo Cruz Institute, FIOCRUZ, approved by', 'resolution number CSN196/96 from the Oswaldo Cruz Foundation Ethical Committee in', 'Research (CEP 274/05), Ministry of Health, Brazil. As a Regional Reference', 'Laboratory for the Brazilian Ministry of Health, suspected cases are received as', 'convenience sampling for diagnosis and informed consent is waived. CONSENT FOR', 'PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they', ""have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral"", 'with regard to jurisdictional claims in published maps and institutional', 'affiliations.']",,"['303822/2015-5/Conselho Nacional de Desenvolvimento Cientifico e', 'Tecnologico/International', '407690/2012-3/Programa Estrategico de Pesquisa em Saude/PAPES', 'VI-FIOCRUZ/International', 'E-26/202.003/2016/Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do', 'Rio de Janeiro/International']",,,,,,,,,,,,,,,,
7030558,NLM,MEDLINE,19820222,20041117,0308-2261 (Print) 0308-2261 (Linking),10,1981 Oct,Haemorrhagic disorders. Part 2: Tropical Asia.,933-62,,,"['Suvatte, V']",['Suvatte V'],,,['eng'],"['Journal Article', 'Review']",,England,Clin Haematol,Clinics in haematology,0331547,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Asia', 'Blood Coagulation', 'Blood Platelets/cytology', 'Child', 'Child, Preschool', 'Dengue/blood/diagnosis/*epidemiology/pathology/therapy', 'Disease Outbreaks/*epidemiology', 'Female', 'Hematocrit', 'Hemorrhage/therapy', 'Humans', 'Infant', 'Leukocytes/cytology', 'Male', 'Seasons', 'Shock/therapy', 'Tropical Climate']",,1981/10/01 00:00,1981/10/01 00:01,['1981/10/01 00:00'],"['1981/10/01 00:00 [pubmed]', '1981/10/01 00:01 [medline]', '1981/10/01 00:00 [entrez]']",,ppublish,Clin Haematol. 1981 Oct;10(3):933-62.,3,,,,,,,109,,,,,,,,,,,,,,,
7844838,NLM,MEDLINE,19950307,20150901,0257-5655 (Print) 0257-5655 (Linking),10 Suppl,1994 Dec,Dengue control programme in Malaysia.,S113-5,,,,,,,['eng'],['Journal Article'],,China (Republic : 1949- ),Gaoxiong Yi Xue Ke Xue Za Zhi,Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,8603880,,IM,"['Dengue/epidemiology/*prevention & control', 'Humans', 'Malaysia/epidemiology']",,1994/12/01 00:00,1994/12/01 00:01,['1994/12/01 00:00'],"['1994/12/01 00:00 [pubmed]', '1994/12/01 00:01 [medline]', '1994/12/01 00:00 [entrez]']",,ppublish,Gaoxiong Yi Xue Ke Xue Za Zhi. 1994 Dec;10 Suppl:S113-5.,,,,,,,,,,,,,,,,,,,,,,,
33907917,NLM,MEDLINE,20210809,20210809,0973-7693 (Electronic) 0019-5456 (Linking),88,2021 Jul,A Clinical Audit of Adherence to Guidelines During Emergency Management of Pediatric Dengue Patients.,717,10.1007/s12098-021-03781-x [doi],,"['Choudhary, Bharat', 'Jayappa, Manjesh', 'Gupta, Priya', 'Singh, Kuldeep', 'Choudhary, Yachana']","['Choudhary B', 'Jayappa M', 'Gupta P', 'Singh K', 'Choudhary Y']",['ORCID: 0000-0002-4289-4415'],"['Department of Trauma and Emergency (Pediatrics), All India Institute of Medical Sciences, Jodhpur, Rajasthan, 342005, India. drbharatpaeder@gmail.com.', 'Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.', 'Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.', 'Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.', 'Department of Community Medicine & Family Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.']",['eng'],['Letter'],20210428,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Child', '*Clinical Audit', '*Dengue/diagnosis/therapy', 'Emergency Service, Hospital', 'Guideline Adherence', 'Humans', 'Medical Audit']",,2021/04/29 06:00,2021/08/10 06:00,['2021/04/28 06:28'],"['2020/12/04 00:00 [received]', '2021/04/15 00:00 [accepted]', '2021/04/29 06:00 [pubmed]', '2021/08/10 06:00 [medline]', '2021/04/28 06:28 [entrez]']","['10.1007/s12098-021-03781-x [pii]', '10.1007/s12098-021-03781-x [doi]']",ppublish,Indian J Pediatr. 2021 Jul;88(7):717. doi: 10.1007/s12098-021-03781-x. Epub 2021 Apr 28.,7,,,,,,,,,,,,,,,,,,,,,,
33768451,NLM,MEDLINE,20210726,20210726,1865-7265 (Electronic) 1865-7265 (Linking),14,2021 Aug,A case of dengue fever that should be considered as imported infectious disease with digestive symptoms.,1115-1120,10.1007/s12328-021-01391-w [doi],"Patients with dengue fever usually present with fever and rash, but non-specific symptoms such as headache, myalgia, arthralgia, and digestive symptoms are sometimes seen. We report a case of dengue fever with digestive symptoms in a patient who traveled to Indonesia. A 35-year-old man presented with fever, diarrhea, headache, and arthralgia. He later developed generalized rash. Dengue fever was clinically suspected from the travel history and confirmed by laboratory tests. He tested positive for anti-dengue virus antibodies, so dengue fever was diagnosed. Dengue fever should be included in the differential diagnosis of patients with digestive symptoms after returning to Japan.","['Kinoshita, Keisuke', 'Fukuchi, Satoshi', 'Fukuda, Kensuke', 'Okamoto, Kazuhisa', 'Ogawa, Ryo', 'Matsunari, Osamu', 'Mizukami, Kazuhiro', 'Okimoto, Tadayoshi', 'Kodama, Masaaki', 'Murakami, Kazunari']","['Kinoshita K', 'Fukuchi S', 'Fukuda K', 'Okamoto K', 'Ogawa R', 'Matsunari O', 'Mizukami K', 'Okimoto T', 'Kodama M', 'Murakami K']",['ORCID: 0000-0002-4534-6174'],"['Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan. kkinoshita@oita-u.ac.jp.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Almeida Memorial Hospital, Oita, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.', 'Department of Gastroenterology, Oita University Faculty of Medicine Graduate School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan.']",['eng'],"['Case Reports', 'Journal Article']",20210325,Japan,Clin J Gastroenterol,Clinical journal of gastroenterology,101477246,,IM,"['Adult', '*Communicable Diseases, Imported', '*Dengue/complications/diagnosis', 'Fever/etiology', 'Humans', 'Japan', 'Male', 'Travel']",,2021/03/27 06:00,2021/07/27 06:00,['2021/03/26 07:11'],"['2021/01/08 00:00 [received]', '2021/03/16 00:00 [accepted]', '2021/03/27 06:00 [pubmed]', '2021/07/27 06:00 [medline]', '2021/03/26 07:11 [entrez]']","['10.1007/s12328-021-01391-w [pii]', '10.1007/s12328-021-01391-w [doi]']",ppublish,Clin J Gastroenterol. 2021 Aug;14(4):1115-1120. doi: 10.1007/s12328-021-01391-w. Epub 2021 Mar 25.,4,['(c) 2021. Japanese Society of Gastroenterology.'],['NOTNLM'],"['Dengue fever', 'Digestive symptoms', 'Travel history']",,,,,,,,,,,,,,,,,,,
25080833,NLM,MEDLINE,20150819,20141202,1769-664X (Electronic) 0929-693X (Linking),21,2014 Nov,[Dengue fever in mainland France].,1274-8,S0929-693X(14)00320-0 [pii] 10.1016/j.arcped.2014.07.002 [doi],"Dengue fever is the most widespread distributed vector borne viral disease. It is transmitted through the bites of Aedes aegypti and Aedes albopictus mosquitoes. With the expansion of Aedes albopictus and increasing travel exchange, it is no longer limited to the tropical zone and transmission has been documented in temperate areas. In mainland France, where Aedes albopictus has been present and disseminating since 2004, 2 episodes of autochthonous transmission occurred in 2010 and in 2013. Control measures against dengue and chikungunya, which shares the same vector, are implemented every year since 2006, in the areas where the vector is present. They aim at preventing or limiting local transmission of these diseases. They are based on epidemiological and entomological surveillance and vector control measures. The diagnosis of dengue, and chikungunya should be considered in case of suggestive symptoms in patients returning from an area of virus circulation. It should also be considered for patients living or having stayed in areas of mainland France where Aedes albopictus is present, during its activity period from May 1 to November 30. The prevention and control system, including vector control measures and the notification of cases to the local health authority should be known, as the risk of autochthonous transmission increases every year.","['Paty, M-C']",['Paty MC'],,"[""Departement des maladies infectieuses, institut de veille sanitaire, 12, rue du Val-d'Osne, 94415 Saint-Maurice cedex, France. Electronic address: mc.paty@invs.sante.fr.""]",['fre'],"['English Abstract', 'Journal Article']",20140728,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Aedes/virology', 'Animals', 'Dengue/diagnosis/*epidemiology/prevention & control/*transmission', 'Disease Notification', 'France', 'Humans', 'Mosquito Control', '*Neglected Diseases', 'Population Surveillance', 'Risk Factors', 'Travel', 'Urban Population']",,2014/08/02 06:00,2015/08/20 06:00,['2014/08/02 06:00'],"['2014/04/23 00:00 [received]', '2014/06/27 00:00 [revised]', '2014/07/04 00:00 [accepted]', '2014/08/02 06:00 [entrez]', '2014/08/02 06:00 [pubmed]', '2015/08/20 06:00 [medline]']","['S0929-693X(14)00320-0 [pii]', '10.1016/j.arcped.2014.07.002 [doi]']",ppublish,Arch Pediatr. 2014 Nov;21(11):1274-8. doi: 10.1016/j.arcped.2014.07.002. Epub 2014 Jul 28.,11,['Copyright (c) 2014 Elsevier Masson SAS. All rights reserved.'],,,,,,,,La dengue en France metropolitaine.,,,,,,,,,,,,,
21907213,NLM,MEDLINE,20120123,20131121,1095-8541 (Electronic) 0022-5193 (Linking),289,2011 Nov 21,The role of seasonality and import in a minimalistic multi-strain dengue model capturing differences between primary and secondary infections: complex dynamics and its implications for data analysis.,181-96,10.1016/j.jtbi.2011.08.043 [doi],"In many countries in Asia and South-America dengue fever (DF) and dengue hemorrhagic fever (DHF) has become a substantial public health concern leading to serious social-economic costs. Mathematical models describing the transmission of dengue viruses have focussed on the so-called antibody-dependent enhancement (ADE) effect and temporary cross-immunity trying to explain the irregular behavior of dengue epidemics by analyzing available data. However, no systematic investigation of the possible dynamical structures has been performed so far. Our study focuses on a seasonally forced (non-autonomous) model with temporary cross-immunity and possible secondary infection, motivated by dengue fever epidemiology. The notion of at least two different strains is needed in a minimalistic model to describe differences between primary infections, often asymptomatic, and secondary infection, associated with the severe form of the disease. We extend the previously studied non-seasonal (autonomous) model by adding seasonal forcing, mimicking the vectorial dynamics, and a low import of infected individuals, which is realistic in the dynamics of dengue fever epidemics. A comparative study between three different scenarios (non-seasonal, low seasonal and high seasonal with a low import of infected individuals) is performed. The extended models show complex dynamics and qualitatively a good agreement between empirical DHF monitoring data and the obtained model simulation. We discuss the role of seasonal forcing and the import of infected individuals in such systems, the biological relevance and its implications for the analysis of the available dengue data. At the moment only such minimalistic models have a chance to be qualitatively understood well and eventually tested against existing data. The simplicity of the model (low number of parameters and state variables) offer a promising perspective on parameter values inference from the DHF case notifications.","['Aguiar, Maira', 'Ballesteros, Sebastien', 'Kooi, Bob W', 'Stollenwerk, Nico']","['Aguiar M', 'Ballesteros S', 'Kooi BW', 'Stollenwerk N']",,"['Centro de Matematica e Aplicacoes Fundamentais da Universidade de Lisboa, Avenida Prof. Gama Pinto 2, 1649-003 Lisboa, Portugal. maira@ptmat.fc.ul.pt']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20110909,England,J Theor Biol,Journal of theoretical biology,0376342,,IM,"['Dengue/*epidemiology/immunology/virology', 'Dengue Virus/classification', 'Disease Outbreaks', 'Disease Susceptibility', 'Humans', 'Immunologic Memory', '*Models, Biological', 'Recurrence', '*Seasons', 'Severe Dengue/epidemiology/immunology/virology']",,2011/09/13 06:00,2012/01/24 06:00,['2011/09/13 06:00'],"['2011/02/27 00:00 [received]', '2011/05/25 00:00 [revised]', '2011/08/30 00:00 [accepted]', '2011/09/13 06:00 [entrez]', '2011/09/13 06:00 [pubmed]', '2012/01/24 06:00 [medline]']","['S0022-5193(11)00446-2 [pii]', '10.1016/j.jtbi.2011.08.043 [doi]']",ppublish,J Theor Biol. 2011 Nov 21;289:181-96. doi: 10.1016/j.jtbi.2011.08.043. Epub 2011 Sep 9.,,['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
36537278,NLM,MEDLINE,20230420,20230420,2048-7207 (Electronic) 2048-7193 (Linking),12,2023 Apr 18,The 2019-2020 Dengue Fever Epidemic: Genomic Markers Indicating Severity in Dominican Republic Children.,169-172,10.1093/jpids/piac136 [doi],"We performed an observational cohort study to assess associations between genetic factors of dengue fever (DF) severity in children in the Dominican Republic. A total of 488 participants had serologically confirmed DF. We replicated the association between the IFIH1 gene (rs1990760) and severe DF (n = 80/488, p = 0.006) and identified novel associations needing further investigation.","['Simpson, Brittany N', 'Mejia Sang, Miguel E', 'Collado Puello, Yonairy', 'Diaz Brockmans, Elvira J', 'Diaz Soto, Maria F', 'Rivera Defillo, Stephanie M', 'Taveras Cruz, Karla M', 'Santiago Perez, Javier O', 'Husami, Ammar', 'Day, Melissa E', 'Pilipenko, Valentina', 'Mena, Rafael', 'Mota, Cesar', 'Hostetter, Margaret K', 'Muglia, Louis J', 'Schlaudecker, Elizabeth', 'Gonzalez Del Rey, Javier', 'Martin, Lisa J', 'Prada, Carlos E']","['Simpson BN', 'Mejia Sang ME', 'Collado Puello Y', 'Diaz Brockmans EJ', 'Diaz Soto MF', 'Rivera Defillo SM', 'Taveras Cruz KM', 'Santiago Perez JO', 'Husami A', 'Day ME', 'Pilipenko V', 'Mena R', 'Mota C', 'Hostetter MK', 'Muglia LJ', 'Schlaudecker E', 'Gonzalez Del Rey J', 'Martin LJ', 'Prada CE']",['ORCID: 0000-0002-2131-0177'],"[""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', 'School of Medicine, Universidad Iberamericana (UNIBE), Santo Domingo, Dominican Republic.', 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', 'Instituto Tecnologico de Santo Domingo, School of Medicine, Santo Domingo, Dominican Republic.', ""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", 'Centro de Obstetricia y Ginecologia, Santo Domingo, Dominican Republic.', 'Pediatric Emergency Medicine Department, Hospital Infantil Dr. Robert Reid, Santo Domingo, Dominican Republic.', ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", 'Burroughs Welcome Fund, Research Triangle Park, North Carolina, USA.', ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Pediatric Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA."", ""Division of Genetics, Genomics & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA."", 'Department of Pediatrics, Feinberg School of Medicine of Northwestern University, Chicago, Illinois, USA.']",['eng'],"['Journal Article', 'Observational Study']",,England,J Pediatric Infect Dis Soc,Journal of the Pediatric Infectious Diseases Society,101586049,,IM,"['Humans', 'Child', '*Dengue/diagnosis/epidemiology', 'Dominican Republic/epidemiology', '*Severe Dengue', 'Cohort Studies', 'Genomics']",,2022/12/21 06:00,2023/04/20 10:17,['2022/12/20 04:44'],"['2022/08/16 00:00 [received]', '2022/12/19 00:00 [accepted]', '2023/04/20 10:17 [medline]', '2022/12/21 06:00 [pubmed]', '2022/12/20 04:44 [entrez]']","['6947090 [pii]', '10.1093/jpids/piac136 [doi]']",ppublish,J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):169-172. doi: 10.1093/jpids/piac136.,3,"['(c) The Author(s) 2022. Published by Oxford University Press on behalf of The', 'Journal of the Pediatric Infectious Diseases Society. All rights reserved. For', 'permissions, please e-mail: journals.permissions@oup.com.']",['NOTNLM'],"['children', 'dengue fever', 'genomic risk factors', 'interferon']",,,"[""Cincinnati Children's Hospital Medical Center/""]",,,,,,,,,,,,,,,,
8036818,NLM,MEDLINE,19940812,20080310,0043-3144 (Print) 0043-3144 (Linking),43,1994 Mar,"Dengue incidence in CAREC member countries, 1993.",32,,,,,,,['eng'],['Journal Article'],,Jamaica,West Indian Med J,The West Indian medical journal,0417410,,IM,"['Caribbean Region/epidemiology', 'Cross-Sectional Studies', 'Dengue/diagnosis/*epidemiology', 'Humans', 'Incidence']",,1994/03/01 00:00,1994/03/01 00:01,['1994/03/01 00:00'],"['1994/03/01 00:00 [pubmed]', '1994/03/01 00:01 [medline]', '1994/03/01 00:00 [entrez]']",,ppublish,West Indian Med J. 1994 Mar;43(1):32.,1,,,,,,,,,,,,,,,,,,,,,,
27037107,NLM,MEDLINE,20170102,20170104,1526-3347 (Electronic) 0191-9601 (Linking),37,2016 Apr,Dengue and Chikungunya.,179-81,10.1542/pir.2015-0172 [doi],,"['Lee, Paul J', 'Krilov, Leonard R']","['Lee PJ', 'Krilov LR']",,"[""Children's Medical Center, Winthrop-University Hospital, Mineola, NY."", 'State University of New York at Stony Brook School of Medicine, Stony Brook, NY.']",['eng'],['Journal Article'],,United States,Pediatr Rev,Pediatrics in review,8103046,,IM,"['Chikungunya Fever/*diagnosis/therapy/virology', 'Dengue/*diagnosis/therapy/virology', 'Diagnosis, Differential', 'Humans']",,2016/04/03 06:00,2017/01/04 06:00,['2016/04/03 06:00'],"['2016/04/03 06:00 [entrez]', '2016/04/03 06:00 [pubmed]', '2017/01/04 06:00 [medline]']","['37/4/179 [pii]', '10.1542/pir.2015-0172 [doi]']",ppublish,Pediatr Rev. 2016 Apr;37(4):179-81. doi: 10.1542/pir.2015-0172.,4,,,,,,,,,,,,,,,,,,,,,,
8622446,NLM,MEDLINE,19960618,20190611,0140-6736 (Print) 0140-6736 (Linking),347,1996 May 4,"Mosquitoes, models, and dengue.",1201-2,,,"['Lifson, A R']",['Lifson AR'],,"['Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, USA.']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['*Aedes', 'Animals', 'Dengue/*epidemiology/transmission', 'Humans', '*Insect Vectors', 'Models, Theoretical']",,1996/05/04 00:00,1996/05/04 00:01,['1996/05/04 00:00'],"['1996/05/04 00:00 [pubmed]', '1996/05/04 00:01 [medline]', '1996/05/04 00:00 [entrez]']","['S0140-6736(96)90730-8 [pii]', '10.1016/s0140-6736(96)90730-8 [doi]']",ppublish,Lancet. 1996 May 4;347(9010):1201-2. doi: 10.1016/s0140-6736(96)90730-8.,9010,,['PIP'],"['Americas', 'Behavior', '*Caribbean', '*Dengue--transmission', 'Developing Countries', 'Diseases', '*Epidemics--determinants', '*Epidemiologic Methods', 'Examinations And Diagnoses', 'Health', '*Laboratory Examinations And Diagnoses', 'Latin America', '*Models, Theoretical', 'North America', '*Parasite Control', 'Public Health', 'Research Methodology', '*Travel And Tourism', 'Viral Diseases']",,,,,,,,"['PIP: 113452', 'POP: 00252373']","['In the last 10 years dengue has spread markedly through Latin America and the', 'Caribbean (Dominican Republic, Jamaica, Barbados, Mexico, Guatemala, El Salvador,', 'Honduras, Nicaragua, Costa Rica, Panama, Ecuador, Colombia, Venezuela, and', 'Brazil). The mosquito Aedes aegypti has taken advantage of increased urbanization', 'and crowding to transmit the dengue virus. The mosquito infests tires, cans, and', 'water jars near dwellings. The female mosquito practices multiple, interrupted', 'feeding. Thus, mosquito infesting and feeding practices facilitate dengue', 'transmission in crowded conditions. Factors contributing to the spread of dengue', 'include numbers of infected and susceptible human hosts, strain of dengue virus,', 'size of mosquito population, feeding habits, time from infection to ability to', 'transmit virus for both vector and host, likelihood of virus transmission from', 'human to mosquito to human, and temperature (which affects vector distribution,', 'size, feeding habits, and extrinsic incubation period). Public health models may', 'use simulation models to help them plan or evaluate the potential impact of', 'different intervention strategies and/or of environmental changes (e.g., global', 'warming). Other factors contributing to the dengue epidemic are international', 'travel, urbanization, population growth, crowding, poverty, a weakened public', 'health infrastructure, and limited support for sustained disease control', 'programs. Molecular epidemiology by nucleic acid sequence analysis is another', 'sophisticated technique used to study infectious diseases. It showed that dengue', 'type 3 isolated from Panama and Nicaragua in 1994 was identical to that', 'responsible for the major dengue hemorrhagic fever epidemics in Sri Lanka and', 'India in the 1980s. Public health officials must remember three priorities', 'relevant to dengue and other emerging infections: the need to strengthen', 'surveillance efforts, dedicated and sustained involvement in prevention and', 'control needs at the local level, and a strong public health infrastructure at', 'the international, national, and local levels to maintain support for', 'surveillance and control activities.']",['eng'],['PIP: TJ: LANCET.'],,,,,,,,
3647549,NLM,MEDLINE,19870715,20061115,0864-0319 (Print) 0864-0319 (Linking),2,1987 Jan-Apr,[Results of follow-up in a group of patients with severe hemorrhagic dengue].,68-77,,,"['Reyes Caballero, M', 'Allen Brown, A', 'Martinez Torres, E']","['Reyes Caballero M', 'Allen Brown A', 'Martinez Torres E']",,,['spa'],"['English Abstract', 'Journal Article']",,Cuba,Rev Cubana Enferm,Revista cubana de enfermeria,9301327,,,"['Child', 'Child, Preschool', 'Dengue/complications/*nursing', 'Female', 'Follow-Up Studies', 'Humans', 'Male']",,1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Rev Cubana Enferm. 1987 Jan-Apr;2(1):68-77.,1,,,,,,,,,Resultado del seguimiento a un grupo de pacientes graves de dengue hemorragico.,,,,,,,,,,,,,
17719483,NLM,MEDLINE,20071113,20141120,1074-5521 (Print) 1074-5521 (Linking),14,2007 Aug,Deadly dengue: new vaccines promise to tackle this escalating global menace.,871-2,,,"['Shekhar, Chandra']",['Shekhar C'],,['chandra@nasw.org'],['eng'],['Journal Article'],,United States,Chem Biol,Chemistry & biology,9500160,['0 (Viral Vaccines)'],IM,"['Dengue/epidemiology/immunology/*prevention & control', 'Dengue Virus/immunology', '*Global Health', 'Humans', 'Viral Vaccines/immunology/*therapeutic use']",,2007/08/28 09:00,2007/11/14 09:00,['2007/08/28 09:00'],"['2007/08/28 09:00 [pubmed]', '2007/11/14 09:00 [medline]', '2007/08/28 09:00 [entrez]']","['S1074-5521(07)00259-1 [pii]', '10.1016/j.chembiol.2007.08.004 [doi]']",ppublish,Chem Biol. 2007 Aug;14(8):871-2. doi: 10.1016/j.chembiol.2007.08.004.,8,,,,,,,,,,,,,,,,,,,,,,
2772694,NLM,MEDLINE,19891006,20061115,0125-1562 (Print) 0125-1562 (Linking),20,1989 Mar,Dengue fever in American military personnel in the Philippines: clinical observations on hospitalized patients during a 1984 epidemic.,1-8,,"From June - August, 1984, 24 American military personnel were hospitalized with dengue (DEN) at Clark Air Base in the Philippines. Their infections were confirmed by serology using the hemagglutination-inhibition test and/or by virus isolation in Aedes pseudoscutellaris cell cultures. Most of the patients had a secondary type of antibody response probably reflecting prior vaccination against yellow fever. Three serotypes of DEN virus were isolated; 7 isolates of DEN 1, 4 isolates of DEN 3 and 3 isolates of DEN 2. All of the patients were Caucasian males between the ages of 20-43 years. All of the cases were clinically diagnosed as classical dengue fever. A platelet count of less than or equal to 100,000/microliters was a common finding (83.3%); however, hemoconcentration was not documented. Other major findings were the occurrence of mild hypotension (62.5%) and petechiae (37.5%). One patient presented with shock and upper gastrointestinal bleeding, but his diagnosis was complicated by a history of epigastric pain and use of aspirin. Although all of the patients fully recovered, the severity of illness was clearly documented by the average-length of hospitalization (5.9 days) and average time absent from work (8.7 days).","['Hayes, C G', ""O'Rourke, T F"", 'Fogelman, V', 'Leavengood, D D', 'Crow, G', 'Albersmeyer, M M']","['Hayes CG', ""O'Rourke TF"", 'Fogelman V', 'Leavengood DD', 'Crow G', 'Albersmeyer MM']",,"['U.S. Naval Medical Research Unit No. 2, APO San Francisco, California 96528-5000.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Adult', 'Dengue/blood/*epidemiology/physiopathology', 'Dengue Virus/isolation & purification', '*Disease Outbreaks', 'Humans', 'Length of Stay', 'Male', '*Military Personnel', 'Philippines']",,1989/03/01 00:00,1989/03/01 00:01,['1989/03/01 00:00'],"['1989/03/01 00:00 [pubmed]', '1989/03/01 00:01 [medline]', '1989/03/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1989 Mar;20(1):1-8.,1,,,,,,,,,,,,,,,,,,,,,,
25299251,NLM,MEDLINE,20160208,20211021,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),8,2014 Oct,"Physician survey to determine how dengue is diagnosed, treated and reported in puerto rico.",e3192,10.1371/journal.pntd.0003192 [doi] e3192,"Dengue is a major cause of morbidity in Puerto Rico and is well-known to its physicians. Early case identification and timely initiation of treatment for patients with severe dengue can reduce medical complications and mortality. To determine clinical management and reporting practices, and assess knowledge of dengue and its management, a survey was sent to 2,512 physicians with a medical license in Puerto Rico. Of the 2,313 physicians who received the survey, 817 (35%) completed the questionnaire. Of the respondents, 708 were currently practicing medicine; 138 were board certified (Group 1), 282 were board eligible (Group 2), and 288 had not finished residency (Group 3). Although respondents clinically diagnosed, on average, 12 cases of dengue in the preceding three months, 31% did not report any suspected cases to public health officials while about half (56%) reported all cases. Overall, 29% of respondents correctly identified early signs of shock and 48% identified severe abdominal pain and persistent vomiting as warning signs for severe dengue with the proportion of correct respondents highest in Group 1. Reportedly about sixty percent (57%) appropriately never give corticosteroids or prophylactic platelet transfusions to dengue patients. One third (30%) of respondents correctly identified administration of intravenous colloid solution as the best treatment option for dengue patients with refractory shock and elevated hematocrit after an initial trial of intravenous crystalloids, and nearly one half (46%) correctly identified administration of a blood transfusion as the best option for dengue patients with refractory shock and decreased hematocrit after a trial of intravenous crystalloids. Even though dengue has been endemic in Puerto Rico for nearly 4 decades, knowledge of dengue management is still limited, compliance with WHO treatment guidelines is suboptimal, and underreporting is significant. These findings were used to design a post graduate training course to improve the clinical management of dengue.","['Tomashek, Kay M', 'Biggerstaff, Brad J', 'Ramos, Mary M', 'Perez-Guerra, Carmen L', 'Garcia Rivera, Enid J', 'Sun, Wellington']","['Tomashek KM', 'Biggerstaff BJ', 'Ramos MM', 'Perez-Guerra CL', 'Garcia Rivera EJ', 'Sun W']",,"['Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America.', 'Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.', 'Puerto Rico Department of Health, San Juan, Puerto Rico.', 'Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.']",['eng'],['Journal Article'],20141009,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adult', 'Data Collection', 'Dengue/*diagnosis/epidemiology/*therapy', 'Disease Notification/*methods', 'Female', 'Humans', 'Male', 'Middle Aged', 'Puerto Rico/epidemiology', 'Surveys and Questionnaires', 'Young Adult']",PMC4191957,2014/10/10 06:00,2016/02/09 06:00,['2014/10/10 06:00'],"['2014/06/05 00:00 [received]', '2014/08/14 00:00 [accepted]', '2014/10/10 06:00 [entrez]', '2014/10/10 06:00 [pubmed]', '2016/02/09 06:00 [medline]']","['PNTD-D-14-00961 [pii]', '10.1371/journal.pntd.0003192 [doi]']",epublish,PLoS Negl Trop Dis. 2014 Oct 9;8(10):e3192. doi: 10.1371/journal.pntd.0003192. eCollection 2014 Oct.,10,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,['ClinicalTrials.gov/NCT01030211']
37536724,NLM,MEDLINE,20230807,20230808,1756-1833 (Electronic) 0959-8138 (Linking),382,2023 Aug 3,How climate change is changing dengue fever.,1690,10.1136/bmj.p1690 [doi],,"['Bashir, Aliya']",['Bashir A'],,['Delhi.'],['eng'],['Journal Article'],20230803,England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['Humans', '*Climate Change', '*Dengue/epidemiology/prevention & control', 'Incidence']",,2023/08/04 01:08,2023/08/07 06:41,['2023/08/03 20:43'],"['2023/08/07 06:41 [medline]', '2023/08/04 01:08 [pubmed]', '2023/08/03 20:43 [entrez]']",['10.1136/bmj.p1690 [doi]'],epublish,BMJ. 2023 Aug 3;382:1690. doi: 10.1136/bmj.p1690.,,,,,"['Competing interests: I have read and understood BMJ policy on declaration of', 'interests and have no relevant interests to declare.']",,,,,,,,,,,,,,,,,,
33478539,NLM,MEDLINE,20210514,20210514,1756-0500 (Electronic) 1756-0500 (Linking),14,2021 Jan 21,A silent public health threat: emergence of Mayaro virus and co-infection with Dengue in Peru.,29,10.1186/s13104-021-05444-8 [doi] 29,"OBJECTIVE: To describe frequency and clinical characteristics of MAYV infection in Piura, as well as the association of this pathogen with DENV. RESULTS: A total of 86/496 (17.3%) cases of MAYV were detected, of which 54 were MAYV mono-infection and 32 were co-infection with DENV, accounting for 10.9% and 6.4%, respectively. When evaluating monoinfection by MAYV the main groups were 18-39 and 40-59 years old, with 25.9% and 20.4% respectively. Co-infections were more common in the age group 18-39 and those > 60 years old, with 34.4% and 21.9%, respectively. The most frequent clinical presentation were headaches (94.4%, 51/54) followed by arthralgias (77.8%, 42/54). During the 8-month study period the most cases were identified in the months of May (29.1%) and June (50.0%).","['Aguilar-Luis, Miguel Angel', 'Del Valle-Mendoza, Juana', 'Sandoval, Isabel', 'Silva-Caso, Wilmer', 'Mazulis, Fernando', 'Carrillo-Ng, Hugo', 'Tarazona-Castro, Yordi', 'Martins-Luna, Johanna', 'Aquino-Ortega, Ronald', 'Pena-Tuesta, Isaac', 'Cornejo-Tapia, Angela', 'Del Valle, Luis J']","['Aguilar-Luis MA', 'Del Valle-Mendoza J', 'Sandoval I', 'Silva-Caso W', 'Mazulis F', 'Carrillo-Ng H', 'Tarazona-Castro Y', 'Martins-Luna J', 'Aquino-Ortega R', 'Pena-Tuesta I', 'Cornejo-Tapia A', 'Del Valle LJ']",['ORCID: 0000-0002-6011-5040'],"['School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru. juana.delvalle@upc.pe.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru. juana.delvalle@upc.pe.', 'Subregion Morropon Huancabamba, Direccion Regional de Salud de Piura (DIRESA), Piura, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Escuela Profesional de Genetica Y Biotecnologia. Facultad de Ciencias Biologicas, Universidad Nacional Mayor de San Marcos, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', 'Laboratorio de Biologia Molecular, Instituto de Investigacion Nutricional, Lima, Peru.', 'School of Medicine, Research and Innovation Center of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.', ""Barcelona Research Center for Multiscale Science and Engineering, Departament D'Enginyeria Quimica, EEBE, Universitat Politecnica de Catalunya (UPC), Barcelona, Spain. luis.javier.del.valle@upc.edu.""]",['eng'],['Journal Article'],20210121,England,BMC Res Notes,BMC research notes,101462768,,IM,"['*Alphavirus Infections', '*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Humans', 'Middle Aged', 'Peru/epidemiology', 'Public Health']",PMC7818721,2021/01/23 06:00,2021/05/15 06:00,['2021/01/22 05:45'],"['2020/10/12 00:00 [received]', '2021/01/07 00:00 [accepted]', '2021/01/22 05:45 [entrez]', '2021/01/23 06:00 [pubmed]', '2021/05/15 06:00 [medline]']","['10.1186/s13104-021-05444-8 [pii]', '5444 [pii]', '10.1186/s13104-021-05444-8 [doi]']",epublish,BMC Res Notes. 2021 Jan 21;14(1):29. doi: 10.1186/s13104-021-05444-8.,1,,['NOTNLM'],"['Alphavirus', 'Arbovirus', 'Dengue', 'Mayaro virus', 'PCR', 'Peru']","['On behalf of all authors, the corresponding author states that there are no', 'conflicts of interest or funding related to this study.']",,"['UPC-A-058-2020/Incentives for Research of the Universidad Peruana de Ciencias', 'Aplicadas/', 'No. 2015M3A9B6073666/Bio & Medical TechnologyDevelopment Program of the National', 'Research Foundation (NRF)funded by the Korean government (MSIT)/']",,,,,,,,,,,,,,,,
34929011,NLM,MEDLINE,20220110,20220110,1932-6203 (Electronic) 1932-6203 (Linking),16,2021,Different domains of dengue research in the Philippines: A systematic review and meta-analysis of questionnaire-based studies.,e0261412,10.1371/journal.pone.0261412 [doi] e0261412,"BACKGROUND: Dengue is the most rapidly spreading mosquito-borne viral disease of humans worldwide, including southeast Asia region. This review provides a comprehensive overview of questionnaire-related dengue studies conducted in the Philippines and evaluates their reliability and validity in these surveys. METHODS: A review protocol constructed by a panel of experienced academic reviewers was used to formulate the methodology, research design, search strategy and selection criteria. An extensive literature search was conducted between March-June 2020 in various major electronic biomedical databases including PubMed, EMBASE, MEDLINE and ScienceDirect. A systematic review and meta-analysis (PRISMA) were selected as the preferred item reporting method. RESULTS: Out of a total of 34 peer-reviewed dengue-related KAP studies that were identified, 15 published from 2000 to April 2020 met the inclusion criteria. Based on the meta-analysis, a poor mean score was obtained for each of knowledge (68.89), attitude (49.86) and preventive practice (64.69). Most respondents were equipped with a good knowledge of the major clinical signs of dengue. Worryingly, 95% of respondents showed several negative attitudes towards dengue prevention, claiming that this was not possible and that enacting preventive practices was not their responsibility. Interestingly, television or radio was claimed as the main source of gaining dengue information (range 50-95%). Lastly, only five articles (33.3%) piloted or pretested their questionnaire before surveying, of which three reported Cronbach's alpha coefficient (range 0.70 to 0.90). CONCLUSION: This review indicates that to combat the growing public health threat of dengue to the Philippines, we need the active participation of resident communities, full engagement of healthcare personnel, promotion of awareness campaigns, and access to safe complementary and alternative medicines. Importantly, the psychometric properties of each questionnaire should be assessed rigorously.","['Guad, Rhanye Mac', 'Carandang, Rogie Royce', 'Solidum, Judilynn N', 'W Taylor-Robinson, Andrew', 'Wu, Yuan Seng', 'Aung, Yin Nwe', 'Low, Wah Yun', 'Sim, Maw Shin', 'Sekaran, Shamala Devi', 'Azizan, Nornazirah']","['Guad RM', 'Carandang RR', 'Solidum JN', 'W Taylor-Robinson A', 'Wu YS', 'Aung YN', 'Low WY', 'Sim MS', 'Sekaran SD', 'Azizan N']","['ORCID: 0000-0003-2453-3760', 'ORCID: 0000-0001-6668-911X']","['Faculty of Pharmacy, Department of Pharmaceutical Life Sciences, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine and Health Science, Department of Biomedical Science and Therapeutics, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.', 'Department of Community and Global Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.', 'College of Pharmacy, University of the Philippines, Manila, Philippines.', 'School of Health, Medical & Applied Sciences, Central Queensland University, Brisbane, QLD, Australia.', 'College of Health & Human Sciences, Charles Darwin University, Casuarina, NT, Australia.', 'College of Health Sciences, Vin University, Gia Lam District, Hanoi, Vietnam.', 'Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, Selangor, Malaysia.', 'Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Selangor, Malaysia.', 'Faculty of Medicine & Health Sciences, UCSI University, Port Dickson, Negeri Sembilan, Malaysia.', 'Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.', 'Asia-Europe Institute, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Pharmacy, Department of Pharmaceutical Life Sciences, Universiti Malaya, Kuala Lumpur, Malaysia.', 'Faculty of Medicine & Health Sciences, UCSI University, Port Dickson, Negeri Sembilan, Malaysia.', 'Department of Pathology and Microbiology, Faculty of Medicine and Health Science, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", 'Systematic Review']",20211220,United States,PLoS One,PloS one,101285081,,IM,"['Dengue/etiology/*prevention & control/psychology/virology', 'Dengue Virus/*isolation & purification', '*Health Knowledge, Attitudes, Practice', 'Health Personnel/*psychology', 'Health Services Research/*statistics & numerical data', 'Humans', 'Philippines/epidemiology', 'Reproducibility of Results', 'Surveys and Questionnaires/*statistics & numerical data']",PMC8687574,2021/12/21 06:00,2022/01/11 06:00,['2021/12/20 17:25'],"['2021/05/25 00:00 [received]', '2021/12/01 00:00 [accepted]', '2021/12/20 17:25 [entrez]', '2021/12/21 06:00 [pubmed]', '2022/01/11 06:00 [medline]']","['PONE-D-21-14318 [pii]', '10.1371/journal.pone.0261412 [doi]']",epublish,PLoS One. 2021 Dec 20;16(12):e0261412. doi: 10.1371/journal.pone.0261412. eCollection 2021.,12,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
17467495,NLM,MEDLINE,20070510,20220408,1474-547X (Electronic) 0140-6736 (Linking),369,2007 Apr 28,The burden of dengue infection.,1410-1411,S0140-6736(07)60645-X [pii] 10.1016/S0140-6736(07)60645-X [doi],,"['Halstead, Scott B', 'Suaya, Jose A', 'Shepard, Donald S']","['Halstead SB', 'Suaya JA', 'Shepard DS']",,"['Pediatric Dengue Vaccine Initiative, Rockville, MD 20852, USA. Electronic address: halsteads@erols.com.', 'Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.', 'Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.']",['eng'],"['Comment', 'Journal Article']",,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Child', '*Cost of Illness', 'Dengue/classification/*economics/epidemiology', 'Hospitalization/*statistics & numerical data', 'Humans', 'Population Surveillance/*methods', 'Severe Dengue/classification/*economics/epidemiology', 'Severity of Illness Index', 'Thailand/epidemiology']",,2007/05/01 09:00,2007/05/11 09:00,['2007/05/01 09:00'],"['2007/05/01 09:00 [pubmed]', '2007/05/11 09:00 [medline]', '2007/05/01 09:00 [entrez]']","['S0140-6736(07)60645-X [pii]', '10.1016/S0140-6736(07)60645-X [doi]']",ppublish,Lancet. 2007 Apr 28;369(9571):1410-1411. doi: 10.1016/S0140-6736(07)60645-X.,9571,,,,,,,,['Lancet. 2007 Apr 28;369(9571):1452-9. PMID: 17467515'],,,,,,,,,,,,,,
20585645,NLM,MEDLINE,20110113,20211020,1932-6203 (Electronic) 1932-6203 (Linking),5,2010 Jun 23,Classification of dengue fever patients based on gene expression data using support vector machines.,e11267,10.1371/journal.pone.0011267 [doi] e11267,"BACKGROUND: Symptomatic infection by dengue virus (DENV) can range from dengue fever (DF) to dengue haemorrhagic fever (DHF), however, the determinants of DF or DHF progression are not completely understood. It is hypothesised that host innate immune response factors are involved in modulating the disease outcome and the expression levels of genes involved in this response could be used as early prognostic markers for disease severity. METHODOLOGY/PRINCIPAL FINDINGS: mRNA expression levels of genes involved in DENV innate immune responses were measured using quantitative real time PCR (qPCR). Here, we present a novel application of the support vector machines (SVM) algorithm to analyze the expression pattern of 12 genes in peripheral blood mononuclear cells (PBMCs) of 28 dengue patients (13 DHF and 15 DF) during acute viral infection. The SVM model was trained using gene expression data of these genes and achieved the highest accuracy of approximately 85% with leave-one-out cross-validation. Through selective removal of gene expression data from the SVM model, we have identified seven genes (MYD88, TLR7, TLR3, MDA5, IRF3, IFN-alpha and CLEC5A) that may be central in differentiating DF patients from DHF, with MYD88 and TLR7 observed to be the most important. Though the individual removal of expression data of five other genes had no impact on the overall accuracy, a significant combined role was observed when the SVM model of the two main genes (MYD88 and TLR7) was re-trained to include the five genes, increasing the overall accuracy to approximately 96%. CONCLUSIONS/SIGNIFICANCE: Here, we present a novel use of the SVM algorithm to classify DF and DHF patients, as well as to elucidate the significance of the various genes involved. It was observed that seven genes are critical in classifying DF and DHF patients: TLR3, MDA5, IRF3, IFN-alpha, CLEC5A, and the two most important MYD88 and TLR7. While these preliminary results are promising, further experimental investigation is necessary to validate their specific roles in dengue disease.","['Gomes, Ana Lisa V', 'Wee, Lawrence J K', 'Khan, Asif M', 'Gil, Laura H V G', 'Marques, Ernesto T A Jr', 'Calzavara-Silva, Carlos E', 'Tan, Tin Wee']","['Gomes AL', 'Wee LJ', 'Khan AM', 'Gil LH', 'Marques ET Jr', 'Calzavara-Silva CE', 'Tan TW']",,"['Department of Virology and Experimental Therapy, Aggeu Magalhaes Research Center-CPqAM/FIOCRUZ, Recife, Brazil.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20100623,United States,PLoS One,PloS one,101285081,"['0 (RNA, Messenger)']",IM,"['Dengue/*classification/genetics/immunology', '*Gene Expression', 'Humans', 'Immunity, Innate/genetics', 'RNA, Messenger/genetics']",PMC2890409,2010/06/30 06:00,2011/01/14 06:00,['2010/06/30 06:00'],"['2010/01/18 00:00 [received]', '2010/05/14 00:00 [accepted]', '2010/06/30 06:00 [entrez]', '2010/06/30 06:00 [pubmed]', '2011/01/14 06:00 [medline]']","['10-PONE-RA-16107R1 [pii]', '10.1371/journal.pone.0011267 [doi]']",epublish,PLoS One. 2010 Jun 23;5(6):e11267. doi: 10.1371/journal.pone.0011267.,6,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
23608712,NLM,MEDLINE,20140505,20130603,1879-3134 (Electronic) 0025-5564 (Linking),244,2013 Jul,A simple periodic-forced model for dengue fitted to incidence data in Singapore.,22-8,S0025-5564(13)00097-7 [pii] 10.1016/j.mbs.2013.04.001 [doi],"Dengue is the world's major arbovirosis and therefore an important public health concern in endemic areas. The availability of weekly reports of dengue cases in Singapore offers the opportunity to analyze the transmission dynamics and the impact of vector control strategies. Based on a previous model studying the impact of vector control strategies in Singapore during the 2005 outbreak, a simple vector-host model accounting for seasonal fluctuation in vector density was developed to estimate the parameters governing the vector population dynamics using dengue fever incidence data from August 2003 to December 2007. The impact of vector control, which consisted principally of a systematic removal of actual and potential breeding sites during a six-week period in 2005, was also investigated. Although our approach does not account for the complex life cycle of the vector, the good fit between data and model outputs showed that the impact of seasonality on the transmission dynamics is highly important. Moreover, the periodic fluctuations of the vector population were found in phase with temperature variations, suggesting a strong climate effect on the vector density and, in turn, on the transmission dynamics.","['Andraud, Mathieu', 'Hens, Niel', 'Beutels, Philippe']","['Andraud M', 'Hens N', 'Beutels P']",,"['Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium. mathieu.andraud@ua.ac.be']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130419,United States,Math Biosci,Mathematical biosciences,0103146,,IM,"['Dengue/epidemiology/*transmission/virology', '*Dengue Virus/pathogenicity/physiology', 'Humans', 'Incidence', '*Models, Biological', 'Singapore/epidemiology']",,2013/04/24 06:00,2014/05/06 06:00,['2013/04/24 06:00'],"['2012/06/19 00:00 [received]', '2013/04/03 00:00 [revised]', '2013/04/05 00:00 [accepted]', '2013/04/24 06:00 [entrez]', '2013/04/24 06:00 [pubmed]', '2014/05/06 06:00 [medline]']","['S0025-5564(13)00097-7 [pii]', '10.1016/j.mbs.2013.04.001 [doi]']",ppublish,Math Biosci. 2013 Jul;244(1):22-8. doi: 10.1016/j.mbs.2013.04.001. Epub 2013 Apr 19.,1,['Copyright (c) 2013 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
9237695,NLM,MEDLINE,19970825,20190512,0022-1899 (Print) 0022-1899 (Linking),176,1997 Aug,Early clinical and laboratory indicators of acute dengue illness.,313-21,,"A prospective observational study was conducted to identify early indicators of acute dengue virus infection. Children with fever for <72 h without obvious cause were studied at hospitals in Bangkok and Kamphaeng Phet, Thailand, until resolution of fever. Of 172 evaluable subjects (91% of enrollees), 60 (35%) had dengue, including 32 with dengue fever (DF) and 28 with dengue hemorrhagic fever (DHF). At enrollment, children with dengue were more likely than children with other febrile illnesses (OFI) to report anorexia, nausea, and vomiting and to have a positive tourniquet test, and they had lower total white blood cell counts, absolute neutrophil and absolute monocyte counts, and higher plasma alanine and aspartate (AST) aminotransferase levels than children with OFI. Plasma AST levels were higher in children who developed DHF than in those with DF. These data identify simple clinical and laboratory parameters that help to identify children with DF or DHF.","['Kalayanarooj, S', 'Vaughn, D W', 'Nimmannitya, S', 'Green, S', 'Suntayakorn, S', 'Kunentrasai, N', 'Viramitrachai, W', 'Ratanachu-eke, S', 'Kiatpolpoj, S', 'Innis, B L', 'Rothman, A L', 'Nisalak, A', 'Ennis, F A']","['Kalayanarooj S', 'Vaughn DW', 'Nimmannitya S', 'Green S', 'Suntayakorn S', 'Kunentrasai N', 'Viramitrachai W', 'Ratanachu-eke S', 'Kiatpolpoj S', 'Innis BL', 'Rothman AL', 'Nisalak A', 'Ennis FA']",,"[""Bangkok Children's Hospital, Department of Virology, Armed Forces Research Institute of Medical Sciences, Thailand.""]",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",,United States,J Infect Dis,The Journal of infectious diseases,0413675,['0 (Biomarkers)'],IM,"['Acute Disease', 'Biomarkers', 'Child', 'Child, Preschool', 'Dengue/blood/*diagnosis/physiopathology', 'Female', 'Fever', 'Humans', 'Male', 'Predictive Value of Tests', 'Prospective Studies', 'Thailand']",,1997/08/01 00:00,1997/08/01 00:01,['1997/08/01 00:00'],"['1997/08/01 00:00 [pubmed]', '1997/08/01 00:01 [medline]', '1997/08/01 00:00 [entrez]']",['10.1086/514047 [doi]'],ppublish,J Infect Dis. 1997 Aug;176(2):313-21. doi: 10.1086/514047.,2,,,,,,['AI-34533/AI/NIAID NIH HHS/United States'],,,,,,,,,,,,,,,,
36732718,NLM,MEDLINE,20230206,20230207,1472-6947 (Electronic) 1472-6947 (Linking),23,2023 Feb 2,Mapping patient pathways and understanding clinical decision-making in dengue management to inform the development of digital health tools.,24,10.1186/s12911-023-02116-4 [doi] 24,"BACKGROUND: Dengue is a common viral illness and severe disease results in life-threatening complications. Healthcare services in low- and middle-income countries treat the majority of dengue cases worldwide. However, the clinical decision-making processes which result in effective treatment are poorly characterised within this setting. In order to improve clinical care through interventions relating to digital clinical decision-support systems (CDSS), we set out to establish a framework for clinical decision-making in dengue management to inform implementation. METHODS: We utilised process mapping and task analysis methods to characterise existing dengue management at the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. This is a tertiary referral hospital which manages approximately 30,000 patients with dengue each year, accepting referrals from Ho Chi Minh city and the surrounding catchment area. Initial findings were expanded through semi-structured interviews with clinicians in order to understand clinical reasoning and cognitive factors in detail. A grounded theory was used for coding and emergent themes were developed through iterative discussions with clinician-researchers. RESULTS: Key clinical decision-making points were identified: (i) at the initial patient evaluation for dengue diagnosis to decide on hospital admission and the provision of fluid/blood product therapy, (ii) in those patients who develop severe disease or other complications, (iii) at the point of recurrent shock in balancing the need for fluid therapy with complications of volume overload. From interviews the following themes were identified: prioritising clinical diagnosis and evaluation over existing diagnostics, the role of dengue guidelines published by the Ministry of Health, the impact of seasonality and caseload on decision-making strategies, and the potential role of digital decision-support and disease scoring tools. CONCLUSIONS: The study highlights the contemporary priorities in delivering clinical care to patients with dengue in an endemic setting. Key decision-making processes and the sources of information that were of the greatest utility were identified. These findings serve as a foundation for future clinical interventions and improvements in healthcare. Understanding the decision-making process in greater detail also allows for development and implementation of CDSS which are suited to the local context.","['Nguyen, Quang Huy', 'Ming, Damien K', 'Luu, An Phuoc', 'Chanh, Ho Quang', 'Tam, Dong Thi Hoai', 'Truong, Nguyen Thanh', 'Huy, Vo Xuan', 'Hernandez, Bernard', 'Van Nuil, Jennifer Ilo', 'Paton, Chris', 'Georgiou, Pantelis', 'Nguyen, Nguyet Minh', 'Holmes, Alison', 'Tho, Phan Vinh', 'Yacoub, Sophie']","['Nguyen QH', 'Ming DK', 'Luu AP', 'Chanh HQ', 'Tam DTH', 'Truong NT', 'Huy VX', 'Hernandez B', 'Van Nuil JI', 'Paton C', 'Georgiou P', 'Nguyen NM', 'Holmes A', 'Tho PV', 'Yacoub S']",,"['Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Centre for Antimicrobial Optimisation (CAMO), Imperial College London, London, UK. d.ming@imperial.ac.uk.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.', 'Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.', 'Centre for BioInspired Technology, Imperial College London, London, UK.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Department of Information Science, University of Otago, Dunedin, New Zealand.', 'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.', 'Centre for BioInspired Technology, Imperial College London, London, UK.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Centre for Antimicrobial Optimisation (CAMO), Imperial College London, London, UK.', 'Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.', 'Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.', 'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20230202,England,BMC Med Inform Decis Mak,BMC medical informatics and decision making,101088682,,IM,"['Humans', 'Clinical Decision-Making', '*Dengue/diagnosis/therapy', '*Decision Support Systems, Clinical', 'Risk Factors', 'Referral and Consultation']",PMC9893980,2023/02/03 06:00,2023/02/07 06:00,['2023/02/02 23:58'],"['2022/08/04 00:00 [received]', '2023/01/19 00:00 [accepted]', '2023/02/02 23:58 [entrez]', '2023/02/03 06:00 [pubmed]', '2023/02/07 06:00 [medline]']","['10.1186/s12911-023-02116-4 [pii]', '2116 [pii]', '10.1186/s12911-023-02116-4 [doi]']",epublish,BMC Med Inform Decis Mak. 2023 Feb 2;23(1):24. doi: 10.1186/s12911-023-02116-4.,1,['(c) 2023. The Author(s).'],['NOTNLM'],"['Clinical decision-making', 'Decision support', 'Dengue', 'Digital health', 'Implementation research', 'Vietnam']",['The authors declare that they have no competing interests.'],,['215010/Z/18/Z/Wellcome Trust/United Kingdom'],,,,,,,,,,,['Vietnam ICU Translational Applications Laboratory (VITAL) investigators'],,,,,
16780000,NLM,MEDLINE,20061106,20060619,0022-0892 (Print) 0022-0892 (Linking),68,2006 Jun,"Climate-based descriptive models of dengue fever: the 2002 epidemic in Colima, Mexico.","40-4, 55",,"Dengue is a public health problem on the rise in many tropical regions and affects approximately 100 million people every year worldwide. In this paper, the authors retrospectively assess the association between five climatological variables and dengue incidence using data from the 2002 dengue epidemic in Colima, Mexico. Pluvial precipitation (mm), evaporation (mm), and mean, maximum, and minimum temperatures (degrees C) were obtained from local meteorological stations. The highest correlation of dengue incidence with maximum temperature was found at a lag of one month, and the highest correlation for evaporation was found at a lag of three months. A multiple-linear-regression model that includes all the climatological variables was correlated with 94 percent of the observed variance. Two simpler linear models with variables significant at the 99 percent confidence level were correlated with 88 percent (Precipitation + Evaporation) and 79 percent (Precipitation + Maximum Temperature) of the observed variance.","['Chowell, Gerardo', 'Sanchez, Fabio']","['Chowell G', 'Sanchez F']",,"['Los Alamos National Laboratory, Mathematical Modeling and Analysis & Statistics Science, Los Alamos, NM 87545, USA. chowell@lanl.gov']",['eng'],['Journal Article'],,United States,J Environ Health,Journal of environmental health,0405525,,IM,"['Dengue/*epidemiology/transmission', '*Disease Outbreaks', 'Incidence', 'Mexico', 'Models, Theoretical', '*Weather']",,2006/06/20 09:00,2006/11/07 09:00,['2006/06/20 09:00'],"['2006/06/20 09:00 [pubmed]', '2006/11/07 09:00 [medline]', '2006/06/20 09:00 [entrez]']",,ppublish,"J Environ Health. 2006 Jun;68(10):40-4, 55.",10,,,,,,,,,,,,,,,,,,,,,,
19725380,NLM,MEDLINE,20091029,20090903,0025-682X (Print) 0025-682X (Linking),69,2009 Aug,[Dengue fever: from disease to vaccination].,333-4,,"Dengue is a tropical disease affecting 110 countries throughout the world and placing over 3 billion people at risk of infection. According the World Health Organization 70 to 500 million persons are infected every year including 2 million who develop hemorrhagic form and 20,000 who die. Children are at highest risk for death. Due to the absence of specialized laboratories in most endemic regions and to the lack of specifici clinical presentation, the incidence of dengue and its economic costs are certainly underestimated. Dengue iscaused by an arbovirus belonging to the Flavivirus genus of the family Flaviviridae. There are four dengue virus serotypes and no cross protection between them. The disease is transmitted through the bites of mosquitoes belonging to the Aedes genus, mainly Aedes aegypti. However A. albopictus has played an important role in the spread of the disease and other species may be involved in specific locations (e.g., A. polynesiensis in the South Pacific). There is no specific treatment for dengue. Management of severe forms depends on symptomatic treatment of hemorrhagic complications and hypovolemic shock. Prevention requires control of vector mosquitoes that is difficult to implement and maintain. Dengue is a major emerging infectious disease with a heavy impact on public health. The high human and economic costs as well as the absence of specific preventive measures underscore the need to develop a vaccine. However finding and distributing such a vaccine to populations at risk is hampered by numerous obstacles. The most notable challenges standing in the way of development of a candidate vaccine are as follows: absence of an animal model, which has important implications for the preclinical development strategy; need to develop a live attenuated vaccine; existence of 4 antigenically distinct serotypes with the resulting risk of competition between vaccine strains; immunologic risks related to antibody-dependent enhancement that has been hypothesized to be the cause of severe forms of the illness; absence of a well defined correlate of protection and preexisting vaccine, which will require the organization of large-scale pre-clinical trials to demonstrate the efficacy of the virus; complexity associated with industrial production of a tetravalent vaccine. Development and production of a safe and reliable vaccine are only the first steps to ensuring protection of the populations at risk, It twill also be necessary to identify and take into account a variety of geographic, economic, regulatory, and logistic factors: The epidemiological profile of dengue is variable. For example the age at which the likelihood of developing the disease is highest is not the same in Asia and Latin America. Vaccination programs must be tailored to regional and national epidemiological specificities. Introduction of dengue vaccination in the national immunization programs must take into account the special features of each country without jeopardizing the existing vaccines already in use. The need for an additional visit can represent a hardship both economically and logistically. Alternative funding will be needed to finance vaccination programs in some countries located in endemic zones, Long-term phase 4 effectiveness and tolerance field studies must be planned in collaboration with national authorities. All these challenges and obstacles have been taken into account in the development of Sanofi Pasteur's live attenuated tetravalent vaccine. Research for development of a dengue vaccine began during the 1990s. Clinical studies with the most promising tetravalent vaccine were started in the 2000s. A trial carried out in adults in the United States has shown that administration of three doses of the tetravalent candidate vaccine was 100% successful in inducing an antibody response capable of neutralizing all four dengue virus serotypes. Phase II clinical trials are now under way in children and adults in Mexico, Peru, and the Philippines. The first efficacy trial in children began in Thailand in February 2009. The purpose is to evaluate the efficacy of the tetravalent dengue vaccine in children. The study is being conducted in the Ratchaburi province in collaboration with the University of Mahidol and the Thai Ministry of Health as well as the Pediatric Dengue Vaccine Initiative (PDVI). This efficacy trial will be an important step for successful development of a live attenuated tetravalent vaccine.","['Teyssou, R']",['Teyssou R'],,"['Sanofi Pasteur Lyon, France. remy.teyssou@sanofipasteur.com']",['fre'],"['English Abstract', 'Journal Article']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,['0 (Dengue Vaccines)'],IM,"['Dengue/*prevention & control/transmission', '*Dengue Vaccines', 'Humans', 'Public Health']",,2009/09/04 06:00,2009/10/30 06:00,['2009/09/04 09:00'],"['2009/09/04 09:00 [entrez]', '2009/09/04 06:00 [pubmed]', '2009/10/30 06:00 [medline]']",,ppublish,Med Trop (Mars). 2009 Aug;69(4):333-4.,4,,,,,,,,,La dengue: de la maladie a la vaccination.,,,,,,,,,,,,,
23697347,NLM,MEDLINE,20131029,20181202,1080-6059 (Electronic) 1080-6040 (Linking),19,2013 May,In memoriam: Susumu Hotta (1918-2011).,843-4,10.3201/eid1905.IM0986 [doi],,"['Konishi, Eiji', 'Kuno, Goro']","['Konishi E', 'Kuno G']",,"['BIKEN Endowed Department of Dengue Vaccine Development, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Rd, Ratchathewi, Bangkok 10400, Thailand. ekon@biken.osaka-u.ac.jp']",['eng'],"['Biography', 'Historical Article', 'Journal Article', 'Portrait']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,['0 (Dengue Vaccines)'],IM,"['Dengue/*history/immunology/prevention & control', 'Dengue Vaccines/*history/immunology', 'Dengue Virus/*isolation & purification/physiology', 'History, 20th Century', 'History, 21st Century', 'Humans', 'Japan']",,2013/05/24 06:00,2013/10/30 06:00,['2013/05/24 06:00'],"['2013/05/24 06:00 [entrez]', '2013/05/24 06:00 [pubmed]', '2013/10/30 06:00 [medline]']",['10.3201/eid1905.IM0986 [doi]'],ppublish,Emerg Infect Dis. 2013 May;19(5):843-4. doi: 10.3201/eid1905.IM0986.,5,,['NOTNLM'],"['Japan', 'Susumu Hotta', 'arbovirus', 'dengue', 'in memoriam', 'virus isolation', 'viruses']",,,,,,,,,,,,,,,,,['Hotta S'],"['Hotta, Susumu']",
7186787,NLM,MEDLINE,19831123,20041117,0020-2495 (Print) 0020-2495 (Linking),49,1982,[Dengue. View from the Arbovirus Laboratory of the Pasteur Institute of Madagascar].,107-17,,,"['Coulanges, P', 'Clerc, Y']","['Coulanges P', 'Clerc Y']",,,['fre'],['Journal Article'],,Madagascar,Arch Inst Pasteur Madagascar,Archives de l'Institut Pasteur de Madagascar,7502526,,IM,"['Aedes/microbiology', 'Animals', '*Dengue/diagnosis/epidemiology/therapy', 'Dengue Virus', 'Humans', 'Insect Vectors/microbiology', 'Madagascar']",,1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Arch Inst Pasteur Madagascar. 1982;49(1):107-17.,1,,,,,,,,,La dengue. Vue du Laboratoire des Arbovirus de l'Institut Pasteur de Madagascar.,,,,,,,,,,,,,
22578590,NLM,MEDLINE,20121105,20161018,1768-3122 (Electronic) 0248-8663 (Linking),33,2012 Jun,[Plasmacytosis and dengue fever: an underestimated abnormality?].,343-5,10.1016/j.revmed.2012.03.357 [doi],"INTRODUCTION: A significant peripheral blood plasmacytosis is a rare finding associated with viral infections. We reported five consecutive cases of dengue virus infection, with circulating plasma cells. CASE REPORTS: Three women and two men, aged 26 to 75 years, had returned from French West Indies less than one week before the onset of the symptoms (mean: 2.5 days). The transient blood plasmacytosis was variable in intensity (0.1 to 0.8 G/L) with a maximal level between the fourth and the seventh day following the onset of the symptoms, and was associated in four patients, with activated lymphocytes and lympho-plasma cells. CONCLUSION: Reactive plasmacytosis during dengue fever is common and probably underestimated because it is transient and only identified by careful microscopic examination of a blood smear. Plasmacytosis could be explained by the intensity of the immunological response and the production of large amount of interleukins.","['Gerome, P', 'Foucher, B', 'Otto, M-P', 'Crevon, L', 'Rabar, D', 'Pasquet, F', 'Tolou, H']","['Gerome P', 'Foucher B', 'Otto MP', 'Crevon L', 'Rabar D', 'Pasquet F', 'Tolou H']",,"['Service de biologie medicale, HIA Desgenettes, 108, boulevard Pinel, 69275 Lyon cedex 03, France.']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",20120509,France,Rev Med Interne,La Revue de medecine interne,8101383,,IM,"['Adult', 'Aged', 'Dengue/*blood/complications/*epidemiology/pathology', 'Female', 'Hemolysis/physiology', 'Humans', 'Male', 'Middle Aged', 'Plasma Cells/*pathology', 'Prevalence', 'Travel', 'West Indies']",,2012/05/15 06:00,2012/11/06 06:00,['2012/05/15 06:00'],"['2011/08/29 00:00 [received]', '2012/02/10 00:00 [revised]', '2012/03/31 00:00 [accepted]', '2012/05/15 06:00 [entrez]', '2012/05/15 06:00 [pubmed]', '2012/11/06 06:00 [medline]']","['S0248-8663(12)00456-0 [pii]', '10.1016/j.revmed.2012.03.357 [doi]']",ppublish,Rev Med Interne. 2012 Jun;33(6):343-5. doi: 10.1016/j.revmed.2012.03.357. Epub 2012 May 9.,6,"['Copyright (c) 2012 Societe nationale francaise de medecine interne (SNFMI).', 'Published by Elsevier SAS. All rights reserved.']",,,,,,,,Plasmocytose sanguine et dengue: une anomalie biologique sous-estimee?,,,,,,,,,,,,,
2698983,NLM,MEDLINE,19900524,20041117,0126-8635 (Print) 0126-8635 (Linking),11,1989 Aug,Diagnosis and surveillance of dengue virus infections: gold standards and new directions.,7-10,,,"['Cardosa, M J']",['Cardosa MJ'],,,['eng'],"['Journal Article', 'Review']",,Malaysia,Malays J Pathol,The Malaysian journal of pathology,8101177,['0 (Immunoglobulin M)'],IM,"['Animals', 'Dengue/diagnosis/*epidemiology/immunology', 'Forecasting', 'Hemagglutination Tests', 'Humans', 'Immunoglobulin M/analysis', 'Immunologic Techniques/trends', 'Malaysia/epidemiology']",,1989/08/01 00:00,1989/08/01 00:01,['1989/08/01 00:00'],"['1989/08/01 00:00 [pubmed]', '1989/08/01 00:01 [medline]', '1989/08/01 00:00 [entrez]']",,ppublish,Malays J Pathol. 1989 Aug;11:7-10.,,,,,,,,18,,,,,,,,,,,,,,,
22494122,NLM,MEDLINE,20120419,20220408,1533-4406 (Electronic) 0028-4793 (Linking),366,2012 Apr 12,Dengue.,1423-32,10.1056/NEJMra1110265 [doi],,"['Simmons, Cameron P', 'Farrar, Jeremy J', 'Nguyen, van Vinh Chau', 'Wills, Bridget']","['Simmons CP', 'Farrar JJ', 'Nguyen vV', 'Wills B']",,"['Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.']",['eng'],"['Journal Article', 'Review']",,United States,N Engl J Med,The New England journal of medicine,0255562,"['0 (Antibodies, Viral)', '0 (Immunoglobulin M)']",IM,"['Antibodies, Viral/blood', 'Blood Transfusion', '*Dengue/diagnosis/epidemiology/etiology/therapy', 'Dengue Virus/immunology', 'Diagnosis, Differential', 'Humans', 'Immunoglobulin M/blood', '*Pandemics']",,2012/04/13 06:00,2012/04/20 06:00,['2012/04/13 06:00'],"['2012/04/13 06:00 [entrez]', '2012/04/13 06:00 [pubmed]', '2012/04/20 06:00 [medline]']",['10.1056/NEJMra1110265 [doi]'],ppublish,N Engl J Med. 2012 Apr 12;366(15):1423-32. doi: 10.1056/NEJMra1110265.,15,,,,,"['N Engl J Med. 2012 Jul 12;367(2):180; author reply 181. PMID: 22784125', 'N Engl J Med. 2012 Jul 12;367(2):180-1; author reply 181. PMID: 22784126']",,,,,,,,,,,,,,,,,
20464142,NLM,MEDLINE,20100803,20190907,1678-9849 (Electronic) 0037-8682 (Linking),43,2010 Mar-Apr,"[Progression of dengue virus circulation in the State of Bahia, Brazil, 1994-2000].",139-44,S0037-86822010000200007 [pii],"INTRODUCTION: The strength of the re-emergence of dengue virus and the severity of these infections put this disease in the priority agenda of the institutions responsible for protecting the health of populations. Important for understanding the epidemiology of dengue nowadays refers to the knowledge of the patterns of spatial-temporal diffusion, though there is few research addressing this issue. This study describes the process of dissemination of dengue in the state of Bahia, from 1994 to 2000. METHODS: This ecological study space-time, with the units of analysis, county, epidemiological week, month, trimester and year. There has been construction of the trend line and has been mapping the sequential occurrence of dengue in the municipality for the period. RESULTS: There were 164,050 reported cases of dengue and the introduction of this virus in Bahia, unlike other states, occurred on a small city, though there is intermittency in spatial and temporal records of cases at the beginning of this epidemic. The virus circulated in all climatic zones fact what highlight its high transmission power. The highest intensity of detection of cases and territorial expansion was in the littoral (zone humid and half-humid) ideal area for the survive of the vector. CONCLUSIONS: Hypothetically, the intermittent space-time pattern initially observed, could have allowed the control of the progression of the epidemic, if structured action to vectorial combat was carried out.","['Melo, Maria Suely Silva', 'Barreto, Florisneide Rodrigues', 'Costa, Maria da Conceicao Nascimento', 'Morato, Vanessa Cristina', 'Teixeira, Maria Gloria']","['Melo MS', 'Barreto FR', 'Costa Mda C', 'Morato VC', 'Teixeira MG']",,"['Faculdade de Medicina, Universidade Federal da Bahia, Salvador, BA.']",['por'],"['English Abstract', 'Journal Article']",,Brazil,Rev Soc Bras Med Trop,Revista da Sociedade Brasileira de Medicina Tropical,7507456,,IM,"['Animals', 'Brazil/epidemiology', 'Dengue/*epidemiology/transmission/virology', '*Dengue Virus', 'Humans', '*Insect Vectors', 'Risk Factors', 'Space-Time Clustering']",,2010/05/14 06:00,2010/08/04 06:00,['2010/05/14 06:00'],"['2009/09/10 00:00 [received]', '2010/03/05 00:00 [accepted]', '2010/05/14 06:00 [entrez]', '2010/05/14 06:00 [pubmed]', '2010/08/04 06:00 [medline]']","['S0037-86822010000200007 [pii]', '10.1590/s0037-86822010000200007 [doi]']",ppublish,Rev Soc Bras Med Trop. 2010 Mar-Apr;43(2):139-44. doi: 10.1590/s0037-86822010000200007.,2,,,,,,,,,"Progressao da circulacao do virus do dengue no Estado da Bahia, 1994-2000.",,,,,,,,,,,,,
37271848,NLM,MEDLINE,20230606,20230608,0300-5283 (Print) 0300-5283 (Linking),78,2023 May,Association of dengue serotypes and its complications: a retrospective cohort study.,372-378,,"INTRODUCTION: Dengue fever is an arthropod-borne disease and has a wide clinical spectrum. It is hypothesised that dengue serotypes could be a possible factor for such phenomena and therefore be a possible predictor for the development of severe dengue. METHOD: A retrospective cohort study was done to explore the association between dengue serotypes and the various complications. All patients who underwent dengue serotyping from 1st January to 31st December 2018 in Tengku Ampuan Rahimah Hospital were selected. Serotypes were randomly done for admitted dengue patients. Notes were then retrieved for data collection. Secondary outcomes like length of stay and highest lactate level were also studied. Data analysis was done using SPSS version 20. RESULT: A total of 193 patient records were included in the analysis. Chi-square test for independence indicated that the proportion of dengue complications between male and female were significantly different (chi(2)(1) = 11.37, p = 0.001). Dengue serotype was not associated with the development of dengue complications, total number of dengue complications, length of admission, lactate level and survival among the serotypes. Results of the binary logistic regression showed that men have thrice the odds (AOR = 3.3, 95% CI: 1.6 6.7) for developing dengue complications. One patient was found to be co-infected with serotype 2 and 3. CONCLUSION: Our study did not reveal any association between the different dengue virus serotypes and its complications. Therefore, all dengue infection should be approached with equal meticulousness. There are possibilities that apart from serotype, dengue genotype and lineage would determine clinical outcome. However, more studies are required to study such associations.","['Lau, Q', 'Lee, Z M', 'Shunmugarajoo, A', 'Tan, C Y', 'Azmel, A', 'Yap, S Y']","['Lau Q', 'Lee ZM', 'Shunmugarajoo A', 'Tan CY', 'Azmel A', 'Yap SY']",,"['Hospital Tengku Ampuan Rahimah, Internal Medicine Department, Ministry of Health, Selangor, Malaysia. qinglinlau@gmail.com.', 'Hospital Duchness of Kent, Internal Medicine, Ministry of Health, Sabah, Malaysia.', 'Hospital Tengku Ampuan Rahimah, Internal Medicine Department, Ministry of Health, Selangor, Malaysia.', 'Hospital Tengku Ampuan Rahimah, Infectious Disease Unit, Ministry of Health, Selangor, Malaysia.', 'Hospital Tengku Ampuan Rahimah, Infectious Disease Unit, Ministry of Health, Selangor, Malaysia.', 'Hospital Tengku Ampuan Rahimah, Clinical Research Center (CRC), Ministry of Health, Selangor, Malaysia.']",['eng'],['Journal Article'],,Malaysia,Med J Malaysia,The Medical journal of Malaysia,0361547,['0 (Lactates)'],IM,"['Humans', 'Male', 'Female', '*Dengue/complications/epidemiology', '*Dengue Virus/genetics', 'Retrospective Studies', '*Severe Dengue', 'Lactates']",,2023/06/05 00:42,2023/06/06 06:42,['2023/06/04 23:43'],"['2023/06/06 06:42 [medline]', '2023/06/05 00:42 [pubmed]', '2023/06/04 23:43 [entrez]']",,ppublish,Med J Malaysia. 2023 May;78(3):372-378.,3,,,,,,,,,,,,,,,,,,,,,,
26506739,NLM,MEDLINE,20151201,20181202,0125-1562 (Print) 0125-1562 (Linking),46 Suppl 1,2015,INTERIM ANALYSIS OF THE CONTRIBUTION OF HIGH-LEVEL EVIDENCE FOR DENGUE VECTOR CONTROL.,131-7,,"This interim analysis reviews the available systematic literature for dengue vector control on three levels: 1) single and combined vector control methods, with existing work on peridomestic space spraying and on Bacillus thuringiensis israelensis; further work is available soon on the use of Temephos, Copepods and larvivorous fish; 2) or for a specific purpose, like outbreak control, and 3) on a strategic level, as for example decentralization vs centralization, with a systematic review on vector control organization. Clear best practice guidelines for methodology of entomological studies are needed. There is a need to include measuring dengue transmission data. The following recommendations emerge: Although vector control can be effective, implementation remains an issue; Single interventions are probably not useful; Combinations of interventions have mixed results; Careful implementation of vector control measures may be most important; Outbreak interventions are often applied with questionable effectiveness.","['Horstick, Olaf', 'Ranzinger, Silvia Runge']","['Horstick O', 'Ranzinger SR']",,,['eng'],"['Journal Article', 'Review', 'Systematic Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Animals', 'Dengue/*epidemiology/*prevention & control/virology', 'Disease Outbreaks/*prevention & control', 'Humans', '*Insect Vectors', 'Mosquito Control/instrumentation/*methods']",,2015/10/29 06:00,2015/12/15 06:00,['2015/10/29 06:00'],"['2015/10/29 06:00 [entrez]', '2015/10/29 06:00 [pubmed]', '2015/12/15 06:00 [medline]']",,ppublish,Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:131-7.,,,,,,,,,,,,,,,,,,,,,,,
1758008,NLM,MEDLINE,19920204,20071115,0022-5304 (Print) 0022-5304 (Linking),94,1991 Dec,"Beliefs about the prevention of dengue and other febrile illnesses in Merida, Mexico.",377-87,,"A series of open interviews and a survey were conducted in several neighbourhoods in the city of Merida, Mexico to find out whether poor response to government dengue control programmes might be related to the explanatory models about dengue and its prevention held by community members. Dengue was grouped by informants with other mild febrile illnesses, all of which were thought to be inevitable and capable of converting into more serious illnesses. Although vector control personnel think of prevention in terms of eliminating the larval habitats of mosquito vectors, the form of prevention most commonly described involved looking after oneself once sick, so that mild fevers do not evolve into serious fevers. Due to the prevalence of this different model of prevention, it is argued that simple messages about dengue may be misinterpreted. Vector control programmes need to take into account local models of febrile illnesses and their prevention in order to be effective.","['Winch, P', 'Lloyd, L', 'Godas, M D', 'Kendall, C']","['Winch P', 'Lloyd L', 'Godas MD', 'Kendall C']",,"['Center for International Community Based Health Research, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Trop Med Hyg,The Journal of tropical medicine and hygiene,0406044,,IM,"['Adult', 'Aedes', 'Animals', '*Attitude to Health', 'Child', 'Dengue/etiology/*prevention & control/transmission', 'Fever/etiology', 'Health Education', 'Humans', 'Insect Vectors', 'Interviews as Topic', 'Mexico', 'Weather']",,1991/12/01 00:00,1991/12/01 00:01,['1991/12/01 00:00'],"['1991/12/01 00:00 [pubmed]', '1991/12/01 00:01 [medline]', '1991/12/01 00:00 [entrez]']",,ppublish,J Trop Med Hyg. 1991 Dec;94(6):377-87.,6,,,,,,,,,,,,,,,,,,,,,,
6700459,NLM,MEDLINE,19840326,20210522,0025-729X (Print) 0025-729X (Linking),140,1984 Mar 3,Dengue fever. Reappearance in northern Queensland after 26 years.,264-8,,"During March, 1981, a number of cases of dengue fever occurred in Cairns and Townsville, northern Queensland. From October, 1981, an outbreak of the infection was recognized on Thursday Island and, by May 1982, an estimated 38% of residents had been infected. Isolated cases were reported from other towns in northern Queensland and from other islands in the Torres Strait. Clinical presentation varied from that of severe incapacitating illness lasting up to seven days to infections which were confirmed by serological tests, but were not associated with apparent illness. No deaths were reported. Entomological surveys indicated that the domestic breeding vector of dengue, Aedes aegypti, is widely distributed throughout Queensland - southwards to Dirranbandi and westwards to Mornington Island. In some localities, the indices of Ae. aegypti abundance are alarmingly high, but at least in some suburbs of Townsville, it has been effectively controlled.","['Kay, B H', 'Barker-Hudson, P', 'Stallman, N D', 'Wiemers, M A', 'Marks, E N', 'Holt, P J', 'Muscio, M', 'Gorman, B M']","['Kay BH', 'Barker-Hudson P', 'Stallman ND', 'Wiemers MA', 'Marks EN', 'Holt PJ', 'Muscio M', 'Gorman BM']",,,['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Australia,Med J Aust,The Medical journal of Australia,0400714,,IM,"['Aedes', 'Animals', 'Child', 'Dengue/*epidemiology/microbiology/transmission', 'Dengue Virus/isolation & purification', 'Disease Outbreaks/*epidemiology', 'Disease Vectors', 'Female', 'Humans', 'Middle Aged', 'Population Density']",,1984/03/03 00:00,1984/03/03 00:01,['1984/03/03 00:00'],"['1984/03/03 00:00 [pubmed]', '1984/03/03 00:01 [medline]', '1984/03/03 00:00 [entrez]']",['10.5694/j.1326-5377.1984.tb104033.x [doi]'],ppublish,Med J Aust. 1984 Mar 3;140(5):264-8. doi: 10.5694/j.1326-5377.1984.tb104033.x.,5,,,,,,,,,,,,,,,,,,,,,,
15969972,NLM,MEDLINE,20051230,20190608,1020-4989 (Print) 1020-4989 (Linking),17,2005 Apr,The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy.,221-4,,,"['Gubler, Duane']",['Gubler D'],,,['eng'],"['Comment', 'Editorial']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Americas/epidemiology', 'Dengue/*epidemiology/prevention & control', 'Health Policy', 'Humans', 'Public Health', 'Severe Dengue/epidemiology']",,2005/06/23 09:00,2005/12/31 09:00,['2005/06/23 09:00'],"['2005/06/23 09:00 [pubmed]', '2005/12/31 09:00 [medline]', '2005/06/23 09:00 [entrez]']","['S1020-49892005000400001 [pii]', '10.1590/s1020-49892005000400001 [doi]']",ppublish,Rev Panam Salud Publica. 2005 Apr;17(4):221-4. doi: 10.1590/s1020-49892005000400001.,4,,,,,,,,"['Rev Panam Salud Publica. 2005 Apr;17(4):225-9. PMID: 15969973', 'Rev Panam Salud Publica. 2005 Apr;17(4):243-53. PMID: 15969976', 'Rev Panam Salud Publica. 2005 Apr;17(4):282-93. PMID: 15969980']",,,,,,,,,,,,,,
25272543,NLM,MEDLINE,20141014,20141216,0030-9982 (Print) 0030-9982 (Linking),64,2014 May,Dengue fever in patients admitted in tertiary care hospitals in Pakistan.,553-9,,"OBJECTIVES: To assess the gaps in the diagnosis and management of dengue fever cases. METHODS: The retrospective descriptive analytical study was done with a case record analysis of patients with dengue fever admitted from January to December 2010 at five tertiary care hospitals in different Pakistani cities. Using a questionnaire, information was gathered on demography, haematological profile, management, use of blood and platelet transfusions and the outcome. For comparison, data of serologically-confirmed dengue patients from a private laboratory in Islamabad was collected to see the age, gender and month-wise distribution of cases tested over the same period. SPSS 16 was used for statistical analysis. RESULTS: Out of the 841 confirmed dengue cases, 514 (79%) were males and 139 (21%) females. The overall mean age was 31.3 +/- 14.0 years. Dengue fever was seen in 653 (78%) and dengue haemorrhagic fever (DHF) in 188 (22%) patients. Most cases were between 20 and 49 years of age. A gradual increase in dengue fever and dengue haemorrhagic fever was seen from August, with a peak in October/November. Tourniquet test was done only in 20 (2.3%) cases, out of which 11 (55%) were positive and 9 (45%) were negative. Serial haematocrit was not done in any case. Total deaths were 5 (0.6%). CONCLUSIONS: Most cases were seen in October/November with the majority being in the 20-39 age group. Tourniquet test and serial haematocrit were infrequently used. No standard national guidelines were employed.","['Munir, Muhammad Arif', 'Alam, Syed Ejaz', 'Khan, Zareef Uddin', 'Saeed, Quaid', 'Arif, Ambreen', 'Iqbal, Rizwan', 'Saqib, Muhammad Arif Nadeem', 'Qureshi, Huma']","['Munir MA', 'Alam SE', 'Khan ZU', 'Saeed Q', 'Arif A', 'Iqbal R', 'Saqib MA', 'Qureshi H']",,,['eng'],['Journal Article'],,Pakistan,J Pak Med Assoc,JPMA. The Journal of the Pakistan Medical Association,7501162,,IM,"['Adult', 'Dengue/*diagnosis/epidemiology/*therapy', 'Female', 'Hematocrit', 'Humans', 'Male', 'Middle Aged', 'Pakistan/epidemiology', 'Retrospective Studies', 'Seasons', 'Tertiary Care Centers/statistics & numerical data', 'Young Adult']",,2014/10/03 06:00,2014/10/15 06:00,['2014/10/03 06:00'],"['2014/10/03 06:00 [entrez]', '2014/10/03 06:00 [pubmed]', '2014/10/15 06:00 [medline]']",['6472 [pii]'],ppublish,J Pak Med Assoc. 2014 May;64(5):553-9.,5,,,,,,,,,,,,,,,,,,,,,,
19174065,NLM,MEDLINE,20090622,20090128,0025-7753 (Print) 0025-7753 (Linking),132,2009 Jan 17,[Dengue and pregnancy].,36,10.1016/j.medcli.2008.07.004 [doi],,"['Torres-Cepeda, Duly', 'Santos-Bolivar, Joel', 'Pena-Paredes, Elvia', 'Reyna-Villasmil, Eduardo']","['Torres-Cepeda D', 'Santos-Bolivar J', 'Pena-Paredes E', 'Reyna-Villasmil E']",,,['spa'],"['Case Reports', 'Letter']",20081203,Spain,Med Clin (Barc),Medicina clinica,0376377,,IM,"['Adult', '*Dengue/diagnosis/therapy', 'Female', 'Humans', 'Pregnancy', '*Pregnancy Complications, Infectious/diagnosis/therapy']",,2009/01/29 09:00,2009/06/23 09:00,['2009/01/29 09:00'],"['2008/06/20 00:00 [received]', '2008/07/15 00:00 [accepted]', '2009/01/29 09:00 [entrez]', '2009/01/29 09:00 [pubmed]', '2009/06/23 09:00 [medline]']","['S0025-7753(08)00014-6 [pii]', '10.1016/j.medcli.2008.07.004 [doi]']",ppublish,Med Clin (Barc). 2009 Jan 17;132(1):36. doi: 10.1016/j.medcli.2008.07.004. Epub 2008 Dec 3.,1,,,,,,,,,Dengue y embarazo.,,,,,,,,,,,,,
14740881,NLM,MEDLINE,20040206,20220321,0002-9637 (Print) 0002-9637 (Linking),69,2003 Dec,Use of a geographic information system for defining spatial risk for dengue transmission in Bangladesh: role for Aedes albopictus in an urban outbreak.,634-40,,"We used conventional and spatial analytical tools to characterize patterns of transmission during a community-wide outbreak of dengue fever and dengue hemorrhagic fever in Dhaka, Bangladesh in 2000. A comprehensive household-level mosquito vector survey and interview was conducted to obtain data on mosquito species and breeding as well as illness consistent with dengue. Clusters of dengue illnesses and high-density vector populations were observed in a distinct sector of the city. Dengue clusters are less identifiable in areas further away from major hospitals, suggesting that proximity to hospitals determines whether cases of dengue are diagnosed. Focusing on those areas relatively close to hospitals, we found a spatial association between dengue clusters and vector populations. Households reporting a recent dengue illness were more likely to have Aedes albopictus larvae present in the home when compared with households not reporting cases. Households reporting a recent dengue illness were also more likely to have a neighbor with Ae. albopictus present in the home. In contrast, the presence of Aedes aegypti within the premises as well as the homes of neighbors (within 50 meters) was not associated with dengue illness. Given that the breeding habitats for Ae. albopictus are somewhat distinct from those of Ae. aegypti, the findings of this study have implications for control of dengue transmission in this urban setting where much of the focus has been on indoor mosquito breeding and transmission. Public health officials may find the disease-environment map useful for planning targeted interventions because it displays areas where transmission is most intense.","['Ali, Mohammad', 'Wagatsuma, Yukiko', 'Emch, Michael', 'Breiman, Robert F']","['Ali M', 'Wagatsuma Y', 'Emch M', 'Breiman RF']",,"['Centre for Health and Population Research, International Centre for Diarrhoeal Disease Research, Bangladesh, Mohakhali, Dhaka, Bangladesh. mali@ivi.int']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Aedes/*physiology', 'Animals', 'Attitude to Health', 'Bangladesh/epidemiology', 'Dengue/*epidemiology/etiology/prevention & control/*transmission', '*Disease Outbreaks', 'Geography', 'Health Behavior', 'Humans', 'Insect Vectors/*physiology', 'Larva/physiology', 'Mosquito Control', 'Residence Characteristics', 'Urban Health']",,2004/01/27 05:00,2004/02/10 05:00,['2004/01/27 05:00'],"['2004/01/27 05:00 [pubmed]', '2004/02/10 05:00 [medline]', '2004/01/27 05:00 [entrez]']",,ppublish,Am J Trop Med Hyg. 2003 Dec;69(6):634-40.,6,,,,,,,,,,,,,,,,,,,,,,
27460696,NLM,MEDLINE,20180423,20190112,2045-2322 (Electronic) 2045-2322 (Linking),6,2016 Jul 27,Dynamic spatiotemporal trends of imported dengue fever in Australia.,30360,10.1038/srep30360 [doi] 30360,"Dengue fever (DF) epidemics in Australia are caused by infected international travellers and confined to Northern Queensland where competent vectors exist. Recent analyses suggest that global trade and climate change could lead to the re-establishment of Ae. aegypti across the country and promote the spread of dengue nationally. This study aimed to describe the dynamic spatiotemporal trends of imported DF cases and their origins, identify the current and potential future high-risk regions and locate areas that might be at particular risk of dengue transmission should competent mosquito vectors expand their range. Our results showed that the geographical distribution of imported DF cases has significantly expanded in mainland Australia over the past decade. In recent years, the geographical distribution of source countries of DF has expanded from the Pacific region and Asia to include Africa and the Americas. Australia is now exposed to dengue importations from all of the regions involved in the current global pandemic. The public health implications of a range expansion of dengue mosquito vectors are severe. Enhanced mosquito surveillance in those areas that have high imported cases is called for to reduce emerging threats from this globally expanding pathogen.","['Huang, Xiaodong', 'Yakob, Laith', 'Devine, Gregor', 'Frentiu, Francesca D', 'Fu, Shiu-Yun', 'Hu, Wenbiao']","['Huang X', 'Yakob L', 'Devine G', 'Frentiu FD', 'Fu SY', 'Hu W']",,"['School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.', 'Department of Disease Control, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.', 'Mosquito Control Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.', 'School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.', 'Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.', 'School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.']",['eng'],['Journal Article'],20160727,England,Sci Rep,Scientific reports,101563288,,IM,"['Australia', 'Dengue/*epidemiology/transmission', 'Humans', 'Models, Statistical']",PMC4961948,2016/07/28 06:00,2018/04/24 06:00,['2016/07/28 06:00'],"['2016/04/15 00:00 [received]', '2016/06/29 00:00 [accepted]', '2016/07/28 06:00 [entrez]', '2016/07/28 06:00 [pubmed]', '2018/04/24 06:00 [medline]']","['srep30360 [pii]', '10.1038/srep30360 [doi]']",epublish,Sci Rep. 2016 Jul 27;6:30360. doi: 10.1038/srep30360.,,,,,,,,,,,,,,,,,,,,,,,
1528183,NLM,MEDLINE,19921020,20080214,0149-2195 (Print) 0149-2195 (Linking),41,1992 Oct 2,"Imported dengue--United States, 1991.","725, 731-2",,"Serum samples from 82 persons with suspected imported dengue (1) who had onset in 1991 were submitted to CDC from 27 states and the District of Columbia (Table 1, page 731). Of these, 25 (34%) cases (from 18 states) were serologically or virologically diagnosed as dengue. This report summarizes these cases.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adult', 'Dengue/epidemiology/*etiology', 'Female', 'Humans', 'Male', 'Middle Aged', '*Travel', 'United States/epidemiology']",,1992/10/02 00:00,1992/10/02 00:01,['1992/10/02 00:00'],"['1992/10/02 00:00 [pubmed]', '1992/10/02 00:01 [medline]', '1992/10/02 00:00 [entrez]']",,ppublish,"MMWR Morb Mortal Wkly Rep. 1992 Oct 2;41(39):725, 731-2.",39,,,,,,,,,,,,,,,,,['Centers for Disease Control (CDC)'],,,,,
31237836,NLM,MEDLINE,20200129,20200309,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),25,2019 Sep,"Dengue Virus Type 1 Infection in Traveler Returning from Tanzania to Japan, 2019.",1782-1784,10.3201/eid2509.190814 [doi],"The largest outbreak of dengue fever in Tanzania is ongoing. Dengue virus type 1 was diagnosed in a traveler who returned from Tanzania to Japan. In phylogenetic analysis, the detected strain was close to the Singapore 2015 strain, providing a valuable clue for investigating the dengue outbreak in Tanzania.","['Okada, Kazuma', 'Morita, Ryo', 'Egawa, Kazutaka', 'Hirai, Yuki', 'Kaida, Atsushi', 'Shirano, Michinori', 'Kubo, Hideyuki', 'Goto, Tetsushi', 'Yamamoto, Seiji P']","['Okada K', 'Morita R', 'Egawa K', 'Hirai Y', 'Kaida A', 'Shirano M', 'Kubo H', 'Goto T', 'Yamamoto SP']",,,['eng'],"['Case Reports', 'Letter', ""Research Support, Non-U.S. Gov't""]",20190917,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adult', 'Dengue/*diagnosis/drug therapy/virology', 'Dengue Virus/genetics/*isolation & purification', 'Humans', 'Japan', 'Male', 'Phylogeny', 'Tanzania', 'Travel']",PMC6711223,2019/06/27 06:00,2020/01/30 06:00,['2019/06/26 06:00'],"['2019/06/27 06:00 [pubmed]', '2020/01/30 06:00 [medline]', '2019/06/26 06:00 [entrez]']","['19-0814 [pii]', '10.3201/eid2509.190814 [doi]']",ppublish,Emerg Infect Dis. 2019 Sep;25(9):1782-1784. doi: 10.3201/eid2509.190814. Epub 2019 Sep 17.,9,,['NOTNLM'],"['Japan', 'Tanzania', 'Tanzania dengue', 'dengue virus 1', 'type 1', 'viruses']",,,,,,,,,,,,,,,,,,,
30025788,NLM,MEDLINE,20190716,20190716,1879-3134 (Electronic) 0025-5564 (Linking),304,2018 Oct,Mathematical assessment of the role of Dengvaxia vaccine on the transmission dynamics of dengue serotypes.,25-47,S0025-5564(17)30158-X [pii] 10.1016/j.mbs.2018.07.003 [doi],"A new mathematical model is designed and used to assess the impact of the newly-released Dengvaxia vaccine on the transmission dynamics of two co-circulating dengue strains (where strain 1 consists of dengue serotypes 1, 3 and 4; and strain 2 consists of dengue serotype 2). It is shown that the model exhibits the phenomenon of backward bifurcation when the disease-induced mortality in the host population exceeds a certain threshold value or if the vaccine does not provide perfect protection against infection with the two strains. In the absence of backward bifurcation, the disease-free equilibrium of the model is shown to be globally-asymptotically stable whenever the associated reproduction number is less than unity. It is shown that the community-wide use of the vaccine could induce positive, negative or no population-level impact, depending on the sign of a certain epidemiological threshold quantity (known as the vaccine impact factor). Simulations of the model, using data from Oaxaca, Mexico, show that, although the community-wide use of the vaccine will significantly reduce dengue burden in the community, it is unable to lead to the elimination of the two dengue strains. It is further shown that the use of Dengvaxia vaccine in dengue-naive populations may induce increased risk of severe disease in these populations.","['Iboi, Enahoro A', 'Gumel, Abba B']","['Iboi EA', 'Gumel AB']",,"['School of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, USA.', 'School of Mathematical and Statistical Sciences, Arizona State University, Tempe, AZ, USA. Electronic address: agumel@asu.edu.']",['eng'],['Journal Article'],20180717,United States,Math Biosci,Mathematical biosciences,0103146,['0 (Dengue Vaccines)'],IM,"['Dengue/*prevention & control/*transmission', '*Dengue Vaccines', 'Dengue Virus/*classification', 'Humans', '*Models, Theoretical', '*Serogroup']",,2018/07/22 06:00,2019/07/17 06:00,['2018/07/21 06:00'],"['2017/03/25 00:00 [received]', '2018/05/12 00:00 [revised]', '2018/07/05 00:00 [accepted]', '2018/07/22 06:00 [pubmed]', '2019/07/17 06:00 [medline]', '2018/07/21 06:00 [entrez]']","['S0025-5564(17)30158-X [pii]', '10.1016/j.mbs.2018.07.003 [doi]']",ppublish,Math Biosci. 2018 Oct;304:25-47. doi: 10.1016/j.mbs.2018.07.003. Epub 2018 Jul 17.,,['Copyright (c) 2018 Elsevier Inc. All rights reserved.'],['NOTNLM'],"['Dengue serotypes', 'Reproduction number', 'Stability', 'Vaccine effects']",,,,,,,,,,,,,,,,,,,
26590155,NLM,MEDLINE,20170110,20181113,0973-7693 (Electronic) 0019-5456 (Linking),82,2015 Dec,Dengue Infection: Challenges and Way Forward.,1077-9,10.1007/s12098-015-1946-5 [doi],,"['Lodha, Rakesh', 'Kabra, Sushil K']","['Lodha R', 'Kabra SK']",,"['Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India. rakesh_lodha@hotmail.com.', 'Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India.']",['eng'],['Journal Article'],20151121,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Communicable Disease Control/organization & administration', '*Dengue/diagnosis/epidemiology/therapy/virology', 'Dengue Virus/*classification', 'Diagnostic Errors/*prevention & control', 'Disease Management', 'Disease Notification/standards', '*Endemic Diseases', 'Humans', 'India/epidemiology', 'Serotyping/methods']",,2015/11/22 06:00,2017/01/11 06:00,['2015/11/22 06:00'],"['2015/11/02 00:00 [received]', '2015/11/03 00:00 [accepted]', '2015/11/22 06:00 [entrez]', '2015/11/22 06:00 [pubmed]', '2017/01/11 06:00 [medline]']","['10.1007/s12098-015-1946-5 [pii]', '10.1007/s12098-015-1946-5 [doi]']",ppublish,Indian J Pediatr. 2015 Dec;82(12):1077-9. doi: 10.1007/s12098-015-1946-5. Epub 2015 Nov 21.,12,,,,,,,,,,,,,,,,,,,,,,
10330754,NLM,MEDLINE,19990615,20131121,0300-8495 (Print) 0300-8495 (Linking),28,1999 Apr,Dengue fever. An Australian perspective.,319-23,,BACKGROUND: An estimated 2.5 billion people live in areas where dengue fever is endemic with around 100 million cases per year. A more serious form of the disease called dengue haemorrhagic fever (DHF) is the most common cause of hospitalisation and death among children in some Southeast Asian countries. OBJECTIVE: This article reviews the ecology and the pathogenesis of the disease and its clinical features. The history of dengue fever in Australia will be presented and the prospects for the future discussed. DISCUSSION: Dengue fever was common in Australia in the late 19th century and the first clinical description of DHF were published by an Australian clinician in Charters Towers north Queensland. Since that time there have been sporadic outbreaks of dengue fever. In recent years there has been an increase in the number of epidemics in north Queensland. If Australia follows a pattern observed elsewhere in the world there might again be cases of DHF recorded on Australian soil.,"['McBride, J H']",['McBride JH'],,"['Cairns Base Hospital, Queensland.']",['eng'],"['Journal Article', 'Review']",,Australia,Aust Fam Physician,Australian family physician,0326701,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Australia/epidemiology', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/*epidemiology/transmission', 'Disease Outbreaks/prevention & control/statistics & numerical data', 'Disease Transmission, Infectious', 'Female', 'Humans', 'Incidence', 'Male', 'Prognosis', 'Risk Factors', 'Severe Dengue/diagnosis/epidemiology/physiopathology', 'Survival Rate']",,1999/05/20 00:00,1999/05/20 00:01,['1999/05/20 00:00'],"['1999/05/20 00:00 [pubmed]', '1999/05/20 00:01 [medline]', '1999/05/20 00:00 [entrez]']",,ppublish,Aust Fam Physician. 1999 Apr;28(4):319-23.,4,,,,,,,9,,,,,,,,,,,,,,,
23475504,NLM,MEDLINE,20140617,20211021,1439-0973 (Electronic) 0300-8126 (Linking),41,2013 Oct,Accuracy and applicability of the revised WHO classification (2009) of dengue.,1047,10.1007/s15010-013-0435-x [doi],,"['Wiwanitkit, V']",['Wiwanitkit V'],,"['Hainan Medical University, Haikou, China, wviroj@yahoo.com.']",['eng'],"['Comment', 'Letter']",20130309,Germany,Infection,Infection,0365307,,IM,"['Clinical Medicine/*methods/*standards', 'Dengue/*classification/*diagnosis', 'Female', 'Humans', 'Male', '*Severity of Illness Index']",,2013/03/12 06:00,2014/06/18 06:00,['2013/03/12 06:00'],"['2013/02/12 00:00 [received]', '2013/02/15 00:00 [accepted]', '2013/03/12 06:00 [entrez]', '2013/03/12 06:00 [pubmed]', '2014/06/18 06:00 [medline]']",['10.1007/s15010-013-0435-x [doi]'],ppublish,Infection. 2013 Oct;41(5):1047. doi: 10.1007/s15010-013-0435-x. Epub 2013 Mar 9.,5,,,,,,,,['Infection. 2013 Aug;41(4):775-82. PMID: 23381875'],,,,,,,,,,,,,,
3238470,NLM,MEDLINE,19890511,20061115,0125-1562 (Print) 0125-1562 (Linking),19,1988 Dec,A dot enzyme immunoassay for dengue 3 virus: comparison with the haemagglutination inhibition test.,591-4,,"A dot enzyme immunoassay (DEIA) was used to determine the levels of antibody to dengue 3 virus in the acute and convalescent sera of febrile patients with a clinical diagnosis of dengue fever or dengue haemorrhagic fever. The antibody titres were compared with titres determined by the haemagglutination inhibition (HI) test. The results of the study showed that, besides being more simple to perform, the DEIA is in order of magnitude more sensitive than the HI test. Furthermore, the data suggest that it is possible to use a single dilution as a cutoff point to predict with reasonable accuracy, if a patient has had a recent dengue infection. The DEIA test for antibodies to dengue virus is an appropriate technology highly suitable for rapid diagnosis and surveillance in developing countries.","['Cardosa, M J', 'Noor Sham, S', 'Tio, P H', 'Lim, S S']","['Cardosa MJ', 'Noor Sham S', 'Tio PH', 'Lim SS']",,"['School of Medical Sciences, Universiti Sains Malaysia, Penang.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Dengue/*diagnosis/microbiology', 'Dengue Virus/*isolation & purification', 'Hemagglutination Inhibition Tests', 'Humans', '*Immunoblotting']",,1988/12/01 00:00,1988/12/01 00:01,['1988/12/01 00:00'],"['1988/12/01 00:00 [pubmed]', '1988/12/01 00:01 [medline]', '1988/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1988 Dec;19(4):591-4.,4,,,,,,,,,,,,,,,,,,,,,,
22931747,NLM,MEDLINE,20130117,20211021,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),18,2012 Sep,"Dengue fever in South Korea, 2006-2010.",1525-7,10.3201/eid1809.111811 [doi],,"['Park, Ji-Hyuk', 'Lee, Dong-Woo']","['Park JH', 'Lee DW']",,,['eng'],['Letter'],,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Dengue/*epidemiology/transmission', 'Humans', 'Republic of Korea/epidemiology', 'Travel']",PMC3437702,2012/08/31 06:00,2013/01/18 06:00,['2012/08/31 06:00'],"['2012/08/31 06:00 [entrez]', '2012/08/31 06:00 [pubmed]', '2013/01/18 06:00 [medline]']","['11-1811 [pii]', '10.3201/eid1809.111811 [doi]']",ppublish,Emerg Infect Dis. 2012 Sep;18(9):1525-7. doi: 10.3201/eid1809.111811.,9,,,,,,,,,,,,,,,,,,,,,,
20142380,NLM,MEDLINE,20100929,20211020,1488-2329 (Electronic) 0820-3946 (Print) 0820-3946 (Linking),182,2010 Mar 9,Dengue fever on the rise at tourist getaways.,E195-6,10.1503/cmaj.109-3169 [doi],,"['Rynor, Becky']",['Rynor B'],,,['eng'],['News'],20100208,Canada,CMAJ,CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,9711805,,IM,"['Canada', 'Dengue/*epidemiology/transmission', '*Health Promotion', 'Humans', '*Information Dissemination', 'Travel/*statistics & numerical data']",PMC2831700,2010/02/10 06:00,2010/09/30 06:00,['2010/02/10 06:00'],"['2010/02/10 06:00 [entrez]', '2010/02/10 06:00 [pubmed]', '2010/09/30 06:00 [medline]']","['cmaj.109-3169 [pii]', '182e195 [pii]', '10.1503/cmaj.109-3169 [doi]']",ppublish,CMAJ. 2010 Mar 9;182(4):E195-6. doi: 10.1503/cmaj.109-3169. Epub 2010 Feb 8.,4,,,,,['CMAJ. 2010 Jun 15;182(9):941. PMID: 20547726'],,,,,,,,,,,,,,,,,
2904591,NLM,MEDLINE,19890126,20190611,0140-6736 (Print) 0140-6736 (Linking),2,1988 Dec 24-31,Outbreak of Dengue fever in Delhi.,1485-6,,,"['Acharya, S K', 'Buch, P', 'Irshad, M', 'Gandhi, B M', 'Joshi, Y K', 'Tandon, B N']","['Acharya SK', 'Buch P', 'Irshad M', 'Gandhi BM', 'Joshi YK', 'Tandon BN']",,,['eng'],['Letter'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Adult', 'Dengue/diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Humans', 'India', 'Male', 'Serologic Tests/methods']",,1988/12/24 00:00,1988/12/24 00:01,['1988/12/24 00:00'],"['1988/12/24 00:00 [pubmed]', '1988/12/24 00:01 [medline]', '1988/12/24 00:00 [entrez]']","['S0140-6736(88)90954-3 [pii]', '10.1016/s0140-6736(88)90954-3 [doi]']",ppublish,Lancet. 1988 Dec 24-31;2(8626-8627):1485-6. doi: 10.1016/s0140-6736(88)90954-3.,8626-8627,,,,,,,,,,,,,,,,,,,,,,
23725977,NLM,MEDLINE,20130906,20130603,1560-7917 (Electronic) 1025-496X (Linking),18,2013 May 23,"Detection on four continents of dengue fever cases related to an ongoing outbreak in Luanda, Angola, March to May 2013.",,20488 [pii],,"['Schwartz, E', 'Meltzer, E', 'Mendelson, M', 'Tooke, A', 'Steiner, F', 'Gautret, P', 'Friedrich-Jaenicke, B', 'Libman, M', 'Bin, H', 'Wilder-Smith, A', 'Gubler, Dj', 'Freedman, D O', 'Parola, P']","['Schwartz E', 'Meltzer E', 'Mendelson M', 'Tooke A', 'Steiner F', 'Gautret P', 'Friedrich-Jaenicke B', 'Libman M', 'Bin H', 'Wilder-Smith A', 'Gubler Dj', 'Freedman DO', 'Parola P']",,"['Center for Geographic Medicine and Department of Medicine C the Sheba medical center, Tel Hashomer & Sackler School of Medicine, Tel Aviv, Israel.']",['eng'],['Journal Article'],20130523,Sweden,Euro Surveill,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,100887452,,IM,"['Adult', 'Angola/epidemiology', 'Dengue/complications/*diagnosis/*epidemiology', 'Dengue Virus/*isolation & purification', 'Disease Outbreaks/prevention & control/*statistics & numerical data', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'Male', 'Middle Aged', '*Travel']",,2013/06/04 06:00,2013/09/07 06:00,['2013/06/04 06:00'],"['2013/06/04 06:00 [entrez]', '2013/06/04 06:00 [pubmed]', '2013/09/07 06:00 [medline]']",['20488 [pii]'],epublish,Euro Surveill. 2013 May 23;18(21):20488.,21,,,,,,,,,,,,,,,,,,,,,,
28098525,NLM,MEDLINE,20180226,20231112,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),23,2017 Feb,"Genetic Diversity and New Lineages of Dengue Virus Serotypes 3 and 4 in Returning Travelers, Germany, 2006-2015.",272-275,10.3201/eid2302.160751 [doi],"During 2006-2015, we analyzed 70 dengue virus (DENV) strains isolated from febrile travelers returning to Germany. High genetic diversity, including multiple co-circulating DENV lineages and emerging new lineages of DENV-3 and DENV-4, was demonstrated. Our passive surveillance system based on returning travelers yielded substantial information on DENV diversity.","['Shihada, Sami', 'Emmerich, Petra', 'Thome-Bolduan, Corinna', 'Jansen, Stephanie', 'Gunther, Stephan', 'Frank, Christina', 'Schmidt-Chanasit, Jonas', 'Cadar, Daniel']","['Shihada S', 'Emmerich P', 'Thome-Bolduan C', 'Jansen S', 'Gunther S', 'Frank C', 'Schmidt-Chanasit J', 'Cadar D']",,,['eng'],"['Historical Article', 'Journal Article']",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Dengue/*epidemiology/history/transmission/*virology', 'Dengue Virus/*classification/*genetics/isolation & purification', '*Genetic Variation', 'Genotype', 'Geography, Medical', 'Germany/epidemiology', 'History, 21st Century', 'Humans', 'Phylogeny', 'Public Health Surveillance', 'Serogroup', '*Travel']",PMC5324807,2017/01/19 06:00,2018/02/27 06:00,['2017/01/19 06:00'],"['2017/01/19 06:00 [entrez]', '2017/01/19 06:00 [pubmed]', '2018/02/27 06:00 [medline]']","['16-0751 [pii]', '10.3201/eid2302.160751 [doi]']",ppublish,Emerg Infect Dis. 2017 Feb;23(2):272-275. doi: 10.3201/eid2302.160751.,2,,['NOTNLM'],"['DENV', 'Germany', 'dengue virus', 'lineage', 'mosquito-borne', 'phylogeny', 'serotype', 'travel-associated infection', 'traveler', 'vector-borne', 'viruses']",,,,,,,,,,,,,,,,,,,
1842417,NLM,MEDLINE,19930107,20190516,0074-0276 (Print) 0074-0276 (Linking),86,1991 Apr-Jun,Dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) caused by serotype 2 in Brazil.,269,,,"['Nogueira, R M', 'Zagner, S M', 'Martins, I S', 'Lampe, E', 'Miagostovich, M P', 'Schatzmayr, H G']","['Nogueira RM', 'Zagner SM', 'Martins IS', 'Lampe E', 'Miagostovich MP', 'Schatzmayr HG']",,"['Instituto Oswaldo Cruz, Departamento de Virologia, Rio de Janeiro, Brasil.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Brazil,Mem Inst Oswaldo Cruz,Memorias do Instituto Oswaldo Cruz,7502619,,IM,"['Adult', 'Brazil', 'Dengue/diagnosis/*microbiology', 'Dengue Virus/*isolation & purification', 'Humans', 'Male']",,1991/04/01 00:00,1991/04/01 00:01,['1991/04/01 00:00'],"['1991/04/01 00:00 [pubmed]', '1991/04/01 00:01 [medline]', '1991/04/01 00:00 [entrez]']","['S0074-02761991000200018 [pii]', '10.1590/s0074-02761991000200018 [doi]']",ppublish,Mem Inst Oswaldo Cruz. 1991 Apr-Jun;86(2):269. doi: 10.1590/s0074-02761991000200018.,2,,,,,,,,,,,,,,,,,,,,,,
20414506,NLM,MEDLINE,20100901,20190608,1680-5348 (Electronic) 1020-4989 (Linking),27,2010 Mar,[Direct costs of the dengue fever control and prevention program in 2005 in the City of Sao Paulo].,175-80,S1020-49892010000300004 [pii],"OBJECTIVE: To estimate the direct costs associated with the control of Aedes aegypti and prevention of dengue fever in the City of Sao Paulo Dengue Control Program, Brazil, in 2005. METHOD: The following items were considered: human resources, uniforms, field materials, individual protection equipment, spraying equipment, strategic supplies (insecticides and larvicides), and vehicles. The costs associated with laboratory tests for entomological surveillance and dengue fever diagnosis were also calculated, as well as costs relating to information and printed materials for educational campaigns. RESULTS: The total direct costs of the City of Sao Paulo Dengue Fever Program in 2005 were R$ 21,774,282.82 (US$ 12,486,941.34 considering the dollar/real exchange rate in December 2009). Of this amount, 59.4% were directed to human resources, 38.3% to epidemic control measures, and 2.2% to capital expenditure. The cost per capita was R$ 1.99 in 2005. CONCLUSIONS: The control of dengue fever is essential given the growth of epidemics. Knowledge about the costs of strategies and priority items employed in dengue fever control and prevention programs can guide decision-making regarding the application of budget resources in both the City of Sao Paulo and Brazil as a whole.","['Taliberti, Helena', 'Zucchi, Paola']","['Taliberti H', 'Zucchi P']",,['Universidade Federal de Sao Paulo.'],['por'],"['English Abstract', 'Journal Article']",,United States,Rev Panam Salud Publica,Revista panamericana de salud publica = Pan American journal of public health,9705400,,IM,"['Brazil', 'Costs and Cost Analysis', 'Dengue/*economics/*prevention & control', 'Humans', 'Preventive Health Services/*economics', 'Urban Health']",,2010/04/24 06:00,2010/09/02 06:00,['2010/04/24 06:00'],"['2009/06/01 00:00 [received]', '2009/09/25 00:00 [accepted]', '2010/04/24 06:00 [entrez]', '2010/04/24 06:00 [pubmed]', '2010/09/02 06:00 [medline]']","['S1020-49892010000300004 [pii]', '10.1590/s1020-49892010000300004 [doi]']",ppublish,Rev Panam Salud Publica. 2010 Mar;27(3):175-80. doi: 10.1590/s1020-49892010000300004.,3,,,,,,,,,Custos diretos do programa de prevencao e controle da dengue no Municipio de Sao Paulo em 2005.,,,,,,,,,,,,,
22842941,NLM,MEDLINE,20121128,20220409,1972-2680 (Electronic) 1972-2680 (Linking),6,2012 Jul 23,Clinical profile of dengue infection at a teaching hospital in North India.,551-4,,"INTRODUCTION: Dengue viral infections are among the most important mosquito-borne diseases of the Indian subcontinent and have become a major global public health concern. Spread of disease has led to increased recognition of atypical manifestations apart from the classical clinical features of dengue infection. METHODOLOGY: A cross-sectional study of admitted patients suspected to have dengue infection was conducted during the monsoon and post-monsoon seasons in the year 2010. Patients who had serological confirmation of dengue infection were classified according to World Health Organization definitions of dengue fever and dengue hemorrhagic fever. Clinical and biochemical parameters were compared between the two groups. RESULTS: Out of 356 patients with suspected dengue fever enrolled in the study, 138 (39%) had serologically confirmed dengue infection. Eighty (58%) patients were males and 58 (42%) were females. Ninety-six (70%) patients had classical dengue fever while 42 (30%) had dengue hemorrhagic fever. The most common symptoms were headache (105, 76%), abdominal pain (87, 63%), vomiting (80, 58%), rash (36, 26%), and cutaneous hypersensitivity (22, 16%). Hemorrhagic manifestations were present in 55 (40%) patients. Atypical manifestations were recorded. Notably, 14% of patients had neurological involvement and 4% had acute hepatic failure. Overall mortality was 6% and all fatal cases were due to multi-organ failure. CONCLUSION: Dengue infection poses a huge burden to the health-care system; its spectrum ranges from mild self-limiting illness to severe fatal disease. It can have varied and multi-systemic manifestations which can go unrecognized. Clinicians should have a high index of suspicion for atypical manifestations.","['Karoli, Ritu', 'Fatima, Jalees', 'Siddiqi, Zeba', 'Kazmi, Khursheed I', 'Sultania, Amit R']","['Karoli R', 'Fatima J', 'Siddiqi Z', 'Kazmi KI', 'Sultania AR']",,"[""Era's Lucknow Medical College, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh, India. ritu.karoli@rediffmail.com""]",['eng'],['Journal Article'],20120723,Italy,J Infect Dev Ctries,Journal of infection in developing countries,101305410,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cross-Sectional Studies', 'Dengue/diagnosis/mortality/*pathology', 'Female', 'Hospitals, Teaching', 'Humans', 'India', 'Male', 'Middle Aged', 'Serologic Tests', 'Survival Analysis', 'Young Adult']",,2012/07/31 06:00,2012/12/10 06:00,['2012/07/31 06:00'],"['2011/04/01 00:00 [received]', '2011/08/04 00:00 [accepted]', '2011/07/26 00:00 [revised]', '2012/07/31 06:00 [entrez]', '2012/07/31 06:00 [pubmed]', '2012/12/10 06:00 [medline]']",['10.3855/jidc.2010 [doi]'],epublish,J Infect Dev Ctries. 2012 Jul 23;6(7):551-4. doi: 10.3855/jidc.2010.,7,,,,,,,,,,,,,,,,,,,,,,
34289153,NLM,MEDLINE,20210927,20210927,1096-9071 (Electronic) 0146-6615 (Linking),93,2021 Nov,"Dengue fever outbreak in Cook Island: A rising concern, efforts, challenges, and future recommendations.",6073-6076,10.1002/jmv.27223 [doi],"The Cook Island government has made several efforts to ensure zero confirmed cases and transmission of COVID-19, especially among visiting travelers. However, the Cook Island ministry of health has to deal with the new strain of dengue fever outbreak, known as dengue fever type 2 (DEN-2), by adopting several measures to control its spread, especially in the affected parts of the subtropical country. This paper aims to describe the dengue fever response taken in Cook Island and suggest recommendations to control the risk of transmission in endemic parts of the world.","['Uwishema, Olivier', 'Nnagha, Ekene M', 'Chalhoub, Elie', 'Nchasi, Goodluck', 'Mwazighe, Rehema M', 'Akin, Burak T', 'Adanur, Irem', 'Onyeaka, Helen']","['Uwishema O', 'Nnagha EM', 'Chalhoub E', 'Nchasi G', 'Mwazighe RM', 'Akin BT', 'Adanur I', 'Onyeaka H']","['ORCID: 0000-0002-0692-9027', 'ORCID: 0000-0002-8624-3067', 'ORCID: 0000-0002-1002-0596', 'ORCID: 0000-0003-0567-2757', 'ORCID: 0000-0002-3875-0574', 'ORCID: 0000-0003-3846-847X']","['Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'Clinton Global Initiative University, New York, New York, USA.', 'Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.', 'Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'College of Medicine, University of Calabar, Calabar, Nigeria.', 'Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'Faculty of Medicine, University of Saint Joseph of Beirut, Beirut, Lebanon.', 'Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'Catholic University of Health and Allied Science, Mwanza, Tanzania.', 'Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'Medical Laboratory Technologist, The Mombasa Hospital, Mombasa, Kenya.', 'Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.', 'Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.', 'Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.', 'School of Chemical Engineering, University of Birmingham, Birmingham, UK.']",['eng'],['Journal Article'],20210728,United States,J Med Virol,Journal of medical virology,7705876,,IM,"['COVID-19/diagnosis/epidemiology', 'Dengue/diagnosis/*epidemiology/prevention & control/virology', 'Dengue Virus/classification', '*Disease Outbreaks', 'Endemic Diseases', 'Humans', 'Mosquito Control', 'Polynesia/epidemiology', 'Serogroup']",,2021/07/22 06:00,2021/09/28 06:00,['2021/07/21 17:37'],"['2021/07/06 00:00 [received]', '2021/07/16 00:00 [accepted]', '2021/07/22 06:00 [pubmed]', '2021/09/28 06:00 [medline]', '2021/07/21 17:37 [entrez]']",['10.1002/jmv.27223 [doi]'],ppublish,J Med Virol. 2021 Nov;93(11):6073-6076. doi: 10.1002/jmv.27223. Epub 2021 Jul 28.,11,['(c) 2021 Wiley Periodicals LLC.'],['NOTNLM'],"['COVID-19', 'Cook Island', 'DEN-2', 'dengue fever', 'endemic', 'outbreak', 'travelers']",,,,,,,,,,,,,,,,,,,
15683045,NLM,MEDLINE,20050311,20151119,0043-5325 (Print) 0043-5325 (Linking),116 Suppl 4,2004,Imported Dengue fever presenting with febrile diarrhoea: report of two cases.,58-60,,"Dengue fever is a significant health problem in most tropical regions and increasingly observed among travelers returning from tropical countries. Clinical presentation might not be typical in patients from non-endemic areas. We report 2 patients returning from South-East Asia with proven Dengue-virus infection initially presenting with ""febrile diarrhea"" followed by hemorrhagic skin lesions during hospitalization. Blood and stool examination remained negative for bacteria, parasites and plasmodia. Dengue fever was suspected early, mainly due to the typical course of the complete blood cell count with thrombocytopenia (19 x 10(9)/L and 86 x 10(9)/L) and leucopenia (3 x 10(9)/L and 1.8 x 10(9)/L). Both patients had a benign clinical course, which still required intensive care monitoring. Platelet inhibitors and NSAIDs should be stopped when Dengue infection (Dengue fever and Dengue hemorrhagic fever) is suspected in order to minimalize the risk of bleeding. Although presentation of the disease might not always be typical, Dengue infection has to be considered early in the course of disease by taking an in-depth history and profound physical examination.","['Helbok, Raimund', 'Dent, Wolfgang', 'Gattringer, Klaus', 'Innerebner, Martha', 'Schmutzhard, Erich']","['Helbok R', 'Dent W', 'Gattringer K', 'Innerebner M', 'Schmutzhard E']",,"['Department of Neurology, University of Innsbruck, Innsbruck, Austria. raimund_helbok@yahoo.com']",['eng'],"['Case Reports', 'Comparative Study', 'Journal Article']",,Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,,IM,"['Adult', 'Aged', 'Asia, Southeastern', 'Blood Cell Count', 'Critical Care', 'Dengue/blood/complications/*diagnosis', 'Dengue Virus/isolation & purification', 'Diagnosis, Differential', 'Diarrhea/etiology', 'Female', 'Humans', 'Male', 'Physical Examination', 'Severe Dengue/diagnosis', '*Travel']",,2005/02/03 09:00,2005/03/12 09:00,['2005/02/03 09:00'],"['2005/02/03 09:00 [pubmed]', '2005/03/12 09:00 [medline]', '2005/02/03 09:00 [entrez]']",,ppublish,Wien Klin Wochenschr. 2004;116 Suppl 4:58-60.,,,,,,,,,,,,,,,,,,,,,,,
36374056,NLM,MEDLINE,20221116,20221202,1668-3501 (Electronic) 0325-0075 (Linking),120,2022 Dec,Dengue beyond the tropics: a time-series study comprising 2015-2016 versus 2019-2020 at a children's hospital in the City of Buenos Aires.,384-390,10.5546/aap.2022.eng.384 [doi],"INTRODUCTION: Dengue is a public health problem worldwide. It was originally confined to tropical and subtropical areas, but it is now present in other regions, such as Argentina. Epidemic outbreaks have been observed in the City of Buenos Aires since 2008, with few reports in children. OBJECTIVE: To analyze and compare the clinical, epidemiological, laboratory, and evolutionary characteristics of the latest 2 dengue outbreaks outside the endemic area. POPULATION AND METHODS: Time-series study. Patients under 18 years of age with probable or confirmed dengue and evaluated in a children's hospital of the City of Buenos Aires during the periods 2015-2016 and 2019-2020 were included. RESULTS: A total of 239 patients were included; 29 (12%) had a history of travel. Their median age was 132 months (interquartile range: 102- 156). All had a fever. Other symptoms included headache in 170 (71%), myalgia in 129 (54%), and rash in 122 (51%). Forty patients (17%) had comorbidities. Warning signs were observed in 79 patients (33%); 14 (6%) developed severe dengue; 115 (45%) were hospitalized; none died. DENV-1 was the most common serotype. A history of travel and hospitalization prevailed in the first period; severe dengue and prior infection, in the second period. CONCLUSIONS: No patient died due to dengue in either study period. Statistically significant differences were observed in the frequency of hospitalization; a history of travel was more common in the 2015-2016 period and severe dengue, in the 2019-2020 period.","['Berberian, Griselda', 'Perez, Guadalupe', 'Mangano, Andrea', 'Borgnia, Daniela', 'Buchovsky, Ana', 'Costa, Marina', 'Fabbri, Cintia', 'Luppo, Victoria', 'Mistchenko, Alicia S', 'Deschutter, Veronica', 'Botana, Claudia', 'Martiren, Soledad', 'Brizuela, Martin', 'Arias, Ana P', 'Rosanova, Maria T']","['Berberian G', 'Perez G', 'Mangano A', 'Borgnia D', 'Buchovsky A', 'Costa M', 'Fabbri C', 'Luppo V', 'Mistchenko AS', 'Deschutter V', 'Botana C', 'Martiren S', 'Brizuela M', 'Arias AP', 'Rosanova MT']","['ORCID: 0000-0002-8610-7284', 'ORCID: 0000-0002-5771-9353', 'ORCID: 0000-0002-6273-7628', 'ORCID: 0000-0002-1325-8938', 'ORCID: 0000-0002-0755-7237', 'ORCID: 0000-0002-3285-7602', 'ORCID: 0000-0003-1838-7349', 'ORCID: 0000-0001-7587-0084', 'ORCID: 0000-0003-2113-449X', 'ORCID: 0000-0003-2195-7779', 'ORCID: 0000-0002-6503-0185']","['Servicio de Infectologia y Epidemiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina. griselberberian@yahoo.com.ar.', 'Servicio de Infectologia y Epidemiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Servicio de Microbiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan. Ciudad Autonoma de Buenos Aires, Argentina.', 'Servicio de Microbiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan. Ciudad Autonoma de Buenos Aires, Argentina.', 'Sector de Serologias, Laboratorio central, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Sector de Serologias, Laboratorio central, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Instituto Nacional de Enfermedades Virales Humanas, Dr. Julio I. Maiztegui, Pergamino, Argentina.', 'Instituto Nacional de Enfermedades Virales Humanas, Dr. Julio I. Maiztegui, Pergamino, Argentina.', 'Servicio de Virologia. Hospital de Ninos Ricardo Gutierrez, Ciudad Autonoma de Buenos Aires, Argentina.', 'Servicio de Infectologia y Epidemiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Clinica de Bajo Riesgo, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Servicio de Infectologia y Epidemiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.', 'Servicio de Infectologia y Epidemiologia, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Ciudad Autonoma de Buenos Aires, Argentina.']","['eng', 'spa']",['Journal Article'],20221018,Argentina,Arch Argent Pediatr,Archivos argentinos de pediatria,0372460,,IM,"['Humans', 'Child', 'Adolescent', '*Dengue/epidemiology/diagnosis', '*Severe Dengue/epidemiology', 'Disease Outbreaks', '*Exanthema', 'Hospitals, Pediatric']",,2022/11/15 06:00,2022/11/18 06:00,['2022/11/14 09:06'],"['2021/06/25 00:00 [received]', '2022/03/14 00:00 [accepted]', '2022/11/14 09:06 [entrez]', '2022/11/15 06:00 [pubmed]', '2022/11/18 06:00 [medline]']",['10.5546/aap.2022.eng.384 [doi]'],ppublish,Arch Argent Pediatr. 2022 Dec;120(6):384-390. doi: 10.5546/aap.2022.eng.384. Epub 2022 Oct 18.,6,['Sociedad Argentina de Pediatria.'],['NOTNLM'],"['child', 'dengue', 'mosquito-borne diseases']",['None.'],,,,,Dengue mas alla del tropico: estudio de series temporales 2015-2016 versus 2019-2020 en un hospital pediatrico de la Ciudad de Buenos Aires.,,,,,,,,,,,,,
23911088,NLM,MEDLINE,20140131,20211021,1654-9880 (Electronic) 1654-9716 (Print) 1654-9880 (Linking),6,2013 Aug 2,"Exploring the origin and potential for spread of the 2013 dengue outbreak in Luanda, Angola.",21822,10.3402/gha.v6i0.21822 [doi],"INTRODUCTION: Dengue in Africa is underreported. Simultaneous reports of travellers with dengue returning from Luanda, Angola, to six countries on four continents suggest that a major dengue outbreak is currently occurring in Angola, South West Africa. METHODS: To identify the origin of the imported dengue virus, we sequenced the virus from Angola and investigated the interconnectivity via air travel between dengue-endemic countries and Angola. RESULTS AND CONCLUSION: Our analyses show that the Angola outbreak was most likely caused by an endemic virus strain that had been circulating in West Africa for many years. We also show that Portugal and South Africa are most likely at the highest risk of importation of dengue from Angola due to the large number of air passengers between Angola and these countries.","['Sessions, October M', 'Khan, Kamran', ""Hou, Yan'an"", 'Meltzer, Eyal', 'Quam, Mikkel', 'Schwartz, Eli', 'Gubler, Duane J', 'Wilder-Smith, Annelies']","['Sessions OM', 'Khan K', 'Hou Y', 'Meltzer E', 'Quam M', 'Schwartz E', 'Gubler DJ', 'Wilder-Smith A']",,"['Program in Emerging Infectious Diseases, Duke-NUS, Singapore. october.sessions@duke-nus.edu.sg']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130802,United States,Glob Health Action,Global health action,101496665,,IM,"['Angola/epidemiology', 'Dengue/diagnosis/*epidemiology/transmission', 'Dengue Virus/genetics', 'Disease Outbreaks/*statistics & numerical data', 'Genotype', 'Humans', 'Phylogeny', 'Polymerase Chain Reaction', 'Risk Factors', 'Sequence Alignment', 'Travel']",PMC3733016,2013/08/06 06:00,2014/02/01 06:00,['2013/08/06 06:00'],"['2013/06/23 00:00 [received]', '2013/07/08 00:00 [revised]', '2013/07/10 00:00 [accepted]', '2013/08/06 06:00 [entrez]', '2013/08/06 06:00 [pubmed]', '2014/02/01 06:00 [medline]']","['21822 [pii]', '10.3402/gha.v6i0.21822 [doi]']",epublish,Glob Health Action. 2013 Aug 2;6:21822. doi: 10.3402/gha.v6i0.21822.,,,['NOTNLM'],"['Angola', 'dengue', 'dengue in Africa', 'dengue sequence', 'international travel']",,,,,,,,,,,,,,,,,,,
16792959,NLM,MEDLINE,20060914,20190917,1695-4033 (Print) 1695-4033 (Linking),64,2006 Jun,[Early indicators of dengue infection in children].,523-9,,"OBJECTIVE: To identify clinical manifestations and laboratory findings useful for the early diagnosis of dengue in children. MATERIALS AND METHODS: We prospectively evaluated 125 children (aged 5 to 12 years old) with acute febrile syndrome with no apparent etiology. Paired serologic tests and/or viral culture were performed and dengue infection was confirmed in 40 patients and ruled out in 68 (17 indefinite cases). Early clinical manifestations (within the first 4 days of the disease) in the groups with dengue and other causes of febrile syndrome were compared. Independent indicators of dengue were determined in a multivariate logistic regression analysis. RESULTS: When clinical manifestations and complete blood count were considered, the independent indicators of dengue were: absence of nasal discharge, facial flushing, and leukocyte count < or = 4,500/.l. With at least two of these findings, a sensitivity of 67 % and a specificity of 72 % for the diagnosis of dengue were obtained. When coagulation tests were considered, a model for diagnosis was composed of: absence of nasal discharge, leukocyte count < or = 4500/.l, prothrombin time > 14 seconds, and partial thromboplastin time > 29 seconds. Two of these findings suggested a diagnosis of dengue with a sensitivity of 90 % and a specificity of 52.9 %. With at least 3 findings, specificity increased to 89.7 % and sensitivity decreased to 50 %. The presence of the four components of this latter model shows a specificity of 100 %. CONCLUSIONS: Some clinical manifestations and simple laboratory tests could aid the early detection of dengue infection in children.","['Diaz-Quijano, F A', 'Villar-Centeno, L A', 'Martinez-Vega, R A']","['Diaz-Quijano FA', 'Villar-Centeno LA', 'Martinez-Vega RA']",,"['Centro de Investigaciones Epidemiologicas, Facultad de Salud, Universidad Industrial de Santander, Ctra. 32 no. 29-31, Bucaramanga, Colombia. fre_diazq@yahoo.com']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Spain,An Pediatr (Barc),"Anales de pediatria (Barcelona, Spain : 2003)",101162596,,IM,"['Child', 'Dengue/blood/*diagnosis', 'Humans', 'Prospective Studies']",,2006/06/24 09:00,2006/09/15 09:00,['2006/06/24 09:00'],"['2006/06/24 09:00 [pubmed]', '2006/09/15 09:00 [medline]', '2006/06/24 09:00 [entrez]']","['13089916 [pii]', '10.1157/13089916 [doi]']",ppublish,An Pediatr (Barc). 2006 Jun;64(6):523-9. doi: 10.1157/13089916.,6,,,,,,,,,Indicadores tempranos de infeccion por dengue en ninos.,,,,,,,,,,,,,
29293624,NLM,MEDLINE,20180221,20181113,1932-6203 (Electronic) 1932-6203 (Linking),13,2018,"Epidemiological, clinical and climatic characteristics of dengue fever in Kaohsiung City, Taiwan with implication for prevention and control.",e0190637,10.1371/journal.pone.0190637 [doi] e0190637,"BACKGROUND: The early identification of dengue infection is essential for timely and effective quarantine and vector control measures for preventing outbreaks of the disease. Kaohsiung City is responsible for most of the dengue cases in Taiwan. Thus, this study aims to identify major factors involved in the prevalence of dengue fever by analyzing the epidemiological and clinical characteristics, and to establish associations between weather parameters and dengue occurrence in this City. METHODS: A retrospective study was conducted with 3,322 confirmed dengue cases. Appropriate statistical methods were used to compare differences and correlations between dengue occurrence and demographic, clinical and weather parameters. RESULTS: The outbreak of dengue fever was found to be initiated by imported cases of dengue viruses from other endemic countries. Most of the confirmed cases were not reported to the health authority during the first visit to a doctor, and it took a median of 5 days after the appearance of the first syndromes for medical personnel to report suspected dengue cases. Accordingly, Aedes mosquitoes would have enough time to be infected and transmit the dengue virus. The diagnosis and notification criteria should not only include common symptoms of fever, myalgia, headache, skin rash and arthralgia, but should also be adjusted to include the most frequent symptoms of loss of appetite and feeling thirsty to shorten the notification time. Significantly positive correlations were found between the number of confirmed cases and weather parameters (i.e., temperature, rainfall and relative humidity) at a time lag of 1 month and 2 months. The predictive models for dengue occurrence using these three parameters at a 2-month lag time were established. CONCLUSIONS: The surveillance of imported cases, adjustment of notification criteria and application of climatic predictive models would be helpful in strengthening the dengue early warning surveillance system.","['Chang, Chiu-Jung', 'Chen, Colin S', 'Tien, Chien-Jung', 'Lu, Mei-Rou']","['Chang CJ', 'Chen CS', 'Tien CJ', 'Lu MR']",['ORCID: 0000-0002-0818-3134'],"['Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan.', 'Department of Biotechnology, National Kaohsiung Normal University, Kaohsiung, Taiwan.', 'Department of Biotechnology, National Kaohsiung Normal University, Kaohsiung, Taiwan.', 'Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan.']",['eng'],['Journal Article'],20180102,United States,PLoS One,PloS one,101285081,,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', '*Climate', 'Dengue/*epidemiology/pathology/prevention & control', 'Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Taiwan/epidemiology', 'Young Adult']",PMC5749826,2018/01/03 06:00,2018/02/22 06:00,['2018/01/03 06:00'],"['2017/09/02 00:00 [received]', '2017/12/18 00:00 [accepted]', '2018/01/03 06:00 [entrez]', '2018/01/03 06:00 [pubmed]', '2018/02/22 06:00 [medline]']","['PONE-D-17-31675 [pii]', '10.1371/journal.pone.0190637 [doi]']",epublish,PLoS One. 2018 Jan 2;13(1):e0190637. doi: 10.1371/journal.pone.0190637. eCollection 2018.,1,,,,['Competing Interests: The authors have declared that no competing interests exit.'],,,,,,,,,,,,,,,,,,
34715814,NLM,MEDLINE,20211102,20211102,1471-2334 (Electronic) 1471-2334 (Linking),21,2021 Oct 29,Comparison of clinical manifestation of dengue fever in Bangladesh: an observation over a decade.,1113,10.1186/s12879-021-06788-z [doi] 1113,"BACKGROUND: The clinical presentation of dengue fever had been observed to change with time since its first outbreak in 2000 in Bangladesh. This report showed the clinical presentation of the 2019 outbreak in Bangladesh along with its comparison to previous outbreaks witnessed in this region. METHODS: This hospital-based cross-sectional study was conducted in one of the largest tertiary care hospitals in Dhaka city. A total of 553 laboratory-confirmed and 194 probable dengue cases were interviewed. The clinical manifestation of the confirmed cases of the current outbreak was compared with three of the outbreak reports retrieved from the databases. R version 3.6.3 was used for data analysis. RESULTS: Among the confirmed cases, two-thirds were male (63.2%) and the average age was 27(+/- 11) years. Positive tests for NS1 and IgM were present in 99.6% (n = 525/527) and 82.6% (n = 38/46) of the cases, respectively. Thrombocytopenia was present in 66.1% of cases. Fever (100%) was common for all. Gastrointestinal (GIT) features, including abdominal pain (86.5%), anorexia and/or vomiting (69.6%), and Diarrhea (> 3 motions/day) (26.2%) were more frequent than typical rash and other pain symptoms. Hypotension was present in approximately a quarter of patients (25%). GIT features (anorexia, nausea, and/or vomiting) and hypotension were more common among adult participants while bleeding manifestation (melena and vaginal bleeding, p = 0.009 & 0.032) was more frequent in pediatric patients. Compared to outbreaks of 2008, 2016, and 2018, increasing trends in GIT symptoms e.g. anorexia, abdominal pain, and diarrhea were observed. While a negative trend in hemorrhagic manifestations (skin rash, melena, and conjunctival hemorrhage/hemorrhagic sclera) and arthralgia/joint pain were found. CONCLUSION: The present outbreak was noticeably characterized by GIT symptoms and hypotension in addition to the typical clinical features like rash and pain symptoms. An increasing trend in GIT features and decreasing trend in hemorrhagic manifestations was noted over the last decade of dengue outbreaks.","['Hasan, Mohammad Jahid', 'Tabassum, Tamanna', 'Sharif, Mohiuddin', 'Khan, Md Abdullah Saeed', 'Bipasha, Akhi Roy', 'Basher, Ariful', 'Islam, Mohammad Rafiqul', 'Amin, Mohammad Robed']","['Hasan MJ', 'Tabassum T', 'Sharif M', 'Khan MAS', 'Bipasha AR', 'Basher A', 'Islam MR', 'Amin MR']",['ORCID: 0000-0001-9212-1739'],"['Pi Research Consultancy Center, Dhaka, Bangladesh. dr.jahid61@gmail.com.', 'Pi Research Consultancy Center, Dhaka, Bangladesh.', 'Department of Medicine, Dhaka Medical College and Hospital-2, Dhaka, Bangladesh.', 'Pi Research Consultancy Center, Dhaka, Bangladesh.', 'Pi Research Consultancy Center, Dhaka, Bangladesh.', 'BSMMU, OSD, Directorate General of Health Service, Dhaka, Bangladesh.', 'Department of Medicine, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh.', 'Department of Medicine, Dhaka Medical College and Hospital-2, Dhaka, Bangladesh.']",['eng'],['Journal Article'],20211029,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adolescent', 'Adult', 'Bangladesh/epidemiology', 'Child', 'Cross-Sectional Studies', '*Dengue/complications/diagnosis/epidemiology', '*Disease Outbreaks', 'Female', 'Fever/epidemiology/etiology', 'Humans', 'Male', 'Young Adult']",PMC8555248,2021/10/31 06:00,2021/11/03 06:00,['2021/10/30 05:22'],"['2020/04/12 00:00 [received]', '2021/10/13 00:00 [accepted]', '2021/10/30 05:22 [entrez]', '2021/10/31 06:00 [pubmed]', '2021/11/03 06:00 [medline]']","['10.1186/s12879-021-06788-z [pii]', '6788 [pii]', '10.1186/s12879-021-06788-z [doi]']",epublish,BMC Infect Dis. 2021 Oct 29;21(1):1113. doi: 10.1186/s12879-021-06788-z.,1,['(c) 2021. The Author(s).'],['NOTNLM'],"['Dengue fever', 'Dengue hemorrhagic fever', 'Dengue outbreak', 'Dengue shock syndrome', 'Shift of paradigm']",['The authors declare no competing interests.'],,,,,,,,,,,,,,,,,,
22246838,NLM,MEDLINE,20120613,20131121,1096-9071 (Electronic) 0146-6615 (Linking),84,2012 Mar,"Epidemiology of dengue infections in Kassala, Eastern Sudan.",500-3,10.1002/jmv.23218 [doi],"Eighty-one (71.7%) out of 113 patients had confirmed dengue infection (using ELISA IgM serology) at Kassala, Eastern Sudan during the period of August through November 2010. According to the WHO criteria, dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) were observed in 30.9, 58, and 11.1% of these patients, respectively. The mean age of these 81 patients was 25.5 years. Male:female ratio was 1.8:1. Various symptoms including fever (100%), headache (75.3%), vomiting (55.6%), nausea (53.1%), and backache (30.9%) were observed among these patients. Thrombocytopenia (<100/10(9) platelets/L), and leucopenia (WBC count <4,000 x 10(9) cells/L) and hemoconcentration (hematocrit >45) were reported in 86.4, 69.1, and 67.9% of the patients, respectively. High alanine aminotransferase (ALT, >65 U/L) and aspartate aminotransferase (AST >37 U/L) were seen in 9.9 and 14.8% of the patients, respectively. There were five (6.1%) deaths, three of them had DHF and the other two patients had DSS.","['Abdallah, Tajeldin M', 'Ali, Abdel Aziem A', 'Karsany, Mubarak S', 'Adam, Ishag']","['Abdallah TM', 'Ali AA', 'Karsany MS', 'Adam I']",,"['Faculty of Medicine, Kassala University, Kassala, Sudan.']",['eng'],['Journal Article'],,United States,J Med Virol,Journal of medical virology,7705876,,IM,"['Adolescent', 'Adult', 'Child', 'Dengue/diagnosis/*epidemiology', '*Epidemics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Severe Dengue/diagnosis/*epidemiology', 'Sudan/epidemiology', 'Young Adult']",,2012/01/17 06:00,2012/06/14 06:00,['2012/01/17 06:00'],"['2012/01/17 06:00 [entrez]', '2012/01/17 06:00 [pubmed]', '2012/06/14 06:00 [medline]']",['10.1002/jmv.23218 [doi]'],ppublish,J Med Virol. 2012 Mar;84(3):500-3. doi: 10.1002/jmv.23218.,3,"['Copyright (c) 2012 Wiley Periodicals, Inc.']",,,,,,,,,,,,,,,,,,,,,
28724363,NLM,MEDLINE,20171016,20181202,1471-2334 (Electronic) 1471-2334 (Linking),17,2017 Jul 19,Comparing patient and healthcare worker experiences during a dengue outbreak in Singapore: understanding the patient journey and the introduction of a point-of-care test (POCT) toward better care delivery.,503,10.1186/s12879-017-2580-9 [doi] 503,"BACKGROUND: In the aftermath of an upsurge in the number of dengue cases in 2013 and 2014, the SD BIOLINE Dengue Duo rapid diagnostic Point-of-Care Test (POCT) kit was introduced in Tan Tock Seng Hospital, Singapore in June 2013. It is known that the success of POCT usage is contingent on its implementation within the health system. We evaluated health services delivery and the Dengue Duo rapid diagnostic test kit application in Singapore from healthcare workers' perspectives and patient experiences of dengue at surge times. METHODS: Focus group discussions were conducted with dengue patients, from before and after the POCT implementation period. In-depth interviews with semi-structured components with healthcare workers were carried out. A patient centred process mapping technique was used for evaluation, which mapped the patient's journey and was mirrored from the healthcare worker's perspective. RESULTS: Patients and healthcare workers confirmed a wide range of symptoms in adults, making it challenging to determine diagnosis. There were multiple routes to help seeking, and no 'typical patient journey', with patients either presenting directly to the hospital emergency department, or being referred there by a primary care provider. Patients groups diagnosed before and after POCT implementation expressed some differences between speed of diagnoses and attitudes of doctors, yet shared negative feelings about waiting times and a lack of communication and poor information delivery. However, the POCT did not in its current implementation do much to help waiting times. Healthcare workers expressed that public perceptions of dengue in recent years was a major factor in changing patient management, and that the POCT kit was helpful in improving the speed and accuracy of diagnoses. CONCLUSIONS: Health service delivery for dengue patients in Singapore was overall perceived to be of an acceptable clinical standard, which was enhanced by the introduction of the POCT. However, improvements can be focused on Adapting to outbreaks by reducing and rendering Waiting experiences more comfortable; Advancing education about symptom recognition, while also Recognising better communication strategies; and Expanding follow-up care options. This is presented as the Dengue AWARE model of care delivery.","['Tan, Qinghui', 'Hildon, Zoe J-L', 'Singh, Shweta', 'Jing, Jin', 'Thein, Tun Linn', 'Coker, Richard', 'Vrijhoef, Hubertus J M', 'Leo, Yee Sin']","['Tan Q', 'Hildon ZJ', 'Singh S', 'Jing J', 'Thein TL', 'Coker R', 'Vrijhoef HJM', 'Leo YS']",['ORCID: 0000-0003-2099-3719'],"['Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Block MD1, 12 Science Drive 2, Singapore, 117549, Singapore. tan_qing_hui@brc.a-star.edu.sg.', 'Biological Resource Centre, Agency for Science, Technology and Research (A*Star), Singapore, Singapore. tan_qing_hui@brc.a-star.edu.sg.', 'Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Block MD1, 12 Science Drive 2, Singapore, 117549, Singapore.', 'London School of Hygiene and Tropical Medicine, London, United Kingdom.', 'Johns Hopkins Bloomberg School of Public Health, Centre for Communication Programs, 111 Market Place, Suite 310, Baltimore, Maryland, 21202, USA.', 'Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Block MD1, 12 Science Drive 2, Singapore, 117549, Singapore.', 'Institute of Infectious Diseases & Epidemiology, Communicable Disease Centre; Tan Tock Seng Hospital, Moulmein Road, Singapore, 308433, Singapore.', 'Institute of Infectious Diseases & Epidemiology, Communicable Disease Centre; Tan Tock Seng Hospital, Moulmein Road, Singapore, 308433, Singapore.', 'London School of Hygiene and Tropical Medicine, London, United Kingdom.', 'Mahidol University, 9th Floor, Satharanaukwisit Bldg, 420/1 Rajwithi Rd, Bangkok, -10400, Thailand.', 'Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Block MD1, 12 Science Drive 2, Singapore, 117549, Singapore.', 'National University Health System, Singapore, Singapore.', 'Department of Patient & Care, Maastricht University Medical Center, Maastricht, Netherlands.', 'Department of Family Medicine, Vrije Universiteit Brussel, Brussels, Belgium.', 'Saw Swee Hock School of Public Health, National University of Singapore, Tahir Foundation Building, Block MD1, 12 Science Drive 2, Singapore, 117549, Singapore.', 'Institute of Infectious Diseases & Epidemiology, Communicable Disease Centre; Tan Tock Seng Hospital, Moulmein Road, Singapore, 308433, Singapore.']",['eng'],['Journal Article'],20170719,England,BMC Infect Dis,BMC infectious diseases,100968551,"['0 (Reagent Kits, Diagnostic)']",IM,"['Adult', 'Attitude of Health Personnel', '*Delivery of Health Care', 'Dengue/*diagnosis/epidemiology/therapy', 'Disease Outbreaks', 'Female', 'Focus Groups', '*Health Personnel', 'Humans', 'Male', 'Middle Aged', 'Point-of-Care Systems', 'Public Opinion', 'Reagent Kits, Diagnostic', 'Singapore/epidemiology', 'Time Factors']",PMC5517990,2017/07/21 06:00,2017/10/17 06:00,['2017/07/21 06:00'],"['2016/09/14 00:00 [received]', '2017/06/29 00:00 [accepted]', '2017/07/21 06:00 [entrez]', '2017/07/21 06:00 [pubmed]', '2017/10/17 06:00 [medline]']","['10.1186/s12879-017-2580-9 [pii]', '2580 [pii]', '10.1186/s12879-017-2580-9 [doi]']",epublish,BMC Infect Dis. 2017 Jul 19;17(1):503. doi: 10.1186/s12879-017-2580-9.,1,,['NOTNLM'],"['Dengue', 'Focus groups', 'Health personnel', 'Model of care delivery', 'Perception', 'Point-of-care testing']","[""ETHICS APPROVAL AND CONSENT TO PARTICIPATE: INsights into DEngue Survivors'"", 'Perception on HealTHcare Study (IN-DEPTH study) ref.: 2014/01295 was approved on', '3rd March 2015 by the Domain Specific Review Board (DSRB), Singapore. Exploring', 'the Health Systems Capacity for Response to Infectious Disease Surges in Urban', 'Settings: The Case of Singapore ref.: B-14-112 was approved by the NUS-IRB on', '29th July 2014. Informed consent to record, conduct and publish the findings of', 'this study was sought and obtained from all participants before data collection', 'commenced. To maintain confidentiality, all recordings were saved in password', 'protected files on a laptop. CONSENT FOR PUBLICATION: Not applicable. COMPETING', ""INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S"", 'NOTE: Springer Nature remains neutral with regard to jurisdictional claims in', 'published maps and institutional affiliations.']",,,,,,,,,,,,,,,,,,
31317717,NLM,MEDLINE,20190816,20190816,0004-5772 (Print) 0004-5772 (Linking),66,2018 Oct,Dengue Fever as a Rare Cause of Acute Pancreatitis.,82-83,,Dengue is an arthropod borne viral infection endemic in tropical and subtropical climate. Here we report an unusual presentation of Dengue fever as acute pancreatitis. Timely recognition of such atypical complication can reduce the morbidity and mortality.,"['Nawal, C L', 'Meena, P D', 'Chejara, Radhey Shyam', 'Jain, Swapnil', 'Marker, Sebastian', 'Tuteja, Vinay']","['Nawal CL', 'Meena PD', 'Chejara RS', 'Jain S', 'Marker S', 'Tuteja V']",,"['Sr. Prof., Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.', 'Prof., Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.', 'Asst. Prof., Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.', 'PG Student, Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.', 'PG Student, Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.', 'PG Student, Deptt. of Medicine, SMS Medical College and Attached Group of Hospitals Jaipur, Rajasthan.']",['eng'],"['Case Reports', 'Journal Article']",,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,,"['Acute Disease', 'Chronic Disease', 'Dengue/complications/*diagnosis', 'Humans', 'Pancreatitis/*diagnosis/etiology']",,2019/07/19 06:00,2019/08/17 06:00,['2019/07/19 06:00'],"['2019/07/19 06:00 [entrez]', '2019/07/19 06:00 [pubmed]', '2019/08/17 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2018 Oct;66(10):82-83.,10,['(c) Journal of the Association of Physicians of India 2011.'],,,,,,,,,,,,,,,,,,,,,
21681938,NLM,MEDLINE,20120103,20111118,1545-5017 (Electronic) 1545-5009 (Linking),57,2011 Dec 15,Dengue Fever in patients with pediatric malignancy on chemotherapy: a concern in tropical countries.,1249-50,10.1002/pbc.23229 [doi],,"['Bahl, Ankur', 'Bakhshi, Sameer']","['Bahl A', 'Bakhshi S']",,,['eng'],"['Case Reports', 'Letter']",20110616,United States,Pediatr Blood Cancer,Pediatric blood & cancer,101186624,['0 (Antineoplastic Agents)'],IM,"['Adolescent', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', 'Dengue/*complications/diagnosis/*epidemiology', 'Endemic Diseases', 'Humans', 'India/epidemiology', 'Male', 'Neoplasms/*complications/drug therapy/*epidemiology', 'Young Adult']",,2011/06/18 06:00,2012/01/04 06:00,['2011/06/18 06:00'],"['2011/05/03 00:00 [received]', '2011/05/17 00:00 [accepted]', '2011/06/18 06:00 [entrez]', '2011/06/18 06:00 [pubmed]', '2012/01/04 06:00 [medline]']",['10.1002/pbc.23229 [doi]'],ppublish,Pediatr Blood Cancer. 2011 Dec 15;57(7):1249-50. doi: 10.1002/pbc.23229. Epub 2011 Jun 16.,7,,,,,,,,,,,,,,,,,,,,,,
33302815,NLM,MEDLINE,20210602,20210602,1758-1133 (Electronic) 0049-4755 (Linking),51,2021 Apr,Subacute thyroiditis complicating dengue fever - Case report and brief review of literature.,254-256,10.1177/0049475520977821 [doi],"The spectrum of dengue infection illness ranges from mildly symptomatic disease to severe forms of dengue haemorrhagic fever and dengue shock syndrome. Expanded dengue syndrome refers to unusual complications involving gastrointestinal, hepatic, neurological, pulmonary and renal systems. Subacute thyroiditis represents a very rare and under-recognised complication of dengue. We report a case of a 38-year-old female presenting with recurrent fever and throat pain following an episode of dengue. After detailed clinical examination, biochemical evaluation and imaging studies, a diagnosis of subacute thyroiditis complicating dengue was made. We discuss its clinical course and management in this report. Only four such cases have previously been reported in literature. Subacute thyroiditis may represent another rare facet of dengue expanded syndrome.","['Mangaraj, Swayamsidha']",['Mangaraj S'],['ORCID: 0000-0003-1339-1269'],"['Assistant Professor, Department of Endocrinology, IMS & SUM Medical College and Hospital, Bhubaneswar, India.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",20201210,England,Trop Doct,Tropical doctor,1301706,,IM,"['Adult', 'Dengue/complications/*diagnosis', 'Female', 'Humans', 'Thyroiditis, Subacute/complications/*diagnosis']",,2020/12/12 06:00,2021/06/03 06:00,['2020/12/11 05:34'],"['2020/12/12 06:00 [pubmed]', '2021/06/03 06:00 [medline]', '2020/12/11 05:34 [entrez]']",['10.1177/0049475520977821 [doi]'],ppublish,Trop Doct. 2021 Apr;51(2):254-256. doi: 10.1177/0049475520977821. Epub 2020 Dec 10.,2,,['NOTNLM'],"['Dengue fever', 'expanded dengue syndrome', 'subacute thyroiditis', 'viral infection']",,,,,,,,,,,,,,,,,,,
30652459,NLM,MEDLINE,20200317,20200317,1668-3501 (Electronic) 0325-0075 (Linking),117,2019 Feb 1,"[Dengue outbreak in Buenos Aires, Argentina, 2016: Clinical and hematological features in children].",e63-e67,10.5546/aap.2019.e63 [doi],"Dengue is the human arbovirus with the highest morbidity and mortality in the world. The largest outbreak of dengue in Buenos Aires, Argentina, occurred during 2016. OBJECTIVE: To describe clinical and hematological features in children with confirmed dengue infection. METHODS: Cross sectional study that included children attended since January 18th to April 15th 2016 at Hospital de Ninos ""Dr. Ricardo Gutierrez"". RESULTS: among 156 registered cases, 82 confirmed cases by virology test; 130 (83 %) autochthonous cases. The most frequent clinical manifestations were fever, headache and retro-ocular pain. Laboratory abnormalities were leukopenia, thrombocytopenia and increased liver enzymes. Thirty-five children were hospitalized (23 %), 25 (16 %) with warning signs. In our study, no cases of severe dengue occurred. CONCLUSIONS: early recognition of warning signs and hematological monitoring is essential in order to detect patients at risk and offer them adequate early treatment.","['Cazes, Claudia I', 'Carballo, Carolina M', 'Praino, Maria L', 'Ferolla, Fausto M', 'Mistchenko, Alicia', 'Contrini, Maria M', 'Fallo, Aurelia', 'Lopez, Eduardo L']","['Cazes CI', 'Carballo CM', 'Praino ML', 'Ferolla FM', 'Mistchenko A', 'Contrini MM', 'Fallo A', 'Lopez EL']",,"['Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina. clauinescazes@gmail.com.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.', 'Laboratorio de Virologia, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CIC), Argentina.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.', 'Programa de Infectologia Pediatrica, Facultad de Medicina, Universidad de Buenos Aires, Hospital de Ninos Ricardo Gutierrez, Ciudad de Buenos Aires, Argentina.']",['spa'],['Journal Article'],,Argentina,Arch Argent Pediatr,Archivos argentinos de pediatria,0372460,,IM,"['Adolescent', 'Argentina/epidemiology', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', 'Dengue/blood/*diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Male', 'Urban Health', 'Young Adult']",,2019/01/18 06:00,2020/03/18 06:00,['2019/01/18 06:00'],"['2018/05/24 00:00 [received]', '2018/08/09 00:00 [accepted]', '2019/01/18 06:00 [entrez]', '2019/01/18 06:00 [pubmed]', '2020/03/18 06:00 [medline]']",['10.5546/aap.2019.e63 [doi]'],ppublish,Arch Argent Pediatr. 2019 Feb 1;117(1):e63-e67. doi: 10.5546/aap.2019.e63.,1,['Sociedad Argentina de Pediatria.'],['NOTNLM'],"['dengue virus, child, pediatric']",,,,,,"Brote epidemico de dengue en la Ciudad de Buenos Aires, 2016: caracteristicas clinicas y hematologicas de la infeccion en una poblacion pediatrica.",,,,,,,,,,,,,
23995543,NLM,MEDLINE,20140711,20220408,1851-8265 (Electronic) 1669-2381 (Linking),8,2012 May-Aug,[Dengue in Argentina: an economic analysis of the impact of the 2009 epidemic].,151-62,S1851-82652012000200004 [pii] 10.1590/S1851-82652012000200004 [doi],"The present study estimates the economic burden associated with the cases of dengue recorded during the 2009 Argentine epidemic. Among the costs considered are the medical costs necessary for the treatment of those affected and the opportunity costs for those who stopped working or studying because of the disease. In order to assess the costs of the disease, at the end of 2009 an ad-hoc survey was carried out in 201 households where people that had contracted dengue during the 2009 epidemic lived. The results allow us to estimate between 26 to 40 million Argentine pesos (6 to 9 million US dollars) as the total cost of the recorded cases. The regions in the north of Argentina bore the highest economic burden of the disease (more than 90% of the total burden). For all regions, the social cost of one dengue case accounts for more than 40% of the average monthly net individual income.","['Tarragona, Sonia', 'Monteverde, Malena', 'Marchioni, Silvia', 'Caporale, Joaquin', 'Pereiro, Ana Cristina', 'Palacios, Julio Maximiliano']","['Tarragona S', 'Monteverde M', 'Marchioni S', 'Caporale J', 'Pereiro AC', 'Palacios JM']",,"['Fundacion Mundo Sano, Argentina. starragona@mundosano.org']",['spa'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Argentina,Salud Colect,Salud colectiva,101276038,,IM,"['Argentina/epidemiology', '*Cost of Illness', 'Dengue/*economics/epidemiology/therapy', 'Epidemics/*economics/statistics & numerical data', 'Health Care Costs/*statistics & numerical data', 'Humans', 'Models, Economic']",,2013/09/03 06:00,2014/07/12 06:00,['2013/09/03 06:00'],"['2012/02/13 00:00 [received]', '2012/05/16 00:00 [accepted]', '2013/09/03 06:00 [entrez]', '2013/09/03 06:00 [pubmed]', '2014/07/12 06:00 [medline]']","['S1851-82652012000200004 [pii]', '10.1590/S1851-82652012000200004 [doi]']",ppublish,Salud Colect. 2012 May-Aug;8(2):151-62. doi: 10.1590/S1851-82652012000200004.,2,,,,,,,,,Dengue en la Argentina: un analisis economico del impacto de la epidemia de 2009.,,,,,,,,,,,,,
27130747,NLM,MEDLINE,20180917,20181202,0300-5283 (Print) 0300-5283 (Linking),71,2016 Feb,Early central nervous system involvement in a young patient with dengue encephalitis.,41-3,,"A previously well 13-year-old boy presented with a short history of fever and altered mental status. His mother was admitted for dengue fever and there had been a recent dengue outbreak in their neighbourhood. He was diagnosed with dengue encephalitis as both his dengue non-structural protein 1 (NS-1) antigen and cerebrospinal fluid (CSF) dengue polymerase chain reaction (PCR) were positive. He did not have haemoconcentration, thrombocytopenia or any warning signs associated with severe dengue. He recovered fully with supportive treatment. This case highlights the importance of considering the diagnosis of dengue encephalitis in patients from dengue endemic areas presenting with an acute febrile illness and neurological symptoms.","['Alice, V', 'Cheong, B M K']","['Alice V', 'Cheong BM']",,"['Hospital Teluk Intan, Department of Medicine, Jalan Changkat Jong, 36000 Teluk Intan, Perak, Malaysia. alice_ver@yahoo.com.', 'Hospital Teluk Intan, Department of Medicine, Jalan Changkat Jong, 36000 Teluk Intan, Perak, Malaysia.']",['eng'],"['Case Reports', 'Journal Article']",,Malaysia,Med J Malaysia,The Medical journal of Malaysia,0361547,,IM,"['Adolescent', 'Dengue/*complications/diagnosis', 'Dengue Virus', 'Encephalitis/*etiology', 'Female', 'Fever', 'Humans', 'Male']",,2016/05/01 06:00,2018/09/18 06:00,['2016/05/01 06:00'],"['2016/05/01 06:00 [entrez]', '2016/05/01 06:00 [pubmed]', '2018/09/18 06:00 [medline]']",,ppublish,Med J Malaysia. 2016 Feb;71(1):41-3.,1,,,,,,,,,,,,,,,,,,,,,,
28984261,NLM,MEDLINE,20171227,20171227,0974-7559 (Electronic) 0019-6061 (Linking),54,2017 Sep 15,Factors Affecting Outcome in Children with Dengue in Kolkata.,778-780,,"This observational, descriptive study was conducted on 260 dengue patients diagnosed as per the revised 2009 WHO guidelines in a tertiary-care hospital of eastern India between June and November 2015. Children were evaluated for clinical symptoms, signs, and laboratory parameters. Clinical variables viz., rash, nausea/vomiting, bleeding, oliguria, capillary leak and liver enlargement; and laboratory variables viz., rising haemoglobin, haematocrit, thrombocytopenia, blood urea, serum Creatinine, ALT, hypo albuminemia and cholesterol were found to be significantly associated with outcome.","['Majumdar, Ishita', 'Mukherjee, Devdeep', 'Kundu, Ritabrata', 'Niyogi, Prabal', 'Das, Joydeep']","['Majumdar I', 'Mukherjee D', 'Kundu R', 'Niyogi P', 'Das J']",,"['Department of Pediatric Medicine, Institute of Child Health, 11 Dr Biresh Guha Street, Kolkata 700017, West Bengal, India. devdeep_dm@rediffmail.com.']",['eng'],"['Journal Article', 'Observational Study']",,India,Indian Pediatr,Indian pediatrics,2985062R,,IM,"['Adolescent', 'Child', 'Child, Preschool', '*Dengue/complications/epidemiology/mortality', 'Exanthema', 'Hemorrhage', 'Humans', 'India/epidemiology', 'Infant', 'Nausea', 'Risk Factors']",,2017/10/07 06:00,2017/12/28 06:00,['2017/10/07 06:00'],"['2017/10/07 06:00 [entrez]', '2017/10/07 06:00 [pubmed]', '2017/12/28 06:00 [medline]']",,ppublish,Indian Pediatr. 2017 Sep 15;54(9):778-780.,9,,,,,,,,,,,,,,,,,,,,,,
24275335,NLM,MEDLINE,20140617,20211021,1757-790X (Electronic) 1757-790X (Linking),2013,2013 Nov 25,Skin rash from dengue fever.,,10.1136/bcr-2013-201598 [doi] bcr2013201598,,"['Kenzaka, Tsuneaki', 'Kumabe, Ayako']","['Kenzaka T', 'Kumabe A']",,"['Division of General Medicine, Center for Community Medicine, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.']",['eng'],"['Case Reports', 'Journal Article']",20131125,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['Dengue/complications/*diagnosis', 'Exanthema/*etiology/pathology', 'Humans', 'Male', 'Middle Aged', 'Travel']",PMC3847512,2013/11/28 06:00,2014/06/18 06:00,['2013/11/27 06:00'],"['2013/11/27 06:00 [entrez]', '2013/11/28 06:00 [pubmed]', '2014/06/18 06:00 [medline]']","['bcr-2013-201598 [pii]', '10.1136/bcr-2013-201598 [doi]']",epublish,BMJ Case Rep. 2013 Nov 25;2013:bcr2013201598. doi: 10.1136/bcr-2013-201598.,,,,,,,,,,,,,,,,,,,,,,,
12962604,NLM,MEDLINE,20031002,20220408,1195-1982 (Print) 1195-1982 (Linking),9,2002 Sep-Oct,First confirmed dengue-1 fever cases reported from Cameroon.,273-4,,,"['Krippner, Reinhard', 'von Laer, Gunther']","['Krippner R', 'von Laer G']",,"['Health Unit, Embassy of the Federal Republic of Germany, Yaounde Cameroon.']",['eng'],"['Case Reports', 'Journal Article']",,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Cameroon/epidemiology', 'Dengue/diagnosis/*epidemiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Male', 'Middle Aged']",,2003/09/10 05:00,2003/10/03 05:00,['2003/09/10 05:00'],"['2003/09/10 05:00 [pubmed]', '2003/10/03 05:00 [medline]', '2003/09/10 05:00 [entrez]']",['10.2310/7060.2002.24119 [doi]'],ppublish,J Travel Med. 2002 Sep-Oct;9(5):273-4. doi: 10.2310/7060.2002.24119.,5,,,,,,,,,,,,,,,,,,,,,,
12085693,NLM,MEDLINE,20020718,20041117,0026-6620 (Print) 0026-6620 (Linking),99,2002 Jun,Dengue fever in mid-Missouri. A case report.,259-61,,,"['Chan-Tack, Kirk M']",['Chan-Tack KM'],,"['Department of Medicine, University of Missouri-Columbia, USA.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Mo Med,Missouri medicine,0400744,,IM,"['Adult', 'Bangladesh', 'Dengue/*diagnosis/physiopathology', 'Humans', 'Male', 'Missouri', 'Risk Factors', 'Travel']",,2002/06/28 10:00,2002/07/19 10:01,['2002/06/28 10:00'],"['2002/06/28 10:00 [pubmed]', '2002/07/19 10:01 [medline]', '2002/06/28 10:00 [entrez]']",,ppublish,Mo Med. 2002 Jun;99(6):259-61.,6,,,,,,,,,,,,,,,,,,,,,,
5828783,NLM,MEDLINE,19651125,20041117,,41,1965 Jun,Further observations on dengue infections among Filipino children (1964).,390-5,,,"['Mundo, F D', 'Barrion, L E']","['Mundo FD', 'Barrion LE']",,,['eng'],['Journal Article'],,Philippines,J Philipp Med Assoc,Journal of the Philippine Medical Association,7503102,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/*epidemiology', 'Hemorrhagic Fevers, Viral/*epidemiology', 'Humans', 'Infant', 'Philippines']",,1965/06/01 00:00,1965/06/01 00:01,['1965/06/01 00:00'],"['1965/06/01 00:00 [pubmed]', '1965/06/01 00:01 [medline]', '1965/06/01 00:00 [entrez]']",,ppublish,J Philipp Med Assoc. 1965 Jun;41(6):390-5.,6,,,,,,,,,,,,,,,,,,,,,,
24743730,NLM,MEDLINE,20141030,20220311,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),8,2014 Apr,Air travel is associated with intracontinental spread of dengue virus serotypes 1-3 in Brazil.,e2769,10.1371/journal.pntd.0002769 [doi] e2769,"Dengue virus and its four serotypes (DENV-1 to DENV-4) infect 390 million people and are implicated in at least 25,000 deaths annually, with the largest disease burden in tropical and subtropical regions. We investigated the spatial dynamics of DENV-1, DENV-2 and DENV-3 in Brazil by applying a statistical framework to complete genome sequences. For all three serotypes, we estimated that the introduction of new lineages occurred within 7 to 10-year intervals. New lineages were most likely to be imported from the Caribbean region to the North and Northeast regions of Brazil, and then to disperse at a rate of approximately 0.5 km/day. Joint statistical analysis of evolutionary, epidemiological and ecological data indicates that aerial transportation of humans and/or vector mosquitoes, rather than Aedes aegypti infestation rates or geographical distances, determine dengue virus spread in Brazil.","['Nunes, Marcio R T', 'Palacios, Gustavo', 'Faria, Nuno Rodrigues', 'Sousa, Edivaldo Costa Jr', 'Pantoja, Jamilla A', 'Rodrigues, Sueli G', 'Carvalho, Valeria L', 'Medeiros, Daniele B A', 'Savji, Nazir', 'Baele, Guy', 'Suchard, Marc A', 'Lemey, Philippe', 'Vasconcelos, Pedro F C', 'Lipkin, W Ian']","['Nunes MR', 'Palacios G', 'Faria NR', 'Sousa EC Jr', 'Pantoja JA', 'Rodrigues SG', 'Carvalho VL', 'Medeiros DB', 'Savji N', 'Baele G', 'Suchard MA', 'Lemey P', 'Vasconcelos PF', 'Lipkin WI']",,"['Centro de Inovacao Tecnologica, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Center for Genomic Sciences, United States Army Medical Research Institute for Infectious Diseases, Frederick, Maryland, United States of America; Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, United States of America.', 'Department of Zoology, University of Oxford, Oxford, United Kingdom.', 'Centro de Inovacao Tecnologica, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Centro de Inovacao Tecnologica, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Departamento de Arbovirologia e Febres Hemorragicas, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Departamento de Arbovirologia e Febres Hemorragicas, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Departamento de Arbovirologia e Febres Hemorragicas, Instituto Evandro Chagas, Ananindeua, Brazil.', 'Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, United States of America.', 'Department of Zoology, University of Oxford, Oxford, United Kingdom.', 'Department of Biomathematics, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, United States of America; Department of Human Genetics, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California, United States of America; Department of Biostatistics, UCLA Fielding School of Public Health, University of California - Los Angeles, Los Angeles, California, United States of America.', 'Department of Zoology, University of Oxford, Oxford, United Kingdom.', 'Departamento de Arbovirologia e Febres Hemorragicas, Instituto Evandro Chagas, Ananindeua, Brazil; Universidade do Estado do Para, Belem, Para, Brazil.', 'Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, United States of America.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20140417,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['*Air Travel', 'Animals', 'Brazil/epidemiology', 'Dengue/*epidemiology/*transmission/virology', 'Dengue Virus/classification/*isolation & purification', 'Humans']",PMC3990485,2014/04/20 06:00,2014/10/31 06:00,['2014/04/19 06:00'],"['2013/11/06 00:00 [received]', '2014/02/18 00:00 [accepted]', '2014/04/19 06:00 [entrez]', '2014/04/20 06:00 [pubmed]', '2014/10/31 06:00 [medline]']","['PNTD-D-13-01776 [pii]', '10.1371/journal.pntd.0002769 [doi]']",epublish,PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2769. doi: 10.1371/journal.pntd.0002769. eCollection 2014 Apr.,4,,,,['The authors have declared that no competing interests exist.'],,"['R01 GM086887/GM/NIGMS NIH HHS/United States', 'R01 HG006139/HG/NHGRI NIH HHS/United States']",,,,,,,,,,,,,,,,
17448946,NLM,MEDLINE,20070717,20091021,1477-8939 (Print) 1477-8939 (Linking),5,2007 May,Dengue fever and pregnancy - a review and comment.,183-8,,"BACKGROUND: The increasing incidence of dengue with the concomitant rise in travel during pregnancy makes it likely that a pregnant woman will plan travel to or present after travel to endemic areas. METHOD: Literature search and communication with researchers. RESULTS: Case reports of dengue during pregnancy, the peripartum period and neonatal dengue were found. There is little systematic research. CONCLUSIONS: Pregnancy appears not to increase the incidence or severity of dengue, but some case reports suggest that dengue may predispose to certain pregnancy complications. Transplacental infection occurs, but protective antibodies pass transplacentally and fetal effects may be minimal given sufficient immune response. In near-term disease, severe fetal or neonatal illness and death may occur. Such illness may also predispose the newborn to subsequent dengue hemorrhagic fever. Clinicians should be aware that presentation in either maternal or neonatal disease may be atypical and confound diagnosis. Women in late pregnancy should avoid travel to areas of ongoing disease, and those earlier in pregnancy should consider dengue a serious hazard. If travel is unavoidable, mosquito avoidance measures are mandated. If a woman acquires dengue fever while pregnant, conservative medical and obstetrical management are the treatments of choice. Further research is required.","['Carroll, I Dale', 'Toovey, Stephen', 'Van Gompel, Alfons']","['Carroll ID', 'Toovey S', 'Van Gompel A']",,"['The Pregnant Traveler, 4475 Wilson Ave., SW, Suite 8, Grandville, MI 49418, USA. travdoc@travdoc.com']",['eng'],"['Journal Article', 'Review']",20070105,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,,IM,"['Dengue/*epidemiology/etiology/prevention & control', 'Female', 'Humans', 'Incidence', 'Pregnancy', 'Pregnancy Complications, Infectious/*epidemiology/etiology/prevention & control', '*Travel', 'Tropical Climate']",,2007/04/24 09:00,2007/07/18 09:00,['2007/04/24 09:00'],"['2006/11/09 00:00 [received]', '2006/11/09 00:00 [accepted]', '2007/04/24 09:00 [pubmed]', '2007/07/18 09:00 [medline]', '2007/04/24 09:00 [entrez]']","['S1477-8939(06)00128-1 [pii]', '10.1016/j.tmaid.2006.11.002 [doi]']",ppublish,Travel Med Infect Dis. 2007 May;5(3):183-8. doi: 10.1016/j.tmaid.2006.11.002. Epub 2007 Jan 5.,3,,,,,,,44,,,,,,,,,,,,,,,
34806685,NLM,MEDLINE,20211125,20211125,0300-5283 (Print) 0300-5283 (Linking),76,2021 Nov,Concurrent COVID-19 and dengue with hyperferritinaemia: A case report.,918-920,,"The current pandemic of coronavirus disease 2019 (COVID- 19) poses a bigger challenge to the population in tropical countries where dengue fever is also endemic as both diseases share similar clinical and laboratory features. In COVID-19, hyperferritinaemia is associated with severe disease and clinical outcome while in dengue fever, hyperferritinaemia is a key feature of haemophagocytic lymphohistiocytosis (HLH), which is a complication with high mortality. In this case report, we present a case of coinfection of COVID-19 and dengue with hyperferritinaemia in Queen Elizabeth Hospital, Sabah, Malaysia.","['Saw, Y T', 'Lee, H G']","['Saw YT', 'Lee HG']",,"['Queen Elizabeth Hospital, Department of Medicine, Kota Kinabalu, Sabah, Malaysia.', 'Queen Elizabeth Hospital, Department of Medicine, Infectious Disease Unit, Kota Kinabalu, Sabah, Malaysia. henggee77@gmail.com.']",['eng'],"['Case Reports', 'Journal Article']",,Malaysia,Med J Malaysia,The Medical journal of Malaysia,0361547,,IM,"['*COVID-19', '*Coinfection', '*Dengue/complications/diagnosis', 'Humans', '*Lymphohistiocytosis, Hemophagocytic', 'SARS-CoV-2']",,2021/11/23 06:00,2021/11/26 06:00,['2021/11/22 08:52'],"['2021/11/22 08:52 [entrez]', '2021/11/23 06:00 [pubmed]', '2021/11/26 06:00 [medline]']",,ppublish,Med J Malaysia. 2021 Nov;76(6):918-920.,6,,,,,,,,,,,,,,,,,,,,,,
9274575,NLM,MEDLINE,19970912,20150616,0140-6736 (Print) 0140-6736 (Linking),350,1997 Aug 16,Dengue in the Americas--time to talk.,455,,,,,,,['eng'],['Editorial'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['*Aedes', 'Americas/epidemiology', 'Animals', 'Cuba/epidemiology', 'Dengue/epidemiology/*prevention & control/transmission', 'Humans', '*Mosquito Control', '*Public Health']",,1997/08/16 00:00,1997/08/16 00:01,['1997/08/16 00:00'],"['1997/08/16 00:00 [pubmed]', '1997/08/16 00:01 [medline]', '1997/08/16 00:00 [entrez]']",['S0140673697210330 [pii]'],ppublish,Lancet. 1997 Aug 16;350(9076):455.,9076,,,,,,,,,,,,,,,,,,,,,,
31299837,NLM,MEDLINE,20190807,20220409,0004-5772 (Print) 0004-5772 (Linking),67,2019 Apr,"Dengue Encephalopathy in Hadoti Region: Clinical Presentation, Diagnostic Evaluation, Management and Outcome.",39-42,,"BACKGROUND: Dengue viral infection is common worldwide. Recent studies have shown dengue viral infection causing encephalopathy, with high morbidity and mortality. Dengue encephalopathy patients usually present with altered sensorium, elevated lab parameters and high antibody titres at the time of admission. Dengue infection was very common and virulent in Hadoti region during August to November 2017 and many patients presented with encephalopathy. AIMS: To study the clinical presentation, lab parameters and other diagnostic features, management and outcome of patients of dengue fever with encephalopathy in Hadoti region in August to November 2017. SETTINGS AND DESIGN: The study was done in Govt Medical college Hospital Kota and other multi-speciality hospitals of Kota. Study population comprised of 60 patients presenting with febrile illness and thrombocytopenia, serologically proved to be having Dengue fever. Among these 60 patients, 30 patients had encephalopathy who presented with altered sensorium, seizures or any other neurological symptoms and remaining 30 had no signs and symptoms of encephalopathy. RESULTS: Among 30 patients with encephalopathy and positive serology (NS1/IgM/ IgG), fever and altered sensorium was most common symptom, while amongst patients without encephalopathy fever with chills and generalised bodyache was more common clinical feature. Convulsions and respiratory distress were very common among encephalopathy patients. Out of 30 encephalopathy patients 16 patients (53%) had convulsions, 14 (46%) had respiratory distress, 17(56%) had shock and 3 patients (10%) had hemiplegia. 2 patients also had visual blurring and dysarthria. Mean duration between appearance of fever and altered sensorium was 4.6 (+/-2.1) days. Most of patients with encephalopathy had deranged hepatic (bilirubin, SGOT, SGPT), renal (urea, creatinine, decreased urine output) and coagulation parameters (PT/INR, bleeding manifestations). 9 (30%) patients died and 21(70%) patients improved with complete recovery (except 3 hemiplegic patients). CONCLUSION: Increased incidence of dengue fever with encephalopathy in the recent years, in the absence of single sensitive test for detecting dengue encephalopathy, variable CSF and MRI Brain features, and associated high morbidity and mortality poses a big problem for clinician. This study may be helpful in focussing on early diagnosis and aggressive initial management which can influence final outcome.","['Saluja, Manoj', 'Swami, Yogesh Kumar', 'Chittora, Saurabh', 'Vimlani, Hemant']","['Saluja M', 'Swami YK', 'Chittora S', 'Vimlani H']",,"['Professor, Govt. Medical College, Kota, Rajasthan.', 'Resident, Govt. Medical College, Kota, Rajasthan; *Corresponding Author.', 'Assistant Professor, Govt. Medical College, Kota, Rajasthan.', 'Professor, Govt. Medical College, Kota, Rajasthan.']",['eng'],['Journal Article'],,India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,,,"['Brain Diseases/*diagnosis/therapy', 'Dengue/*diagnosis/therapy', 'Dengue Virus', 'Fever', 'Humans', 'India', 'Seizures']",,2019/07/14 06:00,2019/08/08 06:00,['2019/07/14 06:00'],"['2019/07/14 06:00 [entrez]', '2019/07/14 06:00 [pubmed]', '2019/08/08 06:00 [medline]']",,ppublish,J Assoc Physicians India. 2019 Apr;67(4):39-42.,4,['(c) Journal of the Association of Physicians of India 2011.'],,,,,,,,,,,,,,,,,,,,,
8800801,NLM,MEDLINE,19960927,20191101,0939-1983 (Print) 0939-1983 (Linking),11,1996,Arboviruses as imported disease agents: the need for increased awareness.,21-32,,The arboviruses are an important group of etiologic agents that are transported between geographic regions in infected animals and humans. This group of viruses is briefly reviewed as agents of imported disease and dengue viruses are discussed as an example to illustrate the trend of increasing incidence of imported arboviral diseases.,"['Gubler, D J']",['Gubler DJ'],,"['Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, 80522, USA.']",['eng'],"['Journal Article', 'Review']",,Austria,Arch Virol Suppl,Archives of virology. Supplementum,9214275,,IM,"['Animals', 'Arbovirus Infections/*epidemiology/transmission/veterinary', 'Arboviruses/*classification', 'Dengue/*epidemiology/transmission/veterinary', 'Geography', 'Humans', 'Incidence', 'Insect Vectors', '*Travel', 'Vertebrates']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",['10.1007/978-3-7091-7482-1_3 [doi]'],ppublish,Arch Virol Suppl. 1996;11:21-32. doi: 10.1007/978-3-7091-7482-1_3.,,,,,,,,29,,,,,,,,,,,,,,,
37409936,NLM,MEDLINE,20230821,20230824,2165-0497 (Electronic) 2165-0497 (Linking),11,2023 Aug 17,"Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody.",e0091823,10.1128/spectrum.00918-23 [doi] e00918-23,"Humans infected with dengue virus (DENV) acquire long-term protection against the infecting serotype, whereas cross-protection against other serotypes is short-lived. Long-term protection induced by low levels of type-specific neutralizing antibodies can be assessed using the virus-neutralizing antibody test. However, this test is laborious and time-consuming. In this study, a blockade-of-binding enzyme-linked immunoassay was developed to assess antibody activity by using a set of neutralizing anti-E monoclonal antibodies and blood samples from dengue virus-infected or -immunized macaques. Diluted blood samples were incubated with plate-bound dengue virus particles before the addition of an enzyme-conjugated antibody specific to the epitope of interest. Based on blocking reference curves constructed using autologous purified antibodies, sample blocking activity was determined as the relative concentration of unconjugated antibody that resulted in the same percent signal reduction. In separate DENV-1-, -2-, -3-, and -4-related sets of samples, moderate to strong correlations of the blocking activity with neutralizing antibody titers were found with the four type-specific antibodies 1F4, 3H5, 8A1, and 5H2, respectively. Significant correlations were observed for single samples taken 1 month after infection as well as samples drawn before and at various time points after infection/immunization. Similar testing using a cross-reactive EDE-1 antibody revealed a moderate correlation between the blocking activity and the neutralizing antibody titer only for the DENV-2-related set. The potential usefulness of the blockade-of-binding activity as a correlative marker of neutralizing antibodies against dengue viruses needs to be validated in humans. IMPORTANCE This study describes a blockade-of-binding assay for the determination of antibodies that recognize a selected set of serotype-specific or group-reactive epitopes in the envelope of dengue virus. By employing blood samples collected from dengue virus-infected or -immunized macaques, moderate to strong correlations of the epitope-blocking activities with the virus-neutralizing antibody titers were observed with serotype-specific blocking activities for each of the four dengue serotypes. This simple, rapid, and less laborious method should be useful for the evaluation of antibody responses to dengue virus infection and may serve as, or be a component of, an in vitro correlate of protection against dengue in the future.","['Keelapang, Poonsook', 'Kraivong, Romchat', 'Pulmanausahakul, Rojjanaporn', 'Sriburi, Rungtawan', 'Prompetchara, Eakachai', 'Kaewmaneephong, Jutamart', 'Charoensri, Nicha', 'Pakchotanon, Pattarakul', 'Duangchinda, Thaneeya', 'Suparattanagool, Piyanan', 'Luangaram, Prasit', 'Masrinoul, Promsin', 'Mongkolsapaya, Juthathip', 'Screaton, Gavin', 'Ruxrungtham, Kiat', 'Auewarakul, Prasert', 'Yoksan, Sutee', 'Malasit, Prida', 'Puttikhunt, Chunya', 'Ketloy, Chutitorn', 'Sittisombut, Nopporn']","['Keelapang P', 'Kraivong R', 'Pulmanausahakul R', 'Sriburi R', 'Prompetchara E', 'Kaewmaneephong J', 'Charoensri N', 'Pakchotanon P', 'Duangchinda T', 'Suparattanagool P', 'Luangaram P', 'Masrinoul P', 'Mongkolsapaya J', 'Screaton G', 'Ruxrungtham K', 'Auewarakul P', 'Yoksan S', 'Malasit P', 'Puttikhunt C', 'Ketloy C', 'Sittisombut N']","['ORCID: 0000-0003-2036-4437', 'ORCID: 0000-0003-4678-8721']","['Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.', 'Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Center of Excellence in Vaccine Research and Development (Chula-VRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.', 'Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.', 'Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.', 'Center for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Clinical Epidemiology Unit, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University at Salaya, Nakhon Pathom, Thailand.', 'Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.', 'Chinese Academy of Medical Science (CAMS), Oxford Institute (COI), University of Oxford, Oxford, United Kingdom.', 'Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.', 'Chinese Academy of Medical Science (CAMS), Oxford Institute (COI), University of Oxford, Oxford, United Kingdom.', 'Center of Excellence in Vaccine Research and Development (Chula-VRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.', 'Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University at Salaya, Nakhon Pathom, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.', 'Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.', 'Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Siriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.', 'Center of Excellence in Vaccine Research and Development (Chula-VRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.', 'Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.', 'Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.', 'Medical Biotechnology Research Unit, BIOTEC, NSTDA, Bangkok, Thailand.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20230706,United States,Microbiol Spectr,Microbiology spectrum,101634614,"['0 (Epitopes)', '0 (Antibodies, Viral)', '0 (Antibodies, Neutralizing)']",IM,"['Humans', '*Dengue Virus', 'Epitopes', 'Antibodies, Viral', '*Dengue/diagnosis/prevention & control', 'Antibodies, Neutralizing', 'Cross Reactions']",PMC10433959,2023/07/06 13:14,2023/08/21 06:42,['2023/07/06 10:04'],"['2023/08/21 06:42 [medline]', '2023/07/06 13:14 [pubmed]', '2023/07/06 10:04 [entrez]']","['00918-23 [pii]', 'spectrum.00918-23 [pii]', '10.1128/spectrum.00918-23 [doi]']",ppublish,Microbiol Spectr. 2023 Aug 17;11(4):e0091823. doi: 10.1128/spectrum.00918-23. Epub 2023 Jul 6.,4,,['NOTNLM'],"['ELISA', 'blockade of binding', 'dengue virus', 'neutralizing antibody']",['The authors declare no conflict of interest.'],,,,,,,,,,,,,,,,,,
32175713,NLM,MEDLINE,20210405,20210405,2210-6014 (Electronic) 2210-6006 (Print) 2210-6006 (Linking),10,2020 Mar,"Dengue Outbreak Response and Control in Khyber Pakhtunkhwa, Pakistan: A Mixed Methods Study.",74-81,10.2991/jegh.k.191125.001 [doi],"BACKGROUND: Since 2008, dengue fever outbreaks had occurred repeatedly in various districts of Khyber Pakhtunkhwa (KP) province of Pakistan. Most importantly the outbreak of 2017 caused 70 deaths, about 121,083 suspected and 24,938 confirmed cases in 23 districts of KP. In 2018, an abrupt decline in suspected and confirmed dengue cases was observed and 2018 was declared as dengue outbreak free. This study characterizes and explores the control and response measure activities of the outbreak. In addition, we explored the challenges faced and lessons learned for control of future dengue outbreaks from the perspectives of health authorities and dengue response staff in the KP province of Pakistan. METHODS: This was a mixed methods study with quantitative data on dengue outbreaks obtained from health department in KP followed by qualitative study to explore activities and responses that enabled the Dengue Response Unit (DRU) for a successful dengue outbreak control in 2018. In-depth interviews were conducted with the key informants from the department of health and the dengue response unit. RESULTS: The quantitative data analysis revealed a huge decline of suspected and confirmed dengue cases in comparison with the previous year in most of the KP districts. A similar decline in dengue reported cases was also observed from previously high dengue burden 14 union counsels of Peshawar district. Among the 70 verified deaths in 2017, 44 (63%) were males and 26 (37%) were females. The cases were about 20% each from age groups of 21-30, 41-50, and 51-60 years. The qualitative study findings showed four prominent major themes for successful control: (1) control and response strategy; (2) organizing specific dengue control and response intervention activities; (3) addressing dengue control and response challenges; and (4) generating lesson for future dengue control and response.","['Mohamud, Mohamed Ali', 'Qazi, Umair', 'Latif, Abdul', 'Khan, Iftikhar Uddin', 'Anwar, Saeed']","['Mohamud MA', 'Qazi U', 'Latif A', 'Khan IU', 'Anwar S']",,"['Department of Postgraduate Program, Prime Institute of Public Health, Riphah International University, Islamabad, Pakistan.', 'Department of Postgraduate Program, Prime Institute of Public Health, Riphah International University, Islamabad, Pakistan.', 'Department of Postgraduate Program, Prime Institute of Public Health, Riphah International University, Islamabad, Pakistan.', 'Bacha Khan Medical College, Mardan, Khyber Pakhtunkhwa, Pakistan.', 'Department of Postgraduate Program, Prime Institute of Public Health, Riphah International University, Islamabad, Pakistan.', 'Peshawar Medical College, Riphah International University Islamabad, Pakistan.']",['eng'],['Journal Article'],,Switzerland,J Epidemiol Glob Health,Journal of epidemiology and global health,101592084,,IM,"['Adult', 'Aged', 'Aged, 80 and over', 'Dengue/*diagnosis/*epidemiology/*therapy', 'Disease Outbreaks/*prevention & control/*statistics & numerical data', 'Female', 'Health Promotion/*methods', 'Humans', 'Male', 'Middle Aged', 'Pakistan/epidemiology', 'Prevalence', '*Preventive Health Services', 'Young Adult']",PMC7310815,2020/03/17 06:00,2021/04/07 06:00,['2020/03/17 06:00'],"['2019/07/01 00:00 [received]', '2019/11/21 00:00 [accepted]', '2020/03/17 06:00 [entrez]', '2020/03/17 06:00 [pubmed]', '2021/04/07 06:00 [medline]']","['j10/1/74 [pii]', 'JEGH-10-1-74 [pii]', '10.2991/jegh.k.191125.001 [doi]']",ppublish,J Epidemiol Glob Health. 2020 Mar;10(1):74-81. doi: 10.2991/jegh.k.191125.001.,1,['(c) 2019 Atlantis Press International B.V.'],['NOTNLM'],"['Dengue fever', 'Pakistan', 'dengue control strategies', 'dengue mortality and morbidity in KP', 'dengue outbreaks in KP', 'mixed method study']",['The authors declare they have no conflicts of interest.'],,,,,,,,,,,,,,,,,,
34453836,NLM,MEDLINE,20220509,20220716,1876-3405 (Electronic) 1876-3413 (Print) 1876-3405 (Linking),14,2022 May 2,"An economic evaluation of implementing a decentralized dengue screening intervention under the National Vector Borne Disease Control Programme in Tamil Nadu, South India.",295-308,10.1093/inthealth/ihab045 [doi],"BACKGROUND: Lack of effective early screening is a major obstacle for reducing the fatality rate and disease burden of dengue. In light of this, the government of Tamil Nadu has adopted a decentralized dengue screening strategy at the primary healthcare (PHC) facilities using blood platelet count. Our objective was to determine the cost-effectiveness of a decentralized screening strategy for dengue at PHC facilities compared with the current strategy at the tertiary health facility (THC) level. METHODS: Decision tree analysis followed a hypothetical cohort of 1000 suspected dengue cases entering the model. The cost-effectiveness analysis was performed at a 3% discount rate for the proposed and current strategy. The outcomes are expressed in incremental cost-effectiveness ratios (ICERs) per quality-adjusted life years gained. One-way sensitivity analysis and probabilistic sensitivity analysis were done to check the uncertainty in the outcome. RESULTS: The proposed strategy was found to be cost-saving and ICER was estimated to be -41 197. PSA showed that the proposed strategy had a 0.84 probability of being an economically dominant strategy. CONCLUSIONS: The proposed strategy is cost-saving, however, it is recommended to consider optimal population coverage, costs to economic human resources and collateral benefits of equipment.","['Muniyandi, Malaisamy', 'Karikalan, Nagarajan', 'Ravi, Karunya', 'Sengodan, Senthilkumar', 'Krishnan, Rajendran', 'Tyagi, Kirti', 'Rajsekar, Kavitha', 'Raju, Sivadhas', 'Selvavinayagam, T S']","['Muniyandi M', 'Karikalan N', 'Ravi K', 'Sengodan S', 'Krishnan R', 'Tyagi K', 'Rajsekar K', 'Raju S', 'Selvavinayagam TS']",,"['Scientist-D & Head, Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, No. 1, Sathyamoorthy Road, Chetpet, Chennai 60003, India.', 'Scientist-D & Head, Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, No. 1, Sathyamoorthy Road, Chetpet, Chennai 60003, India.', 'Scientist-D & Head, Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, No. 1, Sathyamoorthy Road, Chetpet, Chennai 60003, India.', 'Scientist-D & Head, Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, No. 1, Sathyamoorthy Road, Chetpet, Chennai 60003, India.', 'Scientist-D & Head, Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, No. 1, Sathyamoorthy Road, Chetpet, Chennai 60003, India.', 'Department of Health Research, Ministry of Health and Family Welfare, 2nd Floor, IRCS Building, 1, Red Cross Road, New Delhi 110001, India.', 'Department of Health Research, Ministry of Health and Family Welfare, 2nd Floor, IRCS Building, 1, Red Cross Road, New Delhi 110001, India.', 'Department of Public Health and Preventive Medicine, Government of Tamil Nadu, 359, Anna Salai, Chokkalingam Nagar, Teynampet, Chennai 600006, India.', 'Department of Public Health and Preventive Medicine, Government of Tamil Nadu, 359, Anna Salai, Chokkalingam Nagar, Teynampet, Chennai 600006, India.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,Int Health,International health,101517095,,IM,"['Cost-Benefit Analysis', '*Dengue/diagnosis/prevention & control', 'Humans', 'India', 'Quality-Adjusted Life Years', '*Vector Borne Diseases']",PMC9070504,2021/08/29 06:00,2022/05/10 06:00,['2021/08/28 17:04'],"['2021/05/08 00:00 [received]', '2021/06/29 00:00 [revised]', '2021/08/23 00:00 [accepted]', '2021/08/29 06:00 [pubmed]', '2022/05/10 06:00 [medline]', '2021/08/28 17:04 [entrez]']","['6359249 [pii]', 'ihab045 [pii]', '10.1093/inthealth/ihab045 [doi]']",ppublish,Int Health. 2022 May 2;14(3):295-308. doi: 10.1093/inthealth/ihab045.,3,"['(c) The Author(s) 2021. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene.']",['NOTNLM'],"['QALY', 'cost-effectiveness', 'dengue', 'economic evaluation', 'screening']",,,,,,,,,,,,,,,,,,,
20833000,NLM,MEDLINE,20110128,20101018,1872-7913 (Electronic) 0924-8579 (Linking),36 Suppl 1,2010 Nov,Update on the global spread of dengue.,S40-2,10.1016/j.ijantimicag.2010.06.018 [doi],"The global spread of dengue fever within and beyond the usual tropical boundaries threatens a large percentage of the world's population, as human and environmental conditions for persistence and even spread are present in all continents. The disease causes great human suffering, a sizable mortality from dengue haemorrhagic fever and its complications, and major costs. This situation has worsened in the recent past and may continue to do so in the future. Efforts to decrease transmission by vector control have failed, and no effective antiviral treatment is available or foreseeable on the immediate horizon. A safe and effective vaccine protective against all serotypes of dengue viruses is sorely needed.","['Guzman, Alfonso', 'Isturiz, Raul E']","['Guzman A', 'Isturiz RE']",,"['Department of Medicine, Centro Medico de Caracas, San Bernardino, Caracas, Venezuela. aguzmans@cantv.net']",['eng'],"['Journal Article', 'Review']",20100915,Netherlands,Int J Antimicrob Agents,International journal of antimicrobial agents,9111860,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/*epidemiology/mortality/pathology/virology', 'Dengue Vaccines/immunology', 'Dengue Virus/*isolation & purification', 'Humans', 'Incidence', '*Pandemics', 'Tropical Climate', 'Zoonoses/*epidemiology/virology']",,2010/09/14 06:00,2011/02/01 06:00,['2010/09/14 06:00'],"['2010/09/14 06:00 [entrez]', '2010/09/14 06:00 [pubmed]', '2011/02/01 06:00 [medline]']","['S0924-8579(10)00259-1 [pii]', '10.1016/j.ijantimicag.2010.06.018 [doi]']",ppublish,Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S40-2. doi: 10.1016/j.ijantimicag.2010.06.018. Epub 2010 Sep 15.,,"['Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All', 'rights reserved.']",,,,,,,,,,,,,,,,,,,,,
31211672,NLM,MEDLINE,20191223,20231012,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),25,2019 Jul,"Asymptomatic Dengue Virus Infections, Cambodia, 2012-2013.",1354-1362,10.3201/eid2507.181794 [doi],"We investigated dengue virus (DENV) and asymptomatic DENV infections in rural villages of Kampong Cham Province, Cambodia, during 2012 and 2013. We conducted perifocal investigations in and around households for 149 DENV index cases identified through hospital and village surveillance. We tested participants 0.5-30 years of age by using nonstructural 1 rapid tests and confirmed DENV infections using quantitative reverse transcription PCR or nonstructural 1-capture ELISA. We used multivariable Poisson regressions to explore links between participants' DENV infection status and household characteristics. Of 7,960 study participants, 346 (4.4%) were infected with DENV, among whom 302 (87.3%) were <15 years of age and 225 (65.0%) were <9 years of age. We identified 26 (7.5%) participants with strictly asymptomatic DENV infection at diagnosis and during follow-up. We linked symptomatic DENV infection status to familial relationships with index cases. During the 2-year study, we saw fewer asymptomatic DENV infections than expected based on the literature.","['Ly, Sowath', 'Fortas, Camille', 'Duong, Veasna', 'Benmarhnia, Tarik', 'Sakuntabhai, Anavaj', 'Paul, Richard', 'Huy, Rekol', 'Sorn, Sopheak', 'Nguon, Kunthy', 'Chan, Siam', 'Kimsan, Souv', 'Ong, Sivuth', 'Kim, Kim Srorn', 'Buoy, Sowathy', 'Voeung, Lim', 'Dussart, Philippe', 'Buchy, Philippe', 'Tarantola, Arnaud']","['Ly S', 'Fortas C', 'Duong V', 'Benmarhnia T', 'Sakuntabhai A', 'Paul R', 'Huy R', 'Sorn S', 'Nguon K', 'Chan S', 'Kimsan S', 'Ong S', 'Kim KS', 'Buoy S', 'Voeung L', 'Dussart P', 'Buchy P', 'Tarantola A']",,,['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Asymptomatic Diseases/*epidemiology', 'Cambodia/epidemiology', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/history/*virology', '*Dengue Virus', 'Disease Outbreaks', 'Female', 'History, 21st Century', 'Humans', 'Male', 'Mass Screening', 'Public Health Surveillance', 'Sentinel Surveillance', 'Young Adult']",PMC6590774,2019/06/19 06:00,2019/12/24 06:00,['2019/06/19 06:00'],"['2019/06/19 06:00 [entrez]', '2019/06/19 06:00 [pubmed]', '2019/12/24 06:00 [medline]']","['18-1794 [pii]', '10.3201/eid2507.181794 [doi]']",ppublish,Emerg Infect Dis. 2019 Jul;25(7):1354-1362. doi: 10.3201/eid2507.181794.,7,,['NOTNLM'],"['Aedes aegypti', 'Aedes albopictus', 'Asia', 'Cambodia', 'Mekong', 'asymptomatic', 'dengue', 'dengue virus', 'epidemiology', 'mosquitoes', 'risk factors', 'vector-borne infections', 'viruses']",,,,,,,,,,,,,,,,,,,
29443656,NLM,MEDLINE,20190906,20190906,1557-7465 (Electronic) 1079-9907 (Linking),38,2018 Feb,"Highlights for Dengue Immunopathogenesis: Antibody-Dependent Enhancement, Cytokine Storm, and Beyond.",69-80,10.1089/jir.2017.0037 [doi],"Infection with dengue virus (DENV) can lead to a wide spectrum of clinical presentations, ranging from asymptomatic infection to death. It is estimated that the disease manifests only in 90 million cases out of the total 390 million yearly infections. Even though research has not yet elucidated which are the precise pathophysiological mechanisms that trigger severe forms of dengue, the infection elicits a critical immune response significant for dengue pathogenesis development. Understanding how the immune response to DENV is established and how it can resolve the infection or turn into an immunopathology is of great importance in DENV research. Currently, studies have extensively debated 2 hypotheses involving immune response: antibody-dependent enhancement and cytokine storm. However, despite its undeniable importance in severe forms of the disease, these 2 hypotheses are based on a primed immune status resulting from previous heterologous infection, abstaining them from explaining the severe forms of dengue in naive immune subjects, for example. Thus, it seems that a more intricate arrangement of causes and conditions must be achieved to severe dengue to occur. Among them, the cytokine network signature elicited, in association with viral aspects deserves special attention regarding the establishment of infection and evolution to pathogenesis. In this work, we intend to shed light on how those elements contribute to severe dengue development.","['Kuczera, Diogo', 'Assolini, Joao Paulo', 'Tomiotto-Pellissier, Fernanda', 'Pavanelli, Wander Rogerio', 'Silveira, Guilherme Ferreira']","['Kuczera D', 'Assolini JP', 'Tomiotto-Pellissier F', 'Pavanelli WR', 'Silveira GF']",,"['1 Laboratorio de Virologia Molecular, Instituto Carlos Chagas , ICC/Fiocruz/PR, Curitiba, Brazil .', '2 Departamento de Ciencias Patologicas, Centro de Ciencias Biologicas , Universidade Estadual de Londrina, Londrina, Brazil .', '2 Departamento de Ciencias Patologicas, Centro de Ciencias Biologicas , Universidade Estadual de Londrina, Londrina, Brazil .', '2 Departamento de Ciencias Patologicas, Centro de Ciencias Biologicas , Universidade Estadual de Londrina, Londrina, Brazil .', '1 Laboratorio de Virologia Molecular, Instituto Carlos Chagas , ICC/Fiocruz/PR, Curitiba, Brazil .']",['eng'],"['Journal Article', 'Review']",,United States,J Interferon Cytokine Res,Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,9507088,['0 (Cytokines)'],IM,"['Animals', 'Antibody-Dependent Enhancement/*immunology', 'Cytokines/*immunology', 'Dengue/genetics/*immunology/*pathology', 'Humans']",,2018/02/15 06:00,2019/09/07 06:00,['2018/02/15 06:00'],"['2018/02/15 06:00 [entrez]', '2018/02/15 06:00 [pubmed]', '2019/09/07 06:00 [medline]']",['10.1089/jir.2017.0037 [doi]'],ppublish,J Interferon Cytokine Res. 2018 Feb;38(2):69-80. doi: 10.1089/jir.2017.0037.,2,,['NOTNLM'],"['ADE', 'NS1', 'cytokine', 'cytokine storm', 'dengue', 'innate immunity']",,,,,,,,,,,,,,,,,,,
18232165,NLM,MEDLINE,20080219,20131121,0019-557X (Print) 0019-557X (Linking),51,2007 Oct-Dec,Profile of pediatric dengue cases from a tertiary care hospital in Kolkata.,234-6,,"A study was conducted on the 52 serologically positive cases of dengue, admitted to the Dept. of Paediatrics, R.G. Kar Medical College & Hospital, from an outbreak in Kolkata. The most unusual feature observed in this study was that the rash in some cases was urticarial and intensely pruritic. The shock appeared early in the course of the disease and it was less commonly associated with bleeding (22%). One out of three dengue cases was a severe disease. It was not possible to predict a severe disease from the early symptomatology.","['Basu, M', 'Dasgupta, M K', 'Kundu, T K', 'Sengupta, B', 'De, G K', 'Roy, B N']","['Basu M', 'Dasgupta MK', 'Kundu TK', 'Sengupta B', 'De GK', 'Roy BN']",,"['Department of Paediatric Medicine, R G Kar Medical College, Kolkata. maitreyibasu27@yahoo.co.in']",['eng'],['Journal Article'],,India,Indian J Public Health,Indian journal of public health,0400673,,IM,"['Child', 'Child, Preschool', 'Dengue/complications/*epidemiology/physiopathology', '*Disease Outbreaks', 'Female', 'Hospitals, Teaching/statistics & numerical data', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Severe Dengue/complications/*epidemiology/physiopathology', 'Severity of Illness Index', 'Shock/etiology']",,2008/02/01 09:00,2008/02/20 09:00,['2008/02/01 09:00'],"['2008/02/01 09:00 [pubmed]', '2008/02/20 09:00 [medline]', '2008/02/01 09:00 [entrez]']",,ppublish,Indian J Public Health. 2007 Oct-Dec;51(4):234-6.,4,,,,,,,,,,,,,,,,,,,,,,
15566333,NLM,MEDLINE,20050411,20191109,1478-7210 (Print) 1478-7210 (Linking),2,2004 Dec,Dengue vaccine: priorities and progress.,895-911,,"Dengue transmission has increased considerably in the past 20 years. Currently, it can only be reduced by mosquito control; however, the application of vector-control methods are labor intensive, require discipline and diligence, and are hard to sustain. In this context, a safe dengue vaccine that confers long-lasting protection against infection with the four dengue viruses is urgently required. This review will discuss the requirements of a dengue vaccine, problems, and advances that have been made. Finally, new targets for research will be presented.","['Guzman, Maria G', 'Mune, Mayra', 'Kouri, Gustavo']","['Guzman MG', 'Mune M', 'Kouri G']",,"['Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodia, Km 6 1\\2 P.O. Box Marianao 13, C. Habana, Cuba. lupe@ipk.sld.cu']",['eng'],"['Journal Article', 'Review']",,England,Expert Rev Anti Infect Ther,Expert review of anti-infective therapy,101181284,['0 (Viral Vaccines)'],IM,"['Animals', 'Biomedical Research/trends', 'Dengue/immunology/*prevention & control/transmission', 'Dengue Virus/immunology/pathogenicity', 'Humans', 'Viral Vaccines/*immunology']",,2004/11/30 09:00,2005/04/12 09:00,['2004/11/30 09:00'],"['2004/11/30 09:00 [pubmed]', '2005/04/12 09:00 [medline]', '2004/11/30 09:00 [entrez]']","['ERI020611 [pii]', '10.1586/14789072.2.6.895 [doi]']",ppublish,Expert Rev Anti Infect Ther. 2004 Dec;2(6):895-911. doi: 10.1586/14789072.2.6.895.,6,,,,,,,199,,,,,,,,,,,,,,,
22692495,NLM,MEDLINE,20130429,20211021,1757-790X (Electronic) 1757-790X (Linking),2011,2011 Jun 17,Hypokalaemic quadriparesis: an unusual manifestation of dengue fever.,,10.1136/bcr.12.2010.3673 [doi] bcr1220103673,"Dengue is the most common and widespread arthropod borne arboviral infection in the world today. Recent observations indicate that the clinical profile of dengue fever is changing with neurological manifestations being reported more frequently. A patient with dengue fever presented to us with symptoms suggestive of acute flaccid paralysis, and on subsequent investigation he was diagnosed as a case of hypokalaemic quadriparesis. Clinicians in the endemic area should be aware of such association of acute pure motor reversible quadriparesis with dengue fever.","['Gupta, Durgesh Kumar', 'Vaish, A K', 'Arya, Rajesh Kumar', 'Chaudhary, Shyam Chand']","['Gupta DK', 'Vaish AK', 'Arya RK', 'Chaudhary SC']",,"['Department of Medicine, CSM Medical University, Lucknow, India. durgesh.llrm@gmail.com']",['eng'],"['Case Reports', 'Journal Article']",20110617,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['Adult', 'Dengue/complications/*diagnosis', 'Humans', 'Hypokalemia/etiology', 'Male', 'Quadriplegia/etiology']",PMC3118907,2011/01/01 00:00,2013/04/30 06:00,['2012/06/14 06:00'],"['2012/06/14 06:00 [entrez]', '2011/01/01 00:00 [pubmed]', '2013/04/30 06:00 [medline]']","['bcr.12.2010.3673 [pii]', '10.1136/bcr.12.2010.3673 [doi]']",epublish,BMJ Case Rep. 2011 Jun 17;2011:bcr1220103673. doi: 10.1136/bcr.12.2010.3673.,,,,,['Competing interests None.'],,,,,,,,,,,,,,,,,,
16103617,NLM,MEDLINE,20051011,20131121,0002-9637 (Print) 0002-9637 (Linking),73,2005 Aug,Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines.,435-40,,"To demonstrate the differences of clinical features and hematologic abnormalities between dengue fever (DF) and dengue hemorrhagic fever (DHF), 359 pediatric patients admitted St. Luke's Medical Center in Quezon City, between 1999 and 2001 in Metro Manila, and adjoining provinces the Philippines, with a laboratory-confirmed dengue virus infection were evaluated. One third of the patients had DHF, and most of these patients were without shock. Restlessness, epistaxis, and abdominal pain were more associated with DHF. The platelet count was significantly lower in the DHF group than in the DF group before and after defervescence. In the DHF patients, the hematocrit was significantly increased before defervescence, and decreased the day after due to administration of intravenous fluid. Coagulation abnormalities associated with most DHF patients were thrombocytopenia and an increased fibrinolysis, but not disseminated intravascular coagulation. We present recent data on readily obtained clinical and laboratory data that can be used for early diagnosis and consequently earlier appropriate treatment of dengue virus infections.","['Carlos, Celia C', 'Oishi, Kazunori', 'Cinco, Maria T D D', 'Mapua, Cynthia A', 'Inoue, Shingo', 'Cruz, Deu John M', 'Pancho, Mary Ann M', 'Tanig, Carol Z', 'Matias, Ronald R', 'Morita, Kouichi', 'Natividad, Filipinas F', 'Igarashi, Akira', 'Nagatake, Tsuyoshi']","['Carlos CC', 'Oishi K', 'Cinco MT', 'Mapua CA', 'Inoue S', 'Cruz DJ', 'Pancho MA', 'Tanig CZ', 'Matias RR', 'Morita K', 'Natividad FF', 'Igarashi A', 'Nagatake T']",,"[""Department of Pediatrics, and Research and Biotechnology Division, St. Luke's Medical Center, Quezon City, The Philippines.""]",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Blood Coagulation', 'Child', 'Child, Preschool', 'Dengue/epidemiology/pathology/*physiopathology', 'Female', 'Hematocrit', 'Hematologic Diseases/epidemiology/*physiopathology', 'Humans', 'Male', 'Philippines/epidemiology', 'Platelet Count', 'Severe Dengue/epidemiology/pathology/*physiopathology']",,2005/08/17 09:00,2005/10/12 09:00,['2005/08/17 09:00'],"['2005/08/17 09:00 [pubmed]', '2005/10/12 09:00 [medline]', '2005/08/17 09:00 [entrez]']",['73/2/435 [pii]'],ppublish,Am J Trop Med Hyg. 2005 Aug;73(2):435-40.,2,,,,,,,,,,,,,,,,,,,,,,
34507547,NLM,MEDLINE,20210924,20210924,1471-2334 (Electronic) 1471-2334 (Linking),21,2021 Sep 10,Cardiac evaluation in adults with dengue virus infection by serial echocardiography.,940,10.1186/s12879-021-06639-x [doi] 940,"BACKGROUND: Dengue virus infection (DVI) is a major health problem in many parts of the world. Its manifestations range from asymptomatic infections to severe disease. Although cardiac involvement has been reported in DVI, its incidence has not yet been well established. METHODS: From July 2016 to January 2018, patients hospitalized at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand, with dengue virus infection confirmed by positive NS1 or positive dengue immunoglobulin M findings, participated in the study. We characterized the incidence and change in cardiac function by serial echocardiography and levels of troponin-T and creatine kinase-myocardial band (CK-MB) on the day of admission, the day of defervescence, the first day of hypotension (if any), and at 2 week follow-up. RESULTS: Of the 81 patients evaluated, 6 (7.41%) exhibited elevated biomarker levels. There was no difference in clinical presentation amongst dengue fever, dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), except for the amount of bleeding. Cardiac involvement was found in 22.2% of patients: 3 (3.70%) had left ventricular systolic dysfunction, 3 (3.70%) had transient diastolic dysfunction, 6 (7.41%) had increased levels of at least one cardiac biomarker (troponin-T or CK-MB), and 6 (7.41%) had small pericardial effusion. Myocarditis was suspected in only two patients (with DHF); thus, myocarditis was uncommon in patients with dengue virus infection. Three patients developed DSS during admission and were transferred to the intensive care unit. CONCLUSION: Cardiac involvement in adults with dengue infection was common, ranging from elevated cardiac biomarker to myocarditis. Abnormalities in cardiac function had resolved spontaneously by the day of follow-up, without specific treatment. We found that DHF was a significant risk factor for cardiac involvement. Echocardiography is the investigation of choice for evaluating the haemodynamic status of patients with DVI, especially in severe dengue.","['Mansanguan, Chayasin', 'Hanboonkunupakarn, Borimas', 'Muangnoicharoen, Sant', 'Huntrup, Arun', 'Poolcharoen, Akkapon', 'Mansanguan, Suyanee', 'Piyaphanee, Watcharapong', 'Phumratanaprapin, Weerapong']","['Mansanguan C', 'Hanboonkunupakarn B', 'Muangnoicharoen S', 'Huntrup A', 'Poolcharoen A', 'Mansanguan S', 'Piyaphanee W', 'Phumratanaprapin W']",['ORCID: 0000-0002-7852-626X'],"['Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. chayasin.man@mahidol.ac.th.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'Bhumibol Adulyadej Hospital, Bangkok, Thailand.', 'Bhumibol Adulyadej Hospital, Bangkok, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.']",['eng'],['Journal Article'],20210910,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adult', '*Cardiomyopathies', '*Dengue/diagnostic imaging/epidemiology', 'Echocardiography', 'Heart', 'Humans', '*Myocarditis']",PMC8431916,2021/09/12 06:00,2021/09/25 06:00,['2021/09/11 05:20'],"['2020/05/21 00:00 [received]', '2021/08/31 00:00 [accepted]', '2021/09/11 05:20 [entrez]', '2021/09/12 06:00 [pubmed]', '2021/09/25 06:00 [medline]']","['10.1186/s12879-021-06639-x [pii]', '6639 [pii]', '10.1186/s12879-021-06639-x [doi]']",epublish,BMC Infect Dis. 2021 Sep 10;21(1):940. doi: 10.1186/s12879-021-06639-x.,1,['(c) 2021. The Author(s).'],['NOTNLM'],"['Cardiac involvement', 'Dengue infection', 'Haemodynamic', 'Myocarditis', 'Serial echocardiography']",['The authors declare that they have no competing interests.'],,"['ECF-019-05/Faculty of Tropical Medicine, Mahidol University/']",,,,,,,,,,,,,,,,
3795423,NLM,MEDLINE,19870211,20161017,0098-7484 (Print) 0098-7484 (Linking),257,1987 Jan 23-30,Leads from the MMWR. Dengue hemorrhagic fever--Puerto Rico.,"441, 448",,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Male', 'Puerto Rico']",,1987/01/23 00:00,1987/01/23 00:01,['1987/01/23 00:00'],"['1987/01/23 00:00 [pubmed]', '1987/01/23 00:01 [medline]', '1987/01/23 00:00 [entrez]']",,ppublish,"JAMA. 1987 Jan 23-30;257(4):441, 448.",4,,,,,,,,,,,,,,,,,,,,,,
19020803,NLM,MEDLINE,20090317,20211020,0300-8126 (Print) 0300-8126 (Linking),36,2008 Dec,Clinical and laboratory signs as dengue markers during an outbreak in Rio de Janeiro.,570-4,10.1007/s15010-008-7334-6 [doi],"BACKGROUND: One of the main challenges for clinical research in dengue is the low validity of clinical diagnosis. OBJECTIVE: To analyze clinical and laboratory data as predicitve factors of dengue diagnosis at Evandro Chagas Clinical Research Institute, Oswaldo Cruz Foundation, during the 2001-2002 dengue outbreak in Rio de Janeiro. METHODS: Cross sectional study comparing clinical laboratory data collected from the National Information System for Compulsory Notification Diseases (SINAN) in two serologically confirmed groups: dengue D (N = 453) and non-dengue ND (N = 80). RESULTS: Fever, exanthema, itching, mean platelet count < 150,000, WBC count < 4,000 and absence of vomiting and of abdominal pain help to distinguish D from ND groups. When considered individually, these signs and symptoms enhance diagnostic sensitivity and, when used in combination, improve specificity. CONCLUSION: A combination of symptoms not necessarily considered indicative of dengue diagnosis could improve surveillance and medical decision-making in simple clinical settings.","['Passos, S R L', 'Bedoya, S J', 'Hokerberg, Y H M', 'Maia, S C', 'Georg, I', 'Nogueira, R M R', 'Souza, R V', 'Marzochi, K B F']","['Passos SR', 'Bedoya SJ', 'Hokerberg YH', 'Maia SC', 'Georg I', 'Nogueira RM', 'Souza RV', 'Marzochi KB']",,"['Clinical Epidemiology Laboratory, Evandro Chagas Clinical Research Institute, Av Brasil 4365 Manguinhos, Rio de Janeiro, 21045900, Brazil. sonialambert@ipec.fiocruz.br']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20081119,Germany,Infection,Infection,0365307,['0 (Biomarkers)'],IM,"['Adolescent', 'Adult', '*Biomarkers', 'Brazil/epidemiology', 'Child', 'Child, Preschool', '*Clinical Laboratory Techniques', 'Cross-Sectional Studies', '*Dengue/diagnosis/epidemiology/physiopathology', 'Dengue Virus', '*Disease Outbreaks', 'Female', 'Fever', 'Humans', 'Male', 'Middle Aged']",,2008/11/21 09:00,2009/03/18 09:00,['2008/11/21 09:00'],"['2007/08/13 00:00 [received]', '2008/03/10 00:00 [accepted]', '2008/11/21 09:00 [pubmed]', '2009/03/18 09:00 [medline]', '2008/11/21 09:00 [entrez]']",['10.1007/s15010-008-7334-6 [doi]'],ppublish,Infection. 2008 Dec;36(6):570-4. doi: 10.1007/s15010-008-7334-6. Epub 2008 Nov 19.,6,,,,,,,,,,,,,,,,,,,,,,
10972384,NLM,MEDLINE,20000914,20150616,0140-6736 (Print) 0140-6736 (Linking),356,2000 Jul 29,Bangladeshi government appeals to WHO.,409,,,"['Ahmad, K']",['Ahmad K'],,,['eng'],['News'],,England,Lancet,"Lancet (London, England)",2985213R,"['0 (Reagent Kits, Diagnostic)']",IM,"['Adult', 'Bangladesh', 'Child', 'Dengue/diagnosis/epidemiology/*prevention & control', 'Disease Outbreaks/*prevention & control', 'Humans', 'Reagent Kits, Diagnostic/supply & distribution', '*World Health Organization']",,2000/09/06 11:00,2000/09/19 11:01,['2000/09/06 11:00'],"['2000/09/06 11:00 [pubmed]', '2000/09/19 11:01 [medline]', '2000/09/06 11:00 [entrez]']","['S0140-6736(05)73562-5 [pii]', '10.1016/S0140-6736(05)73562-5 [doi]']",ppublish,Lancet. 2000 Jul 29;356(9227):409. doi: 10.1016/S0140-6736(05)73562-5.,9227,,['PIP'],"['Asia', 'Bangladesh', '*Dengue--prevention and control', 'Developing Countries', 'Diseases', '*Government', 'International Agencies', 'Organizations', 'Political Factors', 'Southern Asia', 'Un', 'Viral Diseases', '*Who']",,,,,,,,"['PIP: 151243', 'POP: 00296305']","['In Dhaka, Bangladesh, it has been recorded that hundreds of people are infected', 'by dengue (a mosquito-borne viral infection), and there have been at least 12', 'dengue-related deaths. Those who have died include a dentist, an orthopedic', 'surgeon, a hospital auxiliary, and a number of patients coming to the hospitals', 'everyday. Such an outbreak is attributed to unchecked growth in the urban', 'population, poor household water storage, and inadequate solid waste disposal', 'services. Dengue fever has also hit the cities of Chittagong, Faridpur and', 'Sylhet. Despite the enormity of the outbreak, the government insists that the', 'situation is not that serious and that there is no reason to panic. However,', ""Bangladesh has made an emergency appeal to the WHO to help control the country's"", 'increase in dengue fever.']",['eng'],['PIP: TJ: LANCET.'],,,,,,,,
34461977,NLM,MEDLINE,20210906,20210906,1752-1947 (Electronic) 1752-1947 (Linking),15,2021 Aug 30,Challenges of dengue and coronavirus disease 2019 coinfection: two case reports.,439,10.1186/s13256-021-02973-5 [doi] 439,"BACKGROUND: Dengue fever and coronavirus disease 2019 have now begun to overlap within tropical and subtropical regions. This is due to the high prevalence of dengue fever in these regions and the current severe acute respiratory syndrome coronavirus 2 pandemic situation. The similarity of symptoms between the two diseases can confuse diagnoses, but coinfection can also occur. CASE PRESENTATION: We present two cases of patients with dengue and severe acute respiratory syndrome coronavirus 2 coinfection. The first case is that of a 24-year-old Hispanic woman with acute fever, odynophagia, and diarrhea, without respiratory symptoms and with positive molecular tests for both dengue and severe acute respiratory syndrome coronavirus 2. The second case is that of a 59-year-old Hispanic male patient with fever and respiratory symptoms of 2 weeks duration, negative molecular tests, and positive serological tests for both viruses. The clinical and epidemiological characteristics of both viral infections can help elucidate diagnoses and prognoses. CONCLUSIONS: Severe dengue infection is common in young adults, while coronavirus disease 2019 is generally asymptomatic. In older people, the severity of dengue fever will depend on their comorbidities or the infectious serotype, but coronavirus disease 2019 is consistently more severe in this group. The accurate diagnosis of both infections can better guide clinical management, as well as public health actions in transmission control, now especially important during the coronavirus disease 2019 pandemic.","['Agudelo Rojas, Olga Lucia', 'Tello-Cajiao, Maria Elena', 'Rosso, Fernando']","['Agudelo Rojas OL', 'Tello-Cajiao ME', 'Rosso F']",['ORCID: 0000-0001-5250-2801'],"['Fundacion Valle del Lili, Centro de Investigaciones Clinicas (CIC), Cali, Colombia.', 'Fundacion Valle del Lili, Centro de Investigaciones Clinicas (CIC), Cali, Colombia.', 'Fundacion Valle del Lili, Centro de Investigaciones Clinicas (CIC), Cali, Colombia. fernando.rosso@fvl.org.co.', 'Internal Medicine Department, Infectious Disease Service, Fundacion Valle del Lili, Cali, Valle del Cauca, Colombia. fernando.rosso@fvl.org.co.']",['eng'],"['Case Reports', 'Journal Article']",20210830,England,J Med Case Rep,Journal of medical case reports,101293382,,IM,"['Adult', 'Aged', '*COVID-19', '*Coinfection/diagnosis', '*Dengue/complications/diagnosis', 'Female', 'Humans', 'Male', 'Middle Aged', 'Pandemics', 'SARS-CoV-2', '*Severe Dengue', 'Young Adult']",PMC8404025,2021/09/01 06:00,2021/09/07 06:00,['2021/08/31 05:42'],"['2020/12/14 00:00 [received]', '2021/06/18 00:00 [accepted]', '2021/08/31 05:42 [entrez]', '2021/09/01 06:00 [pubmed]', '2021/09/07 06:00 [medline]']","['10.1186/s13256-021-02973-5 [pii]', '2973 [pii]', '10.1186/s13256-021-02973-5 [doi]']",epublish,J Med Case Rep. 2021 Aug 30;15(1):439. doi: 10.1186/s13256-021-02973-5.,1,['(c) 2021. The Author(s).'],['NOTNLM'],"['COVID-19', 'Coinfection', 'Dengue', 'SARS CoV-2']",['The authors declare that they have no competing interests to report.'],,,,,,,,,,,,,,,,,,
22030689,NLM,MEDLINE,20120529,20111027,2539-3596 (Electronic) 0124-0064 (Linking),12,2010 Dec,[Classical dengue transmission dynamics involving mechanical control and prophylaxis].,1020-32,S0124-00642010000600014 [pii],"Dengue fever transmission dynamics were studied in an endemic region considering the use of preventative measures and mechanical control in reducing transmission of the disease. A system of ordinary differential equations was proposed, describing the dynamics and their evolution as determined by numerical simulation. Different mechanical control and prophylaxis strategies were compared to the situation without control. The basic reproduction number R(0) was determined R(0) to show that if R(0) > 1 there would be a risk of an epidemic and otherwise the disease would have low impact levels. The basic reproduction number helps determine the dynamics' future pattern and contrast the results so obtained with those obtained numerically. It was concluded that although prophylaxis and mechanical control alone provide effective results in controlling the disease, if both controls are combined then infection levels become significantly reduced. Around 60 % mechanical control and prevention levels are needed to provide suitable results in controlling dengue outbreaks.","['Toro-Zapata, Hernan D', 'Restrepo, Leonardo D', 'Vergano-Salazar, Juan G', 'Munoz-Loaiza, Anibal']","['Toro-Zapata HD', 'Restrepo LD', 'Vergano-Salazar JG', 'Munoz-Loaiza A']",,"['Departamento de Matematicas, Facultad de Educacion, Universidad del Quindio, Armenia, Colombia. hdtoro@uniquindio.edu.co']",['spa'],"['English Abstract', 'Journal Article']",,Colombia,Rev Salud Publica (Bogota),"Revista de salud publica (Bogota, Colombia)",100936348,,IM,"['Aedes', 'Animals', 'Communicable Disease Control/*methods', 'Dengue/epidemiology/prevention & control/*transmission', 'Disease Outbreaks/prevention & control', '*Endemic Diseases', 'Humans', 'Insect Vectors', '*Models, Biological', 'Mosquito Control', 'Population Density']",,2011/10/28 06:00,2012/05/30 06:00,['2011/10/28 06:00'],"['2010/02/26 00:00 [received]', '2010/12/27 00:00 [accepted]', '2011/10/28 06:00 [entrez]', '2011/10/28 06:00 [pubmed]', '2012/05/30 06:00 [medline]']",['S0124-00642010000600014 [pii]'],ppublish,Rev Salud Publica (Bogota). 2010 Dec;12(6):1020-32.,6,,,,,,,,,Dinamica de transmision del Dengue clasico con control mecanico y profilaxis.,,,,,,,,,,,,,
12674826,NLM,MEDLINE,20030416,20130418,0971-5916 (Print) 0971-5916 (Linking),116,2002 Oct,Dengue fever outbreaks in two villages of Dharmapuri district in Tamil Nadu.,133-9,,"BACKGROUND & OBJECTIVES: Dengue fever is an important public health problem in India. In recent years this disease has extended to rural areas also due to rapid urbanization. In Tamil Nadu, fever outbreaks were reported in two villages of Dharmapuri district during May and September 2001 with clinical symptoms suggestive of dengue fever. Epidemiological, virological and entomological investigations were carried out in these two villages to ascertain the etiology of the outbreaks. METHODS: Paired serum samples were collected from febrile patients clinically suspected to have dengue and were tested for the presence of IgM antibodies to dengue virus by MAC ELISA. Samples were also tested by Dengue Duo IgM/IgG rapid strip. Surveys of larval and adult Aedes mosquitoes were carried out before and after anti-larval and anti-adult measures were implemented. Female Ae. aegypti mosquitoes collected in Mampatti village were tested individually for the presence of dengue-2 viral antigen by indirect immunofluorescence assay (IIFA). In addition, two pools of female Ae. aegypti mosquitoes were tested for the presence of dengue viral antigen by ELISA and then subjected to Toxo-IFA system for demonstration of dengue virus. RESULTS: A total of 124 and 267 fever cases with clinical symptoms and signs suggestive of dengue were reported in Kadumuchandiram and Mampatti villages of Dharmapuri district, respectively. Serodiagnosis revealed that 13 of 31 and 14 of 52 patients tested were positive for dengue-2 virus by MAC ELISA in Kadumuchandiram and Mampatti villages respectively. Dengue Duo rapid strip test also detected 14 (of 31 tested) patients positive for dengue virus specific IgM antibodies in Kadumuchandiram village and 8 (of 12 tested) in Mampatti village. Application of temephos and fogging with pyrethrum 2 per cent extract were found to be effective against immatures and adults respectively. Both the pools of Ae. aegypti tested for the presence of dengue viral antigen were positive by ELISA and one mosquito (tested individually) was positive by IIFA. Supernatants of two pools were found to be positive for dengue-2 virus by Toxo-IFA. INTERPRETATION & CONCLUSION: Virological and serological investigations confirmed that the outbreaks of fever were due to dengue virus infection. High breeding of Ae. aegypti in the study villages, detection of dengue-2 viral antigen and isolation of dengue-2 virus in Ae. aegypti mosquitoes confirmed the etiology.","['Victor, T John', 'Malathi, M', 'Gurusamy, D', 'Desai, Anita', 'Ravi, V', 'Narayanasamy, G', 'Anuradha, L', 'Rani, C', 'Krishnamurthy, P']","['Victor TJ', 'Malathi M', 'Gurusamy D', 'Desai A', 'Ravi V', 'Narayanasamy G', 'Anuradha L', 'Rani C', 'Krishnamurthy P']",,"['Institute of Vector Control & Zoonoses, Hosur, India.']",['eng'],['Journal Article'],,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Dengue/diagnosis/*epidemiology', '*Disease Outbreaks', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'India/epidemiology', 'Male']",,2003/04/05 05:00,2003/04/17 05:00,['2003/04/05 05:00'],"['2003/04/05 05:00 [pubmed]', '2003/04/17 05:00 [medline]', '2003/04/05 05:00 [entrez]']",,ppublish,Indian J Med Res. 2002 Oct;116:133-9.,,,,,,,,,,,,,,,,,,,,,,,
34037787,NLM,MEDLINE,20210616,20210616,1465-3664 (Electronic) 0142-6338 (Linking),67,2021 May 17,Does Malaria Co-Infection Alter the Clinical Course in Children Infected with Dengue? Analysis from 623 Indian Children Admitted with Dengue Infection.,,fmab006 [pii] 10.1093/tropej/fmab006 [doi],"BACKGROUND: Dengue and malaria co-infection has been reported in several case reports. We aim to study effect of malaria co-infection on clinical outcomes of dengue infection. METHODS: Records of 623 children with dengue infection, based on NS-1 antigen and IgM ELISA testing, were collected. Malaria co-infection was identified in 20 cases, based on peripheral blood smear examination. Clinical and hematological parameters were compared in two groups (malaria co-infection vs. dengue mono-infection). RESULTS: Duration of hospitalization was significantly higher in co-infected group. Significantly higher proportion of malaria co-infection cases had hepatosplenomegaly, hemoglobin </=8 g/dl, serum albumin </=3 g/dl, serum bilirubin >/=1 mg/dl, serum aspartate aminotransferase >/=500 U/l and serum alanine aminotransferase >/=300 U/l. Number of transfusions (PRBC and platelets) required in malaria co-infection group was higher. CONCLUSION: Malaria co-infection in dengue impacts clinical presentation, hematological parameters, requirement of blood transfusion and morbidity. High index of suspicion is warranted while evaluating febrile patients.","['Bhakhri, Bhanu Kiran', 'Singh, Dharmendra Kumar', 'Singh, Nupur', 'Rai, Ruchi']","['Bhakhri BK', 'Singh DK', 'Singh N', 'Rai R']",,"['Department of Pediatrics, Superspecialty Pediatric Hospital & Postgraduate Teaching Institute, Noida, Uttar Pradesh 201301, India.', 'Department of Pediatrics, Superspecialty Pediatric Hospital & Postgraduate Teaching Institute, Noida, Uttar Pradesh 201301, India.', 'Department of Pediatrics, Superspecialty Pediatric Hospital & Postgraduate Teaching Institute, Noida, Uttar Pradesh 201301, India.', 'Department of Neonatology & MRH, Superspecialty Pediatric Hospital & Postgraduate Teaching Institute, Noida, Uttar Pradesh 201301, India.']",['eng'],['Journal Article'],,England,J Trop Pediatr,Journal of tropical pediatrics,8010948,,IM,"['Child', '*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', 'Fever', 'Hospitalization', 'Humans', '*Malaria/complications/diagnosis/epidemiology']",,2021/05/27 06:00,2021/06/17 06:00,['2021/05/26 12:35'],"['2021/05/26 12:35 [entrez]', '2021/05/27 06:00 [pubmed]', '2021/06/17 06:00 [medline]']","['6284319 [pii]', '10.1093/tropej/fmab006 [doi]']",ppublish,J Trop Pediatr. 2021 May 17;67(2):fmab006. doi: 10.1093/tropej/fmab006.,2,"['(c) The Author(s) [2021]. Published by Oxford University Press. All rights', 'reserved. For permissions, please email: journals.permissions@oup.com.']",['NOTNLM'],"['clinical outcome', 'co-infection', 'dengue', 'malaria']",,,,,,,,,,,,,,,,,,,
33541977,NLM,MEDLINE,20210514,20230205,1757-790X (Electronic) 1757-790X (Linking),14,2021 Feb 4,Myocarditis: an uncommon manifestation of dengue fever infection.,,10.1136/bcr-2021-241569 [doi] e241569,,"['Adams, Christian David', 'Syro, Daniel', 'Llano, Juan Felipe', 'Betancur, Juan Felipe']","['Adams CD', 'Syro D', 'Llano JF', 'Betancur JF']",['ORCID: 0000-0003-1331-6605'],"['Division of Cardiology, Fundacion Valle del Lili, Cali, Colombia.', 'Department of Emergency Medicine, Clinica Medellin - Grupo Quironsalud, Medellin, Colombia.', 'Department of Emergency Medicine, Clinica Medellin - Grupo Quironsalud, Medellin, Colombia.', 'Department of Internal Medicine, Clinica Medellin - Grupo Quironsalud, Medellin, Colombia juanfebp@hotmail.com.', 'Department of Internal Medicine, Salud Sura, Medellin, Colombia.']",['eng'],"['Case Reports', 'Journal Article']",20210204,England,BMJ Case Rep,BMJ case reports,101526291,,IM,"['*Dengue/complications/diagnosis', '*Dengue Virus', 'Humans', '*Myocarditis/diagnosis/etiology']",PMC7868252,2021/02/06 06:00,2021/05/15 06:00,['2021/02/05 05:46'],"['2021/02/05 05:46 [entrez]', '2021/02/06 06:00 [pubmed]', '2021/05/15 06:00 [medline]']","['14/2/e241569 [pii]', 'bcr-2021-241569 [pii]', '10.1136/bcr-2021-241569 [doi]']",epublish,BMJ Case Rep. 2021 Feb 4;14(2):e241569. doi: 10.1136/bcr-2021-241569.,2,,['NOTNLM'],"['Clinical diagnostic tests', 'Infectious diseases', 'Radiology (diagnostics)', 'Tropical medicine (infectious disease)']",['Competing interests: None declared.'],,,,,,,,,,,,,,,,,,
2098929,NLM,MEDLINE,19910729,20071114,0125-1562 (Print) 0125-1562 (Linking),21,1990 Dec,Antigen and antibody detection and update on the diagnosis of dengue.,642-5,,"The diagnosis of dengue is an imperfect science. By 1983 we had sensitive isolation systems including arthropods and arthropod cell cultures, specific-and group-reactive monoclonal antibodies, and a rapid and sensitive immunoassay for IgM and IgG. Progress in the past 7 years encompasses the use of monocyte lines for primary isolation, a more rapid plaque reduction neutralization test with BHK-21 cells, labeled RNA probes to detect dengue-specific nucleic acid, and improved ELISA technology with specific synthetic and engineered antigens.","['Shope, R E']",['Shope RE'],,"['Yale Arbovirus Research Unit, New Haven, CT 06510.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,"['0 (Antibodies, Viral)', '0 (Antigens, Viral)']",IM,"['Antibodies, Viral/*analysis', 'Antigens, Viral/*analysis', 'Dengue/*diagnosis/epidemiology/immunology', 'Humans', 'Immunoassay/*methods/trends', 'Sensitivity and Specificity']",,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):642-5.,4,,,,,,['AI 10984/AI/NIAID NIH HHS/United States'],23,,,,,,,,,,,,,,,
17292087,NLM,MEDLINE,20070416,20070212,1549-9642 (Electronic) 1549-9634 (Linking),1,2005 Sep,"Weak binding affinity of immunoglobin G, an explanation for the immune mimicking theory in pathophysiologic findings in the recovery phase of dengue.",239-40,,"The actual mechanisms underlying severe bleeding in dengue hemorrhagic fever (DHF) are not completely understood. The immune mimicking theory is a widely mentioned hypothesis that might help answer questions. In this study, the author performed a prediction on the binding affinity on the NS1 immunoglobulin (IgG and CD61-IgG) complexes using a computation medicine technique. According to this study, the significant discrimination of modeled Ig complexes can be detected. The finding, which is expected for the late recovery phase of dengue, implies the difficulty in mimicking immune complex formation.","['Wiwanitkit, Viroj']",['Wiwanitkit V'],,"['Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. wviroj@pioneer.netserv.chula.ac.th <wviroj@pioneer.netserv.chula.ac.th>']",['eng'],['Journal Article'],,United States,Nanomedicine,"Nanomedicine : nanotechnology, biology, and medicine",101233142,['0 (Immunoglobulin G)'],IM,"['Antibody Affinity/*immunology', 'Biomimetics', 'Dengue/*immunology/pathology/*physiopathology', 'Immunoglobulin G/*immunology', 'Models, Immunological']",,2007/02/13 09:00,2007/04/17 09:00,['2007/02/13 09:00'],"['2005/05/30 00:00 [received]', '2005/06/20 00:00 [accepted]', '2007/02/13 09:00 [pubmed]', '2007/04/17 09:00 [medline]', '2007/02/13 09:00 [entrez]']","['S1549-9634(05)00121-8 [pii]', '10.1016/j.nano.2005.06.002 [doi]']",ppublish,Nanomedicine. 2005 Sep;1(3):239-40. doi: 10.1016/j.nano.2005.06.002.,3,,,,,,,,,,,,,,,,,,,,,,
12657162,NLM,MEDLINE,20040809,20191027,1475-925X (Electronic) 1475-925X (Linking),2,2003 Feb 19,A model of dengue fever.,4,,"BACKGROUND: Dengue is a disease which is now endemic in more than 100 countries of Africa, America, Asia and the Western Pacific. It is transmitted to the man by mosquitoes (Aedes) and exists in two forms: Dengue Fever and Dengue Haemorrhagic Fever. The disease can be contracted by one of the four different viruses. Moreover, immunity is acquired only to the serotype contracted and a contact with a second serotype becomes more dangerous. METHODS: The present paper deals with a succession of two epidemics caused by two different viruses. The dynamics of the disease is studied by a compartmental model involving ordinary differential equations for the human and the mosquito populations. RESULTS: Stability of the equilibrium points is given and a simulation is carried out with different values of the parameters. The epidemic dynamics is discussed and illustration is given by figures for different values of the parameters. CONCLUSION: The proposed model allows for better understanding of the disease dynamics. Environment and vaccination strategies are discussed especially in the case of the succession of two epidemics with two different viruses.","['Derouich, M', 'Boutayeb, A', 'Twizell, E H']","['Derouich M', 'Boutayeb A', 'Twizell EH']",,"['Department of Mathematics, Faculty of Sciences, Mohamed I university, Oujda-Morocco. Derouich@sciences.univ-oujda.ac.ma']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20030219,England,Biomed Eng Online,Biomedical engineering online,101147518,,IM,"['Animals', '*Culicidae', 'Dengue/classification/*epidemiology/*transmission/virology', 'Dengue Virus/classification', 'Disease Outbreaks/*prevention & control', 'Host-Parasite Interactions', 'Humans', '*Insect Vectors', '*Models, Statistical', 'Mosquito Control', 'Population Dynamics', 'Serotyping', 'Vaccination']",PMC153427,2003/03/27 05:00,2004/08/10 05:00,['2003/03/27 05:00'],"['2002/11/29 00:00 [received]', '2003/02/19 00:00 [accepted]', '2003/03/27 05:00 [pubmed]', '2004/08/10 05:00 [medline]', '2003/03/27 05:00 [entrez]']","['1475-925X-2-4 [pii]', '10.1186/1475-925x-2-4 [doi]']",epublish,Biomed Eng Online. 2003 Feb 19;2:4. doi: 10.1186/1475-925x-2-4.,,,,,,,,,,,,,,,,,,,,,,,
32468769,NLM,MEDLINE,20201030,20201030,1819-2718 (Electronic) 1025-9589 (Linking),32,2020 Jan-Mar,"An Attempt Towards Lab And Clinical Combine Appraised, Including Future Concerns Regarding Dengue Infection.",115-123,,"BACKGROUND: Dengue infection is a deadly global pandemic due to its fatal nature, being emerged from mild stage to turn into more severe stages and consequently causing casualties. it upsurges various phases, namely subclinical infection, undifferentiated febrile fever, Dengue fever (DF) and devastating states which often ends to life, they are Dengue haemorrhagic fever (DHF) and Dengue shock syndrome (DSS). Dengue infection is a mosquito born disease which has engulfed many regions in general and tropical zone in particular, causing many casualties and has posed a threat to humanity, demanding strategies to resolve the global issue. It is reported that 50-200 million people fall prey to it globally by dint of its causative agents and imperative to mention that over proportional are the minor among the victims. Because of awful joint pain dengue fever is also named break bone fever. The common indicator in infected individuals is thrombocytopenia, coagulopathy and vasculopathy. Apart from supportive therapy, no aphoristic therapy has been introduced so far, however care may prove rescuer. Timely prognosis thwarts to enter it in deteriorating phase. METHODS: In the list of laboratory diagnosis virus serology and detection of Ribonucleic acid are primed. In general, there's no specific decisive diagnostic biomarker present through which accurate and prompt prognosis can possible during the entire patient presentation time, particularly in case of secondary dengue infection. Although, through the advancement and commercialization of point-care combined tests, capable of tracking disease markers present during various phases of infection (viral non-structural protein 1 and immunoglobulin M), such evaluation massively improved the treatment through lab-based. CONCLUSIONS: Despite such improvements, major hurdles persist in the clinical management of patients with dengue infection, particularly lack of dependable biomarkers that have an efficacious prognostic gauge to predict steady progress to severe disease. In the described review both clinical and laboratory diagnosis of dengue infection has been highlighted, including concern regarding future accessibility.","['Ali, Qaisar', 'Kalam, Irfan', 'Mabood, Fazal', 'Imran, Muhammad']","['Ali Q', 'Kalam I', 'Mabood F', 'Imran M']",,"['Department of Medical of Laboratory Technology, Premier Institute of Health and Management Sciences (PIHMS), Peshawar, Pakistan.', 'Department of Medical Laboratory Sciences (DMLS), Faculty of Health Allied Sciences (FHAS), Imperial College of Business Studies (ICBS), Lahore, Pakistan.', 'Department of Medical Laboratory Sciences (DMLS), Faculty of Health Allied Sciences (FHAS), Imperial College of Business Studies (ICBS), Lahore, Pakistan.', 'Department of Microbiology, University of Health Sciences (UHS), Lahore, Pakistan.']",['eng'],['Journal Article'],,Pakistan,J Ayub Med Coll Abbottabad,"Journal of Ayub Medical College, Abbottabad : JAMC",8910750,['0 (Biomarkers)'],IM,"['Biomarkers/analysis', 'Dengue/*diagnosis/virology', 'Dengue Virus', 'Humans', 'Microbiological Techniques', 'Virology']",,2020/05/30 06:00,2020/10/31 06:00,['2020/05/30 06:00'],"['2020/05/30 06:00 [entrez]', '2020/05/30 06:00 [pubmed]', '2020/10/31 06:00 [medline]']",['6542/2857 [pii]'],ppublish,J Ayub Med Coll Abbottabad. 2020 Jan-Mar;32(1):115-123.,1,,['NOTNLM'],"['Dengue shock syndrome; Dengue haemorrhagic fever', 'thrombocytopenia; Dengue fever']",,,,,,,,,,,,,,,,,,,
35532585,NLM,MEDLINE,20220511,20230107,0971-5916 (Print) 0975-9174 (Electronic) 0971-5916 (Linking),154,2021 May,Concurrent dengue infections: Epidemiology & clinical implications.,669-679,10.4103/ijmr.IJMR_1219_18 [doi],"Multiple dengue virus (DENV) serotypes circulating in a geographical area most often lead to simultaneous infection of two or more serotypes in a single individual. The occurrence of such concurrent infections ranges from 2.5 to 30 per cent, reaching as high as 40-50 per cent in certain dengue hyper-endemic areas. Concurrent dengue manifests itself differently than mono-infected patients, and it becomes even more important to understand the effects of co-infecting serotypes in concurrent infections to ascertain the clinical outcomes of the disease progression and transmission. In addition, there have also been reports of concurrent DENV infections in the presence of other arboviral infections. In this review, we provide a comprehensive breakdown of concurrent dengue infections globally. Furthermore, this review also touches upon the clinical presentations during those concurrent infections categorized as mild or severe forms of disease presentation. Another aspect of this review was aimed at providing insight into the concurrent dengue incidences in the presence of other arboviruses.","['N Sirisena, P D N', 'Mahilkar, Shakuntala', 'Sharma, Chetan', 'Jain, Jaspreet', 'Sunil, Sujatha']","['N Sirisena PDN', 'Mahilkar S', 'Sharma C', 'Jain J', 'Sunil S']",,"['ImmunifyMe Healthcare Technologies Pvt. Ltd., Altrade Business Centre, Gurugram, Haryana, India.', 'Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.', 'Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.', 'Human Retrovirology Laboratory, Montreal Clinical Research Institute (IRCM), Montreal, Quebec H2W 1R7, Canada.', 'Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.']",['eng'],"['Journal Article', 'Review']",,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['*Dengue/complications/epidemiology', '*Dengue Virus', 'Disease Outbreaks', 'Humans', 'Incidence', 'Serogroup']",PMC9210535,2022/05/10 06:00,2022/05/12 06:00,['2022/05/09 10:58'],"['2022/05/09 10:58 [entrez]', '2022/05/10 06:00 [pubmed]', '2022/05/12 06:00 [medline]']","['IndianJMedRes_2021_154_5_669_344547 [pii]', 'IJMR-154-669 [pii]', '10.4103/ijmr.IJMR_1219_18 [doi]']",ppublish,Indian J Med Res. 2021 May;154(5):669-679. doi: 10.4103/ijmr.IJMR_1219_18.,5,,['NOTNLM'],"['Concurrent dengue infections', 'dengue serotypes', 'epidemiology', 'public health']",['Conflicts of Interest: None.'],,,,,,,,,,,,,,,,,,
26922851,NLM,MEDLINE,20161230,20161231,1099-1654 (Electronic) 1052-9276 (Linking),26,2016 May,Repetitive dengue outbreaks in East Africa: A proposed phased mitigation approach may reduce its impact.,183-96,10.1002/rmv.1877 [doi],"Dengue outbreaks have persistently occurred in eastern African countries for several decades. We assessed each outbreak to identify risk factors and propose a framework for prevention and impact mitigation. Seven out of ten countries in eastern Africa and three islands in the Indian Ocean have experienced dengue outbreaks between 1823 and 2014. Major risk factors associated with past dengue outbreaks include climate, virus and vector genetics and human practices. Appropriate use of dengue diagnostic tools and their interpretation are necessary for both outbreak investigations and sero-epidemiological studies. Serosurvey findings during inter-epidemic periods have not been adequately utilised to prevent re-occurrence of dengue outbreaks. Local weather variables may be used to predict dengue outbreaks, while entomological surveillance can complement other disease-mitigation efforts during outbreaks and identify risk-prone areas during inter-epidemic periods. The limitations of past dengue outbreak responses and the enormous socio-economic impacts of the disease on human health are highlighted. Its repeated occurrence in East Africa refutes previous observations that susceptibility may depend on race. Alternate hypotheses on heterotypic protection among flaviviruses may not be applied to all ecologies. Prevention and mitigation of severe dengue outbreaks should necessarily consider the diverse factors associated with their occurrence. Implementation of phased dengue mitigation activities can enforce timely and judicious use of scarce resources, promote environmental sanitation, and drive behavioural change, hygienic practices and community-based vector control. Understanding dengue epidemiology and clinical symptoms, as determined by its evolution, are significant to preventing future dengue epidemics.","['Baba, Marycelin', 'Villinger, Jandouwe', 'Masiga, Daniel K']","['Baba M', 'Villinger J', 'Masiga DK']",,"['Martin Luscher Emerging Infectious Diseases Laboratory (ML-EID), International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya.', 'Department of Medical Laboratory Science, P.M.B. 1069, University of Maiduguri, Maiduguri, Nigeria.', 'Martin Luscher Emerging Infectious Diseases Laboratory (ML-EID), International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya.', 'Martin Luscher Emerging Infectious Diseases Laboratory (ML-EID), International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya.']",['eng'],"['Historical Article', 'Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", 'Review']",20160229,England,Rev Med Virol,Reviews in medical virology,9112448,,IM,"['Africa, Eastern/epidemiology', 'Dengue/*epidemiology/*etiology/history/prevention & control', '*Dengue Virus/immunology', '*Disease Outbreaks', 'Genetic Predisposition to Disease', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Host-Pathogen Interactions/genetics/immunology', 'Humans', 'Risk Factors', 'Socioeconomic Factors']",,2016/03/01 06:00,2016/12/31 06:00,['2016/03/01 06:00'],"['2015/09/22 00:00 [received]', '2016/02/03 00:00 [revised]', '2016/02/04 00:00 [accepted]', '2016/03/01 06:00 [entrez]', '2016/03/01 06:00 [pubmed]', '2016/12/31 06:00 [medline]']",['10.1002/rmv.1877 [doi]'],ppublish,Rev Med Virol. 2016 May;26(3):183-96. doi: 10.1002/rmv.1877. Epub 2016 Feb 29.,3,"['Copyright (c) 2016 John Wiley & Sons, Ltd.']",,,,,,,,,,,,,,,,,,,,,
23652501,NLM,MEDLINE,20130510,20161017,1538-3598 (Electronic) 0098-7484 (Linking),309,2013 May 8,Dengue more prevalent than previously thought.,1882,10.1001/jama.2013.4903 [doi],,"['Mitka, Mike']",['Mitka M'],,,['eng'],['News'],,United States,JAMA,JAMA,7501160,,IM,"['Animals', 'Culicidae/virology', 'Dengue/complications/diagnosis/*epidemiology/transmission', '*Global Health', 'Humans', 'Incidence', 'Insect Vectors', 'Models, Theoretical', 'Prevalence', 'Risk', 'Tropical Climate', 'World Health Organization']",,2013/05/09 06:00,2013/05/11 06:00,['2013/05/09 06:00'],"['2013/05/09 06:00 [entrez]', '2013/05/09 06:00 [pubmed]', '2013/05/11 06:00 [medline]']","['1685853 [pii]', '10.1001/jama.2013.4903 [doi]']",ppublish,JAMA. 2013 May 8;309(18):1882. doi: 10.1001/jama.2013.4903.,18,,,,,,,,,,,,,,,,,,,,,,
31815129,NLM,MEDLINE,20200420,20220411,2314-6141 (Electronic) 2314-6133 (Print),2019,2019,Epidemiological and Clinical Features of Dengue Infection in Adults in the 2017 Outbreak in Vietnam.,3085827,10.1155/2019/3085827 [doi] 3085827,"PURPOSE: The clinical features and laboratory results of dengue-infected adult patients admitted to the hospital during the 2017 outbreak were analyzed in this study. METHOD: This is a cross-sectional study. 2922 patients aged 18 years or more with dengue fever in National Hospital for Tropical Diseases (NHTD) in the North and Hospital for Tropical Disease (HTD) in the South of Vietnam were recruited in this study. RESULT: Patients were admitted in the hospital around the year and concentrated from August to December, in 53/63 (84.0%) provinces in Vietnam, and patients in all ages were affected. The number of patients with dengue fever was 1675 (57.3%), dengue with warning signs 914 (31.3%), and severe dengue 333 (11.4%), respectively. Among patients with severe dengue, severe plasma leakage and dengue shock account for 238 (8.1%), severe organ impairment 73 (2.5%), and severe bleeding 22 (0.75%). The rate of mortality was 0.8%, and the outcome of dengue patients is worse in the elderly and people with underlying diseases. CONCLUSION: The 2017 dengue outbreak occurred in a larger scale than in the previous years in terms of time, location, and number of patients. More elderly patients were infected by dengue in this outbreak, and this may contribute to the mortality rate. Clinical manifestations of dengue patients in Southern Vietnam are more typical than the northern, but the rate of severe dengue is not different. The mortality risk and underlying conditions associated with dengue-infected elderly patients are worthy of further investigations in the future.","['Huy, Bui Vu', 'Hoa, Le Nguyen Minh', 'Thuy, Dang Thi', 'Van Kinh, Nguyen', 'Ngan, Ta Thi Dieu', 'Duyet, Le Van', 'Hung, Nguyen Thanh', 'Minh, Ngo Ngoc Quang', 'Truong, Nguyen Thanh', 'Chau, Nguyen Van Vinh']","['Huy BV', 'Hoa LNM', 'Thuy DT', 'Van Kinh N', 'Ngan TTD', 'Duyet LV', 'Hung NT', 'Minh NNQ', 'Truong NT', 'Chau NVV']","['ORCID: 0000-0002-9273-6503', 'ORCID: 0000-0002-0389-6514']","['Hanoi Medical University, Hanoi, Vietnam.', 'National Hospital for Tropical Diseases, Hanoi, Vietnam.', 'National Hospital for Tropical Diseases, Hanoi, Vietnam.', 'National Hospital for Tropical Diseases, Hanoi, Vietnam.', 'Hanoi Medical University, Hanoi, Vietnam.', 'National Hospital for Tropical Diseases, Hanoi, Vietnam.', ""Children's Hospital 1, Ho Chi Minh City, Vietnam."", ""Children's Hospital 1, Ho Chi Minh City, Vietnam."", 'Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.', 'Hospital for Tropical Disease, Ho Chi Minh City, Vietnam.']",['eng'],['Journal Article'],20191107,United States,Biomed Res Int,BioMed research international,101600173,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cross-Sectional Studies', 'Dengue/*diagnosis/*epidemiology/physiopathology', 'Dengue Virus/pathogenicity', '*Disease Outbreaks', 'Female', 'Hemorrhage/epidemiology', 'Hospitalization', 'Hospitals', 'Humans', 'Male', 'Middle Aged', 'Severe Dengue/diagnosis/epidemiology', 'Vietnam/epidemiology', 'Young Adult']",PMC6877935,2019/12/10 06:00,2020/04/21 06:00,['2019/12/10 06:00'],"['2019/06/12 00:00 [received]', '2019/08/08 00:00 [accepted]', '2019/12/10 06:00 [entrez]', '2019/12/10 06:00 [pubmed]', '2020/04/21 06:00 [medline]']",['10.1155/2019/3085827 [doi]'],epublish,Biomed Res Int. 2019 Nov 7;2019:3085827. doi: 10.1155/2019/3085827. eCollection 2019.,,['Copyright (c) 2019 Bui Vu Huy et al.'],,,"['The authors declare that there are no conflicts of interest regarding the', 'publication of this paper.']",,,,,,,,,,,,,,,,,,
16324564,NLM,MEDLINE,20060501,20191210,0213-005X (Print) 0213-005X (Linking),23,2005 Nov,[Early indicators of severity in dengue virus infection].,529-32,,"OBJECTIVE: To identify clinical markers of severity in dengue, different from those of major hemorrhage. DESIGN: Cross-sectional study. POPULATION AND METHODS: Patients with a diagnosis of dengue infection admitted to hospitals in Santander (Colombia) during the years 1993 to 1998 were studied. On admittance or during hospitalization, patients were classified as cases of dengue hemorrhagic fever (DHF) or dengue fever (DF). Clinical findings differing from those of major hemorrhage were recorded in the emergency room and during the first assessment at hospitalization. The association between these findings and the outcome of DHF were evaluated using univariate and multivariate analyses. RESULTS: 891 patients (DF: 420; DHF: 471) were included in the study. Associations were found between DHF and the following signs and symptoms: vomiting (OR: 1.89; 95% CI: 1.37-2.6; p = 0.0001); gingival hemorrhage (OR: 1.55; 95% CI: 1.11-2.18; p = 0.01); epistaxis (OR: 1.78; 95% CI: 1.28-2.48; p = 0.001); hepatomegaly (OR: 2.56; 95% CI: 1.61-4.07; p < 0.0001); microscopic hematuria (OR: 2.33; 95% CI: 1.36-4; p = 0.002); and rash (OR: 1.36; 95% CI: 1.04-1.77; p = 0.02). The hematocrit in the emergency room and on the first day of hospitalization was significantly higher in the group with DHF (p < 0.001, in both observations). On multivariate analysis, the hematocrit from DHF patients obtained in the emergency room was higher than that from DF, independently of the other relevant variables (difference: 3.65; 95% CI: 2.81-4.49). CONCLUSION: Under the study conditions, there was an association between early clinical findings and DHF. These results must be evaluated in a cohort study.","['Diaz-Quijano, Fredi Alexander', 'Martinez-Vega, Ruth Arali', 'Villar-Centeno, Luis Angel']","['Diaz-Quijano FA', 'Martinez-Vega RA', 'Villar-Centeno LA']",,"['Centro de Investigaciones Epidemiologicas, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia. fre_diazq@yahoo.com']",['spa'],"['Comparative Study', 'Evaluation Study', 'Journal Article']",,Spain,Enferm Infecc Microbiol Clin,Enfermedades infecciosas y microbiologia clinica,9104081,,IM,"['Adolescent', 'Adult', 'Child', 'Cross-Sectional Studies', 'Dengue/*complications/diagnosis/epidemiology', 'Early Diagnosis', 'Exanthema/etiology', 'Female', '*Hematocrit', 'Hemorrhage/etiology', 'Hepatomegaly/etiology', 'Hospitalization', 'Humans', 'Male', 'Platelet Count', 'Severe Dengue/*complications/diagnosis/epidemiology', '*Severity of Illness Index', 'Vomiting/etiology']",,2005/12/06 09:00,2006/05/02 09:00,['2005/12/06 09:00'],"['2005/12/06 09:00 [pubmed]', '2006/05/02 09:00 [medline]', '2005/12/06 09:00 [entrez]']","['13080262 [pii]', '10.1157/13080262 [doi]']",ppublish,Enferm Infecc Microbiol Clin. 2005 Nov;23(9):529-32. doi: 10.1157/13080262.,9,,,,,,,,,Indicadores tempranos de gravedad en el dengue.,,,,,,,,,,,,,
28620811,NLM,MEDLINE,20180402,20180402,1432-8798 (Electronic) 0304-8608 (Linking),162,2017 Oct,"Serological, molecular and clinical correlates of dengue from a tertiary care centre in Chennai, India.",2983-2988,10.1007/s00705-017-3429-7 [doi],"Dengue disease is caused by dengue viruses 1-4 and has been ranked by the World Health Organisation (WHO) as the fastest spreading vector-borne viral disease. Dengue is often underreported and misdiagnosed due to a wide spectrum of clinical manifestations. Diagnosis of dengue is based on clinical case definitions and laboratory methods. Newer case definitions of dengue have been formulated by clinical studies in order to improve case detection. Owing to its epidemic potential, mortality and morbidity, there is a need for a rapid and accurate diagnostic assay for dengue in order to help the clinician in the early detection of cases and to prevent disease progression. A duplex real time PCR targeting the 3'UTR region for rapid and simultaneous detection of all dengue viruses serotypes (1-4) was standardized based on published literature. About 150 patients with acute undifferentiated febrile illness classified based on the 2009 WHO dengue case definition were tested using the duplex real time dengue PCR. Sequencing based PCR was performed on selected PCR positive samples for partial nucleotide sequence of the CprM gene and a phylogenetic tree was constructed. Statistical analysis was done using the MedCalc software. Out of the 126 patients classified as dengue disease positive, according to the 2009 WHO dengue case definition, 54% had ""probable dengue"", 43% had ""dengue with warning signs"" and 3% had ""severe dengue"". The performance of the duplex real time PCR was assessed among the various clinical groups of dengue and it was found that in the ""dengue with warning signs group"" PCR had a positive predictive value of 85.29% (range - 68.94% to 95.05%) when compared with dengue NS1 ELISA. The average time for PCR positivity was found to be four days from the onset of illness. The cycling threshold values obtained from real time PCR were used as a semi quantitative measure of viremia. Accordingly, there was a relatively low CT value among the ""warning signs dengue group"" when compared to the ""probable dengue group"". The use of the duplex PCR is suggested in the early diagnosis of dengue, especially in the 'warning signs' group of patients as they showed a higher positivity rate. Also, the use of the resultant CT value as a semi-quantitative measure of viremia will assist the clinician in early diagnosis and prevention of disease development.","['Seshan, Vigna', 'Sarangan, Gopalsamy', 'Sheriff, Khaleefathullah', 'Krishnasamy, Kaveri', 'Palani, Gunasekaran', 'Srikanth, Padma']","['Seshan V', 'Sarangan G', 'Sheriff K', 'Krishnasamy K', 'Palani G', 'Srikanth P']",,"['Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, 600116, India.', 'Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, 600116, India.', 'King Institute of Preventive Medicine and Research, SIDCO Industrial Area, Guindy, Chennai, Tamil Nadu, 600032, India.', 'King Institute of Preventive Medicine and Research, SIDCO Industrial Area, Guindy, Chennai, Tamil Nadu, 600032, India.', 'King Institute of Preventive Medicine and Research, SIDCO Industrial Area, Guindy, Chennai, Tamil Nadu, 600032, India.', 'Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, 600116, India. srikanth_padma@rediffmail.com.']",['eng'],['Journal Article'],20170616,Austria,Arch Virol,Archives of virology,7506870,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/*blood/epidemiology/*pathology', 'Female', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Middle Aged', 'Tertiary Care Centers', 'Young Adult']",,2017/06/18 06:00,2018/04/03 06:00,['2017/06/17 06:00'],"['2017/01/24 00:00 [received]', '2017/04/07 00:00 [accepted]', '2017/06/18 06:00 [pubmed]', '2018/04/03 06:00 [medline]', '2017/06/17 06:00 [entrez]']","['10.1007/s00705-017-3429-7 [pii]', '10.1007/s00705-017-3429-7 [doi]']",ppublish,Arch Virol. 2017 Oct;162(10):2983-2988. doi: 10.1007/s00705-017-3429-7. Epub 2017 Jun 16.,10,,,,,,,,,,,,,,,,,,,,,,
21946721,NLM,MEDLINE,20120119,20120627,0972-9062 (Print) 0972-9062 (Linking),48,2011 Sep,Dengue encephalopathy.,180-1,,,"['Kanade, Tarun', 'Shah, Ira']","['Kanade T', 'Shah I']",,"['Department of Pediatrics, B.J. Wadia Hospital for Children, Parel, Mumbai, India.']",['eng'],"['Case Reports', 'Journal Article']",,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['Brain/*pathology', 'Dengue/*complications/*diagnosis/pathology', 'Encephalitis, Viral/*diagnosis/*pathology', 'Humans', 'Infant', 'Male']",,2011/09/29 06:00,2012/01/20 06:00,['2011/09/28 06:00'],"['2011/09/28 06:00 [entrez]', '2011/09/29 06:00 [pubmed]', '2012/01/20 06:00 [medline]']",,ppublish,J Vector Borne Dis. 2011 Sep;48(3):180-1.,3,,,,,['J Vector Borne Dis. 2012 Mar;49(1):52; author reply 52-3. PMID: 22585248'],,,,,,,,,,,,,,,,,
5419205,NLM,MEDLINE,19700723,20211203,0044-0086 (Print) 1551-4056 (Electronic) 0044-0086 (Linking),42,1970 Apr,Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease.,293-310,,,"['Nisalak, A', 'Halstead, S B', 'Singharaj, P', 'Udomsakdi, S', 'Nye, S W', 'Vinijchaikul, K']","['Nisalak A', 'Halstead SB', 'Singharaj P', 'Udomsakdi S', 'Nye SW', 'Vinijchaikul K']",,,['eng'],['Journal Article'],,United States,Yale J Biol Med,The Yale journal of biology and medicine,0417414,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Autopsy', 'Child', 'Child, Preschool', 'Complement Fixation Tests', 'Culture Techniques', 'Dengue/epidemiology/etiology/*microbiology/*mortality', 'Dengue Virus/*isolation & purification', 'Ethnicity', 'Female', 'Hemagglutination Inhibition Tests', 'Hemorrhagic Disorders/mortality', 'Humans', 'Infant', 'Kidney', 'Male', 'Middle Aged', 'Neutralization Tests', 'Sex Factors', 'Thailand']",PMC2591707,1970/04/01 00:00,1970/04/01 00:01,['1970/04/01 00:00'],"['1970/04/01 00:00 [pubmed]', '1970/04/01 00:01 [medline]', '1970/04/01 00:00 [entrez]']",,ppublish,Yale J Biol Med. 1970 Apr;42(5):293-310.,5,,,,,,,,,,,,,,,,,,,,,,
18337325,NLM,MEDLINE,20080430,20131121,0002-9637 (Print) 0002-9637 (Linking),78,2008 Mar,Dengue and dengue hemorrhagic fever in northern Mexico and south Texas: do they really respect the border?,361-2,,,"['Clark, Gary G']",['Clark GG'],,,['eng'],['Editorial'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Dengue/*epidemiology/transmission', 'Dengue Virus/classification', 'Disease Outbreaks', 'Humans', 'Mexico/epidemiology', 'Severe Dengue/*epidemiology/transmission', 'Texas/epidemiology']",,2008/03/14 09:00,2008/05/01 09:00,['2008/03/14 09:00'],"['2008/03/14 09:00 [pubmed]', '2008/05/01 09:00 [medline]', '2008/03/14 09:00 [entrez]']",['78/3/361 [pii]'],ppublish,Am J Trop Med Hyg. 2008 Mar;78(3):361-2.,3,,,,,,,,,,,,,,,,,,,,,,
19400025,NLM,MEDLINE,20090429,20090428,1481-8531 (Electronic) 1188-4169 (Linking),35,2009 Apr,Statement on dengue. An Advisory Committee Statement (ACS).,1-12,,,,,,,"['eng', 'fre']",['Journal Article'],,Canada,Can Commun Dis Rep,Canada communicable disease report = Releve des maladies transmissibles au Canada,9303729,,IM,"['Canada/ethnology', 'Dengue/epidemiology/*prevention & control', 'Humans', '*Travel']",,2009/04/30 09:00,2009/04/30 09:01,['2009/04/30 09:00'],"['2009/04/30 09:00 [entrez]', '2009/04/30 09:00 [pubmed]', '2009/04/30 09:01 [medline]']",,ppublish,Can Commun Dis Rep. 2009 Apr;35(ACS-2):1-12.,ACS-2,,,,,,,,,,,,,,,,,['Committee to Advise on Tropical Medicine and Travel (CATMAT)'],"['Plourde, P J', 'Beallor, C', 'Henteleff, A', 'Houston, S', 'Kuhn, S', 'McCarthy, A', 'McClean, K L']","['Plourde PJ', 'Beallor C', 'Henteleff A', 'Houston S', 'Kuhn S', 'McCarthy A', 'McClean KL']",,,
35854098,NLM,MEDLINE,20220822,20221006,0973-7693 (Electronic) 0019-5456 (Print) 0019-5456 (Linking),89,2022 Sep,COVID-19 Antibody Status and Its Impact on the Severity of Dengue Fever among Children: An Observational Study.,944,10.1007/s12098-022-04266-1 [doi],,"['Thangamani, Niveditha', 'Velmurugan, Lakshmi Shanmugavel', 'Varadarajan, Poovazhagi', 'Shanmugam, Selvakumar', 'Ravindran, Aishvarya']","['Thangamani N', 'Velmurugan LS', 'Varadarajan P', 'Shanmugam S', 'Ravindran A']",['ORCID: 0000-0001-9096-9744'],"['Department of Pediatric Medicine, Institute of Child Health and Hospital for Children, Egmore, Chennai, Tamil Nadu, 600008, India. niviniraj@gmail.com.', 'Department of Pediatric Medicine, Institute of Child Health and Hospital for Children, Egmore, Chennai, Tamil Nadu, 600008, India.', 'Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Chennai, Tamil Nadu, India.', 'Department of Pediatric Medicine, Institute of Child Health and Hospital for Children, Egmore, Chennai, Tamil Nadu, 600008, India.', 'Department of Pediatric Medicine, Institute of Child Health and Hospital for Children, Egmore, Chennai, Tamil Nadu, 600008, India.']",['eng'],"['Letter', 'Observational Study']",20220720,India,Indian J Pediatr,Indian journal of pediatrics,0417442,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral', '*COVID-19', 'Child', '*Dengue/diagnosis/epidemiology', 'Humans']",PMC9296363,2022/07/20 06:00,2022/08/23 06:00,['2022/07/19 23:31'],"['2022/02/23 00:00 [received]', '2022/04/29 00:00 [accepted]', '2022/04/19 00:00 [revised]', '2022/07/20 06:00 [pubmed]', '2022/08/23 06:00 [medline]', '2022/07/19 23:31 [entrez]']","['10.1007/s12098-022-04266-1 [pii]', '4266 [pii]', '10.1007/s12098-022-04266-1 [doi]']",ppublish,Indian J Pediatr. 2022 Sep;89(9):944. doi: 10.1007/s12098-022-04266-1. Epub 2022 Jul 20.,9,,,,['None.'],,,,,,,,,,,,,,,,,,
32687019,NLM,MEDLINE,20210618,20220126,1080-6059 (Electronic) 1080-6040 (Print) 1080-6040 (Linking),26,2020 Aug,Association of Dengue Virus and Leptospira Co-Infections with Malaria Severity.,1645-1653,10.3201/eid2608.191214 [doi],"Plasmodium infections are co-endemic with infections caused by other agents of acute febrile illnesses, such as dengue virus (DENV), chikungunya virus, Leptospira spp., and Orientia tsutsugamushi. However, co-infections may influence disease severity, treatment outcomes, and development of drug resistance. When we analyzed cases of acute febrile illness at the All India Institute of Medical Sciences, New Delhi, India, from July 2017 through September 2018, we found that most patients with malaria harbored co-infections (Plasmodium mixed species and other pathogens). DENV was the most common malaria co-infection (44% of total infections). DENV serotype 4 was associated with mild malaria, and Leptospira was associated with severe malaria. We also found the presence of P. knowlesi in our study population. Therefore, in areas with a large number of severe malaria cases, diagnostic screening for all 4 DENV serotypes, Leptospira, and all Plasmodium species should be performed.","['Mandage, Rajendra', 'Kaur, Charandeep', 'Pramanik, Atreyi', 'Kumar, Vinod', 'Kodan, Parul', 'Singh, Adarsh', 'Saha, Sounak', 'Pandey, Shivam', 'Wig, Naveet', 'Pandey, Ravindra Mohan', 'Soneja, Manish', 'Acharya, Pragyan']","['Mandage R', 'Kaur C', 'Pramanik A', 'Kumar V', 'Kodan P', 'Singh A', 'Saha S', 'Pandey S', 'Wig N', 'Pandey RM', 'Soneja M', 'Acharya P']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,Emerg Infect Dis,Emerging infectious diseases,9508155,,IM,"['*Coinfection/epidemiology', '*Dengue/complications/diagnosis/epidemiology', '*Dengue Virus', 'Humans', 'India', '*Leptospira', '*Malaria/complications/diagnosis/epidemiology']",PMC7392441,2020/07/21 06:00,2021/06/22 06:00,['2020/07/21 06:00'],"['2020/07/21 06:00 [entrez]', '2020/07/21 06:00 [pubmed]', '2021/06/22 06:00 [medline]']","['19-1214 [pii]', '10.3201/eid2608.191214 [doi]']",ppublish,Emerg Infect Dis. 2020 Aug;26(8):1645-1653. doi: 10.3201/eid2608.191214.,8,,['NOTNLM'],"['Leptospira', 'Orientia tsutsugamushi', 'acute febrile illness', 'bacteria', 'co-infection', 'dengue', 'malaria', 'microbiology', 'mild malaria', 'parasites', 'parasitology', 'plasmodium', 'scrub typhus', 'severe malaria', 'viruses']",,,,,,,,,,,,,,,,,,,
8271979,NLM,MEDLINE,19940202,20041117,0025-729X (Print) 0025-729X (Linking),160,1994 Jan 3,Diseases caused by arboviruses--dengue haemorrhagic fever and Japanese B encephalitis.,22-6,,"Dengue haemorrhagic fever is a recent and more serious variant of dengue infection, causing significant mortality in children under 14 years of age in South-East Asia and the Western Pacific regions. Successful treatment depends on early recognition of the disease and careful monitoring of the development of shock. Japanese B encephalitis has a case fatality rate of 10%-30% in these regions, but may be controlled by vaccination.","['Thisyakorn, U', 'Thisyakorn, C']","['Thisyakorn U', 'Thisyakorn C']",,"['Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.']",['eng'],['Journal Article'],,Australia,Med J Aust,The Medical journal of Australia,0400714,,IM,"['Capillary Permeability', 'Child', '*Dengue/diagnosis/physiopathology/therapy', '*Encephalitis, Japanese/diagnosis/therapy', 'Humans', 'Prognosis']",,1994/01/03 00:00,1994/01/03 00:01,['1994/01/03 00:00'],"['1994/01/03 00:00 [pubmed]', '1994/01/03 00:01 [medline]', '1994/01/03 00:00 [entrez]']",,ppublish,Med J Aust. 1994 Jan 3;160(1):22-6.,1,,,,,,,,,,,,,,,,,,,,,,
23948177,NLM,MEDLINE,20131115,20220408,1474-4465 (Electronic) 1474-4422 (Linking),12,2013 Sep,Neurological complications of dengue virus infection.,906-919,S1474-4422(13)70150-9 [pii] 10.1016/S1474-4422(13)70150-9 [doi],"Dengue is the second most common mosquito-borne disease affecting human beings. In 2009, WHO endorsed new guidelines that, for the first time, consider neurological manifestations in the clinical case classification for severe dengue. Dengue can manifest with a wide range of neurological features, which have been noted--depending on the clinical setting--in 0.5-21% of patients with dengue admitted to hospital. Furthermore, dengue was identified in 4-47% of admissions with encephalitis-like illness in endemic areas. Neurological complications can be categorised into dengue encephalopathy (eg, caused by hepatic failure or metabolic disorders), encephalitis (caused by direct virus invasion), neuromuscular complications (eg, Guillain-Barre syndrome or transient muscle dysfunctions), and neuro-ophthalmic involvement. However, overlap of these categories is possible. In endemic countries and after travel to these regions, dengue should be considered in patients presenting with fever and acute neurological manifestations.","['Carod-Artal, Francisco Javier', 'Wichmann, Ole', 'Farrar, Jeremy', 'Gascon, Joaquim']","['Carod-Artal FJ', 'Wichmann O', 'Farrar J', 'Gascon J']",,"['Neurology Department, Raigmore Hospital, Inverness, UK; Medicine and Health Sciences Faculty, Universitat Internacional de Catalunya (UIC), Barcelona, Spain. Electronic address: javier.carodartal@nhs.net.', 'Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.', 'Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Centre for Tropical Medicine, Oxford University, Ho Chi Minh City, Vietnam; Department of Medicine, National University of Singapore, Singapore.', 'Barcelona Center for International Health Research (CRESIB), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Lancet Neurol,The Lancet. Neurology,101139309,,IM,"['Dengue/*complications/diagnosis/*virology', 'Encephalitis, Viral/diagnosis/etiology', 'Humans', 'Nervous System Diseases/diagnosis/*etiology/*virology']",,2013/08/21 06:00,2013/11/16 06:00,['2013/08/17 06:00'],"['2013/08/17 06:00 [entrez]', '2013/08/21 06:00 [pubmed]', '2013/11/16 06:00 [medline]']","['S1474-4422(13)70150-9 [pii]', '10.1016/S1474-4422(13)70150-9 [doi]']",ppublish,Lancet Neurol. 2013 Sep;12(9):906-919. doi: 10.1016/S1474-4422(13)70150-9.,9,['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],,,,['Arq Neuropsiquiatr. 2014 Mar;72(3):263. PMID: 24676453'],"['089276/WT_/Wellcome Trust/United Kingdom', 'MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,,,,,,,
35081857,NLM,MEDLINE,20220414,20220606,2374-4243 (Electronic) 2374-4243 (Linking),54,2022 Jun,Using first-contact serum ferritin to predict severe thrombocytopenia in dengue patients: determination and validation in independent cohorts.,425-430,10.1080/23744235.2022.2032823 [doi],"BACKGROUND: Severe thrombocytopenia and associated haemorrhage are dreaded complications of dengue fever. The identification of a biomarker that can predict, or rule out, its subsequent development can help identify at-risk individuals. METHODS: 200 dengue patients were included - the first 100 in the deterministic cohort and the latter, the validation cohort. Serum ferritin levels were measured at first presentation. Platelets were monitored serially. Data from the first cohort was used to determine the optimal ferritin level to predict significant thrombocytopenia (<20,000/microL). This threshold was validated in the second cohort. RESULTS: In the deterministic cohort, a ferritin threshold of 593 ng/mL predicted severe thrombocytopenia with a sensitivity of 93.33%, negative predictive value of 98.18% and negative likelihood ratio (LR-) of 0.10. In the validation cohort, the sensitivity and negative predictive value of this threshold were both 100%. The power of the study (determined post-hoc) for each cohort was 98.4% and 86.4% respectively. CONCLUSION: First-contact ferritin consistently identified at-risk individuals. Individuals with ferritin levels below 593 ng/mL were unlikely to develop severe thrombocytopenia independent of clinical presentation.","['Lodha, Abhijit', 'Pillai, Ashwin', 'Reddy, Pavan', 'Munshi, Nita']","['Lodha A', 'Pillai A', 'Reddy P', 'Munshi N']",['ORCID: 0000-0003-0543-2235'],"['Department of Medicine, Ruby Hall Clinic, Pune, India.', 'Department of Medicine, Ruby Hall Clinic, Pune, India.', 'Department of Medicine, Ruby Hall Clinic, Pune, India.', 'Department of Pathology, Ruby Hall Clinic, Pune, India.']",['eng'],['Journal Article'],20220126,England,Infect Dis (Lond),"Infectious diseases (London, England)",101650235,"['0 (Biomarkers)', '9007-73-2 (Ferritins)']",IM,"['Biomarkers', 'Cohort Studies', '*Dengue/complications/diagnosis', 'Ferritins', 'Humans', '*Thrombocytopenia']",,2022/01/28 06:00,2022/04/15 06:00,['2022/01/27 05:35'],"['2022/01/28 06:00 [pubmed]', '2022/04/15 06:00 [medline]', '2022/01/27 05:35 [entrez]']",['10.1080/23744235.2022.2032823 [doi]'],ppublish,Infect Dis (Lond). 2022 Jun;54(6):425-430. doi: 10.1080/23744235.2022.2032823. Epub 2022 Jan 26.,6,,['NOTNLM'],"['Dengue', 'ferritin', 'thrombocytopenia', 'triage']",,,,,,,,,,,,,,,,,,,
32179138,NLM,MEDLINE,20200624,20200624,1878-3511 (Electronic) 1201-9712 (Linking),94,2020 May,Cost-effectiveness of community mobilization (Camino Verde) for dengue prevention in Nicaragua and Mexico: A cluster randomized controlled trial.,59-67,S1201-9712(20)30145-4 [pii] 10.1016/j.ijid.2020.03.026 [doi],"BACKGROUND: We assessed the cost-effectiveness of Camino Verde, a community-based mobilization strategy to prevent and control dengue and other mosquito-borne diseases. A cluster-randomized controlled trial in Managua, Nicaragua, and in three coastal regions in Guerrero, Mexico (75 intervention and 75 control clusters), Camino Verde used non-governmental community health workers, called brigadistas, to support community mobilization. This donor-funded trial demonstrated reductions of 29.5% (95% confidence interval, CI: 3.8%-55.3%) on dengue infections and 24.7% (CI: 1.8%-51.2%) on self-reported cases. METHODS: We estimated program costs through a micro-costing approach and semi-structured questionnaires. We show results as incremental cost-effectiveness ratios (ICERs) for costs per disability-adjusted life-year (DALYs) averted and conducted probabilistic sensitivity analyses. FINDINGS: The Camino Verde trial spent US$16.72 in Mexico and $7.47 in Nicaragua per person annually. We found an average of 910 (CI: 487-1 353) and 500 (CI: 250-760) dengue cases averted annually per million population in Mexico and Nicaragua, respectively, compared to control communities. The ICER in Mexico was US$29 618 (CI: 13 869-66 898) per DALY averted, or 3.0 times per capita GDP. For Nicaragua, the ICER was US$29 196 (CI: 14294-72181) per DALY averted, or 16.9 times per capita GDP. INTERPRETATION: Camino Verde, as implemented in the research context, was marginally cost-effective in Mexico, and not cost-effective in Nicaragua, from a healthcare sector perspective. Nicaragua's low per capita GDP and the use of grant-funded management personnel weakened the cost-effectiveness results. Achieving efficiencies by incorporating Camino Verde activities into existing public health programs would make Camino Verde cost-effective.","['Tschampl, Cynthia A', 'Undurraga, Eduardo A', 'Ledogar, Robert J', 'Coloma, Josefina', 'Legorreta-Soberanis, Jose', 'Paredes-Solis, Sergio', 'Arostegui, Jorge', 'Hernandez-Alvarez, Carlos', 'Harris, Eva', 'Andersson, Neil', 'Shepard, Donald S']","['Tschampl CA', 'Undurraga EA', 'Ledogar RJ', 'Coloma J', 'Legorreta-Soberanis J', 'Paredes-Solis S', 'Arostegui J', 'Hernandez-Alvarez C', 'Harris E', 'Andersson N', 'Shepard DS']",,"['Schneider Institutes for Health Policy, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.', 'Escuela de Gobierno, Pontificia Universidad Catolica de Chile, Santiago, RM, Chile.', 'CIET International, New York, USA.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.', 'Centro de Investigacion de Enfermedades Tropicales (CIET), Universidad Autonoma de Guerrero, Acapulco, Mexico.', 'Centro de Investigacion de Enfermedades Tropicales (CIET), Universidad Autonoma de Guerrero, Acapulco, Mexico.', 'CIET, Nicaragua.', 'CIET, Nicaragua.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.', 'Centro de Investigacion de Enfermedades Tropicales (CIET), Universidad Autonoma de Guerrero, Acapulco, Mexico; Department of Family Medicine, McGill University, Montreal, Canada.', 'Schneider Institutes for Health Policy, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. Electronic address: shepard@brandeis.edu.']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",20200314,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,,IM,"['Aedes', 'Animals', 'Cluster Analysis', 'Community Medicine/*methods', 'Cost-Benefit Analysis', 'Dengue/economics/epidemiology/*prevention & control', 'Dengue Virus', 'Humans', 'Mexico', 'Mosquito Control', '*Mosquito Vectors', 'Nicaragua']",,2020/03/18 06:00,2020/06/25 06:00,['2020/03/18 06:00'],"['2019/12/19 00:00 [received]', '2020/03/07 00:00 [revised]', '2020/03/08 00:00 [accepted]', '2020/03/18 06:00 [pubmed]', '2020/06/25 06:00 [medline]', '2020/03/18 06:00 [entrez]']","['S1201-9712(20)30145-4 [pii]', '10.1016/j.ijid.2020.03.026 [doi]']",ppublish,Int J Infect Dis. 2020 May;94:59-67. doi: 10.1016/j.ijid.2020.03.026. Epub 2020 Mar 14.,,['Copyright (c) 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Cluster', 'Community', 'Cost', 'Cost-effectiveness', 'Dengue', 'Mexico', 'Nicaragua', 'Vector control']",,,,,,,,,,,,,,,,,,,
28011974,NLM,MEDLINE,20171204,20190816,2532-8689 (Electronic) 1124-9390 (Linking),24,2016 Dec 1,Hospital management in patients with Dengue: what challenges do we face in Latin America?,359-360,,Not available.,"['Torres-Roman, Junior Smith', 'Diaz-Velez, Cristian', 'Bazalar-Palacios, Janina', 'Helguero-Santin, Luis Miguel']","['Torres-Roman JS', 'Diaz-Velez C', 'Bazalar-Palacios J', 'Helguero-Santin LM']",,"['School of Medicine, Universidad Nacional San Luis Gonzaga, Ica, Peru; CONEVID, Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Lima, Peru.', 'Hospital Nacional Almanzor Aguinaga Asenjo, Chiclayo, Peru; Universidad San Martin de Porres - Filial Norte, Chiclayo, Peru.', 'Research Institute, Catholic University Los Angeles of Chimbote, Chimbote, Peru.', 'School of Medicine, Universidad Nacional de Piura, Piura, Peru.']",['eng'],['Journal Article'],,Italy,Infez Med,Le infezioni in medicina,9613961,"['0 (Anti-Inflammatory Agents, Non-Steroidal)']",IM,"['Aedes', 'Animals', 'Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use', 'Dengue/epidemiology/prevention & control/*therapy/*transmission', '*Fluid Therapy/methods', 'Guidelines as Topic', '*Hospitals, University', 'Humans', 'Insect Vectors', 'Latin America/epidemiology', 'Peru/epidemiology', 'Population Surveillance', 'Treatment Outcome', 'World Health Organization']",,2016/12/25 06:00,2017/12/05 06:00,['2016/12/25 06:00'],"['2016/12/25 06:00 [entrez]', '2016/12/25 06:00 [pubmed]', '2017/12/05 06:00 [medline]']",,ppublish,Infez Med. 2016 Dec 1;24(4):359-360.,4,,,,,,,,,,,,,,,,,,,,,,
26460637,NLM,MEDLINE,20151026,20171019,1474-547X (Electronic) 0140-6736 (Linking),386,2015 Sep 26,Dengue challenges India's health system.,1212,S0140-6736(15)00313-X [pii] 10.1016/S0140-6736(15)00313-X [doi],,['The Lancet'],['The Lancet'],,,['eng'],['Editorial'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Delivery of Health Care/organization & administration', 'Dengue/*epidemiology/therapy', '*Disease Outbreaks', 'Humans', 'India/epidemiology']",,2015/10/16 06:00,2015/10/27 06:00,['2015/10/14 06:00'],"['2015/10/14 06:00 [entrez]', '2015/10/16 06:00 [pubmed]', '2015/10/27 06:00 [medline]']","['S0140-6736(15)00313-X [pii]', '10.1016/S0140-6736(15)00313-X [doi]']",ppublish,Lancet. 2015 Sep 26;386(10000):1212. doi: 10.1016/S0140-6736(15)00313-X.,10000,,,,,,,,,,,,,,,,,,,,,,
24702301,NLM,MEDLINE,20141203,20140411,1744-8395 (Electronic) 1476-0584 (Linking),13,2014 May,Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop.,581-7,10.1586/14760584.2014.907529 [doi],"The independent, scientific and educational The Association of South East Asian Nations (ASEAN) Member States Dengue Vaccination Advocacy Steering Committee (ADVASC) was established in 2011 to address the practical challenges faced by ASEAN countries as they prepare for the eventual introduction of a dengue vaccine. ADVASC convened a workshop in September 2012 that drew together public health representatives and dengue experts from seven ASEAN countries in order to make practical recommendations to improve current surveillance and diagnostics for dengue to enable countries to assess consistently, and accurately communicate, the impact of a dengue vaccine. The workshop compared surveillance and diagnostic capacity in these ASEAN countries and made recommendations to streamline and harmonize key elements of these systems. In particular, attendees recommended the need for reconciliation and harmonization of the different World Health Organization guidelines, in use in ASEAN countries for case definition and surveillance of dengue.","['Thisyakorn, Usa', 'Capeding, Maria R', 'Goh, Daniel Yam Thiam', 'Hadinegoro, Sri Rezeki', 'Ismail, Zulkifli', 'Tantawichien, Terapong', 'Yoksan, Sutee', 'Pang, Tikki']","['Thisyakorn U', 'Capeding MR', 'Goh DY', 'Hadinegoro SR', 'Ismail Z', 'Tantawichien T', 'Yoksan S', 'Pang T']",,"['Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20140404,England,Expert Rev Vaccines,Expert review of vaccines,101155475,['0 (Dengue Vaccines)'],IM,"['Asia, Southeastern/epidemiology', 'Dengue/*epidemiology/*prevention & control', 'Dengue Vaccines/*therapeutic use', 'Education/*trends', '*Health Planning Guidelines', 'Humans']",,2014/04/08 06:00,2014/12/15 06:00,['2014/04/08 06:00'],"['2014/04/08 06:00 [entrez]', '2014/04/08 06:00 [pubmed]', '2014/12/15 06:00 [medline]']",['10.1586/14760584.2014.907529 [doi]'],ppublish,Expert Rev Vaccines. 2014 May;13(5):581-7. doi: 10.1586/14760584.2014.907529. Epub 2014 Apr 4.,5,,,,,,,,,,,,,,,,,,,,,,
15962658,NLM,MEDLINE,20050718,20051116,0125-2208 (Print) 0125-2208 (Linking),88,2005 Mar,Concomitant dengue infection and Kawasaki disease in an infant: a case report and literature review.,436-9,,"A previously healthy 11-month-old girl presented with fever and rash for 6 days. Physical examination revealed an irritable infant with a high fever, injected conjunctivae, red cracked lips, posterior auricular lymphadenopathy, hepatomegaly, generalized erythematous maculopapular rash and petechial hemorrhage on trunk, face and extremities. Complete blood count showed atypical lymphocytosis and thrombocytopenia. Dengue infection was initially diagnosed. The persistent fever and clinical manifestations of Kawasaki disease (KD) were observed on day 8 with high erythrocyte sedimentation rate (56 mm/hr). Treatment of KD included intravenous immunoglobulin on day 9 of the illness. Desquamation of the fingers was found on day 15 of the illness. Ectasia of left coronary artery with small aneurysmal dilatation was detected by echocardiography on day 15 of the illness. Hemagglutination-inhibition test and enzyme-linked immunosorbent assay for dengue virus eventually showed a four-fold rising. According to the literature review, this is the second reported case of dengue infection concomitant with KD. The natural course of each disease may be modified and causes some difficulties in diagnosis and management.","['Mekmullica, Jutarat', 'Pancharoen, Chitsanu', 'Deerojanawong, Jitladda', 'Lertsapcharoen, Pornthep', 'Thisyakorn, Usa', 'Thisyakorn, Chule']","['Mekmullica J', 'Pancharoen C', 'Deerojanawong J', 'Lertsapcharoen P', 'Thisyakorn U', 'Thisyakorn C']",,"['Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Rama IV Rd, Bangkok 10330, Thailand.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",,Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Dengue/*complications/diagnosis', 'Female', 'Humans', 'Infant', 'Mucocutaneous Lymph Node Syndrome/*complications']",,2005/06/21 09:00,2005/07/19 09:00,['2005/06/21 09:00'],"['2005/06/21 09:00 [pubmed]', '2005/07/19 09:00 [medline]', '2005/06/21 09:00 [entrez]']",,ppublish,J Med Assoc Thai. 2005 Mar;88(3):436-9.,3,,,,,,,17,,,,,,,,,,,,,,,
26119675,NLM,MEDLINE,20160408,20150629,2081-3252 (Electronic) 1641-9251 (Linking),66,2015,Different serotypes of dengue virus (DENV) imported by Polish travellers from dengue endemic areas to Poland.,72-6,10.5603/IMH.2015.0018 [doi],"BACKGROUND: Dengue viruses are the most widespread arboviruses (transmitted mainly by Aedes aegypti and Ae. albopictus mosquitoes), which have shown an unexpected geographic expansion. There are four dengue virus serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Subsequent infections increase the risk of developing severe dengue fever. MATERIALS AND METHODS: Samples from travellers returning from the endemic area of dengue fever were examined with the reverse transcription-polymerase chain reaction method. Primers amplified 743 bp fragment of the NS5 and 3'UTR genomic region of mosquito-borne flaviviruses of JEV group were used. RESULTS: The sequences from the 10 examined patients were compared to available DENV sequences in GenBank database and the basic local alignment search tool (BLAST) results confirmed that the infective virus was DENV-1 (6 patients), DENV-2 (2 patients) and DENV-3 (2 patients). CONCLUSIONS: For the first time in Poland, dengue virus serotypes were determined in travellers returning from dengue-endemic areas.","['Biernat, Beata', 'Stanczak, Joanna', 'Szostakowska, Beata', 'Wroczynska, Agnieszka', 'Kuna, Anna', 'Nahorski, Waclaw L', 'Racewicz, Maria']","['Biernat B', 'Stanczak J', 'Szostakowska B', 'Wroczynska A', 'Kuna A', 'Nahorski WL', 'Racewicz M']",,"['Department of Tropical Parasitology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Poland. bebe@gumed.edu.pl.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Poland,Int Marit Health,International maritime health,100958373,,IM,"['Dengue/epidemiology/*transmission/virology', '*Dengue Virus/genetics', 'Humans', 'Poland/epidemiology', 'Retrospective Studies', 'Sequence Alignment', 'Serogroup', '*Travel']",,2015/06/30 06:00,2016/04/09 06:00,['2015/06/30 06:00'],"['2015/06/17 00:00 [received]', '2015/06/17 00:00 [accepted]', '2015/06/30 06:00 [entrez]', '2015/06/30 06:00 [pubmed]', '2016/04/09 06:00 [medline]']","['VM/OJS/J/42435 [pii]', '10.5603/IMH.2015.0018 [doi]']",ppublish,Int Marit Health. 2015;66(2):72-6. doi: 10.5603/IMH.2015.0018.,2,,,,,,,,,,,,,,,,,,,,,,
24053394,NLM,MEDLINE,20140402,20220321,1744-8395 (Electronic) 1476-0584 (Linking),12,2013 Sep,"Challenges in reducing dengue burden; diagnostics, control measures and vaccines.",995-1010,10.1586/14760584.2013.824712 [doi],"Dengue is a major public health concern worldwide, with the number of infections increasing globally. The illness imposes the greatest economic and human burden on developing countries that have limited resources to deal with the scale of the problem. No cure for dengue exists; treatment is limited to rehydration therapy, and with vector control strategies proving to be relatively ineffective, a vaccine is an urgent priority. Despite the numerous challenges encountered in the development of a dengue vaccine, several vaccine candidates have shown promise in clinical development and it is believed that a vaccination program would be at least as cost-effective as current vector control programs. The lead candidate vaccine is a tetravalent, live attenuated, recombinant vaccine, which is currently in Phase III clinical trials. Vaccine introduction is a complex process that requires consideration and is discussed here. This review discusses the epidemiology, burden and pathogenesis of dengue, as well as the vaccine candidates currently in clinical development.","['Lam, Sai Kit']",['Lam SK'],,"['Office of the Vice-Chancellor, University of Malaya, Jalan Pantai Baru, 50603, Kuala Lumpur, Malaysia +60 17 8800044 +60 37 7259635 sklam@nipahvirus.org.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,England,Expert Rev Vaccines,Expert review of vaccines,101155475,['0 (Dengue Vaccines)'],IM,"['Clinical Trials as Topic', 'Dengue/diagnosis/*epidemiology/*prevention & control', 'Dengue Vaccines/*administration & dosage/*immunology', 'Drug Discovery/trends', 'Humans', 'Mosquito Control/*methods']",,2013/09/24 06:00,2014/04/03 06:00,['2013/09/24 06:00'],"['2013/09/24 06:00 [entrez]', '2013/09/24 06:00 [pubmed]', '2014/04/03 06:00 [medline]']",['10.1586/14760584.2013.824712 [doi]'],ppublish,Expert Rev Vaccines. 2013 Sep;12(9):995-1010. doi: 10.1586/14760584.2013.824712.,9,,,,,,,,,,,,,,,,,,,,,,
2449549,NLM,MEDLINE,19880407,20161017,0098-7484 (Print) 0098-7484 (Linking),259,1988 Mar 25,"Leads from the MMWR. Dengue and dengue hemorrhagic fever in the Americas, 1986.",1781-2,,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Aedes', 'Americas', 'Animals', 'Child', 'Dengue/*epidemiology/transmission', '*Disease Outbreaks', 'Humans']",,1988/03/25 00:00,1988/03/25 00:01,['1988/03/25 00:00'],"['1988/03/25 00:00 [pubmed]', '1988/03/25 00:01 [medline]', '1988/03/25 00:00 [entrez]']",,ppublish,JAMA. 1988 Mar 25;259(12):1781-2.,12,,,,,,,,,,,,,,,,,,,,,,
11374134,NLM,MEDLINE,20010614,20061115,0025-7680 (Print) 0025-7680 (Linking),61,2001,[Dengue imported from Paraguay to Buenos Aires. Clinical and epidemiological report of 38 cases].,137-41,,"Thirty eight patients with classic dengue fever, were studied from December 1999 up to April 2000. All of them acquired the infection in Paraguay; 66% of patients arrived at Buenos Aires metropolitan area within the viremia period. Given Aedes aegypti abundance in the region they represent a high risk for local transmission. Unusual clinical findings in these patients were diarrhea (29%), transitory rise of seric aspartate aminotransferase (52%) and pruritic rash in all cases. Only 15.7% showed a biphasic course and none of the five patients with hemorrhages had a positive loop test. These observations show that dengue fever could be misdiagnosed as gastroenteritis or flue-like illness. These patients remain at risk of suffering hemorrhagic dengue. DEN 1 has not been reported in Buenos Aires. This fact and the unusual number of imported cases, represent a serious public health problem.","['Seijo, A', 'Cernigoi, B', 'Deodato, B']","['Seijo A', 'Cernigoi B', 'Deodato B']",,"['Servicio de Zoonosis, Hospital de Enfermedades infecciosas Francisco J Muniz, Buenos Aires. acseijo@infovia.com.ar']",['spa'],"['English Abstract', 'Journal Article']",,Argentina,Medicina (B Aires),Medicina,0204271,,IM,"['Adolescent', 'Adult', 'Aedes', 'Aged', 'Animals', 'Argentina/epidemiology', 'Child', 'Dengue/diagnosis/*epidemiology/transmission', 'Disease Outbreaks', 'Female', 'Humans', 'Male', 'Middle Aged', 'Paraguay/epidemiology']",,2001/05/26 10:00,2001/06/23 10:01,['2001/05/26 10:00'],"['2001/05/26 10:00 [pubmed]', '2001/06/23 10:01 [medline]', '2001/05/26 10:00 [entrez]']",,ppublish,Medicina (B Aires). 2001;61(2):137-41.,2,,,,,,,,,Dengue importado del Paraguay a Buenos Aires. Estudio clinico y epidemiologico de 38 casos.,,,,,,,,,,,,,
29608873,NLM,MEDLINE,20180927,20181004,1873-6254 (Electronic) 0001-706X (Linking),183,2018 Jul,Spatiotemporal responses of dengue fever transmission to the road network in an urban area.,8-13,S0001-706X(17)31129-4 [pii] 10.1016/j.actatropica.2018.03.026 [doi],"Urbanization is one of the important factors leading to the spread of dengue fever. Recently, some studies found that the road network as an urbanization factor affects the distribution and spread of dengue epidemic, but the study of relationship between the distribution of dengue epidemic and road network is limited, especially in highly urbanized areas. This study explores the temporal and spatial spread characteristics of dengue fever in the distribution of road network by observing a dengue epidemic in the southern Chinese cities. Geographic information technology is used to extract the spatial location of cases and explore the temporal and spatial changes of dengue epidemic and its spatial relationship with road network. The results showed that there was a significant ""severe"" period in the temporal change of dengue epidemic situation, and the cases were mainly concentrated in the vicinity of narrow roads, the spread of the epidemic mainly along the high-density road network area. These results show that high-density road network is an important factor to the direction and scale of dengue epidemic. This information may be helpful to the development of related epidemic prevention and control strategies.","['Li, Qiaoxuan', 'Cao, Wei', 'Ren, Hongyan', 'Ji, Zhonglin', 'Jiang, Huixian']","['Li Q', 'Cao W', 'Ren H', 'Ji Z', 'Jiang H']",,"['State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China; School of Geographical Sciences, Fujian Normal University, Fuzhou 350007, China. Electronic address: liqx@lreis.ac.cn.', 'State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: caowei@igsnrr.ac.cn.', 'State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: renhy@igsnrr.ac.cn.', 'State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China; School of Geographical Sciences, Fujian Normal University, Fuzhou 350007, China. Electronic address: jizl@lreis.ac.cn.', 'School of Geographical Sciences, Fujian Normal University, Fuzhou 350007, China. Electronic address: jhx155@163.com.']",['eng'],['Journal Article'],20180330,Netherlands,Acta Trop,Acta tropica,0370374,,IM,"['China/epidemiology', 'City Planning', 'Dengue/*epidemiology/prevention & control/*transmission', 'Disease Outbreaks/prevention & control/*statistics & numerical data', 'Geography', 'Humans', 'Information Technology', '*Spatio-Temporal Analysis', 'Transportation/*statistics & numerical data', '*Urbanization']",,2018/04/03 06:00,2018/09/28 06:00,['2018/04/03 06:00'],"['2017/09/21 00:00 [received]', '2018/03/27 00:00 [revised]', '2018/03/29 00:00 [accepted]', '2018/04/03 06:00 [pubmed]', '2018/09/28 06:00 [medline]', '2018/04/03 06:00 [entrez]']","['S0001-706X(17)31129-4 [pii]', '10.1016/j.actatropica.2018.03.026 [doi]']",ppublish,Acta Trop. 2018 Jul;183:8-13. doi: 10.1016/j.actatropica.2018.03.026. Epub 2018 Mar 30.,,['Copyright (c) 2018. Published by Elsevier B.V.'],['NOTNLM'],"['Dengue', 'Foshan', 'Guangzhou', 'Road networks']",,,,,,,,,,,,,,,,,,,
35210652,NLM,MEDLINE,20220228,20220716,1815-672X (Electronic) 0028-2715 (Print) 0028-2715 (Linking),60,2022 Feb 15,Seropositivity among Blood Samples Drawn from Suspected Dengue Cases at a Tertiary Care Centre of Nepal: A Descriptive Cross-sectional Study.,155-159,10.31729/jnma.5253 [doi],"INTRODUCTION: The cases of dengue fever have been reported more frequently in Nepal these days. The aim of this study was to find the prevalence of seropositivity among blood samples drawn from suspected dengue cases at a tertiary care centre of Nepal. METHODS: A descriptive cross-sectional study was conducted at a tertiary care hospital from 1st June 2017 to 31st October 2018 after getting approval from the Institutional Review Committee (Reference number: 23/2016). A total of 537 suspected dengue patients were selected for the study using convenience sampling. These dengue positive sera were assayed for their reactivity with Immunoglobulin M and Immunoglobulin G present in sera and synthetic peptides of dengue virus by enzyme linked immunosorbent assay. Data was entered and analysed in Microsoft Excel 2016. Point estimate at 95% Confidence Interval was calculated along with frequency, percentage, mean and standard deviation. RESULTS: Among 537 suspected dengue cases, the seropositivity for dengue was found in 124 (23.09%) (19.52-26.65 at 95% Confidence Interval) of the serum. CONCLUSIONS: The present study revealed that dengue was more prevalent in our setting compared to similar studies. All the synthetic peptides showed reactivity with dengue-positive sera with maximum reactivity shown by RR2 peptide. In dengue-positive sera, RR2 peptide of dengue virus identified more Immunoglobulin M than Immunoglobulin G.","['Shreewastav, Rupesh Kumar', 'Thakur, Manoj Kumar', 'Singh, Arambam Giridhari']","['Shreewastav RK', 'Thakur MK', 'Singh AG']",,"['Department of Biochemistry, Nobel Medical College Teaching Hospital, Biratnagar, Morang, Nepal.', 'Department of Medicine, Nobel Medical College Teaching Hospital, Biratnagar, Morang, Nepal.', 'Department of Biochemistry, Nobel Medical College Teaching Hospital, Biratnagar, Morang, Nepal.']",['eng'],['Journal Article'],20220215,Nepal,JNMA J Nepal Med Assoc,JNMA; journal of the Nepal Medical Association,0045233,['0 (Immunoglobulin M)'],IM,"['Cross-Sectional Studies', '*Dengue/diagnosis/epidemiology', 'Humans', 'Immunoglobulin M', 'Nepal/epidemiology', 'Tertiary Care Centers']",PMC9200015,2022/02/26 06:00,2022/03/01 06:00,['2022/02/25 05:36'],"['2020/08/05 00:00 [received]', '2022/02/25 05:36 [entrez]', '2022/02/26 06:00 [pubmed]', '2022/03/01 06:00 [medline]']",['10.31729/jnma.5253 [doi]'],epublish,JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):155-159. doi: 10.31729/jnma.5253.,246,,['NOTNLM'],['dengue; IgG; IgM; tertiary care.'],['None.'],,,,,,,,,,,,,,,,,,
7996638,NLM,MEDLINE,19950118,20161017,0098-7484 (Print) 0098-7484 (Linking),273,1995 Jan 4,"From the Centers for Disease Control and Prevention. Dengue fever among U.S. military personnel--Haiti, September-November, 1994.",14-5,,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Dengue/diagnosis/*epidemiology', 'Haiti/epidemiology', 'Humans', '*Military Personnel', 'Serologic Tests', 'United States']",,1995/01/04 00:00,1995/01/04 00:01,['1995/01/04 00:00'],"['1995/01/04 00:00 [pubmed]', '1995/01/04 00:01 [medline]', '1995/01/04 00:00 [entrez]']",,ppublish,JAMA. 1995 Jan 4;273(1):14-5.,1,,,,,,,,,,,,,,,,,,,,,,
31909593,NLM,MEDLINE,20201224,20201224,1520-6882 (Electronic) 0003-2700 (Linking),92,2020 Feb 4,SERS Platform for Dengue Diagnosis from Clinical Samples Employing a Hand Held Raman Spectrometer.,2527-2534,10.1021/acs.analchem.9b04129 [doi],"Dengue is a serious global health concern especially in tropical and subtropical countries. About 2.5 billion of the world's population is at risk for dengue infection. Early diagnosis is the key to prevent the deterioration of health of the patient to severe illness. Laboratory diagnosis of dengue is essential for providing appropriate supportive treatment to dengue patients with febrile illness, which is difficult to diagnose clinically. Here, we demonstrate surface enhanced Raman scattering (SERS) based diagnosis of dengue virus in clinical blood samples collected from total of 102 subjects. All of the samples were well characterized by conventional NS1 antigen and IgM antibody ELISA kits. The silver nanorods array fabricated by glancing angle deposition technique were employed as SERS substrates. A small amount of patient blood serum (5 muL) was taken for analysis and the report was prepared within a minute. SERS spectra of pure NS1 protein as well as spiked in serum was also recorded separately. Principal component analysis (PCA) was employed as the statistical tool to differentiate dengue positive, dengue negative, and healthy subjects on the basis of their respective SERS spectra. This method provides a sensitive, rapid, and field deployable diagnosis of dengue at the early stage (within 5 days of the onset of symptoms).","['Gahlaut, S K', 'Savargaonkar, D', 'Sharan, C', 'Yadav, Sarjana', 'Mishra, P', 'Singh, J P']","['Gahlaut SK', 'Savargaonkar D', 'Sharan C', 'Yadav S', 'Mishra P', 'Singh JP']","['ORCID: 0000-0002-9947-0496', 'ORCID: 0000-0001-8145-0561']","['Department of Physics , Indian Institute of Technology Delhi , Hauz Khas , New Delhi 110016 , India.', 'ICMR-National Institute of Malaria Research , Dwarka , New Delhi 110077 , India.', 'Department of Physics , Indian Institute of Technology Delhi , Hauz Khas , New Delhi 110016 , India.', 'Department of Physics , Indian Institute of Technology Delhi , Hauz Khas , New Delhi 110016 , India.', 'Department of Biochemical Engineering and Biotechnology , Indian Institute of Technology Delhi , Hauz Khas , New Delhi 110016 , India.', 'Department of Physics , Indian Institute of Technology Delhi , Hauz Khas , New Delhi 110016 , India.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20200117,United States,Anal Chem,Analytical chemistry,0370536,"['0 (NS1 protein, dengue-1 virus)', '0 (Viral Nonstructural Proteins)']",IM,"['Dengue/blood/*diagnosis', 'Humans', 'Spectrum Analysis, Raman', 'Viral Nonstructural Proteins/analysis']",,2020/01/08 06:00,2020/12/29 06:00,['2020/01/08 06:00'],"['2020/01/08 06:00 [pubmed]', '2020/12/29 06:00 [medline]', '2020/01/08 06:00 [entrez]']",['10.1021/acs.analchem.9b04129 [doi]'],ppublish,Anal Chem. 2020 Feb 4;92(3):2527-2534. doi: 10.1021/acs.analchem.9b04129. Epub 2020 Jan 17.,3,,,,,,,,,,,,,,,,,,,,,,
31900851,NLM,MEDLINE,20210201,20210201,0973-7693 (Electronic) 0019-5456 (Linking),87,2020 Mar,Dengue Associated Hemophagocytic Lymphohistiocytosis.,237,10.1007/s12098-019-03158-1 [doi],,"['Chaitanya, Krishna', 'Karanam, Sandeep', 'Kumar, Kiran']","['Chaitanya K', 'Karanam S', 'Kumar K']",['ORCID: 0000-0002-2936-2334'],"['Department of Pediatric Intensive Care Unit, Paramitha Childrens Hospital, Hyderabad, Telangana, India. dkrishnac7@gmail.com.', 'Department of Pediatric Intensive Care Unit, Paramitha Childrens Hospital, Hyderabad, Telangana, India.', 'Department of Pediatric Intensive Care Unit, Paramitha Childrens Hospital, Hyderabad, Telangana, India.']",['eng'],['Letter'],20200103,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/*complications/physiopathology/therapy', 'Female', 'Humans', 'India', 'Infant', 'Lymphohistiocytosis, Hemophagocytic/*complications/physiopathology/therapy', 'Male']",,2020/01/05 06:00,2021/02/02 06:00,['2020/01/05 06:00'],"['2019/09/28 00:00 [received]', '2019/12/17 00:00 [accepted]', '2020/01/05 06:00 [pubmed]', '2021/02/02 06:00 [medline]', '2020/01/05 06:00 [entrez]']","['10.1007/s12098-019-03158-1 [pii]', '10.1007/s12098-019-03158-1 [doi]']",ppublish,Indian J Pediatr. 2020 Mar;87(3):237. doi: 10.1007/s12098-019-03158-1. Epub 2020 Jan 3.,3,,,,,,,,,,,,,,,,,,,,,,
14531982,NLM,MEDLINE,20040219,20090707,1195-1982 (Print) 1195-1982 (Linking),10,2003 Sep-Oct,Imported Dengue in French University Hospitals: a 6-year survey.,286-9,,"Dengue fever (DF) is a mosquito-transmitted acute disease caused by any of four dengue flavivirus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4) which is becoming a major public health problem in intertropical areas.1 DF is increasingly observed in febrile travelers returning from tropical areas,2 especially those returning from the Caribbean islands and Southeast Asia, but it is rarely diagnosed in travelers returning from Africa.3-8 Diagnosis is often serologic, and in most cases is not confirmed; virus isolation remains exceptional. In a retrospective study of 44 cases of imported DF diagnosed in France, we found that the epidemiologic, clinical and diagnostic characteristics of these cases were similar to those reported in other previous published studies; diagnosis was carried out with serology, and no virus isolation was reported. To draw the attention of physicians from nonendemic areas to the possible occurrence of dengue infection in febrile travelers from all tropical countries, including those in Africa, and to reinforce recommendations required to establish diagnosis with certainty, we report herein a prospective study from 1998-1999 which we compiled with our previously published data.","['Badiaga, Sekene', 'Barrau, Karine', 'Brouqui, Philippe', 'Durant, Jacques', 'Malvy, Denis', 'Janbon, Francois', 'Bonnet, Eric', 'Bosseray, Annick', 'Sotto, Albert', 'Peyramont, Dominique', 'Dydymski, Serge', 'Cazorla, Celine', 'Tolou, Herve', 'Durant, Jean Paul', 'Delmont, Jean']","['Badiaga S', 'Barrau K', 'Brouqui P', 'Durant J', 'Malvy D', 'Janbon F', 'Bonnet E', 'Bosseray A', 'Sotto A', 'Peyramont D', 'Dydymski S', 'Cazorla C', 'Tolou H', 'Durant JP', 'Delmont J']",,"['Service des Maladies Infectieuses et Tropicales, Hopital Nord, Marseille, and Infectio-Sud formation et recherche, 18 avenue des Baumettes, Nice, France.']",['eng'],['Journal Article'],,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adolescent', 'Adult', 'Aged', 'Dengue/*epidemiology/*etiology/prevention & control', 'Female', 'France/epidemiology', 'Hospitals, University/statistics & numerical data', 'Humans', 'Male', 'Medical Records', 'Middle Aged', 'Retrospective Studies', '*Travel']",,2003/10/09 05:00,2004/02/20 05:00,['2003/10/09 05:00'],"['2003/10/09 05:00 [pubmed]', '2004/02/20 05:00 [medline]', '2003/10/09 05:00 [entrez]']",,ppublish,J Travel Med. 2003 Sep-Oct;10(5):286-9.,5,,,,,,,,,,,,,,,,,['Infectio-Sud Group'],,,,,
29200948,NLM,MEDLINE,20180720,20220330,1449-1907 (Electronic) 1449-1907 (Linking),14,2017,Peptides as Therapeutic Agents for Dengue Virus.,1342-1359,10.7150/ijms.21875 [doi],"Dengue is an important global threat caused by dengue virus (DENV) that records an estimated 390 million infections annually. Despite the availability of CYD-TDV as a commercial vaccine, its long-term efficacy against all four dengue virus serotypes remains unsatisfactory. There is therefore an urgent need for the development of antiviral drugs for the treatment of dengue. Peptide was once a neglected choice of medical treatment but it has lately regained interest from the pharmaceutical industry following pioneering advancements in technology. In this review, the design of peptide drugs, antiviral activities and mechanisms of peptides and peptidomimetics (modified peptides) action against dengue virus are discussed. The development of peptides as inhibitors for viral entry, replication and translation is also described, with a focus on the three main targets, namely, the host cell receptors, viral structural proteins and viral non-structural proteins. The antiviral peptides designed based on these approaches may lead to the discovery of novel anti-DENV therapeutics that can treat dengue patients.","['Chew, Miaw-Fang', 'Poh, Keat-Seong', 'Poh, Chit-Laa']","['Chew MF', 'Poh KS', 'Poh CL']",,"['Research Centre for Biomedical Sciences, Sunway University, Bandar Sunway, Selangor 47500, Malaysia.', 'Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, 50603, Malaysia.', 'Research Centre for Biomedical Sciences, Sunway University, Bandar Sunway, Selangor 47500, Malaysia.']",['eng'],"['Journal Article', 'Review']",20171015,Australia,Int J Med Sci,International journal of medical sciences,101213954,"['0 (Antiviral Agents)', '0 (CYD-TDV vaccine)', '0 (Dengue Vaccines)', '0 (Peptides)', '0 (Peptidomimetics)']",IM,"['Antiviral Agents/therapeutic use', 'Dengue/*drug therapy/epidemiology/virology', 'Dengue Vaccines/therapeutic use', 'Dengue Virus/*drug effects/pathogenicity', 'Humans', 'Peptides/*therapeutic use', 'Peptidomimetics/*therapeutic use', 'Virus Internalization/drug effects']",PMC5707751,2017/12/05 06:00,2018/07/22 06:00,['2017/12/05 06:00'],"['2017/07/12 00:00 [received]', '2017/09/01 00:00 [accepted]', '2017/12/05 06:00 [entrez]', '2017/12/05 06:00 [pubmed]', '2018/07/22 06:00 [medline]']","['ijmsv14p1342 [pii]', '10.7150/ijms.21875 [doi]']",epublish,Int J Med Sci. 2017 Oct 15;14(13):1342-1359. doi: 10.7150/ijms.21875. eCollection 2017.,13,,['NOTNLM'],"['Antiviral therapeutics.', 'Dengue virus', 'Drug discovery', 'Peptides']",['Competing Interests: The authors have declared that no competing interest exists.'],,,,,,,,,,,,,,,,,,
37054972,NLM,MEDLINE,20230619,20230619,2666-9919 (Electronic) 2666-9919 (Linking),53,2023 Jun,Hydration and clinical warning signs of dengue fever in primary care: An observational prospective study.,104708,S2666-9919(23)00070-2 [pii] 10.1016/j.idnow.2023.104708 [doi],"OBJECTIVES: Dengue fever is an arbovirosis expanding worldwide, for which hydration has been reported to reduce the risk of hospitalization. Our objective was to estimate the volume of hydration in Reunionese patients with dengue. METHODS: A prospective observational study included patients presenting with a 'dengue-like' syndrome in ambulatory care. General practitioners recruited patients during consultation, and beverage consumption over the previous 24 hours was reported at two different times. Warning signs were defined according to the 2009 WHO guidelines. RESULTS: GPs included 174 patients from April to July 2019. Average oral hydration volume was 1863 mL and 1944 mL, at the 1st and 2nd medical consultations, respectively. Water was the most wide consumed liquid. Drinking at least 5 glasses of liquid was significantly associated with fewer clinical warning signs at the 1st medical consultation (p = 0.044). CONCLUSIONS: Sufficient hydration volume could prevent dengue warning signs. Further studies with standardized measurement of hydration would be needed.","['Besnard, O', 'Maillard, O', 'Franco, J-M', 'Lebreton, N', 'Reix, G', 'Legrand, F', 'Bertolotti, A', 'Leruste, S']","['Besnard O', 'Maillard O', 'Franco JM', 'Lebreton N', 'Reix G', 'Legrand F', 'Bertolotti A', 'Leruste S']",,"[""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France."", 'INSERM, CIC1410, CHU de La Reunion, Saint-Pierre, France. Electronic address: olmaillard@yahoo.fr.', ""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France; INSERM, CIC1410, CHU de La Reunion, Saint-Pierre, France."", ""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France."", ""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France."", ""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France; Institut de Recherche pour le Developpement - Ceped - UMR 196, Universite de Paris, 45, rue des Saint-Peres, 75006 Paris, France."", 'INSERM, CIC1410, CHU de La Reunion, Saint-Pierre, France; CHU de La Reunion, Service de maladies infectieuses-medecine interne-dermatologie, Saint Pierre, France.', ""Universite de La Reunion - UFR Sante - Departement universitaire de medecine generale, Site de l'IES, CHU de La Reunion, Saint-Pierre, France; INSERM, CIC1410, CHU de La Reunion, Saint-Pierre, France.""]",['eng'],"['Journal Article', 'Observational Study']",20230411,France,Infect Dis Now,Infectious diseases now,101775152,,IM,"['Humans', '*Dengue/diagnosis/prevention & control', 'Prospective Studies', 'Hospitalization', 'Ambulatory Care', 'Primary Health Care']",,2023/04/14 06:00,2023/06/19 13:09,['2023/04/13 19:25'],"['2022/11/21 00:00 [received]', '2023/03/16 00:00 [revised]', '2023/04/01 00:00 [accepted]', '2023/06/19 13:09 [medline]', '2023/04/14 06:00 [pubmed]', '2023/04/13 19:25 [entrez]']","['S2666-9919(23)00070-2 [pii]', '10.1016/j.idnow.2023.104708 [doi]']",ppublish,Infect Dis Now. 2023 Jun;53(4):104708. doi: 10.1016/j.idnow.2023.104708. Epub 2023 Apr 11.,4,"['Copyright (c) 2023 The Author(s). Published by Elsevier Masson SAS.. All rights', 'reserved.']",['NOTNLM'],"['Dengue', 'Fluid therapy', 'Oral rehydration therapy', 'Primary health care']","['Declaration of Competing Interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",,,,,,,,,,,,,,,,,,
19725384,NLM,MEDLINE,20091029,20090903,0025-682X (Print) 0025-682X (Linking),69,2009 Aug,[Dengue virus infection in neotropical forest mammals: incidental hosts or potential reservoirs?].,345-50,,"The arboviral disease with the highest human incidence in South America is dengue fever. In French Guiana, where all four dengue serotypes, i.e., DENV-1, DENV-2, DENV-3 and DENV-4, are present, the disease is endemic with epidemic outbreaks. Though previous serological studies have suggested a sylvatic cycle, involvement of wild mammals in the dengue cycle in the neotropics has never been confirmed. The purpose of this study was to search for the presence of DENV in wild animals captured at two different sites between 2001 and 2007. About 10,000 trap/nights were performed leading to the capture of 464 non-flying mammals (rodents and marsupials). In addition, mistnests placed in the same zone yielded 152 bats. Reverse transcription-polymerase chain reaction amplification to detect infection by any of the four dengue serotypes demonstrated viral RNA in the livers and/or sera of 92 captured animals. Sequence analysis of amplification products revealed that the DENV-1, DENV-3 and DENV-4 serotypes were distinct from those circulating in humans at the same periods. Analysis for DENV-2 showed that some strains were divergent from concurrent human strains but that others were identical. The latter finding suggests that wild neotropical mammals living in periurban area can be infected by dengue virus strains circulating in humans. However, further investigation will be needed to determine if neotropical mammals are incidental hosts or potential reservoirs of dengue virus.","['Lavergne, A', 'Lacoste, V', 'Germain, A', 'Matheus, S', 'Dussart, P', 'Deparis, X', 'de Thoisy, B']","['Lavergne A', 'Lacoste V', 'Germain A', 'Matheus S', 'Dussart P', 'Deparis X', 'de Thoisy B']",,"['Laboratoire des Interactions Virus-Hotes, Institut Pasteur de la Guyane, Cayenne. alavergne@pasteur-cayenne.fr']",['fre'],"['English Abstract', 'Journal Article']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,"['0 (RNA, Viral)']",IM,"['Animals', 'Dengue/classification/genetics/*transmission', '*Disease Vectors', 'Humans', 'Mammals/*virology', 'RNA, Viral/isolation & purification', 'Reverse Transcriptase Polymerase Chain Reaction', '*Tropical Climate']",,2009/09/04 06:00,2009/10/30 06:00,['2009/09/04 09:00'],"['2009/09/04 09:00 [entrez]', '2009/09/04 06:00 [pubmed]', '2009/10/30 06:00 [medline]']",,ppublish,Med Trop (Mars). 2009 Aug;69(4):345-50.,4,,,,,,,,,Infection par le virus de la dengue de mammiferes sauvages en region neotropicale: hotes accidentels ou reservoirs potentiels?,,,,,,,,,,,,,
30110348,NLM,MEDLINE,20190123,20221207,1932-6203 (Electronic) 1932-6203 (Linking),13,2018,Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore.,e0201441,10.1371/journal.pone.0201441 [doi] e0201441,"Dengue is endemic in Singapore but not China. We compared clinical features and disease severity of dengue between local and migrant Chinese, most of whom were construction workers, in Singapore. A retrospective study with all hospitalized dengue patients from 2005 to 2008 were performed, including 2609 local and 1195 migrant Chinese. Compared with local Chinese, migrant Chinese were younger. There were more males, but fewer had comorbidities. Migrant Chinese had more headache, eye pain, nausea and myalgia. They had significantly lower median leukocyte count, ALT and AST, and higher platelet count nadir. Among warning signs, migrant Chinese had significantly less persistent vomiting, clinical fluid accumulation, hepatomegaly, hematocrit rise with rapid platelet drop, and more mucosal bleeding. Adjusted for age, gender and comorbidities, migrant Chinese were significantly at higher risk of dengue hemorrhagic fever (DHF) (adjusted odds ratio [aOR]: 1.20, 95% confidence interval [CI]: 1.03-1.41) and dengue shock syndrome (aOR: 1.49, 95% CI: 1.06-2.10), and had longer hospitalization (beta coefficient value: 0.27, 95%CI: 0.09-0.44, p = 0.003). There was 1 death among migrant Chinese and 2 deaths among local Chinese. We documented differences in clinical and laboratory features, and dengue severity between local and migrant Chinese in Singapore. Migrant Chinese may need more medical attention given higher risk of DHF.","['Xu, Chuanhui', 'Pang, Junxiong', 'Hsu, Jung Pu', 'Leo, Yee Sin', 'Lye, David Chien Boon']","['Xu C', 'Pang J', 'Hsu JP', 'Leo YS', 'Lye DCB']",['ORCID: 0000-0002-3222-7168'],"['Communicable Disease Centre, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore.', 'Communicable Disease Centre, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.', 'Communicable Disease Centre, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.', 'Saw Swee Hock School of Public Health, National University of Singapore, Singapore.', 'Yong Loo Lin School of Medicine, National University of Singapore, Singapore.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.', 'Communicable Disease Centre, Institute of Infectious Diseases and Epidemiology, Tan Tock Seng Hospital, Singapore.', 'Yong Loo Lin School of Medicine, National University of Singapore, Singapore.', 'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.']",['eng'],"['Comparative Study', 'Journal Article', 'Observational Study']",20180815,United States,PLoS One,PloS one,101285081,,IM,"['Adult', '*Asian People', '*Dengue/epidemiology/pathology/therapy', '*Emigrants and Immigrants', 'Female', '*Hospitalization', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Risk Factors', '*Severity of Illness Index', 'Singapore/epidemiology']",PMC6093606,2018/08/16 06:00,2019/01/24 06:00,['2018/08/16 06:00'],"['2018/02/11 00:00 [received]', '2018/07/16 00:00 [accepted]', '2018/08/16 06:00 [entrez]', '2018/08/16 06:00 [pubmed]', '2019/01/24 06:00 [medline]']","['PONE-D-18-04615 [pii]', '10.1371/journal.pone.0201441 [doi]']",epublish,PLoS One. 2018 Aug 15;13(8):e0201441. doi: 10.1371/journal.pone.0201441. eCollection 2018.,8,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
26011728,NLM,MEDLINE,20160223,20181113,1932-6203 (Electronic) 1932-6203 (Linking),10,2015,Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand.,e0127998,10.1371/journal.pone.0127998 [doi] e0127998,"RV144 was a community-based HIV vaccine efficacy trial conducted in HIV-uninfected adults in Thailand, where dengue virus continues to cause a large number of infections every year. We attempted to document the accuracy of clinically diagnosed dengue episodes reported as serious adverse events (SAEs) and adverse events (AEs) and examine whether dengue serology would support the clinical diagnosis. Subjects without a clinical dengue diagnosis but with an infection or idiopathic fever were selected as a control population. Dengue serology was performed by hemagglutination inhibition on plasma samples. A total of 124 clinical dengue episodes were reported (103 SAEs and 21 AEs). Overall 82.6% of the clinically diagnosed dengue episodes were supported by a positive dengue serology: 71.4% of the AEs and 85.0% of the SAEs. Of the 100 subjects with both clinical dengue and positive serology, all presented with fever, 83% with leucopenia, 54% with thrombocytopenia, and 27% with hemorrhagic symptoms. All episodes resolved spontaneously without sequellae. Only two of 15 subjects with a negative serology presented with fever. The sensitivity and specificity of clinical dengue diagnosis were 90.9% and 74.4%, respectively, when compared to the control population, and with a positive predictive value of 82.6% and negative predictive value of 84.7% when compared to dengue serology. Clinical diagnosis of dengue is an accurate method of dengue diagnosis in adults in Thailand. Large-scale clinical trials offer the opportunity to systematically study infectious diseases such as dengue and other infections that may occur during the trial.","['Pitisuttithum, Punnee', 'Rerks-Ngarm, Supachai', 'Stablein, Donald', 'Dawson, Peter', 'Nitayaphan, Sorachai', 'Kaewkungwal, Jaranit', 'Michael, Nelson L', 'Kim, Jerome H', 'Robb, Merlin L', ""O'Connell, Robert J"", 'Yoon, In-Kyu', 'Fernandez, Stefan', 'Excler, Jean-Louis']","['Pitisuttithum P', 'Rerks-Ngarm S', 'Stablein D', 'Dawson P', 'Nitayaphan S', 'Kaewkungwal J', 'Michael NL', 'Kim JH', 'Robb ML', ""O'Connell RJ"", 'Yoon IK', 'Fernandez S', 'Excler JL']",,"['Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'Department of Diseases Control, Ministry of Public Health, Nonthaburi, Thailand.', 'EMMES Corporation, Rockville, Maryland, United States of America.', 'EMMES Corporation, Rockville, Maryland, United States of America.', 'Royal Thai Army Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.', 'Center of Excellence for Biomedical and Public Health Informatics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.', 'US Military HIV Research Program (MHRP), Bethesda, Maryland, United States of America.', 'US Military HIV Research Program (MHRP), Bethesda, Maryland, United States of America.', 'US Military HIV Research Program (MHRP), Bethesda, Maryland, United States of America; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.', 'US Military HIV Research Program (MHRP), Bethesda, Maryland, United States of America; Department of Retrovirology, US Component-Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.', 'Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.', 'Department of Virology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.', 'US Military HIV Research Program (MHRP), Bethesda, Maryland, United States of America; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20150526,United States,PLoS One,PloS one,101285081,['0 (AIDS Vaccines)'],IM,"['*AIDS Vaccines', 'Adult', 'Dengue/*diagnosis/etiology', 'Female', 'Hemagglutination Inhibition Tests', 'Humans', 'Male', 'Sensitivity and Specificity', 'Thailand', 'Young Adult']",PMC4444125,2015/05/27 06:00,2016/02/26 06:00,['2015/05/27 06:00'],"['2015/02/19 00:00 [received]', '2015/04/21 00:00 [accepted]', '2015/05/27 06:00 [entrez]', '2015/05/27 06:00 [pubmed]', '2016/02/26 06:00 [medline]']","['PONE-D-15-06956 [pii]', '10.1371/journal.pone.0127998 [doi]']",epublish,PLoS One. 2015 May 26;10(5):e0127998. doi: 10.1371/journal.pone.0127998. eCollection 2015.,5,,,,"['Competing Interests: Co-authors Donald Stablein and Peter Dawson are employed by', 'The EMMES Corporation. The EMMES Corporation is an independent contract research', 'organization providing statistical support for USMHRP activities through a', 'contract with the Henry Jackson Foundation. The EMMES Corporation has no related', 'patents, products in development or marketed products to declare. The EMMES', 'Corporation will adhere to all the PLOS ONE policies on sharing data and', 'materials, as detailed online in the guidelines for authors.']",,['Y1-AI-2642-12/AI/NIAID NIH HHS/United States'],,,,,,,,,,,,,,,,
9139379,NLM,MEDLINE,19970502,20041117,0125-1562 (Print) 0125-1562 (Linking),26,1995 Dec,"The 1993 epidemic of dengue fever in Mangalore, Karnataka state, India.",699-704,,"An epidemic of febrile illness with hemorrhagic manifestations occurred in certain parts of Mangalore city, Karnataka state, India, from the last week of July 1993. The epidemic reached its peak by mid-August and then started declining. Sporadic cases, however, continued to occur till early December. About 200 cases were reported covering all age groups and both sexes. The cases presented with pyrexia, myalgia, arthralgia and headache. Palatal petechiae, magenta colored tongue with central coating, maculopapular rash and facial flush were observed as classical signs. The tourniquet test was positive in 12% of the cases. Hemorrhage was observed in the form of epistaxis (2 cases), subconjunctival hemorrhage (2 cases) or purpura (3 cases). There were no deaths which were attributable to the epidemic. Five strains of dengue (DEN-2) virus were recovered from the acute-phase sera. Dengue virus-specific IgM type of antibodies were detected in 29/116 (25%) sera. Breeding of Aedes aegypti was observed in some of the areas where cases had occurred. No virus was isolated from any of the field-caught Ae. aegypti mosquitos.","['Padbidri, V S', 'Adhikari, P', 'Thakare, J P', 'Ilkal, M A', 'Joshi, G D', 'Pereira, P', 'Guttikar, S N', 'Walhekar, B D', 'Chowta, N', 'Hegde, B M']","['Padbidri VS', 'Adhikari P', 'Thakare JP', 'Ilkal MA', 'Joshi GD', 'Pereira P', 'Guttikar SN', 'Walhekar BD', 'Chowta N', 'Hegde BM']",,"['Department of Medicine, Kastutba Medical College, Mangalore, India.']",['eng'],['Journal Article'],,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Acute Disease', 'Animals', 'Case-Control Studies', 'Convalescence', 'Culicidae', 'Dengue/*epidemiology/immunology/transmission/virology', '*Disease Outbreaks', 'Female', 'Humans', 'India/epidemiology', 'Insect Vectors', 'Male', 'Risk Factors', '*Urban Health']",,1995/12/01 00:00,1995/12/01 00:01,['1995/12/01 00:00'],"['1995/12/01 00:00 [pubmed]', '1995/12/01 00:01 [medline]', '1995/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1995 Dec;26(4):699-704.,4,,,,,,,,,,,,,,,,,,,,,,
31357059,NLM,MEDLINE,20191120,20191120,1878-3511 (Electronic) 1201-9712 (Linking),86,2019 Sep,"Clinical features and virological confirmation of perinatal dengue infection in Jambi, Indonesia: A case report.",197-200,S1201-9712(19)30304-2 [pii] 10.1016/j.ijid.2019.07.019 [doi],"The hyper-endemicity of dengue in Indonesia poses a significant threat of dengue virus (DENV) vertical transmission during pregnancy. A 29-year-old female at 38 weeks of pregnancy presented to hospital with acute fever and later confirmed with DENV infection. Due to signs of fetal distress, the neonate was delivered by emergency caesarean section. The mother developed a dengue critical phase post-caesarean with excessive bleeding and required blood transfusion. During the 6th day of life, the neonate was diagnosed and later confirmed with dengue. Next-generation sequencing of DENV RNA isolated directly from sera of both mother and neonate revealed identical DENV-2 whole-genome sequences. Plaque reduction neutralization test (PRNT) detected anti-dengue antibodies in both mother and neonate. Altogether, our data confirmed the occurrence of vertical transmission. Dengue vertical transmission during pregnancy may lead to severe manifestation, hence early diagnosis, close monitoring, and prompt intervention are critical.","['Haryanto, Sotianingsih', 'Yohan, Benediktus', 'Santoso, Marsha Sinditia', 'Hayati, Rahma F', 'Denis, Dionisius', 'Udjung, Gorga I V W', 'Herlambang', 'Kendarsari, R Indah', 'Trimarsanto, Hidayat', 'Sasmono, R Tedjo']","['Haryanto S', 'Yohan B', 'Santoso MS', 'Hayati RF', 'Denis D', 'Udjung GIVW', 'Herlambang', 'Kendarsari RI', 'Trimarsanto H', 'Sasmono RT']",,"['Siloam Hospital and Raden Mattaher Hospital, Jambi, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Siloam Hospital and Raden Mattaher Hospital, Jambi, Indonesia.', 'Faculty of Medicine and Health Science, Universitas Jambi, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia.', 'Eijkman Institute for Molecular Biology, Ministry of Research, Technology, and Higher Education of the Republic of Indonesia, Jakarta, Indonesia. Electronic address: sasmono@eijkman.go.id.']",['eng'],['Journal Article'],20190726,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,"['0 (Antibodies, Viral)']",IM,"['Adult', 'Antibodies, Viral/blood', 'Cesarean Section', 'Dengue/congenital/diagnosis/*transmission/virology', 'Dengue Virus/immunology', 'Female', 'Humans', 'Indonesia', 'Infant, Newborn', 'Infectious Disease Transmission, Vertical', 'Neutralization Tests', 'Pregnancy', '*Pregnancy Complications, Infectious', 'Serologic Tests']",,2019/07/30 06:00,2019/11/21 06:00,['2019/07/30 06:00'],"['2019/05/15 00:00 [received]', '2019/07/18 00:00 [revised]', '2019/07/22 00:00 [accepted]', '2019/07/30 06:00 [pubmed]', '2019/11/21 06:00 [medline]', '2019/07/30 06:00 [entrez]']","['S1201-9712(19)30304-2 [pii]', '10.1016/j.ijid.2019.07.019 [doi]']",ppublish,Int J Infect Dis. 2019 Sep;86:197-200. doi: 10.1016/j.ijid.2019.07.019. Epub 2019 Jul 26.,,['Copyright (c) 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue', 'Neonate', 'Next-generation sequencing', 'Perinatal', 'Pregnancy', 'Vertical transmission']",,,,,,,,,,,,,,,,,,,
10970418,NLM,MEDLINE,20001124,20200724,0095-1137 (Print) 1098-660X (Electronic) 0095-1137 (Linking),38,2000 Sep,Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells.,3508-10,,"A rapid centrifugation assay was compared with conventional tube cell culture for dengue virus isolation in both sera and autopsy samples from dengue and dengue hemorrhagic fever/dengue shock syndrome fatal cases. The rapid centrifugation assay allowed isolation of virus from 16.6% more samples than the conventional method, and it shortened the time for dengue virus detection. Finally, it allowed the isolation of dengue 2 virus in 42.8% of tissue samples from five fatal cases. Our results suggest that the rapid centrifugation assay may be useful for detection of dengue virus in clinical specimens.","['Rodriguez Roche, R', 'Alvarez, M', 'Guzman, M G', 'Morier, L', 'Kouri, G']","['Rodriguez Roche R', 'Alvarez M', 'Guzman MG', 'Morier L', 'Kouri G']",,"['Department of Virology, PAHO/WHO Collaborator Center for Viral Diseases, ""Pedro Kouri"" Tropical Medicine Institute, Havana, Cuba.']",['eng'],"['Comparative Study', 'Evaluation Study', 'Journal Article']",,United States,J Clin Microbiol,Journal of clinical microbiology,7505564,,IM,"['Aedes', 'Animals', 'Cells, Cultured', '*Centrifugation', 'Dengue/blood/*diagnosis/virology', 'Dengue Virus/*growth & development/*isolation & purification', 'Humans', 'Severe Dengue/blood/*diagnosis/virology', 'Virology/*methods', 'Virus Cultivation']",PMC87421,2000/09/02 11:00,2001/02/28 10:01,['2000/09/02 11:00'],"['2000/09/02 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/02 11:00 [entrez]']","['1453 [pii]', '10.1128/JCM.38.9.3508-3510.2000 [doi]']",ppublish,J Clin Microbiol. 2000 Sep;38(9):3508-10. doi: 10.1128/JCM.38.9.3508-3510.2000.,9,,,,,,,,,,,,,,,,,,,,,,
19999827,NLM,MEDLINE,20100114,20161026,0070-217X (Print) 0070-217X (Linking),338,2010,Early scientific progress.,v-ix,,,"['Rothman, Alan L']",['Rothman AL'],,"['Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA 01655, USA. alan.rothman@umassmed.edu']",['eng'],['Introductory Journal Article'],,Germany,Curr Top Microbiol Immunol,Current topics in microbiology and immunology,0110513,['0 (Dengue Vaccines)'],IM,"['Animals', '*Dengue/epidemiology/physiopathology/prevention & control/virology', 'Dengue Vaccines/administration & dosage/genetics', 'Dengue Virus/*pathogenicity/physiology', '*Disease Outbreaks', 'Global Health', 'Host-Pathogen Interactions', 'Humans', 'Vaccination']",,2009/12/17 06:00,2010/01/15 06:00,['2009/12/17 06:00'],"['2009/12/17 06:00 [entrez]', '2009/12/17 06:00 [pubmed]', '2010/01/15 06:00 [medline]']",,ppublish,Curr Top Microbiol Immunol. 2010;338:v-ix.,,,,,,,,,,,,,,,,,,,,,,,
36124479,NLM,MEDLINE,20220922,20220922,0972-9062 (Print) 0972-9062 (Linking),59,2022 Apr-Jun,The effectiveness of MyMAT Aedes mosquito trap in reducing dengue cases.,139-144,10.4103/0972-9062.335727 [doi],"Malaysia Mosquito Autocidal Trap (MyMAT) is a green technology Aedes mosquito trap that does not use harmful chemical substances. This study aimed to evaluate the efficiency of MyMAT in reducing dengue cases and relating the cases to rainfall. An experimental field study was conducted for 42 weeks at Pangsapuri Nilam Sari, Shah Alam, Selangor. A total of 624 MyMAT was allocated at four blocks: inside each apartment and outside at the corridors in each level. Mosquito and rainfall data were collected weekly using MyMAT and a mobile rain gauge, respectively. The dengue cases data was retrieved from the e-dengue system obtained from the Malaysia Ministry of Health. The findings showed that MyMAT could catch 97% of Aedes mosquitoes and reduced dengue cases on average of 78%, indicating MyMAT is a reliable Aedes mosquito trap. Interestingly the findings also revealed a significant relationship between dengue cases, the number of Aedes mosquitoes, and rainfall. This week notified dengue cases increased when last two weeks mosquitoes increased due to previous two weeks rainfall increment. Thus indicating an indirect but significant relationship between this week notified dengue cases with the last four weeks rainfall. These relationships can be used in establishing a dengue outbreak forecasting model, which can act as an early warning system.","['Shahar, Mohd Khadri', 'Ismail, Suzilah', 'Ahmad, Rohani', 'Omar, Topek']","['Shahar MK', 'Ismail S', 'Ahmad R', 'Omar T']",,"['Medical Entomology Unit, Institute for Medical Research, National Institute of Health, Ministry of Health, Malaysia.', 'School of Quantitative Sciences, Universiti Utara Malaysia, UUM Sintok, Kedah, Malaysia.', 'Medical Entomology Unit, Institute for Medical Research, National Institute of Health, Ministry of Health, Malaysia.', 'Disease Control Division, Ministry of Health, Malaysia.']",['eng'],['Journal Article'],,India,J Vector Borne Dis,Journal of vector borne diseases,101212761,,IM,"['*Aedes', 'Animals', '*Dengue/epidemiology/prevention & control', 'Disease Outbreaks', 'Malaysia/epidemiology', 'Rain']",,2022/09/21 06:00,2022/09/23 06:00,['2022/09/20 03:23'],"['2022/09/20 03:23 [entrez]', '2022/09/21 06:00 [pubmed]', '2022/09/23 06:00 [medline]']","['JVectorBorneDis_2022_59_2_139_335727 [pii]', '10.4103/0972-9062.335727 [doi]']",ppublish,J Vector Borne Dis. 2022 Apr-Jun;59(2):139-144. doi: 10.4103/0972-9062.335727.,2,,['NOTNLM'],"['Malaysia Mosquito Autocidal Trap', 'MyMAT', 'dengue cases', 'green technology', 'rainfall']",['None'],,,,,,,,,,,,,,,,,,
11357995,NLM,MEDLINE,20010607,20220310,0002-9637 (Print) 0002-9637 (Linking),63,2000 Jul-Aug,"Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.",5-11,,"From July to December 1998, a hospital- and health center-based surveillance system for dengue was established at selected sites in Nicaragua to better define the epidemiology of this disease. Demographic and clinical information as well as clinical laboratory results were obtained, and virus isolation, reverse transcriptase-polymerase chain reaction, and serologic assays were performed. World Health Organization criteria were used to classify disease severity; however, a number of patients presented with signs of shock in the absence of thrombocytopenia or hemoconcentration. Therefore, a new category was designated as ""dengue with signs associated with shock"" (DSAS). Of 1,027 patients enrolled in the study, 614 (60%) were laboratory-confirmed as positive cases; of these, 268 (44%) were classified as dengue fever (DF); 267 (43%) as DF with hemorrhagic manifestations (DFHem); 40 (7%) as dengue hemorrhagic fever (DHF); 20 (3%) as dengue shock syndrome (DSS); and 17 (3%) as DSAS. Interestingly, secondary infection was not significantly correlated with DHF/DSS, in contrast to previous studies in Southeast Asia. DEN-3 was responsible for the majority of cases, with a minority due to DEN-2; both serotypes contributed to severe disease. As evidenced by the analysis of this epidemic, the epidemiology of dengue can differ according to geographic region and viral serotype.","['Harris, E', 'Videa, E', 'Perez, L', 'Sandoval, E', 'Tellez, Y', 'Perez, M L', 'Cuadra, R', 'Rocha, J', 'Idiaquez, W', 'Alonso, R E', 'Delgado, M A', 'Campo, L A', 'Acevedo, F', 'Gonzalez, A', 'Amador, J J', 'Balmaseda, A']","['Harris E', 'Videa E', 'Perez L', 'Sandoval E', 'Tellez Y', 'Perez ML', 'Cuadra R', 'Rocha J', 'Idiaquez W', 'Alonso RE', 'Delgado MA', 'Campo LA', 'Acevedo F', 'Gonzalez A', 'Amador JJ', 'Balmaseda A']",,"['Division of Infectious Diseases, School of Public Health, University of California, Berkeley 94720-7360, USA. eharris@socrates.berkeley.edu']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Dengue/blood/diagnosis/*epidemiology/virology', 'Dengue Virus/*classification/isolation & purification', '*Disease Outbreaks', 'Enzyme-Linked Immunosorbent Assay', 'Female', 'Humans', 'Infant', 'Male', 'Nicaragua/epidemiology', 'Reverse Transcriptase Polymerase Chain Reaction', 'Seasons', 'Severity of Illness Index']",,2001/05/19 10:00,2001/06/08 10:01,['2001/05/19 10:00'],"['2001/05/19 10:00 [pubmed]', '2001/06/08 10:01 [medline]', '2001/05/19 10:00 [entrez]']",['10.4269/ajtmh.2000.63.5 [doi]'],ppublish,Am J Trop Med Hyg. 2000 Jul-Aug;63(1-2):5-11. doi: 10.4269/ajtmh.2000.63.5.,1-2,,,,,,['TW-00905/TW/FIC NIH HHS/United States'],,,,,,,,,,,,,,,,
9652206,NLM,MEDLINE,19980730,20161201,0049-8114 (Print) 0049-8114 (Linking),73,1998 Jun 12,"Dengue and dengue haemorrhagic fever, Malaysia.",182-3,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Dengue/diagnosis/*epidemiology', 'Humans', 'Incidence', 'Malaysia/epidemiology', 'Middle Aged', 'Severe Dengue/diagnosis/epidemiology', 'Survival Rate']",,1998/07/04 00:00,1998/07/04 00:01,['1998/07/04 00:00'],"['1998/07/04 00:00 [pubmed]', '1998/07/04 00:01 [medline]', '1998/07/04 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1998 Jun 12;73(24):182-3.,24,,,,,,,,,,,,,,,,,,,,,,
6605216,NLM,MEDLINE,19831220,20181113,0042-9686 (Print) 0042-9686 (Linking),61,1983,"Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia.",693-701,,"Thirty virologically confirmed cases of dengue infection with a fatal outcome were studied clinically in Jakarta, Indonesia, from 1975 to 1978. All 4 dengue virus serotypes were isolated from fatal cases, but dengue type 3 was responsible for 21 (70%) of these isolates, compared to only 47% of isolates from all cases of dengue infection. The majority (60%) of these 30 cases were males in the 5-9-year age group. Nonspecific signs and symptoms in the fatal cases were no different from those in patients who survived dengue infection, but 70% of the patients with fatal outcome had one or more signs of encephalitis, primarily convulsions and somnolence; 3 of them developed spastic tetraparesis before death and 2 died of an illness clinically compatible with viral encephalitis. Other unexpected observations were that only 63% of the patients had classical dengue shock syndrome with haemoconcentration, thrombocytopenia and shock. A high percentage (80%) had gastrointestinal haemorrhage, and in 9 patients (30%) this was severe enough to cause shock and death. In these 9 cases, the gastrointestinal haemorrhage and haematemesis began before the onset of shock and there was no evidence of haemoconcentration or pleural effusion at any time during hospitalization. According to certain widely accepted criteria, these patients would not be diagnosed as dengue haemorrhagic fever (DHF). But as they made up nearly one-third of the confirmed fatal dengue infections in this study and had massive gastrointestinal haemorrhages with thrombocytopenia, the definition of DHF should be changed to include this type of patient. It is proposed that the disease should be more realistically classified as dengue fever with or without haemorrhage and dengue shock syndrome.","['Sumarmo', 'Wulur, H', 'Jahja, E', 'Gubler, D J', 'Suharyono, W', 'Sorensen, K']","['Sumarmo', 'Wulur H', 'Jahja E', 'Gubler DJ', 'Suharyono W', 'Sorensen K']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,,IM,"['Age Factors', 'Child', 'Child, Preschool', 'Dengue/complications/microbiology/*mortality', 'Encephalitis/complications', 'Female', 'Gastrointestinal Hemorrhage/complications', 'Humans', 'Male', 'Serotyping', 'Sex Factors']",PMC2536140,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",,ppublish,Bull World Health Organ. 1983;61(4):693-701.,4,,,,,,,,,,,,,,,,,,,,,,
9698884,NLM,MEDLINE,19981020,20190516,0074-0276 (Print) 0074-0276 (Linking),93,1998 Mar-Apr,"Retrospective study on dengue in Fortaleza, state of Ceara, Brazil.",155-9,,"A retrospective serologic study was carried out in Fortaleza, State of Ceara, Brazil, in order to detect the dengue virus activity before recognizing the epidemic of 1994. Mac-Elisa was performed by using a mixture of specific DEN-1 and DEN-2 antigens on serum samples from the Emilio Ribas Laboratory collection. Samples were obtained from 1,224 patients with exanthematic febrile disease and negative serological results for rubella. All specimens were taken during November 1993 to May 1994. The results confirmed dengue infections in Fortaleza by November 1993, approximately six months before the beginning of the epidemic, proving how misleading diagnosis of dengue infection are still troublesome, in spite of the strong dengue activity in Ceara. The authors stress the urgent necessity to implement the active surveillance system in order to prevent another extensive dengue fever epidemics in the state. Epidemiological background of the dengue activity in the State of Ceara is described.","['da Cunha, R V', 'Miagostovich, M P', 'Petrola, Z', 'de Araujo, E S', 'Cortez, D', 'Pombo, V', 'de Souza, R V', 'Nogueira, R M', 'Schatzmayr, H G']","['da Cunha RV', 'Miagostovich MP', 'Petrola Z', 'de Araujo ES', 'Cortez D', 'Pombo V', 'de Souza RV', 'Nogueira RM', 'Schatzmayr HG']",,"['Departmento de Clinica Medica, Universidade Federal de Mato Grosso do Sul, Instituo Oswaldo Cruz, Rio de Janeiro.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Brazil,Mem Inst Oswaldo Cruz,Memorias do Instituto Oswaldo Cruz,7502619,['0 (Immunoglobulin M)'],IM,"['Brazil/epidemiology', 'Dengue/blood/*diagnosis/*epidemiology/virology', 'Disease Outbreaks/*classification/prevention & control', 'Humans', 'Immunoglobulin M', 'Population Surveillance/*methods', 'Retrospective Studies']",,1998/08/12 00:00,1998/08/12 00:01,['1998/08/12 00:00'],"['1998/08/12 00:00 [pubmed]', '1998/08/12 00:01 [medline]', '1998/08/12 00:00 [entrez]']","['S0074-02761998000200003 [pii]', '10.1590/s0074-02761998000200003 [doi]']",ppublish,Mem Inst Oswaldo Cruz. 1998 Mar-Apr;93(2):155-9. doi: 10.1590/s0074-02761998000200003.,2,,,,,,,,,,,,,,,,,,,,,,
27367615,NLM,MEDLINE,20170728,20180222,1471-4973 (Electronic) 1471-4892 (Linking),30,2016 Oct,Towards antiviral therapies for treating dengue virus infections.,1-7,S1471-4892(16)30050-9 [pii] 10.1016/j.coph.2016.06.002 [doi],"Dengue virus is an emerging human pathogen that poses a huge public health burden by infecting annually about 390 million individuals of which a quarter report with clinical manifestations. Although progress has been made in understanding dengue pathogenesis, a licensed vaccine or antiviral therapy against this virus is still lacking. Treatment of patients is confined to symptomatic alleviation and supportive care. The development of dengue therapeutics thus remains of utmost importance. This review focuses on the few molecules that were evaluated in dengue virus-infected patients: balapiravir, chloroquine, lovastatin, prednisolone and celgosivir. The lessons learned from these clinical trials can be very helpful for the design of future trials for the next generation of dengue virus inhibitors.","['Kaptein, Suzanne Jf', 'Neyts, Johan']","['Kaptein SJ', 'Neyts J']",,"['KU Leuven - University of Leuven, Department of Immunology and Microbiology, Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium.', 'KU Leuven - University of Leuven, Department of Immunology and Microbiology, Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Electronic address: Johan.Neyts@kuleuven.be.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20160628,England,Curr Opin Pharmacol,Current opinion in pharmacology,100966133,['0 (Antiviral Agents)'],IM,"['Animals', 'Antiviral Agents/*pharmacology', 'Clinical Trials as Topic/methods', 'Dengue/*drug therapy/epidemiology/virology', 'Dengue Virus/drug effects', '*Drug Design', 'Humans', 'Public Health']",,2016/10/21 06:00,2017/07/29 06:00,['2016/07/02 06:00'],"['2016/06/06 00:00 [received]', '2016/06/08 00:00 [accepted]', '2016/10/21 06:00 [pubmed]', '2017/07/29 06:00 [medline]', '2016/07/02 06:00 [entrez]']","['S1471-4892(16)30050-9 [pii]', '10.1016/j.coph.2016.06.002 [doi]']",ppublish,Curr Opin Pharmacol. 2016 Oct;30:1-7. doi: 10.1016/j.coph.2016.06.002. Epub 2016 Jun 28.,,['Copyright (c) 2016 Elsevier Ltd. All rights reserved.'],,,,,['Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
32901600,NLM,MEDLINE,20201130,20220316,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),103,2020 Nov,Case Report: Acute Vision Loss in a Young Returning Traveler with Dengue Fever.,2026-2028,tpmd200562 [pii] 10.4269/ajtmh.20-0562 [doi],"Ocular complications are rare in patients with dengue fever, but may cause permanent loss of vision. We present the case of a 29-year-old German woman who developed severe acute vision loss because of dengue-associated maculopathy after traveling to Vietnam and Cambodia. Initially, the optical coherence tomography showed detachment of the retinal pigment epithelium, a central shift in the retinal pigmentation and intraretinal cysts. The patient was hospitalized and treated with a short course of intravenous prednisolone. Vision improved, and the patient showed full recovery at 9 months after the onset. This case highlights the importance of awareness and adequate management for ocular involvement in patients with dengue fever, including travelers.","['Heinemann, Melina', 'Bigdon, Eileen', 'Veletzky, Luzia', 'Jordan, Sabine', 'Jochum, Johannes', 'Knospe, Volker', 'Schmiedel, Stefan', 'Ramharter, Michael']","['Heinemann M', 'Bigdon E', 'Veletzky L', 'Jordan S', 'Jochum J', 'Knospe V', 'Schmiedel S', 'Ramharter M']",,"['1Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '2Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', '3Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '2Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', '4I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '2Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', '4I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '2Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', '4I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '3Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '1Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.', '2Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.', '4I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Adult', 'Cambodia', 'Dengue/complications/*diagnostic imaging/parasitology/pathology', 'Female', 'Germany', 'Humans', 'Macular Degeneration', 'Retina/diagnostic imaging/parasitology/pathology', 'Retinal Diseases/complications/*diagnostic imaging/parasitology/pathology', 'Tomography, Optical Coherence', 'Travel', 'Vietnam']",PMC7646753,2020/09/10 06:00,2020/12/01 06:00,['2020/09/09 08:46'],"['2020/09/10 06:00 [pubmed]', '2020/12/01 06:00 [medline]', '2020/09/09 08:46 [entrez]']","['tpmd200562 [pii]', '10.4269/ajtmh.20-0562 [doi]']",ppublish,Am J Trop Med Hyg. 2020 Nov;103(5):2026-2028. doi: 10.4269/ajtmh.20-0562.,5,,,,,,,,,,,,,,,,,,,,,,
22548535,NLM,MEDLINE,20120829,20151006,1948-7134 (Electronic) 1081-1710 (Linking),37,2012 Jun,"Spatial and temporal dynamics of Aedes aegypti larval sites in Bello, Colombia.",37-48,10.1111/j.1948-7134.2012.00198.x [doi],"Counts of immature stages of the mosquito Aedes aegypti have been used to calculate several entomological indices of dengue vector abundance. Some studies have concluded that these indices can be used as indicators of dengue epidemic risk, while other studies have failed to find a predictive relationship. Ecological niche models have been able to predict distributional patterns in space and time, not only of vectors, but also of the diseases that they transmit. In this study, we used Landsat 7 ETM+ images and two niche-modeling algorithms to estimate the local-landscape ecological niche and the dynamics of Ae. aegypti larval habitats in Bello, Colombia, and to evaluate their potential spatial and temporal distribution. Our models showed low omission error with high confidence levels: about 13.4% of the area presents conditions consistently suitable for breeding across the entire study period (2002-2008). The proportion of neighborhoods predicted to be suitable showed a positive association with dengue case rates, whereas the vector-focused Bretau index had no relationship to case rates. As a consequence, niche models appear to offer a superior option for predictive evaluation of dengue transmission risk and anticipating the potential for outbreaks.","['Arboleda, Sair', 'Jaramillo-O, Nicolas', 'Peterson, A Townsend']","['Arboleda S', 'Jaramillo-O N', 'Peterson AT']",,"['Grupo de Biologia y Control de Enfermedades Infecciosas (BCEI), Instituto de Biologia, Universidad de Antioquia, Sede de Investigaciones Universitarias, Medellin, Colombia. sairorieta@yahoo.es']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,United States,J Vector Ecol,Journal of vector ecology : journal of the Society for Vector Ecology,9512496,,IM,"['*Aedes', 'Animals', 'Colombia', 'Dengue/epidemiology/*transmission', 'Insect Vectors', '*Larva']",,2012/05/03 06:00,2012/08/30 06:00,['2012/05/03 06:00'],"['2012/05/03 06:00 [entrez]', '2012/05/03 06:00 [pubmed]', '2012/08/30 06:00 [medline]']",['10.1111/j.1948-7134.2012.00198.x [doi]'],ppublish,J Vector Ecol. 2012 Jun;37(1):37-48. doi: 10.1111/j.1948-7134.2012.00198.x.,1,['(c) 2012 The Society for Vector Ecology.'],,,,,,,,,,,,,,,,,,,,,
2448599,NLM,MEDLINE,19880321,20080214,0149-2195 (Print) 0149-2195 (Linking),37,1988 Mar 4,"Dengue and dengue hemorrhagic fever in the Americas, 1986.",129-31,,,,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Aedes', 'Americas', 'Animals', 'Child', 'Dengue/*epidemiology/transmission', '*Disease Outbreaks', 'Humans']",,1988/03/04 00:00,1988/03/04 00:01,['1988/03/04 00:00'],"['1988/03/04 00:00 [pubmed]', '1988/03/04 00:01 [medline]', '1988/03/04 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1988 Mar 4;37(8):129-31.,8,,,,,,,,,,,,,,,,,['Centers for Disease Control (CDC)'],,,,,
37753727,NLM,MEDLINE,20231115,20231122,1748-6963 (Electronic) 1743-5889 (Linking),18,2023 Sep,Nanomedicine as a potential novel therapeutic approach against the dengue virus.,1567-1584,10.2217/nnm-2022-0217 [doi],"Dengue is an arbovirus infection which is transmitted by Aedes mosquitoes. Its prompt detection and effective treatment is a global health challenge. Various nanoparticle-based vaccines have been formulated to present immunogen (antigens) to instigate an immune response or prevent virus spread, but no specific treatment has been devised. This review explores the role of nanomedicine-based therapeutic agents against dengue virus, taking into consideration the applicable dengue virus assays that are sensitive, specific, have a short turnaround time and are inexpensive. Various kinds of metallic, polymeric and lipid nanoparticles with safe and effective profiles present an alternative strategy that could provide a better remedy for eradicating the dengue virus.","['Zohra, Tanzeel', 'Saeed, Faryal', 'Ikram, Aamer', 'Khan, Tariq', 'Alam, Siyab', 'Adil, Muhammad', 'Gul, Ayesha', 'Almawash, Saud', 'Ayaz, Muhammad']","['Zohra T', 'Saeed F', 'Ikram A', 'Khan T', 'Alam S', 'Adil M', 'Gul A', 'Almawash S', 'Ayaz M']","['ORCID: 0000-0002-0489-8538', 'ORCID: 0000-0001-8999-3464', 'ORCID: 0000-0002-4299-2445']","['Public Health Laboratories Division, National Institute of Health, Islamabad, 45500, Pakistan.', 'Department of Biotechnology, Quaid-i-Azam University, Islamabad, 45320, Pakistan.', 'Public Health Laboratories Division, National Institute of Health, Islamabad, 45500, Pakistan.', 'Department of Biotechnology, University of Malakand, University of Malakand, Chakdara, 18800 Dir (L), KP, Pakistan.', 'Department of Biotechnology, University of Malakand, University of Malakand, Chakdara, 18800 Dir (L), KP, Pakistan.', 'Department of Biotechnology, University of Malakand, University of Malakand, Chakdara, 18800 Dir (L), KP, Pakistan.', 'Department of Chemical Engineering, Polytechnique Montreal, H3T IJ4, Canada.', 'Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, 11961, Saudi Arabia.', 'Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18800 Dir (L), KP, Pakistan.']",['eng'],"['Journal Article', 'Review']",20230927,England,Nanomedicine (Lond),"Nanomedicine (London, England)",101278111,,IM,"['Animals', '*Dengue/drug therapy/prevention & control', '*Dengue Virus/physiology', 'Nanomedicine', '*Aedes']",,2023/09/27 06:43,2023/11/15 06:42,['2023/09/27 05:43'],"['2023/11/15 06:42 [medline]', '2023/09/27 06:43 [pubmed]', '2023/09/27 05:43 [entrez]']",['10.2217/nnm-2022-0217 [doi]'],ppublish,Nanomedicine (Lond). 2023 Sep;18(22):1567-1584. doi: 10.2217/nnm-2022-0217. Epub 2023 Sep 27.,22,,['NOTNLM'],"['arbovirus', 'calcium phosphate nanoparticle vaccine', 'dengue infection', 'dengue virus', 'drug delivery', 'nanomedicine', 'nanoparticle-based vaccines', 'nanotherapeutics', 'nanovaccine', 'therapeutic approach']",,,,,,,,,,,,,,,,,,,
25960096,NLM,MEDLINE,20161005,20220318,2214-9996 (Electronic) 2214-9996 (Linking),80,2014 Nov-Dec,The burden of dengue and chikungunya worldwide: implications for the southern United States and California.,466-75,S2214-9996(15)00011-9 [pii] 10.1016/j.aogh.2015.02.006 [doi],"BACKGROUND: Dengue virus (DENV) spreads to humans through the bite of an infected Aedes aegypti or Aedes albopictus mosquito and is a growing public health threat to both industrialized and developing nations worldwide. Outbreaks of autochthonous dengue in the United States occurred extensively in the past but over the past 3 decades have again taken place in Florida, Hawaii, and Texas as well as in American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and the US Virgin Islands. As the Aedes vectors spread worldwide it is anticipated that DENV as well as other viruses also transmitted by these vectors, such as Chikungunya virus (CHKV), will invade new areas of the world, including the United States. OBJECTIVES: In this review, we describe the current burden of dengue disease worldwide and the potential introduction of DENV and CHKV into different areas of the United States. Of these areas, the state of California saw the arrival and spread of the Aedes aegypti vector beginning in 2013. This invasion presents a developing situation when considering the state's number of imported dengue cases and proximity to northern Mexico as well as the rising specter of chikungunya in the Western hemisphere. FINDINGS: In light of the recent arrival of Aedes aegypti mosquito vectors to California, there is now a small but appreciable risk for endemic transmission of dengue and chikungunya within the State. It is likely, however, that if DENV or CHKV were to become endemic that the public health situation would be similar to that currently found along the Texas-Mexico border. The distribution of Aedes vectors in California as well as a discussion of several factors contributing to the risk for dengue importation are discussed and evaluated. CONCLUSIONS: Dengue and chikungunya viruses present real risks to states where the Aedes vector is now established. Scientists, physicians, and public health authorities should familiarize themselves with these risks and prepare appropriately.","['Fredericks, Anthony C', 'Fernandez-Sesma, Ana']","['Fredericks AC', 'Fernandez-Sesma A']",,"['Department of Microbiology and The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.', 'Department of Microbiology and The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: ana.sesma@mssm.edu.']",['eng'],"['Journal Article', 'Review']",,United States,Ann Glob Health,Annals of global health,101620864,,IM,"['*Aedes', 'Animals', 'Chikungunya Fever/*epidemiology/transmission', 'Chikungunya virus', 'Dengue/diagnosis/*epidemiology/therapy/transmission', 'Dengue Virus', '*Disease Outbreaks', 'Global Health', 'Humans', '*Insect Vectors', 'Risk Factors', 'United States/epidemiology']",PMC4427842,2015/05/12 06:00,2016/10/07 06:00,['2015/05/12 06:00'],"['2015/05/12 06:00 [entrez]', '2015/05/12 06:00 [pubmed]', '2016/10/07 06:00 [medline]']","['S2214-9996(15)00011-9 [pii]', '10.1016/j.aogh.2015.02.006 [doi]']",ppublish,Ann Glob Health. 2014 Nov-Dec;80(6):466-75. doi: 10.1016/j.aogh.2015.02.006.,6,['Copyright (c) 2014 The Authors. Published by Elsevier Inc. All rights reserved.'],['NOTNLM'],"['California', 'antiviral', 'arbovirus', 'chikungunya', 'dengue', 'flavivirus', 'vaccine']",,,"['1R01AI073450/AI/NIAID NIH HHS/United States', '1R21AI116022/AI/NIAID NIH HHS/United States', 'HHSN272201400008C/AI/NIAID NIH HHS/United States', 'HHSN272201400008C/PHS HHS/United States', 'R01 AI073450/AI/NIAID NIH HHS/United States', '1P01AI090935/AI/NIAID NIH HHS/United States', 'P01 AI090935/AI/NIAID NIH HHS/United States', 'R21 AI116022/AI/NIAID NIH HHS/United States']",,,,['NIHMS682343'],,,,,,,,,,,,
1404729,NLM,MEDLINE,19921104,20161017,0098-7484 (Print) 0098-7484 (Linking),268,1992 Oct 21,"From the Centers for Disease Control. Imported dengue--United States, 1991.",2000,,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Adult', 'Dengue/epidemiology/*etiology', 'Female', 'Humans', 'Male', 'Middle Aged', '*Travel', 'United States/epidemiology']",,1992/10/21 00:00,1992/10/21 00:01,['1992/10/21 00:00'],"['1992/10/21 00:00 [pubmed]', '1992/10/21 00:01 [medline]', '1992/10/21 00:00 [entrez]']",,ppublish,JAMA. 1992 Oct 21;268(15):2000.,15,,,,,,,,,,,,,,,,,,,,,,
1196646,NLM,MEDLINE,19760209,20041117,0030-9311 (Print) 0030-9311 (Linking),15,1975 May-Jun,Observations on hospitalized patients with dengue hemorrhagic fever.,125-42,,,"['Widya, M S', 'Puranto, L']","['Widya MS', 'Puranto L']",,,['eng'],['Journal Article'],,Indonesia,Paediatr Indones,Paediatrica Indonesiana,0376416,,IM,"['Child', 'Child, Hospitalized', 'Child, Preschool', 'Dengue/*diagnosis/mortality/therapy', 'Dengue Virus/isolation & purification', 'Female', 'Hemorrhagic Fevers, Viral/*diagnosis/mortality/therapy', 'Humans', 'Indonesia', 'Male', 'Syndrome']",,1975/05/01 00:00,1975/05/01 00:01,['1975/05/01 00:00'],"['1975/05/01 00:00 [pubmed]', '1975/05/01 00:01 [medline]', '1975/05/01 00:00 [entrez]']",,ppublish,Paediatr Indones. 1975 May-Jun;15(5-6):125-42.,5-6,,,,,,,,,,,,,,,,,,,,,,
28719315,NLM,MEDLINE,20170731,20181113,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),97,2017 Jul,Analysis of Clinical and Laboratory Alterations Related to Dengue Case Severity: Comparison between Serotypes 2 and 4 in Brazil.,137-145,10.4269/ajtmh.16-0227 [doi],"The increase in severe dengue (SD) cases has caused great impact on public health and has concerned authorities of countries where the disease is endemic and epidemics reach high proportions. The recognition of progression signs of this severe disease during the initial febrile phase can be difficult, since the symptoms are often indistinguishable from other febrile diseases. The aim of this study was to evaluate the clinical manifestations and laboratory findings in patients from two dengue outbreaks and their association with the disease. The study was conducted in patients (n = 153) with signs and symptoms consistent with dengue occurred during two distinct epidemics, 2010 and 2013, in the city of Campos dos Goytacazes, Rio de Janeiro, Brazil. According to the 2009 World Health Organization criteria, patients were classified as dengue without warning signs ([DwoWS] 60.6%, 57/94), dengue with warning signs ([DwWS] 30.9%, 29/94), and SD (4.25%, 4/94). Patients with DwWS/SD presented lower platelet and leukocyte counts and higher transaminase levels when compared with the DwoWS ones. Interestingly, patients from the epidemic of 2010 caused by dengue virus 2 (DENV-2) had lower platelet counts than patients of the 2013 epidemic caused by DENV-4. Furthermore, plasma leakage, gastrointestinal bleeding, and pleural effusion, hallmarks for a more severe disease, were also more frequently observed in those cases. Although previous studies may have extensively reported the wide range of the clinical aspects of dengue, the characterization of DENV-4 is desirable considering the burden of the disease during epidemics, especially for the health units and hospitals performing patient's management.","['da Costa Faria, Nieli Rodrigues', 'Solorzano, Victor Edgar Fiestas', 'de Souza, Luiz Jose', 'Nogueira, Rita Maria Ribeiro', 'de Bruycker-Nogueira, Fernanda', 'Chouin-Carneiro, Thais', 'Santos Simoes, Jaqueline Bastos', 'da Rocha Queiroz Lima, Monique', 'de Oliveira Pinto, Luzia Maria', 'Kubelka, Claire Fernandes', 'Heringer, Manoela', 'de Azeredo, Elzinandes Leal', 'Barreto Dos Santos, Flavia']","['da Costa Faria NR', 'Solorzano VEF', 'de Souza LJ', 'Nogueira RMR', 'de Bruycker-Nogueira F', 'Chouin-Carneiro T', 'Santos Simoes JB', 'da Rocha Queiroz Lima M', 'de Oliveira Pinto LM', 'Kubelka CF', 'Heringer M', 'de Azeredo EL', 'Barreto Dos Santos F']",,"['Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Hospital dos Plantadores de Cana, Campos dos Goytacazes, Rio de Janeiro, Brazil.', 'Flavivirus Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Hospital dos Plantadores de Cana, Campos dos Goytacazes, Rio de Janeiro, Brazil.', 'Hospital dos Plantadores de Cana, Campos dos Goytacazes, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.', 'Hospital dos Plantadores de Cana, Campos dos Goytacazes, Rio de Janeiro, Brazil.', 'Viral Immunology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil Oswaldo Cruz Institute, Rio de Janeiro, Brazil.']",['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Brazil/epidemiology', 'Dengue/epidemiology/*pathology/*virology', 'Dengue Virus/*classification/genetics/pathogenicity', 'Epidemics', 'Humans', 'Serogroup']",PMC5508884,2017/07/19 06:00,2017/08/02 06:00,['2017/07/19 06:00'],"['2017/07/19 06:00 [entrez]', '2017/07/19 06:00 [pubmed]', '2017/08/02 06:00 [medline]']","['tpmd160227 [pii]', '10.4269/ajtmh.16-0227 [doi]']",ppublish,Am J Trop Med Hyg. 2017 Jul;97(1):137-145. doi: 10.4269/ajtmh.16-0227.,1,,,,,,,,,,,,,,,,,,,,,,
30223572,NLM,MEDLINE,20190201,20190201,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),15,2018 Sep 15,"The Sensitivity, Specificity and Accuracy of Warning Signs in Predicting Severe Dengue, the Severe Dengue Prevalence and Its Associated Factors.",,10.3390/ijerph15092018 [doi] 2018,"Objectives: To study Malaysian dengue clinical practice guideline (CPG) warning signs (WS) in predicting severe dengue (SD) and its associated factors among confirmed cases presented to a teaching hospital in north-eastern Malaysia in 2014. Methods: A cross-sectional study was performed in February 2015 using secondary data acquired from the hospital records. There were 2607 confirmed dengue cases presented to Hospital Universiti Sains Malaysia (HUSM) in 2014. Seven hundred patients were selected after proportionate stratified random sampling conducted according to the number of cases in 12 different months in 2014. Data were collected and analysed using SPSS version 22.0. Results: Severe dengue outcomes represented 4.9% of cases. The prevalence of any of WS in SD was 91.2%. The most common WSs prior to SD were persistent vomiting (55.9%), and abdominal pain/tenderness (52.9%). The most sensitive warning sign in detecting SD was abdominal pain (59%). Specificity of individual WS were generally good, especially of clinical fluid accumulation (99%), hepatomegaly (98%) and mucosal bleeding (93%). Factors associated with SD were persistent vomiting (Adjusted odds ratio (aOR)): 2.41), mucosal bleeding (aOR: 4.73) and haematocrit rise with rapid platelet drop (aOR: 2.74). Conclusion: A focus on sensitivity, specificity, predictive values and association of a number of particular WS should be emphasized in order to better predict severe dengue outcomes.","['Ahmad, Mohd Hanief', 'Ibrahim, Mohd Ismail', 'Mohamed, Zeehaida', 'Ismail, Nabilah', 'Abdullah, Muhammad Amiruddin', 'Shueb, Rafidah Hanim', 'Shafei, Mohd Nazri']","['Ahmad MH', 'Ibrahim MI', 'Mohamed Z', 'Ismail N', 'Abdullah MA', 'Shueb RH', 'Shafei MN']","['ORCID: 0000-0002-5470-4180', 'ORCID: 0000-0002-7023-9717']","['Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. haniefahmad@gmail.com.', 'Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. ismaildr@usm.my.', 'Department of Microbiology & Parasitology, School of Medical Sciences, Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. zeehaida@usm.my.', 'Department of Microbiology & Parasitology, School of Medical Sciences, Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. drnabilah@usm.my.', 'Department of Microbiology & Parasitology, School of Medical Sciences, Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. amiruddin@usm.my.', 'Department of Microbiology & Parasitology, School of Medical Sciences, Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. hanimkk@usm.my.', 'Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu 16150, Kelantan, Malaysia. drnazri@usm.my.']",['eng'],['Journal Article'],20180915,Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', 'Dengue/diagnosis/epidemiology/pathology', 'Female', 'Humans', 'Malaysia/epidemiology', 'Male', 'Middle Aged', 'Odds Ratio', 'Predictive Value of Tests', 'Prevalence', 'Sensitivity and Specificity', 'Severe Dengue/*diagnosis/*epidemiology/pathology', 'Young Adult']",PMC6163319,2018/09/19 06:00,2019/02/02 06:00,['2018/09/19 06:00'],"['2018/08/12 00:00 [received]', '2018/09/10 00:00 [revised]', '2018/09/13 00:00 [accepted]', '2018/09/19 06:00 [entrez]', '2018/09/19 06:00 [pubmed]', '2019/02/02 06:00 [medline]']","['ijerph15092018 [pii]', 'ijerph-15-02018 [pii]', '10.3390/ijerph15092018 [doi]']",epublish,Int J Environ Res Public Health. 2018 Sep 15;15(9):2018. doi: 10.3390/ijerph15092018.,9,,['NOTNLM'],"['Malaysia', 'accuracy', 'prediction', 'severe dengue', 'warning signs']",['The authors declare no conflict of interest.'],"['Int J Environ Res Public Health. 2019 Mar 14;16(6):. PMID: 30875811', 'Int J Environ Res Public Health. 2019 Apr 17;16(8):. PMID: 30999608']",,,,,,,,,,,,,,,,,
4615598,NLM,MEDLINE,19750504,20220331,0002-9637 (Print) 0002-9637 (Linking),23,1974 Sep,Etiologies of the experimental dengues of Siler and Simmons.,974-82,,"Four participants in the American Army Philippine dengue (d) studies of Siler (1924-25) and five subjects from the studies of Simmons (1929-30) were bled 42 to 48 years after experimental infection. Sera were studied by hemagglutination-inhibition, complement-fixation and plaque reduction neutralization (PRNT) tests for antibodies to the known viral causes of the dengue syndrome in Asia and to St. Louis encephalitis virus. PRNT tests were done with and without fresh normal human serum (accessory factor). Serum from one of four Siler study volunteers had unequivocal evidence of only a previous d4 infection; the remainder had broadly reactive group B antibodies, including d4, suggesting past infection with two or more different dengue viruses. Sera from four of the Simmons study group had high-titered PRNT antibodies to d1 and the remaining serum had d1 antibody when accessory factor was added. In three sera there was monotypic PRNT antibody to d1. Acessory factor increased PRNT titers, particularly to d1 virus in the Simmons group. Only sera with antibody patterns suggesting past infections with two or more dengue viruses had high levels of SLE PRNT antibody. It is concluded that d4 was transmitted in the 1924 to 1925 and d1 in the 1929 to 1930 experiments. Notable differences in clinical features of dengue infections in the two studies suggest the possibility of the existence of an unique spectrum of responses to infection with different dengue virus type.","['Halstead, S B']",['Halstead SB'],,,['eng'],"['Biography', 'Historical Article', 'Journal Article']",,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,"['0 (Antibodies, Viral)', '0 (Antigens, Viral)']",IM,"['Adult', 'Aged', 'Antibodies, Viral/analysis', 'Antigens, Viral', 'Complement Fixation Tests', 'Dengue/*etiology/history/immunology/transmission', 'Dengue Virus/immunology', 'Hemagglutination Inhibition Tests', 'History, 20th Century', 'Humans', 'Male', 'Neutralization Tests', 'Philippines', 'Retrospective Studies', 'United States']",,1974/09/01 00:00,1974/09/01 00:01,['1974/09/01 00:00'],"['1974/09/01 00:00 [pubmed]', '1974/09/01 00:01 [medline]', '1974/09/01 00:00 [entrez]']",['10.4269/ajtmh.1974.23.974 [doi]'],ppublish,Am J Trop Med Hyg. 1974 Sep;23(5):974-82. doi: 10.4269/ajtmh.1974.23.974.,5,,,,,,,,,,,,,,,,,,,,"['Siler JF', 'Simmons JS']","['Siler, J F', 'Simmons, J S']",
17491374,NLM,MEDLINE,20070618,20131121,0047-1852 (Print) 0047-1852 (Linking),65 Suppl 3,2007 Mar 28,[Dengue fever and dengue hemorrhagic fever].,117-21,,,"['Takasaki, Tomohiko']",['Takasaki T'],,"['Laboratory of Vector-borne Viruses, Department of Virology 1, National Institute of Infectious Diseases.']",['jpn'],"['Journal Article', 'Review']",,Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,,IM,"['Animals', 'Culicidae/virology', '*Dengue/epidemiology/transmission', 'Humans', '*Severe Dengue/epidemiology/transmission']",,2007/05/12 09:00,2007/06/19 09:00,['2007/05/12 09:00'],"['2007/05/12 09:00 [pubmed]', '2007/06/19 09:00 [medline]', '2007/05/12 09:00 [entrez]']",,ppublish,Nihon Rinsho. 2007 Mar 28;65 Suppl 3:117-21.,,,,,,,,8,,,,,,,,,,,,,,,
36480945,NLM,MEDLINE,20221223,20230208,1474-4457 (Electronic) 1473-3099 (Linking),23,2023 Jan,Climate change and the increased burden of dengue fever in Pakistan.,17-18,S1473-3099(22)00808-8 [pii] 10.1016/S1473-3099(22)00808-8 [doi],,"['Abid, Muhammad Abbas', 'Abid, Muhammad Bilal']","['Abid MA', 'Abid MB']",,"['Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi 74000, Pakistan. Electronic address: abbas.abid@aku.edu.', 'Divisions of Hematology, Oncology, and Infectious Diseases, BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.']",['eng'],['Journal Article'],20221205,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,,IM,"['Humans', 'Pakistan/epidemiology', '*Climate Change', '*Dengue/epidemiology/prevention & control', 'Disease Outbreaks']",,2022/12/09 06:00,2022/12/24 06:00,['2022/12/08 23:15'],"['2022/11/24 00:00 [received]', '2022/11/24 00:00 [revised]', '2022/11/25 00:00 [accepted]', '2022/12/09 06:00 [pubmed]', '2022/12/24 06:00 [medline]', '2022/12/08 23:15 [entrez]']","['S1473-3099(22)00808-8 [pii]', '10.1016/S1473-3099(22)00808-8 [doi]']",ppublish,Lancet Infect Dis. 2023 Jan;23(1):17-18. doi: 10.1016/S1473-3099(22)00808-8. Epub 2022 Dec 5.,1,,,,['We declare no competing interests.'],,,,,,,,,,,,,,,,,,
24210959,NLM,MEDLINE,20140903,20181202,1873-5967 (Electronic) 1386-6532 (Linking),58,2013 Dec,Comment on: Fulminant myocarditis and viral infection.,752,S1386-6532(13)00467-8 [pii] 10.1016/j.jcv.2013.10.019 [doi],,"['Arya, Subhash C', 'Agarwal, Nirmala']","['Arya SC', 'Agarwal N']",,"['Sant Parmanand Hospital, Delhi, India. Electronic address: subhashbhapaji@gmail.com.']",['eng'],"['Comment', 'Letter']",20131026,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,,IM,"['Dengue/*diagnosis/*pathology', 'Female', 'Humans', 'Myocarditis/*pathology/*virology']",,2013/11/12 06:00,2014/09/04 06:00,['2013/11/12 06:00'],"['2013/09/20 00:00 [received]', '2013/10/12 00:00 [revised]', '2013/10/16 00:00 [accepted]', '2013/11/12 06:00 [entrez]', '2013/11/12 06:00 [pubmed]', '2014/09/04 06:00 [medline]']","['S1386-6532(13)00467-8 [pii]', '10.1016/j.jcv.2013.10.019 [doi]']",ppublish,J Clin Virol. 2013 Dec;58(4):752. doi: 10.1016/j.jcv.2013.10.019. Epub 2013 Oct 26.,4,,['NOTNLM'],"['Dengue virus', 'Emergency setting', 'Fulminant myocarditis', 'In situ PCR', 'Rapid diagnosis']",,,,,['J Clin Virol. 2013 Sep;58(1):1-3. PMID: 22824228'],,,,,,,,,,,,,,
32557142,NLM,MEDLINE,20210324,20210324,0973-7693 (Electronic) 0019-5456 (Linking),87,2020 Dec,Renal Manifestations in Children with Dengue Fever Hospitalized in Pediatric Intensive Care Unit.,1014-1017,10.1007/s12098-020-03402-z [doi],"OBJECTIVE: To study the pattern of acute kidney injury in children with dengue infection hospitalized in an intensive care unit. METHODS: This is a retrospective study from January 2019 through December 2019. Various renal manifestations of dengue were studied and compared between the severity of dengue fever. RESULTS: Three hundred nineteen children with dengue fever were hospitalized and 127 needed intensive care admission. Among the 127 patients, 26 (20.5%) children developed acute kidney injury (AKI). Children with severe dengue developed a higher number of AKI (n = 20; 28.6%), as compared to dengue with warning sign group (n = 6; 11.8%). Colloid infusion, inotropic support, ventilatory requirement and presence of secondary hemophagocytic lymphohistiocytosis were the risk factors for AKI. Nine children underwent dialysis. Among the AKI group, 23 recovered and 3 died and all three had multi organ dysfunction syndrome. CONCLUSIONS: It is essential to recognize the various renal manifestations of dengue AKI which is associated with increased mortality and morbidity.","['Rajan, Mahalakshmi', 'Geminiganesan, Sangeetha', 'Sankaranarayanan, Shuba', 'Padmanaban, Ramachandran', 'Selvam, Mahalakshmi Panneer']","['Rajan M', 'Geminiganesan S', 'Sankaranarayanan S', 'Padmanaban R', 'Selvam MP']",['ORCID: 0000-0003-0734-1126'],"['Department of Pediatric Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamilnadu, India.', 'Department of Pediatric Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamilnadu, India. sangeethaperungo@gmail.com.', 'Department of Pediatric Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamilnadu, India.', 'Department of Pediatric Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamilnadu, India.', 'Department of Pediatric Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamilnadu, India.']",['eng'],['Journal Article'],20200615,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Acute Kidney Injury/diagnosis/epidemiology/etiology', 'Child', '*Dengue/complications/diagnosis/therapy', 'Humans', 'Intensive Care Units, Pediatric', 'Lymphohistiocytosis, Hemophagocytic', 'Retrospective Studies', 'Risk Factors']",,2020/06/20 06:00,2021/03/25 06:00,['2020/06/20 06:00'],"['2020/04/07 00:00 [received]', '2020/06/09 00:00 [accepted]', '2020/06/20 06:00 [pubmed]', '2021/03/25 06:00 [medline]', '2020/06/20 06:00 [entrez]']","['10.1007/s12098-020-03402-z [pii]', '10.1007/s12098-020-03402-z [doi]']",ppublish,Indian J Pediatr. 2020 Dec;87(12):1014-1017. doi: 10.1007/s12098-020-03402-z. Epub 2020 Jun 15.,12,,['NOTNLM'],"['Acute kidney injury', 'Dengue fever', 'Dialysis', 'Severe dengue']",,['Indian J Pediatr. 2020 Dec;87(12):993-994. PMID: 33063275'],,,,,,,,,,,,,,,,,
27212578,NLM,MEDLINE,20170824,20180207,1545-5882 (Electronic) 0145-9740 (Linking),36,2017 Feb-Mar,"Local Biologies, Leaky Things, and the Chemical Infrastructure of Global Health.",141-156,10.1080/01459740.2016.1186672 [doi],"This article examines how two chemical substances are woven into the infrastructure of global health as well as into the social lives of health workers in urban Nicaragua. One chemical is temephos, an organophosphate used to control mosquitoes. The other is chlorine-based products, which are used to disinfect surfaces and water. While global health projects tend to treat these substances as stable objects, there are three ways in which they might be understood as leaky things, implicated in fluid social interactions. First, global health chemicals are tracked through rigid accounting, but because of numerical leakages, they become vehicles for fashioning new forms of concern. Second, chemicals leak structurally: They can be dissolved and reproduced at a molecular level, although that dissolution is never absolute, and that reproduction is not everywhere the same. Third, chemicals leak in a sensory fashion. Sensory interactions with chemicals produce an entanglement of knowledge about bodies and environments.","['Nading, Alex M']",['Nading AM'],,"['a Social Anthropology, School of Social and Political Science, University of Edinburgh , Edinburgh , Scotland , UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20160521,United States,Med Anthropol,Medical anthropology,7707343,"['0 (Disinfectants)', '0 (Insecticides)', '4R7X1O2820 (Chlorine)', 'ONP3ME32DL (Temefos)']",IM,"['Anthropology, Medical', 'Chlorine', '*Dengue/ethnology/prevention & control/transmission', 'Disinfectants', '*Environmental Exposure', '*Global Health', 'Humans', '*Insecticides', 'Nicaragua/ethnology', '*Temefos']",,2016/05/24 06:00,2017/08/25 06:00,['2016/05/24 06:00'],"['2016/05/24 06:00 [pubmed]', '2017/08/25 06:00 [medline]', '2016/05/24 06:00 [entrez]']",['10.1080/01459740.2016.1186672 [doi]'],ppublish,Med Anthropol. 2017 Feb-Mar;36(2):141-156. doi: 10.1080/01459740.2016.1186672. Epub 2016 May 21.,2,,['NOTNLM'],"['Aesthetics', 'community health workers', 'dengue', 'environmental health', 'mosquitoes']",,,,,,,,,,,,,,,,,,,
32900825,NLM,MEDLINE,20210907,20210907,1469-0756 (Electronic) 0032-5473 (Linking),96,2020 Dec,Atypical neurological manifestations of dengue fever: a case series and mini review.,759-765,10.1136/postgradmedj-2020-137533 [doi],"BACKGROUND: In this mini review, we discuss some of the atypical neurological manifestations of dengue virus and attempt to bring them to attention to highlight the neurotropic property of the dengue virus. METHODS: Cases were chosen from retrospective hospital and outpatient records of all patients seropositive for dengue who attended the neurology referral. Seven patients have been chosen as illustrative examples of dengue-associated neurological involvement. We discuss the various central and peripheral nervous system involvement of patients and discuss the relevant findings in them. CONCLUSION: Through this case series, we wish to highlight that the dengue virus can affect the nervous system at various targets, using multiple mechanisms of pathogenesis to generate a plethora of presentations. Hence, it is vital to be aware of its presentations to be able to diagnose dengue and treat it accordingly.","['Prabhat, Nandita', 'Ray, Sucharita', 'Chakravarty, Kamalesh', 'Kathuria, Heena', 'Saravana, Sukriya', 'Singh, Deependra', 'Rebello, Alex', 'Lakhanpal, Vikas', 'Goyal, Manoj Kumar', 'Lal, Vivek']","['Prabhat N', 'Ray S', 'Chakravarty K', 'Kathuria H', 'Saravana S', 'Singh D', 'Rebello A', 'Lakhanpal V', 'Goyal MK', 'Lal V']",['ORCID: 0000-0002-7769-6611'],"['Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India sucharita.pgi@gmail.com.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.', 'Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.']",['eng'],"['Journal Article', 'Review']",20200908,England,Postgrad Med J,Postgraduate medical journal,0234135,,IM,"['*Dengue/diagnosis/physiopathology', 'Dengue Virus/*pathogenicity', 'Diagnosis, Differential', 'Humans', '*Nervous System Diseases/diagnosis/virology', 'Neurologic Examination/methods']",,2020/09/10 06:00,2021/09/08 06:00,['2020/09/09 05:25'],"['2020/01/23 00:00 [received]', '2020/06/01 00:00 [accepted]', '2020/09/10 06:00 [pubmed]', '2021/09/08 06:00 [medline]', '2020/09/09 05:25 [entrez]']","['postgradmedj-2020-137533 [pii]', '10.1136/postgradmedj-2020-137533 [doi]']",ppublish,Postgrad Med J. 2020 Dec;96(1142):759-765. doi: 10.1136/postgradmedj-2020-137533. Epub 2020 Sep 8.,1142,"['(c) Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and', 'permissions. Published by BMJ.']",['NOTNLM'],"['Adult neurology', 'Dementia', 'Migraine', 'Motor neurone disease', 'Multiple sclerosis', 'Neurology']",['Competing interests: None declared.'],,,,,,,,,,,,,,,,,,
17939180,NLM,MEDLINE,20071030,20191110,1473-3099 (Print) 1473-3099 (Linking),7,2007 Oct,Dengue fever: what hope for control?,636,,,"['Senior, Kathryn']",['Senior K'],,,['eng'],['News'],,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,"['0 (Dengue Vaccines)', 'CIW5S16655 (DDT)']",IM,"['Aedes/genetics/*virology', 'Animals', 'DDT', 'Dengue/epidemiology/*prevention & control/transmission/virology', '*Dengue Vaccines', 'Dengue Virus/physiology', 'Disease Outbreaks/*prevention & control', 'Humans', 'Mosquito Control/methods', '*Organisms, Genetically Modified', 'Severe Dengue/epidemiology/*prevention & control/transmission/virology']",,2007/10/17 09:00,2007/10/31 09:00,['2007/10/17 09:00'],"['2007/10/17 09:00 [pubmed]', '2007/10/31 09:00 [medline]', '2007/10/17 09:00 [entrez]']","['S1473-3099(07)70221-9 [pii]', '10.1016/s1473-3099(07)70221-9 [doi]']",ppublish,Lancet Infect Dis. 2007 Oct;7(10):636. doi: 10.1016/s1473-3099(07)70221-9.,10,,,,,['Lancet Infect Dis. 2008 Jan;8(1):7-9. PMID: 18156083'],,,,,,,,,,,,,,,,,
80571,NLM,MEDLINE,19781118,20190610,0140-6736 (Print) 0140-6736 (Linking),2,1978 Sep 16,Circulating immune complexes in dengue haemorrhagic fever.,638-9,,,"['Petchclai, B', 'Saelim, P']","['Petchclai B', 'Saelim P']",,,['eng'],['Letter'],,England,Lancet,"Lancet (London, England)",2985213R,['0 (Antigen-Antibody Complex)'],IM,"['Antigen-Antibody Complex', 'Dengue/*etiology/immunology', 'Humans', 'Immune Complex Diseases/*complications']",,1978/09/16 00:00,1978/09/16 00:01,['1978/09/16 00:00'],"['1978/09/16 00:00 [pubmed]', '1978/09/16 00:01 [medline]', '1978/09/16 00:00 [entrez]']",['10.1016/s0140-6736(78)92872-6 [doi]'],ppublish,Lancet. 1978 Sep 16;2(8090):638-9. doi: 10.1016/s0140-6736(78)92872-6.,8090,,,,,,,,,,,,,,,,,,,,,,
36287255,NLM,MEDLINE,20221028,20221123,1522-9602 (Electronic) 0092-8240 (Linking),84,2022 Oct 26,Mathematical Modelling of Dengue Transmission with Intervention Strategies Using Fractional Derivatives.,138,10.1007/s11538-022-01096-2 [doi],"This paper deals with a deterministic mathematical model of dengue based on a system of fractional-order differential equations (FODEs). In this study, we consider dengue control strategies that are relevant to the current situation in Malaysia. They are the use of adulticides, larvicides, destruction of the breeding sites, and individual protection. The global stability of the disease-free equilibrium and the endemic equilibrium is constructed using the Lyapunov function theory. The relations between the order of the operator and control parameters are briefly analysed. Numerical simulations are performed to verify theoretical results and examine the significance of each intervention strategy in controlling the spread of dengue in the community. The model shows that vector control tools are the most efficient method to combat the spread of the dengue virus, and when combined with individual protection, make it more effective. In fact, the massive use of personal protection alone can significantly reduce the number of dengue cases. Inversely, mechanical control alone cannot suppress the excessive number of infections in the population, although it can reduce the Aedes mosquito population. The result of the real-data fitting revealed that the FODE model slightly outperformed the integer-order model. Thus, we suggest that the FODE approach is worth to be considered in modelling an infectious disease like dengue.","[""Hamdan, Nur 'Izzati"", 'Kilicman, Adem']","[""Hamdan N'"", 'Kilicman A']",['ORCID: 0000-0002-8333-6153'],"['School of Mathematical Sciences, College of Computing, Informatics and Media, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia. izzatihamdan@uitm.edu.my.', 'Department of Mathematics and Statistics, Faculty of Science, Universiti Putra Malaysia (UPM), 43400, Serdang, Selangor, Malaysia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20221026,United States,Bull Math Biol,Bulletin of mathematical biology,0401404,,IM,"['Animals', 'Humans', '*Dengue/epidemiology/prevention & control', 'Models, Biological', 'Mathematical Concepts', '*Aedes', 'Models, Theoretical']",,2022/10/27 06:00,2022/10/29 06:00,['2022/10/26 11:14'],"['2022/01/17 00:00 [received]', '2022/10/10 00:00 [accepted]', '2022/10/26 11:14 [entrez]', '2022/10/27 06:00 [pubmed]', '2022/10/29 06:00 [medline]']","['10.1007/s11538-022-01096-2 [pii]', '10.1007/s11538-022-01096-2 [doi]']",epublish,Bull Math Biol. 2022 Oct 26;84(12):138. doi: 10.1007/s11538-022-01096-2.,12,"['(c) 2022. The Author(s), under exclusive licence to Society for Mathematical', 'Biology.']",['NOTNLM'],"['Dengue', 'Dengue control', 'Fractional derivative', 'Global stability', 'Lyapunov function']",,,,,,,,,,,,,,,,,,,
25421705,NLM,MEDLINE,20150928,20220801,1439-0973 (Electronic) 0300-8126 (Linking),43,2015 Feb,The revised dengue fever classification in German travelers: clinical manifestations and indicators for severe disease.,21-8,10.1007/s15010-014-0688-z [doi],"BACKGROUND: The number of dengue cases imported to Germany has increased significantly in recent years. Among returning travelers, dengue is now a frequent cause of hospitalization. The aim of this study was to determine the proportion of patients with severe disease hospitalized in a European, non-endemic country applying the revised 2009 WHO classification system and to determine predictors of severe disease. METHODS: A retrospective single-center analysis of clinical data from 56 patients, 31 (55 %) women and 25 (45 %) men, between 14 and 70 years of age treated in a tertiary care hospital between 1996 and 2010 was conducted. RESULTS: Thirty-nine patients (69.6 %) presented with dengue fever without warning signs, 11 (19.6 %) with warning signs and 6 (10.7 %) with signs for severe dengue fever. Two patients (4 %) developed dengue shock syndrome. Non-European descent (p = 0.001), plasma protein level <6.5 mg/dl (p = 0.001), platelets <30/nl (p = 0.017) and activated partial thromboplastin time (aPTT) >44 s (p = 0.003) were associated with severe disease. CONCLUSIONS: A significant proportion of patients hospitalized with symptomatic imported dengue fever in Germany have evidence of severe disease. Simple routine laboratory parameters such as complete blood count, plasma protein level and aPTT are helpful tools for identifying adult patients at risk for severe disease.","['Hoffmeister, B', 'Suttorp, N', 'Zoller, T']","['Hoffmeister B', 'Suttorp N', 'Zoller T']",,"['Department of Infectious Diseases and Respiratory Medicine, Charite University Medicine Berlin, Chariteplatz 1, 10117, Berlin, Germany, b.hoffmeister-infekt@charite.de.']",['eng'],['Journal Article'],20141125,Germany,Infection,Infection,0365307,,IM,"['Adolescent', 'Adult', 'Aged', 'Dengue/diagnosis/*epidemiology/physiopathology', 'Female', 'Germany/epidemiology', 'Hospitalization/statistics & numerical data', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Tertiary Care Centers', '*Travel Medicine', 'Young Adult']",,2014/11/26 06:00,2015/09/29 06:00,['2014/11/26 06:00'],"['2014/06/30 00:00 [received]', '2014/10/03 00:00 [accepted]', '2014/11/26 06:00 [entrez]', '2014/11/26 06:00 [pubmed]', '2015/09/29 06:00 [medline]']",['10.1007/s15010-014-0688-z [doi]'],ppublish,Infection. 2015 Feb;43(1):21-8. doi: 10.1007/s15010-014-0688-z. Epub 2014 Nov 25.,1,,,,,,,,,,,,,,,,,,,,,,
29726966,NLM,MEDLINE,20190612,20190613,1878-3503 (Electronic) 0035-9203 (Linking),112,2018 Mar 1,Pattern of dengue virus infections in adult patients from Sri Lanka.,144-153,10.1093/trstmh/try034 [doi],"BACKGROUND: Sri Lanka experienced its largest dengue epidemic in 2017. This study describes the disease pattern of adult dengue patients from two hospitals in Sri Lanka. METHODS: Demographic, clinical and investigation findings of adult dengue patients admitted to the two hospitals from June to August 2017 were collected and analysed. RESULTS: A total of 1167 patients (777 males [66.2%], mean age 32.9 y) were studied. There were 775 (66.4%) patients with dengue fever (DF), 334 (28.6%) with dengue haemorrhagic fever grade I, 54 (4.6%) with DHF grade II and 4 (0.3%) with DHF grade III. DHF was significantly associated with abdominal symptoms/signs and bleeding manifestations (p<0.001). A considerable variation in time of onset of the critical phase was noted (day 3, 11.9%; day 4-5, 63.1%; day 6, 16.2%; day >/=7, 8.7%). Significantly lower platelet and white blood cell counts and elevated transaminase levels were found in DHF than DF (p<0.001). Other complications included myocarditis (two patients) and mild renal impairment (three patients). None had neurological manifestations. CONCLUSIONS: We found abdominal symptoms/signs, low platelet and white blood cell counts and high transaminase to be associated with DHF. The onset of the critical phase was variable and difficult to predict. Compiling data from various regions would help to understand disease patterns, which in turn would help in formulating evidence-based management guidelines and the allocation of limited health care resources.","['Jayarajah, Umesh', 'de Silva, Pradeep K', 'Jayawardana, Priyankara', 'Dissanayake, Upul', 'Kulatunga, Aruna', 'Fernando, Harshini', 'Perera, Lakshika', 'Kannangara, Vibhavee', 'Udayangani, Champika', 'Peiris, Ranga', 'Faizer, Shuaib', 'Yasawardene, Pamodh', 'de Zoysa, Ishan', 'Seneviratne, Suranjith L']","['Jayarajah U', 'de Silva PK', 'Jayawardana P', 'Dissanayake U', 'Kulatunga A', 'Fernando H', 'Perera L', 'Kannangara V', 'Udayangani C', 'Peiris R', 'Faizer S', 'Yasawardene P', 'de Zoysa I', 'Seneviratne SL']",,"['Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Department of Medicine, Base Hospital, Panadura, Sri Lanka.', 'Department of Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Department of Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Dengue Research Group, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, 25 Kynsey Road, Colombo 00800, Sri Lanka.', 'Institute of Immunity and Transplantation, Royal Free Hospital and University College London, Pond Street, Hampstead, London, NW3 2QG, UK.']",['eng'],"['Journal Article', 'Multicenter Study']",,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Adult', 'Dengue/*epidemiology/*physiopathology/therapy/virology', 'Dengue Virus/isolation & purification/*pathogenicity', 'Epidemiologic Studies', 'Evidence-Based Practice', 'Female', 'Hospitals/statistics & numerical data', 'Humans', 'Male', 'Middle Aged', 'Practice Guidelines as Topic', 'Serologic Tests', 'Sri Lanka/epidemiology', 'Young Adult']",,2018/05/05 06:00,2019/06/14 06:00,['2018/05/05 06:00'],"['2017/11/05 00:00 [received]', '2018/04/04 00:00 [accepted]', '2018/05/05 06:00 [pubmed]', '2019/06/14 06:00 [medline]', '2018/05/05 06:00 [entrez]']","['4991831 [pii]', '10.1093/trstmh/try034 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2018 Mar 1;112(3):144-153. doi: 10.1093/trstmh/try034.,3,,,,,,,,,,,,,,,,,,,,,,
8599144,NLM,MEDLINE,19960424,20061115,0036-3634 (Print) 0036-3634 (Linking),37 Suppl,1995,[Dengue in Mexico: a priority problem of public health].,S12-20,,Dengue fever is a viral disease transmitted by Aedes aegypti. It has been recently incorporated to the agenda of priorities in many countries in the Americas. The emergence of dengue hemorrhagic fever cases is becoming a public health threat and requires the implementation of intensive surveillance and control strategies. The epidemiological panorama of dengue in Mexico provides the opportunity to analyze a regional health problem and the risk factors involved in the genesis of hemorrhagic cases under a situation that has not reached epidemic proportions yet.,"['Narro-Robles, J', 'Gomez-Dantes, H']","['Narro-Robles J', 'Gomez-Dantes H']",,"['Secretaria de Salud, Mexico.']",['spa'],"['English Abstract', 'Journal Article']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Aged', 'Child', 'Child, Preschool', 'Dengue/*epidemiology/prevention & control/transmission', 'Disease Outbreaks/statistics & numerical data', '*Health Priorities', 'Humans', 'Incidence', 'Infant', 'Mexico/epidemiology', 'Middle Aged']",,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1995;37 Suppl:S12-20.,,,,,,,,,,El dengue en Mexico: un problema prioritario de salud publica.,,,,,,,,,,,,,
21398046,NLM,MEDLINE,20110915,20140827,1532-2777 (Electronic) 0306-9877 (Linking),76,2011 Jun,Hypothesis: Impregnated school uniforms reduce the incidence of dengue infections in school children.,861-2,10.1016/j.mehy.2011.02.037 [doi],"Dengue infection causes a significant economic, social and medical burden in affected populations in over 100 countries in the tropics and sub-tropics. Current dengue control efforts have generally focused on vector control but have not shown major impact. School-aged children are especially vulnerable to infection, due to sustained human-vector-human transmission in the close proximity environments of schools. Infection in children has a higher rate of complications, including dengue hemorrhagic fever and shock syndromes, than infections in adults. There is an urgent need for integrated and complementary population-based strategies to protect vulnerable children. We hypothesize that insecticide-treated school uniforms will reduce the incidence of dengue in school-aged children. The hypothesis would need to be tested in a community based randomized trial. If proven to be true, insecticide-treated school uniforms would be a cost-effective and scalable community based strategy to reduce the burden of dengue in children.","['Wilder-Smith, A', 'Lover, A', 'Kittayapong, P', 'Burnham, G']","['Wilder-Smith A', 'Lover A', 'Kittayapong P', 'Burnham G']",,"['National University of Singapore, Department of Medicine, Singapore. epvws@pacific.net.sg']",['eng'],['Journal Article'],20110312,United States,Med Hypotheses,Medical hypotheses,7505668,,IM,"['Child', '*Clothing', 'Dengue/epidemiology/*prevention & control', 'Humans', '*Schools', 'Thailand/epidemiology']",,2011/03/15 06:00,2011/09/16 06:00,['2011/03/15 06:00'],"['2010/10/27 00:00 [received]', '2011/02/20 00:00 [accepted]', '2011/03/15 06:00 [entrez]', '2011/03/15 06:00 [pubmed]', '2011/09/16 06:00 [medline]']","['S0306-9877(11)00088-0 [pii]', '10.1016/j.mehy.2011.02.037 [doi]']",ppublish,Med Hypotheses. 2011 Jun;76(6):861-2. doi: 10.1016/j.mehy.2011.02.037. Epub 2011 Mar 12.,6,['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
29210497,NLM,MEDLINE,20181024,20181024,1099-1654 (Electronic) 1052-9276 (Linking),28,2018 Jan,"Dengue in Rio Grande do Sul, Brazil: 2014 to 2016.",,10.1002/rmv.1960 [doi],"The first autochthonous dengue case in Rio Grande do Sul (RS), Southern Brazil, occurred in 2007. In 2008 and 2009, only imported cases were reported in RS, but from 2010 to 2013, reports of autochthonous infections increased significantly. This study analyzes and discusses laboratory, demographic, and clinical data regarding dengue cases in RS, from 2014 to 2016. This study analyzed 13,420 serum samples from notified patients with suspicion of dengue fever in RS from 2014 to 2016. Seasonality of positive cases, viral serotypes, and clinical and epidemiological aspects were analyzed. There was no difference in gender (P = .4); dengue fever occurred mainly in adults, with similar distribution among age groups. The number of dengue virus (DENV) cases increased from 89 cases in 2014 to 2518 in 2016. Dengue virus 1 was the most prevalent circulating serotype during this period (97.5% of cases). Dengue virus infections show peaks in March and April (late summer and early autumn), after periods of high temperatures and rainfall. In 2014, dengue cases were concentrated in the northwestern and eastern regions of RS, and in 2015 and 2016, the northern region also confirmed a high number of cases. With increase in DENV circulation in RS, a rise in the number of autochthonous infections was also observed, mainly in highly urbanized areas. This study revealed that circulation of DENV in RS increased significantly in 2015 and 2016, with a rise in the number of autochthonous infections and cocirculation with Chikungunya and Zika viruses, recently introduced into RS.","['Gregianini, Tatiana Schaffer', 'Tumioto-Giannini, Gabriela Luchiari', 'Favreto, Catia', 'Plentz, Luciana Ciarelli', 'Ikuta, Nilo', 'da Veiga, Ana B Gorini']","['Gregianini TS', 'Tumioto-Giannini GL', 'Favreto C', 'Plentz LC', 'Ikuta N', 'da Veiga ABG']",['ORCID: 0000-0003-1462-5506'],"['Laboratorio Central de Saude Publica da Secretaria de Saude do Estado do Rio Grande do Sul (LACEN/SES-RS), Porto Alegre, Brazil.', 'Laboratorio Central de Saude Publica da Secretaria de Saude do Estado do Rio Grande do Sul (LACEN/SES-RS), Porto Alegre, Brazil.', 'Centro Estadual de Vigilancia em Saude da Secretaria de Saude do Estado do Rio Grande do Sul (CEVS/SES-RS), Porto Alegre, Brazil.', 'Universidade Luterana do Brasil (ULBRA), Canoas, Brazil.', 'Universidade Luterana do Brasil (ULBRA), Canoas, Brazil.', 'PPG-Patologia, PPG-Biociencias, Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Brazil.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20171206,England,Rev Med Virol,Reviews in medical virology,9112448,,IM,"['Adolescent', 'Adult', 'Aged', 'Brazil/epidemiology', 'Child', 'Child, Preschool', 'Comorbidity', 'Dengue/diagnosis/*epidemiology/history/*virology', '*Dengue Virus/classification/genetics', 'Female', 'Geography', 'History, 21st Century', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Middle Aged', 'Population Surveillance', 'Serogroup', 'Young Adult']",,2017/12/07 06:00,2018/10/26 06:00,['2017/12/07 06:00'],"['2017/12/07 06:00 [pubmed]', '2018/10/26 06:00 [medline]', '2017/12/07 06:00 [entrez]']",['10.1002/rmv.1960 [doi]'],ppublish,Rev Med Virol. 2018 Jan;28(1). doi: 10.1002/rmv.1960. Epub 2017 Dec 6.,1,"['Copyright (c) 2017 John Wiley & Sons, Ltd.']",['NOTNLM'],"['DENV Serotypes', 'arboviral disease', 'dengue fever']",,,,,,,,,,,,,,,,,,,
32931859,NLM,MEDLINE,20210527,20210527,1874-1754 (Electronic) 0167-5273 (Linking),324,2021 Feb 1,Spectrum of cardiac involvement in patients with dengue fever.,180-185,S0167-5273(20)33815-8 [pii] 10.1016/j.ijcard.2020.09.034 [doi],"BACKGROUND: Dengue fever (DF) is an infectious disease of viral origin common in the tropics. Studies on a large number of patients with dengue infection to assess associated cardiac involvement are rare. METHODS: We analyzed the incidence and spectrum of cardiac abnormalities in 320 patients with dengue fever admitted to our hospital located in an endemic area for dengue infection. All patients were evaluated following the WHO guidelines. Those confirmed to have dengue infection by serology had detailed clinical evaluation, 12lead electrocardiography (ECG), assay for cardiac markers (troponin T, CK-MB, NT Pro BNP) and 2-D echocardiography. RESULTS: Among the 320 patients selected for the study 112 (35%) had changes of cardiac involvement as detected by investigations. Changes in ECG were seen in all of them. Sinus bradycardia in spite of fever was the most common abnormality (n = 63;19.7%). Forty-two (13.1%) patients had left ventricular ejection fraction less than 40%. Forty-eight patients (15%) had increased serum levels of troponin-T. Serum levels of CK-MB were elevated in 34 (10.6%) and serum levels of NT-pro BNP was increased in 19 (5.9%). Fourteen patients died and all of them had abnormalities in electrocardiogram, echocardiogram and serum markers. CONCLUSION: Our study reveals that cardiac involvement in patients with dengue infection is not uncommon. We found that ECHO or ECG abnormalities or elevated serum levels of markers of cardiac injury are predictors of risk for adverse outcome. Absence of these abnormalities has a 100% negative predictive value.","['Shah, Chintan', 'Vijayaraghavan, Govindan', 'Kartha, Chandrasekharan C']","['Shah C', 'Vijayaraghavan G', 'Kartha CC']",,"['Department of Cardiology, Society for Continuing Medical Education & Research, Kerala Institute of Medical Sciences, Trivandrum 695029, Kerala, India.', 'Department of Cardiology, Society for Continuing Medical Education & Research, Kerala Institute of Medical Sciences, Trivandrum 695029, Kerala, India. Electronic address: drvijayaraghavan@kimsglobal.com.', 'Department of Cardiology, Society for Continuing Medical Education & Research, Kerala Institute of Medical Sciences, Trivandrum 695029, Kerala, India.']",['eng'],['Journal Article'],20200913,Netherlands,Int J Cardiol,International journal of cardiology,8200291,"['0 (Biomarkers)', 'EC 2.7.3.2 (Creatine Kinase, MB Form)']",IM,"['Biomarkers', 'Creatine Kinase, MB Form', '*Dengue/diagnosis/diagnostic imaging', 'Echocardiography', 'Humans', 'Stroke Volume', '*Ventricular Function, Left']",,2020/09/16 06:00,2021/05/28 06:00,['2020/09/15 20:12'],"['2019/09/05 00:00 [received]', '2020/08/27 00:00 [revised]', '2020/09/10 00:00 [accepted]', '2020/09/16 06:00 [pubmed]', '2021/05/28 06:00 [medline]', '2020/09/15 20:12 [entrez]']","['S0167-5273(20)33815-8 [pii]', '10.1016/j.ijcard.2020.09.034 [doi]']",ppublish,Int J Cardiol. 2021 Feb 1;324:180-185. doi: 10.1016/j.ijcard.2020.09.034. Epub 2020 Sep 13.,,['Copyright (c) 2020. Published by Elsevier B.V.'],['NOTNLM'],"['Cardiac arrhythmias', 'Cardiac biomarkers', 'Cardiac failure', 'Cardiac involvement', 'Dengue fever', 'Left ventricular dysfunction']",['Declaration of Competing Interest Nil'],,,,,,,,,,,,,,,,,,
19850226,NLM,MEDLINE,20091105,20220321,1474-4457 (Electronic) 1473-3099 (Linking),9,2009 Nov,Progress towards a dengue vaccine.,678-87,10.1016/S1473-3099(09)70254-3 [doi],"The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue. A safe and effective vaccine for dengue is urgently needed. The pathogenesis of severe dengue results from a complex interaction between the virus, the host, and, at least in part, immune-mediated mechanisms. Vaccine development has been slowed by fears that immunisation might predispose individuals to the severe form of dengue infection. A pipeline of candidate vaccines now exists, including live attenuated, inactivated, chimeric, DNA, and viral-vector vaccines, some of which are at the stage of clinical testing. In this Review, we present what is understood about dengue pathogenesis and its implications for vaccine design, the progress that is being made in the development of a vaccine, and the future challenges.","['Webster, Daniel P', 'Farrar, Jeremy', 'Rowland-Jones, Sarah']","['Webster DP', 'Farrar J', 'Rowland-Jones S']",,"['Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford, UK. danwebster@doctors.org.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,['0 (Dengue Vaccines)'],IM,"['Dengue/epidemiology/*immunology/*prevention & control', 'Dengue Vaccines/*immunology', 'Dengue Virus/*immunology/*pathogenicity', 'Humans']",,2009/10/24 06:00,2009/11/06 06:00,['2009/10/24 06:00'],"['2009/10/24 06:00 [entrez]', '2009/10/24 06:00 [pubmed]', '2009/11/06 06:00 [medline]']","['S1473-3099(09)70254-3 [pii]', '10.1016/S1473-3099(09)70254-3 [doi]']",ppublish,Lancet Infect Dis. 2009 Nov;9(11):678-87. doi: 10.1016/S1473-3099(09)70254-3.,11,,,,,,"['MC_U137884180/MRC_/Medical Research Council/United Kingdom', 'WT_/Wellcome Trust/United Kingdom']",124,,,,,,,,,['Lancet Infect Dis. 2010 May;10(5):304'],,,,,,
20701858,NLM,MEDLINE,20101214,20220409,1876-035X (Electronic) 1876-0341 (Linking),2,2009,"Knowledge, attitudes, and practices relating to Dengue fever among females in Jeddah high schools.",30-40,10.1016/j.jiph.2009.01.004 [doi],"Dengue is increasingly recognized as one of the world's major infectious diseases. Dengue vectors, human knowledge and human behavior have each been reported to play an important role in the transmission of the disease. A cross-sectional approach was conducted to assess knowledge, attitudes and practice (KAP) of high school female students, teachers and supervisors towards Dengue fever (DF), and to determine scoring predictors of high school students' knowledge and practice scores. A multistage, stratified, random sample method was applied. A total of 2693 students, 356 teachers and 115 supervisors completed confidential self-administered questionnaires. RESULTS: Students obtained the lowest mean knowledge score compared to the other two groups (F=51.5, P<0.001). A positive family history of DF (a OR=2.05; 95% CI=1.15-3.64), having literate mothers (>or=secondary education), and students' age >or=17 were the predictors of high students' knowledge score. The only predictor of high practice score was obtaining high knowledge score (a OR=2.06; 95% CI=1.73-2.44). CONCLUSION: KAP towards DF was deficient among target populations, especially among students. School-based educational campaigns and social mobilization for raising knowledge and changing it into sound practice is urgently needed for controlling dengue epidemics in Jeddah.","['Ibrahim, Nahla Khamis Ragab', 'Al-Bar, Adnan', 'Kordey, Mohamed', 'Al-Fakeeh, Ali']","['Ibrahim NK', 'Al-Bar A', 'Kordey M', 'Al-Fakeeh A']",,"['Family and Community Medicine Department, Faculty of Medicine, King AbdulAziz University, Jeddah, Saudi Arabia. nahlakhamis@yahoo.com']",['eng'],['Journal Article'],20090304,England,J Infect Public Health,Journal of infection and public health,101487384,,IM,"['Adolescent', 'Adult', 'Age Distribution', 'Child', 'Cross-Sectional Studies', 'Dengue/prevention & control/*psychology/transmission', 'Faculty', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Middle Aged', 'Saudi Arabia', 'Schools', 'Students', 'Surveys and Questionnaires', 'Young Adult']",,2009/01/01 00:00,2010/12/16 06:00,['2010/08/13 06:00'],"['2008/12/04 00:00 [received]', '2009/01/12 00:00 [revised]', '2009/01/12 00:00 [accepted]', '2010/08/13 06:00 [entrez]', '2009/01/01 00:00 [pubmed]', '2010/12/16 06:00 [medline]']","['S1876-0341(09)00005-7 [pii]', '10.1016/j.jiph.2009.01.004 [doi]']",ppublish,J Infect Public Health. 2009;2(1):30-40. doi: 10.1016/j.jiph.2009.01.004. Epub 2009 Mar 4.,1,,,,,,,,,,,,,,,,['J Infect Public Health. 2009;2(3):155'],,,,,,
18584920,NLM,MEDLINE,20090522,20161018,0248-8663 (Print) 0248-8663 (Linking),30,2009 Mar,[Peripheral and bone marrow plasmacytosis in dengue fever: report of a case].,274-6,10.1016/j.revmed.2008.05.012 [doi],"We report a case of dengue fever with plasma cells in the blood (3980 per cubic millimeter) and bone marrow (30%) in a 55-year-old woman hospitalized for fever, arthralgias and thrombocytopenia (66,000 per cubic millimeter) on returning from the West Indies. Serological testing confirmed the diagnosis. Plasmacytosis is rare in dengue fever and its frequency and correlation with the different forms of the disease remain to be determined.","['Bibi-Triki, T', 'Aras, N', 'Braun, T', 'Lautridou, C', 'Boukari, L', 'Morin, A S', 'Maquarre, E', 'Stirnemann, J', 'Brichler, S', 'Laurian, Y', 'Fain, O']","['Bibi-Triki T', 'Aras N', 'Braun T', 'Lautridou C', 'Boukari L', 'Morin AS', 'Maquarre E', 'Stirnemann J', 'Brichler S', 'Laurian Y', 'Fain O']",,"[""Laboratoire d'hematologie, Hopital Jean-Verdier, Universite Paris-13, 93143 Bondy cedex, France. tewfik.bibi-triki@jvr.aphp.fr""]",['fre'],"['Case Reports', 'Comparative Study', 'English Abstract', 'Journal Article']",20080626,France,Rev Med Interne,La Revue de medecine interne,8101383,,IM,"['*Bone Marrow/pathology', 'Bone Marrow Examination', '*Dengue/blood/complications/diagnosis/pathology', 'Female', 'Follow-Up Studies', 'Humans', 'Middle Aged', '*Plasma Cells/pathology', 'Thrombocytopenia/diagnosis/etiology', 'Time Factors']",,2008/07/01 09:00,2009/05/23 09:00,['2008/07/01 09:00'],"['2008/01/15 00:00 [received]', '2008/05/05 00:00 [revised]', '2008/05/08 00:00 [accepted]', '2008/07/01 09:00 [pubmed]', '2009/05/23 09:00 [medline]', '2008/07/01 09:00 [entrez]']","['S0248-8663(08)00635-8 [pii]', '10.1016/j.revmed.2008.05.012 [doi]']",ppublish,Rev Med Interne. 2009 Mar;30(3):274-6. doi: 10.1016/j.revmed.2008.05.012. Epub 2008 Jun 26.,3,,,,,,,,,Plasmocytose sanguine et medullaire au cours de la dengue : une observation.,,,,,,,,,,,,,
21457980,NLM,MEDLINE,20111007,20161229,1879-3479 (Electronic) 0020-7292 (Linking),113,2011 Jun,Dengue fever as a cause of menorrhagia.,247-8,10.1016/j.ijgo.2011.01.003 [doi],,"['Jain, Meenu', 'Sehgal, Alka']","['Jain M', 'Sehgal A']",,"['Department of Obstetrics and Gynecology, Government Medical College and Hospital, Chandigarh, India. meenujainbagga1976@gmail.com']",['eng'],"['Case Reports', 'Journal Article']",20110401,United States,Int J Gynaecol Obstet,International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,0210174,,IM,"['Adult', 'Dengue/complications/*diagnosis', 'Female', 'Humans', 'Menorrhagia/*etiology']",,2011/04/05 06:00,2011/10/08 06:00,['2011/04/05 06:00'],"['2010/11/19 00:00 [received]', '2011/01/05 00:00 [revised]', '2011/02/16 00:00 [accepted]', '2011/04/05 06:00 [entrez]', '2011/04/05 06:00 [pubmed]', '2011/10/08 06:00 [medline]']","['S0020-7292(11)00078-6 [pii]', '10.1016/j.ijgo.2011.01.003 [doi]']",ppublish,Int J Gynaecol Obstet. 2011 Jun;113(3):247-8. doi: 10.1016/j.ijgo.2011.01.003. Epub 2011 Apr 1.,3,,,,,,,,,,,,,,,,,,,,,,
9057456,NLM,MEDLINE,19970408,20041117,0019-5138 (Print) 0019-5138 (Linking),28,1996 Dec,Haemorrhagic manifestations associated with dengue virus infection in Nagaland.,301-3,,,"['Baruah, H C', 'Mohapatra, P K', 'Kire, M', 'Pegu, D K', 'Mahanta, J']","['Baruah HC', 'Mohapatra PK', 'Kire M', 'Pegu DK', 'Mahanta J']",,"['Regional Medical Research Centre, N.E. Region (ICMR), Dibrugarh, Assam, India.']",['eng'],['Journal Article'],,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['Dengue/*complications/mortality', 'Hemorrhage/*etiology', 'Humans', 'India', 'Rural Population']",,1996/12/01 00:00,1996/12/01 00:01,['1996/12/01 00:00'],"['1996/12/01 00:00 [pubmed]', '1996/12/01 00:01 [medline]', '1996/12/01 00:00 [entrez]']",,ppublish,J Commun Dis. 1996 Dec;28(4):301-3.,4,,,,,,,,,,,,,,,,,,,,,,
23591999,NLM,MEDLINE,20140328,20220409,1861-0293 (Electronic) 1340-3443 (Print) 1340-3443 (Linking),67,2013 Oct,Potential anti-dengue medicinal plants: a review.,677-89,10.1007/s11418-013-0767-y [doi],"Dengue fever causes mortality and morbidity around the world, specifically in the Tropics and subtropic regions, which has been of major concern to governments and the World Health Organization (WHO). As a consequence, the search for new anti-dengue agents from medicinal plants has assumed more urgency than in the past. Medicinal plants have been used widely to treat a variety of vector ailments such as malaria. The demand for plant-based medicines is growing as they are generally considered to be safer, non-toxic and less harmful than synthetic drugs. This article reviews potential anti-dengue activities from plants distributed around the world. Sixty-nine studies from 1997 to 2012 describe 31 different species from 24 families that are known for their anti-dengue activities. About ten phytochemicals have been isolated from 11 species, among which are compounds with the potential for development of dengue treatment. Crude extracts and essential oils obtained from 31 species showed a broad activity against Flavivirus. Current studies show that natural products represent a rich potential source of new anti-dengue compounds. Further ethnobotanical surveys and laboratory investigations are needed established the potential of identified species in contributing to dengue control.","['Abd Kadir, Siti Latifah', 'Yaakob, Harisun', 'Mohamed Zulkifli, Razauden']","['Abd Kadir SL', 'Yaakob H', 'Mohamed Zulkifli R']",,"['Department of Bioprocess Engineering, Faculty of Chemical Engineering, Universiti Teknologi Malaysia, 81310, Skudai, Johor, Malaysia, slatifah2@live.utm.my.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130417,Japan,J Nat Med,Journal of natural medicines,101518405,"['0 (Antiviral Agents)', '0 (Plant Extracts)']",IM,"['Antiviral Agents/chemistry/pharmacology/*therapeutic use', 'Dengue/*drug therapy/epidemiology/virology', 'Humans', '*Phytotherapy', 'Plant Extracts/pharmacology/therapeutic use', '*Plants, Medicinal/chemistry']",PMC3765846,2013/04/18 06:00,2014/03/29 06:00,['2013/04/18 06:00'],"['2012/06/18 00:00 [received]', '2013/03/12 00:00 [accepted]', '2013/04/18 06:00 [entrez]', '2013/04/18 06:00 [pubmed]', '2014/03/29 06:00 [medline]']","['767 [pii]', '10.1007/s11418-013-0767-y [doi]']",ppublish,J Nat Med. 2013 Oct;67(4):677-89. doi: 10.1007/s11418-013-0767-y. Epub 2013 Apr 17.,4,,,,,,,,,,,,,,,,,,,,,,
30517314,NLM,MEDLINE,20190603,20190603,1678-4464 (Electronic) 0102-311X (Linking),34,2018 Nov 29,"[Costs of an Aedes aegypti vector control program in municipalities in Colombia: a case study in Giron and Guadalajara de Buga, 2016].",e00044518,S0102-311X2018001205006 [pii] 10.1590/0102-311X00044518 [doi],"The aim of this study was to measure the costs of vector-borne disease control programs at the local level in Colombia (2016). A cost analysis was performed for this purpose from the policymaker's perspective in the municipalities (counties) of Giron and Guadalajara de Buga, specifically for the Aedes aegypti control program, the principal mosquito vector of dengue, Zika, and chikungunya. The analysis involved the quantification of all the costs required for each of the prevention and control strategies in vector-borne diseases. The costs were classified as operating and capital costs, and for purposes of comparison the costs were also calculated per case and per capita. The programs' total estimated costs were USD 146,651 in Giron and USD 97,936 in Guadalajara de Buga. Per capita cost was USD 0.88 in Giron and USD 0.99 in Guadalajara de Buga. In general, the predominant cost strategies were chemical spraying of adult mosquitos, accounting for 26% of the total costs in Giron and 47% in Guadalajara de Buga, with personnel representing 40% of the total costs for this strategy in Giron and 66% of the operating costs in Guadalajara de Buga.","['Salinas-Lopez, Manuel Alejandro', 'Soto-Rojas, Victoria Eugenia', 'Ocampo, Clara Beatriz']","['Salinas-Lopez MA', 'Soto-Rojas VE', 'Ocampo CB']",,"['Universidad Icesi, Cali, Colombia.', 'Universidad Icesi, Cali, Colombia.', 'Centro de Estudios en Proteccion Social y Economia de la Salud, Cali, Colombia.', 'Universidad Icesi, Cali, Colombia.', 'Centro Internacional de Entrenamiento e Investigaciones Medicas, Cali, Colombia.']",['spa'],['Journal Article'],20181129,Brazil,Cad Saude Publica,Cadernos de saude publica,8901573,,IM,"['*Aedes', 'Animals', 'Colombia/epidemiology', 'Costs and Cost Analysis', 'Dengue/*economics/epidemiology/prevention & control/transmission', 'Humans', 'Mosquito Control/*economics/methods/statistics & numerical data', 'Mosquito Vectors']",,2018/12/06 06:00,2019/06/04 06:00,['2018/12/06 06:00'],"['2018/03/06 00:00 [received]', '2018/08/17 00:00 [accepted]', '2018/12/06 06:00 [entrez]', '2018/12/06 06:00 [pubmed]', '2019/06/04 06:00 [medline]']","['S0102-311X2018001205006 [pii]', '10.1590/0102-311X00044518 [doi]']",epublish,Cad Saude Publica. 2018 Nov 29;34(12):e00044518. doi: 10.1590/0102-311X00044518.,12,,,,,['Cad Saude Publica. 2019 Mar 11;35(3):e00242318. PMID: 30864616'],,,,"Costos de un programa de control del vector Aedes aegypti en municipios de Colombia: el caso de Giron y Guadalajara de Buga, 2016.",,,,,,,,,,,,,
17932434,NLM,MEDLINE,20071127,20220331,0971-5916 (Print) 0971-5916 (Linking),126,2007 Aug,"Laboratory-based dengue fever surveillance in Tamil Nadu, India.",112-5,,"Dengue fever and dengue haemorrhagic fever (DF/DHF) have become a serious public health problem in many parts of India in recent years. Several vertical national programmes for communicable diseases, which include vector-borne diseases such as malaria and filariasis have been in operation for over five decades in India. The remarkable increase in dengue fever and DHF related deaths during the last decade has necessitated an effective surveillance system to detect the cases and adopt appropriate control measures against dengue vectors. Although the existence of all the four serotypes of dengue virus was proved as early as in 1960s, it was only after 1990, several outbreaks of DF/DHF were reported in Tamil Nadu. Further, dengue, once considered as urban problem has now penetrated into rural areas also, due to various changes in the environment. The geographic spread, increase in number of cases, reporting system, laboratory diagnosis, monitoring of vector density and investigation of outbreaks in Tamil Nadu during the last decade are comprehensively documented and discussed here to further strengthen the surveillance network to prevent possible major outbreaks of DF/DHF.","['Victor, T John', 'Malathi, M', 'Asokan, R', 'Padmanaban, P']","['Victor TJ', 'Malathi M', 'Asokan R', 'Padmanaban P']",,"['Institute of Vector Control & Zoonoses, Hosur, India. victorsherene@rediffmail.com']",['eng'],"['Journal Article', 'Review']",,India,Indian J Med Res,The Indian journal of medical research,0374701,,IM,"['Aedes/virology', 'Animals', '*Clinical Laboratory Techniques', 'Dengue/*diagnosis/epidemiology/transmission', 'Dengue Virus/isolation & purification', 'Disease Outbreaks', 'Humans', 'India/epidemiology', 'Insect Vectors', 'Population Surveillance/*methods', 'Severe Dengue/*diagnosis/epidemiology/transmission']",,2007/10/13 09:00,2007/12/06 09:00,['2007/10/13 09:00'],"['2007/10/13 09:00 [pubmed]', '2007/12/06 09:00 [medline]', '2007/10/13 09:00 [entrez]']",,ppublish,Indian J Med Res. 2007 Aug;126(2):112-5.,2,,,,,,,11,,,,,,,,,,,,,,,
4429191,NLM,MEDLINE,19750125,20190516,0002-9637 (Print) 0002-9637 (Linking),23,1974 Nov,Dengue type 3 infection in Panama.,1205-6,,,"['Rosen, L']",['Rosen L'],,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral/analysis', 'Antibody Formation', 'Dengue/classification/*epidemiology/immunology', 'Dengue Virus/isolation & purification', 'Hemagglutination Inhibition Tests', 'Humans', 'Neutralization Tests', 'Panama', 'Serotyping', 'Viral Plaque Assay']",,1974/11/01 00:00,1974/11/01 00:01,['1974/11/01 00:00'],"['1974/11/01 00:00 [pubmed]', '1974/11/01 00:01 [medline]', '1974/11/01 00:00 [entrez]']",['10.4269/ajtmh.1974.23.1205 [doi]'],ppublish,Am J Trop Med Hyg. 1974 Nov;23(6):1205-6. doi: 10.4269/ajtmh.1974.23.1205.,6,,,,,,,,,,,,,,,,,,,,,,
27613205,NLM,MEDLINE,20170417,20170417,1946-1968 (Electronic) 1524-0436 (Linking),,2016 Oct-Dec,Protection of Military Personnel Against Vector-Borne Diseases: A Review of Collaborative Work of the Australian and US Military Over the Last 30 Years.,14-21,,"Australian and US military medical services have collaborated since World War II to minimize vector-borne diseases such as malaria, dengue, and scrub typhus. In this review, collaboration over the last 30 years is discussed. The collaborative projects and exchange scientist programs have resulted in mutually beneficial outcomes in the fields of drug development and personal protection measures against vector-borne diseases.","['Frances, Stephen P', 'Edstein, Michael D', 'Debboun, Mustapha', 'Shanks, G Dennis']","['Frances SP', 'Edstein MD', 'Debboun M', 'Shanks GD']",,"['Australian Army Malaria Institute, Enoggera, Queensland, Australia.']",['eng'],['Journal Article'],,United States,US Army Med Dep J,U.S. Army Medical Department journal,9617037,"['0 (Aminoquinolines)', '262P8GS9L9 (tafenoquine)']",IM,"['Aminoquinolines/pharmacology', 'Animals', 'Australia/epidemiology', 'Dengue/drug therapy/epidemiology/prevention & control/transmission', '*Disease Vectors', 'Humans', 'Internationality', 'Malaria/drug therapy/prevention & control/transmission', '*Military Personnel', 'United States/epidemiology']",,2016/09/11 06:00,2017/04/18 06:00,['2016/09/11 06:00'],"['2016/09/11 06:00 [entrez]', '2016/09/11 06:00 [pubmed]', '2017/04/18 06:00 [medline]']",,ppublish,US Army Med Dep J. 2016 Oct-Dec;(3-16):14-21.,3-16,,['NOTNLM'],"['Australia', 'Malaysia', 'Thailand', 'drug development', 'malaria', 'personal protection', 'scrub typhus']",,,,,,,,,,,,,,,,,,,
2386674,NLM,MEDLINE,19900925,20161201,0049-8114 (Print) 0049-8114 (Linking),65,1990 Apr 6,Epidemiology of dengue fever/dengue haemorrhagic fever.,104-6,,,,,,,"['eng', 'fre']",['Journal Article'],,Switzerland,Wkly Epidemiol Rec,Releve epidemiologique hebdomadaire,0240017,,IM,"['Adolescent', 'Adult', 'Aedes', 'Animals', 'Dengue/*epidemiology/etiology/transmission', '*Disease Outbreaks', 'Female', 'Humans', 'Incidence', 'Male', 'Mosquito Control', 'Prevalence', 'Seasons', 'Seroepidemiologic Studies', 'Singapore']",,1990/04/06 00:00,1990/04/06 00:01,['1990/04/06 00:00'],"['1990/04/06 00:00 [pubmed]', '1990/04/06 00:01 [medline]', '1990/04/06 00:00 [entrez]']",,ppublish,Wkly Epidemiol Rec. 1990 Apr 6;65(14):104-6.,14,,,,,,,,,,,,,,,,,,,,,,
15460008,NLM,MEDLINE,20041102,20051116,0254-6450 (Print) 0254-6450 (Linking),21,2000 Jun,[Current status in the prevention and control of dengue fever in China].,223-4,,,"['Zhao, Z']",['Zhao Z'],,"['Hainan Province Public Health Station, Haikou 570203, China']",['chi'],"['Journal Article', 'Review']",,China,Zhonghua Liu Xing Bing Xue Za Zhi,Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,8208604,,IM,"['China/epidemiology', 'Dengue/*epidemiology/*prevention & control', 'Humans', 'Prevalence']",,2004/10/06 09:00,2004/11/04 09:00,['2004/10/06 09:00'],"['2004/10/06 09:00 [pubmed]', '2004/11/04 09:00 [medline]', '2004/10/06 09:00 [entrez]']",,ppublish,Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Jun;21(3):223-4.,3,,,,,,,9,,,,,,,,,,,,,,,
5632303,NLM,MEDLINE,19681106,20130405,,60,1967 Jul-Aug,"[On an epidemic of dengue occurring in Tahiti in 1964. Relations to the ""hemorrhagic fevers"" of Southeast Asia].",339-53,,,"['Laigret, J', 'Rosen, L', 'Scholammer, G']","['Laigret J', 'Rosen L', 'Scholammer G']",,,['fre'],['Journal Article'],,France,Bull Soc Pathol Exot Filiales,Bulletin de la Societe de pathologie exotique et de ses filiales,7503399,,IM,"['Adult', 'Asia, Southeastern', 'Child', 'Dengue/classification/*epidemiology', 'Dengue Virus/*isolation & purification', '*Disease Outbreaks', 'Humans', 'Polynesia']",,1967/07/01 00:00,1967/07/01 00:01,['1967/07/01 00:00'],"['1967/07/01 00:00 [pubmed]', '1967/07/01 00:01 [medline]', '1967/07/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot Filiales. 1967 Jul-Aug;60(14):339-53.,14,,,,,,,,,"Sur une epidemie de dengue survenue a Tahiti en 1964. Relations avec les ""fievres hemorragiques"" du Sud-Est Asiatique.",,,,,,,,,,,,,
12505032,NLM,MEDLINE,20030123,20191106,1473-3099 (Print) 1473-3099 (Linking),3,2003 Jan,Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence.,33-41,,"Despite efforts to elucidate the pathogenesis of dengue fever, the progression into severe disease remains poorly understood. In-vitro findings suggest that coagulopathy and disturbances in fibrinolysis have a pivotal role in the pathophysiology. If disturbances in these processes are predictive of clinical outcome in this disease, there could be important consequences for both diagnosis and treatment. We have critically reviewed publications on this topic to assess whether there is an association between activation of coagulation and fibrinolysis and clinical outcome of dengue-virus infections. In general, the selected studies showed activation of both the coagulation and fibrinolytic systems in this infection. The activation was more pronounced in severe infections and in cases with a poor clinical outcome. However, the findings were not consistent, and owing to a lack of detailed information on characteristics of patients, disease, and study design, we could not ascertain whether inconsistencies were caused by differences in these characteristics, selection bias, or confounding factors. We conclude that an association between activation of coagulation and fibrinolysis and clinical outcome of dengue-virus infections is conceivable but has been inadequately assessed and that methodologically sound studies, complemented with complete and reliable reporting, are needed to show whether there is a true association.","['Mairuhu, A T A', 'Mac Gillavry, M R', 'Setiati, T E', 'Soemantri, A', 'ten Cate, H', 'Brandjes, D P M', 'van Gorp, E C M']","['Mairuhu AT', 'Mac Gillavry MR', 'Setiati TE', 'Soemantri A', 'ten Cate H', 'Brandjes DP', 'van Gorp EC']",,"['Department of Internal Medicine, Slotervaart Hospital, Amsterdam, Netherlands. atamairuhu@hotmail.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,['EC 3.4.21.68 (Tissue Plasminogen Activator)'],IM,"['Adult', 'Blood Coagulation Disorders/*etiology', 'Case-Control Studies', 'Child', '*Dengue/classification/mortality/physiopathology', 'Female', '*Fibrinolysis', 'Humans', 'Male', 'Severity of Illness Index', 'Tissue Plasminogen Activator']",,2002/12/31 04:00,2003/01/24 04:00,['2002/12/31 04:00'],"['2002/12/31 04:00 [pubmed]', '2003/01/24 04:00 [medline]', '2002/12/31 04:00 [entrez]']","['S1473309903004870 [pii]', '10.1016/s1473-3099(03)00487-0 [doi]']",ppublish,Lancet Infect Dis. 2003 Jan;3(1):33-41. doi: 10.1016/s1473-3099(03)00487-0.,1,,,,,,,76,,,,,,,,,,,,,,,
34053466,NLM,MEDLINE,20210617,20220323,1745-6215 (Electronic) 1745-6215 (Linking),22,2021 May 30,Measuring the effectiveness of integrated vector management with targeted outdoor residual spraying and autodissemination devices on the incidence of dengue in urban Malaysia in the iDEM trial (intervention for Dengue Epidemiology in Malaysia): study protocol for a cluster randomized controlled trial.,374,10.1186/s13063-021-05298-2 [doi] 374,"BACKGROUND: In common with many South East Asian countries, Malaysia is endemic for dengue. Dengue control in Malaysia is currently based on reactive vector management within 24 h of a dengue case being reported. Preventive rather than reactive vector control approaches, with combined interventions, are expected to improve the cost-effectiveness of dengue control programs. The principal objective of this cluster randomized controlled trial is to quantify the effectiveness of a preventive integrated vector management (IVM) strategy on the incidence of dengue as compared to routine vector control efforts. METHODS: The trial is conducted in randomly allocated clusters of low- and medium-cost housing located in the Federal Territory of Kuala Lumpur and Putrajaya. The IVM approach combines: targeted outdoor residual spraying with K-Othrine Polyzone, deployment of mosquito traps as auto-dissemination devices, and community engagement activities. The trial includes 300 clusters randomly allocated in a 1:1 ratio. The clusters receive either the preventive IVM in addition to the routine vector control activities or the routine vector control activities only. Epidemiological data from monthly confirmed dengue cases during the study period will be obtained from the Vector Borne Disease Sector, Malaysian Ministry of Health e-Dengue surveillance system. Entomological surveillance data will be collected in 12 clusters randomly selected from each arm. To measure the effectiveness of the IVM approach on dengue incidence, a negative binomial regression model will be used to compare the incidence between control and intervention clusters. To quantify the effect of the interventions on the main entomological outcome, ovitrap index, a modified ordinary least squares regression model using a robust standard error estimator will be used. DISCUSSION: Considering the ongoing expansion of dengue burden in Malaysia, setting up proactive control strategies is critical. Despite some limitations of the trial such as the use of passive surveillance to identify cases, the results will be informative for a better understanding of effectiveness of proactive IVM approach in the control of dengue. Evidence from this trial may help justify investment in preventive IVM approaches as preferred to reactive case management strategies. TRIAL REGISTRATION: ISRCTN ISRCTN81915073 . Retrospectively registered on 17 April 2020.","['Saadatian-Elahi, Mitra', 'Alexander, Neal', 'Mohlmann, Tim', 'Langlois-Jacques, Carole', 'Suer, Remco', 'Ahmad, Nazni Wasi', 'Mudin, Rose Nani', 'Ariffin, Farah Diana', 'Baur, Frederic', 'Schmitt, Frederic', 'Richardson, Jason H', 'Rabilloud, Muriel', 'Hamid, Nurulhusna Ab']","['Saadatian-Elahi M', 'Alexander N', 'Mohlmann T', 'Langlois-Jacques C', 'Suer R', 'Ahmad NW', 'Mudin RN', 'Ariffin FD', 'Baur F', 'Schmitt F', 'Richardson JH', 'Rabilloud M', 'Hamid NA']",['ORCID: 0000-0003-1265-8806'],"['Service Hygiene, Epidemiologie, Infection, Vigilance et Prevention, Centre Hospitalier Edouard Herriot, Hospices Civils de Lyon, Lyon, France. mitra.elahi@chu-lyon.fr.', 'CIRI, Centre International de Recherche en Infectiologie, (Equipe Laboratoire des Pathogenes Emergents), Univ Lyon, Inserm, U1111, Universite Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France. mitra.elahi@chu-lyon.fr.', 'MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK.', 'In2Care B.V., Marijkeweg 22, 6709PG, Wageningen, The Netherlands.', 'Universite de Lyon, F-69000, Lyon, France; Universite Lyon 1, F-69100, Villeurbanne, France; Hospices Civils de Lyon, Pole Sante Publique, Service de Biostatistique et Bioinformatique, F-69003, Lyon, France; CNRS, UMR 5558, Laboratoire de Biometrie et Biologie Evolutive, Equipe Biostatistique-Sante, F-69100, Villeurbanne, France.', 'In2Care B.V., Marijkeweg 22, 6709PG, Wageningen, The Netherlands.', 'Medical Entomology Unit, WHO Collaborating Centre for Vectors, Institute for Medical Research, Ministry of Health Malaysia, National Institutes of Health, Block C, Jalan Setia Murni U13/52, Seksyen U13, Setia Alam, 40170, Shah Alam, Malaysia.', 'Vector Borne Disease Sector, Disease Control Division, Ministry of Health Malaysia, Level 4, Block E10, Complex E, Federal Government Administrative Center, 62590, Putrajaya, Malaysia.', 'Medical Entomology Unit, WHO Collaborating Centre for Vectors, Institute for Medical Research, Ministry of Health Malaysia, National Institutes of Health, Block C, Jalan Setia Murni U13/52, Seksyen U13, Setia Alam, 40170, Shah Alam, Malaysia.', 'Bayer S.A.S, Environnemental Science, Crop Science Division, 16 rue Jean Marie Leclair, 69266, Lyon, Cedex 09, France.', 'Bayer S.A.S, Environnemental Science, Crop Science Division, 16 rue Jean Marie Leclair, 69266, Lyon, Cedex 09, France.', 'Innovative Vector Control Consortium, Pembroke Place, L3 5QA, Liverpool, UK.', 'Universite de Lyon, F-69000, Lyon, France; Universite Lyon 1, F-69100, Villeurbanne, France; Hospices Civils de Lyon, Pole Sante Publique, Service de Biostatistique et Bioinformatique, F-69003, Lyon, France; CNRS, UMR 5558, Laboratoire de Biometrie et Biologie Evolutive, Equipe Biostatistique-Sante, F-69100, Villeurbanne, France.', 'Medical Entomology Unit, WHO Collaborating Centre for Vectors, Institute for Medical Research, Ministry of Health Malaysia, National Institutes of Health, Block C, Jalan Setia Murni U13/52, Seksyen U13, Setia Alam, 40170, Shah Alam, Malaysia.']",['eng'],"['Clinical Trial Protocol', 'Journal Article']",20210530,England,Trials,Trials,101263253,,IM,"['*Aedes', 'Animals', '*Dengue/diagnosis/epidemiology/prevention & control', 'Humans', 'Incidence', 'Malaysia/epidemiology', 'Mosquito Control', 'Mosquito Vectors', 'Randomized Controlled Trials as Topic']",PMC8166066,2021/06/01 06:00,2021/06/22 06:00,['2021/05/31 05:43'],"['2020/10/27 00:00 [received]', '2021/04/27 00:00 [accepted]', '2021/05/31 05:43 [entrez]', '2021/06/01 06:00 [pubmed]', '2021/06/22 06:00 [medline]']","['10.1186/s13063-021-05298-2 [pii]', '5298 [pii]', '10.1186/s13063-021-05298-2 [doi]']",epublish,Trials. 2021 May 30;22(1):374. doi: 10.1186/s13063-021-05298-2.,1,,['NOTNLM'],"['Aedes', 'Autodissemination', 'Cluster Randomized', 'Dengue', 'Epidemiology', 'Malaysia', 'Vector control', 'outdoor residual spray']","['RS and TM are remunerated by and hold shares in In2Care BV. FB and FS are', 'employees of Bayer. Other authors do not have any competing interest to declare.']",,['MR/R010161/1/MRC_/Medical Research Council/United Kingdom'],,,,,,,,,,,,,,,,
37991044,NLM,MEDLINE,20231127,20231127,1726-4642 (Electronic) 1726-4634 (Linking),40,2023 Jul-Sep,Dengue health emergency in Peru: need for a budget allocation in line with the epidemiological scenario.,374-376,10.17843/rpmesp.2023.403.13117 [doi],,"['Pisfil-Benites, Nilthon', 'Vilcarromero, Stalin', 'Azanedo, Diego']","['Pisfil-Benites N', 'Vilcarromero S', 'Azanedo D']","['ORCID: 0000-0002-2275-7106', 'ORCID: 0000-0002-9097-0638', 'ORCID: 0000-0003-1375-8788']","['Universidad Tecnologica del Peru, Chiclayo, Peru.', 'Hospital Nacional Edgardo Rebagliati Martins, ESSALUD, Lima, Peru.', 'Universidad Cientifica del Sur, Lima, Peru.']","['spa', 'eng']",['Letter'],20230926,Peru,Rev Peru Med Exp Salud Publica,Revista peruana de medicina experimental y salud publica,101227566,,IM,"['Humans', 'Peru/epidemiology', '*Dengue/epidemiology/prevention & control', '*Dengue Virus']",,2023/11/22 12:45,2023/11/27 12:42,['2023/11/22 07:01'],"['2023/07/11 00:00 [received]', '2023/08/23 00:00 [accepted]', '2023/11/27 12:42 [medline]', '2023/11/22 12:45 [pubmed]', '2023/11/22 07:01 [entrez]']",['10.17843/rpmesp.2023.403.13117 [doi]'],ppublish,Rev Peru Med Exp Salud Publica. 2023 Jul-Sep;40(3):374-376. doi: 10.17843/rpmesp.2023.403.13117. Epub 2023 Sep 26.,3,,,,,,,,,Emergencia sanitaria por dengue en el Peru: necesidad de una asignacion presupuestal acorde a la situacion epidemiologica.,,,,,,,,,,,,,
35199799,NLM,MEDLINE,20220225,20220716,1815-672X (Electronic) 0028-2715 (Print) 0028-2715 (Linking),59,2021 Dec 11,Admitted Cases of Dengue Fever among Dengue Positive Cases in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.,1272-1276,10.31729/jnma.5307 [doi],"INTRODUCTION: Dengue fever, a mosquito-borne disease, is one of the emerging tropical diseases that appear primarily in rainy seasons. The number of dengue cases was increased in recent years in Nepal. Chitwan is one of the risky areas of dengue. This aim of the study is to find out the prevalence of hospital admission among the dengue positive cases. METHODS: The descriptive cross-sectional study was carried out among 323 serologically confirmed dengue fever positive patient admitted in Medicine Inpatients Department of Chitwan Medical College Teaching Hospital. Ethical approval was taken from the Institutional Review Committee (Reference number. 076/077-121 dated August 30, 2019). Data were collected from 1st September 2019 to 31st December 2019 using a structured interview schedule and record review. Convenience sampling was done. Data was analysed using Statistical Package for Social Sciences version 11. Point estimate at 95% Confidence Interval was calculated, with frequency and percentage. RESULTS: Among 1206 patient with dengue fever, 323 (26.78%) (24.29-29.27 at 95% confidence Interval) were admitted in the tertiary care hospital. Study findings revealed that out of 323 admitted patients with dengue fever, 182 (56.3%) patients were between 20-40 years of age and 179 (55.4%) were males. The highest number of patients were admitted in the months of September 192 (59.4%) and October 101 (31.2%). CONCLUSIONS: Admission rate among dengue positive cases are comparable to other studies of the similar settings. Dengue fever is common among community people especially in young adult and males. Hence, screening of dengue fever in febrile illness is necessary for the early diagnosis and prompt treatment.","['Poudyal, Sunita', 'Subba, Hem Kumari', 'Sharma, Kalpana']","['Poudyal S', 'Subba HK', 'Sharma K']",,"['School of Nursing, Chitwan Medical College, Bharatpur, Chitwan, Nepal.', 'School of Nursing, Chitwan Medical College, Bharatpur, Chitwan, Nepal.', 'School of Nursing, Chitwan Medical College, Bharatpur, Chitwan, Nepal.']",['eng'],['Journal Article'],20211211,Nepal,JNMA J Nepal Med Assoc,JNMA; journal of the Nepal Medical Association,0045233,,IM,"['Cross-Sectional Studies', '*Dengue/diagnosis/epidemiology', '*Hospitalization', 'Humans', 'Male', 'Prevalence', 'Tertiary Care Centers', 'Young Adult']",PMC9200038,2022/02/25 06:00,2022/02/26 06:00,['2022/02/24 08:42'],"['2020/08/22 00:00 [received]', '2021/12/08 00:00 [accepted]', '2022/02/24 08:42 [entrez]', '2022/02/25 06:00 [pubmed]', '2022/02/26 06:00 [medline]']",['10.31729/jnma.5307 [doi]'],epublish,JNMA J Nepal Med Assoc. 2021 Dec 11;59(244):1272-1276. doi: 10.31729/jnma.5307.,244,,['NOTNLM'],['dengue; fever; profile.'],['None.'],,,,,,,,,,,,,,,,,,
35383748,NLM,MEDLINE,20220407,20220407,2408-8757 (Electronic) 1022-4742 (Linking),31,2022 Apr,Clinical and Haematological Findings in Dengue Fever.,344-349,,"From 2000 onwards dengue fever has been occurring at regular intervals in Bangladesh. Ultrasonography is a useful diagnostic procedure. This study was done, keeping this background in mind. Objective of this study was to identify the role of ultrasonography as a useful tool in early diagnosis of dengue haemorrhagic fever. This was a cross-sectional descriptive type of observational study. Results of ultrasonography, haematogy an immunology were observed in 2004 and 2019 in 32 patients on each occasion. In 2004 out of 32 patients 29 had positive ultrsonographic findings supported by corresponding haematological and immunological findings. In 2019 ultrsonography was done in three out of thirty two patients, all three had had positive ultra sonographic findings which were supported by haematological and immunological findings. Dengue fever has serious complications like plasma leakage which manifest in the form of ascites, pleural effusion, thick gallbladder wall etc. If such complications can be detected at an early stage many lives can be saved.","['Razi, R Z', 'Ahmed, A M', 'Sultana, S', 'Amin, K', 'Ahsan, M', 'Akter, P', 'Paul, P', 'Sangma, M A', 'Ferdousi, R A', 'Jahan, F', 'Hasan, M S', 'Ahsan, S B']","['Razi RZ', 'Ahmed AM', 'Sultana S', 'Amin K', 'Ahsan M', 'Akter P', 'Paul P', 'Sangma MA', 'Ferdousi RA', 'Jahan F', 'Hasan MS', 'Ahsan SB']",,"['Dr RMA Ziauddin Razi, Associate Professor, Department of Radiology & Imaging, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; E-mail: ziauddinrazi@gmail.com.']",['eng'],"['Journal Article', 'Observational Study']",,Bangladesh,Mymensingh Med J,Mymensingh medical journal : MMJ,9601799,,IM,"['Cross-Sectional Studies', '*Dengue/complications/diagnosis', 'Gallbladder/diagnostic imaging', 'Humans', '*Pleural Effusion', 'Ultrasonography']",,2022/04/07 06:00,2022/04/08 06:00,['2022/04/06 09:10'],"['2022/04/06 09:10 [entrez]', '2022/04/07 06:00 [pubmed]', '2022/04/08 06:00 [medline]']",,ppublish,Mymensingh Med J. 2022 Apr;31(2):344-349.,2,,,,,,,,,,,,,,,,,,,,,,
24626308,NLM,MEDLINE,20150209,20220311,1678-8060 (Electronic) 0074-0276 (Print) 0074-0276 (Linking),109,2014 Feb,"Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceara, Brazil.",93-8,S0074-02762014000100093 [pii] 10.1590/0074-0276140384 [doi],"In 2009, the World Health Organization (WHO) issued a new guideline that stratifies dengue-affected patients into severe (SD) and non-severe dengue (NSD) (with or without warning signs). To evaluate the new recommendations, we completed a retrospective cross-sectional study of the dengue haemorrhagic fever (DHF) cases reported during an outbreak in 2011 in northeastern Brazil. We investigated 84 suspected DHF patients, including 45 (53.6%) males and 39 (46.4%) females. The ages of the patients ranged from five-83 years and the median age was 29. According to the DHF/dengue shock syndrome classification, 53 (63.1%) patients were classified as having dengue fever and 31 (36.9%) as having DHF. According to the 2009 WHO classification, 32 (38.1%) patients were grouped as having NSD [4 (4.8%) without warning signs and 28 (33.3%) with warning signs] and 52 (61.9%) as having SD. A better performance of the revised classification in the detection of severe clinical manifestations allows for an improved detection of patients with SD and may reduce deaths. The revised classification will not only facilitate effective screening and patient management, but will also enable the collection of standardised surveillance data for future epidemiological and clinical studies.","['Cavalcanti, Luciano Pamplona de Goes', 'Mota, Lia Alves Martins', 'Lustosa, Gustavo Porto', 'Fortes, Mayara Carvalho', 'Mota, Davi Alves Martins', 'Lima, Antonio Afonso Bezerra', 'Coelho, Ivo Castelo Branco', 'Mourao, Maria Paula Gomes']","['Cavalcanti LP', 'Mota LA', 'Lustosa GP', 'Fortes MC', 'Mota DA', 'Lima AA', 'Coelho IC', 'Mourao MP']",,"['Departamento de Saude Comunitaria, Universidade Federal do Ceara, FortalezaCE, Brasil, Departamento de Saude Comunitaria , Universidade Federal do Ceara , Fortaleza , CE , Brasil.', 'Faculdade de Medicina, Centro Universitario Christus, FortalezaCE, Brasil, Faculdade de Medicina , Centro Universitario Christus , Fortaleza , CE , Brasil.', 'Faculdade de Medicina, Centro Universitario Christus, FortalezaCE, Brasil, Faculdade de Medicina , Centro Universitario Christus , Fortaleza , CE , Brasil.', 'Faculdade de Medicina, Centro Universitario Christus, FortalezaCE, Brasil, Faculdade de Medicina , Centro Universitario Christus , Fortaleza , CE , Brasil.', 'Faculdade de Medicina, Universidade Federal do Ceara, FortalezaCE, Brasil, Faculdade de Medicina , Universidade Federal do Ceara , Fortaleza , CE , Brasil.', 'Hospital Sao Jose de Doencas Infecciosas, FortalezaCE, Brasil, Hospital Sao Jose de Doencas Infecciosas , Fortaleza , CE , Brasil.', 'Nucleo de Medicina Tropical Prof JE Alencar, Universidade Federal do Ceara, FortalezaCE, Brasil, Nucleo de Medicina Tropical Prof JE Alencar , Universidade Federal do Ceara , Fortaleza , CE , Brasil.', 'Fundacao de Medicina Tropical Dr Heitor Vieira Dourado, ManausAM, Brasil, Fundacao de Medicina Tropical Dr Heitor Vieira Dourado , Manaus , AM , Brasil.']",['eng'],"['Evaluation Study', 'Journal Article']",,Brazil,Mem Inst Oswaldo Cruz,Memorias do Instituto Oswaldo Cruz,7502619,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Brazil/epidemiology', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', 'Dengue/classification/diagnosis/epidemiology', 'Disease Notification/statistics & numerical data', '*Epidemics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Severe Dengue/*classification/diagnosis/*epidemiology', '*Severity of Illness Index', 'Symptom Assessment', '*World Health Organization', 'Young Adult']",PMC4005528,2014/03/15 06:00,2015/02/11 06:00,['2014/03/15 06:00'],"['2013/07/28 00:00 [received]', '2013/10/18 00:00 [accepted]', '2014/03/15 06:00 [entrez]', '2014/03/15 06:00 [pubmed]', '2015/02/11 06:00 [medline]']","['S0074-02762014000100093 [pii]', '0074-0276140384 [pii]', '10.1590/0074-0276140384 [doi]']",ppublish,Mem Inst Oswaldo Cruz. 2014 Feb;109(1):93-8. doi: 10.1590/0074-0276140384.,1,,,,,,,,,,,,,,,,,,,,,,
483366,NLM,MEDLINE,19791121,20041117,0041-3232 (Print) 0041-3232 (Linking),31,1979 Mar,Dengue hemorrhagic shock in the western hemisphere.,127-31,,"A 39-year-old man after visiting an endemic dengue area during a local outbreak developed a febrile illness complicated by skin petechiae, bleeding, shock, hemoconcentration, and death. The presumptive diagnosis of dengue was made based on hemagglutination inhibition and complement fixation titers in a single sample. The serologic evidence and ancillary laboratory findings are compatible with a secondary antibody response.","['Ramirez-Ronda, C H', 'Maldonado, N M', 'Rabell, V', 'Sather, G', 'Cline, B L']","['Ramirez-Ronda CH', 'Maldonado NM', 'Rabell V', 'Sather G', 'Cline BL']",,,['eng'],"['Case Reports', 'Journal Article']",,Netherlands,Trop Geogr Med,Tropical and geographical medicine,0376231,,IM,"['Adult', 'Dengue/complications/*diagnosis', 'Disease Outbreaks', 'Dominican Republic', 'Humans', 'Male', 'Shock/*diagnosis/etiology']",,1979/03/01 00:00,1979/03/01 00:01,['1979/03/01 00:00'],"['1979/03/01 00:00 [pubmed]', '1979/03/01 00:01 [medline]', '1979/03/01 00:00 [entrez]']",,ppublish,Trop Geogr Med. 1979 Mar;31(1):127-31.,1,,,,,,,,,,,,,,,,,,,,,,
1462664,NLM,MEDLINE,19930108,20080226,0379-8070 (Print) 0379-8070 (Linking),45,1992,The XXth century dengue pandemic: need for surveillance and research.,292-8,,"By the last decade of the XXth century Aedes aegypti and the 4 dengue viruses had spread to nearly all countries of the tropical world. Some 2 billion persons live in dengue-endemic areas with tens of millions infected annually. Dengue pandemics were also documented in the XVIIIth and XIXth centuries; they were contained by organized anti-Aedes aegypti campaigns and urban improvements. The XXth century dengue pandemic has brought with it the simultaneous circulation of multiple serotypes and in its aftermath, endemic dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Nearly 3 million children have been hospitalized with this syndrome in the past 3 decades, mainly in South-East Asia. Recent outbreaks of DHF/DSS in the Pacific Islands, China, India, Sri Lanka, Cuba and Venezuela are indicators of the high intensity and rapid spread of dengue transmission. The magnitude of the XXth century dengue pandemic requires urgent improvements in early warning surveillance by WHO Member States and the development of the capacity to study underlying mechanisms of the disease. A key research question is why does DHF/DSS not occur with all second dengue infections? Two answers have been suggested: (1) a human resistance gene. Data from the 1981 DHF/DSS epidemic in Cuba have demonstrated the existence in blacks of a resistance gene. The effect of such a gene in reducing disease susceptibility of American and African blacks requires more study. (2) The existence of dengue ""biotypes"". Some, but not all biotypes may cause DHF/DSS during a second dengue infection.(ABSTRACT TRUNCATED AT 250 WORDS)","['Halstead, S B']",['Halstead SB'],,"['Rockefeller Foundation, New York.']",['eng'],['Journal Article'],,Switzerland,World Health Stat Q,World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales,7900237,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/transmission', '*Disease Outbreaks', 'Humans', 'Population Surveillance']",,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,World Health Stat Q. 1992;45(2-3):292-8.,2-3,,['PIP'],"['Americas', 'Asia', '*Blacks', 'Caribbean', 'Cuba', 'Cultural Background', 'Demographic Factors', '*Dengue--history', 'Developing Countries', 'Diseases', 'Ethnic Groups', 'Latin America', 'North America', 'Population', 'Population Characteristics', 'Viral Diseases']",,,,,,,,"['PIP: 090080', 'POP: 00238936']","['By the last decade of the 20th century Aedes aegypti and the 4 dengue viruses had', 'spread to nearly all countries of the tropical world. Some 2 billion persons live', 'in dengue-endemic areas with tens of millions infected annually. The 20th century', 'dengue pandemic has brought with it the simultaneous circulation of multiple', 'serotypes and, in its aftermath, endemic dengue hemorrhagic fever/dengue shock', 'syndrome (DHF/DSS). Nearly 3 million children have been hospitalized with this', 'syndrome in the past 3 decades, mainly in South-East Asia. Recent outbreaks of', 'DHF/DSS in the Pacific Islands, China, India, Sri Lanka, Cuba, and Venezuela are', 'indicators of the high intensity and rapid spread of dengue transmission. A key', 'question why DHF/DSS does not occur with all second dengue infections has been', 'attributed to: 1) a human resistance gene. Data from the 1981 DHF/DSS epidemic in', 'Cuba have demonstrated the existence in Blacks of a resistance gene. 2) The', 'existence of dengue biotypes. Some, but not all, biotypes may cause DHF/DSS', 'during a second dengue infection. A South-East Asian dengue 2 biotype introduced', 'into Cuba is thought to be responsible for the 1981 DHF/DSS epidemic. A recent', 'study in Thailand suggests that when antibody residual from the first infection', 'is able to neutralize a second virus type, a secondary infection will occur, but', 'its severity is down-regulated and the disease mild. When no cross-reactive', 'neutralizing antibodies are raised, a second infection is under the influence of', 'enhancing antibodies; the resulting infection and disease are severe. The', 'presence or absence of antigens on both the first and second virus determine', 'disease severity. Enhanced surveillance for DHF/DSS and improved research', 'including the study of pre- and post-epidemic sera and the isolation of viruses', 'from serologically documented cases is lacking in most countries.']",['eng'],"['PIP: TJ: WORLD HEALTH STATISTICS QUARTERLY. RAPPORT TRIMESTRIEL DE STATISTIQUES', 'SANITAIRES MONDIALES.']",,,,,,,,
24986196,NLM,MEDLINE,20161103,20211021,0973-7693 (Electronic) 0019-5456 (Linking),82,2015 Feb,Clinical profile of dengue among children according to revised WHO classification: analysis of a 2012 outbreak from Southern India.,109-13,10.1007/s12098-014-1523-3 [doi],"OBJECTIVE: To study the clinical profile of dengue fever and its outcome in children with application of revised WHO classification and to identify risk factors for severe dengue. METHODS: This study was a prospective observational study of children diagnosed with dengue from July 2012 through February 2013 at a tertiary care hospital in Bangalore, Karnataka (South India). RESULTS: Eighty one children including 55(67.9 %) boys and 26(32.1 %) girls were diagnosed with dengue. Mean age of presentation was 8 y. Vomiting (60.5 %), pain abdomen (32 %), headache (30.9 %), myalgia (23.5 %) and bleeding manifestations (16 %) were the common presenting complaints. Facial puffiness (63 %), hepatomegaly (51.9 %), ascites (48.1 %), pleural effusion (39.5 %) and petechiae (14.8 %) were noted during examination. Dengue NS1 antigen, IgM, IgG were positive in 66.7 %, 29.6 % and 18.5 % of cases respectively. Investigations showed hemoconcentration in 72.8 %, leucopenia (34.5 %), thrombocytopenia (82.7 %), abnormal liver function test (LFT) (33.3 %). USG abdomen was suggestive of dengue in 66.7 % and gall bladder edema was noted in 53.1 %. Two patients died out of the total 81 patients with mortality rate of 2.5 %. Number of cases classified as Dengue without warning signs (D), Dengue with warning signs (DW) and Severe Dengue (SD) were 48.1 %, 27.2 % and 24.7 % respectively. CONCLUSIONS: Children between 5 and 15 y were most affected by dengue fever. Pain abdomen and vomiting were most common presenting symptoms. Ascites, plerural effusion, hepatomegaly, gall bladder wall thickening and abnormal LFT were found significantly high in severe dengue cases.","['Sahana, K S', 'Sujatha, R']","['Sahana KS', 'Sujatha R']",,"['Department of Pediatrics, Sapthagiri Institute of Medical Sciences and Research Center, Bangalore, India, dr_sahana2003@yahoo.co.in.']",['eng'],"['Journal Article', 'Observational Study']",20140703,India,Indian J Pediatr,Indian journal of pediatrics,0417442,,IM,"['Abdominal Pain/etiology', 'Adolescent', 'Child', 'Child, Preschool', '*Dengue/diagnosis/epidemiology/physiopathology', 'Dengue Virus/*immunology', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Risk Factors', '*Severe Dengue/diagnosis/epidemiology/physiopathology', 'Symptom Assessment/methods/statistics & numerical data', 'Vomiting/etiology', 'World Health Organization']",,2014/07/06 06:00,2016/11/04 06:00,['2014/07/03 06:00'],"['2013/08/09 00:00 [received]', '2014/06/16 00:00 [accepted]', '2014/07/03 06:00 [entrez]', '2014/07/06 06:00 [pubmed]', '2016/11/04 06:00 [medline]']",['10.1007/s12098-014-1523-3 [doi]'],ppublish,Indian J Pediatr. 2015 Feb;82(2):109-13. doi: 10.1007/s12098-014-1523-3. Epub 2014 Jul 3.,2,,,,,,,,,,,,,,,,,,,,,,
28185868,NLM,MEDLINE,20170613,20220310,1474-4457 (Electronic) 1473-3099 (Print) 1473-3099 (Linking),17,2017 Mar,"Dengue: knowledge gaps, unmet needs, and research priorities.",e88-e100,S1473-3099(16)30473-X [pii] 10.1016/S1473-3099(16)30473-X [doi],"Dengue virus is a mosquito-borne pathogen that causes up to about 100 million cases of disease each year, placing a major public health, social, and economic burden on numerous low-income and middle-income countries. Major advances by investigators, vaccine developers, and affected communities are revealing new insights and enabling novel interventions and approaches to dengue prevention and control. Such research has highlighted further questions about both the basic understanding of dengue and efforts to develop new tools. In this report, the third in a Series on dengue, we discuss existing approaches to dengue diagnostics, disease prognosis, surveillance, and vector control in low-income and middle-income countries, as well as potential consequences of vaccine introduction. We also summarise current knowledge and recent insights into dengue epidemiology, immunology, and pathogenesis, and their implications for understanding natural infection and current and future vaccines.","['Katzelnick, Leah C', 'Coloma, Josefina', 'Harris, Eva']","['Katzelnick LC', 'Coloma J', 'Harris E']",,"['Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.', 'Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA. Electronic address: eharris@berkeley.edu.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",20170207,United States,Lancet Infect Dis,The Lancet. Infectious diseases,101130150,['0 (Dengue Vaccines)'],IM,"['Animals', 'Dengue/*diagnosis/*epidemiology/immunology/prevention & control', 'Dengue Vaccines/administration & dosage/*immunology', 'Dengue Virus/immunology', 'Humans', 'Insect Vectors/virology', 'Public Health', '*Research']",PMC5967882,2017/02/12 06:00,2017/06/14 06:00,['2017/02/11 06:00'],"['2016/03/04 00:00 [received]', '2016/08/29 00:00 [revised]', '2016/10/18 00:00 [accepted]', '2017/02/12 06:00 [pubmed]', '2017/06/14 06:00 [medline]', '2017/02/11 06:00 [entrez]']","['S1473-3099(16)30473-X [pii]', '10.1016/S1473-3099(16)30473-X [doi]']",ppublish,Lancet Infect Dis. 2017 Mar;17(3):e88-e100. doi: 10.1016/S1473-3099(16)30473-X. Epub 2017 Feb 7.,3,['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],,,,,['P01 AI106695/AI/NIAID NIH HHS/United States'],,,,['NIHMS966772'],,,,,,,,,,,,
9005306,NLM,MEDLINE,19970128,20080214,0149-2195 (Print) 0149-2195 (Linking),45,1996 Nov 15,"Imported dengue--United States, 1995.",988-91,,"Dengue is an acute disease caused by any of four mosquito-transmitted virus serotypes (DEN-1, DEN-2, DEN-3 and DEN-4) and characterized by the sudden onset of fever, headache, myalgias, rash, nausea, and vomiting. The disease is endemic in most tropical areas of the world and can occur in U.S. residents returning from travel to such areas. This report summarizes information about imported dengue among U.S. residents during 1995 and documents a substantially increased incidence of dengue in the Caribbean, Central America, and Mexico.",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Caribbean Region', 'Central America', 'Dengue/diagnosis/*epidemiology', 'Humans', 'Mexico', '*Travel', 'United States/epidemiology']",,1996/11/15 00:00,1996/11/15 00:01,['1996/11/15 00:00'],"['1996/11/15 00:00 [pubmed]', '1996/11/15 00:01 [medline]', '1996/11/15 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1996 Nov 15;45(45):988-91.,45,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
29566984,NLM,MEDLINE,20180703,20180703,1557-8194 (Electronic) 0011-5029 (Linking),64,2018 May,Selected mosquito borne illnesses - Dengue.,246-274,S0011-5029(18)30011-7 [pii] 10.1016/j.disamonth.2018.01.011 [doi],,"['McFee, Robin B']",['McFee RB'],,"['Department of Emergency/Family Medicine, Lincoln Memorial University DeBusk College of Osteopathic Medicine, United States. Electronic address: drrbmcfee@gmail.com.']",['eng'],"['Journal Article', 'Review']",20180319,United States,Dis Mon,Disease-a-month : DM,0370657,,IM,"['Animals', 'Anorexia/etiology', 'Arthralgia/etiology', 'Culicidae/virology', 'Dengue/complications/diagnosis/physiopathology/therapy', 'Dengue Virus', 'Fever/etiology', 'Headache/etiology', 'Humans', 'Mosquito Vectors/virology', 'Myalgia/etiology', 'Severe Dengue/complications/diagnosis/*physiopathology/therapy', 'Shock/etiology']",,2018/03/24 06:00,2018/07/04 06:00,['2018/03/24 06:00'],"['2018/03/24 06:00 [pubmed]', '2018/07/04 06:00 [medline]', '2018/03/24 06:00 [entrez]']","['S0011-5029(18)30011-7 [pii]', '10.1016/j.disamonth.2018.01.011 [doi]']",ppublish,Dis Mon. 2018 May;64(5):246-274. doi: 10.1016/j.disamonth.2018.01.011. Epub 2018 Mar 19.,5,,,,,,,,,,,,,,,,,,,,,,
11898460,NLM,MEDLINE,20021011,20041117,0019-5138 (Print) 0019-5138 (Linking),33,2001 Mar,"Observations on the breeding habitat of Aedes species in the steel township, Rourkela.",28-35,,"Prompted by report of large number of dengue fever cases in township of Rourkela steel plant, entomological surveys were carried out to know the distribution and extent of Aedes breeding in and around the dengue fever affected areas. Out of 2062 water containers searched, 819 were positive for Aedes larvae. The house index (HI), container index (CI) and Breteau index (BI) were 53.4, 39.7 and 118.5 respectively. 27.9% of the houses had single breeding habitats. The breateau index of single storeyed houses and double storeyed buildings was 149.8 and 54.6 respectively, showing that the single storeyed houses have more potential for Aedes breeding. The breeding preference ratio (BPR) was highest for plastic containers. Three species of Aedes were found breeding in different habitats and Aedes aegypti was found breeding in coolers, cement tanks, tyres and miscellaneous containers with a prevalence rate of 13.2%. The role of entomological surveillance and health education has been highlighted for the control of disease through community participation.","['Sharma, S K', 'Padhan, K', 'Rath, Y', 'Rao, S K']","['Sharma SK', 'Padhan K', 'Rath Y', 'Rao SK']",,"['Malaria Research Centre (Field Station), Civil Township, Rourkela, Orissa-769 004.']",['eng'],['Journal Article'],,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['Aedes/*physiology', 'Animals', '*Breeding', 'Dengue/*epidemiology/prevention & control/transmission', 'Humans', 'India/epidemiology', 'Prevalence', '*Water Pollution']",,2002/03/20 10:00,2002/10/12 04:00,['2002/03/20 10:00'],"['2002/03/20 10:00 [pubmed]', '2002/10/12 04:00 [medline]', '2002/03/20 10:00 [entrez]']",,ppublish,J Commun Dis. 2001 Mar;33(1):28-35.,1,,,,,,,,,,,,,,,,,,,,,,
8154004,NLM,MEDLINE,19940510,20190512,0035-9203 (Print) 0035-9203 (Linking),88,1994 Jan-Feb,"The basic reproduction number for dengue fever in Sao Paulo state, Brazil: 1990-1991 epidemic.",58-9,,,"['Marques, C A', 'Forattini, O P', 'Massad, E']","['Marques CA', 'Forattini OP', 'Massad E']",,['Faculdade de Saude Publica.'],['eng'],['Journal Article'],,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['Brazil/epidemiology', 'Dengue/epidemiology/*transmission', '*Disease Outbreaks', 'Humans', 'Urban Population']",,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",['10.1016/0035-9203(94)90498-7 [doi]'],ppublish,Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):58-9. doi: 10.1016/0035-9203(94)90498-7.,1,,,,,,,,,,,,,,,,,,,,,,
20464214,NLM,MEDLINE,20100923,20191027,1606-7916 (Electronic) 0036-3634 (Linking),51 Suppl 3,2009,[Population genetics of dengue virus and transmission of dengue fever].,S403-9,S0036-36342009000900006 [pii],"The endemic behavior of dengue fever in Mexico during the past five years is of major concern to every sector related with public health and the effort to control the transmission has been focused on vector control. However, regardless of the effectiveness of the intervention measures it is important to know which elements determine dengue transmission. With regard to the molecular basis for dengue transmission, a great deal of progress has been made due to the introduction of genomic and bioinformatic approaches. The goal of this review is to describe the most recent developments in this area with emphasis on the Mexican situation.","['Falcon-Lezama, Jorge', 'Sanchez-Burgos, Gilma Guadalupe', 'Ramos-Castaneda, Jose']","['Falcon-Lezama J', 'Sanchez-Burgos GG', 'Ramos-Castaneda J']",,"['Departamento de Prevencion y Control de Enfermedades, Servicios de Salud del Estado de Morelos, Cuernavaca, Morelos, Mexico.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Dengue/epidemiology/*transmission/*virology', 'Dengue Virus/classification/*genetics', 'Genetics, Population', 'Humans', 'Mexico/epidemiology', 'Serotyping']",,2009/01/01 00:00,2010/09/24 06:00,['2010/05/14 06:00'],"['2008/07/28 00:00 [received]', '2009/02/10 00:00 [accepted]', '2010/05/14 06:00 [entrez]', '2009/01/01 00:00 [pubmed]', '2010/09/24 06:00 [medline]']","['S0036-36342009000900006 [pii]', '10.1590/s0036-36342009000900006 [doi]']",ppublish,Salud Publica Mex. 2009;51 Suppl 3:S403-9. doi: 10.1590/s0036-36342009000900006.,,,,,,,,50,,Genetica de las poblaciones virales y transmision del dengue.,,,,,,,,,,,,,
23349922,NLM,MEDLINE,20130719,20211021,1932-6203 (Electronic) 1932-6203 (Linking),8,2013,Assessment of microalbuminuria for early diagnosis and risk prediction in dengue infections.,e54538,10.1371/journal.pone.0054538 [doi] e54538,"BACKGROUND: Dengue is the most important arboviral infection of humans. Following an initial febrile period, a small proportion of infected patients develop a vasculopathy, with children at particular risk for severe vascular leakage and shock. Differentiation between dengue and other common childhood illnesses is difficult during the early febrile phase, and risk prediction for development of shock is poor. The presence of microalbuminuria is recognized as a useful early predictor for subsequent complications in a number of other disorders with vascular involvement. Significant proteinuria occurs in association with dengue shock syndrome and it is possible that early-phase microalbuminuria may be helpful both for diagnosis of dengue and for identification of patients likely to develop severe disease. METHODOLOGY/PRINCIPAL FINDINGS: We measured formal urine albumin to creatinine ratios (UACRs) in daily samples obtained from a large cohort of children with suspected dengue recruited at two outpatient clinics in Ho Chi Minh City, Vietnam. Although UACRs were increased in the 465 confirmed dengue patients, with a significant time trend showing peak values around the critical period for dengue-associated plasma leakage, urine albumin excretion was also increased in the comparison group of 391 patients with other febrile illnesses (OFI). The dengue patients generally had higher UACRs than the OFI patients, but microalbuminuria, using the conventional cutoff of 30 mg albumin/g creatinine discriminated poorly between the two diagnostic groups in the early febrile phase. Secondly UACRs did not prove useful in predicting either development of warning signs for severe dengue or need for hospitalization. CONCLUSION/SIGNIFICANCE: Low-level albuminuria is common, even in relatively mild dengue infections, but is also present in many OFIs. Simple point-of-care UACR tests are unlikely to be useful for early diagnosis or risk prediction in dengue endemic areas.","['Hanh Tien, Nguyen Thi', 'Lam, Phung Khanh', 'Duyen, Huynh Thi Le', 'Ngoc, Tran Van', 'Ha, Phan Thi Thanh', 'Kieu, Nguyen Tan Thanh', 'Simmons, Cameron', 'Wolbers, Marcel', 'Wills, Bridget']","['Hanh Tien NT', 'Lam PK', 'Duyen HT', 'Ngoc TV', 'Ha PT', 'Kieu NT', 'Simmons C', 'Wolbers M', 'Wills B']",,"['Oxford University Clinical Research Unit, Hospital for Tropical Diseases, District 5, Ho Chi Minh City, Vietnam.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130122,United States,PLoS One,PloS one,101285081,"['0 (Albumins)', 'AYI8EX34EU (Creatinine)']",IM,"['Adult', 'Albumins/*analysis', 'Albuminuria/*diagnosis', 'Child', 'Child, Preschool', 'Creatinine/urine', 'Dengue/*diagnosis/epidemiology/physiopathology/*urine', 'Dengue Virus/pathogenicity', 'Early Diagnosis', 'Female', 'Fever', 'Humans', 'Male', 'Vietnam/epidemiology']",PMC3551767,2013/01/26 06:00,2013/07/20 06:00,['2013/01/26 06:00'],"['2012/09/21 00:00 [received]', '2012/12/13 00:00 [accepted]', '2013/01/26 06:00 [entrez]', '2013/01/26 06:00 [pubmed]', '2013/07/20 06:00 [medline]']","['PONE-D-12-29274 [pii]', '10.1371/journal.pone.0054538 [doi]']",ppublish,PLoS One. 2013;8(1):e54538. doi: 10.1371/journal.pone.0054538. Epub 2013 Jan 22.,1,,,,['Competing Interests: The authors have declared that no competing interests exist.'],['Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):557. PMID: 31031399'],['089276/Wellcome Trust/United Kingdom'],,,,,,,,,,,,,,,,
28887788,NLM,MEDLINE,20180806,20181113,0973-7693 (Electronic) 0019-5456 (Linking),84,2017 Dec,The Clinical and Serological Profile of Pediatric Dengue.,897-901,10.1007/s12098-017-2423-0 [doi],"OBJECTIVE: To classify suspected dengue into dengue, dengue with warning signs and severe dengue, based on clinical features as per the revised WHO guidelines with special emphasis on serology. METHODS: It was a prospective cross-sectional study for five years from 2011-2016 in a tertiary care medical college hospital in Bangalore. All cases of fever of three to five days duration with symptoms like dengue were enrolled for the study. They were categorized into three groups as per the Revised WHO 2012 criteria. Laboratory parameters, serology, ultrasound abdomen and X-ray were done in almost all patients. Data was analysed by SPSS software, version 16, and different groups were compared with Chi square test. RESULTS: Five hundred sixty eight children were diagnosed to have dengue fever; 4.2% of the sample belonged to infancy. Majority were in the age group of 5-10 y (42.6%). Fever and flushing were present in majority of the children. Gastrointestinal bleed was more commonly seen in the severe dengue group. Dengue nonstructural protein antigen (NS1Ag) was positive in 78%, immunoglobulin M (IgM) in 15.8% and immunoglobulin G (IgG) in 14.6%. Children with IgG had more complications, though not statistically significant. Mortality was reported in 1.2%. Dengue serology helped to confirm the diagnosis, however did not help in patient management. CONCLUSIONS: There is a considerable overlap in the symptomatology of dengue with warning signs and severe dengue. More studies are required on the severity and type of response to treatment in infants and obese adoloscents with severe dengue.","['Ramabhatta, Sujatha', 'Palaniappan, Saravanan', 'Hanumantharayappa, Navya', 'Begum, Shaik Vajidunnisa']","['Ramabhatta S', 'Palaniappan S', 'Hanumantharayappa N', 'Begum SV']",['ORCID: 0000-0001-7322-9920'],"['Department of Pediatrics, Shifaa Hospital, Bengaluru, Karnataka, 560052, India. sujatharamabhatta@yahoo.com.', 'Department of Pediatrics, Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.', 'Department of Pediatrics, Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.', 'Department of Pediatrics, Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India.']",['eng'],"['Journal Article', 'Observational Study']",20170908,India,Indian J Pediatr,Indian journal of pediatrics,0417442,['0 (Biomarkers)'],IM,"['Adolescent', 'Biomarkers/analysis', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', 'Dengue/*classification/*epidemiology', 'Female', 'Humans', 'India/epidemiology', 'Infant', 'Male', 'Prospective Studies', 'Severe Dengue/classification/epidemiology', 'World Health Organization']",,2017/09/10 06:00,2018/08/07 06:00,['2017/09/10 06:00'],"['2016/12/28 00:00 [received]', '2017/07/05 00:00 [accepted]', '2017/09/10 06:00 [pubmed]', '2018/08/07 06:00 [medline]', '2017/09/10 06:00 [entrez]']","['10.1007/s12098-017-2423-0 [pii]', '10.1007/s12098-017-2423-0 [doi]']",ppublish,Indian J Pediatr. 2017 Dec;84(12):897-901. doi: 10.1007/s12098-017-2423-0. Epub 2017 Sep 8.,12,,['NOTNLM'],"['Dengue', 'Dengue with warning signs', 'IgG', 'IgM antibodies', 'NS1Ag', 'Severe dengue']",,,,,,,,,,,,,,,,,,,
11407002,NLM,MEDLINE,20010712,20051116,0019-5138 (Print) 0019-5138 (Linking),32,2000 Sep,Dengue/DHF: an emerging disease in India.,175-9,,"Dengue/DHF is an emergent disease in India and some parts of country are endemic and periodically contributing annual outbreaks of dengue/DHF. Dengue infection manifests as undifferentiated fever, dengue haemorrhagic fever (DHF) which leads to hospitalization large number of people in a localized area. There is high mortality and morbidity associated with the onset of each dengue outbreak leading to great socio-economic impact. The prevention and control of dengue outbreak depends upon the proper monitoring of the disease case through disease surveillance so as to ensure timely management of cases. Vector surveillance helps in the proper and timely implementation of emergency control measures against dengue vector i.e. Aedes aegypti. There is an urgent need for an effective diagnostic strategy for early diagnosis to shorten the illness duration, hospitalization time and the associated complications.","['Sharma, S N', 'Raina, V K', 'Kumar, A']","['Sharma SN', 'Raina VK', 'Kumar A']",,,['eng'],"['Journal Article', 'Review']",,India,J Commun Dis,The Journal of communicable diseases,0261652,,IM,"['*Aedes', 'Animals', '*Arthropod Vectors', 'Dengue/*epidemiology/prevention & control/virology', '*Dengue Virus', '*Disease Outbreaks', 'Humans', 'India/epidemiology', 'Mosquito Control', 'Population Surveillance']",,2001/06/16 10:00,2001/07/13 10:01,['2001/06/16 10:00'],"['2001/06/16 10:00 [pubmed]', '2001/07/13 10:01 [medline]', '2001/06/16 10:00 [entrez]']",,ppublish,J Commun Dis. 2000 Sep;32(3):175-9.,3,,,,,,,9,,,,,,,,,,,,,,,
17189016,NLM,MEDLINE,20070109,20150616,1474-547X (Electronic) 0140-6736 (Linking),368,2006 Dec 23,Dengue: setting the global research agenda.,2193-5,,,"['Kroeger, Axel', 'Nathan, Michael B']","['Kroeger A', 'Nathan MB']",,"['UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), CH-1211 Geneva 27, Switzerland. kroegera@who.int']",['eng'],['Journal Article'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Dengue/*epidemiology/prevention & control', '*Global Health', 'Humans', 'Research/*trends', '*Urban Population']",,2006/12/26 09:00,2007/01/11 09:00,['2006/12/26 09:00'],"['2006/12/26 09:00 [pubmed]', '2007/01/11 09:00 [medline]', '2006/12/26 09:00 [entrez]']","['S0140-6736(06)69873-5 [pii]', '10.1016/S0140-6736(06)69873-5 [doi]']",ppublish,Lancet. 2006 Dec 23;368(9554):2193-5. doi: 10.1016/S0140-6736(06)69873-5.,9554,,,,,['Lancet. 2007 Feb 24;369(9562):641. PMID: 17321308'],,,,,,,,,,,,,,,,,
28408424,NLM,MEDLINE,20180117,20210202,1528-0020 (Electronic) 0006-4971 (Linking),129,2017 Apr 13,Plasmacytoid lymphocytes: a clue to dengue diagnosis.,2202,10.1182/blood-2017-01-762500 [doi],,"['Datta, Lagnajita', 'Menon, Madhu P']","['Datta L', 'Menon MP']",['ORCID: 0000-0002-4075-4961'],"['Henry Ford Health System.', 'Henry Ford Health System.']",['eng'],"['Case Reports', 'Journal Article']",,United States,Blood,Blood,7603509,,IM,"['Adult', '*Dengue/blood/diagnosis/pathology', 'Humans', 'Male', '*Plasma Cells/metabolism/pathology']",,2017/04/15 06:00,2018/01/18 06:00,['2017/04/15 06:00'],"['2017/04/15 06:00 [entrez]', '2017/04/15 06:00 [pubmed]', '2018/01/18 06:00 [medline]']","['S0006-4971(20)33497-2 [pii]', '10.1182/blood-2017-01-762500 [doi]']",ppublish,Blood. 2017 Apr 13;129(15):2202. doi: 10.1182/blood-2017-01-762500.,15,,,,,,,,,,,,,,,,,,,,,,
11065050,NLM,MEDLINE,20010301,20190831,0004-8666 (Print) 0004-8666 (Linking),40,2000 Aug,Menorrhagia caused by dengue fever.,354-5,,,"['McGready, R', 'Paw, E', 'Nosten, F']","['McGready R', 'Paw E', 'Nosten F']",,"['Department of Obstetrics, Maela Refugee Camp, Mae Sot, Thailand.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",,Australia,Aust N Z J Obstet Gynaecol,The Australian & New Zealand journal of obstetrics & gynaecology,0001027,,IM,"['Adolescent', 'Dengue/*complications/*diagnosis/therapy', 'Female', 'Follow-Up Studies', 'Humans', 'Menorrhagia/*diagnosis/*etiology/therapy', 'Thailand']",,2000/11/07 11:00,2001/03/07 10:01,['2000/11/07 11:00'],"['2000/11/07 11:00 [pubmed]', '2001/03/07 10:01 [medline]', '2000/11/07 11:00 [entrez]']",['10.1111/j.1479-828x.2000.tb03351.x [doi]'],ppublish,Aust N Z J Obstet Gynaecol. 2000 Aug;40(3):354-5. doi: 10.1111/j.1479-828x.2000.tb03351.x.,3,,,,,,,,,,,,,,,,,,,,,,
34129393,NLM,MEDLINE,20220125,20220125,1557-7759 (Electronic) 1530-3667 (Linking),21,2021 Aug,"Forest Coverage and Socioeconomic Factors Associated with Dengue in El Salvador, 2011-2013.",602-613,10.1089/vbz.2020.2685 [doi],"Dengue virus serotypes 1, 2, 3, and 4 are transmitted by Aedes aegypti and Aedes albopictus mosquitoes, which cause illness in an estimated 100 million annually. Although dengue viruses are endemic throughout El Salvador, very little is known about their ecology and epidemiology. The principal methods to prevent and reduce dengue cases are through vector control and by adoption of a vaccine. In addition, understanding the environmental and socioeconomic factors associated with dengue could contribute to case reduction by targeting prevention efforts in dengue hotspots. This study investigated environmental and socioeconomic factors associated with dengue cases in El Salvador. Dengue cases were obtained from 2011 to 2013 for 262 municipalities. The mean incidence was determined for each municipality for the 3 year period. Negative binomial regression models evaluated the relationship between dengue cases and the environmental factors elevation, forest coverage, mean annual temperature, and cumulative precipitation. Twelve socioeconomic and infrastructure variables and their relationship with dengue were also investigated by using negative binomial regression. A total of 29,764 confirmed dengue cases were reported. The mean dengue incidence for 2011-2013 was 135/100,000. The highest number of dengue cases occurred in San Salvador and surrounding municipalities, as well as in two additional cities, Santa Ana and San Miguel; the highest incidence of dengue cases (per 100,000) occurred in cities in the west and at the center of the country. Significant environmental variables associated with dengue included temperature, precipitation, and non-forested area. The socioeconomic variables poverty rate, illiteracy rate, and school attendance, and the infrastructure variables percent of homes with sanitary service, municipal trash service, electricity, and cement brick flooring, as well as population density, were also significant predictors of dengue. Understanding these environmental and socioeconomic factors and their relationship with dengue will help design and implement timely prevention strategies and vector control to reduce dengue in El Salvador.","['Joyce, Andrea L', 'Alvarez, Francisco Samuel', 'Hernandez, Eunis']","['Joyce AL', 'Alvarez FS', 'Hernandez E']",,"['Department of Public Health, School of Social Sciences Humanities and Arts, University of California Merced, Merced, California, USA.', 'Fundacion Naturaleza El Salvador, Colonia Escalon, San Salvador, El Salvador.', 'Department of Public Health, School of Social Sciences Humanities and Arts, University of California Merced, Merced, California, USA.']",['eng'],['Journal Article'],20210614,United States,Vector Borne Zoonotic Dis,"Vector borne and zoonotic diseases (Larchmont, N.Y.)",100965525,,IM,"['*Aedes', 'Animals', '*Dengue/epidemiology/veterinary', 'El Salvador/epidemiology', 'Forests', 'Mosquito Vectors', 'Socioeconomic Factors']",,2021/06/16 06:00,2022/01/27 06:00,['2021/06/15 17:13'],"['2021/06/16 06:00 [pubmed]', '2022/01/27 06:00 [medline]', '2021/06/15 17:13 [entrez]']",['10.1089/vbz.2020.2685 [doi]'],ppublish,Vector Borne Zoonotic Dis. 2021 Aug;21(8):602-613. doi: 10.1089/vbz.2020.2685. Epub 2021 Jun 14.,8,,['NOTNLM'],"['Aedes aegypti', 'GIS', 'deforestation', 'infrastructure', 'population density', 'urbanization']",,,,,,,,,,,,,,,,,,,
9376246,NLM,MEDLINE,19971107,20131121,0256-1859 (Print) 0256-1859 (Linking),18,1997 Jul,Inhibition ELISA: an alternative in the serological study of cases of dengue.,7-8,,,,,,,['eng'],['Journal Article'],,United States,Epidemiol Bull,Epidemiological bulletin,8011598,,IM,"['Americas', 'Dengue/*diagnosis/prevention & control', 'Enzyme-Linked Immunosorbent Assay/*methods', '*Hemagglutination Inhibition Tests', 'Humans', 'Population Surveillance/methods', 'Seroepidemiologic Studies', 'Severe Dengue/diagnosis/prevention & control']",,1997/07/01 00:00,1997/11/05 00:01,['1997/07/01 00:00'],"['1997/07/01 00:00 [pubmed]', '1997/11/05 00:01 [medline]', '1997/07/01 00:00 [entrez]']",,ppublish,Epidemiol Bull. 1997 Jul;18(2):7-8.,2,,,,,,,,,,,,,,,,,,,,,,
23875045,NLM,MEDLINE,20140207,20220409,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),7,2013,Health beliefs and practices related to dengue fever: a focus group study.,e2310,10.1371/journal.pntd.0002310 [doi] e2310,"BACKGROUND: This qualitative study aimed to provide an in-depth understanding of the meaning of dengue fever (DF) amongst people living in a dengue endemic region, dengue prevention and treatment-seeking behaviours. The Health Belief Model was used as a framework to explore and understand dengue prevention behaviours. METHODS: A total of 14 focus group discussions were conducted with 84 Malaysian citizens of different socio-demographic backgrounds between 16(th) December, 2011 and 12(th) May, 2012. RESULTS: The study revealed that awareness about DF and prevention measures were high. The pathophysiology of dengue especially dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) were rarely known; as a result, it was seen as deadly by some but was also perceived as easily curable by others without a basis of understanding. Young adults and elderly participants had a low perception of susceptibility to DF. In general, the low perceived susceptibility emerged as two themes, namely a perceived natural ability to withstand infection and a low risk of being in contact with the dengue virus vector, Aedes spp. mosquitoes. The barriers to sustained self-prevention against dengue prevention that emerged in focus groups were: i) lack of self-efficacy, ii) lack of perceived benefit, iii) low perceived susceptibility, and iv) unsure perceived susceptibility. Low perceived benefit of continued dengue prevention practices was a result of lack of concerted action against dengue in their neighborhood. Traditional medical practices and home remedies were widely perceived and experienced as efficacious in treating DF. CONCLUSION: Behavioural change towards attaining sustainability in dengue preventive practices may be enhanced by fostering comprehensive knowledge of dengue and a change in health beliefs. Wide use of unconventional therapy for DF warrants the need to enlighten the public to limit their reliance on unproven alternative treatments.","['Wong, Li Ping', 'AbuBakar, Sazaly']","['Wong LP', 'AbuBakar S']",,"['Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. wonglp@ummc.edu.my']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130711,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adult', 'Aged', 'Animals', 'Dengue/*epidemiology/*prevention & control/transmission', 'Disease Transmission, Infectious/*prevention & control', 'Female', 'Focus Groups', 'Health Education', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Malaysia', 'Male', 'Middle Aged', '*Patient Acceptance of Health Care', 'Young Adult']",PMC3708882,2013/07/23 06:00,2014/02/08 06:00,['2013/07/23 06:00'],"['2012/12/24 00:00 [received]', '2013/05/31 00:00 [accepted]', '2013/07/23 06:00 [entrez]', '2013/07/23 06:00 [pubmed]', '2014/02/08 06:00 [medline]']","['PNTD-D-13-00011 [pii]', '10.1371/journal.pntd.0002310 [doi]']",epublish,PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2310. doi: 10.1371/journal.pntd.0002310. Print 2013.,7,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
33439764,NLM,MEDLINE,20220125,20220125,1557-7759 (Electronic) 1530-3667 (Linking),21,2021 Apr,Current Knowledge and Ecological and Human Impact Variables Involved in the Distribution of the Dengue Virus by Bats in the Americas.,217-231,10.1089/vbz.2020.2696 [doi],"Dengue fever, caused by the dengue virus (DENV), is one of the most important reemerging viral diseases transmitted by arthropods worldwide. DENV is maintained in nature in two transmission cycles: urban and sylvatic. The latter has only been recorded in Africa and Asia and involves nonhuman primates as natural hosts, although it has been suggested that other mammals may play a secondary role as potential reservoir host, including bats. The objective of this article is to review the current state of knowledge about DENV-positive bats in the Americas and to determine what ecological and human impact variables could favor DENV infection in bats. We performed a search of published studies on natural and experimental DENV infection in bats. From 1952 to 2019, 14 studies have been carried out (71.4% in the last decade) examining DENV infection in bats in seven countries of the Americas. DENV infection was examined in 1884 bats of 63 species and DENV was detected in 19 of these species. Clench's model estimated that more than 75 species could be carriers of DENV; therefore, considering that at least 350 species of bats are distributed in the Americas, to detect 95% of the DENV-bearing species, it would be necessary to examine about 10,206 bats of  approximately 287 species that have not been analyzed until 2019. The species with the highest number of positive cases were Molossus sinaloae and Artibeus jamaicensis. Species, colony size, mean annual temperature, mean annual precipitation, human population size, and bat collection site (site inhabited by humans, vegetation cover, and caves) contributed to explain the variation in DENV detection in bats in the Americas. These results provide evidence on the exposure of bats to DENV in different geographic areas of the Americas and a bat sylvatic transmission cycle is very likely to be occurring, where bats may be either accidental hosts, dead-end hosts, or potential reservoir hosts for DENV.","['Hernandez-Aguilar, Itandehui', 'Lorenzo, Consuelo', 'Santos-Moreno, Antonio', 'Navarrete Gutierrez, Dario', 'Naranjo, Eduardo J']","['Hernandez-Aguilar I', 'Lorenzo C', 'Santos-Moreno A', 'Navarrete Gutierrez D', 'Naranjo EJ']",,"['Departamento de Conservacion de la Biodiversidad. El Colegio de la Frontera Sur, Unidad San Cristobal, San Cristobal de Las Casas, Mexico.', 'Departamento de Conservacion de la Biodiversidad. El Colegio de la Frontera Sur, Unidad San Cristobal, San Cristobal de Las Casas, Mexico.', 'Laboratorio de Ecologia Animal, Centro Interdisciplinario de Investigacion para el Desarrollo Integral Regional, Unidad Oaxaca, Instituto Politecnico Nacional, Santa Cruz Xoxocotlan, Mexico.', 'Departamento de Observacion y Estudio de la Tierra, la Atmosfera y el Oceano, El Colegio de la Frontera Sur, Unidad San Cristobal, San Cristobal de Las Casas, Mexico.', 'Departamento de Conservacion de la Biodiversidad. El Colegio de la Frontera Sur, Unidad San Cristobal, San Cristobal de Las Casas, Mexico.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20210113,United States,Vector Borne Zoonotic Dis,"Vector borne and zoonotic diseases (Larchmont, N.Y.)",100965525,,IM,"['Americas/epidemiology', 'Animals', 'Anthropogenic Effects', '*Chiroptera', '*Dengue/epidemiology/veterinary', '*Dengue Virus']",,2021/01/14 06:00,2022/01/27 06:00,['2021/01/13 17:09'],"['2021/01/14 06:00 [pubmed]', '2022/01/27 06:00 [medline]', '2021/01/13 17:09 [entrez]']",['10.1089/vbz.2020.2696 [doi]'],ppublish,Vector Borne Zoonotic Dis. 2021 Apr;21(4):217-231. doi: 10.1089/vbz.2020.2696. Epub 2021 Jan 13.,4,,['NOTNLM'],"['bats', 'hemorrhagic fever', 'reservoir', 'sylvatic cycle', 'zoonosis']",,,,,,,,,,,,,,,,,,,
8599151,NLM,MEDLINE,19960424,20061115,0036-3634 (Print) 0036-3634 (Linking),37 Suppl,1995,[Organizational decision making in health: the case of dengue].,S77-87,,"Intelligent organizations (IO) represent a valuable tool to organize and guide dengue fever surveillance, prevention and control interventions. IO entail state of the art technology in managerial science to generate behavioral frameworks of organizational structures and policies. They present a systematic description of problems and construct computerized models to develop systemic thinking; they produce a shared vision and build progressive mental learning and advancement models. Also, IO promote team building and personal control skills. Scientific-technological advances have produced a wealth of information in medicine, with the corresponding growth of organizations and difficulty of responses because of sudden and incessant change. This new environment calls for the application of IO know-how. This article is oriented to prove the usefulness of the IO technology in the ordering and systematization of the reports about the medical sciences facts. Dengue was chosen to exemplify the use of IO technology as it represents an increasing health problem in America, as well as in Mexico; it is so complex that it can evolve to a more serious problem, besides it can be analyzed within a systemic method.","['Ortiz-Quesada, F', 'Mendez-Galvan, J F', 'Ritchie-Dunham, J', 'Rosado-Munoz, F J']","['Ortiz-Quesada F', 'Mendez-Galvan JF', 'Ritchie-Dunham J', 'Rosado-Munoz FJ']",,['Instituto Tecnologico Autonomo de Mexico.'],['spa'],"['English Abstract', 'Journal Article']",,Mexico,Salud Publica Mex,Salud publica de Mexico,0404371,,IM,"['Aedes', 'Animals', 'Computer Simulation', '*Decision Making, Organizational', '*Decision Support Techniques', 'Dengue/epidemiology/*prevention & control/transmission', 'Humans', 'Insect Vectors', 'Mexico', 'Models, Biological', 'Mosquito Control', 'Risk Factors', 'Software']",,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Salud Publica Mex. 1995;37 Suppl:S77-87.,,,,,,,,,,Las organizaciones inteligentes en la toma de decisiones en salud: el caso del dengue.,,,,,,,,,,,,,
23821270,NLM,MEDLINE,20140124,20191210,1940-6029 (Electronic) 1064-3745 (Linking),1030,2013,A duplex real-time RT-PCR assay for profiling inhibitors of four dengue serotypes.,195-203,10.1007/978-1-62703-484-5_16 [doi],"We have developed a duplex real-time RT-PCR assay for profiling antiviral inhibitors of four dengue virus (DENV) serotypes. In this assay, the primers and the probe for amplifying DENV were designed in the conserved regions of the genome after aligned more than 300 nucleotide sequences of four dengue serotypes deposited in the GeneBank. To discriminate the antiviral activity from the cytotoxicity of compounds, a housekeeping gene of the Vero cells, beta-actin, was used to design the primers and the probe for the second set of PCR as an internal control, which is used to normalize the RNA levels of dengue-specific PCR due to the cellular toxicity of test compounds. For compound profiling, the duplex PCR is performed using LightCycler((R)) in a single tube to simultaneously amplify both the dengue target gene and the Vero cell housekeeping gene from the compound-treated Vero cell lysates. This assay was validated against a panel of reference compounds. The results show that the universal primers and probe in this duplex RT-PCR assay can efficiently amplify all four dengue serotypes and that the PCR efficiency for both the dengue target gene and the Vero cells beta-actin gene is 100%.","['Gong, Edwin Yunhao', 'Smets, Alexandra', 'Verheyen, Nick', 'Clynhens, Marleen', 'Gustin, Emmanuel', 'Lory, Pedro', 'Kraus, Guenter']","['Gong EY', 'Smets A', 'Verheyen N', 'Clynhens M', 'Gustin E', 'Lory P', 'Kraus G']",,"['Janssen Infectious Diseases-Diagnostics BVBA, Johnson & Johnson Corporation, Beerse, Belgium.']",['eng'],['Journal Article'],,United States,Methods Mol Biol,"Methods in molecular biology (Clifton, N.J.)",9214969,['0 (Antiviral Agents)'],IM,"['Animals', 'Antiviral Agents/*pharmacology', 'Chlorocebus aethiops', 'Dengue/classification/*drug therapy/*genetics', 'Humans', 'Inhibitory Concentration 50', 'Microbial Sensitivity Tests/*methods', '*Reverse Transcriptase Polymerase Chain Reaction/methods', 'Serotyping', 'Vero Cells']",,2013/07/04 06:00,2014/01/25 06:00,['2013/07/04 06:00'],"['2013/07/04 06:00 [entrez]', '2013/07/04 06:00 [pubmed]', '2014/01/25 06:00 [medline]']",['10.1007/978-1-62703-484-5_16 [doi]'],ppublish,Methods Mol Biol. 2013;1030:195-203. doi: 10.1007/978-1-62703-484-5_16.,,,,,,,,,,,,,,,,,,,,,,,
9713136,NLM,MEDLINE,19981203,20190607,0036-4665 (Print) 0036-4665 (Linking),40,1998 Jan-Feb,"Involvement of the central nervous system in dengue fever: three serologically confirmed cases from Fortaleza Ceara, Brazil.",35-9,,"Three cases of dengue fever involving the central nervous system (CNS) are reported. All occurred in 1994 during a dengue (DEN) epidemic caused by serotypes DEN-1 and DEN-2. The first case examined was a 17-year-old girl who complained of fever, nuchal rigidity and genital bleeding. Three blood samples were positive by anti-dengue IgM ELISA and showed hemagglutination-inhibition (HI) test titers > or = 1,280. The second case concerned a 86-year-old women with fever, muscle and joint pains, altered consciousness, syncope, nuchal rigidity and meningismus. Her blood sample showed an HI titer of 1:320 for flaviviruses, and an IgM ELISA positive for dengue. The third case was a 67-year-old women with fever, abnormal behaviour, seizures, tremor of extremities, thrombocytopenia, increased hematocrit and leukopenia. The patient suffered a typical case of dengue hemorrhagic fever with ensuing shock and a fatal outcome. A single blood sample showed HI antibodies of > or = 1,280 and an IgM ELISA positive for dengue. No virus could be isolated from any patient by inoculation of blood into C6/36 cells and suckling mice. No other agent of disease was encountered in the patient.","['Vasconcelos, P F', 'da Rosa, A P', 'Coelho, I C', 'Menezes, D B', 'da Rosa, E S', 'Rodrigues, S G', 'da Rosa, J F']","['Vasconcelos PF', 'da Rosa AP', 'Coelho IC', 'Menezes DB', 'da Rosa ES', 'Rodrigues SG', 'da Rosa JF']",,"['WHO Collaborating Center for Arbovirus Reference and Research, Instituto Evandro Chagas, Belem, PA, Brasil.']",['eng'],"['Case Reports', 'Journal Article']",,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Adolescent', 'Aged', 'Aged, 80 and over', 'Blood Platelets', 'Blood Pressure', 'Central Nervous System Diseases/*virology', 'Dengue/blood/*complications/diagnosis', 'Female', 'Hematocrit', 'Humans', 'Leukocyte Count', 'Time Factors']",,1998/08/26 00:00,1998/08/26 00:01,['1998/08/26 00:00'],"['1998/08/26 00:00 [pubmed]', '1998/08/26 00:01 [medline]', '1998/08/26 00:00 [entrez]']",['10.1590/s0036-46651998000100008 [doi]'],ppublish,Rev Inst Med Trop Sao Paulo. 1998 Jan-Feb;40(1):35-9. doi: 10.1590/s0036-46651998000100008.,1,,,,,,,,,,,,,,,,,,,,,,
7934791,NLM,MEDLINE,19941101,20041117,0025-682X (Print) 0025-682X (Linking),54,1994,[Acute post-infectious thrombopenic purpura: atypical manifestation of dengue].,191,,,"['Imbert, P', 'Verrot, D', 'de Pina, J J', 'Debord, T']","['Imbert P', 'Verrot D', 'de Pina JJ', 'Debord T']",,,['fre'],"['Case Reports', 'Letter']",,France,Med Trop (Mars),Medecine tropicale : revue du Corps de sante colonial,8710146,,IM,"['Acute Disease', 'Adult', 'Dengue/blood/*complications/physiopathology', 'Humans', 'Male', 'Purpura, Thrombocytopenic/*virology']",,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Med Trop (Mars). 1994;54(2):191.,2,,,,,,,,,Purpura thrombopenique aigu post-infectieux: manifestation atypique de la dengue.,,,,,,,,,,,,,
35099021,NLM,MEDLINE,20220509,20220523,1537-6613 (Electronic) 0022-1899 (Linking),225,2022 May 4,Transfusion-Transmitted Infections: Lessons From Dengue in Taiwan.,1497-1499,10.1093/infdis/jiac015 [doi],,"['Yan, Gabriel', 'Tambyah, Paul']","['Yan G', 'Tambyah P']",['ORCID: 0000-0003-0405-771X'],"['Department of Laboratory Medicine, National University Health System, Singapore, Singapore.', 'Department of Medicine, National University Health System, Singapore, Singapore.', 'Department of Medicine, National University Health System, Singapore, Singapore.', 'Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.']",['eng'],"['Comment', 'Editorial']",,United States,J Infect Dis,The Journal of infectious diseases,0413675,['63231-63-0 (RNA)'],IM,"['Blood Donors', '*Dengue/blood/epidemiology/prevention & control', '*Dengue Virus', 'Disease Outbreaks', 'Humans', 'Incidence', 'RNA', 'Taiwan/epidemiology', '*Transfusion Reaction/epidemiology']",,2022/02/01 06:00,2022/05/10 06:00,['2022/01/31 08:43'],"['2022/01/19 00:00 [received]', '2022/01/24 00:00 [accepted]', '2022/02/01 06:00 [pubmed]', '2022/05/10 06:00 [medline]', '2022/01/31 08:43 [entrez]']","['6517711 [pii]', '10.1093/infdis/jiac015 [doi]']",ppublish,J Infect Dis. 2022 May 4;225(9):1497-1499. doi: 10.1093/infdis/jiac015.,9,,['NOTNLM'],"['blood-borne viruses', 'dengue', 'transfusion-transmitted infections']",,,,,['J Infect Dis. 2022 May 4;225(9):1504-1512. PMID: 35099002'],,,,,,,,,,,,,,
8924771,NLM,MEDLINE,19961115,20061115,0037-9085 (Print) 0037-9085 (Linking),89,1996,[Dengue and its vectors in Brazil].,128-35; discussion 136,,"History of dengue in Brazil is covered from the first citations in the XIXth century to the great outbreaks of the last ten years. DEN-1 and DEN-4 viruses have been isolated for the first time in 1982 during an epidemic in Boa Vista, Roraima State. In 1986-1987, epidemics of dengue type 1 covered an extended area from Rio de Janeiro/Sao Paulo States to the North East States of Brazil. During 1990-1991, dengue type 2 epidemics have been notified in the South East (Rio de Janeiro/Sao Paulo) and in some States of the interior of the country (Mato Grosso do Sul, Tocantins). DEN-1 virus was also circulating the same year in Sao Paulo and Minas Gerais States. Recently (1994), an important outbreak has been studied in Ceara State, where DEN-2 and DEN-1 viruses have been isolated. In Rio de Janeiro and Ceara (1990 and 1994, respectively), it is probably the succession of infections by DEN-1 and DEN-2 viruses which has caused many DHF/DSS cases. The urban vector has always been the mosquito Aedes aegypti, from which 4, 7 and 16 strains of DEN-4, DEN-1 and DEN-2 have been isolated, respectively. In Brazil, transovarial transmission of dengue viruses by this species has not yet been shown to occur in nature.","['Degallier, N', 'da Rosa, A P', 'Vasconcelos, P F', 'Figueiredo, L T', 'da Rosa, J F', 'Rodrigues, S G', 'da Rosa, E S']","['Degallier N', 'da Rosa AP', 'Vasconcelos PF', 'Figueiredo LT', 'da Rosa JF', 'Rodrigues SG', 'da Rosa ES']",,"[""Laboratoire d'epidemiologie des maladies a vecteurs, ORSTOM Centre de Montpellier BP 5045, France.""]",['fre'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",,France,Bull Soc Pathol Exot,Bulletin de la Societe de pathologie exotique (1990),9212564,,IM,"['Aedes', 'Animals', 'Brazil/epidemiology', 'Dengue/*epidemiology/*transmission/virology', 'Dengue Virus/classification/isolation & purification', 'Disease Outbreaks', 'Humans', '*Insect Vectors']",,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot. 1996;89(2):128-35; discussion 136.,2,,,,,,,95,,La dengue et ses vecteurs au Bresil.,,,,,,,,,,,,,
33632088,NLM,MEDLINE,20211021,20211021,1758-1133 (Electronic) 0049-4755 (Linking),51,2021 Jul,Bacterial sepsis in dengue fever - A paediatric perspective.,371-375,10.1177/0049475521993608 [doi],"Dengue fever is the most common arthropod borne infection worldwide. Bacterial sepsis in dengue fever is not widely recognised. This is a retrospective cohort study of children who had sepsis coexisting along with Dengue fever. One hundred and twenty-four patients aged between three months and eighteen years admitted in two private hospitals in North India were studied. Thirteen children had concurrent sepsis (13/124, 10.4%). Children between 0 and five years (7/13, 53.8%, p = 0.019), having longer hospital stay (7/13, 53.8%, p = 0.00029), shock (10/13, 76.9%, p = 0.00001), and increased PCT (13/13, 100%, p < 0.001) were some indicators of sepsis in these patients. Blood cultures were positive in five children. It is a matter of speculation as to why these patients of dengue are more susceptible to sepsis. Increased vascular permeability may increase the chances of bacterial contamination. Antibiotics should not be used routinely in dengue fever. However, young children presenting with severe symptoms especially shock should be screened for sepsis, and appropriate antibiotics should be started early.","['Sunil, Taneja', 'Alexandra, Bansal', 'Tanu, Midha', 'Ali, Mansuri M', 'Neha, Agarwal', 'Navin, Burman']","['Sunil T', 'Alexandra B', 'Tanu M', 'Ali MM', 'Neha A', 'Navin B']","['ORCID: 0000-0003-4412-8148', 'ORCID: 0000-0002-2975-7088']","['Consultant and HOD, Department of Pediatrics, Madhuraj Hospital, Kanpur, India.', 'Resident, Department of Pediatrics, Madhuraj Hospital, Kanpur, India.', 'Professor of Community Medicine, GMC, Kannauj, India.', 'Resident, Department of Pediatrics, Madhuraj Hospital, Kanpur, India.', 'Lecturer, Department of Pediatrics, 30076GSVM Medical College, Kanpur.', 'Resident, Department of Pediatrics, Madhuraj Hospital, Kanpur, India.']",['eng'],['Journal Article'],20210225,England,Trop Doct,Tropical doctor,1301706,['0 (Anti-Bacterial Agents)'],IM,"['Adolescent', 'Anti-Bacterial Agents/therapeutic use', 'Child', 'Child, Preschool', 'Dengue/complications/diagnosis/*epidemiology', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Length of Stay', 'Male', 'Retrospective Studies', 'Sepsis/diagnosis/*epidemiology']",,2021/02/27 06:00,2023/02/25 06:00,['2021/02/26 05:37'],"['2021/02/27 06:00 [pubmed]', '2023/02/25 06:00 [medline]', '2021/02/26 05:37 [entrez]']",['10.1177/0049475521993608 [doi]'],ppublish,Trop Doct. 2021 Jul;51(3):371-375. doi: 10.1177/0049475521993608. Epub 2021 Feb 25.,3,,['NOTNLM'],"['Dengue fever', 'bacterial sepsis', 'paediatric']",,,,,,,,,,,,,,,,,,,
25286105,NLM,MEDLINE,20150924,20181202,0009-0875 (Print) 0009-0875 (Linking),59,2014 Sep,Platelet recovery in dengue--a reply.,109,10.4038/cmj.v59i3.7483 [doi],,"['Yasri, S', 'Wiwanitkit, V']","['Yasri S', 'Wiwanitkit V']",,"['Primary Care Unit, KMT Center, Bangkok, Thailand. sorayasri@outlook.co.th.']",['eng'],"['Comment', 'Letter']",,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['Dengue/*blood/*epidemiology', '*Disease Outbreaks', 'Humans', '*Recovery of Function']",,2014/10/07 06:00,2015/09/25 06:00,['2014/10/07 06:00'],"['2014/10/07 06:00 [entrez]', '2014/10/07 06:00 [pubmed]', '2015/09/25 06:00 [medline]']",['10.4038/cmj.v59i3.7483 [doi]'],ppublish,Ceylon Med J. 2014 Sep;59(3):109. doi: 10.4038/cmj.v59i3.7483.,3,,,,,,,,['Ceylon Med J. 2014 Jun;59(2):61-3. PMID: 24977425'],,,,,,,,,,,,,,
2633942,NLM,MEDLINE,19900525,20091111,0016-3813 (Print) 0016-3813 (Linking),125,1989 Jan-Feb,[Classic dengue and hemorrhagic dengue in Mexico].,37-9,,,"['Kumate-Rodriguez, J', 'Llausas, A']","['Kumate-Rodriguez J', 'Llausas A']",,,['spa'],['Journal Article'],,Mexico,Gac Med Mex,Gaceta medica de Mexico,0010333,,IM,"['Animals', 'Dengue/*epidemiology/mortality', 'Disease Vectors', 'Humans', 'Mexico/epidemiology']",,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Gac Med Mex. 1989 Jan-Feb;125(1-2):37-9.,1-2,,,,,,,,,Dengue clasico y dengue hemorragico en Mexico.,,,,,,,,,,,,,
6123900,NLM,MEDLINE,19820826,20190611,0140-6736 (Print) 0140-6736 (Linking),2,1982 Jul 24,Dengue-2 virus in Kenya.,208-9,,,"['Johnson, B K', 'Musoke, S', 'Ocheng, D', 'Gichogo, A', 'Rees, P H']","['Johnson BK', 'Musoke S', 'Ocheng D', 'Gichogo A', 'Rees PH']",,,['eng'],['Letter'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Dengue/*epidemiology/transmission', 'Dengue Virus/*classification', 'Humans', 'Kenya', 'Serotyping']",,1982/07/24 00:00,1982/07/24 00:01,['1982/07/24 00:00'],"['1982/07/24 00:00 [pubmed]', '1982/07/24 00:01 [medline]', '1982/07/24 00:00 [entrez]']","['S0140-6736(82)91047-9 [pii]', '10.1016/s0140-6736(82)91047-9 [doi]']",ppublish,Lancet. 1982 Jul 24;2(8291):208-9. doi: 10.1016/s0140-6736(82)91047-9.,8291,,,,,,,,,,,,,,,,,,,,,,
10587752,NLM,MEDLINE,19991228,20190831,0929-693X (Print) 0929-693X (Linking),6,1999 Nov,[Dengue shock syndrome in two brothers].,1239-40,,,"['Mbou, F M', 'Monlouis Eugenie, M M', 'Elana, G', 'Chout, R', 'Yebakima, A']","['Mbou FM', 'Monlouis Eugenie MM', 'Elana G', 'Chout R', 'Yebakima A']",,,['fre'],"['Case Reports', 'Journal Article']",,France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Child', 'Dengue/*complications/diagnosis', 'Diagnosis, Differential', 'Fever/etiology', 'Humans', 'Male', 'Nuclear Family', 'Shock/*etiology']",,1999/12/10 09:00,2000/05/05 09:00,['1999/12/10 09:00'],"['1999/12/10 09:00 [pubmed]', '2000/05/05 09:00 [medline]', '1999/12/10 09:00 [entrez]']","['S0929693X00863113 [pii]', '10.1016/s0929-693x(00)86311-3 [doi]']",ppublish,Arch Pediatr. 1999 Nov;6(11):1239-40. doi: 10.1016/s0929-693x(00)86311-3.,11,,,,,,,,,Syndrome de choc de la dengue chez deux freres.,,,,,,,,,,,,,
2805215,NLM,MEDLINE,19891221,20220310,0042-9686 (Print) 0042-9686 (Linking),67,1989,"Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.",375-80,,"Dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) is one of the principal causes of hospitalization and death among children in several south-east Asian countries. Also, in the Region of the Americas, there has been an increase in the frequency of dengue fever epidemics and in the number of cases of DHF/DSS. In 1981 an epidemic of dengue haemorrhagic fever occurred in Cuba and this suggests that there is a high risk that such epidemics could recur in the region. The article summarizes the main clinical, virological, and epidemiological data obtained during the outbreak, some of which are reported for the first time.","['Kouri, G P', 'Guzman, M G', 'Bravo, J R', 'Triana, C']","['Kouri GP', 'Guzman MG', 'Bravo JR', 'Triana C']",,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,,IM,"['Adult', 'Aedes', 'Animals', 'Child', 'Cuba', 'Dengue/*epidemiology/mortality/prevention & control', '*Disease Outbreaks', 'Female', 'Humans', 'Incidence', 'Insect Vectors', 'Male', 'Mosquito Control/methods']",PMC2491263,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Bull World Health Organ. 1989;67(4):375-80.,4,,,,,,,,,,,,,,,,,,,,,,
26598561,NLM,MEDLINE,20160526,20181113,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),94,2016 Jan,Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool.,187-92,10.4269/ajtmh.15-0392 [doi],"Dengue remains a problem in Brazil, and a substantial number of cases that progress to death are not diagnosed by health services. We evaluated the impact of a protocol adopted by the Coroner's Office Rocha Furtado (CO-RF) for the detection of unreported deaths from dengue in Brazil. We evaluated prospectively cases of deaths referred to the CO-RF with suspicion of dengue and those referred with other diagnosis in which the pathologists suspected dengue as the cause of death. Biological material was collected from all bodies autopsied, for which the suspected cause of death was dengue, between January 2011 and December 2012. Of the 214 bodies autopsied, 134 (62.6%) tested positive for dengue; of these cases, 121 were classified as dengue according to the World Health Organization's case definition (1997 or 2009, as appropriate). Thus, CO-RF detected 90 deaths from dengue, which were not suspected during disease progression. This CO-RF protocol, through a combined effort of the surveillance and laboratory teams, increased the detection of fatal dengue cases by 5-fold. This is the largest series of autopsies performed in cases of death related to dengue in the world to date.","['Cavalcanti, Luciano Pamplona de Goes', 'Braga, Deborah Nunes de Melo', 'da Silva, Livia Maria Alexandre', 'Aguiar, Marina Gondim', 'Castiglioni, Mariana', 'Silva-Junior, Jose Udevanier', 'Araujo, Fernanda Montenegro de Carvalho', 'Pereira, Renata Allana da Costa', 'Malta, Danielle Lima', 'Pompeu, Margarida Maria de Lima']","['Cavalcanti LP', 'Braga DN', 'da Silva LM', 'Aguiar MG', 'Castiglioni M', 'Silva-Junior JU', 'Araujo FM', 'Pereira RA', 'Malta DL', 'Pompeu MM']",,"['Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil pamplona.luciano@gmail.com.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.', 'Department of Community Health, Federal University of Ceara, Fortaleza, Brazil; Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil; Faculdade de Medicina, Centro Universitario Christus, Fortaleza, Brazil; Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Brazil; Central Public Health Laboratory, Department of Health of Ceara State, Fortaleza, Brazil; Curso de Medicina, Universidade de Fortaleza, Fortaleza, Brazil; Programa de Pos-graduacao em Patologia da Universidade Federal do Ceara, Departmento de Patologia, Universidade Federal do Ceara, Fortaleza, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20151123,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,"['0 (Antibodies, Viral)']",IM,"['Antibodies, Viral', 'Brazil/epidemiology', 'Cause of Death', 'Dengue/*diagnosis/*epidemiology/mortality', 'Forensic Medicine', 'Humans', 'Pathology, Clinical', 'Population Surveillance/*methods', 'Specimen Handling']",PMC4710428,2015/11/26 06:00,2016/05/27 06:00,['2015/11/25 06:00'],"['2015/05/26 00:00 [received]', '2015/10/07 00:00 [accepted]', '2015/11/25 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2016/05/27 06:00 [medline]']","['ajtmh.15-0392 [pii]', '10.4269/ajtmh.15-0392 [doi]']",ppublish,Am J Trop Med Hyg. 2016 Jan;94(1):187-92. doi: 10.4269/ajtmh.15-0392. Epub 2015 Nov 23.,1,['(c) The American Society of Tropical Medicine and Hygiene.'],,,,,,,,,,,,,,,,,,,,,
5838908,NLM,MEDLINE,19660113,20131121,0008-7335 (Print) 0008-7335 (Linking),104,1965 Sep 17,[Dengue fever disease in the Czechoslovak health mission during the epidemic in the summer of 1960 in the Vietnam Democratic Republic. I. Clinical picture and treatment].,1016-21,,,"['Mirovsky, J']",['Mirovsky J'],,,['cze'],"['Case Reports', 'Journal Article']",,Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,['VB0R961HZT (Prednisone)'],IM,"['Dengue/*drug therapy/*epidemiology', 'Humans', 'Middle Aged', 'Prednisone/*therapeutic use', 'Vietnam']",,1965/09/17 00:00,1965/09/17 00:01,['1965/09/17 00:00'],"['1965/09/17 00:00 [pubmed]', '1965/09/17 00:01 [medline]', '1965/09/17 00:00 [entrez]']",,ppublish,Cas Lek Cesk. 1965 Sep 17;104(37):1016-21.,37,,,,,,,,,Onemocneni dengue v ceskoslovenske zdravotnicke skupine za epidemie v lete 1960 ve Vietnamske Demokraticke Republice. I. Klinicky obraz a leceni.,,,,,,,,,,,,,
3625979,NLM,MEDLINE,19871022,20161017,0098-7484 (Print) 0098-7484 (Linking),258,1987 Oct 2,"Leads from the MMWR. Imported and indigenous dengue fever--United States, 1986.",1712-3,,,,,,,['eng'],['Journal Article'],,United States,JAMA,JAMA,7501160,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/transmission', 'Humans', 'Insect Vectors', 'Travel', 'United States']",,1987/10/02 00:00,1987/10/02 00:01,['1987/10/02 00:00'],"['1987/10/02 00:00 [pubmed]', '1987/10/02 00:01 [medline]', '1987/10/02 00:00 [entrez]']",,ppublish,JAMA. 1987 Oct 2;258(13):1712-3.,13,,,,,,,,,,,,,,,,,,,,,,
6111919,NLM,MEDLINE,19810613,20211203,0001-706X (Print) 0001-706X (Linking),38,1981 Mar,Bleeding manifestations of dengue haemorrhagic fever in Malaysia.,71-8,,"Analysis of the bleeding manifestations of 130 cases of dengue haemorrhagic fever admitted into the Children's ward of the General Hospital, Kuala Lumpur from May 1973 to September 1978 has been done. Petechial skin rash, epistaxis and gum bleeding were seen most commonly in mild and moderately severe cases. However, blood stained gastric aspirates, and severe haematemesis were seen in severe or very severe cases. Though with better vector control and preventive measures, a marked reduction in the incidence of the cases has been noted, severe cases were seen with symptoms of shock and gastrointestinal bleeding. These symptoms carried a bad prognosis. Among 15 children that died 10 had gastrointestinal bleeding and 2 had a disseminated intravascular coagulation defect. Lymphocytosis with atypical lymphocytes, low platelet count, low reticulocyte count and raised packed cell volume were the main haematological features seen in all these cases. All these features reverted to normal within a week. Mild evidence of disseminated intravascular coagulation was seen in a number of cases, but severe features were seen only in four. Two cases improved as a result of heparin therapy.","['George, R', 'Duraisamy, G']","['George R', 'Duraisamy G']",,,['eng'],['Journal Article'],,Netherlands,Acta Trop,Acta tropica,0370374,,IM,"['Age Factors', 'Child', 'Child, Preschool', 'Dengue/*complications/epidemiology/mortality', 'Female', 'Hemorrhage/*etiology', 'Humans', 'Infant', 'Malaysia', 'Male', 'Racial Groups', 'Seasons']",,1981/03/01 00:00,1981/03/01 00:01,['1981/03/01 00:00'],"['1981/03/01 00:00 [pubmed]', '1981/03/01 00:01 [medline]', '1981/03/01 00:00 [entrez]']",,ppublish,Acta Trop. 1981 Mar;38(1):71-8.,1,,,,,,,,,,,,,,,,,,,,,,
32877069,NLM,MEDLINE,20200914,20200914,2101-017X (Electronic) 0035-2640 (Linking),70,2020 Mar,[Dengue fever: an emerging infectious disease].,318-325,,"Dengue fever: an emerging infectious disease. Dengue fever is caused by an arbovirus of the family Flaviviridae and the genus Flavivirus, of which there are 4 serotypes (DEN-1, DEN-2, DEN-3, DEN-4). It is transmitted by the bite of a diurnal mosquito of the genus Aedes, mainly A. aegypti and A. albopictus. An increasing cause of acute fever in travellers, it threatens to emerge in temperate regions where competent mosquitoes (Aedes) are established. Dengue fever is characterized by its clinical polymorphism ranging from asymptomatic to severe forms, which are rare in travellers. Its definite diagnosis is based on virological tests selected according to the stage of the disease and the kinetics of the virus. Its treatment is only symptomatic. It is a notifiable disease in mainland France and is subject to a plan to combat its spread and to specific surveillance in the overseas departments. Dengue prevention is based on the application of personal anti-vectorial protection measures among travellers, awareness-raising among health professionals and social mobilization to combat larval gites in endemic regions or regions colonized by Aedes. In France, the tetravalent vaccine Dengvaxia, which is licensed in France, is not recommended for people residing in overseas departments and for travelers to endemic areas.","['Rapp, Christophe']",['Rapp C'],,"['Hopital americain de Paris, pole medecine, Neuilly-sur-Seine, France.', ""Service des maladies infectieuses et tropicales, hopital d'instruction des armees Begin, Saint-Mande, France.""]",['fre'],['Journal Article'],,France,Rev Prat,La Revue du praticien,0404334,,IM,"['*Aedes', 'Animals', '*Communicable Diseases, Emerging', '*Dengue/epidemiology/transmission', '*Dengue Virus', 'France/epidemiology', 'Travel Medicine']",,2020/09/03 06:00,2020/09/15 06:00,['2020/09/03 06:00'],"['2020/09/03 06:00 [entrez]', '2020/09/03 06:00 [pubmed]', '2020/09/15 06:00 [medline]']",,ppublish,Rev Prat. 2020 Mar;70(3):318-325.,3,,['NOTNLM'],"['Arbovirus Infections', 'Dengue']","['C. Rapp declare participer ou avoir participe a des interventions ponctuelles', 'pour le laboratoire Alfasigma France.']",,,,,Dengue : une infection emergente.,,,,,,,,,,,,,
23590206,NLM,MEDLINE,20130812,20130613,1365-3156 (Electronic) 1360-2276 (Linking),18,2013 Jul,Temporal trends and regional variability of 2001-2002 multiwave DENV-3 epidemic in Havana City: did Hurricane Michelle contribute to its severity?,830-8,10.1111/tmi.12105 [doi],"OBJECTIVES: To investigate the temporal and regional variability of the 2001-2002 dengue outbreak in Havana City where 12 889 cases, mostly of DENV-3 type, were reported over a period of 7 months. METHODS: A simple mathematical model, the Richards model, was used to fit the weekly reported dengue case data by municipality, in order to quantify the transmissibility and temporal changes in the epidemic in each municipality via the basic reproduction number R0 . RESULTS: Model fits indicate either a 2-wave or 3-wave outbreak in all municipalities. Estimates for R0 varied greatly, from 1.97 (95% CI: 1.94, 2.01), for Arroyo Naranjo, to 61.06 (60.44, 61.68), for Boyeros, most likely due to heterogeneity in community structure, geographical locations and social networking. CONCLUSIONS: Our results illustrate the potential impact of climatological events on disease spread, further highlighting the need to be well prepared for potentially worsening disease spread in the aftermath of natural disasters such as hurricanes/typhoons.","['Hsieh, Ying-Hen', 'de Arazoza, Hector', 'Lounes, Rachid']","['Hsieh YH', 'de Arazoza H', 'Lounes R']",,"['Department of Public Health and Center for Infectious Disease Education and Research, China Medical University, Taichung, Taiwan. hsieh@mail.cmu.edu.tw']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20130417,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Cuba/epidemiology', '*Cyclonic Storms', 'Dengue/*epidemiology/transmission/virology', '*Dengue Virus', '*Epidemics', 'Humans', 'Interpersonal Relations', 'Models, Theoretical', 'Reproduction', 'Residence Characteristics']",,2013/04/18 06:00,2013/08/13 06:00,['2013/04/18 06:00'],"['2013/04/18 06:00 [entrez]', '2013/04/18 06:00 [pubmed]', '2013/08/13 06:00 [medline]']",['10.1111/tmi.12105 [doi]'],ppublish,Trop Med Int Health. 2013 Jul;18(7):830-8. doi: 10.1111/tmi.12105. Epub 2013 Apr 17.,7,['(c) 2013 Blackwell Publishing Ltd.'],,,,,,,,,,,,,,,,,,,,,
31793412,NLM,MEDLINE,20200610,20200610,1751-3766 (Electronic) 1751-3758 (Linking),13,2019 Dec,Dengue transmission: mathematical model with discrete time delays and estimation of the reproduction number.,1-25,10.1080/17513758.2018.1562572 [doi],"In this paper, we establish a mathematical model with two delays to reflect the intrinsic and extrinsic incubation periods of virus in dengue transmission. The basic reproduction number [Formula: see text] of the model is defined. It is proved that the disease-free equilibrium is stable when [Formula: see text] and the positive equilibrium is stable when [Formula: see text]. Next, we derive an estimation formula for the reproduction number [Formula: see text] when the human population is partially susceptible to dengue. As an application, the [Formula: see text] values of dengue transmission in Singapore in the years 2013-2015 are estimated. Our estimation method can be applied to estimating [Formula: see text] of other infectious diseases, especially when the human population is not completely susceptible to the disease.","['Wu, Chunqing', 'Wong, Patricia J Y']","['Wu C', 'Wong PJY']",,"[""School of Mathematics and Physics, Changzhou University, Changzhou, People's Republic of China."", 'School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",,England,J Biol Dyn,Journal of biological dynamics,101299725,,IM,"['*Basic Reproduction Number', 'Dengue/epidemiology/*transmission', 'Humans', '*Models, Theoretical', 'Singapore/epidemiology', 'Time Factors']",,2019/12/04 06:00,2020/06/11 06:00,['2019/12/04 06:00'],"['2019/12/04 06:00 [entrez]', '2019/12/04 06:00 [pubmed]', '2020/06/11 06:00 [medline]']",['10.1080/17513758.2018.1562572 [doi]'],ppublish,J Biol Dyn. 2019 Dec;13(1):1-25. doi: 10.1080/17513758.2018.1562572.,1,,['NOTNLM'],"['Dengue transmission', 'delay', 'estimation', 'mathematical model', 'reproduction number', 'stability']",,,,,,,,,,,,,,,,,,,
31254116,NLM,MEDLINE,20190910,20200225,1573-2959 (Electronic) 0167-6369 (Linking),191,2019 Jun 28,Landscapes of healthcare utilization during a dengue fever outbreak in an urban environment of Colombia.,279,10.1007/s10661-019-7415-2 [doi],"The well-being of a population and its health are influenced by a myriad of socioeconomic and environmental factors that interact across a wide range of scales, from the individual to the national and global levels. One of these factors is the provision of health services, which is regulated by both demand and supply. Although an adequate provision can significantly improve health outcomes of a population, lopsided flow of patients to specific health centers can result in serious disparities and potentially delay the timeliness of a diagnosis. In this paper, utilization patterns during an epidemic of dengue fever in the city of Cali, Colombia for the year 2010 are investigated. Specifically, the objectives are to (1) identify health facilities that exhibit patterns of over- and underutilization, (2) determine where patients who are being diagnosed at a particular facility originate from, and (3) whether patients are traveling to their closest facility and hence (4) estimate how far patients are willing to travel to be diagnosed and treated for dengue fever. Analysis is further decomposed by age group and by gender, in an attempt to test whether utilization patterns drastically change according to these variables. Answers to these questions can help health authorities plan for future epidemics, for instance, by providing guidelines as to which facilities require more resources and by improving the organization of health prevention campaigns to direct population seeking health assistance to use facilities that are underutilized.","['Casas, Irene', 'Delmelle, Eric']","['Casas I', 'Delmelle E']",['ORCID: 0000-0002-5117-2238'],"['Louisiana Tech University, Ruston, LA, 71272, USA.', 'University of North Carolina at Charlotte, Charlotte, NC, 28223, USA. Eric.Delmelle@uncc.edu.']",['eng'],['Journal Article'],20190628,Netherlands,Environ Monit Assess,Environmental monitoring and assessment,8508350,,IM,"['Adult', 'Cities', 'Colombia/epidemiology', 'Dengue/*epidemiology/therapy/virology', '*Disease Outbreaks', '*Environmental Monitoring', 'Female', 'Geographic Information Systems', 'Health Facilities', 'Humans', 'Male', 'Middle Aged', 'Travel']",,2019/06/30 06:00,2019/09/11 06:00,['2019/06/30 06:00'],"['2017/04/19 00:00 [received]', '2019/03/20 00:00 [accepted]', '2019/06/30 06:00 [entrez]', '2019/06/30 06:00 [pubmed]', '2019/09/11 06:00 [medline]']","['10.1007/s10661-019-7415-2 [pii]', '10.1007/s10661-019-7415-2 [doi]']",epublish,Environ Monit Assess. 2019 Jun 28;191(Suppl 2):279. doi: 10.1007/s10661-019-7415-2.,Suppl 2,,['NOTNLM'],"['Access', 'Dengue fever', 'Geographic information systems (GIS)', 'Healthcare utilization']",,,,,,,,,,,,,,,,,,,
26209406,NLM,MEDLINE,20160518,20150725,1873-5967 (Electronic) 1386-6532 (Linking),69,2015 Aug,An unusual case of dengue infection presenting with hypokalemic paralysis with hypomagnesemia.,197-9,S1386-6532(15)00283-8 [pii] 10.1016/j.jcv.2015.06.098 [doi],"Neurological manifestations are unusual in dengue fever and can be due to neurotropic effect, systemic complications of dengue infection, or immune mediated. Acute hypokalemic paralysis is a rare systemic complication of dengue infection; however, hypokalemia along with hypomagnesemia has not been reported earlier. We herein report an extremely unusual and probably the first case of dengue infection in a 30-year-old male who presented to us with hypokalemic paralysis along with hypomagnesemia. This case report highlights that hypomagnesemia may be a significant complication in dengue infection. Correction of hypomagnesemia is of paramount importance to avoid refractory hypokalemia leading to severe consequences.","['Jain, Rajendra Singh', 'Gupta, Pankaj Kumar', 'Agrawal, Rakesh', 'Kumar, Sunil', 'Khandelwal, Kapil']","['Jain RS', 'Gupta PK', 'Agrawal R', 'Kumar S', 'Khandelwal K']",,"['Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India.', 'Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India. Electronic address: pankajniw04@gmail.com.', 'Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India.', 'Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India.', 'Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India.']",['eng'],"['Case Reports', 'Journal Article']",20150626,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,['RWP5GA015D (Potassium)'],IM,"['Adult', 'Dengue/*complications/metabolism/*physiopathology', 'Humans', 'Hypokalemia/metabolism/physiopathology', 'Male', 'Paralysis/metabolism/physiopathology', 'Potassium/*analysis']",,2015/07/26 06:00,2016/05/19 06:00,['2015/07/26 06:00'],"['2015/03/05 00:00 [received]', '2015/06/20 00:00 [revised]', '2015/06/23 00:00 [accepted]', '2015/07/26 06:00 [entrez]', '2015/07/26 06:00 [pubmed]', '2016/05/19 06:00 [medline]']","['S1386-6532(15)00283-8 [pii]', '10.1016/j.jcv.2015.06.098 [doi]']",ppublish,J Clin Virol. 2015 Aug;69:197-9. doi: 10.1016/j.jcv.2015.06.098. Epub 2015 Jun 26.,,['Copyright (c) 2015 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['Dengue infection', 'Hypokalemia', 'Hypomagnesemia', 'Paralysis']",,,,,,,,,,,,,,,,,,,
3886182,NLM,MEDLINE,19850617,20220321,,78,1985,[Dengue in Burkina Faso (ex-Upper Volta): seasonal epidemics in the urban area of Ouagadougou].,7-14,,"During the rainy season of 1982 30 patients (29 european and 1 voltaic) presented with an intense dengue-like syndrome in Ouagadougou city. 73.3% of these cases possessed anti-flavivirus fluorescent antibodies while 30%, were positive for specific anti-Dengue IgM antibodies. Vero type E 6 cell cultures were used to isolate six strains of Dengue 2 virus; monoclonal antibodies were used for viral identification. These strains constitute the first isolates of human Dengue virus in Upper Volta. Authors present conditions of virus isolations, describe the observed syndrome and discuss the epidemiological interest of this outbreak.","['Gonzalez, J P', 'Du Saussay, C', 'Gautun, J C', 'McCormick, J B', 'Mouchet, J']","['Gonzalez JP', 'Du Saussay C', 'Gautun JC', 'McCormick JB', 'Mouchet J']",,,['fre'],"['English Abstract', 'Journal Article']",,France,Bull Soc Pathol Exot Filiales,Bulletin de la Societe de pathologie exotique et de ses filiales,7503399,"['0 (Antibodies, Monoclonal)']",IM,"['Adolescent', 'Adult', 'Antibodies, Monoclonal', 'Burkina Faso', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology/immunology', 'Dengue Virus/isolation & purification', 'Female', 'Fluorescent Antibody Technique', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Urban Health']",,1985/01/01 00:00,1985/01/01 00:01,['1985/01/01 00:00'],"['1985/01/01 00:00 [pubmed]', '1985/01/01 00:01 [medline]', '1985/01/01 00:00 [entrez]']",,ppublish,Bull Soc Pathol Exot Filiales. 1985;78(1):7-14.,1,,,,,,,,,La dengue au Burkina Faso (ex-Haute-Volta): epidemies saisonnieres en milieu urbain a Ouagadougou.,,,,,,,,,,,,,
31925430,NLM,MEDLINE,20210624,20210624,1878-3503 (Electronic) 0035-9203 (Linking),114,2020 Jun 1,The atypical lymphocyte count: a novel predictive factor for severe thrombocytopenia related to dengue.,424-432,10.1093/trstmh/trz128 [doi],"BACKGROUND: Early identification of patients at risk of severe dengue disease (DD) is critical to guide its management. We evaluated whether the atypical lymphocyte count (ALC), generated from the Sysmex automated full blood count analyzer, is predictive of severe thrombocytopenia secondary to Dengue infection. METHODS: We prospectively collected data on patients admitted with DD between December 2017 and October 2018. ALC data were extracted from the Sysmex XS500i analyzer from day 1 to day 7 of admission. Clinical data were obtained from patients' medical records. RESULTS: We enrolled 256 patients with DD. A negative correlation between ALC on admission and platelet count on day 5 to day 7 (Spearmen's correlation; day 5:-0.485, day 6:-0.428 and day 7:-0.344) (p=0.001) was observed. Based on receiver operator characteristic curve analysis, we found that an ALC of >0.5x103/L had 90% sensitivity and 70% specificity for severe thrombocytopenia (platelet count <50x109/L) on day 5. The positive and negative predictive values were 74.4 and 91.2%, respectively (power 84.7). CONCLUSIONS: We propose that ALC on admission may be a novel negative predictive factor for severe thrombocytopenia on day 5 to day 7 of DD. Further studies are required to validate our findings and evaluate whether ALC is predictive of other complications of DD.","['Abeysuriya, Visula', 'Choong, Clarice Shi Hui', 'Thilakawardana, Basuru Uvindu', 'de Mel, Primesh', 'Shalindi, Malka', 'de Mel, Chandima', 'Chandrasena, Lal', 'Seneviratne, Suranjith L', 'Yip, Christina', 'Yap, Eng-Soo', 'de Mel, Sanjay']","['Abeysuriya V', 'Choong CSH', 'Thilakawardana BU', 'de Mel P', 'Shalindi M', 'de Mel C', 'Chandrasena L', 'Seneviratne SL', 'Yip C', 'Yap ES', 'de Mel S']",,"['Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Department of Haematology- Oncology, National University Cancer Institute, National University Health System Singapore.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka.', 'Institute of Immunity and Transplantation, Royal Free Hospital and University College London, London, UK.', 'Department of Laboratory Medicine, National University Health System Singapore.', 'Department of Haematology- Oncology, National University Cancer Institute, National University Health System Singapore.', 'Department of Laboratory Medicine, National University Health System Singapore.', 'Department of Haematology- Oncology, National University Cancer Institute, National University Health System Singapore.']",['eng'],['Journal Article'],,England,Trans R Soc Trop Med Hyg,Transactions of the Royal Society of Tropical Medicine and Hygiene,7506129,,IM,"['*Dengue/complications/diagnosis', 'Humans', 'Lymphocyte Count', 'Lymphocytes', 'Platelet Count', '*Severe Dengue', '*Thrombocytopenia/diagnosis/etiology']",,2020/01/12 06:00,2021/06/25 06:00,['2020/01/12 06:00'],"['2019/08/05 00:00 [received]', '2019/10/25 00:00 [revised]', '2019/11/11 00:00 [accepted]', '2020/01/12 06:00 [pubmed]', '2021/06/25 06:00 [medline]', '2020/01/12 06:00 [entrez]']","['5699687 [pii]', '10.1093/trstmh/trz128 [doi]']",ppublish,Trans R Soc Trop Med Hyg. 2020 Jun 1;114(6):424-432. doi: 10.1093/trstmh/trz128.,6,"['(c) The Author(s) 2020. Published by Oxford University Press on behalf of Royal', 'Society of Tropical Medicine and Hygiene.']",['NOTNLM'],"['atypical lymphocyte count', 'dengue', 'thrombocytopenia']",,,,,,,,,,,,,,,,,,,
22276682,NLM,MEDLINE,20120620,20220321,1471-2458 (Electronic) 1471-2458 (Linking),12,2012 Jan 26,A local outbreak of dengue caused by an imported case in Dongguan China.,83,10.1186/1471-2458-12-83 [doi],"BACKGROUND: Dengue, a mosquito-borne febrile viral disease, is found in tropical and sub-tropical regions around the world. Since the first occurrence of dengue was confirmed in Guangdong, China in 1978, dengue outbreaks have been reported sequentially in different provinces in South China transmitted by peridomestic Ae. albopictus mosquitoes, diplaying Ae. aegypti, a fully domestic vector that transmits dengue worldwide. Rapid and uncontrolled urbanization is a characteristic change in developing countries, which impacts greatly on vector habitat, human lifestyle and transmission dynamics on dengue epidemics. In September 2010, an outbreak of dengue was detected in Dongguan, a city in Guangdong province characterized by its fast urbanization. An investigation was initiated to identify the cause, to describe the epidemical characteristics of the outbreak, and to implement control measures to stop the outbreak. This is the first report of dengue outbreak in Dongguan, even though dengue cases were documented before in this city. METHODS: Epidemiological data were obtained from local Center of Disease Control and prevention (CDC). Laboratory tests such as real-time Reverse Transcription Polymerase Chain Reaction (RT-PCR), the virus cDNA sequencing, and Enzyme-Linked immunosorbent assay (ELISA) were employed to identify the virus infection and molecular phylogenetic analysis was performed with MEGA5. The febrile cases were reported every day by the fever surveillance system. Vector control measures including insecticidal fogging and elimination of habitats of Ae. albopictus were used to control the dengue outbreak. RESULTS: The epidemiological studies results showed that this dengue outbreak was initiated by an imported case from Southeast Asia. The outbreak was characterized by 31 cases reported with an attack rate of 50.63 out of a population of 100,000. Ae. albopictus was the only vector species responsible for the outbreak. The virus cDNA sequencing analysis showed that the virus responsible for the outbreak was Dengue Virus serotype-1 (DENV-1). CONCLUSIONS: Several characterized points of urbanization contributed to this outbreak of dengue in Dongguan: the residents are highly concentrated; the residents' life habits helped to form the habitats of Ae. albopictus and contributed to the high Breteau Index; the self-constructed houses lacks of mosquito prevention facilities. This report has reaffirmed the importance of a surveillance system for infectious diseases control and aroused the awareness of an imported case causing the epidemic of an infectious disease in urbanized region.","['Peng, Hong-Juan', 'Lai, Hui-Bing', 'Zhang, Qiao-Li', 'Xu, Ba-Yi', 'Zhang, Hao', 'Liu, Wen-Hua', 'Zhao, Wei', 'Zhou, Yuan-Ping', 'Zhong, Xin-Guang', 'Jiang, Shu', 'Duan, Jin-Hua', 'Yan, Gui-Yun', 'He, Jian-Feng', 'Chen, Xiao-Guang']","['Peng HJ', 'Lai HB', 'Zhang QL', 'Xu BY', 'Zhang H', 'Liu WH', 'Zhao W', 'Zhou YP', 'Zhong XG', 'Jiang S', 'Duan JH', 'Yan GY', 'He JF', 'Chen XG']",,"['Key Laboratory of Prevention and Control for Emerging Infectious Diseases of Guangdong Higher Institutes, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, Peoples Republic of China.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",20120126,England,BMC Public Health,BMC public health,100968562,"['0 (DNA, Viral)']",IM,"['Adult', 'Aged', 'Aged, 80 and over', 'Animals', 'China/epidemiology', 'DNA, Viral/isolation & purification', 'Dengue/diagnosis/*epidemiology/physiopathology/*transmission', '*Disease Outbreaks/prevention & control', 'Disease Vectors', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mosquito Control', 'Population Surveillance/methods', 'Real-Time Polymerase Chain Reaction', 'Sequence Analysis, DNA', 'Urbanization', 'Young Adult']",PMC3311058,2012/01/27 06:00,2012/06/21 06:00,['2012/01/27 06:00'],"['2011/06/20 00:00 [received]', '2012/01/26 00:00 [accepted]', '2012/01/27 06:00 [entrez]', '2012/01/27 06:00 [pubmed]', '2012/06/21 06:00 [medline]']","['1471-2458-12-83 [pii]', '10.1186/1471-2458-12-83 [doi]']",epublish,BMC Public Health. 2012 Jan 26;12:83. doi: 10.1186/1471-2458-12-83.,,,,,,,['R01AI093202-01A1/AI/NIAID NIH HHS/United States'],,,,,,,,,,,,,,,,
32829129,NLM,MEDLINE,20210630,20210630,1879-6265 (Electronic) 1879-6257 (Linking),43,2020 Aug,Dengue virus infection and Nrf2 regulation of oxidative stress.,35-40,S1879-6257(20)30058-4 [pii] 10.1016/j.coviro.2020.07.015 [doi],"Dengue virus is a positive sense, single-stranded RNA virus of the Flaviviridae family that causes mild to severe dengue fever in hundreds of millions of people in tropical/subtropical regions of the world each year. Like many other viruses, dengue has evolved strategies to evade the innate immune response of the host to establish infection. Here we provide an overview of the major alterations provoked by dengue in infected cells, that is, oxidative stress, metabolic reprogramming, and antiviral/inflammatory responses. These biological processes are interconnected and coordinated through the anti-oxidant transcription factor Nrf2, which functions at the interface of metabolism and antiviral immunity.","['Zevini, Alessandra', 'Ferrari, Matteo', 'Olagnier, David', 'Hiscott, John']","['Zevini A', 'Ferrari M', 'Olagnier D', 'Hiscott J']",,"['Laboratorio Pasteur, Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome 00161, Italy.', 'Laboratorio Pasteur, Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome 00161, Italy.', 'Dept. of Biomedicine, Aarhus University, Aarhus, Denmark. Electronic address: olagnier@biomed.au.dk.', 'Laboratorio Pasteur, Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome 00161, Italy. Electronic address: john.hiscott@istitutopasteur.it.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20200821,Netherlands,Curr Opin Virol,Current opinion in virology,101560941,['0 (NF-E2-Related Factor 2)'],IM,"['Animals', 'Dengue/genetics/immunology/metabolism/*virology', 'Dengue Virus/genetics/*physiology', 'Humans', 'NF-E2-Related Factor 2/genetics/*immunology', 'Oxidative Stress']",,2020/08/24 06:00,2021/07/01 06:00,['2020/08/24 06:00'],"['2020/06/19 00:00 [received]', '2020/07/21 00:00 [revised]', '2020/07/23 00:00 [accepted]', '2020/08/24 06:00 [pubmed]', '2021/07/01 06:00 [medline]', '2020/08/24 06:00 [entrez]']","['S1879-6257(20)30058-4 [pii]', '10.1016/j.coviro.2020.07.015 [doi]']",ppublish,Curr Opin Virol. 2020 Aug;43:35-40. doi: 10.1016/j.coviro.2020.07.015. Epub 2020 Aug 21.,,['Copyright (c) 2020 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,,,,,,
22403320,NLM,MEDLINE,20120423,20211021,1476-1645 (Electronic) 0002-9637 (Print) 0002-9637 (Linking),86,2012 Mar,Severe dengue virus infection in pediatric travelers visiting friends and relatives after travel to the Caribbean.,474-6,10.4269/ajtmh.2012.11-0411 [doi],"Of eight children given a diagnosis of dengue, a complicated course developed in three (38%), including one infant with dengue shock syndrome. Children visiting friends and relatives in dengue-endemic regions are at risk for severe dengue-associated morbidity. Children of families originally from these locations may benefit from pre-travel advice and may represent candidates for a future dengue vaccine.","['Krishnan, Nivedita', 'Purswani, Murli', 'Hagmann, Stefan']","['Krishnan N', 'Purswani M', 'Hagmann S']",,"['Department of Pediatrics, Division of Pediatric Infectious Diseases, Bronx Center for Travel and International Health, Bronx-Lebanon Hospital Center, New York, USA. nkrishna@bronxleb.org']",['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,['0 (Dengue Vaccines)'],IM,"['Adolescent', 'Caribbean Region/epidemiology', 'Child', 'Dengue/*diagnosis/drug therapy/*epidemiology', 'Dengue Vaccines/administration & dosage/immunology', 'Dengue Virus/*pathogenicity', 'Female', 'Humans', 'Infant', 'Male', 'Morbidity', 'Retrospective Studies', 'Risk Factors', 'Severe Dengue/diagnosis/*epidemiology', 'Travel', 'Treatment Outcome']",PMC3284365,2012/03/10 06:00,2012/04/24 06:00,['2012/03/10 06:00'],"['2012/03/10 06:00 [entrez]', '2012/03/10 06:00 [pubmed]', '2012/04/24 06:00 [medline]']","['86/3/474 [pii]', '10.4269/ajtmh.2012.11-0411 [doi]']",ppublish,Am J Trop Med Hyg. 2012 Mar;86(3):474-6. doi: 10.4269/ajtmh.2012.11-0411.,3,,,,,,,,,,,,,,,,,,,,,,
22480104,NLM,MEDLINE,20120814,20120406,0019-5847 (Print) 0019-5847 (Linking),109,2011 Sep,Guillain-Barre syndrome occurring during dengue fever.,"675, 682",,"Various types of neurological manifestations are described in dengue fever, of which peripheral neuropathy is rarely reported. We are reporting such a case that presented with three days' history of fever and weakness of all the four limbs of two days' duration. On investigations it turned out to be acute motor sensory axonal neuropathy (AMSAN) type of Guillain-Barre syndrome with decrease platelet counts and positive serology for dengue. All other causes of acute polyneuropathy were ruled out by history and relevant investigations. Patient improved with intravenous immunoglobulin and other supportive therapy.","['Sharma, Chandra Mohan', 'Kumawat, B L', 'Ralot, Tarun', 'Tripathi, Gautam', 'Dixit, Shailesh']","['Sharma CM', 'Kumawat BL', 'Ralot T', 'Tripathi G', 'Dixit S']",,"['Department of Neurology, BMRC, SMS Medical College, Jaipur 302004.']",['eng'],"['Case Reports', 'Journal Article']",,India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,,IM,"['Dengue/*complications/*diagnosis/therapy', 'Guillain-Barre Syndrome/*diagnosis/*etiology/therapy', 'Humans', 'Male', 'Middle Aged']",,2012/04/07 06:00,2012/08/15 06:00,['2012/04/07 06:00'],"['2012/04/07 06:00 [entrez]', '2012/04/07 06:00 [pubmed]', '2012/08/15 06:00 [medline]']",,ppublish,"J Indian Med Assoc. 2011 Sep;109(9):675, 682.",9,,,,,,,,,,,,,,,,,,,,,,
1913986,NLM,MEDLINE,19911114,20220318,0009-0875 (Print) 0009-0875 (Linking),36,1991 Jun,Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever.,63-5,,"Acute and convalescent phase blood samples from five dengue fever (DF) patients and four dengue haemorrhagic fever (DHF) patients were tested for the presence of tumour necrosis factor (TNF). While all blood samples showed elevated levels, the acute phase blood sample levels were much higher. The mean TNF level in the acute samples of the five DF cases was 862 while in the DHF cases the level was 1722 pg/ml. Though the sample size is small, the difference appears to be statistically significant. Unlike in DF the distinctive features in DHF are the occurrence of shock, thrombocytopaenic purpura and sometimes disseminated intravascular coagulation (DIC). Increased TNF levels have not been reported in the literature in association with DHF, although it has been shown to contribute to these features which appear in some other diseases.","['Vitarana, T', 'de Silva, H', 'Withana, N', 'Gunasekera, C']","['Vitarana T', 'de Silva H', 'Withana N', 'Gunasekera C']",,"['Department of Virology, Medical Research Institute, Colombo.']",['eng'],['Journal Article'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,['0 (Tumor Necrosis Factor-alpha)'],IM,"['Blood Specimen Collection/methods', 'Dengue/*blood/epidemiology/physiopathology', 'Humans', 'Sri Lanka/epidemiology', 'Tumor Necrosis Factor-alpha/*analysis']",,1991/06/01 00:00,1991/06/01 00:01,['1991/06/01 00:00'],"['1991/06/01 00:00 [pubmed]', '1991/06/01 00:01 [medline]', '1991/06/01 00:00 [entrez]']",,ppublish,Ceylon Med J. 1991 Jun;36(2):63-5.,2,,,,,,,,,,,,,,,,,,,,,,
9830728,NLM,MEDLINE,19990325,20190607,0036-4665 (Print) 0036-4665 (Linking),40,1998 May-Jun,Simultaneous infection with dengue 1 and 2 in a Brazilian patient.,151-4,,"Dengue outbreaks have occurred in several Brazilian States since 1986 involving serotypes 1 (DEN-1) and 2 (DEN-2). In view of the few cases of double infection documented in the literature, we report here a case of simultaneous infection with DEN-1 and DEN-2 in a patient residing in the municipality of Miranda, State of Mato Grosso do Sul, Western region of Brazil. DEN-1 was introduced in this State in 1989 and DEN-2 in 1996, both of them circulating in some municipalities. This double infection was identified by virus isolation and by indirect immunofluorescence using monoclonal antibodies and confirmed by the polymerase chain reaction (PCR). This is the first documented case of simultaneous infection with serotypes DEN-1 and DEN-2 in Brazil.","['Rocco, I M', 'Barbosa, M L', 'Kanomata, E H']","['Rocco IM', 'Barbosa ML', 'Kanomata EH']",,"['Secao de Virus Transmitidos por Artropodos, Instituto Adolfo Lutz, Sao Paulo, SP, Brasil.']",['eng'],"['Case Reports', 'Journal Article']",,Brazil,Rev Inst Med Trop Sao Paulo,Revista do Instituto de Medicina Tropical de Sao Paulo,7507484,,IM,"['Adult', 'Brazil', 'Dengue/diagnosis/*virology', 'Dengue Virus/*classification', 'Female', 'Humans']",,1998/11/27 00:00,1998/11/27 00:01,['1998/11/27 00:00'],"['1998/11/27 00:00 [pubmed]', '1998/11/27 00:01 [medline]', '1998/11/27 00:00 [entrez]']",['10.1590/s0036-46651998000300004 [doi]'],ppublish,Rev Inst Med Trop Sao Paulo. 1998 May-Jun;40(3):151-4. doi: 10.1590/s0036-46651998000300004.,3,,,,,,,,,,,,,,,,,,,,,,
8345549,NLM,MEDLINE,19930909,20041117,0022-5304 (Print) 0022-5304 (Linking),96,1993 Aug,Protocol for out-patient management of dengue illness in young adults.,259-63,,"A prospective study on the practicality of an out-patient management protocol for dengue infection in adults was carried out during a 2-month period. Doctors were requested to follow the protocol and assessment was done on the patients' outcome, the admission rate, and the compliance to the protocol by doctors and patients. One hundred and sixty-two patients (mean age 27.3 years) were clinically diagnosed to have dengue illness. Among them, 82.7% had dengue fever (DF); 13.0% had dengue haemorrhagic fever (DHF) and 4.3% had dengue shock syndrome (DSS). Dengue aetiology was confirmed in 69.4% of the DF group and 85.7% of the DHF and DSS groups. There were no deaths among the 162 patients. The admission rate was 43.8%. A high compliance rate of 86.4% by the doctors and a low patient default rate of 16.4% showed that the protocol was practical.","['Chin, C K', 'Kang, B H', 'Liew, B K', 'Cheah, P C', 'Nair, R', 'Lam, S K']","['Chin CK', 'Kang BH', 'Liew BK', 'Cheah PC', 'Nair R', 'Lam SK']",,"['Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur.']",['eng'],['Journal Article'],,England,J Trop Med Hyg,The Journal of tropical medicine and hygiene,0406044,,IM,"['Adolescent', 'Adult', '*Ambulatory Care', 'Clinical Protocols', 'Dengue/diagnosis/*therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Patient Compliance', 'Prospective Studies']",,1993/08/01 00:00,1993/08/01 00:01,['1993/08/01 00:00'],"['1993/08/01 00:00 [pubmed]', '1993/08/01 00:01 [medline]', '1993/08/01 00:00 [entrez]']",,ppublish,J Trop Med Hyg. 1993 Aug;96(4):259-63.,4,,,,,,,,,,,,,,,,,,,,,,
6621601,NLM,MEDLINE,19831123,20200527,1545-8636 (Print),32,1983 Feb,"Dengue in the United States, 1981.",23SS-26SS,,,"['Gubler, D J']",['Gubler DJ'],,,['eng'],['Journal Article'],,United States,MMWR CDC Surveill Summ,MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries,8407977,,IM,"['Dengue/*epidemiology/microbiology', 'Dengue Virus/isolation & purification', 'Humans', 'Puerto Rico', 'United States']",,1983/02/01 00:00,1983/02/01 00:01,['1983/02/01 00:00'],"['1983/02/01 00:00 [pubmed]', '1983/02/01 00:01 [medline]', '1983/02/01 00:00 [entrez]']",,ppublish,MMWR CDC Surveill Summ. 1983 Feb;32(1):23SS-26SS.,1,,,,,,,,,,,,,,,,,,,,,,
20144249,NLM,MEDLINE,20100701,20100531,1469-4409 (Electronic) 0950-2688 (Linking),138,2010 Jul,The 2007 dengue outbreak in Singapore.,958-9; author reply 959-61,10.1017/S0950268810000026 [doi],,"['Ooi, E E', 'Wilder-Smith, A', 'Ng, L C', 'Gubler, D J']","['Ooi EE', 'Wilder-Smith A', 'Ng LC', 'Gubler DJ']",,,['eng'],"['Comment', 'Letter']",20100210,England,Epidemiol Infect,Epidemiology and infection,8703737,['0 (Particulate Matter)'],IM,"['Air Pollution/statistics & numerical data', 'Animals', 'Culicidae/growth & development', 'Dengue/*epidemiology/etiology/transmission', '*Disease Outbreaks', 'Humans', 'Models, Theoretical', 'Particulate Matter/analysis', 'Population Dynamics', 'Singapore/epidemiology']",,2010/02/11 06:00,2010/07/02 06:00,['2010/02/11 06:00'],"['2010/02/11 06:00 [entrez]', '2010/02/11 06:00 [pubmed]', '2010/07/02 06:00 [medline]']","['S0950268810000026 [pii]', '10.1017/S0950268810000026 [doi]']",ppublish,Epidemiol Infect. 2010 Jul;138(7):958-9; author reply 959-61. doi: 10.1017/S0950268810000026. Epub 2010 Feb 10.,7,,,,,,,,['Epidemiol Infect. 2010 Jul;138(7):951-7. PMID: 19653928'],,,,,,,,,,,,,,
37068115,NLM,MEDLINE,20230501,20230505,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),17,2023 Apr,Associated risk factors of severe dengue in Reunion Island: A prospective cohort study.,e0011260,10.1371/journal.pntd.0011260 [doi] e0011260,"BACKGROUND: Since 2018, a dengue epidemic has been raging annually in Reunion Island, which poses the major problem of its morbidity and mortality. However, there is no consensus in the literature on factors associated with severity of illness. The objective of this study was to identify the factors associated with the occurrence of severe dengue (SD) according to the criteria adopted in 2009 by the World Health Organization (WHO), during the 2019 epidemic. METHODOLOGY/PRINCIPAL FINDINGS: A total of 163 patients with RT-PCR-confirmed dengue were included in a multicenter prospective cohort study in Reunion Island between January and June 2019. Of these, 37 (23%) were classified as SD, which involves presentation dominated by at least one organ failure, and 126 (77%) classified as non-SD (of which 90 (71%) had warning signs). Confusion, dehydration, and relative hypovolemia were significantly associated with SD in bivariate analysis (p < 0.05). The factors associated with SD in multivariate analysis were a time from first symptom to hospital consultation over 2 days (OR: 2.46, CI: 1.42-4.27), a history of cardiovascular disease (OR: 2.75, 95%CI: 1.57-4.80) and being of Western European origin (OR: 17.60, CI: 4.15-74). CONCLUSIONS/SIGNIFICANCE: This study confirms that SD is a frequent cause of hospitalization during dengue epidemics in Reunion Island. It suggests that cardiovascular disease, Western European origin, and delay in diagnosis and management are risk factors associated with SD fever, and that restoration of blood volume and correction of dehydration must be performed early to be effective. TRIAL REGISTRATION: NCT01099852; clinicaltrials.gov.","['Carras, Mathys', 'Maillard, Olivier', 'Cousty, Julien', 'Gerardin, Patrick', 'Boukerrou, Malik', 'Raffray, Loic', 'Mavingui, Patrick', 'Poubeau, Patrice', 'Cabie, Andre', 'Bertolotti, Antoine']","['Carras M', 'Maillard O', 'Cousty J', 'Gerardin P', 'Boukerrou M', 'Raffray L', 'Mavingui P', 'Poubeau P', 'Cabie A', 'Bertolotti A']",['ORCID: 0000-0001-6677-3952'],"['Intensive Care Unit, CHU Reunion, Saint Pierre, Reunion, France.', 'Department of Public Health and Research, CHU Reunion, Saint-Pierre, Reunion, France.', 'Clinical Investigation Center, INSERM CIC1410, CHU Reunion, Saint Pierre, Reunion, France.', 'Intensive Care Unit, CHU Reunion, Saint Pierre, Reunion, France.', 'Department of Public Health and Research, CHU Reunion, Saint-Pierre, Reunion, France.', 'Clinical Investigation Center, INSERM CIC1410, CHU Reunion, Saint Pierre, Reunion, France.', 'Department of Gynecology and Obstetrics, CHU Reunion, Saint Pierre, Reunion, France.', 'Department of Internal Medicine, CHU Reunion, Saint Denis, Reunion, France.', 'UMR Processus Infectieux en Milieu Insulaire Tropical (PIMIT), CNRS 9192, INSERM 1187, IRD 249, Universite de La Reunion, Sainte-Clotilde, Reunion, France.', 'UMR Processus Infectieux en Milieu Insulaire Tropical (PIMIT), CNRS 9192, INSERM 1187, IRD 249, Universite de La Reunion, Sainte-Clotilde, Reunion, France.', 'Department of Infectious Diseases, CHU Reunion, Saint-Pierre, Reunion, France.', 'Department of Infectious and Tropical Diseases, CHU Martinique, Fort-de-France, Martinique, France.', 'Clinical Investigation Center, INSERM CIC1424, CHU Martinique, Fort-de-France, Martinique, France.', 'Clinical Investigation Center, INSERM CIC1410, CHU Reunion, Saint Pierre, Reunion, France.', 'Department of Infectious Diseases, CHU Reunion, Saint-Pierre, Reunion, France.']",['eng'],"['Journal Article', 'Multicenter Study', ""Research Support, Non-U.S. Gov't""]",20230417,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Humans', '*Severe Dengue/diagnosis', '*Dengue/epidemiology/diagnosis', 'Reunion/epidemiology', 'Prospective Studies', '*Cardiovascular Diseases', 'Dehydration', 'Risk Factors']",PMC10138848,2023/04/18 06:00,2023/05/01 06:42,['2023/04/17 13:44'],"['2022/09/20 00:00 [received]', '2023/03/21 00:00 [accepted]', '2023/04/27 00:00 [revised]', '2023/05/01 06:42 [medline]', '2023/04/18 06:00 [pubmed]', '2023/04/17 13:44 [entrez]']","['PNTD-D-22-01199 [pii]', '10.1371/journal.pntd.0011260 [doi]']",epublish,PLoS Negl Trop Dis. 2023 Apr 17;17(4):e0011260. doi: 10.1371/journal.pntd.0011260. eCollection 2023 Apr.,4,"['Copyright: (c) 2023 Carras et al. This is an open access article distributed under', 'the terms of the Creative Commons Attribution License, which permits unrestricted', 'use, distribution, and reproduction in any medium, provided the original author', 'and source are credited.']",,,['The authors have declared that no competing interests exist'],,,,,,,,,,,,,,,,,,['ClinicalTrials.gov/NCT01099852']
26222979,NLM,MEDLINE,20160415,20190202,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),9,2015,"Weather Regulates Location, Timing, and Intensity of Dengue Virus Transmission between Humans and Mosquitoes.",e0003957,10.1371/journal.pntd.0003957 [doi] e0003957,"BACKGROUND: Dengue is one of the most aggressively expanding mosquito-transmitted viruses. The human burden approaches 400 million infections annually. Complex transmission dynamics pose challenges for predicting location, timing, and magnitude of risk; thus, models are needed to guide prevention strategies and policy development locally and globally. Weather regulates transmission-potential via its effects on vector dynamics. An important gap in understanding risk and roadblock in model development is an empirical perspective clarifying how weather impacts transmission in diverse ecological settings. We sought to determine if location, timing, and potential-intensity of transmission are systematically defined by weather. METHODOLOGY/PRINCIPAL FINDINGS: We developed a high-resolution empirical profile of the local weather-disease connection across Peru, a country with considerable ecological diversity. Applying 2-dimensional weather-space that pairs temperature versus humidity, we mapped local transmission-potential in weather-space by week during 1994-2012. A binary classification-tree was developed to test whether weather data could classify 1828 Peruvian districts as positive/negative for transmission and into ranks of transmission-potential with respect to observed disease. We show that transmission-potential is regulated by temperature-humidity coupling, enabling epidemics in a limited area of weather-space. Duration within a specific temperature range defines transmission-potential that is amplified exponentially in higher humidity. Dengue-positive districts were identified by mean temperature >22 degrees C for 7+ weeks and minimum temperature >14 degrees C for 33+ weeks annually with 95% sensitivity and specificity. In elevated-risk locations, seasonal peak-incidence occurred when mean temperature was 26-29 degrees C, coincident with humidity at its local maximum; highest incidence when humidity >80%. We profile transmission-potential in weather-space for temperature-humidity ranging 0-38 degrees C and 5-100% at 1 degrees C x 2% resolution. CONCLUSIONS/SIGNIFICANCE: Local duration in limited areas of temperature-humidity weather-space identifies potential locations, timing, and magnitude of transmission. The weather-space profile of transmission-potential provides needed data that define a systematic and highly-sensitive weather-disease connection, demonstrating separate but coupled roles of temperature and humidity. New insights regarding natural regulation of human-mosquito transmission across diverse ecological settings advance our understanding of risk locally and globally for dengue and other mosquito-borne diseases and support advances in public health policy/operations, providing an evidence-base for modeling, predicting risk, and surveillance-prevention planning.","['Campbell, Karen M', 'Haldeman, Kristin', 'Lehnig, Chris', 'Munayco, Cesar V', 'Halsey, Eric S', 'Laguna-Torres, V Alberto', 'Yagui, Martin', 'Morrison, Amy C', 'Lin, Chii-Dean', 'Scott, Thomas W']","['Campbell KM', 'Haldeman K', 'Lehnig C', 'Munayco CV', 'Halsey ES', 'Laguna-Torres VA', 'Yagui M', 'Morrison AC', 'Lin CD', 'Scott TW']",,"['Computational Science Research Center, San Diego State University, San Diego, California, United States of America.', 'Computational Science Research Center, San Diego State University, San Diego, California, United States of America.', 'Computational Science Research Center, San Diego State University, San Diego, California, United States of America.', 'Department of Preventive Medicine and Biometrics, Uniformed Services University of Health Sciences, Bethesda, Maryland, United States of America.', 'US Naval Medical Research Unit No.6, Lima, Peru.', 'Direccion General de Epidemiologia, Lima, Peru.', 'Direccion General de Epidemiologia, Lima, Peru.', 'Department of Entomology, University of California, Davis, Davis, California, United States of America.', 'Department of Mathematics and Statistics, San Diego State University, San Diego, California, United States of America.', 'Department of Entomology, University of California, Davis, Davis, California, United States of America; Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",20150729,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Animals', 'Dengue/epidemiology/*transmission/*virology', 'Dengue Virus/*physiology', 'Epidemics/statistics & numerical data', 'Humans', 'Peru/epidemiology', 'Time Factors', '*Weather']",PMC4519153,2015/07/30 06:00,2016/04/16 06:00,['2015/07/30 06:00'],"['1969/02/09 00:00 [received]', '2015/07/07 00:00 [accepted]', '2015/07/30 06:00 [entrez]', '2015/07/30 06:00 [pubmed]', '2016/04/16 06:00 [medline]']","['PNTD-D-15-00207 [pii]', '10.1371/journal.pntd.0003957 [doi]']",epublish,PLoS Negl Trop Dis. 2015 Jul 29;9(7):e0003957. doi: 10.1371/journal.pntd.0003957. eCollection 2015.,7,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,['PLoS Negl Trop Dis. 2015 Sep;9(9):e0004047. PMID: 26379271'],,,,,,
37377238,NLM,MEDLINE,20230629,20230629,1726-4642 (Electronic) 1726-4634 (Linking),40,2023 Jan-Mar,Clinical-epidemiological characteristics of deaths due to dengue during an outbreak in northern Peru.,67-72,10.17843/rpmesp.2023.401.12148 [doi],"Motivation for the study. To describe the characteristics of patients who died from severe dengue fever during the 2017 El Nino in Piura. Main findings. Mortality from severe dengue was higher in adult women. First contact with healthcare took place mostly in higher level hospitals. Admission to a specialized unit was late for severe dengue cases. Implications. Control of dengue fever involves several aspects, such as, access to health, prevention, water availability, vector control and education; therefore, it is important to strengthen public health policies in this regard. In order to achieve this goal, local and central government sectors must be involved.","['Luque, Nestor', 'Cilloniz, Catia', 'Pons, Maria J', 'Donaires, Fernando', 'Albornoz, Roger', 'Mendocilla-Risco, Moises', 'Espinoza, Manuel']","['Luque N', 'Cilloniz C', 'Pons MJ', 'Donaires F', 'Albornoz R', 'Mendocilla-Risco M', 'Espinoza M']","['ORCID: 0000-0002-6192-4392', 'ORCID: 0000-0002-4646-9838', 'ORCID: 0000-0001-8384-2315', 'ORCID: 0000-0002-4456-4946', 'ORCID: 0000-0001-6155-0848', 'ORCID: 0000-0003-4729-9022', 'ORCID: 0000-0003-1283-2253']","['Escuela de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Peruana Union (UPeU), Lima, Peru.', 'Universidad Continental, Lima, Peru.', 'Grupo enfermedades infecciosas re-emergentes, Universidad Cientifica del Sur, Lima, Peru.', 'Instituto Nacional de Salud, Lima, Peru.', 'Escuela de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Peruana Union (UPeU), Lima, Peru.', 'Universidad Nacional Mayor San Marcos, Lima, Peru.', 'Instituto Nacional de Salud, Lima, Peru.']","['spa', 'eng']",['Journal Article'],20230623,Peru,Rev Peru Med Exp Salud Publica,Revista peruana de medicina experimental y salud publica,101227566,,IM,"['Adult', 'Humans', 'Female', '*Dengue/epidemiology/prevention & control', '*Severe Dengue/epidemiology', 'Peru/epidemiology', 'Disease Outbreaks', 'El Nino-Southern Oscillation']",,2023/06/28 13:08,2023/06/29 06:43,['2023/06/28 08:15'],"['2022/09/24 00:00 [received]', '2023/03/22 00:00 [accepted]', '2023/06/29 06:43 [medline]', '2023/06/28 13:08 [pubmed]', '2023/06/28 08:15 [entrez]']",['10.17843/rpmesp.2023.401.12148 [doi]'],ppublish,Rev Peru Med Exp Salud Publica. 2023 Jan-Mar;40(1):67-72. doi: 10.17843/rpmesp.2023.401.12148. Epub 2023 Jun 23.,1,,,,,,,,,Caracteristicas clinicas y epidemiologicas de las muertes por dengue durante un brote en el norte del Peru.,,,,,,,,,,,,,
34821485,NLM,MEDLINE,20220125,20220125,0009-0875 (Print) 0009-0875 (Linking),65,2020 Dec 31,Clinical management of dengue infection in pregnancy.,75-78,10.4038/cmj.v65i4.9275 [doi],,"['Tissera, Hasitha T', 'Wijewickrama, Ananda W', 'Weeraman, Jayantha W', 'Ghouse, Azhar G', 'Kaluarachchi, Athula K', 'Fernando, LakKumar F', 'Wijesundere, Anula W']","['Tissera H T', 'Wijewickrama A W', 'Weeraman J W', 'Ghouse A G', 'Kaluarachchi A K', 'Fernando L F', 'Wijesundere A W']",,"['Epidemiology Unit, Ministry of Health, Sri Lanka, dr_korelege@yahoo.co.uk.', 'National Insitute of Infectious Disease (IDH), Sri Lanka.', 'Epidemiology Unit, Ministry of Health, Sri Lanka.', 'Department of Obstetics and Gynaecology, Faculty of Medicine, University of Colombo, Sri Lanka.', 'District General Hospital, Negombo, Sri Lanka.', 'Sri Lanka Medical Association.']",['eng'],['Journal Article'],,Sri Lanka,Ceylon Med J,The Ceylon medical journal,1264702,,IM,"['*Dengue/diagnosis/therapy', 'Female', 'Humans', 'Pregnancy', '*Pregnancy Complications, Infectious/diagnosis/drug therapy', 'Pregnancy Outcome']",,2021/11/26 06:00,2022/01/27 06:00,['2021/11/25 09:06'],"['2021/11/25 09:06 [entrez]', '2021/11/26 06:00 [pubmed]', '2022/01/27 06:00 [medline]']",['10.4038/cmj.v65i4.9275 [doi]'],ppublish,Ceylon Med J. 2020 Dec 31;65(4):75-78. doi: 10.4038/cmj.v65i4.9275.,4,,,,,,,,,,,,,,,,,,,,,,
23951370,NLM,MEDLINE,20140228,20211021,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),7,2013,Fatal dengue in patients with sickle cell disease or sickle cell anemia in Curacao: two case reports.,e2203,10.1371/journal.pntd.0002203 [doi] e2203,,"['Moesker, Fleur M', 'Muskiet, Fred D', 'Koeijers, Jeanne J', 'Fraaij, Pieter L A', 'Gerstenbluth, Isaac', 'van Gorp, Eric C M', 'Osterhaus, Albert D M E']","['Moesker FM', 'Muskiet FD', 'Koeijers JJ', 'Fraaij PL', 'Gerstenbluth I', 'van Gorp EC', 'Osterhaus AD']",,"['Department of Viroscience Lab, Erasmus MC, Rotterdam, The Netherlands.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20130808,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Anemia, Sickle Cell/*complications/*diagnosis', 'Child', 'Dengue/*diagnosis/mortality/*pathology', 'Fatal Outcome', 'Female', 'Humans', 'Young Adult']",PMC3738493,2013/08/21 06:00,2014/03/01 06:00,['2013/08/17 06:00'],"['2013/08/17 06:00 [entrez]', '2013/08/21 06:00 [pubmed]', '2014/03/01 06:00 [medline]']","['PNTD-D-12-01496 [pii]', '10.1371/journal.pntd.0002203 [doi]']",epublish,PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2203. doi: 10.1371/journal.pntd.0002203. eCollection 2013.,8,,,,"[""We have read the journal's policy and have the following conflicts: FMM's,"", ""PLAF's, and ADMEO's scientific work is supported by the Virgo consortium, funded"", 'by the Dutch government (project number FES0908). In addition ADMEO has share', 'certificates in ViroClinics Biosciences B.V. The majority of the shares in', 'ViroClinics Biosciences B.V. (>75%) are owned by Erasmus MC through its Erasmus', 'MC Holding B.V. To avoid any possible conflict of interest and to safeguard its', 'employees against the possibility of unethical decisions, the Erasmus MC does not', 'allow any of its employees to hold shares in person in any companies that are', '(partly) owned by Erasmus MC. As a result thereof, any shares provided by such', 'companies to any Erasmus MC employees are held by a Foundation Administration', 'Office. The board of this foundation is appointed by Erasmus MC. The employees', 'receive share certificates of their shares. Apart form those described above the', 'authors have declared that no competing interests exist.']",,,,,,,,,,,,,,,,,,
30563480,NLM,MEDLINE,20190204,20200225,1471-2334 (Electronic) 1471-2334 (Linking),18,2018 Dec 18,Series of 10 dengue fever cases with unusual presentations and complications in Sri Lanka: a single centre experience in 2016.,674,10.1186/s12879-018-3596-5 [doi] 674,"BACKGROUND: Dengue has global importance as a dreaded arboviral infection. It has 4 serotypes of epidemiological imporatnce. The classification denotes two clinical spectrums- dengue fever (DF) and dengue haemorragic fever (DHF). Most cases are stereotype and amenable to fluid resuscitation. However, unusual manifestations cause fatalities and often overlooked. This study describes 10 such dengue cases to fill the knowledge gaps. CASE PRESENTATION: All 10 patients presented to the Teaching Hospital, Peradeniya, Sri Lanka during mid-year epidemic of dengue in 2016. The mean age is 27 years (range 12-51 years) comprising 6 females and 4 males. The group had 7 DHF, 3 DF and 2 primary dengue infections who predominantly had severe bleeding into gut. Other potentially life threatening problems were acute severe hepatitis, severe septic shock, myocarditis, erratic rapid plasma leak, intracranial bleeding, diarrhoea and decompenstaed dengue shock due to 3rd space fluid leak. Blood transfusions and other empirical therapeutic methods were used apart from meticulous fluid management to suit issues of each patient. Bedside ultrasound scanning helped early detection of critical phase. All recovered fully. CONCLUSIONS: Dengue is an extremely challenging infection to treat in the globe today. Above unusual presentation and complications could be fatal, if not detected early where therapeutic window period is very short. Clinicians need awareness of these problems which are not uncommon, but underreported and often overlooked. The clinical management of each patient was described for the purpose sharing the experiences.","['Kularatne, S A M', 'Ralapanawa, Udaya', 'Dalugama, Chamara', 'Jayasinghe, Jayanika', 'Rupasinghe, Sawandika', 'Kumarihamy, Prabashini']","['Kularatne SAM', 'Ralapanawa U', 'Dalugama C', 'Jayasinghe J', 'Rupasinghe S', 'Kumarihamy P']",['ORCID: 0000-0002-7416-7984'],"['Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.', 'Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. udayapralapanawa@yahoo.com.', 'Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.', 'Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.', 'Department of Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.', 'Teaching Hospital Peradeniya, Peradeniya, Sri Lanka.']",['eng'],"['Case Reports', 'Journal Article']",20181218,England,BMC Infect Dis,BMC infectious diseases,100968551,,IM,"['Adolescent', 'Adult', 'Child', 'Dengue/*complications/*diagnosis', 'Disease Outbreaks', 'Epidemics', 'Female', 'Hemorrhage', 'Hospitals, Teaching', 'Humans', 'Male', 'Middle Aged', 'Severe Dengue/complications/diagnosis', 'Sri Lanka/epidemiology', 'Young Adult']",PMC6299528,2018/12/20 06:00,2019/02/05 06:00,['2018/12/20 06:00'],"['2018/06/14 00:00 [received]', '2018/12/07 00:00 [accepted]', '2018/12/20 06:00 [entrez]', '2018/12/20 06:00 [pubmed]', '2019/02/05 06:00 [medline]']","['10.1186/s12879-018-3596-5 [pii]', '3596 [pii]', '10.1186/s12879-018-3596-5 [doi]']",epublish,BMC Infect Dis. 2018 Dec 18;18(1):674. doi: 10.1186/s12879-018-3596-5.,1,,['NOTNLM'],"['DHF', 'Dengue', 'Dengue shock syndrome', 'Expanded dengue syndrome', 'Fulminant liver failure', 'Myocarditis', 'Septic shock', 'Sri Lanka']","['ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR', 'PUBLICATION: Written informed consent was obtained from the patients and/or', 'relatives for publication of this case report and any accompanying images. A copy', 'of the written consent is available for review by the Editor-in-Chief of this', 'journal. COMPETING INTERESTS: The authors declare that they have no competing', ""interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to"", 'jurisdictional claims in published maps and institutional affiliations.']",,,,,,,,,,,,,,,,,,
29520688,NLM,MEDLINE,20180709,20180709,1432-8798 (Electronic) 0304-8608 (Linking),163,2018 Jul,Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.,1717-1726,10.1007/s00705-018-3784-z [doi],"Dengue is the most prevalent arboviral disease in humans and leads to significant morbidity and socioeconomic burden in tropical and subtropical areas. Dengue is caused by infection with any of the four closely related serotypes of dengue virus (DENV1-4) and usually manifests as a mild febrile illness, but may develop into fatal dengue hemorrhagic fever and shock syndrome. There are no specific antiviral therapies against dengue because understanding of DENV biology is limited. A tetravalent chimeric dengue vaccine, Dengvaxia, has finally been licensed for use, but its efficacy was significantly lower against DENV-2 infections and in dengue-naive individuals. The identification of mechanisms underlying the interactions between DENV and immune responses will help to determine efficient therapeutic and preventive options. It has been well established how the innate immune system responds to DENV infection and how DENV overcomes innate antiviral defenses, however further progress in this field remains hampered by the absence of appropriate experimental dengue models. Herein, we review the available in vitro and in vivo approaches to study the innate immune responses to DENV.","['Kitab, Bouchra', 'Kohara, Michinori', 'Tsukiyama-Kohara, Kyoko']","['Kitab B', 'Kohara M', 'Tsukiyama-Kohara K']",,"['Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima, 890-0065, Japan.', 'Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.', 'Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima, 890-0065, Japan. kkohara@vet.kagshima-u.ac.jp.']",['eng'],"['Journal Article', 'Review']",20180308,Austria,Arch Virol,Archives of virology,7506870,"['0 (Antiviral Agents)', '0 (Dengue Vaccines)']",IM,"['Animals', 'Antiviral Agents/therapeutic use', 'Dengue/drug therapy/*immunology/prevention & control/virology', 'Dengue Vaccines/administration & dosage/immunology', 'Dengue Virus/drug effects/*immunology', 'Disease Models, Animal', 'Humans', '*Immunity, Innate', 'Mice', 'Primates', 'Severe Dengue/drug therapy/*immunology/prevention & control/virology']",,2018/03/10 06:00,2018/07/10 06:00,['2018/03/10 06:00'],"['2017/12/15 00:00 [received]', '2018/01/24 00:00 [accepted]', '2018/03/10 06:00 [pubmed]', '2018/07/10 06:00 [medline]', '2018/03/10 06:00 [entrez]']","['10.1007/s00705-018-3784-z [pii]', '10.1007/s00705-018-3784-z [doi]']",ppublish,Arch Virol. 2018 Jul;163(7):1717-1726. doi: 10.1007/s00705-018-3784-z. Epub 2018 Mar 8.,7,,,,,,,,,,,,,,,,,,,,,,
20718665,NLM,MEDLINE,20110110,20100909,1557-850X (Electronic) 1538-7135 (Linking),8,2010 Sep,The dengue threat to the United States.,273-6,10.1089/bsp.2010.0032 [doi],"Over the past 3 decades, dengue has spread rapidly and has emerged as one of the world's most common mosquitoborne viral diseases. Although often found in tropical and semitropical areas, dengue is capable of being transmitted in temperate climates as well. Dengue is currently endemic to Mexico, most other Latin American countries, and parts of the Caribbean, and it has the potential to become reestablished as an endemic disease in the United States. In fact, sustained transmission of dengue has occurred in Florida within the past year. Conditions exist in the U.S. that could facilitate sustained dengue transmission, including environmental factors, competent mosquito vectors, limited vector and dengue surveillance, increased domestic outdoor daytime activities in warmer months, and low public awareness of the disease. If dengue were to be reestablished in the U.S., it could have significant medical, public health, and economic consequences for the country. The impact of dengue as a public health threat could be lessened through enhanced awareness and reporting of cases, increased support for vector surveillance and control programs, and a greater focus on vaccine development.","['Franco, Crystal', 'Hynes, Noreen A', 'Bouri, Nidhi', 'Henderson, D A']","['Franco C', 'Hynes NA', 'Bouri N', 'Henderson DA']",,"['Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA. cfranco@upmc-bisoecurity.org']",['eng'],['Journal Article'],,United States,Biosecur Bioterror,"Biosecurity and bioterrorism : biodefense strategy, practice, and science",101156085,,IM,"['Animals', 'Culicidae', '*Dengue/etiology/transmission', 'Population Surveillance', 'Public Health', 'Risk Factors', 'United States']",,2010/08/20 06:00,2011/01/11 06:00,['2010/08/20 06:00'],"['2010/08/20 06:00 [entrez]', '2010/08/20 06:00 [pubmed]', '2011/01/11 06:00 [medline]']",['10.1089/bsp.2010.0032 [doi]'],ppublish,Biosecur Bioterror. 2010 Sep;8(3):273-6. doi: 10.1089/bsp.2010.0032.,3,,,,,,,,,,,,,,,,,,,,,,
25839074,NLM,MEDLINE,20150413,20190823,1096-8652 (Electronic) 0361-8609 (Linking),90,2015 Mar,Dengue fever in returning travellers.,263,,,"['Bain, Barbara J', 'Stubbs, Matthew J']","['Bain BJ', 'Stubbs MJ']",,,['eng'],"['Case Reports', 'Journal Article']",,United States,Am J Hematol,American journal of hematology,7610369,,IM,"['Dengue/complications/*diagnosis/pathology', 'Humans', 'Lymphocytes/*pathology', 'Male', 'Microscopy', 'Middle Aged', 'Thrombocytopenia/complications/*diagnosis/pathology', 'Travel', 'Young Adult']",,2015/04/04 06:00,2015/04/14 06:00,['2015/04/04 06:00'],"['2015/04/04 06:00 [entrez]', '2015/04/04 06:00 [pubmed]', '2015/04/14 06:00 [medline]']",['10.1002/ajh.23940 [doi]'],ppublish,Am J Hematol. 2015 Mar;90(3):263. doi: 10.1002/ajh.23940.,3,,,,,,,,,,,,,,,,,,,,,,
21079655,NLM,MEDLINE,20110518,20220408,1740-1534 (Electronic) 1740-1526 (Print) 1740-1526 (Linking),8,2010 Dec,Dengue: a continuing global threat.,S7-16,10.1038/nrmicro2460 [doi],"Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are  approximately 50 million dengue infections and  approximately 500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.","['Guzman, Maria G', 'Halstead, Scott B', 'Artsob, Harvey', 'Buchy, Philippe', 'Farrar, Jeremy', 'Gubler, Duane J', 'Hunsperger, Elizabeth', 'Kroeger, Axel', 'Margolis, Harold S', 'Martinez, Eric', 'Nathan, Michael B', 'Pelegrino, Jose Luis', 'Simmons, Cameron', 'Yoksan, Sutee', 'Peeling, Rosanna W']","['Guzman MG', 'Halstead SB', 'Artsob H', 'Buchy P', 'Farrar J', 'Gubler DJ', 'Hunsperger E', 'Kroeger A', 'Margolis HS', 'Martinez E', 'Nathan MB', 'Pelegrino JL', 'Simmons C', 'Yoksan S', 'Peeling RW']",,"[""Instituto de Medicina Tropical, 'Pedro Kouri', PO Box 601, Marianao 13, Ciucad de la Habana, Cuba.""]",['eng'],"['Journal Article', 'Review']",,England,Nat Rev Microbiol,Nature reviews. Microbiology,101190261,,IM,"['Americas/epidemiology', 'Asia, Southeastern/epidemiology', 'Dengue/*diagnosis/*epidemiology/prevention & control', 'Dengue Virus/*isolation & purification', 'Hospitalization/statistics & numerical data', 'Humans', 'Insect Control/methods', 'Pacific Islands/epidemiology']",PMC4333201,2010/11/17 06:00,2011/05/19 06:00,['2010/11/17 06:00'],"['2010/11/17 06:00 [entrez]', '2010/11/17 06:00 [pubmed]', '2011/05/19 06:00 [medline]']","['nrmicro2460 [pii]', '10.1038/nrmicro2460 [doi]']",ppublish,Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460.,12 Suppl,,,,,,['084368/WT_/Wellcome Trust/United Kingdom'],,,,['EMS34592'],['NLM: EMS34592'],,,,,,,,,,,
25743300,NLM,MEDLINE,20150417,20150313,1438-3276 (Print) 1438-3276 (Linking),157,2015 Jan 19,[Dengue fever and chikungunya fever: travel associated viral infections].,42-3,,,"['Stingl, Peter', 'Stingl, Thomas']","['Stingl P', 'Stingl T']",,,['ger'],"['Journal Article', 'Review']",,Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,,IM,"['Aedes', 'Animals', 'Chikungunya Fever/*diagnosis/*transmission', 'Dengue/*diagnosis/*transmission', 'Diagnosis, Differential', 'General Practice', 'Humans', 'Severe Dengue/*diagnosis/*transmission', '*Travel']",,2015/03/07 06:00,2015/04/18 06:00,['2015/03/07 06:00'],"['2015/03/07 06:00 [entrez]', '2015/03/07 06:00 [pubmed]', '2015/04/18 06:00 [medline]']",['10.1007/s15006-015-2587-3 [doi]'],ppublish,MMW Fortschr Med. 2015 Jan 19;157(1):42-3. doi: 10.1007/s15006-015-2587-3.,1,,,,,,,,,Nach der Tropenreise plozlichi Fieber und Gelenkschmerzen. Dengue und Chikungunya sind im Kommen.,,,,,,,,,,,,,
16501759,NLM,MEDLINE,20060424,20220310,0037-8682 (Print) 0037-8682 (Linking),39,2006 Jan-Feb,"[Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002].",9-13,,"This paper shows data regarding dengue and hemorrhagic fever of the dengue epidemic in Recife in 2002 and the clinical, laboratorial and necropsy results from the 14 patients who died that year. The serotype Den-3 was detected in 76.3% of cases. The majority of deaths occurred among men, over 20 years old, on the 11th day of disease, attended in the private hospitals. The average values of the hematocrit and platelets were 40.7% and 56,313 p/mm3, respectively. Hepatitis, with high levels of transaminases, occurred in the majority of patients, who generally were anicteric. Of the fourteen deaths, 13 received laboratorial confirmation of the infection. In eight cases death occurred due to hemorrhagic phenomena, however, in the other 6 cases significant bleeding was not identified. Vascular collapse (shock) was present in 12 (85.7%) cases, with or without the association of major bleeding, and was the most important cause of death.","['Montenegro, Demetrius', 'Lacerda, Heloisa Ramos', 'Lira, Tereza Maciel', 'Oliveira, Denise Santos Correia de', 'Lima, Ana Antunes Fonseca de', 'Guimaraes, Maria Jose Bezerra', 'Vasconcelos, Petronio Gusmao de']","['Montenegro D', 'Lacerda HR', 'Lira TM', 'Oliveira DS', 'Lima AA', 'Guimaraes MJ', 'Vasconcelos PG']",,"['Diretoria de Vigilancia Epidemiologica, Secretaria Municipal de Saude, Recife, PE.']",['por'],"['English Abstract', 'Journal Article']",20060223,Brazil,Rev Soc Bras Med Trop,Revista da Sociedade Brasileira de Medicina Tropical,7507456,,IM,"['Adolescent', 'Adult', 'Animals', 'Brazil/epidemiology', 'Cause of Death', 'Dengue/diagnosis/*mortality/virology', 'Dengue Virus/*genetics', '*Disease Outbreaks', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Severe Dengue/diagnosis/mortality/virology']",,2006/02/28 09:00,2006/04/25 09:00,['2006/02/28 09:00'],"['2006/02/28 09:00 [pubmed]', '2006/04/25 09:00 [medline]', '2006/02/28 09:00 [entrez]']","['S0037-86822006000100002 [pii]', '10.1590/s0037-86822006000100002 [doi]']",ppublish,Rev Soc Bras Med Trop. 2006 Jan-Feb;39(1):9-13. doi: 10.1590/s0037-86822006000100002. Epub 2006 Feb 23.,1,,,,,,,,,"Aspectos clinicos e epidemiologicos da epidemia de dengue no Recife, PE, em 2002.",,,,,,,,,,,,,
869095,NLM,MEDLINE,19770723,20190516,0002-9637 (Print) 0002-9637 (Linking),26,1977 May,"The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever.",337-43,,,"['Rosen, L']",['Rosen L'],,,['eng'],['Journal Article'],,United States,Am J Trop Med Hyg,The American journal of tropical medicine and hygiene,0370507,,IM,"['Asia, Southeastern', 'Child', 'Dengue/*etiology/immunology', 'Dengue Virus/*pathogenicity', 'Humans', 'Pacific Islands', 'Virulence']",,1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.4269/ajtmh.1977.26.337 [doi]'],ppublish,Am J Trop Med Hyg. 1977 May;26(3):337-43. doi: 10.4269/ajtmh.1977.26.337.,3,,,,,,,,,,,,,,,,,,,,,,
26981859,NLM,MEDLINE,20160802,20190219,1932-6203 (Electronic) 1932-6203 (Linking),11,2016,"Incidence and Predictive Factors of Central Nervous System Dysfunction in Patients Consulting for Dengue Fever in Cayenne Hospital, French Guiana.",e0150828,10.1371/journal.pone.0150828 [doi] e0150828,"INTRODUCTION: The frequency, the clinical characteristics, and the prognosis of dengue is highly variable. Dengue fever is associated with a range of neurological manifestations. The objective of the present study was to determine the incidence of neurological signs and their predictive factors using data from cases of dengue seen and followed in Cayenne Hospital during the Dengue 2 epidemic in 2013. METHODS: In 2013, a longitudinal study using data from all cases of dengue seen in Cayenne hospital was collected. Medical records used a standardized form to collect demographic information, clinical signs and biological results and the date at which they were present. The analysis used Cox proportional modeling to obtain adjusted Hazard ratios. RESULTS: A total of 1574 patients were included 221 of whom developed central nervous system signs. These signs were spontaneously resolutive. There were 9298person days of follow-up and the overall incidence rate for central nervous system signs was 2.37 per 100 person-days. The variables independently associated with central nervous system anomalies were headache, Adjusted Hazard ratio (AHR) = 1.9(95%CI = 1.4-2.6), bleeding AHR = 2 ((95%CI = 1.3-3.1), P = 0.001, abdominal pain AHR = 1.9 ((95%CI = 1.4-2.6), P<0.001, aches AHR = 2.1 ((95%CI = 1.5-2.9), P<0.001, and fatigue AHR = 1.5 ((95%CI = 1.3-1.7), P<0.001. DISCUSSION: Overall, the present study suggests that neurological signs of dengue are not exceptional even in patients without the most severe features of dengue. These manifestations were spontaneously resolutive. Here it was not possible to distinguish between encephalitis or encephalopathy. Further studies would require more in depth exploration of the patients.","['Djossou, Felix', 'Vesin, Guillaume', 'Bidaud, Bastien', 'Mosnier, Emilie', 'Simonnet, Christine', 'Matheus, Severine', 'Prince, Christelle', 'Balcaen, John', 'Donutil, Gerd', 'Egmann, Gerald', 'Okandze, Antoine', 'Malvy, Denis', 'Nacher, Mathieu']","['Djossou F', 'Vesin G', 'Bidaud B', 'Mosnier E', 'Simonnet C', 'Matheus S', 'Prince C', 'Balcaen J', 'Donutil G', 'Egmann G', 'Okandze A', 'Malvy D', 'Nacher M']",,"['Department of Infectious and Tropical Diseases, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', ""Equipe d'Accueil EA3593 Ecosystemes Amazoniens et Pathologie Tropicale, Universite de Guyane, Cayenne, French Guiana."", 'Department of Infectious and Tropical Diseases, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Department of Infectious and Tropical Diseases, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Department of Infectious and Tropical Diseases, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Laboratory, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Laboratoire de virologie, Institut Pasteur de la Guyane, Cayenne, French Guiana.', 'Department of Infectious and Tropical Diseases, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Department of Pediatrics, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', ""Service d'accueil des Urgences/Service d'aide medicale urgente, Centre Hospitalier de Cayenne, Cayenne, French Guiana."", ""Service d'accueil des Urgences/Service d'aide medicale urgente, Centre Hospitalier de Cayenne, Cayenne, French Guiana."", 'Laboratory, Centre Hospitalier de Cayenne, Cayenne, French Guiana.', 'Unite des Maladies Tropicales et du Voyageur, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.', ""Equipe d'Accueil EA3593 Ecosystemes Amazoniens et Pathologie Tropicale, Universite de Guyane, Cayenne, French Guiana."", ""Centre d'Investigation Clinique Antilles Guyane, INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20160316,United States,PLoS One,PloS one,101285081,,IM,"['Central Nervous System Diseases/*etiology/physiopathology', 'Dengue/complications/*epidemiology/physiopathology', 'French Guiana/epidemiology', '*Hospitals', 'Humans', 'Incidence', 'Longitudinal Studies', 'Prognosis']",PMC4794179,2016/03/18 06:00,2016/08/03 06:00,['2016/03/17 06:00'],"['2015/09/23 00:00 [received]', '2016/02/20 00:00 [accepted]', '2016/03/17 06:00 [entrez]', '2016/03/18 06:00 [pubmed]', '2016/08/03 06:00 [medline]']","['PONE-D-15-42149 [pii]', '10.1371/journal.pone.0150828 [doi]']",epublish,PLoS One. 2016 Mar 16;11(3):e0150828. doi: 10.1371/journal.pone.0150828. eCollection 2016.,3,,,,['Competing Interests: The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
3097497,NLM,MEDLINE,19870113,20080214,0149-2195 (Print) 0149-2195 (Linking),35,1986 Dec 19,Dengue hemorrhagic fever--Puerto Rico.,779-82,,,,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Dengue/diagnosis/*epidemiology', '*Disease Outbreaks', 'Female', 'Humans', 'Infant', 'Male', 'Puerto Rico']",,1986/12/19 00:00,1986/12/19 00:01,['1986/12/19 00:00'],"['1986/12/19 00:00 [pubmed]', '1986/12/19 00:01 [medline]', '1986/12/19 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1986 Dec 19;35(50):779-82.,50,,,,,,,,,,,,,,,,,['Centers for Disease Control (CDC)'],,,,,
26304704,NLM,MEDLINE,20160811,20151109,1872-9096 (Electronic) 0166-3542 (Linking),123,2015 Nov,Animal models for studying dengue pathogenesis and therapy.,5-14,S0166-3542(15)00199-0 [pii] 10.1016/j.antiviral.2015.08.013 [doi],"Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery.","['Chan, Kitti Wing Ki', 'Watanabe, Satoru', 'Kavishna, Ranmali', 'Alonso, Sylvie', 'Vasudevan, Subhash G']","['Chan KW', 'Watanabe S', 'Kavishna R', 'Alonso S', 'Vasudevan SG']",,"['Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8-College Road, Singapore 169857, Singapore; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.', 'Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8-College Road, Singapore 169857, Singapore. Electronic address: satoru.watanabe@duke-nus.edu.sg.', 'Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Immunology Programme, Life Science Institute, National University of Singapore, Singapore.', 'Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Immunology Programme, Life Science Institute, National University of Singapore, Singapore.', 'Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8-College Road, Singapore 169857, Singapore; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: subhash.vasudevan@duke-nus.edu.sg.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",20150821,Netherlands,Antiviral Res,Antiviral research,8109699,,IM,"['Animals', 'Dengue/*drug therapy/*virology', 'Dengue Virus/*pathogenicity', '*Disease Models, Animal', 'Drug Evaluation, Preclinical/methods']",,2015/08/26 06:00,2016/08/12 06:00,['2015/08/26 06:00'],"['2015/06/30 00:00 [received]', '2015/08/05 00:00 [revised]', '2015/08/19 00:00 [accepted]', '2015/08/26 06:00 [entrez]', '2015/08/26 06:00 [pubmed]', '2016/08/12 06:00 [medline]']","['S0166-3542(15)00199-0 [pii]', '10.1016/j.antiviral.2015.08.013 [doi]']",ppublish,Antiviral Res. 2015 Nov;123:5-14. doi: 10.1016/j.antiviral.2015.08.013. Epub 2015 Aug 21.,,['Copyright (c) 2015 Elsevier B.V. All rights reserved.'],['NOTNLM'],"['AG129 mice', 'Animal models', 'Antiviral therapy', 'Dengue', 'Dengue hemorrhagic fever']",,,,,,,,,,,,,,,,,,,
20563439,NLM,MEDLINE,20100920,20170225,1678-4391 (Electronic) 1413-8670 (Linking),14,2010 Mar-Apr,Correlation of disease spectrum among four Dengue serotypes: a five years hospital based study from India.,141-6,,"The recognition of DF (DHF Dengue Hemorrhagic Fever) is very complicated due to occurrence of a wide spectrum of clinical signs and symptoms during acute phase of illness. Moreover, presence of four serotypes further complicates the prognosis. To investigate the predictors of disease severity and elucidate the prognostic markers among four dengue serotypes, this study was conducted on 320 inpatients having acute febrile illness clinically suspected as DI, over a period of five years. Dengue serotypes were confirmed by multiplex reverse transcriptase (RT)-PCR. Eighty patients were positive for DI with presence of Den-1, Den-2, Den-3, and Den-4 in 8, 35, 27 and 10 patients, respectively. The severe clinical manifestations, abdominal pain and hepatomegaly, were comparatively higher in Den-2 patients. Liver aminotransferases levels were also higher in Den-2 patients (app. 5 fold). This study clearly indicates the hyperendemicity of all dengue serotypes. Nucleotide sequencing of Envelope region revealed that the presently emerged Den-3 belongs to type III, having high homology with genotype responsible for number of outbreaks in 1980s. The re-emergence of this deadly type can be suspected to cause more outbreaks in future and is a matter of great concern.","['Kumaria, Rajni']",['Kumaria R'],,"['Singapore-MIT Alliance for Research and Technology, National University of Singapore, Singapore. rankumaria@gmail.com']",['eng'],['Journal Article'],,Brazil,Braz J Infect Dis,The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,9812937,"['0 (RNA, Viral)']",IM,"['Case-Control Studies', 'Dengue/diagnosis/epidemiology/*virology', 'Dengue Virus/classification/*genetics/isolation & purification', 'Genotype', 'Humans', 'India/epidemiology', 'Phylogeny', 'RNA, Viral/analysis', 'Reverse Transcriptase Polymerase Chain Reaction', 'Serotyping', 'Severe Dengue/diagnosis/epidemiology/virology']",,2010/06/22 06:00,2010/09/21 06:00,['2010/06/22 06:00'],"['2009/11/06 00:00 [received]', '2009/06/08 00:00 [accepted]', '2010/06/22 06:00 [entrez]', '2010/06/22 06:00 [pubmed]', '2010/09/21 06:00 [medline]']",['S1413-8670(10)70027-1 [pii]'],ppublish,Braz J Infect Dis. 2010 Mar-Apr;14(2):141-6.,2,,,,,['Braz J Infect Dis. 2011 Mar-Apr;15(2):184-5. PMID: 21503411'],,,,,,,,,,,,,,,,,
37463399,NLM,MEDLINE,20230816,20230822,1532-0987 (Electronic) 0891-3668 (Linking),42,2023 Sep 1,Unique Immune Blood Markers Between Severe Dengue and Sepsis in Children.,792-800,10.1097/INF.0000000000003990 [doi],"BACKGROUND: Pediatric dengue and sepsis share clinical and pathophysiologic aspects. Multiple inflammatory and regulatory cytokines, decoy receptors and vascular permeability factors have been implicated in the pathogenesis of both diseases. The differential pattern and dynamic of these soluble factors, and the relationship with clinical severity between pediatric dengue and sepsis could offer new diagnosis and therapeutic strategies. METHODS: We evaluated the concentration levels of 11 soluble factors with proinflammatory, regulatory and vascular permeability involvement, in plasma from children with dengue or sepsis, both clinically ranging from mild to severe, in the early, late and convalescence phases of the disease. RESULTS: During early acute infection, children with sepsis exhibited specific higher concentration levels of IL-6, vascular endothelial growth factor (VEGF), and its soluble decoy receptor II (sVEGFR2) and lower concentration levels of IL-10 and the soluble tumor necrosis factor receptor 2 (sTNFR2), in comparison with children with severe dengue. In addition, the circulating amounts of soluble ST2, and VEGF/sVEGFR2 were widely associated with clinical and laboratory indicators of dengue severity, whereas secondary dengue virus infections were characterized by an enhanced cytokine response, relative to primary infections. In severe forms of dengue, or sepsis, the kinetics and the cytokines response during the late and convalescence phases of the disease also differentiate. CONCLUSIONS: Dengue virus infection and septic processes in children are characterized by cytokine responses of a specific magnitude, pattern and kinetics, which are implicated in the pathophysiology and clinical outcome of these diseases.","['Salgado, Doris M', 'Rivera, Gina M', 'Pinto, William A', 'Rodriguez, Jairo', 'Acosta, Gladys', 'Castaneda, Diana M', 'Vega, Rocio', 'Perdomo-Celis, Federico', 'Bosch, Irene', 'Narvaez, Carlos F']","['Salgado DM', 'Rivera GM', 'Pinto WA', 'Rodriguez J', 'Acosta G', 'Castaneda DM', 'Vega R', 'Perdomo-Celis F', 'Bosch I', 'Narvaez CF']",['ORCID: 0000-0003-0129-5210'],"['From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'Division de Inmunologia, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.', 'From the Departamento de Pediatria, Universidad Surcolombiana, E.S.E. Hospital Universitario de Neiva, Neiva, Huila, Colombia.', 'Instituto de Genetica Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogota, Colombia.', 'Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.', 'Division de Inmunologia, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20230718,United States,Pediatr Infect Dis J,The Pediatric infectious disease journal,8701858,"['0 (Vascular Endothelial Growth Factor A)', '0 (Cytokines)', '0 (Biomarkers)']",IM,"['Humans', 'Child', '*Severe Dengue/diagnosis/complications', 'Vascular Endothelial Growth Factor A', '*Dengue/diagnosis/complications', 'Convalescence', 'Cytokines', '*Sepsis/diagnosis/complications', 'Biomarkers']",,2023/07/18 18:42,2023/08/16 06:42,['2023/07/18 16:03'],"['2023/08/16 06:42 [medline]', '2023/07/18 18:42 [pubmed]', '2023/07/18 16:03 [entrez]']","['00006454-202309000-00013 [pii]', '10.1097/INF.0000000000003990 [doi]']",ppublish,Pediatr Infect Dis J. 2023 Sep 1;42(9):792-800. doi: 10.1097/INF.0000000000003990. Epub 2023 Jul 18.,9,"['Copyright (c) 2023 Wolters Kluwer Health, Inc. All rights reserved.']",,,"['Supported by Ministerio de Ciencia Tecnologia e Innovacion, grant 112451929026', '(D.M.S.) and the Sistema General de Regalias del Departamento del Huila (S.G.R.),', 'project BPIN 2020000100145 (C.F.N.) and Vicerrectoria de Investigacion y', 'Proyeccion Social, Universidad Surcolombiana (C.F.N.). The other authors have no', 'conflicts of interest to disclose.']",,,,,,,,,,,,,,,,,,
25107464,NLM,MEDLINE,20150330,20141013,1878-3511 (Electronic) 1201-9712 (Linking),27,2014 Oct,"Severe dengue outbreak in Yunnan, China, 2013.",4-6,S1201-9712(14)01486-6 [pii] 10.1016/j.ijid.2014.03.1392 [doi],"In recent decades, the impact of dengue has increased both geographically and in intensity, and this disease is now a threat to approximately half of the world's population. An unexpected large outbreak of dengue fever was reported in Xishuangbanna Dai Autonomous Prefecture, Yunnan Province, China, in 2013. This was the first autochthonous outbreak with a significant proportion of severe dengue cases in mainland China in a decade. According to the 2009 World Health Organization guidelines, half of the 136 laboratory confirmed cases during the epidemic were severe dengue. The clinical presentation included severe haemorrhage (such as massive vaginal and gastrointestinal bleeding), severe plasma leakage (such as pleural effusion, ascites, or hypoproteinaemia), and organ involvement (such as myocarditis and lung impairment); 21 cases eventually deteriorated to shock. During this outbreak, all severe cases occurred in adults, among whom about 43% had co-morbid conditions. Nucleic acid detection and virus isolation confirmed dengue virus serotype 3 (DENV-3) to be the pathogenic agent of this outbreak. Phylogenetic analyses of envelope gene sequences showed that these DENV-3 isolates belonged to genotype II. This finding is of great importance to understand the circulation of DENV and predict the risk of severe disease in mainland China. Here, we provide a brief report of the epidemiology, clinical manifestations, and aetiology of this dengue fever outbreak, and characterize DENV strains isolated from clinical specimens.","['Zhang, Fu-Chun', 'Zhao, Hui', 'Li, Li-Hua', 'Jiang, Tao', 'Hong, Wen-Xin', 'Wang, Jian', 'Zhao, Ling-Zhai', 'Yang, Hui-Qin', 'Ma, De-Hong', 'Bai, Chun-Hai', 'Shan, Xi-Yun', 'Deng, Yong-Qiang', 'Qin, Cheng-Feng']","['Zhang FC', 'Zhao H', 'Li LH', 'Jiang T', 'Hong WX', 'Wang J', 'Zhao LZ', 'Yang HQ', 'Ma DH', 'Bai CH', 'Shan XY', 'Deng YQ', 'Qin CF']",,"[""Guangzhou 8th People's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China."", ""Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China."", ""Xishuangbanna Dai Autonomous Prefecture People's Hospital, Xishuangbanna, People's Republic of China."", ""Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China."", ""Guangzhou 8th People's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China."", ""Guangzhou 8th People's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China."", ""Guangzhou 8th People's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China."", ""Guangzhou 8th People's Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China; Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China."", ""Xishuangbanna Dai Autonomous Prefecture People's Hospital, Xishuangbanna, People's Republic of China."", ""Xishuangbanna Dai Autonomous Prefecture People's Hospital, Xishuangbanna, People's Republic of China."", ""Xishuangbanna Dai Autonomous Prefecture People's Hospital, Xishuangbanna, People's Republic of China."", ""Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China."", ""Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China. Electronic address: qincf@bmi.ac.cn.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20140811,Canada,Int J Infect Dis,International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,9610933,,IM,"['Adolescent', 'Adult', 'China/epidemiology', 'Dengue/*epidemiology/pathology/virology', 'Dengue Virus/classification/isolation & purification', '*Disease Outbreaks', 'Female', 'Humans', 'Male', 'Middle Aged', 'Young Adult']",,2014/08/12 06:00,2015/03/31 06:00,['2014/08/10 06:00'],"['2014/01/21 00:00 [received]', '2014/03/21 00:00 [revised]', '2014/03/27 00:00 [accepted]', '2014/08/10 06:00 [entrez]', '2014/08/12 06:00 [pubmed]', '2015/03/31 06:00 [medline]']","['S1201-9712(14)01486-6 [pii]', '10.1016/j.ijid.2014.03.1392 [doi]']",ppublish,Int J Infect Dis. 2014 Oct;27:4-6. doi: 10.1016/j.ijid.2014.03.1392. Epub 2014 Aug 11.,,['Copyright (c) 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['China', 'Dengue', 'Dengue virus serotype 3', 'Severe dengue']",,,,,,,,,,,,,,,,,,,
22051664,NLM,MEDLINE,20120125,20220318,1476-4687 (Electronic) 0028-0836 (Linking),479,2011 Nov 2,Epidemic: Control of dengue fever in Pakistan.,41,10.1038/479041d [doi],,"['Rai, Mohammad A']",['Rai MA'],,,['eng'],['Letter'],20111102,England,Nature,Nature,0410462,['0 (Agrochemicals)'],IM,"['Agrochemicals/pharmacology', 'Animals', 'Culicidae/drug effects', 'Dengue/*epidemiology/mortality/prevention & control', 'Drug Resistance', 'Humans', 'Insect Vectors/drug effects', 'Pakistan/epidemiology']",,2011/11/05 06:00,2012/01/26 06:00,['2011/11/05 06:00'],"['2011/11/05 06:00 [entrez]', '2011/11/05 06:00 [pubmed]', '2012/01/26 06:00 [medline]']","['479041d [pii]', '10.1038/479041d [doi]']",epublish,Nature. 2011 Nov 2;479(7371):41. doi: 10.1038/479041d.,7371,,,,,,,,,,,,,,,,,,,,,,
23912441,NLM,MEDLINE,20140721,20130805,2539-3596 (Electronic) 0124-0064 (Linking),14,2012 Jun,[A mathematical model for controlling the spread of dengue].,512-23,S0124-00642012000300014 [pii],"OBJECTIVE: A mathematical model is presented in this paper showing the dynamics of dengue transmission. The goal was to studyAedes aegyptipopulation behaviour and that of affected people to scientifically support the decision-making involved in surveillance and control programmes. METHODS: The proposed mathematical model involved eight differential equations having constant delays; each represented each population's variation either in humans or the mosquito vector. RESULTS: Two of the mathematical model's simulation scenarios are presented; they were solved by means of an algorithm implemented in MATLAB software. The data was obtained from the Colombian Statistics Department (DANE), the World Health Organisation (WHO) and from a review of the pertinent literature. The data regarding human and vector populations was analysed (with and without using controls). CONCLUSIONS: The proposed mathematical model was able to simulate the dynamics of dengue transmission; it simulated the population-related behaviour ofAedes aegyptiand the affected people. This model could be a tool for scientifically supporting surveillance and control programmes' decision-making.","['Lopez, Luis E', 'Munoz-Loaiza, Anibal', 'Olivar-Tost, Gerard', 'Betancourt-Bethencourt, Jose']","['Lopez LE', 'Munoz-Loaiza A', 'Olivar-Tost G', 'Betancourt-Bethencourt J']",,"['Universidad Nacional de Colombia, Manizales, Colombia. lelopezm@unal.edu.co']",['spa'],"['English Abstract', 'Journal Article']",,Colombia,Rev Salud Publica (Bogota),"Revista de salud publica (Bogota, Colombia)",100936348,,IM,"['Aedes', 'Animals', 'Dengue/*prevention & control/*transmission', 'Humans', '*Models, Theoretical', 'Population Dynamics']",,2012/06/01 00:00,2014/07/22 06:00,['2013/08/06 06:00'],"['2012/02/09 00:00 [received]', '2012/06/15 00:00 [accepted]', '2013/08/06 06:00 [entrez]', '2012/06/01 00:00 [pubmed]', '2014/07/22 06:00 [medline]']",['S0124-00642012000300014 [pii]'],ppublish,Rev Salud Publica (Bogota). 2012 Jun;14(3):512-23.,3,,,,,,,,,Modelo matematico para el control de la transmision del Dengue.,,,,,,,,,,,,,
29636483,NLM,MEDLINE,20191001,20220318,2045-2322 (Electronic) 2045-2322 (Linking),8,2018 Apr 10,ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela.,5727,10.1038/s41598-018-24003-z [doi] 5727,"Dengue is a mosquito-borne viral disease of global impact. In Venezuela, dengue has emerged as one of the most important public health problems of urban areas with frequent epidemics since 2001. The long-term pattern of this disease has involved not only a general upward trend in cases but also a dramatic increase in the size and frequency of epidemic outbreaks. By assuming that climate variability has a relevant influence on these changes in time, we quantified the periodicity of dengue incidence in time-series of data from two northern regions of Venezuela. Disease cycles of 1 and 3-4 years (p < 0.05) were detected. We determined that dengue cycles corresponded with local climate and the El Nino Southern Oscillation (ENSO) variation at both seasonal and inter-annual scales (every 2-3 years). Dengue incidence peaks were more prevalent during the warmer and dryer years of El Nino confirming that ENSO is a regional climatic driver of such long-term periodicity through local changes in temperature and rainfall. Our findings support the evidence of the effect of climate on dengue dynamics and advocate the incorporation of climate information in the surveillance and prediction of this arboviral disease in Venezuela.","['Vincenti-Gonzalez, M F', 'Tami, A', 'Lizarazo, E F', 'Grillet, M E']","['Vincenti-Gonzalez MF', 'Tami A', 'Lizarazo EF', 'Grillet ME']",['ORCID: 0000-0003-2922-6751'],"['Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.tami@umcg.nl.', 'Departamento de Parasitologia, Facultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela. a.tami@umcg.nl.', 'Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.', 'Laboratorio de Biologia de Vectores y Parasitos, Instituto de Zoologia y Ecologia Tropical, Facultad de Ciencias, Universidad Central de Venezuela, Caracas, Venezuela. maria.grillet@ciens.ucv.ve.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20180410,England,Sci Rep,Scientific reports,101563288,,IM,"['*Climate', 'Dengue/*epidemiology/transmission/virology', '*Disease Outbreaks', '*El Nino-Southern Oscillation', 'Geography, Medical', 'Humans', 'Incidence', 'Seasons', 'Spatio-Temporal Analysis', 'Venezuela/epidemiology']",PMC5893565,2018/04/11 06:00,2019/10/02 06:00,['2018/04/12 06:00'],"['2017/09/26 00:00 [received]', '2018/03/20 00:00 [accepted]', '2018/04/12 06:00 [entrez]', '2018/04/11 06:00 [pubmed]', '2019/10/02 06:00 [medline]']","['10.1038/s41598-018-24003-z [pii]', '24003 [pii]', '10.1038/s41598-018-24003-z [doi]']",epublish,Sci Rep. 2018 Apr 10;8(1):5727. doi: 10.1038/s41598-018-24003-z.,1,,,,['The authors declare no competing interests.'],,,,,,,,,,,,,,,,,,
22686428,NLM,MEDLINE,20121120,20221207,1365-3156 (Electronic) 1360-2276 (Linking),17,2012 Aug,Dengue in travellers: applicability of the 1975-1997 and the 2009 WHO classification system of dengue fever.,1023-30,10.1111/j.1365-3156.2012.03020.x [doi],"OBJECTIVES: The aim of this study was to assess the applicability and benefits of the new WHO dengue fever guidelines in clinical practice, for returning travellers. METHODS: We compared differences in specificity and sensitivity between the old and the new guidelines for diagnosing dengue and assessed the usefulness in predicting the clinical course of the disease. Also, we investigated whether hypertension, diabetes or allergies, ethnicity or high age influenced the course of disease. RESULTS: In our setting, the old classification, compared with the new, had a marginally higher sensitivity for diagnosing dengue. The new classification had a slightly higher specificity and was less rigid. Patients with dengue who had warning signs as postulated in the new classification were admitted more often than those who had no warning signs (RR, 8.09 [1.80-35.48]). We did not find ethnicity, age, hypertension, diabetes mellitus or allergies to be predictive of the clinical course. CONCLUSIONS: In our cohort of returned travellers, the new classification system did not differ in sensitivity and specificity from the old system to a clinically relevant degree. The guidelines did not improve identification of severe disease.","['Wieten, Rosanne W', 'Vlietstra, Wytze', 'Goorhuis, Abraham', 'van Vugt, Michele', 'Hodiamont, Caspar J', 'Leenstra, Tjalling', 'de Vries, Peter J', 'Janssen, Saskia', 'van Thiel, Pieter P', 'Stijnis, Kees', 'Grobusch, Martin P']","['Wieten RW', 'Vlietstra W', 'Goorhuis A', 'van Vugt M', 'Hodiamont CJ', 'Leenstra T', 'de Vries PJ', 'Janssen S', 'van Thiel PP', 'Stijnis K', 'Grobusch MP']",,"['Center for Tropical Medicine and Travel Medicine, University of Amsterdam, Amsterdam, The Netherlands.']",['eng'],['Journal Article'],20120612,England,Trop Med Int Health,Tropical medicine & international health : TM & IH,9610576,,IM,"['Adult', 'Age Factors', 'Comorbidity', 'Dengue/*diagnosis/ethnology/physiopathology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Netherlands', '*Practice Guidelines as Topic', 'Risk Factors', 'Sensitivity and Specificity', 'Socioeconomic Factors', '*Travel', 'White People', '*World Health Organization']",,2012/06/13 06:00,2012/12/10 06:00,['2012/06/13 06:00'],"['2012/06/13 06:00 [entrez]', '2012/06/13 06:00 [pubmed]', '2012/12/10 06:00 [medline]']",['10.1111/j.1365-3156.2012.03020.x [doi]'],ppublish,Trop Med Int Health. 2012 Aug;17(8):1023-30. doi: 10.1111/j.1365-3156.2012.03020.x. Epub 2012 Jun 12.,8,['(c) 2012 Blackwell Publishing Ltd.'],,,,,,,,,,,,,,,,,,,,,
26460646,NLM,MEDLINE,20151026,20171019,1474-547X (Electronic) 0140-6736 (Linking),386,2015 Sep 26,Dengue surveillance poor in India.,1228,S0140-6736(15)00315-3 [pii] 10.1016/S0140-6736(15)00315-3 [doi],,"['Bagcchi, Sanjeet']",['Bagcchi S'],,,['eng'],['News'],,England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Dengue/diagnosis/*epidemiology', 'Disease Outbreaks/*statistics & numerical data', 'Humans', 'India/epidemiology', 'Population Surveillance']",,2015/10/16 06:00,2015/10/27 06:00,['2015/10/14 06:00'],"['2015/10/14 06:00 [entrez]', '2015/10/16 06:00 [pubmed]', '2015/10/27 06:00 [medline]']","['S0140-6736(15)00315-3 [pii]', '10.1016/S0140-6736(15)00315-3 [doi]']",ppublish,Lancet. 2015 Sep 26;386(10000):1228. doi: 10.1016/S0140-6736(15)00315-3.,10000,,,,,,,,,,,,,,,,,,,,,,
7844840,NLM,MEDLINE,19950307,20150901,0257-5655 (Print) 0257-5655 (Linking),10 Suppl,1994 Dec,National dengue prevention and control program in the Philippines.,S118-21,,,"['Dominguez, N N']",['Dominguez NN'],,"['Department of Health, Manila, Philippines.']",['eng'],['Journal Article'],,China (Republic : 1949- ),Gaoxiong Yi Xue Ke Xue Za Zhi,Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,8603880,,IM,"['Dengue/epidemiology/*prevention & control', 'Female', 'Humans', 'Male', '*National Health Programs', 'Philippines/epidemiology']",,1994/12/01 00:00,1994/12/01 00:01,['1994/12/01 00:00'],"['1994/12/01 00:00 [pubmed]', '1994/12/01 00:01 [medline]', '1994/12/01 00:00 [entrez]']",,ppublish,Gaoxiong Yi Xue Ke Xue Za Zhi. 1994 Dec;10 Suppl:S118-21.,,,,,,,,,,,,,,,,,,,,,,,
1509881,NLM,MEDLINE,19920922,20220310,0374-5600 (Print) 0374-5600 (Linking),34,1992 Jun,Dengue encephalopathy.,350-7,,"Dengue encephalopathy or dengue hemorrhagic fever (DHF) with CNS involvement used to be considered a relatively rare condition; but the number of cases reported in human studies has been increasing every year. Diagnosis of dengue encephalopathy is based on clinically diagnosed DHF according to the W.H.O. criteria (1980), with CNS manifestations consisting of abrupt onset of hyperpyrexia, non-transient alteration of consciousness, headache, vomiting--with or without seizures--and normal CSF. Many factors may be considered to be directly or indirectly associated with CNS signs and symptoms in DHF, the main pathology being leakage of plasma into serous spaces and abnormal hemostasis, leading to hypovolemic shock and hemorrhage in many organs of the body. Acute liver failure is considered to be one of the main factors causing brain pathology. One hundred fifty-two cases of dengue encephalopathy admitted during 3 periods at the Cipto Mangunkusumo Hospital in Jakarta were studied retrospectively. The overall incidence was 152 out of 2,441 DHF cases, or 6.2%. The most pronounced symptoms were hyperpyrexia, alteration of consciousness and convulsions. Laboratory examination showed an unusually high increase of serum transaminases, hyponatremia, and hypoxia. Neurologic abnormalities detected were hemiparesis and tetraparesis of the extremities, and second nerve atrophy; such abnormalities were found in 10 out of the 152 cases, or 6.5%.","['Hendarto, S K', 'Hadinegoro, S R']","['Hendarto SK', 'Hadinegoro SR']",,"['Department of Child Health, Medical Faculty, University of Indonesia, Jakarta.']",['eng'],"['Comparative Study', 'Journal Article']",,Australia,Acta Paediatr Jpn,Acta paediatrica Japonica : Overseas edition,0370357,,IM,"['Age Factors', 'Child', 'Child, Preschool', 'Dengue/classification/diagnosis/*epidemiology', 'Encephalitis/classification/diagnosis/*epidemiology', 'Humans', 'Indonesia/epidemiology', 'Infant', 'Retrospective Studies', 'Severity of Illness Index']",,1992/06/01 00:00,1992/06/01 00:01,['1992/06/01 00:00'],"['1992/06/01 00:00 [pubmed]', '1992/06/01 00:01 [medline]', '1992/06/01 00:00 [entrez]']",['10.1111/j.1442-200x.1992.tb00971.x [doi]'],ppublish,Acta Paediatr Jpn. 1992 Jun;34(3):350-7. doi: 10.1111/j.1442-200x.1992.tb00971.x.,3,,,,,,,,,,,,,,,,,,,,,,
2098925,NLM,MEDLINE,19910729,20071115,0125-1562 (Print) 0125-1562 (Linking),21,1990 Dec,Dengue virus serotypic identification using suckling mouse and western blot technique.,614-20,,"The suckling mouse which is used in the classical method to detect and propagate dengue viruses was evaluated in conjunction with the western blot and immunoenzymatic methods to detect the infecting strains of dengue viruses. After intracerebral inoculation of patients' sera into the suckling mice for 7 days, the mice were examined for the presence of dengue proteins, even though the mice did not have the neurological symptoms which usually serve as an indicator for the presence of dengue infection in the mouse brain. With a blind study of a set of 12 specimens, the suckling mice could detect the virus with the same frequency as the mosquito system but in shorter time of incubation period. The whole process to identify the type of infection takes 9 days. Another important finding is the demonstration of the virion antigen in the liver. The quantity and quality of viral proteins in liver are comparable to those in the brain suggesting that the virus may replicate in the liver as well as in the brain.","['Churdboonchart, V', 'Khemarunmanus, M', 'Yoksan, S', 'Bhamarapravati, N']","['Churdboonchart V', 'Khemarunmanus M', 'Yoksan S', 'Bhamarapravati N']",,"['Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",,Thailand,Southeast Asian J Trop Med Public Health,The Southeast Asian journal of tropical medicine and public health,0266303,,IM,"['Animals', '*Animals, Suckling', 'Blotting, Western/methods/*standards', 'Dengue/classification/diagnosis/*epidemiology', 'Evaluation Studies as Topic', 'Immunoenzyme Techniques/*standards', 'Mice', 'Sensitivity and Specificity', 'Serotyping']",,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):614-20.,4,,,,,,,,,,,,,,,,,,,,,,
32794470,NLM,MEDLINE,20210824,20210824,1972-2680 (Electronic) 1972-2680 (Linking),14,2020 Jul 31,Comparing the 2009 and 1997 World Health Organization dengue case classifications in a large cohort of South Asian patients.,781-787,10.3855/jidc.12468 [doi],"INTRODUCTION: Due to the shortcomings in the 1997-World Health Organisation (WHO) dengue case classification (DCC), a revised classification was proposed in 2009. This study was aimed to assess the clinical usefulness of the two classifications during a large dengue epidemic. METHODOLOGY: Clinical data of dengue patients admitted to selected units at National Hospital of Sri Lanka, Panadura Base Hospital and Nawaloka Hospital Colombo between June and August 2017 were collected prospectively. Cases were classified using the 1997 and 2009 WHO DCCs. RESULTS: 1,878 patients [adult = 1,573 (83.8%)] were studied. Based on 1997-WHO-DCC-DF (Dengue Fever): 1,316 (70.1%), DHF (Dengue Haemorrhagic Fever) -1: 468 (24.9%), DHF-2: 86 (4.6%) and DHF-3: 8 (0.4%). Based on 2009-WHO-DCC-Dengue with warning signs (WS): 1647 (87.7%), Dengue without WS: 231 (12.3%) and severe dengue (SD): 41 (2.18%). A total of 1,088 (82.7%) DF and 559 (99.5%) DHF patients developed WS. Of those without WS, 228 (17.3%) were DF patients and 3 (0.5%) were DHF patients. Three (0.23%) DF and 38 (6.76%) DHF patients had SD. All SD patients had WS. The level of agreement between the two systems of classification was poor (Kappa = - 0.035, p < 0.001). CONCLUSIONS: The 2009-WHO-DCC was more useful than 1997-WHO-DCC in predicting dengue disease severity as few DF patients also had SD. Furthermore, the presence of WS identified patients with SD. However, the 2009-WHO-DCC may not suit the resource limited countries as WS are non-specific, and lack of diagnostic tests can result in case overload.","['Jayarajah, Umesh', 'Dissanayake, Upul', 'Abeysuriya, Visula', 'De Silva, Pradeep K', 'Jayawardena, Priyankara', 'Kulatunga, Aruna', 'Fernando, Harshini', 'Madarasinghe, Manohari', 'Hapugoda, Damayanthi', 'Perera, Lakshika', 'Kannangara, Vibhavee', 'Udayangani, Champika', 'Peiris, Ranga', 'Faizer, Shuaib', 'Yasawardene, Pamodh', 'De Mel, Sanjay', 'De Zoysa, Ishan', 'Seneviratne, Suranjith L']","['Jayarajah U', 'Dissanayake U', 'Abeysuriya V', 'De Silva PK', 'Jayawardena P', 'Kulatunga A', 'Fernando H', 'Madarasinghe M', 'Hapugoda D', 'Perera L', 'Kannangara V', 'Udayangani C', 'Peiris R', 'Faizer S', 'Yasawardene P', 'De Mel S', 'De Zoysa I', 'Seneviratne SL']",,"['Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. umeshe.jaya@gmail.com.', 'Department of Medicine, Base Hospital, Panadura, Sri Lanka. upulpushpa.ud@gmail.com.', 'Nawaloka Hospital, Colombo, Sri Lanka. visulasrilanka@hotmail.com.', 'Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. mpkdesilva@yahoo.com.', 'Dengue Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka. priyankara.jayawardana@gmail.com.', 'Department of Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka. kulatunga.aruna@gmail.com.', 'Department of Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka. harshi.fernando39@gmail.com.', 'Department of Paediatrics, Base Hospital, Panadura, Sri Lanka. manoharimd@gmail.com.', 'Department of Paediatrics, Base Hospital, Panadura, Sri Lanka. damayanthihapugoda@gmail.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. piumaliperera1278@gmail.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. kannagarav@gmail.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. champikaudukala2@gmail.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. rangapieris90.rp@gmail.com.', 'Dengue Research Group, Colombo, Sri Lanka. shuaibfaizer@gmail.com.', 'Dengue Research Group, Colombo, Sri Lanka. pcyasawardene@gmail.com.', 'Nawaloka Hospital, Colombo, Sri Lanka. wspdm199@yahoo.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. ishandz@hotmail.com.', 'Department of Surgery, Faculty of Medicine, University of Colombo, Sri Lanka. suran200@yahoo.co.uk.']",['eng'],"['Comparative Study', 'Journal Article', 'Multicenter Study']",20200731,Italy,J Infect Dev Ctries,Journal of infection in developing countries,101305410,,IM,"['Adult', 'Child', 'Child, Preschool', 'Dengue/*diagnosis/*epidemiology/pathology', 'Dengue Virus/isolation & purification', 'Female', 'Hospitals', 'Humans', 'Male', 'Prospective Studies', 'Severity of Illness Index', 'Sri Lanka/epidemiology', 'World Health Organization']",,2020/08/15 06:00,2021/08/25 06:00,['2020/08/15 06:00'],"['2020/01/26 00:00 [received]', '2020/05/18 00:00 [accepted]', '2020/08/15 06:00 [entrez]', '2020/08/15 06:00 [pubmed]', '2021/08/25 06:00 [medline]']",['10.3855/jidc.12468 [doi]'],epublish,J Infect Dev Ctries. 2020 Jul 31;14(7):781-787. doi: 10.3855/jidc.12468.,7,"['Copyright (c) 2020 Umesh Jayarajah, Visula Abeysuriya, Pradeep K de Silva,', 'Priyankara Jayawardena, Aruna Kulatunga, Harshini Fernando, Manohari', 'Madarasinghe, Damayanthi Hapugoda, Lakshika Perera, Vibhavee Kannangara, Champika', 'Udayangani, Ranga Peiris, Shuaib Faizer, Pamodh Yasawardene, Sanjay de Mel, Ishan', 'de Zoysa, Suranjith L Seneviratne.']",['NOTNLM'],"['1997 WHO dengue case definitions', '2009 WHO dengue case definitions', 'Sri Lanka', 'dengue virus infections']",['No Conflict of Interest is declared'],,,,,,,,,,,,,,,,,,
33362244,NLM,MEDLINE,20210222,20220322,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),14,2020 Dec,Assessing the risk of dengue severity using demographic information and laboratory test results with machine learning.,e0008960,10.1371/journal.pntd.0008960 [doi] e0008960,"BACKGROUND: Dengue virus causes a wide spectrum of disease, which ranges from subclinical disease to severe dengue shock syndrome. However, estimating the risk of severe outcomes using clinical presentation or laboratory test results for rapid patient triage remains a challenge. Here, we aimed to develop prognostic models for severe dengue using machine learning, according to demographic information and clinical laboratory data of patients with dengue. METHODOLOGY/PRINCIPAL FINDINGS: Out of 1,581 patients in the National Cheng Kung University Hospital with suspected dengue infections and subjected to NS1 antigen, IgM and IgG, and qRT-PCR tests, 798 patients including 138 severe cases were enrolled in the study. The primary target outcome was severe dengue. Machine learning models were trained and tested using the patient dataset that included demographic information and qualitative laboratory test results collected on day 1 when they sought medical advice. To develop prognostic models, we applied various machine learning methods, including logistic regression, random forest, gradient boosting machine, support vector classifier, and artificial neural network, and compared the performance of the methods. The artificial neural network showed the highest average discrimination area under the receiver operating characteristic curve (0.8324 +/- 0.0268) and balance accuracy (0.7523 +/- 0.0273). According to the model explainer that analyzed the contributions/co-contributions of the different factors, patient age and dengue NS1 antigenemia were the two most important risk factors associated with severe dengue. Additionally, co-existence of anti-dengue IgM and IgG in patients with dengue increased the probability of severe dengue. CONCLUSIONS/SIGNIFICANCE: We developed prognostic models for the prediction of dengue severity in patients, using machine learning. The discriminative ability of the artificial neural network exhibited good performance for severe dengue prognosis. This model could help clinicians obtain a rapid prognosis during dengue outbreaks. However, the model requires further validation using external cohorts in future studies.","['Huang, Sheng-Wen', 'Tsai, Huey-Pin', 'Hung, Su-Jhen', 'Ko, Wen-Chien', 'Wang, Jen-Ren']","['Huang SW', 'Tsai HP', 'Hung SJ', 'Ko WC', 'Wang JR']","['ORCID: 0000-0002-9127-7616', 'ORCID: 0000-0001-7497-149X']","['National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Tainan, Taiwan.', 'Department of Pathology, National Cheng Kung University Hospital, and College of Medicine, National Cheng Kung University, Tainan, Taiwan.', 'Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.', 'National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Tainan, Taiwan.', 'Department of Internal Medicine, National Cheng Kung University Hospital, and College of Medicine, National Cheng Kung University, Tainan, Taiwan.', 'Department of Pathology, National Cheng Kung University Hospital, and College of Medicine, National Cheng Kung University, Tainan, Taiwan.', 'Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan.', 'National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Tainan, Taiwan.', 'Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",20201223,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Demography', 'Dengue/diagnosis/*epidemiology/virology', 'Diagnostic Tests, Routine', 'Female', 'Humans', 'Logistic Models', '*Machine Learning', 'Male', 'Middle Aged', 'Neural Networks, Computer', 'Prognosis', 'ROC Curve', 'Risk Factors']",PMC7757819,2020/12/29 06:00,2021/02/23 06:00,['2020/12/28 11:53'],"['2020/07/29 00:00 [received]', '2020/11/08 00:00 [accepted]', '2020/12/28 11:53 [entrez]', '2020/12/29 06:00 [pubmed]', '2021/02/23 06:00 [medline]']","['PNTD-D-20-01360 [pii]', '10.1371/journal.pntd.0008960 [doi]']",epublish,PLoS Negl Trop Dis. 2020 Dec 23;14(12):e0008960. doi: 10.1371/journal.pntd.0008960. eCollection 2020 Dec.,12,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
5419206,NLM,MEDLINE,19700723,20181113,0044-0086 (Print) 1551-4056 (Electronic) 0044-0086 (Linking),42,1970 Apr,Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.,311-28,,,"['Halstead, S B', 'Nimmannitya, S', 'Cohen, S N']","['Halstead SB', 'Nimmannitya S', 'Cohen SN']",,,['eng'],['Journal Article'],,United States,Yale J Biol Med,The Yale journal of biology and medicine,0417414,['0 (Antibodies)'],IM,"['Adolescent', 'Age Factors', 'Antibodies/*analysis', 'Antibody Formation', 'Child', 'Child, Preschool', 'Dengue/*complications/etiology/immunology/microbiology', 'Dengue Virus/classification/*isolation & purification', 'Female', 'Hemagglutination Inhibition Tests', 'Hemorrhagic Disorders/complications', 'Humans', 'Infant', 'Male', 'Sex Factors', 'Shock/*epidemiology']",PMC2591704,1970/04/01 00:00,1970/04/01 00:01,['1970/04/01 00:00'],"['1970/04/01 00:00 [pubmed]', '1970/04/01 00:01 [medline]', '1970/04/01 00:00 [entrez]']",,ppublish,Yale J Biol Med. 1970 Apr;42(5):311-28.,5,,,,,,,,,,,,,,,,,,,,,,
25272519,NLM,MEDLINE,20150113,20140929,0535-5133 (Print) 0535-5133 (Linking),55,2014 Sep,[Is the fight against dengue complicated with the emergence of a new viral serotype?].,203-5,,"Dengue is a viral acute febrile illness, currently considered one of the most important arbovirosis worldwide in terms of morbidity, mortality and economic impact. Various theories have been proposed to explain the pathogenesis of severe forms of dengue, involving among other factors, features related to the virus, such as the presence of more virulent strains and/or strains with increased replicative capacity. A crucial point at this time is the discovery of a new viral type, dengue 5, from nonhuman primates in Malaysia-Borneo, which could result in greater difficulties for control and vaccine production (currently in efficacy tests). Once the circulation of this viral type has been demonstrated in the human population, the high risk of infection will have extreme or controversial public health implications. Therefore, a worldwide program to combat dengue should include an urgent need to implement continuous vector elimination, community education and prevention and control of the disease. Only then, we will be aiming to reduce the morbidity and transmission risk of dengue, while new technological and effective alternatives come about.","['Valero, Nereida', 'Quiroz, Yasmir']","['Valero N', 'Quiroz Y']",,,['spa'],"['Editorial', 'English Abstract']",,Venezuela,Invest Clin,Investigacion clinica,0421531,,IM,"['Dengue/*prevention & control/*virology', 'Dengue Virus/*classification', 'Humans', '*Serotyping']",,2014/10/03 06:00,2015/01/15 06:00,['2014/10/03 06:00'],"['2014/10/03 06:00 [entrez]', '2014/10/03 06:00 [pubmed]', '2015/01/15 06:00 [medline]']",,ppublish,Invest Clin. 2014 Sep;55(3):203-5.,3,,,,,,,,,Se complica la lucha contra el dengue ante el surgimiento de un nuevo serotipo viral?,,,,,,,,,,,,,
28625589,NLM,MEDLINE,20180326,20181202,1532-2653 (Electronic) 0967-5868 (Linking),43,2017 Sep,Acute disseminated encephalomyelitis in dengue viral infection.,25-31,S0967-5868(17)30318-1 [pii] 10.1016/j.jocn.2017.05.033 [doi],"Dengue is the most common arboviral disease affecting many countries worldwide. An RNA virus from the flaviviridae family, dengue has four antigenically distinct serotypes (DEN-1-DEN-4). Neurological involvement in dengue can be classified into dengue encephalopathy immune-mediated syndromes, encephalitis, neuromuscular or dengue muscle dysfunction and neuro-ophthalmic involvement. Acute disseminated encephalomyelitis (ADEM) is an immune mediated acute demyelinating disorder of the central nervous system following recent infection or vaccination. This monophasic illness is characterised by multifocal white matter involvement. Many dengue studies and case reports have linked ADEM with dengue virus infection but the association is still not clear. Therefore, this article is to review and discuss concerning ADEM in dengue as an immune-medicated neurological complication; and the management strategy required based on recent literature.","['Wan Sulaiman, Wan Aliaa', 'Inche Mat, Liyana Najwa', 'Hashim, Hasnur Zaman', 'Hoo, Fan Kee', 'Ching, Siew Mooi', 'Vasudevan, Ramachandran', 'Mohamed, Mohd Hazmi', 'Basri, Hamidon']","['Wan Sulaiman WA', 'Inche Mat LN', 'Hashim HZ', 'Hoo FK', 'Ching SM', 'Vasudevan R', 'Mohamed MH', 'Basri H']",,"['Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia; Institute of Gerontology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia. Electronic address: wanaliaa@upm.edu.my.', 'Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia; Institute of Gerontology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.', 'Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia.', 'Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia; Institute of Gerontology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.', 'Department of Family Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia; Institute of Gerontology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.', 'Institute of Gerontology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.', 'Department of Surgery, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia.', 'Department of Medicine, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia.']",['eng'],"['Journal Article', 'Review']",20170729,Scotland,J Clin Neurosci,Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,9433352,,IM,"['Dengue/*complications/diagnosis/therapy', 'Diagnosis, Differential', 'Encephalomyelitis, Acute Disseminated/diagnosis/*etiology/therapy', 'Humans', 'Immunotherapy']",,2017/06/20 06:00,2018/03/27 06:00,['2017/06/20 06:00'],"['2017/02/15 00:00 [received]', '2017/05/22 00:00 [accepted]', '2017/06/20 06:00 [pubmed]', '2018/03/27 06:00 [medline]', '2017/06/20 06:00 [entrez]']","['S0967-5868(17)30318-1 [pii]', '10.1016/j.jocn.2017.05.033 [doi]']",ppublish,J Clin Neurosci. 2017 Sep;43:25-31. doi: 10.1016/j.jocn.2017.05.033. Epub 2017 Jul 29.,,['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Acute disseminated', 'Demyelinating diseases', 'Dengue virus', 'Encephalomyelitis', 'Nervous system disorders', 'Severe dengue']",,,,,,,,,,,,,,,,,,,
37595484,NLM,MEDLINE,20230913,20230913,1876-035X (Electronic) 1876-0341 (Linking),16,2023 Oct,Dengue overview: An updated systemic review.,1625-1642,S1876-0341(23)00258-7 [pii] 10.1016/j.jiph.2023.08.001 [doi],"Dengue is caused by the dengue virus (DENVs) infection and clinical manifestations include dengue fever (DF), dengue hemorrhagic fever (DHF), or dengue shock syndrome (DSS). Due to a lack of antiviral drugs and effective vaccines, several therapeutic and control strategies have been proposed. A systemic literature review was conducted according to PRISMA guidelines to select proper references to give an overview of DENV infection. Results indicate that understanding the virus characteristics and epidemiology are essential to gain the basic and clinical knowledge as well as dengue disseminated pattern and status. Different factors and mechanisms are thought to be involved in the presentation of DHF and DSS, including antibody-dependent enhancement, immune dysregulation, viral virulence, host genetic susceptibility, and preexisting dengue antibodies. This study suggests that dissecting pathogenesis and risk factors as well as developing different types of therapeutic and control strategies against DENV infection are urgently needed.","['Khan, Muhammad Bilal', 'Yang, Zih-Syuan', 'Lin, Chih-Yen', 'Hsu, Ming-Cheng', 'Urbina, Aspiro Nayim', 'Assavalapsakul, Wanchai', 'Wang, Wen-Hung', 'Chen, Yen-Hsu', 'Wang, Sheng-Fan']","['Khan MB', 'Yang ZS', 'Lin CY', 'Hsu MC', 'Urbina AN', 'Assavalapsakul W', 'Wang WH', 'Chen YH', 'Wang SF']",,"['Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.', 'Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.', 'School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung 804201, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung 804201, Taiwan; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.', 'Center for Tropical Medicine and Infectious Disease Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. Electronic address: wasf1234@kmu.edu.tw.']",['eng'],"['Journal Article', 'Systematic Review']",20230803,England,J Infect Public Health,Journal of infection and public health,101487384,['0 (Antiviral Agents)'],IM,"['Humans', '*Antiviral Agents/therapeutic use', '*Dengue/epidemiology/therapy', 'Genetic Predisposition to Disease', 'Risk Factors', 'Virulence']",,2023/08/19 11:42,2023/09/11 06:42,['2023/08/18 18:07'],"['2023/03/30 00:00 [received]', '2023/07/24 00:00 [revised]', '2023/08/01 00:00 [accepted]', '2023/09/11 06:42 [medline]', '2023/08/19 11:42 [pubmed]', '2023/08/18 18:07 [entrez]']","['S1876-0341(23)00258-7 [pii]', '10.1016/j.jiph.2023.08.001 [doi]']",ppublish,J Infect Public Health. 2023 Oct;16(10):1625-1642. doi: 10.1016/j.jiph.2023.08.001. Epub 2023 Aug 3.,10,['Copyright (c) 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.'],['NOTNLM'],"['Dengue fever', 'Dengue hemorrhagic fever', 'Dengue shock syndrome', 'Dengue virus', 'PRISMA', 'Systemic review']",['Declaration of Competing Interest We have no conflict of interest to declare.'],,,,,,,,,,,,,,,,,,
3112547,NLM,MEDLINE,19870921,20080214,0149-2195 (Print) 0149-2195 (Linking),36,1987 Aug 28,"Imported and indigenous dengue fever--United States, 1986.",551-4,,,,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Aedes', 'Animals', 'Dengue/*epidemiology/transmission', 'Humans', 'Insect Vectors', 'Travel', 'United States']",,1987/08/28 00:00,1987/08/28 00:01,['1987/08/28 00:00'],"['1987/08/28 00:00 [pubmed]', '1987/08/28 00:01 [medline]', '1987/08/28 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1987 Aug 28;36(33):551-4.,33,,,,,,,,,,,,,,,,['MMWR 1987 Sep 4;36(34):579'],['Centers for Disease Control (CDC)'],,,,,
17357041,NLM,MEDLINE,20070515,20141120,0022-1899 (Print) 0022-1899 (Linking),195,2007 Apr 15,Severe dengue virus infection in travelers.,1081-3,,,"['Wilder-Smith, Annelies', 'Tambyah, Paul Ananth']","['Wilder-Smith A', 'Tambyah PA']",,,['eng'],"['Comment', 'Editorial']",20070302,United States,J Infect Dis,The Journal of infectious diseases,0413675,,IM,"['Communicable Diseases, Emerging/classification/*epidemiology/physiopathology', 'Dengue/classification/*epidemiology/physiopathology', 'Dengue Virus', 'Global Health', 'Humans', 'Risk Factors', '*Travel', 'Tropical Climate']",,2007/03/16 09:00,2007/05/16 09:00,['2007/03/16 09:00'],"['2006/10/27 00:00 [received]', '2006/10/30 00:00 [accepted]', '2007/03/16 09:00 [pubmed]', '2007/05/16 09:00 [medline]', '2007/03/16 09:00 [entrez]']","['JID37568 [pii]', '10.1086/512684 [doi]']",ppublish,J Infect Dis. 2007 Apr 15;195(8):1081-3. doi: 10.1086/512684. Epub 2007 Mar 2.,8,,,,,,,,['J Infect Dis. 2007 Apr 15;195(8):1089-96. PMID: 17357044'],,,,,,,,,,,,,,
26782129,NLM,MEDLINE,20160920,20160119,1708-8305 (Electronic) 1195-1982 (Linking),23,2016 Jan,Paediatric Dengue Fever diagnosed through parents' epidemiologic report and preventive strategy during the acute phase of infection.,,tav013 [pii] 10.1093/jtm/tav013 [doi],"In Europe, Dengue Fever is one of the most frequent imported diseases and also autochthonous cases occurred in areas where the insect vector is present. Here, we describe a child returning from Philippines and diagnosed with Dengue Fever, through the information provided by parents about an ongoing outbreak in their municipality. An appropriate clinical management in the hospital was established to monitor the occurrence of complications and to cancel the risk of dengue virus transmission in the acute phase of infection.","['Poddighe, Dimitri', 'Bonomelli, Irene', 'Giardinetti, Silvia', 'Nedbal, Marco', 'Bruni, Paola']","['Poddighe D', 'Bonomelli I', 'Giardinetti S', 'Nedbal M', 'Bruni P']",,"['Department of Pediatrics, Azienda Ospedaliera di Melegnano, Vizzolo Predabissi, Milan, Italy dimimedpv@yahoo.it.', 'Department of Pediatrics, Azienda Ospedaliera di Melegnano, Vizzolo Predabissi, Milan, Italy.', 'Department of Pediatrics, Azienda Ospedaliera di Melegnano, Vizzolo Predabissi, Milan, Italy.', 'Department of Pediatrics, Azienda Ospedaliera di Melegnano, Vizzolo Predabissi, Milan, Italy.', 'Department of Pediatrics, Azienda Ospedaliera di Melegnano, Vizzolo Predabissi, Milan, Italy.']",['eng'],"['Case Reports', 'Journal Article']",20160118,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Child', 'Dengue/*diagnosis/*epidemiology', 'Dengue Virus', 'Disease Outbreaks', 'Humans', 'Italy', 'Male', 'Parents', 'Philippines', '*Travel']",,2016/01/20 06:00,2016/09/22 06:00,['2016/01/20 06:00'],"['2015/09/29 00:00 [accepted]', '2016/01/20 06:00 [entrez]', '2016/01/20 06:00 [pubmed]', '2016/09/22 06:00 [medline]']","['tav013 [pii]', '10.1093/jtm/tav013 [doi]']",epublish,J Travel Med. 2016 Jan 18;23(1):tav013. doi: 10.1093/jtm/tav013. Print 2016 Jan.,1,"['(c) The Author 2016. Published by Oxford University Press on behalf of', 'International society of travel medicine. All rights reserved. For permissions,', 'please e-mail: journals.permissions@oup.com.']",['NOTNLM'],"['Dengue infection', 'Philippines', 'disease prevention', 'imported diseases', 'vector-borne disease']",,,,,,,,,,,,,,,,,,,
31172625,NLM,MEDLINE,20200407,20200408,1099-1654 (Electronic) 1052-9276 (Linking),29,2019 Sep,Serum lipid profile as a predictor of dengue severity: A systematic review and meta-analysis.,e2056,10.1002/rmv.2056 [doi],"Dengue virus is known to modulate host cell lipid metabolism in order to promote efficient viral replication. Recent studies have focused on circulating lipids as potential biomarkers of dengue severity; however, the results obtained so far lack the consistency to establish a definite relationship between the two. Therefore, in the present study, we investigated serum lipids as potential biomarkers of dengue severity by conducting a meta-analysis of the currently available clinical data. Nine studies that evaluated 1,953 patients were included in the review, many of which were cross-sectional (44.4%) and conducted in Asian countries (55.5%). These studies observed the presence of lipids in serum samples (77%) of patients in the acute phase of the disease (88.8%). Circulating total-cholesterol (P = .001) and LDL (P = .001) levels, but not HDL (P = .07), VLDL (P = .9) and triglyceride (P = .57) levels, were inversely and significantly correlated with dengue severity. Total cholesterol (P </= .001) and LDL (P = .001) were also useful in determining the risk of hypovolemic shock in patients with severe dengue. Subgroup analysis showed that factors, such as design (cross-sectional vs cohort), racial-ethnic differences (Asian vs Latin Americans), and age range (children vs adult) influenced the correlation and also contributed to the high level of heterogeneity in the studies. Our meta-analysis demonstrates that total-cholesterol and LDL-cholesterol levels should be explored as routine laboratory markers for dengue severity, as they will help in employing an appropriate patient therapy, and thus optimize the use of available resources.","['Lima, William Gustavo', 'Souza, Nayara Alves', 'Fernandes, Simone Odilia Antunes', 'Cardoso, Valbert Nascimento', 'Godoi, Isabella Piassi']","['Lima WG', 'Souza NA', 'Fernandes SOA', 'Cardoso VN', 'Godoi IP']",['ORCID: 0000-0001-8946-9363'],"['Laboratorio de Radioisotopos, Departamento de Analises Clinicas e Toxicologicas, Faculdade de farmacia, Campus Pampulha, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.', 'Escola de Enfermagem, Campus Centro-oeste Dona Lindu, Universidade Federal de Sao Joao Del-rei, Divinopolis, MG, Brazil.', 'Laboratorio de Radioisotopos, Departamento de Analises Clinicas e Toxicologicas, Faculdade de farmacia, Campus Pampulha, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.', 'Laboratorio de Radioisotopos, Departamento de Analises Clinicas e Toxicologicas, Faculdade de farmacia, Campus Pampulha, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.', 'Instituto de Saude e Estudos Biologicos, Universidade Federal do Sul e Sudeste do Para, Maraba, Para, Brazil.']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", 'Systematic Review']",20190606,England,Rev Med Virol,Reviews in medical virology,9112448,"['0 (Biomarkers)', '0 (Lipids)']",IM,"['*Biomarkers', 'Dengue/*blood/*diagnosis', 'Humans', 'Lipids/*blood', 'Prognosis', 'Publication Bias', 'Severe Dengue/blood/diagnosis', 'Severity of Illness Index']",,2019/06/07 06:00,2020/04/09 06:00,['2019/06/08 06:00'],"['2019/02/08 00:00 [received]', '2019/04/24 00:00 [revised]', '2019/04/27 00:00 [accepted]', '2019/06/07 06:00 [pubmed]', '2020/04/09 06:00 [medline]', '2019/06/08 06:00 [entrez]']",['10.1002/rmv.2056 [doi]'],ppublish,Rev Med Virol. 2019 Sep;29(5):e2056. doi: 10.1002/rmv.2056. Epub 2019 Jun 6.,5,"['(c) 2019 John Wiley & Sons, Ltd.']",['NOTNLM'],"['LDL-cholesterol', 'biomarkers', 'dengue', 'lipid metabolism', 'total-cholesterol', 'triglycerides']",,,,,,,,,,,,,,,,,,,
16036184,NLM,MEDLINE,20051003,20050722,1386-6532 (Print) 1386-6532 (Linking),33,2005 Aug,An outbreak of primary dengue infection among migrant Chinese workers in Singapore characterized by prominent gastrointestinal symptoms and a high proportion of symptomatic cases.,336-40,,"BACKGROUND: An outbreak of dengue occurred among Chinese migrant workers at a construction site in Singapore that was characterized by a number of unusual features. METHODS: Clinical and laboratory data were prospectively collected from workers who were hospitalized with fever. We compared the frequency of disease manifestations in these patients with historical data from other cases of dengue admitted to the same centre. A serological survey was performed at the construction site one month after the onset of the outbreak. RESULTS: Thirty-nine patients were admitted from the affected construction site with confirmed acute dengue infection in March and April 2002. Fever, headache and rash were common and occurred at similar frequency in outbreak patients and historical controls. Gastrointestinal manifestations were significantly more common in the outbreak patients compared with controls (nausea 68%, diarrhea 41%, hyponatremia 47% and elevated urea 20%). Of the 274 studied in the serological survey, 27 had serological evidence of acute dengue, of whom 24 (89%) had experienced a febrile illness in the previous month. The virus was cultured and identified as Dengue-2. Few patients had a positive IgG for dengue indicating that this was likely a primary infection. CONCLUSION: This outbreak of primary dengue infection was characterized by unusually prominent gastrointestinal symptoms and a high proportion of symptomatic transmission. Manifestations of dengue may be altered when outbreaks involve immunologically naive adults who have migrated to dengue endemic areas.","['Seet, Raymond C S', 'Ooi, Eng Eong', 'Wong, Hwee Bee', 'Paton, Nicholas I']","['Seet RC', 'Ooi EE', 'Wong HB', 'Paton NI']",,"['Department of Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore. raymond_seet@nus.edu.sg']",['eng'],['Journal Article'],20050425,Netherlands,J Clin Virol,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,9815671,,IM,"['Adult', 'China', 'Dengue/*epidemiology/physiopathology/virology', 'Dengue Virus', '*Disease Outbreaks', 'Gastrointestinal Diseases/*epidemiology/*physiopathology/virology', 'Humans', 'Male', 'Singapore/epidemiology', '*Transients and Migrants']",,2005/07/23 09:00,2005/10/04 09:00,['2005/07/23 09:00'],"['2004/12/17 00:00 [received]', '2005/03/14 00:00 [revised]', '2005/03/17 00:00 [accepted]', '2005/07/23 09:00 [pubmed]', '2005/10/04 09:00 [medline]', '2005/07/23 09:00 [entrez]']","['S1386-6532(05)00089-2 [pii]', '10.1016/j.jcv.2005.03.002 [doi]']",ppublish,J Clin Virol. 2005 Aug;33(4):336-40. doi: 10.1016/j.jcv.2005.03.002. Epub 2005 Apr 25.,4,,,,,,,,,,,,,,,,,,,,,,
37498793,NLM,MEDLINE,20230731,20230802,1545-861X (Electronic) 0149-2195 (Print) 0149-2195 (Linking),72,2023 Jul 28,"Travel-Associated Dengue Cases - United States, 2010-2021.",821-826,10.15585/mmwr.mm7230a3 [doi],"Dengue, the leading cause of arboviral disease worldwide, can be fatal without appropriate treatment. Among 7,528 confirmed or probable travel-associated U.S. dengue cases reported during 2010-2021, one in five (1,474, 20%) was reported in 2019. This is 168% higher than the annual average number of cases reported during 2010-2018 and 2020-2021 (approximately 550 per year) and 61% higher than the 913 cases reported in 2016, the second highest year on record. The number of cases as a fraction of air traffic volume to international destinations outside North America or Europe was also highest in 2019, with 41.9 cases per million trips, compared with 21.0 per million in other years during 2010-2021. This report compares the number and characteristics of travel-associated dengue cases reported to national surveillance in the United States in 2019 with cases reported during 2010-2018 and 2020-2021. Areas with conditions suitable for dengue transmission as well as the population at risk for dengue are expected to increase, placing U.S. travelers at higher risk for infection. Health care providers should be aware that dengue is a common cause of fever in the returning traveler and be familiar with its signs and symptoms, testing, and management. Dengue vaccines are not currently recommended for U.S. travelers; therefore, persons should review areas of dengue risk and follow guidance for preventing mosquito bites.","['Wong, Joshua M', 'Rivera, Aidsa', 'Volkman, Hannah R', 'Torres-Velasquez, Brenda', 'Rodriguez, Dania M', 'Paz-Bailey, Gabriela', 'Adams, Laura E']","['Wong JM', 'Rivera A', 'Volkman HR', 'Torres-Velasquez B', 'Rodriguez DM', 'Paz-Bailey G', 'Adams LE']",,"['Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.', 'Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC.']",['eng'],['Journal Article'],20230728,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Humans', 'United States/epidemiology', '*Travel', 'Population Surveillance', 'Europe', 'Fever', '*Dengue/epidemiology/diagnosis']",PMC10390089,2023/07/27 19:10,2023/07/31 06:42,['2023/07/27 13:13'],"['2023/07/31 06:42 [medline]', '2023/07/27 19:10 [pubmed]', '2023/07/27 13:13 [entrez]']","['mm7230a3 [pii]', '10.15585/mmwr.mm7230a3 [doi]']",epublish,MMWR Morb Mortal Wkly Rep. 2023 Jul 28;72(30):821-826. doi: 10.15585/mmwr.mm7230a3.,30,,,,"['All authors have completed and submitted the International Committee of Medical', 'Journal Editors form for disclosure of potential conflicts of interest. No', 'potential conflicts of interest were disclosed.']",,,,,,,,,,,,,,,,,,
31430283,NLM,MEDLINE,20200113,20200309,1935-2735 (Electronic) 1935-2727 (Print) 1935-2727 (Linking),13,2019 Aug,Assessment of the new World Health Organization's dengue classification for predicting severity of illness and level of healthcare required.,e0007144,10.1371/journal.pntd.0007144 [doi] e0007144,"The objective of this study was to assess the validity of the new dengue classification proposed by the World Health Organization (WHO) in 2009 and to develop pragmatic guidelines for case triage and management. This retrospective study involved 357 laboratory-confirmed cases of dengue infection diagnosed at King Abdulaziz University Hospital, Jeddah, Saudi Arabia over a 4-year period from 2014 to 2017. The sensitivity of the new classification for identifying severe cases was limited (65%) but higher than the old one (30%). It had a higher sensitivity for identifying patients who needed advanced healthcare compared to the old one (72% versus 32%, respectively). We propose adding decompensation of chronic diseases and thrombocytopenia-related bleeding to the category of severe dengue in the new classification. This modification improves sensitivity from 72% to 98% for identifying patients who need advanced healthcare without altering specificity (97%). It also improves sensitivity in predicting severe outcomes from 32% to 88%. In conclusion, the new classification had a low sensitivity for identifying patients needing advanced care and for predicting morbidity and mortality. We propose to include decompensation of chronic diseases and thrombocytopenia-related bleeding to the category of severe dengue in the new classification to improve the sensitivity of predicting cases requiring advanced care.","['Ajlan, Balgees A', 'Alafif, Maram M', 'Alawi, Maha M', 'Akbar, Naeema A', 'Aldigs, Eman K', 'Madani, Tariq A']","['Ajlan BA', 'Alafif MM', 'Alawi MM', 'Akbar NA', 'Aldigs EK', 'Madani TA']",['ORCID: 0000-0003-2453-0623'],"['Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Department of Microbiology and Parasitology, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Infection Control and Environmental Health Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.', 'Department of Epidemiology and Public Health, Ministry of Health, Jeddah, Saudi Arabia.', 'Department of Microbiology and Parasitology, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.', 'Infection Control and Environmental Health Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.']",['eng'],['Journal Article'],20190820,United States,PLoS Negl Trop Dis,PLoS neglected tropical diseases,101291488,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Chronic Disease', 'Clinical Medicine/methods/standards', 'Dengue/*classification/*diagnosis/physiopathology', 'Female', 'Hemorrhage', 'Hospitals, University', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies', 'Saudi Arabia', 'Sensitivity and Specificity', 'Severe Dengue/classification/diagnosis', 'Severity of Illness Index', 'Thrombocytopenia', '*World Health Organization', 'Young Adult']",PMC6716674,2019/08/21 06:00,2020/01/14 06:00,['2019/08/21 06:00'],"['2018/12/31 00:00 [received]', '2019/06/26 00:00 [accepted]', '2019/08/30 00:00 [revised]', '2019/08/21 06:00 [pubmed]', '2020/01/14 06:00 [medline]', '2019/08/21 06:00 [entrez]']","['PNTD-D-18-01772 [pii]', '10.1371/journal.pntd.0007144 [doi]']",epublish,PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007144. doi: 10.1371/journal.pntd.0007144. eCollection 2019 Aug.,8,,,,['The authors have declared that no competing interests exist.'],,,,,,,,,,,,,,,,,,
24620990,NLM,MEDLINE,20150331,20140826,1708-8305 (Electronic) 1195-1982 (Linking),21,2014 Sep-Oct,"Three cases of imported dengue virus infection from Madeira to Belgium, 2012.",344-8,10.1111/jtm.12113 [doi],"We report three laboratory-confirmed dengue virus (DENV) infections imported to Belgium by travelers returning from Madeira (Portugal). Despite the use of a mosquito-repellent spray as reported by two patients, the infection could not be prevented. Diagnosis was made by antigen detection and real-time reverse transcriptase polymerase chain reaction (RT-PCR) in two cases and by serology 1 month after onset of symptoms in a third one. The responsible virus was identified as DENV serotype 1, American/African genotype (genotype V). The close relationship to isolates from Colombia supports the previous findings that a South American strain originated the outbreak in Madeira in 2012.","['Cnops, Lieselotte', 'Franco, Leticia', 'Van Meensel, Britt', 'Van den Ende, Jef', 'Paz Sanchez-Seco, Maria', 'Van Esbroeck, Marjan']","['Cnops L', 'Franco L', 'Van Meensel B', 'Van den Ende J', 'Paz Sanchez-Seco M', 'Van Esbroeck M']",,"['Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",20140313,England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Adult', 'Animals', 'Belgium/epidemiology', 'Culicidae', 'Dengue/blood/*diagnosis/epidemiology', 'Diagnosis, Differential', 'Female', 'Humans', 'Insect Vectors', 'Male', 'Middle Aged', 'Portugal', '*Travel']",,2014/03/14 06:00,2015/04/01 06:00,['2014/03/14 06:00'],"['2013/10/05 00:00 [received]', '2013/12/20 00:00 [revised]', '2014/01/20 00:00 [accepted]', '2014/03/14 06:00 [entrez]', '2014/03/14 06:00 [pubmed]', '2015/04/01 06:00 [medline]']",['10.1111/jtm.12113 [doi]'],ppublish,J Travel Med. 2014 Sep-Oct;21(5):344-8. doi: 10.1111/jtm.12113. Epub 2014 Mar 13.,5,['(c) 2014 International Society of Travel Medicine.'],,,,['J Travel Med. 2015 Jan-Feb;22(1):72. PMID: 25560231'],,,,,,,,,,,,,,,,,
30740874,NLM,MEDLINE,20191218,20191218,1545-5017 (Electronic) 1545-5009 (Linking),66,2019 Jun,Initial presentation with dengue infection masking the diagnosis of acute lymphoblastic leukemia.,e27632,10.1002/pbc.27632 [doi],,"['Kooijmans, Esmee C M', 'Raphael, Martine F']","['Kooijmans ECM', 'Raphael MF']",['ORCID: 0000-0001-6961-1684'],"[""Emma's Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, the Netherlands."", ""Emma's Children's Hospital, Amsterdam UMC, University of Amsterdam, Pediatric Oncology, Amsterdam, the Netherlands.""]",['eng'],"['Case Reports', 'Letter']",20190210,United States,Pediatr Blood Cancer,Pediatric blood & cancer,101186624,,IM,"['Child, Preschool', 'Dengue/complications/*diagnosis/virology', 'Dengue Virus/*isolation & purification', 'Diagnosis, Differential', 'Female', 'Humans', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications/*diagnosis', 'Prognosis']",,2019/02/12 06:00,2019/12/19 06:00,['2019/02/12 06:00'],"['2018/12/18 00:00 [received]', '2019/01/13 00:00 [accepted]', '2019/02/12 06:00 [pubmed]', '2019/12/19 06:00 [medline]', '2019/02/12 06:00 [entrez]']",['10.1002/pbc.27632 [doi]'],ppublish,Pediatr Blood Cancer. 2019 Jun;66(6):e27632. doi: 10.1002/pbc.27632. Epub 2019 Feb 10.,6,,,,,,,,,,,,,,,,,,,,,,
36928186,NLM,MEDLINE,20230321,20230325,1545-861X (Electronic) 0149-2195 (Print) 0149-2195 (Linking),72,2023 Mar 17,"Notes From the Field: First Evidence of Locally Acquired Dengue Virus Infection - Maricopa County, Arizona, November 2022.",290-291,10.15585/mmwr.mm7211a5 [doi],,"['Kretschmer, Melissa', 'Collins, Jennifer', 'Dale, Ariella P', 'Garrett, Brenna', 'Koski, Lia', 'Zabel, Karen', 'Staab, R Nicholas', 'Turnbow, Katie', 'Nativio, Judah', 'Andrews, Kelsey', 'Smith, William E', 'Townsend, John', 'Busser, Nicole', 'Will, James', 'Burr, Kathryn', 'Jones, Forrest K', 'Santiago, Gilberto A', 'Fitzpatrick, Kelly A', 'Ruberto, Irene', 'Fitzpatrick, Kathryn', 'White, Jessica R', 'Adams, Laura', 'Sunenshine, Rebecca H']","['Kretschmer M', 'Collins J', 'Dale AP', 'Garrett B', 'Koski L', 'Zabel K', 'Staab RN', 'Turnbow K', 'Nativio J', 'Andrews K', 'Smith WE', 'Townsend J', 'Busser N', 'Will J', 'Burr K', 'Jones FK', 'Santiago GA', 'Fitzpatrick KA', 'Ruberto I', 'Fitzpatrick K', 'White JR', 'Adams L', 'Sunenshine RH']",,,['eng'],['Journal Article'],20230317,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Humans', 'Arizona/epidemiology', '*Dengue/diagnosis/epidemiology', '*Virus Diseases']",PMC10027408,2023/03/18 06:00,2023/03/22 06:00,['2023/03/17 08:55'],"['2023/03/17 08:55 [entrez]', '2023/03/18 06:00 [pubmed]', '2023/03/22 06:00 [medline]']","['mm7211a5 [pii]', '10.15585/mmwr.mm7211a5 [doi]']",epublish,MMWR Morb Mortal Wkly Rep. 2023 Mar 17;72(11):290-291. doi: 10.15585/mmwr.mm7211a5.,11,,,,"['All authors have completed and submitted the International Committee of Medical', 'Journal Editors form for disclosure of potential conflicts of interest. Ariella', 'P. Dale reports travel support from the Arizona Infectious Diseases Society of', 'America, a scholarship from the National Association of County and City Health', 'Officials to attend the 2023 Integrated Foodborne Outbreak Response and', 'Management western regional epidemiology meeting, and service as an alternate', 'member of the Arizona Department of Health Services Human Subjects Review Board', 'since August 2022. No other potential conflicts of interest were disclosed.']",,,,,,,,,,,,,,,,,,
24994569,NLM,MEDLINE,20150528,20181202,1758-1133 (Electronic) 0049-4755 (Linking),44,2014 Oct,Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases.,190-5,10.1177/0049475514541650 [doi],"Dengue fever has emerged as a major public health problem globally in the past three decades. A 13-year national surveillance data analysis was done to describe the epidemiology and its trend of dengue disease in Oman reported between 2001 and 2013. Laboratory-confirmed dengue virus infections reported were studied retrospectively during the study period. A total of 64 laboratory confirmed cases were reported. All the patients contracted the disease during their visit to South-East Asian countries, hence classified as imported cases. The majority of the cases were reported in the year 2012 (23.4%). The most important clinical characteristics were fever (90.6%), myalgia (35.9%) and rash/petechial rash (20.3%). Thrombocytopenia was seen in 31.2% of the study subjects. The mortality was nearly 4.6% and all other patients made a full recovery. The most effective measure for travellers is taking precautions to avoid mosquito bites.","['Al Awaidy, Salah Thabit', 'Al Obeidani, Idris', 'Bawikar, Shyam', 'Al Mahrouqi, Salim', 'Al Busaidy, Suleiman Salim', 'Al Baqlani, Said', 'Patel, Prakash K']","['Al Awaidy ST', 'Al Obeidani I', 'Bawikar S', 'Al Mahrouqi S', 'Al Busaidy SS', 'Al Baqlani S', 'Patel PK']",,"['Senior Consultant Epidemiologist and Communicable Disease Advisor, Office of HE of Health Affairs, Ministry of Health, Oman salah.awaidy@gmail.com.', 'Acting Director, Department of Communicable Disease Surveillance & Control, DGHA, Ministry of Health, Oman.', 'Epidemiologist Advisor, Department of Communicable Disease Surveillance & Control, DGHA, Ministry of Health, Oman.', 'Vaccine Preventable Diseases Surveillance National Focal Point, Department of Communicable Disease Surveillance & Control, DGHA, Ministry of Health, Oman.', 'Public Health Lab Advisor, Central Public Health Laboratory, DGHA, Ministry of Health, Oman.', 'Head of Virology Section, Central Public Health Laboratory, DGHA, Ministry of Health, Oman.', 'Epidemiologist, Department of Communicable Disease Surveillance & Control, DGHA, Ministry of Health, Oman.']",['eng'],['Journal Article'],20140703,England,Trop Doct,Tropical doctor,1301706,,IM,"['Adolescent', 'Adult', 'Dengue/*epidemiology/mortality/prevention & control', 'Dengue Virus', 'Female', 'Humans', 'Male', 'Middle Aged', 'Oman/epidemiology', 'Retrospective Studies', 'Risk Factors', 'Travel Medicine']",,2014/07/06 06:00,2015/05/29 06:00,['2014/07/05 06:00'],"['2014/07/05 06:00 [entrez]', '2014/07/06 06:00 [pubmed]', '2015/05/29 06:00 [medline]']","['0049475514541650 [pii]', '10.1177/0049475514541650 [doi]']",ppublish,Trop Doct. 2014 Oct;44(4):190-5. doi: 10.1177/0049475514541650. Epub 2014 Jul 3.,4,"['(c) The Author(s) 2014 Reprints and permissions:', 'sagepub.co.uk/journalsPermissions.nav.']",['NOTNLM'],"['Dengue fever', 'disease control', 'disease prevention', 'epidemiology', 'viral infection']",,,,,,,,,,,,,,,,,,,
7969002,NLM,MEDLINE,19941209,20080214,0149-2195 (Print) 0149-2195 (Linking),43,1994 Nov 25,"Dengue fever among U.S. military personnel--Haiti, September-November, 1994.",845-8,,"Since September 19, 1994, approximately 20,000 U. S. military personnel have been deployed to Haiti as part of Operation Uphold Democracy. To monitor the occurrence of mosquitoborne illnesses (including dengue fever [DF] and malaria) among deployed military personnel, on September 19 the U. S. Army established a surveillance system for febrile illness. Before deployment, all military personnel were instructed to take antimalarial chemoprophylaxis, either chloroquine phosphate (500 mg weekly) or doxycycline (100 mg daily). This report summarizes surveillance findings for September 19-November 4.(ABSTRACT TRUNCATED AT 250 WORDS)",,,,,['eng'],['Journal Article'],,United States,MMWR Morb Mortal Wkly Rep,MMWR. Morbidity and mortality weekly report,7802429,,IM,"['Dengue/diagnosis/*epidemiology', 'Haiti/epidemiology', 'Humans', '*Military Personnel', 'Serologic Tests', 'United States']",,1994/11/25 00:00,1994/11/25 00:01,['1994/11/25 00:00'],"['1994/11/25 00:00 [pubmed]', '1994/11/25 00:01 [medline]', '1994/11/25 00:00 [entrez]']",,ppublish,MMWR Morb Mortal Wkly Rep. 1994 Nov 25;43(46):845-8.,46,,,,,,,,,,,,,,,,,['Centers for Disease Control and Prevention (CDC)'],,,,,
24463831,NLM,MEDLINE,20140923,20200825,2972-4066 (Electronic) 0304-4602 (Linking),42,2013 Dec,Haze and dengue: the unanswered questions.,687-8,,,"['Wilder-Smith, Annelies', 'Earnest, Arul', 'Ma, Stefan', 'Ng, Leeching']","['Wilder-Smith A', 'Earnest A', 'Ma S', 'Ng L']",,"['Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.']",['eng'],['Journal Article'],,Singapore,Ann Acad Med Singap,"Annals of the Academy of Medicine, Singapore",7503289,['0 (Air Pollutants)'],IM,"['*Air Pollutants', 'Dengue/epidemiology/*transmission', 'Disease Notification', 'Humans', 'Models, Theoretical', 'Singapore/epidemiology']",,2014/01/28 06:00,2014/09/24 06:00,['2014/01/28 06:00'],"['2014/01/28 06:00 [entrez]', '2014/01/28 06:00 [pubmed]', '2014/09/24 06:00 [medline]']",,ppublish,Ann Acad Med Singap. 2013 Dec;42(12):687-8.,12,,,,,,,,,,,,,,,,,,,,,,
31075425,NLM,MEDLINE,20191024,20191024,1873-0442 (Electronic) 1477-8939 (Linking),30,2019 Jul-Aug,"Yellow fever (YF) vaccination does not increase dengue severity: A retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region.",25-31,S1477-8939(18)30247-3 [pii] 10.1016/j.tmaid.2019.05.002 [doi],"BACKGROUND: We study the association between prior yellow fever immunization and clinical outcomes of dengue infections in individuals of varying sexes and ages. Serological interactions between dengue virus and other flaviviruses could drive antibody dependent enhancement, which is associated with disease severity in dengue infections. This effect may influence disease severity in individuals subsequently affected by related flaviviruses, such as dengue. We compare the severity of dengue episodes between patients vaccinated and non-vaccinated against yellow fever. METHODS: We evaluated the severity of 11,448 lab-confirmed dengue cases reported in Sao Jose do Rio Preto, Brazil, in 7370YF vaccinated patients compared to 4043 unvaccinated patients. We regressed dengue severity against YF vaccine status and a number of demographic, clinical, and laboratory variables as controls. We also evaluated the association between YF vaccination status and the clinical and laboratory symptoms of dengue patients. RESULTS: We did not find any evidence of increased risk for severe dengue in patients vaccinated against YF (odds ratio=1.00; 95% confidence interval=0.87-1.14). Most of the variables analyzed did not have a statistically significant association with YF vaccination status. CONCLUSIONS: We found no evidence that YF vaccination in dengue-endemic areas increases the risk of severe dengue fever.","['Luppe, Marina Jolli', 'Verro, Alice Tobal', 'Barbosa, Alana S', 'Nogueira, Mauricio L', 'Undurraga, Eduardo A', 'da Silva, Natal S']","['Luppe MJ', 'Verro AT', 'Barbosa AS', 'Nogueira ML', 'Undurraga EA', 'da Silva NS']",,"['Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil.', 'Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil; Laboratorio de Modelagens Matematica e Estatistica em Medicina, Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil.', 'Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil.', 'Laboratorio de Pesquisa em Virologia, Faculdade de Medicina de Sao Jose do Rio Preto, Av. Brigadeiro Faria Lima, 5416. Vila Sao Pedro, 15090-000, Sao Jose do Rio Preto, SP, Brazil.', 'Escuela de Gobierno, Pontificia Universidad Catolica de Chile, Vicuna Mackenna 4860, Macul CP, 7820436, Santiago, Region Metropolitana, Chile.', 'Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil; Laboratorio de Modelagens Matematica e Estatistica em Medicina, Faculdade de Medicina, Uniao das Faculdades dos Grandes Lagos, Rua Dr. Eduardo Nielsem, 960 Jardim Novo Aeroporto, 15030-070, Sao Jose do Rio Preto, Sao Paulo, Brazil; Laboratorio de Pesquisa em Virologia, Faculdade de Medicina de Sao Jose do Rio Preto, Av. Brigadeiro Faria Lima, 5416. Vila Sao Pedro, 15090-000, Sao Jose do Rio Preto, SP, Brazil. Electronic address: natalss@gmail.com.']",['eng'],['Journal Article'],20190508,Netherlands,Travel Med Infect Dis,Travel medicine and infectious disease,101230758,['0 (Yellow Fever Vaccine)'],IM,"['Adolescent', 'Adult', 'Brazil/epidemiology', 'Child', 'Demography', 'Dengue/diagnosis/epidemiology/immunology/*pathology', 'Female', 'Humans', 'Male', 'Retrospective Studies', 'Risk Factors', 'Severity of Illness Index', 'Yellow Fever Vaccine/*immunology/standards']",,2019/05/11 06:00,2019/10/28 06:00,['2019/05/11 06:00'],"['2018/07/28 00:00 [received]', '2019/04/30 00:00 [revised]', '2019/05/02 00:00 [accepted]', '2019/05/11 06:00 [pubmed]', '2019/10/28 06:00 [medline]', '2019/05/11 06:00 [entrez]']","['S1477-8939(18)30247-3 [pii]', '10.1016/j.tmaid.2019.05.002 [doi]']",ppublish,Travel Med Infect Dis. 2019 Jul-Aug;30:25-31. doi: 10.1016/j.tmaid.2019.05.002. Epub 2019 May 8.,,['Copyright (c) 2019 Elsevier Ltd. All rights reserved.'],['NOTNLM'],"['Dengue', 'Dengue severity', 'Neglected tropical diseases', 'Yellow fever', 'Yellow fever vaccination']",,,,,,,,,,,,,,,,,,,
26732932,NLM,MEDLINE,20170928,20181202,1726-4642 (Electronic) 1726-4634 (Linking),32,2015 Oct,[Differences and similarities in approach of integrated strategy for dengue prevention and control between Colombia and Peru].,801-7,S1726-46342015000400025 [pii],"We analyzed and compared two Integrated Management Strategies for Dengue Prevention and Control (IMS-dengue Colombia and IMS-dengue Peru), through a narrative review of available literature, in order to identify common and dissimilar patterns in two Andean countries with epidemiological differences in the context of dengue disease. We were able to identify differences related to: formal assessment of problem, formation of groups of actors, and quantitative information provided by performance indicators. These limitations identified in IMS-dengue Colombia 2006-2010 were overcome in a new version of the strategy (IMS-dengue Colombia 2012-2021). We were able to document an epidemiological impact of implementation of IMS-dengue Colombia 2006-2010. Additionally, a gradual increase was observed in incidence rates of dengue cases that could be related to the strengthening of surveillance system of IMS- dengue Peru.","['Castro-Orozco, Raimundo', 'Alvis-Guzman, Nelson', 'Gomez-Arias, Ruben']","['Castro-Orozco R', 'Alvis-Guzman N', 'Gomez-Arias R']",,"['Universidad de San Buenaventura, Cartagena de Indias, Colombia.', 'Universidad de San Buenaventura, Cartagena de Indias, Colombia.', 'Universidad de Antioquia, Medellin, Colombia.']",['spa'],['Journal Article'],,Peru,Rev Peru Med Exp Salud Publica,Revista peruana de medicina experimental y salud publica,101227566,,IM,"['Colombia/epidemiology', 'Dengue/epidemiology/*prevention & control', 'Humans', 'Incidence', 'Peru']",,2016/01/07 06:00,2017/09/29 06:00,['2016/01/07 06:00'],"['2015/05/18 00:00 [received]', '2015/09/02 00:00 [accepted]', '2016/01/07 06:00 [entrez]', '2016/01/07 06:00 [pubmed]', '2017/09/29 06:00 [medline]']",['S1726-46342015000400025 [pii]'],ppublish,Rev Peru Med Exp Salud Publica. 2015 Oct;32(4):801-7.,4,,,,,,,,,Diferencias y similitudes entre las estrategias de gestion integrada para la prevencion y control del dengue en Colombia y Peru.,,,,,,,,,,,,,
